<SEC-DOCUMENT>0001628280-22-012595.txt : 20220506
<SEC-HEADER>0001628280-22-012595.hdr.sgml : 20220506
<ACCEPTANCE-DATETIME>20220505154733
ACCESSION NUMBER:		0001628280-22-012595
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220505
DATE AS OF CHANGE:		20220505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			InfuSystem Holdings, Inc
		CENTRAL INDEX KEY:			0001337013
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				203341405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35020
		FILM NUMBER:		22895920

	BUSINESS ADDRESS:	
		STREET 1:		3851 WEST HAMLIN ROAD
		CITY:			ROCHESTER HILLS
		STATE:			MI
		ZIP:			48309
		BUSINESS PHONE:		(248) 291-1210

	MAIL ADDRESS:	
		STREET 1:		3851 WEST HAMLIN ROAD
		CITY:			ROCHESTER HILLS
		STATE:			MI
		ZIP:			48309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HAPC, Inc.
		DATE OF NAME CHANGE:	20060425

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Healthcare Acquisition Partners Corp.
		DATE OF NAME CHANGE:	20050824
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>infu-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9c45a9a1-f9a1-46d4-ab6e-c84379cf91bb,g:e62fa09c-9414-4caa-b36a-5012b4171a20,d:f7e56f0d6eeb4fafa9d6d38963769ac3--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:infu="http://infusystem.com/20220331" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>infu-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY18zLTEtMS0xLTkwNjY1_86ef5074-17f9-4867-bc06-331c331e527f">0001337013</ix:nonNumeric><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY180LTEtMS0xLTkwNjY1_3c63fa86-83c4-4a59-9db8-509fd0fe9302">false</ix:nonNumeric><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY181LTEtMS0xLTkwNjY1_66854a5a-0c1b-4bab-aae1-3b4eae374522">December 31</ix:nonNumeric><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY182LTEtMS0xLTkwNjY1_ddfaff17-7de0-4353-aff0-14d280add087">Q1</ix:nonNumeric><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY183LTEtMS0xLTkwNjY1_91b2894f-adcf-451d-b2f1-d853eed5e263">2022</ix:nonNumeric><ix:nonNumeric contextRef="icfcd91dfbd3b4861afdcf33774cf868a_I20220331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMzUz_c5ee57a4-2e68-4541-8653-b24cb86c7ae1">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="infu-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1afb9f64c12245cfbcdf7e70f7a26741_I20220429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i01f05e29baa14bd0a757fcfc29360491_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i25f33d209715440fbb5be414480b1768_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb95b32e4654392b07c0102083ff1de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e27a3a029534186a1f04cd4900ea788_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7f89d0d1f4445978bf16c0f5f8792ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95bc362b5d314368999d043bce1b654a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if785a73c71834ed59f0446734c77df79_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf436762a17484ebfcec7f989d83620_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30e45981adc34974b1489e559c4a7b7b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if578c620ff804879877d88b6707147d7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i100e31c2a3f141098462c1bae67f7c14_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd4cfb7b4b0a448ea084cf971ba89514_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8f287da32c34a4382931967c22f2986_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b643b684c364bcd8ec30529ba06e134_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ca1cca292344a08bf352fbd442ee45_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2be1d671b114cf08009f612708ee32e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i247580c074ba4302b7e3c71ddea3bae5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963ea4ed6904434cba81f9b35544822a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99185486b44a43db8dee855c0e2e3a15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie03f91b078594271bd4e14d68978bf06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c341c2ae934d3897c08cd614b84edb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c477f12061c46b79bd5fb63d4373a4e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia35e3080b1b8404cba8a212ab094986f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ef62092fb404ae79ccb143d6c18f047_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8003ee2c2474deca1adb94e55f98442_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19444b1c10474d8490f92d04a10e148f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2aa136b42f543bb8d61228fb3ab265f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib951efad10c64237873bd1580ccacf5b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7876b1efc8a54b39b1afc22d1abf2ec0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf5aee4ba8347b58d13695506bc288c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42616323608f4b44a460de02c3482936_D20210131-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:FilAMedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-31</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-18</xbrli:startDate><xbrli:endDate>2021-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i751082717be544698a176938b3add8c3_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:FilAMedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ede16521fc64b74b1f49fe77c8a9798_D20210419-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-19</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7797bc0f95b940b39aa0182a7088eb53_I20210418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6070f50a0324f03942b82573c417cdf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4990fd3a38c4f3eb1d7099fb3c52dff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id82fee9ebb5a42a9890e2723157a39ae_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fffd8c4d1c944babfd356c6577863a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie996aa5ccd674a0d8c3da996d58461d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9485abe60939498a8c78a8987d9934b6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d5f226368ed474b99f5057977d175c1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fbe9dbc0da14959be7205dd13d84c0b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e029b8ec12f40869e606cbefce19746_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2e5ce00d4ed4d9a97f7aed53faa1ff6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ThirdPartyPayerRentalRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if49785589581493ebb90d7a0199ea525_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ThirdPartyPayerRentalRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if8ef7499ada54e7e9ad7851db5747696_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ThirdPartyPayerRentalRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb56702f67294df0b173f365472c73ca_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ThirdPartyPayerRentalRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4982a0329516423a9136efc7957f9aab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29edb7af843f4319acdf73d40cbd3a19_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff148b282eb4181803b5f6562d8734a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i447d77e0640e4266805ed52d0e06d21b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44bc98dc84754947aca9ffc1d3e8bbf0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76aeb4498a0b4c5889d9b44b13e75ebb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ProductSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3db6d103273445e8e1f89920aa09ed6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dca92952a174b78b27dc46eeaa65d99_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ProductSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7f79ccd7d5f40ae837e2fafc736606e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a7c684f949741a3981a761e9bbcbf9d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf3c886d74bc45548114cbfdf0c6983b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea3ee5aa2d194f4c8a4c459c8fc91b98_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27169791ade7453ea172c0da7b9f2a47_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1822b59343e4f53b58f3e3f7280600e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4fd38174ba44b03a584466ebe9ab057_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60c58188de1b4fc3af027ccbcd0a1fb3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8204bc432ee142d3bad5b48145ed8618_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55927c5429ab4da4b5c134d3ea056150_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5095ccbbd602407d910da1f13f5d8d6d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a16fc3aeb5143d2908ebc833b38ed1d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab9576cec45e4a449fa940366d43de5c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb1bc7267ab4f3b8a2ba31c8f332d5f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef9d8e70d0d44f6881d0cc953b6c86c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d32500896b341cb86356b976a1a7e6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc6296cc506a4da2b9d7da01f0ce124c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16ee9bf588434522bd80adcc901d4ef9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic700dbf08af94b2eae2ba16cb3c059e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd7edbf7b2bd4b21aa91040e49a07b37_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d3f2b23fb394007a3aae9607cd8f47d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53c7ee1171d34f9ead27a9700cd1fcf4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69120393fdcf4f98b5f3643efcf1ba48_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfb5ef2d8f814683800aefa4d847067f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2007dc85e9fb4c4eb7d1a818c44c551b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3955a41377c6464b8b96323f2127c3ac_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1511ac8ff546a283d31d4c98b6133f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ed66385f90b4519b38d4183d11d53b9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5adc6accdfb4947bc052bfbd05a41a4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b34086db73244b8b360acb9f538d2ac_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9db5ef6e072245c6836ab464e21b81d6_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i280422ec877d4871b85139ef7dab2895_D20210205-20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88c67caf15574e31981968dbcfd092ba_D20210205-20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2015CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11787656cdd7485983ece34ada8d626d_D20210205-20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5755350e04f34d40bf1835b45c2e72c7_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdfe551e6db54288aab0d8b7eaf87872_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2015CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c5050671c134292bc772cc44ffea56a_I20190415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3149a0ad24134e48ad364d402109026e_D20190415-20190415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-15</xbrli:startDate><xbrli:endDate>2019-04-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33b5522177ae46f8a72045d13d78d239_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c1fe4e839584747a8e98242a4f539a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if15ae0b27a6244e18335b6d84819ccdd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7be2e6385d2e4a1f81cede9f9325baf4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6870ed273a94fee99d887c2cff01c3b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31619f4fd16547b6a88ad77ca83de2b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i621754a0bc234c319f31862d80d9e6bf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i648fe53f400e4a9fa1260cef7c260580_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4114f950c2d4190904d6635dfffe982_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcc44660e52943efa3af89d8516b33e7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cfd39a0ac8040ccb08858cf8fa5bf15_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46375b7fb651451ea71759de00ad04f8_I20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="numberofagreement"><xbrli:measure>infu:numberOfAgreement</xbrli:measure></xbrli:unit><xbrli:context id="i18d15197765c4fbe87a2fbc20e38f379_D20210205-20210205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i718b8b354a364afc9026b010eb60129b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11453ba9eaac46c4bb4e7d291baadf1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93ef1df061524c8b9663782244eb5d30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf2eab998bda4fbd8fbc14723f4850ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i085e4370af544db9a0d15a2675df534e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cdfd77a386045118c342ea3d171f086_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0066368dfe234730a0ec98982a4f6be1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib91337cd039b4e1fb73ba260c56f4232_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b1ca0fa1a4549d0b3d620aeaa0f1a50_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97d7dd5690f147b482bf2fe489cfcf4a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c35755c8447450b8e419647303eac4d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17cfc9c479c543688ef515f286847c44_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0649b764378d49608401c1e982e219f9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad5338f58cd45369e7740b50719ff1d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfcd91dfbd3b4861afdcf33774cf868a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9823e66bcb094044aa90984c93101af3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3eb1c6975d549109036d441a4208693_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7948825b6e95471c8a412984f797602e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i814be89047894da9a58c9f276f7bd602_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e9dc825e4341c0b5c96f30ce2f3772_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b961b3af684edb8219f8ad50fba90b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f1cbecf89194e0ebc676764e029ed03_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ace98423094ec1812718f76386b5e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001337013</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;padding-left:7.2pt;padding-right:7.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">WASHINGTON, D.C. 20549</span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.052%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg5_f6c09de6-a419-4d28-9957-371ee183753a">10-Q</ix:nonNumeric></span></div><div style="margin-top:12pt;padding-left:7.2pt;padding-right:7.2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.052%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTkw_fb1c2a36-8acf-43f6-8386-a7a0d76b559b">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Quarterly Report Pursuant to Section</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">for the quarterly period ended <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTQ_f046ff34-b6fe-4b73-bd95-19a4e8619dc2">March&#160;31, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTkx_9567b53b-ec63-4011-ae49-061ca3e1026c">&#168;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> &#160;&#160;&#160;&#160;Transition Report Pursuant to Section</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">for the transition period from _____ to _____</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk0_48054590-965c-4eaf-ad7a-a2a7588d8e7d">001-35020</ix:nonNumeric></span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><img src="infu-20220331_g1.jpg" alt="infu-20220331_g1.jpg" style="height:76px;margin-bottom:5pt;vertical-align:text-bottom;width:238px"/></div><div style="margin-top:6pt;padding-left:3.6pt;padding-right:3.6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.052%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk1_33cdc0a1-9361-4cb4-99f7-2ae742484944">INFUSYSTEM HOLDINGS, INC</ix:nonNumeric>.</span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt;padding-left:3.6pt;padding-right:3.6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.052%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:58.991%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDc2MDI2M2FiNzg3NDE3YmFkODg3OGM3ZGQ1YTdmOTcvdGFibGVyYW5nZTowNzYwMjYzYWI3ODc0MTdiYWQ4ODc4YzdkZDVhN2Y5N18wLTAtMS0xLTkwNjY1_f2dad4fd-e65a-40c2-b4a7-4b7b5445aa5a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDc2MDI2M2FiNzg3NDE3YmFkODg3OGM3ZGQ1YTdmOTcvdGFibGVyYW5nZTowNzYwMjYzYWI3ODc0MTdiYWQ4ODc4YzdkZDVhN2Y5N18wLTEtMS0xLTkwNjY1_1ddfe07d-823c-4a51-83c6-15a7c3a61535">20-3341405</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(State or Other Jurisdiction of</span></div><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Incorporation or Organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(I.R.S. Employer</span></div><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg1_3aac69d2-77f0-4790-8d06-aacf70c8a0d2">3851 West Hamlin Road</ix:nonNumeric></span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk2_3c01c8e3-fae5-4052-9386-b6b8246714c0">Rochester Hills</ix:nonNumeric>, <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTkz_05657b67-1faa-46b1-9000-1ffa6a161800">Michigan</ix:nonNumeric> <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk3_14d4dc63-a1b9-4c9a-b2dc-bcd9b1b4a509">48309</ix:nonNumeric></span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Address of Principal Executive Offices)</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">s Telephone Number, including Area Code: (<ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk5_9887480d-38bd-461c-b9be-7891f1830c7b">248</ix:nonNumeric>) <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg2_9ca12c93-5cb8-4fe4-9f55-2b4d2958b4b4">291-1210</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:3.6pt;padding-right:3.6pt;text-align:center;text-indent:25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.052%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Securities Registered Pursuant to Section</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">12(b) of the Act: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.966%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 9.68pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 7.2pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 8.44pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Name of Each Exchange on which Registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 9.68pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDA4NmUzMGY1YzkwNDViYmEwMTliMGRlZmQwNTRhZDIvdGFibGVyYW5nZTowMDg2ZTMwZjVjOTA0NWJiYTAxOWIwZGVmZDA1NGFkMl8xLTAtMS0xLTkwNjY1_906d15e0-8e96-4795-9c75-c8f159cf85c7">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 7.2pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDA4NmUzMGY1YzkwNDViYmEwMTliMGRlZmQwNTRhZDIvdGFibGVyYW5nZTowMDg2ZTMwZjVjOTA0NWJiYTAxOWIwZGVmZDA1NGFkMl8xLTEtMS0xLTkwNjY1_a109a582-c480-4250-9975-11f9e274aa7c">INFU</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 8.44pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDA4NmUzMGY1YzkwNDViYmEwMTliMGRlZmQwNTRhZDIvdGFibGVyYW5nZTowMDg2ZTMwZjVjOTA0NWJiYTAxOWIwZGVmZDA1NGFkMl8xLTItMS0xLTkwNjY1_6581aecf-c451-4c7a-9a8d-f1baab4f98db">NYSE American LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk4_2eb42296-0e33-43cc-ae0a-8b76fcd7b489">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg3_64bf6af2-350d-483e-a3e5-f8ea3116b5ad">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"></td><td style="width:24.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.884%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.138%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.920%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Large accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6Njc4NTNhOWRiYTgxNGMwM2I2ODJjMzA4NDA5MWFjNDkvdGFibGVyYW5nZTo2Nzg1M2E5ZGJhODE0YzAzYjY4MmMzMDg0MDkxYWM0OV8wLTQtMS0xLTkwNjY1_973a9c3b-1272-47db-ac38-2fa0065dc322">Non-accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6Njc4NTNhOWRiYTgxNGMwM2I2ODJjMzA4NDA5MWFjNDkvdGFibGVyYW5nZTo2Nzg1M2E5ZGJhODE0YzAzYjY4MmMzMDg0MDkxYWM0OV8wLTctMS0xLTkwNjY1_753a2cff-b0da-4896-9361-fded6ec9fda9">x</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6Njc4NTNhOWRiYTgxNGMwM2I2ODJjMzA4NDA5MWFjNDkvdGFibGVyYW5nZTo2Nzg1M2E5ZGJhODE0YzAzYjY4MmMzMDg0MDkxYWM0OV8yLTEtMS0xLTkwNjY1_ae3617d2-201b-4347-8c89-7ecc2137296d">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg4_44444032-4def-4c86-93e9-11e1fa51e837">&#168;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;29, 2022, <ix:nonFraction unitRef="shares" contextRef="i1afb9f64c12245cfbcdf7e70f7a26741_I20220429" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMDk0_29b6b7a9-6f2f-4263-8508-03f2cb87ce94">20,540,143</ix:nonFraction> shares of the registrant&#8217;s common stock, par value $0.0001 per share, were outstanding.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Form 10-Q </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">PAGE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_10">PART I -</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_10">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16">&#160;-Unaudited Condensed Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16"> and December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">&#160;-Unaudited Condensed Consolidated Statements of Operations and Comprehensive </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">Income for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22">&#160;-Unaudited Condensed Consolidated Statements of Stockholders&#8217; Equity for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25">&#160;-Unaudited Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25">three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_28">&#160;-Notes to the Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_76">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_76">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_100">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_100">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_100">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_103">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_103">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_103">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_106">PART II -</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_106">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_109">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_109">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_109">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_112">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_112">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_112">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_115">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_115">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_115">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_118">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_118">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_118">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_121">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_121">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_121">30</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_124">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_124">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_124">30</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_127">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_127">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_127">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_130">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_130">32</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL INFORMATION</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_13"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">As of</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">in thousands, except par value and share data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNS0xLTEtMS05MDY2NQ_609176f6-38ad-4e94-b2b1-00870c39d212">405</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNS0zLTEtMS05MDY2NQ_f313ec8a-801f-48b1-b1cd-dc7bd1f4a3ef">186</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNi0xLTEtMS05MDY2NQ_5c75fd94-7713-4107-aa00-73de703c2987">16,392</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNi0zLTEtMS05MDY2NQ_1b46c591-72d4-405b-afe4-94baf80ee54e">15,405</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNy0xLTEtMS05MDY2NQ_54a1351d-f267-407c-a69f-1c71b6fc3c42">3,878</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNy0zLTEtMS05MDY2NQ_d218ba42-9714-466c-8f4c-f7b466fc7bb0">3,939</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfOC0xLTEtMS05MDY2NQ_335ff290-9da6-4995-b714-fd9dc54b5a42">2,585</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfOC0zLTEtMS05MDY2NQ_d519ee30-3fd4-402f-8428-92a55da9ffd2">2,535</ix:nonFraction></span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTAtMS0xLTEtOTA2NjU_fbdbd219-f9c8-4d5c-9642-e461c2f61bc5">23,260</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTAtMy0xLTEtOTA2NjU_f2fc8e53-c1e6-4363-829a-453c28b3af74">22,065</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRental" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTEtMS0xLTEtOTA2NjU_73a3e3f3-58c5-4c9c-b530-3ce313a060f5">1,987</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRental" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTEtMy0xLTEtOTA2NjU_83f04904-55ef-48ec-af39-2b1ce5da18b2">1,742</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service, net of accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTItMS0xLTEtOTA2NjU_86aaf035-57c3-4261-8f22-1492518f6730">39,113</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTItMy0xLTEtOTA2NjU_1f5e0ad9-1573-403d-8ff4-fc7eef7aa6ac">39,871</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property &amp; equipment, net of accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTMtMS0xLTEtOTA2NjU_d0e4643c-2c6b-4322-8cd7-1b62adeddb82">4,375</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTMtMy0xLTEtOTA2NjU_940ad6d6-1703-46fa-8f5f-cc8a55dd4c8c">4,523</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTQtMS0xLTEtOTA2NjU_2548af0d-9071-4d2a-9a15-38a6d99ed3af">3,710</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTQtMy0xLTEtOTA2NjU_892d4d9d-f537-4797-930b-5c280f03034e">3,710</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTUtMS0xLTEtOTA2NjU_970f8880-66ed-432b-8b9c-3a4ae2568744">10,219</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTUtMy0xLTEtOTA2NjU_0c16d4f1-3437-4569-add2-489546e7d639">10,930</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTYtMS0xLTEtOTA2NjU_6bc0fe55-219e-4890-b434-fa96be3945ca">3,916</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTYtMy0xLTEtOTA2NjU_07a48c1e-ec72-4c88-8d87-5c020038d35d">4,241</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTctMS0xLTEtOTA2NjU_cfd0afd0-0045-44ba-9a0d-7dc118981775">10,277</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTctMy0xLTEtOTA2NjU_57afc885-763e-487c-accc-abd9ff534da7">10,033</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTgtMS0xLTEtOTA2NjU_863b8e78-1ebe-417b-ae38-037aee5028d2">1,380</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTgtMy0xLTEtOTA2NjU_9381bfdb-2fad-4a02-918c-d963ff373068">471</ix:nonFraction></span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjAtMS0xLTEtOTA2NjU_8135d2be-7ae4-4412-aa38-f515f020781b">98,237</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjAtMy0xLTEtOTA2NjU_08e6f695-e136-460d-8259-774a85dae4fc">97,586</ix:nonFraction></span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">LIABILITIES AND STOCKHOLDERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> EQUITY</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjQtMS0xLTEtOTA2NjU_453a1282-4920-4990-8585-bb035d0fe132">8,242</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjQtMy0xLTEtOTA2NjU_157ae14d-eef0-44d7-ae4b-71dca4dbdda6">7,862</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjUtMS0xLTEtOTA2NjU_079881b8-4036-4c05-a79f-50be9034ae66">156</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjUtMy0xLTEtOTA2NjU_53e09b52-c0dd-424e-91e6-7aec5e0bb3e4">349</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjYtMS0xLTEtOTA2NjU_6f15e147-31d8-45ee-babf-cc87377a74fa">5,543</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjYtMy0xLTEtOTA2NjU_174636b8-a73c-47c9-aba8-cea5cfee97ae">4,685</ix:nonFraction></span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjgtMS0xLTEtOTA2NjU_f98e4986-c1ba-458e-82c4-2a624d48b38a">13,941</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjgtMy0xLTEtOTA2NjU_03259216-8edd-450a-8050-77813a130e87">12,896</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Long-term debt, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjktMS0xLTEtOTA2NjU_1c0e596f-8631-468e-8c19-1de2c18cc1ef">34,792</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjktMy0xLTEtOTA2NjU_5fff6592-c38c-47cf-905e-c071b134a31e">32,748</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzEtMS0xLTEtOTA2NjU_754babbf-c78a-4656-8ec5-6f2c015583d2">3,451</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzEtMy0xLTEtOTA2NjU_b5b8c836-d195-4a63-bbe5-c3e0257026ae">3,670</ix:nonFraction></span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzMtMS0xLTEtOTA2NjU_67c5801b-0158-4535-aa63-a4c1672a7c4e">52,184</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzMtMy0xLTEtOTA2NjU_2c4edd79-8642-4e9c-9376-0504466e869c">49,314</ix:nonFraction></span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV8yMQ_3d3dac30-28ea-4fcd-92b8-c96474249229"><ix:nonFraction unitRef="usdPerShare" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV8yMQ_def5e16c-d455-43b9-946e-c6b3ea3bde17">0.0001</ix:nonFraction></ix:nonFraction> par value: authorized <ix:nonFraction unitRef="shares" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV80Ng_3938d12c-d72e-4dc6-8ab4-597c2a682530"><ix:nonFraction unitRef="shares" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV80Ng_d8c9c00f-7d03-47f1-ad5e-3f770d099ea4">1,000,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV81Nw_70f6b2be-6881-47bd-80ae-29e710ecac58"><ix:nonFraction unitRef="shares" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV81Nw_a91e83bf-5e46-4f2c-bfc9-25c4a64e9c23">none</ix:nonFraction></ix:nonFraction> issued</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMS0xLTEtOTA2NjU_44254a10-dd3a-4419-b17f-13c7c6c1479b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMy0xLTEtOTA2NjU_3679b09d-8655-4ebc-bc7c-27e0450f3321">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9.07pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF8xOA_7eac2b7f-09bb-4a15-ad7f-55ad2e62345f"><ix:nonFraction unitRef="usdPerShare" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF8xOA_f6689456-6268-4d43-9d29-d81368cd4c7a">0.0001</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="shares" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF80Mw_14fcdcf5-3d2d-4118-a880-6a411c619706"><ix:nonFraction unitRef="shares" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF80Mw_a01c9329-cf4c-4960-be6f-606749fa31e9">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF83Nw_90c9c187-f800-4401-b3cb-b59f01ec2d40"><ix:nonFraction unitRef="shares" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF83Nw_e2988d46-be32-4d2d-b456-97d019fd91e6">20,540,143</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF8xMzk_3bfe2a83-48ff-4c44-a2d7-6c63839a677f"><ix:nonFraction unitRef="shares" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF8xMzk_90994a86-ebc8-45ff-9cbc-04ccbc2bcf9d">20,699,546</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMS0xLTEtOTA2NjU_bafc0227-8cb7-4af0-ae21-a92004986b20">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMy0xLTEtOTA2NjU_96e994a4-0ed0-4d70-8f72-7fd354b45064">2</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzgtMS0xLTEtOTA2NjU_611ecbf5-b5dc-4abe-af4a-5df4702e2dfb">103,373</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzgtMy0xLTEtOTA2NjU_74e5ec39-c0f1-4069-a7ba-86c1873c2927">101,905</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzktMS0xLTEtOTA2NjU_9c5c93e8-5e0d-489a-aa30-cff1c57d5dbd">955</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzktMy0xLTEtOTA2NjU_9b6cba1d-9b17-479e-843d-510f7df790d5">268</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Retained deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDAtMS0xLTEtOTA2NjU_61538889-b666-41d5-8bfd-befb795eda9d">58,277</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDAtMy0xLTEtOTA2NjU_ce00e52a-d5c2-4dec-89bf-f94165b95b97">53,903</ix:nonFraction>)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDItMS0xLTEtOTA2NjU_83584b98-114a-4cb4-be84-40c37bb79a81">46,053</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDItMy0xLTEtOTA2NjU_044ebe86-7a00-4b5e-aadc-1d5768f306a6">48,272</ix:nonFraction></span></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDQtMS0xLTEtOTA2NjU_06297913-216b-472f-aa8a-f295280c3df9">98,237</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDQtMy0xLTEtOTA2NjU_cc6eeaea-a5a5-4312-883c-42921d1a72fa">97,586</ix:nonFraction></span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES</span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(UNAUDITED)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%;text-decoration:underline">in thousands, except share and per share data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">)</span></div></td><td colspan="9" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMy0xLTEtMS05MDY2NQ_9e7d5c58-78fb-470e-95f6-1df83bda63bc">26,763</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMy0zLTEtMS05MDY2NQ_25fabb09-8953-4162-8541-ffeba4bb3f7b">24,463</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfNC0xLTEtMS05MDY2NQ_f075dcce-18db-491e-8543-edf82fa565d7">11,396</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfNC0zLTEtMS05MDY2NQ_e4abbe12-9b34-4418-a9ee-09362fb09306">9,887</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfNS0xLTEtMS05MDY2NQ_d1029787-7006-4787-9d92-b8b976cea0e4">15,367</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfNS0zLTEtMS05MDY2NQ_49c5941d-3f47-4583-84ae-0ed9e7d3acbd">14,576</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provision for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfOC0xLTEtMS05MDY2NQ_2f21af91-d848-47cf-adc3-91ee372cec34">47</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfOC0zLTEtMS05MDY2NQ_8d4b8eaa-a1a2-4020-abe0-bae21e011a04">70</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfOS0xLTEtMS05MDY2NQ_4f82d6f3-3fab-43ec-bcac-59fdf353c3ac">710</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfOS0zLTEtMS05MDY2NQ_f66deac8-26c6-47de-9f8f-00eeb0232995">1,043</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTAtMS0xLTEtOTA2NjU_1dfb7f84-db86-4c12-a7c5-501687ffa054">3,319</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTAtMy0xLTEtOTA2NjU_c1f4039b-b8c1-47d5-93c9-b944388b8fe5">2,376</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTEtMS0xLTEtOTA2NjU_f4e9be76-cc87-4b0c-a6ad-99a1f9d28ce4">11,816</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTEtMy0xLTEtOTA2NjU_7c8309a1-1022-4e78-9eba-1c0727d45fda">10,354</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total selling, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTMtMS0xLTEtOTA2NjU_7ac53f72-55f1-4190-8eeb-cabcabf2ea2d">15,892</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTMtMy0xLTEtOTA2NjU_6757be46-30d6-4e70-b56b-b3b5eb1420cd">13,703</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTUtMS0xLTEtOTA2NjU_c63d3c88-cd7a-4d06-a64a-b281f5603143">525</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTUtMy0xLTEtOTA2NjU_57f6b05f-5394-4263-b906-1dbf6932a179">873</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTctMS0xLTEtOTA2NjU_e0e5f54a-d16e-4fd8-9526-3cf383fc496f">277</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTctMy0xLTEtOTA2NjU_bda41e6c-c20b-4cba-95fd-7bd057c9be8b">322</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTgtMS0xLTEtOTA2NjU_63060600-db78-4aa7-ba52-e352ebe431ad">28</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTgtMy0xLTEtOTA2NjU_704e223c-c1ad-4d9f-93e2-3a0d586b4b99">69</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Loss) income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjAtMS0xLTEtOTA2NjU_ca34d7fe-2d1f-4b99-9294-e3acb7adf30e">830</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjAtMy0xLTEtOTA2NjU_a0ba5cf4-fef0-4365-9fb7-aac7164e3146">482</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjEtMS0xLTEtOTA2NjU_451a92a3-f57e-48ac-8c30-131731e961e9">462</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjEtMy0xLTEtOTA2NjU_b7943e31-6339-405e-9e44-1c71179a7ab1">179</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjItMS0xLTEtOTA2NjU_366bae70-cfae-40d3-9891-2ba7df6a6260">368</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjItMy0xLTEtOTA2NjU_38f99c3d-5193-4adb-b584-0d131d8d8bcd">661</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income per share</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjQtMS0xLTEtOTA2NjU_4a7da7ca-9469-48ca-bb14-879f00ab2552">0.02</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjQtMy0xLTEtOTA2NjU_48876e09-5d8c-4296-8760-08f0bdfa6d8b">0.03</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjUtMS0xLTEtOTA2NjU_cc674984-6814-4487-a45e-ff16abf8c0bb">0.02</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjUtMy0xLTEtOTA2NjU_a108e519-3cdb-477d-ae73-836dc88ebb70">0.03</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjctMS0xLTEtOTA2NjU_1f60d10d-8371-4415-9523-5cb062e1cc1c">20,609,372</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjctMy0xLTEtOTA2NjU_cc552ec5-e3f6-43e3-996a-87296cd4824d">20,338,160</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 46.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjgtMS0xLTEtOTA2NjU_09f028ac-627f-441f-bfa2-bf7898c26311">20,609,372</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjgtMy0xLTEtOTA2NjU_7561116b-c7d4-476a-b7c2-34ff338cc3b2">21,937,639</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzEtMS0xLTEtOTA2NjU_60256dc6-133f-45f4-a08e-715477e860a0">368</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzEtMy0xLTEtOTA2NjU_74298e4a-97a6-4d00-86d4-fec499d691ef">661</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized gain on hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzMtMS0xLTEtOTA2NjU_218f38bf-7489-4cfe-8617-a03115bb11b6">905</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzMtMy0xLTEtOTA2NjU_3b16794f-05ec-4e08-a501-a3b6672a20a8">158</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provision for income tax on unrealized hedge gain</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzQtMS0xLTEtOTA2NjU_22415b58-8e39-4b2e-aa9b-d76dceef729b">218</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzQtMy0xLTEtOTA2NjU_29202c52-5a07-4141-82d3-c7217b8d7e07">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzUtMS0xLTEtOTA2NjU_8787f2ba-ca24-4d8d-9b8f-8a664bd49f6a">319</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzUtMy0xLTEtOTA2NjU_7abb9620-9a79-4e49-95f0-894e92cf59e2">819</ix:nonFraction></span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_22"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES </span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CONDENSED CONSOLIDATED STATEMENTS OF </span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">STOCKHOLDERS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> EQUITY </span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.824%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.039%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.292%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.335%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Additional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Paid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">in Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Retained</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Accumulated Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Comprehensive Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Stockholders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Equity</span></div></td></tr><tr style="height:34pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%">(in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:115%"> thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Par Value Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Par Value Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Balances at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5fb95b32e4654392b07c0102083ff1de_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0yLTEtMS05MDY2NQ_62b3714f-1d52-44cf-830d-4a7096cca45c">23,816</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5fb95b32e4654392b07c0102083ff1de_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi00LTEtMS05MDY2NQ_f1fa6453-4895-4a19-a4aa-3b00761e3544">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i8e27a3a029534186a1f04cd4900ea788_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi02LTEtMS05MDY2NQ_75bfec09-a4cc-4686-b534-36d6329d4f90">84,785</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if7f89d0d1f4445978bf16c0f5f8792ae_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi04LTEtMS05MDY2NQ_a9dad9f1-2316-403c-b1b7-ee45cf4490c6">44,035</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i95bc362b5d314368999d043bce1b654a_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0xMC0xLTEtOTA2NjU_4c1ae0bd-42c6-4d25-84ad-66ff8da102c2">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="if785a73c71834ed59f0446734c77df79_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0xMi0xLTEtOTA2NjU_b60d26f5-801b-4c66-bd2c-00aae6dac794">3,518</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if785a73c71834ed59f0446734c77df79_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0xNC0xLTEtOTA2NjU_b006c7ac-e2a7-410e-9ff6-e2aa787f4bf1">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="idaf436762a17484ebfcec7f989d83620_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0xNi0xLTEtOTA2NjU_4c2f5668-1d19-4369-8827-e6ca7dc60d58">40,752</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based shares issued upon vesting - gross</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i30e45981adc34974b1489e559c4a7b7b_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMy0yLTEtMS05MDY2NQ_9ae951a1-9088-43ef-bf33-7139923eae05">129</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if578c620ff804879877d88b6707147d7_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMy02LTEtMS05MDY2NQ_1439955b-b226-4137-abba-ed2449d17185">139</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMy0xNi0xLTEtOTA2NjU_43f2af56-c6e6-4a3f-a013-669a68d8b341">139</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if578c620ff804879877d88b6707147d7_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNC02LTEtMS05MDY2NQ_ae0e608c-3f40-4ee4-9364-d4fea4e14c3b">1,635</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNC0xNi0xLTEtOTA2NjU_57457a90-e4f2-4ef0-9874-ff237aae62a4">1,635</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if578c620ff804879877d88b6707147d7_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNS02LTEtMS05MDY2NQ_e0fe7f96-4247-4756-9ace-c9de78cf7ff1">169</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNS0xNi0xLTEtOTA2NjU_21ea3def-a4d2-4d64-b1c2-e2ef2260e4aa">169</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="i30e45981adc34974b1489e559c4a7b7b_D20210101-20210331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNi0yLTEtMS05MDY2NQ_aa9fc580-9f12-4d7b-b7e5-ffb7d36686b3">30</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if578c620ff804879877d88b6707147d7_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNi02LTEtMS05MDY2NQ_97ecf72d-010f-4f66-b20d-a0aa6c169690">565</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNi0xNi0xLTEtOTA2NjU_fc2f90b1-52b5-40b9-9609-ae52fe281b7a">565</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i100e31c2a3f141098462c1bae67f7c14_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfOC0xMC0xLTEtOTA2NjU_a180360d-ddd9-4fdb-bc47-c088dd2f02ab">158</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfOC0xNi0xLTEtOTA2NjU_7c0fd0aa-4eff-4df9-b0e2-33933879e135">158</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="icd4cfb7b4b0a448ea084cf971ba89514_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfOS04LTEtMS05MDY2NQ_084b9e0d-13bc-48d8-87b2-22f3b1be6754">661</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfOS0xNi0xLTEtOTA2NjU_36f96ae0-176f-4d91-b04e-76ad5ae91da3">661</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Balances at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if8f287da32c34a4382931967c22f2986_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMi0xLTEtOTA2NjU_d082ff59-92b2-4db2-b467-62d1b894e676">23,915</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if8f287da32c34a4382931967c22f2986_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtNC0xLTEtOTA2NjU_c34ed137-5dcf-403f-a591-3f1b9beb259f">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i8b643b684c364bcd8ec30529ba06e134_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtNi0xLTEtOTA2NjU_4f861526-50ad-4d77-ac7b-4a0835933a8b">86,163</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i90ca1cca292344a08bf352fbd442ee45_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtOC0xLTEtOTA2NjU_98fdfe00-4242-43e2-9b81-203eee8dbba3">43,374</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia2be1d671b114cf08009f612708ee32e_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMTAtMS0xLTkwNjY1_5d602b59-923d-434a-9079-7a28b92ab481">158</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="i247580c074ba4302b7e3c71ddea3bae5_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMTItMS0xLTkwNjY1_769ea5ae-4a28-4f80-a4f3-eec1cd3a7bf3">3,518</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i247580c074ba4302b7e3c71ddea3bae5_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMTQtMS0xLTkwNjY1_1b958e76-c9ff-4f81-af96-f3e50abd13d1">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMTYtMS0xLTkwNjY1_2d7b8d02-16df-4736-88c6-f1fabcd044e7">42,949</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Balances at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i99185486b44a43db8dee855c0e2e3a15_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMi0xLTEtOTA2NjU_bf1784a9-87ec-42a1-b886-daf773d3c465">20,700</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i99185486b44a43db8dee855c0e2e3a15_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItNC0xLTEtOTA2NjU_53384ccb-3b2a-4025-855d-fa6c563c4ff6">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie03f91b078594271bd4e14d68978bf06_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItNi0xLTEtOTA2NjU_0949df24-c0b4-4cd7-afe7-c4f33bf4a3be">101,905</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib4c341c2ae934d3897c08cd614b84edb_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItOC0xLTEtOTA2NjU_351d25e9-7d8a-4c8a-ba8e-0b0a8fc8bd0a">53,903</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4c477f12061c46b79bd5fb63d4373a4e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMTAtMS0xLTkwNjY1_0a3e67a2-a01b-495c-ad0b-0b934f6a0698">268</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ia35e3080b1b8404cba8a212ab094986f_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMTItMS0xLTkwNjY1_da8ecb3c-31ad-4444-a551-192f00d092a5">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia35e3080b1b8404cba8a212ab094986f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMTQtMS0xLTkwNjY1_9211c5a8-86d5-42f5-9191-a8789bc07bc9">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMTYtMS0xLTkwNjY1_337551df-1321-4d36-b070-e38f12fcb884">48,272</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based shares issued upon vesting - gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTMtMi0xLTEtOTA2NjU_dbeb5494-781d-4e64-8e9e-ad429325857e">125</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTMtNi0xLTEtOTA2NjU_d494c24f-cb34-428b-990c-9e21f02d4693">239</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTMtMTYtMS0xLTkwNjY1_21cfb6d9-32fd-4db4-87f2-f1a1efff08d2">239</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTQtNi0xLTEtOTA2NjU_8dd291e1-78b3-436c-b95c-5461abbd9645">1,047</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTQtMTYtMS0xLTkwNjY1_76eccf81-01b9-4c66-9f10-c065ad11ad2f">1,047</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTUtMi0xLTEtOTA2NjU_81c9b461-db87-4e09-8943-9c93d1383346">28</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTUtNi0xLTEtOTA2NjU_0a2f1652-a0c8-4cce-ade0-1c123c0a5e4b">236</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTUtMTYtMS0xLTkwNjY1_93c11ff0-8883-4b81-9117-143d5af889aa">236</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTYtMi0xLTEtOTA2NjU_95fce083-a0c6-4e66-b99c-600349abb763">3</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTYtNi0xLTEtOTA2NjU_bb445a00-bd0b-41f2-a7cd-2fb246de28c6">54</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTYtMTYtMS0xLTkwNjY1_0bb24e83-af43-49da-aa6d-2d8e79f5660b">54</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock repurchased as part of share repurchase program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 5.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMi0xLTEtOTEzMDU_35a4f3de-4fca-4ac4-a780-567531359846">310</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9ef62092fb404ae79ccb143d6c18f047_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtOC0xLTEtOTEzMDU_ee456b5c-db3a-40d1-a8ee-8fb3f3ce4d00">4,006</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTYtMS0xLTkxMzA1_aea52b22-57e5-4eda-bf59-5111b61cdf4b">4,006</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if8003ee2c2474deca1adb94e55f98442_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTgtMTAtMS0xLTkwNjY1_85094d8a-54c8-4ff9-83e6-1b3973fb7d92">687</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTgtMTYtMS0xLTkwNjY1_62d6a018-aff9-4f3d-b149-12a47c6ec213">687</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9ef62092fb404ae79ccb143d6c18f047_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTktOC0xLTEtOTA2NjU_36ea996a-650e-4f65-b550-c99095818456">368</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTktMTYtMS0xLTkwNjY1_88f40d37-c98a-4e0b-bfc2-0107803e8fe1">368</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Balances at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i19444b1c10474d8490f92d04a10e148f_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMi0xLTEtOTA2NjU_b0036648-8965-49d9-8a93-1d8085fbffc9">20,540</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i19444b1c10474d8490f92d04a10e148f_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtNC0xLTEtOTA2NjU_bb64ec3c-0c12-4aa2-9c42-48d0e98cab31">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id2aa136b42f543bb8d61228fb3ab265f_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtNi0xLTEtOTA2NjU_e5ac6efe-2f7a-43ee-abc9-28a21e3911ff">103,373</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib951efad10c64237873bd1580ccacf5b_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtOC0xLTEtOTA2NjU_1304e75b-ed8f-45dc-946a-d25e0a21e365">58,277</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7876b1efc8a54b39b1afc22d1abf2ec0_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTAtMS0xLTkwNjY1_2470e8fb-aed5-4dcf-9563-a5cf938d4544">955</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i2cf5aee4ba8347b58d13695506bc288c_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTItMS0xLTkwNjY1_edbf74b9-488d-4a47-9f52-a8855cd95cb0">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2cf5aee4ba8347b58d13695506bc288c_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTQtMS0xLTkwNjY1_1b0abf9d-6a74-4886-b78f-fb6d9823cb8c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTYtMS0xLTkwNjY1_6dc1c499-9112-4422-bb97-c24026421349">46,053</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See accompanying notes to unaudited condensed consolidated financial statements. </span></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES</span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(UNAUDITED)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2021</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNC0xLTEtMS05MDY2NQ_0efab052-4e06-46c8-89fb-cfd0ee4cbb2b">368</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNC0zLTEtMS05MDY2NQ_144a80f1-2895-4c69-8c85-1b2e55965f0a">661</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Provision for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNi0xLTEtMS05MDY2NQ_e183a94d-49af-457a-9e26-10ebebc3620b">47</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNi0zLTEtMS05MDY2NQ_004c50e4-a900-4ce9-96f4-dc8bbf07bec9">70</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNy0xLTEtMS05MDY2NQ_6df4aa6f-0d95-4a70-9828-401dc9d51325">2,706</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNy0zLTEtMS05MDY2NQ_56e1aa14-9130-4a68-a493-76bb664cbabf">2,527</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss on disposal of and reserve adjustments for medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfOC0xLTEtMS05MDY2NQ_49336dc0-1a67-474a-b67b-614f5e88275d">275</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfOC0zLTEtMS05MDY2NQ_124deaa1-499d-4f56-8bd4-8e8f16549155">597</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Gain) loss on sale of medical equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfOS0xLTEtMS05MDY2NQ_6c928cb2-0a14-485a-b0e9-f8ce24e1d9a8">228</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfOS0zLTEtMS05MDY2NQ_7220402a-ecf5-40b0-89a1-dfd18990117f">89</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTAtMS0xLTEtOTA2NjU_df8fd00d-cef9-494c-b756-359d2f4d704c">710</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTAtMy0xLTEtOTA2NjU_415d8e36-6766-4842-9162-c491a470ee07">1,043</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization of deferred debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTEtMS0xLTEtOTA2NjU_72c6ec3a-ec66-41d8-b5b8-5509b0bd6636">18</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTEtMy0xLTEtOTA2NjU_73896797-a76a-4b56-a284-a82d77c36883">96</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTItMS0xLTEtOTA2NjU_68c56009-d838-4959-8809-5bb147cd0993">1,047</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTItMy0xLTEtOTA2NjU_5e12caec-5437-4c67-8cf3-62a17ed1abbd">1,635</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTMtMS0xLTEtOTA2NjU_1d6cc864-7dc6-40bf-a626-552823739e7c">462</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTMtMy0xLTEtOTA2NjU_dc657c58-36df-4f29-b090-0bfcdf19c5fb">180</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Changes in assets - (increase)/decrease:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTUtMS0xLTEtOTA2NjU_319d2104-2a8f-40c3-88c8-0dd2bb33192b">1,278</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTUtMy0xLTEtOTA2NjU_20f8cda5-6bea-4306-9125-6905b5c84795">420</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTYtMS0xLTEtOTA2NjU_ab85dc4c-dfba-463d-8481-d9321822e4a0">61</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTYtMy0xLTEtOTA2NjU_3699dfad-710a-4404-b989-2342d2c1f576">154</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTctMS0xLTEtOTA2NjU_ed8cefb7-c873-4079-b221-44d49ada0af7">50</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTctMy0xLTEtOTA2NjU_83a0c9c6-94b4-40e2-bc01-dcd57acced9d">244</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTgtMS0xLTEtOTA2NjU_a7040dc7-6ccd-40e2-b9be-8d823234671a">41</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTgtMy0xLTEtOTA2NjU_cc218a7f-0ca7-4227-82a5-23f5afb673ab">40</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Changes in liabilities - increase/(decrease):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts payable and other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjAtMS0xLTEtOTA2NjU_ca007b31-48ff-4691-b6e9-97f1f7e7a288">1,641</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjAtMy0xLTEtOTA2NjU_fd73d5da-6236-4c6d-9da0-5eaf0674ab3e">2,889</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">NET CASH PROVIDED BY OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjEtMS0xLTEtOTA2NjU_74c6ad7d-6370-4f2d-8964-e8935ed640be">4,078</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjEtMy0xLTEtOTA2NjU_3ccfc9e9-2cc7-4fe0-8dc7-11876bb70648">2,651</ix:nonFraction></span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Acquisition of business</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjQtMS0xLTEtOTA2NjU_fc8248c9-bcb1-4545-a768-e7e7d2fcc87c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjQtMy0xLTEtOTA2NjU_391a6e90-9b99-4942-928e-9ac80a197470">1,204</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchase of medical equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjUtMS0xLTEtOTA2NjU_42414376-1a9f-4ded-a812-0c76a9e426f3">2,931</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjUtMy0xLTEtOTA2NjU_31b9158a-19c0-485c-bc35-51d81fa65fad">2,336</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchase of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjYtMS0xLTEtOTA2NjU_c230ea03-87a2-4043-90e3-bdb980b2140a">178</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjYtMy0xLTEtOTA2NjU_fe5a6003-e8e8-4131-9488-bc9dc97ec2c2">138</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Proceeds from sale of medical equipment, property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjctMS0xLTEtOTA2NjU_a7842cff-2968-463b-bf9c-8095fc4648da">966</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjctMy0xLTEtOTA2NjU_cda70e6c-3411-42cd-841a-ec0c1c8d0d44">876</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">NET CASH USED IN INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjgtMS0xLTEtOTA2NjU_739a47e8-f89c-46de-8c64-548e62a08191">2,143</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjgtMy0xLTEtOTA2NjU_5414ac69-4ab5-4204-b0d6-b2f394ae7a7c">2,802</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Principal payments on long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzEtMS0xLTEtOTA2NjU_96b03628-7019-4039-b5ce-b84fdd9b68cf">10,696</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzEtMy0xLTEtOTA2NjU_0a3022a1-6ae4-4093-98cd-b313a5e5320b">40,093</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash proceeds from long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzItMS0xLTEtOTA2NjU_fbb4312d-f982-44be-8299-e5a642ed2552">12,529</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzItMy0xLTEtOTA2NjU_7ecef313-f064-460b-a545-8d74a4a32a20">34,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzMtMS0xLTEtOTA2NjU_31759277-9d1a-48d0-9e7d-a97da7c11015">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzMtMy0xLTEtOTA2NjU_16f6d9be-0454-4a8b-a6ab-a98465891b5a">386</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 35.57pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzQtMS0xLTEtOTA2NjU_42d769d7-62b5-4c00-ab67-a652304473ee">54</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzQtMy0xLTEtOTA2NjU_639bfeff-a155-418c-9a09-b40ab8300147">565</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Common stock repurchased as part of share repurchase program</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzUtMS0xLTEtOTE0MDc_88cee5cd-cad8-404c-a3ba-1005c06df22c">4,006</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzUtMy0xLTEtOTE0MTQ_ade45cde-cff4-423a-baa0-a969f1621fe1">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash proceeds from stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzUtMS0xLTEtOTA2NjU_4e24e086-2e9e-4f75-9f3d-de8178e3af38">511</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzUtMy0xLTEtOTA2NjU_43ac843f-dd3d-4bfe-8fe0-4571a4282bd6">308</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">NET CASH USED IN FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzctMS0xLTEtOTA2NjU_e8112669-9717-426c-a060-8c7328bc0cd2">1,716</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzctMy0xLTEtOTA2NjU_a20a0ae7-8fb9-4e68-8892-c25825a4f54b">6,736</ix:nonFraction>)</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzktMS0xLTEtOTA2NjU_2f8f461e-c84f-460e-8ed4-e53b5a47e5bd">219</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzktMy0xLTEtOTA2NjU_92cb5fa6-efcb-4b27-8f09-2cb3dde8f179">6,887</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash and cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNDAtMS0xLTEtOTA2NjU_235308d3-a86f-4356-9807-7d0c4758ea26">186</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="idaf436762a17484ebfcec7f989d83620_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNDAtMy0xLTEtOTA2NjU_a3628b1d-6ff4-40c6-b92e-c0da5e9c5b57">9,648</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 26.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash and cash equivalents, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNDEtMS0xLTEtOTA2NjU_d5948e20-8a72-44a7-91e4-8fec0d2b45e8">405</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNDEtMy0xLTEtOTA2NjU_349120a9-bfec-4bf9-af7e-da8069a2cab9">2,761</ix:nonFraction></span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">See accompanying notes to unaudited condensed consolidated financial statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">INFUSYSTEM HOLDINGS, INC. AND SUBSIDIARIES</span></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_31"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zMS9mcmFnOjJkMDRjODczMWZhMjQ3N2Y5NThiYzcxNDYxZjYzZjNkL3RleHRyZWdpb246MmQwNGM4NzMxZmEyNDc3Zjk1OGJjNzE0NjFmNjNmM2RfMzgyMw_a03935d5-7023-415d-80c8-8549e9ca5b49" continuedAt="ic617f596a8584b13b976f87cc315f12b" escape="true">Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ic617f596a8584b13b976f87cc315f12b"><div style="margin-top:12pt;padding-right:7.2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The terms &#8220;InfuSystem&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221; and &#8220;us&#8221; are used herein to refer to InfuSystem Holdings, Inc. and its subsidiaries. InfuSystem is a leading provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care. The Company provides products and services to hospitals, oncology practices and facilities and other alternative site health care providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial information. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) for complete financial statements. The accompanying unaudited condensed consolidated financial statements include all adjustments, composed of normal recurring adjustments, considered necessary by management to fairly state the Company&#8217;s results of operations, financial position and cash flows. The operating results for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 as filed with the SEC on March&#160;15, 2022.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires the use of estimates, judgments and assumptions that affect the amounts of assets and liabilities at the reporting date and the amounts of revenue and expenses in the periods presented. The Company believes that the accounting estimates employed are appropriate and the resulting balances are reasonable; however, due to the inherent uncertainties in making estimates, actual results could differ from the original estimates, requiring adjustments to these balances in future periods.</span></div></ix:continuation><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_34"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNC9mcmFnOjM0ZDhlM2E3M2U3MTQ1ZmZiNzg5ZmEwMmQ5YjY0MzhhL3RleHRyZWdpb246MzRkOGUzYTczZTcxNDVmZmI3ODlmYTAyZDliNjQzOGFfMTI5Ng_8d8a22e5-f154-4bd1-8402-be4a9154362d" continuedAt="i6c2e5594c1174d42970d332cd22fc9d4" escape="true">Recent Accounting Pronouncements and Developments</ix:nonNumeric></span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i6c2e5594c1174d42970d332cd22fc9d4">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2016-13, &#8220;Financial Instruments (Topic 326) Credit Losses&#8221;. Topic 326 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investments in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. Topic 326 was originally effective as of January 1, 2020, although in November 2019, the FASB delayed the effective date until fiscal years beginning after December 15, 2022 for SEC filers eligible as of the FASB's deferral date to be smaller reporting companies under the SEC&#8217;s definition. The Company qualified as a smaller reporting company in November 2019 when the FASB delayed the effective date of Topic 326. Early adoption is permitted. The Company is currently evaluating the impact of Topic 326 on its consolidated balance sheets, statements of operations, statements of cash flows and related disclosures.</ix:continuation></span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_37"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAyMQ_e2fd18ab-4709-420a-be96-66324c57f570" continuedAt="ia3f2f33cb74c4820a8066da363556aad" escape="true">Business Combinations</ix:nonNumeric></span></div><ix:continuation id="ia3f2f33cb74c4820a8066da363556aad" continuedAt="i84e041ceabed4aeca860b13cbdcf582e"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Acquisitions Accounted for Using the Purchase Method</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January&#160;31, 2021, the Company acquired the business and the majority of the assets of FilAMed, a privately-held biomedical services company based in Bakersfield, California. In becoming a part of the Company&#8217;s Durable Medical Equipment Services ("DME Services") segment, this acquisition supplements the Company's existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April&#160;18, 2021, the Company acquired the business and substantially all of the assets of OB Healthcare Corporation (&#8220;OB Healthcare&#8221;), a privately-held biomedical services company based in Mesquite, Texas. OB Healthcare specializes in on-site repair, preventative maintenance, and device physical inventory management to hospitals and healthcare systems nationwide. The acquisition further develops and expands InfuSystem&#8217;s DME Services segment and complements the Company&#8217;s purchase of FilAMed.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><ix:continuation id="i84e041ceabed4aeca860b13cbdcf582e" continuedAt="i3fe9d49e6b6d405da72b80523481fd90"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The results of operations for FilAMed and OB Healthcare are included in the Company&#8217;s consolidated statements of operations from the respective closing dates.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Final Purchase Price Allocation </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to FASB Accounting Standards Codification (&#8220;ASC&#8221;) Topic 805, &#8220;Business Combinations,&#8221; the purchase price for each of the acquisitions was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the respective acquisition dates. The purchase price allocations were primarily based upon a valuation using management&#8217;s estimates and assumptions. The purchase price allocation was completed for FilAMed and OB Healthcare as of December&#160;31, 2021. <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAxOA_1414e70b-6cba-4516-aaf3-35f0f48eeda9" continuedAt="i8fd92777c15f477897b4c6892a71f908" escape="true"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAyMg_2abd70d9-f4de-4c0f-9e55-6cf314d5c650" continuedAt="i65b4cde8cce94f55acbb242758f086ca" escape="true">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i8fd92777c15f477897b4c6892a71f908"><ix:continuation id="i65b4cde8cce94f55acbb242758f086ca"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FilAMed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consideration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i42616323608f4b44a460de02c3482936_D20210131-20210131" decimals="-3" name="infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMS0xLTEtMS05MDY2NQ_cd55e7f8-4cb6-4a91-9176-ba2ab54c9f07">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418" decimals="-3" name="infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMS0zLTEtMS05MDY2NQ_a9881356-6c26-4785-94b1-6821c6ede4be">6,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231" decimals="-3" name="infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMS01LTEtMS05MDY2NQ_8768a788-266b-4c05-b9ac-19e4e2e60255">7,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Working capital adjustment, paid in cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i42616323608f4b44a460de02c3482936_D20210131-20210131" decimals="-3" name="infu:WorkingCapital" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMi0xLTEtMS05MDY2NQ_416a22a8-bf84-474f-a0a4-fe46db1d121d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418" decimals="-3" name="infu:WorkingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMi0zLTEtMS05MDY2NQ_b5f5c19d-6fa0-4be1-b17e-0621f5d7a13e">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231" decimals="-3" name="infu:WorkingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMi01LTEtMS05MDY2NQ_9fbf5e9d-b25a-4575-b045-9263efa199eb">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i42616323608f4b44a460de02c3482936_D20210131-20210131" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMy0xLTEtMS05MDY2NQ_70a93421-a03a-4c56-852f-a045af98b373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMy0zLTEtMS05MDY2NQ_be250253-f366-4116-9301-ae96626dcadf">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMy01LTEtMS05MDY2NQ_d812dd16-7709-4a6d-8e4b-3f378d8aa84e">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - consideration</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i42616323608f4b44a460de02c3482936_D20210131-20210131" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfNC0xLTEtMS05MDY2NQ_55060e17-ebe6-4873-9571-dc8f9060ff80">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfNC0zLTEtMS05MDY2NQ_3c7d3ec9-b356-424c-ad87-05655243b934">7,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfNC01LTEtMS05MDY2NQ_dfcd56b5-04ba-4b87-90ac-576a6fa2ef40">8,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FilAMed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMS0yLTEtMS05MDY2NQ_dd329d48-da6c-4ecf-8bab-dc1baac2cf28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMS00LTEtMS05MDY2NQ_5fc89bb0-7f10-443a-8b47-59c463c7d254">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMS02LTEtMS05MDY2NQ_ac431ca4-8949-413c-96ad-e7cfbb6bdd59">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMi0yLTEtMS05MDY2NQ_b1431e0f-0b0b-435b-9e87-d52cf40c9c55">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMi00LTEtMS05MDY2NQ_0aafffe6-702c-453a-9d41-6304650d9e1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMi02LTEtMS05MDY2NQ_740bc2d6-9644-4951-baa6-17df7ce12d74">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment held for sale or rental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMy0yLTEtMS05MDY2NQ_c0f74f3f-a455-4b2c-aed4-dbf6bc1458af">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMy00LTEtMS05MDY2NQ_5efd6fb0-8b38-4fb6-b099-26f4d9a66685">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMy02LTEtMS05MDY2NQ_69d3d533-5ce5-4c9f-8223-befc71d59229">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNC0yLTEtMS05MDY2NQ_9645903f-33a4-46fe-bcd1-d8b589f849ce">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNC00LTEtMS05MDY2NQ_e3019556-73fd-44ae-80d9-1b51f37da276">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNC02LTEtMS05MDY2NQ_50b7afee-c19f-4536-84ae-237cf87dbb64">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNS0yLTEtMS05MDY2NQ_eb3eaa35-534d-4430-aa7c-61807d7a7f8b">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNS00LTEtMS05MDY2NQ_92ac87b8-e8f8-4465-b3dc-b13adbd17283">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNS02LTEtMS05MDY2NQ_9a62ca03-f9c0-417f-b5e8-438893a6ec93">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNi0yLTEtMS05MDY2NQ_3dbf946e-ee2b-450f-b155-45ab1d4f5084">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNi00LTEtMS05MDY2NQ_d4f047e2-91b8-4d0b-bcd0-04789f34f470">3,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNi02LTEtMS05MDY2NQ_f818c5aa-5bb4-48ae-b50b-8a9fcf870d25">3,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNy0yLTEtMS05MDY2NQ_55c0fdf0-41d9-4db0-aef0-733dcc4dc4fc">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNy00LTEtMS05MDY2NQ_0d1d2194-810f-4dd0-b404-2355b5ab4411">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNy02LTEtMS05MDY2NQ_e0617907-9944-49af-9177-9ca73fa40545">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOC0yLTEtMS05MDY2NQ_8c4fefe3-a02e-4727-a8e2-93ceacad6519">281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOC00LTEtMS05MDY2NQ_d33a609a-b572-4890-a49e-8909a7ef73a1">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOC02LTEtMS05MDY2NQ_df187bd2-82f2-41ff-8025-eea2dc8bd830">288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - purchase price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i751082717be544698a176938b3add8c3_I20210131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOS0yLTEtMS05MDY2NQ_2d243007-fc1f-48c2-b89a-cd898bedc6d3">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOS00LTEtMS05MDY2NQ_66b3b5a5-03af-4ac6-a17a-904bdc13ae7e">7,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOS02LTEtMS05MDY2NQ_05908de4-01e9-4e85-80d7-f0eedb550457">8,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount of acquisition costs for both transactions was less than $<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMjM4MA_f12f2636-ced3-4892-a99c-b09b44ca288b">0.1</ix:nonFraction> million for the three months ended March 31, 2021 and was included in general and administrative expenses.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company fully paid all consideration for FilAMed as of December&#160;31, 2021. On the OB Healthcare acquisition date, the Company made an initial cash payment of $<ix:nonFraction unitRef="usd" contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMjk0Nw_75f87d1c-f7e4-4815-b2cc-56b739b460f8">6.1</ix:nonFraction>&#160;million with subsequent cash payments totaling $<ix:nonFraction unitRef="usd" contextRef="i9ede16521fc64b74b1f49fe77c8a9798_D20210419-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMjk4NA_15098578-150d-4df1-a716-6ad1e9cb2a46">0.4</ix:nonFraction>&#160;million during the year ended December 31, 2021 and had an additional estimated amount due to the seller for contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i7797bc0f95b940b39aa0182a7088eb53_I20210418" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMzE2OA_072b2b4a-c393-40c9-ab32-a31c28230802">0.8</ix:nonFraction>&#160;million, which was recorded in the balance sheet under the heading for other current liabilities. The contingent consideration arrangement, as amended, required the Company to pay OB Healthcare $<ix:nonFraction unitRef="usd" contextRef="i7797bc0f95b940b39aa0182a7088eb53_I20210418" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMzM1Mw_072b2b4a-c393-40c9-ab32-a31c28230802">0.8</ix:nonFraction>&#160;million if certain written contracts were executed.  As of March&#160;31, 2022, the Company had a $<ix:nonFraction unitRef="usd" contextRef="id6070f50a0324f03942b82573c417cdf_I20220331" decimals="-5" name="infu:BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMzQ5Ng_85fad16d-23d4-4956-b855-ed961fc7ce29">0.8</ix:nonFraction>&#160;million remaining liability relating to this acquisition. However, the requirement under the contingent consideration arrangement was satisfied on April 28, 2022, and the Company paid the remaining payment shortly thereafter.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><ix:continuation id="i3fe9d49e6b6d405da72b80523481fd90"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAxOQ_4ec9ab6a-c475-4e6d-b3ab-cf0ecc5ec4e8" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Thousands)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted-Average</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization Period</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Years)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia4990fd3a38c4f3eb1d7099fb3c52dff_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMS0yLTEtMS05MDY2NQ_69b9fc8d-6fa1-411d-be98-d137ce6843bb">2,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="id82fee9ebb5a42a9890e2723157a39ae_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMS00LTEtMS05MDY2NQ_f2cfa7ee-eaee-4688-a362-8f3320a47ffe">15</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9fffd8c4d1c944babfd356c6577863a7_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMi0yLTEtMS05MDY2NQ_9310fdbe-fba3-4434-a71b-a6e023d47b35">943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ie996aa5ccd674a0d8c3da996d58461d4_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMi00LTEtMS05MDY2NQ_e20ea398-b1b5-46a2-9d75-e9d3a3c477d2">7</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMy0yLTEtMS05MDY2NQ_12ca55de-7c21-4d4a-a276-d8c8a371365b">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i9485abe60939498a8c78a8987d9934b6_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMy00LTEtMS05MDY2NQ_06c6872e-4134-4968-ad66-680f620479ef">5</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9d5f226368ed474b99f5057977d175c1_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfNC0yLTEtMS05MDY2NQ_0d2b92f1-ae84-42fc-b354-6bb274b7d0ef">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i5fbe9dbc0da14959be7205dd13d84c0b_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfNC00LTEtMS05MDY2NQ_6e72ef6e-d337-4ddb-8260-c64f9ac6abcc">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfNi0yLTEtMS05MDY2NQ_7deb1c0e-9c88-4ab9-9bc8-29ff2a9336ab">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfNi00LTEtMS05MDY2NQ_70a8c4e1-6c47-4ec5-847a-9972d49081ea">11.2</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The goodwill acquired consists of expected synergies from combining operations of FilAMed and OB Healthcare with the DME Services segment as well as their respective assembled workforce who have specialized knowledge and experience. All of the goodwill is deductible for tax purposes. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Unaudited Pro Forma Financial Information </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited pro forma financial information in the table below summarizes the combined results of operations of the Company, FilAMed and OB Healthcare as though the companies&#8217; businesses had been combined as of January 1, 2021. The pro forma financial information for the three months ended March&#160;31, 2021 was adjusted by less than $<ix:nonFraction unitRef="usd" contextRef="i0e029b8ec12f40869e606cbefce19746_D20210101-20210331" decimals="-5" name="infu:BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNDMyNQ_ec1efa0a-c23d-4a4a-bf5a-a005b3a1bf95">0.1</ix:nonFraction> million for the tax effected amount of acquisition costs and non-recurring expenses directly attributable to the FilAMed and OB Healthcare acquisitions. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place at the beginning of the period presented nor is it indicative of future results. <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAyMA_559882d7-5297-4b69-9f4a-457d92e7efb1" continuedAt="i96a00bff945a48ba862b16f145a26ec5" escape="true">The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the three months ended March&#160;31, 2021 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i96a00bff945a48ba862b16f145a26ec5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOmMyYmQ0ZWYzNjQyMDQ0YjRiMmE4NDNkOGI5YmE0ZjFiL3RhYmxlcmFuZ2U6YzJiZDRlZjM2NDIwNDRiNGIyYTg0M2Q4YjliYTRmMWJfMi0zLTEtMS05MDY2NQ_3b013e05-f0fb-4eca-82a8-1502e0b46139">24,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOmMyYmQ0ZWYzNjQyMDQ0YjRiMmE4NDNkOGI5YmE0ZjFiL3RhYmxlcmFuZ2U6YzJiZDRlZjM2NDIwNDRiNGIyYTg0M2Q4YjliYTRmMWJfMy0zLTEtMS05MDY2NQ_5ff8a3fd-36a9-4206-82e3-114d4a874f1a">639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfODQ1_4f4e8202-2638-43e9-8dd5-6946b8dd9bd3" continuedAt="i7700ce5172ec413293e8e78139191e19" escape="true">Revenue Recognition</ix:nonNumeric></span></div><ix:continuation id="i7700ce5172ec413293e8e78139191e19"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfODQ3_1d9f2fea-f880-46c3-b067-c1c537b65814" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the Company&#8217;s disaggregated revenue by offering type (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of Total Net Revenues</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of Total Net Revenues</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Third-Party Payer Rentals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia2e5ce00d4ed4d9a97f7aed53faa1ff6_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNC0xLTEtMS05MDY2NQ_03196c72-ccce-4ba6-90f0-7baaaae0f107">13,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="if49785589581493ebb90d7a0199ea525_D20220101-20220331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNC0zLTEtMS05MDY2NQ_c66598ce-e5e3-44d3-bdbe-c29b1e1279a4">50.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if8ef7499ada54e7e9ad7851db5747696_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNC01LTEtMS05MDY2NQ_d2618e1e-efbd-4095-a351-fe4dfc33f450">12,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="ifb56702f67294df0b173f365472c73ca_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNC03LTEtMS05MDY2NQ_103180e7-21bd-4313-bfab-739a889be94c">52.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Direct Payer Rentals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4982a0329516423a9136efc7957f9aab_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNS0xLTEtMS05MDY2NQ_f009bc52-ff5f-4b5c-b0b3-eb8855d07bfb">7,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="i29edb7af843f4319acdf73d40cbd3a19_D20220101-20220331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNS0zLTEtMS05MDY2NQ_5dea8368-9a43-410d-b0e0-50c747848610">29.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3ff148b282eb4181803b5f6562d8734a_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNS01LTEtMS05MDY2NQ_11dd6d8c-c0e4-4ba7-933c-8868fbbfe079">7,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="i447d77e0640e4266805ed52d0e06d21b_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNS03LTEtMS05MDY2NQ_8c159310-6d8d-4b4d-8415-900f505b3939">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i44bc98dc84754947aca9ffc1d3e8bbf0_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNi0xLTEtMS05MDY2NQ_cdc974cb-fbb9-4944-ac9d-a46503dc9120">3,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="i76aeb4498a0b4c5889d9b44b13e75ebb_D20220101-20220331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNi0zLTEtMS05MDY2NQ_38b04787-ef70-4f7c-897d-24709c3737bb">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib3db6d103273445e8e1f89920aa09ed6_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNi01LTEtMS05MDY2NQ_af7b1da8-cf23-4058-a9a0-4495b60dd742">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="i3dca92952a174b78b27dc46eeaa65d99_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNi03LTEtMS05MDY2NQ_fff19d93-6c2a-4c4d-9a73-bf34271f0cd3">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia7f79ccd7d5f40ae837e2fafc736606e_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNy0xLTEtMS05NDYzNw_ea1497d5-5c6c-4c42-9149-91ea95653871">1,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="i1a7c684f949741a3981a761e9bbcbf9d_D20220101-20220331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNy0zLTEtMS05NDY0NA_eb41f225-46eb-45f7-a364-54a749053ae7">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="idf3c886d74bc45548114cbfdf0c6983b_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNy01LTEtMS05NDY1MQ_783b36ea-7f52-4b47-9a8a-b49193e53ecb">688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="iea3ee5aa2d194f4c8a4c459c8fc91b98_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNy03LTEtMS05NDY1OA_636d6eb3-bb8d-4fb6-a24f-1816dfe9dc0a">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfOC0xLTEtMS05MDY2NQ_3e645914-fdde-40de-b924-a2126dd6ac52">26,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="i27169791ade7453ea172c0da7b9f2a47_D20220101-20220331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfOC0zLTEtMS05MDY2NQ_2966f990-e3f6-4267-8a9a-7608f4cdf7b3">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfOC01LTEtMS05MDY2NQ_6db9f639-af91-4d9b-8105-3cf6cd0d262e">24,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="ib1822b59343e4f53b58f3e3f7280600e_D20210101-20210331" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfOC03LTEtMS05MDY2NQ_eec95a9a-57f3-4cd5-b7fe-53e9b9a1e3aa">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-Party Payer Rentals are entirely attributed to revenues of the Integrated Therapy Services (&#8220;ITS&#8221;) segment. For the three months ended March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="if4fd38174ba44b03a584466ebe9ab057_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfNjE0_6773effb-45ba-4ba9-97ac-df1dd2f608c9">3.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i60c58188de1b4fc3af027ccbcd0a1fb3_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfNjIx_0dec59ed-66b9-4935-b5ef-8b9e5e9ba398">4.8</ix:nonFraction>&#160;million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i8204bc432ee142d3bad5b48145ed8618_D20210101-20210331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfNzQ0_901ec036-26bd-469e-baf1-6795d0205604">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i55927c5429ab4da4b5c134d3ea056150_D20210101-20210331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfNzUx_44120df4-b2c3-4d1a-88d2-bb88c06f8f24">4.3</ix:nonFraction> million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i5095ccbbd602407d910da1f13f5d8d6d_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfMTA5OTUxMTYyOTc2OQ_ac1f8cfe-4549-417d-a547-3a7c52ddba73">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3a16fc3aeb5143d2908ebc833b38ed1d_D20220101-20220331" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfMTA5OTUxMTYyOTc4NQ_3e455716-2752-4fab-a01c-239459a837a9">3.6</ix:nonFraction> million of Product Sales were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2021, all Product Sales were entirely attributed to the DME Services segment. For the three months ended March&#160;31, 2022 and 2021, all Services revenues were entirely attributed to the DME Services segment.</span></div></ix:continuation><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_43"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="infu:MedicalEquipmentAndPropertyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RleHRyZWdpb246YjljMGFmMzhkZDk2NGJkN2JiMDE1NjgyNjczZjBmZTBfMzA1_85e9998f-f069-45f0-abdd-8aec065cb154" continuedAt="i70dcd29bf50e46948ce45932d5479224" escape="true">Medical Equipment</ix:nonNumeric></span></div><ix:continuation id="i70dcd29bf50e46948ce45932d5479224"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="infu:ScheduleOfMedicalEquipmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RleHRyZWdpb246YjljMGFmMzhkZDk2NGJkN2JiMDE1NjgyNjczZjBmZTBfMzA0_847a3f1b-4e44-4677-918d-5bffce5ea5d3" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medical equipment consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRentalGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMS0xLTEtMS05MDY2NQ_59b8d157-465a-4122-9b38-f37f527289b6">2,031</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRentalGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMS0zLTEtMS05MDY2NQ_4060053b-d2c7-4d9d-a33a-c4c55008bff7">1,788</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental - pump reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentForSaleOrRentalReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMi0xLTEtMS05MDY2NQ_97e921da-bde4-442f-ac37-56108478509b">44</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentForSaleOrRentalReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMi0zLTEtMS05MDY2NQ_d07241e6-f31c-4c03-be53-4b67fa2bb548">46</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental - net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRental" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMy0xLTEtMS05MDY2NQ_844fd341-c3e6-481b-b5dc-739a6ec3be79">1,987</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentHeldForSaleOrRental" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMy0zLTEtMS05MDY2NQ_03c23eea-15b0-47c0-ac94-47737dd94059">1,742</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentInRentalServicesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNS0xLTEtMS05MDY2NQ_2df87c5a-f23a-4d54-88c1-6c6c23a5485b">92,630</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNS0zLTEtMS05MDY2NQ_a4f9806a-dc4e-4447-a42e-fce794e0d8a8">91,891</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service - pump reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentInRentalServicesReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNi0xLTEtMS05MDY2NQ_01063c3e-5135-4653-940d-f3ef0fbf6315">1,246</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNi0zLTEtMS05MDY2NQ_1dfe9607-1d3c-49fd-b35e-7ef8f2c359d7">1,074</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNy0xLTEtMS05MDY2NQ_e54e9b08-347b-46a0-bf65-d8f872c7b952">52,271</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNy0zLTEtMS05MDY2NQ_37666d33-b0c2-4443-b457-bac94163f3ea">50,946</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service - net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfOC0xLTEtMS05MDY2NQ_780d35bc-350f-4202-beec-d629764f5024">39,113</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfOC0zLTEtMS05MDY2NQ_a28094b2-9f38-464d-ae64-d9e2d308ccd9">39,871</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:MedicalEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMTAtMS0xLTEtOTA2NjU_6bd0cde9-6576-4f4e-aad3-d3ea5690dac3">41,100</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:MedicalEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMTAtMy0xLTEtOTA2NjU_2c90b28d-dcdd-4914-b1e1-c9b4999e1e65">41,613</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation expense for medical equipment for the three months ended March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was $<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-5" name="infu:DepreciationExpenseRelatedToMedicalEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RleHRyZWdpb246YjljMGFmMzhkZDk2NGJkN2JiMDE1NjgyNjczZjBmZTBfMTQ3_833be254-b057-4bd9-aaa7-0be3820a2af7">2.4</ix:nonFraction> million, compared to $<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-5" name="infu:DepreciationExpenseRelatedToMedicalEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RleHRyZWdpb246YjljMGFmMzhkZDk2NGJkN2JiMDE1NjgyNjczZjBmZTBfMTg0_7ecfa580-4e11-4afe-b3f5-49f049a74b3d">2.3</ix:nonFraction> million for the same prior year period. This expense was recorded in &#8220;cost of revenues&#8221; for each period.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RleHRyZWdpb246MzJhYjM5Y2YwOGZhNDgwNGI0ZjJkOTUwMTc3Njg2NjRfMzM4_a0b3351a-c955-425d-9094-f3157aed13d4" continuedAt="i6b8ff02feecc48d7a5a6e65176888fae" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="i6b8ff02feecc48d7a5a6e65176888fae"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RleHRyZWdpb246MzJhYjM5Y2YwOGZhNDgwNGI0ZjJkOTUwMTc3Njg2NjRfMzM5_9663e36b-02bf-48ee-b980-b5e91885f096" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accumulated</span></div><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accumulated Depreciation</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture, fixtures, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iab9576cec45e4a449fa940366d43de5c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi0xLTEtMS05MDY2NQ_6cb88201-5e28-4a87-8b5c-86fab8586ad2">4,924</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="iab9576cec45e4a449fa940366d43de5c_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi0zLTEtMS05MDY2NQ_63a369cf-cc10-4ba1-882b-474928bbeb52">2,703</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iab9576cec45e4a449fa940366d43de5c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi01LTEtMS05MDY2NQ_232c0a19-de74-457a-97ae-73abb4298009">2,221</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4bb1bc7267ab4f3b8a2ba31c8f332d5f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi03LTEtMS05MDY2NQ_f665b69b-5ec5-4121-aed1-29f504753bcd">4,812</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4bb1bc7267ab4f3b8a2ba31c8f332d5f_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi05LTEtMS05MDY2NQ_d153ded1-90d5-4080-b93d-0bc6e9dc9497">2,528</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4bb1bc7267ab4f3b8a2ba31c8f332d5f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi0xMS0xLTEtOTA2NjU_b919544d-f679-4c79-8c90-79b8b1de5930">2,284</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Automobiles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibef9d8e70d0d44f6881d0cc953b6c86c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy0xLTEtMS05MDY2NQ_a5b7a213-864d-4ea7-ac55-b3c65ec6865a">110</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ibef9d8e70d0d44f6881d0cc953b6c86c_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy0zLTEtMS05MDY2NQ_042c207d-6e70-4b15-b2bf-577a0f5bf1da">104</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibef9d8e70d0d44f6881d0cc953b6c86c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy01LTEtMS05MDY2NQ_f0cd5688-b436-4fb8-b297-5f0ad871a440">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d32500896b341cb86356b976a1a7e6f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy03LTEtMS05MDY2NQ_d65195e7-750e-4e19-9efe-f4025fbed551">110</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5d32500896b341cb86356b976a1a7e6f_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy05LTEtMS05MDY2NQ_6dfc5d4c-5b66-4729-a5eb-8e6342750414">103</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d32500896b341cb86356b976a1a7e6f_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy0xMS0xLTEtOTA2NjU_4e594203-06c0-46aa-a3e7-dc9bd8b201a8">7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ifc6296cc506a4da2b9d7da01f0ce124c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC0xLTEtMS05MDY2NQ_f41fdcce-db70-4be2-847a-8a1364ebe2b0">3,449</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ifc6296cc506a4da2b9d7da01f0ce124c_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC0zLTEtMS05MDY2NQ_5318e527-c35e-4289-be0a-db096efaca78">1,301</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ifc6296cc506a4da2b9d7da01f0ce124c_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC01LTEtMS05MDY2NQ_4a5bac8e-51a3-4842-a15e-f31385403338">2,148</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i16ee9bf588434522bd80adcc901d4ef9_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC03LTEtMS05MDY2NQ_c2ac419c-250f-4427-b645-d4da8a888480">3,444</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i16ee9bf588434522bd80adcc901d4ef9_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC05LTEtMS05MDY2NQ_6bf3f14f-de9c-4ffa-9c89-893e87a7fd65">1,212</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i16ee9bf588434522bd80adcc901d4ef9_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC0xMS0xLTEtOTA2NjU_086e3965-2767-495f-90be-dff47ce5ea66">2,232</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi0xLTEtMS05MDY2NQ_6b1ed1fe-5b50-4cea-9a81-0096ccb3acea">8,483</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi0zLTEtMS05MDY2NQ_3e2ebb55-f7c3-4205-a3c1-b2f58ce74808">4,108</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi01LTEtMS05MDY2NQ_6044eb16-d84e-4670-bb02-a3e6c8ab72b8">4,375</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi03LTEtMS05MDY2NQ_2e6b0fb6-2266-4c6b-a642-d1bb3ec1f58f">8,366</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi05LTEtMS05MDY2NQ_94b92b2c-1f69-48d1-9edd-461f868b36ff">3,843</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi0xMS0xLTEtOTA2NjU_bd7db455-5cac-461d-b7fd-738e2f166aad">4,523</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation expense for property and equipment for the three months ended March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-5" name="us-gaap:DepreciationNonproduction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RleHRyZWdpb246MzJhYjM5Y2YwOGZhNDgwNGI0ZjJkOTUwMTc3Njg2NjRfMTYy_0fd17dbe-6d07-418f-84cd-df775b0dccc1">0.3</ix:nonFraction> million, compared to $<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-5" name="us-gaap:DepreciationNonproduction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RleHRyZWdpb246MzJhYjM5Y2YwOGZhNDgwNGI0ZjJkOTUwMTc3Njg2NjRfMTk5_dc6730ba-d9b9-425a-bb18-9b5a50e8a0df">0.2</ix:nonFraction> million for the same prior year period. This expense was recorded in &#8220;general and administrative expenses&#8221; for each period.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfNjI3_1eeca677-4e39-4a73-8112-bcfe797db11a" continuedAt="iaff7f3a6f723412a9c9496e76860369e" escape="true">Goodwill &amp; Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="iaff7f3a6f723412a9c9496e76860369e"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfNjI4_8e008396-b859-4076-bf97-547663ef9891" continuedAt="i32f13eaa10aa4916b3c1be065fc8d28a" escape="true">The changes in the carrying value of goodwill by segment for the three months ended March&#160;31, 2022 are as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i32f13eaa10aa4916b3c1be065fc8d28a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services (a)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic700dbf08af94b2eae2ba16cb3c059e1_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmFiMjc2NmYyYjFjZjQzMzk4NDIzM2YyOGYxZjQyMDNiL3RhYmxlcmFuZ2U6YWIyNzY2ZjJiMWNmNDMzOTg0MjMzZjI4ZjFmNDIwM2JfMS0yLTEtMS05MDY2NQ_b7755017-af64-49be-b0b9-a60997a33b6c">3,710</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ifd7edbf7b2bd4b21aa91040e49a07b37_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmFiMjc2NmYyYjFjZjQzMzk4NDIzM2YyOGYxZjQyMDNiL3RhYmxlcmFuZ2U6YWIyNzY2ZjJiMWNmNDMzOTg0MjMzZjI4ZjFmNDIwM2JfMi0yLTEtMS05MDY2NQ_df820537-56b3-4174-91dc-3b4344d1fa10">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7d3f2b23fb394007a3aae9607cd8f47d_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmFiMjc2NmYyYjFjZjQzMzk4NDIzM2YyOGYxZjQyMDNiL3RhYmxlcmFuZ2U6YWIyNzY2ZjJiMWNmNDMzOTg0MjMzZjI4ZjFmNDIwM2JfMy0yLTEtMS05MDY2NQ_8b9d557a-dd68-40ab-8b56-ff352c91a84a">3,710</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) The ITS segment has <ix:nonFraction unitRef="usd" contextRef="i53c7ee1171d34f9ead27a9700cd1fcf4_I20220331" decimals="INF" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmFiMjc2NmYyYjFjZjQzMzk4NDIzM2YyOGYxZjQyMDNiL3RhYmxlcmFuZ2U6YWIyNzY2ZjJiMWNmNDMzOTg0MjMzZjI4ZjFmNDIwM2JfNS0wLTEtMS05MDY2NS90ZXh0cmVnaW9uOmNlYjg4MzQ1YjdjODQ5ZGViYjgwMThjMDRmNjM0ZWYyXzk_7d558179-8f49-4cf5-8266-429d97b9bc37">no</ix:nonFraction> recorded goodwill. </span></div></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfNjMw_87da29ee-cb7f-4125-adb6-ce1e36c28a18" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The carrying amount and accumulated amortization of intangible assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Assets</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Assets</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Nonamortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMy0xLTEtMS05MDY2NQ_49af0cfc-c609-4796-aa03-dfc319a761ed">2,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMy01LTEtMS05MDY2NQ_75cfc3aa-879f-4c61-ab21-3480d081265e">2,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMy03LTEtMS05MDY2NQ_cf8f7137-e16a-4557-a808-50f8b7caf18d">2,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMy0xMS0xLTEtOTA2NjU_0822b0e3-54b7-48cd-b3c4-fa56b670d566">2,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i69120393fdcf4f98b5f3643efcf1ba48_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS0xLTEtMS05MDY2NQ_29052631-22aa-4beb-b631-acd647f5b0e3">23</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i69120393fdcf4f98b5f3643efcf1ba48_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS0zLTEtMS05MDY2NQ_7f002053-cbef-4604-a351-3f24c8ac3990">23</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i69120393fdcf4f98b5f3643efcf1ba48_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS01LTEtMS05MDY2NQ_3e8fbadf-3f7b-4666-a14d-b9f39b38d10e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="idfb5ef2d8f814683800aefa4d847067f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS03LTEtMS05MDY2NQ_2c2cebff-f2a6-4d4f-9e82-95553dee75e0">23</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="idfb5ef2d8f814683800aefa4d847067f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS05LTEtMS05MDY2NQ_1bf85b1c-5689-4cf1-80f0-a64f108bc383">23</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="idfb5ef2d8f814683800aefa4d847067f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS0xMS0xLTEtOTA2NjU_e352c69e-c888-40e9-89d2-4d7b36190ef2">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Physician and customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2007dc85e9fb4c4eb7d1a818c44c551b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi0xLTEtMS05MDY2NQ_8fd5c83a-2eef-490b-ae83-b1d75ab8861a">38,834</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i2007dc85e9fb4c4eb7d1a818c44c551b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi0zLTEtMS05MDY2NQ_150e0cd6-4ab9-4747-bec4-15b2cba56499">32,033</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2007dc85e9fb4c4eb7d1a818c44c551b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi01LTEtMS05MDY2NQ_a35152f6-d2cb-4955-ba5e-0a45dca8d03e">6,801</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3955a41377c6464b8b96323f2127c3ac_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi03LTEtMS05MDY2NQ_45f7730c-933f-4e37-8df6-647017d6d333">38,834</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i3955a41377c6464b8b96323f2127c3ac_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi05LTEtMS05MDY2NQ_9e1b5c58-246f-4eaa-9b43-c85ee8cce024">31,401</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3955a41377c6464b8b96323f2127c3ac_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi0xMS0xLTEtOTA2NjU_b47cfe56-a3d0-403f-aa15-b08dca78ca02">7,433</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6f1511ac8ff546a283d31d4c98b6133f_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy0xLTEtMS05MDY2NQ_eec37577-1e0e-4d21-8bee-09e8190d2ef4">472</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i6f1511ac8ff546a283d31d4c98b6133f_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy0zLTEtMS05MDY2NQ_3aaa148b-231d-4058-8336-daa2b42138a7">90</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6f1511ac8ff546a283d31d4c98b6133f_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy01LTEtMS05MDY2NQ_411c20cc-65c1-440c-8262-edf389790753">382</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy03LTEtMS05MDY2NQ_4a84240a-7d96-4661-a60e-9ff553ded510">472</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy05LTEtMS05MDY2NQ_f63b7fb9-004c-4019-a83d-2b8d231c3c6d">67</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy0xMS0xLTEtOTA2NjU_54920880-3d3a-4761-bb25-03fbcdc1ba21">405</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2ed66385f90b4519b38d4183d11d53b9_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC0xLTEtMS05MDY2NQ_c8d49901-8e27-42d8-997b-86ac65061819">943</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i2ed66385f90b4519b38d4183d11d53b9_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC0zLTEtMS05MDY2NQ_4ddb5bc5-c092-4fab-9cce-b9869a64d44d">157</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2ed66385f90b4519b38d4183d11d53b9_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC01LTEtMS05MDY2NQ_f85a4206-a630-4325-9b37-4a4722fc1802">786</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9fffd8c4d1c944babfd356c6577863a7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC03LTEtMS05MDY2NQ_63bd689d-e1c7-447e-bd22-85f9d279dcb3">943</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9fffd8c4d1c944babfd356c6577863a7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC05LTEtMS05MDY2NQ_d92c2b91-c56a-42af-ad17-8c3c3306fcc4">123</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9fffd8c4d1c944babfd356c6577863a7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC0xMS0xLTEtOTA2NjU_5b98db27-5dce-466f-8691-a2a650f5526a">820</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic5adc6accdfb4947bc052bfbd05a41a4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS0xLTEtMS05MDY2NQ_9b7e1e00-cd67-452b-9d4f-945328e74662">11,530</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ic5adc6accdfb4947bc052bfbd05a41a4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS0zLTEtMS05MDY2NQ_463fd9ea-349b-4a67-af92-61a4401b55df">11,280</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic5adc6accdfb4947bc052bfbd05a41a4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS01LTEtMS05MDY2NQ_3c726375-e864-430d-84ab-ea59070a7f93">250</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9d5f226368ed474b99f5057977d175c1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS03LTEtMS05MDY2NQ_3abffaf4-d89f-44de-9b15-4a0a4f3cb3ef">11,530</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9d5f226368ed474b99f5057977d175c1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS05LTEtMS05MDY2NQ_a561106f-2006-4f7e-ba2b-a152bae6b103">11,258</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9d5f226368ed474b99f5057977d175c1_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS0xMS0xLTEtOTA2NjU_be395217-c4b8-444c-aaa1-39ee131ba719">272</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total nonamortizable and amortizable intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtMS0xLTEtOTA2NjU_2efcc8c1-d681-4215-8a93-6a3c1744b19d">53,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtMy0xLTEtOTA2NjU_5f54e6d0-51e8-4a06-8eba-4eadf65e5ce9">43,583</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtNS0xLTEtOTA2NjU_4152e3c9-2350-4bad-a720-9586dc5b87ce">10,219</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtNy0xLTEtOTA2NjU_55763767-be2f-4601-8cbb-2dbea02298ef">53,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtOS0xLTEtOTA2NjU_466310e7-e1c4-4489-875f-60570e16ad9a">42,872</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtMTEtMS0xLTkwNjY1_43823338-da4a-42a6-ad36-bdd75ca27781">10,930</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three months ended March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfMzA2_75f68240-e8db-4ff8-aad8-2728c6883f44">0.7</ix:nonFraction>&#160;million, compared to $<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfMzQz_d7ead1da-3242-4633-afe7-d259c3d6c39b">1.0</ix:nonFraction>&#160;million for the same prior year period. This expense was recorded in &#8220;amortization of intangibles expenses&#8221; for each period. <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfNjI2_45eb3f13-cf80-4909-a46a-d15e6bdfec52" continuedAt="i79c8754ae59e4d25a79f9cf4d8bb51f6" escape="true">Expected remaining annual amortization expense for the next five years for intangible assets recorded as of March&#160;31, 2022 is as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i79c8754ae59e4d25a79f9cf4d8bb51f6"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2027 and thereafter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi0xLTEtMS05MDY2NQ_9cf4e824-ce05-4b2d-a145-80b7c7d17478">1,783</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi0zLTEtMS05MDY2NQ_5f8acd67-9407-46a8-8834-da313c41b827">990</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi01LTEtMS05MDY2NQ_91bb1e30-4d59-4a6b-9de4-d557ef03d7cd">990</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi03LTEtMS05MDY2NQ_5e3d7c81-de38-4485-ac27-6ce7b846e2b3">810</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi05LTEtMS05MDY2NQ_0dd98a5b-6fff-42cb-b0f1-7187a23e34a6">524</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi0xMS0xLTEtOTA2NjU_fb250fbb-9472-4eb4-8311-b9b7780415c4">3,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi0xMy0xLTEtOTA2NjU_5b71b9a5-9dfa-492b-86ff-5869bc9e56e9">8,219</ix:nonFraction></span></td></tr></table></ix:continuation></div></ix:continuation><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_52"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjg0NA_021bc7ec-70ce-4d6b-b6aa-e269bb830f78" continuedAt="ia732c32c02c9430daded3d5d72753975" escape="true">Debt</ix:nonNumeric></span></div><div style="margin-top:12pt;text-indent:27pt"><ix:continuation id="ia732c32c02c9430daded3d5d72753975" continuedAt="icafa6315f76740baab19cc3cd254d0df"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">February&#160;5, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the Company entered into a Credit Agreement (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2021 Credit Agreement&#8221;) with JPMorgan Chase Bank, N.A., as administrative agent (the &#8220;Agent&#8221;), sole bookrunner and sole lead arranger, and the lenders party thereto. The borrowers under the 2021 Credit Agreement are the Company, InfuSystem Holdings USA, Inc. (&#8220;Holdings&#8221;), InfuSystem, </span></ix:continuation></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><ix:continuation id="icafa6315f76740baab19cc3cd254d0df" continuedAt="ica7f1f783f7641ed99942e3348ae68ad"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inc. (&#8220;ISI&#8221;), First Biomedical, Inc. (&#8220;First Biomedical&#8221;), and IFC LLC (&#8220;IFC&#8221; and, collectively with the Company, Holdings, ISI and First Biomedical, the &#8220;Borrowers&#8221;).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Credit Agreement provides for a revolving credit facility (the &#8220;Revolving Facility&#8221;) of $<ix:nonFraction unitRef="usd" contextRef="i5b34086db73244b8b360acb9f538d2ac_I20210205" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjE3_526256d5-19ab-4048-8aed-9ab2f3348ce5">75.0</ix:nonFraction> million that matures on February 5, 2026. The Revolving Facility may be increased by $<ix:nonFraction unitRef="usd" contextRef="i5b34086db73244b8b360acb9f538d2ac_I20210205" decimals="INF" name="infu:LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjk0_91381c02-b2c4-47c7-833c-fa3faf0af59c">25.0</ix:nonFraction> million, subject to certain conditions, including the consent of the Agent and obtaining necessary commitments. The lenders under the 2021 Credit Agreement may issue up to $<ix:nonFraction unitRef="usd" contextRef="i9db5ef6e072245c6836ab464e21b81d6_I20210205" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfODYx_c7641bd6-d523-4f65-924b-1024f9dcd84b">7.0</ix:nonFraction> million in letters of credit subject to the satisfaction of certain conditions. On February&#160;5, 2021, the Borrowers made an initial borrowing of $<ix:nonFraction unitRef="usd" contextRef="i280422ec877d4871b85139ef7dab2895_D20210205-20210205" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfOTg2_e8a29329-bb8e-406f-a2f2-383e706298aa">30.0</ix:nonFraction> million under the Revolving Facility. Proceeds from the loan, along with approximately $<ix:nonFraction unitRef="usd" contextRef="i88c67caf15574e31981968dbcfd092ba_D20210205-20210205" decimals="-5" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMTA2OA_fa0b45e1-78ce-4d0b-9075-15dcbdcbe1e7">8.2</ix:nonFraction> million in cash, were used to repay all amounts due under the Company&#8217;s then existing credit facility dated March 23, 2015 (the &#8220;2015 Credit Agreement&#8221;).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Credit Agreement has customary representations and warranties. The ability to borrow under the facility is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations on indebtedness, liens, mergers, acquisitions, investments, asset sales, affiliate transactions and restricted payments, as well as financial covenants, including the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a minimum fixed charge coverage ratio (defined as the ratio of consolidated EBITDA (as defined in the 2021 Credit Agreement) less <ix:nonFraction unitRef="number" contextRef="i11787656cdd7485983ece34ada8d626d_D20210205-20210205" decimals="INF" name="infu:PercentageOfTotalDepreciationExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMTc1Ng_e5033731-7dba-4c3d-baf4-f649868e1c0e">50</ix:nonFraction>% of depreciation expense), to consolidated fixed charges (as defined in the 2021 Credit Agreement)) for the prior four most recently ended calendar quarters of <ix:nonFraction unitRef="number" contextRef="i5755350e04f34d40bf1835b45c2e72c7_I20210205" decimals="INF" name="infu:DebtInstrumentCovenantMinimumFixedCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMTkxOA_9a058775-fc5b-44e0-bc56-cf0471d5daf3">1.20</ix:nonFraction> to 1.00; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a maximum leverage ratio (defined as total indebtedness to EBITDA for the prior four most recently ended calendar quarters) of <ix:nonFraction unitRef="number" contextRef="i5755350e04f34d40bf1835b45c2e72c7_I20210205" decimals="INF" name="infu:DebtInstrumentCovenantMaximumLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMjA2MQ_e1014d5b-3294-498a-95c7-e8c6770bd469">3.50</ix:nonFraction> to 1.00.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Credit Agreement includes customary events of default. The occurrence of an event of default will permit the lenders to terminate commitments to lend under the Revolving Facility and accelerate payment of all amounts outstanding thereunder.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Simultaneous with the execution of the 2021 Credit Agreement, the Company entered into a Pledge and Security Agreement to secure repayment of the obligations of the Borrowers. Under the Pledge and Security Agreement, each Borrower has granted to the Agent, for the benefit of various secured parties, a first priority security interest in substantially all of the personal property assets of each of the Borrowers, including the shares of each of Holdings, ISI and First Biomedical and the equity interests of IFC.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February&#160;5, 2021, in connection with the execution and closing of the 2021 Credit Agreement, the Company, along with its wholly owned subsidiaries as borrowers, terminated the 2015 Credit Agreement. All outstanding loans under the 2015 Credit Agreement were repaid and all liens under the 2015 Credit Agreement were released, except that a letter of credit originally issued under the 2015 Credit Agreement in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="ibdfe551e6db54288aab0d8b7eaf87872_I20210205" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMzI3NQ_ef617719-a153-45b5-b724-e528c1f00977">0.8</ix:nonFraction> million was transferred to the 2021 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Credit Agreement was accounted for as a debt modification. As of March&#160;31, 2022, the Company was in compliance with all debt-related covenants under the 2021 Credit Agreement.  </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April&#160;15, 2019, the Company sold for $<ix:nonFraction unitRef="usd" contextRef="i0c5050671c134292bc772cc44ffea56a_I20190415" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNDg0NA_f343adb8-66f3-4309-959a-149b2e29bc04">2.0</ix:nonFraction> million and immediately leased back certain medical equipment in rental service to a third party specializing in such transactions. The leaseback term is <ix:nonNumeric contextRef="i3149a0ad24134e48ad364d402109026e_D20190415-20190415" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNDk5Mw_e1141b0f-c2dd-4d72-8da5-c3dbb4b4e0af">36</ix:nonNumeric> months. Because the arrangement contains a purchase option that the Company is reasonably certain to exercise, this transaction did not qualify for the sale-leaseback accounting under ASC 842. The medical equipment remains recorded on the accompanying condensed consolidated balance sheet and the proceeds received have been classified as an other financing liability, which is being paid off monthly over the term of the lease. The balance of other financing as of March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i33b5522177ae46f8a72045d13d78d239_I20220331" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNTQ2Mg_57551d2a-c5f4-4cc0-b0ec-f24b0e8fa47f">0.2</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><ix:continuation id="ica7f1f783f7641ed99942e3348ae68ad"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As referenced above, the Company executed and closed the 2021 Credit Agreement during the first quarter of 2021, and in connection with entering into that agreement, terminated the 2015 Credit Agreement. <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgzMA_4939a600-4f7c-4154-8dd7-219432b9e4b5" continuedAt="if5d620f0c9b9495ab6c8f266bb1e478f" escape="true">The following table illustrates the net availability under the Revolving Facility as of the applicable balance sheet date (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="if5d620f0c9b9495ab6c8f266bb1e478f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.914%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 66.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">December 31,<br/>2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross availability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfMy0xLTEtMS05MDY2NQ_e7556d02-384a-45c9-8e61-1061ef490469">75,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231" decimals="-3" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfMy0zLTEtMS05MDY2NQ_21bdc9b6-9ca0-44e1-9aae-9fd012185d54">75,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding draws</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNC0xLTEtMS05MDY2NQ_0f3aad02-608d-4c76-bdc3-b9c307b9234d">35,000</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNC0zLTEtMS05MDY2NQ_d0b30c6e-f8c5-4a68-b6e3-a2b8dac142f8">32,974</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Letter of credit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNS0xLTEtMS05MDY2NQ_41564da1-238e-49e8-a682-44483bc75c8a">600</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNS0zLTEtMS05MDY2NQ_7e2e09a1-05d3-4207-8577-51c526803b0c">600</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Availability on Revolving Facility</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNy0xLTEtMS05MDY2NQ_a9134561-d20e-4af5-8246-0b8de1ab894d">39,400</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNy0zLTEtMS05MDY2NQ_f45c4b0f-1dbf-4888-b37a-e46f7c04eece">41,426</ix:nonFraction></span></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgzMQ_a2dfb4c8-8fbe-49d8-8a7c-36e9ef2f1fe7" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company had future maturities of its long-term debt as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2026 and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">thereafter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS0xLTEtMS05MDY2NQ_c3934a65-a406-462f-9407-2b19d2aa932f">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS0zLTEtMS05MDY2NQ_19342f83-1934-41c1-ae90-13f5ed9f04d2">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS01LTEtMS05MDY2NQ_950cec9f-15d5-4694-8092-d3c45ebd21b9">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS03LTEtMS05MDY2NQ_d9da6b5e-e7ae-4708-9325-4481f538728a">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS05LTEtMS05MDY2NQ_15f331cf-221b-448a-a725-129599025726">35,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS0xMS0xLTEtOTA2NjU_8fce2874-fcb7-4480-be7f-d4fc402491c7">35,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other financing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi0xLTEtMS05MDY2NQ_89a59175-244e-459f-8eec-4db2cf6efdb9">230</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi0zLTEtMS05MDY2NQ_d593191a-caa2-4406-9011-72556fdde4ed">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi01LTEtMS05MDY2NQ_d5fe4b1a-36f4-4416-a13a-78a28c96d5ee">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi03LTEtMS05MDY2NQ_03f8827a-326c-4be4-b3f2-2ea7758bc88a">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi05LTEtMS05MDY2NQ_bc610837-1681-4f0b-877a-06efb2e7a3f5">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi0xMS0xLTEtOTA2NjU_6d667336-93ff-499c-b091-11f4c590073a">230</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy0xLTEtMS05MDY2NQ_6aa6049f-0eb6-49b4-9df6-16f705915d6d">230</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy0zLTEtMS05MDY2NQ_aa7f4194-b6d3-4a51-b2a1-3f4f2cdec3a4">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy01LTEtMS05MDY2NQ_f2062505-1cec-48e8-82d5-3e3aa38c9212">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy03LTEtMS05MDY2NQ_5d16bd57-829f-4400-93be-532fded38f91">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy05LTEtMS05MDY2NQ_da128d98-1b62-428b-8cc4-e7273013c5f9">35,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy0xMS0xLTEtOTA2NjU_49481310-e9c4-4bd0-b273-5047f6e8fde5">35,230</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgzNA_90da996c-5fff-4c5c-a6ed-5b75ba725670" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a breakdown of the Company&#8217;s current and long-term debt (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Current </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Long-Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Long-Term </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi0xLTEtMS05MDY2NQ_e8693ff9-3999-4b03-a838-3f0a9eaf6940">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi0zLTEtMS05MDY2NQ_056192db-a0d1-43b0-a8f5-47cf87d6e374">35,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi01LTEtMS05MDY2NQ_7e266f1a-76b6-45be-ac0c-4fa2b90f0640">35,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi03LTEtMS05MDY2NQ_685e087b-6188-4483-9c2c-8a85d28e4484">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi05LTEtMS05MDY2NQ_5d87754b-47b2-400e-87fd-b2c2b5349498">32,974</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi0xMS0xLTEtOTA2NjU_7ab83ed4-835f-427c-a6ab-9825f00e5550">32,974</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other financing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="infu:LongtermDebtGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi0xLTEtMS05MDY2NQ_13087b72-a240-406a-adae-e72129586421">230</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi0zLTEtMS05MDY2NQ_5198f8cd-ef86-4964-81ed-a0d69daab9be">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi01LTEtMS05MDY2NQ_83c6aa7e-d9e3-40a3-972e-549ac5023ea1">230</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if15ae0b27a6244e18335b6d84819ccdd_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi03LTEtMS05MDY2NQ_9666c8fb-1d8d-40f6-9dcb-b80ca13f1bf6">423</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if15ae0b27a6244e18335b6d84819ccdd_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi05LTEtMS05MDY2NQ_d6664f22-a22e-4fbd-b866-3572da75841a">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if15ae0b27a6244e18335b6d84819ccdd_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi0xMS0xLTEtOTA2NjU_23926965-0e21-4037-b467-7c433dc6430c">423</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:LongtermDebtGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy0xLTEtMS05MDY2NQ_a637e082-ca41-40e5-993a-43c4716450ea">230</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy0zLTEtMS05MDY2NQ_c697294a-9c54-42fd-97f9-a1e9951e5f0e">35,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy01LTEtMS05MDY2NQ_9562b9dc-aa72-474a-b80b-4bcf7fd20453">35,230</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:LongtermDebtGrossCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy03LTEtMS05MDY2NQ_03475ec3-b032-4ac8-9b54-41eb1c8fbb06">423</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:LongTermDebtGrossNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy05LTEtMS05MDY2NQ_6661a590-c4c9-455d-bbab-f6b49b466540">32,974</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy0xMS0xLTEtOTA2NjU_b75bcd6c-5fae-425d-9db7-e6a74d2fe7dc">33,397</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unamortized value of debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:UnamortizedDebtIssuanceExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC0xLTEtMS05MDY2NQ_799320bb-c098-4cdd-9d55-76e7a7a70c10">74</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:UnamortizedDebtIssuanceExpenseNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC0zLTEtMS05MDY2NQ_5ff2a749-2793-488e-aaef-a9810c987133">208</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC01LTEtMS05MDY2NQ_6bfb3e0f-0de9-403c-a001-0c23e59ad8cc">282</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:UnamortizedDebtIssuanceExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC03LTEtMS05MDY2NQ_6f63b3cd-d1c0-4c63-aa9e-59a32988828c">74</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="infu:UnamortizedDebtIssuanceExpenseNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC05LTEtMS05MDY2NQ_242558bc-6c49-48ea-aca8-dba9974c788b">226</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC0xMS0xLTEtOTA2NjU_41602a0d-286a-4e8e-a446-acd3fdd672e4">300</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS0xLTEtMS05MDY2NQ_fc7c8118-e2fa-4e61-8dae-ec883b03846a">156</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS0zLTEtMS05MDY2NQ_6989dbed-a51e-49c8-805e-a001a599d67c">34,792</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS01LTEtMS05MDY2NQ_4b30bb2d-e299-488a-bd2a-34bff7f5ef6a">34,948</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS03LTEtMS05MDY2NQ_1c45bad8-0870-4a1b-aeb4-d6897d65b126">349</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS05LTEtMS05MDY2NQ_44e93d92-235b-4ae9-b6ff-46d4cee6d142">32,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS0xMS0xLTEtOTA2NjU_4ba904f4-23fa-4da8-acae-df884c969767">33,097</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March&#160;31, 2022, amounts outstanding under the Revolving Facility provided under the 2021 Credit Agreement bear interest at a variable rate equal to, at the Company&#8217;s election, a LIBO Rate for Eurodollar loans or an Alternative Base Rate for ABR loans, as defined by the 2021 Credit Agreement, plus a spread that will vary depending upon the Company&#8217;s leverage ratio. The spread ranges from <ix:nonFraction unitRef="number" contextRef="i7be2e6385d2e4a1f81cede9f9325baf4_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjYxNg_f513fd94-ecba-45fb-9c5b-77849abd02c1">2.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id6870ed273a94fee99d887c2cff01c3b_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjYyMg_68f713c7-1835-4e16-9ed2-194f9620f124">3.00</ix:nonFraction>% for Eurodollar Loans and <ix:nonFraction unitRef="number" contextRef="i31619f4fd16547b6a88ad77ca83de2b5_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjY1MA_2383e18e-af7d-4dc2-bcdf-eeedebb53763">1.00</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i621754a0bc234c319f31862d80d9e6bf_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjY1Ng_56e8101c-58c7-4085-bec9-c31324054f52">2.00</ix:nonFraction>% for base rate loans. The weighted-average Eurodollar loan rate at March&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="i648fe53f400e4a9fa1260cef7c260580_I20220331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjczMg_4e4d612f-c42b-47aa-92bb-3ed9a5575184">2.37</ix:nonFraction>% (LIBO of <ix:nonFraction unitRef="number" contextRef="i648fe53f400e4a9fa1260cef7c260580_I20220331" decimals="4" name="infu:LIBORRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjc0NA_85ffb0f5-a2be-4ac3-a5c0-f83f9058b55c">0.37</ix:nonFraction>% plus <ix:nonFraction unitRef="number" contextRef="ia4114f950c2d4190904d6635dfffe982_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjc1Mg_311a65d7-48e7-41df-8b2d-6c3e07c0855b">2.00</ix:nonFraction>%). The actual ABR loan rate at March&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="ibcc44660e52943efa3af89d8516b33e7_I20220331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjc5Mg_1b244a65-883a-4aff-b2b8-7ac880fcd3a8">4.25</ix:nonFraction>% (lender&#8217;s prime rate of <ix:nonFraction unitRef="number" contextRef="ibcc44660e52943efa3af89d8516b33e7_I20220331" decimals="4" name="infu:LenderPrimeRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgxOQ_b027ac88-d134-4190-a214-cbcd7b3b1a3e">3.25</ix:nonFraction>% plus <ix:nonFraction unitRef="number" contextRef="i4cfd39a0ac8040ccb08858cf8fa5bf15_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgyNw_59a457c8-fbbe-4b6e-81a5-b0558416c400">1.00</ix:nonFraction>%).</span></div></ix:continuation><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_55"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:19.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTk5OQ_db8aa664-7dcd-4e52-b553-9102e3ff3d6b" continuedAt="ia53877999291434e8c548feea3cee3e6" escape="true">Derivative Financial Instruments and Hedging Activities</ix:nonNumeric></span></div><ix:continuation id="ia53877999291434e8c548feea3cee3e6" continuedAt="i83e145c32f094fff9be4b1ed5804ecbe"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMjc0ODc3OTA3MTYyNQ_9b4d8a66-ea51-455b-927c-69152510d4e2" escape="true">In February 2021, the Company adopted a derivative investment policy which provides guidelines and objectives related to managing financial and operational exposures arising from market changes in short term interest rates. In accordance with this policy, the Company can enter into interest rate swaps or similar instruments, will endeavor to evaluate all the risks inherent in a transaction before entering into a derivative financial instrument and will not enter into derivative financial instruments for speculative or trading purposes. Hedging relationships are formally documented at the inception of the hedge and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.</ix:nonNumeric></span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is exposed to interest rate risk related to its variable rate debt obligations under the 2021 Credit Agreement. In order to manage the volatility in interest rate markets, in February 2021, the Company entered into <ix:nonFraction unitRef="numberofagreement" contextRef="i46375b7fb651451ea71759de00ad04f8_I20210205" decimals="INF" name="us-gaap:DerivativeNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTEyMQ_c12cd4c7-5a7f-4e97-a690-b85b8c4ee9f8">two</ix:nonFraction> interest rate swap agreements to manage exposure arising from this risk. On a combined basis, the agreements have a constant notional amount over a <ix:nonNumeric contextRef="i18d15197765c4fbe87a2fbc20e38f379_D20210205-20210205" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTk5Ng_311b344c-1d10-4e47-8caf-9883fb7d31b6">five-year</ix:nonNumeric> term that ends on February 5, 2026. The agreements both pay the Company 30-day LIBOR on the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><ix:continuation id="i83e145c32f094fff9be4b1ed5804ecbe"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">notional amount and the Company pays a fixed rate of interest equal to <ix:nonFraction unitRef="number" contextRef="i46375b7fb651451ea71759de00ad04f8_I20210205" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTQ0Mw_201f6220-eedb-4207-8ad5-10da4b784289">0.73</ix:nonFraction>%. These derivative instruments are considered cash flow hedges. The Company does not have any other derivative financial instruments.</span></div><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTk5Nw_518a3835-a24d-41f5-bef4-5fbcfdb66c61" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The tables below present the location and gross fair value amounts of our derivative financial instruments and the associated notional amounts designated as cash flow hedges as of the applicable balance sheet date (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i718b8b354a364afc9026b010eb60129b_I20220331" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOjBiZDQzYjdjZTZmMDQ3ZDE5NmUzOTE5ZmY0YjU2ZjA5L3RhYmxlcmFuZ2U6MGJkNDNiN2NlNmYwNDdkMTk2ZTM5MTlmZjRiNTZmMDlfNC00LTEtMS05MDY2NQ_a335bb22-f64a-4345-89c3-9ed1445c7913">20,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i718b8b354a364afc9026b010eb60129b_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOjBiZDQzYjdjZTZmMDQ3ZDE5NmUzOTE5ZmY0YjU2ZjA5L3RhYmxlcmFuZ2U6MGJkNDNiN2NlNmYwNDdkMTk2ZTM5MTlmZjRiNTZmMDlfNC02LTEtMS05MDY2NQ_9e21b111-41da-4402-befc-ae423e7a28b9">1,260</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.302%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i11453ba9eaac46c4bb4e7d291baadf1c_I20211231" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOjExNzkyODRiNDc4NDQzYmVhZDIwYTRhNGE5MWQ2MzFiL3RhYmxlcmFuZ2U6MTE3OTI4NGI0Nzg0NDNiZWFkMjBhNGE0YTkxZDYzMWJfNC00LTEtMS05MjU5OA_6267d35b-6613-4ba5-83fe-64de71b4f44d">20,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i11453ba9eaac46c4bb4e7d291baadf1c_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOjExNzkyODRiNDc4NDQzYmVhZDIwYTRhNGE5MWQ2MzFiL3RhYmxlcmFuZ2U6MTE3OTI4NGI0Nzg0NDNiZWFkMjBhNGE0YTkxZDYzMWJfNC02LTEtMS05MjYwNQ_8ceef931-4ddb-4dbe-8833-7b0590f51fc2">355</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTk5OA_3740cb5b-fc03-479d-bab2-6c5d05fce20c" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2021</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on cash flow hedges - interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i93ef1df061524c8b9663782244eb5d30_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMi0yLTEtMS05MDY2NQ_f1c0a9cf-1427-46e0-9d72-ba0e42cfc438">268</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="idf2eab998bda4fbd8fbc14723f4850ab_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMi00LTEtMS05MDY2NQ_ae208bf2-4a4d-4f2e-bace-e7aa3570b22f">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized gain recognized in AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i085e4370af544db9a0d15a2675df534e_D20220101-20220331" decimals="-3" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMy0yLTEtMS05MDY2NQ_57125c86-add0-465c-90e1-4069a2b30764">877</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9cdfd77a386045118c342ea3d171f086_D20210101-20210331" decimals="-3" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMy00LTEtMS05MDY2NQ_7bc78034-2251-46af-8fb5-dafe7fa38c13">148</ix:nonFraction></span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amounts reclassified to interest expense (a)(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i085e4370af544db9a0d15a2675df534e_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNC0yLTEtMS05MDY2NQ_e645f4c8-1fdb-4493-bedd-b232166b157e">28</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9cdfd77a386045118c342ea3d171f086_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNC00LTEtMS05MDY2NQ_64bbd935-33a3-4c8f-8c08-91060b65e5dd">10</ix:nonFraction></span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i085e4370af544db9a0d15a2675df534e_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNS0yLTEtMS05MDY2NQ_9f12fcfe-2e04-4154-a1b4-7e23f876727e">218</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9cdfd77a386045118c342ea3d171f086_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNS00LTEtMS05MDY2NQ_cdc012a8-f03a-48a5-ad97-fe327b2f672d">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0066368dfe234730a0ec98982a4f6be1_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNi0yLTEtMS05MDY2NQ_7c41e5c2-0bba-43e4-b68c-51548934799b">955</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib91337cd039b4e1fb73ba260c56f4232_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNi00LTEtMS05MDY2NQ_a9b9b3f8-3499-450e-9288-f9433e984236">158</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) Positive amounts represented interest expense. Total interest expense as presented in the condensed consolidated statement of operations and comprehensive income for the three months ended March&#160;31, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfOS0wLTEtMS05MDY2NS90ZXh0cmVnaW9uOjUzMDIxNDFmOGY3NDQ5MGJiNGJiNmE0Y2UwYzljYTdmXzE1NQ_c79ddb81-24ad-4f40-b59f-75a49ca5bcfd">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfOS0wLTEtMS05MDY2NS90ZXh0cmVnaW9uOjUzMDIxNDFmOGY3NDQ5MGJiNGJiNmE0Y2UwYzljYTdmXzEwOTk1MTE2MjgwMTE_e7312163-6ecb-4052-b2d7-9a27b9c43d60">0.3</ix:nonFraction> million, respectively.</span></div></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(b) As of March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i4b1ca0fa1a4549d0b3d620aeaa0f1a50_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMTAtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjozMWFiMTQwOTIwNzg0MzZiOTcxMWJmYzQzYTk4MTIwOV85_60090b7d-4cb5-44f3-b7eb-e2a5091cd026">0.2</ix:nonFraction> million of income is expected to be reclassified into earnings within the next 12 months.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company did <ix:nonFraction unitRef="usd" contextRef="i4b1ca0fa1a4549d0b3d620aeaa0f1a50_D20220101-20220331" decimals="INF" name="us-gaap:DerivativeNetHedgeIneffectivenessGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTkyMw_302d621d-d7d4-44aa-b4c3-4c86e7e94ec9"><ix:nonFraction unitRef="usd" contextRef="i97d7dd5690f147b482bf2fe489cfcf4a_D20210101-20210331" decimals="INF" name="us-gaap:DerivativeNetHedgeIneffectivenessGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTkyMw_43c2b6fc-c581-4154-9d80-b3bd693f72bf">not</ix:nonFraction></ix:nonFraction> incur any hedge ineffectiveness during the three months ended March&#160;31, 2022 and 2021, respectively.</span></div></ix:continuation><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_58"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:14.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfMTAzMA_6b375825-8ec7-4011-8b85-6169af2929aa" continuedAt="ib78dc477104d4ef5912e40ff16045866" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="ib78dc477104d4ef5912e40ff16045866" continuedAt="i3306a2fd36614ee1970c4da2ae48c36d"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recorded a benefit from income taxes of $<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfNzg_032cc8d4-cbcb-4bdb-9ea0-7e88df155ef0">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfMzg0ODI5MDcwMDgxMg_810303bb-5c0d-45dc-8b3b-8cab13144f9c">0.2</ix:nonFraction> million during the three months ended March&#160;31, 2022 and 2021, respectively. The income tax benefit during 2022 relates principally to a pre-tax loss whereas the benefit during 2021 relates to excess tax benefits on exercises of stock options and vesting of restricted stock during the period. Other differences in the effective tax rate include the estimate of the Company&#8217;s annual state and local taxes and taxes relating to its foreign operations in Canada. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (&#8220;CARES&#8221;) Act was enacted in response to the COVID-19 pandemic. The CARES Act among other things, allows employers to defer the deposit and payment of the employer's share of Social Security taxes. Under the CARES Act, the Company deferred paying $<ix:nonFraction unitRef="usd" contextRef="i1c35755c8447450b8e419647303eac4d_I20201231" decimals="-5" name="us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfNzc3_7dc3d26e-c010-4e8c-adbb-3fc9e83f0347"><ix:nonFraction unitRef="usd" contextRef="i17cfc9c479c543688ef515f286847c44_I20211231" decimals="-5" name="us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfNzc3_e70f3cc2-8cc4-4e40-a13f-e1c7a74cb14a">0.7</ix:nonFraction></ix:nonFraction> million of applicable </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i3306a2fd36614ee1970c4da2ae48c36d">gross payroll taxes as of December&#160;31, 2020, which was included in other liabilities. The $<ix:nonFraction unitRef="usd" contextRef="i1c35755c8447450b8e419647303eac4d_I20201231" decimals="-5" name="us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfODc2_7dc3d26e-c010-4e8c-adbb-3fc9e83f0347"><ix:nonFraction unitRef="usd" contextRef="i17cfc9c479c543688ef515f286847c44_I20211231" decimals="-5" name="us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfODc2_e70f3cc2-8cc4-4e40-a13f-e1c7a74cb14a">0.7</ix:nonFraction></ix:nonFraction> million balance of the deferred Social Security taxes was expected to be paid in two equal annual installments during the years ending December&#160;31, 2021 and 2022, respectively. In December 2021, the Company made the first of these two equal annual installment payments. As of March&#160;31, 2022, the remaining balance of approximately $<ix:nonFraction unitRef="usd" contextRef="i0649b764378d49608401c1e982e219f9_I20220331" decimals="-5" name="us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfMjc0ODc3OTA3MzAxMw_a5586a96-821b-48a3-a586-261ae18beac5">0.3</ix:nonFraction>&#160;million is included in other liabilities.</ix:continuation></span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_61"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:14.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182MS9mcmFnOjlhMGI4MjhjNTYxMDRkZTQ4ZjcyZGNkOTQyMGI1YTBhL3RleHRyZWdpb246OWEwYjgyOGM1NjEwNGRlNDhmNzJkY2Q5NDIwYjVhMGFfMTM0Ng_888993bf-5bd1-4a28-b124-843c4211d2ab" continuedAt="iafc35e0f3c68422ba266e273c6e4f39e" escape="true">Commitments, Contingencies and Litigation</ix:nonNumeric></span></div><ix:continuation id="iafc35e0f3c68422ba266e273c6e4f39e"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time in the ordinary course of its business, the Company may be involved in legal and regulatory proceedings, the outcomes of which may not be determinable. The results of litigation and regulatory proceedings are inherently unpredictable. Any claims against the Company, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. The Company is not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable, primarily for the following reasons: (i) many of the relevant legal proceedings are in preliminary stages and, until such proceedings develop further, there is often uncertainty regarding the relevant facts and circumstances at issue and potential liability; and (ii) many of these proceedings involve matters of which the outcomes are inherently difficult to predict. The Company has insurance policies covering potential losses where such coverage is cost effective.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is not at this time involved in any proceedings that the Company currently believes could have a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</span></div></ix:continuation><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_64"></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:14.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTkwNQ_9c431ec9-485c-4114-aefb-7203d1357eca" continuedAt="iae73329e94a84ec5b772f6e291b49296" escape="true">(Loss) Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="iae73329e94a84ec5b772f6e291b49296"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic (loss) income per share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted (loss) income per share assumes the issuance of potentially dilutive shares of common stock during the period. <ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTkwNg_3b25abf4-0b9b-463e-be97-8e550e1c349c" continuedAt="i7c45bfcf87b1405d8806cf32ca645441" escape="true">The following table reconciles the numerators and denominators of the basic and diluted (loss) income per share computations:</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i7c45bfcf87b1405d8806cf32ca645441"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Numerator </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">:</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfMi0xLTEtMS05MDY2NQ_f8668f69-3719-4ac0-8bec-5ee21827b3a5">368</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfMi0zLTEtMS05MDY2NQ_b95bc7c9-d6d9-4444-b2b6-3724563d8d15">661</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNS0xLTEtMS05MDY2NQ_99777740-09bf-4ff8-8ab0-a500a0bf6550">20,609,372</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNS0zLTEtMS05MDY2NQ_447b2765-0467-488d-a5a1-9afad2d1257a">20,338,160</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dilutive effect of common stock equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNi0xLTEtMS05MDY2NQ_aec17e68-8be8-471b-940b-cec37b291d08">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNi0zLTEtMS05MDY2NQ_cc08ed80-78eb-4d10-a0e3-68904c89aec9">1,599,479</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNy0xLTEtMS05MDY2NQ_e7c3621b-ea6d-4dd2-b0a7-1f75dc16eb87">20,609,372</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNy0zLTEtMS05MDY2NQ_500c5825-5dc0-45e5-a9df-8b9e225205d1">21,937,639</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="INF" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfOS0xLTEtMS05MDY2NQ_8717a99a-9ed8-4439-bdfe-5ca8fd19314a">0.02</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="INF" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfOS0zLTEtMS05MDY2NQ_9ebbcc2b-6242-42ad-b27c-c37608eeb247">0.03</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="INF" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfMTAtMS0xLTEtOTA2NjU_b2a10771-a60b-4ef2-aae0-f6e6e0853429">0.02</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="INF" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfMTAtMy0xLTEtOTA2NjU_c6ca23c9-76d6-410c-89e2-6108f6d9e492">0.03</ix:nonFraction></span></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended March 31, 2022, all outstanding options and unvested restricted stock units were anti-dilutive due to the Company's net losses for the period and therefore are not included in the calculation. For the three months ended March&#160;31, 2021, less than <ix:nonFraction unitRef="shares" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTA5OTUxMTYzMTAzOQ_fe3f353e-f643-4504-8274-e89de9c91228">0.1</ix:nonFraction> million of outstanding options and unvested restricted stock units with an exercise price above the current market value of the Company&#8217;s common stock were not included in the calculation because they would have an anti-dilutive effect.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Share Repurchase Program</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 30, 2021, our Board of Directors approved a stock repurchase program (the &#8220;Share Repurchase Program&#8221;) that authorizes the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i9ad5338f58cd45369e7740b50719ff1d_I20210630" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTI0MQ_8bb9635a-3630-4f8d-8865-4bea3738a402">20.0</ix:nonFraction> million of the Company&#8217;s outstanding common stock through June 30, 2024. Repurchases under the Share Repurchase Program are subject to market conditions, the periodic capital needs of the Company&#8217;s operating activities, and the continued satisfaction of all covenants under the Company&#8217;s existing 2021 Credit Agreement. Repurchases under the Share Repurchase Program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase Program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. As of March&#160;31, 2022, the Company had repurchased approximately $<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:ShareRepurchaseProgramCumulativeSharesRepurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTY0OTI2NzQ0NDI5MA_8233e7a6-a3d9-4b14-a9e5-8b28bcd5042e">4.6</ix:nonFraction> million, or <ix:nonFraction unitRef="shares" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="INF" name="infu:ShareRepurchaseProgramCumulativeSharesPurchasedShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTY0OTI2NzQ0NDMwMg_f38e6318-fb8e-4029-96d2-00e38f60f890">343,514</ix:nonFraction> shares, of the Company's outstanding common stock under the Share Repurchase Program.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:14.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMTU5MA_229bc179-25a9-4d50-8304-623b8e687e9d" continuedAt="iae61c5e89b00483f84c2613d5250126b" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="iae61c5e89b00483f84c2613d5250126b" continuedAt="i45b91a5dc376425f9c7e16f0b106a9fc"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next <ix:nonNumeric contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMjc0ODc3OTA3MTA1MA_a62c60df-b4c9-4c7e-920f-562a09aa3c0a">ten years</ix:nonNumeric>. The Company&#8217;s leases do not contain any restrictive covenants. The Company&#8217;s office leases generally contain renewal options for periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMzUz_c5ee57a4-2e68-4541-8653-b24cb86c7ae1">one</span> to <ix:nonNumeric contextRef="i9823e66bcb094044aa90984c93101af3_I20220331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMTU4Nw_8d141d24-5a58-47c1-a90a-c0cf0a626c80">five years</ix:nonNumeric>. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#8217;s office leases do not contain any material residual value guarantees. The Company&#8217;s equipment leases generally do not contain renewal options.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Payments due under the Company&#8217;s operating leases include fixed payments as well as variable payments. For the Company&#8217;s office leases, variable payments include amounts for the Company&#8217;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#8217;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.</span></div><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMTU4OA_0db8aaa9-4315-4e92-9cd5-15ffc8a5f5c8" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease costs for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfMi0yLTEtMS05MDY2NQ_1361ba2c-5b42-450e-810d-2facf3162b9b">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfMi00LTEtMS05MDY2NQ_dd578f19-27c6-46d6-815c-7b6c89875c35">348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfMy0yLTEtMS05MDY2NQ_f8661938-1074-4874-a20f-c8cd03ca9e7e">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfMy00LTEtMS05MDY2NQ_ffb86dd5-0216-424c-905b-8476ee3c20ee">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfNC0yLTEtMS05MDY2NQ_5bb1c756-9097-41a7-96f2-2717d57da0d0">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfNC00LTEtMS05MDY2NQ_178d2557-4864-41e3-87a9-ca6ab0d45261">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Supplemental cash flow information and non-cash activity related to the Company&#8217;s leases are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurement of lease liabilities and right of use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flow from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjkwNmJkNDgyZTQ4ZjRjNmZiYjEzZjE3N2E1YWUzYTc1L3RhYmxlcmFuZ2U6OTA2YmQ0ODJlNDhmNGM2ZmJiMTNmMTc3YTVhZTNhNzVfMy0yLTEtMS05MDY2NQ_9aede945-a332-439b-92a8-4a7bb3e82676">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjkwNmJkNDgyZTQ4ZjRjNmZiYjEzZjE3N2E1YWUzYTc1L3RhYmxlcmFuZ2U6OTA2YmQ0ODJlNDhmNGM2ZmJiMTNmMTc3YTVhZTNhNzVfMy00LTEtMS05MDY2NQ_5f5703f5-3d16-41ca-83fa-f2381ddf00c3">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right of use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjkwNmJkNDgyZTQ4ZjRjNmZiYjEzZjE3N2E1YWUzYTc1L3RhYmxlcmFuZ2U6OTA2YmQ0ODJlNDhmNGM2ZmJiMTNmMTc3YTVhZTNhNzVfNi0yLTEtMS05MDY2NQ_8c817ecd-69f9-40ac-8c85-1d4dc56fb228">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjkwNmJkNDgyZTQ4ZjRjNmZiYjEzZjE3N2E1YWUzYTc1L3RhYmxlcmFuZ2U6OTA2YmQ0ODJlNDhmNGM2ZmJiMTNmMTc3YTVhZTNhNzVfNi00LTEtMS05MDY2NQ_105829df-0b1a-4bc5-b066-bd62e39eb355">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average remaining lease terms and discount rates for the Company&#8217;s operating leases are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjNiYWU3ZTZkZWVkNjQ1MDhiZjM1NmE4ZjU3OGQ5NWEzL3RhYmxlcmFuZ2U6M2JhZTdlNmRlZWQ2NDUwOGJmMzU2YThmNTc4ZDk1YTNfNC0yLTEtMS05MDY2NQ_2c4abc2a-95d2-4899-82f9-9c96c96f64a5">6.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjNiYWU3ZTZkZWVkNjQ1MDhiZjM1NmE4ZjU3OGQ5NWEzL3RhYmxlcmFuZ2U6M2JhZTdlNmRlZWQ2NDUwOGJmMzU2YThmNTc4ZDk1YTNfNC00LTEtMS05MDY2NQ_537d847f-c58e-467a-968a-e8a4ec71a37e">6.6</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjNiYWU3ZTZkZWVkNjQ1MDhiZjM1NmE4ZjU3OGQ5NWEzL3RhYmxlcmFuZ2U6M2JhZTdlNmRlZWQ2NDUwOGJmMzU2YThmNTc4ZDk1YTNfNy0yLTEtMS05MDY2NQ_c944446d-bb86-4e7f-8095-8e6858f1522a">7.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="number" contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjNiYWU3ZTZkZWVkNjQ1MDhiZjM1NmE4ZjU3OGQ5NWEzL3RhYmxlcmFuZ2U6M2JhZTdlNmRlZWQ2NDUwOGJmMzU2YThmNTc4ZDk1YTNfNy00LTEtMS05MDY2NQ_7c1ec0eb-03f9-467b-89eb-9e127d08ae8b">7.7</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><ix:continuation id="i45b91a5dc376425f9c7e16f0b106a9fc"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMTU4OQ_3ce9722b-cbab-4ed6-bdfc-9372adb943d5" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Future maturities of lease liabilities as of March&#160;31, 2022 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operating</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Leases</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfMS0yLTEtMS05MDY2NQ_6f6983e4-6b39-4f87-98e2-fcd43b1808c4">869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfMi0yLTEtMS05MDY2NQ_c68e92aa-44f7-4add-bb00-4c727997d857">1,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfMy0yLTEtMS05MDY2NQ_62624b5e-6302-4bd3-884c-160487c7462d">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfNC0yLTEtMS05MDY2NQ_1271b1fe-d351-4a04-942f-91f5d2fbe2a7">1,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfNS0yLTEtMS05MDY2NQ_cb4655a4-4bb4-4b1b-9c79-af346e1ea10d">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027 and thereafter</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="infu:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfNi0yLTEtMS05MDY2NQ_1e3461f1-b3ad-4fb1-b5ae-84a5cfd9bba4">1,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfNy0yLTEtMS05MDY2NQ_24dcfdb1-25b9-4120-a1f8-ef889e130384">6,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfOC0yLTEtMS05MDY2NQ_17d91ae6-1a8b-48cc-ae23-583585f5c8ff">2,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfOS0yLTEtMS05MDY2NQ_d1edaa8d-e049-44f1-a2af-33df35351402">4,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_70"></div><div style="margin-top:12pt;padding-left:27pt;padding-right:7.2pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:14.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RleHRyZWdpb246MzQ2N2U2ZTBkZTFmNDk5MWExOWZhNmM0NjAyYzZjYjdfODg1_1fea7f43-aaf0-47e8-8c6d-7772b4764caf" continuedAt="i56d1a6e6d0b4461ea2a81faaf90c9b04" escape="true">Business Segment Information</ix:nonNumeric></span></div><ix:continuation id="i56d1a6e6d0b4461ea2a81faaf90c9b04" continuedAt="i57d29f62bf2243d991afcf4da7da7f86"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s reportable segments are organized based on service platforms, with the ITS segment reflecting higher margin rental revenues that generally include payments made by third-party and direct payers and the DME Services segment reflecting lower margin product sales, direct payer rental and services revenues. Resources are allocated and performance is assessed for these segments by the Company&#8217;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker. The Company believes that reporting performance at the gross profit level is the best indicator of segment performance.</span></div><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RleHRyZWdpb246MzQ2N2U2ZTBkZTFmNDk5MWExOWZhNmM0NjAyYzZjYjdfODg2_e94688fe-adf7-4ccc-8181-c117c406a87e" continuedAt="ib9abbf7f8cc647a9b4120a5cc5e2fc1a" escape="true"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The financial information summarized below is presented by reportable segment for the three months ended March&#160;31, 2022 and 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ITS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate/</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMy0yLTEtMS05MDY2NQ_5a16aa87-6c33-43dd-978c-f1e3d5676648">16,641</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMy00LTEtMS05MDY2NQ_9356397b-3fb5-4885-b61e-38a5144b1a44">10,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" name="infu:RevenuesExternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMy02LTEtMS05MDY2NQ_bc67c930-b404-4340-8818-74a97a92e9c2">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMy04LTEtMS05MDY2NQ_907d7cf4-9571-40f0-93c6-4afa73c0da7d">26,763</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNC0yLTEtMS05MDY2NQ_700f3228-55ee-4759-a444-410cbe40a8db">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331" decimals="-3" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNC00LTEtMS05MDY2NQ_ad8a205b-b10d-4a69-a37d-32b454d71d06">1,488</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" sign="-" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNC02LTEtMS05MDY2NQ_29b4414b-3e13-4138-9838-25c89e2cdef3">1,488</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNC04LTEtMS05MDY2NQ_6f760d32-94b5-40e7-8350-5e6d46b0c054">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNS0yLTEtMS05MDY2NQ_352ccfc4-1b34-4770-add9-9fcaacb55e3e">16,641</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNS00LTEtMS05MDY2NQ_df857214-c486-4504-a5f9-8dede42cdbc2">11,610</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNS02LTEtMS05MDY2NQ_41749289-a9b0-4fd5-9ef1-39c867bca4f6">1,488</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNS04LTEtMS05MDY2NQ_b9585b65-4548-4de4-9428-2fc73ff5ca13">26,763</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNi0yLTEtMS05MDY2NQ_276442dc-0635-47ed-befd-b9155225bf39">10,738</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNi00LTEtMS05MDY2NQ_069c867a-aae4-4a91-ad97-4c9ef379c203">4,629</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNi02LTEtMS05MDY2NQ_f5348626-d5c6-45f9-96e4-266666df2e0e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNi04LTEtMS05MDY2NQ_eda45e29-8bc7-4e2d-8014-a8ee5d68b7e9">15,367</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfOC02LTEtMS05MDY2NQ_75de3372-376c-4faa-869e-7505661fb324">15,892</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfOC04LTEtMS05MDY2NQ_7a55103e-6800-482c-8dcd-7232f729af77">15,892</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfOS02LTEtMS05MDY2NQ_dee0b917-edce-4337-8581-4798314f67d4">277</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfOS04LTEtMS05MDY2NQ_1559d21c-8612-46b7-8909-7c1aac4ca23f">277</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTAtNi0xLTEtOTA2NjU_fefcde72-7364-4a75-ae7b-c6e76d7ac9f7">28</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTAtOC0xLTEtOTA2NjU_c7b59a46-6729-45d6-a175-6d4a3bb7eeaf">28</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTEtNi0xLTEtOTA2NjU_2c49ab5e-5290-432f-9b33-496b9f87c921">462</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTEtOC0xLTEtOTA2NjU_2f481cc9-487c-410d-813c-10374c5ef441">462</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTMtOC0xLTEtOTA2NjU_f251dd11-ef4c-4a84-8cc5-32ae89e11bac">368</ix:nonFraction>)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7948825b6e95471c8a412984f797602e_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTUtMi0xLTEtOTA2NjU_dfe5e56c-db7b-49cb-a8a5-b60e3ccbd72c">61,991</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i814be89047894da9a58c9f276f7bd602_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTUtNC0xLTEtOTA2NjU_e1d4025f-d308-4597-a1b5-1ecae4cf98f0">34,246</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i91e9dc825e4341c0b5c96f30ce2f3772_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTUtNi0xLTEtOTA2NjU_7d8531e2-cd1b-4bc3-b45e-c87b2bdeee07">2,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTUtOC0xLTEtOTA2NjU_51f7d73d-4218-42e4-898f-15e7965e680f">98,237</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTYtMi0xLTEtOTA2NjU_c0c13f54-deb4-4f2b-8cb4-568192f378e2">1,511</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTYtNC0xLTEtOTA2NjU_23ff4eb7-62b3-48f5-a3f3-54804cb022a0">1,420</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTYtNi0xLTEtOTA2NjU_bad7e2e0-c1e1-4882-82ff-25e11e3ce7bc">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTYtOC0xLTEtOTA2NjU_b678ecd7-799d-4298-8690-ff37f0779f4e">2,931</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTctMi0xLTEtOTA2NjU_ca0d43c2-2161-4c99-93d5-7627e9c22ab9">2,398</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTctNC0xLTEtOTA2NjU_e4b5b70a-2563-4263-b745-19487caf3e5b">1,018</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTctNi0xLTEtOTA2NjU_46d2d8c6-bfb4-4bba-abf3-88fc74c6ab49">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTctOC0xLTEtOTA2NjU_5c83252c-33e1-4928-ac17-139c7f8b8495">3,416</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><ix:continuation id="i57d29f62bf2243d991afcf4da7da7f86"><ix:continuation id="ib9abbf7f8cc647a9b4120a5cc5e2fc1a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ITS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate/</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMy0yLTEtMS05MDY2NQ_f0419267-b6a5-495d-9148-b98ad68b4bc9">15,911</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMy00LTEtMS05MDY2NQ_cdd99bca-bf02-4d6e-97d5-1cd72cd56ded">8,552</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" name="infu:RevenuesExternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMy02LTEtMS05MDY2NQ_2647e168-f9d6-4855-8622-297264175c87">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="infu:RevenuesExternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMy04LTEtMS05MDY2NQ_edca2c8a-e61e-4170-ac59-f8e9d20bfd79">24,463</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNC0yLTEtMS05MDY2NQ_1a064282-6d51-4f7f-8358-dd6bc261152f">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331" decimals="-3" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNC00LTEtMS05MDY2NQ_a70dcd9f-6f22-4ce8-9bd7-1d0e9ca64aae">1,446</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" sign="-" name="infu:RevenuesInternal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNC02LTEtMS05MDY2NQ_31baef3f-c25e-407b-9393-ede8774beed1">1,446</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="infu:RevenuesInternal" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNC04LTEtMS05MDY2NQ_2b256976-9a5f-4878-a28e-6dbe3347d7dc">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNS0yLTEtMS05MDY2NQ_25310357-d514-49c7-9e24-7cfcbc3f4c40">15,911</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNS00LTEtMS05MDY2NQ_e167350b-07cb-4e79-96c2-4117a12f977d">9,998</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNS02LTEtMS05MDY2NQ_9c3c7e1f-5c9e-4bea-8594-ff9ded2c6299">1,446</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNS04LTEtMS05MDY2NQ_1d3e10fd-5c1d-4ff7-a1d6-5a905b50c4d5">24,463</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNi0yLTEtMS05MDY2NQ_2e455f76-84fb-41a4-ab44-3ef97b296de2">10,003</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNi00LTEtMS05MDY2NQ_515e76eb-63f8-4541-abba-22e555b2b05e">4,573</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNi02LTEtMS05MDY2NQ_46ccf40f-6e1e-45f6-a18b-c1c1fbbb6b01">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNi04LTEtMS05MDY2NQ_4f2e5363-db61-424c-897a-709fbc18fcdf">14,576</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfOC02LTEtMS05MDY2NQ_b0ebc284-0d6d-44da-87f0-72c9be268ef5">13,703</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfOC04LTEtMS05MDY2NQ_b439d3d3-f695-449e-a2d8-e7ef80227039">13,703</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfOS02LTEtMS05MDY2NQ_6794c746-70da-495a-8505-7172f87be884">322</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfOS04LTEtMS05MDY2NQ_847e8a5e-1afb-4646-a6bd-981ca3880af2">322</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTAtNi0xLTEtOTA2NjU_42c8a478-975a-44dc-b057-4386cf38845f">69</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTAtOC0xLTEtOTA2NjU_bb07aa03-d644-4ff4-8bac-6102cf2d9a7b">69</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTEtNi0xLTEtOTA2NjU_15a32639-e57c-48dd-8d9d-ed434c6aa15b">179</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTEtOC0xLTEtOTA2NjU_77423193-96a1-4a0f-9d4e-5d0001472d4c">179</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTMtOC0xLTEtOTA2NjU_261a2bda-a283-4445-b02e-e58bea570ee5">661</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i16b961b3af684edb8219f8ad50fba90b_I20210331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTUtMi0xLTEtOTA2NjU_ec07c7cd-6186-4562-8df1-61bdf0c897ac">62,508</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i8f1cbecf89194e0ebc676764e029ed03_I20210331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTUtNC0xLTEtOTA2NjU_92967ead-7fa6-4cd3-9970-39e170963185">26,079</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic7ace98423094ec1812718f76386b5e1_I20210331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTUtNi0xLTEtOTA2NjU_cbcb8623-c7dd-4019-9381-d6495d39eb26">2,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTUtOC0xLTEtOTA2NjU_558dd4a1-cad2-41a3-925c-d9bde321fb56">90,587</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTYtMi0xLTEtOTA2NjU_67a1a100-6e4c-436d-b453-d27fe434aeab">1,621</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTYtNC0xLTEtOTA2NjU_ce23aae1-e51f-44ba-a404-853520367ab9">715</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTYtNi0xLTEtOTA2NjU_e7b1f136-03f5-4c59-8f1f-ef559e78425a">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="infu:PaymentsToAcquireMedicalEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTYtOC0xLTEtOTA2NjU_a4f56efd-6697-4527-bf4d-6083ab2c70d4">2,336</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTctMi0xLTEtOTA2NjU_8bc1aba3-bae3-4aea-92d0-0d007ef62c33">2,696</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTctNC0xLTEtOTA2NjU_91b2e999-a563-45f1-a10e-0110a38b05d9">874</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTctNi0xLTEtOTA2NjU_f4c9e33e-bdee-4a73-b522-f5fd5dde9e5a">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTctOC0xLTEtOTA2NjU_97daf4ab-c8f0-4215-8bf4-613992c7c43b">3,570</ix:nonFraction></span></td></tr></table></ix:continuation></ix:continuation></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_73"></div><div style="margin-top:12pt;padding-left:27pt;padding-right:7.2pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:14.5pt"><ix:nonNumeric contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331" name="infu:EffectOfCovid19PandemicTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183My9mcmFnOmE3NGY3N2Q3NTliYTQ0ZGRiOGM4OTU1ZmRiOTYxZDZmL3RleHRyZWdpb246YTc0Zjc3ZDc1OWJhNDRkZGI4Yzg5NTVmZGI5NjFkNmZfMTQ5Mg_83aff6d0-b3c1-41c5-91de-41b472c116b5" continuedAt="i2d95471ad8e544c09603f5f9928fc465" escape="true">COVID-19</ix:nonNumeric></span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i2d95471ad8e544c09603f5f9928fc465">On March 11, 2020, the World Health Organization declared the outbreak of coronavirus (&#8220;COVID-19&#8221;) as a pandemic, which has spread globally and throughout the United States. During the period of the pandemic, we took a number of precautionary and preemptive steps to protect the safety and well-being of our employees while ensuring continuity of service to our clients, including, transitioning our employees to a remote work environment, suspending employee travel, canceling participation in industry events and in-person group meetings, promoting social distancing and enhanced cleaning and sanitization efforts across office locations, and implementing protocols to quarantine employees who may have been exposed to COVID-19, or showed relevant symptoms. We also undertook preparedness plans at our facilities to maintain continuity of operations, which provide for flexible work arrangements without any significant disruptions to our business or control processes. Our management team continues to actively monitor the situation and is in constant communication with our workforce, customers and vendors. During the three months ended March&#160;31, 2022, outbreaks of COVID-19, including the Delta and Omicron variants, unfavorably impacted our revenue growth initiatives in certain product lines including Pain Management and NPWT. The impacts included scattered restrictions on elective surgeries and delayed ramp-up in treatment volumes for new customers, both of which unfavorably impacted the Pain Management business, and restricted physical access to our customers facilities, which unfavorably impacted both the Pain Management and NPWT businesses. While the COVID-19 pandemic has not had any material unfavorable effects in our financial results for the three months ended March&#160;31, 2022, beyond this delay to our revenue growth plans, the extent of any future impact will depend on future developments, which are highly uncertain, cannot be predicted and could have a material adverse impact on our financial position, operating results and cash flows.</ix:continuation></span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The terms &#8220;InfuSystem&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221; and &#8220;us&#8221; used herein refer to InfuSystem Holdings, Inc. and its subsidiaries.</span></div><div style="margin-top:12pt;padding-left:3.6pt;padding-right:3.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain statements contained in this quarterly report on Form 10-Q are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. In connection with the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, the Company is identifying certain factors that could cause actual results to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">differ, perhaps materially, from those indicated by these forward-looking statements. Those factors, risks and uncertainties include, but are not limited to, the effect of the coronavirus (&#8220;COVID-19&#8221;) pandemic or any resurgence thereof on our business, potential changes in healthcare payer mix and overall healthcare reimbursement, including the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) competitive bidding and fee schedule reductions, sequestration, concentration of customers, increased focus on early detection of cancer, competitive treatments, dependency on Medicare Supplier Number, availability of chemotherapy drugs, global financial conditions, changes and enforcement of state and federal laws, natural forces, competition, dependency on suppliers, risks in acquisitions &amp; joint ventures, U.S. Healthcare Reform, relationships with healthcare professionals and organizations, technological changes related to infusion therapy, the Company&#8217;s ability to implement information technology improvements and to respond to technological changes, the ability of the Company to successfully integrate acquired businesses, dependency on key personnel, dependency on banking relations and the ability to comply with our credit facility covenants, and other risks associated with our common stock, as well as any litigation in which the Company may be involved from time to time; and other risk factors as discussed in the Company&#8217;s annual report on Form 10-K for the year ended December&#160;31, 2021 filed on March&#160;15, 2022, this quarterly report on Form 10-Q and in other filings made by the Company from time to time with the Securities and Exchange Commission (&#8220;SEC&#8221;). Our annual report on Form 10-K is available on the SEC&#8217;s EDGAR website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, and a copy may also be obtained by contacting the Company. All forward-looking statements made in this Form 10-Q speak only as of the date of this report. We do not intend, and do not undertake any obligation, to update any forward-looking statements to reflect future events or circumstances after the date of such statements, except as required by law.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_79"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Overview</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national health care service provider, facilitating outpatient care for Durable Medical Equipment manufacturers and health care providers. We provide our products and services to hospitals, oncology practices, ambulatory surgery centers, and other alternate site health care providers. Our headquarters is in Rochester Hills, Michigan, and we operate our business from a total of seven locations in the United States and Canada. We deliver local, field-based customer support as well as operate pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. InfuSystem, Inc., a wholly-owned subsidiary of the Company, is accredited by the Community Health Accreditation Partner (CHAP) while First Biomedical, Inc., a wholly-owned subsidiary of the Company, is ISO 9001 certified at our Kansas, Michigan, Massachusetts, Canada and Santa Fe Springs, California locations and also ISO 13485 certified at our Bakersfield, California location.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">InfuSystem competes for and retains its business primarily on the basis of its long participation and strong reputation in the Durable Medical Equipment space, its long-standing relationships with Durable Medical Equipment manufacturers and its health care provider customers, and the high levels of service it provides. Current barriers to entry for potential competitors are created by our: (i) growing number of third-party payer networks under contract; (ii) economies of scale, which allow for predictable reimbursement and less costly purchase and management of the pumps, respectively; (iii) established, long-standing relationships as a provider of pumps to outpatient oncology practices in the U.S. and Canada; (iv) pump fleet of ambulatory and large volume infusion pumps for rent and for sale, which may allow us to be more responsive to the needs of physicians, outpatient oncology practices, hospitals, outpatient surgery centers, homecare practices, patient rehabilitation centers and patients than a new market entrant; (v) seven geographic locations in the U.S. and Canada that allow for same day or next day delivery of pumps; and (vi) pump repair and service capabilities at all of these facilities and at our customer's locations. We do not perform any research and development on pumps, but we have made, and continue to make investments in our information technology. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Integrated Therapy Services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ITS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">) Segment</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our ITS segment&#8217;s core purpose is to seek opportunities to leverage our unique know-how in clinic-to-home health care involving Durable Medical Equipment, our logistics and billing capabilities, our growing network of third-party payers under contract, and our clinical and biomedical capabilities. This leverage may take the form of new products and/or services, strategic alliances, joint ventures and/or acquisitions. The leading service within our ITS segment is to supply electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states (&#8220;Oncology Business&#8221;). Colorectal cancer is the third most prevalent form of cancer in the United States, according to the American Cancer Society, and the standard of care for the treatment of colorectal cancer relies upon continuous chemotherapy infusions delivered via ambulatory infusion pumps. One of the primary goals for the ITS segment is to expand into treatment of other types of cancers. There are a number of approved treatment protocols for pancreatic, head and neck, esophageal and other types of cancers, as well as other disease states which present opportunities for growth. There are also a number of other drugs currently approved by the U.S. Food and Drug Administration (the "FDA"), as well as agents in the pharmaceutical development pipeline, which we believe could potentially be used with continuous infusion protocols for the treatment of diseases other than colorectal cancer. Additional drugs or protocols currently in clinical trials may also obtain regulatory </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">approval over the next several years. If these new drugs or protocols obtain regulatory approval for use with continuous infusion protocols, we expect the pharmaceutical companies to focus their sales and marketing efforts on promoting the new drugs and protocols to physicians.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furthermore, our Oncology Business focuses mainly on the continuous infusion of chemotherapy. Continuous infusion of chemotherapy can be described as the gradual administration of a drug via a small, lightweight, portable infusion pump over a prolonged period of time. A cancer patient can receive his or her medicine anywhere from one to 30 days per month depending on the chemotherapy regimen that is most appropriate to that individual&#8217;s health status and disease state. This may be followed by periods of rest and then repeated cycles with treatment goals of progression-free disease survival. This drug administration method has replaced intravenous push or bolus administration in specific circumstances. The advantages of slow continuous low doses of certain drugs are well documented. Clinical studies support the use of continuous infusion chemotherapy for decreased toxicity without loss of anti-tumor efficacy. The 2015 National Comprehensive Cancer Network ("NCCN") Guidelines recommend the use of continuous infusion for treatment of numerous cancer diagnoses. We believe that the growth of continuous infusion therapy is driven by three factors: evidence of improved clinical outcomes; lower toxicity and side effects; and a favorable reimbursement environment.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that oncology practitioners have a heightened sensitivity to providing quality service and to their ability to obtain reimbursement for services they provide. Simultaneously, CMS and private insurers are increasingly focused on evidence-based medicine to inform their reimbursement decisions &#8212; that is, aligning reimbursement with clinical outcomes and adherence to standards of care. Continuous infusion therapy is a main component of the standard of care for certain types of cancers because clinical evidence demonstrates superior outcomes. Payers&#8217; recognition of this benefit is reflected in their relative reimbursement policies for clinical services related to the delivery of this care.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additional areas of focus for our ITS segment are as follows:</span></div><div style="margin-top:12pt;padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Pain Management - providing our ambulatory pumps, products, and services for pain management in the area of post-surgical continuous peripheral nerve block.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Negative Pressure Wound Therapy (&#8220;NPWT&#8221;) - NPWT includes providing the Durable Medical Equipment and related consumables, overseeing logistics, providing biomedical services, and managing third-party billing of the U.S. home healthcare market, which as a subset of the broader NPWT market, has an estimated addressable home healthcare market of $600 million per year.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Lymphedema Therapy &#8211; as announced in June 2021, Lymphedema therapy includes providing patient care and customer service, pneumatic compression devices and associated garments through our partnership with Bio Compression Systems, Inc. to outpatients, initially targeting our existing acute care and oncology customers, estimated to be 20% of the multi-billion-dollar Lymphedema market.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Acquisitions - we believe there are opportunities to acquire smaller, regional health care service providers, in whole or part that perform similar services to us but do not have the national market access, network of third-party payer contracts or operating economies of scale that we currently enjoy. We may also pursue acquisition opportunities of companies that perform similar services, but offer different therapies or utilize different devices.</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Information technology-based services - we also plan to continue to capitalize on key new information technology-based services such as EXPRESS, InfuSystem Mobile, InfuBus or InfuConnect, Pump Portal and BlockPain Dashboard&#174;.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The payer environment within our ITS segment is in a constant state of change. We continue to extend our considerable breadth of payer networks under contract as patients move into different insurance coverage plans, including Medicaid and Insurance Marketplace products. In some cases, this may slightly reduce our aggregate billed revenues payment rate but result in an overall increase in collected revenues, due to a reduction in concessions. Consequently, we are increasingly focused on net revenues less concessions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Durable Medical Equipment Services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">DME Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">) Segment</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our DME Services segment&#8217;s core service is to: (i) sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; (ii) sell treatment-related consumables; and (iii) provide biomedical recertification, maintenance and repair services for oncology practices as well as other alternate site settings, including, home care and home infusion providers, skilled nursing facilities, pain centers and others. We also provide these products and services to customers in the hospital market. We purchase new and pre-owned pole-mounted and ambulatory infusion pumps from a variety of sources on a non-exclusive basis. We repair, refurbish and provide biomedical certification for the devices as needed. The pumps are then available for sale, rental or to be used within our ambulatory infusion pump management service. Our recent acquisition of FilAMed, a privately-held biomedical services company, on January&#160;31, 2021 supplements the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Company&#8217;s existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings, including, home care and home infusion providers, skilled nursing facilities, pain centers and others. Our recent acquisition of OB Healthcare Corporation (&#8220;OB Healthcare&#8221;), a privately-held biomedical services company, on April&#160;18, 2021 further develops and expands InfuSystem&#8217;s DME Services segment by extending our existing biomedical service capability into our customer's locations. OB Healthcare complements the Company&#8217;s purchase of FilAMed.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">COVID-19 Update</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 11, 2020, the World Health Organization declared the outbreak of coronavirus (&#8220;COVID-19&#8221;) as a pandemic, which has spread globally and throughout the United States. During the period of the pandemic, we took a number of precautionary and preemptive steps to protect the safety and well-being of our employees while ensuring continuity of service to our clients, including, transitioning our employees to a remote work environment, suspending employee travel, canceling participation in industry events and in-person group meetings, promoting social distancing and enhanced cleaning and sanitization efforts across office locations, and implementing protocols to quarantine employees who may have been exposed to COVID-19, or showed relevant symptoms. We also undertook preparedness plans at our facilities to maintain continuity of operations, which provide for flexible work arrangements without any significant disruptions to our business or control processes. Our management team continues to actively monitor the situation and is in constant communication with our workforce, customers and vendors. During the three months ended March&#160;31, 2022, outbreaks of COVID-19, including the Delta and Omicron variants, unfavorably impacted our revenue growth initiatives in certain product lines including Pain Management and NPWT. The impacts included scattered restrictions on elective surgeries and delayed ramp-up in treatment volumes for new customers, both of which unfavorably impacted the Pain Management business, and restricted physical access to our customers facilities, which unfavorably impacted both the Pain Management and NPWT businesses. While the COVID-19 pandemic has not had any material unfavorable effects in our financial results for the three months ended March&#160;31, 2022, beyond this delay to our revenue growth plans, the extent of any future impact will depend on future developments, which are highly uncertain, cannot be predicted and could have a material adverse impact on our financial position, operating results and cash flows.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">InfuSystem Holdings, Inc. Results of Operations for the Three Months Ended March 31, 2022 Compared to the Three Months Ended March 31, 2021</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following represents the Company&#8217;s results of operations for the three months ended March 31, 2022 and 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.58pt;padding-right:17.58pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended March 31,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(in thousands, except share and per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Better </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Worse)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;ITS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;DME Services (inclusive of inter-segment revenues)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: elimination of inter-segment revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,446)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit (inclusive of certain inter-segment allocations) (a):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;ITS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;DME Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;Provision for doubtful accounts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;Selling and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;&#160;&#160;&#160;&#160;&#160;Total selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,892&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,189)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(525)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(305)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Loss) income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(830)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Benefit from) income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 73pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 73pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.05)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 73pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,609,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,338,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">271,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 73pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,609,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,937,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,328,267)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) Inter-segment allocations are for cleaning and repair services performed on medical equipment.</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Net Revenues</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net revenues for the quarter ended March&#160;31, 2022 (&#8220;first quarter of 2022&#8221;) were $26.8 million, an increase of $2.3 million, or 9.4%, compared to $24.5 million for the quarter ended March&#160;31, 2021 (&#8220;first quarter of 2021&#8221;). The increase included higher net revenues for both the ITS and DME Services segments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ITS</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ITS net revenue of $16.6 million increased $0.7 million, or 4.6%, during the first quarter of 2022 as compared to the prior year period. This increase was primarily attributable to additional treatment volume in all three therapies including Oncology, Pain Management and NPWT, and improved third party payer collections on billings. Pain Management net revenue for the first quarter of 2022 increased slightly as compared to the prior year first quarter due to additional sites of care added over the last year offset partially by decreased patient volume related to COVID-19 market impacts. NPWT net revenues increased due to higher treatment volume and from the sale of equipment under lease contracts for the first time since the therapy was launched. We expect NPWT equipment sales to create new opportunities for patient treatment referrals in future periods.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">DME Services</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">DME Services net revenue of $10.1 million increased $1.6 million, or 18.4%, during the first quarter of 2022 as compared to the prior year period. This increase was mainly due to $1.0 million in additional net revenues contributed by the FilAMed and OB Healthcare businesses, which we acquired during the first and second quarters of 2021, respectively. Other net revenue increases included higher equipment rental and disposable medical supplies revenue, which increased by $0.5 million and $0.2 million, respectively. These increases were partially offset by lower equipment sales.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Gross Profit (inclusive of certain inter-segment allocations)</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gross profit for the first quarter of 2022 of $15.4 million increased $0.8 million, or 5.4%, from $14.6 million for the first quarter of 2021. The increase was driven by the increase in net revenues offset partially by a lower gross profit as a percentage of net revenue (&#8220;gross margin&#8221;). Gross margin was 57.4% during the first quarter of 2022 as compared to 59.6% during the prior year, a decrease of 2.2%. Decreased gross margin for the DME Services segment was partially offset by an increase in gross margin for the ITS segment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ITS</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ITS gross profit was $10.7 million during the first quarter of 2022, representing an increase of $0.7 million compared to the prior year. The improvement reflected an increase in net revenues, as well as a higher gross margin, which increased from the prior year by 1.6% to 64.5%. The higher gross margin was the result of a more normalized expense for missing equipment for the first quarter of 2022, which was unusually high during the first quarter of 2021, and improved collections on billings.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">DME Services</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">DME Services gross profit during the first quarter of 2022 was $4.6 million, representing an increase of $0.1 million, or 1.2%, compared to the prior year. This increase was due to the increase in net revenues offset partially by a lower gross margin. The DME gross margin was 45.7% during the current quarter, which was 7.8% lower than the prior year. This decrease was the result of an increase in labor costs related to an increase in biomedical technicians. The increase in biomedical technician labor, which totaled $0.7 million, resulted from an increase in team members who were hired in order to increase the capacity in biomedical services in anticipation of increased biomedical services demand. These newly hired team members mainly spent their time training during the period but will be deployed to support higher demand and related revenue volumes in future quarters.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Selling and Marketing Expenses</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Selling and marketing expenses for the first quarter of 2022 were $3.3 million, representing an increase of $0.9 million, or 39.7%, as compared to the first quarter of 2021. Selling and marketing expenses as a percentage of net revenues increased to 12.4% compared to 9.7% for the prior year. This increase reflected $0.6 million in higher expenses for NPWT and Pain Management dedicated sales personnel hired during the 2021 second quarter and increased digital marketing expenses. The additional sales team members and digital marketing expenses represent a strategic investment to accelerate revenue growth for these therapies in future periods and the expense included in selling and marketing is a portion of an overall expense increase of $1.0 million incurred during the first quarter of 2022 associated with this initiative. The remainder of the expense increase totaling $0.4 million is included in general and administrative expense. The remaining increase in selling and marketing expenses totaling $0.3 million reflected higher marketing expenses related to our national sales meeting which was held in-person for the first time since the outbreak of COVID-19, increased participation in trade shows and other increased expenses. Selling and marketing expenses consists of sales personnel salaries, commissions and associated fringe benefit and payroll-related items, marketing, travel and entertainment and other miscellaneous expenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative (&#8220;G&amp;A&#8221;) expenses for the first quarter of 2022 were $11.8 million, an increase of 14.1% from $10.4 million for the first quarter of 2021. G&amp;A expenses during these periods consisted primarily of accounting, administrative, third-party payer billing and contract services, customer service, nurses on staff, new product services, service center personnel salaries, fringe benefits and other payroll-related items, professional fees, legal fees, stock-based compensation, insurance and other miscellaneous items. The increase of $1.5 million was due to $0.4 million in additional expenses related to the investments in NPWT and Pain Management, $0.1 million of additional G&amp;A expenses for the FilAMed and OB Healthcare businesses and higher travel expenses and other increases including higher personnel, healthcare and general business expenses. These increases were partially offset by a decrease in stock-based compensation expense of $0.6 million. G&amp;A expenses as a percentage of net revenues for the first quarter of 2022 increased to 44.2% compared to 42.3% for the same prior year period, mainly reflecting the year-over-year increases partially offset by improved net revenue leverage over fixed costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Other Expenses</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the first quarter of 2022, other expense included interest expense of $0.3 million, which was slightly lower than interest expense for the first quarter of 2021. This decrease resulted from lower average outstanding debt balances offset by higher weighted average interest rates and additional commitment fees on a higher unused revolving line availability during the first quarter of 2022 as compared to the first quarter of 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Benefit From Income Taxes</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the first quarter of 2022, the Company recorded a benefit from income taxes totaling $0.5 million representing an effective tax rate of 55.7% on a pre-tax loss of $0.8 million. This effective tax rate differed from the U.S. statutory rate mainly due to the effects of local, state and foreign jurisdiction income taxes.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the first quarter of 2021, the Company recorded a benefit from income taxes totaling $0.2 million. This amount included a benefit of $0.3 million due to an excess tax benefit associated with a higher amount of equity compensation expense deductible for tax purposes as compared to amounts historically recognized for book purposes on exercises of stock options and vesting of restricted stock during the quarter. This benefit was partially offset by an estimated tax provision totaling $0.1 million representing an effective tax rate of 30.3% on pre-tax income totaling $0.5 million. This effective tax rate differed from the U.S. statutory rate mainly due to the effects of local, state and foreign jurisdiction income taxes.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">:</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We finance our operations and capital expenditures with cash generated from operations and borrowings under our existing credit agreement. On February 5, 2021, we and certain of our subsidiaries, as borrowers, entered into a Credit Agreement (the &#8220;2021 Credit Agreement&#8221;) with JPMorgan Chase Bank, N.A., as administrative agent, sole bookrunner and sole lead arranger, and the lenders party thereto, which replaced our then existing credit facility, dated March 23, 2015 (the &#8220;2015 Credit Agreement&#8221;). See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_52">Note 8 (Debt)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the notes to the accompanying unaudited condensed consolidated financial statements for additional information regarding the 2021 Credit Agreement and 2015 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes our available liquidity (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Liquidity</span></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Available liquidity</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our liquidity and borrowing plans are established to align with our financial and strategic planning processes and ensure we have the necessary funding to meet our operating commitments, which primarily include the purchase of pumps, inventory, payroll and general expenses. We also take into consideration our overall capital allocation strategy, which includes investment for future organic growth, potential acquisitions and share repurchases. We believe we have adequate sources of liquidity and funding available to meet our liquidity requirements for at least the next year from the filing date of this report, as well as for our currently anticipated long-term needs, including our long-term lease obligations discussed above in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_67">Note 13 (Leases)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in the notes to the accompanying unaudited condensed consolidated financial statements. However, any projections of future earnings and cash flows are subject to substantial uncertainty, including factors such as the successful execution of our business plan and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">general economic conditions. We may need to access debt and equity markets in the future if unforeseen costs or opportunities arise, to meet working capital requirements, fund acquisitions or investments or repay indebtedness under the 2021 Credit Agreement. If we need to obtain new debt or equity financing in the future, the terms and availability of such financing may be impacted by economic and financial market conditions as well as our financial condition and results of operations at the time we seek additional financing.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Long-Term Debt Activities:</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company executed and closed the 2021 Credit Agreement during the first quarter of 2021, and in connection with entering into that agreement, terminated the 2015 Credit Agreement. The following table illustrates the net availability under the revolving credit facility ("Revolving Facility") as of the applicable balance sheet date (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.716%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 66.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 66.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 66.77pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross availability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding draws</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(35,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,974)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Letters of credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(600)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(600)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Availability on Revolving Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,400</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,426</span></td></tr></table></div><div style="margin-top:7pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March&#160;31, 2022, amounts outstanding under the Revolving Facility provided under the 2021 Credit Agreement bear interest at a variable rate equal to, at the Company&#8217;s election, a LIBO Rate for Eurodollar loans or an Alternative Base Rate for ABR loans, as defined by the 2021 Credit Agreement, plus a spread that will vary depending upon the Company&#8217;s leverage ratio. The spread ranges from 2.00% to 3.00% for Eurodollar Loans and 1.00% to 2.00% for base rate loans. The weighted-average Eurodollar loan rate at March&#160;31, 2022 was 2.37% (LIBO of 0.37% plus 2.00%). The actual ABR loan rate at March&#160;31, 2022 was 4.25% (lender&#8217;s prime rate of 3.25% plus 1.00%).  As of March&#160;31, 2022, the Company was in compliance with all debt-related covenants under the 2021 Credit Agreement. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Share Repurchase Program</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 30, 2021, our Board of Directors approved a stock repurchase program (the &#8220;Share Repurchase Program&#8221;) that authorizes the Company to repurchase up to $20.0 million of the Company&#8217;s outstanding common stock through June 30, 2024. Repurchases under the Share Repurchase Program are subject to market conditions, the periodic capital needs of the Company&#8217;s operating activities, and the continued satisfaction of all covenants under the Company&#8217;s existing 2021 Credit Agreement. Repurchases under the Share Repurchase Program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase Program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2022, the Company had repurchased approximately $4.6 million, or 343,514 shares, of the Company's outstanding common stock under the Share Repurchase Program.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cash Flows:</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes our cash flows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2021 vs. 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash used in financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Operating Cash Flow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Net cash provided by operating activities for the first quarter of 2022 was $4.1 million compared to $2.7 million for the first quarter of 2021. This $1.4 million, or 53.8%, increase was primarily attributable to the positive cash flow effect of a swing from $3.7 million in cash being used to fund increased working capital amounts during the first quarter of 2021 to cash being provided by reduced working capital amounts during the first quarter of 2022 of $0.3 million for a net improvement in cash flow totaling $4.1 million. This amount was partially offset by a decrease in net income adjusted for non-cash items of $3.7 million during the first quarter of 2022 as compared to $6.4 million during the first quarter of 2021, a decrease of $2.7 million. During 2022, cash received from net lower working capital balances included a $1.3 million increase </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in accounts receivable, a $0.1 million decrease in inventory and a $1.6 million increase in accounts payable and accrued liabilities. In 2021, investments in working capital balances included a $0.4 million increase in accounts receivable, a $0.2 million increase in inventories and a $2.9 million decrease in accounts payable and accrued liabilities.  </span></div><div style="margin-top:7pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The $1.3 million increase in accounts receivable during the first three-month period of 2022 as compared to the $0.4 million increase during the same prior year period was mainly due to a sequential quarterly growth in net revenues for the first three-month period of 2022 as compared to a sequential quarterly decrease in net revenues for the first three-month period of 2021. Accounts payable and other liabilities, net of capital items, increased by $1.6 million during the first three-month period of 2022, and decreased by $2.9 million during the first three-month period of 2021, a $4.5 million favorable cash flow swing, mainly due to a reduction in the amount paid in 2022 for the 2021 short-term incentive bonus plan as compared to the amount paid in 2021 for the 2020 short-term incentive bonus plan. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Investing Cash Flow. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Net cash used in investing activities was $2.1 million for the first three-month period of 2022 compared to $2.8 million for the first three-month period of 2021, a decrease of $0.7 million. The decrease was due to the acquisition of FilAMed totaling $1.2 million during the first three-month period of 2021. There were no acquisitions during 2022. This amount was partially offset by an increase in cash used to purchase medical equipment of $0.6 million. Purchases of medical equipment were higher during 2022 due to an increase in expected future growth during the current year as compared to 2021.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Financing Cash Flow. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Net cash used in financing activities for the three-month period of 2022 was $1.7 million compared to $6.7 million for the first three-month period of 2021. Amounts of cash used in financing activities during the first three-month period of 2022 included net revolving line of credit borrowings under the 2021 Credit Agreement totaling $2.0 million, $0.2 million in principal payments on our other financing and $4.0 million to buy back the Company's common stock. These amounts were partially offset by cash proceeds from employee stock option exercises totaling $0.5 million. The use of cash during 2021 was mainly related to the refinancing of our bank debt on February 5, 2021. Prior to that date, we operated under the 2015 Credit Agreement which included three term notes and a revolving line of credit. At the beginning of 2021, we had $9.6 million in cash on hand and no outstanding borrowings under the revolving line of credit. The 2015 Credit Agreement was completely repaid and replaced by the 2021 Credit Agreement, which has a new $75 million revolving line of credit and no term notes. This structure allowed the Company to use a portion of its available cash, totaling $7.9 million, to reduce its overall outstanding debt on the closing date of the financing. Other cash used in financing activities for the first three-month period of 2021 included a $3.1 million net reduction in outstanding borrowings under the 2015 Credit Agreement, which included amortization installments on term notes totaling $5.8 million, debt issuance costs totaling $0.4 million and cash used to repurchase shares to satisfy statutory withholding on employee stock based compensation totaling $0.6 million. These amounts were partially offset by $2.7 million in borrowings under an equipment line of credit and $0.3 million in cash proceeds from employee stock option exercises.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which require the use of estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses in the periods presented. We believe that the accounting estimates employed are appropriate and resulting balances are reasonable; however, due to inherent uncertainties in making estimates, actual results could differ from the original estimates, requiring adjustments to these balances in future periods. The critical accounting estimates that affect the unaudited condensed consolidated financial statements and the judgments and assumptions used are consistent with those described in the notes to the audited consolidated financial statements in our annual report on Form 10-K for the year ended December&#160;31, 2021 filed with the SEC on March&#160;15, 2022. There have been no material changes to our critical accounting policies described in the notes to the audited consolidated financial statements in our annual report on Form 10-K for the year ended December&#160;31, 2021.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of the date of the unaudited condensed consolidated financial statements presented in this Form 10-Q, there have been no material negative financial impacts on our operations resulting from the COVID-19 pandemic. However, the future effects of this pandemic or any resurgence thereof on economic and market conditions is uncertain and increases the subjectivity that will be involved in evaluating our estimates and assumptions underlying our critical accounting policies. Any events and changes in circumstances arising after March&#160;31, 2022, including those resulting from the impacts of the COVID-19 pandemic, will be reflected in management&#8217;s estimates for future periods.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk from changes in foreign currency exchange rates and short-term interest rates. Market risks for changes in interest rates relate primarily to our debt obligations under our 2021 Credit Agreement. Foreign currency </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in our functional currency which is the U.S. Dollar and include exposures primarily to the Canadian Dollar.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company periodically enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. We did not have any foreign currency derivative contracts outstanding at any time during the three months ended March 31, 2022. The maximum length of time over which we hedge our exposure to short-term interest rate risk is equal to the remaining term for the debt obligation being hedged. We had interest rate derivative contracts with a notional value of $20.0 million as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive income in the consolidated balance sheet.&#160;&#160;When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income is recorded in earnings in the consolidated statement of income on the same line as the gain or loss on the hedged item attributable to the hedged risk.&#160;&#160;We record the ineffective portion of interest rate hedging instruments, if any, to interest expense in the consolidated statements of income. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_55">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to our consolidated financial statements for information related to the fair values of derivative instruments in our condensed consolidated balance sheets as of March&#160;31, 2022 and December&#160;31, 2021, respectively, and information related to the effect of derivative instruments included in our condensed consolidated statements of operations and comprehensive income including the amount of unrealized gain associated with our interest rate derivatives reported in accumulated other comprehensive income that was reclassified into earnings during the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounting such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument&#8217;s full term.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In July 2017, Financial Conduct Authority (the authority that regulates LIBOR) previously announced its intent to stop compelling banks to submit rates for the calculation of LIBOR after 2021, and the administrator of LIBOR announced its intention to cease the publication of the one week and two month USD LIBOR settings immediately following December 31, 2021, and the remaining USD LIBOR settings immediately following the LIBOR publication on June 30, 2023. The one week and two month USD LIBOR settings were last published on December 31, 2021. Additionally, it is expected that banks will no longer issue LIBOR-based debt after December 31, 2021. Accordingly, there is considerable uncertainty regarding the publication of such rates beyond these dates. The Alternative Reference Rates Committee ("ARRC") has proposed that the Secured Overnight Financing Rate ("SOFR") is the rate that represents best practice as the alternative to USD LIBOR for use in derivatives and other financial contracts that are currently indexed to USD LIBOR. ARRC has proposed a paced market transition plan to SOFR from USD LIBOR and organizations are currently working on industry wide and company specific transition plans as it relates to derivatives and cash markets exposed to USD LIBOR. At this time, it is not known whether or when SOFR or other alternative reference rates will attain market traction as replacements for LIBOR. The Company's 2021 Credit Agreement, discussed in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_52">Note 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to the condensed consolidated financial statements, and the Company's interest rate swap agreements, discussed in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_55">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> to the condensed consolidated financial statements, are indexed to USD LIBOR and management is monitoring this activity and evaluating the related risks.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures and Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a set of disclosure controls and procedures designed to ensure that material information required to be disclosed in our filings under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that material information is accumulated and communicated to our management, including our Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;), as appropriate, to allow timely decisions regarding required disclosures. Our CEO and CFO have evaluated these disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q and have determined that such disclosure controls and procedures were effective.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting during our most recent calendar quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the ordinary course of our business, we may be involved in legal and regulatory proceedings, the outcomes of which may not be determinable. The results of litigation and regulatory proceedings are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable, primarily for the following reasons: (i) many of the relevant legal proceedings are in preliminary stages and until such proceedings develop further, there is often uncertainty regarding the relevant facts and circumstances at issue and potential liability; and (ii) many of these proceedings involve matters of which the outcomes are inherently difficult to predict. We have insurance policies covering potential losses where such coverage is cost effective.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not at this time involved in any proceedings that we believe could have a material effect on our business, financial condition, results of operations or cash flows.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding factors that could affect our results of operations, financial condition and liquidity, refer to the section entitled &#8220;Risk Factors&#8221; in Part I, Item 1A in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 filed with the SEC on March&#160;15, 2022.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_115"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A summary of our purchases of our common stock during the three months ended March&#160;31, 2022 is as follows: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.587%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in thousands) (b)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022 through January 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,297</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18,245,811</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2022 through February 28, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,071</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,999,030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022 through March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,677</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,440,579</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,373&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.94&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,045</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(a) Of the 313,373 shares of common stock presented in the table above, 3,328 shares were originally granted to employees and directors as restricted stock awards. Our stock plans allow for the withholding of shares to satisfy tax obligations due upon the vesting of restricted stock. Pursuant to our stock plans, the 3,328 shares reflected above were relinquished by employees or directors in exchange for our agreement to pay U.S. federal, state and local tax withholding obligations resulting from the vesting of the Company's restricted stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(b) On June 30, 2021, our Board of Directors approved a stock repurchase program (the "Share Repurchase Program") authorizing the Company to repurchase up to $20.0 million of the Company's outstanding common stock through June 30, 2024 (which was announced on August 12, 2021). Repurchases under the Share Repurchase Program will be subject to market conditions, the periodic capital needs of the Company's operating activities, and the continued satisfaction of all covenants under the Company's existing credit agreement. Repurchases under the Share Repurchase Program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase Program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. As of March&#160;31, 2022, the Company had repurchased 343,514 shares under the Share Repurchase Program.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Exhibits</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000119312514194753/d724130dex31.htm">Amended and Restated Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on May 12, 2014).</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1337013/000143774918013086/ex_117488.htm">Amended and Restated By-Laws (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K (File No. 1-35020) filed on July 9, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="infu-20220331xexx3111.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="infu-20220331xexx3121.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="infu-20220331xexx3211.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.2**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="infu-20220331xexx3221.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.INS*</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Instance Document</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.SCH*</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.CAL*</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.DEF*</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.LAB*</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.PRE*</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104*</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">*</span></div><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">**</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Filed herewith</span></div><div style="padding-left:4.57pt;padding-right:4.57pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furnished herewith</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</span></div></div></div><div id="if7e56f0d6eeb4fafa9d6d38963769ac3_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#if7e56f0d6eeb4fafa9d6d38963769ac3_7">Table of Contents</a></span></div></div><div style="text-align:center;text-indent:25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">INFUSYSTEM HOLDINGS, INC. </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: May 5, 2022</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Richard DiIorio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Richard DiIorio </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Executive Officer and Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Principal Executive Officer) </span></div></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.076%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: May 5, 2022</span></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Barry Steele</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Barry Steele</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Principal Accounting and Financial Officer) </span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>infu-20220331xexx3111.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9085e16afb5c4f96ab8f5cf257969a21_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CERTIFICATION BY CHIEF EXECUTIVE OFFICER</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">I, Richard DiIorio, certify that&#58;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1. I have reviewed this quarterly report on Form 10-Q of InfuSystem Holdings, Inc.&#59;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c. evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d. disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.691%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date&#58; May 5, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Richard DiIorio</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Richard DiIorio</font></div><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chief Executive Officer and Director</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>infu-20220331xexx3121.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3f7ec3cbbe434ea0a478f4b078e80d74_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CERTIFICATION BY CHIEF FINANCIAL OFFICER</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">I, Barry Steele, certify that&#58;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1. I have reviewed this quarterly report on Form 10-Q of InfuSystem Holdings, Inc.&#59;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c. evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d. disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.691%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date&#58; May 5, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Barry Steele</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Barry Steele</font></div><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chief Financial Officer</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>infu-20220331xexx3211.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifae0b98221ce4f61b61843635ddbc7ea_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of InfuSystem Holdings, Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The quarterly report on Form 10-Q for the quarter ended March&#160;31, 2022 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.387%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:25pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date&#58; May 5, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Richard DiIorio</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Richard DiIorio</font></div><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chief Executive Officer and Director</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>infu-20220331xexx3221.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i54958b89a06f4d6b9329d669426217dd_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of InfuSystem Holdings, Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:12pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The quarterly report on Form 10-Q for the quarter ended March&#160;31, 2022 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.387%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:25pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date&#58; May 5, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Barry Steele</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;Barry Steele</font></div><div style="text-indent:25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chief Financial Officer</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>infu-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9c45a9a1-f9a1-46d4-ab6e-c84379cf91bb,g:e62fa09c-9414-4caa-b36a-5012b4171a20-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:infu="http://infusystem.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://infusystem.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="infu-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="infu-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="infu-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="infu-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://infusystem.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies" roleURI="http://infusystem.com/role/BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentAccountingPronouncementsandDevelopments" roleURI="http://infusystem.com/role/RecentAccountingPronouncementsandDevelopments">
        <link:definition>2102102 - Disclosure - Recent Accounting Pronouncements and Developments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://infusystem.com/role/BusinessCombinations">
        <link:definition>2103103 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://infusystem.com/role/BusinessCombinationsTables">
        <link:definition>2304301 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsDetailsTextual" roleURI="http://infusystem.com/role/BusinessCombinationsDetailsTextual">
        <link:definition>2405401 - Disclosure - Business Combinations (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsPurchasePriceAllocationDetails" roleURI="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails">
        <link:definition>2406402 - Disclosure - Business Combinations - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" roleURI="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails">
        <link:definition>2407403 - Disclosure - Business Combinations - Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsAcquiredDetails" roleURI="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails">
        <link:definition>2408404 - Disclosure - Business Combinations - Intangible Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsProFormaInformationDetails" roleURI="http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails">
        <link:definition>2409405 - Disclosure - Business Combinations - Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://infusystem.com/role/RevenueRecognition">
        <link:definition>2110104 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://infusystem.com/role/RevenueRecognitionTables">
        <link:definition>2311302 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDetailsTextual" roleURI="http://infusystem.com/role/RevenueRecognitionDetailsTextual">
        <link:definition>2412406 - Disclosure - Revenue Recognition (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" roleURI="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails">
        <link:definition>2413407 - Disclosure - Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalEquipment" roleURI="http://infusystem.com/role/MedicalEquipment">
        <link:definition>2114105 - Disclosure - Medical Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalEquipmentTables" roleURI="http://infusystem.com/role/MedicalEquipmentTables">
        <link:definition>2315303 - Disclosure - Medical Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalEquipmentDetailsTextual" roleURI="http://infusystem.com/role/MedicalEquipmentDetailsTextual">
        <link:definition>2416408 - Disclosure - Medical Equipment (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalEquipmentSummaryofMedicalEquipmentDetails" roleURI="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails">
        <link:definition>2417409 - Disclosure - Medical Equipment - Summary of Medical Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://infusystem.com/role/PropertyandEquipment">
        <link:definition>2118106 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://infusystem.com/role/PropertyandEquipmentTables">
        <link:definition>2319304 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetailsTextual" roleURI="http://infusystem.com/role/PropertyandEquipmentDetailsTextual">
        <link:definition>2420410 - Disclosure - Property and Equipment (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentScheduleofPropertyandEquipmentDetails" roleURI="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails">
        <link:definition>2421411 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillIntangibleAssets" roleURI="http://infusystem.com/role/GoodwillIntangibleAssets">
        <link:definition>2122107 - Disclosure - Goodwill &amp; Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillIntangibleAssetsTables" roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsTables">
        <link:definition>2323305 - Disclosure - Goodwill &amp; Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillIntangibleAssetsDetailsTextual" roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsDetailsTextual">
        <link:definition>2424412 - Disclosure - Goodwill &amp; Intangible Assets (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillIntangibleAssetsGoodwillDetails" roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails">
        <link:definition>2425413 - Disclosure - Goodwill &amp; Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails">
        <link:definition>2426414 - Disclosure - Goodwill &amp; Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1">
        <link:definition>2426414 - Disclosure - Goodwill &amp; Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails" roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails">
        <link:definition>2427415 - Disclosure - Goodwill &amp; Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://infusystem.com/role/Debt">
        <link:definition>2128108 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://infusystem.com/role/DebtTables">
        <link:definition>2329306 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetailsTextual" roleURI="http://infusystem.com/role/DebtDetailsTextual">
        <link:definition>2430416 - Disclosure - Debt (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" roleURI="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails">
        <link:definition>2431417 - Disclosure - Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofFutureMaturitiesofLoansDetails" roleURI="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails">
        <link:definition>2432418 - Disclosure - Debt - Summary of Future Maturities of Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofCompanysCurrentandLongtermDebtDetails" roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails">
        <link:definition>2433419 - Disclosure - Debt - Summary of Company's Current and Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1">
        <link:definition>2433419 - Disclosure - Debt - Summary of Company's Current and Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivities" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities">
        <link:definition>2134109 - Disclosure - Derivative Financial Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesPolicies" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesPolicies">
        <link:definition>2235201 - Disclosure - Derivative Financial Instruments and Hedging Activities (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesTables" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables">
        <link:definition>2336307 - Disclosure - Derivative Financial Instruments and Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual">
        <link:definition>2437420 - Disclosure - Derivative Financial Instruments and Hedging Activities (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails">
        <link:definition>2438421 - Disclosure - Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails" roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails">
        <link:definition>2439422 - Disclosure - Derivative Financial Instruments and Hedging Activities - Derivative Financial Instruments Designated as Hedging Instruments in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://infusystem.com/role/IncomeTaxes">
        <link:definition>2140110 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetailsTextual" roleURI="http://infusystem.com/role/IncomeTaxesDetailsTextual">
        <link:definition>2441423 - Disclosure - Income Taxes (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsContingenciesandLitigation" roleURI="http://infusystem.com/role/CommitmentsContingenciesandLitigation">
        <link:definition>2142111 - Disclosure - Commitments, Contingencies and Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossEarningsPerShare" roleURI="http://infusystem.com/role/LossEarningsPerShare">
        <link:definition>2143112 - Disclosure - (Loss) Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossEarningsPerShareTables" roleURI="http://infusystem.com/role/LossEarningsPerShareTables">
        <link:definition>2344308 - Disclosure - (Loss) Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossEarningsPerShareDetailsTextual" roleURI="http://infusystem.com/role/LossEarningsPerShareDetailsTextual">
        <link:definition>2445424 - Disclosure - (Loss) Earnings Per Share (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossEarningsPerShareCalculationofBasicandDilutedEPSDetails" roleURI="http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails">
        <link:definition>2446425 - Disclosure - (Loss) Earnings Per Share - Calculation of Basic and Diluted EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://infusystem.com/role/Leases">
        <link:definition>2147113 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://infusystem.com/role/LeasesTables">
        <link:definition>2348309 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetailsTextual" roleURI="http://infusystem.com/role/LeasesDetailsTextual">
        <link:definition>2449426 - Disclosure - Leases (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://infusystem.com/role/LeasesLeaseCostDetails">
        <link:definition>2450427 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>2451428 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>2451428 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformation" roleURI="http://infusystem.com/role/BusinessSegmentInformation">
        <link:definition>2152114 - Disclosure - Business Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationTables" roleURI="http://infusystem.com/role/BusinessSegmentInformationTables">
        <link:definition>2353310 - Disclosure - Business Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentInformationDetails" roleURI="http://infusystem.com/role/BusinessSegmentInformationDetails">
        <link:definition>2454429 - Disclosure - Business Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COVID19" roleURI="http://infusystem.com/role/COVID19">
        <link:definition>2155115 - Disclosure - COVID-19</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="infu_PhysicianAndCustomerRelationshipsMember" abstract="true" name="PhysicianAndCustomerRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentNet" abstract="false" name="MedicalEquipmentNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_LongtermDebtGrossCurrent" abstract="false" name="LongtermDebtGrossCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" abstract="false" name="MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_The2021CreditAgreementMember" abstract="true" name="The2021CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_ShareRepurchaseProgramCumulativeSharesRepurchased" abstract="false" name="ShareRepurchaseProgramCumulativeSharesRepurchased" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" abstract="false" name="BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_EurodollarLoanMember" abstract="true" name="EurodollarLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_DepreciationExpenseRelatedToMedicalEquipment" abstract="false" name="DepreciationExpenseRelatedToMedicalEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServicesGross" abstract="false" name="MedicalEquipmentInRentalServicesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" abstract="false" name="CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" abstract="false" name="PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" abstract="false" name="DebtInstrumentCovenantMinimumFixedCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="infu_DMEServicesSegmentMember" abstract="true" name="DMEServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentHeldForSaleOrRental" abstract="false" name="MedicalEquipmentHeldForSaleOrRental" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServicesReserve" abstract="false" name="MedicalEquipmentInRentalServicesReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_LenderPrimeRate" abstract="false" name="LenderPrimeRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_EffectOfCovid19PandemicTextBlock" abstract="false" name="EffectOfCovid19PandemicTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_RevenuesExternal" abstract="false" name="RevenuesExternal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentHeldForSaleOrRentalGross" abstract="false" name="MedicalEquipmentHeldForSaleOrRentalGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_Covid19Abstract" abstract="true" name="Covid19Abstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="infu_ScheduleOfMedicalEquipmentTableTextBlock" abstract="false" name="ScheduleOfMedicalEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" abstract="false" name="LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_ProductSalesMember" abstract="true" name="ProductSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentMember" abstract="true" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_LIBORRate" abstract="false" name="LIBORRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares" abstract="false" name="ShareRepurchaseProgramCumulativeSharesPurchasedShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="infu_ITSSegmentMember" abstract="true" name="ITSSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentAndPropertyDisclosureTextBlock" abstract="false" name="MedicalEquipmentAndPropertyDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="infu_DirectPayerRentalsMember" abstract="true" name="DirectPayerRentalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_LongTermDebtGrossNoncurrent" abstract="false" name="LongTermDebtGrossNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_CorporateAndEliminationsMember" abstract="true" name="CorporateAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_UnamortizedDebtIssuanceExpenseCurrent" abstract="false" name="UnamortizedDebtIssuanceExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_FilAMedMember" abstract="true" name="FilAMedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_PercentageOfTotalDepreciationExpense" abstract="false" name="PercentageOfTotalDepreciationExpense" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="infu_ThirdPartyPayerRentalRevenueMember" abstract="true" name="ThirdPartyPayerRentalRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" abstract="false" name="FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_FinancingAgreementMember" abstract="true" name="FinancingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentForSaleOrRentalReserve" abstract="false" name="MedicalEquipmentForSaleOrRentalReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_PaymentsToAcquireMedicalEquipment" abstract="false" name="PaymentsToAcquireMedicalEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_ABRLoansMember" abstract="true" name="ABRLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" abstract="false" name="MedicalEquipmentInRentalServicesAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_WorkingCapital" abstract="false" name="WorkingCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_RevenuesInternal" abstract="false" name="RevenuesInternal" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_MedicalEquipmentAbstract" abstract="true" name="MedicalEquipmentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="infu_The2015CreditAgreementMember" abstract="true" name="The2015CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" abstract="false" name="LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" abstract="false" name="BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_DebtInstrumentCovenantMaximumLeverageRatio" abstract="false" name="DebtInstrumentCovenantMaximumLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="infu_UnamortizedDebtIssuanceExpenseNoncurrent" abstract="false" name="UnamortizedDebtIssuanceExpenseNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="infu_OBHealthcareMember" abstract="true" name="OBHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>infu-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9c45a9a1-f9a1-46d4-ab6e-c84379cf91bb,g:e62fa09c-9414-4caa-b36a-5012b4171a20-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1422224e-8e20-4af1-8c10-904123d09d45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_97554032-4c46-4c51-a8a2-3c16cb337387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1422224e-8e20-4af1-8c10-904123d09d45" xlink:to="loc_us-gaap_StockholdersEquity_97554032-4c46-4c51-a8a2-3c16cb337387" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9da40c60-a2f6-4f5a-95ec-9ae50da513a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1422224e-8e20-4af1-8c10-904123d09d45" xlink:to="loc_us-gaap_Liabilities_9da40c60-a2f6-4f5a-95ec-9ae50da513a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3bfb9c57-7393-4a8e-9e97-df45ddee547e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_7270032e-87b4-4391-abe7-10999ebc1360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3bfb9c57-7393-4a8e-9e97-df45ddee547e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_7270032e-87b4-4391-abe7-10999ebc1360" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9a6cafe0-668e-4504-8452-db8d57e75f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3bfb9c57-7393-4a8e-9e97-df45ddee547e" xlink:to="loc_us-gaap_PreferredStockValue_9a6cafe0-668e-4504-8452-db8d57e75f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a94f426f-b16e-4d63-aca7-5d94ea564f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3bfb9c57-7393-4a8e-9e97-df45ddee547e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a94f426f-b16e-4d63-aca7-5d94ea564f5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26aba190-d4df-46a1-b8a5-1203c39acf38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3bfb9c57-7393-4a8e-9e97-df45ddee547e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26aba190-d4df-46a1-b8a5-1203c39acf38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_358a1fdd-1369-4a80-9927-b0f98208a48e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3bfb9c57-7393-4a8e-9e97-df45ddee547e" xlink:to="loc_us-gaap_CommonStockValue_358a1fdd-1369-4a80-9927-b0f98208a48e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_64e564bf-e501-4ad4-83a7-e88de46c1ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_02728388-907a-4bb0-8c16-a05087fccc00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_64e564bf-e501-4ad4-83a7-e88de46c1ba6" xlink:to="loc_us-gaap_AccountsPayableCurrent_02728388-907a-4bb0-8c16-a05087fccc00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_61e35fb0-5f18-450c-9425-453d7adb6848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_64e564bf-e501-4ad4-83a7-e88de46c1ba6" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_61e35fb0-5f18-450c-9425-453d7adb6848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3c7f1ab0-ac03-4d9d-b19d-4d9cdb8a0aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_64e564bf-e501-4ad4-83a7-e88de46c1ba6" xlink:to="loc_us-gaap_LongTermDebtCurrent_3c7f1ab0-ac03-4d9d-b19d-4d9cdb8a0aba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a8afd8e0-a4db-4293-b92d-06c9da656a03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f38f6e06-278e-4188-926d-a1ffea9b02bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a8afd8e0-a4db-4293-b92d-06c9da656a03" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f38f6e06-278e-4188-926d-a1ffea9b02bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c0ccb96f-b8a0-4760-93ff-7f79f0b4b508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a8afd8e0-a4db-4293-b92d-06c9da656a03" xlink:to="loc_us-gaap_LiabilitiesCurrent_c0ccb96f-b8a0-4760-93ff-7f79f0b4b508" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_461b1841-4d48-40a0-bc49-6824df476f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a8afd8e0-a4db-4293-b92d-06c9da656a03" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_461b1841-4d48-40a0-bc49-6824df476f9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ef9b55fe-1d9f-492c-9f97-31244821b677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ef9b55fe-1d9f-492c-9f97-31244821b677" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_f3692f95-4fe1-4b95-a402-9b32f7be8a54" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_f3692f95-4fe1-4b95-a402-9b32f7be8a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cdee960d-521c-4621-87b9-312b4e901dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cdee960d-521c-4621-87b9-312b4e901dba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_df3f8644-ad7b-497e-ad85-f821d6eb6b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_us-gaap_Goodwill_df3f8644-ad7b-497e-ad85-f821d6eb6b7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_f14bec33-64c9-4619-bfd1-374554b10441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_f14bec33-64c9-4619-bfd1-374554b10441" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7e5ac22a-d5fa-466f-bfd7-22fa1fdc38e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7e5ac22a-d5fa-466f-bfd7-22fa1fdc38e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_d008d4bb-12bd-4000-bfb5-c3a27cdaeb7a" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRental_d008d4bb-12bd-4000-bfb5-c3a27cdaeb7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5f405211-0de8-460a-997e-b57bcd336b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_us-gaap_AssetsCurrent_5f405211-0de8-460a-997e-b57bcd336b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b5c54bb7-b412-4452-a399-3332d7fad5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8d680f8f-4408-440a-b6c7-3df52fe1c308" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b5c54bb7-b412-4452-a399-3332d7fad5d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2e70af98-3ace-4194-8e9b-7e4b9b813c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3c5a721a-0ada-4c93-8fb4-bb07fc8a468d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2e70af98-3ace-4194-8e9b-7e4b9b813c02" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3c5a721a-0ada-4c93-8fb4-bb07fc8a468d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1da68252-145b-4538-bbd9-5ffbe4542bff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2e70af98-3ace-4194-8e9b-7e4b9b813c02" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1da68252-145b-4538-bbd9-5ffbe4542bff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_3062e039-0296-48cb-8c52-c493fe255807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2e70af98-3ace-4194-8e9b-7e4b9b813c02" xlink:to="loc_us-gaap_OtherAssetsCurrent_3062e039-0296-48cb-8c52-c493fe255807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_25a6d407-151d-453d-b73b-e4d275d5eef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2e70af98-3ace-4194-8e9b-7e4b9b813c02" xlink:to="loc_us-gaap_InventoryNet_25a6d407-151d-453d-b73b-e4d275d5eef2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fb63b435-f55b-4696-8a74-7b851342acdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_972ab005-93b0-4fa9-9c2c-e7a916e5c91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fb63b435-f55b-4696-8a74-7b851342acdd" xlink:to="loc_us-gaap_GrossProfit_972ab005-93b0-4fa9-9c2c-e7a916e5c91c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_740b8327-eacb-4312-bef0-e34daec07c81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fb63b435-f55b-4696-8a74-7b851342acdd" xlink:to="loc_us-gaap_OperatingExpenses_740b8327-eacb-4312-bef0-e34daec07c81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1458ec10-db37-47d9-9372-856e53662940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_913d0616-2a3a-4e63-95e8-55e672c4931a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1458ec10-db37-47d9-9372-856e53662940" xlink:to="loc_us-gaap_InterestExpense_913d0616-2a3a-4e63-95e8-55e672c4931a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3b35ca63-1b91-4db2-a001-51e7ee9e5758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1458ec10-db37-47d9-9372-856e53662940" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3b35ca63-1b91-4db2-a001-51e7ee9e5758" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_12ef5b74-b01e-4e87-84b5-fd7a4e9fa726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1458ec10-db37-47d9-9372-856e53662940" xlink:to="loc_us-gaap_OperatingIncomeLoss_12ef5b74-b01e-4e87-84b5-fd7a4e9fa726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c417bf0b-8d0f-4d37-9f6e-28773dca5480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3cd6226c-1272-4e39-994d-747a315e17fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c417bf0b-8d0f-4d37-9f6e-28773dca5480" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3cd6226c-1272-4e39-994d-747a315e17fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7eb0a13e-0cee-4311-a6e4-ad0eb8fb6aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c417bf0b-8d0f-4d37-9f6e-28773dca5480" xlink:to="loc_us-gaap_Revenues_7eb0a13e-0cee-4311-a6e4-ad0eb8fb6aa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9fcfb9c0-492f-4fc1-b1a4-e5ae16a926d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bea9f94e-7b2b-4a6f-9c96-1295b64c5297" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9fcfb9c0-492f-4fc1-b1a4-e5ae16a926d6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bea9f94e-7b2b-4a6f-9c96-1295b64c5297" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c280d4ed-3717-477f-bd30-fbd36e648312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_9fcfb9c0-492f-4fc1-b1a4-e5ae16a926d6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c280d4ed-3717-477f-bd30-fbd36e648312" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3ba26ee6-383b-444e-a3be-4088b48080f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_4363fe68-1fe7-4973-b308-e2854409cf13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3ba26ee6-383b-444e-a3be-4088b48080f0" xlink:to="loc_us-gaap_SellingAndMarketingExpense_4363fe68-1fe7-4973-b308-e2854409cf13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_39028b2b-4c2f-4eee-9268-a15f70934a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3ba26ee6-383b-444e-a3be-4088b48080f0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_39028b2b-4c2f-4eee-9268-a15f70934a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7e6c400c-d019-47d8-9890-62c00d10b7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3ba26ee6-383b-444e-a3be-4088b48080f0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7e6c400c-d019-47d8-9890-62c00d10b7b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_45bd2d4d-f3a2-45ce-9e32-7b7ce0fb078b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3ba26ee6-383b-444e-a3be-4088b48080f0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_45bd2d4d-f3a2-45ce-9e32-7b7ce0fb078b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_86fcfb84-6de8-4b16-b482-c55693477cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_6bcab2a7-1d92-41e8-8de6-44f08330ff8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_86fcfb84-6de8-4b16-b482-c55693477cdc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_6bcab2a7-1d92-41e8-8de6-44f08330ff8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fa3e9dda-67d8-41a9-93dc-907ac283a6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_86fcfb84-6de8-4b16-b482-c55693477cdc" xlink:to="loc_us-gaap_NetIncomeLoss_fa3e9dda-67d8-41a9-93dc-907ac283a6a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_71b0c6ae-43e6-478a-b978-3b5f7d4cb00a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_86fcfb84-6de8-4b16-b482-c55693477cdc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_71b0c6ae-43e6-478a-b978-3b5f7d4cb00a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_766c9deb-adf5-47b1-b745-f0232699c9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_61504782-43a4-410f-92b4-e2c88573fcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_766c9deb-adf5-47b1-b745-f0232699c9b2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_61504782-43a4-410f-92b4-e2c88573fcb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_088d7c65-3f3b-495b-8b2e-9fa158249dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_766c9deb-adf5-47b1-b745-f0232699c9b2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_088d7c65-3f3b-495b-8b2e-9fa158249dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2276a86-8237-40cb-85b7-f8b74ad7b4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_766c9deb-adf5-47b1-b745-f0232699c9b2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f2276a86-8237-40cb-85b7-f8b74ad7b4d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e233648c-d266-444f-a411-e7949e3a2d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d45a3164-d0a6-4deb-8dc2-53e182195e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e233648c-d266-444f-a411-e7949e3a2d58" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d45a3164-d0a6-4deb-8dc2-53e182195e7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment_3c86f6c2-93db-44f9-beef-8b41918c1666" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e233648c-d266-444f-a411-e7949e3a2d58" xlink:to="loc_infu_PaymentsToAcquireMedicalEquipment_3c86f6c2-93db-44f9-beef-8b41918c1666" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_dedf857a-8f7c-4a73-94a3-18833ce1ee8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e233648c-d266-444f-a411-e7949e3a2d58" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_dedf857a-8f7c-4a73-94a3-18833ce1ee8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a1df4926-989d-43a6-a68f-17d20408c3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e233648c-d266-444f-a411-e7949e3a2d58" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a1df4926-989d-43a6-a68f-17d20408c3fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d0ac493-b8b5-42e0-a978-55c34beed246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_c3e8981c-21eb-4d31-9ff4-862f1ffc0603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d0ac493-b8b5-42e0-a978-55c34beed246" xlink:to="loc_us-gaap_ProceedsFromStockPlans_c3e8981c-21eb-4d31-9ff4-862f1ffc0603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_91f0853b-fe28-4533-b08e-96c04f041078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d0ac493-b8b5-42e0-a978-55c34beed246" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_91f0853b-fe28-4533-b08e-96c04f041078" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ef9cb127-77d1-4e54-9652-8ac22d7b4fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d0ac493-b8b5-42e0-a978-55c34beed246" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ef9cb127-77d1-4e54-9652-8ac22d7b4fdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2cbd9cf3-c925-4f42-8f12-15f92a361905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d0ac493-b8b5-42e0-a978-55c34beed246" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2cbd9cf3-c925-4f42-8f12-15f92a361905" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_75c30aa0-3b92-46e7-8bd6-45f4287b02b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d0ac493-b8b5-42e0-a978-55c34beed246" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_75c30aa0-3b92-46e7-8bd6-45f4287b02b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5b376a70-0b2c-4042-afd3-732c54e4ffa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d0ac493-b8b5-42e0-a978-55c34beed246" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5b376a70-0b2c-4042-afd3-732c54e4ffa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_1c933bb2-70d6-4dd1-a4d0-e33faaad4222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_1c933bb2-70d6-4dd1-a4d0-e33faaad4222" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0fa8ecb8-adfa-4acd-a2d4-cb815729fbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_Depreciation_0fa8ecb8-adfa-4acd-a2d4-cb815729fbe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fe8d1d40-36cb-489e-b214-02c2e63e6ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fe8d1d40-36cb-489e-b214-02c2e63e6ba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_78f62082-eb0a-40d0-8e7b-6f16f681541e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_78f62082-eb0a-40d0-8e7b-6f16f681541e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_e14df42f-de2e-4b7b-9ee1-659155e9090e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_e14df42f-de2e-4b7b-9ee1-659155e9090e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_87de2092-c8ad-4d9e-bc80-ce5ca414a0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_87de2092-c8ad-4d9e-bc80-ce5ca414a0d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_11685280-297c-4821-b9f7-ee3377acf6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_NetIncomeLoss_11685280-297c-4821-b9f7-ee3377acf6e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7c9f52ab-4620-4544-a877-3fa58fe3bd49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7c9f52ab-4620-4544-a877-3fa58fe3bd49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f2ae509-0566-450f-a820-eea351fbc5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f2ae509-0566-450f-a820-eea351fbc5aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ff06e5b6-4964-45dd-baff-f7016c8da949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ff06e5b6-4964-45dd-baff-f7016c8da949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_8d6ce55c-b568-49bf-a755-45d052fe46e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_8d6ce55c-b568-49bf-a755-45d052fe46e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_31016706-e1b6-40eb-9b45-5e8bab04e8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_ShareBasedCompensation_31016706-e1b6-40eb-9b45-5e8bab04e8a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_c76668c2-696d-4025-9d6d-284cb04815e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_c76668c2-696d-4025-9d6d-284cb04815e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4bef7349-0927-42c7-97b1-da22232527fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98091c32-a4b1-4895-94a4-cb585743a51f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4bef7349-0927-42c7-97b1-da22232527fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_755f3940-5087-46fc-8f84-1adebc111e28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e68a6b5a-6eee-418a-a077-a6fe066fe4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_755f3940-5087-46fc-8f84-1adebc111e28" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e68a6b5a-6eee-418a-a077-a6fe066fe4a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_WorkingCapital_32cd35e3-ac29-478b-a4e5-8fd660d1fe00" xlink:href="infu-20220331.xsd#infu_WorkingCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_755f3940-5087-46fc-8f84-1adebc111e28" xlink:to="loc_infu_WorkingCapital_32cd35e3-ac29-478b-a4e5-8fd660d1fe00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_3397db1f-c8eb-4b7e-9f54-55b8c8ea8e60" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_755f3940-5087-46fc-8f84-1adebc111e28" xlink:to="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_3397db1f-c8eb-4b7e-9f54-55b8c8ea8e60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_320d0a9d-56e3-436b-a964-9caa0e92f9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_320d0a9d-56e3-436b-a964-9caa0e92f9ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_670f4305-d9e0-4a17-8ae8-610aa778c358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_670f4305-d9e0-4a17-8ae8-610aa778c358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cc619ad9-21b2-448e-acc0-9a02f477af54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:to="loc_us-gaap_Goodwill_cc619ad9-21b2-448e-acc0-9a02f477af54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d37dc7e5-f3ef-4c40-9665-26fea712b404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d37dc7e5-f3ef-4c40-9665-26fea712b404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_54818ac3-ab61-4064-87bd-92ea8f499968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_54818ac3-ab61-4064-87bd-92ea8f499968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_da26ac1c-c111-441c-8c6c-f1dd819210a4" xlink:href="infu-20220331.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_da26ac1c-c111-441c-8c6c-f1dd819210a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_90d4b80e-21ad-4952-a02f-57f58d62f9db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_90d4b80e-21ad-4952-a02f-57f58d62f9db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_b98fc255-0447-44f4-a581-ec7190179c3a" xlink:href="infu-20220331.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_40daacb7-2908-44cf-98f0-2a4c1e903a9f" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_b98fc255-0447-44f4-a581-ec7190179c3a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#MedicalEquipmentSummaryofMedicalEquipmentDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentNet_d23d0752-7995-4b45-a8f0-81af582d387a" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_6823f3b9-fb89-48d2-8e99-098bbca6c7d0" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentNet_d23d0752-7995-4b45-a8f0-81af582d387a" xlink:to="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_6823f3b9-fb89-48d2-8e99-098bbca6c7d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_53f6f8f9-6924-48b4-b9bf-5b5818253696" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentNet_d23d0752-7995-4b45-a8f0-81af582d387a" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRental_53f6f8f9-6924-48b4-b9bf-5b5818253696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_7a952f06-3427-44a5-8c89-c5df1f79bc67" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_148f3679-7f30-4f55-8b7f-16645f4b3f5b" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_7a952f06-3427-44a5-8c89-c5df1f79bc67" xlink:to="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_148f3679-7f30-4f55-8b7f-16645f4b3f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesReserve_5a1bc127-1078-4075-9931-6cf8ba9a6d89" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesReserve"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_7a952f06-3427-44a5-8c89-c5df1f79bc67" xlink:to="loc_infu_MedicalEquipmentInRentalServicesReserve_5a1bc127-1078-4075-9931-6cf8ba9a6d89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesGross_b2223b72-d1a4-4d62-bac9-a168ba266dc2" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_7a952f06-3427-44a5-8c89-c5df1f79bc67" xlink:to="loc_infu_MedicalEquipmentInRentalServicesGross_b2223b72-d1a4-4d62-bac9-a168ba266dc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_6029e1a6-2333-4de8-86af-07c2071f17db" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentForSaleOrRentalReserve_4d0abf1c-c25d-4412-a68c-a722eda3ab51" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentForSaleOrRentalReserve"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentHeldForSaleOrRental_6029e1a6-2333-4de8-86af-07c2071f17db" xlink:to="loc_infu_MedicalEquipmentForSaleOrRentalReserve_4d0abf1c-c25d-4412-a68c-a722eda3ab51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross_89896832-97a0-44e1-bde9-c58a5ddf5324" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRentalGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_infu_MedicalEquipmentHeldForSaleOrRental_6029e1a6-2333-4de8-86af-07c2071f17db" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross_89896832-97a0-44e1-bde9-c58a5ddf5324" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f351fe0c-09f2-414a-b950-8b450f3fdb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_818cbc8e-ad72-44cc-827d-64579f623ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f351fe0c-09f2-414a-b950-8b450f3fdb66" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_818cbc8e-ad72-44cc-827d-64579f623ed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9fab3e45-8969-44bd-9ced-bb27578c1a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f351fe0c-09f2-414a-b950-8b450f3fdb66" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9fab3e45-8969-44bd-9ced-bb27578c1a04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8e72626b-602a-44a7-a654-7d22b0f4ed6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_068f574e-95e5-4c88-80aa-e2da58826433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8e72626b-602a-44a7-a654-7d22b0f4ed6f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_068f574e-95e5-4c88-80aa-e2da58826433" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c37a1df4-f428-4218-9afd-10ddb962d440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8e72626b-602a-44a7-a654-7d22b0f4ed6f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c37a1df4-f428-4218-9afd-10ddb962d440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b066361c-98d0-4318-8797-00cd433c546b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_75fd12d2-12e6-4b1b-a928-b5f9a71b6284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b066361c-98d0-4318-8797-00cd433c546b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_75fd12d2-12e6-4b1b-a928-b5f9a71b6284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3f9ff429-3a2e-48cb-a446-90943b90368d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_b066361c-98d0-4318-8797-00cd433c546b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3f9ff429-3a2e-48cb-a446-90943b90368d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_27ab83f6-def1-420a-95b4-e2e3814d4912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e1c0d56f-7dbc-448b-a85f-5ad5e5813f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_27ab83f6-def1-420a-95b4-e2e3814d4912" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e1c0d56f-7dbc-448b-a85f-5ad5e5813f4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_086edd02-781c-4f39-8d86-1aa674d2368f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_27ab83f6-def1-420a-95b4-e2e3814d4912" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_086edd02-781c-4f39-8d86-1aa674d2368f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cdae445e-23f1-45de-ba91-90ee78998fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cd2e1ef0-c33b-4cd5-9a7b-223cc6c30b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cdae445e-23f1-45de-ba91-90ee78998fdf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cd2e1ef0-c33b-4cd5-9a7b-223cc6c30b53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d7421819-fa23-485c-8e66-1e0ecc20c4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cdae445e-23f1-45de-ba91-90ee78998fdf" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d7421819-fa23-485c-8e66-1e0ecc20c4e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f8a043b-8593-4704-bd35-9271b805b1c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter_9b07ea72-9140-41ed-9c32-5da74936fcc4" xlink:href="infu-20220331.xsd#infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f8a043b-8593-4704-bd35-9271b805b1c0" xlink:to="loc_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter_9b07ea72-9140-41ed-9c32-5da74936fcc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1fc2c761-6fc3-47b1-9f27-e0e593f8ccd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f8a043b-8593-4704-bd35-9271b805b1c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1fc2c761-6fc3-47b1-9f27-e0e593f8ccd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_e337af2d-7a21-427e-96d3-52c7e78b217d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f8a043b-8593-4704-bd35-9271b805b1c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_e337af2d-7a21-427e-96d3-52c7e78b217d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dd6ddcec-372f-4f2b-9ead-a082e9636ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f8a043b-8593-4704-bd35-9271b805b1c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dd6ddcec-372f-4f2b-9ead-a082e9636ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_93d895c8-259b-4305-80a7-8f26badeeebf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f8a043b-8593-4704-bd35-9271b805b1c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_93d895c8-259b-4305-80a7-8f26badeeebf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_42357cc4-0dfd-48c5-bd90-375ebe594908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f8a043b-8593-4704-bd35-9271b805b1c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_42357cc4-0dfd-48c5-bd90-375ebe594908" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_538b4110-c8ce-4e63-8861-2e67d7933895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_7cd3e250-6be9-4a00-9068-8538da6798c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_538b4110-c8ce-4e63-8861-2e67d7933895" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_7cd3e250-6be9-4a00-9068-8538da6798c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_0d9a6512-bee6-4200-bdb6-3181c5c75689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_538b4110-c8ce-4e63-8861-2e67d7933895" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_0d9a6512-bee6-4200-bdb6-3181c5c75689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_8e4fa85d-68cf-4594-b211-3aa868cad639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_538b4110-c8ce-4e63-8861-2e67d7933895" xlink:to="loc_us-gaap_LineOfCredit_8e4fa85d-68cf-4594-b211-3aa868cad639" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofFutureMaturitiesofLoansDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4d59447c-cee1-4e76-9448-53ef86e11588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c366e8e0-f3a8-40a2-b6c0-8f468512a027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4d59447c-cee1-4e76-9448-53ef86e11588" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c366e8e0-f3a8-40a2-b6c0-8f468512a027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_9c779d44-2334-4b8a-94b3-418e01bf1516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4d59447c-cee1-4e76-9448-53ef86e11588" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_9c779d44-2334-4b8a-94b3-418e01bf1516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_95bc9f91-0292-4da1-bb4c-e3911a803940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4d59447c-cee1-4e76-9448-53ef86e11588" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_95bc9f91-0292-4da1-bb4c-e3911a803940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_48d81240-d163-42bb-b8d2-003060d2c85f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4d59447c-cee1-4e76-9448-53ef86e11588" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_48d81240-d163-42bb-b8d2-003060d2c85f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_03bd2e65-86df-4052-a20e-47ed74b90add" xlink:href="infu-20220331.xsd#infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4d59447c-cee1-4e76-9448-53ef86e11588" xlink:to="loc_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_03bd2e65-86df-4052-a20e-47ed74b90add" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_3f78bcba-368b-4220-adde-5785913b7a27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_ba7ff84c-b4cc-4110-b9cc-1f0706dcb6fe" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense_3f78bcba-368b-4220-adde-5785913b7a27" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_ba7ff84c-b4cc-4110-b9cc-1f0706dcb6fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_a9c53518-c5a2-4b44-a068-02f7cf717f65" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense_3f78bcba-368b-4220-adde-5785913b7a27" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_a9c53518-c5a2-4b44-a068-02f7cf717f65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1f585171-0c9a-4a77-bf18-f5677081fe2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_91571190-c708-44d9-bc84-2bcbc616614b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1f585171-0c9a-4a77-bf18-f5677081fe2a" xlink:to="loc_us-gaap_LongTermDebtCurrent_91571190-c708-44d9-bc84-2bcbc616614b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_11c9af18-4837-4c99-a0e0-2cf03ff92ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_1f585171-0c9a-4a77-bf18-f5677081fe2a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_11c9af18-4837-4c99-a0e0-2cf03ff92ba8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_43d83601-eb2c-4590-892a-6472356a8e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent_325bf5e4-2f2e-4cc2-b8ae-3387244d2c51" xlink:href="infu-20220331.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_43d83601-eb2c-4590-892a-6472356a8e1d" xlink:to="loc_infu_LongtermDebtGrossCurrent_325bf5e4-2f2e-4cc2-b8ae-3387244d2c51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent_90be54da-2bca-4bc7-926b-bc04d8cf2877" xlink:href="infu-20220331.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_43d83601-eb2c-4590-892a-6472356a8e1d" xlink:to="loc_infu_LongTermDebtGrossNoncurrent_90be54da-2bca-4bc7-926b-bc04d8cf2877" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3d0d1a66-f5bc-4cd0-b08d-56feb6324f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent_8d24915f-a805-467d-b03d-3e57b46f986a" xlink:href="infu-20220331.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtCurrent_3d0d1a66-f5bc-4cd0-b08d-56feb6324f77" xlink:to="loc_infu_LongtermDebtGrossCurrent_8d24915f-a805-467d-b03d-3e57b46f986a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_13da77f1-7dec-43d1-a1e0-3af15e19258a" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtCurrent_3d0d1a66-f5bc-4cd0-b08d-56feb6324f77" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_13da77f1-7dec-43d1-a1e0-3af15e19258a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7111c927-3b1b-492b-98b6-3388042345f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent_e8554e14-a606-404c-9e5d-1b5c54f83b17" xlink:href="infu-20220331.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_7111c927-3b1b-492b-98b6-3388042345f1" xlink:to="loc_infu_LongTermDebtGrossNoncurrent_e8554e14-a606-404c-9e5d-1b5c54f83b17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_c5dea2dc-3c09-4f12-a579-5b928e734d75" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_7111c927-3b1b-492b-98b6-3388042345f1" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_c5dea2dc-3c09-4f12-a579-5b928e734d75" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_66409e9a-7e1d-4511-8689-f1c233ac4843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_77f4fcec-6dd9-4512-8527-39f27575ff4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_66409e9a-7e1d-4511-8689-f1c233ac4843" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_77f4fcec-6dd9-4512-8527-39f27575ff4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_5059ee34-8bca-412b-8cc7-3e8a51e0c55d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_66409e9a-7e1d-4511-8689-f1c233ac4843" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_5059ee34-8bca-412b-8cc7-3e8a51e0c55d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cff5d5dc-67f6-4184-91c0-38247b60ead0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f8ee247-163a-4c8b-aa56-5d4b87e5d3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cff5d5dc-67f6-4184-91c0-38247b60ead0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f8ee247-163a-4c8b-aa56-5d4b87e5d3c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_61d1fdfe-0299-41c8-b3e3-40801cb85cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cff5d5dc-67f6-4184-91c0-38247b60ead0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_61d1fdfe-0299-41c8-b3e3-40801cb85cc6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_59c78d2b-45aa-44ba-a24c-bab0ef6f96e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_6b19e91f-b002-4a06-86e8-d9668ecd870b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_59c78d2b-45aa-44ba-a24c-bab0ef6f96e3" xlink:to="loc_us-gaap_OperatingLeaseCost_6b19e91f-b002-4a06-86e8-d9668ecd870b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_2532a91b-c1dc-4d55-9f62-74acaf7af010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_59c78d2b-45aa-44ba-a24c-bab0ef6f96e3" xlink:to="loc_us-gaap_VariableLeaseCost_2532a91b-c1dc-4d55-9f62-74acaf7af010" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd9ae428-c592-4ff8-99e5-37be46954169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_bedb9fa4-cb72-4b18-81ed-7ed09c98a330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd9ae428-c592-4ff8-99e5-37be46954169" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_bedb9fa4-cb72-4b18-81ed-7ed09c98a330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_083007b8-b0aa-4c72-86e8-5e51fab90965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd9ae428-c592-4ff8-99e5-37be46954169" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_083007b8-b0aa-4c72-86e8-5e51fab90965" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_725e9e16-8277-46c0-adc0-843ef677fdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd9ae428-c592-4ff8-99e5-37be46954169" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_725e9e16-8277-46c0-adc0-843ef677fdb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_5edb689d-5576-4531-ac51-97018d360ac5" xlink:href="infu-20220331.xsd#infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd9ae428-c592-4ff8-99e5-37be46954169" xlink:to="loc_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_5edb689d-5576-4531-ac51-97018d360ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8476e5e7-e16a-4d51-9cea-e5b13765a410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd9ae428-c592-4ff8-99e5-37be46954169" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8476e5e7-e16a-4d51-9cea-e5b13765a410" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d4abb39e-119e-4608-ba55-8e765d049bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bd9ae428-c592-4ff8-99e5-37be46954169" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d4abb39e-119e-4608-ba55-8e765d049bec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a16fa2ae-0340-4a90-b1e7-e136daadc136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1b242361-ca67-4cc7-bcb5-0cd8f314945a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a16fa2ae-0340-4a90-b1e7-e136daadc136" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1b242361-ca67-4cc7-bcb5-0cd8f314945a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a88c7365-3c63-4e11-9271-5758eca1aa2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a16fa2ae-0340-4a90-b1e7-e136daadc136" xlink:to="loc_us-gaap_OperatingLeaseLiability_a88c7365-3c63-4e11-9271-5758eca1aa2e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7c82f5ec-e1e1-4635-8983-dd98a99280ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesExternal_933179dc-7545-4733-aba7-24ffb88e3b30" xlink:href="infu-20220331.xsd#infu_RevenuesExternal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_7c82f5ec-e1e1-4635-8983-dd98a99280ff" xlink:to="loc_infu_RevenuesExternal_933179dc-7545-4733-aba7-24ffb88e3b30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesInternal_20aa4e2a-11b7-43de-8e7d-f1a618938663" xlink:href="infu-20220331.xsd#infu_RevenuesInternal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_7c82f5ec-e1e1-4635-8983-dd98a99280ff" xlink:to="loc_infu_RevenuesInternal_20aa4e2a-11b7-43de-8e7d-f1a618938663" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>infu-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9c45a9a1-f9a1-46d4-ab6e-c84379cf91bb,g:e62fa09c-9414-4caa-b36a-5012b4171a20-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="extended" id="i7a7f744e00f54c1c961be4aa732bf31f_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8731cda8-3b5e-428e-8253-475f79e2d44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8731cda8-3b5e-428e-8253-475f79e2d44f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_f3e6da61-4def-4ecf-8cca-3e717bb7558c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_SharesOutstanding_f3e6da61-4def-4ecf-8cca-3e717bb7558c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_59e66746-6c9c-421c-b932-19e78f6b7ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockholdersEquity_59e66746-6c9c-421c-b932-19e78f6b7ea0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_3d91227c-b62d-4f27-9e8e-0c0778b6922f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_3d91227c-b62d-4f27-9e8e-0c0778b6922f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_bfc9965d-e787-4259-aa63-1c641aa09680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_bfc9965d-e787-4259-aa63-1c641aa09680" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0bd9ae64-2568-48ed-9c1a-5dad7a5cb28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0bd9ae64-2568-48ed-9c1a-5dad7a5cb28c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_001e7493-cd36-47fd-b0ca-422b17a5ccee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_001e7493-cd36-47fd-b0ca-422b17a5ccee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_a6cd8b6b-e0e6-437b-929f-46e13530d73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_a6cd8b6b-e0e6-437b-929f-46e13530d73a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_76888c90-c1ee-4b44-a8f7-0e84bbeeae7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_76888c90-c1ee-4b44-a8f7-0e84bbeeae7d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_628c19be-e86c-47db-93d6-0bbbb73093c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_628c19be-e86c-47db-93d6-0bbbb73093c0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_463cf091-507a-4643-ba3c-e92c702563f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_463cf091-507a-4643-ba3c-e92c702563f0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e1c99f49-41bb-47ff-be28-199034414cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e1c99f49-41bb-47ff-be28-199034414cef" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a3f469f3-190a-4950-849e-0a5a259083a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a3f469f3-190a-4950-849e-0a5a259083a5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_43b9ac04-f27d-472e-ba25-a0ce5b389727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_NetIncomeLoss_43b9ac04-f27d-472e-ba25-a0ce5b389727" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_8fc452f0-858d-4d51-a051-22b553927248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c221c1bb-6197-4e45-911a-474c492c4bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_aa03c12e-14eb-4fd1-a745-316d98c99949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8731cda8-3b5e-428e-8253-475f79e2d44f" xlink:to="loc_us-gaap_StatementTable_aa03c12e-14eb-4fd1-a745-316d98c99949" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_aa03c12e-14eb-4fd1-a745-316d98c99949" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed" xlink:to="loc_us-gaap_EquityComponentDomain_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed" xlink:to="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d6bbaf3b-dd33-4d79-8ba0-cd927a3c72b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_CommonStockMember_d6bbaf3b-dd33-4d79-8ba0-cd927a3c72b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_763a751f-e54a-4439-a403-22965a02b402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_763a751f-e54a-4439-a403-22965a02b402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_84d28f4b-ef1e-44dc-82c0-b68b35e3326e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_RetainedEarningsMember_84d28f4b-ef1e-44dc-82c0-b68b35e3326e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f6a08f47-0677-4281-81d4-e3aa22122367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f6a08f47-0677-4281-81d4-e3aa22122367" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_b665350e-71a3-4e00-8c8c-d7d2c76589e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_TreasuryStockMember_b665350e-71a3-4e00-8c8c-d7d2c76589e9" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessCombinationsDetailsTextual" xlink:type="extended" id="iadf0c9b3732c4968883d4de92ffbe289_BusinessCombinationsDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a76c43db-005b-491b-8dac-a18b72b92eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a76c43db-005b-491b-8dac-a18b72b92eb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e30fb7c1-e163-4e4a-b49c-c7416ce6d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e30fb7c1-e163-4e4a-b49c-c7416ce6d8da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c1f4419f-c91d-4f2f-8837-410d61f47341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c1f4419f-c91d-4f2f-8837-410d61f47341" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability_84ad8685-0630-4f1b-97ed-acaf9344529b" xlink:href="infu-20220331.xsd#infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability_84ad8685-0630-4f1b-97ed-acaf9344529b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_6d40e3ab-6656-42bd-b9f5-83e17493b8cd" xlink:href="infu-20220331.xsd#infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_6d40e3ab-6656-42bd-b9f5-83e17493b8cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_53f3db85-6fb0-4eca-a059-41acf4ca94f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_53f3db85-6fb0-4eca-a059-41acf4ca94f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_53f3db85-6fb0-4eca-a059-41acf4ca94f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_53f3db85-6fb0-4eca-a059-41acf4ca94f5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_53f3db85-6fb0-4eca-a059-41acf4ca94f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_97dfc8e6-61b0-4989-ae16-74abc085e3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_53f3db85-6fb0-4eca-a059-41acf4ca94f5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_97dfc8e6-61b0-4989-ae16-74abc085e3f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_56add3a0-02eb-41b9-ac55-d18ee47e48dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_97dfc8e6-61b0-4989-ae16-74abc085e3f5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_56add3a0-02eb-41b9-ac55-d18ee47e48dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_70de6392-662a-421b-97b7-fa35cec04ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_70de6392-662a-421b-97b7-fa35cec04ee1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70de6392-662a-421b-97b7-fa35cec04ee1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_70de6392-662a-421b-97b7-fa35cec04ee1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70de6392-662a-421b-97b7-fa35cec04ee1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9387e8d3-ddae-4bf7-b3b0-5ee83f804266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_70de6392-662a-421b-97b7-fa35cec04ee1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9387e8d3-ddae-4bf7-b3b0-5ee83f804266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_6a12127b-1782-4fa5-bc3c-38822a0c3bee" xlink:href="infu-20220331.xsd#infu_FilAMedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9387e8d3-ddae-4bf7-b3b0-5ee83f804266" xlink:to="loc_infu_FilAMedMember_6a12127b-1782-4fa5-bc3c-38822a0c3bee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_aa8a3c13-1870-453e-bb1f-061903b68d87" xlink:href="infu-20220331.xsd#infu_OBHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9387e8d3-ddae-4bf7-b3b0-5ee83f804266" xlink:to="loc_infu_OBHealthcareMember_aa8a3c13-1870-453e-bb1f-061903b68d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_217296f6-c142-4b6a-a627-5c8d35b5eadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_217296f6-c142-4b6a-a627-5c8d35b5eadd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_217296f6-c142-4b6a-a627-5c8d35b5eadd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_217296f6-c142-4b6a-a627-5c8d35b5eadd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_217296f6-c142-4b6a-a627-5c8d35b5eadd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_240bb093-5ace-4f86-bebf-86ab4c4135b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_217296f6-c142-4b6a-a627-5c8d35b5eadd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_240bb093-5ace-4f86-bebf-86ab4c4135b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_78fc0e87-880d-49ac-a4f5-090407d0a49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_240bb093-5ace-4f86-bebf-86ab4c4135b2" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_78fc0e87-880d-49ac-a4f5-090407d0a49f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended" id="i929a5349ae484ba2b0015d0e447b9bfb_BusinessCombinationsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_309caba2-dcdd-475d-89b0-8f7051a1fe3b" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_309caba2-dcdd-475d-89b0-8f7051a1fe3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_WorkingCapital_eb98f2cf-c9b0-4304-a683-b3cd0d9b60f7" xlink:href="infu-20220331.xsd#infu_WorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_infu_WorkingCapital_eb98f2cf-c9b0-4304-a683-b3cd0d9b60f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_ec4065b5-ff46-4258-ae80-c1be7dccd8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_ec4065b5-ff46-4258-ae80-c1be7dccd8dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e2b7cb6c-fcc6-4d15-b843-50e37f43cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e2b7cb6c-fcc6-4d15-b843-50e37f43cb31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2882ab0e-cb5d-474a-a939-73e9100a8a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2882ab0e-cb5d-474a-a939-73e9100a8a7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e433a935-bf6c-4006-a9c1-427b9bab4845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2882ab0e-cb5d-474a-a939-73e9100a8a7c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e433a935-bf6c-4006-a9c1-427b9bab4845" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e433a935-bf6c-4006-a9c1-427b9bab4845_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e433a935-bf6c-4006-a9c1-427b9bab4845" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e433a935-bf6c-4006-a9c1-427b9bab4845_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886fa1a9-826c-4505-ba5c-b28ec3f6d3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e433a935-bf6c-4006-a9c1-427b9bab4845" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886fa1a9-826c-4505-ba5c-b28ec3f6d3d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_2eca2471-5233-464b-9dac-d7ba82f387d3" xlink:href="infu-20220331.xsd#infu_FilAMedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886fa1a9-826c-4505-ba5c-b28ec3f6d3d5" xlink:to="loc_infu_FilAMedMember_2eca2471-5233-464b-9dac-d7ba82f387d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_0a06e3d6-46ae-4486-8045-798dd2293340" xlink:href="infu-20220331.xsd#infu_OBHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886fa1a9-826c-4505-ba5c-b28ec3f6d3d5" xlink:to="loc_infu_OBHealthcareMember_0a06e3d6-46ae-4486-8045-798dd2293340" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended" id="i36574a37c2344ae787c96781825a4e91_BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e9714d1-883e-4220-bc12-65543f31c33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e9714d1-883e-4220-bc12-65543f31c33f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7c8d06ab-c3cd-4f35-80e0-ef722185439c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7c8d06ab-c3cd-4f35-80e0-ef722185439c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_c4fca742-e08d-43eb-933d-988380878a5c" xlink:href="infu-20220331.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_c4fca742-e08d-43eb-933d-988380878a5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_696b56bf-3d1a-4cd8-8e60-723bd13bdd10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_696b56bf-3d1a-4cd8-8e60-723bd13bdd10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c74641e6-c4a9-4241-8db4-86d796cb3c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c74641e6-c4a9-4241-8db4-86d796cb3c7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b20016a0-282b-448a-be2d-fb03f3ee3487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_Goodwill_b20016a0-282b-448a-be2d-fb03f3ee3487" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_a71d8b29-6715-486a-8fda-fd810f14d2df" xlink:href="infu-20220331.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_a71d8b29-6715-486a-8fda-fd810f14d2df" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_01862ea2-9c8e-4322-9a7b-d33fee4df199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_01862ea2-9c8e-4322-9a7b-d33fee4df199" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e20a444c-ef14-41fa-b576-6a7cf1221208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e20a444c-ef14-41fa-b576-6a7cf1221208" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_3f57f133-ed3a-4293-bb7c-069a57552b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_3f57f133-ed3a-4293-bb7c-069a57552b88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_08a8f112-7522-46fb-b060-be225c78a14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_3f57f133-ed3a-4293-bb7c-069a57552b88" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_08a8f112-7522-46fb-b060-be225c78a14a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08a8f112-7522-46fb-b060-be225c78a14a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_08a8f112-7522-46fb-b060-be225c78a14a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08a8f112-7522-46fb-b060-be225c78a14a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71fa9fbf-914b-4ec3-8f3d-e81cca5123d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_08a8f112-7522-46fb-b060-be225c78a14a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71fa9fbf-914b-4ec3-8f3d-e81cca5123d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_58a56667-c5ba-4ea0-9192-ede1873a01ba" xlink:href="infu-20220331.xsd#infu_FilAMedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71fa9fbf-914b-4ec3-8f3d-e81cca5123d1" xlink:to="loc_infu_FilAMedMember_58a56667-c5ba-4ea0-9192-ede1873a01ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_7edc9eb7-1c0c-4155-a1e0-ad08d3fc4327" xlink:href="infu-20220331.xsd#infu_OBHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71fa9fbf-914b-4ec3-8f3d-e81cca5123d1" xlink:to="loc_infu_OBHealthcareMember_7edc9eb7-1c0c-4155-a1e0-ad08d3fc4327" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsIntangibleAssetsAcquiredDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails" xlink:type="extended" id="if425fe901823444a92e4bddb026391bd_BusinessCombinationsIntangibleAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e9c0ed24-518a-4743-a845-0545df8b9338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_274b5253-6e84-429e-a5d2-26581cd9eed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e9c0ed24-518a-4743-a845-0545df8b9338" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_274b5253-6e84-429e-a5d2-26581cd9eed5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f6c51856-db52-4d77-844b-5702fcca2038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e9c0ed24-518a-4743-a845-0545df8b9338" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f6c51856-db52-4d77-844b-5702fcca2038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_54f9bb65-c576-4a07-babf-813a5b192afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e9c0ed24-518a-4743-a845-0545df8b9338" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_54f9bb65-c576-4a07-babf-813a5b192afa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f07fad2-ad45-4da1-898c-6b5419ad70a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_54f9bb65-c576-4a07-babf-813a5b192afa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f07fad2-ad45-4da1-898c-6b5419ad70a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f07fad2-ad45-4da1-898c-6b5419ad70a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f07fad2-ad45-4da1-898c-6b5419ad70a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6f07fad2-ad45-4da1-898c-6b5419ad70a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f07fad2-ad45-4da1-898c-6b5419ad70a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9b052458-c264-4276-9806-0a60ed6c3861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9b052458-c264-4276-9806-0a60ed6c3861" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a63bebf4-deaf-4f03-a988-26b27376aa59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a63bebf4-deaf-4f03-a988-26b27376aa59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_814d03df-4feb-472e-9d2f-3e6cc37f6627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_814d03df-4feb-472e-9d2f-3e6cc37f6627" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f20578c2-edfb-4250-9b08-3d0b348ff0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f20578c2-edfb-4250-9b08-3d0b348ff0de" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#RevenueRecognitionDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/RevenueRecognitionDetailsTextual" xlink:type="extended" id="ib49c60438df24ce7853ec672d011370c_RevenueRecognitionDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f1182388-6979-4ba9-b16c-6eecb814eb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a8f81ae6-e481-49e4-9fc6-2a4291bce177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f1182388-6979-4ba9-b16c-6eecb814eb1a" xlink:to="loc_us-gaap_Revenues_a8f81ae6-e481-49e4-9fc6-2a4291bce177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f1182388-6979-4ba9-b16c-6eecb814eb1a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_dc095709-43c7-4f2b-8352-d09431246a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_dc095709-43c7-4f2b-8352-d09431246a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_dc095709-43c7-4f2b-8352-d09431246a5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_dc095709-43c7-4f2b-8352-d09431246a5f" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_dc095709-43c7-4f2b-8352-d09431246a5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_089514ae-1f0f-4832-a3ed-8bc657a4096d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_dc095709-43c7-4f2b-8352-d09431246a5f" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_089514ae-1f0f-4832-a3ed-8bc657a4096d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember_88eb33b2-d61c-4234-b478-c1a1251779b6" xlink:href="infu-20220331.xsd#infu_DirectPayerRentalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_089514ae-1f0f-4832-a3ed-8bc657a4096d" xlink:to="loc_infu_DirectPayerRentalsMember_88eb33b2-d61c-4234-b478-c1a1251779b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d9dd82db-f48d-4703-8f24-ad39aadafc46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d9dd82db-f48d-4703-8f24-ad39aadafc46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d9dd82db-f48d-4703-8f24-ad39aadafc46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9dd82db-f48d-4703-8f24-ad39aadafc46" xlink:to="loc_us-gaap_SegmentDomain_d9dd82db-f48d-4703-8f24-ad39aadafc46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d9888f5c-52cb-422d-9644-4dd77acc6ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9dd82db-f48d-4703-8f24-ad39aadafc46" xlink:to="loc_us-gaap_SegmentDomain_d9888f5c-52cb-422d-9644-4dd77acc6ffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_7ab5a1c5-e48e-4be0-8682-705267abdad6" xlink:href="infu-20220331.xsd#infu_ITSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d9888f5c-52cb-422d-9644-4dd77acc6ffc" xlink:to="loc_infu_ITSSegmentMember_7ab5a1c5-e48e-4be0-8682-705267abdad6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_339b67ca-4957-41c0-a9a2-23bdb0a39ad7" xlink:href="infu-20220331.xsd#infu_DMEServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d9888f5c-52cb-422d-9644-4dd77acc6ffc" xlink:to="loc_infu_DMEServicesSegmentMember_339b67ca-4957-41c0-a9a2-23bdb0a39ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ca5b13b9-7fe1-42f2-ba0a-8250464adc62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:to="loc_srt_ProductOrServiceAxis_ca5b13b9-7fe1-42f2-ba0a-8250464adc62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ca5b13b9-7fe1-42f2-ba0a-8250464adc62_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ca5b13b9-7fe1-42f2-ba0a-8250464adc62" xlink:to="loc_srt_ProductsAndServicesDomain_ca5b13b9-7fe1-42f2-ba0a-8250464adc62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_662474fa-6fdd-4e8f-9073-b6c1053cc95f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ca5b13b9-7fe1-42f2-ba0a-8250464adc62" xlink:to="loc_srt_ProductsAndServicesDomain_662474fa-6fdd-4e8f-9073-b6c1053cc95f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_0f1a18e1-9e29-4bac-9657-4947e6d7cfa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_662474fa-6fdd-4e8f-9073-b6c1053cc95f" xlink:to="loc_us-gaap_ProductMember_0f1a18e1-9e29-4bac-9657-4947e6d7cfa7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" xlink:type="extended" id="ifd629b10a4404390a77155e2079219fa_RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_709b1145-db38-4c1c-8f4e-62b054a95608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bfb72e21-5230-4871-b0be-0707bbc63570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_709b1145-db38-4c1c-8f4e-62b054a95608" xlink:to="loc_us-gaap_Revenues_bfb72e21-5230-4871-b0be-0707bbc63570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_74755721-66b6-4399-8bc0-b53bd20fa108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_709b1145-db38-4c1c-8f4e-62b054a95608" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_74755721-66b6-4399-8bc0-b53bd20fa108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_709b1145-db38-4c1c-8f4e-62b054a95608" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9680f454-3d28-4643-9d52-7abac8abf15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9680f454-3d28-4643-9d52-7abac8abf15a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9680f454-3d28-4643-9d52-7abac8abf15a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9680f454-3d28-4643-9d52-7abac8abf15a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9680f454-3d28-4643-9d52-7abac8abf15a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8ae8cde7-601b-495c-8f73-bc9d8ab77687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9680f454-3d28-4643-9d52-7abac8abf15a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8ae8cde7-601b-495c-8f73-bc9d8ab77687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_5204fb86-0e52-443a-92a1-a8a777f4c7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8ae8cde7-601b-495c-8f73-bc9d8ab77687" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_5204fb86-0e52-443a-92a1-a8a777f4c7e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_96f939f4-2d78-4636-8c68-c6d384767d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_96f939f4-2d78-4636-8c68-c6d384767d60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_96f939f4-2d78-4636-8c68-c6d384767d60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_96f939f4-2d78-4636-8c68-c6d384767d60" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_96f939f4-2d78-4636-8c68-c6d384767d60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_77eda8f4-98ef-494d-8e7a-0ea1acb5aa47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_96f939f4-2d78-4636-8c68-c6d384767d60" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_77eda8f4-98ef-494d-8e7a-0ea1acb5aa47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4f93398e-9c96-456b-8ae2-6fd792d8d072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_77eda8f4-98ef-494d-8e7a-0ea1acb5aa47" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4f93398e-9c96-456b-8ae2-6fd792d8d072" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_b8a9075c-7107-4687-8adf-b9e80aeacf00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_b8a9075c-7107-4687-8adf-b9e80aeacf00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_b8a9075c-7107-4687-8adf-b9e80aeacf00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_b8a9075c-7107-4687-8adf-b9e80aeacf00" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_b8a9075c-7107-4687-8adf-b9e80aeacf00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_b8a9075c-7107-4687-8adf-b9e80aeacf00" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThirdPartyPayerRentalRevenueMember_5f6faf36-aa85-4ad2-9036-becd1ca8ae40" xlink:href="infu-20220331.xsd#infu_ThirdPartyPayerRentalRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:to="loc_infu_ThirdPartyPayerRentalRevenueMember_5f6faf36-aa85-4ad2-9036-becd1ca8ae40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember_52084d0b-d8f5-40ef-b4c9-57b42989aa0e" xlink:href="infu-20220331.xsd#infu_DirectPayerRentalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:to="loc_infu_DirectPayerRentalsMember_52084d0b-d8f5-40ef-b4c9-57b42989aa0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ProductSalesMember_b661c628-85ea-4669-ad24-1425daa9a47f" xlink:href="infu-20220331.xsd#infu_ProductSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:to="loc_infu_ProductSalesMember_b661c628-85ea-4669-ad24-1425daa9a47f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_01cea83a-12c9-41a5-bdf4-dd68afb443e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:to="loc_us-gaap_ServiceMember_01cea83a-12c9-41a5-bdf4-dd68afb443e6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended" id="i714e76d07687464789f4904811711a2a_PropertyandEquipmentScheduleofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c43ae8ae-f958-4bb3-9ad8-0ee93b0a93d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c43ae8ae-f958-4bb3-9ad8-0ee93b0a93d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a91b0d2-e58e-412a-a318-0488f1976c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a91b0d2-e58e-412a-a318-0488f1976c12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4e3be989-ba0f-40ca-9a2d-198f76471d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4e3be989-ba0f-40ca-9a2d-198f76471d51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6fd6023a-c17f-42cb-bbbd-6b3c4d72d506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6fd6023a-c17f-42cb-bbbd-6b3c4d72d506" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6fd6023a-c17f-42cb-bbbd-6b3c4d72d506" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_9fbb8ea5-f825-4588-95fb-4d70337c62c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_9fbb8ea5-f825-4588-95fb-4d70337c62c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_91148bb0-8beb-4318-bab2-022cb01533f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:to="loc_us-gaap_AutomobilesMember_91148bb0-8beb-4318-bab2-022cb01533f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_cb9a031e-9c67-44f6-b989-c68adde16cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_cb9a031e-9c67-44f6-b989-c68adde16cb3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i01705a9f3c764fabb5fce6671f78daf8_GoodwillIntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f396cb98-5021-4c67-b54e-c6e2a10744d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_f396cb98-5021-4c67-b54e-c6e2a10744d2" xlink:to="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9ec42fae-924a-412a-9098-341c62ea748d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:to="loc_us-gaap_Goodwill_9ec42fae-924a-412a-9098-341c62ea748d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e867df22-3581-4a02-a009-f1528560cfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e867df22-3581-4a02-a009-f1528560cfbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebf695f2-7b63-4945-ad8c-298a934acdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e7feb799-4dc4-44d7-a461-61ed05974827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_f396cb98-5021-4c67-b54e-c6e2a10744d2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e7feb799-4dc4-44d7-a461-61ed05974827" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d83c35ea-f469-4d86-ae04-32d74a2a0a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e7feb799-4dc4-44d7-a461-61ed05974827" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d83c35ea-f469-4d86-ae04-32d74a2a0a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d83c35ea-f469-4d86-ae04-32d74a2a0a2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d83c35ea-f469-4d86-ae04-32d74a2a0a2c" xlink:to="loc_us-gaap_SegmentDomain_d83c35ea-f469-4d86-ae04-32d74a2a0a2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_728ca6c5-53c7-4b5e-86d9-0c4e5caf6ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d83c35ea-f469-4d86-ae04-32d74a2a0a2c" xlink:to="loc_us-gaap_SegmentDomain_728ca6c5-53c7-4b5e-86d9-0c4e5caf6ca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_b25d8c8c-8e3f-46ac-8818-e284a9b3445c" xlink:href="infu-20220331.xsd#infu_DMEServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_728ca6c5-53c7-4b5e-86d9-0c4e5caf6ca8" xlink:to="loc_infu_DMEServicesSegmentMember_b25d8c8c-8e3f-46ac-8818-e284a9b3445c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_e62c62f1-3c84-462c-8f9f-0e5104fea36e" xlink:href="infu-20220331.xsd#infu_ITSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_728ca6c5-53c7-4b5e-86d9-0c4e5caf6ca8" xlink:to="loc_infu_ITSSegmentMember_e62c62f1-3c84-462c-8f9f-0e5104fea36e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i754972f542c44f88b8f3e55b79742205_GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_38358d2e-1b69-4668-b27f-cb56e2213862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_38358d2e-1b69-4668-b27f-cb56e2213862" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_145c5937-2e59-4874-8248-2aacad877426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_145c5937-2e59-4874-8248-2aacad877426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1662c4f6-2132-4ae2-953c-af25ca1adba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1662c4f6-2132-4ae2-953c-af25ca1adba0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3e7b034f-f9e9-4bad-9640-f5cf5bfdccf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3e7b034f-f9e9-4bad-9640-f5cf5bfdccf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c68e6a7e-839d-4e66-8571-747cc3df5521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c68e6a7e-839d-4e66-8571-747cc3df5521" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f7127711-5873-4410-9f63-1258ecf8e716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f7127711-5873-4410-9f63-1258ecf8e716" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d60ff58e-0aa8-4ef8-94f4-1ff39ad4a77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d60ff58e-0aa8-4ef8-94f4-1ff39ad4a77f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d9b18b5-fdde-429a-b3d6-2d41881975ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d60ff58e-0aa8-4ef8-94f4-1ff39ad4a77f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d9b18b5-fdde-429a-b3d6-2d41881975ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4d9b18b5-fdde-429a-b3d6-2d41881975ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d9b18b5-fdde-429a-b3d6-2d41881975ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4d9b18b5-fdde-429a-b3d6-2d41881975ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d9b18b5-fdde-429a-b3d6-2d41881975ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c14dcc82-0b59-40e1-a951-aa567ba29f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_us-gaap_TradeNamesMember_c14dcc82-0b59-40e1-a951-aa567ba29f0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember_412b5f24-32a5-4c8e-9cea-7e034aa4c8ba" xlink:href="infu-20220331.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_infu_PhysicianAndCustomerRelationshipsMember_412b5f24-32a5-4c8e-9cea-7e034aa4c8ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_9c17c6fe-d529-4481-86db-53b7a785bcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_9c17c6fe-d529-4481-86db-53b7a785bcfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_66750c7a-3923-482c-892b-255f950db169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_66750c7a-3923-482c-892b-255f950db169" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_c2bc537e-36b1-447d-bc0a-085db151179f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_c2bc537e-36b1-447d-bc0a-085db151179f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DebtDetailsTextual" xlink:type="extended" id="i2c524b1ada864505a301d5932507e1f0_DebtDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_25517867-9a96-4e5f-a612-306b8f11e26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_25517867-9a96-4e5f-a612-306b8f11e26c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_a5b2f560-b802-4c69-83b3-26d70734783c" xlink:href="infu-20220331.xsd#infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_a5b2f560-b802-4c69-83b3-26d70734783c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_80e6e1a6-a8c1-4e49-8ff5-e938bb42cfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_80e6e1a6-a8c1-4e49-8ff5-e938bb42cfb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_1d92b588-1a25-4040-8d60-d2a4afae4b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_1d92b588-1a25-4040-8d60-d2a4afae4b25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageOfTotalDepreciationExpense_61759805-9a11-476a-9d70-389e8b6e0fd9" xlink:href="infu-20220331.xsd#infu_PercentageOfTotalDepreciationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_PercentageOfTotalDepreciationExpense_61759805-9a11-476a-9d70-389e8b6e0fd9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_ed1f6b82-c050-451d-90b5-aea6f15e6e66" xlink:href="infu-20220331.xsd#infu_DebtInstrumentCovenantMinimumFixedCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_ed1f6b82-c050-451d-90b5-aea6f15e6e66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio_24c69557-71bb-40d8-b591-285c17a15c55" xlink:href="infu-20220331.xsd#infu_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio_24c69557-71bb-40d8-b591-285c17a15c55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_701f5ac1-4134-4b9a-868b-06fa74b96530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_LineOfCredit_701f5ac1-4134-4b9a-868b-06fa74b96530" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_aeec95c1-7598-4427-96a4-5e040e48017d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentTerm_aeec95c1-7598-4427-96a4-5e040e48017d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_13eabec2-1427-4635-8b69-be6166219415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_13eabec2-1427-4635-8b69-be6166219415" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9d050e46-7a01-439d-aed2-12e460eba194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9d050e46-7a01-439d-aed2-12e460eba194" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d2f120d1-ac15-4c5d-ab4a-d5b4b3690398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d2f120d1-ac15-4c5d-ab4a-d5b4b3690398" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LIBORRate_287fa770-9bf2-4c2b-9fd2-a3cbc308c421" xlink:href="infu-20220331.xsd#infu_LIBORRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_LIBORRate_287fa770-9bf2-4c2b-9fd2-a3cbc308c421" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LenderPrimeRate_3a5fceff-65e4-46c2-8162-559dc4e1b10d" xlink:href="infu-20220331.xsd#infu_LenderPrimeRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_LenderPrimeRate_3a5fceff-65e4-46c2-8162-559dc4e1b10d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_79fa7716-9923-4eee-bae4-9e8a48d75b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_DebtInstrumentAxis_79fa7716-9923-4eee-bae4-9e8a48d75b37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_79fa7716-9923-4eee-bae4-9e8a48d75b37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_79fa7716-9923-4eee-bae4-9e8a48d75b37" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_79fa7716-9923-4eee-bae4-9e8a48d75b37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_79fa7716-9923-4eee-bae4-9e8a48d75b37" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2021CreditAgreementMember_affb564a-4f4a-408f-8215-7cec62c54511" xlink:href="infu-20220331.xsd#infu_The2021CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:to="loc_infu_The2021CreditAgreementMember_affb564a-4f4a-408f-8215-7cec62c54511" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2015CreditAgreementMember_4d2b64cb-dfc3-4555-912f-0309697b802e" xlink:href="infu-20220331.xsd#infu_The2015CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:to="loc_infu_The2015CreditAgreementMember_4d2b64cb-dfc3-4555-912f-0309697b802e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_c4bbc828-090a-4f39-a496-8f9aaa027c94" xlink:href="infu-20220331.xsd#infu_FinancingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:to="loc_infu_FinancingAgreementMember_c4bbc828-090a-4f39-a496-8f9aaa027c94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f0dd5179-38a8-4d66-9ed0-2add437aeca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_CreditFacilityAxis_f0dd5179-38a8-4d66-9ed0-2add437aeca4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f0dd5179-38a8-4d66-9ed0-2add437aeca4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f0dd5179-38a8-4d66-9ed0-2add437aeca4" xlink:to="loc_us-gaap_CreditFacilityDomain_f0dd5179-38a8-4d66-9ed0-2add437aeca4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d4d39280-0b8b-4fa0-a32d-dc2df41fb288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f0dd5179-38a8-4d66-9ed0-2add437aeca4" xlink:to="loc_us-gaap_CreditFacilityDomain_d4d39280-0b8b-4fa0-a32d-dc2df41fb288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f75849fe-aaab-4fe2-9775-deb4edc32f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d4d39280-0b8b-4fa0-a32d-dc2df41fb288" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f75849fe-aaab-4fe2-9775-deb4edc32f11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b254a681-7663-4f71-b718-a69e7b27f971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d4d39280-0b8b-4fa0-a32d-dc2df41fb288" xlink:to="loc_us-gaap_LetterOfCreditMember_b254a681-7663-4f71-b718-a69e7b27f971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_84ca59c7-4b6e-438a-aa54-36f5496bf9d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_srt_RangeAxis_84ca59c7-4b6e-438a-aa54-36f5496bf9d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_84ca59c7-4b6e-438a-aa54-36f5496bf9d8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_84ca59c7-4b6e-438a-aa54-36f5496bf9d8" xlink:to="loc_srt_RangeMember_84ca59c7-4b6e-438a-aa54-36f5496bf9d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c95d33a-8174-4641-a8fc-31863d2f45c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_84ca59c7-4b6e-438a-aa54-36f5496bf9d8" xlink:to="loc_srt_RangeMember_2c95d33a-8174-4641-a8fc-31863d2f45c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_56258229-5e61-426a-ba2f-4dc22d629480" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c95d33a-8174-4641-a8fc-31863d2f45c8" xlink:to="loc_srt_MinimumMember_56258229-5e61-426a-ba2f-4dc22d629480" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_616a4d9b-6864-4c05-976c-015e94f9bbcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2c95d33a-8174-4641-a8fc-31863d2f45c8" xlink:to="loc_srt_MaximumMember_616a4d9b-6864-4c05-976c-015e94f9bbcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_65dab5c7-d46a-449e-a075-09b8c560b292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_VariableRateAxis_65dab5c7-d46a-449e-a075-09b8c560b292" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_65dab5c7-d46a-449e-a075-09b8c560b292_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_65dab5c7-d46a-449e-a075-09b8c560b292" xlink:to="loc_us-gaap_VariableRateDomain_65dab5c7-d46a-449e-a075-09b8c560b292_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0bf44688-ec97-42d4-9f93-6de87468dd47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_65dab5c7-d46a-449e-a075-09b8c560b292" xlink:to="loc_us-gaap_VariableRateDomain_0bf44688-ec97-42d4-9f93-6de87468dd47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_67690654-5554-427b-9cdd-eb8cb14ff3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_0bf44688-ec97-42d4-9f93-6de87468dd47" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_67690654-5554-427b-9cdd-eb8cb14ff3c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4ccb9f3d-fb73-4c5a-b31f-07f77ff217f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_0bf44688-ec97-42d4-9f93-6de87468dd47" xlink:to="loc_us-gaap_BaseRateMember_4ccb9f3d-fb73-4c5a-b31f-07f77ff217f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9e61cff3-9682-48a9-9bb6-bbd0baed6b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9e61cff3-9682-48a9-9bb6-bbd0baed6b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EurodollarLoanMember_2bf4b3bc-3e2d-4da1-85ce-b84bfa612849" xlink:href="infu-20220331.xsd#infu_EurodollarLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e61cff3-9682-48a9-9bb6-bbd0baed6b32" xlink:to="loc_infu_EurodollarLoanMember_2bf4b3bc-3e2d-4da1-85ce-b84bfa612849" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ABRLoansMember_f37ffcca-5eb8-4b9d-83f0-288164b358ed" xlink:href="infu-20220331.xsd#infu_ABRLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e61cff3-9682-48a9-9bb6-bbd0baed6b32" xlink:to="loc_infu_ABRLoansMember_f37ffcca-5eb8-4b9d-83f0-288164b358ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis_c4e3b2eb-5d95-4126-a435-7768be54dbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_CollateralAxis_c4e3b2eb-5d95-4126-a435-7768be54dbfe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_c4e3b2eb-5d95-4126-a435-7768be54dbfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CollateralAxis_c4e3b2eb-5d95-4126-a435-7768be54dbfe" xlink:to="loc_us-gaap_CollateralDomain_c4e3b2eb-5d95-4126-a435-7768be54dbfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_b9d51d75-f3dd-4784-9dcc-6f19c92add9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CollateralAxis_c4e3b2eb-5d95-4126-a435-7768be54dbfe" xlink:to="loc_us-gaap_CollateralDomain_b9d51d75-f3dd-4784-9dcc-6f19c92add9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentMember_fdfbf2bf-d5c8-4215-bde1-7aeaf60ab7b3" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollateralDomain_b9d51d75-f3dd-4784-9dcc-6f19c92add9e" xlink:to="loc_infu_MedicalEquipmentMember_fdfbf2bf-d5c8-4215-bde1-7aeaf60ab7b3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="extended" id="idaa01864cef648b6a19f77aaa6beb6c6_DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_803c319c-66bd-49c1-8042-bb11e44aed9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_803c319c-66bd-49c1-8042-bb11e44aed9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f872e885-902a-4120-85ff-ecef3e8385da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_LineOfCredit_f872e885-902a-4120-85ff-ecef3e8385da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_db7e7a02-4b95-4474-8abc-e0117d481112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_db7e7a02-4b95-4474-8abc-e0117d481112" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d6ece9d0-d287-4643-bb10-c9700f52df0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d6ece9d0-d287-4643-bb10-c9700f52df0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f72ae816-1b40-4321-a8d2-c2ac5772ba39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_DebtInstrumentTable_f72ae816-1b40-4321-a8d2-c2ac5772ba39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2fc83fd6-8ccb-4230-b429-28d96ced31bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f72ae816-1b40-4321-a8d2-c2ac5772ba39" xlink:to="loc_us-gaap_CreditFacilityAxis_2fc83fd6-8ccb-4230-b429-28d96ced31bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2fc83fd6-8ccb-4230-b429-28d96ced31bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2fc83fd6-8ccb-4230-b429-28d96ced31bd" xlink:to="loc_us-gaap_CreditFacilityDomain_2fc83fd6-8ccb-4230-b429-28d96ced31bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_20ea8325-eee6-4587-a09e-b4a5e9616e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2fc83fd6-8ccb-4230-b429-28d96ced31bd" xlink:to="loc_us-gaap_CreditFacilityDomain_20ea8325-eee6-4587-a09e-b4a5e9616e62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_34dba946-8192-464a-90b8-fbfb67d9480a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_20ea8325-eee6-4587-a09e-b4a5e9616e62" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_34dba946-8192-464a-90b8-fbfb67d9480a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofFutureMaturitiesofLoansDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="extended" id="ic3d0c58f58244f17aedffe948ac2ada2_DebtSummaryofFutureMaturitiesofLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0a3201f7-6fbb-4892-ac54-e0cba2eaef00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0a3201f7-6fbb-4892-ac54-e0cba2eaef00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_510890f7-6ca4-4260-8142-1b0b25f2929a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_510890f7-6ca4-4260-8142-1b0b25f2929a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4dabe683-89df-45a8-be74-4107c4f0917b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4dabe683-89df-45a8-be74-4107c4f0917b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d4f3e801-8e62-4268-9d64-4f5be2005b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d4f3e801-8e62-4268-9d64-4f5be2005b8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_8aa7cb03-a1ad-402c-92d4-7b2819f01298" xlink:href="infu-20220331.xsd#infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_8aa7cb03-a1ad-402c-92d4-7b2819f01298" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_749f09a8-79ca-49f3-bacf-4ef5f6e4cd69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_749f09a8-79ca-49f3-bacf-4ef5f6e4cd69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_355b9f12-cfa3-4e47-9ef6-3f391a200cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:to="loc_us-gaap_CreditFacilityAxis_355b9f12-cfa3-4e47-9ef6-3f391a200cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_355b9f12-cfa3-4e47-9ef6-3f391a200cba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_355b9f12-cfa3-4e47-9ef6-3f391a200cba" xlink:to="loc_us-gaap_CreditFacilityDomain_355b9f12-cfa3-4e47-9ef6-3f391a200cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_512c151d-f5a6-4487-aba4-3b5054f7552c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_355b9f12-cfa3-4e47-9ef6-3f391a200cba" xlink:to="loc_us-gaap_CreditFacilityDomain_512c151d-f5a6-4487-aba4-3b5054f7552c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c1c65c63-1c41-4118-a57d-e424af964518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_512c151d-f5a6-4487-aba4-3b5054f7552c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c1c65c63-1c41-4118-a57d-e424af964518" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:to="loc_us-gaap_DebtInstrumentAxis_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_860f391e-7488-4596-b32e-c9e62fe67172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_860f391e-7488-4596-b32e-c9e62fe67172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_20fd09eb-6617-4345-953b-45d14c4b689f" xlink:href="infu-20220331.xsd#infu_FinancingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860f391e-7488-4596-b32e-c9e62fe67172" xlink:to="loc_infu_FinancingAgreementMember_20fd09eb-6617-4345-953b-45d14c4b689f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="extended" id="i94c17126e9c3437a8b05f09a287ca602_DebtSummaryofCompanysCurrentandLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent_07729894-7db6-4225-b4a6-81130336f5d0" xlink:href="infu-20220331.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_infu_LongtermDebtGrossCurrent_07729894-7db6-4225-b4a6-81130336f5d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent_7a02a8a8-992a-41bf-9bc5-901a06dae8a9" xlink:href="infu-20220331.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_infu_LongTermDebtGrossNoncurrent_7a02a8a8-992a-41bf-9bc5-901a06dae8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9235810b-a11a-4c04-ac2c-39e996c370fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_9235810b-a11a-4c04-ac2c-39e996c370fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_ed04c696-e113-4069-add1-727bccd96d4b" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_ed04c696-e113-4069-add1-727bccd96d4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_40e2d1c9-b902-4cfa-a3e5-0da9b65107f6" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_40e2d1c9-b902-4cfa-a3e5-0da9b65107f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8e806248-f4af-4d75-b81c-b2dea9320cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8e806248-f4af-4d75-b81c-b2dea9320cb8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3570fa0a-42ca-409b-af37-983033414d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_LongTermDebtCurrent_3570fa0a-42ca-409b-af37-983033414d12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bcd7aacd-8b22-4222-84e8-e9cf6a8131a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bcd7aacd-8b22-4222-84e8-e9cf6a8131a6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_41c98b70-347c-4472-88e7-4fc3042f76a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_LongTermDebt_41c98b70-347c-4472-88e7-4fc3042f76a3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:to="loc_us-gaap_CreditFacilityAxis_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54" xlink:to="loc_us-gaap_CreditFacilityDomain_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2bf6f423-820e-4ef9-9156-d0f7e8f8f34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54" xlink:to="loc_us-gaap_CreditFacilityDomain_2bf6f423-820e-4ef9-9156-d0f7e8f8f34c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_79afea56-315d-4b49-ae9e-35ef96e2b990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2bf6f423-820e-4ef9-9156-d0f7e8f8f34c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_79afea56-315d-4b49-ae9e-35ef96e2b990" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2211ef3e-c510-4e32-9282-89b556350a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:to="loc_us-gaap_DebtInstrumentAxis_2211ef3e-c510-4e32-9282-89b556350a0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2211ef3e-c510-4e32-9282-89b556350a0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2211ef3e-c510-4e32-9282-89b556350a0f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2211ef3e-c510-4e32-9282-89b556350a0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35e0b768-22ea-44da-b19a-8b3d8edbfa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2211ef3e-c510-4e32-9282-89b556350a0f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35e0b768-22ea-44da-b19a-8b3d8edbfa3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_10ce65e7-933a-46a8-8fc9-e693cc3f1f64" xlink:href="infu-20220331.xsd#infu_FinancingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35e0b768-22ea-44da-b19a-8b3d8edbfa3f" xlink:to="loc_infu_FinancingAgreementMember_10ce65e7-933a-46a8-8fc9-e693cc3f1f64" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" xlink:type="extended" id="i9d91e4f292eb4d6f8dfc1216802272c9_DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_619491ff-30d1-47d0-8434-dd386237d599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_619491ff-30d1-47d0-8434-dd386237d599" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_776e934e-7a09-4ccd-8719-f4c4f770346f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeTermOfContract_776e934e-7a09-4ccd-8719-f4c4f770346f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_a37ee05a-4d5e-474c-96c8-f0aa655a8db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_a37ee05a-4d5e-474c-96c8-f0aa655a8db9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_4cef1579-2b95-4b24-93cd-f85af66bc119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_4cef1579-2b95-4b24-93cd-f85af66bc119" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2af821bf-d576-4f69-b258-ad0075f3ad2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2af821bf-d576-4f69-b258-ad0075f3ad2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2af821bf-d576-4f69-b258-ad0075f3ad2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2af821bf-d576-4f69-b258-ad0075f3ad2d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2af821bf-d576-4f69-b258-ad0075f3ad2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2ac26913-b9c2-4822-b403-bbf51f22ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2af821bf-d576-4f69-b258-ad0075f3ad2d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2ac26913-b9c2-4822-b403-bbf51f22ad94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_532ff63c-322b-45ae-b7d6-bed8ec44f93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2ac26913-b9c2-4822-b403-bbf51f22ad94" xlink:to="loc_us-gaap_InterestRateSwapMember_532ff63c-322b-45ae-b7d6-bed8ec44f93a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:to="loc_us-gaap_HedgingDesignationAxis_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73" xlink:to="loc_us-gaap_HedgingDesignationDomain_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9debfaf3-5887-4887-93e2-14c5d10967fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73" xlink:to="loc_us-gaap_HedgingDesignationDomain_9debfaf3-5887-4887-93e2-14c5d10967fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c97db3fb-8df7-44ba-8d85-cd9689828a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9debfaf3-5887-4887-93e2-14c5d10967fd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c97db3fb-8df7-44ba-8d85-cd9689828a45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6c0f8acb-7e68-4151-a343-a289ceab61e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6c0f8acb-7e68-4151-a343-a289ceab61e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_6c0f8acb-7e68-4151-a343-a289ceab61e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6c0f8acb-7e68-4151-a343-a289ceab61e6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_6c0f8acb-7e68-4151-a343-a289ceab61e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fafa0d84-1f6a-4979-94e6-41abb4152069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6c0f8acb-7e68-4151-a343-a289ceab61e6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fafa0d84-1f6a-4979-94e6-41abb4152069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_419ca0cb-809d-4e94-a1e3-0ca7119e6eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_fafa0d84-1f6a-4979-94e6-41abb4152069" xlink:to="loc_us-gaap_CashFlowHedgingMember_419ca0cb-809d-4e94-a1e3-0ca7119e6eaf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" xlink:type="extended" id="icf85013523cd461baa132630983f84c0_DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_df77b045-d1f8-42e0-bc0c-d109d12e27aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_0138d1a4-052f-4b0f-bd09-373d52f03571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_df77b045-d1f8-42e0-bc0c-d109d12e27aa" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_0138d1a4-052f-4b0f-bd09-373d52f03571" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_ae772c28-f2c3-4221-a0a1-d8fa2be39faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_df77b045-d1f8-42e0-bc0c-d109d12e27aa" xlink:to="loc_us-gaap_DerivativeAssets_ae772c28-f2c3-4221-a0a1-d8fa2be39faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_df77b045-d1f8-42e0-bc0c-d109d12e27aa" xlink:to="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9737fe5-a99e-4aa3-8d58-3f69c729970a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9737fe5-a99e-4aa3-8d58-3f69c729970a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e9737fe5-a99e-4aa3-8d58-3f69c729970a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9737fe5-a99e-4aa3-8d58-3f69c729970a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e9737fe5-a99e-4aa3-8d58-3f69c729970a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_70b90345-5ba9-4744-bd17-431f7525fccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9737fe5-a99e-4aa3-8d58-3f69c729970a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_70b90345-5ba9-4744-bd17-431f7525fccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7bdad8c7-2980-4ace-9948-feec0329679a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_70b90345-5ba9-4744-bd17-431f7525fccd" xlink:to="loc_us-gaap_CashFlowHedgingMember_7bdad8c7-2980-4ace-9948-feec0329679a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6d7a6195-7451-4134-aafd-57cf6225370f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6d7a6195-7451-4134-aafd-57cf6225370f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6d7a6195-7451-4134-aafd-57cf6225370f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d7a6195-7451-4134-aafd-57cf6225370f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6d7a6195-7451-4134-aafd-57cf6225370f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_13f7f84b-088d-4929-bc0d-2b7a81bc922f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d7a6195-7451-4134-aafd-57cf6225370f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_13f7f84b-088d-4929-bc0d-2b7a81bc922f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_05c85df0-1e2d-47dd-87b8-cfed8e16e044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_13f7f84b-088d-4929-bc0d-2b7a81bc922f" xlink:to="loc_us-gaap_InterestRateSwapMember_05c85df0-1e2d-47dd-87b8-cfed8e16e044" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_24117d5b-db1f-4eda-878b-7cf28a2d0e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_HedgingDesignationAxis_24117d5b-db1f-4eda-878b-7cf28a2d0e96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_24117d5b-db1f-4eda-878b-7cf28a2d0e96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_24117d5b-db1f-4eda-878b-7cf28a2d0e96" xlink:to="loc_us-gaap_HedgingDesignationDomain_24117d5b-db1f-4eda-878b-7cf28a2d0e96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8f1b8cac-1418-45a7-9b38-31687dd1b9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_24117d5b-db1f-4eda-878b-7cf28a2d0e96" xlink:to="loc_us-gaap_HedgingDesignationDomain_8f1b8cac-1418-45a7-9b38-31687dd1b9be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_270cf550-520d-4c48-b776-5728c9371698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_8f1b8cac-1418-45a7-9b38-31687dd1b9be" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_270cf550-520d-4c48-b776-5728c9371698" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_90a1972d-96df-414a-b946-7368dd6bdcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_90a1972d-96df-414a-b946-7368dd6bdcb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_90a1972d-96df-414a-b946-7368dd6bdcb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_90a1972d-96df-414a-b946-7368dd6bdcb8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_90a1972d-96df-414a-b946-7368dd6bdcb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8bff1feb-8dfc-42d2-b2d3-d03fa9af1d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_90a1972d-96df-414a-b946-7368dd6bdcb8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8bff1feb-8dfc-42d2-b2d3-d03fa9af1d6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_1a251c19-34b9-44cd-afc5-ca52059d9afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8bff1feb-8dfc-42d2-b2d3-d03fa9af1d6f" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_1a251c19-34b9-44cd-afc5-ca52059d9afb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails" xlink:type="extended" id="iaa15f9241d4648afb851bf0351c97648_DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4e00a0ab-1172-4135-be2b-49e9510aab00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_StockholdersEquity_4e00a0ab-1172-4135-be2b-49e9510aab00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_c5235ceb-baac-4194-8281-5e2a6abd1954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_c5235ceb-baac-4194-8281-5e2a6abd1954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_45dd4f99-ddb8-43a1-979c-b0fc31809aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_45dd4f99-ddb8-43a1-979c-b0fc31809aab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_a2939a08-c18e-42b0-9b1f-37c07f5e6acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_a2939a08-c18e-42b0-9b1f-37c07f5e6acb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a7da4a76-b6e9-45ec-a204-f3d291af92e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_18ba17d8-a9d3-458f-b5de-90af94faecd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_InterestExpense_18ba17d8-a9d3-458f-b5de-90af94faecd3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_ba77e390-1f34-46b6-97d0-f28950390721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_ba77e390-1f34-46b6-97d0-f28950390721" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5d7435b6-d358-4075-833a-e90ab71c8024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5d7435b6-d358-4075-833a-e90ab71c8024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5d7435b6-d358-4075-833a-e90ab71c8024_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5d7435b6-d358-4075-833a-e90ab71c8024" xlink:to="loc_us-gaap_EquityComponentDomain_5d7435b6-d358-4075-833a-e90ab71c8024_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d95ffed0-0716-4184-a491-b48e7af7a203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5d7435b6-d358-4075-833a-e90ab71c8024" xlink:to="loc_us-gaap_EquityComponentDomain_d95ffed0-0716-4184-a491-b48e7af7a203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_11cbaf0b-15e4-473e-8105-21a5342fd4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d95ffed0-0716-4184-a491-b48e7af7a203" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_11cbaf0b-15e4-473e-8105-21a5342fd4d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7f1363e4-55b5-4459-856e-2cace69e1124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7f1363e4-55b5-4459-856e-2cace69e1124" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7f1363e4-55b5-4459-856e-2cace69e1124_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f1363e4-55b5-4459-856e-2cace69e1124" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7f1363e4-55b5-4459-856e-2cace69e1124_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c8280e2a-53d5-43d2-8995-dc9c1d3ceffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f1363e4-55b5-4459-856e-2cace69e1124" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c8280e2a-53d5-43d2-8995-dc9c1d3ceffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_412a7660-802f-47fd-9d1f-b1fa089df44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c8280e2a-53d5-43d2-8995-dc9c1d3ceffc" xlink:to="loc_us-gaap_InterestRateSwapMember_412a7660-802f-47fd-9d1f-b1fa089df44a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0655a201-c5d3-4667-9132-cdf8e690d572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0655a201-c5d3-4667-9132-cdf8e690d572" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0655a201-c5d3-4667-9132-cdf8e690d572_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0655a201-c5d3-4667-9132-cdf8e690d572" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0655a201-c5d3-4667-9132-cdf8e690d572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f8a61fbe-a7c4-40f0-8a52-bdef46e5fe2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0655a201-c5d3-4667-9132-cdf8e690d572" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f8a61fbe-a7c4-40f0-8a52-bdef46e5fe2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_68604d4c-d732-44b8-98d9-1c78abe0ed3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f8a61fbe-a7c4-40f0-8a52-bdef46e5fe2f" xlink:to="loc_us-gaap_CashFlowHedgingMember_68604d4c-d732-44b8-98d9-1c78abe0ed3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1d014948-f724-4c1f-8283-3cc91c5284b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_HedgingDesignationAxis_1d014948-f724-4c1f-8283-3cc91c5284b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1d014948-f724-4c1f-8283-3cc91c5284b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_1d014948-f724-4c1f-8283-3cc91c5284b7" xlink:to="loc_us-gaap_HedgingDesignationDomain_1d014948-f724-4c1f-8283-3cc91c5284b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fad8441a-96f4-4dbd-8ce7-a6b6df8cc2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_1d014948-f724-4c1f-8283-3cc91c5284b7" xlink:to="loc_us-gaap_HedgingDesignationDomain_fad8441a-96f4-4dbd-8ce7-a6b6df8cc2d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f2f7cf9d-7639-4671-8b09-dcf74c89ecc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fad8441a-96f4-4dbd-8ce7-a6b6df8cc2d6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f2f7cf9d-7639-4671-8b09-dcf74c89ecc1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#IncomeTaxesDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/IncomeTaxesDetailsTextual" xlink:type="extended" id="ib7093faddb29445891dee0c58d00402b_IncomeTaxesDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_5d5b8f11-6fe2-4020-8cce-3be313da4c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_909f75c2-7e95-4e8d-a2a7-a0d646a486e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_5d5b8f11-6fe2-4020-8cce-3be313da4c11" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_909f75c2-7e95-4e8d-a2a7-a0d646a486e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_7be931ee-3888-449c-9cc3-a72449f5168c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_5d5b8f11-6fe2-4020-8cce-3be313da4c11" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_7be931ee-3888-449c-9cc3-a72449f5168c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_dfc2bc9e-c468-4674-9189-035670cb644d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_5d5b8f11-6fe2-4020-8cce-3be313da4c11" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_dfc2bc9e-c468-4674-9189-035670cb644d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_cbf33204-2dc3-4abb-bf1e-0e41414004fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_dfc2bc9e-c468-4674-9189-035670cb644d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_cbf33204-2dc3-4abb-bf1e-0e41414004fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cbf33204-2dc3-4abb-bf1e-0e41414004fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cbf33204-2dc3-4abb-bf1e-0e41414004fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cbf33204-2dc3-4abb-bf1e-0e41414004fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_79038a25-801f-4015-871e-f10de659a7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cbf33204-2dc3-4abb-bf1e-0e41414004fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_79038a25-801f-4015-871e-f10de659a7fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_36a37cc0-90e9-4245-b587-e2770c342c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_79038a25-801f-4015-871e-f10de659a7fe" xlink:to="loc_us-gaap_OtherLiabilitiesMember_36a37cc0-90e9-4245-b587-e2770c342c0a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesDetailsTextual"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/LeasesDetailsTextual" xlink:type="extended" id="i4bda682aa65646b4bbc07be89df3e046_LeasesDetailsTextual">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_931c78d2-2676-48cf-8c11-c3420e1292e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f3f00a83-990d-4e05-9858-d0300d5e2b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_931c78d2-2676-48cf-8c11-c3420e1292e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f3f00a83-990d-4e05-9858-d0300d5e2b42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1d674eef-96a6-445d-8bb5-5fcf135a942d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_931c78d2-2676-48cf-8c11-c3420e1292e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1d674eef-96a6-445d-8bb5-5fcf135a942d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_65ccf191-577f-429c-86a5-d99fc44c864f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_931c78d2-2676-48cf-8c11-c3420e1292e4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_65ccf191-577f-429c-86a5-d99fc44c864f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f52d311e-f58d-44f6-a118-620d13047141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_65ccf191-577f-429c-86a5-d99fc44c864f" xlink:to="loc_srt_RangeAxis_f52d311e-f58d-44f6-a118-620d13047141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f52d311e-f58d-44f6-a118-620d13047141_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f52d311e-f58d-44f6-a118-620d13047141" xlink:to="loc_srt_RangeMember_f52d311e-f58d-44f6-a118-620d13047141_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2a721cac-e2ff-4112-ba39-1104cefda3c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f52d311e-f58d-44f6-a118-620d13047141" xlink:to="loc_srt_RangeMember_2a721cac-e2ff-4112-ba39-1104cefda3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f4039521-6e5a-47ef-bd02-7bba2a2e2b92" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2a721cac-e2ff-4112-ba39-1104cefda3c0" xlink:to="loc_srt_MinimumMember_f4039521-6e5a-47ef-bd02-7bba2a2e2b92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e9722ef2-8d29-430c-8b6e-0d5f6ef9e2ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2a721cac-e2ff-4112-ba39-1104cefda3c0" xlink:to="loc_srt_MaximumMember_e9722ef2-8d29-430c-8b6e-0d5f6ef9e2ae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="extended" id="i96d9048169a540e598c7d2f5d66fa080_BusinessSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesExternal_0f1f93a3-53ad-448a-87cc-192e73e23b0e" xlink:href="infu-20220331.xsd#infu_RevenuesExternal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_infu_RevenuesExternal_0f1f93a3-53ad-448a-87cc-192e73e23b0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesInternal_d9994f45-6168-47d5-81a0-3bf004ec4866" xlink:href="infu-20220331.xsd#infu_RevenuesInternal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_infu_RevenuesInternal_d9994f45-6168-47d5-81a0-3bf004ec4866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cdf02a52-3a0a-4092-b77f-23789f92509a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_Revenues_cdf02a52-3a0a-4092-b77f-23789f92509a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0ad09db1-a250-4cdb-9b3c-0a8a275d77bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_GrossProfit_0ad09db1-a250-4cdb-9b3c-0a8a275d77bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_343b7419-9bc8-40fc-b940-d2c4fc415a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_OperatingExpenses_343b7419-9bc8-40fc-b940-d2c4fc415a78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c3994e8c-ce86-454a-b3c2-69e7d5c82965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_InterestExpense_c3994e8c-ce86-454a-b3c2-69e7d5c82965" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a9f0ae87-269d-403a-8a27-7c49922d1bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a9f0ae87-269d-403a-8a27-7c49922d1bac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_041eaff6-39a9-4df2-83a2-0b537f9e313c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_041eaff6-39a9-4df2-83a2-0b537f9e313c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3b1c0d3b-1cab-4fdc-b80c-a2bd5e028c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_NetIncomeLoss_3b1c0d3b-1cab-4fdc-b80c-a2bd5e028c23" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7f708698-f363-4764-8693-289257c2b63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_Assets_7f708698-f363-4764-8693-289257c2b63b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment_e53ebea6-410d-45d0-8357-dc9bd773990c" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_infu_PaymentsToAcquireMedicalEquipment_e53ebea6-410d-45d0-8357-dc9bd773990c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c9f28ac1-4268-40af-a0cb-41e3acdf752b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_DepreciationAndAmortization_c9f28ac1-4268-40af-a0cb-41e3acdf752b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1dc2d3e7-9e40-45f5-a008-183c0b58e23b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1dc2d3e7-9e40-45f5-a008-183c0b58e23b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1dc2d3e7-9e40-45f5-a008-183c0b58e23b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1dc2d3e7-9e40-45f5-a008-183c0b58e23b" xlink:to="loc_us-gaap_SegmentDomain_1dc2d3e7-9e40-45f5-a008-183c0b58e23b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b5e32d48-93e0-4c87-af92-99f92e694172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1dc2d3e7-9e40-45f5-a008-183c0b58e23b" xlink:to="loc_us-gaap_SegmentDomain_b5e32d48-93e0-4c87-af92-99f92e694172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_2ba00ff1-f1a7-4f88-96f2-6b2443b26935" xlink:href="infu-20220331.xsd#infu_ITSSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b5e32d48-93e0-4c87-af92-99f92e694172" xlink:to="loc_infu_ITSSegmentMember_2ba00ff1-f1a7-4f88-96f2-6b2443b26935" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_1e3147a0-2ed9-409e-8a07-e43ffffea3c9" xlink:href="infu-20220331.xsd#infu_DMEServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b5e32d48-93e0-4c87-af92-99f92e694172" xlink:to="loc_infu_DMEServicesSegmentMember_1e3147a0-2ed9-409e-8a07-e43ffffea3c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3c6b50c6-2034-4476-a16e-10f65e4dcaaa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:to="loc_srt_ConsolidationItemsAxis_3c6b50c6-2034-4476-a16e-10f65e4dcaaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3c6b50c6-2034-4476-a16e-10f65e4dcaaa_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3c6b50c6-2034-4476-a16e-10f65e4dcaaa" xlink:to="loc_srt_ConsolidationItemsDomain_3c6b50c6-2034-4476-a16e-10f65e4dcaaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6b0ea262-4586-4720-b9de-9aa5ee006d34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3c6b50c6-2034-4476-a16e-10f65e4dcaaa" xlink:to="loc_srt_ConsolidationItemsDomain_6b0ea262-4586-4720-b9de-9aa5ee006d34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f449bcd4-6055-4700-afc3-c29f9cb0181c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6b0ea262-4586-4720-b9de-9aa5ee006d34" xlink:to="loc_us-gaap_OperatingSegmentsMember_f449bcd4-6055-4700-afc3-c29f9cb0181c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CorporateAndEliminationsMember_dd15672d-4158-494b-a978-fceff24f8711" xlink:href="infu-20220331.xsd#infu_CorporateAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_6b0ea262-4586-4720-b9de-9aa5ee006d34" xlink:to="loc_infu_CorporateAndEliminationsMember_dd15672d-4158-494b-a978-fceff24f8711" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>infu-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9c45a9a1-f9a1-46d4-ab6e-c84379cf91bb,g:e62fa09c-9414-4caa-b36a-5012b4171a20-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_19728a9e-1096-4b73-a7a7-f5e26f2c4aef_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses:</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c2752639-e967-4870-847d-1ec15197ab59_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_f4f0351e-036d-4564-a155-1a5ecbebaff2_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_4deed39c-c1bc-4faa-a66b-6dcf797a4bf9_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_33415c1b-0e4e-437b-aeb6-fe1e5833d26f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_73fdf476-1f97-412f-a97d-7f5560690960_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_99fbeba2-c75a-46de-8d0e-0d6e8fda871f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_7e7463cc-7cf9-440b-8829-1faf0f7f1948_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability_11845c84-4078-4505-95b9-c0f517ee9e62_terseLabel_en-US" xlink:label="lab_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration and working capital</link:label>
    <link:label id="lab_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability_label_en-US" xlink:label="lab_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration and Working Capital, Liability</link:label>
    <link:label id="lab_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability_documentation_en-US" xlink:label="lab_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration and Working Capital, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" xlink:href="infu-20220331.xsd#infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" xlink:to="lab_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c2a12d6a-b9e4-40f6-9a1f-63b7359c4348_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right of use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_eec3b647-1198-4144-b8e8-363bf0adb0c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock_9e89062d-2ebe-49a0-83ec-ee1ea3e2b384_terseLabel_en-US" xlink:label="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Medical Equipment</link:label>
    <link:label id="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock_label_en-US" xlink:label="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Medical Equipment [Table Text Block]</link:label>
    <link:label id="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock_documentation_en-US" xlink:label="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of medical equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:href="infu-20220331.xsd#infu_ScheduleOfMedicalEquipmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:to="lab_infu_ScheduleOfMedicalEquipmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_89fd28c2-507e-4a97-9a68-2d2d3fb133a6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e913e76c-cb40-465b-bb68-e8f8956b4e1a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_22258d7e-d11d-421a-bd92-2f168afa9ef7_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_77fd87df-3eee-4429-899d-8a868723b615_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs and non-recurring expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8a57fb52-2079-4806-9048-6725387429a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_eec91753-621e-42ac-a272-d210f191bafc_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4b3e624b-8cdd-43cf-911b-e21e687905af_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_f292d138-7272-4737-8388-130211b3b9ed_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based shares issued upon vesting - gross (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2666e692-f38f-4df3-9a8a-937388d9a3ab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term:</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0abaa2bd-845e-46e9-8e83-6d5cecd7a7d7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_e97f0ab9-f130-48ec-817f-4130fcfc9677_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Accounting Policy</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentForSaleOrRentalReserve_74ff9c7f-d423-42ae-8883-8d058666a8cf_negatedTerseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment for sale or rental - pump reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentForSaleOrRentalReserve_label_en-US" xlink:label="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment For Sale Or Rental Reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentForSaleOrRentalReserve_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of reserve associated with medical equipment for sale or rental, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentForSaleOrRentalReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:to="lab_infu_MedicalEquipmentForSaleOrRentalReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_ca12d390-a85e-4c6e-a583-54a65d7d723e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ac88268e-17f3-4358-a37f-0de4e8d627e3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_89aa0429-aa8d-4b11-ad46-68e0a4175fe1_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6bad29e5-4b33-460e-9114-0b9cfe960372_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9a955239-bcce-48b1-b128-6b8cc88692ed_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EffectOfCovid19PandemicTextBlock_741e23b9-b994-426d-ba00-be9407bdaeb2_terseLabel_en-US" xlink:label="lab_infu_EffectOfCovid19PandemicTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19</link:label>
    <link:label id="lab_infu_EffectOfCovid19PandemicTextBlock_label_en-US" xlink:label="lab_infu_EffectOfCovid19PandemicTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Covid-19 Pandemic [Text Block]</link:label>
    <link:label id="lab_infu_EffectOfCovid19PandemicTextBlock_documentation_en-US" xlink:label="lab_infu_EffectOfCovid19PandemicTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for effects of COVID-19 pandemic.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EffectOfCovid19PandemicTextBlock" xlink:href="infu-20220331.xsd#infu_EffectOfCovid19PandemicTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EffectOfCovid19PandemicTextBlock" xlink:to="lab_infu_EffectOfCovid19PandemicTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_9eeadbb8-84c7-41d9-942d-1c27f225e71b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_de6583f2-e7ce-46e7-90d1-191fcf01d65a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_136b0487-54b0-46f4-9e39-e8a645fedc62_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_2c08fb2e-cd38-4848-b371-a22e35810caa_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4e4c975a-c029-453c-b4f5-e73ac09ab233_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_2c5c6d44-9d24-4a43-9abb-d5b043282f4a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of and reserve adjustments for medical equipment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_2f760aa1-7a91-4507-a11b-24f0d3fbfbff_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6a346e61-2a8f-4fac-8416-314ad49286d6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate:</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_12a586ee-9a5f-4a02-b31a-dd01708ebf5c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_771e75d9-b41d-47b1-be69-0fe0c9de9861_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_e33c184e-dea2-4151-86eb-d52bfb1d6e3c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll taxes</link:label>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_c4879283-f3bd-4f58-8ef1-f4039682b905_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bc20cae0-7ce1-4304-affe-e21e39641037_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_c3e8f942-1c27-4979-a992-cdc5b9dc858b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_839f463f-059c-4130-bec7-99b73701ab4b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a300ee8b-af01-48f8-8aac-06e8d4f0eae0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_3ff4f9ab-e13a-498a-8784-f9248fa5fd61_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_651839d3-1df8-4817-a14e-bb0b58da738e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6f7eb395-89ef-4680-bef1-f06493aa125b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_97cc1d11-b8d2-49db-a652-afaaec18df92_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_9811787b-0f64-494e-82b3-ec40c90004bc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_49cb30d2-acd3-4fc1-bb4d-74f5b22156d8_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_3ce5eb92-4734-455a-a8c4-b968a5f3d659_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2ab02ce2-8381-49c4-8d5c-2528e854a498_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4efdb1e9-e8a1-4923-bf52-8e8a7ab32ddc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments, Contingencies and Litigation</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_92208446-6db5-4841-9f88-851b641c0771_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased as part of share repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2cacc8e9-67e0-40c8-adc4-ca62c12ec465_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_2a7ac93d-a668-490c-850d-2e0c33fea591_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e79dbded-489e-476a-a73c-20cdb03b4f92_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_408d4dd3-377a-4a8d-a05c-3fe43b7ec8f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_be7009ac-41fc-4e95-ac3c-0d143828c7f5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_b49fe9c3-00f2-4535-b58e-531aac6bb0ce_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c7f058f3-3c7c-4a43-8dcc-b94ee660e948_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_591ab3b9-f71a-480c-a325-83077133f895_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_f41e5bdc-820a-4600-93ff-7768b60e5a7b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ad093980-754c-4850-9cb9-c8b4b7bd12fd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Availability on Revolving Facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_86e7512e-ae4b-4019-8a4b-8983eba2de3b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5f1e008b-709a-4fc3-a895-98812b5b3bc9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_de941a10-113d-4ddd-a1bc-a6be38a09283_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_56dbfdf4-abee-4c2b-b445-2c17d29b2286_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f32cf44a-47bc-43ed-9080-0ea5cfc8b4a2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_d2c2d604-a92e-4a8f-a65e-da1a975309e3_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized value of the debt issuance costs, Total</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_b178e76c-a520-418c-81b7-6a5428d96c6a_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental service, net of accumulated depreciation</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_27a4480b-5304-4675-967c-594ed5cfbb0e_totalLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental service - net</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental service, net of accumulated depreciation</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:to="lab_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_e2a057cc-ce09-48c2-b245-88be859353bb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares_28d93c56-a2be-4ef5-90ab-429aef2e6530_terseLabel_en-US" xlink:label="lab_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative shares purchased (in shares)</link:label>
    <link:label id="lab_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares_label_en-US" xlink:label="lab_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program, Cumulative Shares Purchased, Shares</link:label>
    <link:label id="lab_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares_documentation_en-US" xlink:label="lab_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program, Cumulative Shares Purchased, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares" xlink:href="infu-20220331.xsd#infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares" xlink:to="lab_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_af48ad38-49aa-4257-bf5a-0d5f8b529f81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition date fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2307c0c2-6561-4ad6-b27a-28409729a0e8_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_36bb5634-3dbf-47da-9bff-c77d26ddaa75_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_eb4897be-e1a5-43ea-8912-c641320731dd_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total - consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_1701a65a-534f-4f22-a971-ec1d135a1223_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ITSSegmentMember_89a9d2f7-cd0d-488a-81cf-c0b1a080a85f_terseLabel_en-US" xlink:label="lab_infu_ITSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ITS</link:label>
    <link:label id="lab_infu_ITSSegmentMember_label_en-US" xlink:label="lab_infu_ITSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ITS Segment [Member]</link:label>
    <link:label id="lab_infu_ITSSegmentMember_documentation_en-US" xlink:label="lab_infu_ITSSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the ITS segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember" xlink:href="infu-20220331.xsd#infu_ITSSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ITSSegmentMember" xlink:to="lab_infu_ITSSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LongtermDebtGrossCurrent_07b09e21-472d-45ca-b83d-9ad99a88c6f4_verboseLabel_en-US" xlink:label="lab_infu_LongtermDebtGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Portion</link:label>
    <link:label id="lab_infu_LongtermDebtGrossCurrent_label_en-US" xlink:label="lab_infu_LongtermDebtGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Longterm Debt Gross Current</link:label>
    <link:label id="lab_infu_LongtermDebtGrossCurrent_documentation_en-US" xlink:label="lab_infu_LongtermDebtGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, before unamortized (discount) premium and debt issuance costs, of the current portion of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent" xlink:href="infu-20220331.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LongtermDebtGrossCurrent" xlink:to="lab_infu_LongtermDebtGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_45d199ff-0f5b-4d3a-9a1f-4d1051234d9e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_8401023f-d17e-4b4e-b1bb-7064a893b7ca_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_fce5dd0e-8a80-487b-a787-f9922a0c7d41_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseCurrent_a98f55cb-f553-46e2-8e8f-56fa1078400f_negatedTerseLabel_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized value of the debt issuance costs, current portion of long-term debt</link:label>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseCurrent_label_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense Current</link:label>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseCurrent_documentation_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The current portion of unamortized debt issuance expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:to="lab_infu_UnamortizedDebtIssuanceExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_75a566e2-ea33-40c2-bd0b-57f2b4c38b1d_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_d6421957-ff34-4ad8-b04a-e93dfe040dd9_terseLabel_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, minimum fixed coverage ratio</link:label>
    <link:label id="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_label_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Covenant Minimum Fixed Coverage Ratio</link:label>
    <link:label id="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_documentation_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum fixed coverage ratio required by the debt agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:href="infu-20220331.xsd#infu_DebtInstrumentCovenantMinimumFixedCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:to="lab_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8a67344a-134a-46fa-84e7-864672a096a7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_0da95593-c31c-4fbe-9c9d-34f565bd9e55_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_28b91b19-fec8-4e82-b776-f3e78db081d0_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_469bf075-b5a9-4b1a-b934-ecd2a117d7de_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_692da11f-0426-4f93-b44c-1b2015ea925c_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_5eca9368-2e01-4509-9485-2921529a41f4_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-competition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_058e2581-c709-4825-8c6c-9519cef0f880_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_c347bf0b-caca-40e2-a18d-dee3dffca0a0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2895609c-e78c-4ec9-ae0c-5c493bdec39e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_a8999d79-4d40-49d8-b10a-ba0044268502_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_01c68693-49e3-43e9-a35f-e30f3561176b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_f9b67651-351f-4b12-affb-918f17c7861f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_12aa3048-5d08-4094-b8c5-873833b93945_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_48ca661c-be7d-42db-a05f-e490d729f2ab_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_82b6f6b4-b079-4e2d-9cb7-9ebea5abf168_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_5fec7918-7153-494b-818a-1d1afa65b748_terseLabel_en-US" xlink:label="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets</link:label>
    <link:label id="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_documentation_en-US" xlink:label="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the carrying amount and accumulated amortization of identifiable intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:href="infu-20220331.xsd#infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:to="lab_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_29e1e13d-d532-4050-9c84-f0b86fda482b_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_bbdf2aac-0684-4e51-980b-178e3bd1a946_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_c5d87501-c69e-401c-b9de-c77d5919b0b8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DirectPayerRentalsMember_214a566b-14dc-48dd-af65-fbd73ea793c4_terseLabel_en-US" xlink:label="lab_infu_DirectPayerRentalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Payer Rentals</link:label>
    <link:label id="lab_infu_DirectPayerRentalsMember_label_en-US" xlink:label="lab_infu_DirectPayerRentalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Payer Rentals [Member]</link:label>
    <link:label id="lab_infu_DirectPayerRentalsMember_documentation_en-US" xlink:label="lab_infu_DirectPayerRentalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents direct payer rental revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember" xlink:href="infu-20220331.xsd#infu_DirectPayerRentalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DirectPayerRentalsMember" xlink:to="lab_infu_DirectPayerRentalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_990ae302-bb33-4842-a21f-e929995fb187_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_0e799911-705e-41e5-9d3a-fb7dab648918_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a0b30b03-4bee-4c33-818e-28b53b4569b9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_790bb8d2-7fe6-4a4d-8811-6d12f15614da_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_c03b7814-4b22-4c22-9fad-2b7254e1339d_negatedLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding draws</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_The2021CreditAgreementMember_8cf8aee8-b95e-431a-a7be-e0953eab4dd9_terseLabel_en-US" xlink:label="lab_infu_The2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2021 Credit Agreement</link:label>
    <link:label id="lab_infu_The2021CreditAgreementMember_label_en-US" xlink:label="lab_infu_The2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2021 Credit Agreement [Member]</link:label>
    <link:label id="lab_infu_The2021CreditAgreementMember_documentation_en-US" xlink:label="lab_infu_The2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the "2021 Credit Agreement".</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2021CreditAgreementMember" xlink:href="infu-20220331.xsd#infu_The2021CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_The2021CreditAgreementMember" xlink:to="lab_infu_The2021CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_8715e232-d590-42ae-bb69-295e0db721bc_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_36e6afee-8b8f-40f0-b03f-cfc8c38558ee_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_01452ea7-9a18-4829-a378-1809f790ab08_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of medical equipment, property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PhysicianAndCustomerRelationshipsMember_dd1d20f6-911c-40fb-b5e6-589e0b5b68c0_terseLabel_en-US" xlink:label="lab_infu_PhysicianAndCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician and customer relationships</link:label>
    <link:label id="lab_infu_PhysicianAndCustomerRelationshipsMember_label_en-US" xlink:label="lab_infu_PhysicianAndCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician and Customer Relationships [Member]</link:label>
    <link:label id="lab_infu_PhysicianAndCustomerRelationshipsMember_documentation_en-US" xlink:label="lab_infu_PhysicianAndCustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to physician and customer relationships.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember" xlink:href="infu-20220331.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PhysicianAndCustomerRelationshipsMember" xlink:to="lab_infu_PhysicianAndCustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b5faecdc-4f47-4df9-bbab-05f8d3cf32c6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3aebcc6b-24bb-4cff-a20b-09394094982e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentNet_78d72b80-e612-4b64-81d0-bb83a94b4e4e_totalLabel_en-US" xlink:label="lab_infu_MedicalEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_infu_MedicalEquipmentNet_label_en-US" xlink:label="lab_infu_MedicalEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment Net</link:label>
    <link:label id="lab_infu_MedicalEquipmentNet_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the net amount of medical equipment, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentNet" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentNet" xlink:to="lab_infu_MedicalEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_aaf3549d-ea7e-4a7e-945d-c895ab8db81b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_101e1d28-0b5f-4681-9e06-ae75ace74df6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ProductSalesMember_6d71c052-78a2-4dae-a961-879de08d6f67_terseLabel_en-US" xlink:label="lab_infu_ProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales</link:label>
    <link:label id="lab_infu_ProductSalesMember_label_en-US" xlink:label="lab_infu_ProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales [Member]</link:label>
    <link:label id="lab_infu_ProductSalesMember_documentation_en-US" xlink:label="lab_infu_ProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information about product sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ProductSalesMember" xlink:href="infu-20220331.xsd#infu_ProductSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ProductSalesMember" xlink:to="lab_infu_ProductSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_c4ed70e4-2ecd-468f-85e8-b188b7e65fd1_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a57db1d3-0fa6-4485-a796-dfe7a86ea1b3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_2cb27f38-0b5b-4c83-b4f4-831878a70d8f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_a94f2b11-b847-42ae-9007-d2d5f810f067_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_5964a33c-4168-4950-8d8c-c082fa089b02_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_73c16c44-ec89-4348-80ad-6a9d5d16138f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_acf4553a-971e-4f61-b150-d797da421ac9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_f870f302-24bf-4b2d-9ae1-fb758e54ec20_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_b2b18706-f9dc-42ca-8ef8-ccdf38cc4102_negatedLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_a5c1c0db-097f-4986-9773-82629c1a6a7e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e9d321b7-dec3-4155-a074-83289025ae9e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value: 200,000,000 shares authorized; 20,540,143 shares issued and outstanding as of March&#160;31, 2022 and 20,699,546 shares issued and outstanding as of December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_5884e5c3-4ccb-414b-b014-2c7ae8ad29fc_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_e5b9c592-00d2-4e8b-af4f-feadc91fe4a3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_697c017e-f659-4d6e-9d4d-79577e34fbc1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ed6aeecc-5ac7-424f-847a-ed7bcd5b2ce8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ce05c741-95e0-4353-bb01-d3d5ddae4a02_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_567b2928-f690-4faf-9858-f60cdcadd797_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b90bccfd-bd42-4978-a1fb-3ebcf1ec844f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_ea476c9d-8e22-4798-9ce2-277565f79d8a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_EurodollarLoanMember_8847df12-e628-4cb9-85c9-85d764d21635_terseLabel_en-US" xlink:label="lab_infu_EurodollarLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Loan</link:label>
    <link:label id="lab_infu_EurodollarLoanMember_label_en-US" xlink:label="lab_infu_EurodollarLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Loan [Member]</link:label>
    <link:label id="lab_infu_EurodollarLoanMember_documentation_en-US" xlink:label="lab_infu_EurodollarLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to the Eurodollar Loan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EurodollarLoanMember" xlink:href="infu-20220331.xsd#infu_EurodollarLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_EurodollarLoanMember" xlink:to="lab_infu_EurodollarLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ShareRepurchaseProgramCumulativeSharesRepurchased_984c6663-cce6-435e-b1e1-81ec31ea5db3_terseLabel_en-US" xlink:label="lab_infu_ShareRepurchaseProgramCumulativeSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative shares purchased</link:label>
    <link:label id="lab_infu_ShareRepurchaseProgramCumulativeSharesRepurchased_label_en-US" xlink:label="lab_infu_ShareRepurchaseProgramCumulativeSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program, Cumulative Shares Repurchased</link:label>
    <link:label id="lab_infu_ShareRepurchaseProgramCumulativeSharesRepurchased_documentation_en-US" xlink:label="lab_infu_ShareRepurchaseProgramCumulativeSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program, Cumulative Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareRepurchaseProgramCumulativeSharesRepurchased" xlink:href="infu-20220331.xsd#infu_ShareRepurchaseProgramCumulativeSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ShareRepurchaseProgramCumulativeSharesRepurchased" xlink:to="lab_infu_ShareRepurchaseProgramCumulativeSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_8542b319-98e4-4b07-b0fb-54d51d80f523_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_label_en-US" xlink:label="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment and Property Disclosure [Text Block]</link:label>
    <link:label id="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for medical equipment and property.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentAndPropertyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:to="lab_infu_MedicalEquipmentAndPropertyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_695c43b3-1552-4b7c-9da3-b61c745b0a8e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_eed2efd5-019b-4ad6-84b0-72f8abb3e4e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_2ec83faa-5ccd-4187-a438-60fc3b1ed8b2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5bacf15f-9727-4e7a-976e-09a81438ec61_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_70ea7ed7-6eb1-4f52-beaa-f9909724c6e6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_fa2b26bb-89d1-413e-a6b8-42a0b4d3ab6a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_13f41c6c-df39-4971-8d30-16ec6ee66393_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_d8281760-132a-4e4c-9136-e966bc72ed5d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DepreciationExpenseRelatedToMedicalEquipment_2ff39ccc-54e3-4e4f-94f9-f225874cb0c3_terseLabel_en-US" xlink:label="lab_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense related to medical equipment</link:label>
    <link:label id="lab_infu_DepreciationExpenseRelatedToMedicalEquipment_label_en-US" xlink:label="lab_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation Expense Related To Medical Equipment</link:label>
    <link:label id="lab_infu_DepreciationExpenseRelatedToMedicalEquipment_documentation_en-US" xlink:label="lab_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of depreciation expense related to medical equipment recorded during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:href="infu-20220331.xsd#infu_DepreciationExpenseRelatedToMedicalEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:to="lab_infu_DepreciationExpenseRelatedToMedicalEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesReserve_1a6d8dc9-9db4-4ff1-8f4c-f1ab3ead2a42_negatedTerseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental service - pump reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesReserve_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment In Rental Services Reserve</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesReserve_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of medical equipment in rental services reserve, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesReserve" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServicesReserve" xlink:to="lab_infu_MedicalEquipmentInRentalServicesReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_61ca115a-7ee3-4690-99e0-42a179ba8a5f_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRental_36bfe0d4-c9f4-4b3e-813d-2ebedc7d2b65_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment for sale or rental</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRental_958cb598-68e7-4c43-b89f-1ac0e8d2bfa5_totalLabel_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment for sale or rental - net</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRental_label_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment for sale or rental</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRental_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents medical equipment held for sale or rental as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentHeldForSaleOrRental" xlink:to="lab_infu_MedicalEquipmentHeldForSaleOrRental" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_119ff3d5-98f7-4465-8c0e-4c3f430b30ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets - (increase)/decrease:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_0e948cde-bb37-4e36-944c-333618859c98_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_eeb3f802-9b0c-430b-87c7-743d52532622_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_400f76ae-36f9-4299-856e-39315fcf1e0a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_dad0dc9e-9df8-431f-b4d3-3c1e3fbd4ce0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_92b678cc-0e31-4646-add5-66f3aff47083_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c9d585a2-63fd-44e7-9f08-d3340d34ad50_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2c1a8d8c-a563-47da-bc64-6018eb07ab78_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ThirdPartyPayerRentalRevenueMember_7f447fa7-3478-403e-9578-ec8ea8aa8e41_terseLabel_en-US" xlink:label="lab_infu_ThirdPartyPayerRentalRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Payor Rental Revenue</link:label>
    <link:label id="lab_infu_ThirdPartyPayerRentalRevenueMember_label_en-US" xlink:label="lab_infu_ThirdPartyPayerRentalRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third-Party Payer Rental Revenue [Member]</link:label>
    <link:label id="lab_infu_ThirdPartyPayerRentalRevenueMember_documentation_en-US" xlink:label="lab_infu_ThirdPartyPayerRentalRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents third-party payor rental revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThirdPartyPayerRentalRevenueMember" xlink:href="infu-20220331.xsd#infu_ThirdPartyPayerRentalRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ThirdPartyPayerRentalRevenueMember" xlink:to="lab_infu_ThirdPartyPayerRentalRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e2a20bcc-08f9-4c5a-bbc2-c97ea9b97773_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_cb81cef2-3fae-4234-9062-4743281722a4_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1d4632f1-3190-4160-a22d-9aca3708a41f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_05160ed7-f416-4746-aabe-54bd7bd39816_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ba5bc79e-5bc9-4ca1-a7cb-1aa81cf57735_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_0a9801be-8e15-4848-ab03-9ecfec2104bd_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_ebe5aa1c-ec3c-4c05-a4cd-b5afd9914c6e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5cd4e357-2b1e-45f8-a347-d52e0f88592a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_907715ef-a166-4c1e-83db-cad37c4e1c8e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_ae37baad-04bb-46ba-a0ae-61f5e0404d4e_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_The2015CreditAgreementMember_e01f289e-d0f8-481d-8c8a-97e3084340dc_terseLabel_en-US" xlink:label="lab_infu_The2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2015 Credit Agreement</link:label>
    <link:label id="lab_infu_The2015CreditAgreementMember_label_en-US" xlink:label="lab_infu_The2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2015 Credit Agreement [Member]</link:label>
    <link:label id="lab_infu_The2015CreditAgreementMember_documentation_en-US" xlink:label="lab_infu_The2015CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the "2015 Credit Agreement".</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2015CreditAgreementMember" xlink:href="infu-20220331.xsd#infu_The2015CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_The2015CreditAgreementMember" xlink:to="lab_infu_The2015CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_b900a9de-e442-4780-9d94-fe6206112290_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_37de0b60-62ca-4f9c-959c-d4bb353d826f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_8a89cd2a-2ba4-4731-ab7d-0f2b693a8aa6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralDomain_c032dc25-6f52-4266-9924-d6e4f7bd34e1_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Domain]</link:label>
    <link:label id="lab_us-gaap_CollateralDomain_label_en-US" xlink:label="lab_us-gaap_CollateralDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralDomain" xlink:to="lab_us-gaap_CollateralDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_WorkingCapital_c47a4fdb-d9f4-4ee6-add6-67ae33ed414d_terseLabel_en-US" xlink:label="lab_infu_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital adjustment, paid in cash</link:label>
    <link:label id="lab_infu_WorkingCapital_label_en-US" xlink:label="lab_infu_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital</link:label>
    <link:label id="lab_infu_WorkingCapital_documentation_en-US" xlink:label="lab_infu_WorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of working capital adjustments incurred by the acquirer as part of consideration transferred in a business combination.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_WorkingCapital" xlink:href="infu-20220331.xsd#infu_WorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_WorkingCapital" xlink:to="lab_infu_WorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross_eda8acdf-bc4d-4997-a02a-d31289c577da_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment for sale or rental</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross_label_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment Held For Sale Or Rental Gross</link:label>
    <link:label id="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents medical equipment held for sale or rental as of the balance sheet date, before reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRentalGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:to="lab_infu_MedicalEquipmentHeldForSaleOrRentalGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3948a088-6796-4997-9c7a-b614902783b9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_6acb0dee-61b4-495d-b511-db49b72be6e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased as part of share repurchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3c55900f-d0b4-448e-853e-522e12b790aa_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_f8808920-a95f-4892-a33c-a099aaafdf76_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_94d367ed-6d53-41de-8eae-d4d374d0ce74_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination</link:label>
    <link:label id="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_db3a71ff-25c2-4ffc-9f0d-5b7b337ed05a_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b6f7b503-9308-48fc-9d82-220570731b68_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d12c676d-531e-40a9-99d4-67374524000f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_073c99b3-1a8d-4619-80f5-b3a3a743a44f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f14b4cc4-6570-43b4-8eac-d0acd93b613d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_9fe39738-f44b-48ff-babe-dc15843f880e_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_09fb7d1b-635d-48da-825e-32d32dd7b5d5_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_47af95d1-e04b-4f94-a4cb-276e0690184a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f8d34377-1391-4c06-a427-73d118e69138_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_71a9c8db-c537-4579-8719-35ff8d9e42c0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_53614293-5f63-404c-8495-592808de7a71_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4aec85b3-8e3d-4ab4-a75c-cbfef6718646_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_RevenuesInternal_b3df2426-21d7-46b7-a547-47945410bcb6_terseLabel_en-US" xlink:label="lab_infu_RevenuesInternal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues - internal</link:label>
    <link:label id="lab_infu_RevenuesInternal_label_en-US" xlink:label="lab_infu_RevenuesInternal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues - internal</link:label>
    <link:label id="lab_infu_RevenuesInternal_documentation_en-US" xlink:label="lab_infu_RevenuesInternal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of internal net revenues recognized during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesInternal" xlink:href="infu-20220331.xsd#infu_RevenuesInternal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_RevenuesInternal" xlink:to="lab_infu_RevenuesInternal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_646c28c2-7b14-455f-90e6-7cb1d68044a2_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a919c1d4-16da-4616-82a4-fcc10ae08cb2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_91d1c808-fcb7-41d9-8783-24074e6585ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased as part of share repurchase program</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_fbe75c72-6d24-48c4-a99a-41154039f9e0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LongTermDebtGrossNoncurrent_96d794e6-1fa1-4766-8f5b-2c9e1dbe6717_verboseLabel_en-US" xlink:label="lab_infu_LongTermDebtGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Portion</link:label>
    <link:label id="lab_infu_LongTermDebtGrossNoncurrent_label_en-US" xlink:label="lab_infu_LongTermDebtGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term Debt Gross Noncurrent</link:label>
    <link:label id="lab_infu_LongTermDebtGrossNoncurrent_documentation_en-US" xlink:label="lab_infu_LongTermDebtGrossNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt, excluding the current portion. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent" xlink:href="infu-20220331.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LongTermDebtGrossNoncurrent" xlink:to="lab_infu_LongTermDebtGrossNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_a7833871-c47a-4968-a456-2e832b3d3092_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_e85c9d4c-c2ec-4cf6-b2bb-8ea0208cd2cc_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d7211535-8b51-4a8f-8949-f40bc52da041_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7170e40e-9073-406a-9ecd-1a874e661009_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_5dbca7d7-1a34-475e-ab94-4eab669336c4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_1bd91def-20d6-4228-984d-d6595ef58bf0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d25891d4-5c31-43d8-b7c6-a2a3e98fa4b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_22189652-59d7-437f-8954-747839fbb6e5_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total - purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3ce655c5-e9d4-47d7-9f0e-24f451c281de_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_14ed4039-9543-4b4f-be91-389a346687f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_7d13c9f6-7ae2-426d-86bf-54bfa19941ed_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_2f021ac3-151d-4322-a807-960e0cf26432_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_5c5ec98f-df0f-4280-8fcd-6ce20f1313ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_80824dd8-b328-4450-82d1-5e8bc893b936_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_999b152a-5002-446f-9c9b-bcd414a710ed_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_CorporateAndEliminationsMember_0db43794-2ddd-4b1a-8ba9-2cd8ce793b2f_terseLabel_en-US" xlink:label="lab_infu_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Eliminations</link:label>
    <link:label id="lab_infu_CorporateAndEliminationsMember_label_en-US" xlink:label="lab_infu_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Eliminations [Member]</link:label>
    <link:label id="lab_infu_CorporateAndEliminationsMember_documentation_en-US" xlink:label="lab_infu_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding corporate and eliminations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CorporateAndEliminationsMember" xlink:href="infu-20220331.xsd#infu_CorporateAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_CorporateAndEliminationsMember" xlink:to="lab_infu_CorporateAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LIBORRate_b7a95df2-485a-4cd9-b25f-b28b5234119a_terseLabel_en-US" xlink:label="lab_infu_LIBORRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR rate</link:label>
    <link:label id="lab_infu_LIBORRate_label_en-US" xlink:label="lab_infu_LIBORRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR Rate</link:label>
    <link:label id="lab_infu_LIBORRate_documentation_en-US" xlink:label="lab_infu_LIBORRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the LIBOR rate as of the specified date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LIBORRate" xlink:href="infu-20220331.xsd#infu_LIBORRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LIBORRate" xlink:to="lab_infu_LIBORRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_fd3d3fcb-0920-414f-8ccc-dd30c86ba641_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_03fdecdd-949f-4390-8d5d-725aab4bbf06_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income tax on unrealized hedge gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_be005f25-6800-421b-8cd8-eaa08b028bf6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1516838e-82dc-4273-b2f7-82bca97bd836_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_82b430ea-f2cd-471e-a2b3-946771bbfc1b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ff600bf8-2bea-462d-a7fb-d8072649d936_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_fca7525f-3bac-425a-ac48-cec38d9e6d7e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements and Developments</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_37d9586c-011c-4d6f-a486-bfbc9d46272d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e0d316ec-ba00-414f-893d-8b22f79150b2_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_d4af73f7-e22d-4b2b-9b33-c0e57bdba328_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract (year)</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a526ce63-57d3-4ec0-8e7a-79c02b83fb3a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c4406237-da8b-490b-bf90-40adbb8b3601_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7a1a005b-cbf3-4464-ab41-9a19330bfb60_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fa294787-634e-4f31-8ac9-c7491bfce5f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_69f559d4-426b-40b1-9efe-31f7b3e7f525_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_828bf71e-84a3-495c-911f-4f04a7632b0a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_798ab75f-e8a0-406f-abd5-78a1d1a13514_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1041dfa6-fad1-49a2-bc6b-db798e708a51_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_80fa8e38-fc75-4c1c-a45e-bc54b0a33ff1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5354f59c-361c-4d3e-9dc8-b8fa1f38feaa_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c66bd66e-91de-4406-b3b2-8257bb415988_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_decc5201-ccfe-43bb-8eba-7d45f54d1824_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_792ccb14-17d0-4d41-9293-8994d07d61ea_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_7afc923c-ca9d-4bf2-80f5-7261c456cf0d_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f6d8473d-6cbd-408d-8adb-4c0291f09231_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_573b1fb4-79ed-4838-a3a4-9640f95dc6e7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_b7ab7b13-bab6-46ca-a787-ee958d76eba8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_adccd944-43fc-40b4-b929-3c4741560976_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_3d526976-c6f4-4532-8b55-4c043ed0366f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_738595cc-5732-4071-8c0f-29a1bce46980_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_b9711f37-ccaf-4d66-93cd-275c12fafd37_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_33889a13-bb15-4a3d-98fd-bf3d19e547a3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_3089cefa-8dd4-4b55-ab33-3fdcf299eb1c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_a655e2aa-5e75-4cda-b3e9-2ea00df172e4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based shares issued upon vesting - gross</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_35248746-edae-4ab9-8349-4a7b3d3ff40d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_095a37e6-f952-4dac-a054-5421f6f04ed1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_29ea39e4-5adb-4e1c-8c98-a638e40d9e2d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_3100d627-792b-4090-8c87-9c5482e68329_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on sale of medical equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter_a7e68709-40cf-40ef-927f-68b744eaaaa9_terseLabel_en-US" xlink:label="lab_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 and thereafter</link:label>
    <link:label id="lab_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter_label_en-US" xlink:label="lab_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Amortization Expense, Year Five and After</link:label>
    <link:label id="lab_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter_documentation_en-US" xlink:label="lab_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" xlink:href="infu-20220331.xsd#infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" xlink:to="lab_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_RevenuesExternal_1ac8a0ef-6259-42a1-9df3-b45b53e63349_terseLabel_en-US" xlink:label="lab_infu_RevenuesExternal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues - external</link:label>
    <link:label id="lab_infu_RevenuesExternal_label_en-US" xlink:label="lab_infu_RevenuesExternal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues - external</link:label>
    <link:label id="lab_infu_RevenuesExternal_documentation_en-US" xlink:label="lab_infu_RevenuesExternal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of external net revenues recognized during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesExternal" xlink:href="infu-20220331.xsd#infu_RevenuesExternal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_RevenuesExternal" xlink:to="lab_infu_RevenuesExternal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_29ff0fb6-5706-4759-9893-51bb7c126091_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_aaf101e8-6c01-4456-8eac-feaf681f407d_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total nonamortizable and amortizable intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_3b9c7301-5c2f-4dad-9894-ca3e2a0e79f6_terseLabel_en-US" xlink:label="lab_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 and thereafter</link:label>
    <link:label id="lab_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability To Be Paid After Year Four</link:label>
    <link:label id="lab_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="infu-20220331.xsd#infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_06f09d44-5a58-49c6-b24a-0f6f92e1908c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a4c2ecf3-6b99-4e59-9392-5575255ec0a8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_da1d16cb-2cac-414f-a8c1-a3f8b65f7592_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_41fcb7a9-1cd2-4b47-bf75-711626a98bbc_terseLabel_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right of use assets</link:label>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Asset</link:label>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of operating lease right of use asset recognized as of the acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:href="infu-20220331.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:to="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1334e6f3-0d62-4a86-810b-614d46816b84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_83e9ab68-0d7f-4df7-81ed-567d96bd7af2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_99aeff77-587f-4425-91b9-53a588655123_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_81a9ff42-d80b-4a93-b78d-487cd98c1944_negatedLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified within twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7673196e-e8a8-46d0-a771-45e6b82bcc9b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f557a084-8383-41e8-aaf2-0cc624108daa_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_f873b010-0b39-41a9-a9e3-c791cbde619d_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_71a2bd69-e0f3-48e6-92a9-9e20e6335d07_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock,, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_746b3429-4f3a-4778-8e17-79650023679c_terseLabel_en-US" xlink:label="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma acquisition cost and non-recurring expense</link:label>
    <link:label id="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_label_en-US" xlink:label="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Pro Forma Acquisition Cost And Nonrecurring Expense</link:label>
    <link:label id="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_documentation_en-US" xlink:label="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The pro forma acquisition cost and non-recurring expense for a period as if the business combination or combinations had been completed at the beginning of the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:href="infu-20220331.xsd#infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:to="lab_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6b96a058-d278-4f36-a723-2b019e8f2d75_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_3b578bb3-8863-42a7-a720-6fde0a7efcf3_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_55ac3cc2-8954-4823-885b-2c0ce82638bc_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_39bcd998-a00c-4cae-bcfb-604f8f4b3086_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_e2b61616-4d28-4b56-b6f7-193605e3c94c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, renewal term (year)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f6062ae3-b4e2-48ef-abbc-e61474e9a0c3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_3c0320a5-f73a-482c-95a9-3b8bfdcf6b63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_87e1ba12-83c6-4979-9dc3-452d37b0f0ba_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7522ea88-3827-483c-b3dc-3cc2b4b4dc48_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_8ef89c47-8743-48bc-abf5-4c20b50d75be_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_b129cfde-f445-431b-a554-f8a9aeea8263_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures, and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_74db79e4-045a-4fdc-a2fd-c44626e73a36_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_ef6050c5-8efe-4cc0-8ebe-f060f08e49fd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PercentageOfTotalDepreciationExpense_8616ac0a-5a8d-4828-9ff3-693762e5dd61_terseLabel_en-US" xlink:label="lab_infu_PercentageOfTotalDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total depreciation expense</link:label>
    <link:label id="lab_infu_PercentageOfTotalDepreciationExpense_label_en-US" xlink:label="lab_infu_PercentageOfTotalDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Depreciation Expense</link:label>
    <link:label id="lab_infu_PercentageOfTotalDepreciationExpense_documentation_en-US" xlink:label="lab_infu_PercentageOfTotalDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of total depreciation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageOfTotalDepreciationExpense" xlink:href="infu-20220331.xsd#infu_PercentageOfTotalDepreciationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PercentageOfTotalDepreciationExpense" xlink:to="lab_infu_PercentageOfTotalDepreciationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a097d078-816a-43ee-b33d-8cebcf397bff_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_327b55f1-7fbe-40ba-95fb-ac563e594325_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_f04e87a4-182a-42d6-b348-d7a8d6ed631b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_bd1b6c0d-4b0a-4a8e-939d-30c914ab58c3_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_af66e202-d92e-4895-88ab-b7db5536830a_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_37f2226b-a682-422b-af94-61f894ac36cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentAbstract_bd804bd1-590b-428c-a0af-2ab27b99cd52_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes To Financial Statements [Abstract]</link:label>
    <link:label id="lab_infu_MedicalEquipmentAbstract_label_en-US" xlink:label="lab_infu_MedicalEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Abstract]</link:label>
    <link:label id="lab_infu_MedicalEquipmentAbstract_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentAbstract" xlink:to="lab_infu_MedicalEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e018712f-a839-4a11-b206-66a2d343c5e5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6a8bf23b-94f9-4fed-befb-66ef8f400935_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_c7e52fd8-bc80-4218-9304-94fa95dc0318_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_4f48ab0a-2033-478a-82e1-ae6504b3c876_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED IN FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ec40a1d4-7d00-4afb-9b56-3ead818f0546_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_83b9e199-d89e-4bde-997b-ea684721622f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_dbce5f45-b77a-4e69-a1de-1705e86f49ee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PaymentsToAcquireMedicalEquipment_96f24b88-a714-46b3-8dfa-d4fcfe045aa0_negatedLabel_en-US" xlink:label="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of medical equipment</link:label>
    <link:label id="lab_infu_PaymentsToAcquireMedicalEquipment_b5fcddb5-3f95-4b16-b95a-6864c31b61a5_terseLabel_en-US" xlink:label="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of medical equipment</link:label>
    <link:label id="lab_infu_PaymentsToAcquireMedicalEquipment_label_en-US" xlink:label="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Medical Equipment</link:label>
    <link:label id="lab_infu_PaymentsToAcquireMedicalEquipment_documentation_en-US" xlink:label="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of cash paid during the period to acquire medical equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PaymentsToAcquireMedicalEquipment" xlink:to="lab_infu_PaymentsToAcquireMedicalEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent_618dbf07-7fee-4c42-881f-dcda3145a08d_negatedTerseLabel_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized value of the debt issuance costs, long-term debt</link:label>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent_label_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense Noncurrent</link:label>
    <link:label id="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent_documentation_en-US" xlink:label="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The noncurrent portion of unamortized debt issuance expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:to="lab_infu_UnamortizedDebtIssuanceExpenseNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ab570248-5117-4ea6-936b-72ecadf08dac_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d700e309-f3aa-4af7-89c8-c67385103ca0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralAxis_3170091e-767e-47b0-b506-d9d740e72a3d_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Axis]</link:label>
    <link:label id="lab_us-gaap_CollateralAxis_label_en-US" xlink:label="lab_us-gaap_CollateralAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralAxis" xlink:to="lab_us-gaap_CollateralAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_f7367e08-9f59-4efd-aa9e-6a7132ae1319_terseLabel_en-US" xlink:label="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_label_en-US" xlink:label="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Business, Excluding Working Capital Adjustments</link:label>
    <link:label id="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_documentation_en-US" xlink:label="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Business, Excluding Working Capital Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:to="lab_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_744d70ff-d7ee-4671-8d1b-e1cfb5cf2f35_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_68c9e023-32ba-4bd8-a073-080a8ee62e0a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_17a41a9b-a14d-4bf5-9c53-f4d719b09827_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5caf81ea-009e-478e-aa39-64edd7762d94_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_227cd664-88b8-424b-8389-a8d1ff656d2e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_096ef3d6-e7ab-43a5-92ec-361b490d342c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationNonproduction_8226818d-7e21-4716-8f39-595e5ad52d7d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationNonproduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_DepreciationNonproduction_label_en-US" xlink:label="lab_us-gaap_DepreciationNonproduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationNonproduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationNonproduction" xlink:to="lab_us-gaap_DepreciationNonproduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_0892eb35-52a3-4eb6-b4ef-8576ed2fd9b6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_fd7ca8a2-2922-4cd8-846f-3bd2bc0ccd03_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_ecb36f53-dd90-4fd3-af3e-3f535495dd66_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_9a0b8a92-b608-43df-8761-cb3d2a8ef448_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9eff8ab4-76b1-49d3-bf2d-bc28e7d5f29b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_f34bc876-b9b7-4504-9c59-cdb0a8912078_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_b4b832d5-1ebe-4a95-bd1e-f9f723a505c5_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_76f5c150-bd9d-4b04-ba6e-3cb177b66197_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_dcd52ab1-783a-4749-95ce-b206f3468f74_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_be610a0b-14e7-40c9-abce-5dd98debe145_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_b7efcc2c-315c-493e-b818-33860d7658eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_477e4701-1f57-4360-8efb-98e4bb09c897_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician and customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b32e5e66-7b5a-407f-8063-a9ce798d71bd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property &amp; equipment, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c0e54319-85eb-428b-ae13-06d4336a5a71_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property &amp; equipment, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_64657921-b737-4a2e-8d92-1a9e16742e20_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_a6f80658-210e-469f-96d9-687fac2dd85f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_9781ab95-88d2-417f-9596-4b833568fe61_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_ae5d4bca-e923-4d0c-bad3-04853d0b367a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_90edd064-e75e-4bea-bd21-2e098d31cf3e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a4d93d3a-e50d-4808-a83f-45403ff0a80f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_bc305036-8d50-42e9-861e-d846eab31c88_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Derivative Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio_4974f526-da4d-43eb-9e5d-37a55df30aa8_terseLabel_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, maximum leverage ratio</link:label>
    <link:label id="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio_label_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Covenant Maximum Leverage Ratio</link:label>
    <link:label id="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio_documentation_en-US" xlink:label="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum leverage ratio required by the debt agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:href="infu-20220331.xsd#infu_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:to="lab_infu_DebtInstrumentCovenantMaximumLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_8223ee18-7be3-4f45-8811-844675fab4e1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c94e971f-a448-49f6-a9d9-4e94e59536a9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Assets</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_DMEServicesSegmentMember_e6912354-6fcf-4259-b600-fcdc73427108_terseLabel_en-US" xlink:label="lab_infu_DMEServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DME Services</link:label>
    <link:label id="lab_infu_DMEServicesSegmentMember_label_en-US" xlink:label="lab_infu_DMEServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DME Services Segment [Member]</link:label>
    <link:label id="lab_infu_DMEServicesSegmentMember_documentation_en-US" xlink:label="lab_infu_DMEServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the DME Services segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember" xlink:href="infu-20220331.xsd#infu_DMEServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_DMEServicesSegmentMember" xlink:to="lab_infu_DMEServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_059a7b0a-4d44-477a-88ff-736ab6a53b25_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_9061d691-fa8b-47d8-bda8-3db23bac27fe_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_ae9314db-dc6f-4c8c-9905-a11982d2cd2c_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_012baf20-aa72-4150-a9cc-67d144c17aa9_totalLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross availability</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_85ac0f7d-4858-4d92-9355-eeb329f92473_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_ec46467e-4c14-492e-bdd6-64f37e6b6ac7_terseLabel_en-US" xlink:label="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_label_en-US" xlink:label="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility Additional Borrowing Capacity Subject To Certain Conditions</link:label>
    <link:label id="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_documentation_en-US" xlink:label="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional borrowing capacity under the credit facility subject to certain conditions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:href="infu-20220331.xsd#infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:to="lab_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_728843d4-e680-484b-bf9f-67825f051d80_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_6a4a24d6-1042-4e13-afb6-7dae1c6ebf56_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_bd151161-c9eb-49b9-a83d-3d6723f3ba56_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_f782e470-5601-47ec-966e-07eed18e8ef4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_68bb979b-f8f2-480c-b107-47a516dceaa6_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0a517f45-18e9-425a-a3e7-0c379cd512cd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_94450522-eae7-4f42-bcae-64759dee4044_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_21454fff-4233-4708-9d89-97f0d45d211f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net hedge ineffectiveness gain (loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_label_en-US" xlink:label="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Net Hedge Ineffectiveness Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:to="lab_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_b78620b8-cff5-449c-a3db-89962f819f6d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd7108f8-24b8-4436-a634-841c62b20b30_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fe1f1d63-81c4-45d8-bdbd-836ccad1e605_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3ef2da18-5b7c-4f2b-b0c9-fb8ed70f53a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1189f2cd-f145-414b-b6d0-c9276cea2579_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_b6f3d9ba-faf5-4472-9bd2-5a07e8094abe_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_94210af0-0c5c-446c-bdb5-84423e11efa7_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_ABRLoansMember_7ed2c22a-d7b1-4d14-ac5d-731880e4e608_terseLabel_en-US" xlink:label="lab_infu_ABRLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABR Loans</link:label>
    <link:label id="lab_infu_ABRLoansMember_label_en-US" xlink:label="lab_infu_ABRLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABR Loans [Member]</link:label>
    <link:label id="lab_infu_ABRLoansMember_documentation_en-US" xlink:label="lab_infu_ABRLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the ABR loans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ABRLoansMember" xlink:href="infu-20220331.xsd#infu_ABRLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_ABRLoansMember" xlink:to="lab_infu_ABRLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_52c5ba7f-fb2f-4c3f-972d-40eea95cd2af_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_Covid19Abstract_label_en-US" xlink:label="lab_infu_Covid19Abstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covid-19 [Abstract]</link:label>
    <link:label id="lab_infu_Covid19Abstract_documentation_en-US" xlink:label="lab_infu_Covid19Abstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covid-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_Covid19Abstract" xlink:href="infu-20220331.xsd#infu_Covid19Abstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_Covid19Abstract" xlink:to="lab_infu_Covid19Abstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_6c07dfbc-84ca-49a1-bfad-d67484c1f9d4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in liabilities - increase/(decrease):</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_502ac315-23e8-40a7-b1fb-20bde4d14168_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to interest expense</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_2b85f2ce-a0d8-4da8-82c8-06a0483a9524_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_8f27c61b-a377-4585-ba07-0a679df40965_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_e36b11fe-3659-484d-9bfd-2b505f9d70f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_73eb9e81-47ec-4f84-865a-cd8c1a15e7f0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b9c5b18d-4d8f-4dd9-9145-29790096970a_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c4b18f25-15b9-4a79-8c6a-954bcc334899_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTable_46f1f292-6616-4b26-be58-448b92732dcc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSegmentAllocationTable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Segment Allocation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:to="lab_us-gaap_BusinessCombinationSegmentAllocationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2dcbb5f0-b6a5-416b-aa58-bb46792aef08_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f8a88d31-dcab-4f91-bbc3-c1b5d9361aa9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_962ada99-d6fe-462e-b81b-7fe8ee2f64b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(loss) on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_FilAMedMember_a6b854e0-9a49-4093-bdbf-87cba402d5c0_terseLabel_en-US" xlink:label="lab_infu_FilAMedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FilAMed</link:label>
    <link:label id="lab_infu_FilAMedMember_label_en-US" xlink:label="lab_infu_FilAMedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FilAMed [Member]</link:label>
    <link:label id="lab_infu_FilAMedMember_documentation_en-US" xlink:label="lab_infu_FilAMedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to FilAMed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember" xlink:href="infu-20220331.xsd#infu_FilAMedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_FilAMedMember" xlink:to="lab_infu_FilAMedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2d8e066f-b4c4-4778-b0c0-3fb59d154924_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_56105cae-dec3-4013-8b43-994ed53a3fee_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_94d2aa7d-6074-430f-ad7b-86f7c2847e5d_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_e0f32a9f-30f3-4895-a69c-a28f7ce4a8da_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_16525693-1e3a-4cc4-a840-0fa1226859da_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_475c72b4-4d01-40a8-bf0c-6214e69e07c7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6db7d32-706b-4351-878b-ab5feceb9685_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0d80d223-d81f-4149-b6e2-2d5a57bb31e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_8c02db20-cd10-459a-a0dd-23108b47482f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1b1eef5d-b45d-428f-b932-9ebf2d30359d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_5d9abeca-42fa-4d3e-a937-0e5f1f37153a_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_5237b9a7-d116-4c4c-a0d1-d31ee8bc7d85_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_8fd8c36e-abed-4ce9-9ea7-628ce660ae45_terseLabel_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment held for sale or rental</link:label>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_label_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Medical Equipment Held For Sale Or Rental</link:label>
    <link:label id="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_documentation_en-US" xlink:label="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of medical equipment in rental service recognized as of the acquisition date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:href="infu-20220331.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:to="lab_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_a91b01e3-c1e8-4be8-9025-c65dff18faf2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_339adec2-1e3e-4449-a3e5-613a11a1df87_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_9ac71d9c-eeb3-4011-9a8b-a5e7f9cbe750_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5aab031a-f12b-4a01-a371-1d009ceab04d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_b01d6466-f767-4f32-a1e7-80cd3a55a0f8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_98495874-e8de-4678-978f-e8d95f34042b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LenderPrimeRate_740e79fe-1ea9-4fc7-a9e6-fd0cf25f98b0_terseLabel_en-US" xlink:label="lab_infu_LenderPrimeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender prime rate</link:label>
    <link:label id="lab_infu_LenderPrimeRate_label_en-US" xlink:label="lab_infu_LenderPrimeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Prime Rate</link:label>
    <link:label id="lab_infu_LenderPrimeRate_documentation_en-US" xlink:label="lab_infu_LenderPrimeRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the lender's prime rate as of the specified date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LenderPrimeRate" xlink:href="infu-20220331.xsd#infu_LenderPrimeRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LenderPrimeRate" xlink:to="lab_infu_LenderPrimeRate" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_OBHealthcareMember_0dc8f1e4-66a7-4ce7-bdb1-55e252cc7650_terseLabel_en-US" xlink:label="lab_infu_OBHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OB Healthcare</link:label>
    <link:label id="lab_infu_OBHealthcareMember_label_en-US" xlink:label="lab_infu_OBHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OB Healthcare [Member]</link:label>
    <link:label id="lab_infu_OBHealthcareMember_documentation_en-US" xlink:label="lab_infu_OBHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the acquisition of OB Healthcare Corporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember" xlink:href="infu-20220331.xsd#infu_OBHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_OBHealthcareMember" xlink:to="lab_infu_OBHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_129545d7-7a36-44d7-b704-9c79d385897f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_3c315047-7f89-4b81-abbc-a409e5b4872f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds from stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_4256d99a-0e64-4352-90a7-03b95ef82996_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_dd198c9c-ca99-4aa7-b801-b41707bc860f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_bc16e755-f60e-4b9b-bb8e-e49a560415c4_negatedTerseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment In Rental Services Accumulated Depreciation</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of accumulated depreciation related to medical equipment in rental services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:to="lab_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_067c939a-5d6f-4af1-b730-d59cf7c0f4b1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesGross_96654c57-e4ad-4899-80bf-e755e163ba72_verboseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment in rental service</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesGross_label_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment In Rental Services Gross</link:label>
    <link:label id="lab_infu_MedicalEquipmentInRentalServicesGross_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentInRentalServicesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the gross amount of medical equipment in rental services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesGross" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentInRentalServicesGross" xlink:to="lab_infu_MedicalEquipmentInRentalServicesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_3eb26960-18a4-42ff-8333-195b906667c1_terseLabel_en-US" xlink:label="lab_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_label_en-US" xlink:label="lab_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term Debt Maturities Repayments Of Principal Year Four And Thereafter</link:label>
    <link:label id="lab_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_documentation_en-US" xlink:label="lab_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year and after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" xlink:href="infu-20220331.xsd#infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" xlink:to="lab_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9fc1cb9f-bee0-4bfe-96fb-43624c28b396_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ec76a5b1-eb63-4204-9448-096bdfbc4676_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_4877aa30-4da0-4c97-a1f8-419997acb872_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_be78357d-8c40-4d06-b55b-a95d299781d6_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_2697251a-9e3b-44ae-b0e2-4a8b531bacac_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_MedicalEquipmentMember_b4d20710-e742-40f2-a72b-b6ab46fd0b18_terseLabel_en-US" xlink:label="lab_infu_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_infu_MedicalEquipmentMember_label_en-US" xlink:label="lab_infu_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:label id="lab_infu_MedicalEquipmentMember_documentation_en-US" xlink:label="lab_infu_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents medical equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentMember" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_MedicalEquipmentMember" xlink:to="lab_infu_MedicalEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_6711ef7e-ec44-417b-8bcf-8d5c2e6010f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3e2bdc9e-739a-4b8a-9ccc-5252fb09dc0a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_e8d030f2-7d1d-4755-ab2c-93f01b2fdbf7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_96fda408-fd0e-44a5-9bf3-e66f5bf16164_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_86675ccc-70c2-489c-b3b7-c133c83719fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_infu_FinancingAgreementMember_7846f7d8-8e8d-4eed-bc69-66562f721a9f_terseLabel_en-US" xlink:label="lab_infu_FinancingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Agreement</link:label>
    <link:label id="lab_infu_FinancingAgreementMember_label_en-US" xlink:label="lab_infu_FinancingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Agreement [Member]</link:label>
    <link:label id="lab_infu_FinancingAgreementMember_documentation_en-US" xlink:label="lab_infu_FinancingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information pertaining to the financing agreement (the "Financing Agreement").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember" xlink:href="infu-20220331.xsd#infu_FinancingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_infu_FinancingAgreementMember" xlink:to="lab_infu_FinancingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_d424dd77-9ce4-4d30-9a1d-0e7ff977bc86_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AutomobilesMember_3c5f26c7-0acd-4d6e-beb6-4b13cd45a833_terseLabel_en-US" xlink:label="lab_us-gaap_AutomobilesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automobiles</link:label>
    <link:label id="lab_us-gaap_AutomobilesMember_label_en-US" xlink:label="lab_us-gaap_AutomobilesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Automobiles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AutomobilesMember" xlink:to="lab_us-gaap_AutomobilesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_862cd081-3926-487d-8093-1de01a7d4b60_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>infu-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9c45a9a1-f9a1-46d4-ab6e-c84379cf91bb,g:e62fa09c-9414-4caa-b36a-5012b4171a20-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://infusystem.com/role/Cover" xlink:type="simple" xlink:href="infu-20220331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_436da9cf-6f12-4c0a-9f70-ac8a31c515e8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityCentralIndexKey_436da9cf-6f12-4c0a-9f70-ac8a31c515e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_70bb761b-b74f-4fa1-8228-ca7fffc97bf3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_AmendmentFlag_70bb761b-b74f-4fa1-8228-ca7fffc97bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2762c32b-89ba-48a1-b4e3-7cbea5fa4530" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_CurrentFiscalYearEndDate_2762c32b-89ba-48a1-b4e3-7cbea5fa4530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_aa567452-a21d-4095-9996-61ed9994a2c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_aa567452-a21d-4095-9996-61ed9994a2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e5aa6aaf-b6a3-4365-ac21-5392d0a8ee5b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_DocumentFiscalYearFocus_e5aa6aaf-b6a3-4365-ac21-5392d0a8ee5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_132e3da7-a295-4ec6-ab91-e11fc799a5f9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_DocumentType_132e3da7-a295-4ec6-ab91-e11fc799a5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a6edff91-4ceb-42e5-8ff5-feff8da3ae77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_DocumentQuarterlyReport_a6edff91-4ceb-42e5-8ff5-feff8da3ae77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b95ef20f-1796-4f74-bb73-87effc3c4aff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_DocumentPeriodEndDate_b95ef20f-1796-4f74-bb73-87effc3c4aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8c4806e3-2f35-480e-9f37-e44a8df8114e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_DocumentTransitionReport_8c4806e3-2f35-480e-9f37-e44a8df8114e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d74711c7-d381-4230-8132-cd539610c1d1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityFileNumber_d74711c7-d381-4230-8132-cd539610c1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5a9aad32-bbe2-4684-b7c1-223c1192d6dc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityRegistrantName_5a9aad32-bbe2-4684-b7c1-223c1192d6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4dc828ba-0df1-4a36-94db-061974ae8f65" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4dc828ba-0df1-4a36-94db-061974ae8f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_12d7f9de-7673-4c81-b2cb-7fdab2d607e6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityTaxIdentificationNumber_12d7f9de-7673-4c81-b2cb-7fdab2d607e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_76e2e793-30ef-4050-86d6-a73e18bb44ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityAddressAddressLine1_76e2e793-30ef-4050-86d6-a73e18bb44ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f84cbd9d-0af6-41ee-b515-4e83159ecfb1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityAddressCityOrTown_f84cbd9d-0af6-41ee-b515-4e83159ecfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_af40b550-b264-4934-b9f6-e655ebee79fc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityAddressStateOrProvince_af40b550-b264-4934-b9f6-e655ebee79fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d566a788-5cb0-485a-b155-639f94a7eb26" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityAddressPostalZipCode_d566a788-5cb0-485a-b155-639f94a7eb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_842ddec6-5de5-4ef1-a6d3-d430f040f0d3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_CityAreaCode_842ddec6-5de5-4ef1-a6d3-d430f040f0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_71320b9c-38ba-4526-8ce2-555ae002b159" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_LocalPhoneNumber_71320b9c-38ba-4526-8ce2-555ae002b159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_020f80ba-920a-4baa-96c9-2d86787646e2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_Security12bTitle_020f80ba-920a-4baa-96c9-2d86787646e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a8d69763-ba5c-48f7-9ed1-7a11a1b068e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_TradingSymbol_a8d69763-ba5c-48f7-9ed1-7a11a1b068e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_62eb6a6c-13e9-4857-ac83-2239f3d1c7d7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_SecurityExchangeName_62eb6a6c-13e9-4857-ac83-2239f3d1c7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_5f3eb924-9dab-4a30-9432-b71b528a3b79" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityCurrentReportingStatus_5f3eb924-9dab-4a30-9432-b71b528a3b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c38e8613-ced4-45d1-82db-f90719bdc46b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityInteractiveDataCurrent_c38e8613-ced4-45d1-82db-f90719bdc46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_dc1759bc-19de-47a6-a862-ac7fa058faba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityFilerCategory_dc1759bc-19de-47a6-a862-ac7fa058faba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8aa2a176-5ead-4897-8fe3-faa49af53c0a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntitySmallBusiness_8aa2a176-5ead-4897-8fe3-faa49af53c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_fc36c8be-1f39-4407-a668-5a4701841d7f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityEmergingGrowthCompany_fc36c8be-1f39-4407-a668-5a4701841d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6d8b9888-c75e-435d-9412-b725736631a8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityShellCompany_6d8b9888-c75e-435d-9412-b725736631a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a6ca0028-696a-4eaa-ad98-5f302a7bb70f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_766b6ff5-1f06-43f3-bf69-3a8b2b7874a7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a6ca0028-696a-4eaa-ad98-5f302a7bb70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6137e4ad-6171-4323-a460-65a4100b38dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6137e4ad-6171-4323-a460-65a4100b38dd" xlink:to="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_971a8e95-ab61-4f1f-a0ac-7f689c6b7832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_us-gaap_AssetsCurrentAbstract_971a8e95-ab61-4f1f-a0ac-7f689c6b7832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b540786e-bfaf-4989-b808-cadff43223af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_971a8e95-ab61-4f1f-a0ac-7f689c6b7832" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b540786e-bfaf-4989-b808-cadff43223af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_915925c7-b028-4947-9d72-627168278966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_971a8e95-ab61-4f1f-a0ac-7f689c6b7832" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_915925c7-b028-4947-9d72-627168278966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_10ec464a-a932-4b27-9d2b-fdf251ebf9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_971a8e95-ab61-4f1f-a0ac-7f689c6b7832" xlink:to="loc_us-gaap_InventoryNet_10ec464a-a932-4b27-9d2b-fdf251ebf9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_55e85635-9934-4e60-b6d0-9daa3e1459ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_971a8e95-ab61-4f1f-a0ac-7f689c6b7832" xlink:to="loc_us-gaap_OtherAssetsCurrent_55e85635-9934-4e60-b6d0-9daa3e1459ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c81e9f44-3b75-415b-93d9-d92fb08d18d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_971a8e95-ab61-4f1f-a0ac-7f689c6b7832" xlink:to="loc_us-gaap_AssetsCurrent_c81e9f44-3b75-415b-93d9-d92fb08d18d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_47970b17-65dd-4b39-b9f1-9f5fd83ebaac" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRental_47970b17-65dd-4b39-b9f1-9f5fd83ebaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_a8d5173d-cc23-4e5a-9ce1-b7971809c89f" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_a8d5173d-cc23-4e5a-9ce1-b7971809c89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7cca1995-4dec-4d62-a647-20394991a283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7cca1995-4dec-4d62-a647-20394991a283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_47eef040-41fc-4603-b102-4a9601f05a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_us-gaap_Goodwill_47eef040-41fc-4603-b102-4a9601f05a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b7b234aa-71ad-43f4-802b-80515adafbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b7b234aa-71ad-43f4-802b-80515adafbbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e2348c6-93b5-462f-abd6-cfd52ed5599a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e2348c6-93b5-462f-abd6-cfd52ed5599a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_f71be83e-75c3-4ab4-8846-d7fd3b5e80b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_f71be83e-75c3-4ab4-8846-d7fd3b5e80b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8b3e084b-0a53-473f-9b7e-b795dfe43c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8b3e084b-0a53-473f-9b7e-b795dfe43c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0db998b7-b2b0-4411-9dac-b5dca03cd4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c46d3510-f08d-481b-9f14-3caacc370d8a" xlink:to="loc_us-gaap_Assets_0db998b7-b2b0-4411-9dac-b5dca03cd4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a54fbdb-5779-455a-a6fd-482ec5b55e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6137e4ad-6171-4323-a460-65a4100b38dd" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a54fbdb-5779-455a-a6fd-482ec5b55e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_5b2c0270-20e3-407a-a3df-176a5e266101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a54fbdb-5779-455a-a6fd-482ec5b55e15" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_5b2c0270-20e3-407a-a3df-176a5e266101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a663a010-2019-4104-9dcc-f559d2ed89f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5b2c0270-20e3-407a-a3df-176a5e266101" xlink:to="loc_us-gaap_AccountsPayableCurrent_a663a010-2019-4104-9dcc-f559d2ed89f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b3827e97-db98-4608-9456-c36a8cdf3d15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5b2c0270-20e3-407a-a3df-176a5e266101" xlink:to="loc_us-gaap_LongTermDebtCurrent_b3827e97-db98-4608-9456-c36a8cdf3d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_68074b5c-f729-48fd-94b3-09b3b601a5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5b2c0270-20e3-407a-a3df-176a5e266101" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_68074b5c-f729-48fd-94b3-09b3b601a5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_22f71b28-a275-41f5-aa89-2f77522e623d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5b2c0270-20e3-407a-a3df-176a5e266101" xlink:to="loc_us-gaap_LiabilitiesCurrent_22f71b28-a275-41f5-aa89-2f77522e623d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_14bc68b6-c55a-4fe7-a38e-b91c49ad5a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a54fbdb-5779-455a-a6fd-482ec5b55e15" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_14bc68b6-c55a-4fe7-a38e-b91c49ad5a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_06b61aad-8543-4750-bc0e-d6eb12bcc3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a54fbdb-5779-455a-a6fd-482ec5b55e15" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_06b61aad-8543-4750-bc0e-d6eb12bcc3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2d62c1fb-b187-41db-8778-796e5b7f9112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9a54fbdb-5779-455a-a6fd-482ec5b55e15" xlink:to="loc_us-gaap_Liabilities_2d62c1fb-b187-41db-8778-796e5b7f9112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e3d89f46-2981-495f-a0e9-c5cb12654511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6137e4ad-6171-4323-a460-65a4100b38dd" xlink:to="loc_us-gaap_StockholdersEquityAbstract_e3d89f46-2981-495f-a0e9-c5cb12654511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f529d114-8b02-4ec0-9cda-606e7b0594cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e3d89f46-2981-495f-a0e9-c5cb12654511" xlink:to="loc_us-gaap_PreferredStockValue_f529d114-8b02-4ec0-9cda-606e7b0594cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4694b3e1-05cb-428b-b609-8cef66f115fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e3d89f46-2981-495f-a0e9-c5cb12654511" xlink:to="loc_us-gaap_CommonStockValue_4694b3e1-05cb-428b-b609-8cef66f115fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bc533927-4fd6-4394-98d7-9b60d75fe07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e3d89f46-2981-495f-a0e9-c5cb12654511" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bc533927-4fd6-4394-98d7-9b60d75fe07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c646d5fc-9d50-4dd9-bc2a-952039e7288d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e3d89f46-2981-495f-a0e9-c5cb12654511" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c646d5fc-9d50-4dd9-bc2a-952039e7288d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f447a291-23b8-4020-869b-977796ff6e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e3d89f46-2981-495f-a0e9-c5cb12654511" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f447a291-23b8-4020-869b-977796ff6e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6514607f-5a01-4d15-a67e-d5960b8eb7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e3d89f46-2981-495f-a0e9-c5cb12654511" xlink:to="loc_us-gaap_StockholdersEquity_6514607f-5a01-4d15-a67e-d5960b8eb7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5e84500-425a-4e43-a1aa-882b18daa6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6137e4ad-6171-4323-a460-65a4100b38dd" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5e84500-425a-4e43-a1aa-882b18daa6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_fc68f107-abc5-4bab-81a5-76e70a990e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7db26bd7-8056-49c9-b460-299f748c5fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fc68f107-abc5-4bab-81a5-76e70a990e9f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7db26bd7-8056-49c9-b460-299f748c5fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_404cf5be-e61f-4523-a01c-9c6e8d7812cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fc68f107-abc5-4bab-81a5-76e70a990e9f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_404cf5be-e61f-4523-a01c-9c6e8d7812cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f3be86f7-438d-4b7f-9dd5-e10cc451c8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fc68f107-abc5-4bab-81a5-76e70a990e9f" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f3be86f7-438d-4b7f-9dd5-e10cc451c8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_db7de82a-817d-4073-b1db-3bff63930ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fc68f107-abc5-4bab-81a5-76e70a990e9f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_db7de82a-817d-4073-b1db-3bff63930ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f6970e0f-722c-4f9f-aa8e-cddace5329c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fc68f107-abc5-4bab-81a5-76e70a990e9f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f6970e0f-722c-4f9f-aa8e-cddace5329c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d4b9f2b4-9a49-4cff-ad76-2b72d7f4c40e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fc68f107-abc5-4bab-81a5-76e70a990e9f" xlink:to="loc_us-gaap_CommonStockSharesIssued_d4b9f2b4-9a49-4cff-ad76-2b72d7f4c40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d3d895c2-d2fc-46ad-8e3e-20108a28200e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_fc68f107-abc5-4bab-81a5-76e70a990e9f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d3d895c2-d2fc-46ad-8e3e-20108a28200e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_497720dd-45c7-456a-9e7b-64f426a9cdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_Revenues_497720dd-45c7-456a-9e7b-64f426a9cdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_fc8e6a30-562d-4b44-a2c6-5f3103f023eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_fc8e6a30-562d-4b44-a2c6-5f3103f023eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d9f7b85c-81c6-465c-9f85-488ae5ce0c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_GrossProfit_d9f7b85c-81c6-465c-9f85-488ae5ce0c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_7673f07e-a38d-4147-8629-8a91201c0993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_7673f07e-a38d-4147-8629-8a91201c0993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_8f80a25d-c959-461d-a05b-c7423302b7ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_7673f07e-a38d-4147-8629-8a91201c0993" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_8f80a25d-c959-461d-a05b-c7423302b7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6ebf9f2b-1390-403d-a280-b6a09fabb5db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_7673f07e-a38d-4147-8629-8a91201c0993" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6ebf9f2b-1390-403d-a280-b6a09fabb5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_9400818c-33e7-41ec-b414-bc89ccde62c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_7673f07e-a38d-4147-8629-8a91201c0993" xlink:to="loc_us-gaap_SellingAndMarketingExpense_9400818c-33e7-41ec-b414-bc89ccde62c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_64105679-dbf7-4ff9-94a2-5868a5698011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_7673f07e-a38d-4147-8629-8a91201c0993" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_64105679-dbf7-4ff9-94a2-5868a5698011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c460b566-647a-45f5-b1d7-ed329598563c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract_7673f07e-a38d-4147-8629-8a91201c0993" xlink:to="loc_us-gaap_OperatingExpenses_c460b566-647a-45f5-b1d7-ed329598563c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7a29545d-4cbd-4891-b99e-53cb525b875c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_OperatingIncomeLoss_7a29545d-4cbd-4891-b99e-53cb525b875c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e683fd84-369b-4d5c-9101-249adf68b84a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e683fd84-369b-4d5c-9101-249adf68b84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4c8f0fde-9e5b-4556-9802-5647d441186f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e683fd84-369b-4d5c-9101-249adf68b84a" xlink:to="loc_us-gaap_InterestExpense_4c8f0fde-9e5b-4556-9802-5647d441186f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_29754995-77b1-4a15-b07d-07f383a903a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e683fd84-369b-4d5c-9101-249adf68b84a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_29754995-77b1-4a15-b07d-07f383a903a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db6377e3-e8f6-42fd-81dc-7367e0e24344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db6377e3-e8f6-42fd-81dc-7367e0e24344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_018e0b7a-ba1b-4375-95b9-780f264692db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_018e0b7a-ba1b-4375-95b9-780f264692db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d63e96b-6847-43fb-b483-995460f034c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_NetIncomeLoss_5d63e96b-6847-43fb-b483-995460f034c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a3ab40f4-c460-4cd8-b4b5-a9b5ac2acdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a3ab40f4-c460-4cd8-b4b5-a9b5ac2acdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6287aaea-ecb9-4fbb-b3bd-6b90077736b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a3ab40f4-c460-4cd8-b4b5-a9b5ac2acdf9" xlink:to="loc_us-gaap_EarningsPerShareBasic_6287aaea-ecb9-4fbb-b3bd-6b90077736b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_374555ed-13af-4ad1-927c-2ecc10eb4cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a3ab40f4-c460-4cd8-b4b5-a9b5ac2acdf9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_374555ed-13af-4ad1-927c-2ecc10eb4cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4adf7f88-ba31-49a2-bbdb-1071a007ebad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4adf7f88-ba31-49a2-bbdb-1071a007ebad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ac0e4bb-fda8-448f-ae6a-e5ea55f3b7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4adf7f88-ba31-49a2-bbdb-1071a007ebad" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ac0e4bb-fda8-448f-ae6a-e5ea55f3b7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba48b524-72e4-4f11-a929-f2cef4cb52c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4adf7f88-ba31-49a2-bbdb-1071a007ebad" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba48b524-72e4-4f11-a929-f2cef4cb52c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_93b6c5d6-d886-4311-b373-b0d9a6371d29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8c345c2-be1d-42d1-8266-4d688ba6e8a8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_93b6c5d6-d886-4311-b373-b0d9a6371d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_78b7dc18-828d-45bf-a1dd-acb72d5257ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_93b6c5d6-d886-4311-b373-b0d9a6371d29" xlink:to="loc_us-gaap_NetIncomeLoss_78b7dc18-828d-45bf-a1dd-acb72d5257ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_9bdec60a-a6c5-4915-b2aa-a7391994b096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_93b6c5d6-d886-4311-b373-b0d9a6371d29" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_9bdec60a-a6c5-4915-b2aa-a7391994b096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_d3f09edd-6560-4ad8-9c4d-d776a9164a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_9bdec60a-a6c5-4915-b2aa-a7391994b096" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_d3f09edd-6560-4ad8-9c4d-d776a9164a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_9a42c36c-0c0f-4f36-891e-70742b55fc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_9bdec60a-a6c5-4915-b2aa-a7391994b096" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_9a42c36c-0c0f-4f36-891e-70742b55fc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_31eb29b7-d05e-42bf-a383-b7caff77fe4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_93b6c5d6-d886-4311-b373-b0d9a6371d29" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_31eb29b7-d05e-42bf-a383-b7caff77fe4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f564f7c4-c60b-4bf8-8220-a9e64d123bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_aa03c12e-14eb-4fd1-a745-316d98c99949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f564f7c4-c60b-4bf8-8220-a9e64d123bf6" xlink:to="loc_us-gaap_StatementTable_aa03c12e-14eb-4fd1-a745-316d98c99949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aa03c12e-14eb-4fd1-a745-316d98c99949" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_36910fa1-ce78-4b02-ae5f-f44b30b0a7ed" xlink:to="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_d6bbaf3b-dd33-4d79-8ba0-cd927a3c72b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_CommonStockMember_d6bbaf3b-dd33-4d79-8ba0-cd927a3c72b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_763a751f-e54a-4439-a403-22965a02b402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_763a751f-e54a-4439-a403-22965a02b402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_84d28f4b-ef1e-44dc-82c0-b68b35e3326e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_RetainedEarningsMember_84d28f4b-ef1e-44dc-82c0-b68b35e3326e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f6a08f47-0677-4281-81d4-e3aa22122367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f6a08f47-0677-4281-81d4-e3aa22122367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_b665350e-71a3-4e00-8c8c-d7d2c76589e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06de3e07-aac2-4ed4-be79-f1cac41bc632" xlink:to="loc_us-gaap_TreasuryStockMember_b665350e-71a3-4e00-8c8c-d7d2c76589e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8731cda8-3b5e-428e-8253-475f79e2d44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aa03c12e-14eb-4fd1-a745-316d98c99949" xlink:to="loc_us-gaap_StatementLineItems_8731cda8-3b5e-428e-8253-475f79e2d44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8731cda8-3b5e-428e-8253-475f79e2d44f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_f3e6da61-4def-4ecf-8cca-3e717bb7558c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_SharesOutstanding_f3e6da61-4def-4ecf-8cca-3e717bb7558c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_59e66746-6c9c-421c-b932-19e78f6b7ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockholdersEquity_59e66746-6c9c-421c-b932-19e78f6b7ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_3d91227c-b62d-4f27-9e8e-0c0778b6922f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_3d91227c-b62d-4f27-9e8e-0c0778b6922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_bfc9965d-e787-4259-aa63-1c641aa09680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_bfc9965d-e787-4259-aa63-1c641aa09680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0bd9ae64-2568-48ed-9c1a-5dad7a5cb28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_0bd9ae64-2568-48ed-9c1a-5dad7a5cb28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_001e7493-cd36-47fd-b0ca-422b17a5ccee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_001e7493-cd36-47fd-b0ca-422b17a5ccee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_a6cd8b6b-e0e6-437b-929f-46e13530d73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_a6cd8b6b-e0e6-437b-929f-46e13530d73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_76888c90-c1ee-4b44-a8f7-0e84bbeeae7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_76888c90-c1ee-4b44-a8f7-0e84bbeeae7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_628c19be-e86c-47db-93d6-0bbbb73093c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_628c19be-e86c-47db-93d6-0bbbb73093c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_463cf091-507a-4643-ba3c-e92c702563f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_463cf091-507a-4643-ba3c-e92c702563f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e1c99f49-41bb-47ff-be28-199034414cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_e1c99f49-41bb-47ff-be28-199034414cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a3f469f3-190a-4950-849e-0a5a259083a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a3f469f3-190a-4950-849e-0a5a259083a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_43b9ac04-f27d-472e-ba25-a0ce5b389727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_NetIncomeLoss_43b9ac04-f27d-472e-ba25-a0ce5b389727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_8fc452f0-858d-4d51-a051-22b553927248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_SharesOutstanding_8fc452f0-858d-4d51-a051-22b553927248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c221c1bb-6197-4e45-911a-474c492c4bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f012b00-f344-4c0d-af81-b6270c487f3b" xlink:to="loc_us-gaap_StockholdersEquity_c221c1bb-6197-4e45-911a-474c492c4bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="infu-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8898b56d-e4c7-4668-a614-e54cb6aeec4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0b08c459-9949-43aa-8187-9f9b137d43f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8898b56d-e4c7-4668-a614-e54cb6aeec4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0b08c459-9949-43aa-8187-9f9b137d43f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8d13fb11-b2e4-42ae-b176-7106fca0c182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0b08c459-9949-43aa-8187-9f9b137d43f6" xlink:to="loc_us-gaap_NetIncomeLoss_8d13fb11-b2e4-42ae-b176-7106fca0c182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0b08c459-9949-43aa-8187-9f9b137d43f6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e06bb200-7a25-49d0-a92e-15c0cc1632f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e06bb200-7a25-49d0-a92e-15c0cc1632f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_bcbf0926-45e1-48a8-ae1f-2502473f8a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:to="loc_us-gaap_Depreciation_bcbf0926-45e1-48a8-ae1f-2502473f8a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_c37f1ae1-01d3-40a0-9111-9b1929f567ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_c37f1ae1-01d3-40a0-9111-9b1929f567ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_92c26bf9-6d66-4c36-b9d7-2f3efdfd3874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_92c26bf9-6d66-4c36-b9d7-2f3efdfd3874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4791dba3-6c1c-4969-a233-f4ea4d2c6279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4791dba3-6c1c-4969-a233-f4ea4d2c6279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_582f378a-e915-49ea-b109-d06deea1bad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_582f378a-e915-49ea-b109-d06deea1bad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_770cdcde-b5f4-42c7-bbb2-55fb998a2669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:to="loc_us-gaap_ShareBasedCompensation_770cdcde-b5f4-42c7-bbb2-55fb998a2669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8cc1b09a-d3a9-409c-a867-50936ad02676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_627587fc-71e2-41af-8206-d303b959661a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8cc1b09a-d3a9-409c-a867-50936ad02676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_18c3c029-235a-4eac-afb6-64d2aa003a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0b08c459-9949-43aa-8187-9f9b137d43f6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_18c3c029-235a-4eac-afb6-64d2aa003a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a35568f7-cf9b-4be3-a6f9-76d89312b93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_18c3c029-235a-4eac-afb6-64d2aa003a6a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a35568f7-cf9b-4be3-a6f9-76d89312b93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f49c75d8-eda8-4811-b56f-48f3d603c288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_18c3c029-235a-4eac-afb6-64d2aa003a6a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f49c75d8-eda8-4811-b56f-48f3d603c288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_9b15feb6-e6ae-4e2b-b634-cc08d89b9d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_18c3c029-235a-4eac-afb6-64d2aa003a6a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_9b15feb6-e6ae-4e2b-b634-cc08d89b9d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a06d2e5c-d3e3-4d47-9523-0ba480413a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_18c3c029-235a-4eac-afb6-64d2aa003a6a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a06d2e5c-d3e3-4d47-9523-0ba480413a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_37fcc416-6531-4d01-ad44-9b8925d4f48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0b08c459-9949-43aa-8187-9f9b137d43f6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_37fcc416-6531-4d01-ad44-9b8925d4f48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_967b21a4-2535-4a0a-b142-043b34487d24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_37fcc416-6531-4d01-ad44-9b8925d4f48c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_967b21a4-2535-4a0a-b142-043b34487d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7e3be81a-122f-4fb7-b8bf-33d4c0ae4868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0b08c459-9949-43aa-8187-9f9b137d43f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7e3be81a-122f-4fb7-b8bf-33d4c0ae4868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c9f97f7-4572-454f-a4b4-1f5ae8386b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8898b56d-e4c7-4668-a614-e54cb6aeec4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c9f97f7-4572-454f-a4b4-1f5ae8386b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_61b670c3-1beb-478e-b9a3-fc3571c98c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c9f97f7-4572-454f-a4b4-1f5ae8386b5f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_61b670c3-1beb-478e-b9a3-fc3571c98c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment_b3ddbe4d-d46d-4726-9294-813dddee4795" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c9f97f7-4572-454f-a4b4-1f5ae8386b5f" xlink:to="loc_infu_PaymentsToAcquireMedicalEquipment_b3ddbe4d-d46d-4726-9294-813dddee4795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6eabd66e-003a-4e63-a4a3-514340244673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c9f97f7-4572-454f-a4b4-1f5ae8386b5f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6eabd66e-003a-4e63-a4a3-514340244673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_90446c58-2264-418f-9b07-7d55a7f0a8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c9f97f7-4572-454f-a4b4-1f5ae8386b5f" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_90446c58-2264-418f-9b07-7d55a7f0a8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_af1c7f0b-5ac1-4205-9c5a-80caa7bb6e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6c9f97f7-4572-454f-a4b4-1f5ae8386b5f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_af1c7f0b-5ac1-4205-9c5a-80caa7bb6e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8898b56d-e4c7-4668-a614-e54cb6aeec4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_4548aef3-6dab-41f6-881b-bc2726524656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_4548aef3-6dab-41f6-881b-bc2726524656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d9c583cb-284a-4f6a-918d-abaace225b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d9c583cb-284a-4f6a-918d-abaace225b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6b6d0863-6513-4803-b316-1918bb991c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6b6d0863-6513-4803-b316-1918bb991c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e7ff102c-b012-4cb3-b43f-daf1b3481050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e7ff102c-b012-4cb3-b43f-daf1b3481050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cac778f6-b622-46c2-969a-fafc2542e0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_cac778f6-b622-46c2-969a-fafc2542e0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_46356b7d-5176-47fd-b483-72712008efba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:to="loc_us-gaap_ProceedsFromStockPlans_46356b7d-5176-47fd-b483-72712008efba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8094129f-db5f-4b1e-83ae-4342fa297794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c3168846-82f3-4c68-a8c6-0775070b9ae3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8094129f-db5f-4b1e-83ae-4342fa297794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ea5eeee5-17b0-407d-91a2-9ce216292e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8898b56d-e4c7-4668-a614-e54cb6aeec4a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ea5eeee5-17b0-407d-91a2-9ce216292e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a639806f-308f-44a4-91fd-c49d9dfb55cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8898b56d-e4c7-4668-a614-e54cb6aeec4a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a639806f-308f-44a4-91fd-c49d9dfb55cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cb65e3ee-5dca-40b7-991f-fd775b501063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8898b56d-e4c7-4668-a614-e54cb6aeec4a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cb65e3ee-5dca-40b7-991f-fd775b501063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="infu-20220331.xsd#BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9a36db4d-43ba-4f83-8ede-ac6db0817902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_4d6b79a8-b598-45bb-bc31-33e5f2d95b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9a36db4d-43ba-4f83-8ede-ac6db0817902" xlink:to="loc_us-gaap_BasisOfAccounting_4d6b79a8-b598-45bb-bc31-33e5f2d95b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RecentAccountingPronouncementsandDevelopments" xlink:type="simple" xlink:href="infu-20220331.xsd#RecentAccountingPronouncementsandDevelopments"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RecentAccountingPronouncementsandDevelopments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1a734739-5af5-4386-b4c7-35e876a34b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_0a7c0e95-b63a-4ee2-a2f9-313d231b879d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1a734739-5af5-4386-b4c7-35e876a34b0c" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_0a7c0e95-b63a-4ee2-a2f9-313d231b879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinations" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2bc8b9d7-0f3b-4815-b8ee-5d143f2d2006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_024b965a-ee33-4d63-bcba-5291f6362a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2bc8b9d7-0f3b-4815-b8ee-5d143f2d2006" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_024b965a-ee33-4d63-bcba-5291f6362a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_82177ace-ad2b-467f-ac95-57714e649c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_78c93a84-b2cf-48e5-bdab-e3211b453b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_82177ace-ad2b-467f-ac95-57714e649c7d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_78c93a84-b2cf-48e5-bdab-e3211b453b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_c95fd648-ed0e-4a40-b989-6b3eba4d45a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_82177ace-ad2b-467f-ac95-57714e649c7d" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_c95fd648-ed0e-4a40-b989-6b3eba4d45a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_85febce9-b0a6-4c48-ab92-3d7e992a4f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_82177ace-ad2b-467f-ac95-57714e649c7d" xlink:to="loc_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock_85febce9-b0a6-4c48-ab92-3d7e992a4f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_8defd7a0-56c2-4a6f-a1a7-bd15d7cca133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_82177ace-ad2b-467f-ac95-57714e649c7d" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_8defd7a0-56c2-4a6f-a1a7-bd15d7cca133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_49984536-89c1-4f96-96c8-661615c199fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_49984536-89c1-4f96-96c8-661615c199fe" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_53f3db85-6fb0-4eca-a059-41acf4ca94f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_53f3db85-6fb0-4eca-a059-41acf4ca94f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_97dfc8e6-61b0-4989-ae16-74abc085e3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_53f3db85-6fb0-4eca-a059-41acf4ca94f5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_97dfc8e6-61b0-4989-ae16-74abc085e3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_56add3a0-02eb-41b9-ac55-d18ee47e48dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_97dfc8e6-61b0-4989-ae16-74abc085e3f5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_56add3a0-02eb-41b9-ac55-d18ee47e48dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_70de6392-662a-421b-97b7-fa35cec04ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_70de6392-662a-421b-97b7-fa35cec04ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9387e8d3-ddae-4bf7-b3b0-5ee83f804266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_70de6392-662a-421b-97b7-fa35cec04ee1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9387e8d3-ddae-4bf7-b3b0-5ee83f804266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_6a12127b-1782-4fa5-bc3c-38822a0c3bee" xlink:href="infu-20220331.xsd#infu_FilAMedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9387e8d3-ddae-4bf7-b3b0-5ee83f804266" xlink:to="loc_infu_FilAMedMember_6a12127b-1782-4fa5-bc3c-38822a0c3bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_aa8a3c13-1870-453e-bb1f-061903b68d87" xlink:href="infu-20220331.xsd#infu_OBHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9387e8d3-ddae-4bf7-b3b0-5ee83f804266" xlink:to="loc_infu_OBHealthcareMember_aa8a3c13-1870-453e-bb1f-061903b68d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_217296f6-c142-4b6a-a627-5c8d35b5eadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_217296f6-c142-4b6a-a627-5c8d35b5eadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_240bb093-5ace-4f86-bebf-86ab4c4135b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_217296f6-c142-4b6a-a627-5c8d35b5eadd" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_240bb093-5ace-4f86-bebf-86ab4c4135b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_78fc0e87-880d-49ac-a4f5-090407d0a49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_240bb093-5ace-4f86-bebf-86ab4c4135b2" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_78fc0e87-880d-49ac-a4f5-090407d0a49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f238dc1d-6ffd-4d05-8fee-dd59c8e3065b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a76c43db-005b-491b-8dac-a18b72b92eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a76c43db-005b-491b-8dac-a18b72b92eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e30fb7c1-e163-4e4a-b49c-c7416ce6d8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e30fb7c1-e163-4e4a-b49c-c7416ce6d8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c1f4419f-c91d-4f2f-8837-410d61f47341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c1f4419f-c91d-4f2f-8837-410d61f47341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability_84ad8685-0630-4f1b-97ed-acaf9344529b" xlink:href="infu-20220331.xsd#infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability_84ad8685-0630-4f1b-97ed-acaf9344529b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_6d40e3ab-6656-42bd-b9f5-83e17493b8cd" xlink:href="infu-20220331.xsd#infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_49837a3f-3284-48df-8166-19dd6cc48048" xlink:to="loc_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense_6d40e3ab-6656-42bd-b9f5-83e17493b8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_bd58d581-2375-4a40-8865-ce2e5f5ad5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2882ab0e-cb5d-474a-a939-73e9100a8a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_bd58d581-2375-4a40-8865-ce2e5f5ad5a7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2882ab0e-cb5d-474a-a939-73e9100a8a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e433a935-bf6c-4006-a9c1-427b9bab4845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2882ab0e-cb5d-474a-a939-73e9100a8a7c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e433a935-bf6c-4006-a9c1-427b9bab4845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886fa1a9-826c-4505-ba5c-b28ec3f6d3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e433a935-bf6c-4006-a9c1-427b9bab4845" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886fa1a9-826c-4505-ba5c-b28ec3f6d3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_2eca2471-5233-464b-9dac-d7ba82f387d3" xlink:href="infu-20220331.xsd#infu_FilAMedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886fa1a9-826c-4505-ba5c-b28ec3f6d3d5" xlink:to="loc_infu_FilAMedMember_2eca2471-5233-464b-9dac-d7ba82f387d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_0a06e3d6-46ae-4486-8045-798dd2293340" xlink:href="infu-20220331.xsd#infu_OBHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_886fa1a9-826c-4505-ba5c-b28ec3f6d3d5" xlink:to="loc_infu_OBHealthcareMember_0a06e3d6-46ae-4486-8045-798dd2293340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2882ab0e-cb5d-474a-a939-73e9100a8a7c" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_309caba2-dcdd-475d-89b0-8f7051a1fe3b" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments_309caba2-dcdd-475d-89b0-8f7051a1fe3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_WorkingCapital_eb98f2cf-c9b0-4304-a683-b3cd0d9b60f7" xlink:href="infu-20220331.xsd#infu_WorkingCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_infu_WorkingCapital_eb98f2cf-c9b0-4304-a683-b3cd0d9b60f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_ec4065b5-ff46-4258-ae80-c1be7dccd8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_ec4065b5-ff46-4258-ae80-c1be7dccd8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e2b7cb6c-fcc6-4d15-b843-50e37f43cb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5a99c4cc-b86f-4481-a909-292e7df30a55" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e2b7cb6c-fcc6-4d15-b843-50e37f43cb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_016fef05-4e09-42ed-9531-bb22351ba02f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_3f57f133-ed3a-4293-bb7c-069a57552b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_016fef05-4e09-42ed-9531-bb22351ba02f" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_3f57f133-ed3a-4293-bb7c-069a57552b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_08a8f112-7522-46fb-b060-be225c78a14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_3f57f133-ed3a-4293-bb7c-069a57552b88" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_08a8f112-7522-46fb-b060-be225c78a14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71fa9fbf-914b-4ec3-8f3d-e81cca5123d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_08a8f112-7522-46fb-b060-be225c78a14a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71fa9fbf-914b-4ec3-8f3d-e81cca5123d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FilAMedMember_58a56667-c5ba-4ea0-9192-ede1873a01ba" xlink:href="infu-20220331.xsd#infu_FilAMedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71fa9fbf-914b-4ec3-8f3d-e81cca5123d1" xlink:to="loc_infu_FilAMedMember_58a56667-c5ba-4ea0-9192-ede1873a01ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_OBHealthcareMember_7edc9eb7-1c0c-4155-a1e0-ad08d3fc4327" xlink:href="infu-20220331.xsd#infu_OBHealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71fa9fbf-914b-4ec3-8f3d-e81cca5123d1" xlink:to="loc_infu_OBHealthcareMember_7edc9eb7-1c0c-4155-a1e0-ad08d3fc4327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_3f57f133-ed3a-4293-bb7c-069a57552b88" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e9714d1-883e-4220-bc12-65543f31c33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5e9714d1-883e-4220-bc12-65543f31c33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7c8d06ab-c3cd-4f35-80e0-ef722185439c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7c8d06ab-c3cd-4f35-80e0-ef722185439c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_c4fca742-e08d-43eb-933d-988380878a5c" xlink:href="infu-20220331.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental_c4fca742-e08d-43eb-933d-988380878a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_696b56bf-3d1a-4cd8-8e60-723bd13bdd10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_696b56bf-3d1a-4cd8-8e60-723bd13bdd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c74641e6-c4a9-4241-8db4-86d796cb3c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c74641e6-c4a9-4241-8db4-86d796cb3c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b20016a0-282b-448a-be2d-fb03f3ee3487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_Goodwill_b20016a0-282b-448a-be2d-fb03f3ee3487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_a71d8b29-6715-486a-8fda-fd810f14d2df" xlink:href="infu-20220331.xsd#infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset_a71d8b29-6715-486a-8fda-fd810f14d2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_01862ea2-9c8e-4322-9a7b-d33fee4df199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_01862ea2-9c8e-4322-9a7b-d33fee4df199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e20a444c-ef14-41fa-b576-6a7cf1221208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_680eeeb4-0b93-4748-8460-4e699e5b2740" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e20a444c-ef14-41fa-b576-6a7cf1221208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsIntangibleAssetsAcquiredDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8612215b-077a-4fc2-b978-990dc959c0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSegmentAllocationTable_54f9bb65-c576-4a07-babf-813a5b192afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSegmentAllocationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8612215b-077a-4fc2-b978-990dc959c0ae" xlink:to="loc_us-gaap_BusinessCombinationSegmentAllocationTable_54f9bb65-c576-4a07-babf-813a5b192afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f07fad2-ad45-4da1-898c-6b5419ad70a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_54f9bb65-c576-4a07-babf-813a5b192afa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f07fad2-ad45-4da1-898c-6b5419ad70a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6f07fad2-ad45-4da1-898c-6b5419ad70a6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9b052458-c264-4276-9806-0a60ed6c3861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9b052458-c264-4276-9806-0a60ed6c3861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a63bebf4-deaf-4f03-a988-26b27376aa59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_a63bebf4-deaf-4f03-a988-26b27376aa59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_814d03df-4feb-472e-9d2f-3e6cc37f6627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_814d03df-4feb-472e-9d2f-3e6cc37f6627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f20578c2-edfb-4250-9b08-3d0b348ff0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0c8b2f64-25b9-4833-9209-7962a896b1b0" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f20578c2-edfb-4250-9b08-3d0b348ff0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e9c0ed24-518a-4743-a845-0545df8b9338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSegmentAllocationTable_54f9bb65-c576-4a07-babf-813a5b192afa" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e9c0ed24-518a-4743-a845-0545df8b9338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_274b5253-6e84-429e-a5d2-26581cd9eed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e9c0ed24-518a-4743-a845-0545df8b9338" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_274b5253-6e84-429e-a5d2-26581cd9eed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f6c51856-db52-4d77-844b-5702fcca2038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e9c0ed24-518a-4743-a845-0545df8b9338" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f6c51856-db52-4d77-844b-5702fcca2038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessCombinationsProFormaInformationDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e74384b4-64d3-4ff9-b844-f3c5d7197c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_506e5e29-5575-4cde-8d49-85ce2739fde1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e74384b4-64d3-4ff9-b844-f3c5d7197c40" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_506e5e29-5575-4cde-8d49-85ce2739fde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7a702f51-7321-4b17-a0aa-2a7cd3949296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e74384b4-64d3-4ff9-b844-f3c5d7197c40" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7a702f51-7321-4b17-a0aa-2a7cd3949296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognition" xlink:type="simple" xlink:href="infu-20220331.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_7308f707-a3c4-4924-803d-54d1ab32c3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4a0f849c-395b-47a6-93a2-fafc78b9b849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_7308f707-a3c4-4924-803d-54d1ab32c3c2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_4a0f849c-395b-47a6-93a2-fafc78b9b849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="infu-20220331.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_7a198573-b770-4a8f-856d-10747c79f031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_212b9ce4-bd09-45b0-ac4c-a7afecedddeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_7a198573-b770-4a8f-856d-10747c79f031" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_212b9ce4-bd09-45b0-ac4c-a7afecedddeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#RevenueRecognitionDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RevenueRecognitionDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_c2efd8be-7504-462d-9c1d-a5268d8002b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_c2efd8be-7504-462d-9c1d-a5268d8002b2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_dc095709-43c7-4f2b-8352-d09431246a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_dc095709-43c7-4f2b-8352-d09431246a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_089514ae-1f0f-4832-a3ed-8bc657a4096d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_dc095709-43c7-4f2b-8352-d09431246a5f" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_089514ae-1f0f-4832-a3ed-8bc657a4096d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember_88eb33b2-d61c-4234-b478-c1a1251779b6" xlink:href="infu-20220331.xsd#infu_DirectPayerRentalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_089514ae-1f0f-4832-a3ed-8bc657a4096d" xlink:to="loc_infu_DirectPayerRentalsMember_88eb33b2-d61c-4234-b478-c1a1251779b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d9dd82db-f48d-4703-8f24-ad39aadafc46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d9dd82db-f48d-4703-8f24-ad39aadafc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d9888f5c-52cb-422d-9644-4dd77acc6ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9dd82db-f48d-4703-8f24-ad39aadafc46" xlink:to="loc_us-gaap_SegmentDomain_d9888f5c-52cb-422d-9644-4dd77acc6ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_7ab5a1c5-e48e-4be0-8682-705267abdad6" xlink:href="infu-20220331.xsd#infu_ITSSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d9888f5c-52cb-422d-9644-4dd77acc6ffc" xlink:to="loc_infu_ITSSegmentMember_7ab5a1c5-e48e-4be0-8682-705267abdad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_339b67ca-4957-41c0-a9a2-23bdb0a39ad7" xlink:href="infu-20220331.xsd#infu_DMEServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d9888f5c-52cb-422d-9644-4dd77acc6ffc" xlink:to="loc_infu_DMEServicesSegmentMember_339b67ca-4957-41c0-a9a2-23bdb0a39ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ca5b13b9-7fe1-42f2-ba0a-8250464adc62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:to="loc_srt_ProductOrServiceAxis_ca5b13b9-7fe1-42f2-ba0a-8250464adc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_662474fa-6fdd-4e8f-9073-b6c1053cc95f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ca5b13b9-7fe1-42f2-ba0a-8250464adc62" xlink:to="loc_srt_ProductsAndServicesDomain_662474fa-6fdd-4e8f-9073-b6c1053cc95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_0f1a18e1-9e29-4bac-9657-4947e6d7cfa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_662474fa-6fdd-4e8f-9073-b6c1053cc95f" xlink:to="loc_us-gaap_ProductMember_0f1a18e1-9e29-4bac-9657-4947e6d7cfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f1182388-6979-4ba9-b16c-6eecb814eb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4c64162a-16d9-4125-af48-b44ba30fefc5" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f1182388-6979-4ba9-b16c-6eecb814eb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a8f81ae6-e481-49e4-9fc6-2a4291bce177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f1182388-6979-4ba9-b16c-6eecb814eb1a" xlink:to="loc_us-gaap_Revenues_a8f81ae6-e481-49e4-9fc6-2a4291bce177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_2ec664bc-3b90-40c5-b83d-b9da12b442ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_2ec664bc-3b90-40c5-b83d-b9da12b442ed" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9680f454-3d28-4643-9d52-7abac8abf15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9680f454-3d28-4643-9d52-7abac8abf15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8ae8cde7-601b-495c-8f73-bc9d8ab77687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9680f454-3d28-4643-9d52-7abac8abf15a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8ae8cde7-601b-495c-8f73-bc9d8ab77687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_5204fb86-0e52-443a-92a1-a8a777f4c7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8ae8cde7-601b-495c-8f73-bc9d8ab77687" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_5204fb86-0e52-443a-92a1-a8a777f4c7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_96f939f4-2d78-4636-8c68-c6d384767d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_96f939f4-2d78-4636-8c68-c6d384767d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_77eda8f4-98ef-494d-8e7a-0ea1acb5aa47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_96f939f4-2d78-4636-8c68-c6d384767d60" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_77eda8f4-98ef-494d-8e7a-0ea1acb5aa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4f93398e-9c96-456b-8ae2-6fd792d8d072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_77eda8f4-98ef-494d-8e7a-0ea1acb5aa47" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4f93398e-9c96-456b-8ae2-6fd792d8d072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_b8a9075c-7107-4687-8adf-b9e80aeacf00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_b8a9075c-7107-4687-8adf-b9e80aeacf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_b8a9075c-7107-4687-8adf-b9e80aeacf00" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ThirdPartyPayerRentalRevenueMember_5f6faf36-aa85-4ad2-9036-becd1ca8ae40" xlink:href="infu-20220331.xsd#infu_ThirdPartyPayerRentalRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:to="loc_infu_ThirdPartyPayerRentalRevenueMember_5f6faf36-aa85-4ad2-9036-becd1ca8ae40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DirectPayerRentalsMember_52084d0b-d8f5-40ef-b4c9-57b42989aa0e" xlink:href="infu-20220331.xsd#infu_DirectPayerRentalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:to="loc_infu_DirectPayerRentalsMember_52084d0b-d8f5-40ef-b4c9-57b42989aa0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ProductSalesMember_b661c628-85ea-4669-ad24-1425daa9a47f" xlink:href="infu-20220331.xsd#infu_ProductSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:to="loc_infu_ProductSalesMember_b661c628-85ea-4669-ad24-1425daa9a47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_01cea83a-12c9-41a5-bdf4-dd68afb443e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_8ea0d38c-a774-4d59-8405-2018cf486bdb" xlink:to="loc_us-gaap_ServiceMember_01cea83a-12c9-41a5-bdf4-dd68afb443e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_709b1145-db38-4c1c-8f4e-62b054a95608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5bb5f740-49cc-4f9e-a83f-73266584a1d7" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_709b1145-db38-4c1c-8f4e-62b054a95608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_bfb72e21-5230-4871-b0be-0707bbc63570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_709b1145-db38-4c1c-8f4e-62b054a95608" xlink:to="loc_us-gaap_Revenues_bfb72e21-5230-4871-b0be-0707bbc63570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_74755721-66b6-4399-8bc0-b53bd20fa108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_709b1145-db38-4c1c-8f4e-62b054a95608" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_74755721-66b6-4399-8bc0-b53bd20fa108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipment" xlink:type="simple" xlink:href="infu-20220331.xsd#MedicalEquipment"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/MedicalEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract_322a713a-91bb-45a6-a1dc-8e8a98e0b326" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_d4087e76-91ac-40c3-b990-aee035874002" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentAndPropertyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_322a713a-91bb-45a6-a1dc-8e8a98e0b326" xlink:to="loc_infu_MedicalEquipmentAndPropertyDisclosureTextBlock_d4087e76-91ac-40c3-b990-aee035874002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipmentTables" xlink:type="simple" xlink:href="infu-20220331.xsd#MedicalEquipmentTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/MedicalEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract_3ada811a-c28a-49d4-a009-712ad9f5e854" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ScheduleOfMedicalEquipmentTableTextBlock_9644bd8f-6312-4b7b-a2be-c6034a92f8ea" xlink:href="infu-20220331.xsd#infu_ScheduleOfMedicalEquipmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_3ada811a-c28a-49d4-a009-712ad9f5e854" xlink:to="loc_infu_ScheduleOfMedicalEquipmentTableTextBlock_9644bd8f-6312-4b7b-a2be-c6034a92f8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipmentDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#MedicalEquipmentDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/MedicalEquipmentDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract_6cc60e2e-a51a-40ea-8f36-4ac64901236a" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DepreciationExpenseRelatedToMedicalEquipment_9b3129dc-b6ed-4648-926f-b035f90b84e1" xlink:href="infu-20220331.xsd#infu_DepreciationExpenseRelatedToMedicalEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_6cc60e2e-a51a-40ea-8f36-4ac64901236a" xlink:to="loc_infu_DepreciationExpenseRelatedToMedicalEquipment_9b3129dc-b6ed-4648-926f-b035f90b84e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#MedicalEquipmentSummaryofMedicalEquipmentDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross_e6a2b74b-28b3-4803-b5f1-c02753c1122a" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRentalGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRentalGross_e6a2b74b-28b3-4803-b5f1-c02753c1122a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentForSaleOrRentalReserve_cbba91f6-2a5a-4fef-af01-d030a87baa2a" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentForSaleOrRentalReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:to="loc_infu_MedicalEquipmentForSaleOrRentalReserve_cbba91f6-2a5a-4fef-af01-d030a87baa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentHeldForSaleOrRental_1740766c-de57-49d6-bcf4-b9692248a33c" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentHeldForSaleOrRental"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:to="loc_infu_MedicalEquipmentHeldForSaleOrRental_1740766c-de57-49d6-bcf4-b9692248a33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesGross_b46814c5-836f-4d0d-a929-b5a16d396d2f" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:to="loc_infu_MedicalEquipmentInRentalServicesGross_b46814c5-836f-4d0d-a929-b5a16d396d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesReserve_4b57d9fe-2f8e-43ef-8c4f-7d4993dc6300" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:to="loc_infu_MedicalEquipmentInRentalServicesReserve_4b57d9fe-2f8e-43ef-8c4f-7d4993dc6300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_04dc416a-1751-479f-88f1-c9a4a179c5c9" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:to="loc_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation_04dc416a-1751-479f-88f1-c9a4a179c5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_83d835c5-62f5-4aaa-9153-986ba0315e34" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:to="loc_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation_83d835c5-62f5-4aaa-9153-986ba0315e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentNet_4f9342fb-3b60-4564-9b29-e77a5ca68bf2" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_MedicalEquipmentAbstract_1bdd2b53-e4f0-4341-ac1c-1c8ce14db59a" xlink:to="loc_infu_MedicalEquipmentNet_4f9342fb-3b60-4564-9b29-e77a5ca68bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="infu-20220331.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_28fb0bbf-4d95-44cd-b6fe-c8a9ea8f89cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ace44ff3-55ee-4d1c-9a7e-4d4958b4239c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_28fb0bbf-4d95-44cd-b6fe-c8a9ea8f89cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ace44ff3-55ee-4d1c-9a7e-4d4958b4239c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="infu-20220331.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a7ba64e9-07be-4333-960c-57aac892b97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8ed7e72f-28ca-4ecf-9748-824561e95a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a7ba64e9-07be-4333-960c-57aac892b97f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_8ed7e72f-28ca-4ecf-9748-824561e95a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#PropertyandEquipmentDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/PropertyandEquipmentDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_56306c97-6fea-4f8e-aa84-a010895bbc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction_ed74f57d-295e-42c9-9475-9228bcf9b9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationNonproduction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_56306c97-6fea-4f8e-aa84-a010895bbc0d" xlink:to="loc_us-gaap_DepreciationNonproduction_ed74f57d-295e-42c9-9475-9228bcf9b9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1f9007a7-4456-442d-bc96-a2f71265a3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6fd6023a-c17f-42cb-bbbd-6b3c4d72d506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1f9007a7-4456-442d-bc96-a2f71265a3a9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6fd6023a-c17f-42cb-bbbd-6b3c4d72d506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6fd6023a-c17f-42cb-bbbd-6b3c4d72d506" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0ded9038-9fe9-4d1e-8f9a-7e0b19971e26" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_9fbb8ea5-f825-4588-95fb-4d70337c62c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_9fbb8ea5-f825-4588-95fb-4d70337c62c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AutomobilesMember_91148bb0-8beb-4318-bab2-022cb01533f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AutomobilesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:to="loc_us-gaap_AutomobilesMember_91148bb0-8beb-4318-bab2-022cb01533f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_cb9a031e-9c67-44f6-b989-c68adde16cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fa3603a8-d501-4cb5-a96f-46eaa8b6a881" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_cb9a031e-9c67-44f6-b989-c68adde16cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6fd6023a-c17f-42cb-bbbd-6b3c4d72d506" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c43ae8ae-f958-4bb3-9ad8-0ee93b0a93d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c43ae8ae-f958-4bb3-9ad8-0ee93b0a93d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a91b0d2-e58e-412a-a318-0488f1976c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a91b0d2-e58e-412a-a318-0488f1976c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4e3be989-ba0f-40ca-9a2d-198f76471d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6f6f8ff8-5f4e-4c44-a35c-0f74a6920bb8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4e3be989-ba0f-40ca-9a2d-198f76471d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssets" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssets"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3459c8a0-2890-4393-a68b-21c2c6250c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6e0a73c8-239c-4406-9c5a-5ea1456445ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3459c8a0-2890-4393-a68b-21c2c6250c29" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6e0a73c8-239c-4406-9c5a-5ea1456445ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsTables" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8260dbb0-e667-470a-a645-8c182dc58abb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_fac940dd-8a0a-48c3-96f7-d8b9cdd28aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8260dbb0-e667-470a-a645-8c182dc58abb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_fac940dd-8a0a-48c3-96f7-d8b9cdd28aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_09d931a6-6622-486b-9845-1ae94e05dd94" xlink:href="infu-20220331.xsd#infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8260dbb0-e667-470a-a645-8c182dc58abb" xlink:to="loc_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock_09d931a6-6622-486b-9845-1ae94e05dd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_26e58a0c-52d2-47e5-a9a6-05a67445d00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8260dbb0-e667-470a-a645-8c182dc58abb" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_26e58a0c-52d2-47e5-a9a6-05a67445d00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0ab46292-481c-4aa9-88c3-91a8aa06ba81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_895c458c-77ce-485e-a7b5-14db283634b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0ab46292-481c-4aa9-88c3-91a8aa06ba81" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_895c458c-77ce-485e-a7b5-14db283634b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19da719e-b9ed-4006-bc79-7c96b3983333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e7feb799-4dc4-44d7-a461-61ed05974827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_19da719e-b9ed-4006-bc79-7c96b3983333" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e7feb799-4dc4-44d7-a461-61ed05974827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d83c35ea-f469-4d86-ae04-32d74a2a0a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e7feb799-4dc4-44d7-a461-61ed05974827" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d83c35ea-f469-4d86-ae04-32d74a2a0a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_728ca6c5-53c7-4b5e-86d9-0c4e5caf6ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d83c35ea-f469-4d86-ae04-32d74a2a0a2c" xlink:to="loc_us-gaap_SegmentDomain_728ca6c5-53c7-4b5e-86d9-0c4e5caf6ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_b25d8c8c-8e3f-46ac-8818-e284a9b3445c" xlink:href="infu-20220331.xsd#infu_DMEServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_728ca6c5-53c7-4b5e-86d9-0c4e5caf6ca8" xlink:to="loc_infu_DMEServicesSegmentMember_b25d8c8c-8e3f-46ac-8818-e284a9b3445c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_e62c62f1-3c84-462c-8f9f-0e5104fea36e" xlink:href="infu-20220331.xsd#infu_ITSSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_728ca6c5-53c7-4b5e-86d9-0c4e5caf6ca8" xlink:to="loc_infu_ITSSegmentMember_e62c62f1-3c84-462c-8f9f-0e5104fea36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_f396cb98-5021-4c67-b54e-c6e2a10744d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e7feb799-4dc4-44d7-a461-61ed05974827" xlink:to="loc_us-gaap_GoodwillLineItems_f396cb98-5021-4c67-b54e-c6e2a10744d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_f396cb98-5021-4c67-b54e-c6e2a10744d2" xlink:to="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9ec42fae-924a-412a-9098-341c62ea748d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:to="loc_us-gaap_Goodwill_9ec42fae-924a-412a-9098-341c62ea748d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_e867df22-3581-4a02-a009-f1528560cfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_e867df22-3581-4a02-a009-f1528560cfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ebf695f2-7b63-4945-ad8c-298a934acdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d43f7e93-00f2-475f-8ac6-0715759b5bdc" xlink:to="loc_us-gaap_Goodwill_ebf695f2-7b63-4945-ad8c-298a934acdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_357593d0-105e-4a3c-bc2a-c4d724544c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d60ff58e-0aa8-4ef8-94f4-1ff39ad4a77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_357593d0-105e-4a3c-bc2a-c4d724544c31" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d60ff58e-0aa8-4ef8-94f4-1ff39ad4a77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d9b18b5-fdde-429a-b3d6-2d41881975ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d60ff58e-0aa8-4ef8-94f4-1ff39ad4a77f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d9b18b5-fdde-429a-b3d6-2d41881975ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d9b18b5-fdde-429a-b3d6-2d41881975ab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c14dcc82-0b59-40e1-a951-aa567ba29f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_us-gaap_TradeNamesMember_c14dcc82-0b59-40e1-a951-aa567ba29f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PhysicianAndCustomerRelationshipsMember_412b5f24-32a5-4c8e-9cea-7e034aa4c8ba" xlink:href="infu-20220331.xsd#infu_PhysicianAndCustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_infu_PhysicianAndCustomerRelationshipsMember_412b5f24-32a5-4c8e-9cea-7e034aa4c8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_9c17c6fe-d529-4481-86db-53b7a785bcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_9c17c6fe-d529-4481-86db-53b7a785bcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_66750c7a-3923-482c-892b-255f950db169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_66750c7a-3923-482c-892b-255f950db169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_c2bc537e-36b1-447d-bc0a-085db151179f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd121e94-483d-4ffb-a4e6-969e299621fe" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_c2bc537e-36b1-447d-bc0a-085db151179f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d60ff58e-0aa8-4ef8-94f4-1ff39ad4a77f" xlink:to="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_38358d2e-1b69-4668-b27f-cb56e2213862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_38358d2e-1b69-4668-b27f-cb56e2213862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_145c5937-2e59-4874-8248-2aacad877426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_145c5937-2e59-4874-8248-2aacad877426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1662c4f6-2132-4ae2-953c-af25ca1adba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1662c4f6-2132-4ae2-953c-af25ca1adba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3e7b034f-f9e9-4bad-9640-f5cf5bfdccf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3e7b034f-f9e9-4bad-9640-f5cf5bfdccf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c68e6a7e-839d-4e66-8571-747cc3df5521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c68e6a7e-839d-4e66-8571-747cc3df5521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f7127711-5873-4410-9f63-1258ecf8e716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_747be463-1066-4414-a34d-14efc5b4e27b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f7127711-5873-4410-9f63-1258ecf8e716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9bbdd0b-f122-480c-ae14-5cc812d07321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_f83a6458-dbf9-49c6-b7d0-af8d485a0a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9bbdd0b-f122-480c-ae14-5cc812d07321" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_f83a6458-dbf9-49c6-b7d0-af8d485a0a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b500a39b-8629-4ebc-a88e-66fe104b13f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9bbdd0b-f122-480c-ae14-5cc812d07321" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b500a39b-8629-4ebc-a88e-66fe104b13f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7377b1f6-64b2-48c4-9e98-af16f8339100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9bbdd0b-f122-480c-ae14-5cc812d07321" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7377b1f6-64b2-48c4-9e98-af16f8339100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_64f49f2b-14d9-4a86-96ef-1153b4db162c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9bbdd0b-f122-480c-ae14-5cc812d07321" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_64f49f2b-14d9-4a86-96ef-1153b4db162c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_12a20d4e-e703-4a90-b112-14cd9b71a2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9bbdd0b-f122-480c-ae14-5cc812d07321" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_12a20d4e-e703-4a90-b112-14cd9b71a2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter_9380fc02-3d14-4475-9fae-48bc8e5f11b3" xlink:href="infu-20220331.xsd#infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9bbdd0b-f122-480c-ae14-5cc812d07321" xlink:to="loc_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter_9380fc02-3d14-4475-9fae-48bc8e5f11b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f822c55-3c2f-4390-9295-1b0ccf85f823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9bbdd0b-f122-480c-ae14-5cc812d07321" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7f822c55-3c2f-4390-9295-1b0ccf85f823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/Debt" xlink:type="simple" xlink:href="infu-20220331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_32996dd5-799d-4874-8858-77c707c82f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1617d35c-da42-4aa0-9d4d-d8456b29262f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_32996dd5-799d-4874-8858-77c707c82f4f" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1617d35c-da42-4aa0-9d4d-d8456b29262f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtTables" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1d24903b-1d68-4b27-bb39-38ad87ef98df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_77613b39-f53c-4517-a18a-c8bbe3e8214d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1d24903b-1d68-4b27-bb39-38ad87ef98df" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_77613b39-f53c-4517-a18a-c8bbe3e8214d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d65439df-7f72-4c8b-b853-be9e31461725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1d24903b-1d68-4b27-bb39-38ad87ef98df" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d65439df-7f72-4c8b-b853-be9e31461725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_3d8160ce-2f20-4272-9021-8d42853c4044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1d24903b-1d68-4b27-bb39-38ad87ef98df" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_3d8160ce-2f20-4272-9021-8d42853c4044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cd38b302-344c-4337-9e32-a06c36f91a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cd38b302-344c-4337-9e32-a06c36f91a8a" xlink:to="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_79fa7716-9923-4eee-bae4-9e8a48d75b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_DebtInstrumentAxis_79fa7716-9923-4eee-bae4-9e8a48d75b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_79fa7716-9923-4eee-bae4-9e8a48d75b37" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2021CreditAgreementMember_affb564a-4f4a-408f-8215-7cec62c54511" xlink:href="infu-20220331.xsd#infu_The2021CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:to="loc_infu_The2021CreditAgreementMember_affb564a-4f4a-408f-8215-7cec62c54511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_The2015CreditAgreementMember_4d2b64cb-dfc3-4555-912f-0309697b802e" xlink:href="infu-20220331.xsd#infu_The2015CreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:to="loc_infu_The2015CreditAgreementMember_4d2b64cb-dfc3-4555-912f-0309697b802e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_c4bbc828-090a-4f39-a496-8f9aaa027c94" xlink:href="infu-20220331.xsd#infu_FinancingAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b463b7c8-bb48-4df8-9c66-62f89704ad84" xlink:to="loc_infu_FinancingAgreementMember_c4bbc828-090a-4f39-a496-8f9aaa027c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f0dd5179-38a8-4d66-9ed0-2add437aeca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_CreditFacilityAxis_f0dd5179-38a8-4d66-9ed0-2add437aeca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d4d39280-0b8b-4fa0-a32d-dc2df41fb288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f0dd5179-38a8-4d66-9ed0-2add437aeca4" xlink:to="loc_us-gaap_CreditFacilityDomain_d4d39280-0b8b-4fa0-a32d-dc2df41fb288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f75849fe-aaab-4fe2-9775-deb4edc32f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d4d39280-0b8b-4fa0-a32d-dc2df41fb288" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f75849fe-aaab-4fe2-9775-deb4edc32f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b254a681-7663-4f71-b718-a69e7b27f971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d4d39280-0b8b-4fa0-a32d-dc2df41fb288" xlink:to="loc_us-gaap_LetterOfCreditMember_b254a681-7663-4f71-b718-a69e7b27f971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_84ca59c7-4b6e-438a-aa54-36f5496bf9d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_srt_RangeAxis_84ca59c7-4b6e-438a-aa54-36f5496bf9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2c95d33a-8174-4641-a8fc-31863d2f45c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_84ca59c7-4b6e-438a-aa54-36f5496bf9d8" xlink:to="loc_srt_RangeMember_2c95d33a-8174-4641-a8fc-31863d2f45c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_56258229-5e61-426a-ba2f-4dc22d629480" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c95d33a-8174-4641-a8fc-31863d2f45c8" xlink:to="loc_srt_MinimumMember_56258229-5e61-426a-ba2f-4dc22d629480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_616a4d9b-6864-4c05-976c-015e94f9bbcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2c95d33a-8174-4641-a8fc-31863d2f45c8" xlink:to="loc_srt_MaximumMember_616a4d9b-6864-4c05-976c-015e94f9bbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_65dab5c7-d46a-449e-a075-09b8c560b292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_VariableRateAxis_65dab5c7-d46a-449e-a075-09b8c560b292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0bf44688-ec97-42d4-9f93-6de87468dd47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_65dab5c7-d46a-449e-a075-09b8c560b292" xlink:to="loc_us-gaap_VariableRateDomain_0bf44688-ec97-42d4-9f93-6de87468dd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_67690654-5554-427b-9cdd-eb8cb14ff3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_0bf44688-ec97-42d4-9f93-6de87468dd47" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_67690654-5554-427b-9cdd-eb8cb14ff3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4ccb9f3d-fb73-4c5a-b31f-07f77ff217f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_0bf44688-ec97-42d4-9f93-6de87468dd47" xlink:to="loc_us-gaap_BaseRateMember_4ccb9f3d-fb73-4c5a-b31f-07f77ff217f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9e61cff3-9682-48a9-9bb6-bbd0baed6b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8d0b6b8-e4c6-4529-9b69-1f64bf6a888d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9e61cff3-9682-48a9-9bb6-bbd0baed6b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EurodollarLoanMember_2bf4b3bc-3e2d-4da1-85ce-b84bfa612849" xlink:href="infu-20220331.xsd#infu_EurodollarLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e61cff3-9682-48a9-9bb6-bbd0baed6b32" xlink:to="loc_infu_EurodollarLoanMember_2bf4b3bc-3e2d-4da1-85ce-b84bfa612849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ABRLoansMember_f37ffcca-5eb8-4b9d-83f0-288164b358ed" xlink:href="infu-20220331.xsd#infu_ABRLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9e61cff3-9682-48a9-9bb6-bbd0baed6b32" xlink:to="loc_infu_ABRLoansMember_f37ffcca-5eb8-4b9d-83f0-288164b358ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis_c4e3b2eb-5d95-4126-a435-7768be54dbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_CollateralAxis_c4e3b2eb-5d95-4126-a435-7768be54dbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_b9d51d75-f3dd-4784-9dcc-6f19c92add9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollateralAxis_c4e3b2eb-5d95-4126-a435-7768be54dbfe" xlink:to="loc_us-gaap_CollateralDomain_b9d51d75-f3dd-4784-9dcc-6f19c92add9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_MedicalEquipmentMember_fdfbf2bf-d5c8-4215-bde1-7aeaf60ab7b3" xlink:href="infu-20220331.xsd#infu_MedicalEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollateralDomain_b9d51d75-f3dd-4784-9dcc-6f19c92add9e" xlink:to="loc_infu_MedicalEquipmentMember_fdfbf2bf-d5c8-4215-bde1-7aeaf60ab7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a86afb74-2b98-4981-8c6c-5c63a959b719" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_25517867-9a96-4e5f-a612-306b8f11e26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_25517867-9a96-4e5f-a612-306b8f11e26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_a5b2f560-b802-4c69-83b3-26d70734783c" xlink:href="infu-20220331.xsd#infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions_a5b2f560-b802-4c69-83b3-26d70734783c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_80e6e1a6-a8c1-4e49-8ff5-e938bb42cfb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_80e6e1a6-a8c1-4e49-8ff5-e938bb42cfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_1d92b588-1a25-4040-8d60-d2a4afae4b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_1d92b588-1a25-4040-8d60-d2a4afae4b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PercentageOfTotalDepreciationExpense_61759805-9a11-476a-9d70-389e8b6e0fd9" xlink:href="infu-20220331.xsd#infu_PercentageOfTotalDepreciationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_PercentageOfTotalDepreciationExpense_61759805-9a11-476a-9d70-389e8b6e0fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_ed1f6b82-c050-451d-90b5-aea6f15e6e66" xlink:href="infu-20220331.xsd#infu_DebtInstrumentCovenantMinimumFixedCoverageRatio"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio_ed1f6b82-c050-451d-90b5-aea6f15e6e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio_24c69557-71bb-40d8-b591-285c17a15c55" xlink:href="infu-20220331.xsd#infu_DebtInstrumentCovenantMaximumLeverageRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_DebtInstrumentCovenantMaximumLeverageRatio_24c69557-71bb-40d8-b591-285c17a15c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_701f5ac1-4134-4b9a-868b-06fa74b96530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_LineOfCredit_701f5ac1-4134-4b9a-868b-06fa74b96530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_aeec95c1-7598-4427-96a4-5e040e48017d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentTerm_aeec95c1-7598-4427-96a4-5e040e48017d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_13eabec2-1427-4635-8b69-be6166219415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_13eabec2-1427-4635-8b69-be6166219415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9d050e46-7a01-439d-aed2-12e460eba194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9d050e46-7a01-439d-aed2-12e460eba194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d2f120d1-ac15-4c5d-ab4a-d5b4b3690398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d2f120d1-ac15-4c5d-ab4a-d5b4b3690398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LIBORRate_287fa770-9bf2-4c2b-9fd2-a3cbc308c421" xlink:href="infu-20220331.xsd#infu_LIBORRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_LIBORRate_287fa770-9bf2-4c2b-9fd2-a3cbc308c421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LenderPrimeRate_3a5fceff-65e4-46c2-8162-559dc4e1b10d" xlink:href="infu-20220331.xsd#infu_LenderPrimeRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59f9942-3c86-42e2-aa9c-5cfb25fe6ef1" xlink:to="loc_infu_LenderPrimeRate_3a5fceff-65e4-46c2-8162-559dc4e1b10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5429aedc-03f0-43bd-a535-8253ca9be30b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f72ae816-1b40-4321-a8d2-c2ac5772ba39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5429aedc-03f0-43bd-a535-8253ca9be30b" xlink:to="loc_us-gaap_DebtInstrumentTable_f72ae816-1b40-4321-a8d2-c2ac5772ba39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2fc83fd6-8ccb-4230-b429-28d96ced31bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f72ae816-1b40-4321-a8d2-c2ac5772ba39" xlink:to="loc_us-gaap_CreditFacilityAxis_2fc83fd6-8ccb-4230-b429-28d96ced31bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_20ea8325-eee6-4587-a09e-b4a5e9616e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2fc83fd6-8ccb-4230-b429-28d96ced31bd" xlink:to="loc_us-gaap_CreditFacilityDomain_20ea8325-eee6-4587-a09e-b4a5e9616e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_34dba946-8192-464a-90b8-fbfb67d9480a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_20ea8325-eee6-4587-a09e-b4a5e9616e62" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_34dba946-8192-464a-90b8-fbfb67d9480a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f72ae816-1b40-4321-a8d2-c2ac5772ba39" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_803c319c-66bd-49c1-8042-bb11e44aed9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_803c319c-66bd-49c1-8042-bb11e44aed9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f872e885-902a-4120-85ff-ecef3e8385da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_LineOfCredit_f872e885-902a-4120-85ff-ecef3e8385da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_db7e7a02-4b95-4474-8abc-e0117d481112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_db7e7a02-4b95-4474-8abc-e0117d481112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d6ece9d0-d287-4643-bb10-c9700f52df0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e5657022-9bef-4e80-8f49-4162985db5e2" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d6ece9d0-d287-4643-bb10-c9700f52df0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofFutureMaturitiesofLoansDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2aa9600d-1bd2-48b9-bc49-970436b785d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2aa9600d-1bd2-48b9-bc49-970436b785d6" xlink:to="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_355b9f12-cfa3-4e47-9ef6-3f391a200cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:to="loc_us-gaap_CreditFacilityAxis_355b9f12-cfa3-4e47-9ef6-3f391a200cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_512c151d-f5a6-4487-aba4-3b5054f7552c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_355b9f12-cfa3-4e47-9ef6-3f391a200cba" xlink:to="loc_us-gaap_CreditFacilityDomain_512c151d-f5a6-4487-aba4-3b5054f7552c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c1c65c63-1c41-4118-a57d-e424af964518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_512c151d-f5a6-4487-aba4-3b5054f7552c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c1c65c63-1c41-4118-a57d-e424af964518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:to="loc_us-gaap_DebtInstrumentAxis_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_860f391e-7488-4596-b32e-c9e62fe67172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_acc6f1cd-05f4-4c1f-b6ac-fd225deb9d4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_860f391e-7488-4596-b32e-c9e62fe67172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_20fd09eb-6617-4345-953b-45d14c4b689f" xlink:href="infu-20220331.xsd#infu_FinancingAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_860f391e-7488-4596-b32e-c9e62fe67172" xlink:to="loc_infu_FinancingAgreementMember_20fd09eb-6617-4345-953b-45d14c4b689f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c601b567-5a9d-4ff9-8b52-371a591fbf28" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0a3201f7-6fbb-4892-ac54-e0cba2eaef00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0a3201f7-6fbb-4892-ac54-e0cba2eaef00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_510890f7-6ca4-4260-8142-1b0b25f2929a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_510890f7-6ca4-4260-8142-1b0b25f2929a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4dabe683-89df-45a8-be74-4107c4f0917b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4dabe683-89df-45a8-be74-4107c4f0917b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d4f3e801-8e62-4268-9d64-4f5be2005b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d4f3e801-8e62-4268-9d64-4f5be2005b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_8aa7cb03-a1ad-402c-92d4-7b2819f01298" xlink:href="infu-20220331.xsd#infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter_8aa7cb03-a1ad-402c-92d4-7b2819f01298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_749f09a8-79ca-49f3-bacf-4ef5f6e4cd69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2f293238-7098-4a07-a110-8524b2c84999" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_749f09a8-79ca-49f3-bacf-4ef5f6e4cd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2c8c4dd7-4c1f-4832-92cc-5c1aa8b52eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2c8c4dd7-4c1f-4832-92cc-5c1aa8b52eef" xlink:to="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:to="loc_us-gaap_CreditFacilityAxis_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2bf6f423-820e-4ef9-9156-d0f7e8f8f34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_25fdd7af-0a60-4c43-ae1c-5cc308a4ae54" xlink:to="loc_us-gaap_CreditFacilityDomain_2bf6f423-820e-4ef9-9156-d0f7e8f8f34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_79afea56-315d-4b49-ae9e-35ef96e2b990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2bf6f423-820e-4ef9-9156-d0f7e8f8f34c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_79afea56-315d-4b49-ae9e-35ef96e2b990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2211ef3e-c510-4e32-9282-89b556350a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:to="loc_us-gaap_DebtInstrumentAxis_2211ef3e-c510-4e32-9282-89b556350a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_35e0b768-22ea-44da-b19a-8b3d8edbfa3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2211ef3e-c510-4e32-9282-89b556350a0f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_35e0b768-22ea-44da-b19a-8b3d8edbfa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_FinancingAgreementMember_10ce65e7-933a-46a8-8fc9-e693cc3f1f64" xlink:href="infu-20220331.xsd#infu_FinancingAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_35e0b768-22ea-44da-b19a-8b3d8edbfa3f" xlink:to="loc_infu_FinancingAgreementMember_10ce65e7-933a-46a8-8fc9-e693cc3f1f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f0718bf5-ff5a-4a63-9d06-115e91ef02de" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongtermDebtGrossCurrent_07729894-7db6-4225-b4a6-81130336f5d0" xlink:href="infu-20220331.xsd#infu_LongtermDebtGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_infu_LongtermDebtGrossCurrent_07729894-7db6-4225-b4a6-81130336f5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LongTermDebtGrossNoncurrent_7a02a8a8-992a-41bf-9bc5-901a06dae8a9" xlink:href="infu-20220331.xsd#infu_LongTermDebtGrossNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_infu_LongTermDebtGrossNoncurrent_7a02a8a8-992a-41bf-9bc5-901a06dae8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_9235810b-a11a-4c04-ac2c-39e996c370fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_9235810b-a11a-4c04-ac2c-39e996c370fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_ed04c696-e113-4069-add1-727bccd96d4b" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseCurrent_ed04c696-e113-4069-add1-727bccd96d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_40e2d1c9-b902-4cfa-a3e5-0da9b65107f6" xlink:href="infu-20220331.xsd#infu_UnamortizedDebtIssuanceExpenseNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_infu_UnamortizedDebtIssuanceExpenseNoncurrent_40e2d1c9-b902-4cfa-a3e5-0da9b65107f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8e806248-f4af-4d75-b81c-b2dea9320cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8e806248-f4af-4d75-b81c-b2dea9320cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3570fa0a-42ca-409b-af37-983033414d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_LongTermDebtCurrent_3570fa0a-42ca-409b-af37-983033414d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bcd7aacd-8b22-4222-84e8-e9cf6a8131a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bcd7aacd-8b22-4222-84e8-e9cf6a8131a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_41c98b70-347c-4472-88e7-4fc3042f76a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5e768426-3a2b-4c90-9781-1ec9bbae79e7" xlink:to="loc_us-gaap_LongTermDebt_41c98b70-347c-4472-88e7-4fc3042f76a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" xlink:type="simple" xlink:href="infu-20220331.xsd#DebtSummaryofCompanysCurrentandLongtermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f104154d-326a-43cb-b891-40a9a8038211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_891345da-88ee-4d76-bf89-8fb405abcdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f104154d-326a-43cb-b891-40a9a8038211" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_891345da-88ee-4d76-bf89-8fb405abcdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesPolicies" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesPolicies"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09f78c42-3363-4eb4-99d1-2e045f79ea83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_0060cfd2-3933-4cf1-b4b8-03ec488f1013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_09f78c42-3363-4eb4-99d1-2e045f79ea83" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_0060cfd2-3933-4cf1-b4b8-03ec488f1013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_69d687e1-3227-449c-a7b2-c6b61fcada4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_c213c780-2348-45c2-b102-17b0848f9e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_69d687e1-3227-449c-a7b2-c6b61fcada4b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_c213c780-2348-45c2-b102-17b0848f9e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_62293efc-0ff6-4e73-bba0-2114c5ed551b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_69d687e1-3227-449c-a7b2-c6b61fcada4b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_62293efc-0ff6-4e73-bba0-2114c5ed551b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_85ec7b32-624a-4a12-89fa-d95e172ff107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_85ec7b32-624a-4a12-89fa-d95e172ff107" xlink:to="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2af821bf-d576-4f69-b258-ad0075f3ad2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2af821bf-d576-4f69-b258-ad0075f3ad2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2ac26913-b9c2-4822-b403-bbf51f22ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2af821bf-d576-4f69-b258-ad0075f3ad2d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2ac26913-b9c2-4822-b403-bbf51f22ad94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_532ff63c-322b-45ae-b7d6-bed8ec44f93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2ac26913-b9c2-4822-b403-bbf51f22ad94" xlink:to="loc_us-gaap_InterestRateSwapMember_532ff63c-322b-45ae-b7d6-bed8ec44f93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:to="loc_us-gaap_HedgingDesignationAxis_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9debfaf3-5887-4887-93e2-14c5d10967fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_af3c8d28-7f2b-4413-9d02-bb1d4ebefc73" xlink:to="loc_us-gaap_HedgingDesignationDomain_9debfaf3-5887-4887-93e2-14c5d10967fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c97db3fb-8df7-44ba-8d85-cd9689828a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9debfaf3-5887-4887-93e2-14c5d10967fd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c97db3fb-8df7-44ba-8d85-cd9689828a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6c0f8acb-7e68-4151-a343-a289ceab61e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6c0f8acb-7e68-4151-a343-a289ceab61e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fafa0d84-1f6a-4979-94e6-41abb4152069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_6c0f8acb-7e68-4151-a343-a289ceab61e6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fafa0d84-1f6a-4979-94e6-41abb4152069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_419ca0cb-809d-4e94-a1e3-0ca7119e6eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_fafa0d84-1f6a-4979-94e6-41abb4152069" xlink:to="loc_us-gaap_CashFlowHedgingMember_419ca0cb-809d-4e94-a1e3-0ca7119e6eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2b99a51e-2136-4f9c-9f90-125c0f81ff25" xlink:to="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_619491ff-30d1-47d0-8434-dd386237d599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_619491ff-30d1-47d0-8434-dd386237d599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_776e934e-7a09-4ccd-8719-f4c4f770346f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeTermOfContract_776e934e-7a09-4ccd-8719-f4c4f770346f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_a37ee05a-4d5e-474c-96c8-f0aa655a8db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_a37ee05a-4d5e-474c-96c8-f0aa655a8db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_4cef1579-2b95-4b24-93cd-f85af66bc119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNetHedgeIneffectivenessGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_41d19628-c68d-4fa6-9f05-6d7140374502" xlink:to="loc_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss_4cef1579-2b95-4b24-93cd-f85af66bc119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c294a2a3-bd21-4dfd-8d8e-f5b4c84eb004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c294a2a3-bd21-4dfd-8d8e-f5b4c84eb004" xlink:to="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9737fe5-a99e-4aa3-8d58-3f69c729970a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9737fe5-a99e-4aa3-8d58-3f69c729970a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_70b90345-5ba9-4744-bd17-431f7525fccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e9737fe5-a99e-4aa3-8d58-3f69c729970a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_70b90345-5ba9-4744-bd17-431f7525fccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_7bdad8c7-2980-4ace-9948-feec0329679a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_70b90345-5ba9-4744-bd17-431f7525fccd" xlink:to="loc_us-gaap_CashFlowHedgingMember_7bdad8c7-2980-4ace-9948-feec0329679a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6d7a6195-7451-4134-aafd-57cf6225370f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6d7a6195-7451-4134-aafd-57cf6225370f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_13f7f84b-088d-4929-bc0d-2b7a81bc922f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6d7a6195-7451-4134-aafd-57cf6225370f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_13f7f84b-088d-4929-bc0d-2b7a81bc922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_05c85df0-1e2d-47dd-87b8-cfed8e16e044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_13f7f84b-088d-4929-bc0d-2b7a81bc922f" xlink:to="loc_us-gaap_InterestRateSwapMember_05c85df0-1e2d-47dd-87b8-cfed8e16e044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_24117d5b-db1f-4eda-878b-7cf28a2d0e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_HedgingDesignationAxis_24117d5b-db1f-4eda-878b-7cf28a2d0e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8f1b8cac-1418-45a7-9b38-31687dd1b9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_24117d5b-db1f-4eda-878b-7cf28a2d0e96" xlink:to="loc_us-gaap_HedgingDesignationDomain_8f1b8cac-1418-45a7-9b38-31687dd1b9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_270cf550-520d-4c48-b776-5728c9371698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8f1b8cac-1418-45a7-9b38-31687dd1b9be" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_270cf550-520d-4c48-b776-5728c9371698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_90a1972d-96df-414a-b946-7368dd6bdcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_90a1972d-96df-414a-b946-7368dd6bdcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8bff1feb-8dfc-42d2-b2d3-d03fa9af1d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_90a1972d-96df-414a-b946-7368dd6bdcb8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8bff1feb-8dfc-42d2-b2d3-d03fa9af1d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_1a251c19-34b9-44cd-afc5-ca52059d9afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8bff1feb-8dfc-42d2-b2d3-d03fa9af1d6f" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_1a251c19-34b9-44cd-afc5-ca52059d9afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_df77b045-d1f8-42e0-bc0c-d109d12e27aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_58ca9f80-917b-427b-947b-32044da6e1ac" xlink:to="loc_us-gaap_DerivativeLineItems_df77b045-d1f8-42e0-bc0c-d109d12e27aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_0138d1a4-052f-4b0f-bd09-373d52f03571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_df77b045-d1f8-42e0-bc0c-d109d12e27aa" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_0138d1a4-052f-4b0f-bd09-373d52f03571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_ae772c28-f2c3-4221-a0a1-d8fa2be39faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_df77b045-d1f8-42e0-bc0c-d109d12e27aa" xlink:to="loc_us-gaap_DerivativeAssets_ae772c28-f2c3-4221-a0a1-d8fa2be39faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b8ae99de-0648-49b0-8e4e-9da3fa780fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b8ae99de-0648-49b0-8e4e-9da3fa780fb2" xlink:to="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5d7435b6-d358-4075-833a-e90ab71c8024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5d7435b6-d358-4075-833a-e90ab71c8024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d95ffed0-0716-4184-a491-b48e7af7a203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5d7435b6-d358-4075-833a-e90ab71c8024" xlink:to="loc_us-gaap_EquityComponentDomain_d95ffed0-0716-4184-a491-b48e7af7a203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_11cbaf0b-15e4-473e-8105-21a5342fd4d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d95ffed0-0716-4184-a491-b48e7af7a203" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_11cbaf0b-15e4-473e-8105-21a5342fd4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7f1363e4-55b5-4459-856e-2cace69e1124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7f1363e4-55b5-4459-856e-2cace69e1124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c8280e2a-53d5-43d2-8995-dc9c1d3ceffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7f1363e4-55b5-4459-856e-2cace69e1124" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c8280e2a-53d5-43d2-8995-dc9c1d3ceffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_412a7660-802f-47fd-9d1f-b1fa089df44a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c8280e2a-53d5-43d2-8995-dc9c1d3ceffc" xlink:to="loc_us-gaap_InterestRateSwapMember_412a7660-802f-47fd-9d1f-b1fa089df44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0655a201-c5d3-4667-9132-cdf8e690d572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0655a201-c5d3-4667-9132-cdf8e690d572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f8a61fbe-a7c4-40f0-8a52-bdef46e5fe2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0655a201-c5d3-4667-9132-cdf8e690d572" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f8a61fbe-a7c4-40f0-8a52-bdef46e5fe2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_68604d4c-d732-44b8-98d9-1c78abe0ed3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f8a61fbe-a7c4-40f0-8a52-bdef46e5fe2f" xlink:to="loc_us-gaap_CashFlowHedgingMember_68604d4c-d732-44b8-98d9-1c78abe0ed3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_1d014948-f724-4c1f-8283-3cc91c5284b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_HedgingDesignationAxis_1d014948-f724-4c1f-8283-3cc91c5284b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fad8441a-96f4-4dbd-8ce7-a6b6df8cc2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_1d014948-f724-4c1f-8283-3cc91c5284b7" xlink:to="loc_us-gaap_HedgingDesignationDomain_fad8441a-96f4-4dbd-8ce7-a6b6df8cc2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f2f7cf9d-7639-4671-8b09-dcf74c89ecc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fad8441a-96f4-4dbd-8ce7-a6b6df8cc2d6" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f2f7cf9d-7639-4671-8b09-dcf74c89ecc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_622d4fde-5757-436d-89e7-743df34ee472" xlink:to="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4e00a0ab-1172-4135-be2b-49e9510aab00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_StockholdersEquity_4e00a0ab-1172-4135-be2b-49e9510aab00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_c5235ceb-baac-4194-8281-5e2a6abd1954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_c5235ceb-baac-4194-8281-5e2a6abd1954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_45dd4f99-ddb8-43a1-979c-b0fc31809aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_45dd4f99-ddb8-43a1-979c-b0fc31809aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_a2939a08-c18e-42b0-9b1f-37c07f5e6acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_a2939a08-c18e-42b0-9b1f-37c07f5e6acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a7da4a76-b6e9-45ec-a204-f3d291af92e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_StockholdersEquity_a7da4a76-b6e9-45ec-a204-f3d291af92e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_18ba17d8-a9d3-458f-b5de-90af94faecd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_InterestExpense_18ba17d8-a9d3-458f-b5de-90af94faecd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_ba77e390-1f34-46b6-97d0-f28950390721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6415697e-d934-4e28-9e33-39d124e605b3" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_ba77e390-1f34-46b6-97d0-f28950390721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxes" xlink:type="simple" xlink:href="infu-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c7344c7b-2bd8-4658-842a-89a7e366733e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_88673c8b-bf89-450d-9e4f-f30e65c8a931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c7344c7b-2bd8-4658-842a-89a7e366733e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_88673c8b-bf89-450d-9e4f-f30e65c8a931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/IncomeTaxesDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#IncomeTaxesDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/IncomeTaxesDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c3d919c5-76b0-4e97-b02a-d91d6ba4683a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_dfc2bc9e-c468-4674-9189-035670cb644d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c3d919c5-76b0-4e97-b02a-d91d6ba4683a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_dfc2bc9e-c468-4674-9189-035670cb644d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_cbf33204-2dc3-4abb-bf1e-0e41414004fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_dfc2bc9e-c468-4674-9189-035670cb644d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_cbf33204-2dc3-4abb-bf1e-0e41414004fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_79038a25-801f-4015-871e-f10de659a7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_cbf33204-2dc3-4abb-bf1e-0e41414004fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_79038a25-801f-4015-871e-f10de659a7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_36a37cc0-90e9-4245-b587-e2770c342c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_79038a25-801f-4015-871e-f10de659a7fe" xlink:to="loc_us-gaap_OtherLiabilitiesMember_36a37cc0-90e9-4245-b587-e2770c342c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_5d5b8f11-6fe2-4020-8cce-3be313da4c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_dfc2bc9e-c468-4674-9189-035670cb644d" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_5d5b8f11-6fe2-4020-8cce-3be313da4c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_909f75c2-7e95-4e8d-a2a7-a0d646a486e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_5d5b8f11-6fe2-4020-8cce-3be313da4c11" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_909f75c2-7e95-4e8d-a2a7-a0d646a486e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_7be931ee-3888-449c-9cc3-a72449f5168c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_5d5b8f11-6fe2-4020-8cce-3be313da4c11" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_7be931ee-3888-449c-9cc3-a72449f5168c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/CommitmentsContingenciesandLitigation" xlink:type="simple" xlink:href="infu-20220331.xsd#CommitmentsContingenciesandLitigation"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/CommitmentsContingenciesandLitigation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f1a88e3f-3dee-4a94-8895-6d823d69eb10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5b528f27-0149-46d7-a5fb-e23e0ba3d0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f1a88e3f-3dee-4a94-8895-6d823d69eb10" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5b528f27-0149-46d7-a5fb-e23e0ba3d0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LossEarningsPerShare" xlink:type="simple" xlink:href="infu-20220331.xsd#LossEarningsPerShare"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LossEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_78ec5614-877b-4860-8cbf-54b4ce4d1374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_01c1644e-f4dd-43f4-b601-a7a871596d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_78ec5614-877b-4860-8cbf-54b4ce4d1374" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_01c1644e-f4dd-43f4-b601-a7a871596d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LossEarningsPerShareTables" xlink:type="simple" xlink:href="infu-20220331.xsd#LossEarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LossEarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dabb0b9f-6b5b-4e15-b9b5-6302c5cbe3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_031787d6-1a7f-4dae-be9b-c1af08fc18f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dabb0b9f-6b5b-4e15-b9b5-6302c5cbe3c1" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_031787d6-1a7f-4dae-be9b-c1af08fc18f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LossEarningsPerShareDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#LossEarningsPerShareDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LossEarningsPerShareDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_00ccc942-f2f1-4404-b902-39c80798fc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f4c136e0-1402-49ef-bed1-93bd176e9340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ccc942-f2f1-4404-b902-39c80798fc4c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f4c136e0-1402-49ef-bed1-93bd176e9340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2f913725-dbf1-4be4-8b01-f9c778b83138" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ccc942-f2f1-4404-b902-39c80798fc4c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_2f913725-dbf1-4be4-8b01-f9c778b83138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareRepurchaseProgramCumulativeSharesRepurchased_53648c87-07a6-40dd-9b3a-329fcc1e9e35" xlink:href="infu-20220331.xsd#infu_ShareRepurchaseProgramCumulativeSharesRepurchased"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ccc942-f2f1-4404-b902-39c80798fc4c" xlink:to="loc_infu_ShareRepurchaseProgramCumulativeSharesRepurchased_53648c87-07a6-40dd-9b3a-329fcc1e9e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares_d9d46527-f1f8-4981-b1c1-36ea3221324c" xlink:href="infu-20220331.xsd#infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00ccc942-f2f1-4404-b902-39c80798fc4c" xlink:to="loc_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares_d9d46527-f1f8-4981-b1c1-36ea3221324c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0410ce5e-8d4a-4fce-8851-387c4f0626c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ba00ea81-a04c-4e00-8278-4742111a16aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0410ce5e-8d4a-4fce-8851-387c4f0626c8" xlink:to="loc_us-gaap_NetIncomeLoss_ba00ea81-a04c-4e00-8278-4742111a16aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b618531b-aeaa-469e-a468-6a43ab251905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0410ce5e-8d4a-4fce-8851-387c4f0626c8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b618531b-aeaa-469e-a468-6a43ab251905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4b64ede2-adc4-4e93-85d7-6946842a6042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b618531b-aeaa-469e-a468-6a43ab251905" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4b64ede2-adc4-4e93-85d7-6946842a6042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e28a0bf1-e8c0-4a06-8b64-5a43c227db7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b618531b-aeaa-469e-a468-6a43ab251905" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e28a0bf1-e8c0-4a06-8b64-5a43c227db7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ade13692-5c92-49d3-92fa-7b74f10314b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b618531b-aeaa-469e-a468-6a43ab251905" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ade13692-5c92-49d3-92fa-7b74f10314b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a15a977e-0c86-4c7f-b81e-d3717beffee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b618531b-aeaa-469e-a468-6a43ab251905" xlink:to="loc_us-gaap_EarningsPerShareBasic_a15a977e-0c86-4c7f-b81e-d3717beffee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9c472ea1-7019-4ad7-b461-23e65801db5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b618531b-aeaa-469e-a468-6a43ab251905" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9c472ea1-7019-4ad7-b461-23e65801db5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/Leases" xlink:type="simple" xlink:href="infu-20220331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7cb530a5-9016-465e-88a2-6cf1cd8c4c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_95d43a4b-ddf3-4aa1-89d6-2a452e792e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7cb530a5-9016-465e-88a2-6cf1cd8c4c93" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_95d43a4b-ddf3-4aa1-89d6-2a452e792e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesTables" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b526a8a6-d05a-4fa6-a72d-46ac90a562dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_0ad48600-8f5c-48b0-9fc8-a725dc88b4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b526a8a6-d05a-4fa6-a72d-46ac90a562dc" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_0ad48600-8f5c-48b0-9fc8-a725dc88b4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d1967413-8fb4-4653-815d-02b2084402f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b526a8a6-d05a-4fa6-a72d-46ac90a562dc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_d1967413-8fb4-4653-815d-02b2084402f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesDetailsTextual" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesDetailsTextual"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesDetailsTextual" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_831612b1-a8c5-4fd8-b859-4baeeed60052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_65ccf191-577f-429c-86a5-d99fc44c864f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_831612b1-a8c5-4fd8-b859-4baeeed60052" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_65ccf191-577f-429c-86a5-d99fc44c864f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f52d311e-f58d-44f6-a118-620d13047141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_65ccf191-577f-429c-86a5-d99fc44c864f" xlink:to="loc_srt_RangeAxis_f52d311e-f58d-44f6-a118-620d13047141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2a721cac-e2ff-4112-ba39-1104cefda3c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f52d311e-f58d-44f6-a118-620d13047141" xlink:to="loc_srt_RangeMember_2a721cac-e2ff-4112-ba39-1104cefda3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f4039521-6e5a-47ef-bd02-7bba2a2e2b92" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2a721cac-e2ff-4112-ba39-1104cefda3c0" xlink:to="loc_srt_MinimumMember_f4039521-6e5a-47ef-bd02-7bba2a2e2b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e9722ef2-8d29-430c-8b6e-0d5f6ef9e2ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2a721cac-e2ff-4112-ba39-1104cefda3c0" xlink:to="loc_srt_MaximumMember_e9722ef2-8d29-430c-8b6e-0d5f6ef9e2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_931c78d2-2676-48cf-8c11-c3420e1292e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_65ccf191-577f-429c-86a5-d99fc44c864f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_931c78d2-2676-48cf-8c11-c3420e1292e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f3f00a83-990d-4e05-9858-d0300d5e2b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_931c78d2-2676-48cf-8c11-c3420e1292e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f3f00a83-990d-4e05-9858-d0300d5e2b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1d674eef-96a6-445d-8bb5-5fcf135a942d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_931c78d2-2676-48cf-8c11-c3420e1292e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_1d674eef-96a6-445d-8bb5-5fcf135a942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6c18e0eb-6e7b-4bb8-97bc-d36e2006ab4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_178e4c0c-cc5b-4cd3-ba2a-94904e4bb594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c18e0eb-6e7b-4bb8-97bc-d36e2006ab4c" xlink:to="loc_us-gaap_OperatingLeaseCost_178e4c0c-cc5b-4cd3-ba2a-94904e4bb594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3d9f0a28-ddef-47a9-8381-b4acdcf3f30d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c18e0eb-6e7b-4bb8-97bc-d36e2006ab4c" xlink:to="loc_us-gaap_VariableLeaseCost_3d9f0a28-ddef-47a9-8381-b4acdcf3f30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_2fd2c1df-5673-458b-afdb-fc0954390ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c18e0eb-6e7b-4bb8-97bc-d36e2006ab4c" xlink:to="loc_us-gaap_LeaseCost_2fd2c1df-5673-458b-afdb-fc0954390ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_dc898ccb-27db-4d93-8f17-9129b152b93b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c18e0eb-6e7b-4bb8-97bc-d36e2006ab4c" xlink:to="loc_us-gaap_OperatingLeasePayments_dc898ccb-27db-4d93-8f17-9129b152b93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ae4a3d04-dcdd-4abe-a626-0ba53d89cb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c18e0eb-6e7b-4bb8-97bc-d36e2006ab4c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ae4a3d04-dcdd-4abe-a626-0ba53d89cb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1c855d88-6a92-404c-94a3-23574d25c9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c18e0eb-6e7b-4bb8-97bc-d36e2006ab4c" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1c855d88-6a92-404c-94a3-23574d25c9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_71fc95fb-5835-48b0-a87b-4f25407cb2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c18e0eb-6e7b-4bb8-97bc-d36e2006ab4c" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_71fc95fb-5835-48b0-a87b-4f25407cb2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_114c3add-3fa8-42a6-a1b5-7adeee3dd0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_114c3add-3fa8-42a6-a1b5-7adeee3dd0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ad6b3c2f-bf7a-4cb4-83fc-33b7b3252f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_ad6b3c2f-bf7a-4cb4-83fc-33b7b3252f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6510643d-0670-4d32-84c7-220dbf948109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6510643d-0670-4d32-84c7-220dbf948109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9a2336cc-0f5c-4327-8dd1-11bfc612a820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9a2336cc-0f5c-4327-8dd1-11bfc612a820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fbc5765f-4576-40a9-aa83-bedb2693668c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fbc5765f-4576-40a9-aa83-bedb2693668c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_f248ebe4-54e6-4d33-b1eb-566a44fa9f3b" xlink:href="infu-20220331.xsd#infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_f248ebe4-54e6-4d33-b1eb-566a44fa9f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7e314490-94db-4720-a056-c79696fd43ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7e314490-94db-4720-a056-c79696fd43ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ba467216-c668-4a6e-9a62-17cd51699b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ba467216-c668-4a6e-9a62-17cd51699b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e2b79b2a-e1cb-4e33-b86c-e5926e5388a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8192c78b-be02-4287-947c-c279f03f2896" xlink:to="loc_us-gaap_OperatingLeaseLiability_e2b79b2a-e1cb-4e33-b86c-e5926e5388a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="infu-20220331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformation" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessSegmentInformation"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessSegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4b3e81de-65cf-4662-8bc3-122f1c702b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_f8c7d2ad-ccda-4803-9060-d51fcb099a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4b3e81de-65cf-4662-8bc3-122f1c702b9b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_f8c7d2ad-ccda-4803-9060-d51fcb099a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformationTables" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessSegmentInformationTables"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessSegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_afbcf6c7-1a06-4418-8305-e3002fecd6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4b422847-3418-42c7-b56b-038915cb35e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_afbcf6c7-1a06-4418-8305-e3002fecd6f7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4b422847-3418-42c7-b56b-038915cb35e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="simple" xlink:href="infu-20220331.xsd#BusinessSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/BusinessSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_21b4fe3f-4255-4638-b05c-eccb4287dcc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_21b4fe3f-4255-4638-b05c-eccb4287dcc2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1dc2d3e7-9e40-45f5-a008-183c0b58e23b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1dc2d3e7-9e40-45f5-a008-183c0b58e23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b5e32d48-93e0-4c87-af92-99f92e694172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1dc2d3e7-9e40-45f5-a008-183c0b58e23b" xlink:to="loc_us-gaap_SegmentDomain_b5e32d48-93e0-4c87-af92-99f92e694172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_ITSSegmentMember_2ba00ff1-f1a7-4f88-96f2-6b2443b26935" xlink:href="infu-20220331.xsd#infu_ITSSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b5e32d48-93e0-4c87-af92-99f92e694172" xlink:to="loc_infu_ITSSegmentMember_2ba00ff1-f1a7-4f88-96f2-6b2443b26935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_DMEServicesSegmentMember_1e3147a0-2ed9-409e-8a07-e43ffffea3c9" xlink:href="infu-20220331.xsd#infu_DMEServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b5e32d48-93e0-4c87-af92-99f92e694172" xlink:to="loc_infu_DMEServicesSegmentMember_1e3147a0-2ed9-409e-8a07-e43ffffea3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3c6b50c6-2034-4476-a16e-10f65e4dcaaa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:to="loc_srt_ConsolidationItemsAxis_3c6b50c6-2034-4476-a16e-10f65e4dcaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6b0ea262-4586-4720-b9de-9aa5ee006d34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3c6b50c6-2034-4476-a16e-10f65e4dcaaa" xlink:to="loc_srt_ConsolidationItemsDomain_6b0ea262-4586-4720-b9de-9aa5ee006d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f449bcd4-6055-4700-afc3-c29f9cb0181c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6b0ea262-4586-4720-b9de-9aa5ee006d34" xlink:to="loc_us-gaap_OperatingSegmentsMember_f449bcd4-6055-4700-afc3-c29f9cb0181c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_CorporateAndEliminationsMember_dd15672d-4158-494b-a978-fceff24f8711" xlink:href="infu-20220331.xsd#infu_CorporateAndEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_6b0ea262-4586-4720-b9de-9aa5ee006d34" xlink:to="loc_infu_CorporateAndEliminationsMember_dd15672d-4158-494b-a978-fceff24f8711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_30ad3975-62d5-44d3-b3d6-1311df996f2f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesExternal_0f1f93a3-53ad-448a-87cc-192e73e23b0e" xlink:href="infu-20220331.xsd#infu_RevenuesExternal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_infu_RevenuesExternal_0f1f93a3-53ad-448a-87cc-192e73e23b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_RevenuesInternal_d9994f45-6168-47d5-81a0-3bf004ec4866" xlink:href="infu-20220331.xsd#infu_RevenuesInternal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_infu_RevenuesInternal_d9994f45-6168-47d5-81a0-3bf004ec4866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cdf02a52-3a0a-4092-b77f-23789f92509a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_Revenues_cdf02a52-3a0a-4092-b77f-23789f92509a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0ad09db1-a250-4cdb-9b3c-0a8a275d77bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_GrossProfit_0ad09db1-a250-4cdb-9b3c-0a8a275d77bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_343b7419-9bc8-40fc-b940-d2c4fc415a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_OperatingExpenses_343b7419-9bc8-40fc-b940-d2c4fc415a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c3994e8c-ce86-454a-b3c2-69e7d5c82965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_InterestExpense_c3994e8c-ce86-454a-b3c2-69e7d5c82965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a9f0ae87-269d-403a-8a27-7c49922d1bac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a9f0ae87-269d-403a-8a27-7c49922d1bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_041eaff6-39a9-4df2-83a2-0b537f9e313c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_041eaff6-39a9-4df2-83a2-0b537f9e313c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3b1c0d3b-1cab-4fdc-b80c-a2bd5e028c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_NetIncomeLoss_3b1c0d3b-1cab-4fdc-b80c-a2bd5e028c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7f708698-f363-4764-8693-289257c2b63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_Assets_7f708698-f363-4764-8693-289257c2b63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_PaymentsToAcquireMedicalEquipment_e53ebea6-410d-45d0-8357-dc9bd773990c" xlink:href="infu-20220331.xsd#infu_PaymentsToAcquireMedicalEquipment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_infu_PaymentsToAcquireMedicalEquipment_e53ebea6-410d-45d0-8357-dc9bd773990c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c9f28ac1-4268-40af-a0cb-41e3acdf752b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ca8721e-44b9-4ffd-b31a-7f1b400f0185" xlink:to="loc_us-gaap_DepreciationAndAmortization_c9f28ac1-4268-40af-a0cb-41e3acdf752b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://infusystem.com/role/COVID19" xlink:type="simple" xlink:href="infu-20220331.xsd#COVID19"/>
  <link:presentationLink xlink:role="http://infusystem.com/role/COVID19" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_infu_Covid19Abstract_057bf29d-a212-4255-8e4f-5333ec4440a9" xlink:href="infu-20220331.xsd#infu_Covid19Abstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_infu_EffectOfCovid19PandemicTextBlock_db5348e7-eb71-403f-b112-ee6dbbc77428" xlink:href="infu-20220331.xsd#infu_EffectOfCovid19PandemicTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_infu_Covid19Abstract_057bf29d-a212-4255-8e4f-5333ec4440a9" xlink:to="loc_infu_EffectOfCovid19PandemicTextBlock_db5348e7-eb71-403f-b112-ee6dbbc77428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>infu-20220331_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 infu-20220331_g1.jpg
M_]C_X1$817AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    D    <@$R  (    4
M    EH=I  0    !    K    -@ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-#(#(P,3<@*$UA8VEN=&]S:"D ,C Q.3HQ,#HP-" P.3HR.3HU
M-      #H $  P    '__P  H ( !     $   <7H , !     $   (]
M      8! P #     0 &   !&@ %     0   28!&P %     0   2X!*  #
M     0 "   " 0 $     0   38" @ $     0  #]H         2     $
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M<W'J]M&740W_ (JP[W!O_%/993_Q:VFX^%TOZIQU&HV"\"RRL2";;(=4W?\
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M.$))300Z      $/    $     $       MP<FEN=$]U='!U=     4
M4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN
M=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    6 $@ 4  @
M $\ 9@!F &D 8P!E &H 90!T "  4 !R &\ (  X #8 ,0 P       /<')I
M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! !+     $  0$L     0 !.$))300F       .
M     #^    X0DE-! T       0   !:.$))3009       $    'CA"24T#
M\P      "0           0 X0DE-)Q        H  0         !.$))30/U
M      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(
M   ! %H    &       ! #4    ! "T    &       !.$))30/X      !P
M  #_____________________________ ^@     ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@  #A"24T$         @  .$))300"
M   "   X0DE-!#        $! #A"24T$+0      !@ !     CA"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  .7    !@             "/0  !Q<    Q $D ;@!F '4 4P!Y ', = !E
M &T 7P!3 $$ 1@!% "X 4P!- $$ 4@!4 "X 5 !2 %4 4P!4 $4 1  N %\
M4 !- %, 0P!? %, = !A &, :P!E &0 7P Q #  +0 Q #D    !
M                  $             !Q<   (]
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<   (]     %)G:'1L;VYG   '
M%P    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG   "/0    !29VAT;&]N9P  !Q<    #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
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MP  1"  S * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$
M 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T
M<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2D
MA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(! @0$
M P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#
M4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34
MY/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#N
M?K/]:,?H5(8UHNSK@3523  X]:[]VK=_V]_VY97C?5?J?UGZQGN=G!S^EVL=
MO=L])@_T?V6VL,M>[=[?YRS]&M#IOU>JSNIY/7>JL%S[;7C#H>/:RJLFFBQ]
M;O:ZRQC/49^Y_.?SRWLW(^RX=^5MW^A6^S9,3L:7[=VNW=M5DRQPA[<8">26
MDIR_1EVA_=8.')*?'*9A"/RXX_I#][)_WKA=5Z-U'!:[-Z/EY %?N?BNL=9H
M.75"XV;]O^AL_P"M_P"C1OJ[]9/VB?LN4&MR@W<Q[=&V-'):W\VQOY[/^N?\
M7+ZL?67]OLR'?9OLWV<L$;_4W;PX_N5[=NU&QOJW@8W5#U*ISVNESF4Z>FUS
MP6V.;[=WYSO9N4,X2@3"8J0982C,"43<2ZR28D-!<= -25P6)]:?K;UK,>>D
MT,&/6YKG5AK26UN=[?5LN>S?8Y@=_-)V+#+()$$ 1^:4CPC5;DRQ@8@V3/2(
MB.(Z;O?)))*)D4DN:ZC]<ZJ+W485(R-AVFUSMK2X?2%36M>ZS^NK/0OK([JU
MSJ'8KJW,;N=:QV^L>5A(8ZM[OS&HT46'<22202I))5,[JG3^G!AS;A3ZD[)!
M,[8W_1!_>24VTE%CVO8U[#+7 %I\05))2DDDDE*2232$E/\ _]#I>EY^<SZU
MV49%[W,MMNJ=6YQ+(&^RC8QWM9[6-V;5T?6?^1\[_P +6_\ 4.67]8>AY-F0
MSJW3!.926N?5^_L^@]O_  C?H/9_A:O^G:R>HT9_U?SK636]N-:+J7@M?6_T
MW;J[6.VN:GQ^:/F%IVEY%X_ZI9E^#T#K>7C$-NI;4YA<)$P_\U&I^LOUSZAT
M^R_"K::\4N.3DL8SPW^FRNT^[TZ_<_TV6V*E]7W-_P":OU@U&E=7?R>M[ZBD
M'ZKYI!!BZ[_SW6M#-PQ.69A&<ADC'U#O"+0P<<AAQB<H1..1/#W$D&#]9/K'
MU?HC_L%==O4,:YK<@PP-=COKL<+=MSV,]3U6;7;%D?4A_7&YCATJMK\9UF.,
M]SMLMJW/U;ZCV._F_7_F]ZT/\6Y!QNK01_-T_P#4Y"G_ (KR#^T8,^W'_P#=
MA+)PXX\S&,(U$PZ?O]_[OZ"(<627*RE*5R$[_P #_O\ ]-O?5/ZQ=4ZIU?+Q
M<M['4TL<ZL-9M,BS8W7^HFQ/K%U6[ZXV='?8S[&U]K0T, =#:R]GZ3^LN>Z-
MU:OZL_6#.^WU/</TE+VL W@[_4KL#;'5M=6]O\I%Z!F_:?KO]MLK=4;C=:*B
M"7AIJ<^OV#W/<ZK:[VH3P1!RR$!P>U<#_6K>*Z.>1&./$>/W>&8_JW+0MS"N
MS/JSGN^U8V_V^EN=[0X R+,>_:YOO_.9_GK?KZW5GX.6_I ^S]28WUG56,&Y
M^W:''V2V[<P>CNW?Z-4V?76BPWUY6(74DD5M&TNV\;,FJTM:VS][_,57ZK4/
MRNMOS:*O1Q:O4)#=6M]3VUX['?G;=V[_ %8L_P V]Y.S]6^NOS\*]^8]OJXQ
MW/>!M'I.&]CX_LV-_L++Q?K1U5V/EY]NQU->UE%.W;^DM=^BWV?NT4M_2?OJ
MAU:FSHW4<W'J]M&740W_ (JP[W!O_%/993_Q:VFX^%TOZIQU&HV"\"RRL2";
M;(=4W?\ X+TXK9ZGYGII:?:G]C6P>H?6_+%>3CNINJL?MVD,#6ZZNN:S]/6S
M^V^Q5/K6[J9RHSVAN*'6?8W#;)9#-^[8YSO\]JSLIW3*S5=TN[(;>>6O #VG
M\WTKJ=KK';OS?>MKZW-RG].Z9;DB+-CFWNB +7LK.TQ[6^YEB75'1NX74^L=
M/P;\KJ]3?L]==8Q&LV O<Z6AGL>__@_I*H.I?6W(Q'=3J-5>*T%XK:&DEC9W
MO:VS=8YK=O\ I*]_^#8I9.:SK_17XN%79]IP6U6OK('NC<QS*MKO?[6V;/:L
M/'_8'V5S\O[3]L9/LK+ QQ'T?<]A=3_PGJ)*>AO^LV5;T$9V/MJRF7-IN$;F
MR1NW,!/T+&[52LZ[]9WX3,Y@%>(R&/N#&$/?.QSRUYW^GZGZ/V-_ZXAY./A5
M?5C[3C"ZMN3D5%S<@B06@L_1N:VO?4[\RS\]72YO_,*9$;1KV_GTOXJ_@BM^
ML'UCS,8Y>'4*<?&;&3:P-?+P-UCVB[W>DUOYC&/]/_"6K1Z-<>N4TYF2=F3@
MV%CMFC7:-<U^W\W<QW_;BJ]%<#]3\X@B-N3K_9<B?48@X65!!_3#C^HQ!(?_
MT?55%S&.!#F@APVN!$R/W2I))*0MP\1C'5LHK:RS1[0T .C]YL>Y2KHIJ865
M5M8PZEK0 "3Y!9_4.MC"ZEBX!H<XY,1:Y[*V:N%7IU.N<W[1D-GU'8[/TOI(
MN1UC'Q^J8_37M<7Y#9]0?083O]!ECC^=D^AD^C_Q"?P3-;ZCB^D>JWBC]AK[
M6U5C8U((IJ96'0'!C0V8XG:GIQL>B?0J95NB=C0V8XG:LT=>8>NNZ,*AO9$V
M.MK:3-?VB:L=SO7N:WZ+_3:ET[KS,_J63@LJ#/LKK&.<;:R\FIXIW?9FN]=E
M;]WLL<U$X\E$GL)G7]$_*KCC=>)C]6_?@8.18VW(QZKK&?0?8QKG#O[7.!4A
MC8XM]<5,]8_X3:-W&WZ?TOHI\B[T*++MC[/28Y_IUC<]VT;ME;/S['?F-633
M]966=$OZN<<[:#'HUV,L<XG9#/T;OT=WZ78^BW9;ZB$8SD-+(OAW_>Z*)B#K
MY_8Z5W3\#(?ZE^-5:_\ >>QKC_G."62\86!=9CU _9ZGOKI:(!+07AC0P?G?
MU55Z;U["ZGF78V)+V4UUV>MPUWJ;I8S\[=3MVW?N6_HOYRM1P>OXN=C9>14Q
MX&&7':8FRL#U*<FK_@<EH_0I'',7<3I5_P"%\JN*.E$:W7T>?:SJ/UCZO1;D
MXKJ,6F-X+7!@8T^H]N^P5^I9>[;7[/\ !KLR 001(.A!6/TGZQ_M7%R+<;%<
MZVAC'MJ;96YK_4#G,J]=CS75>W9^FIM_F?T?^D5KHW4W]4P_M9QW8U;W$5!S
MFN+FC0O_ $9=M]^]B4L<HW8KAT.H_25&435&^+79L58.%2_U*<>JM_[[&-:?
M\YH17ULL866-#V.T<UPD'X@JAUCJM_36TNKQ'98O>*AM>QD6/+:Z&?I2W^=>
M_P#ZVJO5?K/7TO*JQKL9SWV5-M<&OK#O<[TO2IJ>YKLJ]KO\%0E'%.54+NZU
M'Z*C.(NSMX=W6HQ,7&G[/373N^EZ;0V8\=@"C9@X5MGJVX]3[/WW,:7:?RB-
MRI]1ZY7@'*#J7V?9*J+G;2!(OLLQVM&[]ST=Z63UL4=7IZ7Z!)M /JN>RL'=
MN_F&6N:[*]+9^G;3^DKWUI#',ZUTO[/5_P!THR'?^1=&RNNUNVQC7MYAP!$_
M--Z-/I^CZ;?2_P!' V^/T?HJA3U7*LZM9TYV"]C:@'NR#966^F\V-HL]-KO4
M_3/HL;L_P?\ A$+I?U@9U&S):VD5LQ=VX^K6Y\L>^KWT,=ZM.[TMS/42]N=$
MUL =Q^E\JN..W>QMV=1M-+6&MK&MK,RP  &?I>U*NFJH$5,;6#J0T :_V5E=
M-^L)SJW3AV4Y!QFYF/2YS'>K4\?HW5V5N<UK]WL?7;LV;UI8MUM]6^ZAV,Z2
M/3>6DQV=^B<]ON0E"4;O2O%(D#L__]+U5)?*J22GZ-^L7V/U*O5GUM]'I^K]
MI^R?SS8^U_9?U/=N_HWVG_#^G_@EE]7^R_\ .%^_]G_S^+ZGK?:/M^Z:O3^P
M^E_8]/[+^@_G/M7^'7@R2L0VC_.['Y?./R_U6*77Y-Q\W[7Z8Z?Z7[7ZKL]/
M?OI]39ZF_P#FF[?6]7]!]'Z'V;\S^=_2JATW]G>KU&/6]3U,KU?0^V^A&\^I
MLW?JWV[]_P"Q?I?5]3[,OG9)-'7^<VCMY?I?U?\ -I[?+O+^7_?OU!^A_9FF
M_P!'T/SO4]3;L_.G]<]3;_Z$_P#75SY^P_LSJFS9Z'VG'G[5]L]>?U6/M_K?
MK_J?0^R^G^B]'T=_^&7S^DE#K\_S#Y/[W_33+_!V/S?R^5^B*OLWV_.W_9]W
MV2_?]E]??L^TY?TO1_1^K_W(^S_KOV_[3_P:S_J]]E]+._Y.G["W_D[[1Z7I
MQ;_3_P WUOW/^]#9ZR\'23AL?YWI_=_PO^Y6]1\G7^]]/^Z?H_ZM?9_T_H^G
M/IXL^AZ^S;]GJ]+?]J]OK?U/T_V3[']K]Z;H?V3[#TO9_P -Z/V?[3Z'+_4W
M^M_T?M_^$_HR^<4DV6\OYSIO_<E\_P#+^;2/T?D_E*/ROTQUSTO2Q/5]./MN
M-M]7U(W>HW9L^S_X;_1>K^K_ .G_ $:S^N?9/VC9ZWISZ&-N_I/K;?M;8]'[
M)[?4W_T/TOUG[7]/] OG=)#'^C\_^!]/E3+K\O\ A?M?H/ZQ_9/VB/6]#U?3
MQ_3]7[3LG[0[_E+[)^J_9-W]"^U_]J_4_P &K'6OL?[5P]_](]>C;Z_VG[/&
MYWT/2_R?]O\ ^XGJ_P"$_P"M+YT23AM'^<^66W_<?U?WD'<_)N/Y2_[E^FZO
M3_;F5&SU/LN/NC?ZFWU,O;OW?J_I_3]/T_TW\[ZW^ 6?T+[#Z.1Z&_U)O]2/
MMGV3^=LW>C]L_5O4W?S_ -F_PGK>G^C7SHDFC:7S[1_N_P"%_P"HTG<?+U\_
M\'_NGW[H?[.](^E'I?9\+=Z?VWU]V_V>A]I_6?V3N_HWH_H?Y[[1^B]1=8OE
M5)+-\WZ>_P#E/FZ)A\H^7_!V?__9.$))300A      !=     0$    / $$
M9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    %P!! &0 ;P!B &4 ( !0
M &@ ;P!T &\ <P!H &\ <  @ $, 0P @ #( ,  Q #<    ! #A"24T$!@
M    !P ( 0$  0$ _^% J&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M86(@!]  !P :  4 *0 U86-S<$%04$P     041"10
M  $  /;6  $     TRU!1$)%
M                           *9&5S8P   /P   !T8W!R=    7     K
M=W1P=    9P    403)",    ;   *(&03)",@   ;   *(&03)",0  H[@
M *(&0C)!,  !1<   CBT0C)!,0 #?G0  CBT0C)!,@ %MR@  CBT9V%M=  '
M[]P  )"19&5S8P         :52Y3+B!796(@0V]A=&5D("A35T]0*2!V,@
M
M                                          !T97AT     $-O<'ER
M:6=H=" R,# P($%D;V)E(%-Y<W1E;7,L($EN8RX  %A96B        "U6@
MO&<  )(P;69T,@     $ PD   $                    !
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MXRF#),R5S*^"-L4[M9B!9;Y#G@. RK?+A@F :;'=;7> ,ZR-4\: "*A6-TV
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MPH"]?6*P!8 -:_.KC'^>6;BG9']R1FRCKG^#,6R@WG_!%["A.X"Z  "0;H
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M1*>E>IBL@J03:2^H!*$%5R6CU)Z71#F@")U)+\2<\)PG%Q6<J(^;  "."H
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M"(<G<5ZXGH7<8-NS=83S3Z&NGX19/5*J6H09*2.G2H1.#Z^H3X3N  ",P8
MD('"J9!K@.B](XY?<.FWO(R58&NRAHLF3SJMLHHE/0"I:HF3*/:F2(GC#]JG
M!(D"  ",C(  D"S!Z)A/@)2\6Y6U<)*V\)-T8 NQNY&53NBLUI F/,.HDH]I
M*->E8Y ;$ 2EX8K4  ",7H  C\?!4*!B@$*[M9TW<$VV0)IS7\^Q"9@L3JZL
M)I9Q/)6GT)6R*,*DEI6\$"NDXXKN  ",.(  CV; U:B4?_R[*J30<!:UJJ&'
M7Z*P;Y[?3HFKDYT'/'VG.IRL*+BCX)IN$$ZD!HL&  ",&8  CR; 4;#U?\RZ
MH:R3;_:U'ZC+7XVOXZ783G>K":0:/&^FO*+_*+.C4YN%$&RC1(L;  "+_X
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M;(T99B#!<HMG5G:[FXH:1B2V*(E(-+6Q9HC^(2RN28GD"5VMFX95  "*18
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MQ;#J9F2]DZSR5O*WHZIF1L*R):C?-8BM5J0R(F6IVY=!"T>HL(>@  "*B(
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M-92:?ZF?PI)_;@*<B)"?6YR9B8[V2"R6_8V_,R:5 HTO&<B5+8SM  ")KX
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MN'0W=I"LHG3"9>^HQ75L5&>E*W8Q0:*B"'<#+/"?^'>L$FZB''>L  ")?H
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M9II+<]2H.)?58R^D096M4<Z@E)/E/V:=69+#*T";"Y,3$A";\HPV  "&LX
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M"'K4:JZU/'JL6O2PJWJV2D^L;GKN.%^HU7M#)#2FQWN!"I^H+GQB  "%MH
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MVI]D:/6P[YRN63FL/IIK2,*G[)C;-SFD+)BJ([JAF):C"YRAE(?9  "$FH
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MGH#87T>^/8 /4$ZY"W^@0'VT.G]M+U"P1W]W&WVNDG^K!)>L28!U  "#(8
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M6Z/]7ORYP:$L4!:T89\40&>O=9Y9+XVK5IS3''BHX)- !H>EZX1J  "#'(
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MUA5_#G&VP>5_$'+*K/1_'7//EQ]_-731@'5_5G7=:.Y_B';V4#%_SW@(-)J
M67D'#UB!\GD\U(Q]47Q_P+)]<WQZJ\Y]EWQ\E?Y]P'R/?U-]\WRY9]-^-WSW
M3QY^C7TT,Y!_$GUR#D& 2'V#TP![TH=0OP=\ H9"JD%\,X5$E(%\<81O??Y\
MNX.]9J)]%8,F3@M]=H*8,I-][8(E#4Q^TH&#T6YZAI(8O65ZO) 9J*%Z]XXP
MDPU[0(QI?*I[H8K=97A\#(ER30E\=H@A,:U\WH<>#'A]C83\S_-Y<ISIN^]Y
MJIH+IRUY[9=!D:1Z/Y28>V9ZI9(<9%M[(H_G3!E[DXWA,-Q[ZHQ_"\)\=X?S
MSK-XFZ?2NK-XU*0?I?)Y%:!QD')Y:ISF>DIYUIF18U9Z4Y:$2SYZS)/F,"%[
M%9*""RE[C8>+S:YW\;+3N;!X*JY.I.IX9:F_CVQXN:54>5IY+*$T8H5YKIUQ
M2H1Z(9I++X-Z7)AR"JIZRX<VS.1W<[WQN.-WJKB@I!!WW+,UCHMX)ZWK>(%X
MFZD)8<1Y)Z2W2>5YG*%K+OQYP9U."D)Z+8;PS%5W'LD^N$IW4<,CHU]W=[S@
MC<MWM;;"=\AX)+$O82!XL*Q[251Y)ZCR+GUY09]O"?!YKX:XQGZ(&'"*L_R'
M,W&^H)*&<G+:C!N%T7/N=K>%1W4+8%R$W'8U2+2$GG=5+<6$]'A2"-R&3WE@
MQ4:&@'JXLNJ%NWKJGW.%#'L;BP>$=7M7=:J#^7NG7UN#G'P)1[J#:'QI+-B#
MLGS ""^$JGUUQ!*%#H3YL:B$7(0QGE^#LX-RB=F#+(+2=(>"NH)47E&":X'S
M1L>"1(&?*_N"A8%N!YB#.8$+PJV#QX\JL#&#%HV-G,F"?(OWB'&" (I\<T*!
MJ(DV736!:X@21=6!2H<3*RR!>(9^!Q2!^(0HP52"O9EAKMB"#9;]FW6!>I2=
MARF!!9)1<AN L) M7#6 A(Y410" :(R\*GB A(P)!J. YH1]P#"![:.^K;B!
M0*"6FE> JYUDAA2 .)I%<1Q_YY=:6U%_MI3"1$1_H9*T*==_L)(3!D1__H0]
MOT2!2:XWK,N GZI.F62 !:9+A2!_CJ);<#U_1)ZX6I)_&)N"0Z9^]IDB*5%^
M^)="!?9_/X0(OI" SKC:K!" )K0RF)E_A*]@A$Y_ JJ?;W-^MZ9.6=A^E:*I
M0PQ^=Z!P*-]^7IN"!;9^HX/<OA2 >,/!JX)_T[YCE^Q_)+C!@Y-^D[,U;L9^
M0*Y)645^(*IS0I-^!Z<P*'E]YIM>!8-^)H.ZMUR15V^QIC6/GG#ME"&.''(2
M@/2,R7,N;,N+F'145Y.*E76&0.^)X':D)H&*.W>! RJ*)'F]MEB/X7E3I4..
M1WF>DQZ,U'GI?_F+AWH_:]:*7WJI5JJ)9GLD0 J(M7N8);*(^GOT MN(A'UI
MM4F.BX+JI R- H)=D@.+DH'3?M>*4X%I:LR)-X$95;N(2H#C/S:'GH"Z)/J'
MSH"X I6'%H"BM"R-38R5HM2+RXL^D+:*:HGH?;F)*HBT:;V('X>L5,Z'/H;'
M/FN&F(8-)%"&MH7F EF%V8&6LP6,2Y9)H<**RY0XCYR);Y(M?(N(.I W:+"'
M,8YK4]^&88SE/:6%O8NO([.%Q(NY B6$RH%SL@:+A: ?H+Z*"9U9CIB(K)J/
M>Y*'>9?:9\J&<95;4Q*%F),Q//Z$]Y&N(RR$[)$A ?F#Y8%6L36*Z:H.G^N)
M<::6C<"(#Z,->KR&V9^=9P6%U9Q[4FJ$_9G4/'6$2I@^(L"$,)6= =6#)X$]
ML)**<K0GGT"(_K "C0F'EJN^>@*&5J>79E&%4*/A4<:$@Z#T._"#SI]?(F&#
ME)<_ ;B"C8$IL""*&KZ+GKR(JKG"C&Z'.[3&>5V%[Z_N9;F$XJO 442$$ZCF
M.W^#9*4Q(?^#(I;\ :""$H$9J)N:Z6\(F(Z8<W!!AZ66/'%I=;"4/'*,8K62
M:'.W3I*0U73G.-2/PG7T'J.0AG:$  "*<GM%I\J9G7@GE]*7/7B AM>5#GC=
M=.23#7E'8>N1.WG%3="/K'I0.!F.E7K,'@:/-7L+  "(V7Z3IN^85X$[EM&6
M"8#*A>F3VX!E<^V1Y8 <8060'7_Q30&.F'_?-V.-@7_6'7>-_G_S  "'<H
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M,:P+@:N0!ZA&;\>.!*2G72V,1*&*2::*SY]D-+2)F)W9&XN)AY*?  ""_8
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M8X=$>1B;AH93:$Z8V86$5H"6<X3C0Y.49(1J+MZ2_X0K%0>4/H2   "#*(
MEWZ@?)#=B$.=?(]">$>:H8V]9W27]XQ85=&5@8L:0OR3>XHU+FR2#(G1%,J3
M&XE   "";(  EM>?L)FKAY><N9=Z=Y>9WY579LF7+Y-352^4MY&-0GN2FY!
M+@R1)Y .%)*2%(U&  "!SH  ED:?'**/AQB<*)_/=Q691)T-9CF6BIIT5)V4
M%9A!0?^1_);)+;20;9:%%&&1.(W(  "!2X  E<Z>L:N7AIV;O:A.=I*8TJ3Y
M9;:6#J'75!Z3E9]108>1@IX0+5B/Z9O@%#F0A(VL  " X(  E76>8K3PACN;
M:[$I=B*8>*U&94&5JJFN4[23*J<.02^1$J4Z+0Z/?9YV% *0#(V'  " BX
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M38T-;1ZCP8NT74&@8HJ!3(F=3(F).HV:P8CL)I29,8C_#3^:7(<]  " &H
MBA"J09;$>ZZFEI3-;)BC!9+L7+J?H9$Y3 F<A8_1.C*9W8[T)EN8/X];#4*9
M)XCW  "  (  B:BIGI\@>T"E^)RK;":B9)I&7$B>_9@82Z&;WI9<.>.9+I6&
M)C:77I3<#4J8$8C\  "  (  B4NI-*>G>P6EBJ2]:^>AY*'.6_B>8I\C2TJ;
M.9TY.8J8F9RL)?.6RYER#4J7.8C\  "  (  B0.HZ+"">KRE,ZTJ:Y6A@JG
M6Z.=]J:]2O^:Q:3Z.4Z8'Z+$)<B649F,#4.6H(CW  "  (  ?W*Y_VUL<>&U
MP&YI8[&QO6]Q5*NMZ7" 1)FJ8'&-,P&GDW)X'KNFT7+!!;VG/W-M  "  (
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MK9) 8@BL<9"74P*H8H\F0R6DJHX2,?ZAG8VU'H&@(XW@!R&>HX32  "  (
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ML72+6#J[!'352?&VAG5 .I:R=G6_*8VO?W8A%16OQ'6[  ^IZ7CG  "  (
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M8I;@5ZZU?Y4*26.PSY.-.C^LD)+"*;:I.),'%F"H+8\A D>AM(&*  "  (
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M^I=^AH&#,)5<=&^"@),S88R!\9$P3:J!AH]X.$6!18Y2'K6!6(W=  " ((
MIN*$'*,RELB#1:"(A:V"=IVL<YF!PIK*8,2!-Y@F30" S97R-\> =I2Z'E&
M;))7  "  (  IDJ#CZT(EB."OJFZA/B!YZ8F<N&!)J*,8!* EY]63%. .9S9
M-S=_WYNU'?A_IY1$  "  (  I>.#+;<:E:2"8+,SA%Z!?*[K<CR J:J@7WR
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M6ITP>GF*S9JU:7J)7I@]5ZV((98*1-6'')1;,%Z&5Y/T%O^&LH^-  "  (
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MNGH2<GV7;7I-8F"54WJ543V3:GKI/LN1X7M *EF1''MQ$ :3+WLE  "  (
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M4J)#;P"3 Y^37O:0S9SQ3AV.W)K4/":-3YG<*&N,.)@:#TN,K(I7  "  (
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M.H  9E^?3G^V5TZ<C'^"1QR:&']I-8N8*7]?(:&7=7]8"*Z7BW^3  "  (
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MMZ;L9"Z;IJ0R5/J8K:&E10*6#: M,]F3_)Y\()F2V)8*"..1.X8"  "  (
M=K2SP6=_:?6P.&D(7("LY6J,3ABIO&P"/H>FXFU<+3VDZVYK&+FEEVYL 8FB
MJG "  "  (  =EJRT&]2:<JO*' =7%>KIG#Y3?FH5''=/G"E7G*\+3JC27-J
M&..CIW-& ?Z@-W5A  "  (  =@RQ?';H:6"MV'<;7 *J1W=@3:"FZW?#/BBC
M['@M+1"AQWB$&.ZAZ7A4 EZ=^7I8  "  (  =:RP'7Y=:.FL?7X66W>H\WW=
M332EE'W#/<>BF7W&+-"@:GW1&.>@6GV\ JR;^GZO  "  (  =42N](7A:'^K
M6(4N6P6GSX2'3+>D;8/S/7*A9(./+)"?,H-K&-F>]X._ NV:.X'[  "  (
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M0&@.4..WEFEP0R.T!6K&-"JPZ&OT(Q^O/FRB#B&Q2&OC  "?!'.P  "  (
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M'(G)4$2Q (C<0IZM#8@0,_RID8>2(YVG.H? #^:GJX:X  "9D(    "  (
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M-<""?74X&\B#;W5F  "  'JYH(N!V7;5D6:!B'>+@5V!.W@K<!*! WC 7<"
MWGE52CB UWGD-06 \WI/&S>!FGHL  "  'XZGV: &8 ED#-_W8 B@!=_IX #
M;Q-_>7_>7-M_9'_"28!_9G^M-'A_?G^4&LI_X7]7  "  (  GCM^L(E]CR1^
M?8C/?P=^4(?_;>1^*X<=6]9^'H9*2)%^,H69,[)^0H4-&CE^684,  "  (
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MG67Q=_",>6@@9Y^+B6HG5AN*NVP50SV**FWA+G:**6]'$\B,FV\4  "  'I
ME!"-+6QZABN+]VW^=PZ*Y6]H9LN)]'# 55F))7(+0I&(DW,_+=^(?70>$V**
M?7.L  "  'VVDS&+7W5'A1R*378.=AB)2';$9=2(9'=P5'V'GW@:0=>'$WBY
M+4F&[GD?$P.(?WB:  "  (  DBR)N'W[A N(LGXD=/*'P7XU9.J&XGX[4ZF&
M+GY'02Z%J7Y5+,N%=GY4$KF&H'X&  "  (  D3"(3(;,@P^'4X97<_R&:X7#
M8_6%DH4=4O6$V82!0)R$7(0,+%N$((._$G>$Z(.&  "  (  D%>'.X^^@E2&
M2HZR<T.%8(UW8R*$A8PG4B2#S(KP/_*#1(H *]*"_8F>$A^#9X@Z  "  (
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M'VT":YF3:6YG7$61VV^_2[R0>W$&.;Z/@7(G)7B/=G+("RZ1&')%  "  (
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MW9/P9[R-.Y)B6(:+J)#%2&N*38]H-Q2)0HZ8(YZ(LH[&"L:('8=)  "  (
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M0G,A7YV:]'/F42&8T72L08*6\G5H,$25L77^'#:6!77[!%*3Q7=-  "  (
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M!IB#7-V5KI;+3G.3894,/QZ199/6+F./^Y/2&S"/C)$]!-6,'(-%  "  (
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M WA34_VC+'B<1FJ@>GCO-XF>,WE!)MV<W'EL$I>>,GCU  "4,'QC  "  (
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MI)RH4IF>F)KW1-B;HIE6-C.9%YC/)?R7:I;G$JJ7J8R>  N/BH (  "  (
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MK'R_2+ZL77RM.[FI-'R<+8ZFE7RB'1FECGR9">JEB'T9  ".P8    "  (
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MXZ!7?EAM!9V1;35N'9J\6S9O0I@K2#!P4I89,]%PU)4?&SIO-9%Z  "  (
MG51I\:R7C@AK/:ER?<%L5*7R;)=M7Z)K6J5N?9]-1[5OBIT#,U9O_YMX&L1N
M1Y(9  "  (  F%!_EUY:BDE_<&%&>QA_>&/X:I9_GF9V6-A_UVC51<: +FL-
M,.6 OFS>%K6"/6TT  "  '9<EU-]&V>8B49].6FD>@%]9&N':9%]G&U-5^U]
MXV[^1/M^07"/,#E^O7')%C9_LW&[  "  'IGECEZUW"^B %[('(!>.5[8G,G
M:'A[L'0W5OI\"'4Z1"]\<'8I+Y=\VW;8%<5]2':%  "  'WSE05XQ'GGAKQY
M*GIR=Y=YA7K;9WEYX7LY5A!Z3GN.0W%ZP'O<+PE[&WP*%69['7NF  "  (
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MCZ6*<WUS]**38U5T49^/4E-TQIS]0#-U.9MJ+&QU,YF,$XMTM(TW  "  (
MBRR(?EWP?A&'K6#';].''6-J8$>&N&7;3W2&<6@G/2N&9FH[*+R&[6NY#@:(
M_FM'  "  'G3BE&&-&:M?3J%I&BU;NR%+6J:7W.$SFQB3KJ$BFX//(^$?&^/
M*$"$WW"/#=>&26_U  "  'U8B5Z$!V]3?!V#I'"C;>V#0G';7G>"\W+Z3=^"
MNW0+.]B"L73Z)[."]W6'#9Z#YW3O  "  (  B$^"%'?H>OJ!Q7B7;+B!>'DJ
M782!,GFH30"!#7H>.R.!!WJ!)RR!,GJK#6:!T7I=  "  (  ATJ 5H"+>?V
M&X"C:\)_WX"67(M_IH!N3&=_>X!).JA_?8 M)MQ_CH 0#5)__G_H  "  (
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M%H7[8%Z'*H6'4@N&0H3X0KJ%?(1Q,?*$]X0@'FZ$^80[!I&$/(+;  "  (
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M1V9O6+26HFA 2N&5(VGX.[:3ZFN#*J^3;FRK%C"5%VR4 "^0OFZV  "  (
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MU8JA552/18GD1[.-OXD5.0:,=HAV*,^+G8A1%76+XX@$ 0.'WX"O  "  (
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MN&NX31F>E&SQ/_B<FFX>,7^;$6\:(-":P6^5#'V<;&\&  "*>W>B  "  (
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M2HZ;2M.8'(V^/=B5_8S;+ZZ41(QV'XN3?HRO#(F3)8AZ  "%(8    "  (
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M)F_]05>GJ'"Y-.>E57%M)M^CO''L%@JD3G&K!(2A7'+\  "%07Z*  "  (
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M>I(B0*>ANI%5-"Z?(Y"D)F>=+Y"9%B:<]HWD!6J8<(.I  "!@(    "  (
MM29A4UFRH_YCT5T#DC9F+V W?X9H<6-,:]YJGV9&5RALKFDE02IN8FO/)^MN
MVFW=!KETHV[%LRI=SF1AHG%@FF:LD-1C-FCF?DMEKFL0:KIH#6TH5AYJ0&\N
M0#5K_'$&)QAL$G)>!F-U-7-!L4Y:L6\!H*I=LW!*CTU@@W&,?-9C)G+.:6YE
MK'0-5/MG_G5#/SYINW96)E%I97<*!A=UM7@BKW17Y7F!GMU;%GG<C8Q>"7HY
M>UE@TGJ7:!1C?WL!4]1EZGMK/DYGJ'O$)9=FW7OK!=5V)'R:K;Y5>(/RG498
MSH-UC 1;XX+V>=Y>Q8)Y9N)AC(((4LAD$8&O/79ERH%8)/)DA($1!9UV@X!M
MK%)3=HYFF_=6Z8T8BLQ:%(O >+A=#8IJ9<Y?Y(DH4>=B<(@*/+YD)8<9)&)B
M=8:=!6YVTX.FJRU1SYC5FNI56):VB=!8D92#=\I;F))99.]>@)!4421A%(Z%
M/"EBN(T,(_!@R(RB!49W%H.1JE!0A*,VFAY4&Z!#B0I76ITW=PQ:9)H[9#==
M5)> 4'A?\94>.YQABI-6(XY?;)'L!29W3(-[J<%/F*UUF9)3-*F@B'A6;*6Y
M=GE9<*'X8[!<7IZ94 1>^IO%.RA@?YH%(R)>198>!0UW=X-JJ!=HVUE)F&-J
MJ5ROA\]L:U_F=B5N'V+P8V5ORF7<3W]Q7VBG.B)RKVLJ(.AR\6S, 4Q]SV[S
MIH%EB&-WES1GI67DAKUIFF@Q=2UK=FIC8H!M0FQ]3K-N\6Y_.71P/G!%(%MP
M G%, 2Y^ 7/'I-YBB&V.E7]DV6\.A3=F^W!X<[AH_W'483AJ[W,F399LN'1I
M.(%M_75\'YUM+G7Y 11^+7AEHS1?UW>(D]5B4'@P@Y9DE'C'<E]FN'E17_YH
MS7G<3(QJJGIC-ZMKYGK/'OIJG7KA /U^5'QFH:A=?X%]DF!@&8%=@BUB?($F
M</YDN(#B7NAFX8"D2Y=HU(!W-NAJ X!+'FMH=( = .I^=7_4H&-;D(M[D2M>
M0HJ6@0E@N(F2;^EC"8B#7>9E0(>"2LEG-8:C-D-H6(7X'>YFJX7: -E^D8"3
MGU]9^95TD#)<O)/,@!I?/I'[;P9AFY D71%CXHYO2A-EW(SS-;]FY8OA'8]E
M,XN, ,Q^J("*GIU8NY]ACW-;B)SW?UE>#9I;;DI@;)>_7%IBN)5A26ADN9-I
M-3=ELI(W'3ID!) V ,%^NH""GAU7V*DVCNI:I:8,?L-=(Z*G;;)?>Y].6]!A
MQ)Q82/5CPIH'-,-DHICE',MC#9-X +A^R8!\FS9PLECWC-5QS%Q@?6=R\5^0
M;+QT&V*,6N%U1&5D1\%V9V@3,O)W:&I@&5YWS6M:  "  '(=F>%MAV*-BZ-N
M[F4/?#%P06=I:Z-QC&FA6>5RT6N^1N9T!VVZ,CAT]6]@&-)TR6_<  "  ';(
MF(5JH6P@BC]L0&W'>Q%MO6]5:H5O)G#&6.YP@W(H1AAQR7-T,9ERI71\&&-R
M)G23  "  'KBEP1H!769B,%IRW9^>8-K9W=&:3IL['?Y5[YN;'BC119OPGE!
M,,=PB7FW%\IO['F,  "  'YQE:!EQG\.AV=GIG\\>#-I7G]&9_AJ^7\Y5L9L
MB'\L1#EM[7\H,!INGG\>%U)N!G[P  "  (  E'MCZHB2ADQEWX@*=R9GIH=6
M9O=I4X:,5=9J[87,0W]L3H4K+XALYX2_%NEL<H3   "  (  DX]B8I(2A65D
M9I#8=D9F-H]F9B%G[8WB50UIDHQ]0M9J](M6+Q5K:HJL%IUK(XG'  "  (
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M6)9$:Y5L?)2!7%UMB9*I3"-NCI$/.JIO6X_V)X!O)X_L#P!Q4(HE  "  (
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M#7+W9)9Z:'0%5BYZNW3W1EM[('73-1=[AW:((71[U';0"+)]<'<+  "  (
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M)YK]8/-SFYD04I-S\I<.0S5T296!,G1T>I42'X%SMI+6""QW"H6&  "  (
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M'7B160Z ZGDB2UV MWF8/)F DWG\*^B J7I"&$B _WH3 FZ!1'O   "  (
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M,'U+3@"(9WU[00F'GWV-,MZ'!'V9(MF&S'VC#PN'$GVU  " &X    "  (
M9%J(B(2+65*'YH1W36B'((0O0':&5(/0,EJ%L(.*(H"%6(.)#S.%(8-'  "
M (    "  (  8]Z'@(Q%60V&[XOE32^&'XLD0#^%+(H[,B^$9XFP(C:$!HH!
M#N6#H(?R  "  (    "  (  8WR&L9096*V&(9-\3,N%39)3/^&$3Y$&,>.#
M<Y!N(@*"[9 J#MN"78H+  "  (    "  (  7.">\57?4D*=65B?1L"<"%M%
M.?F:^UVX*XF:?5^^&DF;S6"X!H2<2F$$  "#HVU)  "  (  7 :<W5T=4:R;
M65]51C>9]&%Y.968P&-R*U&8%&4,&E"9$66T!M^8W67C  ""$'(Q  "  (
M6U^:A61#4/69&V7\19^7O6>B.066A&DF*NJ5Q6I6&B:6AVJU!Q>5G&KD  "
MEW<4  "  (  6K:80&M:4#B6YVR>1-&5EVW..&J486[C*FJ3GV^Q&=V4,V_.
M!RZ2L7 C  "  'ME  "  (  6@R63'*!3Y*5!'-;1#"3MW0<-\:2?'2W*@*1
MJW4M&922''4A!S&0*G7>  "  '\N  "  (  67.4MWG(3P:3?7I#0[&2+GJ5
M-U&0Z7K#*9B0!'K?&7&0+7K,!SN-^'O1  "  (    "  (  6/"3:X$33I:2
M/H$[0TR0ZH$C-NV/EX#L*2Z.I8#.&2".J8#K!U",'(#@  "  (    "  (
M6(B27(A@3B^1.H@[0N>/YH?$-I".AH<V*-R-?H<&&+>-<X='!RN*HX39  "
M (    "  (  6#>1CH_E3@F0<H^C0L./%8[.-F^-D(W;*.*,5XW"&/F,"(RA
M!W*)5(4)  "  (    "  (  4*:J851-1F*HF%;2.TVG#5D]+NREY%MI((:E
MV5SW#I>HHUT(  "@"&!\  "  '$N  "  (  3\:HE%LJ1<2FS%TW.K^E'E\R
M+H6CP6#W(%NC;6(K#L>ELF('  "=;&45  "  '7X  "  (  3SVF4V'O12VD
MEF...D&BZV48+A&A?F9Y(!.A!V=6#M&BX6<*  ":WFGN  "  'H\  "  (
M3L>D"VBG1*.B66G>.:2@MFL!+:&?26P '\">OVR1#L:@/VPH  "8=V\K  "
M 'W_  "  (  3DNB"V]Q1"N@:W!..3.>Q7$1+2N=3'&D'XR<I7'V#L"=V7&.
M #66 '4)  "  (    "  (  3=>@:G9@0\J>TW;P..2=*'=5+.N;GG>1'UB:
MUW><#MB;J7=> '&3VGI4  "  (    "  (  37.?$WU50W^=@WVB.*N;SWVP
M++>:-WV>'R:977V,#M&9Y7VU +"2"7[.  "  (    "  (  322> X190TJ<
M<X1Q.(&:MH0R+)F9"(/?'PJ8$H/D#JJ8=X-[ +60F8![  "  (    "  (
M3/&=*8N/0RB;E(N&.&29T(L(+(:8$(J.'Q.6\XJO#MF7'HA$ -V/9X"6  "
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M:H(';J)>\H'?7V5A1H&@3R=C9X%D/9UE"X$[*DUE)($L$>9H]X$[  "  (
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M6H?*9 ]D3(<T5:YF#8:&1CUGF(7K-7!HDX6"(J1GI(6*"LMNSX1#  "  (
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M0XRQ67AJEHO-2^1KL(K./2ALDXH&+-QLWXFZ&BMK]HG,!)EX.H,<  "  (
M<15F<96-981H&I2.6/=I<),B2V5J@Y&>/+UK6)" +(IKA9!?&=!JM(Z(!&QX
MAX+]  "  (  ;,6"V5)[88*"S57G54B"]%DL1\N#.5P].-:#H5\!)]F$>&$L
M$O2&NV&5  "#.F6N  "  'P#:Y9_A%I.8)!_P5TA5&: !U_01Q" 56)3.$.
MN620)W2!:V9$$M>"^V9?  "!"6IB  "  '\V:H1\4V(C7V]\RV1>4W9],F9\
M1BY]D&AN-XM]^&HG)NI^BFMG$I1_B6L_  "  &]Z  "  (  :6UY9FGX7DYZ
M!&NA4E%ZA6TM14MZ]VZ8-K][:&_.)DQ[VW"A$CE\CW!(  "  '3^  "  (
M:&-VU7'3751WD'+U45UX)7/U1%%XHG31-B-Y"W6-)<AY8'8#$?5Y^'6>  "
M 'GB  "  (  9W-TH'G%7'!U>'IB4(AV'GK50YIVG7LE-7]V_WMD)7UW'WN2
M$==WN7M@  "  'X)  "  (  9JYRR(&S6\MSO8';3_9T:X'%0PMTXX&,-.EU
M.8%C)/=U+X%D$:EUVH&)  "  (    "  (  9A)Q28F:6S1R38E53V)S 8B]
M0H)S=(@%-&=SNX>+)')SB8>;$4MT:H;!  "  (    "  (  99AP%I&&6KYQ
M*)#J3NMQX(_;0A-R2XZS- MR?HX")"]R(8XV$1%S/XKP  "  (    "  (
M8*:,;U&85@>+[53<2G>+J5?]/9R+E5KD+QJ+UUUE'@B-*5[Z"8".:E\I  "
M &EI  "  'YP7X^)4EC^52N)$5N[2:J(WEY5//6(Q&"\+J&([F+&'<F)^6/X
M":2*J&/]  "  &XI  "  (  7I^&06!C5"V&,6*82->&%V2O/"^&!&:6+@6&
M)&@I'6*&]6C]":.'46CK  "  '-D  "  (  7;"#:&?)4S*#=VEZ1]6#<6L-
M.V>#:FQZ+56#B6V<'..$)&X8"8:$9VX,  "  'A;  "  (  7,: Z&\]4DZ!
M$G!Q1O2!''&%.HN!%7)O+,"!)W,M'&>!CG-C"6&!XW.*  "  'RL  "  (
M6_1^QW;$48A_"G>%1CU_'W@<.=U_%WB.+"-_%'CB'"5_*'CQ"5I_M'F9  "
M (    "  (  6SQ\\'X]4-=]3WZ219E];WZT.4=]9'ZW*YM]3WZZ&]%])'[$
M"8U]TG\S  "  (    "  (  6JQ[>87+4'1[^87.149\&X5X.09[\83]*V][
MMH3#&XU[6H4;"5)\7(/?  "  (    "  (  6CMZ2HUL4 5ZUXTK1-EZ_XQM
M.*=ZS8N2*R=Z=8M(&V)YV8LR"4Q[*H9)  "  (    "  (  5*66W% ]2HR5
M\5-5/XF53U9*,R:5 ECZ),^5=UL6$N^84ENH 8*4I5V-  "  &T4  "  (
M4YZ3_5<_2;R31%G@/L62IUQ=,HB21%Z;)&>2B&!/$MB4YV"9 =21"F)I  "
M ''X  "  (  4LN1#%X_2-R0>6!G/@J/[&)M,=B/AV0Y(^2/KV6'$IN1I&6.
M @:-RV=G  "  ';D  "  (  4@".0F5 2 :-R&;Q/2B-2VB!,2^,Z6GA(U2-
M 6K0$DJ.DVJ= A^*\&RD  "  'L\  "  (  43F+R&Q51T2+:6V6/&N*]VZU
M,'2*CV^>(N.*BG ]$?Z+OF_F BV(>'):  "  '\&  "  (  4(*)JW. 1IF)
M9W1<.]*(_74-+^J(C'6/(FF(:'77$>*)'W6( D6&57A*  "  (    "  (
M3^*'XGJI1@R'N'LM.UB'5'MU+X"&U7N7(@2&DWNF$:B&Y7N+ G"$@GU7  "
M (    "  (  3V"&8X'$18B&4H'P.MB%]H'7+PR%<(&G(9N%$8&F$2^%&('#
M F&#$8%U  "  (    "  (  3OB%-(DS15J%1HE .KF$\XB]+Q"$.(@4(>V#
M@X@:$>2#'8<D M>!M('L  "  (    "  (  2%BB<4Y?/M^A/%%"-&F@9U/V
M*%F@*%9.&<.A<U>_"*.C&UAE  "1E%_D  "  '!Z  "  (  1T>?YE3^/?B>
M[%=W,WB>&EG%)X^=KUN\&46>H5S8"*>?<UU9  ".W&1^  "  '51  "  (
M1IN=#5N=/32<+5VL,L*;;U^.)MN:^6$D&,.;O6'J")>;SF)0  ",0VE1  "
M 'FI  "  (  1@>:/&(Z/(29;V/<,?:8O&56)D"81V:+&$>8[6<&"("83&=?
M  ")WFY\  "  'V   "  (  1627N&CH.]V7#&HI,5Z66&M ):B5TFP*%_N6
M3&Q+"'65#VRO  "'QG0O  "  (    "  (  1,65DV^^.TJ5"G"G,.246W%?
M)4R3OG'3%[B4 ''0")*2*7)D  "&$'EG  "  (    "  (  1#N3PG:<.L^3
M6G<Y,(*2KG>6)/B2 7>\%VB2'G>9"(*/TGB;  "$LGW*  "  (    "  (
M0\F207V0.FV1]GWM,#*13WWX),.0B'W:%T*0<WW("%*-\'YX  "#18    "
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M#)@6;59'BI7U7H9+DI/R3J!/"I)%/8)119$=*N%0K9$3$]]>:8U   "  (
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M]'.J9T%7*72Y6-1:#W6R25Q<GW:=.$Q>2W=Q)6==@W@)#7YI,7@Z  "  (
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M:7G'7+!;*WI.3Q%=EGJ\0%1?B7LB, =@6'N#'4]@B7N[!M9T<GSJ  "  (
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MXW[T4AM@'W\,139A\G\+-QMC*W\3)T=BWG\O%'%FNW]F 21^$W_Z  "  (
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M[E\72^YT$F&0/R]U#V/7,/IUYF70((%V>&<>#'QY06<:  "  &]6  "  (
M8+!MU60R5AMO468T2K!PEV@=/C=QK&G?,!YR?FM9']5RLVP_##!V6&P@  "
M '31  "  (  7X1J7&OH50-L!&U?2:1M:6Z\/2QNBV_S+WAO3W#Y'TMO'7&(
M"_YST'%N  "  'FR  "  (  7G9G1G.R5 9I&72D2+YJG'5T/&IKQW8B+L]L
M=':P'P-KVW;]"_1QF7<?  "  'W3  "  (  79ADDWMX4TMFE7OS2!MH,WPZ
M.])I7WQB+C-IZ'R+'GII'7RL"]=OPGT]  "  (    "  (  7.=B2H,R4J1D
M;8-!1WUF(8,'.T-G3(*S+:MGLX**'>QFZH*W"XIN7()[  "  (    "  (
M7&)@;8KL4B9BJHJE1O]D;HGU.LQEE8DM+4MEV(C,':AE)HDJ"UEM/H:J  "
M (    "  (  6/.#7$Q@3JN#ED_=0X2$!%,^-PJ$FE9A*+R%@%D"%U:'B5I<
M!'&'U5NB  "  &DU  "  'X:5WA_3E-\381_U5:*0GF 8%EQ-BR \5P;*!.!
ML5Y)%O&#,U]#!(V$"&!N  "  &WQ  "  (  5DA[6EJS3%1\'UU 07M\R5^J
M-3Y]7V'7)U-^ F.1%FM^^V0O!(J MF56  "  ',D  "  (  52MWHF'U2S%X
MDF/]0%9Y567D-%AY]V>:)HAZ?VCF%=-Z^&DO!'-]W&IO  "  '@@  "  (
M5!IT.6E'2BEU4FK./U5V+VPV,V)VT&UL)>)W-VY8%4=WA&Y>!%I[:6_C  "
M 'QR  "  (  4R9Q+'"K24-R;W&[/H1S9'*F,J%T!G-G)3=T/7/K%05TAW/3
M!&)Y0W7?  "  (    "  (  4E%N=W@*2'-OYWBI/<1P]GD:,?5QEGEK)*%Q
MFWF?%*)R)GF !)!X2GMS  "  (    "  (  4:9L)W]T1^]MS'^X/5AN]W^Q
M,:AOB7^-)&5O4G^)%$)P.G^P!%QXHH G  "  (    "  (  425J/X;R1V]L
M 8;I/-QM089X,3EMSH7S)!%M9(7;%!!NI(6X!%%XM8+K  "  (    "  (
M3.^-H$K70V"-:DXV.-6-@U%I++V-_U1$'E6/7U97#("1W5;V  ")BEPT  "
M &RM  "  (  2Y.)RU&40CB)YE2+-[6*%U=0*\6*?UF^'9F+F%ML##F-%5O6
M  "&3F#?  "  '&.  "  (  2H6%^EAG01R&2UKI-KR&E%T\*M>&\U\['-R'
MU&"$"^2(GF"_  "#5&6Z  "  ':(  "  (  28V"5%]'0!>"R&%/-:N#(V,K
M*@&#@62_'""$,66K"XB$MV7"  " JFK>  "  'KK  "  (  2)M^\68\/R=_
MCV?.-,)__FDW*1Z 3VI7&Y6 P6KX"SN!8&K]  "  '!Y  "  'Z^  "  (
M1[I[XFU,/DU\L&YP,_Y]-F]H*'%]?7 B&OM]IG!L"Q-^AG"'  "  '95  "
M (    "  (  1OAY,71=/95Z+74=,UQZRW6G)^9[!78#&G)ZYW83"M1\-G9L
M  "  'M'  "  (    "  (  1D]VT'ML/.MX WO0,KUXO'OX)UUX[7P &?IX
MA'O["FUZ;WRM  "  ']X  "  (    "  (  1=-TVX*\/(=V1(+@,F]W((*?
M)SIW.8)+&B1V<H);"LYXM8(&  "  (    "  (    "  (  0)F914BK-[*8
MK4OE+:.8E$[4(:J945$[$GF<,E)3 U*9OE1@  "$LE^*  "  ' -  "  (
M/S>5O$\$-E25CE'9+"R5F51B($N60%9F$6Z8H5<O PF5%5D_  "!KF1   "
M '4!  "  (  /D&2%E5X-3J2&5?A*QZ2/EH"'SJ2UUN@$*"4PUP? M*0SUXN
M  "  &DC  "  'ET  "  (  /6^.?5O]-%".GUWV*AB.U5^I'F>/9&#H#_^0
MUV$J JJ-!F,Z  "  &Y6  "  'U8  "  (  /)J+%&*:,W2+:60F*42+K65T
M'9F,(F9+#Z>-$&9G IF)Q6B'  "  '0$  "  (    "  (  .\N'\FE=,J:(
MAVJ!*)"(Y6MK'0:)0FOQ#S^)I&O6 J:' VXP  "  'D[  "  (    "  (
M.Q6%*7 I,?2%_G#O)_B&=W%Y'(V&OW&T#N>&KG&& I:$Q713  "  'V8  "
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M?CQ\/7P^?#]]0']!@D*%0XE$C4621IA'FDB;29U*GTNC3*9-JDZO3[10NE'
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M&IV$F AI(YEFE(585I51D05( I$PC6LX6HSPB:\J#8ANA=2KGJGOJUZ;1*6
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M:K2(B$!3'ZU<AOI&,*7PA=<Y]YXLA,4NN98%@]TE&XV-@QJ)(\A"E%![@L&
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M@.<F>HHI@1"8(J^6BWN)R:KTB=M[+J9:B&)L6:''AQM=8IT_A@-.DIBAA0%
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MAKIGQK;2A71;*;!0A'1.K*FB@[1"A:*W@Q4W%IM]@HHLGI/P@B4CP(PS@=^
M^\)3CJ]T6[PJC*-GL+77BL];#*]6B2U.H*BFA[E"B:'-AF4W+YJDA1@LUI,P
M@^8D'(N8@M: W,&4E1]T2[M@DGYGJK4$D E;#:Z!C<).H*?6BYA"E*#\B8,W
M2IGFAW4M!Y*,A7LD:(L6@ZJ O<#YFV)T0+JZF"-GJK13E05;$ZW.DA!.J:<K
MCS5"I*!:C&0W99E#B9<M,Y(!AMTDIXJLA%R G\!^H7)T.;HSG8QGK[/"F;M;
M'*TUE@Y.LZ:7DH%"LI_7COHW?)C*BWDM6)&0B XDVHI5A.^ A\ 9IU!T.+G
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MIV*<[8 $HO:)^7^7GG%VYW]7F?)CY7\ZE651+G\SD*T^MW]>BYTM$'^@A@G
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MD@%=E(2MCN%,)(.WBZD[%8+9B#0K"8( A&VSDHIVIU6C&(CWHX>1_X>,GXR
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MKWK8I.ZF$GKDH7^4R7KRG<V"^WL;F?=Q 'MNEAU?!GOFDC%-97QXCAX\%7U
MB<(KMWXMA/ZV#'I+KCBE9GI:J>V4$7IDI42"0WJ(H&9P4WKAFX)><'MKEHI,
M]GP*D6 [UGS;B^ KH'W7A@&UH7GLMU>DYGG\LBJ3>GGZK'V!I'H4IHQOPGIK
MH)1=^7K[FHA,EGNJE$8[DWR+C;$KCWV3AM>O9HL[:K*@3HGT;*B068C@;GY_
M@X?N<$=N*8<'<B-<H(8I="-+5X51=DDZ0(20>+LI^X/L>YRNBHF2<^J?:HA_
M=.F/78>$==Q^E(:?=M1M3X7(=^%;XX4 >0E*N81!>DHYV8.=>[LIYX,3?6VM
MDX@*?/^>2(<3?2..6X8E?3Y]D856?6)L;X24?9E;+(/F?>5*+8-$?CLY@H*_
M?J0IUH)2?R"L@H:EA@N=*(6ZA6"-*83AA*%\F(0>@^=KEH-Q@T1:A(+;@JE)
ML8)8@@TY-8'V@6DIQH&H@+&K8X5_COZ<+(2:C92,+X/-C M[C(,6BG%JK8)Z
MB-Q9OX(#AU5)(X&6A;PXYH%*A 0IN8$6@ARJ=H2=E_&;.8/ E<"+/X+UDUYZ
MKX)#D-UIZ(&QCEA9(H$^B]-(LX#IB3TXI("VAF\IKH"8@U^IMH/JH,>:=H,5
MG<V*>X)(FHIY[H&7EQEI.8$.DZ-8F("GD")(68!4C(,X;X XB*(II8 PA'>I
M)8-DJ8"9VX*5I;B)U('#H8IY2($)G1QHGX"#F*I8#( NE"A'\W_ICX8X07_2
MBI<IGG_;A66HQ(,&LA>99((\K7V)18%@J%5XLX"8HMQH'H .G6)7J'^^E]U'
MJ'^)DC0X$G^#C$,IF'^6ABFAY904:DZ3[Y(";#^%+9 M;AAUG(YV;^QEEXS!
M<=55;8L)<^9%EHE,=AXV"8>7>*8G=H7I>YNA-9*:<P&3/I"U= B$98[N=0MT
MX(TZ=AEDZHN-=S]4VHGF>(5%'X@]>>8UQX:?>WXGB(4(?5F@;)$I>XV228]@
M>\6#AHVC>_YT 8O_?$5D*(ID?*-4/(C5?1A$JH=$?9PUC(7 ?CPGEX1 ?O>?
M>H_;@^^12(X9@W*"=(QN@NYS)(K2@FIC9(E0@?M3I8?8@99$0X9?@30U683W
M@-4GI(.1@'*>E8ZTC%B07(S_BR.!BXM?B=MR0(G/B(5BM8A0AS93&8;QA?-#
MY(61A*0U+(1#@T,GL(+Z@<B=S8W:E+^/J(PNDM. VHJ.D+UQA8D CHYB!8>+
MC%Q2D(8PBBI#A83DA^HT_8.LA8(GNH)Z@O6=*8TOG0*._(N*FEN +8GHEW)P
MWHA9E&)A<(;LD4Q2&H69CBM#/(1-BO(TVX,KAXDGPH(0@_B<J8ROI1R.=8L0
MH;9_G8EHG?1P4H?1F?E@[89FE?51IH4BD>)"[(/?C;8TOH+!B5,GR(&YA-.<
M3XQ3K1..#(JWJ.Q_(XD'I$%OU8=EGTQ@@87TFE%14X2TE4E"K8. D"8TF()S
MBM8GS8%SA8>4XYTD:?V'VYI=:^1Z+9?(;;]KUY5#;YY=()*R<99.59 0<[@_
M\8U;=@$Q^8J9>)LE*X?)>Y>459O=<C.'6)DP<SUYF9:<=$YK3902=7!<I)&#
M=J]-[X[M>!(_IHQ&>9(QXHF7>TPE88;;?463MYJ!>CB&E9?K>H)X[I5;>M-J
MH)+<>SM<$)!;>[Y-?(W9?%P_6HM'?0PQS(BO?=\ED(8*?M"2^YDZ@A>%Q):N
M@;5X#90M@5-IZY&U@/];<(]*@,!- XS=@)$_#8IA@&@QM8?@@$PEN854@#B2
M.I@LB>"%"96FB-IW4I,MA\II+)"]AK9:Z(Y0A:9,F(OYA*8^S8F1@YXQI(<H
M@H\EVX2W@7F1FI=(D;.$9Y30D -VL9)9CC1HF(_IC%!:8XV!BFM,08LGB(H^
MF8C4AJ(QE8:&A*(E^80S@I.1%9:AF6.#]90PEPMV/Y&RE'1H'(\ZD;E9Z8S9
MCOU+XHJ+C#T^9X@XB6\QAH7^AH F$8/&@X20JY8GH.:#AI.XG=]URI$TFGQG
MJHZREN19@(Q2DTI+A(H0CZ<^*8?$B_8Q>860B"(F)(-LA$^0797.J#^#+Y->
MI(9U9Y#1H$MG1HY%F\M9*HO@ETE+1(FADL$]^X=CCBTQ8X5 B8 F-(,EA/2(
M@*9L::=\4:+X:X%OHY^E;5UB=IQ);T=5!9C*<5!'E94I<X4ZH9%F=>(N.XU_
M>) C(8F >Y.($J57<6Q[_*'H<G-O1YZ"<XUB(YL6=,-4O)>4=AQ'7Y/[=YTZ
MA)!#>3XN3XQO>QPC>8B$?3&'H*0*>/)[:Z"J>45NS)U$>:MAJ)G=>C)45Y9F
M>ME'%Y+>>Z(Z8(\X?( N7(MZ?8<CQH>H?JR'%J+$@$IZS9]L@ !N()P2?[]A
M()BR?Y93XI5-?XA&QI'8?X\Z-XY'?Z,N98J@?\LD"(;I@ *&A:&SAY%Z/)YC
MAJ]MBYL0A<M@C)>SA.M3>911A!Y&=Y#P@UXZ$(UQ@J N;(G@@>8D0(9&@3*&
M!:#ACLYYPIV7C51M%9I!B\-@&);DBBA3$I.#B)!&/9 <AOXY]XROA6TN<XDX
M@](D;X6\@CN%HJ ME>9Y7)SKD\]LK)F4D8E?LY8VCRI2O)+9C,E&!8]XBF4Y
MZHP"A_TN?HBEA8@DEH5+@QR%4)^VG-=Y+)QTFBEL>ID.ER!?=)68D^52>I(V
MD+!%PX[IC7\YOXN%BDTN@8@PAP@DM83O@]F%$I]AHYQX[IP5H$ML-)BCG'=?
M*Y4DF&)2/9&^E%=%F(YSD%(YIXL?C$\N?H?;B$8DSH2EA')\OJ_K:3]Q2ZO7
M:PMEBZ?";.A9?*.";M]-2)\$</Q!+YI,<TDUIY5C=;\JSI!$>(0A5XL,>XU\
M;:\#<)UQ):K8<9UE:*:=<L%98J)"= M--YV[=8%!+9D*=R4UNY0L>.LK"X\?
M>NXASHH!?1]\):V_=ZQPR*F9> 5E'Z58>'Q9&J#\>21- IQ]>?)!$I?<>N@U
MP),/>_DK/8X:?34B-HD9?HM[SJQQ?H1P7JA1?DUDJ*09?BI8PI_$?BQ,N9M5
M?E- Z9;&?I,UO9(-?N4K9HTR?U0BCXA0?])[<*M5A4EP *<\A(ID1Z,(@]-8
M79ZV@R=,>II*@IA P)7/@A\UMY$I@:PKAXQG@4DBVX>E@/-[&:I^C 9OLZ9E
MBKYC_J(LB618%IW8B E,.YEOAKM H93RA7TULY!>A$4KHXNV@Q$C&H<6@>UZ
MT*G7DI9O>:6[D,-CQJ%ZCL%7W)T?C*U,!)B[BJ- @Y1%B*(UMX^LAJ4KO8L=
MA*8C3H:A@L%ZGZE/F.]O2Z4OEHICDZ#HD]U7J9R(D0Q+U9@DCD) 5Y.\BWPU
MJ(\EB, KUXJ<A@4C>(9!@W%Z=*CYGR9O3:3)G#ECCZ!LF,=7CIORE1=+PY>"
MD8) 5I,?C@ ULXZHBI$KZ8I ARDCFH7UA !Q@;FC:-QFJ[4$:I);Q; Q;&U0
MRJK_;G!%T*5I<*([#9^!<PLP\IE8=9PGHY+I>'H?PHQR>X=Q1+CD;]=FJ[02
M<,A;U*\"<?%0Y*FJ<TY%\:0(=.,[/9XE=JPQ-9@&>)DH"I&N>L0@5XM7?0UQ
M*+>B=G-F@++*=LE;NJVP=TQ0S*A/>!-%ZZ*S>0H[3IS>>C$Q8Y;2>W8H7Y"5
M?.@@UXIB?FUQ![9#?,]F3+%O?*);>:Q;?)E0HZ<#?,-%TJ%T?1\[3YNR?9LQ
MA96\?B\HIH^=?N0A18F0?Z=PWK44@Q1F)K!"@G!;4:LO@>!0=*7;@6=%P:!3
M@1@[4)JF@.@QHY3&@,,HXX[$@+<AHXC>@+IPN+0LB5)F$Z]/B#9;0JHUAQ%0
M8Z3AA?5%L)]@A/ [59FWA 4QOI/K@RHI%XX(@EXA\(A(@:=PE[-YCV!F"ZZ+
MC<A;/JEFC E06Z00BD%%J9Z7B(P[6ICXANDQV9,PA54I1HUJ@](B,(?.@F]P
M?K+UE3=F#:WPDR%;0JB\D,!06:-?CD5%GYWIB]P[5)A<B84QYI*@AT,I:XSG
MA1(B9(=J@Q5P;;*6FMEF%ZURF#U;3:@LE3%07*+'D?Q%HYU3CMP[8)?0B]0Q
M\)(GB.4I?8R$AA<BC8<<@YO.H6T89OJ[Z&[L:3VHM7"M:W&4ZG)>;9R M702
M;\YL5G7:<A=8('>_=']$'7G?=R<PR7Q9>C[,OFJT<<6Z:FS!<N2G8&ZM= :3
MOG"+=3!_I')N=F=K8G1G=[-7279^>1)#='C/>ILP8GMX?&+*^6BG?'ZXM&K2
M?(&EZ&SD?(V27F[F?+9^<'#R?/-J7',7?4%6='5;?99"UW?:??LP!WJL?FS)
M.V;7APVV^&D;A@JD.6M$A1:0ZVUHA#5]*6^<@W9I3G'J@K]5I718@@-"17;_
M@3TOMWGW@%;'IV50D7NU<6>FCXNBMFGEC9Z/?&P>B[M[]6YOB>AH3'#CB"A4
MXG-UAE-!P79 A%HO<GE8@AO&7V0<F]:T,F9]F0.A?6C&EAJ.36L0DR]ZX6UT
MD$QG9&_^C6I4,W*RBGA!2W6<ATDO.'C/@[3%6V,FIA*S-66/HEN@?6?<GG*-
M46HNFGAY_6REEH9FI6]$DHA3GW(,CF1 ZG42B?XO"'A<A1W$F6)PL""R=F3<
MJX&?LF<EII2,@&EWH81Y,VOXG'EE^&ZLEV)3'W&)DA- EW2@C&\NX'?]AE7$
M&F'WN>NQ]&1@M%*?&6:?KE>+V&CHJ"UXD6MKH@=E;6XIF]!2IW$5E5Q /W1
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MKX.(;E.6E8,2;^^'C(*O<71WQH)<<O9G?H(8=(A7#8'E=C1&ZH'!=_PW(X'
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M?(<F/H,'?=V6(HDC?AJ(^8@0?D=[)H<,?E]LV880?G%>$H4N?H]/2H1;?KA
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MD%MIT78-CI5=E';7C)A1+'?4BI9$WWD*B)0Y0'I<AI(N07OMA'PDDGVA@F2
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M=U0Q.HX2>/HJ&XK=>JTCNX?2?'8>E(4>?BQ91IM4=_112YCQ>+Y))98X>7Q
M^I,S>CPX^I />Q@Q18SH?!<J.HG8?2,C\8;W?C8>Y(1L?S58]IHB?=!1$9?/
M?B=(_)4=?E% V9(A?G$XWX\,?JDQ0HOZ?OLJ7(CX?V D(H8^?\(?)H/9@!98
MM9DO@WI0YY;G@UM(WI0X@NY Q9$]@F4XT(XQ@?4Q,(LX@9XJ7XA+@5\D2H6E
M@1H?6X-C@-%8BYAOB/50S98IB&%(R9-^AU- N9"%AADXUHUZA/PQ18J-@_TJ
M=(>V@Q4D8X4L@C0?A8,$@6FL?USC52N=,E_]62:-A6,1715]3&8P8/MLGVET
M9.=;Q&SJ:.]+.W"5;2@[$'29<;LL!WCZ=N6JBUCM7V&;L%QO8F",,U_?95=\
M)V-7:$QKG&;T:TE:Z&K&;F%*C&[0<:(ZI7,T=30K]W?R>3ZHO55G:8"9_5D^
M:X"*Q%S_;7YZT6##;X-J>&2O<999_&C5<\%)WFTW=@PZ0''U>)8KZG<'>W:F
M\E(]<W.82U9C=(*))EID=91Y@%YL=JMI4V*F=])9%&<;>0U).FO.>ETYY7#>
M>]DKWG8W?8BE0D]W?4*6RU/@?6Z'Q5@B?9EX-%QD?<1H6V#<??A8266;?CY(
MJVJ6?HXYEF_L?O0KTW6#?VZCU$T@AO&5BU'"ACV&KU8XA7]W/5JQA+MG?5]=
M@_M7J&11@T5(.&F-@I(Y5&\@@=TKRG3I@2*BJ4LID'.4B4_[CM>%SU2;C2IV
M>EE BW5FS5X>B<17&F-#B!%'WFBMAE8Y(FYTA(<KPW1I@J&AQ$F7F;"3PDZ.
MER2%(5--E()UXE@0D=IF1%T3CS=6GV)EC(U'A&?[B<\X^6WFANLKO70 @^FA
M*TAPHH&3-TU[GO>$H%)+FUQU<%<AE\5EYUP[E#A66&&JD)U'1&=BC.0XRFUR
MB/HKN7.KA/N@U6/S5362U&9I63J$26CG72=U&6MX809E<6XL9.Y5HG$0:/E&
M+W0H;3<W*W>5<=8I6WM8=PJ?*V P7N61HV,/8?N#167@90)T/&B\: )DM&N]
M:PI5"F[U;C%%PW)E<8(V\W8O=2HI8WI+>4F=BES.:'F0 6  :J6!VV,;;,=R
M[F9!;N=CFVF/<1-4*FT9<UI%(7#==<(VGG3X>&LI:GE;>V6;ZEG$<>6.;UT]
M<S2 76"7='IQP&/]=;MBEF>8=P=37VMM>&A$EV]^>>$V6'/E>X8I;WB)?5N:
M:%<;>S6-#UK0>Z]_%UYG?!EPC6(%?'EAN&7;?-]2JFGX?5A$'6Y.?=PV'7+V
M?G8I='?3?R69*%3?A&J+[5C$A ]^$UR+@YIOHV!>@Q5@Z&1F@I%2&6BV@AA#
MNFU)@:8UZW(K@30I>7<X@+Z8)E,!C7"+ E</C#Q]/UK[BN)NY5[WB71@/F,P
MB A1E6>NAIU#;FQLA3 UQW& @[,I?':W@B.78E&%EC&*356PE")\E5FWD=YN
M35W0CX-?LV(LC2Q1&F;6BM-#&VN]B' UIW#SA>XI?W9-@U66W5!JGH^)RE2G
MFZ-\$EB]F'-MTUSGE2I?3V%:D>I0T&8ACJ9"V6LIBT\U>G"#A]0I@77YA%*5
M6VLU55:(E&T$659[)V[J73UM!'#G819>9W,#9/M/J75,:0=!4W?$;4DS=GJ-
M<?$FV7VB=RN3YF>C7FJ'8FG789!Z"&P)9*-L#FY,9[!=F7"Q:LE/"'-);@1
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M34UQ8XN0DU'Y9BB";59W:,-SEUL+:V)D7E_5;@Y5!F3J<-A&'6I$<\HWR'
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M>@@H>W=]?*:0=DUU=3>$'%(P=C]W,U;.=T-IP5M[>$-<"&!H>4U.$V6D>FQ
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M,8%L?ODQ)($/?S K5(#*?WPF*("6?]$AFH">@!L>!8#$@%0  /__  #__P
M__\  &UF=#$      P0A   !                     0
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MYO^F.3+_HD9*_:!-8/&D3'+FITR$VJA0EL^F6:;'I62QQ*=OML&G>+N]IX'
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M<)1WSW27=<YWF'/->9IRS7N;<<Q]FW#+?YQORX"=;\N G6_+@)UORX"=;\N
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MTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BTZU_HM.M?Z+3K7^BT_^C.2K_GT9
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MV9&4GMF1E)[9D92>V9&4GMF1E)[9D92>V9&4GMF1E)[9D92>V?^D."K_H$5
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M_YI12O^=4EGWGU1I[:!7>..?7(?:G&>5TIEPH<R6>ZO&E(2SQ).+ML*/C[K
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MA*>2SX"FG-" HZ7/@*&FSH"AILZ H:;.@*&FSH"AILZ H:;.@*&FSH"AILZ
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MW)9QDM63>YS/D(2DRXZ,J\B*D+#%AY2TPX28M\*!F[G!?YZZP7VBN\![IKS
M>:N]OWBRO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MX
ML[V[>+.]NWBSO?^<.!K_FD8M_Y=10?^:4T_^G%5>]9Q:;.R;7WKDF6>'W)9Q
MDM63>YS/D(2DRXZ,J\B*D+#%AY2TPX28M\*!F[G!?YZZP7VBN\![IKS >:N]
MOWBRO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[
M>+.]NWBSO?^<.!K_FD8M_Y=10?^:4T_^G%5>]9Q:;.R;7WKDF6>'W)9QDM63
M>YS/D(2DRXZ,J\B*D+#%AY2TPX28M\*!F[G!?YZZP7VBN\![IKS >:N]OWBR
MO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]NWBSO;MXL[V[>+.]
MNWBSO?^=.!K_FD4N_Y=00?^;44__G51=]9Y8:^R=77GDFV2&W)ANDM65>)S0
MDH&DRX^)J\>-C['%B9.UPX67N,*"FKK!?YZ[P'VBO;][I[Z_>:V^NWBQOK9Y
MLKZV>;*^MGFROK9YLKZV>;*^MGFROK9YLKZV>;*^MGFROK9YLKZV>;*^MGFR
MOO^=.!K_FD4N_YA/0/^=4$[_GU)<]J!5:NV@6GCEGV"%W9QJD=:8<YO0E7VD
MRY*%J\>/C;'$C)&VPH>5N<&#F;N_?YV^OGVBO[UZJ,"\>:_!M'FPP;!ZL,"P
M>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K# L'JPP+!ZL,"P>K# L'JPP/^=
M-QK_FT4N_YE.0/^>3D[_H5!;]Z)3:>ZC5W?FHEV#WI]FC]><;YK1F'FCRY6"
MJ\>2B;'$CH^VPHF3NK^$F+V]@)W O'VCPKM[JL2T>JW$K7NNPZI[K\&J>Z_!
MJGNOP:I[K\&J>Z_!JGNOP:I[K\&J>Z_!JGNOP:I[K\&J>Z_!JGNOP?^>-QK_
MFT0N_YI-0/^?34W_HDY;]Z11:.^E577GI5J"WZ-BC=B@:YC2G'6AS)E^J<B5
MAK#$DHVVP8R1N[Z&EK^\@9S#NGZDQ;=\J\>M>ZO&IWRMQ*1]KL.D?:[#I'VN
MPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#I'VNPZ1]KL.D?:[#I'VNP_^>-QK_FT0N
M_YM,0/^@3$W_I$U:^*9/9_"H4W3HJ%> X*=>C-JD:);3H7&?SIUZI\F9@Z_%
ME8JUP8^/N[V)E<&ZA9W$MH*DQ[" JLBG?:K(HGZLQ9]_KL.??Z[#GW^NPY]_
MKL.??Z[#GW^NPY]_KL.??Z[#GW^NPY]_KL.??Z[#GW^NP_^>-QK_FT0N_YQ+
M/_^A2DS_I4M9^:A.9O&J47/IJU5_XJM;BMNI9935IFZ=SZ-WI<J?@*S%F8:T
MOY.,O+B-D\&RB9G%KH:AR*J$J<FA@*G*G(&LQIN!K<2;@:W$FX&MQ)N!K<2;
M@:W$FX&MQ)N!K<2;@:W$FX&MQ)N!K<2;@:W$FX&MQ/^>-AK_G$0N_YQ*/_^B
M24S_IDI9^:E,9?&L3W'JKE1]XZ]9B-VN8I'6K6N:T:IUHLNE?:O!G8.TN9:)
MO+*1D,&LC);&IXF=R*.'ILJ;@ZC+F(.KQY:$K<66A*W%EH2MQ9:$K<66A*W%
MEH2MQ9:$K<66A*W%EH2MQ9:$K<66A*W%EH2MQ?^>-AK_G$,N_YU)/_^C2$O_
MITE8^JM+9/*N3G#KL5)[Y+-7A=^T8([9LVJ6T;%UGL:H>ZN\H(&TLYJ'O*R4
MC<*FD)3&H(V;R9R+I,N6AZC+DX>KR)*'K,62AZS%DH>LQ9*'K,62AZS%DH>L
MQ9*'K,62AZS%DH>LQ9*'K,62AZS%DH>LQ?^?-AK_G$,N_YY(/_^C1TO_J$A7
M^ZU)8_.P3&_LM%!YYKA6@^&[7HO:NVJ2S;1SGL&K>:JWI'^TKIV$O*:8BL&@
ME)'&FI&8R9:/H<N1C*C,CXJJR(Z*K,:.BJS&CHJLQHZ*K,:.BJS&CHJLQHZ*
MK,:.BJS&CHJLQHZ*K,:.BJS&CHJLQO^?-AK_G$,N_YY'/O^D1DK_JD96_*Y(
M8O2S2VWNN$]WZ+U5?^'!7H;6P&R.R+=QG;VN=ZJRIWVTJ:&"NZ&<B,&:F(_&
ME):6R9"4G\N,DJC,BH^JR8J.K,:*CJS&BHZLQHJ.K,:*CJS&BHZLQHJ.K,:*
MCJS&BHZLQHJ.K,:*CJS&BHZLQO^?-AK_G$,N_Y]&/O^E14K_JT55_+!&8?:V
M26OPO$YTY\)5>]_(88#1PVJ-Q+IPG;BR=:FMJWNSHZ6 NYNAAL&4G8W%CIN4
MR(J9G<J&F:C+AI2JR8:2J\:&DJO&AI*KQH:2J\:&DJO&AI*KQH:2J\:&DJO&
MAI*KQH:2J\:&DJO&AI*KQO^?-1K_G4(N_Z!%/?^G1$G_K4-4_K-$7_>Z1VCO
MP4UPY<E6==S.9'K,QFF-OKYNG+*V=*BGL'FRGJM^NI6FA,".HXO$B*&2QX2?
MFLF GZ?*@9JJR(*8J\:"F*O&@IBKQH*8J\:"F*O&@IBKQH*8J\:"F*O&@IBK
MQH*8J\:"F*O&@IBKQO^@-1K_G4(N_Z%$/?^H0DC_KT%3_[9"7?>^1F7LQTUK
MX])8;=;387K'RF>,N<)MFZR\<J>AMG>QF+%]N8^M@KZ(JHG#@JB0QGVGF<AZ
MIZ7)>Z*KR'V>K,9]GJS&?9ZLQGV>K,9]GJS&?9ZLQGV>K,9]GJS&?9ZLQGV>
MK,9]GJS&?9ZLQO^@-1K_G4(N_Z)"//^J0$?_LCY1_;I 6?/#1&#HSTYCW]Q9
M9\_88'G SV:*LLAKFJ;"<*:;O':OD;A[MXFU@;R"LH? ?;".PWBNEL5VK:'&
M=:RLQG>FK<5WIJW%=Z:MQ7>FK<5WIJW%=Z:MQ7>FK<5WIJW%=Z:MQ7>FK<5W
MIJW%=Z:MQ?^@-!K_GD$N_Z1 ._^L/47_M3M.][\^5>S+1%GAVD]:U-]1;,;:
M6GVXTV*+J\YIF)_&<:25P'>MCKM^M(>W@[F!M(>]?+*,OWFQD\%VL)O"=+"F
MPG*PK<)RL*W"<K"MPG*PK<)RL*W"<K"MPG*PK<)RL*W"<K"MPG*PK<)RL*W"
M<K"MPO^A,QK_GD$O_Z<].O^P.D/]NCA*\,8[3^/514[5X49?R.)+<;K=4H&L
MU5N/G\QFFY;&<*2/P'BKBKQ_L82Y@[6 MX>X?+:+NWFTD+QWM)>]=K2AO72S
MI;YTLZ6^=+.EOG2SI;YTLZ6^=+.EOG2SI;YTLZ6^=+.EOG2SI;YTLZ6^=+.E
MOO^B,QK_H#XN_ZHY-_^T-3_VP#5$Y\\Y1=??/%#)YT%DN^5&=JS<3H6?TUJ2
ME<QGG([&<:2*PGFJA;]^KH"\@K)]NH:T>KF*MG>XCKAUMY.Y<[>:N7.WH+ES
MMZ"Y<[>@N7.WH+ESMZ"Y<[>@N7.WH+ESMZ"Y<[>@N7.WH+ESMZ"Y<[>@N?^C
M,AK_HSHL_ZXT-/ZZ,3KMRC [VMTR/\KG.%6\[#UIK>5$>9_;3H>4TUR2C<QH
MFXC(<J&$Q'FF@,)]JGS @:UYOH6O=[V(L'2\B[)RNY"S<+N5M&^ZFK1ONIJT
M;[J:M&^ZFK1ONIJT;[J:M&^ZFK1ONIJT;[J:M&^ZFK1ONIJT;[J:M/^D,!K_
MIS4J_[0O,/3#*C'>V"LMS.8N1;WR-5JM[CMLG^1$>Y/;48>+U%Z0AL]JF(++
M<YU^R'BA>L9\I'?$@*9UPX.H<\*&J7'!B:MOP(VL;<"2K6R_E:ULOY6M;+^5
MK6R_E:ULOY6M;+^5K6R_E:ULOY6M;+^5K6R_E:ULOY6M;+^5K?^E+QK_K2TE
M_+PG*.70(23.Y"0SOO$L2J[X,UV@[3UMD^1'>HK=5(6#UV&,?])LDGO/<I=W
MS7>:=,M[G'+*?IYPR8&@;LB$H6W'AZ)KQHJC:<:.I&C%D:5HQ9&E:,61I6C%
MD:5HQ9&E:,61I6C%D:5HQ9&E:,61I6C%D:5HQ9&E:,61I?^G+!K_M24?[,D:
M'-#B&2&_\"(XK_TK3:#X-5Z3[D%LB>9-=X'@6(!]W&2&>-AKBW/5<8YPTW61
M;M)YDVS1?)1JT'^6:<^"EVC/A9AFSHB99<V,FF3-CIIDS8Z:9,V.FF3-CIID
MS8Z:9,V.FF3-CIIDS8Z:9,V.FF3-CIIDS8Z:9,V.FO^N)!;UP1<4U-\.$,#O
M&":P_2,\H?\M3I3Y.EV)\4=H@>M2<7KF77ATXF1]<-]K@6W=<(1JW'2&:-MX
MB&;:>XEEV7V*9-B BV+8@XQAUH6-8-:)CE_5BXY?U8N.7]6+CE_5BXY?U8N.
M7]6+CE_5BXY?U8N.7]6+CE_5BXY?U8N.7]6+COZY%@W4T@L&PNX.%K'\&2JB
M_R4]E/\R3(G\0%F!]DUB>O!8:7/L7V]LZ61S:.=J=F;E;WEDY'-Z8N-V?&'C
M>7U@XGM^7^%^?E[A@']=X(. 7."%@5O?B(%;WXB!6]^(@5O?B(%;WXB!6]^(
M@5O?B(%;WXB!6]^(@5O?B(%;WXB!6]^(@=3("0/$UPH'LOL0&:/_'"N5_R@[
MBO\X2('_15)Z_%):<O=98&OT7F1F\F1H8O!I:F#N;6Q>[7%M7.UT;EOL=F]:
M['EP6>M[<5CK?7%8ZG]R5^J"<U;IA'-6Z81S5NF$<U;IA'-6Z81S5NF$<U;I
MA'-6Z81S5NF$<U;IA'-6Z81S5NF$<\3-" &TW0@+I/\2&I?_'RJ+_RXV@?\]
M07G_2DEQ_U)0:?]856/]75A?^V-;7/EG75KX:U]8]VY@5_=Q85;V=&%5]G9B
M5/5W8U/U>6-3]'QD4O1^9%'T@&51](!E4?2 95'T@&51](!E4?2 95'T@&51
M](!E4?2 95'T@&51](!E4?2 9?^6,Q3_E4,E_Y)1-_^74T7_F5=3_9E;8/68
M86WME6AYY9)RA-^/?([:C(66U8>+G-&#D*'/@)6FS7V:J<M[GJO*>:&MR7>E
MK\AUJ;#'=*ZQQW.SLL9SNK+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!=;NR
MP76[LL%UN[+!=;NRP76[LO^6,Q3_E4,E_Y)1-_^74T7_F5=3_9E;8/6886WM
ME6AYY9)RA-^/?([:C(66U8>+G-&#D*'/@)6FS7V:J<M[GJO*>:&MR7>EK\AU
MJ;#'=*ZQQW.SLL9SNK+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!=;NRP76[
MLL%UN[+!=;NRP76[LO^6,Q3_E4,E_Y)1-_^74T7_F5=3_9E;8/6886WME6AY
MY9)RA-^/?([:C(66U8>+G-&#D*'/@)6FS7V:J<M[GJO*>:&MR7>EK\AUJ;#'
M=*ZQQW.SLL9SNK+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!=;NRP76[LL%U
MN[+!=;NRP76[LO^6,Q3_E4,E_Y)1-_^74T7_F5=3_9E;8/6886WME6AYY9)R
MA-^/?([:C(66U8>+G-&#D*'/@)6FS7V:J<M[GJO*>:&MR7>EK\AUJ;#'=*ZQ
MQW.SLL9SNK+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!
M=;NRP76[LO^6,Q3_E4,E_Y)1-_^74T7_F5=3_9E;8/6886WME6AYY9)RA-^/
M?([:C(66U8>+G-&#D*'/@)6FS7V:J<M[GJO*>:&MR7>EK\AUJ;#'=*ZQQW.S
MLL9SNK+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!=;NR
MP76[LO^6,Q3_E4,E_Y)1-_^74T7_F5=3_9E;8/6886WME6AYY9)RA-^/?([:
MC(66U8>+G-&#D*'/@)6FS7V:J<M[GJO*>:&MR7>EK\AUJ;#'=*ZQQW.SLL9S
MNK+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!=;NRP76[LL%UN[+!=;NRP76[
MLO^6,Q3_E4,E_Y-1-_^74T7_F592_9E;8/688&WMEF=YY9-QA-^0>X[:C826
MU8B*G-&$D*+/@)6FS'V9J<M[G:S)>:&NR'>EK\AVJK''=*ZRQW.TLL1TNK*_
M=;JROW6ZLK]UNK*_=;JROW6ZLK]UNK*_=;JROW6ZLK]UNK*_=;JROW6ZLO^6
M,Q3_ED,E_Y50-_^9443_FU12_IQ87_6;76SMF61XYI9L@]^3=HW:CX"6U(R(
MG=&'CJ/-@Y.HRX"8J\E]G*[(>J&QQGBELL9WJK3%=;"UQ72XM;UWN+6X=[BU
MN'>XM;AWN+6X=[BUN'>XM;AWN+6X=[BUN'>XM;AWN+6X=[BUN'>XM?^7,Q3_
MED,E_Y9.-_^:3T3_G5)1_IY57O:>6FKNG&!VYYIG@N"6<HS:DGN5U(Z$G="*
MBZ/-AI&IRH*6K<A^F[#&>Z"SQ7FFM<1WK+;#=K.WOG>WM[=XMKBR>;:XLGFV
MN+)YMKBR>;:XLGFVN+)YMKBR>;:XLGFVN+)YMKBR>;:XLGFVN/^8,Q3_ET,E
M_Y=--_^;34/_GU!0_Z!37?>@6&GOGUUUZ)UD@.&:;HO;EG>4U9& G-".B:/,
MB8^IR825KL> FK+%?:"UPWJGM\)XKKG =[6YN'BUN;%YM;FL>K6YK'JUN:QZ
MM;FL>K6YK'JUN:QZM;FL>K6YK'JUN:QZM;FL>K6YK'JUN?^8,Q3_F$,E_YA,
M-O^<3$/_H$Y/_Z)17/BC56CPHEMTZ:%A?^*>:HG<FG.3UI5\F]&1A:/,C(RI
MR8>3K\:"F;/#?J"WPGJHN<%XL;NY>+.\L7FSNZMZM+NG>[6ZIWNUNJ=[M;JG
M>[6ZIWNUNJ=[M;JG>[6ZIWNUNJ=[M;JG>[6ZIWNUNO^9,Q3_F$,E_YE+-O^>
M2T+_H4Q._Z1/6_FE4V;QI5ARZJ1>?>.B9H?=GG"1UYEXF=*5@:'-CXFIR8J1
MK\6#F+3"?Y^XO7RGN[IZL+VR>K*^JWNRO:9\L[RC?;2ZHWVTNJ-]M+JC?;2Z
MHWVTNJ-]M+JC?;2ZHWVTNJ-]M+JC?;2ZHWVTNO^9,Q3_F$,F_YE*-O^?2D+_
MHTM._Z9.6?JH467RJ%9PZZA<>^6G8H7?HVR.V9]UE].:?I_-DX:HQ8V-K[^'
ME+6Y@YRYM7^CO+%]K+ZL?+&_I7RQOZ%^L[V>?K2[GGZTNYY^M+N>?K2[GGZT
MNYY^M+N>?K2[GGZTNYY^M+N>?K2[GGZTN_^9,Q3_F4,F_YI)-?^@2$'_I$E-
M_Z=,6/JJ4&3SJU1N[:Q:>>:L8(+@JFF+VJ9SE,^??)W&EX.HOI"*L+B+D;:R
MAIBZK8.@O:F!J+^E@+# GW^PP)R LKV:@;.[FH&SNYJ!L[N:@;.[FH&SNYJ!
ML[N:@;.[FH&SNYJ!L[N:@;.[FH&SN_^:,Q3_F4,F_YM(-?^A1T'_I4A,_ZE*
M5_NL3F+UKU)L[K!8=NBQ7G_?L&B(U:QTD,JC>IW FX&HN)2'L+&/CK:KBI6[
MIH>=OJ*%I<"?A*_!F8&OP9>"LKZ5@[.\E8.SO)6#L[R5@[.\E8.SO)6#L[R5
M@[.\E8.SO)6#L[R5@[.\E8.SO/^:,Q3_F4,F_YQ'-?^B1D#_IT=+_ZM)5OVO
M3&#VLE%J[K17<^6W7GS=MFJ#SZ]RD,6F>)V[GGZGLIB%L*N3B[:ECI.[GXN:
MOIN)HL&8B*S"DX6OPI*&L;^1AK.\D8:SO)&&L[R1AK.\D8:SO)&&L[R1AK.\
MD8:SO)&&L[R1AK.\D8:SO/^:,Q3_F4(F_YQ&-/^C14#_J$5*_ZU'5?ZQ2E_U
MM5!HZ[E6<..]7G?9NVJ R[)PD,"I=IVVHGRGK9R"KZ67B;:>DY"[F8^8OI2-
MH,&1C*G"C8JNPHV)L;^-B;*]C8FRO8V)LKV-B;*]C8FRO8V)LKV-B;*]C8FR
MO8V)LKV-B;*]C8FRO?^;,Q3_FD(F_YU%-/^D1#__JD1)_Z]%4_RT25WRN4]E
MZ;Y6;.'#8'+3OFF QK5NC[NM=)RPIGJGIZ" KY^;AK68EXZ[DY65OHZ2G<&*
MDJ?"B)"NPHB.L,"(C;*]B(VRO8B-LKV(C;*]B(VRO8B-LKV(C;*]B(VRO8B-
MLKV(C;*]B(VRO?^;,Q3_FD(F_YY$,_^E0C[_JT)(_[%$4OJW2%KPO4YAYL16
M9][)8FW.P6=_P;EMCK:Q<INKJGBFHJ5^KIF@A+62G8NZC)J3OH>8F\"$EZ3"
M@I:OPH.3L,"$D;*^A)&ROH21LKZ$D;*^A)&ROH21LKZ$D;*^A)&ROH21LKZ$
MD;*^A)&ROO^;,Q3_FD$F_Y]",_^F0#W_K4!'_[1"3_>[1U?MPTU=Y,Q88-G-
M8&S)Q69^O+UKC;"U<9JEKW:EG*I\K9.F@K2,HHFYAJ"0O8&>F;]]GJ+!>YZO
MP7V9L,!_EK*^?Y:ROG^6LKY_EK*^?Y:ROG^6LKY_EK*^?Y:ROG^6LKY_EK*^
M?Y:ROO^<,Q3_FD$F_Z!!,O^H/SS_L#Y%_[=!3?3 15/JR4Y6XM5:5]+17FO$
MR61]ML%JC*J[;YF?M72DEK!ZK(VL@+*&J8>W?Z>.NWJFEKYWI:"_=*:MOW>A
ML;]ZG;*^>IVROGJ=LKYZG;*^>IVROGJ=LKYZG;*^>IVROGJ=LKYZG;*^>IVR
MOO^=,Q3_FT$F_Z(_,?^J/#K_LSQ"^[L^2?#&1$WFTD]-W-Q75LS576J^S6-[
ML,=HBZ3!;9>9O'.BC[AXJH:T?K!_LH6U>;",N'2OE;MQKI^\;J^KO7&JL[QT
MI;.\=*6SO'2EL[QTI;.\=*6SO'2EL[QTI;.\=*6SO'2EL[QTI;.\=*6SO/^=
M,Q3_FT F_Z0\,/^M.3C_MCD_]<$\0^G.1$3>W4U'TN!36,7;7&BWTV%ZJ<UF
MB9S(:Y61Q'&?B,!VIW^]?:UXNX2Q<[J+M&^XE+=LMYVX:K>HN6FVMKAMK[6Y
M;:^UN6VOM;EMK[6Y;:^UN6VOM;EMK[6Y;:^UN6VOM;EMK[6Y;:^UN?^>,A3_
MG3XE_Z<Y+O^Q-C7[O#8Z[<DZ/.#:1#K2XD=,Q^)-7KG>5&ZLV5M\G]1BB)30
M:).*S&^;@L=WHGS#?JAVP(2L<KZ*KV^\D;%MO)BR:[NALVJ[K;)GNK:T9[JV
MM&>ZMK1GNK:T9[JVM&>ZMK1GNK:T9[JVM&>ZMK1GNK:T9[JVM/^?,A3_H#HD
M_ZHT+/^U,C'SPS(SX]0X,-/A/#_&Z$)2N>5(8ZSB37*?WU1_D]E=BHG29Y.#
MS7":?<EWGWC&?:1TQ(.G<,*(J6[!CJMLP)2L:K^;K6F_I:UHOZZM:+^NK6B_
MKJUHOZZM:+^NK6B_KJUHOZZM:+^NK6B_KJUHOZZM:+^NK?^@,!3_HS8B_Z\P
M*/N\+2OHS2PHU> P,,?I.$2Y[#Y7K.E%9Y[G2W62X%. B=E>B8+4:)%\T'&6
M>,QWFW3*?9YPR(*A;L>'HVO%BZ5IQ)"F:,26IV;#GJAEPZ6H9<.EJ&7#I:AE
MPZ6H9<.EJ&7#I:AEPZ6H9<.EJ&7#I:AEPZ6H9<.EJ/^A+Q3_J"\?_[4J(O#&
M)"'8W2,@R.DM-;KR-4FL\3Q:GO!#:9+H3'6(X55_@=MAAWO7:HUVTW&1<M%W
ME6_/?)=LS8"::LR%FVC+B9UFRHV>9<F2GV/)F*!BR)ZA8LB>H6+(GJ%BR)ZA
M8LB>H6+(GJ%BR)ZA8LB>H6+(GJ%BR)ZA8LB>H?^C+13_KBD:^+\@&M[6&!/)
MZ"(ENO0K.JSX-$V>]SQ<DO%&:8CI4'-_XUE[>M]D@G3<:X9PV7&*;=9VC6K5
M>X]HTW^19M*#DF31AY1CT8J58="/EF#/E)=>SYF87L^9F%[/F9A>SYF87L^9
MF%[/F9A>SYF87L^9F%[/F9A>SYF87L^9F/^G*!+_MQ\2YLX1#<OF%1:[]"$J
MK/XK/I[_-$Z2^C]<B/)*9G_L56]YZ%YU<N1D>V[A:WYJWW"!:-YUA&7<>85C
MVWV'8MJ!B&#:A(E?V8>*7=B+BUS7D(Q;UI2-6]:4C5O6E(U;UI2-6]:4C5O6
ME(U;UI2-6]:4C5O6E(U;UI2-6]:4C?^P'@OMQ@X(S=L+"+OS%1JL_R$NGO\L
M/Y+_-TV'_418?_9/87CQ66AQ[5]M:NMD<6?H:G1DYV]W8N5T>6#D>'I?XWM[
M7>-^?%SB@7U;X81^6N&(?UG@C(!8X(^!6."/@5C@CX%8X(^!6."/@5C@CX%8
MX(^!6."/@5C@CX%8X(^!6."/@?.]#03,SPD!O>4,#*S_%QZ>_R0ODO\O/8?_
M/4E__TE2>/Q46G#X6E]I]%]D9/)E9V'P:FE>[VYK7.YR;5OM=FY:['EO6.Q\
M<%?K?G!6ZX%Q5>J$<E3JB'-3Z8MT4^F+=%/IBW13Z8MT4^F+=%/IBW13Z8MT
M4^F+=%/IBW13Z8MT4^F+=,S&" "]U @#K?4.#Y__&A^3_R<MB/\T.7[_0D-W
M_TU*;O]34&?_655B_%Y87OMD6UOY:%U9^&Q>5_=P8%;W<V%5]G9B5/5X8E/U
M>V-2]'UD4?2 9%#S@V5/\X9F3_.&9D_SAF9/\X9F3_.&9D_SAF9/\X9F3_.&
M9D_SAF9/\X9F3_.&9KW+!@"NVP8$G_\0$)/_'1V(_RHH?O\X,G;_1#IM_TM!
M9?]11E__5TE;_UU,6/]B3E7_9E!3_VI14O]M4E#_<%-/_W)43O]U5$W_=U5-
M_WE53/Y[5DO^?E=*_8%72OV!5TK]@5=*_8%72OV!5TK]@5=*_8%72OV!5TK]
M@5=*_8%72OV!5_^-+0[_C#X=_XI,+O^24SO_E%=(_Y5<5/V38F#UD6IK[XUR
M=NF)?'_DA82&X("+C=Q\D9+:>9>6V':<F=5SH)O4<:6=TV^IG])NKJ#2;;.A
MT6RYHM%KP*/-;,6CR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(
M;L:BR&[&HO^-+0[_C#X=_XI,+O^24SO_E%=(_Y5<5/V38F#UD6IK[XUR=NF)
M?'_DA82&X("+C=Q\D9+:>9>6V':<F=5SH)O4<:6=TV^IG])NKJ#2;;.AT6RY
MHM%KP*/-;,6CR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:B
MR&[&HO^-+0[_C#X=_XI,+O^24SO_E%=(_Y5<5/V38F#UD6IK[XUR=NF)?'_D
MA82&X("+C=Q\D9+:>9>6V':<F=5SH)O4<:6=TV^IG])NKJ#2;;.AT6RYHM%K
MP*/-;,6CR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&
MHO^-+0[_C#X=_XI,+O^24SO_E%=(_Y5<5/V38F#UD6IK[XUR=NF)?'_DA82&
MX("+C=Q\D9+:>9>6V':<F=5SH)O4<:6=TV^IG])NKJ#2;;.AT6RYHM%KP*/-
M;,6CR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HO^-
M+0[_C#X=_XI,+O^24SO_E%=(_Y5<5/V38F#UD6IK[XUR=NF)?'_DA82&X("+
MC=Q\D9+:>9>6V':<F=5SH)O4<:6=TV^IG])NKJ#2;;.AT6RYHM%KP*/-;,6C
MR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HLANQJ+(;L:BR&[&HO^-+0[_
MC3X=_XQ,+O^44SO_E59'_Y9;5/V586#VDFAK[X]P=>F+>G_DAX.'WX**C=Q^
MD)+9>I:7UG>;FM5TH)W3<J6?TG"IH=%NKJ+0;;2CT&RZI-!LPJ3*;L2DQ&_$
MI,1OQ*3$;\2DQ&_$I,1OQ*3$;\2DQ&_$I,1OQ*3$;\2DQ&_$I/^.+0[_CCX=
M_XY++O^543K_F%1'_YA84_Z87E_VE61J[Y)L=>F.=G[DBH"'WX6'CMN CI38
M?)28U7F:G--VGY_1<Z2BT'&JI,]OKZ7.;K:FSFV]I\INPJ?#<,*GO7'"I[UQ
MPJ>]<<*GO7'"I[UQPJ>]<<*GO7'"I[UQPJ>]<<*GO7'"I_^/+0[_CCX>_Y!*
M+?^73SK_F5%&_YM64OZ:6U[WF&%I\)5H=.J1<7[DCGR&WXF$CMN#BY37?Y*:
MU'N8GM)WGJ'0=*2DSG*JILUPL:C-;[FIRV_!J<-QP:F\<L"JMW/ JK=SP*JW
M<\"JMW/ JK=SP*JW<\"JMW/ JK=SP*JW<\"JMW/ JO^/+0[_CSX>_Y)*+?^8
M33G_FT]%_YU34?^=6%SXFUYH\9EE<NJ5;7SDD7>&WXR!CMN'B976@9":TWV6
MG]!YG:/.=:.FS7*KJ<QPLZK+;[VKQ7*_J[USOZRV=+ZLL76^K;%UOJVQ=;ZM
ML76^K;%UOJVQ=;ZML76^K;%UOJVQ=;ZML76^K?^0+0[_D#X>_Y-)+?^93#G_
MG4Y$_Y]14/^?5EOYGEQF\IQB<>N8:7OEE'.$X(]]C=N*AI36A(V;TG^5H,]Z
MG*7-=J.HRW.KJ\IQM:W&<;ZMOG2]KK9UO:ZP=KVNK'>]KJQWO:ZL=[VNK'>]
MKJQWO:ZL=[VNK'>]KJQWO:ZL=[VNK'>]KO^0+0[_D#X>_Y5)+/^;2CC_GDQ#
M_Z%/3_^B5%KZH5EE\Z!?;^R=9GGFF&^#X)-YC-N.@I/6AXJ;TH&2H<]\FJ;*
M>**JQW6KK<-SM*^_<[RPMW6\L+!WN["J>+NPIWF\L*=YO+"G>;RPIWF\L*=Y
MO+"G>;RPIWF\L*=YO+"G>;RPIWF\L/^1+0[_D3X>_Y9(+/^<2#?_H$I"_Z--
M3?^D4EC[I5=C]*1=;>ZA8W?HGFN XIAUB=R2?I+3C(>:S(:/H<: EZ?!?)ZL
MO7FFK[EVK[&W=KJRKW>ZLJIYNK*E>KJRHGN[L:)[N[&B>[NQHGN[L:)[N[&B
M>[NQHGN[L:)[N[&B>[NQHGN[L?^1+0[_D3X>_YA'+/^=1S?_H4A!_Z5+3/^G
M4%;\J%5A]:A;:^VG873EI&E^WI]SA]28?9#+D82:Q(J,HKZ$DZBX@)JMM'RB
ML+!ZJ[.M>;6TJ'JYM*1[N;2@?;FSG7VZLYU]NK.=?;JSG7VZLYU]NK.=?;JS
MG7VZLYU]NK.=?;JSG7VZL_^2+0[_DCX>_YA&*_^>1C;_HT=!_Z=)2_^J3E7Z
MJU->\JQ9:.FL8''BJ6AZV:5S@\V<>H_%E8&:O8Z(HK>(D*FQA)>NK("?L:A^
MI[2E?;&UH7VXMIU^N+6:?[FTF8"ZLYF NK.9@+JSF8"ZLYF NK.9@+JSF8"Z
MLYF NK.9@+JSF8"ZL_^2+0[_DCX>_YE%*_^?1#7_I$5 _ZE(2?^L3%/XKE)<
M[[!89>:Q7VW>L&EVTJEQ@LB@>(^_F'Z:MY*%HK",C*FJB)2NI(6<LJ""I+6=
M@:ZVFH"WMY>!M[:5@KFTE(*YLY2"N;.4@KFSE(*YLY2"N;.4@KFSE(*YLY2"
MN;.4@KFSE(*YL_^3+0[_DCT>_YI$*O^@0S7_ID0^_ZM&2/^N2U'ULE!9[+57
M8>2W7FG:M&ESS:QO@L*D=H^YG'R9L9:#HJJ1BJFCC)&NGHF9LIF'H;66A:NW
MDX6VMY&$M[>0A;BUD(6YM)"%N;20A;FTD(6YM)"%N;20A;FTD(6YM)"%N;20
MA;FTD(6YM/^3+0[_DST>_YM#*O^B0C3_J$(]_ZU%1ORQ2D_RM4]6Z;I67>&]
M8&34N&=RR*]M@;VG=(ZTH'J9JYJ HJ25AZF=D8ZNEXZ6LI*+G[6/BJBWC(JS
MN(N)M[>+B+BUBXBYM(N(N;2+B+FTBXBYM(N(N;2+B+FTBXBYM(N(N;2+B+FT
MBXBYM/^3+0[_DST>_YQ!*O^C0#/_J4$\_Z]$1?JT2$SPNDY3Y[]66=["8&#/
MNV9QP[-L@;BK<HZNI'B8I9Y^H9Z:A*B7EHRND9.4LHR1G+6(CZ:WA8^QN(6.
MMK>&C;BVAXRXM8>,N+6'C+BUAXRXM8>,N+6'C+BUAXRXM8>,N+6'C+BUAXRX
MM?^4+ [_E#T>_YU *?^D/C+_JS\[_[%"0OBX1TGMODY/Y<974]K&7E_+OF1Q
MOK9J@+.O<(VIJ7:8H*-\H9B?@JB1FXFMBIF2LH66FK6!E:2W?Y6NMWZ4M[>!
MD;>V@I"XM8*0N+6"D+BU@I"XM8*0N+6"D+BU@I"XM8*0N+6"D+BU@I"XM?^4
M+ [_E#T>_YX_*/^F/3'_K3XY_[1!0/2\1D7KQ$U)XLY82]/*7%[&PF-PN;IH
M?ZZT;HRCKG27FJEZGY*E@*>*H8>LA)^/L7^=E[1[G*&V>)NLMW>;M[9ZE[BU
M?)6YM'R5N;1\E;FT?)6YM'R5N;1\E;FT?)6YM'R5N;1\E;FT?)6YM/^5+ [_
ME3T>_Z ])_^H.S#_L#PW_;@_//'!1$#HRTY"WM-52L[-6UW QF%NM+]G?JBY
M;8J=M'*5E*]XGHNK?J6$J(6J?::,KWBDE;)THY^T<:.JM7"CN+5SGKFT=INY
MLW:;N;-VF[FS=INYLW:;N;-VF[FS=INYLW:;N;-VF[FS=INYL_^6+ [_ESP>
M_Z(Z)O^J.2[_LSHT^;T\..[(0SGCU5 WU]I22,C265RZRU]MK<5E?*' :XF7
MNG"3C;9VG(2S?*)]L(.H=ZZ*K'*MDZ]NK)VQ:ZRHLFFMMK)LJ+NQ;Z.[L6^C
MN[%OH[NQ;Z.[L6^CN[%OH[NQ;Z.[L6^CN[%OH[NQ;Z.[L?^7+ [_FCL=_Z0W
M)?^M-BO_MS<P\\,Z,>;00S#<WTHUS]]21\'86%JST5YKILMC>IK':8:/PFZ0
MAK]TF'V\>I]VNH&D<+B)J&NWDJMHMYRM9;>GKF2WM*YEL[VN:*V]KFBMO:YH
MK;VN:*V]KFBMO:YHK;VN:*V]KFBMO:YHK;VN:*V]KO^8+ [_G3D<_Z<T(_^Q
M,RCYO3(JZLLW*=S=/BG0XT8ZQ>)-2[C>55JLV5QHGM-B=Y+/9X*(RVV,?LES
ME';'>9IPQ8&?:L2)HF;#DJ5BPYRG8,.FJ%_#M*A?P<*H8;K!J6&ZP:EANL&I
M8;K!J6&ZP:EANL&I8;K!J6&ZP:EANL&I8;K!J?^9+ [_H#4:_ZHQ(/^V+B/P
MQ2TBW]@S'-#C.B[$Z$) N.5)4*OA3E^>WE5LDMM<=X?88X%^U6J)=M1QCV_1
M>91KSH"89\R(FV3*D)UBR9B?8,FAH%_)JZ!?R;F?7,C#HES(PZ)<R,.B7,C#
MHES(PZ)<R,.B7,C#HES(PZ)<R,.B7,C#HO^;+ [_I# 8_Z\L&_B^)QODT287
MT>(M(,3K-S.WZSY%JNE%5)[G3&*2Y5)NAN-8>'W@8']VW&F&<-AQBVO5>(]H
MTW^29=&&E&+/C99@SI287LZ;F5W-HYI<S:V:6\VWFEO-MYI;S;>:6\VWFEO-
MMYI;S;>:6\VWFEO-MYI;S;>:6\VWFO^=+ [_J"L4_[<D%>O*'!'3X!X3Q.LK
M)K?Q-#BJ\#Q)G>]$5Y'N2V.&[5)M?>A;=77C8GQPX&N!:]URA6C:>(ADV7Z+
M8M>$C5_5BHY>U)"07-.5D5K3G))9TJ236-*LDUC2K)-8TJR36-*LDUC2K)-8
MTJR36-*LDUC2K)-8TJR36-*LD_^A*PW_KR,/],(7#-;=$ ?%ZQX8M_8I*ZGW
M,SR=]CQ+D?=$6(;V36)]\%9J=NM><6[G9'9JY&MZ9N)R?63@=X!AWWV"7]Z"
MA%W=AX5;W(R&6MN1AUC:EHA7V9V)5MFCBE;9HXI6V:.*5MFCBE;9HXI6V:.*
M5MFCBE;9HXI6V:.*5MFCBO^H(PG]N18'UM$+ \;J$ NV]QX=J?TI+IS^-#Z0
M_SY+AOY'5GWX45YV\UEE;O!?:FCM96YDZFMR8>EQ=%_G=G9=YGMX6^5_>5GD
MA'I8XXA\5^.,?5;BD7Y4X9=_4^&<?U/AG']3X9Q_4^&<?U/AG']3X9Q_4^&<
M?U/AG']3X9Q_4^&<?_^Q%0/4QPD!QM8* [;W$@^H_Q\@F_\K,)#_-CV%_T!(
M??]+477]5%AM^5I=9_9@8F/S9F5?\FMG7/!P:5KO=&M8[GAL5^U\;E7L@&]4
M[(1P4^N(<5+KC'%1ZI%R4.F5<U#IE7-0Z95S4.F5<U#IE7-0Z95S4.F5<U#I
ME7-0Z95S4.F5<]:^!P#%RP@ M]L)!:C_%!*;_R(AD/\N+H7_.3I\_T1#=/].
M2FS_5%!E_UI48/U?6%W[95I:^FI<5_EN7E7X<E]4]W9@4O9Y85'V?6)0]8!C
M3_2$9$[TAV1-\XQE3/.09DSSD&9,\Y!F3/.09DSSD&9,\Y!F3/.09DSSD&9,
M\Y!F3/.09L3"!@"VT0< J.T+!IO_%Q.0_R4?A?\Q*GS_/#1S_T8[:O],06/_
M4T9>_UE)6O]>3%;_8TY4_VA04O]L45#_;U)/_W)33O]V5$S_>55+_WQ52OY_
M5DG^@E=(_8981_V*6$?]BEA'_8I81_V*6$?]BEA'_8I81_V*6$?]BEA'_8I8
M1_V*6+;)! "HV00!F_\.!X__&A&%_R<;>_\S)''_/"QH_T,R8?]*-UO_4#M6
M_U8]4_]<0%#_8$%._V1#3/]H1$K_:T5)_VY&2/]Q1D?_=$=&_W9(1?]Y2$3_
M?$E#_X!)0O^#2D+_@TI"_X-*0O^#2D+_@TI"_X-*0O^#2D+_@TI"_X-*0O^#
M2O^"* G_@CD6_X%()?^*3S'_CE8]_X]<2?^.8U3^BFI>^(5Q:/* >G#N?(-W
MZGB+?>=TDH+D<9B%XF^=B.%MHHO@:Z>-WVFLCMYHL9#=9[>1W6:]D=QEQ9+<
M9<V2U&;1DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DO^"
M* G_@CD6_X%()?^*3S'_CE8]_X]<2?^.8U3^BFI>^(5Q:/* >G#N?(-WZGB+
M?>=TDH+D<9B%XF^=B.%MHHO@:Z>-WVFLCMYHL9#=9[>1W6:]D=QEQ9+<9<V2
MU&;1DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DO^"* G_
M@CD6_X%()?^*3S'_CE8]_X]<2?^.8U3^BFI>^(5Q:/* >G#N?(-WZGB+?>=T
MDH+D<9B%XF^=B.%MHHO@:Z>-WVFLCMYHL9#=9[>1W6:]D=QEQ9+<9<V2U&;1
MDL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DO^"* G_@CD6
M_X%()?^*3S'_CE8]_X]<2?^.8U3^BFI>^(5Q:/* >G#N?(-WZGB+?>=TDH+D
M<9B%XF^=B.%MHHO@:Z>-WVFLCMYHL9#=9[>1W6:]D=QEQ9+<9<V2U&;1DL]H
MTI+/:-*2SVC2DL]HTI+/:-*2SVC2DL]HTI+/:-*2SVC2DO^"* G_@SD6_X-'
M)?^,3C'_D%4]_Y%;2/^085/^C6A>^(AO:/*#>'#M?H)XZ7J*?N9VD8/D<Y>'
MXG"=BN!NHHS?:Z>.W6JLD-UHLI'<9[B3VV:_D]MFQY399M"4SVC0D\MIT)3+
M:="4RVG0E,MIT)3+:="4RVG0E,MIT)3+:="4RVG0E/^#* G_@SD7_X9&)/^.
M33#_DU0\_Y181_^27E/_D&5=^(QM9_*&=7#M@7]XZ7V'?N5YCX3B=96(X'*;
MC-YOH8_=;*>1W&NLD]MILY3::+J6V6?#EMEFS9?0:<Z6R&K.E\1KS9?$:\V7
MQ&O-E\1KS9?$:\V7Q&O-E\1KS9?$:\V7Q&O-E_^$* G_A#D7_XA%)/^13##_
ME5$[_Y961_^57%+_DV)<^8]J9O.*<G#MA7MXZ8"$?^5[C(7B=Y.*WW.:CMUP
MH)';;::4VFNMEMEIM)?8:+V8V&?(F=%IS)G):\R9PFS,FKUMRYJ];<N:O6W+
MFKUMRYJ];<N:O6W+FKUMRYJ];<N:O6W+FO^%* G_A3D7_XI$)/^32R__ET\Z
M_YA41O^765#_EF!;^9)G9?..;V_NB7AWZ8.!?^1^BH7A>9&+WG68C]QQGY/:
M;J:6V&RNF-=JMIK6:,&;TVG+F\IKRYO";<J<NV[*G;AORIVX;\J=N&_*G;AO
MRIVX;\J=N&_*G;AORIVX;\J=N&_*G?^%* G_ACD7_XQ$(_^52B__F4TZ_YI1
M1/^:5D__F5U:^I9D9/22:V[NC71VZ8=^?N2!AX7@?(^+W7>7D-MSGI78;Z:8
MUFROFM5JN9S4:<:=RVS)G<-MR9Z\;\B?M7#(G[)QR)^R<<B?LG'(G[)QR)^R
M<<B?LG'(G[)QR)^R<<B?LG'(G_^&)PG_ACD7_XY#(_^722[_FDLY_YQ/0_^=
M5$[_G%I8^YI@8O66:&SOD6]UZHMY?N6%@X7@?XR,W7F5D=ETG9;4<*6:T&ZN
MG<ULMY_+:\.@PV['H+MOQZ&U<<:AKW+&H:QSQJ&L<\:AK'/&H:QSQJ&L<\:A
MK'/&H:QSQJ&L<\:AK'/&H?^')PG_ASD7_Y!"(_^81RW_G$DX_Y],0O^@44S_
MH%=6^YY>8/2;96KMEFQSYY!V?.&*@(3;A(F+TWZ1DLYXF9C)=*&<QG&IG\)P
MLJ+ ;[VCNG#%H[-RQ:2N<\6DJ73%HZ9UQ:.F=<6CIG7%HZ9UQ:.F=<6CIG7%
MHZ9UQ:.F=<6CIG7%H_^')PG_B#@7_Y%!(O^:12S_GD<V_Z%*0/^C4$K^HU54
M]J)<7>^@8F?HG&EPX99T>=J0?8+1B8:+RH*-D\5]E9G >9V>O':EH;ASK:2U
M<KBELG+#IJQTPZ:G=L.FHW?$I:%XQ*6A>,2EH7C$I:%XQ*6A>,2EH7C$I:%X
MQ*6A>,2EH7C$I?^()PG_B#@7_Y-!(O^;1"S_H$4U_Z-)/_^E3DC[IU11\Z9:
M6^NE8&3CHFAMW)US=M&5>H+)C8*+PH>*D[R"D9JW?9F?LGJAHZ]WJ::K=K.G
MJ7; J*1WPJBA><*GG7K#IYMZPZ:;>L.FFWK#IIMZPZ:;>L.FFWK#IIMZPZ:;
M>L.FFWK#IO^()PG_B3@7_Y5 (?^=0BO_HD0T_Z5(/?^H3$;XJE)/[ZM85^>K
M7V#@J&EIU*%P=<N9>('"DG^+NXN&E+6&CIJO@I6@JGZ=I*9[IJ>C>K"IH'F\
MJIUZP:F:?,&IF'W"J)9]PJ>6?<*GEGW"IY9]PJ>6?<*GEGW"IY9]PJ>6?<*G
MEGW"I_^))PG_B3@7_Y8_(?^>02K_HT(S_Z=&._ZK2T3UKE%,[+!75.2Q7ES;
MK6AFSZ5N=<6==8&\EGR+M9"#E*Z*BYNHAI*@HX*:I9Z HJB;?JRJF'ZXJY9^
MP*N4?\"JDX#!J)* PJB2@,*HDH#"J)* PJB2@,*HDH#"J)* PJB2@,*HDH#"
MJ/^))PG_BC@7_Y@_(/^?/RG_I4$R_ZI%.ORN24'RL4])Z;564.&W7U?5L65E
MRJAL=,"A<X"WFGJ+KY2!E*B/B)NBBH^@G(>7I9>$H*B4@JFJD8*UJX^"OZN.
M@\"JC8/!J8V#P:B-@\&HC8/!J(V#P:B-@\&HC8/!J(V#P:B-@\&HC8/!J/^*
M)PG_BS@7_YD^(/^A/BC_ID P_ZQ#./FQ2#_PM4Y%Y[I52]Z[7E30M&1EQ:QK
M<[ND<8"QGGB*J9A^DZ*3A9J;CXV@EHR5I9&)G:B-AZ>KBH>RK(B'OZR(A\"K
MB(; J8B&P:B(AL&HB(;!J(B&P:B(AL&HB(;!J(B&P:B(AL&HB(;!J/^*)PG_
MC#<7_YL]'_^B/2?_J#\O_ZY"-O>T1SSMNDU!Y,!61MF_7%/+MV-DP*]I<[:H
M;W^LHG6*I)Q\DYR8@YJ5E(J@CY&2I8J.FZB&C:2K@XROK(&-O:R"C+^K@XK
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M8]^!U&/?@=1CWX'48]^!U&/?@=1CWX'48]^!U&/?@?]U) ;_=C40_W=#'/^
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MEW=\K)%^A::,AHR@B(V1FH65EI:"GIJ2@*>=CW^RGHV P9Z,@,F>BX#*G8J
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M5T#]IEA _*E80/RI6$#\J5A _*E80/RI6$#\J5A _*E80/RI6,:X! "VQ 0
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M7NAQV%[H<=A>Z''87NAQV%[H<?]K(P3_:C$*_W$\%/]Z0QW_@$LH_X%3,O^
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M?=1BX7W*8^!^PV3@?[UFWX"W9]^ MV??@+=GWX"W9]^ MV??@+=GWX"W9]^
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M9TCFWV=*X.QG2M_L9TK?[&=*W^QG2M_L9TK?[&=*W^QG2M_L9_^<#0#;L08
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M=%.UY'14L.=U5JSG=5:LYW56K.=U5JSG=5:LYW56K.=U5JSG=?^#$@'_EA$
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M44#M\5% [?%10.WQ44#M\5% [?%10.WQ4=2E  #$L@, MKP# *O)!0"@V @
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M3$;<WDQ&VNU,1-CY3T/8^T]#V/M/0]C[3T/8^T]#V/M/0]C[3]N:  #*J0(
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M)RG_OB<I_[XG*?^^)RG_OB<I_[XG*?^^)Z:V  "8P@  B\X  '[;  !U^0<
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M5!W_5V D_U1K*O]0>"__380S_TJ/-O]'F3G_1J$[_T6I//]$L#[_0[<__T+
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M(P/_B"L%_8TT"?.0.P[JD$,4XH]*&MJ*5"70@UTPR7YG.L-X;T*^='A(N7&
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M5C!ZMETX<[1D/VZR:D1HL7%)9+!Y35^N@5%;K8I46*V55U2LH5E2K*];4*S
M6U"LVEI/J^Y;3ZKZ6U&F^EM1IOI;4:;Z6U&F^EM1IOI;4:;Z6_^ "0#AD@$
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M*EO49R]7U&XS4]-V-E#3?SE,TX@[2M.4/D?3H#]%U*Y 1-2_04/5V$!$T^Q
M0M+V0D'1_D1!T?Y$0='^1$'1_D1!T?Y$0='^1-&8  ##I0  M:X  *FX  ">
MPP( E,T& (K9"@"$XQ@!?>0F W7D,@ANXSP/9^-%%6'C31M<XU4@5^-=)%3C
M9"=0XFLJ3>)S+4KC?#!(XX8R1>.0-$/CG#5!Y*DV0.2X-S_ERS<_Y>0W/^/S
M-CWB^S@]XOLX/>+[.#WB^S@]XOLX/>+[.,:A  "WJP  JK0  )Z^  "3R0(
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M2WTI_TB(+/]&DB[_19LP_T2B,O]#J3/_0K T_T*W-?]!OS;_0<DV_T#7-_]
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M6"Z(FU\U@IEF/'V6;4%XE'1&<Y)[2V^0@T]KCXQ29XZ6562-HEAAC*]97XS
M6E^,V5E?C.Y97XS[6&&*_5=AB?U788G]5V&)_5=AB?U788G]5_]O# #_?PD
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M24BP_TI(L/]*2+#_2DBP_TI(L/]*2+#_2N*&  #.E   PJ$  +:I  "KL0
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M(S3K^",TZ_@C-.OX([.E  "FK0  F;<  (W!  " RP  ==4! &GA!@!D\Q$
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M4&YWV5!N=^]/;G?\3FYW_TUO=_],;W?_3&]W_TQO=_],;W?_3/]D#0#_<@H
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M2E>._TI8CO])6([_25B._TE8CO])6([_2?]Q 0#@@   SXP  ,26 @"[G@(
MLJ0  *FJ!0"BK!4 FZPF I2K- >,JC\/A:A(%WZF4!YXI%@E<Z)>*VZA93!J
MGVPT99YS.6&=>SQ>FX1 6IJ.0U>9FD54F:='4IFV2%&9RDA1F.9(49?U2%&7
M_T=1EO]'49;_1U&6_T=1EO]'49;_1_9W  #8A0  R9$  +^; 0"TH@  JZ@
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M-T"W_S= M_\W0+?_-\Z+  "_F   LJ$  *>I  "<L   D;@  (;  @![R <
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M&P!6XR<!4N0R D[D/ 1*Y$0&1^5-"$7E50I"Y5P,0.5D#C[F;! [YG82.>:
M%#?GC!4UYYD6-.>H%S+HN!@RZ,P8,>CE&#'F]!@QY?P8,>7\&#'E_!@QY?P8
M,>7\&*ZB  "AJ@  E+,  (B]  ![Q@  ;\X  &/6 0!8W@4 5.X0 %'O&P!-
M[R8!2? O D7P. -!\3\$/O%'!3SR3@8Z\E4'-_)<"#7S9 DS\VT*,?1W#"_T
M@@TM](\.*_6=#RKVJQ I]KP0*/;.$2?WYA$G]?$1)_7Q$2?U\1$G]?$1)_7Q
M$:.H  "6L@  B+L  'O%  !OS@  8M<  %;>  !.\ < 2OH0 $;[&0!"^R(!
M/_PJ 3O],@(X_3D"-?X_ S+^1@,P_TP$+O]3!2O_6@4I_V(&)_]K!B3_=@<C
M_X(((?^0""#_G0D?_ZL)'O^Z"1W_R0D<_]T)'/_="1S_W0D<_]T)'/_="9BP
M  "*N@  ?,0  &_-  !BV   5=X  $GD  !$^P4 /_\. #O_%0 X_QP -/\D
M 3'_*P$M_S$!*O\V B?_/ (E_T("(_]( B#_3@,>_U4#'/]= QG_9P07_W($
M%?]_!!3_C 43_YH%$O^F!1'_L@41_[P%$?^\!1'_O 41_[P%$?^\!8RX  !]
MP@  ;\P  &+8  !4WP  1^4  #[Q   Y_P$ -/\+ ##_$  L_Q8 *?\< ";_
M(@ B_R<!'_\L 1S_,0$:_S8!&/\\ 17_00$3_T@"$?]/ A#_5P(-_V$"#/]L
M @K_>0()_X8#"/^2 P?_G0,&_Z4#!O^E P;_I0,&_Z4#!O^E _\Q,0+_-BX"
M_SHO O\[,@/_.SD$_SM#!?\Y3P?_.%P*_S9H#?\T=!#_,H 2_S&+%/\PE!;_
M,)L7_R^B%_\OJ!C_+J\9_RZU&?\NO!G_+L4:_R[/&O\NX!K_+NL:_R[T&O\N
M_!K\+_\9^R__&OHN_QOZ+O\<^B[_'/HN_QSZ+O\<^B[_'/\S+P+_.2P"_STM
M O\^, /_/S8$_S]!!?\]30?_/%D*_SIE#O\X<A'_-GT3_S6(%?\TD1?_,YD8
M_S.@&?\RIAG_,JP:_S&S&O\QNAO_,<(;_S',&_\QW1O_,>D;_3'S&_HR^QOX
M,O\;]S+_'/8Q_QWU,?\>]3'_'O4Q_Q[U,?\>]3'_'O\U+ +_/"H"_T J O]"
M+0/_0S0$_T0_!?]"2@?_058*_S]B#O\];A'_.WH4_SF$%O\XCAC_-Y89_S:=
M&O\VI!O_-:H<_S6P'/\UMQW_-;\=_S7)'?PUV!WZ-><=]S7Q'?0U^AWR-?\>
M\37_'_ U_R#O-/\A[S3_(>\T_R'O-/\A[S3_(?\X*@+_/R<"_T,F O]&*0+_
M23(#_TD\!?](1P?_1E,+_T1?#_]":A+_0'85_SZ &/\\BAG_/)(;_SN:'/TZ
MH!W\.J<=^SFM'OHYM!_Y.;P?^#G&'_8YTQ_R.>0?[SGP'^PZ^A_J.?\AZ3G_
M(^@Y_R3G.?\DYSG_)><Y_R7G.?\EYSG_)?\\)P+_0R,"_T@B O],)@+_3R\#
M_U Y!?].0P?_3$\+_TI;#_](9A/_17$6_$-\&?I"AAOX08X<]D"6'O4_G1_S
M/Z,@\CZJ(/$^L2'P/KDA[C[#(>T^SR'J/N(AYC_O(>,^^2/A/?\EWSW_)]X]
M_RC</?\HW#W_*-P]_RC</?\HW#W_*/\_(P'_1R !_TP> ?]1) +_52P#_U8U
M!/]5/P;_4TH*_E!6#_I.8A/V2VT7\TEW&O!'@1SN1HH>[$62(.M$F2'I0Z B
MZ$.G(^9#KB/E0K8DY$+ ).)#S"3?0^ DVT/M)=9"^"C30O\JT4+_*\]!_RO.
M0?\LSD'_+,Y!_RS.0?\LSD'_+/]#( '_2AP!_U ; ?]7(0'_6R@"_UPR _];
M.P;\648)]E91#O%471/M46@7Z4]R&N9-?!WD2X4@XDJ.(>!)E2/>2)PDW$>C
M)MI'JR?81K,HU4:\*--&R"G11MPJS4?L*LE&]RS'1O\NQ$;_+\-&_R_"1O\O
MP4;_+\%&_R_!1O\OP4;_+_]&'0'_3A@!_U88 ?]<'@'_8"4"_V(M _QB-P7T
M8$$([EU,#>A:6!+C6&,7WU5N&]M2=Q_84( BU$^))-%-D"?/3)<HS4R>*LM+
MIBO)2JTLQTJW+<9*PB[$2M$OP4OG+[U*]#&[2O\RN$K_,K=+_S.V2_\SMDO_
M,[9+_S.V2_\SMDO_,_]*&@'_4A4!_UH6 ?]A&P'_9B$!_F@I O1H,@/L9SP&
MY61("]]A5!#97EX7TEMI',Y8<B#+5GLDR%2#)\52BRK#49(LP5"9+K]/H2^]
M3Z@QNTZQ,KE.O#.W3LHTM4[A-+).\36O3_TVK4__-JQ/_S:K3_\VJT__-JM/
M_S:K3_\VJT__-O]-%P'_51(!_U\4 /]F& #_:QT!^&TD >UN+ +E;38$W6M#
M"-1G3Q#-9%H7R&!D'<1=;2+!6W8FO5E^*;M7A2RX5HTOME64,;14G#.R4Z0T
ML%*M-JU2MS>L4L4XJE+:.*=2[3FE4_HYHU/_.:)3_SFA5/\XH53_.*%4_SBA
M5/\XH53_./]/% '_61  _V,2 /]J% #_;QD \G(? .9T)@'==#$"TW$_",MM
M2P_%:587P&9@';MC:2*W8'$GM%YY*[%<@"ZN6X@QK%F/,ZI8ES6G5Y\WI5>H
M.:-6LSJA5L [GU;2/)U6Z3R;5_@\FE?_/)E8_SN86/\[F%C_.IA8_SJ86/\Z
MF%C_.O]2$@'_7 X _V80 /]M$0#Z<Q0 ZW<8 .!Y'P#4>2T"RW8\!\1R2 Z^
M;U,6N&M<';-H92*O96TGK&-U*ZEA?"^F7X0RHUZ+-:%=DS>>7)LYG%ND.YE:
MKSV76KL^EEK,/Y1:Y3^26_4^D5O_/I!<_SV07/\\CUS_/(]<_SR/7/\\CUS_
M//]5$0#_7PT _VD. /]Q#@#U=Q  YGL1 -E]& #.?2H"Q7LY!KYW10ZW=% 5
ML7!9'*UM8B*H:FDGI6AQ+*%F>"^>9( SFV*'-IAACSB68)@[DU^A/9%>JS^/
M7KA C5[(08M>X4&*7_- B5__/XE@_SZ(8/\^B&#_/8A@_SV(8/\]B&#_/?]7
M#P#_8@P _VP, /AT# #I>@P WGX, -*!%0#(@2<!P'\V!KA\0@VR>$T5K'56
M&Z=R7R*B;V8GGFQN+)MJ=3"7:'PSE&>$-I%EC#F.9)4\C&.>/HEBJ$"'8K5"
MA6+%0H1BWD.#8_%"@F/]08)D_T""9/\_@F3_/X)D_S^"9/\_@F3_/_]9#@#_
M9 L _VX* .IW" #;?0@ U((* ,R$$@##A20!NX,T!;. 0 RM?$L4IGE4&Z%V
M7"&<<V0FF'%K*Y1O<B^1;7DSCFN!-HMJB3F(:)(\A6>;/X)FID& 9K)#?F;!
M1'UFV41\9^]#?&?\07QH_T!\:/] ?&C_/WQH_S]\:/\_?&C_/_];# #_9PD
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M0V9X_T)F>/]!9GC_0&9X_T!F>/] 9GC_0/]D P#N<0  V'P  ,N% @##C ,
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M/$^1_SQ/D?\\3Y'_/.1T  #/@0  PHP  +B6  "MG   HZ$  )BH  "0J@T
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M)+V1  "PFP  I*(  )BJ  ",L0  @+D  '6_  !JQ@0 7LP( %G/$@!7T"$
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M!R7PIP@D\;@((_',""+RY0@B\/,((N_U""+O]0@B[_4((N_U")ZF  "1KP
MA+@  '?!  !JR0  7=   %'7  !&W0  /^H% #SV#@ Y]A< -O<@ #/W*  Q
M^#  +ODV 2OY/0$I^D0!)_I* B7[4@(C^UH"(/QC Q[\;@,<_7L#&_Z)!!G^
MF 08_Z@$%_^W!!;_R 06_^ $%O_D!!;_Y 06_^0$%O_D!).N  "%MP  >,
M &K)  !=T@  4-D  $3?   ZY   -?<# #+_#  N_Q( *_\: "C_(0 F_R<
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M-)!6W32.5_ TC5?],XQ8_S.,6/\RC%C_,8Q8_S&,6/\QC%C_,?]1# #_6PD
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M.')G_S=R:/\V<FC_-7)H_S5R:/\U<FC_-?]9 @#V90  W6X  ,]V 0#'>P,
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M-5YX_S5>>/\U7GC_-?5D  #<<   RGH  ,"#  "VB0  KHT  *2/  "=D1
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M%S>]M1@VO<H8-[SG%S6[]ADUNO\:-+G_&S2Y_QLTN?\;-+G_&[B/  "JF
MGY\  ).F  "'K   >[,  &^Y  !CO@  6,0$ %#(# !-R!< 3,DE $K*,0!'
MRCL!1<I$ D/*3 -!RE0$/LI<!CS*9 <ZRVX).,MX"C;+A0PTRY(-,LNB#C'+
ML@\PS,</,,OE#B_)]0\NR/T1+L?_$B['_Q(NQ_\2+L?_$JZ7  "AG@  E:4
M (FM  !\M   <+L  &3!  !9Q@  3LL# $70"  ^U0X /=4: #S6)@ [US$
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M A#[Q@(0^]T"$/OI A#[Z0(0^^D"$/OI H^K  "!M   <[T  &;&  !9S0
M2],  $#9   UW@  +.,  ";Q   D_@H (?\0 !__%@ <_QP &?\B !?_*  5
M_RX $_\U !+_/  0_T, #O],  W_5@ +_V( "?]O  C_?P$'_Y !!?^@ 03_
MK@$$_[P! __' 0/_QP$#_\<! __' 8.T  !UO0  9\8  %K/  !+U0  /]P
M #/A   IY0  (>P  ![]   :_P4 %_\, !7_$  2_Q0 $/\9  [_'@ -_R,
M"_\H  C_+@ &_S4  _\]  #_1@  _U$  /]=  #_:P  _WL  /^+  #_F0
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M'ZI%XR"G1O,AI4;_(:-&_R*B1O\AHD;_(:)&_R&B1O\AHD;_(?]%#@#_2PH
M_U,, /]7#0#Y6A  ZUL4 -]:' #46BL S%H[ L982 7!5E,)O%1<#;E291&U
M4&T4LT]U%[!.?!FN380:K$R+'*I+DAZH2IH?IDJC(:1)K"*C2;@CH4G&))]*
MWB2=2O DFTK])9E+_R292_\DF$O_))A+_R282_\DF$O_)/](# #_3P@ _U8(
M /5;"0#I7@H Y%X- -5?%0#+8"< Q%\V KY>0P6X6TX)M%E8#K!781*L56D5
MJE1P&*=3>!JE4G\<HE&&'J!0CB">3Y8BG$Z?(YI.J"683K,FET[")Y5.UB>3
M3NPGD4_[)Y!/_R>04/\FCU#_)H]0_R:/4/\FCU#_)O]*"0#_4P4 ^%H$ .)?
M P#:8@8 U&,) ,UC$@#$92, O&4R K9C0 6Q84L)K%Y4#JA<71*E6V46H5EL
M&)]8<QN<5GH>FE6"()A4BB*55)(DDU.;)I%2I2>/4K IC5*^*HQ2T"J*4^DJ
MB5/Y*8A4_RF'5/\HAU3_*(=4_RB'5/\HAU3_*/],!0#_5@$ Z5T  -QC @#1
M9P4 S&@' ,9H$ "]:B  MFDO ;!H/ 2J94<)I6-1#:%A6A*=7V$6FEYI&9=<
M<!R56W<>DEI^(9!9AB.-6(XEBU>7)XE7H2F&5JTKA5:Z+(-6S"R"5^8L@5?W
M*X!8_RJ 6/\J@%C_*8!8_RF 6/\I@%C_*?]/ @#]60  XF   -5G  #,:@,
MQFP% ,!L#@"W;1T L&XL :IL.02E:D0(H&A.#9MF5Q&79%X5E&)E&9%@;!R.
M7W,>BUY[(8E=@B2&7(LFA%N4*(%;GBI_6JHL?5JW+7Q:R2YZ6N,N>EOU+7I<
M_RQY7/\K>ES_*GI<_RIZ7/\J>ES_*O]1  #R6P  WF0  ,]J  #';@( P' $
M +IP# "R<1H JW$I :5P-P.?;D('FFQ+#)9J5!&2:%P5CF9C&(ME:1N(8W >
MA6)X(8)A?R2 8(@F?5^1*7M?G"MX7J<M=EZU+G5>QB]T7N$O=%_S+G1?_RQT
M8/\K=&#_*W1@_RMT8/\K=&#_*_]3  #H7@  V6<  ,MM  ##<0$ NW," +5S
M"0"M=1< IW4G :%T- .;<C\'E7!)"Y%N4A",;%D4B6I@&(5I9QN":&X>?V9U
M(7UE?21Z9(4F=V2/*75CFBMR8J4M<&*S+V]BQ"]N8MXO;F/R+FYC_BUN8_\L
M;F/_*VYC_RMN8_\K;F/_*_]5  #E8   TVD  ,AP  "_=   MW<! +!W!P"H
M>!4 HGDD )QX,@*6=CT&D71'"XQR3P^(<%<3A&]>%X!M9!I];&L=>FMS('=J
M>B-T:8,F<FB-*6]GERQM9Z,N:V:Q+VEFP3!I9MLP:6?P+VEG_2UI9_\L:F?_
M*VIG_RMJ9_\K:F?_*_Y8  #A8P  SVP  ,1S  "[>   LWH  *MZ! "D>Q(
MGGPB )A\+P*2>CL%C'A%"H=W30Z#=542?W-<%GMR8AIX<&D==6]P(')N>"-O
M;8$F;6R+*6ILEBMH:Z$N9FNO+V1JOS!C:]@P8VOO+V1K_"UD:_\M96O_+&5K
M_RQE:_\L96O_+/1;  #=9@  RV\  ,!V  "W>P  KWX  *9^ 0"??Q  F8 ?
M ). +0*-?SD%B'U#"8-[2PU^>E,2>GA:%G9W81ES=6<<<'1N'VUS=B)J<G\F
M:'&)*&5PE"MB<* M8&^M+U]OO2]>;]0O7F_M+U]O^RU?;_\L8&__+&!O_RQ@
M;_\L8&__+.M>  #8:0  QW(  +QY  "S?P  JX(  *&"  "9@PX E(0= (Z$
M*P&(@S8$@X) "'Z 20QY?U$0=7U8%')\7QAN>V4;:WIL'FAY=")E>'TE8G>'
M)V!VDBI==9XL6W6K+EITNR]9==$O673L+EET^BU:=/\L6G3_*UIT_RM:=/\K
M6G3_*^9A  #1;0  PW8  +E]  "O@P  IH8  )R&  "4B P CHD9 (F)* &#
MB30#?H<^!WF&1PMTA4\/<(16$VV"71=I@6,:9H!J'6-_<B!@?GHC77V$)EI\
MCRE8>YPK5GNI+%1[N2U3>\XM5'KJ+51Z^2Q4>?\K57G_*E5Y_RI5>?\J57G_
M*N%E  #,<0  OWH  +2"  "KAP  H8H  )6+  "-C0D AXX6 (*/) %]CS$"
M>(X[!7.-1 EOC$P-:XI4$6>)6A5DB&$888=H&UZ&<!Y;A7@A6(2")%6$C292
M@YHI4(*G*D^"MRM.@LPK3H+H*TZ!^"I/@/\J3X#_*4^ _RE/@/\I3X#_*=MJ
M  #'=0  NG\  +"'  "FC   G(\  (^1  "&DP4 @)02 'N5(0!WE2T!<I4X
M!&V40@=IDTH+99)1#F*16!)>D%\56X]F&%B.;1M5CG8>4HV (4^,BR--BY@E
M2XNE)TF+M2A(B\HH2(KG)TF)]RA)B/\G28?_)TF'_R=)A_\G28?_)]%O  #!
M>P  M80  *N,  "@D   E90  (F7  !^F@  =YL. '.<' !OG2D!:YPU F:<
M/P5BFT<(7YI/"UR:5@]8F5P259AC%5.8:Q=0EW,:399]'4J5B1]'E94A196D
M(T24LR-#E,@C0Y3E(T.2]21#D?\D0Y#_)$.0_R1#D/\D0Y#_),IU  "[@0
ML(L  *21  ":E0  CYD  (.=  !TH@  ;J,+ &JD%P!FI24 8Z4Q 5^D.P-;
MI$0%6*1+"%6C4PM2HUH-3Z)A$$VB:!-*H7$51Z![&$2@AAI"GY,<0)^B'3Z?
MLAX]G\8>/9_C'3V=]!X]G/\?/)O_'SR;_R \F_\@/)O_(,)\  "UB   J9
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M""K$\ @IPOL)*,'_"BC!_PLHP?\+*,'_"ZB5  "=FP  D:(  (2I  !XKP
M:[4  %^[  !4OP  2<,  #_(!  VS0D ,\X1 #+/'  QSR< ,- Q "_0.@ N
MT4, +=%, "O250 JTE\!*--I 2?3=@$ETX0")-24 B+4I@(AU;D"(=72 B#3
MZP(@TO8#']'_!!_1_P0?T?\$']'_!)^;  "4H@  AZD  'FQ  !MN   8+X
M %3#  !)QP  /LL  #70 0 MU08 )=L+ "3>$@ CWAP (M\E "'@+@ @X#<
M'^%  ![A2@ =XE, '.-> !OC:@ :Y'@ &.2( 1?EF@$6YJP!%>;  13GW0$3
MY>\!$^/Z 1/C^@$3X_H!$^/Z 9:B  ")J0  >[$  &ZY  !AP   5,8  $C*
M   ]SP  ,],  "K9   BW@( 'NL* !SL$  ;[1< &>T? !?N)@ 5[BT %.\U
M !/P/0 1\$8 $/%0  _R6P .\FD #?-X  STB@ +]9P "O6N  GVP@ )]MD
M"/7M  CU[0 (]>T "/7M (NI  !]L@  ;[H  &+"  !5R0  1\X  #O2   Q
MV   )]T  !_A   9Z   %O@& !3Z#0 2^Q( $/P7  [\'0 -_2, #/TI  K^
M,  (_S@ !O]!  /_3   _U@  /]F  #_=P  _XD  /^;  #_JP  _[L  /_.
M  #_SP  _\\  /_/ '^R  !QN@  8\,  %;+  !(T0  .M8  "_=   EX0
M'.4  !3I   1]P  #_\!  W_"0 +_PT "/\0  ;_%  #_Q@  /\>  #_(P
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M"<DQZ@K&,?<,PS'_#L$Q_P_ ,?\/OS'_#[\Q_Q"_,?\0OS'_$/\V$P#_.0\
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M')5&_QN41O\;DT;_&Y-'_QN31_\;DT?_&_]"!0#_2@$ \E   .%4 0#95@4
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M(758_R%U6/\A=5C_(?]-  #E5P  TU\  ,AD  "_9P  MV@  +%G!P"I:!0
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M:0  O'(  +)X  "I?0  GW\  ))^  "*?P< A( 3 ("!(0![@2X!=X Y W*
M0@5N?TH(:WY1"VA]6 YD?%\18GMF%%]Z;1=<>74967A_'%=XBAY4=Y8A4G:D
M(E%VLR-0=L8D4';C(U!U]2-1=?\B473_(5%T_R%1=/\A473_(=AC  #%;0
MN'8  *Y]  "E@@  FH,  (V#  "$A , ?840 'F&'@!UARL!<8<V FV&/P1I
MA4<'981/"F*#5@U?@UP/7()C$EJ!:Q57@',85']]&E%_B!Q/?I0?37ZB($M]
ML2%*?<0B2GWA(4M\]"%+>_\@2WO_($M[_R!+>_\@2WO_(-!G  # <@  M'L
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M%3F8[Q8YE_P6.);_%SB5_Q<XE?\7.)7_%[MZ  "OA0  I(P  )B1  "-E0
M@9H  '6=  !HH   6Z0  %:E# !3IA< 4:<C $^G+P!,IS@!2J=! 4BG20)&
MIU $0Z=8!4&G7P8_IF@(/:9R"CJF?0LXIHH--J69#C2EJ0\SI;L/,Z74#S.D
M[@\RHOL0,J'_$3*A_Q$RH?\1,J'_$;2"  "HC   G9(  )*7  "&G   >:$
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M 1C*_P(8RO\"&,K_ IN9  "/GP  @J8  '6M  !HLP  7+D  %"]  !$P0
M.<0  ##(   HS $ (- & !G5"P 6UQ  %=@9 !79(@ 4V2L $]HT !/:/0 2
MVT@ $=Q3 !'=7P 0W6T $-Y^  [?D0 .X*0 #>"X  S@T@ +W^T #-[W  S=
M^P ,W?L #-W[ )*?  "%IP  =ZX  &JU  !=O   4,$  $3%   XR0  +LT
M "71   >U0  %MH! !'>!@ 0YPT #N<2  WH&0 ,Z"$ "^DI  KJ,0 )ZCL
M!^M%  7K40 $ZUX  ^MN  'K@   ZI0  .JG  #KO   Z](  .OI  #L[P
M[.\  .SO (>G  !YKP  :[<  %Z^  !1Q0  0\D  #?-   MT0  (]8  !O;
M   3WP  #N,   SN @ *]@H !_8.  7V$@ #]A@  /4>  #U)0  ]2X  /4W
M  #V0@  ]DX  /9=  #V;@  ]H$  /:5  #WIP  ][<  /C'  #XT   ^-
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M ?\.A '_#HL!_PZ2 ?\.F '_#IT!_PZC ?X.J '\#JX!^PZU /H.O@#X#LD
M]0[; /(.Z@#N#O4 [ [_ >L/_P'J#_\!ZA#_ >D0_P'I$/\!Z1#_ ?\B'P#_
M(AP _R$< /\?( #_'RD _QPT /\:0 #_%TP!_Q58 ?\48P'_$VX!_Q-W ?X3
M@ '\$X@!^A*. ?D2E0'X$IH!]A*@ ?42I@'T$JP!\Q*S ?$2O 'P$L<![1+8
M >D3Z 'F$_4!Y!3_ >(4_P+A%?\"X17_ N 5_P+@%?\"X!7_ O\E&P#_)A<
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M"K P_PNN,/\+KC#_"ZTP_PNM,/\+K3#_"_\S# #_-@8 _SP) /\^# #]/1
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M%85'_Q6%1_\5A4?_%?\_  #L2   W4\  ,]3  #&50  P%,# +M1# "S4AD
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M'%QBLAU;8L4=6V+A'5MB]!Q;8O\;7&+_&EQB_QI<8O\:7&+_&N!5  #+7P
MO6<  +)L  "I<   GV\  )1L  ",;0@ AFX3 ()O(0!];RT!>6\X G5N00-R
M;4D%;FQ0!VMK5PII:UX,9FIE#F1I;!%A:7037VA^%EUGB1A;9Y4:66:B&U=F
ML!Q69L,=5F;?'59F\QQ79O\;5V;_&E=F_QI79O\:5V;_&MM9  #'8@  NFH
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M&49W[QA'=OP81W;_&$=U_Q='=?\71W7_%\EE  "Z;P  KG<  *1]  "8?P
MBW\  'Y_  !S@0  ;(,) &B$$P!EA2  8H8L %^&-@%<AC\"685& U>%3@54
MA54'4H1<"4^#8PM-@VL-2X)T#TB"?Q%&@8P31(&:%4* J19!@+H60(#2%D%_
M[19!?OL607W_%D%]_Q9!??\607W_%L)J  "U=0  JGT  )^"  "2@P  A80
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M"BV;_PHMF_\*+9O_"J^   "CB0  EXX  (V3  !_E0  <I@  &:<  !;H
M3Z0  $6G   ^J0P /*H4 #JJ'P YJBD .*LR #>K.P UJT, -*Q+ #*L4P$Q
MK%P!+ZQF BVL<0(KK'\#*JR. RBLG@0GK+ $)JS%!":KY ,EJ?4$):C_!26G
M_P4EI_\%):?_!:>)  ";CP  D90  (29  !XG@  :Z(  %^F  !3J@  2*T
M #VP   TLP, +[4. "VU%@ LM2  *[8I "JV,@ IMSH *+=# ">W3  FN%4
M)+A? ".X:P BN'@!(+B( 1^XF0$=N:L!'+G  1RXWP$<MO(!&[7\ ANT_P(;
MM/\"&[3_ I^/  "4E0  B)L  'NA  !NI@  8JL  %:P  !*LP  /[8  #6Y
M   LO   )+\& !_"#0 =PA0 ',(> !O#)@ :PR\ &<0X !C$00 7Q$H %L55
M !7%80 4QF\ $\9_ !+&D0 1QZ0 $,>Y  _'U  0QNX $,3Z !##_P 0P_\
M$,/_ )>6  "+G   ?J(  '&I  !DKP  6+0  $NX  ! NP  -;X  "O!   C
MQ0  &\D! !3,!@ 0T L #M$1  W1&0 -T2$ #-$J  S1-  +TCX "M))  G3
M50 )TV( "--R  ;4A  %U)@ !-2K  /5P  !U=P  =7M  '5]@ !U?8  =7V
M (Z=  " I   <ZL  &:Q  !9N   3+T  #_    TPP  *L<  "'*   9S@
M$M(   W6 0 )VP4 !MP-  3<$0 #W1@  =X@  #>*   WS$  . \  #A1P
MXE0  .-C  #C=   Y(@  .2;  #EK@  Y<$  .75  #FYP  YN<  .;G (.D
M  !UK   :+,  %J[  !-P0  0,0  #/(   HS   ']   !?4   0V0  "]T
M  7A    Y    .4'  #F#0  YQ$  .@6  #I'0  ZB4  .LN  #M.0  [T4
M /!3  #Q9   \78  /**  #SG   \ZT  /2[  #TR   ],@  /3( '>M  !J
MM0  7+T  $_$  ! R0  ,\T  "?1   =U@  %-P   [@   (XP   >8   #J
M    [@   .X   #O!   \ H  /$.  #S$@  ]!@  /8@  #X*@  ^C4  /U#
M  #^4@  _V,  /]V  #_B0  _YH  /^F  #_L   _[   /^P /\6(P#_%2$
M_Q$A /\-) #_"2L _P8W /\#1 #_ %$ _P!= /\ : #_ '( _P![ /\ @P#_
M (H _P"1 /\ E@#_ )P _P"A /T I@#[ *P ^0"S /< NP#U ,4 \P#1 /(
MY #Q /$ [P#Z .X _P#N /\ [0#_ .T _P#M /\ [0#_ /\9( #_&!T _Q4=
M /\0'P#_#BD _PPT /\*00#_!TT _P59 /\$9 #_!&X _P-W /\#@ #_ X<
M_P.- /T"DP#[ ID ^0*> /<"I #U JH \P&P /$!N #O <( [0'/ .L!XP#J
M >\ Z +[ .<$_P#F!?\ Y@;_ .8&_P#F!O\ Y@;_ /\<&P#_&QD _Q<8 /\5
M'0#_$R4 _Q$P /\0/0#_#DD _PQ5 /\+8 #_"VH _0MS /L+? #Y"H, ]PJ*
M /4*D #T"I8 \PJ; /$*H0#O":< [0FN .L)M@#H"<  Y@G- .0)X@#B"O
MWPO[ -X,_P#<#?\ W W_ -L-_P';#?\!VPW_ ?\?%P#_'A, _QL2 /\<&0#_
M&R( _Q@L /\5. #_$T0 _A)0 /D16P#U$&8 \Q!O / 0=P#N$'\ [!"& .H0
MC #I$)( Z!"8 .8/G@#E#Z4 XP^L .$/M #@#[X W@_, -H0X0#5$?  TA+[
M ,\2_P'.$_\!S1/_ <T3_P',$_\!S!/_ ?\B$@#_(@\ _R$/ /\B% #_(AP
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M")PQ_PB<,?\(G#'_"/\P  #_-0  [S@  .(Z  #;.00 UC4) ,XT$P#&-B(
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M  #93   R%,  +U7  "T6   K%<  *52 0">4P\ F%0< )-4*0"/5#4 BU-
M 8A32 *%4E $@E%7!7]07@9]4&0(>T]K"7E/<@MW3GL-=4Z$#G--CA!Q39D1
M;TVE$VU-LQ1L3<44:T[A%&M.]!-K3O\2:T[_$FM._Q%K3O\1:T[_$>A&  #3
M4   Q%8  +E:  "P7   IEH  )]6  "85@T DE<9 (Y8)@")6#( AE@] 8)7
M10)_5DT#?%54!7E46P9W5&$(=5-H"7-3< MQ4G@-;U*!#VU2BQ!K49<2:5&C
M$V=1L11F4<,595+>%652\A1E4O\395+_$F52_Q)E4O\295+_$N1*  #/4P
MP%H  +5>  "L8   HEX  )I9  "26@L C5L6 (A<(P"$7"\ @%LZ 7U;0P)Y
M6DL#=EE2!'186 9Q6%\';U=F"6U7;0MK5G4-:59^#V=6B1%E59428U6A%&)5
MKQ5A5<$68%7;%F!6\15@5OX48%;_$V%6_Q)A5O\285;_$N!-  #+5@  O5T
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M%5%A[1528?L44F'_$U-A_Q)38?\24V'_$M%6  # 7P  LV8  *EK  "<:P
MD&H  (5G  !]:0  =VH- '-K%P!O:R0 ;&PO &EL. %F:T$"8VM) V%K4 1>
M:E<&7&I=!UII90E8:6T+56AV#5-H@0]19XT13V>:$DYGJ11-9[D43&?/%$QF
MZQ1-9OL336;_$DYE_Q).9?\23F7_$LQ:  "\8P  L&H  *5O  "8;@  C&T
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M#CQX_PX]=_\./7?_#KQH  "O<@  I'D  )9Z  "(>@  ?'H  '!\  !C?P
M7((  %>$"P!3A10 488@ $^&*@!.AS0 3(<\ 4J'1 %(ATL"1H=3 D2&6@-"
MAF($0(9L!CZ%=@<[A8,(.861"CB$H LVA+$+-H3&"S:#Y LV@O8+-H'_##:
M_PPV@/\,-H#_#+9O  "J>   GW\  )!^  "#?P  =X   &N"  !>AP  58H
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M J*&  "7C   BX\  'V1  !OE   8Y@  %>=  !-H0  0Z4  #BH   PJP
M**X' "2O$  CKQ< (:\A ""P*0 ?L#$ 'K Z !VQ0@ <L4P &[%6 !JQ80 9
MLF\ &+)^ !:RD  5LJ( %+*V !.RS@ 3L>L $Z_Y !.N_P$3KO\!$Z[_ 9J-
M  "0D@  A)<  '6:  !HGP  6Z,  %"H  !%K   .[   #&R   GM0  (+@
M !BZ!P 4O X $[P5 !*\'@ 1O28 $;TN !"]-P 0OD$ #KY,  Z^5P -OF4
M#+]T  N_A@ *OID "+ZL  >^P@ 'OM\ "+[P  B]^@ (O?P "+W\ ).4  "'
MF0  >I\  &RE  !@J@  4Z\  $>S   \M@  ,;@  ">[   ?O@  %\$  !'$
M 0 ,R @ ",D.  ?)%  &R1P !<DD  3*+  #RC8  LI   #+3   RUD  ,MH
M  #+>0  S(P  ,N?  #+LP  R\@  ,SB  #,[P  S/$  ,SQ (J:  !\H0
M;Z<  &*M  !5LP  2+@  #N[   PO@  )L$  !W$   5R   #\L   K.   $
MT@(  -,*  #3#P  U!0  -4:  #6(@  URH  -DT  #:/P  W$L  -Q:  #=
M:@  W7T  -V1  #=I   WK8  -[(  #>W@  WN(  -[B '^B  !QJ0  9+
M %:W  !)O   /,   "_$   DQP  &\L  !//   -T@  !]8   #;    W@
M -\#  #@"0  X0X  .(2  #C%P  Y1X  .8G  #H,0  ZCT  .Q+  #L6@
M[6P  .Z   #NE   [J4  .ZT  #NP@  [L8  .[& '2J  !FL@  6+D  $O
M   ]Q0  +\D  "3-   9T0  $=8   O;   #W@   .$   #E    Z    .D
M  #J    ZP8  .T+  #O#P  \!,  /(:  #T(P  ]RX  /D[  #[2@  _%L
M /UM  #]@   _I,  /ZB  #^K0  _J\  /ZO /\0'P#_#AT _PH= /\!( #_
M "@ _P U /\ 00#_ $X _P!: /\ 90#_ &X _P!W /\ ?P#^ (8 _ ", /L
MD@#Y )< ^ "< /< H@#V *< ]0"M /, M0#R +T \0#) .\ W #N .L [0#W
M .P _P#K /\ Z@#_ .H _P#J /\ Z@#_ /\3' #_$1D _PT9 /\&' #_ R4
M_P Q /\ /@#_ $H _P!6 /\ 80#_ &L _0!S /H >P#W (, ]0") /0 CP#R
M )0 \0"9 /  GP#N *0 [0"K .P L@#J +H Z #& .< U@#E .@ Y #U .,
M_@#B /\ X0#_ .$ _P#A /\ X0#_ /\5& #_$Q0 _P\4 /\-&0#_"R( _P@M
M /\$.0#_ 48 _P!1 /X 7 #Z &8 ]@!O /( =P#O 'X [0"% .L BP#J )$
MZ "6 .< G #F *$ Y "H ., KP#A +@ WP## -T T0#; .8 V0#S -< _0#5
M O\ U +_ -0#_P#4 _\ U /_ /\8$P#_%1  _Q(/ /\2%0#_$1T _PXH /\,
M- #_"D$ ^0A, /4&5P#Q!F$ [09J .D%<@#F!7H Y 6! .(%AP#@!HT WP:2
M -T&F #;!IX V0:E -<&K0#4!K4 T@;  - 'SP#.".4 S GT ,H+_P#(#/\
MQPS_ ,<,_P#&#/\ Q@S_ /\;#@#_&0P _Q@- /\8$0#_%Q@ _Q0B /L1+@#S
M$#H [0Y& .@-4@#E#5P X0UE -X-;0#;#74 V U\ -4-@@#3#8D T0V/ - -
ME0#.#9P S0ZC ,L.JP#)#K0 R [  ,8.SP##$.8 P!'U +T2_P"\$O\ NQ+_
M +H2_P&Z$O\!NA+_ ?\?"@#_' 0 _Q\( /\?#0#_'1( ^!H; .X6)@#F%#,
MX!,_ -H32P#4$U8 T!-? ,X4: #+%&\ R11W ,<5?0#&%80 Q!6* ,,5D0#!
M%I@ P!:? +X6IP"\%[  NQ>\ +D7RP"W&.( LQGR ;$:_P&O&_\!KAO_ :X;
M_P&M&_\!K1O_ ?\B! #_(@  _R4" /PD!P#W(0P [!T2 .$:' #8&BH T!LX
M ,L=10#''5  PQY: , >8@"^'FH O!]Q +H?> "Y'WX MQ^% +8?C "T'Y,
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M!?\M  #J-0  W#H  ,X]  #&/   P#<" +LS#0"S-!D KC8G *DW- "E-T
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M"G= L@IU0,,+=$#="W-!\0MR0?\*<D'_"G)!_PER0?\)<D'_">D\  #510
MQ4L  +I.  "P3@  ITL  *)&  ";1@X ED<: )%()P".2#, BD@] (='1@&$
M1TX!@D95 H!&7 -^16($?$5I!'I%< 5X1'@&=D2!"'1$BPER1)8*<$2B"V]$
MKPQN1, ,;479#6Q%[PQK1?T+:T;_"VM&_PIK1O\*:T;_"N5   #/20  P4\
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M#UI1Z@Y;4?H-6U'_#%M1_PQ;4?\+6U'_"]9*  ##4P  MED  *M<  ">6@
MDUD  (M4  "$5@, ?E80 'I7&@!V5R8 <U@Q '!7.@!M5T(!:E=) FA64 )F
M5E<#9%9>!&)5905@56T'7E5V"%U5@0I;58T+652:#5A4IPY65;@/5E7,#U95
MZ0Y65?D-5E7_#5=4_PQ75/\,5U3_#-%-  # 5@  LUP  *=>  ":70  CUP
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M#$A@_PM)8/\+26#_"\18  "U8   JF8  )MF  "-9@  @F4  '9D  !N90
M:&8% &-G$ !@:!H 76DE %MJ+P!9:C@ 5VI  55J1P%3:DX"46I5 T]I701-
M:60%2VEM!DEH> =':(0)1FB2"D1GH0M#9[$,0F?%#$)GX@Q"9O4,0V;_"T-E
M_PM#9?\+0V7_"[]<  "Q9   IFH  )9I  "):0  ?6D  '%I  !G:@  8FP!
M %UM#0!9;A8 5V\A %5P*P!3<#4 47 ] %!P10%.<$P!3'!3 DIP6@-(<&($
M1F]K!41O=09";X('0&Z/"3]NG@H];J\*/6[""CQNX H];?0*/6S_"CUK_PH^
M:_\*/FO_"KI@  "M:0  H&X  )%M  "$;0  >&T  &QN  !A<   6W(  %9T
M"@!2=1( 4'8= $YW)P!,=S$ 2W@Y $EX00!(>$D!1GA0 41W5P)"=U\#0'=H
M SYW<P0\=G\&.G:-!SEVG @W=:T(-W7 "#9UW@@W=/((-W/^"#=R_P@W<O\(
M-W+_"+5F  "I;P  FG$  (MQ  !^<0  <W(  &AS  !<=@  5'D  $Y[!0!*
M?0\ 2'X8 $9_(P!%?RP 0X U $* /0!!@$4 /X!, 3V 5 $\@%P".G]E CA_
M;P,V?WP$-'^*!#)_F@4Q?JH&,'Z]!C!^V@8P?? &,'O]!C![_P8P>O\&,'K_
M!K!L  "D=0  E'4  (9U  !Y=@  ;G<  &-Y  !7?0  3X$  $>$  !"A@P
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M !J?C0 8GY\ %Y^R !:?R0 6GN@ %ISW !:;_P$7F_\!%YO_ 9V#  "/A@
M@H8  '2'  !GBP  6X\  %"3  !&F   /)P  #.@   KHP  (Z8  !RH"P :
MJ1$ &*D8 !>I(0 6JBD %:HQ !2J.0 3JD, $ZM- !*K6  1JV4 $*MT  ZK
MA@ .JYD #:NL  RKP0 ,JM\ #*GR  VH_  -J/\ #:C_ ):*  ")C   >HT
M &R1  !@E0  5)H  $F?   _HP  -:<  "NJ   CK@  &[   !2S 0 /M0H
M#;80  RV%@ +MA\ "K8G  FV+P (MCD ![=#  :W3P $MUL  [=J  *W>P
MMXX  +>A  "VM   MLL  +;E  "U\0  M?<  +7W (^1  "!E   <I<  &6<
M  !8H0  3*8  $&K   WKP  ++(  ".U   :N   $[L   Z]   )P 4  \$-
M  #!$0  P1<  ,(>  #")@  PB\  ,,Y  #$1   Q%   ,1>  #%;P  Q8$
M ,65  #%J   Q;P  ,31  #$Y@  Q.X  ,3N (:8  !YG@  :Z,  %VI  !0
MK@  1+,  #>V   LN0  (KP  !F_   1P@  #,4   ;(    RP   ,P'  #,
M#0  S1$  ,T6  #.'0  SR0  - M  #2.   U$0  -12  #580  U7,  -:'
M  #6FP  UJT  ->_  #8S@  V-T  -C= 'N@  !NI@  8*T  %.S  !%N
M.+P  "N_   AP@  %\8  !#)   *S    M    #4    UP   -@   #:!0
MVPL  -P.  #>$P  WQD  .$A  #C*@  Y38  .=#  #G4P  Z&0  .EW  #I
MC   ZI\  .JN  #JN@  ZL,  .K# '"H  !BKP  5;8  $>\   YP   +,0
M "#(   6S   #M    ?4    V0   -T   #A    XP   .0   #F    YP$
M .D'  #K#   [!   .X5  #P'0  \R<  /8S  #W0P  ^%0  /EF  #Y>@
M^HX  /J>  #[J0  ^[   /NP /\+&P#_!QD _P 9 /\ ' #_ "4 _P R /\
M/P#_ $L _P!7 /\ 8@#_ &L _P!S /T >P#[ (( ^@"( /@ C0#W )( ]@"8
M /4 G0#T *( \P"I /$ L #O +@ [@## .P T0#K .8 Z0#S .@ _@#H /\
MZ #_ .@ _P#H /\ Z #_ /\.& #_"A4 _P$4 /\ & #_ "( _P N /\ .P#_
M $< _P!3 /T 7@#Z &< ]P!O /4 =P#S 'X \@"$ /  B0#O (\ [@"4 .P
MF@#K )\ Z0"E .@ K #F +0 Y "_ ., S #A .( WP#P -X ^P#> /\ W0#_
M -T _P#< /\ W #_ /\0$P#_#1$ _P80 /\"%0#_ !X _P I /\ -@#_ $(
M^@!. /0 60#Q &( [@!K .P <@#J 'D Z !_ .< A0#E (L Y "0 .( E@#A
M )P WP"B -T J0#: +$ V "[ -4 R #2 -T T0#M -  ^0#/ /\ S@#_ ,T
M_P#- /\ S0#_ /\1#P#_#@T _PP- /\+$@#_!QD _P(D /\ , #V #P [P!)
M .H 4P#G %T Y !F .$ ;0#? '0 W0![ -L @0#9 (8 U@", -0 D@#2 )@
MT "> ,X I@#, *X R@"X ,@ Q #& -< Q0#J ,, ]P#" /\ P0'_ , "_P#
M O\ P +_ /\4"P#_$ 8 _Q ) /\0#@#_#A0 _PH> /4&*0#K!#8 XP-" -\#
M3@#;!%< U@1@ -,$: #0!&\ S@5V ,P%? #*!8( R06( ,<%C@#&!90 Q 6;
M ,(%HP# !JL O@:U +T&P@"["-0 N@GI +<+^ "U#/\ M S_ +0,_P"T#/\
MM S_ /\7! #_%   _Q8# /\4"0#_$0X \@X5 .@,(0#>"BX U@L[ - ,1P#,
M#%$ R0Q: ,8-8@#$#6H P@UQ , -=P"_#7T O0Z# +P.B@"Z#I$ N0Z8 +<.
MH "V#JD M ^T +(/P0"Q$-0 KA'K *L2^@"I$O\ J!/_ *<3_P"G$_\ IQ/_
M /\:  #_&P  ^1L  .L9  #E% 8 Y1 . -D.%P#/$28 R!(T ,030 "_%$L
MO!14 +D570"W%60 M15K +05<0"R%7@ L19^ *\6A0"N%HP K!:4 *L7G "I
M%Z8 IQBP *88O0"D&,\ HAKG )\:]P"=&_\!G!O_ 9P;_P&;&_\!FQO_ ?\=
M  #W(0  Z"0  -TE  #4(0$ SQL( ,H7$0#"&B  O!PM +<=.@"S'D4 L!Y/
M *T>5P"K'E\ J1]F *@?; "F'W, I1]Y *,?@ "B'X< H""/ )\@F "=(*(
MFR"L 9HAN0&8(<H!EB+D 90C]0&2(_\!D2/_ 9 C_P&0(_\!D"/_ ?\B  #K
M*0  W2X  ,\O  #'+0  P2<# +TB#0"V(QH L"4H *PF- "H)D  I2=) *(G
M4@"@)UH GB=A )PG9P";)VT F2=T )@G>P&6)X(!E2>+ 9,GE &1*)X!D"BI
M 8XHM0*-*<8"BRG? HDJ\@*'*O\"ABK_ H8J_P*&*O\"ABK_ O0H  #C,0
MT38  ,4X  "\-@  MC   +(K"0"K+!0 IBTB *(N+P">+CH FRY$ )@O30"6
M+U4 E"Y< )(N8@"0+FD!CRYO 8TN=@&,+GX!BBZ& H@NCP*'+IH"A2^E X,O
ML@."+\(#@3#: W\P[P-],?X#?3'_ WPQ_P-\,?\#?#'_ ^TO  #;-P  R3T
M +X^  "S/   K#@  *<S! "B,A$ G30= )DU*@"5-34 DC5  (\U20"--5
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M1@  G4,  )<_  "2/@L C3\5 (D_(0"%0"T @D W '] 0 !]0$@ >T!/ 7E
M5@%W/UT!=3]C G,_:@)Q/W(#<#]Z VX_A 1L/Y %:S^<!FD_J09H/[@'9T#,
M!V9 Z =F0/D&94#_!F5 _P9E0/\%94#_!=P^  #'1@  N4L  *Q,  "@2@
MET<  )%#  "+0P@ AD,2 ()$'@!^1"D >T4T 'E%/0!V144 =$1, 7)$4P%P
M1%D!;D1@ FQ#9P)K0V\#:4-W!&=#@05F0XT&9$.9!F)#IP=A1+8(8$3*"&!$
MY@A?1?@'7T7_!V!%_P9@1/\&8$3_!M9!  ##20  MDX  *=/  ";30  DDL
M (Q'  "%1P0 @$<0 'Q(&@!X2"8 =4DP '-).@!P24( ;DE) 6Q(4 %J2%8!
M:$A= F9(9 )E2&P#8TAU!&%'?P5@1XH&7DB7!UU(I0A;2+0(6TC'"5I(Y A:
M2?8(6DG_!UI(_P9:2/\&6DC_!M%%  "_3   LE(  *-1  "74   C4X  (9*
M  " 2@$ >DL. '9,%P!R3", ;TPM &U--@!J3#\ :$Q& &9,30%D3%,!8DQ:
M F%,80)?3&D#7DQR!%Q,? 5:3(@&64R5!U=,HPA63+((54S&"55,X@E53/4(
M54S_!U5,_P=63/\&5DS_!LQ(  "\4   KU4  *!4  "34P  B5$  (%-  !Z
M3@  =4\, '!/%0!M4"  :E J &=0,P!E4#P 8U!# &%02@%?4%$!75!8 EQ0
M7P):4&<#65!P!%=0>@554(8&5%"3!U)0H0A14+$)4%#$"5!0X0E04/0(45#_
M!U%/_P=13_\&44__!LE+  "Y4P  JU<  )Q6  "/50  A50  'Q0  !U40
M<%() &M3$@!H5!T 950G &)4,0!@5#D 7E1! %Q42 %:5$\!6516 5=470)6
M5&4#5%1N!%)4> 515(0&3U21!TY4H A,5*\(3%3""4M4WPE,5/,(3%/_!TQ3
M_P=-4_\&35/_!L5.  "V5@  IUH  )A9  "+6   @5<  '=4  !P50  :E8&
M &97$ !B5QH 8%@D %U8+@!;63< 65D_ %=91@!664T!5%E4 5-96P)166,"
M3UAL TY8=@1,6((%2EB/!DE8G@=(6*X(1UC "$=8W0A'6/((1U?_!TA7_P=(
M5_\&2%?_!L%1  "R60  HUP  )1;  "'6P  ?5H  ')8  !K60  95H# &!;
M#@!=7!< 6EPA %A=*P!6730 5%X\ %->1 !17DL!4%Y2 4Y>60),7F$"2UUJ
M TE== 1'78 %15V-!D1=G =#7:P'0EV^"$)=V@A"7/$'0ES^!T-;_P9#6_\&
M0UO_!KU5  "O70  GU\  )!>  "#7@  >%T  &U<  !E70  7U\  %I@# !7
M810 56(> %)B* !18S$ 3V,Y $YC00!,8T@ 2V-/ 4EC5@%'8UX"16-G D1C
M<0-"8WT$0&*+!3]BF@8^8JH&/6*\!SQBU@<]8>\&/6']!CY@_P8^8/\&/F#_
M!KE9  "K80  FF$  (MA  !_80  =&$  &EA  !?8@  660  %1F"0!19Q$
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M BUYD@(K>*,"*GBU BIXS (J=^H"*G;Y RIU_P,J=/\#*G3_ ZIJ  ":;0
MB6P  'QM  !P;0  9FX  %MQ  !0=0  2'@  $%[   Z?@4 -G\. #2 %@ S
M@2  ,H$H #"!,  O@C@ +H)  "V"2  L@E  *X): "J"9  H@G  )H)_ 26"
MCP$D@J !(X*R 2*"R0$B@><!(G_W 2)^_P(B??\"(GW_ J5Q  "3<0  @W$
M '9Q  !L<@  8'4  %9X  !,?   0X   #N#   SA@  +8D* "J*$0 IBQD
M)XLB ":+*@ EC#$ )(PY ".,0@ BC4H (8U4 ""-7@ ?C6L '8UY !R-B@ ;
MC9P &8VN !B,Q  8C., &8KU !F)_P$9B/\!&8C_ 9UW  ",=@  ?78  ')W
M  !E>0  6GP  %"   !&A   /(D  #2,   MD   )9," !^5#  =EA( ')8:
M !N7(@ :ERH &9<R !B8.@ 7F$, %IA- !686  4F&0 $YAS !&8A  0F)8
M$)BI  Z8OP .E]T #Y;R !"5_  0E/\ $)3_ )5]  "%?   >'P  &M^  !?
M@0  5(8  $J*  ! CP  -I,  "V7   FF@  'IT  !>@ P 2H@P $*,2 !"C
M&0 /HR$ #J0I  ZD,0 -I#H #*1%  ND4  *I%P ":1J  >D>P &HXX !*.A
M  *CM  #HLL  Z+F  .A\P #H?L  Z'[ (V#  !_@@  <80  &2'  !8C
M39$  $*6   XF@  +YX  ":B   >I0  %Z@  !&K   ,K@< !Z\-  .O$@ "
MKQD  :\A  "O*0  L#(  + \  "P1P  L%,  +!A  "P<0  L(,  *^7  "O
MJ@  K[\  *[9  "NZP  KO0  *[T (>)  !XB@  :HX  %V3  !1F   19T
M #NB   PI@  )ZH  !ZN   6L0  $+0   NV   %N0,  +H*  "Z#@  NA,
M +L9  "[(0  O"@  +PQ  "]/   OD@  +Y6  "^90  OG<  +Z,  "^GP
MO;,  +['  "^W@  O>L  +WK '^2  !PE0  8IH  %6?  !)I0  /:L  #*O
M   HM   'K8  !6Y   .O   ";\   +"    Q    ,4$  #&"@  Q@X  ,<2
M  #(&   R1\  ,HG  #,,   SCP  ,Y)  #/60  SVH  ,]^  #/DP  SZ8
M ,^X  #/R   S]L  ,_; '><  !HH0  6Z<  $ZN  !!M   -+<  "BZ   =
MO0  $\    W$   &QP   ,H   #.    T    -$   #2 @  TP@  -4,  #6
M$   V14  -L<  #=)   X"\  .(\  #C2P  Y%P  .1O  #E@P  Y9@  .6I
M  #EM@  Y<,  .7# &RE  !?K   4;(  $2Y   UO   *,   !S$   2R
M#,L   //    TP   -@   #<    WP   -\   #A    XP   .0#  #F"
MZ T  .D1  #L&   [B(  /$N  #S/   ]$T  /5?  #V<P  ]X<  />9  #X
MI0  ^+   /BP /\#%P#_ !4 _P 5 /\ & #_ ", _P O /\ / #_ $@ _P!4
M /\ 7@#_ &< _0!O /L =@#Y 'T ^ "# /8 B #U (X ] "3 /( F #Q )X
M\ "D .X JP#M +, ZP"] .H RP#H .$ YP#Q .8 _0#E /\ Y #_ .0 _P#D
M /\ Y #_ /\'$P#_ !$ _P 1 /\ %0#_ !\ _P K /\ -P#_ $0 _@!/ /H
M6@#W &, ] !K /( <@#P 'D [P!_ .T A #K (H Z@"/ .@ E #G )H Y0"@
M .0 IP#B *\ X "Y -X Q@#< -H V@#L -@ ^0#6 /\ U@#_ -< _P#8 /\
MV #_ /\*$ #_ PX _P - /\ $@#_ !H _P F /P ,@#W #\ ] !* /$ 50#M
M %X Z@!F .@ ;@#E '0 XP!Z .( @ #@ (4 W@"+ -P D #; )8 V "< -4
MHP#3 *L T0"U ,X P0#, -$ RP#G ,D ]0#( /\ R #_ ,@ _P#( /\ R #_
M /\,# #_!@@ _P(* /\ #P#_ !4 _  @ /$ + #L #D Z0!% .4 3P#A %D
MW@!A -L : #7 &\ U !U -( >P#0 (  S@"& ,P C #+ )( R0"8 ,< H #%
M *@ PP"Q ,$ O "_ ,L O0#C +P \@"[ /T NP#_ +H _P"Z /\ N@#_ /\.
M!0#_"0  _PD% /\&"P#_ 1  \  9 .8 )0#A #( W  _ -8 20#1 %, S@!;
M ,L 8P#( &H Q@!P ,4 =@## 'L P0"! ,  AP"^ (X O "4 +L G "Y *0
MMP"N +4 N0"S ,@ L0#? + ![P"O ?L K@+_ *T#_P"M _\ K0/_ /\0  #_
M#@  _PT  /8+ P#R!PH X@$1 -L"'0#2 RL S ,W ,@$0P#$!$T P016 +X%
M70"\!60 N@5K +@%<0"W!78 M05\ +,&@P"R!HD L :1 *\'F0"M!Z$ JP>K
M *D(MP"H"<8 I@K= *4+\ "C#/T H@W_ *$-_P"A#?\ H W_ /\1  #\$@
M[!,  .(3  #;#P, U@D+ ,X(% #&"B( P PP +P-/ "X#48 M0U/ +(.5P"P
M#E\ K@YE *T.:P"K#G$ J@YX *@.?@"G#X4 I0^- *0/E@"B$)\ H!"I )\0
MM0"=$<4 FQ'> )D2\0"7$_\ EA3_ )44_P"5%/\ E!3_ /\5  #M&P  X!\
M -(?  #)&P  Q!0% ,$0#@"Z$AL M!,I + 4-0"L%4  J15) *854@"D%ED
MHA9@ *$69@"?%FP GA9R )P6>0";%X  F1>( )@7D0"6&)L E!BF ),9L@"1
M&<$ D!K8 (T;[@"+'/T BAS_ (H<_P")'/\ B1S_ /0=  #D)0  TRD  ,<J
M  "\)@  MB   +09"P"N&A4 J!PC *0=+P"A'CH GAY$ )L>3 "9'E0 EQ];
M )4?80"4'V< DA]M )$?= "/('P CB"$ (P@C0"*()< B2&B (<AK@"&(KT
MA2+1 8(CZP&!)/L!@"3_ 7\D_P%_)/\!?R3_ >PE  #;+0  R3$  +PQ  "Q
M+@  JRD  *<D!0"C(Q$ GB0= )HE*@"6)C4 DR8_ )$F1P"/)D\ C296 (LG
M7 "))V( B"=I (8G;P"%)W< @R=_ ($GB0& *),!?BB> 7TIJP%[*;D!>BG-
M 7@JZ %W*_D!=BO_ 78K_P%U*_\!=2K_ >4L  #0-   P3@  +,X  "H-0
MHC$  )TM  "9*@X E"L8 ) L) "-+3  BBTZ (<M0P"%+4H @RU1 ($N6 "
M+EX ?BYD 'TN:P![+G,!>2Y[ 7@NA0%V+H\!="^; 7,OJ )Q+[8"<##) F\P
MY0)N,?<";3'_ FTQ_P)M,?\";3'_ M\R  #).0  NSX  *P]  "A.@  FC<
M )4S  "0,0H C#$4 (<R( "$,RL @3,U '\S/@!],T8 >S-- 'DS5 !W,UH
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M UD__P-9/_\#63__ \P_  "\1@  JT@  )Q'  "11@  B$0  ()   !\/P
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M [U,  "N4@  G%$  (U1  "!40  =U   &Y,  !G3@  8D\  %U0#0!:4!0
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M CE=DP(X7:,#-UVU S9=RP,V7.@#-USY S=;_P,X6_\#.%K_ [)7  "@6@
MCUD  (%9  !U60  :UD  &!:  !66P  45T  $Q> @!(8 T 16 4 $1A'@!"
M8B8 0&(N #]B-@ ^8SX /6-% #QC30 [8U4 .6-> #AC: $V8W0!-6.! 3-C
MD0(R8Z$",6.S C%CR (Q8N<",6'X C%A_P(R8/\",F#_ JY<  ";70  BET
M 'Q=  !P70  9ET  %Q>  !28   3&(  $5E  !!9@H /F<1 #QH&@ [:"(
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M !I[OP :>]X &GGR !MX_@ ;=_\!&W?_ 9EI  "(:0  >6D  &UI  !C:@
M66P  $]O  !%<P  /7<  #5Z   N?0  )X$# "*##0 @A!( 'X0: !V$(@ <
MA2H &X4Q !J%.0 9A4( &(9, !>&5@ 6AF, %89Q !2&@0 2AI, $8:F !&%
MNP 0A=8 $8/O !&"^P 2@O\ $H'_ )%N  "!;0  =&X  &EN  !=<   4W,
M $EW  ! ?   -X   "^#   GAP  (8H  !J-!@ 5CPT $Y 3 !*0&@ 2D"(
M$9 J !"1,@ 0D3L #Y%$  Z13P -D5P #)%J  N1>@ *D8T ")"?  >0LP '
MC\D !X_F  >.]  (C?P "(W_ (ES  ![<P  ;W,  &-U  !7>   37T  $.!
M   YA@  ,(H  "B.   AD0  &I4  !.7   .F@@ "YP.  F<$P (G!H !YPB
M  :<*@ $G#,  YP]  *=2   G50  )UB  "<<@  G(0  )R7  ";J@  F[\
M )K;  ":[   FO4  )GX ()Y  !V>0  :'H  %Q^  !1@@  1H<  #R,   R
MD0  *94  "&9   9G0  $J    ZC   )I@4  Z<,  "G$   IQ4  *@<  "H
M(P  J"L  *DT  "I/P  J4L  *E9  "I:   J7H  *F.  "IH0  J+4  *C+
M  "GY   I^\  *?S 'V   !O@0  880  %6)  !)C@  /I0  #29   JG@
M(:(  !FF   2J0  #:P   >O    L@   +,'  "S#   LQ   +05  "T&P
MM2(  +8K  "W-0  MT   +A.  "X70  N&X  +B"  "XEP  N*H  +>^  "W
MT@  M^8  +?J ':(  !GBP  6I   $Z6  !"G   -Z(  "RG   BJP  &:\
M !&S   +M@  !+D   "\    O@   +X   "_!@  P L  ,$/  #"$P  PQD
M ,0@  #%*0  QS0  ,A"  #)40  R6(  ,EU  #)B@  R9\  ,JQ  #*P0
MR=$  ,G9 &Z3  !@F   4YX  $:D   ZJP  +[   "2U   9N   $+P   J_
M   !P0   ,0   #(    R@   ,H   #,    S0,  ,X(  #0#0  T1   -,6
M  #6'@  VB@  -TT  #>0P  WU0  -]G  #@?   X)$  ."D  #@L@  X+X
M .## &:?  !9I@  3*T  #^T   RN   )+P  !B_   0PP  ",<   #*
MS0   -$   #5    V    -D   #;    W0   -\   #A!   XPH  .4.  #G
M$P  ZAP  .TG  #P-0  \48  /)8  #S:P  \X   /24  #THP  ]*X  /2R
M /\ $P#_ !$ _P 1 /\ %0#_ !\ _P L /\ .0#_ $4 _P!0 /\ 6@#^ &,
M^P!K /D <@#W '@ ]0!^ /0 A #R (D \0". /  DP#N )D [0"? .P I@#J
M *X Z "X .8 Q0#E -L XP#M .( ^P#B /\ X0#_ .$ _P#A /\ X0#_ /\
M$ #_  X _P - /\ $@#_ !L _P H /\ - #^ $$ ^P!, /< 5@#T %\ \0!F
M .\ ;0#L '0 Z@!Z .D ?P#G (4 Y@"* .4 CP#C )4 X0"; .  H@#> *H
MVP"T -D P #6 -  TP#H -( ]P#1 /\ T0#_ -  _P#0 /\ T #_ /\ #0#_
M  D _P * /\ #P#_ !8 ^P B /< +P#T #L \ !' .T 40#I %H Y0!B .(
M:0#@ &\ W@!U -P >@#: (  V "% -4 BP#3 )$ T0"7 ,\ G@#- *8 RP"O
M ,D N@#' ,D Q0#B ,0 \@## /X P@#_ ,$ _P#" /\ P@#_ /\#!@#_  $
M_P & /\ # #Y !$ \0 = .L *0#G #8 XP!! -\ 2P#; %0 U0!< -( 8P#/
M &H S0!P ,L =0#) 'L R "  ,8 A@#% (P PP"3 ,$ F@"_ *( O0"K +L
MM@"Y ,0 MP#: +8 [0"T /H M #_ +0 _P"T /\ M #_ /\$  #_    _P
M /\ !@#L  T Y0 6 -X (@#7 "\ T0 [ ,T 10#* $X Q@!7 ,0 7@#! &0
MOP!J +T < "\ '4 N@![ +D @0"W (< M0". +, E0"R )X L "G *X L@"L
M +\ J@#1 *@ Z "H /< IP#_ *< _P"F /\ I@#_ /\&  #_!0  \0,  .@
M  #A  < U0 0 ,T &P#' "< PP S +\ /@"\ $@ N0!1 +8 6 "T %\ L@!E
M +  :@"O '  K0!V *P ? "J (( J0") *< D0"E )H HP"D *$ K@"@ +L
MG@'- )T"Y@"<!/0 FP3_ )H%_P":!?\ F07_ /\*  #Q#@  Y!   -D/  #.
M"P  R ,+ ,( $P"\ A\ MP,L +,$-P"P!4( K09* *H&4@"H!UD I@=? *4'
M90"C!VL H@AQ * (=P"?"'X G0B% )L)C@":"9< F JA )8*K "5"[H DPO,
M )(,Y0"0#?8 CP[_ (X._P".#O\ C0[_ /81  #F%P  UAL  ,<9  "^%0
MN1   +<*#0"Q"Q< K TD *@., "E#CL H@Y$ )\/3 "=#U, FP]: )H/8 "8
M$&8 EQ!L )40<@"3$'D DA"! ) 0B@"/$90 C1&? (L1J@"*$K@ B!++ (83
MY@"%%/< @Q7_ (,5_P""%?\ @A7_ .T:  #<(0  RB4  +LB  "Q'P  JQH
M *D4!@"E$A$ H!0> )P5*@"9%34 EA8^ )061P"2%DX D!95 (X76P",%V$
MBQ=G (D7;0"(%W0 AAA\ (48A@"#&9  @1F; ( :IP!^&K4 ?1O' 'P<X@!Z
M'?4 >1W_ '@=_P!X'?\ >!W_ .4B  #0*0  ORP  + J  "G)P  H",  )T?
M  ":&@X E1P8 )$=) ".'B\ C!XY (D>00"''TD A1]0 (,?5@""'UP @!]B
M '\?:0!]('  ?"!X 'H@@0!Y(8P =R&7 '4BI !T(K( <R/# '(CWP!P)/,
M;R3_ &\D_P!N)/\ ;B3_ -TI  #(,   MS(  *@P  ">+@  ERH  ),G  "0
M(PH C",3 (@D'P"$)2H @B4T ( F/0!])D0 ?"9+ 'HF4@!X)E@ =R9> '4F
M90!T)VP <B=T '$G?0!O*(@ ;BB4 &PHH0!K*:\!:BG  6DJVP%G*O$!9RO_
M 68K_P%F*O\!9BK_ =0O  #"-@  KS8  *$U  "6-   D#   (HM  "'*@8
M@RD0 '\J&@!\*R4 >2LO '<L. !U+$  <RQ' '$L30!P+%0 ;BQ: &TL80!K
M+6@ :BUP &@M>@!G+H4 92Z1 60NG@%B+ZP!82^] 6$PU0%@,.\!7S#] 5\P
M_P%?,/\!7S#_ <TT  "\.P  J3H  )LZ  "0.   B34  (,R  !_, $ >R\.
M '<P%@!T,"$ <3$K &\Q- !M,3P :S%# &HQ2@!H,E  9S)7 &4R70!D,F4
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M < _  "N0P  G$,  (Y#  ""0@  >D   ',]  !M/   :#T% &0]#@!A/A<
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M 4))D@%!2:("0$FS C]*QP(_2N4"/TGW D!)_P) 2/\"0$C_ ;9)  "B2@
MD4H  (-*  !W2@  ;DD  &5%  !>1P  64@  %5)" !12A  3TH8 $Q*(0!*
M2RD 24LQ $=+. !&3#\ 14Q& $1,3@!#358 0DU? $%-: ! 370!/DV! 3U-
MD $\3: !.TZQ CI.Q@(Z3N0".TWV CM-_P$[3/\!/$S_ ;--  ">3   C4P
M '],  !T3   :DP  &!*  !92P  5$P  %!-!0!,3@X 24\5 $=/'@!%3R8
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M 2I=OP$I7=X!*ESR 2I;_@$K6_\!*UK_ :-5  "/50  ?U4  ')5  !G5@
M7E8  %17  !,60  15L  #]=   Z7P0 -F - #1A$P R8AP ,6(C #!B*P O
M8S( +F,Z "UC0@ L8TH *F13 "ED70 H9&D )V1V "9DA@ E9)< )&2I "-D
MO0 B9-H (V/Q "-B_0$D8?\!)&'_ 9Q8  ")6   >ED  &Y9  !C60  6EH
M %!<  !(7@  06   #IC   T9@  +V@* "QI$  J:1< *6H? "AJ)@ G:BX
M)FLU "5K/0 D:T8 (VM/ ")L60 @;&4 'VQR !YL@@ =;)0 '&RF !MKN@ :
M:]0 &VKN !QI_  <:/\ '&C_ )5<  "#7   =5P  &E=  !?70  5EX  $QA
M  !#9   /&<  #5J   O;0  *' $ "-R#0 A<A( (',: !]S(0 ><R@ '70P
M !QT.  ;=$  &G1* !ET5  7=6  %G5N !5U?@ 4=9  $W2B !)TM@ 1=,\
M$G/L !)R^@ 3<?\ $W'_ (Y@  !]8   ;V$  &5A  !;8@  460  $AG   ^
M:P  -VX  #!Q   I=0  (G@  !Q[!P 7?0X %GT3 !5]&P 4?B( $WXJ !)^
M,0 1?CH $7Y$ !!_3@ /?UH #G]H  U_>  ,?XH "WZ=  I^L  )?<8 "GWD
M  I\]  +>_T "WK_ (9E  !W90  :F4  &%F  !6:   3&L  $)O   Y<P
M,7<  "IZ   C?@  '($  !6$   0AP@ #8D.  R)%  ,B1L "XDC  J)*P )
MB3, "(D]  :)2  %B50 !(EA  *)<0 !B8,  (F6  "(J0  A[X  (?:  "&
M[   AO4  (;Z 'YJ  !Q:@  9VL  %ML  !0<   1G0  #QX   S?0  *H$
M ".%   <B   %8P  !"/   ,D@8 !I,,  *3$0  E!8  )0=  "4)   E2P
M )4U  "50   E4P  )99  "6:0  E7H  )6.  "4H0  E+4  )/,  "2Y@
MDO(  )+W 'AP  !M<   8'(  %1U  !)>0  /WX  #6#   LB   (XT  !N1
M   4E   #Y<   J:   $G0,  )X)  "?#@  GQ(  * 7  "@'0  H24  *(M
M  "B-P  HT,  *-0  "C7P  HW$  *.$  "BF0  HJT  *'"  "AW   H>L
M *#R '-V  !F=P  67L  $V   !"A0  .(L  "Z0   DE0  &YH  !2>   .
MH0  ":0   *G    J@   *L$  "K"@  K T  *T1  "M%@  KAP  *\D  "P
M+0  L3D  +%&  "R50  LF8  +)Y  "RC@  L:,  +*W  "QR@  L>   +'I
M &Q^  !?@@  4H<  $:-   [DP  ,)D  ":>   <HP  $Z<   VK   'K@
M +(   "U    MP   +@   "Y @  N0@  +H,  "[$   O!0  +T;  "_(P
MP2T  ,(Z  #"20  PUH  ,-L  #$@@  Q)<  ,2K  #$O   Q,L  ,3: &6)
M  !8C@  2Y4  #^;   SH@  **@  !VM   4L0  #;8   :Y    O    +\
M  ##    Q    ,4   #&    QP   ,D$  #*"0  RPT  ,T1  #/&   TB$
M -4M  #6/   V$T  -E?  #:<P  VHH  -N>  #;K@  V[H  -S# %Z6  !1
MG   1*,  #BJ   LL0  (+<  !6[   -O@  !,(   #%    R0   ,T   #0
M    T@   -(   #5    U@   -D   #;    W@4  . *  #B#P  Y18  .@@
M  #L+0  [3X  .U1  #N90  [WH  .^/  #PGP  \*L  /"S /\ $ #_  X
M_P . /\ $@#_ !T _P I /\ -0#_ $$ _P!- /X 5@#[ %\ ^ !F /8 ;0#T
M '0 \@!Y /$ ?P#P (0 [@") .T CP#K )4 Z@"; .@ H@#F *H Y0"S .,
MP #A -( X #J -\ ^0#= /\ W0#_ -T _P#> /\ W@#_ /\ #0#_  H _P )
M /\ #P#_ !@ _P D /X ,0#[ #T ^ !( /0 4@#P %H [0!B .L :0#I &\
MYP!U .4 >@#C '\ X@"% .  B@#> )  W "6 -H G0#8 *4 U0"O -( N@#0
M ,H S@#C ,T ] #+ /\ RP#_ ,L _P#+ /\ RP#_ /\ " #_  , _P % /\
M# #\ !0 ]P ? /( *P#O #< ZP!" .< 3 #D %4 X != -T 9 #: &H V !P
M -4 =0#2 'H T "  ,\ A0#- (L RP"2 ,D F0#' *$ Q0"J ,, M0#! ,,
MOP#: +X [@"] /P O #_ +P _P"\ /\ O #_ /\   #_    _P   /D !P#Q
M !  Z@ : .0 )0#? #$ VP \ -< 1P#2 %  S@!7 ,L 7@#) &4 Q@!J ,4
M< ## '4 P0!Z ,  @ "^ (8 O "- +H E "Y )P MP"E +4 L "S +T L0#/
M *\ Z "N /@ K@#_ *T _P"M /\ K0#_ /\   #_    _0   .X  0#C  P
MV@ 4 -$ 'P#, "L R  V ,4 0 #" $H OP!2 +P 60"Z %\ N !E +8 :@"T
M &\ LP!U +$ >@"P ($ K@"( *T CP"K )@ J0"A *< JP"E +@ HP#( *(
MX@"A /, H #^ *  _P"@ /\ H #_ /\   #V    Z@   .    #3  8 R0 /
M ,( & "] "0 N0 O +8 .@"T $, L0!, *X 4P"L %D J@!? *D 9 "G &H
MI@!O *0 =0"C 'L H0"" *  B@"> ), G "= )H IP"8 +0 E@## )4 W "4
M .\ DP#[ ), _P"3 /\ D@#_ /D%  #J"P  W T  ,L*  #"!0  O  * +8
M$0"Q !P K@ H *H ,P"G #T I !% *( 30"@ %, G@!9 )P 7P"; &0 F@!J
M )@ < "7 '8 E0!^ ), A@"2 8\ D &9 (X"I ", K$ BP/  (D%U@"(!NT
MB ?Z (<(_P"&"/\ A@C_ .\/  #>%   RA4  +P2  "S$   K@P  *L&#0"G
M Q4 H@4@ )\'+ "<"#8 F0@_ )<)1P"5"4X DPE4 )$*6@"0"E\ C@IE (T*
M:P"+"G( B@MY (@+@@"'"XP A0R7 (,,H@"!#;  @ W  '\-V !]#N\ ? _]
M 'L/_P![$/\ >Q#_ .87  #1'@  O1T  *\<  "F&0  H14  )X0! "=#0\
MF X9 )0.)0"1#R\ CQ Y (P000"*$$@ B!!/ (<050"%$%L A!%A ((19P"
M$6X ?Q%U 'T1?@!\$H@ >A*4 '@2H !W$ZX =1.^ '04U0!S%>X <1;] '$6
M_P!Q%O\ <!;_ -P?  #&)0  LR4  *4C  "<(0  EAX  )(9  "1% L C104
M (D5'P"&%BD @Q8S ($7/ " %T, ?A=* 'P74 !Z%U8 >1A< '<88@!V&&D
M=!AQ ',9>@!Q&80 ;QJ0 &X:G0!L&ZL :QR[ &H<T !I'>P :![[ &@>_P!G
M'O\ 9Q[_ -$F  "]*@  JRH  )TJ  "3*   C24  (@B  "&'08 @QL0 '\<
M&@!\'20 >ATN '<>-@!V'CX =!Y% '(?2P!Q'U$ ;Q]8 &X?7@!L'V4 :R!M
M &D@=@!H(8$ 9B&- &4BF@!C(J@ 8B.X &$CS0!@).D 8"3Z %\D_P!?)/\
M7R3_ ,HL  "V+P  I"\  )8O  ",+0  A2H  ( H  !])   >B(- '8C%0!S
M(R  <20I &\D,@!M)#H :R5! &HE1P!H)4T 9B54 &4E6@!D)F$ 8B9I &$F
M<@!?)WT 7B>* %THEP!;*:4 6BFU %HJR@!9*N< 6"KX %@J_P!8*O\ 6"K_
M ,4Q  "O,P  GC,  ) S  "&,@  ?R\  'DM  !U*@  <B@* &\H$@!K*1L
M:2DE &<J+0!E*C4 8RH] &(J0P!@*DH 7RM0 %XK5P!<*UX 6RQF %DL;P!8
M+7H 5RV' %8NE0!4+J, 4R^S %,OQP!2+^4 4B_W %(O_P!2+_\ 4B__ ,$V
M  "J-@  F38  (LV  "!-0  >3,  ',Q  !O+P  :RX& &@M$ !D+A@ 8BXA
M & O*@!>+S$ 7"\Y %LO0 !9+T8 6"]- %<P4P!6,%L 5#%C %,Q; !2,G<
M43*$ $\SD@!.,Z$ 33.Q $TTQ0%,-.,!3#3V $PT_P!,-/\ 3#/_ +LY  "F
M.0  E3D  (<Y  !\.0  =#<  &XT  !I,P  93(" &$R#0!>,A0 7#,> %HS
M)@!8,RX 5C,U %4T/ !3-$, 4C1* %$T4 !0-5@ 3C5@ $TV:@!,-G4 2S>"
M $HWD !).)\ 2#BP 4<XPP%'..$!1SCU 4<X_P%'./\!1SC_ ;<[  "B/
MD3P  (,\  !X/   <#H  &HW  !D-@  8#8  %PV"P!9-Q( 5C<: %0W(P!2
M-RL 4#<R $\X.0!-.$  3#A' $LX3@!*.54 23E> $@Z: !'.G, 1CN  $4[
MC@!$/)X 0SRN 4(\P@%"/=\!0CSS 4(\_P%"//\!0CO_ ;,]  ">/@  C3X
M '\^  !U/@  ;#T  &8Z  !@.0  6SH  %<Z" !3.Q  43L8 $X[( !,.R@
M2SLO $D\-@!'/#T 1SQ$ $8]2P!%/5, 1#Y< $,^9@!"/W$ 03]^ $ _C0 _
M0)P /D"M 3U P $]0-T!/4#R 3U _P$^/_\!/C__ :Y   ":0   B4$  'Q!
M  !Q00  :$   &$\  !;/0  5CX  %(^!0!./PX 3#\5 $D_'0!'0"4 1D L
M $1 ,P!#0#H 0D%" $%!20! 05$ /T): #Y"8P ]0V\ /$-\ #M#BP Z1)L
M.42K 3E$O@$X1-L!.43Q 3E#_@$Y0_\!.4/_ :I"  "60P  AD,  'A#  !N
M0P  94,  %U   !60   44(  $U" @!)0PP 1D,2 $1$&@!"1"( 040J #]%
M,0 ^13@ /44_ #Q&1P [1D\ .D97 #E'80 X1VP -T=Z #9(B0 U2)D -$BJ
M #1(O0 S2-D -$CP #1'_0 T1_\ -4;_ *9$  "210  @D8  '5&  !J1@
M844  %E$  !11   3$8  $A'  !$1PH 04@0 #])&  ]22  /$DG #I*+@ Y
M2C8 .$H] #=+1  V2TP -4M5 #1,7P S3&H ,DQW #%,A@ P3)< +TVH "Y-
MNP N3=4 +DSO "],_0 O2_\ ,$O_ *%'  ".2   ?D@  '%(  !F20  74@
M %5(  !,20  1TH  $)+   _3 8 .TT. #E.%0 W3AT -D\D #5/*P S3S,
M,E Z #%00@ P4$H +U%2 "Y17  M46< +%%U "M1A  J4I4 *5*F "E2N0 H
M4M( *5'N "E0_  J4/\ *D__ )Q*  ")2@  >DL  &U+  !C3   6DP  %%,
M  !(30  0T\  #U0   Y4@( -5,, #-4$@ Q5!D ,%4A "Y5*  M52\ +%8W
M "M6/@ J5D8 *59/ "A760 G5V0 )E=R "57@0 D5Y( (U>D ")7MP B5\\
M(E?L "-6^@ C5?\ )%7_ )9-  "$3@  =4X  &E.  !?3P  5D\  $U0  !%
M4@  /U,  #E6   S6   +UH( "M;#P J6Q4 *%P= "=<)  F7"L )5PS "1=
M.@ C74, (EU, "%=5@ @7F$ 'UYN !Y>?@ =7H\ '%ZA !M>M  :7<P &UWI
M !M<^0 <6_\ '%O_ )!1  !^40  <%$  &12  !;4@  4E,  $I4  !!5P
M.UD  #5;   N7@  *& # "1B#  B8Q$ (6,8 !]D(  >9"< '60N !QD-@ ;
M93X &F5' !EE40 895T %V5J !9E>@ 598L %&6> !-EL0 29<@ $F3G !-C
M]P 48O\ %&+_ (E4  !X50  :U4  &!6  !75@  3U<  $99   ]7   -E\
M #!B   I9   (V<  !UJ!P 9; X &&P3 !9M&@ 5;2$ %&TI !1M,  3;3D
M$FY" !%N3  0;E@ #VYE  YN=0 -;H< #6Z:  QMK0 +;<( "VS@  QK\P -
M:_T #6K_ ()9  !R60  9ED  %Q:  !46@  2EP  $%?   Y8P  ,68  "II
M   D;   '6\  !=R   2=0D #W</  YW%  .=QL #7<C  QW*@ +=S, "G<\
M  EW1P (=U( !W=?  5W;P $=X   W>4  %VIP  =KL  775  %TZP "=/8
M G3\ 'M=  !M70  8EX  %E>  !.8   16,  #QG   S:P  *VX  "1R   >
M=0  %WD  !)\   -?P8 "8$,  6!$0 #@18  H$=  &!)   @2T  ((V  ""
M0   @DP  ()9  "":   @GD  (*-  "!H   @+0  (#+  !_YP  ?O(  '[Y
M '1B  !H8@  7F(  %-D  !)9P  /VL  #9P   M=   )7@  !Y\   7@
M$8,   V&   (B00  HL*  "+#@  BQ,  (P8  ",'P  C28  (TO  "..0
MCD0  (Y1  ".8   CG$  (Z%  ".F0  C:T  (S#  ",WP  B^X  (OV &YH
M  !D9P  6&D  $UL  !"<0  .'8  "][   F?P  'H0  !:(   0C   #(\
M  :2    E0   )8'  "7#   EP\  )@3  "9&   FA\  )LF  ";,   G#L
M )Q(  "<5P  G&@  )Q[  "<D   FZ4  )NZ  ":T   FN<  )KQ &IM  !>
M;P  47(  $9W   [?   ,8(  ">'   >C   %I$  !"5   *F0  !)P   "@
M    H@   *,!  "C!@  I L  *4.  "F$@  IQ<  *@>  "J)@  JS$  *L^
M  "L30  K%T  *QP  "LA0  K)L  *NO  "KPP  J]D  *KH &1U  !7>0
M2WX  #^$   TB@  *9   !^6   6FP  $)\   FC   !IP   *H   "N
ML    +    "Q    L@,  +0(  "U#0  MA   +<5  "Y'0  NR8  +PS  "]
M00  O5(  +UD  "^>0  OI   +VD  "]MP  O<8  +W7 %Q_  !0A0  1(L
M #B2   LF0  (9\  !>D   0J0  ":X   "R    M@   +D   "]    OP
M +\   #     P0   ,,   #$!0  Q@H  ,<.  #)$P  RQP  ,XF  #0-0
MT44  -)7  #2:P  TX(  -.7  #3J0  TK@  -+$ %6,  !)DP  /9H  #"B
M   EJ   &JX  !&T   )N0   +T   #!    Q    ,@   #+    S0   ,T
M  #/    T    -(   #4    V    -H&  #=#   X!$  .,:  #F)P  YS@
M .A*  #I70  ZG(  .N(  #KFP  [*@  .RR /\ #0#_  L _P + /\ $ #_
M !H _P F /\ ,@#_ #T _P!( /L 4@#X %H ]@!B /, :0#Q &\ \ !U .X
M>@#L '\ ZP"$ .D B@#H )  Y@"6 .0 G0#B *4 X0"O -\ NP#= ,L VP#F
M -D ]P#8 /\ V #_ -< _P#7 /\ U #_ /\ " #_  0 _P $ /\ #0#_ !4
M_@ A /H + #W #@ ] !# /  30#M %4 Z@!= .< 9 #D &H X@!P .  =0#>
M 'H W0!_ -L A0#9 (L U0"1 -, F0#1 *  SP"J ,T M0#+ ,0 R0#= ,@
M\0#' /\ Q@#_ ,8 _P#& /\ QP#_ /\   #_    _P   /\ "@#X !$ \0 <
M .P )P#I #( Y@ ] .( 1P#= %  V0!8 -4 7P#2 &4 T !J ,X < #, '4
MR@!Z ,D ?P#' (4 Q0", ,, E #! )P OP"E +T L "[ +T N@#0 +@ ZP"W
M /L M@#_ +8 _P"V /\ M@#_ /\   #_    _0   /, !0#I  X X0 6 -L
M(0#5 "T T0 W ,X 00#* $H QP!2 ,0 60#" %\ P !E +X :@"\ &\ NP!T
M +D >@"W (  M@"' +0 C@"R )< L "@ *X J@"M +< JP#( *D XP"H /4
MIP#_ *< _P"G /\ I@#_ /\   #^    \0   .4   #7  H S0 1 ,< ' #"
M "8 OP Q +P .P"Z $0 MP!, +0 4P"R %D L0!? *\ 9 "M &D K !O *H
M= "I 'H IP"! *8 B0"D )$ H@"; *  I0"> +( G0#! )L V@": .\ F0#]
M )@ _P"8 /\ F #_ /T   #P    X0   -$   #&  0 O0 - +< %0"S "
ML  K *T -0"K #X J !& *8 30"D %0 HP!9 *$ 7P"@ &0 G@!I )T ;@";
M '4 F@![ )@ @P"6 (P E0"6 ), H0"1 *T CP"[ (T SP", .D BP#X (P
M_P", /\ C #_ /,"  #B!P  S <  +\$  "W    L0 ( *L $ "G !D I  D
M *  +@"> #< G !  )H 1P"8 $X E@!4 )4 60"3 %X D@!D )  :0"/ &\
MC0!V (L ?@"* (@ B "2 (8 G0"% *D @P"X ($ R@"  .4 @ #U '\ _P!_
M /\ ?P#_ .@-  #0$   OA   +$.  "H#0  HP@  * "# "< !, F  = )4
M)P"2 #$ D  Y (X!00", 4@ B@). (D"5 "' ED A@)? (0#9 "# VL @0-R
M ( $>@!^!(0 ?06. 'L%F@!Y!J< > :U '8'R !U"., =0GT '0*_P!S"O\
M<PK_ -T5  #$%P  L1<  *46  "<$P  EA$  )0-! "3" T C@<5 (L)( "(
M"2H A0HS (,+.P"!"T( @ M) 'X+3P!]#%0 >PQ: 'H,8 !X#&< =PQN '4-
M=@!T#8  <@V, ' -F0!O#J8 ;0ZU &P.R0!K#^8 :A#W &D0_P!I$/\ :1#_
M - =  "Y'@  J!X  )L=  "2&P  BQD  (@5  "'$0< A0X0 ($/&@!^$"0
M>Q M 'D0-@!W$3T =A%$ '012@!S$5  <1%6 ' 17 !N$F( ;1)J &L2<P!I
M$WT :!.) &83E@!E%*, 8Q6S &(5Q@!B%N, 81;V & 7_P!@%_\ 8!?_ ,<B
M  "P(P  GR0  )(C  ")(@  @B   'X=  !\&0  >A4- '<5%0!T%A\ <18H
M &\7, !N%S@ ;!<_ &L710!I&$L :!A1 &886 !E&%X 8QEF &(9;P!@&7D
M7QJ% %T;D@!<&Z$ 6QRP %H<PP!9'>  6![T %@>_P!8'O\ 6![_ +\G  "I
M*   F2@  (LH  "")P  >R4  '8C  !S(   <1P) &X<$0!K'!H :1TC &<=
M+ !E'3, 8QXZ &(>00!@'D< 7QY- %X>5 !<'UL 6Q]B %D@:P!8('8 5B&"
M %4AD !4(IX 4R*N %(CP !1(]T 423R %$D_P!1)/\ 42/_ +DK  "C+
MDRP  (8M  !\+   ="H  &\H  !K)0  :2(% &8A#@!C(A8 82(? %\C)P!=
M(R\ 7",V %HC/0!9)$, 5R1* %8D4 !5)%< 4R5? %(E: !1)G, 3R9_ $XG
MC0!-*)P 3"BL $LIO@!+*=H 2BGQ $HI_P!+*?\ 2RG_ +,N  ">+P  CC
M ($P  !W+P  ;RX  &HK  !E*@  8R<! %\G# !<)Q, 6B<; %@H) !6*"L
M52@R %,H.0!2*4  4"E& $\I30!.*50 32I< $PJ90!**W  22M\ $@LBP!'
M+9H 1BVJ $4NO !%+M8 12[O $4N_@!%+O\ 12W_ *XQ  ":,@  B3,  'PS
M  !R,P  :S$  &4O  !@+0  72P  %DL"0!6+!  5"P8 %(L( !0+"@ 3BTO
M $TM-@!,+3P 2BU# $DM2@!(+E$ 1RY9 $8O8P!%,&T 0S!Z $(QB0!!,9@
M03*H $ RNP _,M, /S+N $ R_0! ,O\ 0#+_ *HS  "6-0  AC4  'DV  !N
M-0  9C4  &$R  !<,   5S   %0P!@!1, X 3C 5 $PQ'0!*,24 2#$L $<Q
M,@!&,3D 1#%  $,R1P!",D\ 03-7 $ S8  _-&L /C5X #TUAP \-I8 .S:G
M #LVN0 Z-M$ .C;M #LV_  [-O\ .S;_ *8V  "2-P  @C@  '4X  !K.
M8S<  %TV  !7,P  4S0  $\T P!+- P 2302 $8U&@!%-2( 0S4I $$U+P!
M-38 /S8] #XV1  ]-TP /#=5 #LX7@ Z.&D .3EV #@YA0 W.I4 -SJE #8Z
MN  U.L\ -CKL #8Z^P V.?\ -SG_ *(X  "..0  ?CH  '([  !H.P  7SH
M %DY  !3-@  3C<  $HX  !&. H 1#D0 $$Y%P _.1\ /CDF #PY+0 [.C0
M.CH[ #D[0@ X.TH -SM3 #8\7  U/&< -#UT #,]@P S/I, ,CZD #$^M@ Q
M/LT ,3[J #$^^@ R/?\ ,CW_ )X[  "+/   >SP  &X]  !D/0  7#T  %4\
M  !..@  23L  $4\  !!/0< /CT. #P]%0 Z/AP .3XC #<^*@ V/S$ -3\X
M #0_0  S0$@ ,D!0 #% 6@ P064 +T%R "Y"@0 M0I$ +4*B "Q"M0 K0LL
M+$+I "Q"^0 M0?\ +4'_ )D]  "'/@  =S\  &L_  !A0   63\  %(_  !)
M/@  1#\  $!    \000 .4(- #="$@ U0QD ,T,A #)#*  Q1"\ ,$0V "]$
M/0 N144 +45. "Q%6  K1F, *D9O "E&?@ H1H\ )T>A "9'LP F1\D )D;G
M "=&^  H1?\ *$7_ )5   ""00  <T(  &="  !>0@  54(  $Y"  !%0@
M/T0  #M%   W1@  -$<* #%($  O2!8 +DD> "Q))0 K22P *DDS "E*.@ H
M2D( )TI+ "9+50 E2V  )$MM "-+?  B2XT (4R? "%,L0 @3,< ($OF "%+
M]P B2O\ (DK_ )!#  !^1   ;T0  &1%  !:10  4D4  $I&  !!1P  /$@
M #=)   R2P  +DT' "M.#@ I3A, )T\: "9/(0 E3R@ )$\P "-0-P B4#\
M(5!( "!04@ ?45T 'E%J !U1>0 <48H &U&< !I1KP 94<4 &5'D !I0]@ ;
M3_\ '$__ (I&  !Y1P  :T<  &!(  !62   3D@  $=)   ^2P  .4P  #-.
M   N4   *%," "14"P B51  (%46 !]6'@ >5B0 '58L !Q6,P ;5SL &E=$
M !E73@ 85UD %UAF !58=0 46(< %%B: !-7K  25\( $E?A !-6]  45?\
M%%7_ (1)  !T2@  9DL  %Q+  !32P  2TP  $1-   \3P  -5$  "]4   I
M5@  )%D  !Y;!P :70T &%T2 !==&0 67B  %5XG !1>+@ 37C< $EY  !%?
M2@ 17U4 $%]B  ]?<0 .7X, #5^6  U?J0 ,7KX #%[:  U=\  -7/P #ES_
M 'Y-  !N3@  8DX  %A/  !/3P  2%   $!2   X5   ,%<  "I:   D70
M'U\  !EB 0 390D $68/ !!F%  /9AL #F<B  UG*0 -9S( #&<[  MG10 *
M9U  "6==  =G;  &9WT !6>0  1FHP "9K<  V7/  1EZ0 $9/4 !&3\ '=1
M  !I4@  75(  %12  !,4P  0U4  #M8   S6P  *UX  "5A   ?9   &6<
M !-J   /;08 "W ,  AP_^+_XDE#0U]04D]&24Q%  0)$0 '<!8 !7 =  1P
M)  #<"P  G U  !P/P  <$H  '!7  !P90  <'8  '"*  !OG@  ;[(  &[(
M  !MY0  ;?(  &WY '!6  !C5@  658  %%7  !'6   /EL  #9?   N8@
M)F8  !]J   9;0  $W    YS   +=@0 !7@+  %X#P  >1,  'D9  !Y'P
M>B8  'HO  !Z.0  >D0  'I0  !Z7P  >G   'J#  !ZF   >JP  'G"  !X
MWP  >.\  '?W &I;  !?6P  5EL  $Q<  !"8   .6,  #!H   H;   ('
M !ET   3=P  #GL   E^   $@0(  (((  "##0  @Q   (04  "%&0  AB
M (8H  "',0  ASP  (=)  "'5P  AV@  (=[  "'D   AJ4  (6Z  "%TP
MA.H  (3T &5@  !<8   46$  $9D   \:0  ,FT  "ER   A=P  &7L  !*
M   -@P  "(<   **    C0   (X$  "."0  CPT  ) 0  "1%   DAD  ),@
M  "4*0  E3,  )5   "63@  EE\  )5R  "5B   E9T  )2R  "4R   D^(
M )/N &%E  !69@  2FH  #]N   U=   *WD  "%_   9A   $8D   R-   &
MD0   )0   "8    F@   )L   "< @  G0<  )X+  "?#@  H1(  *(8  "C
M(   I2D  *8V  "F1   IE4  *9H  "F?0  II0  *6I  "DO0  I-$  *3D
M %ML  !/<   0W4  #A[   M@0  (X<  !F-   1D@  "Y<   2<    H
M *,   "F    J    *D   "J    K    *T$  "N"0  L T  +$1  "S%P
MM2   +8K  "W.@  MTL  +A<  "X<0  N(@  +B=  "XL0  M\(  +?0 %1V
M  !(?   /((  #&)   FD   &Y<  !*=   ,H@   Z<   "K    K@   +(
M  "V    N    +@   "Z    NP   +T   "^    P 4  ,$+  ##$   QA8
M ,D@  #*+@  RSX  ,Q0  #,9   S7H  ,V1  #-I   S;0  ,W  $V#  !!
MB@  -9$  "F9   >H   $Z8   RL   #L0   +8   "Z    O@   ,(   #&
M    R    ,@   #*    RP   ,T   #.    T    -(!  #5"   V0X  -T5
M  #A(0  XC$  .1#  #E5@  YFL  .:"  #GE@  YZ4  .:P /\ "0#_  4
M_P & /\ #@#_ !8 _P A /\ +0#_ #@ _0!# /D 30#U %4 \@!= /  8P#N
M &D [ !O .H = #I 'H YP!_ .8 A0#D (L XP"1 .$ F0#? *$ W "J -H
MM@#7 ,8 U0#A -, ] #2 /\ T0#_ -$ _P#/ /\ R@#_ /\  0#_    _P !
M /\ # #_ !( ^@ = /8 * #S #, \  ^ .P 2 #H %  Y0!8 .( 7@#? &0
MW0!J -L ;P#9 '0 U@!Z -0 ?P#2 (4 T ", ,X DP#, )P R0"E ,< L #&
M +X Q #4 ,( [@#! /X P #_ ,  _P"_ /\ O@#_ /\   #_    _P   /H
M!P#Q  \ ZP 8 .8 (P#B "X X  X -L 0@#5 $L T0!2 ,X 60#+ %\ R0!E
M ,< :@#& &\ Q !T ,( >@#! (  OP"& +T C@"[ )8 N0"@ +< J@"V +<
MM #* +( Y@"Q /@ L #_ *\ _P"O /\ L #_ /\   #_    ]P   .H  @#A
M  P UP 3 -  '0#, "@ R0 R ,8 / #" $4 OP!- +P 4P"Z %D N !? +<
M9 "U &D M !N +( = "Q 'H KP"  *T B "L )$ J@": *@ I0"F +$ I #!
M *, W "A /( H0#_ *  _P"@ /\ H0#_ /\   #W    Z    -D   #+  @
MPP 0 +T & "Y "( M@ L +0 -@"R #\ KP!' *P 30"K %0 J0!9 *< 7@"F
M &, I0!H *, ;@"B '0 H !Z )X @@"< (L FP"5 )D GP"8 *P E@"Z )0
MSP"3 .L D@#[ )( _P"2 /\ D0#_ /<   #G    TP   ,8   "[  ( LP ,
M *T $@"J !P IP F *0 , "C #@ H !  )X 1P"< $X F@!3 )D 6 "7 %T
ME@!C )4 : "3 &X D@!T )  ? "/ (4 C0"/ (L F@"* *< B "U (8 QP"%
M .0 A #U (0 _P"# /\ @P#_ .P   #3    P0$  +0   "L    I@ ' *
M#@"= !8 F@ @ )< *0"5 #( DP Z )$ 00"/ $@ C0!- (P 4P"+ %@ B0!=
M (@ 8P"' &D A0!O (, =P"" (  @ "* 'X E@!] *, >P"P 'H P@!Y -T
M> #Q '< _0!X /\ > #_ -X*  #$"P  L@P  *8+  "="   F00  )4 "@"1
M !$ C@ 9 (L (P") "P AP T (4 .P"# $( @@!( (  3@!_ %, ?0!8 'P
M7@![ &0 >0!J '@ <@!V 'L = "& ', D@!Q )\ < "M &X O@!M =8 ;0+M
M &P#^@!L _\ ; /_ ,X0  "W$0  IA(  )H1  "1$   BPX  (D+ P"'!0P
MA $3 ($!' !^ B4 ? ,N 'H#-@!X!#P =P1# '4%2 !T!4X <P54 '$%60!P
M!E\ ;@9F &T&;@!K!W@ :@># &@(D !G"9T 90FL &0)O !C"M0 8POL &(,
M^@!B#/\ 8@S_ ,,6  "M%P  G1@  ) 8  "'%@  @10  'T1  !\#@8 ? H.
M '@*%@!U"Q\ <@LH ' ,, !O##< ;0P^ &P,1 !K#4H :0U/ &@-50!G#5P
M90UC &,.:P!B#G4 8 Z! %\.C@!=#YP 7!"K %L0O0!:$-8 61'P %D1_0!9
M$?\ 61'_ +D;  "E'0  E!X  (@>  !^'0  >!L  '08  !Q%0  <1$) &\0
M$0!L$!D :1 B &<1*@!F$3( 9!$Y &,1/P!B$44 8!)+ %\240!=$E@ 7!)?
M %H3: !9$W( 5Q1] %84BP!4%9D 4Q6I %(6N@!1%M( 41?M %$7_0!1%_\
M41?_ +(@  ">(@  CB(  ($C  !W(@  <"$  &P>  !I&P  9Q@$ &85#@!C
M%A4 818> %\6)@!=%BT 7!<T %H7.P!9%T$ 6!A' %8830!5&%0 4QA< %(9
M9 !1&6X 3QIZ $X;B !-&Y< 2QRF $H<N !*'<\ 21WK $D=^P!)'?\ 2AW_
M *PD  "8)0  B"8  'LG  !Q)@  :B4  &8C  !B(0  8!X  %X<"P!;&Q(
M61P: %<<(@!5'"D 5!PP %,=-P!1'3T 4!U# $\=2@!-'E$ 3!Y8 $L?80!)
M'VL 2"!W $<@A0!&(90 1"*D $0BM@!#(LP 0R/I $,C^@!#(_\ 0R+_ *8G
M  "3*0  @RH  '8J  !M*@  92D  & G  !<)0  62,  %<A!P!5(0\ 4B$6
M % A'@!.(24 32(L $PB,P!*(CD 22)  $@B1@!'(TT 12-5 $0D7@!#)&D
M0B5U $ F@P _)I( /B>C #XGM  ])\H /2CH #TH^0 ])_\ /B?_ *(J  ".
M*P  ?RT  '(M  !H+0  82P  %PK  !8*   5"8  %$F! !.)0T 3"43 $HF
M&@!()B( 1R8I $4F+P!$)C8 0R<\ $$G0P! )TL /RA3 #XI7  ]*68 /"IR
M #LJ@0 Z*Y  .2NA #@LL@ W+,@ -RSF #@L^  X+/\ ."S_ )TL  "*+@
M>R\  &\P  !E,   72\  %@N  !3*P  4"H  $PJ  !)*@L 1BH1 $0J%P!"
M*A\ 02HE #\J+  ^*S, /2LY #PK0  [+$@ .BQ0 #DM60 X+F0 -RYP #8O
M?P U+X\ -#"? #,PL0 R,,< ,C#E #,P]P S,/\ -"__ )DO  "',0  =S(
M &LR  !B,@  6C(  %0Q  !/+P  2RT  $<N  !$+@@ 02X. #\N%  ]+AP
M.RXB #DO*0 X+R\ -R\V #8P/@ U,$8 -3%. #0Q5P S,F( ,C)N #$S?0 P
M,XT +S2> "XTL  M-,4 +33C "XT]@ O,_\ +S/_ )4Q  "#,P  =#0  &@U
M  !>-0  5S0  %$T  !+,@  1C$  $(R   _,@4 /#(- #DS$@ X,QD -C,@
M #0S)@ S,RT ,C0T #$T.P P-4, ,#5, "\V50 N-F  +3=L "PW>P K-XL
M*CB< "DXK@ H.,, *#CB "DX]0 J-_\ *C?_ )(T  !_-0  <38  &4W  !;
M-P  5#<  $TV  !'-@  0C4  #TV   Z-@( -S<+ #0W$  R-Q8 ,3@= "\X
M)  N."L +3DR "PY.0 K.4$ *CI) "HZ4P I.UX *#MJ "<[>0 F/(D )3R;
M "0\K0 C/,( (SS@ "0\]  E._\ )3O_ (TV  !\.   ;3D  &(Y  !8.@
M43D  $HY  !$.0  /3D  #DZ   U.P  ,CL( "\\#@ M/10 +#T: "H](0 I
M/2@ *#XO "<^-@ F/CX )3]' "0_4  C0%L (D!H "% =@ @0(< 'T&9 !]!
MJP >0<  'D'> !] \P ?0/X (#__ (DY  !X.@  :3L  %X\  !5/   33P
M $<\  ! /   .#T  #0^   P0   +4$% "I"#  G0A$ )D,8 "1#'@ C0R4
M(D,L "%$,P @1#L 'T1$ !Y%3@ =15D '$5E !M%=  :184 &4:7 !E&J0 8
M1KX %T7< !A%\0 91/T &D3_ (0\  !S/0  9CX  %L_  !2/P  2C\  $0_
M   ]0   -D$  #%#   L1   )T8! "1'"@ A2 \ ($D4 !Y)&P =22( '$DI
M !M*,  :2C@ &4I! !A*2P 72U4 %DMB !5+<0 42X( $TN4 !)+IP 22[P
M$4O9 !)*\  32OP %$G_ '\_  !O0   84$  %="  !.0@  1T(  $%"   Z
M0P  ,D4  "U'   H20  (TL  !Y-!@ ;3PT &% 1 !=0%P 64!X %5 E !10
M+  3430 $E$] !%11P 145( $%%?  ]2;0 .4GX #5&1  U1I  ,4;@ #%'1
M  U0[  -4/H #D__ 'E#  !J1   740  %-%  !+10  1$4  #Y&   V2
M+TH  "E,   D3P  'U$  !I3   45@D $5<. !!8$P 06!D #U@@  Y8*  -
M6#  #5@Y  Q80P +6$X "EA:  A8:  '6'D !EB,  58GP $6+, !%?*  57
MY@ %5_, !E;\ '-&  !D1P  64@  %!(  !(2   04D  #I*   R30  *U
M "52   @50  &E@  !5:   0708 #& ,  I@$  )8!4 "& <  =@(P %8"L
M!& T  -@/0 !8$D  &!5  !@8P  8',  &"&  !?F@  7ZX  %_$  !>X@
M7O   %[X &Q*  !?2P  54L  $Q,  !%3   /4X  #50   N4P  )U8  "!9
M   :7   %5\  !!B   -900 "&<+  -G#@  :!,  &@8  !H'P  :28  &DN
M  !I.   :4,  &E/  !I70  :6T  &F   !IE   :*D  &B_  !GW   9NX
M &;W &9/  !:3P  44\  $I/  !!40  .%0  #!7   H6P  (5X  !IB   4
M90  $&@   QK   ';@,  7 )  !P#0  <1   '$4  !R&@  <R$  ',H  !S
M,0  <SP  '1(  !S5@  <V8  '-Y  !SC@  <Z,  '*Y  !QT@  <>L  '#T
M &%3  !64P  3U,  $55   [6   ,EP  "I@   B9   &V@  !1L   /;P
M"W(   9V    >0   'H&  !Z"@  >PX  'P1  !]%0  ?AL  '\B  " *@
M@#4  (!!  " 3P  @%\  (!Q  " A@  @)T  '^R  !^R@  ?N4  'WQ %Q8
M  !46   25H  #]=   U80  +&4  "-J   ;;P  %',   YW   )>P   W\
M  ""    A    (8!  "&!@  B H  (D-  "*$   BQ4  (P;  ".(@  CRP
M (\X  "/1@  CU8  (]H  "/?@  CY4  (ZK  "-P0  C=P  (SK %E=  !.
M7P  0V(  #AF   N;   )'$  !QW   4?   #H$   B%    B0   (T   "0
M    D@   ),   "4    E@,  )<(  "8#   F@\  )L3  "=&@  GR,  * N
M  "@/   H$P  *!>  "@=   GXP  )^B  "?MP  GLL  )[@ %-D  !':
M/&T  #%S   G>0  '7\  !2%   -BP  !I    "4    F    )P   "?
MH0   *(   "D    I0   *<   "H!   J@D  *P-  "M$@  L!D  +(C  "R
M,0  LD(  +)4  "R:0  LH   +*8  "QK   LK\  +'. $QN  ! <P  -7H
M "J!   ?B   %8X   Z5   &F@   )\   "D    J    *P   "O    L0
M +$   "S    M0   +8   "X    N@   +P&  "^#   P!$  ,,9  #%)@
MQ3<  ,9)  #&70  QW(  ,>*  #(GP  R*\  ,B\ $9Z   Y@0  +HD  "*0
M   7F   #Y\   >E    J@   *\   "S    MP   +P   "_    P0   ,(
M  #$    Q0   ,<   #)    RP   ,T   #/ P  T@H  -80  #<&@  W2H
M -X\  #?4   X&4  .%[  #AD0  XJ(  .*M /\  @#_    _P # /\ # #_
M !, _P = /\ * #^ #, ^P ^ /< 2 #S %  \ !7 .T 7@#K &0 Z !I .<
M;P#E '0 XP!Y .( ?P#@ (4 W@", -P DP#9 )P U@"F -, L0#1 ,  SP#:
M ,X \0#, /\ RP#_ ,L _P#& /\ P0#_ /\   #_    _P   /\ " #[ !
M]@ 9 /( ) #O "X [0 Y .@ 0@#C $L X !2 -T 60#9 %\ U@!D -, :0#1
M &X SP!T ,X >0#, '\ R@"& ,@ C@#& )8 Q "@ ,( JP#  +D O@#- +P
MZ@"[ /P N@#_ +H _P"Z /\ M@#_ /\   #_    _@   /0 ! #K  T Y  4
M -\ 'P#; "D V  S -, /0#. $4 R@!- ,< 4P#% %D PP!? ,$ 9 "_ &D
MO0!N +L <P"Z 'D N "  +8 B "T )  L@": +$ I0"O +( K0#$ *P X0"K
M /8 J@#_ *H _P"J /\ J@#_ /\   #]    [@   .(   #5  H S0 1 ,<
M&0#$ ", P0 M +\ -P"[ #\ MP!' +4 3@"R %, L !9 *\ 7@"M &, K !H
M *L ;0"I ', J !Z *8 @0"D (H HP"4 *$ GP"? *P G@"[ )P T@"; .X
MF@#_ )H _P"9 /\ F0#_ /X   #N    W@   ,L   #!  4 N0 - +0 % "Q
M !X K@ G *L , "J #D IP!! *0 2 "B $T H0!3 )\ 6 "> %T G0!B )L
M9P": &T F !S )< >P"5 (0 E ". )( F0"0 *8 C@"T (T R ", .8 BP#Y
M (H _P"* /\ BP#_ /    #;    QP   +H   "P    J  * *0 $ "@ !@
MG0 A )L *@": #, F  [ )8 00"4 $@ D@!- )$ 4@"/ %< C@!< (P 80"+
M &< B@!N (@ =0"' 'X A0"( (, E "" *  @ "O '\ P !^ -T ?0#R 'T
M_P!] /\ ?0#_ .    #&    M0   *H   "B    FP % )4 #0"2 !, D  <
M (T ) "+ "T B@ T (@ .P"& $( A0!' (, 30"" %( @0!7 '\ 7 !^ &(
M?0!H 'L < !Z 'D > "# '8 CP!U )P = "J '( N@!Q -$ < #L '  ^P!P
M /\ < #_ ,T$  "W!@  IP<  )L&  "3!   C@   (H " "&  \ A  6 ($
M'@!_ "< ?0 N 'P -@!Z #P >0!" '< 1P!V $P =0!2 ', 5P!R %T <0!C
M &\ :P!N '0 ; !^ &L B@!I )@ : "F &< M@!F ,L 90#G &4 ]P!E /\
M90#_ , ,  "K#0  FPX  (\.  "&#0  @0L  'X' 0!\ 0L >0 1 '< & !U
M "$ <P I '$ , !O #8 ;@ \ &P 0@!K $< :@!- &D 4@!H %@ 9@!? &4
M9P!C '  8@%Z & !AP!? I4 7@*C %P#LP!< \< 6P3D %L%] !;!OX 6P;_
M +40  "A$@  D1,  (43  !\$@  =A$  ',.  !R# 0 <0<- &X$$@!L!!L
M:04C &<%*@!F!C$ 9 8W &,&/0!B!T, 80=) %\'3@!>"%4 70A< %L)8P!:
M"6T 6 IX %<*A0!6"Y, 5 NB %,+LP!2#,< 4@SD %$-]0!1#?\ 40W_ *T5
M  "9%P  B1@  'T9  !T&   ;1<  &H4  !G$0  9PX' &8,#@!C#!4 80P=
M %\,)0!=#2P 7 TS %L-.0!:#3\ 6 U% %<-2P!6#E$ 50Y9 %,.80!2#FL
M4 ]V $X0@P!-$)( 3!"B $L0L@!*$<@ 21'E $D1]P!)$O\ 21'_ *49  "2
M'   @QT  '8>  !M'0  9AP  &(:  !?%P  7A0! %X1"@!;$!$ 61$8 %<1
M( !5$2< 5!$N %,1- !1$3L 4!)! $\21P!.$DX 3!)5 $L37@!)$V< 2!1S
M $84@ !%%8\ 1!6? $,6L !"%L4 0A?C $(7]@!"%_\ 0A?_ )\=  ",(
M?2$  '$B  !H(@  82$  %P?  !9'   5QD  %46!@!4%0X 4144 $\6' !.
M%B, 3!8J $L6, !*%C< 21<] $<70P!&%TH 11A2 $,86@!"&60 01EP #\:
M?0 ^&XT /1N= #P<K@ [',, .QSA #L=]0 ['/\ /!S_ )HA  "'(P  >"0
M &PE  !C)0  7"0  %<C  !3(   41X  $\< @!-&PP 2QH1 $@;& !'&R
M11LF $0;+0!#'#, 0APY $ <0  _'4< /AU/ #T>6  \'F( .A]M #D?>P X
M((L -R&; #8AK0 U(<$ -2'? #4A\P V(?\ -B'_ )8C  "#)@  ="<  &@H
M  !?*   6"<  %,F  !/)   3"(  $D@  !'( D 1!\/ $(?%0! (!P /R C
M #X@*0 \("\ .R$V #HA/0 Y(40 ."), #<B50 V(U\ -"-K #,D>0 R)8D
M,26: # EJP P)K\ +R;< # F\@ P)O\ ,27_ )$F  !_*   <2H  &4J  !<
M*@  52H  $\I  !+*   2"4  $0D  !!) 4 /R0- #TD$@ [)!D .20? #<D
M)@ V)"P -24S #0E.@ S)D$ ,B9* #$G4P P)UT +RAI "XI=P M*8< +"F8
M "LJJ@ J*KT *BK: "LJ\0 K*OX +"G_ (TH  !\*@  ;2P  &(M  !9+0
M42T  $PL  !'*P  0R@  #\H   \* ( .2@+ #<H$  U*!8 ,R@< #(H(P P
M*"D +RDP "\J-P N*C\ +2M' "PK40 K+%L *BQG "DM=0 H+84 )RV7 "8N
MJ  E+KP )2[8 "8N\  F+OT )RW_ (HK  !X+0  :BX  %\O  !6+P  3B\
M $@N  !#+0  /RP  #LL   W+   -"P) #(L#@ P+1, +BT: "TM(  K+2<
M*BXM "HN-0 I+ST *"]% "<P3@ F,%D )3%E "0Q<P C,8, (C*5 "$RIP A
M,KL (#+4 "$R[P B,?P (C'_ (8M  !U+P  9S   %PQ  !3,0  2S$  $4Q
M  ! ,   .S   #8P   S,   ,#$& "TQ#0 K,1$ *3(7 "@R'@ G,B0 )3,K
M "4S,@ D,SH (S1# "(T3  A-5< (#5C !\U<0 >-H$ '3:3 !PVI0 ;-KD
M&S;2 !PV[0 =-OL '37_ ((P  !Q,@  8S,  %DT  !0-   230  $(S   ]
M,P  -S,  #$T   N-0  *S4" "@V"P E-Q  )#<5 "(W&P A."( (#@H !\X
M,  >.#< '3E  !PY20 ;.E0 &CI@ !DZ;@ 8.G\ %SN1 !<[I  6.[< %3O0
M !8Z[  7.OH &#G_ 'TR  !M-   8#4  %4V  !--@  1C8  $ V   Z-@
M-#8  "XX   J.0  )CH  ",["  @/ X 'CT2 !T]&  </1\ &SXE !H^+0 9
M/C0 %SX] !8_1P 5/U$ %#]> !0_;  30'P $D"/ !% H@ 10+8 $$#. !$_
MZP 2/_D $C[_ 'DU  !I-P  7#@  %(Y  !*.0  0SD  #TY   W.0  ,3H
M "L\   G/0  (C\  !Y!!  :0@L &$,0 !=#%0 51!L %$0B !-$*0 31#$
M$D0Z !%%0P 014X $$5;  Y%:0 .17D #46,  U%GP ,1;( "T7)  Q%Y0 -
M1/8 #43_ '0Y  !E.@  6#L  $\[  !'/   0#P  #H\   T/   +CX  "A
M   C0@  'T0  !I&   52 @ $DH- !%*$@ 02A@ #TL>  Y+)0 -2RT #4LV
M  Q+0  +2TH "DM6  E+9  (2W0 !TN'  5+F@ $2ZX !$K$  5*X  %2O
M!DGZ &X\  !@/0  5#X  $L^  !$/@  /3X  #<_   Q0   *D(  "1%   ?
M1P  &DD  !5,   13@4 #E$+  M1$  *410 "5$;  A1(@ '42D !5$R  12
M.P #4D8  5)2  !27P  4F\  %*!  !1E@  4:D  %&_  !0W   4.X  %#W
M &A   !;00  4$$  $A!  !!00  .T(  #1#   M10  )D@  "!+   ;30
M%E   !%3   .500 "E@*  98#@ "6!(  %D7  !9'0  624  %DM  !9-@
M64$  %E-  !:6@  6FD  %E\  !9D   6:4  %BZ  !8U0  5^P  %?V &-$
M  !610  344  $5%   _10  -T<  "])   H3   (D\  !M2   650  $5@
M  U:   )70, !%\)  !@#0  8!   &$4  !A&0  8B   &(G  !B,0  8CL
M &)'  !B50  8V0  &)V  !BBP  8J   &&V  !ASP  8.H  &#U %U(  !2
M20  2D@  $-(   Z2@  ,DT  "I0   C4P  '%<  !9:   170  #6    AC
M   #9@$  &<&  !H"P  :0X  &H1  !K%0  ;!L  &TB  !M*@  ;30  &U
M  !M3@  ;5T  &UO  !MA   ;)H  &RP  !KR   :^8  &KS %A-  !.30
M2$P  #Y.   U40  +%0  "18   =7   %F   !!D   ,9P  !VL   %N
M<    '(#  !R!P  <PL  '4.  !V$0  =Q8  '@<  !Y(P  >BT  'HY  !Z
M1P  >E8  'EH  !Z?   >90  'BJ  !XP0  =]\  '?O %11  !,40  0E(
M #A5   O60  )EX  !YB   69P  $&L   MO   %<P   '<   !Z    ?
M 'X   !_ @  @ 8  ($*  "##0  A!$  (85  "('   B24  (HP  "*/@
MB4T  (E?  ")<P  B(L  (BB  "'N0  A]$  (;H %)6  !'5P  /%H  #)?
M   H9   'VD  !9O   0=   "GD   )]    @0   (4   "(    B@   (P
M  "-    CP   ) $  "2"   DPP  )40  "7%0  F1T  )LG  ";-   FT0
M )I6  "::@  F8(  )J:  "8L   F,<  )?> $M<  ! 8   -64  "MJ   A
M<0  %W<  !!]   )@P   8@   ",    D0   )4   "8    F@   )L   "=
M    GP   *    "B    I 4  *8*  "H#@  JA0  *T=  "M*@  K3D  *U+
M  "M7P  K7<  *R0  "KIP  J[H  *O+ $5F   Y:P  +G$  "-X   9?P
M$(8   F-    DP   )@   "=    H0   *4   "H    JP   *L   "N
MKP   +$   "S    M0   +<!  "Y!P  O T  +\3  #"'P  PBX  ,)   #"
M5   P6L  ,&#  # FP  P:T  ,&\ #YR   R>   )X   !R(   2D   "I<
M  "=    HP   *@   "M    L@   +8   "Y    NP   +P   "^    P
M ,(   #$    Q@   ,@   #+    S@4  -$-  #6%   UR,  -@U  #920
MVEX  -MU  #;C   W)\  -RK /\   #_    _P   /\ "0#_ !  _P 9 /X
M) #\ "\ ^0 Y /0 0P#P $L [0!2 .H 60#G %\ Y !D .( :0#@ &X W@!S
M -P >0#: '\ UP"& -0 C@#1 )8 SP"A ,P K #* +L R #2 ,8 [@#& /\
MQ0#_ ,4 _P"_ /\ N@#_ /\   #_    _P   /X !0#W  X \@ 5 .X 'P#K
M "H Z0 T ., /0#> $4 V0!- -0 4P#1 %D S@!> ,P 8P#* &@ R0!M ,<
M<P#% 'D PP"  ,$ B "_ )  O0"; +L I@"Y +0 MP#( +8 Y@"U /L M #_
M +0 _P"S /\ K@#_ /\   #_    ^    .T   #E  L W0 1 -< &@#2 "0
MSP N ,L -P#' $  PP!' ,  3@"^ %, O !9 +H 7@"X &, M@!H +4 ;0"S
M ', L0!Y *\ @0"M (H JP"4 *D H "H *T I@"^ *4 VP"D /0 I #_ *,
M_P"C /\ H@#_ /\   #V    Y@   -<   #+  8 Q  . +X %0"[ !\ N0 H
M +< ,0"T #H L !! *T 2 "K $X J0!3 *< 6 "F %P I !A *, 9P"A &P
MH !S )X >@"= (, FP". )D F0"7 *8 E@"V )4 S "4 .L DP#] ), _P"3
M /\ DP#_ /<   #D    T    ,$   "W  ( KP + *L $0"G !D I0 B *,
M*P"B #, GP [ )P 0@"; $@ F0!- )< 4@"6 %< E0!; ), 80"2 &8 D !M
M (\ = "- 'T C "' (H DP"( *  AP"O (4 P@"% .( A #W (0 _P"$ /\
MA #_ .4   #-    O    *\   "F    G@ ' )H #@"6 !0 E  = )( )0"1
M "T D  U (T / ", $( B@!' (@ 3 "' %$ A@!6 (0 6P"# &  @0!G (
M;@!^ '< ?0"! 'L C0!Z )H > "I '< N@!V -, =@#O '8 _@!U /\ =0#_
M -    "[    JP   )\   "7    D  " (L "P"( !  A@ 7 (0 ( "" "<
M@0 O '\ -0!] #P ? !! 'L 1@!Y $L > !0 '< 50!V %L = !A ', :0!Q
M '$ < ![ &X AP!M )4 :P"C &H M !J ,D :0#H &D ^0!I /\ :0#_ ,
M  "L    G (  ) "  "(    @P   '\ !@![  T >0 2 '< &@!V "( =  I
M ', , !Q #8 <  \ &\ 00!M $8 ; !+ &L 4 !J %8 : !< &< 9 !E &P
M9 !V &, @@!A )  8 "? %\ KP!> ,, 7@#A %X ] != /\ 70#_ +0'  "@
M"0  D L  (0+  !\"@  =P<  '0$  !Q  D ;P / &T %0!K !P :0 C &@
M*@!G #$ 90 V &0 / !C $$ 8@!& &  3 !? %( 7@!8 %T 7P!; &@ 6@!R
M %@ ?@!7 (P 5@"; %4 JP!4 +X 5 #: %, [P!4 /L 5 #_ *D-  "6#@
MAQ   'H0  !R$   ; X  &D,  !G"0, 9@0+ &0 $ !B !< 8  > %X )0!=
M "L 7  Q %H -P!9 #P 6 !" %<!1P!6 4X 50)4 %,"7 !2 V4 40-O $\$
M>P!.!(H 3069 $P%J0!+!;P 2@;4 $H'[0!*!_D 2@?_ *$0  ".$@  ?A0
M ',4  !J%   9!,  & 1  !>#P  70T% %T)#0!:!A( 6 <9 %8'( !5!R<
M4P<M %((,P!1"#@ 4 @^ $\)1 !."4H 3 E1 $L*60!*"F( 2 MM $<+>@!&
M#(@ 1 R8 $,,J0!"#;P 0@W5 $(-[@!"#?L 0@W_ )H4  "'%@  >!@  &P9
M  !C&0  71@  %D6  !6$P  5!$  %0." !3#0X 40T4 $\-&P!-#2( 3 TH
M $L-+@!*#30 20TZ $<.00!&#D< 10Y/ $0.5P!"#V$ 01!L #\0>0 ^$(@
M/1&8 #L1J0 [$;P .A'6 #H1\  Z$OT .Q'_ ),8  "!&@  <QP  &<=  !>
M'0  6!P  %,;  !0&   3A8  $P3 P!,$0L 2A 0 $@1%P!&$1X 11$D $01
M*@!"$3  01$W $ 2/0 _$D0 /1), #P35  [$UX .11I #@4=@ W%84 -A66
M #06IP T%KH ,Q;3 #,6[@ T%OP -!;_ (X;  !\'0  ;A\  &,@  !:(
M4R   $X>  !*'0  2!H  $88  !%%@< 0Q4. $$5$P _%1H /A4@ #T5)P [
M%2T .A8S #D6.@ X%D$ -Q=) #4740 T&%L ,QEF #(9<P P&H, +QJ4 "X;
MI0 M&[@ +1O0 "T;[  N&_L +AO_ (H>  !X(   :B(  %\C  !6(P  3R(
M $HA  !&(   0QX  $$;   _&@, /1H, #L9$0 Y&18 -QH= #8:(P U&BD
M-!HP #,;-@ Q&SX ,!Q& "\<3P N'5D +1UD "P><0 K'X$ *A^2 "D?I  H
M(+< )R#. "<@ZP H(/H *1__ (8@  !T(P  9R0  %PE  !3)0  3"4  $<D
M  !"(P  /R$  #T?   Z'@  -QX) #4>#@ S'A, ,1X: # >(  O'B8 +A\M
M "T?,P L(#L *R!# "HA3  I(58 *")B "8B;P E(W\ )".0 ",CH@ B)+4
M(B3, "(DZ0 C)/D )"/_ ((C  !Q)0  8R8  %DG  !0*   22<  $,G   _
M)@  .R0  #@B   U(@  ,B(& # B#0 N(A$ +"(7 "HB'0 I(B, *",J "<C
M,0 F)#@ )25! "0E2@ C)E0 (B9@ "$G;0 @)WT 'R>/ !XHH0 >*+0 '2C*
M !THZ  >*/@ 'R?_ 'XE  !N)P  8"D  %8I  !-*@  1BH  $$I   \*
M-R<  #0F   P)@  +28# "LG"P H)Q  )R<4 "4G&@ D)R$ (R@G "(H+@ A
M*38 ("D^ !\J2  >*E( '2M> !PK:P ;*WL &BR- !DLGP 8++( &"S) !@L
MYP 9*_< &BO_ 'HG  !J*@  72L  %,L  !*+   0RP  #XK   Y*P  -"H
M # J   K*@  *2L  "8K"  C+ X (BP2 " L&  ?+!X 'BTE !TM+  <+3,
M&RX\ !HN10 9+U  &"]< !<O:0 6,'D %3"+ !0PG@ 4,+$ $S#' !,PY0 4
M,/8 %2__ '8J  !G+   6BT  % N  !(+@  02X  #LN   V+0  ,2T  "PM
M   G+P  )"\  "$P!0 ?,0P '#$0 !LR%0 :,AP &3(B !@R*0 7,S$ %C,Y
M !4S0P 4-$T $S19 !(T9P 1-7< $36) ! UG  0-;  #C7&  \TY  0-/4
M$#3_ '(L  !C+@  5S   $TP  !%,   /C   #@P   S,   +S   "DQ   D
M,@  (3,  !TU @ :-@D %S<. !4W$P 4.!D $S@? !(X)@ 2."X $3DV ! Y
M0  0.4L #CE7  XZ9  -.G0 ##J&  PZF0 +.:P "CG!  HYW@ +.?$ ##C\
M &XO  !?,0  4S(  $HS  !",P  .S,  #8S   Q,@  +#,  "<T   A-@
M'3@  !DY   5.P8 $CT, ! ^$  0/A4 #CX<  X^(P -/BH ##XS  P^/  +
M/T< "C]2  @_8  '/V\ !C^!  4_E  $/Z@  SZ\  0^UP %/NP !3[W &DS
M  !;-   4#4  $<U   _-0  .34  #0U   N-0  *3<  ",X   >.P  &CP
M !8_   2000 #D,*  Q$#@ *1!, "409  A$(  '1"< !D0O  5$.  #14(
M D5.  !%6P  16H  $5\  !%D   1*0  $2Y  !$T0  1.H  $/U &0V  !7
M-P  3#@  $,X   \.   -S@  #$X   K.0  )3L  " ]   :0   %D(  !)$
M   .1P0 "TD)  =*#0 $2Q$  4L6  !+'   2R,  $LK  !+-   2SX  $Q)
M  !,5P  3&8  $QW  !+C   2Z$  $NU  !*S@  2ND  $KU %\Z  !2.P
M2#L  $ [   Z.P  -#L  "X\   G/@  (D$  !Q#   61@  $DD   Y+   +
M3@, !U (  )1#   41   %(3  !3&   4Q\  %,F  !3+P  4SD  %-%  !3
M4@  4V$  %-R  !3AP  4IP  %*Q  !1R@  4><  %'T %D^  !./@  13X
M #X^   X/@  ,$   "E"   C1   '4<  !=*   230  #E    M3   &50(
M %<'  !8"P  60X  %H1  !:%0  6QH  %PA  !<*@  7#0  %P_  !<30
M7%L  %QL  !<@0  6Y<  %NM  !:Q0  6N0  %GS %1"  !*0@  0D(  #Q"
M   T0P  +$8  "5)   >3   %T\  !)3   .5@  "ED   5;    7@   & $
M  !A"   8@P  &,.  !D$0  918  &8<  !G(P  9RT  &<Y  !G1@  9U4
M &=F  !G>@  9I$  &6H  !EP   9-X  &3P $]&  !'1@  0$4  #='   O
M2@  )DT  !]1   850  $ED   U<   (8    F,   !F    :    &H   !K
M!   ; @  &T,  !O#@  <!(  '(7  !S'0  ="8  '0R  !T/P  =$X  '-?
M  !T<@  <XH  '*A  !QN   <=0  '#L $Q*  !%2@  .TL  #).   I4@
M(%8  !A;   27P  #60   =H    :P   &\   !R    =0   '8   !W
M>0(  'H&  !\"@  ?@X  ( 1  ""%@  A!X  (0I  "$-@  A$4  (16  "#
M:@  @X$  (*9  "!L0  @,D  (#E $I.   _4   -5,  "M7   B7   &6(
M !)G   ,;   !7$   !U    >0   'T   "!    @P   (4   "&    B
M (D   "+!   C0@  (\-  "2$   E!8  )8@  "6+   ECL  )9,  "58
ME78  )20  "3IP  DKT  )+5 $15   Y60  +UT  "1C   ::0  $F\   QU
M   $>P   (    "%    B0   (T   "1    DP   )0   "6    F    )H
M  "<    G@   * &  "B"P  I1   *@7  "I(P  J3$  *E#  "I5@  J&T
M *:'  "GG@  IK,  *7' #Y>   R8P  )VH  !UP   3>   #'\   .%
MBP   )$   "6    FP   )\   "B    I    *4   "G    J0   *L   "M
M    L    +(   "U @  MPD  +L0  "^&   OB8  +XX  "^2P  O6$  +QZ
M  "[E   NJD  +JY #=J   K<   ('@  !:    -B   !8\   "6    G
M *(   "G    K    +    "S    M@   +<   "Y    NP   +T   "_
MP@   ,4   #(    R@   ,X(  #2$   U1L  -4L  #40   U%<  --N  #4
MA@  U)L  -.K /\   #_    _P   /\ !0#_  X _P 5 /P ( #Y "H ]@ T
M /$ /0#M $8 Z0!- .8 4P#D %D X0!> -X 8P#< &@ V0!N -4 <P#3 'D
MT "  ,X B #+ )$ R0"< ,8 IP#$ +< P@#, ,  [ "_ /\ O@#_ +T _P"W
M /\ L@#_ /\   #_    _P   /H  0#S  L [0 2 .@ &P#E "4 Y  N -\
M. #8 $  T@!' ,X 3@#+ %0 R !9 ,8 7@#$ &, P@!G ,  ;0"_ ', O0!Z
M +L @0"Y (L M@"5 +0 H0"R *\ L #" *X XP"N /H K #_ *T _P"I /\
MI@#_ /\   #_    \@   .8   #=  < T@ . ,T %@#* "  R  I ,4 ,@#
M #H O !" +D 2 "W $X M0!3 +, 6 "Q %T L !B *X 9P"L &P J@!S *D
M>P"G (0 I0". *, F@"A *@ GP"Y )X T@"= /( G #_ )T _P"< /\ F0#_
M /P   #N    W0   ,P   #!  ( N@ , +8 $@"R !H L  C *\ + "M #0
MJ0 \ *8 0@"D $@ H@!- *  4@"> %< G0!; )P 8 ": &8 F0!L )< = "5
M 'T DP"' )$ DP"0 *$ C@"Q (T Q@", .@ BP#] (P _P", /\ C #_ .T
M  #8    Q0   +<   "L    I@ ( *$ #@"? !4 G0 > )L )@": "X EP U
M )4 / "3 $( D0!' )  3 ". %$ C0!5 (L 6@"* &  B0!F (< ;0"% '8
MA "  (( C "  )H ?P"I 'T O !\ -P ? #U 'P _P!\ /\ ? #_ -D   #!
M    L0   *0   "<    E  # )  # "- !$ BP 8 (D ( ") "@ AP O (4
M-@"# #P @@!! (  1@!_ $L ?0!/ 'P 5 ![ %H >0!@ '@ 9P!V '  =0!Z
M ', A@!Q ), < "B &\ M !N ,P ;@#M &X _@!N /\ ;@#_ ,0   "O
MH    )0   ",    A@   ($ " !^  X ?  4 'L &P!Y "( >  I '< , !U
M #8 =  [ '( 0 !Q $4 < !* &\ 3P!M %0 ; !; &L 8@!I &H : !T &8
M@ !E (X 8P"= &( K0!A ,( 80#D &$ ^ !A /\ 80#_ +0   "@    D0
M (8   !^    >0   '4  P!Q  L ;P 0 &T %@!L !T :P D &L *@!I #
M:  V &8 .P!E $  9 !% &, 2@!A $\ 8 !6 %\ 70!= &4 7 !O %H >@!9
M (@ 6 "8 %< J !6 +L 5@#8 %8 \0!6 /\ 5@#_ *@!  "4!0  A0<  'H'
M  !R!@  ; 0  &D!  !G  < 9  - &, $0!A !@ 8  ? %\ )0!> "L 70 P
M %L -@!: #L 60!  %@ 10!7 $L 5@!1 %4 6 !3 &$ 4@!J %  =@!/ (0
M3@"3 $T I !, +8 3 #- $P ZP!, /H 3 #_ )T)  "+"P  ? T  ' -  !H
M#0  8@P  %\*  !=!@$ 7 $) %H #@!8 !, 5P 9 %8 ( !5 "8 4P K %(
M,0!1 #8 4  [ $\ 00!. $< 30!- $L 50!* %T 20!G $< <P!& (  10"0
M $0 H0!# +( 0P#( $, Y@!# /4 0P#_ )4-  "##P  =!   &D1  !@$0
M6A   %8.  !4#0  4PH$ %,&"P!1 Q  3P$5 $X!&P!, 2$ 2P$G $H"+ !)
M C( 2 (W $<#/0!% T, 1 -* $,$40!"!%H 0 5D #\%<  ^!GX /0:. #P'
MGP [![$ .@?& #H'XP Z!_, .@C\ (X0  !\$@  ;A0  &(5  !:%0  5!0
M % 3  !-$0  2PX  $L-!@!*"@P 20@1 $<(%@!%"!T 1 @C $((* !!"2X
M0 DS #\).0 ^"D  /0I' #P*3P Z"U@ .0MC #@,;P V#'X -0R. #0-GP S
M#;$ ,@W' #(-XP R#?0 ,@W^ (@3  !W%0  :1<  %X8  !5&   3Q@  $H6
M  !'%0  11,  $,0 @!##@@ 0@T. $ -$@ _#1@ /0T? #P-)  [#2H .0TP
M #@.-P W#CT -@Y% #4.30 S#U< ,@]B #$0;@ O$'T +A". "T1H  L$;(
M*Q'( "L1Y@ K$?8 +!'_ (,6  !R&0  9!H  %D;  !1&P  2QL  $8:  !"
M&   /Q<  #X4   \$@0 .Q$* #H0$  X$!4 -Q ; #41(0 T$2< ,Q$M #(1
M,P P$3H +Q)" "X22P M$U0 *Q-? "H4;  I%'L *!2, "<5G@ F%;  )17&
M "45Y  E%?8 )A7_ 'X9  !N&P  8!T  %8>  !-'@  1QX  $(=   ^'
M.AH  #@8   W%@  -14' #04#0 R%!( ,!07 "\4'0 M%", +!4J "L5,  J
M%3< *18_ "@62  G%U( )AA= "08:@ C&7D (AF* "$9G  @&:\ 'QG$ !\9
MX@ @&?0 (!G_ 'H;  !J'@  71\  %,@  !*(   1"   #X?   Z'@  -QT
M #0<   R&0  ,!D$ "X8"P L&!  *A@4 "D8&@ G&"  )ADF "49+0 D&C4
M(QH] "(;1@ A&U  (!Q; !\=:  >'7< '1V( !P>FP ;'JT &A[# !H>X  :
M'?, &QW_ '<=  !G(   6B$  % B  !((@  02(  #LB   W(0  ,R   # ?
M   M'0  *QT  "@="  F'0X )1T2 ",=%P A'1T (1TD " >*@ ?'C( 'A\Z
M !T?0P <($T &R%9 !HA9@ 9(74 &"*' !<BF0 6(JP %2+! !4BWP 5(?(
M%B'^ ',@  !D(@  5R,  $TD  !%)0  /B0  #DD   T(P  ,"(  "PB   I
M(0  )B$  "0A!@ B(0P ("$0 !XA%0 =(AL &R(A !LB*  :(R\ &2,X !@D
M00 7)$L %B57 !4E9  4)G, $R:% !(FF  1)JL $2;  ! FW0 1)?$ $B7]
M ' B  !A)   5"8  $HF  !")P  /"8  #8F   Q)0  +24  "DD   F)
M(B4  !\E P =)@H &R8. !DG$@ 8)Q@ %R<? !8G)0 5*"T %"@U !,I/@ 2
M*4D $2E5 !$J8@ 0*G$ #RJ#  XJE@ .*JD #2J]  TJUP -*NX #BG[ &PD
M  !=)@  42@  $@H  ! *0  .2@  #0H   O*   *R<  "<G   B*   'BD
M !LJ   8*P< %BL- !0L$0 3+!8 $BP< !$M(P 0+2H $"TR  \N/  .+D8
M#2Y2  TN7P ,+VX "R]_  HOD@ )+Z4 "2ZY  @NT  )+ND "B[W &@G  !:
M*0  3BH  $4K   ]*P  -RL  #$J   M*@  *2H  "0J   @*P  &RT  !@N
M   5+P0 $C$* ! R#@ /,A, #C(9  TR(  -,B< ##(O  LS.  *,T( "3-.
M  @S6P &-&H !31[  0SC@ #,Z(  C.V  (SS0 #,^< !#+S &0J  !6+
M2RT  $(M   Z+0  -"T  "\L   K+   )BP  "(M   =+P  &3$  !4R   2
M- , #S8)  PX#0 *.!$ "3@6  @X'0 '."0 !C@L  0X-  #.#X  CE*   Y
M5P  .64  #EW   YBP  .)\  #BS   XR@  ..8  #?R %\M  !2+@  2"\
M #\P   X+P  ,B\  "TO   I+P  )#   !\Q   :,P  %34  !(W   /.0,
M##L(  @]#0 %/A   SX4   ^&@  /B$  #XH   ^,0  /SL  #]&   _4P
M/V$  #]S   _AP  /IP  #ZP   ]QP  />0  #WR %HP  !.,@  1#(  #PR
M   U,@  ,#$  "LQ   F,@  (#0  !LV   6.   $CL   \]   ,/P, "$$(
M  1##   0PX  $02  !%%@  11T  $4D  !%+0  1C8  $9"  !&3@  1ET
M $9N  !%@@  19@  $2M  !$Q   0^,  $/R %4T  !*-0  034  #DU   S
M-   +C0  "@U   B-P  '3H  !<\   2/P  #T$   Q$   (1@$  T@&  !)
M"@  2@T  $L0  !,%   31D  $X@  !.*   3C(  $T]  !.2@  3E@  $UI
M  !-?0  3)0  $RJ  !+P0  2^$  $KR % X  !&.   /3@  #<X   Q-P
M*CD  "0[   >/0  &$   !-#   /1@  "TD   =+   "3@   % $  !1"
M4@L  %,.  !4$0  514  %8;  !7(P  5RP  %<X  !71   5U(  %9C  !6
M=P  5HX  %6E  !4O0  4]T  %/P $L\  !"/   .SL  #4[   M/   )C\
M !]"   910  $T@   Y+   +3P  !5$   !4    5P   %@!  !:!0  6P@
M %P,  !=#@  7Q$  & 6  !B'0  8B8  &(Q  !B/@  84P  &%=  !A<
M8(@  &"@  !?MP  7M0  %WN $=    _/P  .C\  #%    I0P  (48  !I*
M   33@  #E$   I5   $6    %L   !>    80   &,   !D 0  900  &<(
M  !H"P  :@X  &P2  !N%P  ;R   &\J  !O-@  ;D4  &Y5  !N:   ;7\
M &V8  !LL   :\H  &KH $1$   ^0P  -40  "M'   C2P  &T\  !-4   .
M6   "%P   )@    9    &<   !K    ;0   &\   !P    <@   '0"  !U
M!@  =PH  'D.  !\$@  ?A@  '\B  !_+@  ?ST  'Y-  !]80  ?7<  'R0
M  ![J   >L   'G? $-'   Y20  +TP  "50   <50  %%L   Y@   '90
M &H   !N    <@   '8   !Y    ?    'X   !_    @0   (,   "%
MAP,  (H(  ",#0  CQ$  )(9  "2)0  DC,  ))$  "15P  D&T  (^&  ".
MGP  C;4  (S- #U.   R40  *%8  !Y<   58@  #F@   =N    =    'D
M  !^    @@   (8   ")    C    (X   "0    D@   )0   "6    F
M )L   ">!@  H0P  *01  "F&P  IBD  *8Z  "E30  I6(  *1[  "CE
MH:L  *&_ #97   L7   (6(  !=I   /<   !W<   !^    A    (H   "/
M    E    )@   ";    G@   )\   "B    I    *8   "H    JP   *T
M  "P    LP0  +<,  "[$@  NQ\  +LP  "[0P  NE@  +EP  "WBP  MZ$
M +>S #!B   E:0  &G   !!X   )@    (@   "/    E@   )L   "A
MI@   *H   "N    L    +$   "T    M@   +@   "[    O0   ,    ##
M    QP   ,L#  #/#   TQ4  -(E  #2.   T4X  -!E  #/?@  S98  ,RI
M /\   #_    _P   /\  P#_  L _  1 /D &P#W "4 \P O .X . #I $
MY@!( .( 3@#? %0 W !9 -D 7@#5 &, TP!H -  ;0#. ', RP!Z ,@ @@#&
M (P PP"7 ,  HP"^ +( O #( +H Z@"Y /\ N #_ +$ _P"J /\ IP#_ /\
M  #_    ^P   /8   #M  < YP / .( %@#? "  W@ I -D ,P#1 #L S !"
M ,@ 2 #% $X P@!3 ,  6 "^ %T O !B +H 9P"Y &T MP!T +4 >P"R (4
ML "0 *X G "L *H J0"] *< W@"F /D I0#_ *, _P"= /\ FP#_ /T   #V
M    ZP   -\   #1  , R@ , ,4 $@## !L P  D +X + "Y #4 M@ \ +,
M0P"P $@ K@!. *P 4@"K %< J0!< *< 80"F &< I !M *( = "@ 'T G@"(
M )P E0": *, F "T )8 S0"5 /$ E #_ )4 _P"0 /\ C@#_ /,   #F
MT0   ,(   "X    L0 ( *T #P"J !8 J  > *@ )P"F "\ H@ V )\ / "=
M $( FP!' )D 3 "7 %$ E@!5 )0 6@"3 &  D0!F )  ;@". '8 C "! (H
MC0"( )L A@"L (4 P0"$ .8 @P#] (0 _P"# /\ @0#_ .0   #+    N@
M *P   "B    G  $ )@ # "6 !$ E  9 ), (0"2 "@ CP P (T -@"+ #P
MB0!! (@ 1@"& $L A0!/ (0 5 "" %H @0!@ '\ 9P!^ &\ ? !Z 'H A@!X
M )0 =P"D '4 MP!T -0 <P#T '0 _P!T /\ = #_ ,L   "V    I@   )H
M  "2    B@   (8 " "#  X @0 4 ($ &P"  ", ?P J 'T , ![ #8 >@ [
M '@ 0 !W $4 =0!) '0 3@!S %0 <0!: '  80!N &D ;0!S &L ?P!I (T
M: "= &< K@!F ,< 90#J &8 _P!F /\ 9P#_ +@   "D    E0   (H   "!
M    ?    '8 ! !T  P <@ 0 '$ %@!P !T <  D &X *@!M #  :P U &H
M.@!I #\ : !$ &< 20!E $X 9 !4 &, 6P!A &, 8 !M %X >0!= (< 6P"6
M %H J !9 +T 60#? %D ^ !: /\ 6@#_ *@   "5    AP   'L   !S
M;@   &H  0!G  @ 90 . &0 $@!C !@ 8P ? &( )0!A "H 7P P %X -0!=
M #H 7  ^ %L 1 !9 $D 6 !/ %< 5@!6 %X 5 !H %, <P!1 ($ 4 "1 $\
MH@!. +4 3@#0 $X \ !. /\ 3P#_ )P   ")    >P,  ' #  !H P  8@$
M %\   !=  0 6P + %D #P!8 !0 5P 9 %< ( !6 "4 50 J %, , !2 #0
M40 Y %  /P!/ $0 3@!+ $T 4@!+ %H 2@!C $D ;P!' 'P 1@", $4 G0!%
M +  1 #' $0 Z !$ /H 10#_ )($  " !P  <0H  &8*  !>"@  60D  %4'
M  !4!   4@ ' %  # !/ !  3@ 5 $T &P!, "  2P F $H *P!) #  2  U
M $< .@!& $  10!& $, 3@!" %8 00!? $  :P ^ '@ /0"( #P F0 \ *L
M/ #! #L X  [ /0 .P#_ (D*  !X#   :@X  %\.  !7#@  40X  $T,  !+
M"P  2@@" $D$"0!(  T 1@ 1 $4 %@!$ !P 0P A $( )@!! "L /P Q #X
M-@ ] #P / !# #L 2@ Z %( .0!< #@ :  V '4 -0"% #0 E@ T *@ ,P"\
M #, V  S .\ ,P#[ ((-  !Q#P  9!   %D1  !1$0  2Q$  $<0  !$#@
M0@T  $$+!0!!!PL /P4. #X#$@ \ A@ .P(= #H#(@ Y R@ . ,M #<#,@ V
M!#D -00_ #0%1P S!5  ,09: # &9@ O!W, +@># "T'E0 L!Z< *P>Z "L'
MT@ K!^L *P?W 'T0  !L$0  7Q,  %04  !,%   1A0  $(3   ^$@  /!
M #H. 0 Z#08 .@H, #@)$  V"!0 -0@9 #0)'P R"20 ,0DI # )+P O"C8
M+@H] "T*10 L"TX *PM9 "D,90 H#', )PR# "8-E0 E#:< ) V[ ",-T@ C
M#>L (PWW '@2  !H%   6Q8  %$7  !(%P  0A8  #T6   Y%0  -Q,  #41
M   S$ , ,PX( #(-#0 P#1$ +PT6 "T-&P L#2$ *PTG "H-+0 I#C0 * X[
M "<.1  E#DX ) ]9 ",090 A$', (!"$ !\0E@ >$*D '1"] !P0V  =$.X
M'1#Y ',4  !D%@  5Q@  $T9  !%&0  /QD  #H8   U%P  ,A8  # 5   N
M$P  +1$$ "P0"@ K$ X *1 2 "@0&  F$!X )1 D "00*@ C$3$ (A$Y "$1
M0@ @$DL 'A)6 !T38P <$W$ &A." !D4E0 8%*< %Q2[ !<3U  7$^X &!/Z
M ' 6  !@&0  5!H  $H;  !"'   /!L  #8;   R&@  +QD  "P8   J%@
M*!0! "83!P E$PP (Q,0 "(3%0 @$QH 'Q,A !X4)P =%"X '!4V !L5/P :
M%DD &194 !@780 6%W  %1B! !08DP 3&*8 $ABZ !(7T@ 2%^P $Q?Z &P9
M  !=&P  41T  $<=   _'@  .1T  #0=   O'   *QL  "@:   F&0  )!@
M "(7!  @%PH 'A<. !P7$@ :%Q< &1@> !D8)  8&2P %QDT !8:/0 5&D<
M%!M2 !,;7P 2'&X $1Q_ ! <D@ 0'*4 #QRY  X<T  .&^H #QOX &D;  !:
M'0  3A\  $4?   ](   -A\  #$?   M'@  *1T  "4=   C'   (!L  !T;
M 0 ;&P< &1P- !<<$  6'!4 %1P; !0=(@ 3'2D $AXQ !$>.@ 1'T4 $!]0
M  \@70 .(&P #2!\  T@CP ,(*( "R"U  L@R@ +(.4 #!_T &4=  !7'P
M3"$  $(A   Z(0  -"$  "\A   J(   )A\  ",?   @'@  '1X  !D@   6
M( 0 %" + !(A#@ 1(1, $2(9 ! B'P /(B8 #B,O  XC-P -(T$ #"1-  LD
M60 *)&< "21X  @DBP '))X !R2Q  8DQP &(^, !R/Q &(?  !4(0  22,
M $ C   X(P  ,B,  "PC   H(@  )"$  "$A   >(0  &B$  !8C   3) ,
M$24(  \F#0 .)Q$ #2<6  PG'0 +)R, "B<K  DH-  (*#X !RA)  8H50 %
M*60 !"ET  ,IAP "*9L  2BO   HQ0 !*.$  2?P %XB  !1)   1B4  #TE
M   U)0  +R4  "HD   F)   (B,  !\C   ;)   &"4  !0F   1* , #RD(
M  PL#  *+!  ""P4  <L&@ &+"$ !2PH  ,M,  "+3H  2U%   M4@  +F
M "YQ   MA   +9D  "VM   LP@  +.   "SP %HD  !-)@  0R<  #HG   S
M)P  +2<  "@F   D)@  (28  !TF   9)P  %2D  !$K   /+ , #2X'  DP
M#  &,0X  S$2  $R%P  ,AX  #(E   R+0  ,C8  #-"   S3@  ,UT  #-M
M   S@0  ,I8  #*K   QP0  ,=\  #'P %8G  !**0  /RH  #<J   P*@
M*RD  "<H   C*   'BD  !HJ   6+   $BX   \P   -,0( "C0'  4U"P "
M-@X  #<0   X%   .!H  #@B   X*@  .3,  #D^   Y2@  .5D  #EI   Y
M?0  .),  #BH   WOP  -]X  #;P %$K  !&+   /"P  #0L   N+   *BL
M "4K   @+   &RT  !<O   3,0  $#,   TU   )-P( !3H&  $["@  / T
M #T/   ^$@  /Q<  $ >  ! )0  0"\  $ Z  ! 1@  0%0  $!E   _>
M/X\  #ZF   ^O0  /=P  #WP $TN  !"+P  .2\  #(O   M+@  *"X  "(O
M   =,   &#(  !,U   0-P  ##H   D\   %/@   $$$  !""   0PL  $0-
M  !&$   1Q0  $@9  !((0  2"H  $@U  !(00  2$\  $A@  !'<P  1XH
M $:B  !%N0  1=D  $3P $@R   ^,@  -C(  # Q   K,0  )3(  !\T   9
M-@  $SD  ! \   ,/P  "$(   -$    1@   $@"  !*!0  2P@  $P+  !.
M#@  3Q$  %$5  !2'   4B4  %(P  !2/   44H  %%:  !1;0  4(0  $^=
M  !.M0  3=(  $WN $,V   [-@  -#4  "\T   G-0  (3@  !H[   4/@
M$$$   Q$   '1P   DH   !-    3P   %$   !3 @  5 4  %4(  !7"P
M60X  %L1  !=%P  71\  %TJ  !=-@  7$0  %Q4  !;9P  6WX  %J7  !9
MKP  6,L  %?J #\Y   X.0  ,S@  "LY   C/   '#\  !5#   01P  "TH
M  5.    40   %0   !7    6@   %P   !=    7P   & $  !B!P  9 L
M &8.  !H$@  :QD  &LC  !J+@  :CP  &I-  !I7P  :'4  &>/  !FJ
M9<(  &3C #T]   W/   +CT  "5    =1   %DD  !!-   *40  !%4   !:
M    70   &    !C    9@   &@   !J    :P   &T   !O @  <08  '0*
M  !V#@  >1,  'L;  ![)P  >C4  'E%  !X60  >&T  '>&  !VGP  =;<
M '32 #Q!   R0@  *$4  "!*   73@  $%0   I9   "7@   &,   !G
M:P   &\   !R    =0   '<   !Y    >P   'T   !_    @@   (0#  "'
M"0  B@X  (X3  "/'@  CBL  (X[  "-3@  BV,  (I\  "*E0  B*T  (?%
M #9'   L2P  (D\  !E5   06P  "F$   %G    ;0   '(   !W    >P
M '\   "#    A@   (@   "*    C0   (\   "1    E    )<   ": 0
MG0<  *$-  "E%   I"$  *0Q  "C1   HED  *!P  "?BP  G:(  )VW #!0
M   E50  &UL  !)B   +:0   7    !W    ?0   (,   "(    C0   )$
M  "5    F    )H   "<    GP   *$   "C    I@   *D   "L    L
M +0'  "X#@  NA@  +HG  "Y.0  N$X  +=E  "V?@  M98  +.K "E;   >
M8@  %&D   QQ   ">0   ($   ")    CP   )8   ";    H    *0   "H
M    JP   *P   "O    L@   +0   "V    N0   +P   #     Q    ,@
M  #-!P  TA   -(=  #1+P  T$0  ,];  #-<P  RXT  ,JA /\   #_
M^P   /H   #\  @ ^  / /4 %P#T "  \0 J .L ,P#F #L X@!# -X 20#:
M $\ U@!4 -, 60#0 %X S@!C ,L : #) &X Q@!U ,, ?0#! (8 O@"2 +L
MG@"Y *X M@## +0 Z "S /\ KP#_ *4 _P"> /\ FP#_ /T   #W    \@
M /    #G  , X0 , -P $@#8 !L U@ D -( +0#, #8 Q@ ] ,( 0P"_ $D
MO !. +H 4P"X %@ M@!= +4 8@"S &< L0!N *\ =@"L '\ J@"* *@ EP"E
M *8 HP"Y *$ V0"@ /D G@#_ )@ _P"2 /\ CP#_ /,   #L    XP   -,
M  #(    P0 ) +T #P"[ !8 N0 ? +< )P"S "\ KP W *P /0"J $, J !(
M *8 30"D %( HP!6 *$ 6P"? &$ G@!G )P ;P": '@ EP"# )4 D "3 )X
MD0"P )  R ". /  C0#_ (H _P"% /\ @@#_ .<   #=    Q@   +@   "N
M    J  $ *4 # "A !( H0 9 *  (@"? "D FP P )@ -P"6 #T DP!" )(
M1P"0 $L CP!0 (T 50", %H B@!A (@ : "' '  A0![ (, B "! )8 ?P"G
M 'T O !\ ., ? #] 'P _P!X /\ =@#_ -8   #     KP   *,   "9
MDP   (\ "0"-  X BP 4 (H ' "* ", B  J (4 , "# #8 @@ [ (  0 !_
M $4 ?@!* 'P 3P![ %0 >@!: '@ 80!V &D =0!S ', @ !Q (X ;P"? &X
ML@!M ,\ ; #T &P _P!K /\ :0#_ ,    "K    FP   (\   "'    @
M 'P ! !Z  P >  1 '@ %P!X !X =P D '4 *@!S #  <0 U '  .@!N #\
M;0!$ &P 20!K $X :@!4 &@ 6P!G &, 90!M &0 > !B (< 8 "7 %\ J@!>
M ,( 7@#I %X _P!> /\ 70#_ *P   "9    B@   '\   !W    <0   &T
M  !J  @ :0 . &@ $@!G !@ 9P ? &< )0!E "H 8P O &( - !A #D 8  ^
M %\ 0P!> $@ 70!. %L 50!: %T 6 !G %< <@!5 ($ 5 "1 %, HP!2 +@
M40#< %$ ^0!2 /\ 4@#_ )T   "+    ?    '$   !I    9    &    !>
M  4 7  + %L #P!; !0 6@ 9 %H 'P!9 "4 5P J %8 +P!5 #0 5  X %,
M/0!2 $, 4 !) $\ 4 !. %@ 30!B $L ;0!* 'H 20"+ $@ G0!' +$ 1P#,
M $8 \ !' /\ 1P#_ )    !^    <    &8   !>    60   %8   !3  $
M4@ ( %  #0!/ !  3P 5 $X &@!. "  30 E $P *@!* "X 20 S $@ . !'
M #X 1@!$ $4 2P!$ %, 0P!= $$ : !  '4 /P"% #X EP ] *L /0## #T
MY@ ] /L /@#_ (<   !U P  : 8  %T'  !5!@  4 8  $P$  !* 0  20 $
M $< "@!&  X 10 1 $4 %@!$ !L 0P @ $( )0!! "H 0  O #\ -  ^ #H
M/0!  #L 1P Z $\ .0!9 #@ 9  W '$ -@"! #4 DP T *8 - "[ #0 W0 T
M /4 -0#_ 'X&  !M"0  8 L  %8,  !.#   2 L  $0*  !""   0 4! #\!
M!P ^  L /0 . #P $@ [ !< .P < #H (0 Y "4 -P J #8 ,  U #4 -  \
M #, 0P R $P ,0!5 #  8  O &T +@!] "T CP L *( + "V "P T  L .X
M+ #\ '<*  !G#   6@X  % .  !)#@  0PX  #X-   [#   .0L  #@) P W
M!0@ -@(- #4!$  T !, ,P 8 #( '0 Q "( ,  G "\ +  N #( +0 X "P
M0  K $D *@!2 "D 70 H &L )P%Z "8!C  E )\ )0"R "4 R@ E .@ )0#W
M '(-  !B#@  5A   $P1  !$$0  /A$  #D0   V#P  ,PX  #$- 0 P"P4
M, @* "\&#0 N!1$ + 04 "L#&0 J QX *0,C "@$*0 G!"\ )@4U "4%/0 D
M!48 (P90 "(&7  A!VD ( =Y !\'BP >!YT '@>P !T&Q@ =!N, '07S &T.
M  !>$0  4A(  $@3  ! $P  .A,  #42   Q$0  +A   "P/   J#@, *@T'
M "D+"P H"0X )PD1 "4(%@ D"!L (PD@ "())@ A"2P ( HS !\*.P >"T0
M'0M/ !P,6P ;#&D &@QY !@,BP 8#)X %PRP !8,Q0 6#.$ %@OP &D0  !:
M$@  3A0  $45   ]%0  -Q4  #$4   M$P  *A(  "@1   F$ $ )! $ ",.
M"  C#0P (@P/ " ,$P ?#!@ '@T= !T-(P <#2H &PTR !H..@ 8#D0 %PY0
M !8/7  5#VH $Q![ !(0C0 1$*  $1"S ! /R0 0#^0 $0_R &42  !7%
M2Q8  $(7   Z%P  -!<  "\6   J%0  )Q0  "03   B$P  (!(# !X1!@ =
M$ D '! - !L/$  9$!4 &! ; !<0(0 6$"@ %1$P !01.0 3$4, $A). !$2
M6@ 0$FD $!-Y  X3C  .$YX #1.Q  T2Q0 ,$N$ #1+Q &(4  !4%@  21@
M #\9   W&0  ,1D  "P8   H%P  )!8  "$6   ?%0  '!0" !H3!  9$@8
M%Q(+ !42#@ 4$A( $Q,8 !(3'P 1$R8 $10M ! 4-@ /%4$ #A5,  X65P -
M%F4 #!=U  L7AP *%YH "1:M  @6P0 (%MT "17N %\6  !1&   1AH  #T:
M   U&P  +QH  "H:   E&0  (A@  !\8   <%P  &18! !<6 P 5%@0 $Q8)
M !$6#0 0%Q$ #Q<6  X7'  .&", #1@J  P9,P ,&3P "QI'  H:4P )&F$
M!QMQ  8;@P %&Y< !!JJ  ,:OP #&=H !!GL %P8  !.&@  0QP  #H<   S
M'   +!P  "<<   C&P  (!H  !T9   :&0  %Q@! !48 @ 2&00 $!L'  X;
M#  -'!  #!P3  L<&0 *'!\ "1TG  @=+P ''CD !AY#  0>4  #'UX  A]N
M  $?@   'Y4  !ZI   >O0  '=@  !WL %@:  !+'   01X  #@>   P'@
M*AX  "4=   A'   'AP  !L;   8&P  %AL! !,; @ 1' 0 #AX'  P?"P *
M( X "" 2  8A%P %(1T !"$D  (B+  !(C4  ")    C30  (UH  "-K   C
M?@  (Y,  "*G   BO   (=<  "'M %4=  !('P  /B   #4@   N(   *"
M ",?   @'@  '1T  !H=   6'0  $QX  !$? @ .( 0 #2('  HD"P &)0T
M!"40  (F%   )AH  "8A   G*0  )S(  "<]   G20  *%<  "AG   G>P
M)Y   ">E   FNP  )M8  "7M %$@  !%(0  .R(  #(B   L(@  )B$  "(A
M   >(   &Q\  !@@   4(   $2(   \C   -)0, "B8&  8H"@ #*0T  "L/
M   L$@  +!<  "P>   L)@  +2\  "TY   M1@  +50  "UD   M=P  +(T
M "RD   KN@  *]8  "KN $TB  !!)   ."0  # D   I)   )",  "$B   =
M(@  &2(  !4C   2)   #R8   TH   **@( !BP%  (N"0  +PL  # .   R
M$   ,Q4  #,;   S(@  ,RL  #,V   S0@  ,U   #-@   S<P  ,HH  #*A
M   QN   ,-8  ##O $DE   ^)@  -"<  "TG   H)@  (R4  !\D   ;)0
M%B8  !(H   0*@  #2P   HN   &, $  C($   T!P  -0H  #<,   X#@
M.A(  #H7   Z'P  .B<  #HR   Z/@  .DP  #I<   Z;P  .88  #B>   X
MM@  -]0  #;O $0I   Z*0  ,2D  "LI   F*   (B<  !TH   8*0  $RL
M ! N   -,   "3(   4U   !-P   #D"   [!0  / @  #X+   _#0  01
M $,4  !#&P  0R,  $,N  !#.0  0T<  $)7  !":@  08$  $":   _L@
M/L\  #[O #\L   V+   +RP  "HK   E*@  'RL  !DM   4+P  $#(   TU
M   (.   !#H    \    /P   $$   !# @  104  $8(  !("P  2@X  $P1
M  !-%@  31X  $TH  !--   3$(  $Q1  !+9   2WL  $J4  !)K0  2,H
M $?L #LP   S+P  +2\  "@M   B+P  &S$  !4T   0-P  #3H   @]   "
M0    $,   !&    2    $H   !,    3@$  $\$  !1!P  4PL  %4.  !8
M$@  61D  %@B  !8+@  5SP  %=+  !67@  5G,  %6-  !4IP  4L(  %+F
M #@S   Q,@  +#$  "4R   =-0  %C@  !$\   ,0   !T0   !'    2@
M $T   !0    4P   %4   !7    60   %H   !< P  7@<  &$+  !D#@
M9A,  &<<  !F)P  9C0  &5$  !D5P  9&L  &*%  !AGP  8+D  %[< #4W
M   P-0  *#<  " Z   8/0  $4(   Q&   &2@   $\   !3    5@   %D
M  !<    7P   &$   !D    90   &<   !I    ; $  &X&  !Q"P  = \
M '<5  !W(   =BT  '8]  !U3P  =&,  '-[  !RE0  <*\  &_) #4Z   K
M.P  (C\  !I#   22   #$T   52    5P   %P   !@    9    &@   !K
M    ;@   '$   !S    =0   '<   !Z    ?    '\   ""!   A@H  (H/
M  ",%P  BR0  (HS  ")10  AUL  (9R  "%BP  @Z4  (*\ "]    E1
M'$D  !-.   -5   !%H   !A    9@   &L   !O    =    'D   !]
M@    (,   "%    AP   (H   ",    CP   )(   "6    F0(  )X)  "B
M$   HAH  *$I  "@.P  GU   )UG  ":@0  FID  )FO "E)   ?3@  %50
M  Y;   %8@   &D   !P    =P   'T   ""    A@   (L   "/    DP
M )4   "7    F@   )T   "@    HP   *8   "J    K@   +(   "W"@
MNQ$  +H?  "Y,   MT4  +5<  "T=   L8X  *^D ")4   86P  $&(   =J
M    <P   'L   ""    B0   )    "5    F@   )\   "C    I@   *@
M  "K    K@   +    "S    M@   +H   "]    P@   ,<   #, 0  TPL
M -05  #3)@  T3H  -!1  #-:   RX$  ,J6 /P   #V    \@   /$   #S
M  4 ]  , /( $P#P !P [0 E .@ +@#B #8 W@ ^ -D 1 #4 $H T0!/ ,X
M5 #+ %D R0!> ,8 8P#$ &D P0!P +X > "\ ($ N0"- +8 F@"S *L L0#
M *\ Y@"N /\ I0#_ )H _P"4 /\ CP#_ /0   #L    Z    .<   #?
MV0 ) -( $ #/ !< SP @ ,P * #& #  P  W +P /@"Y $0 MP!) +4 3@"S
M %, L0!7 *\ 70"M &( JP!I *D <0"G 'H I0"% *( DP"@ *( G0"V )L
MU "9 /D E@#_ (T _P"( /\ A #_ .@   #?    V0   ,D   "_    N  $
M +4 #0"S !( L0 : +  (@"M "H J0 Q *8 . "D #T H@!# *  2 "> $P
MG !1 )L 5@"9 %P EP!B )4 :0"3 '( D0!] (\ BP"- )H BP"L (D Q0"(
M .X A@#_ '\ _P!Z /\ > #_ -D   #-    NP   *X   "E    GP   )P
M"0"9  \ F0 5 )D '0"8 "0 E  K )$ ,0". #< C  \ (L 00") $8 B !+
M (8 4 "% %4 @P!; (( 8@"  &L ?@!U 'P @@!Z )( > "C '< N0!V .
M=0#_ '( _P!N /\ ; #_ ,<   "U    I0   )D   "/    B0   (4 ! "$
M  P @@ 1 (( %P"" !X @  E 'X *P!\ #$ >@ V 'D .P!W $  =@!$ '4
M20!S $\ <@!5 '  7 !O &0 ;0!N &P >@!J (H : "; &< KP!F ,P 90#U
M &0 _P!A /\ 8 #_ +0   "@    D    (4   !]    =P   ',   !P  @
M;P . &\ $@!O !@ ;P ? &T )0!K "H :0 P &@ - !G #D 9@ ^ &4 0P!C
M $@ 8@!. &$ 50!? %X 7@!G %P <P!; (( 60"3 %@ I@!7 +\ 5P#J %<
M_P!6 /\ 5 #_ *$   ".    ?P   '4   !L    :    &0   !A  0 8  +
M %\ #P!? !, 7P 9 %\ 'P!= "4 7  J %L +P!9 #, 6  X %< /0!6 $,
M50!) %, 4 !2 %@ 40!A %  ;0!. 'L 30", $P GP!+ +4 2@#< $H ^@!*
M /\ 2@#_ )(   "     <@   &<   !?    6@   %<   !5  $ 4P ' %(
M# !2 !  4@ 4 %( &@!1 !\ 3P D $X *0!- "X 3  S $L . !* #T 20!#
M $@ 2@!& %( 10!< $0 9P!# '4 0@"& $$ F !  *X 0 #+ #\ \@!  /\
M0 #_ (4   !T    9P   %T   !5    3P   $P   !*    2  $ $< "@!'
M  T 1@ 1 $8 %0!& !H 10 ? $0 ) !# "D 0@ M $$ ,P _ #@ /@ ^ #T
M10 \ $X .P!7 #H 8@ Y &\ . "  #< DP V *< -@#  #8 Z  V /X -@#_
M 'P   !K    7@(  %0#  !- P  1P,  $,!  !!    /P ! #X !P ]  L
M/0 . #P $0 \ !8 /  : #H 'P Y "0 .  I #< +@ V #, -0 Z #0 00 S
M $D ,@!3 #$ 7@ P &L +P![ "X C@ M *( +0"X "T W0 M /@ +@#_ ',!
M  !D!0  5P<  $T(  !&"   0 @  #L'   X!0  -P,  #8 !  U  @ -  ,
M #0 #P T !( ,P 6 #( &P Q "  ,  D "\ *0 N "\ +0 V "P /0 K $4
M*@!/ "D 6@ H &< )P!W "8 B0 F )T )0"S "4 SP E /  )@#_ &T&  !>
M"0  4@L  $@,  ! #   .@L  #8+   R"@  , @  "X& @ N P8 +0 * "P
M#0 L !  *P 3 "H %P I !P *  @ "< )0 F "L )0 R "0 .0 C $( (@!+
M "( 5P A &0 ( !S !\ A0 ? )D '@"N !X QP > .D 'P#Z &@)  !9#
M30T  $,.   \#@  -@X  #$-   M#0  *@P  "@+   G"00 )@8( "8$"P E
M PX ) $0 "0!%  B 1@ (0$= "$ (@ @ "@ 'P N !X!-@ = 3\ ' %) !L!
M5  : 6$ &@%P !D!@@ 8 )8 & "J !@ P0 8 .$ & #T &,,  !5#@  20\
M $ 0   X$   ,A   "T/   I#@  )@X  ",-   B# , ( L& " )"0 ?!PP
M'@8. !X%$0 <!14 &P4: !H%'P :!24 &04K !@%,P 7!CP %@9& !8&4@ 5
M!U\ % =N !,'@  2!Y0 $@:G !(%O  2!-D $@/O %\.  !1#P  1A   #P1
M   U$0  +Q$  "H1   F$   (A   " /   =#@( ' T% !H-!P :"PH &0H-
M !@)$  7"1( %@D7 !4)'  4"2( % HI !,*,0 2"CH $@M% !$+40 0#%\
M#PQN  X,@  .#)0 #0NG  T+N@ -"M( #0KJ %P/  !.$0  0Q(  #H3   R
M$P  +!,  "<2   C$0  'Q$  !P0   :$ ( & \$ !8.!P 5#@D % T+ !,,
M#0 2#!  $@P4 !$,&@ 1#2  $ TH  \-,  .#CL #0Y&  T.40 ,#UX "P]M
M  H/?P )#Y, "0^F  @.N0 (#M  !P[H %@1  !+$@  0!,  #<4   P%
M*10  "44   A$P  '1(  !H2   7$0( %1$% !,0!P 2$ D $0\* ! .#  .
M#@X #@\2  T0&  -$!X #! E  P0+0 +$38 "A%!  D130 ($EH !Q)J  82
M?  %$I  !!*D  ,1N  #$<\  A'H %42  !)%   /A4  #46   M%@  )Q8
M "(5   >%   &Q0  !@3   5$@, $Q(% !(1!P 0$0D #Q$*  T1"P ,$@X
M"Q(1  H2%0 )$QL "1,B  @3*@ '%#, !10^  052@ #%5@  A5G  $5>@
M%8X  !6C   4MP  %,\  !/I %(4  !&%@  .Q<  #(7   K%P  )1<  "$6
M   <%@  &14  !84 0 4$P0 $A,& !$2"  /$@@ #A,)  P4"@ *%0T "!80
M  86$P %%AD !!<?  ,7)P "&#   1@[   91P  &54  !ED   9=P  &8P
M !BB   8MP  %\\  !?J $\6  !#&   .1D  # 9   I&0  (QD  !\8   ;
M%P  &!8  !45 @ 3%04 $10& ! 4!@ .%0< #!8(  H7"@ '&0P !!H.  (;
M$@ !&Q8  !L=   <)   '"T  !PX   =1   '5(  !UB   ==0  '8H  !R@
M   <M@  &]   !KK $P8  ! &@  -AL  "T;   F&P  (1H  !T9   9&0
M%Q@  !07 P 2%@0 $!<$  X7!  ,&04 "AH'  <<"0 #'0L  !\-   @$
M(!0  "$:   A(@  (2H  "$U   B00  (D\  ")?   B<@  (8@  "&?   @
MM@  ']$  !_M $@:   ]'   ,QT  "L=   D'0  (!P  !P;   8&@  %AD!
M !,9 0 1&0$ #AH!  P< @ *'0, !Q\%  ,A"   (@H  "0,   F#@  )A(
M "88   G'P  )R<  "<R   G/@  )TL  "=<   G;@  )H4  ":=   EM
M)-$  "/N $0=   Y'P  ,!\  "@?   C'@  'AT  !L<   8&P  %!P  !$<
M   .'0  #1\   HA   &(@$  R0$   F!@  * @  "H+   K#0  +1   "T5
M   M'   +20  "XN   N.@  +D@  "U8   M:@  +8$  "R:   KL@  *M
M "GO $ @   V(0  +2$  "8A   A(   '1\  !H>   6'@  $A\   \A   -
M(@  "B0   8F   "*    "L"   M!   +P8  # )   R#   - X  #42   U
M&   -2   #4J   U-@  -4,  #53   T9@  -'P  #.6   RKP  ,<T  ##O
M #PC   R)   *B0  "0C   @(@  '"$  !<A   3(P  $"4   TG   )*0
M!2L   $N    ,    #(    T 0  -@0  #@&   Z"0  / T  #X0   ^%
M/AP  #XF   ^,0  /C\  #U.   ]80  /'<  #N1   ZJP  .<D  #CM #<G
M   O)P  *"8  ",E   ?)   &24  !0F   0*   #2L   DN   %,    #,
M   U    .    #H    \    /@$  $ #  !"!P  1 H  $8-  !)$0  21<
M $@A  !(+   1SH  $=)  !&6P  17$  $2+  !#I0  0L,  $'H #0J   L
M*@  )R@  "(G   <*   %BH  !$M   -,   "3,   ,V    .0   #P    ^
M    00   $,   !&    2    $H   !, P  3@8  % *  !3#@  5!,  %0<
M  !3)P  4S0  %-#  !250  46H  %"#  !/G@  3;D  $S@ # M   K+
M)BL  !\L   8+@  $C(   TU   (.0   CT   !     0P   $8   !)
M3    $X   !1    4P   %4   !7    60$  %P&  !?"@  8@X  &,5  !C
M'P  8BP  &$\  !@3@  7V(  %Y[  !<E@  6[   %G/ "\P   J+P  (C
M !HS   3-P  #CL   @_   !1    $@   !,    3P   %(   !5    6
M %L   !=    8    &(   !D    9@   &D   !M!0  < L  '00  !T&
M<R4  '(T  !R10  <%D  &]Q  !MBP  :Z8  &K  "XS   E-0  '3@  !0\
M   .00  !T<   !,    40   %4   !9    70   &$   !E    :    &L
M  !M    ;P   '(   !T    =P   'H   !^    @@0  (8+  "*$0  B1P
M (@K  "&/0  A%(  (-G  "!@0  ?YL  'ZR "DZ   @/0  %D(   ](   (
M3@   %0   !:    8    &0   !I    ;@   '(   !V    >@   'T   "
M    @@   (4   "(    BP   (X   "2    E@   )L#  "@#   HA,  * A
M  "?,P  G4<  )I>  "8=P  EX\  )6G "-#   92   $4X   E5    7
M &,   !J    <0   '8   ![    @    (8   "*    C@   )$   "3
ME@   )D   "<    H    *,   "G    JP   +    "V!   O T  +H7  "Y
M*   MSP  +12  "R:@  KX4  *V< !Q.   35   "UP   %D    ;    '0
M  !\    @P   (D   "/    E    )H   "?    H@   *0   "G    J@
M *X   "Q    M    +@   "\    P0   ,<   #-    U 4  -@0  #5'@
MTS$  -!(  #-7P  RW8  ,B.                       ! P0%!@@)"@L-
M#@\1$A,4%A<8&AL<'1\@(2(D)28H*2HK+2XO,#(S-#8W.#D[/#T^0$%"1$5&
M1TE*2TU.3U!24U155UA96UQ=7F!A8F-E9F=I:FML;F]P<7-T=7=X>7I\?7Z
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M________________________________________________
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M^/GZ^_S]_O]M9G0Q      ,$(0   0                    $
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MI9>2YJ67DN:EEY+FI9>2YJ67DN;:RPD;Z,T..NG,$&#<R Z2R[HRK,:W4+3
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MT86FB-&%IHC1A::(T86FB-',T D8RM0*/L73"FVXQ1:EKKE$M:>U7KNCLG#
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M@:6-TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]* I8_2@*6/TH"EC]*
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MF;"$PI2OA,.0KX7$C:Z%Q8JNAL:(K8;&AZV'QH6MB,>#K8G'@:V+QX"LB\>
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MSM$*',;7"D&OZ@YAG>8<>)#:,HB+TDR4B<M?G(C&;J.(PWBHA<!\JX._?ZZ
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ME7*PQ95]M<.7A;C!EXN[OY.,O;Z/CL"\C(_"NXF2Q+J&E,6Y@Y;&N8&9Q[B
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MSWVGFL__N0\'_[H7'/^Y(CG_M2U:[+,P>MW 'Y#)PR&HM;I(M*NU8KRFLG/
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M=5/HCG53Z(YU4^B.=5/HCG6\R04 J]L!")K_"Q:/_QDCA?\K+7[_.3=X_T9
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MS(R-JL>*D;'$B)2VPX66N,*#F;G"@9NYP7^>NL%]H;O!>Z2[P'JGN\!YJKS
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MH%-[X*!7C=2>7Y[*FVNLQ9MUM,.;?KC FX>\O9>*P+J1C,6WBI#*M(27S[*
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M+23_JS8[_[8O2//$*%'@UB96S.0B<;O:*(BJS$&;G\-7J9F\:;*6MW:YE+2
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M&4JB^25>ENTS;HSE07J%WD^#@=E>BG_5:H]ZTG"3=L]UEW/.>9EQS'V;;\N
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M."__LCHN_\ [+O_3.RW_ZSPM_^L\+?_K/"W_ZSPM_^L\+?_K/"W_ZSRXL
MJ+P  )K)  ",V0  @?4# 'G_$ %N_Q8#9?\?!E[_)PM7_S /4?\W$TO_/A=&
M_T490?],&SW_4ATY_U@?-O]?(33_9B(Q_VXD+_]W)2W_@"8K_XPH*?^7*2C_
MHBHG_ZTK)O^Y+";_R2TF_\DM)O_)+2;_R2TF_\DM)O_)+2;_R2VJMP  FL4
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M)@3ML2D%XKHO!M:_-@_*ND0@O[1/,;2N6$"JJ&!.H:-G6IB>;V2/FG=MB):
M=8"2BWMZCY: =(ZDA'&-MH5OCM&%<8O=@W.)WX%UA^!^=H7A?7>$XWMW@^1Z
M=X/D>G>#Y'IW@^1Z=X/D>G>#Y'K_;!0!_W,6 O^%$P'_E!8!_Z(> ?6M( +G
MN"$"W<,F M##- W$OD(>N;E-+ZZS5CZDKEY,FJEE5Y&E;6*)H75K@)U^<GF:
MB'EREY1^;9:B@FF5LX1GELV#:9/>@FR/WX!OC.%^<(KB?'*(XWIRA^1Y<H?D
M>7*'Y'ERA^1Y<H?D>7*'Y'G_;1,!_W83 ?^($@'_F!, _Z<9 >^S%@'BP!4
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M3S[P]TY"YOM/0]W[4434_%-%S_Q41<_\5$7/_%1%S_Q41<_\5$7/_%3AE0
MRZ8  +NP  "NNP$ HL@" )C5!0"0^ \!B?@@!(+X+@MY^3<3</D_&VCY1B)@
M^DTH6OI4+53Z7#%/^V4U2_MM.$?\=SM#_(,]/_V0/SS]GT$Z_J]#./_&1#?_
MZD4V_/U%._+_1#[J_T0^YO]&/N;_1C[F_T8^YO]&/N;_1C[F_T;0GP  O:P
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M'AS_YA\;__ ?&__P'QO_\!\;__ ?&__P'QO_\!^DM0  E<(  (;/  !WW@
M:_0  &+_ P!9_PL!4?\1 4K_%P)$_Q\#/_\F!#K_+04V_S0&,O\Z!R[_0 @K
M_T8(*/],"27_4@DB_UD*(/]B"QW_:PP:_W8-%_^$#A7_D@\4_Z 0$_^M$1/_
MNA$3_\,2$__#$A/_PQ(3_\,2$__#$A/_PQ*7O@  ALP  '?;  !IYP  7/T
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M74NY]U].L?9@4:KV8%.E]F!5H?9@5:'V8%6A]F!5H?9@5:'V8%6A]F#_=P@
MZXP  -.;  #&J ( N[$" +*[ @"JQP8 HM,* )W6&@&5UBP&C-0Z$8/21AUZ
MT$\G<LY8,6K-8#ADRV@_7LIR15C*?$E4R8A-3\F544S)I5-*R;E42<K<4T?(
M]U5(P/Q82KC[64RR^UI.K?I:3JWZ6DZM^EI.K?I:3JWZ6DZM^EK_?P  W),
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M-#?L_S8YY?\X.>7_.#GE_S@YY?\X.>7_.#GE_SC(G@  MJD  *BR  ";O0
MC\@  (/4  !YZ < <_P2 6O]'0)D_2<$7OXQ"%C^.PU3_T,13?]+%4G_4QA%
M_UH:0?]C'3[_;!\[_W8A-_^"(S3_D"4R_Y\G,/^P*"[_R"DM_^HJ+/__*BS_
M_RHO^?\J+_G_*B_Y_RHO^?\J+_G_*B_Y_RJYI@  JJX  )RY  ".Q0  @=$
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M"0W_TPD-_],)#?_3"0W_TPF1O   @<D  '+7  !DY   5.L  $O_  !$_P
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M8%V3[5]>D/A>88SY7&.*^EMDA_M:98;[666&^UEEAOM998;[666&^UG_9@T
M_W<# ..'  #3DP$ RIX$ ,*G! "[KP0 M;8- *ZW(0*EMC()G;,_%92P2B",
MK5,KA*I;-'VH8SQVI6I#<*-R2FJA>T]EH(948)Z16%N=GUM8G;!=5IW'75:=
MZUQ7FOI;6I7Z6ER1^UE>COQ87XW\5U^-_%=?C?Q77XW\5U^-_%?_:@H _WP
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M2D>S_TM)K?],2JO_3$JK_TQ*J_],2JO_3$JK_TSI?P  T9   ,*>  "UIP
MJJ\  *"X  "6P0( C,L' (35#0" U1X!>=4N!7+4/ QLTT<49=)0&U_162%:
MT6(G5=!K+%'0=3!-SX$T2<^.-T;/G3E$T*X[0M#&.T/0ZCI S?T^/LO_0$##
M_T)!O?]#0KG_1$*Y_T1"N?]$0KG_1$*Y_T3=B   QY@  +BC  "KJP  H+0
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M'2KW_QTJ]_\=*O?_'2KW_QVSHP  I*L  )>V  ")P0  >\L  &_6  !CWP
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M5FYZYE5N>OQ3;WG_47!W_T]Q=O]-<77_3'%U_TQQ=?],<77_3'%U_TS_6PX
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M35B0_TQ9C?]+6XK_2EN*_TI;BO]*6XK_2EN*_TK_:   Y7D  -&'  #%D@
MNYP  +&B  "IJ0  H;$" )NS%0"5LR@"CK(V"8:P0A)_KDP;>*Q4(W*J7"IL
MJ&0Q9Z=L-F*E=3M=I'] 6:.*0U6BET=1H:=)3Z&Z2DZBV4E.H/5)3I__25"9
M_TE2EO](5)+_1U22_T=4DO]'5)+_1U22_T?_;@  WG\  ,J-  "^F   LZ
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M-SVX_S<]N/\W/;C_-SVX_S?1A@  P)4  +*?  "EIP  FJ\  (ZW  "#OP
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M"1G__PFBIP  D[$  (6[  !VQ@  :=   %O:  !.X   0^4  #[[ 0 Z_PP
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M1W]FX4=_9_A%?FC_0WYH_T%]9_\_?&?_/GQG_SU\9_\]?&?_/7QG_SW_4@X
M_UT# /UI  #A<@  UGH" ,Y_!0#*@P@ Q882 +R')@&UAC8&KH-##Z> 3ABA
M?%@@FWE@)Y9W:2V2=' SCG)Y-XIP@3R&;HL_@VV50W]LH45\:ZY'>FN_2'AK
MW4AX;/9&>&S_1'=L_T)W:_] =VK_/W=J_SYW:O\^=VK_/G=J_S[_5 P _U\
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M1&9Z_T-G>/]!:';_/VAV_S]H=O\_:';_/VAV_S__6P0 ]VD  -UV  #-@
MPX@  +N.  "TDP$ K9<) *>8&@"@F"P#F98Z"I*411*,DD\:AH]7(H"-7RA[
MBV<N=HEO,W*'=SAMA8$\:82+0&:"ET-B@:5&8(&V1UZ!S4=>@>]&7X'_1&!_
M_T)A??]!8GO_/V-Z_S]C>O\_8WK_/V-Z_S__7@  Z6T  -9Y  #(A   OHP
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M.U"/_SM0C_\[4(__.U"/_SOK;0  TWP  ,.)  "WDP  K)H  **?  "9I0
MCJL  (6P"P"!L1L ?+$K G>P. =QKT,-:ZY-%&:M51EAK%T>7:ME(UFJ;B=5
MJ7<K4:B"+TVGCS)*IYXU2*>O-D>GQC9&INDV1:3^-T6C_S=&H/\W2)S_-TF:
M_S=)FO\W29K_-TF:_S?B=   RH,  +R/  "PF   I9X  )ND  "0JP  A;$
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M(2_(_R&^CP  KYH  **A  "6J0  BK   'VX  !QOP  9L8  %O, @!0T@<
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M Q?_G@,5_[,$%/_3!!3^] 03_/\#$_K_ Q/Y_P,3^?\#$_G_ Q/Y_P.=I0
MCZX  ("X  !RP@  9,L  %;3  !)V@  /M\  #3D   N]   *_\* "C_$  E
M_Q< (O\? !__)@ <_RT &?\T !?_/  4_T0!$O]. 1#_60$._V<!#/]W 0O_
MB@(*_Y\""?^U @C_U0('__0"!___ @?__P('__\"!___ @?__P*1K0  @K@
M '/"  !DS   5M4  $C=   [X@  ,.<  "?N   C_P  (/\$ !S_#  9_Q$
M%O\6 !/_&P 1_R$ #O\G  W_+@ *_S8 !_\^  3_2   _U0  /]B 0#_<P$
M_X<! /^= 0#_L@$ _\H! /_J 0#_\P$ __,! /_S 0#_\P&$MP  =,$  &7,
M  !6V   1]\  #GE   MZ@  (^X  !S]   8_P  %?\  !'_!  /_PL #?\.
M  G_$0 &_Q4  _\:  #_(   _R8  /\N  #_-P  _T$  /]-  #_7   _VT
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MXCJV%N [PA;?.](6VCOH%]0Z]AK0.O\<S3K_'LLZ_Q[*.O\?Q#O_'\ \_Q[
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M,Y94X3235?8SDE7_,I%6_S&/5O\PC5;_+HQ7_RV,5_\MC%?_+8Q7_RW_20X
M_U$% /]: 0#N8@  WV<# -AJ!@#5:PH S6T5 ,5N*0&^;3D$MVM'"[%H4A&L
M9EP8J&1E':1B;2*A8'4FGEY^*9M=ABV87(\OE5J9,I-9I#206; VCEG -HQ9
MVS>*6?,VB5K_-(A;_S.'6_\QAEO_,(5;_R^%6_\OA5O_+X5;_R__2PP _U0
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M.'-H_S9S:/\U<V?_,W-F_S)S9O\R<V;_,G-F_S+_400 _UP  .)G  #2<
MQW8  ,!Z  "Z?0( M'\, *V!'0"G@2X"H'\\")I]1P^5>E$6D'A:'(MV8B&'
M=&DF@W)Q*W]Q>B]\;X,R>&Z--75MF#AR;*4[<&NT/&YKR3QM:^D[;6S^.6UL
M_S=N;/\U;FO_-&YJ_S)N:O\R;FK_,FYJ_S+_4P  ]%\  -YJ  #-<P  PWH
M +M^  "U@0  KH,) *B%&@"BA2L"FX0Z!Y6"10Z0?T\5BGU8&X9[7R"!>6<E
M?7=O*GIV=RYV=( R<W.+-6]RECAL<:,Z:7"R/&APQCQG<.<[9W'\.6AQ_S=H
M</\U:6__-&EN_S-I;O\S:6[_,VEN_S/_5@  ZV(  -AN  #)=@  OWT  +>"
M  "PA0  J(<& **)%P"<BBD!EHDW!I"'0PR+A4T3A8)5&8" 71]\?V4D>'UM
M*71[=2UP>GXQ;7F(-&EWE#=F=J$Z8W:P.V%VQ#QA=N4[87;[.6)V_S=C=?\U
M8W/_-&1R_S-D<O\S9'+_,V1R_S/_6   YF8  -)Q  #%>@  NX$  +*'  "K
MB@  HHP" )R.% "7CR8!D8XT!8N,0 N%BDH1@(A3&'N&6QUVA6,B<H-J)VZ"
M<BMJ@'LO9W^&,V-^D39@?9XY77RN.EM\P3M;?.,Z6WSZ.%Q[_S==>_\U7GG_
M-%]W_S-?=_\S7W?_,U]W_S/^7   X6H  ,UU  # ?@  MH8  *Z+  "EC@
MFY$  )63$0"0E"(!BY,Q X62/0E_D4@/>H]1%G6-61MQC& @;(IH)6B)<"ED
MAWDM88:#,5V%CS1:A)PV5X.L.%6#OSE5@^$X58+Y-U:"_S56@?\T6'__,UE]
M_S)9??\R67W_,EE]_S+O8   VVX  ,=Z  "[@P  LHL  *B0  "?DP  E)8
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M*T27_RO7<@  PX   +:,  "JE   GYD  )2>  ")HP  ?J@  '"N  !JL X
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M#C'(M0\PR-,/,,;T$"[$_Q,MPO\5+,'_%BO _Q<KP/\7*\#_%RO _Q>XC0
MJI<  )Z>  "1I0  A*P  'BR  !KN0  8+\  %3#  !*R ( 0,T' #K2#@ Y
MTAL .-,H #?3-0 VU$  --5+ 3/550$QUF "+]9L RW7>@0KV(L%*MB=!2C9
ML08GVLT&)]?O!B;4_PDETO\+)-'_#"/0_PTCT/\-(]#_#2/0_PVNE@  H)T
M )2D  "&K   >;0  &R[  !@P@  5,8  $C+   ^T   -=4$ "W="@ LX1,
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M  #_R@  __   /__  #__P  __\  /__  #__P"-JP  ?;4  &Z_  !@R
M4M   $/7   WW0  *^(  "+F   9Z@  %?D  !+_   0_P@ #O\.  S_$0 )
M_Q8 !O\<  /_(@  _RH  /\S  #_/0  _TD  /]7  #_:0  _WX  /^5  #_
MK   _\<  /_H  #_^@  __H  /_Z  #_^@" M0  <+\  &')  !2TP  0]L
M #7A   IY@  'NH  !7N   0^   #O\   O_   (_P  !/\&  #_"@  _PX
M /\1  #_%0  _QL  /\C  #_*P  _S8  /]#  #_4P  _V4  /]Z  #_D0
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M&K-!YAJO0?<<K4'_':M!_QVI0?\<J4'_'*9!_QNE0?\;I4'_&Z5!_QO_/1
M_T() /](!0#_30@ _U + /E1#P#K4!4 X4\@ -A0,0#/4$$"R4].!<1.6@G
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M*H-6_RB#5O\G@E;_)8%6_R2!5O\D@5;_)(%6_R3_1P, _T\  .=8  #98
MS60  ,9F 0#!9@0 NV8. +1I( "N:3$"J&@_!:-F2@J?950/FF-=%)=A91B3
M8&T<D%YU'XY=?2*+7(8EB%N0*(5:FBJ#6:8L@%FT+7]9QRY]6>8M?%KZ+'M:
M_RI[6_\H>UO_)WM:_R9Z6O\E>EK_)7I:_R7_20  ^U(  .-<  #28P  QV@
M ,!K  "Z:P( M6L- *YM'0"H;BX!HVT\!9UK2 J9:E$/E&A:%)!F8AB-96H<
MBF-R((=B>B.$88,F@6",*7Y?ERM[7J,M>5ZQ+W==Q"]U7N(O=5[Y+75?_RMU
M7_\I=5__*'5>_R9U7O\F=5[_)G5>_R;_2P  \%4  -Y?  #-9P  PVP  +MO
M  "U<   KV\* *AQ&@"C<BL!G7(Y!)AP10F3;D\.CVU8%(MK8!B':6<<A&AO
M((%G=R-]9H F>F2**7=CE"QU8Z$N<F*O+W!BP3!O8M\P;F/W+F]C_RQO8_\J
M;V/_*&]B_R=O8O\G;V+_)V]B_R?_30  ZU@  -EC  #):@  OW   +=S  "P
M=   J70' *-V%P">=R@!F'8W!)-U0@B.<TP.B7%5$X5P71B!;F4<?FUL'WML
M="-X:GTF=&F'*7%HDBQN9YXN;&>L,&IGOC%I9]PP:6?U+FEG_RQI9_\J:F?_
M*6IF_RAJ9O\G:F;_)VIF_R?_4   YUL  --F  #%;@  NW,  +-W  "K>0
MI'@# )UZ% "8>R4!DWLT XYZ0 >)>$H-A'93$H!U6Q=\<V(;>')J'W5Q<B)R
M;WLF;VZ%*6QMD"QI;)PN9FRJ,&1LO#%C;-DP8VST+V-L_RUD;/\K9&O_*65J
M_RAE:O\H96K_*&5J_RC]4P  XU\  ,YI  #!<0  MW<  *][  "G?0  GGT
M )A^$0"3@"( CH Q HE_/@:$?4@,?WQ1$7MZ619W>6 :<W=H'F]V<"%L=7@E
M:72"*&9SCBMC<IHN8'&H+UYQNC!=<=0P77'R+EYQ_RQ></\K7W#_*6!O_RA@
M;O\H8&[_*&!N_RCQ50  WF(  ,IM  "]=0  LWL  *N   "B@@  F($  )&#
M#P"-A1\ B(4N H.$.P5^@T4*>H%.#W6 5A1Q?UX8;GUF'&I\;2!G>W8C8WJ
M)V!YBRI=>)@L6G>F+EAWN"]7=]$O5W?Q+EAV_RQ8=O\J677_*5IT_RA:=/\G
M6G3_)UIT_R?M60  UV8  ,5Q  "Y>@  KX   *:$  "=A@  D8<  (J)# "&
MBAL @HLK 7V*. 1XB4((=(A,#6^'5!)LA5L6:(1C&F2#:QYA@G0A78%])%J
MB2A7?Y8J57ZD+%)^MBU1?LXM47WO+%)]_RM2?/\I4WO_*%1Z_R=4>O\G5'K_
M)U1Z_R?H7@  T&L  ,!V  "T?@  JX4  *&)  "7BP  B8T  (./" !^D!<
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M'T":L" _FL@@/YGK'S^8_R ^EO\A/I7_(3^4_R$_E/\A/Y3_(3^4_R'-<
MO'T  +"(  "DCP  F90  (Z8  "#G0  =Z   &FD  !@IP@ 7:@4 %NI) !9
MJ3$!5JD\ E.I1010J$X&3:A7"4JH7PQ'IV@.1*=S$4&F?Q0^IHT6/*:=%SJF
MKQ@YIL<8.:7J&#BC_QHWH?\;-Z#_'#>?_QPWG_\<-Y__'#>?_QS$>   M84
M *F/  "=E0  DIH  (:?  !ZHP  ;J@  &*L  !5L   4+(. $ZR&P!-LR@
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M A_-^@,>R_\$'LK_!1W)_P8=R?\&'<G_!AW)_P:HE   G)H  )"A  ""J
M=*\  &>V  !;O   3L   $/#   YQP  +\P  "?0!  ?U@H &]H0 !O;&@ :
MVR8 &MPQ !G=/  8W4@ &-Y5 !??8@ 6X'( %>"% !3AF@ 3XK$ $N// !+@
M]  2WO\!$=W_ 1';_P(1V_\"$=O_ A';_P*>F@  DJ$  (2I  !VL0  :+@
M %N_  !.Q   0L@  #?,   MT   )-4  !S;   5WP4 %.D. !+J%  1ZQT
M$.LF  [L,  .[3H #>Y&  ON4P *[V( "?!T  CQB0 '\J  !?*Z  3QY  "
M\?T  N__  /M_P #[?\  ^W_  /M_P"5H0  AJD  'BR  !IN@  6\(  $W(
M  ! S   --$  "K6   AVP  &>   !+D   /\ $ #?D*  OZ#P )^Q4 !_L<
M  3\)  !_"P  /PW  #\0@  _%   /QA  #]=0  _(P  /RD  #\P0  _.L
M /S_  #]_P  _?\  /W_  #]_P")J0  >;(  &J[  !<Q   3LP  #_1   R
MUP  )]T  !WA   5Y0  #N@   KQ   (_0  !?\#  '_"0  _PX  /\2  #_
M%P  _Q\  /\G  #_,0  _SX  /]-  #_7P  _W4  /^-  #_I@  _\(  /_G
M  #__   __\  /__  #__P!\LP  ;+P  %W&  !.SP  /]8  #'=   EX@
M&N8  !'J   ,[@  !?(   #_    _P   /\   #_    _P4  /\*  #_#@
M_Q(  /\8  #_(0  _RL  /\Y  #_2@  _UT  /]S  #_C   _Z0  /^Y  #_
MU   _]X  /_>  #_W@#_&"P _QDI /\9* #_%2L _Q P /\+. '_ T0!_P!1
M ?\ 7@'_ &P!_P!X ?\ @@'_ (P!_P"4 ?\ G #_ *( _P"H /\ KP#_ +8
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M M@DZ@/2)/D%SR7_!LTE_P?+)?\(RB7_",HD_PC*)/\(RB3_",HD_PC_+A0
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M%YI!_Q>80?\7F$'_%I=!_Q670?\5ET'_%9=!_Q7_.P8 _S\  /E&  #E2P
MW$X  ---! #12@D RDH4 ,)-)P"\3C<!MTY% K)-4 6O3%H(JTMC"JA*; VF
M270/I$E\$:%(A!.?1XP5G4>5%YM&GQB91JH9ET:X&I9&RAN31N8;D4?Y&X]'
M_QJ.1_\9CD?_&(U'_QB-1_\7C4?_%XU'_Q?_/@( _T,  .M+  #=40  T50
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M'796_QQV5O\;=E;_&W96_QO_10  [$X  -I8  #)7@  OV(  +=D  "Q8P
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M'F!F_Q[O3P  VEP  ,9E  "Z;0  L'(  *=U  "==   E',  (UT#0")=AP
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M(4]YKB).><,B37CE(DUW^R%.=_\?3G;_'D]U_QU/=?\=3W7_'4]U_QW?7
MR&@  +ER  "N>@  I8   )J"  ".@@  @(,  'F% @!TAA$ <8@@ &Z(+@%J
MB#D"9X=#!6.'3 A@AE,+785;#EJ$8Q%7A&L45(-U%U&"@!I.@8T<2X&;'DF!
MK!](@,$@1X#C'T=_^AY(?O\>2'W_'4E\_QQ)?/\<27S_'$E\_QS680  PFX
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M#S2=]Q SG/\2,YK_$C.9_Q,SF?\3,YG_$S.9_Q.]=P  KX,  *.+  "8D0
MC94  (&9  !SG   9Y\  %NB  !/I@  1ZD( $2J$@!#JA\ 0:LK $"K-P _
MK$$ /:Q* 3NL4P(YK%P#-ZQG!#6L<P4RK($&,*R1!RZLHP@MK+@)+*S9""RJ
M]0HKJ/\+*J;_#"JE_PTJI?\-*J7_#2JE_PVU@   J(L  )R1  "1E@  A9P
M 'B@  !KI0  7Z@  %.L  !(KP  /;(  #:U"P TM14 ,[8A #*V+  QMS<
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M  O2_P +TO\!"]+_ 0O2_P&:F   CI\  ("F  !RK0  9+0  %>Z  !)OP
M/<(  #+&   HR0  '\T  !?1   1U@  #-L%  C>"P &WQ$ !=\:  3@)  "
MX2X  >(Z  #C1P  Y%8  .1G  #E>P  YI(  .:J  #GR   Y_   .C_  #H
M_P  Z/\  .C_  #H_P"1GP  @J<  '2O  !EMP  5[X  $G#   \QP  ,,L
M "7/   <U   %-D   [=   )X0   N4   #I!@  Z0T  .D1  #J&   ZR$
M .TK  #O-P  \44  /)6  #S:   \WX  /27  #UL   ]M   /?S  #W_P
M]_\  /?_  #W_P"%IP  =K   &:X  !8P0  2L@  #O,   NT0  (]8  !G<
M   1X   #.,   3G    Z@   /4   #T    ]04  /4+  #V#P  ]A0  /@=
M  #Z)P  _#0  /]#  #_50  _VD  /^!  #_F@  _[(  /_/  #_[0  __D
M /_Y  #_^0!XL   :+H  %G#  !+RP  .]$  "W8   AW0  %N(   [F   (
MZ@   .T   #P    ^    /\   #_    _P   /\   #_!@  _PP  /\0  #_
M&   _R(  /\P  #_0   _U,  /]I  #_@0  _YD  /^O  #_PP  _]4  /_5
M  #_U0#_$R@ _Q,E /\1)0#_#2< _P8M /\ -0#_ $$ _P!/ /\ 7 #_ &D
M_P!T /\ ?@#_ (@ _P"0 /\ EP#_ )T _P"D /\ J@#_ +  _P"W /\ P #_
M ,P _P#? /\ [ #_ /@ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\ _P#_ /\
M_P#_%B4 _Q8B /\4(0#_$", _PHH /\ , #_ #T _P!+ /\ 6 #_ &0 _P!P
M /\ >@#_ (0 _P", /\ DP#_ )H _P"@ /\ I@#_ *T _P"T /\ O #^ ,@
M_0#9 /L Z0#Z /8 ^0#_ /@ _P#X /\ ^ #_ /@ _P#Y /\ ^0#_ /D _P#_
M&B( _QH> /\8'0#_$QX _PXB /\*+ #_!SD _P-& /\ 4P#_ &  _P!K /\
M=@#_ '\ _P"( /\ CP#_ )8 _P"= /\ HP#^ *D _ "P /H N0#W ,0 ]0#2
M /, Y@#R /0 \0#_ /  _P#O /\ [P#_ .\ _P#P /\ \ #_ /  _P#_'AT
M_QX9 /\<%P#_%Q@ _Q,> /\1* #_#C0 _PQ! /\*3@#_"%L _P=F /\&<0#_
M!GH _P:# /X&BP#\!I( ^@:9 /@&GP#V!J8 ] :M /(&M0#P!<  [07. .L%
MY #I!O, Y@C_ .4*_P#D"_\ Y O_ >0+_P'D"_\!Y O_ >0+_P'_(1@ _R$3
M /\@$0#_&Q( _QP: /\:) #_%B\ _Q,\ /\120#_$%4 _ YA /D.:P#V#G4
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M!+@E_P6V)?\%M27_!K4E_P:U)?\%M27_!;4E_P7_+ T _RT% /\N 0#_,04
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M$(="_Q"'0O\/AT+_#X="_P__.   \ST  .-'  #23   R$X  ,!-  "[2@(
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M%&M5_Q3R0P  WT\  ,M8  "]70  LV$  *MB  "B8   FUP  )5>$ "08!\
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M&UQBK!Q:8K\<66+?'%EB]QI:8O\96F'_%UMA_Q9;8?\56V'_%5MA_Q7G30
MSUD  +]B  "S:   J6T  )YM  "3:P  B6D  (-K"0!_;14 ?&XE 'AN,@%U
M;CT"<6Y&!&YM3P=K;%8):&Q>#&5K90]C:FT18&EV%%UI@19;:(T86&>;&E9G
MJAM59[T<5&?<'%1G]AI49O\856;_%U5E_Q969?\55F7_%59E_Q7B40  RET
M +MF  "O;   IG$  )EP  ".;P  @VX  'UP!0!X<A( =7,A ')S+P%O<SH"
M;'-$!&ER3 9F<E0(8W%;"V!P8PU=<&L06V]T$UAN?Q55;HL74VV9&5%MJ!I/
M;;L;3FW9&DYL]!E/:_\83VO_%U!J_Q90:O\54&K_%5!J_Q7=50  Q6$  +=J
M  "L<0  HG4  )1T  ")=   ?',  '9U  !Q=Q  ;W@= &QY*P!I>3<!9GE
M V-Y205@>%$'77=8"5MW8 Q8=F@.575Q$5)U?!-0=(@63727%TMSIAA)<[D9
M2'/5&4ER\QA)<?\72G'_%DIP_Q5+</\42W#_%$MP_Q346@  P&8  +-O  "H
M=@  G7D  (]X  "$>   =WD  &]\  !J?0T 9WX9 &1_)@!B@#(!7X ] ER
M1@-:?TX%5W]5!U1^70E2?64,3WUO#DQ\>1%*?(831WN4%45[I!9$>[<60WO2
M%D-Z\A9#>?\50WC_%$1W_Q1$=O\31';_$T1V_Q/-7P  NVL  *YT  "D?
MEWX  (I]  !_?@  <G\  &:#  !AA @ 7H83 %R'(0!:ARX 6(<X 56'0@)3
MATH#4(=2!4Z&6@=+AF()285L"T:%=PU#A(,/0822$3^$HA(]A+43/(3/$SR"
M\!(\@?\2/8#_$CU__Q(]?O\1/7[_$3U^_Q'%9@  M7$  *I[  "?@@  DH(
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M!B2?_P8DGO\'))[_!R2>_P>O?@  HX@  )>.  "-DP  ?I4  '"8  !CFP
M5Y\  $RB  !"I@  .*D  "^L P JK@X *:X8 "BO(P GKRT )K W "6P00 D
ML$L ([%6 "*Q8P AL7$ '[&" !ZRE $<LJD!&[+! 1NQYP$;K_X"&JW_ AJL
M_P,:J_\#&JO_ QJK_P.HB   FX\  )&4  "$F@  =I\  &BB  !;I0  3ZD
M $2M   YL   +[,  ":V   >N04 &+L. !>[%@ 7O"  %KPJ !6]-0 4O4
M$[Y+ !*^6  2OF< $;]X !"_C  0P*( #L"Z  [ X0 /O?L #[S_ !"Z_P$0
MNO\!$+K_ 1"Z_P&?CP  E)4  (>;  !YH0  :Z<  %ZL  !2L0  1;0  #JV
M   ON0  );P  !V_   5PP  #\8%  O*#0 )RA0 ",H=  ?*)P 'RC( !LL^
M  7+2P $S%H  \QJ  +,?@ !S)0  ,RK  #-R   S.T  ,S_  #+_P !RO\
M <K_  '*_P"7E@  BIP  'RC  !NJ@  8+   %*V  !%N0  .;P  "Z_   C
MPP  &\8  !/*   -S0  "-$   '4"0  U X  -45  #6'@  V"<  -DQ  #;
M/@  W$L  -U;  #>;@  WH0  -^;  #?M   WMD  -_W  #?_P  W_\  -__
M  #?_P"-G0  ?Z4  '"L  !ALP  4[H  $6_   XP@  +,8  "')   8S0
M$-$   O5   $V@   -X   #@ 0  X0D  .(.  #D$P  Y1L  .<D  #I+P
MZSP  .U+  #N70  [G$  .^)  #PH@  \+P  /#C  #O^0  \/\  /#_  #P
M_P"!I0  <JT  &.U  !4O0  1L0  #?(   JS   ']   !75   .V@  !]X
M  #B    Y@   .D   #J    [    .X%  #O#   \1   /,7  #U(   ^"L
M /LY  #]2@  _EX  /]T  #_C0  _Z8  /_   #_X0  __4  /_U  #_]0!T
MK@  9;<  %;   !'R   .,T  "K2   =V   $]T   SB   #Y@   .D   #L
M    \    /,   #T    ]@   /@   #Z    _0<  /\-  #_$@  _QL  /\H
M  #_-P  _TH  /]>  #_=@  _X\  /^F  #_N@  _]$  /_1  #_T0#_#R0
M_PXB /\+(0#_ R0 _P I /\ ,@#_ #X _P!, /\ 60#_ &4 _P!P /\ >@#_
M (0 _P", /\ D@#_ )D _P"? /\ I0#_ *L _P"R /\ N@#_ ,4 _P#3 /\
MYP#_ /0 _P#_ /X _P#_ /\ _@#_ /X _P#^ /\ _@#_ /X _P#_$2$ _Q >
M /\-'0#_!Q\ _P C /\ +0#_ #H _P!( /\ 50#_ &$ _P!L /\ =@#_ '\
M_P"' /\ C@#_ )4 _P"; /\ H0#_ *< _@"N /T M@#\ ,  ^P#- /D X@#X
M /  ]P#\ /8 _P#U /\ ]0#_ /4 _P#U /\ ]0#_ /4 _P#_%1T _Q,: /\0
M&0#_"QD _P = /\ *0#_ #8 _P!# /\ 4 #_ %P _P!G /\ <0#_ 'H _@"#
M /P B@#Z )$ ^0"7 /@ G0#W *, ]0"J /0 L@#R +L \0#( .\ W #N .P
M[0#Z .L _P#J /\ Z@#_ .H _P#J /\ Z@#_ .H _P#_&!D _Q85 /\3$P#_
M#A, _PL: /\') #_ C  _P ^ /\ 2P#_ %< _P!B /P ; #X '4 ]0!^ /(
MA0#Q (P [P"3 .X F0#L *  ZP"F .D K@#G +< Y@## .0 U #B .D X0#W
M -\ _P#= /\ W0#_ -T _P#= /\ W0#_ -T _P#_&Q, _QH0 /\6#@#_$@X
M_Q(5 /\/'P#_#"L _PDX /\&10#[ U$ ]P)< /("9@#N G  Z@)X .<"@ #F
M X< Y .. .(#E0#A YP WP2C -T$JP#;!+0 V 7  -8%T #3!N< T CX ,X*
M_P#,"_\ RPS_ ,L,_P#+"_\ RPO_ ,L+_P#_'Q  _QX+ /\:!P#_&0L _Q@1
M /\6&0#_$B0 ^A P /,./@#N#4H Z0Q6 .4,80#B#&H W@US -L->P#9#8,
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M!*$F_P.A)O\#H2;_ Z$F_P/_*0  _R@  /8M  #G,   WR\  -DK! #6(@H
MSB,6 ,8F)P# *#8 NRI$ +@K3P"U+%D LBQB ; L:@&N+7(!K"UZ JHM@0*I
M+8H"IRV2 Z4MFP.D+:4$HBVQ!* MP 2?+=@$G"[O!9DN_P:7+_\&EB__!I4N
M_P65+O\%E2[_!94N_P7_+   _RX  .HU  #=.0  T3D  ,HV  #'+P8 P2T1
M +HP(0"T,C$ L#0^ *PU2@"I-50!IS5= :0U90*B-6T"H#5T Y\U? 2=-80$
MFS6-!9HTEP:8-*$&EC2M!Y0UNPB3-= (D#7L"(XV_@B,-O\(BS;_"(LV_P>*
M-?\'BC7_!XHU_P?_+P  \C0  .(\  #200  QT(  ,!   "[.@$ MC8. + Y
M' "J.RP ICPZ *,]1@"?/5 !G3U9 IH]80.8/6@$ECQP!90\=P:2/( 'D3R(
M!X\[D@B-.YT)BSNI"HD[MPN(.\H+A3SH"X,\^PN"//\*@3S_"H$\_PF!//\(
M@3S_"($\_PC_,P  [#H  -I#  #*1P  OTD  +='  "Q0@  K3X* *9 %P"B
M0B< GD,U )I$0@&71$P!E$15 I%#70./0V0%C4-K!HM"<P>)0GL(AT*$"H5!
MC@N#09D,@4&E#7]!LPY^0<8.?$'D#GI"^0UY0O\,>$+_"WA"_PMX0O\*>$'_
M"GA!_PKV-@  YD   -%(  ##30  N4X  +%-  "I20  I$4& )]&$P":2",
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M$FA0JQ-F4+P395#8$V10\Q)D4/\09%#_#V10_PYE3_\-94__#&5/_PSL00
MU$P  ,-4  "V60  K%P  *!:  "75P  D50  (M5# "&5QD @U@G (!9- !]
M63\!>EE( W=84 1T6%@&<E=?!V]79@EM5FX+:U9W#6A5@0]F58T19%2:$F)4
MJ1-@5+H47U33%%Y4\A->5/\17U3_#U]4_PY?4_\-7U/_#5]3_PWG1   SU
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M$T]B[1)/8?\13V'_$%!@_PY08/\.4&#_#5!@_PW93P  PUH  +1C  "I:0
MFV@  (]G  "$9P  >64  '-G  !O:0X ;&H; &EK* !G;#0 9&P] 6)L1@)?
M:TX$76M6!5IJ70=8:F4)5FEN"U-I> U1:(0/3FB2$$QGH1)+9[(226?)$DEG
MZQ))9O\02F;_#TIE_PY+9?\-2V3_#4MD_PW15   OEX  +%G  "F;0  EVP
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M"S=Y_PHX>/\*.'C_"CAX_PJ^9   L&\  *5X  "6>0  AWD  'MY  !P>@
M9'P  %B   !0@P  2X4* $B&% !'AR  18@K $2(-0!#B#X 08E' 4")3P$^
MB%@"/(AA SJ(; 0WB'@%-8B'!C.(F <RAZH',(C !S"'Y <PA?L(,(/_"#""
M_P@P@?\(,('_"#"!_PBW:P  JG8  *!_  "0?@  @GX  '9_  !J@   7H,
M %.'  !*BP  08X" #V0#@ [D!@ .I$C #F1+0 XDC< -Y)  #:220 TDU(
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M 1.D_P&CA@  EXP  (V1  !]D@  ;94  &"8  !4G   2*   #ZD   TIP
M*JL  "&N   9L0  $K,'  ^U$  .M1< #K4A  VU*P -M38 #+9!  NV3@ *
MMEP ";9L  BV?P 'MI0 !K:J  6VQ0 &MNH ![7_  BT_P (L_\ ";+_  FR
M_P":C0  D),  (28  !TG   9:   %>D  !+J   0*P  #6P   JLP  (;4
M !BX   1NP  #+X"  ; "P "P!$  <$9  #!(@  PBL  ,(V  ##0@  PU
M ,1?  #$<0  Q(<  ,2=  #$M0  Q-H  ,3V  ##_P  P_\  ,/_  ##_P"3
ME   AYH  'B@  !JI@  7*P  $^Q  !!M0  -;<  "FZ   ?O0  %L   !##
M   *Q@   \H   #,!0  S P  ,T1  #.&   SB$  - J  #1-0  TT,  -12
M  #48P  U7@  -6/  #5IP  UL(  -;I  #6_0  UO\  -;_  #6_P"*FP
M>Z(  &RI  !>L   4+8  $*Z   TO0  *,$  !W$   4QP  #<L   ;.
MT@   -<   #9    V@4  -P+  #=$   WQ4  .$=  #C)P  Y3,  .="  #H
M5   Z&<  .E^  #IEP  ZJ\  .K.  #K[P  Z_X  .O_  #K_P!]HP  ;JL
M %^R  !1N@  0L   #3#   GQP  &\L  !+/   +TP   M@   #=    X0
M .0   #E    YP   .D   #K!P  [0T  .\1  #Q&0  ]"0  /<Q  #Y00
M^E4  /IJ  #[A   ^YT  /RV  #\T@  _>T  /WT  #]] !QK   8;4  %*]
M  !$Q   -,D  ";-   :T@  $-@   C=    X0   .4   #H    [    .\
M  #Q    \P   /4   #W    ^0$  /L(  #^#@  _Q4  /\A  #_+P  _T$
M /]6  #_;0  _X<  /^@  #_M@  _\H  /_4  #_U #_"R  _P<> /\ '0#_
M "  _P E /\ +@#_ #L _P!) /\ 5@#_ &( _P!M /\ =@#_ '\ _P"' /\
MC@#_ )0 _P": /\ H #_ *8 _P"M /\ M0#_ +X _P#+ /\ X0#_ /  _@#]
M /T _P#] /\ _0#_ /T _P#\ /\ ^0#_ /D _P#_#1T _PL: /\$&0#_ !H
M_P ? /\ *@#_ #< _P!% /\ 40#_ %X _P!H /\ <@#_ 'H _P"" /\ B0#_
M )  _P"6 /\ G #^ *( _ "I /L L #Y +D ^ #& /8 V0#U .L ] #Y /,
M_P#R /\ \P#_ /, _P#S /\ \P#_ /, _P#_$!D _PX5 /\(% #_ !0 _P 9
M /\ )0#_ #( _P!  /\ 3 #_ %D _P!C /X ;0#\ '4 ^@!] /D A #W (L
M]@"1 /0 EP#S )X \@"D /  K #N +0 [0#  .L SP#I .8 Z #U .8 _P#G
M /\ Y@#_ .4 _P#E /\ Y0#_ .4 _P#_$A0 _Q 0 /\,#P#_ Q  _P 5 /\
M( #_ "P _P Z /\ 1P#Z %, ]P!> /0 9P#Q '  [P!X .T ?P#K (8 Z@",
M .@ DP#G )D Y0"@ ., IP#A +  WP"Z -T R0#; .  V #P -< _@#5 /\
MU #_ -, _P#3 /\ TP#_ -, _P#_%1  _Q(, /\."0#_"PP _PD2 /\#&@#_
M "8 _0 S /0 0 #O $T ZP!8 .@ 80#E &H X@!R .  >@#> (  W "' -H
MC@#8 )4 U "< -( HP#0 *P S@"V ,P Q #* -D R #M ,< ^P#% /\ Q '_
M ,,!_P#$ ?\ Q '_ ,0!_P#_& L _Q4% /\0  #_$ 8 _P\- /\,% #\!Q\
M\0,K .< .0#B $8 W@%1 -H"6P#5 F0 T@-L ,\#= #-!'L RP2" ,H$B0#(
M!9  Q@68 ,0%H #"!JD P0:T +\&P0"]"-4 NPGL +@+_0"V#/\ M0W_ +0-
M_P"T#?\ M W_ +0-_P#_&P4 _Q@  /\7  #_%@  ^Q,& /H0#@#N#!8 XPDB
M -H), #3"CX S@M* ,H,50#'#5X Q0UG ,(.;P#!#G8 OPY^ +T/A0"\#XT
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M HXG_P+_)@  \BD  .,Q  #2-   R#0  , P  "[*0( N",. +$F' "L*"L
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M!WD[K =W.[P(=CS5"'0\\0AS//\'<CS_!G(\_P5R//\%<CO_!7([_P7Q,@
MWCT  ,E$  "\2   L$D  *9&  "?00  FST! )4]$ "1/QT C4$K (I". "'
M0T( A$-+ 8)#4P& 0UL"?D)B WQ":01Z0G$%>$)Z!G9!A =T08\(<D&;"'!!
MJ0EO0;D*;4'0"FQ![@EK0O\(:D+_!VI!_P9J0?\&:D'_!6I!_P7M-P  UD(
M ,1)  "W30  JTT  *!*  "81P  DT(  (Y##0")11H AD8H (-'- " 2#\
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M#5E/Z Q83_T+6$__"5E/_PA93O\'64[_!UE._P??0P  QTT  +A4  "L60
MG5<  )%5  "(5   @5   'M2! !W4Q$ =%0> '%5*P!O5C8 ;%9  6I62 %H
M5E "9E97 V167@1B568%8%5O!UU5> A;5(0*6521"U=4H Q54[ -5%/%#5-3
MY@Q34_P+4U/_"512_PA44O\(5%+_!U12_P?:1@  PU   +58  "H6P  F5H
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M"41@_PA%7_\'15__!T5?_P?(4@  N%P  *MD  ";9   C&,  (!C  !V8P
M:F(  &-D  !?9@8 6V<1 %EH'0!7:2D 5FHS %1J/ !2:D4!4&I, 4YJ5 ),
M:EP#2FIE!$AI;P5&:7H'1&F("$)HF E :*D*/VB]"CYHW@D^9_<)/F;_"#]E
M_P<_9?\'/V3_!S]D_P?#5P  LV$  *=I  "6:   AV<  'MG  !Q9P  96@
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M RE[_P.Q:@  I70  )5V  "%=0  >'4  &UU  !A=P  5WH  $Q^  !#@0
M.X4  #6("0 RB1$ ,8D; #"))0 OBB\ +HHX "V+00 LBTH *HM4 "F+7P H
MBVL )HMZ 22+BP$CBYX!(HNS 2&,S@$ABO$!((C_ B"&_P(@A?\"(87_ B&%
M_P*K<@  H7P  (][  " >@  <WH  &9\  !;?P  4((  $:&   \B@  -(T
M "R1   FDPP ))03 ".4'  BE28 (94O ""5.  ?ED( 'I9, !V66  <EF0
M&I=T !F7A@ 8EYD %Y>N !67R0 6E>X %I/_ 1:2_P$6D?\!%I#_ 1:0_P&E
M>P  F8,  (F!  ![@   ;((  %^$  !4B   28L  #^0   UE   +9<  "6:
M   =G@$ %J , !2A$@ 4H1L $Z$E !*A+@ 1HC@ $:)# !"B3P /HEP #J-K
M  VC?0 -HY( #*.G  JBP  +HN8 #*#^  V?_P -GO\ #9W_  V=_P">A
MDHD  (.(  !SB   98L  %B.  !,D@  09<  #>;   NG@  )*(  !RE   5
MJ   #ZL$  JN#  'K1( !JT;  6M)  $KBX  JXY  &N10  KE(  *YA  "N
M<P  KH<  *Z=  "NM   KM4  *WT  "M_P  K/\  *O_  "K_P"6BP  C)
M 'N0  !KD@  798  %":  !$GP  .:,  "^G   EJP  '*X  !2Q   .M
M";<   &X"0  N X  +D4  "Y'   NB4  +HO  "[.@  O$<  +Q6  "\9P
MO'L  +R1  "\J0  O,0  +SK  "[_@  N_\  +O_  "[_P"0D@  @Y@  '.;
M  !CGP  5:,  $>H   [K0  ,+$  "6T   ;MP  $KH   R]   %OP   ,,
M  #$ @  Q0H  ,4.  #&%   QQL  ,@D  #*+@  S#H  ,U)  #-60  S6P
M ,Z#  #.FP  S;4  ,[:  #.]@  S?\  ,W_  #-_P"&F0  =Z   &FF  !:
MK   3+(  #ZV   PN0  )+P  !F_   1P@  "L4   +)    S    -    #1
M    T@$  -,(  #5#0  UQ$  -H8  #<(0  WRP  .$Z  #B2@  XUT  .1R
M  #DBP  Y:4  .7   #EY@  Y?@  .7_  #E_P!ZH0  :ZD  %RO  !-M@
M/[P  #"_   CPP  %\<   _*   'S@   -$   #6    W    -\   #@
MX@   .0   #F P  Z D  .D.  #L%0  [AX  /$K  #T.@  ]4T  /9A  #W
M>0  ^),  /BM  #YQ@  ^>0  /GS  #Y\P!MJ@  7K(  $^Z  ! P0  ,<4
M "+)   6S@  #=(   38    W0   .$   #D    Z    .L   #M    [P
M /$   #S    ]@   /@#  #Z"P  _1$  /\;  #_*0  _SL  /]/  #_9@
M_W\  /^9  #_KP  _\,  /_6  #_U@#_!!P _P 9 /\ &0#_ !P _P B /\
M*P#_ #@ _P!& /\ 4P#_ %X _P!I /\ <@#_ 'H _P"" /\ B0#_ (\ _P"5
M /\ FP#_ *$ _P"H /\ KP#_ +D _P#% /\ V0#^ .P _0#[ /L _P#[ /\
M^P#_ /H _P#T /\ \ #_ /  _P#_!Q@ _P$5 /\ % #_ !8 _P ; /\ )@#_
M #0 _P!" /\ 3@#_ %H _P!D /\ ;0#_ '4 _P!] /\ A #_ (H _0"0 /P
ME@#Z )T ^0"C /@ JP#W +0 ]0"_ /0 S@#S .8 \0#V /  _P#O /\ [P#_
M .X _P#N /\ Z@#_ .H _P#_"Q0 _P81 /\ $ #_ !  _P 6 /\ (@#_ "X
M_P \ /\ 20#_ %0 _@!? /L : #Y '  ]P!X /4 ?P#S (4 \@"+ /  D@#O
M )@ [0"? .P I@#J *X Z "Y .< QP#E -X XP#P .( _@#@ /\ X #_ .$
M_P#A /\ X0#_ .$ _P#_#1  _PD- /\!# #_  P _P 2 /\ ' #_ "@ _  V
M /D 0P#V $X \@!9 .\ 8@#L &L Z@!R .@ >0#F (  Y "& .( C #A ),
MWP": -T H0#; *H V "T -4 P #2 -, T #J ,X ^@#- /\ S0#_ ,T _P#,
M /\ S #_ ,P _P#_$ P _PP' /\# @#_  @ _P . /\ %@#V "( \  O .P
M/ #I $@ Y0!3 .$ 7 #> &4 VP!L -< <P#4 'H T@"  -  AP#. (X S "5
M ,H G0#( *4 Q@"O ,0 NP#" ,L P #E +X ]0"] /\ O #_ +P _P"\ /\
MO #_ +P _P#_$04 _PX  /\*  #_" $ _P0* /@ $ #I !H XP H -X -0#9
M $$ TP!, ,\ 5@#+ %\ R0!F ,8 ;@#$ '0 P@![ ,$ @@"_ (D O0"0 +P
MF "Z *$ N "K +8 MP"T ,< L@#@ +$!\@"O O\ K@/_ *T$_P"M!/\ K03_
M *T$_P#_%   _Q   /\/  #R#0  Z@H  .D#"0#= !( U  ? ,T!+0#( CH
MQ -% , #4 "]!%D NP5A +D%: "W!F\ M09V +0'?0"R!X0 L0B, *\(E0"M
M"9X JPFH *H*M0"H"L4 I@O? *0-] "B#O\ H [_ )\._P"?#O\ GP[_ )\.
M_P#_%P  _Q,  .\8  #D&0  VQ8  -(0 @#/"0L R @6 ,$*) "\##( MPT^
M +0.20"Q#E, KQ!; *T08P"K$&H J1%Q *@1> "F$8  I1&( *,2D0"A$IL
MH!.F )X3LP"<$\, FQ3> )<6] "5%O\ E!?_ ),7_P"2%_\ DA;_ )(6_P#_
M&@  ]!T  .4C  #5)0  RB0  ,(=  "^%@0 NQ 0 +03'0"O%2L JQ8X *<8
M0P"E&4T HAE6 * :70">&V4 G1ML )L<<P":''L F!R# )<=C0"5'9< DQZB
M )(>KP"0'K\ CQ_8 (P@\0&)(/\!B"#_ 8<@_P&'(/\!AB#_ 88@_P'Z'@
MZR8  -HM  #*,   OBX  +4H  "P(@  KAL, *@=%P"C'R8 GR$S )PB/@"9
M(T@ ER11 )4D60"3)6  DB5G ) F;@".)G8 C29_ (LFB &*)Y,!B">> 88G
MJP&$)[L!@RC1 8 H[@%^*?\!?2G_ 7PH_P%\*/\!?"C_ 7PH_P'U)   XRX
M ,\U  #!.   M#8  *LQ  "E+   HB8& )XF$P"9*"$ E2HN )(K.0"/+$0
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M!64\Y05D//H$9#S_ V,[_P-C._\#8SO_ F,[_P+E-0  S3\  +U&  "N1P
MGT4  )5#  ".0   B3P  (0\"@" /10 ?3XB 'H_+@!X0#@ =4%" '-!2@!R
M05$!<$%9 6Y!8 )L06<":D%P VA!>0-G080$94&1!6-!GP5A0:X&8$'"!EY!
MX@9>0?D%74'_!%U _P-=0/\#74#_ UU _P/?.0  R$,  +E*  "I2P  FTD
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M!4U-_P1-3?\$3DS_ TY,_P/.1   O$X  *Y4  "<4P  CE(  (-1  !Z4
M<DT  &Q/  !H4 L 95$5 &-2(0!A4RP 7U,V %U4/P!;5$< 6E1. 5A45@%6
M5%T"5%1F U)3;P-04WL$3E.(!4Q3EP9+4Z<'25.Z!TA3U0=(4O,&2%+_!4A1
M_P1)4?\$25#_ TE0_P/*2   N5(  *I7  "85@  BE4  ']4  !V4P  ;%$
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M SE>_P.\50  K5\  )Q@  "+7P  ?5\  ')?  !H7P  76   %5B  !/9
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M "9ZAP$E>ID!(WJL 2)ZQ0$B>>D!(G?_ 2)V_P$B=?\"(G3_ B-T_P*L:
MG6X  (IM  ![;   ;VP  &5L  !:;@  4'$  $5U   ]>   -GP  "Y_ @ I
M@0T )X(4 ":"'@ E@B< )((O ".#.  B@T( (8-+ ""$5@ ?A&( 'H1Q !R$
M@@ ;A)4 &H2I !B$P0 8@^8 &('] !F _P$9?_\!&7[_ 1E^_P&F<   E7,
M (1R  !V<0  :W$  %YS  !4=@  27D  #]]   W@0  +X0  ">(   @BP4
M&XT. !J-%0 9C1X &(XG !>.,  6CCD %8Y# !2/3P 3CUL $H]J !&/>P 0
MCX\ #X^D  Z/NP -C^  #HWZ  ^+_P 0BO\ $(G_ !")_P"A>@  CGD  'YW
M  !R=P  9'@  %A[  !-?@  0H(  #F&   OB@  )XX  ""1   8E0  $I@%
M  Z:#@ -FA0 #)H=  N:)@ +FC  "IH[  F:1@ (FE, !IMA  6:<@ $FH8
M IJ;  ":L0 !F<\  IGP  *8_P $E_\ !9;_  66_P"9@0  AW\  'I^  !K
M?@  78$  %"%  !%B0  .XT  #&2   HE@  'YD  !B=   1H   #*,"  :E
M"@ !I1   *46  "F'P  IB@  *8R  "G/0  ITH  *=8  "G:   IWP  *>1
M  "FJ   IL,  *7I  "E_   I?\  *3_  "D_P"1AP  @H8  '*&  !CB
M58P  $F1   ]E@  ,IH  "B>   ?H@  %Z8  !"I   +K   !*\   "Q!@
ML0P  +(1  "R%P  LQ\  +,H  "T,@  M3\  +5-  "U70  M7   +6&  "U
MG0  M;8  +7<  "T]P  M/\  +3_  "T_P"+CP  >HX  &J1  !;E0  39H
M $"?   UI   *J@  ""L   6L   #[0   FW   !N0   +T   "^    O@8
M +\,  # $   P18  ,(=  ##)P  Q3(  ,9   #&40  QV,  ,=X  #'D0
MQZD  ,?'  #'[   Q_X  ,?_  #'_P"#EP  <9H  &&>  !2HP  1:D  #BN
M   LLP  (+<  !:Z   .O0  !L    ##    QP   ,D   #*    S    ,T#
M  #."0  T X  -(3  #4&P  V"4  -LR  #=0@  W50  -YI  #>@0  WIP
M -^U  #?V0  W_,  -__  #?_P!WGP  :*8  %FM  !*LP  .[@  "V[   ?
MOP  %,(   S&   #R0   ,P   #0    U0   -D   #:    W    -X   #@
M    X@4  .0+  #G$   ZA@  .TD  #P,@  \40  /)8  #S;P  ](H  /2D
M  #TOP  ]-\  /3S  #T] !JJ   6Z\  $RW   ]O0  +<$  !_&   3R@
M"\X   #2    UP   -P   #@    Y0   .<   #I    ZP   .T   #O
M\0   /,   #V!P  ^0X  /P6  #_(@  _S,  /]'  #_70  _W8  /^1  #_
MJ0  _[X  /_8  #_VP#_ !@ _P 6 /\ %0#_ !@ _P > /\ )P#_ #8 _P!#
M /\ 3P#_ %H _P!D /\ ;0#_ '4 _P!] /\ A #_ (H _P"0 /\ E@#_ )P
M_P"C /\ JP#_ +0 _@"_ /T SP#[ .< ^@#X /D _P#Y /\ ^0#_ /4 _P#N
M /\ Z0#_ .< _P#_ !0 _P 1 /\ $0#_ !( _P 7 /\ (P#_ #$ _P ^ /\
M2@#_ %8 _P!@ /\ : #_ '  _P!X /T ?@#\ (4 ^@"+ /D D0#X )@ ]P">
M /4 I@#T *X \@"Y /$ QP#O .  [@#R .P _P#L /\ [ #_ .L _P#E /\
MX #_ -X _P#_ Q  _P . /\ #0#_  T _P 3 /\ '@#_ "L _P X /\ 10#^
M %  ^P!: /@ 8P#U &L \P!R /$ >0#O '\ [@"& .P C #J )( Z0"9 .<
MH #F *D Y "S .$ P #@ -, W@#K -P ^P#; /\ V@#_ -H _P#9 /\ U #_
M -( _P#_!PT _P ) /\ !@#_  D _P / /\ & #[ "4 ^  R /4 /P#R $H
M[0!4 .H 70#G &4 Y !L .( <P#@ 'H W@"  -P A@#: (T UP"4 -0 FP#2
M *0 SP"M ,T N0#+ ,D R0#D ,@ ]@#& /\ Q0#_ ,8 _P#' /\ QP#_ ,<
M_P#_"@8 _P$  /\   #_  0 _P + /0 $@#O !\ Z@ L .4 . #B $, W0!.
M -D 5P#4 %\ T0!G ,X ;0#, '0 R@!Z ,@ @ #& (< Q0". ,, E@#! )X
MOP"H +T LP"Z ,( N0#; +< \ "U /\ M@#_ +4 _P"U /\ M0#_ +4 _P#_
M#   _P0  /\   #^    ]@ # .@ #0#@ !< V0 D -$ ,0#- #P R@!' ,8
M40## %D P !@ +X 9P"\ &X N@!T +D >P"W (( M0") +, D0"R )H L "D
M *X KP"L +T J@#0 *@ ZP"G /L I@#_ *8 _P"E /\ I0#_ *4 _P#_#0
M_P<  /0)  #J"0  X@0  -H !P#/ !$ R  < ,( *0"^ #4 NP!  +< 2@"T
M %, L@!; +  8@"N &@ K !O *L =0"I 'T J "$ *8 C0"D )8 HP"@ *$
MJP"? ;D G0/, )P$Z ":!OD F0?_ )@(_P"7"/\ EPC_ )<(_P#_$   ]Q
M .@4  #<%0  SA$  ,8-  #"! L O  4 +<!(0"R RX K@4Z *L&1 "H"$T
MI@A5 *0)7 "B"F, H IJ )\+<0"="W@ G N  )H,B0"9#), EPR> )4-J@"4
M#;@ D@W, ) .Z@".$/P C!#_ (L0_P"+$/\ BQ#_ (H0_P#[$P  [1H  -T@
M  #,(0  OQT  +<7  "S$0  L@L- *L-&0"G#B8 HP\S )\0/@"=$4< FA%0
M )@25P"6$EX E1-E ),3; "2$W, D!1\ (\4A0"-%8\ BQ6: (H5IP"(%K4
MAA;) (07YP""&/L @!G_ '\9_P!_&?\ ?QC_ '\8_P#U&@  Y",  ,\I  #
M*@  LR8  *HB  "E'   I!4( * 4$P";%B$ EQ@M )09. "1&D( CQM+ (T<
M4@"+'%D B1U@ (@=9P"&'F\ A1YW (,?@ ""'XL @!^7 'X@HP!](+( >R#%
M 'DAY !W(OD =B+_ '4B_P!T(?\ ="'_ '0A_P#O(0  VRL  ,<Q  "V,0
MJ2X  * J  ";)@  F"$! )4>$ "0(!L C2$H (DC,P"')#T A21& (,E3@"!
M)E4 ?R9< 'XF8P!\)VL >R=S 'DG? !X*(< =BB3 '0HH %R**\!<2G! 6\I
MX %M*?<!;"G_ 6LI_P%K*?\!:RC_ 6LH_P'H*   T#(  , X  "N-P  H34
M )@R  "2+0  CBD  (LG# "'*!< @RHC ( K+P!^+#D ?"Q" 'HM2@!X+E$
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M TQ%S -+1>T#2T3_ DM$_P)+0_\"3$+_ DQ"_P+*/P  N4@  *9*  "520
MAT@  'U'  !U10  ;D(  &E#  !E1 D 8D43 %]&'@!=1R@ 7$@R %I(.P!9
M24, 5TE* %9)4@!425D!4TEA 5%):P%/278"34F" DM)D0-*2:$#2$FS T=)
MR@-&2>P#1DC_ D9(_P)'1_\"1T;_ D=&_P+&0P  MDP  *),  "13   A$L
M 'E*  !P20  :48  &1'  !?208 7$H0 %I+&P!83"4 5DPO %5-. !334
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M C=5_P(W5/\"-U/_ CA3_P*Z3P  J58  )55  "%5   >%0  &U4  !D5
M6%0  %)6  !.5P  2ED) $=:$0!&6AL 1%LE $-;+@!"7#8 05P^ #]<1@ ^
M74\ /5U7 #M=80 Z76P!.%UY 39=B $T79D",UVK C%=P@(Q7.4",5O\ C%:
M_P(Q6?\",EG_ 3)8_P&V5   I%D  )!8  " 6   <U<  &E7  !@6   5%D
M $Y;  !(70  0U\$ $!@#@ ^81< /6$@ #MB*0 Z8C( .6(Z #AC0@ W8TL
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M 1MM_P&F9@  D64  ']D  !Q9   9F0  %UD  !29@  2&D  #]L   W;P
M,',  "EV   B>0@ 'WL0 !Y[%P <>Q\ &WLH !I[,  9?#D &'Q# !=\3@ 6
M?%H %7QG !1]>  2?8L $7V? !!]M0 /?=4 $'OU !%Y_P 1>/\ $G?_ !)W
M_P">:P  BFH  'II  !M:0  8FD  %=J  !,;0  0W   #ET   Q>   *7L
M ")_   ;@@  %(4) !&&$  1AA< $(<? !"'*  .AS$ #H<[  V'1@ ,AU,
M"X=A  J'<0 )AX0 !X>8  :&K@ %ALD !H7L  >$_P (@_\ "8+_  F"_P"5
M<0  @V\  '1N  !I;@  7&\  %!R  !&=0  /'D  #)]   J@0  (H4  !N)
M   4C   #X\#  J2"P &DA$ !)(8  *2(  !DBD  )(S  "3/@  DTL  )-9
M  "3:0  DWL  )*0  "2I@  D;\  )'E  "0^@  C_\  (__  "/_P"-=P
M?74  '!T  !B=0  57@  $E\   _@   -(0  "N)   BC0  &I$  !.4   .
MEP  "9L   &="   G0X  )T3  ">&@  GB(  )\K  "?-0  H$(  *!0  "@
M7P  H'$  *"'  "?G0  G[4  )[:  "=]@  G?\  )S_  "<_P"&?0  >'P
M &E\  !;?P  3H,  $&(   VC   +)$  ".6   :F@  $IX   VA   &I
M *<   "I P  J0H  *H.  "K$P  K!D  *TB  "N*P  KS<  *]%  "O5
MKV8  *][  "NE   KJL  *[)  "N[P  K?\  *W_  "M_P"!A   <80  &&'
M  !3BP  1I   #F6   NFP  (Z   !JD   2J   #*P   2O    L@   +8
M  "W    MP(  +@(  "Y#0  NA(  +L8  "](0  OBL  , X  # 2   P%H
M ,%N  #!A@  P:   ,&Z  #!XP  P/D  ,#_  # _P!YC0  :)   %F4  !+
MF@  /:   #&E   EJP  &J\  !&S   +N    KL   "^    P0   ,0   #%
M    Q@   ,<   #(!0  R@L  ,P/  #.%0  T!\  -,K  #5.@  U4P  -9@
M  #8=P  V)(  -BL  #9R0  V>P  -G[  #8_P!PF0  8)X  %&D  !#J@
M-;   "BV   <N@  $;X   G!    Q0   ,@   #+    SP   -(   #3
MU@   -@   #;    W0   -\'  #B#0  Y1,  .@=  #L*@  [3P  .U1  #N
M9P  [X$  .^<  #PMP  \-,  /#L  #P] !GI@  6*T  $FT   ZN@  *KX
M !S"   0Q@  !\H   #.    T@   -8   #<    X    .,   #D    Y@
M .@   #K    [0   .\   #R @  ]0H  /@1  #\'   _RP  /\_  #_50
M_VX  /^*  #_I   _[H  /_1  #_X0#_ !0 _P 2 /\ $@#_ !0 _P 9 /\
M)0#_ #( _P _ /\ 2P#_ %8 _P!@ /\ : #_ '  _P!X /\ ?P#_ (4 _P"+
M /\ D0#_ )@ _P"> /X I@#] *X _ "Y /H R #Y .( ^ #T /< _P#V /\
M]@#_ .\ _P#G /\ X@#_ -X _P#_ !$ _P . /\ #@#_  \ _P 4 /\ ( #_
M "T _P Z /\ 1@#_ %$ _P!; /\ 8P#^ &L _ !S /H >0#Y (  ]P"& /8
MC #U )( \P"9 /( H #P *D [@"S .T P0#K -8 Z@#N .D _@#G /\ YP#_
M .4 _P#= /\ U0#_ -$ _P#_  T _P * /\ " #_  D _P 0 /\ &P#_ "@
M_P U /\ 0 #Z $L ]@!5 /, 7@#Q &8 [@!M .P = #K 'H Z0"  .< A@#F
M (T Y "3 .( FP#@ *, W@"M -P N0#: ,H UP#F -0 ^ #2 /\ T@#_ -(
M_P#. /\ R0#_ ,8 _P#_  @ _P # /\   #_  , _P - /P %@#W "( \P N
M .\ .@#L $4 Z !/ .0 6 #A &  W@!G -L ;0#9 '0 U0!Z -, @ #1 (<
MSP". ,T E0#+ )X R0"G ,< LP#% ,( PP#< ,$ \0"_ /\ OP#_ +X _P"^
M /\ O0#_ +L _P#_    _P   /\   #_    ]@ ( .X $0#G !L X0 G -T
M,P#9 #X TP!) ,\ 4@#+ %D R !A ,8 9P#$ &T P@!S ,  >@"_ (  O0"(
M +L D "Y )@ N "B +4 K0"S +L L0#. +  Z@"O /P K0#_ *T _P"N /\
MK@#_ *X _P#_ @  _P   /T   #R    Z    -X # #3 !4 S  A ,@ + #$
M #@ P0!" +T 2P"Z %, N !: +8 80"T &< L@!M +  = "O 'H K0"" *P
MB@"J ), J "= *8 J "D +4 H@#& *$ XP"? /8 G@#_ )X _P"> /\ G@#_
M )X _P#_!@  ^P   .X%  #B!   U0   ,L !@##  \ O0 9 +@ )0"T #$
ML0 [ *X 10"L $T J0!5 *< 6P"E &( I !H *( ;@"A '4 GP!\ )X A0"<
M (X F@"8 )@ I "6 +  E0#! ), W "2 /( D0#_ )  _P"0 /\ CP#_ (\
M_P#]"@  \ X  .$1  #.$   P@T  +L'  "W  H L0 2 *P '@"H "D I0 T
M *( /@"? $< G0!/ )L 5@"9 5P EP%C )8":0"4 G  DP-X )$#@ "0!(H
MC@25 (P%H0"*!:X B0:^ (<(V "&"?  A K_ (,+_P"#"_\ @PO_ (,+_P#V
M$   YA<  -(<  # &@  LQ8  *P2  "H#0  I@<- *(%%@"=!R( F0DN )8*
M. "4"T$ D@Q* ) ,40".#5@ C U> (L-90")#6P B YT (8.?0"%#H< @PZ3
M ($/GP" $*T ?A"^ 'T0VP!Z$?0 >!+_ '<2_P!W$O\ =Q+_ '<2_P#O%P
MVR$  ,8D  "T(P  J"   * <  ";%P  F1$$ )@.$ "3$!L CQ$G (P2,@")
M$SP AQ-$ (443 "#%%, @15: ( 58 !^%F@ ?19O 'L6> !Y%X, >!>/ '88
MG !T&*H <QF[ '(9U !O&O$ ;AO_ &T;_P!M&O\ ;1K_ &T:_P#G(   T"D
M +PK  "K*@  GB@  )8D  "0(   C1P  (P7# "(&!8 A!HB ($;+0!^'#<
M?!U  'H=2 !Y'D\ =QY5 '8?7 !T'V, <Q]K '$@= !P('\ ;B&+ &PAF !K
M(:< :2*X &@BSP!F(NX 92/_ &0C_P!D(O\ 9"+_ &0A_P#@)@  R"\  +0Q
M  "C,   EBX  (TK  "'*   A"0  ((@" !^(!( >R(> '@C*0!U)#, <R4\
M '$E0P!P)DL ;B92 &TG60!K)V  :B=H &DH<0!G*'L 92B( &0IE0!B*:0
M8"FU %\IRP!>*NP 7"K_ %PI_P!<*?\ 7"G_ %PH_P#8+   PS4  *TU  "=
M-   D#,  (8Q  " +0  ?"L  'DH P!V)Q  <BD: ' J)0!M*R\ :RPX &HL
M0 !H+4< 9RU. &4N50!D+ET 8RYE &$O;@!?+W@ 7B^$ %POD@!:+Z$!62^R
M 5@PR %6,.D!53#^ 54O_P!5+_\ 52[_ %4N_P#0,0  O3H  *@Y  "7.
MBC<  ( V  !Z,@  =3   '(N  !N+@T :R\6 &DP(0!F,2L 9#(T &,R/0!A
M,T0 8#-+ %\T4@!=-%H 7#1B %HT:P!9-74 5S6" %4UD %4-9\!4C6P 5$U
MQ@%0-><!3S7] 4\U_P%/-/\!3S3_ 4\S_P'+-@  N#T  *,\  "2/   A3L
M 'LZ  !T-P  ;S4  &PS  !H- H 9343 &(V'@!@-R@ 7C<Q %TX.@!;.$$
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M 3]"_P$_0?\!0$'_ 4! _P&_00  JD4  )9%  "&10  >40  &]$  !G0@
M8#\  %M!  !70@  5$,- %%$%0!/11\ 3D4H $Q&,0!+1CD 2D=! $E'2 !(
M1U  1D=8 $5'80!#2&P 0DAX 4!(AP$^2)<!/$BI 3M(O@$Z2-\!.D?X 3I&
M_P$Z1?\!.T7_ 3M$_P&[10  ID@  ))'  ""1P  =D<  &M'  !C1@  6T,
M %9%  !21P  3D@* $Q)$@!*21P 2$HE $=*+@!&2S8 14L^ $-+1@!"3$T
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M 2I2_P&O40  F%$  (51  !V4   :E   &!0  !840  3E(  $=3  !!50
M.U@  #A9"@ U6A$ -%H: #-;(@ R6RL ,5LS "]<.P N7$, +5Q, "Q<5@ K
M76  *5UM "A=?  F78X )%VA "-=M0 B7=( (ESS ");_P C6O\ (UG_ "18
M_P"H50  DE0  (!4  !Q5   9E0  %Q4  !450  2E8  $-8   \6P  -ET
M #!@!0 M80X *V$5 "IB'0 I8B4 *&(N "=C-@ F8SX )6-' "-C40 B9%P
M(61I !]D>0 >9(H '&2> !MDLP 99,X &F/Q !MA_P ;8/\ '&#_ !Q?_P"A
M60  C%@  'M8  !M6   8E@  %E8  !060  1UL  #Y>   W8   ,6,  "IF
M   D:0D (6H0 "!J%P ?:B  'FLH !UK,  <:SD &VM" !IL3  9;%@ %VQE
M !9L=  4;(8 $VR: !)LKP 1;,H $6OO !)I_P 3:/\ $VC_ !-G_P"970
MA5T  '5<  !H7   7EP  %5<  !+7@  0F$  #ED   R9P  *VH  "1M   >
M< $ %W,+ !5T$0 4=!@ $W0A !)U*0 1=3( $74[ !!U1@ /=5( #G5?  UU
M;@ ,=8$ "W65  IUJ@ (=,, "73G  IS_0 +<?\ #''_  QP_P"18@  ?V$
M '!A  !D80  6F$  $]B  !%90  /&@  #-L   K;P  )'(  !UV   7>0
M$7P$  U_#  +?Q( "G\9  E_(@ (?RH !G\T  5_/P $?TL  G]8  %_9P
M?WD  '^.  !_HP  ?KL  'W@  !]]P  ?/\  'O_  ![_P")9P  >&<  &MF
M  !A9@  5&<  $EI   _;0  -7$  "QU   D>0  '7P  !:    0@P  #(8"
M  :)"@ !B0\  (D4  "*&P  BB,  (LL  "+-P  BT,  (M0  "+7P  BW$
M (N&  "+G   BK,  (G3  "(\P  B/\  (?_  "'_P"";0  <VP  &AL  !:
M;0  3F\  $)S   X=P  +GL  "6    =A   %8@  !",   +CP  !)(   "4
M!@  E0P  )40  "6%0  EQP  )@D  "8+@  F3D  )E'  "95@  F6@  )E]
M  "9E   F*L  )?(  "6[@  EO\  )7_  "5_P![=   ;W,  &%S  !3=@
M1GH  #M_   PA   )H@  !V-   4D@  #I8   F9   !G    *    "A
MH@8  *(,  "D$   I10  *4<  "G)   J"\  *@]  "I3   J5X  *ER  "H
MB0  J*(  *B\  "GY0  IOL  *;_  "E_P!W>P  :'L  %E^  !+@@  /H<
M #*-   GD@  '9<  !2<   .H   !Z0   "H    JP   *X   "O    L
M +$$  "S"@  M X  +43  "V&P  N"0  +HQ  "Z0   NE(  +ME  "[?0
MNI<  +JQ  "ZT@  NO,  +G_  "Y_P!O@P  7X8  %&+  !#D   -I<  "J=
M   ?H@  %:<   VL   %L    +0   "W    NP   +X   "_    P    ,$
M  ## 0  Q <  ,4-  #'$0  RAD  ,TD  #.,P  ST0  -!8  #0;@  T8@
M -"D  #0P0  T>8  -'X  #1_P!GCP  5Y0  $F:   [H0  +J<  "&M   6
MLP  #K@   :\    P    ,,   #&    RP   ,T   #.    T    -$   #4
M    U@   -H"  #<"0  WP\  .,7  #F)   YS8  .A)  #I7P  ZG@  .N4
M  #KKP  Z\P  .SH  #L]@!?G@  4*0  $*K   TL@  )KD  !F^   .P@
M!,4   #*    S0   -$   #8    VP   -\   #@    X@   .0   #F
MZ0   .L   #N    \04  /4-  #Y%@  _"4  /TY  #^3P  _V<  /^"  #_
MG0  _[4  /_+  #_Y #_ !$ _P / /\ #P#_ !$ _P 6 /\ (@#_ "\ _P [
M /\ 1P#_ %( _P!; /\ 9 #_ &P _P!S /\ >@#_ (  _P"& /\ C #^ ),
M_0"9 /L H0#Z *D ^ "T /< P@#V -H ]0#Q /0 _P#S /\ \P#_ .D _P#@
M /\ V #_ -, _P#_  X _P + /\ "@#_  L _P 1 /\ '0#_ "H _P V /\
M00#_ $P _P!6 /X 7P#[ &8 ^0!M /< = #U 'H ] "  /( A@#P (T [P"4
M .T FP#L *0 Z@"N .D N@#G ,T Y0#I .0 ^P#C /\ X@#_ -X _P#1 /\
MS #_ ,@ _P#_  D _P $ /\  0#_  0 _P . /\ & #_ "0 _0 P /L .P#W
M $8 \P!0 .\ 60#L &  Z@!G .< ;@#F '0 Y !Z .( @ #@ (< W@". -P
ME0#: )X U@"H -0 LP#1 ,, SP#? ,X ] #, /\ RP#_ ,L _P#% /\ OP#_
M +P _P#_  ( _P   /\   #_    _0 + /< $P#Q !X [0 J .H -0#G $
MX@!* -T 4@#9 %H U0!A -( 9P#0 &T S@!S ,P >@#* (  R "' ,8 CP#$
M )@ P@"A ,  K0"^ +L O #0 +H [0"Y /X N #_ +@ _P"W /\ LP#_ +
M_P#_    _P   /\   #Y    [@ % .4 #@#> !@ V  C -( +@#/ #D RP!#
M ,< 3 #$ %0 P0!; +\ 80"\ &< NP!M +D <P"W 'H M0"! +0 B0"R )(
ML "; *\ IP"L +0 JP#& *D Y "G /@ I@#_ *8 _P"E /\ I0#_ *0 _P#_
M    _P   /4   #J    W@   -  "@#( !( P@ = +X * "[ #, N0 ] +4
M1@"R $T L !5 *T 6P"L &$ J@!G *@ ;0"G ', I0!Z *0 @@"B (P H "6
M )\ H0"= *X FP"^ )D V "7 /$ E@#_ )8 _P"7 /\ EP#_ )< _P#_
M]0   .<!  #4    R0   ,  ! "X  X LP 6 *\ (0"K "P J  V *8 /P"C
M $< H0!/ )\ 50"= %L FP!A )H 9P"8 &X EP!U )4 ?0"4 (8 D@"1 )
MG ". *D C "X (L S0") .L B #] (@ _P"( /\ B #_ (@ _P#Y!@  Z0P
M -0.  ###   MPD  + "  "K  D I@ 0 *( &@"> "4 FP P )@ .0"6 $$
ME !) )( 4 "0 %8 C@!< (T 8@"+ &D B@!P (@ > "' ($ A0", (0 F ""
M *4 @ "T 'X R !] >< ? +Y 'L#_P![!/\ >P3_ 'L$_P#Q#@  WA4  ,45
M  "T%   J1$  *$.  ">"@  FP,, )< $P"3 !X D $I (T",P"* SP B 1#
M (8%2P"%!E$ @P97 (('7@" !V0 ?PAL 'T(= !\"'X >@F) '@)E@!W"J,
M=0JS ',+QP!R#.8 < W[ ' -_P!O#?\ ;PW_ &\-_P#H%@  T!X  +D=  "I
M'   G1H  )46  "0$P  CPX# (X*#@")"Q< A@PC (,-+0" #38 ?@X^ 'P.
M1@![#DT >0]3 '@06@!V$&$ =1!H ',0<0!Q$7L <!&' &X1E !L$:( :Q*R
M &D2QP!H$^< 9A/] &44_P!E%/\ 91/_ &43_P#?'@  QB0  + D  "@(P
ME"$  (L?  "&&P  @Q<  ((2" !_$1( ?!(= 'D4* !V%#$ =!4Z '(600!Q
M%D@ ;Q=/ &X75@!L%UT :QAD &D8;0!H&7< 9AF# &09D !C&I\ 81JO & :
MQ !>&^0 71S[ %P<_P!<&_\ 7!O_ %P;_P#5)0  O2H  *@I  "8*0  C"@
M (,E  !](@  >1\  '@; P!V&0\ <AH8 &\<(P!M'2T :QTU &D>/0!H'D0
M9A]+ &4?4@!C(%D 8B!A &$@:0!?(7, 72%_ %PAC0!:(IP 62*L %<BP !6
M(^$ 52/Y %0C_P!4(O\ 5"+_ %0B_P#-*P  MBX  *(N  "2+@  A2T  'PK
M  !V*   <B8  &\C  !M(0P :B(5 &<C'P!E)"D 8R0Q &(E.0!@)D$ 7R9(
M %TF3P!<)U8 6R== %DG9@!8*'  5BA\ %0HB@!3*9D 42FJ % IO@!/*=X
M3BGW $TI_P!-*?\ 32C_ $XH_P#(,   L#(  )PR  ",,@  @#$  '8P  !P
M+0  :RL  &@I  !F* D 8R@1 & I' !>*B4 7"LN %LK-@!9+#T 6"Q$ %<M
M3 !5+5, 5"U; %,M8P!1+FX 4"YZ $XNB !,+Y< 2R^H $DONP!(+]L 2"_V
M $<O_P!'+O\ 1RW_ $@M_P#$-   JS4  )<U  "'-0  >S4  '(T  !K,@
M9B\  &(N  !?+04 7"X0 %HO& !8,"( 5C K %4Q,P!3,3H 4C)" %$R20!0
M,E  3C-8 $TS80!+,VL 2C-W $@TA0!'-)4 132F $,TN0!"--8 0C3T $(T
M_P!",_\ 0C+_ $(R_P# .   IS@  ),X  "#.   =S@  &TW  !F-@  83,
M %TR  !9,@( 5S,- %0T%0!2-1\ 434H $\V, !.-C@ 3#<_ $LW1@!*-TX
M23A6 $<X7P!&.&D 1#AU $,X@P!!.9, 0#FD #XYN  ].=, /#GS #PX_P ]
M-_\ /3?_ #TV_P"[.P  HCL  (\[  !_.P  <SL  &HZ  !B.0  73<  %@V
M  !4-P  43@+ $\Y$P!-.1P 2SHE $HZ+0!(.S4 1SL\ $8\1 !%/$L 1#Q3
M $(\7 !!/6< /SUS #X]@0 \/9$ .CVC #D]M@ X/=$ -SWR #<\_P X._\
M.#O_ #@Z_P"V/0  GCX  (L^  !\/@  ;SX  &8]  !>/0  6#L  %,Z  !/
M.P  3#P( $D]$0!'/AD 1C\B $0_*@!#/S( 0D Z $% 00! 0$D /D%1 #U!
M6@ \060 .D%P #A!?P W08\ -4*A #1"M  R0LX ,D'P #) _P S0/\ ,S__
M #0^_P"Q0   FD   (=   !X00  ;$$  &)   !;0   5#\  $X_  !*0
M1D$% $1"#@!"0Q8 0$,? #]$)P ^1"\ /$0W #M%/@ Z148 .45. #A&6  V
M1F( -49N #-&?  Q1HT ,$:? "Y&LP M1LP +4;O "U%_P N1/\ +D/_ "Y#
M_P"L0P  ED,  (-#  !T0P  :$,  %]#  !70P  4$,  $A#  !$10  048!
M #Y'#  \2!, .D@< #E))  X22P -DDT #5*.P T2D, ,TI, #)*50 P2U\
M+TMK "U+>@ L2XL *DN= "A+L0 G2\H )TOM "=*_P H2?\ *$C_ "E'_P"G
M1@  D48  ']&  !P1@  948  %M&  !41@  3$<  $1(   _2@  .TL  #=,
M"0 U31  ,TX8 #).(  Q3R@ ,$\P "]/.  N3T  +%!( "M04@ J4%P *%!H
M "=0=P E4(@ )%"; ")0KP A4,@ (%#K "%/_P B3O\ (DW_ "--_P"A20
MC$D  'I)  !L2@  84H  %A*  !02@  24L  $!,   [3@  -5   #%2!  M
M4PT +%04 "I4'  I520 *%4L "=5,P F53P )59% "163@ B5ED (59E !]6
M=  >5H4 '%:8 !M6K  95L4 &5;I !I5_P ;5/\ &U/_ !Q2_P";30  ADT
M '5-  !H30  74T  %1-  !-3@  14\  #Q1   V4P  ,54  "M8   F6@D
M(UL0 ");%P A7!\ (%PG !]<+@ =7#< '%U  !M=2@ :754 &%UA !==<  5
M78$ %%V5 !-=J@ 17<( $5WG !);_@ 36O\ $UK_ !19_P"440  @%$  '!1
M  !D40  65$  %%1  !)4@  05,  #A6   R60  *UL  "5>   ?80, &F,,
M !AD$0 79!D %F0A !5D*0 493$ $V4Z !)E1  195  $&5=  ]E:P .97T
M#661  QEI0 *9+P "F3@  MC^0 ,8O\ #6'_  UA_P"-50  >E4  &M5  !?
M50  5E4  $Y5  !$5P  /%D  #1<   L7P  )F(  !]E   9:   $VL% !!M
M#0 .;A( #6X:  QN(@ ,;BL "VXT  IN/@ (;DH !VY7  9N90 $;G8  FZ*
M  !MGP  ;;8  &S6  !L\P !:_\  FK_  -J_P"%6@  =%H  &9:  !<60
M4UD  $A:   _70  -F   "YC   F9P  'VH  !EM   3<0  #G0#  IW"@ %
M=Q   7<5  !W'   =R0  '@M  !X-P  >$,  'A0  !X7@  >&\  'B$  !X
MF0  =[   ';-  !U\   =?\  '3_  !T_P!^7P  ;E\  &)>  !97@  35\
M $)B   Y90  ,&@  "=L   ?<   &'0  !)W   ->P  "'X   * "   @0T
M ($1  ""%P  @QX  (,F  "$,   A#L  (1(  "$5P  A&@  (1\  "$DP
M@ZH  (+%  "!ZP  @?X  (#_  " _P!W90  :60  %]C  !29   1V<  #QK
M   Q;P  *',  "!W   8?   $7\   R#   &AP   (H   ", P  C D  (T.
M  ".$0  CQ<  ) >  "1)P  DC(  )(_  "23@  DE\  ))S  "2BP  D:(
M )&\  "0Y0  C_P  ([_  "._P!Q:P  9FH  %AK  !+;0  /W$  #1V   J
M>P  ((   !>%   0B0  "XT   21    E0   )@   "9    F@,  )L(  "<
M#0  GA$  )\6  "@'@  HB@  *(U  "C1   HU4  *-I  "B@   HIH  *&S
M  "@V   H/8  )__  "?_P!N<0  7W(  %%U  !$>0  -WX  "R$   AB@
M%X\  !"4   *F0   9T   "@    I    *<   "H    J0   *H   "L!@
MK0L  *\0  "P%0  LAX  +0I  "T.0  M$H  +5=  "U<P  M8X  +6H  "T
MQ@  L^T  ++_  "R_P!F>@  5WT  $F"   \AP  +XX  ".4   8F@  $)\
M  FD    J0   *T   "P    M    +<   "X    N0   +L   "\    O@(
M , (  #"#@  Q!0  ,<>  #(+   R3T  ,I0  #*9@  RG\  ,J;  #*N
MRMT  ,KU  #*_P!>A@  3XL  $&1   SF   )Y\  !NE   1JP  ";    "U
M    N0   +T   #!    Q@   ,@   #)    RP   ,P   #.    T    -(
M  #4!0  V0P  -T2  #A'@  XBX  .-"  #D5P  Y6\  .:,  #FJ   Y<4
M .7G  #F]@!6E   2)L  #JB   LJ0  '[   !.V   +O    ,$   #%
MR0   ,T   #2    U@   -H   #;    W@   .    #B    Y    .<   #I
M    [0   / *  #T$0  ^!\  /DR  #Z2   ^U\  /QZ  #]EP  _:\  /W'
M  #]Y #_  X _P - /\ # #_  X _P 3 /\ '@#_ "H _P V /\ 0@#_ $T
M_P!7 /\ 7P#_ &< _P!N /\ = #_ 'H _P"! /T AP#\ (T ^@"4 /D G #W
M *4 ]0"O /0 O #S ,\ \0#L /  _@#O /\ [P#_ ., _P#7 /\ S@#_ ,H
M_P#_  H _P & /\ ! #_  @ _P 0 /\ &0#_ "4 _P Q /\ /0#_ $< _@!1
M /L 60#Y &$ ]@!H /0 ;@#S '0 \0!Z .\ @0#N (< [ ". .H E@#H )\
MY@"I ., M0#B ,8 X #C -\ ^ #= /\ W0#_ -0 _P#) /\ P@#_ +X _P#_
M  , _P   /\   #_  $ _P - /\ % #] "  ^@ K /< -@#S $$ [P!+ .P
M5 #H %L Y@!B ., : #A &X WP!T -P >@#: ($ V "( -0 D #2 )@ SP"B
M ,T K@#+ +P R0#3 ,< \ #& /\ Q #_ ,0 _P"[ /\ M@#_ +, _P#_
M_P   /\   #_    ]P ( /  $ #K !H YP E .0 , #A #L W !% -4 30#1
M %4 S@!; ,L 8@#) &< QP!M ,4 <P## 'H P0"! +\ B0"] )( NP"< +D
MIP"W +4 M0#( +, Y@"R /L L0#_ +  _P"N /\ J@#_ *< _P#_    _P
M /X   #Q    Y0 " -P #0#3 !0 S0 ? ,H *@#' #0 Q  ^ ,  1P"\ $X
MN@!5 +< 6P"U &$ LP!G +( ;0"P ', K@!Z *P @@"J (L J "5 *< H "E
M *T HP"^ *$ VP"@ /0 GP#_ )X _P"? /\ G0#_ )L _P#_    _    .X
M  #@    T    ,4 " "^ !  N0 9 +4 (P"S "X L  W *T 0 "J $@ J !/
M *4 50"C %L H@!@ *  9@"? &P G0!S )L >P": (0 F ". )8 F@"5 *<
MDP"W )$ S "0 .P CP#_ (X _P". /\ C@#_ (\ _P#\    [P   -L   #)
M    O0   +4  @"N  P J0 3 *4 '0"B "< H  Q )T .@": $( F !) )8
M3P"4 %4 DP!; )$ 8 "0 &< C@!M (T =0"+ 'X B0") (@ E0"& *( A0"Q
M (, Q "! .0 @ #Y '\ _P"  /\ @ #_ (  _P#T @  X D  ,<(  "W!P
MK ,  *8   "@  < FP / )@ %P"5 "$ D@ J (\ ,P"- #P BP!# (D 20"'
M %  A@!5 (0 6P"# &$ @0!H (  < !^ 'D ? "$ 'L D !Y )T > "L '8
MO@!U -T <P#T ', _P!S /\ <P#_ ', _P#I#0  SQ   +D0  "I$   G@X
M )<+  "3!@  D  + (P $0") !H A@ D (, +@"! #8 ?P ^ 'T 1 !\ $L
M>@!1 'D 5P!W %T =@!D '0 ; !S 74 <0&  &\"C0!N IH ; .J &L#NP!I
M!-8 : ;Q &@'_P!G!_\ 9P?_ &<'_P#?%   PQ<  *X7  ">%@  DQ4  (L2
M  "&$   A P" (,&#0"  Q0 ? 4> 'D'* !W"#  =0@X ',)0 !R"48 < I,
M &\*4P!M"UD ; MA &H+:0!I#'( 9PQ^ &8,BP!D#9D 8@VI &$-NP!@#=@
M7@[S %T._P!=#O\ 70[_ %T._P#4'   N1T  *0>  "5'0  B1P  ($:  ![
M%P  >!,  '@0!@!W#0\ <PX8 ' .(@!N#RL ;! S &H0.P!I$$( 9Q%) &81
M3P!D$58 8Q)= &$29@!@$F\ 7A)[ %P3B !;$Y< 61.G %<4N@!6%-4 517S
M %05_P!4%?\ 5!7_ %04_P#*(@  L"(  )TC  "-(P  @2(  'DA  !S'@
M;QL  &X7  !M$PP :A04 &<5'@!E%B< 8Q8O &$7-P!@%SX 7AA% %T82P!<
M&5( 6AE: %D98@!7&FP 5AIW %0:A0!2&Y0 41ND $\;MP!.&]  31SQ $P<
M_P!,'/\ 31S_ $T;_P##)@  JB<  )8G  "'*   >R<  '(F  !L)   :"$
M &8>  !D&P@ 8AL1 %\<&@!='2, 6QXK %H>,P!8'SH 5Q]! %8@2 !4($\
M4R!7 %$A7P!0(6D 3B%T $TA@@!+(I$ 22*B $@BM !'(LT 1B/O $4C_P!%
M(O\ 1B+_ $8A_P"\*@  I"L  )$K  ""+   =BL  &TJ  !F*0  8B8  %\D
M  !=(@0 6R$. %@B%@!6(Q\ 5"0H %,D, !2)3< 4"4^ $\F10!.)DP 3"94
M $LG7 !))V8 2"=Q $8G?P!%*(\ 0RB@ $$HL@! *,L /RCM #\H_P _*/\
M0"?_ $ G_P"W+0  GRX  (PO  !]+P  <2\  &@N  !A+0  72L  %HH  !7
M)P  5"<, %(H$P!0*1P 3BDE $TJ+ !+*C0 2BL[ $DK0@!(+$D 1BQ1 $4L
M6@!$+&0 0BUO $ M?0 _+8T /2V> #PML  Z+<@ .BWK #HM_P Z+?\ .BS_
M #HL_P"R,   FS$  (@R  !Y,@  ;3(  &0R  !=,0  6"\  %4L  !1+
M3RT) $PM$0!*+AD 22\B $<O*@!&,#$ 13 X $,P/P!",4< 03%/ $ Q5P ^
M,6$ /3)M #LR>P Y,HL .#*< #8RKP U,L< -#+I #0R_P U,?\ -3'_ #4P
M_P"M,P  EC0  (0U  !U-0  :34  & U  !9-   5#,  % P  !,,0  23$&
M $<R#P!%,Q8 0S,? $(T)P! -"X /S4V #XU/0 ]-40 /#9, #HV50 Y-E\
M-S9K #8V>  T-XD ,C>: #$WK0 O-\4 +S?H "\V_@ P-?\ ,#7_ # T_P"I
M-@  DC8  ( W  !R.   9C@  %TW  !6-P  4#8  $LT  !'-0  1#8# $$W
M#0 _.!0 /C@< #PY)  [.2P .CDS #DZ.@ X.D( -CI* #4Z4P T.UT ,CMH
M # [=@ O.X< +3N9 "P[K  J.\, *3OF "HZ_0 J.O\ *SG_ "PX_P"D.
MCCD  'PZ  !N.@  8SH  %HZ  !3.@  33H  $8X  !".@  /SL  #P\"P Z
M/!$ .#T9 #<](0 V/BD -#XP #,^-P R/S\ ,3]' # _4  N/UH +4!F "M
M=  I0(0 *$"7 "9 J@ E0,$ )$#E "0__  E/O\ )CW_ "8]_P"?.P  BCP
M '@]  !J/0  7ST  %8]  !//0  23T  $(]   \/@  .3\  #9!"  T00\
M,D(6 #%"'@ O0R4 +D,M "U#-  L1#P *T1$ "I$30 H1%@ )T5C "5%<0 C
M18( (D65 "!%J  ?1;\ 'D3C !]$^P ?0_\ ($+_ "%!_P":/@  A3\  '1
M  !G0   7$   %-   !,0   1D   #Y!   X0P  -$4  #!& P M1PT *T@2
M "I(&@ I2"( *$DI "=),0 E23D )$E! "-*2@ B2E4 ($IA !]*;P =2G\
M&TJ2 !I*I@ 82KT %TK@ !A)^@ 92/\ &D?_ !I'_P"50@  @$(  '!#  !C
M0P  6$,  %!#  !)0P  0D0  #M%   U1P  ,$D  "M+   F30D )$X0 ").
M%@ A3QT ($\E !]/+  >3S4 '4\] !Q01P :4%$ &5!= !=0:P 64'P %%"/
M !-0I  14+H $5#> !%/^  23O\ $TW_ !1-_P"/10  >T8  &M&  !?1P
M54<  $U'  !&1P  /T<  #=*   Q3   *TX  "90   @4P, '%4, !I6$0 9
M5A@ %U8@ !96)P 55C  %%8Y !-70@ 25TT $5=9 !!7:  /5WD #E>,  U7
MH  +5[8 "U;4  M6]  ,5?\ #53_  Y3_P"(20  =DH  &=*  !;2@  44H
M $I*  !#2@  .TP  #-.   L40  )E0  "%6   ;60  %5P' !%>#0 07A,
M$%X:  Y>(@ .7BH #5XS  Q>/0 +7D@ "EY4  A>8@ '7G, !5Z&  ->FP "
M7K$  EW,  )=[@ #7/\ !%O_  5;_P"!3@  <$X  &).  !73@  3DX  $=.
M   ^3P  -E$  "Y4   G5P  (5H  !M=   58   $&,#  QF"P (9Q  !F<5
M  5G'  $9R0  F<M  %G-P  9T(  &=.  !G7   9VT  &>   !FE0  9JP
M &7'  !EZP  9/P  &3_  !C_P!Z4@  :E,  %U2  !44@  2U(  $)3   Y
M50  ,%@  "A;   A7P  &F(  !1E   0:   #&L!  9N"0  ;PX  &\2  !O
M&   <!\  ' G  !Q,   <3L  '%(  !Q5@  <68  '%Y  !QCP  <*<  &_!
M  !OYP  ;OP  &W_  !M_P!S6   95<  %I7  !15@  1E<  #Q:   R70
M*F$  ")D   ::   %&P   YO   *<@  !'8   !X!0  > L  'D.  !Z$P
M>QD  'P@  !]*0  ?3,  'U   !]3@  ?5X  'UR  !]B   ?*$  'RZ  ![
MX@  >OH  'G_  !X_P!M70  8%P  %=<  !+70  0%\  #5C   K9P  (VL
M !IO   3<P  #G<   A[   "?@   ((   "# 0  A 8  (4+  "&#P  B!,
M (D9  "*(0  BRL  (LW  ",1@  BU8  (MI  "+@   BYD  (JS  ")V
MB/<  (C_  "'_P!H8P  7F(  %%B  !$90  .&D  "YN   D<P  &G@  !-]
M   -@0  !H4   ")    C0   )    "2    D@   )0%  "5"@  EPX  )@2
M  ":&   FR$  )PM  "=/   G4P  )Q?  "<=@  FY$  )NK  ":R0  FO
M )G_  "8_P!E:0  5VD  $EL   ]<0  ,'8  "5\   ;@0  $H<   R,   $
MD0   )4   "9    G0   *    "A    H@   *0   "E 0  IP<  *D,  "J
M$0  K1@  *\B  "O,   KT$  *]4  "O:P  KH4  *ZA  "NO@  K>8  *S\
M  "L_P!><0  3W0  $)Y   U?P  *(4  !V,   3D@  #)@   .=    H@
M *8   "J    K@   +    "Q    LP   +0   "V    N    +H$  "\"@
MOA   ,$7  ##)   PS4  ,1)  #$7@  Q7<  ,63  #%KP  Q=$  ,/R  ##
M_P!6?   1X(  #J(   LCP  ()8  !2=   -HP   ZD   "N    L@   +<
M  "[    OP   ,(   #"    Q0   ,8   #(    R@   ,T   #/    T@@
M -4.  #;&   W2<  -XZ  #?4   X&@  ."$  #AH0  X;T  .'B  #@] !.
MBP  0)(  #*9   EH0  &*@   ZO   %M0   +H   "_    Q    ,@   #.
M    T0   -0   #5    V    -H   #=    WP   .(   #D    YP   .L%
M  #O#@  ]!D  /4K  #V00  ]U@  /AR  #YD   ^:L  /C$  #XX0#_  L
M_P ( /\ "0#_  P _P 2 /\ &@#_ "8 _P R /\ /@#_ $@ _P!2 /\ 6@#_
M &( _P!I /\ ;P#_ '4 _@![ /P @0#[ (@ ^0"/ /< EP#U *  \P"J /(
MMP#O ,D [0#F .P ^P#K /\ ZP#_ -T _P#. /\ Q@#_ ,( _P#_  0 _P
M /\   #_  4 _P - /\ %0#_ "$ _P L /\ . #_ $, _0!, /D 5 #W %P
M] !C /( :0#P &\ [@!U .P >P#J (( Z ") .< D0#D )H X@"D .  L #=
M ,  V@#< -@ ] #5 /\ TP#_ ,L _P#! /\ NP#_ +< _P#_    _P   /\
M  #_    _P * /T $0#Y !L ]@ G /0 ,@#P #P [ !& .@ 3@#D %8 X0!<
M -X 8P#< &@ V0!N -4 = #2 'L T "" ,T B@#+ ), R "= ,8 J #$ +<
MP0#, ,  ZP"^ /\ O0#_ +T _P"T /\ K@#_ *L _P#_    _P   /\   #Z
M    \@ % .H #@#E !8 X  A -T *P#; #8 TP _ ,X 2 #* $\ QP!6 ,0
M7 #" &$ P !G +X ;0"\ ', N@!Z +@ @@"V (L M "6 +( H0"P *\ K@#!
M *T X "K /< J@#_ *D _P"F /\ H0#_ )\ _P#_    _P   /<   #H
MW    -  "@#* !$ Q0 ; ,( )0"_ "\ O  X +@ 00"U $@ L@!/ +  50"N
M %L K !A *H 9@"H &P IP!S *4 >P"C (0 H0". )\ F@"= *< FP"X )H
MT "9 .\ F #_ )< _P"6 /\ E #_ )( _P#_    ]@   .0   #2    Q0
M +L !0"U  X L  5 *P 'P"J "D J  R *4 .@"B $( H !) )X 3P"< %4
MF@!: )@ 8 "6 &8 E0!L ), = "2 'T D "' (X DP", *$ BP"P (H Q0"(
M .8 AP#[ (8 _P"' /\ AP#_ (8 _P#X    Y0   ,T   "]    LP   *H
M  "C  H GP 1 )L &0"9 ", EP L )4 - "2 #P D !# (X 20", $\ B@!4
M (D 6@"' &  A@!F (0 ;@"# '< @0"! '\ C0!^ )L ? "J 'L O !Z -L
M> #U '@ _P!X /\ > #_ '@ _P#M    T0(  +L"  "L 0  H@   )L   "6
M  4 D0 - (T % "+ !T B  F (8 +@"$ #8 @@ ] (  0P!^ $D ?0!/ 'P
M50!Z %L >0!A '< :0!U '$ = !\ '( B !Q )8 ;P"E &X M@!M ,X ; #N
M &L _P!K /\ :P#_ &L _P#?"P  P@P  *X,  ">#   DPL  (P'  "( @
MA0 ) ($ $ !_ !< ?  @ 'H * !X #  =@ X '0 /@!S $0 <0!* '  4 !N
M %8 ;0!= &P 9 !J &T : !W &< A !E )( 9 "A &, L@!A ,D 8 #I &
M_ !@ /\ 8 #_ &  _P#0$   MA$  *(2  "3$@  B!$  ( /  !\#0  >0D!
M '@#"P!U !$ <P : '  (P!N 2L ; $S &H".0!I T  9P-& &8$3 !E!%(
M8P59 &(%80!@!6H 7P9T %T&@0!<!X\ 6@>? %D'L !7!\8 5@GG %8*^P!5
M"O\ 50K_ %8*_P#&%0  K1<  )D8  "*&   ?Q<  '86  !Q$P  ;A   &T-
M!0!M"0T :@D4 &<*'0!E"B8 8PLN &(,-0!@##P 7PQ" %X-2 !<#4\ 6PU6
M %D-7@!8#F@ 5@YS %4.@ !3#H\ 40Z? % .L0!.#L@ 31#J $T0_0!-$/\
M31#_ $T0_P"\&P  I1P  )(=  "#'@  =QT  &\<  !I&@  9A<  &04  !D
M$ @ 8@\0 %\0& !=$"$ 6Q$I %H1,0!8$C@ 5Q(^ %8210!4$DP 4Q-3 %$3
M6P!0$V4 3A1P $P4?0!+%(P 212< $<5K@!&%<4 117H $46_@!%%O\ 117_
M $45_P"U'P  GB$  (LB  !\(@  <2(  &@A  !B'P  7QT  %P:  !;%P(
M6A4- %<6% !5%AT 5!<E %(8+0!1&#0 3Q@[ $X90@!-&4@ 2QI0 $H:6 !(
M&F( 1QIM $4;>@!#&XD 0AN: $ ;K  _&\( /ASE #T<_  ^'/\ /AO_ #X;
M_P"O(P  F"0  (8E  !W)@  ;"8  &,E  !=)   62(  %8?  !4'0  4QP+
M %$<$@!.'1H 31TB $L>*0!*'C$ 21\W $<?/@!&($4 12!- $,@50!"(%\
M0"%J #\A=P ](8< .R&8 #DAJ@ X(L  -R+C #<B^P W(O\ ."'_ #@A_P"J
M)@  E"<  ($I  !S*0  9RD  %\I  !8*   5"8  %$C  !/(@  3"(' $HB
M$ !((A< 1R,? $4D)@!$)"X 0B0T $$E.P! )4, /R5* #TF4P \)EP .B9G
M #DF=0 W)X0 -2>6 #0GJ  R)[X ,2?A #$G^0 R)O\ ,B;_ #,E_P"E*0
MCRH  'TL  !O+   9"T  %LL  !5*P  4"H  $PH  !*)@  1R<$ $0G#0!"
M*!0 02@< #\I(P ^*2L /2DR #PJ.0 [*D  .2I( #@K4  V*UH -2ME #,K
M<@ Q*X( ,"R4 "XLIP L++P *RS> "PL^  L*_\ +2K_ "TJ_P"A+   BRT
M 'DN  !K+P  8"\  %@O  !1+@  3"X  $@L  !%*P  02L  #\L"P ]+!$
M.RT9 #HN(0 Y+B@ -RXO #8O-@ U+SX -"]% #,O3@ Q,%@ ,#!C "XP<  L
M,(  *C"2 "DPI0 G,+H )C#< "8P]P G+_\ *"__ "@N_P"<+@  AS   '8Q
M  !H,@  73(  %4R  !.,0  2#$  $0P  ! +P  /#   #HQ"0 W,1  -C(6
M #4R'@ S,R4 ,C,L #$S,P P-#L +S1# "TT3  L-%8 *C5A "DU;@ G-7X
M)360 ",UHP B-;D (379 "$T]@ B-/\ (S/_ ",R_P"8,0  @S,  '(T  !E
M-   6C4  %$U  !+-   130  $ T   Z,P  -S0  #0U!@ R-@X ,#<3 "\W
M&P N-R( +3@I "LX,0 J.#@ *3E  "@Y20 F.5, )3E? ",Y;  A.GP (#J.
M !XZH@ <.K< &SG5 !PY]0 =./\ '3C_ !XW_P"3-   ?S8  &XW  !A-P
M5S<  $XW  !(-P  0C<  #PW   U.   ,CD  "\Z @ L.PL *CP1 "D\&  H
M/1\ )CTF "4]+@ D/34 (SX] "(^1@ @/E  'SY< !T_:0 ;/WD &C^, !@_
MH  6/[4 %3[2 !8^\P 7/?\ &#S_ !@\_P".-P  >C@  &HY  !>.@  4SH
M $LZ  !%.@  /SH  #DZ   R/   +CX  "E    F00@ )$(. ")"%  A0AL
M($,C !]#*@ >0S( '$,Z !M$0P :1$T &$19 !=$9P 51'< $T2* !)$G@ 1
M1+, $$30 !!#\@ 10O\ $D+_ !-!_P").P  =CP  &8]  !:/0  4#T  $@]
M  !"/0  /#T  #8^   O0   *D(  "5$   A1@, '4@, !M)$0 921< &$D>
M !=))@ 622X %4HV !1*0  32DH $4I6 !!*9  /2G0 #DJ'  U*FP ,2K
M"DK*  M)[  ,2/\ #4?_  U'_P"#/@  <3\  &)   !60   34   $5    _
M0   .4$  #)"   K10  )D<  "%)   <2P  %DX' !-0#@ 24!, $5 9 !!0
M(0 /4"D #E Q  U0.P -448 "U%1  I17P )46\ !U"!  50E@ #4*L  E#%
M  -/Z  #3_L !4[_  9-_P!]0@  :T,  %U$  !21   2D0  $-#   \1
M-44  "Y'   G2@  (4P  !Q/   740  $E0#  Y7"@ +6!  "E@5  A8'  '
M6"0 !E@L  58-@ #6$   5A,  !86@  6&D  %A\  !8D0  5Z<  %?   !6
MY0  5OD  %7_  !5_P!V1P  9D<  %E(  !/1P  1T<  $!'   X2   ,$H
M "E-   B4   '%,  !95   16   #5L"  E>"0 $7PX  %\2  !?&   8!\
M & G  !@,   8#L  &!'  !@5   8&,  &!V  !@BP  7Z(  %^[  !?X@
M7OD  %W_  !=_P!O2P  84P  %5,  !,2P  1$L  #M,   R3@  *U$  "-4
M   <5P  %EL  !%>   -8   "&,   )F!P  9PP  &</  !H$P  :1D  &HA
M  !J*0  :C0  &I   !J30  :ET  &IO  !JA0  :IT  &FV  !HW0  :/<
M &?_  !F_P!I40  7%   %)0  !*3P  /U   #53   M5@  )%D  !U=   6
M8   $&0   QG   &:@   &X   !O P  < @  '$-  !R$   =!0  '4;  !V
M(P  =RP  '<X  !V1@  =E8  '9H  !V?@  =I<  '6Q  !TTP  <_4  '/_
M  !R_P!C5@  6%4  %!4  !$50  .5@  "];   F7P  '6,  !5G   0;
M"G    1S    =@   'H   !\    ? ,  'X(  !_#   @1   ((4  "$&P
MA20  (8O  "&/0  ADT  (5?  "%=0  A8\  (2I  "#R0  @O$  ('_  "
M_P!?6P  5EH  $E;   ]7@  ,F$  "=F   >:P  %7    YU   )>0   7X
M  "!    A0   (@   "*    BP   (T!  ".!@  D L  )$/  "3%   E1L
M )<F  "7-   ET0  )=6  "6;   E88  )6B  "4P0  D^H  )+_  "2_P!=
M80  3V$  $)D   V:0  *FX  !]T   5>0  #G\   >$    B0   (X   "2
M    E@   )@   ":    FP   )T   "?    H0,  *,(  "E#0  IQ,  *D<
M  "J*   JCD  *I+  "J80  J7H  *B9  "HM0  I]T  *?X  "F_P!6:
M2&P  #IP   N=@  (GT  !>$   .B@  !Y    "6    F@   )\   "C
MIP   *H   "K    K0   *\   "Q    LP   +4   "X!0  N@P  +T2  #
M'   P"T  ,!   "_50  OVX  +Z+  "^J   OLD  +WO  "\_@!.=   0'D
M #)_   EAP  &8X  !"5   'G    *(   "G    K    +    "U    N0
M +P   "]    OP   ,$   ##    Q@   ,@   #*    S0(  - +  #5$@
MUB$  -<T  #820  V6   -I\  #:F@  V[4  -O9  #;\@!&@@  .(D  "N0
M   =F   $J    JG    K@   +0   "Y    O@   ,(   #(    RP   ,X
M  #/    T@   -0   #6    V@   -T   #?    X@   .8   #J"@  [Q,
M / E  #R.@  \U$  /1K  #TB0  ]:4  /6_  #UW0#_  8 _P # /\ !0#_
M  L _P 0 /\ %P#_ "( _P M /\ .0#_ $0 _P!- /\ 50#_ %T _P!D /\
M:@#_ '  _0!V /L ? #Y (, ]P"* /4 D@#S )L \ "F .X LP#K ,0 Z0#D
M .< ^0#F /\ Y0#_ -, _P#' /\ OP#_ +L _P#_    _P   /\   #_  (
M_P + /\ $@#_ !T _P H /\ ,P#_ #X _ !' /@ 3P#T %< \0!= .X 8P#L
M &D Z@!O .@ =0#F 'P Y "# .( BP#? )4 W "? -D JP#5 +L T@#4 ,\
M\@#- /\ S #_ ,4 _P"Z /\ M #_ +  _P#_    _P   /\   #_    _P &
M /D #P#U !< \P B /$ +0#M #< YP!  .( 20#? %  VP!7 -< 70#4 &,
MT0!H ,\ ;@#, '4 R@!\ ,@ A #% (T P@"8 ,  I "] +( NP#& +D Z "X
M /T MP#_ +8 _P"M /\ IP#_ *, _P#_    _P   /\   #U    ZP ! .0
M# #> !, V0 < -, )@#1 #  S  Z ,@ 0@#$ $H P !0 +T 5@"[ %P N0!A
M +< 9P"U &T LP!T +$ ? "O (4 K0"0 *H G "H *H I@"[ *4 V@"C /4
MHP#_ *( _P"> /\ F@#_ )< _P#_    _@   .\   #?    T    ,< !P#!
M  \ O  7 +D ( "W "H M0 S +  .P"M $, JP!) *@ 3P"F %4 I !: *,
M8 "A &8 GP!M )T = "< 'T F@"( )@ E "6 *( E "R )( R0"1 .L D0#_
M )  _P"0 /\ C #_ (H _P#\    [    -D   #'    N@   +$  @"K  P
MIP 2 *0 &P"A "0 H  L )X -0"; #P F !# )8 20"4 $\ D@!4 )  6@"/
M %\ C0!F (L ;0") '8 B "  (8 C "$ )H @@"J ($ O@"  .  @ #Y '\
M_P!_ /\ ?P#_ 'X _P#Q    V    ,(   "S    J    *    "9  < E0 .
M )( %0"0 !X C@ F (T +@"* #8 AP ] (4 0P"$ $D @@!. ($ 5 !_ %D
M?@!@ 'P 9P!Z &\ >0!Z '< A@!U )0 = "C '( M0!R ,\ <0#Q '  _P!P
M /\ < #_ '$ _P#A    Q    +    "B    EP   )$   "+  ( A@ + (,
M$0"! !@ ?P A 'T *0!\ #  >0 W '@ /0!V $, = !) ', 3@!R %0 < !:
M &\ 8@!M &H :P!T &H @ !H (X 9P"= &4 KP!E ,8 9 #H &0 _0!C /\
M8P#_ &0 _P#/!0  M@<  *,(  "4"   B0<  ((#  !^    >P & '< #@!U
M !, <@ ; '$ (P!O "L ;0 R &P . !J #X :0!$ &< 20!F $\ 90!6 &,
M70!B &4 8 !O %\ >P!= (D 7 "9 %L J@!9 +\ 60#A %@ ^ !8 /\ 6 #_
M %D _P#"#   J@T  )<.  ")#@  ?0X  '8-  !Q"@  ;P8  &T "@!K !
M:0 6 &< '@!E "8 8P M &$ ,P!@ #D 7P _ %T 10!< $L 6P!2 %H 60!8
M &( 5P!L %4 > !3 (8 4@"6 %$ IP!0 +L 3P'; $X"] !. _\ 3@3_ $X#
M_P"X$   H1(  (X3  !_$P  =!,  &P2  !G$   90X  &,+ P!C!@P 8001
M %X#&0!<!"$ 6P4H %D&+P!8!C4 5@<[ %4'0@!4!T@ 4PA/ %$(5@!0"5\
M3@EI $T)=@!+"H0 20J4 $@*I@!'"KH 1@K8 $4+\P!%#/\ 10S_ $4,_P"P
M%   F18  (<8  !X&0  ;1@  &47  !?%@  7!,  %H1  !:#@8 6@P- %<,
M% !5#!P 4PTD %(-*P!0#3$ 3PXX $X./@!-#D4 2PY- $H.50!(#UX 1P]H
M $4/=0!#$(0 01"5 $ 0I@ ^$+L /1#< #T1]@ ]$?\ /1#_ #X0_P"I&0
MDAL  ($<  !R'0  9QT  %\<  !9&P  51D  %,6  !2$P  4A$* % 0$ !.
M$1@ 3!$@ $H2)P!)$BX 2!,T $<3.P!%$T( 1!-) $,44@!!%%L /Q1E #X5
M<@ \%8$ .A62 #@5I  W%;D -178 #46]0 V%O\ -A;_ #<5_P"C'   C1X
M 'L@  !M(0  8B$  %HA  !4'P  4!X  $T;  !,&0  2Q8& $D6#@!'%Q4
M11<< $08) !"&"H 01@Q $ 9.  _&3\ /1E& #P:3P Z&E@ .1IC #<;;P U
M&WX ,QN0 #(;H@ P&[< +QO3 "\<\P O&_\ ,!O_ # ;_P"='P  B"(  '<C
M  !I)   7B0  %8D  !0(P  2R(  $@@  !&'0  11P" $,<# !!'!( /QT9
M #X=(0 \'B< .QXN #H?-0 Y'SP -Q]$ #8?3  T(%8 ,R!@ #$@;0 O('P
M+2&. "PAH  J(;4 *2'0 "DA\@ I(?\ *B#_ "L@_P"9(@  A"4  ',F  !E
M)P  6R<  %,G  !,)@  1R4  $0D  !"(0  /R$  #TA"0 [(1  .2(6 #@B
M'@ V(R4 -2,K #0D,@ S)#D ,B1! # D2@ O)5, +25> "LE:P J)7H *"6,
M "8EGP D);, (R7. ",E\  D)?\ )23_ "4D_P"4)0  @"<  &\I  !B*@
M5RH  $\J  !)*0  1"@  $ G   ])@  .B4  #<F!@ U)@X -"<4 #(G&P Q
M*"( ,"@I "\H,  M*3< +"D_ "LI1P I*5$ *"I< "8J:0 D*G@ (RJ* "$J
MG0 ?*K( 'BK, !XJ[P ?*?\ ("G_ "$H_P"0*   ?"H  &PK  !?+   5"P
M $PL  !&+   02L  #PK   X*@  -2H  #(K P P*PP +BP1 "TL&  L+!\
M*BTF "DM+0 H+30 )RX\ "8N10 D+D\ (RY: "$O9P ?+W8 '2^( !POFP :
M+[  &"_* !@N[0 9+O\ &RW_ !LM_P",*P  >"T  &@N  !;+P  42\  $DO
M  !#+P  /BX  #DN   T+@  ,"X  "TO   K, H *3$0 "<Q%0 F,1P )3(C
M "0R*@ C,C$ (3,Y " S0@ ?,TP '3-7 !LS9  :-'0 &#2& !8TF@ 4,ZX
M$S/( !,S[  4,_\ %3+_ !8Q_P"'+@  ="\  &4Q  !8,0  3C(  $8R  !
M,0  .S$  #8Q   Q,0  *S,  "@T   E-08 (S8- "$V$@ @-QD 'S<@ !XW
M)P =."X &S@V !HX/P 9.$D %SE5 !4Y8@ 4.7$ $CF$ !$YF  0.:T #CC'
M  XXZP 0./\ $#?_ !$V_P"#,0  <#(  &$T  !5-   2S0  $0T   ]-
M.#0  #,T   M-0  *#<  "0Y   @.@( '3L+ !L\$  9/14 &#T< !<](P 6
M/2L %3XS !0^/  2/D8 $3Y2 ! ^7P //F\ #CZ!  P^E0 +/JD "C[!  H]
MY  +/?L ##S_  T[_P!]-   :S8  %TW  !1-P  2#<  $$W   [-P  -3<
M # W   J.0  )3L  " ]   </P  %T$& !1##0 20Q( $4,8 !%#'P 01"<
M#T0O  Y$.0 -1$, #$1.  M$6P )1&H !T1\  9$D  $0Z4  D.]  -#X  #
M0_8 !$+_  9!_P!X.   9SD  %DZ  !..@  13H  #XZ   X.@  ,SH  "T[
M   G/0  (4   !Q"   71   $T8#  ])"@ -2@\ #$H4  M*&P )2B, "$HK
M  =*-  %2CX !$I)  )*5@  2F4  $IW  !*BP  2J$  $FY  !)W0  2?4
M $C_  !(_P!R/   8CT  %4^  !*/@  0CT  #P]   V/0  +SX  "E    C
M0@  '44  !='   32@  #TP"  M/"0 '4 T  U$1  !1%P  41X  %$F  !1
M+P  43D  %%$  !240  4F   %%R  !1AP  49T  %&U  !0V   4/4  $__
M  !/_P!L0   74$  %%!  !'00  0$   #E    R00  *D,  "1&   >2
M%TL  !).   .40  "U,!  96!P  5PP  %@0  !8$P  61D  %HA  !:*0
M6C,  %H_  !:3   6EH  %IL  !:@0  69D  %FQ  !8T0  6/0  %?_  !7
M_P!E10  6$4  $U%  !%1   /D0  #5%   M1P  )4H  !Y-   84   $E,
M  Y6   *60  !%P   !>!   7PD  & -  !A$   8A4  &,;  !D(P  9"T
M &0X  !D10  9%0  &1F  !D>P  8Y,  &.M  !BS   8?(  &'_  !@_P!?
M2@  4TH  $I)  !#2   .4D  "],   G3P  'U(  !A5   260  #5T   A@
M   "8P   &8   !H 0  :04  &H*  !K#0  ;1$  &X6  !P'0  <28  '$Q
M  !P/@  <$X  '!?  !P<P  ;XT  &^G  !NQ@  ;>\  &S_  !L_P!:3P
M4$X  $A-   ]3@  ,U$  "E4   @6   &%P  !%@   ,9   !F@   !K
M;P   '(   !T    =0   '<$  !X"0  >@T  'P0  !]%@  ?QX  ( H  "
M-0  @$4  ']6  !_:P  ?X0  'Z@  !]O@  ?.D  'O_  !Z_P!65   3E,
M $)4   W5@  +%H  ")?   88P  $6@   MM   #<@   '8   !Z    ?0
M (    "#    A    (8   "' @  B0<  (L,  "-$   D!8  )(?  "2+
MDCL  ))-  "18@  D7H  (^7  "/M   CN$  (S[  ",_P!560  2%H  #M=
M   O80  )&8  !EL   1<@  "G<   )]    @@   (8   "+    C@   )$
M  "3    E0   )<   "9    FP   )T$  "?"@  H@\  *06  "F(0  IC$
M *9#  "E5P  I'   *..  "CJP  H=   *#U  "?_P!.80  0&0  #-I   G
M;@  &W4  !%\   +@P   (D   ".    DP   )@   "=    H0   *0   "E
M    IP   *D   "K    K0   +    "R    M0@  +@.  "\%@  O"4  +PW
M  "[3   NF0  +F!  "WH@  M\   +?J  "W_ !&:P  .7   "MW   ??P
M$X8   N.   !E0   )L   "A    I@   *L   "P    LP   +<   "W
MN@   +P   "_    P0   ,0   #'    R@   ,T%  #1#@  U!D  -0K  #4
M0   TU@  --T  #3D@  TK   -+3  #2\@ ^>0  ,8   ".(   7D0  #9D
M  .@    IP   *X   "S    N    +T   #"    Q@   ,H   #*    S0
M ,\   #2    U0   -D   #=    WP   .,   #G!0  ZP\  .P?  #M,P
M[DL  .]D  #O@@  \)\  /&Y  #QV #_    _P   /\ ! #_  D _P . /\
M%0#_ !X _P I /\ - #_ #\ _P!( /\ 4 #_ %@ _P!> /\ 90#] &L ^P!Q
M /D =P#X 'X ]@"% /, C0#Q )< [@"B .L KP#H ,  Y@#@ ., ^ #B /\
MVP#_ ,L _P#! /\ N0#_ +0 _P#_    _P   /\   #_    _P ) /\ $ #_
M !D _P C /\ +@#] #D ^0!" /4 2@#R %( [@!8 .L 7@#I &0 Y@!J .0
M< #B '8 WP!] -T A@#9 (\ U0": -$ IP#. +8 RP#. ,D \ #' /\ Q0#_
M +L _P"T /\ K0#_ *D _P#_    _P   /\   #_    ^P " /8 #0#Q !,
M[0 > .P * #I #( XP [ -T 1 #8 $L TP!1 -  6 #- %T RP!C ,D : #&
M &\ Q !V ,( ?@"_ (< O "2 +H GP"W *T M0#! +( Y "Q /T KP#_ *P
M_P"E /\ H #_ )P _P#_    _P   /L   #N    Y    -P " #3 !  SP 8
M ,L (@#) "L Q@ T ,$ /0"] $0 N@!+ +< 40"U %8 L@!< +  80"N &<
MK !N *H =@"H '\ I@"* *, E@"A *4 GP"V )T T0"< /, FP#_ )P _P"6
M /\ DP#_ )  _P#_    ]@   .<   #3    Q@   +T  P"X  T LP 3 +$
M' "O "4 K@ N *D -@"F #T HP!$ *$ 2@"? $\ G0!5 )L 6@": &  F !F
M )8 ;@"4 '< D@"! )  C@". )P C "M (H PP") .@ B #_ (D _P"' /\
MA0#_ (( _P#S    XP   ,P   "\    L    *<   "A  @ G@ / )L %@"9
M !\ F  G )8 +P"3 #< D0 ] (X 0P", $D BP!. (D 5 "' %D A0!@ (0
M9P"" &\ @ !Z 'X A@!\ )0 >@"D 'D N !X -@ =P#W '@ _P!X /\ =P#_
M '4 _P#F    RP   +<   "H    G@   )8   "/  0 BP , (@ $@"' !D
MA0 A (0 *0"" #  ?P W 'T /0!\ $, >@!( 'D 30!W %, =@!9 '0 80!R
M &D <0!S &\ ?P!M (T ; "= &H KP!I ,@ : #M &D _P!I /\ :0#_ &D
M_P#2    N    *4   "7    C0   (8   "!    ?  ( 'D #@!W !0 =@ <
M '0 (P!S "L <0 Q &\ -P!N #T ; !# &L 2 !J $X : !4 &< 6P!E &,
M8P!M &( > !@ (< 7P"6 %T J != +X 7 #D %P ^P!< /\ 7 #_ %P _P#"
M    J@$  )@#  ")!   ?P(  '@   !T    <  $ &T # !K !$ :0 7 &@
M'@!F "4 90 L &, ,@!B #@ 8  ] %\ 0P!> $D 7 !/ %L 5@!: %X 6 !H
M %< <P!5 ($ 5 "1 %( HP!1 +< 40#6 %$ ]0!1 /\ 40#_ %( _P"V!P
MGPD  (T+  !^#   <PL  &P*  !H!P  90,  &, !P!A  T 7P 3 %T &@!<
M "$ 6P G %D +0!8 #, 5@ Y %4 /P!4 $4 4P!+ %$ 4@!0 %H 3P!D $T
M;P!, 'T 2@"- $D GP!( +( 1P#, $< [P!& /\ 1P#_ $< _P"L#   E0X
M (,0  !U$   :Q   &,/  !>#@  6PP  %H) @!9! H 5P / %4 %0!3 !P
M4@ C %$ *0!/ "\ 3@ U $T!.P!, 4$ 2@)( $D"3P!( E< 1@-A $4#;0!#
M WH 0@.+ $ #G  _ Z\ /@/( #T$Z@ ]!?P /0;_ #X&_P"D$   CA(  'P3
M  !N%   9!0  %P3  !6$@  4Q$  %$.  !0# 4 4 D, $\'$0!-!Q< 2P@?
M $D()0!("2L 1PDQ $8). !$"CX 0PI% $(*30! "U4 /PM? #T+:P \"WD
M.@R* #@,G  W#*\ -0S' #4,Z0 U#?T -0W_ #8,_P"=$P  AQ4  '87  !I
M&   7A@  %88  !0%P  314  $H3  !)$0  20X' $@-#@!&#1, 1 T: $,.
M(0!"#B@ 0 XN #\.-0 ^#SP /0]# #L02P Z$%0 .!!> #80:P T$'D ,A"*
M #$0G  O$+  +1#) "T1[  M$?\ +A'_ "\0_P"7%@  @AD  '$;  !D'
M61P  %$<  !,&P  1QH  $08  !#%0  0A," $$2"P! $1  /A(7 #P2'@ [
M$R4 .A,K #@3,@ W$SD -A1  #042  S%%$ ,11< # 5:  N%7< +!6( "H5
MF@ H%:X )Q7' "85Z@ G%?\ *!7_ "D5_P"1&@  ?1P  &T>  !@'P  5A\
M $X?  !('@  0QT  $ <   ^&@  /1@  #L7!P Y%@X .!<4 #87&P U&"(
M,Q@H #(8+P Q&38 ,!D] "X91@ M&D\ *QI9 "H:9@ H&G0 )AJ& "0:F0 B
M&JT (1K% " :Z  A&OX (AK_ ",:_P"-'0  >1\  &DA  !<(@  4B(  $HB
M  !$(0  /R$  #P@   Y'@  .!L  #4<!  T' T ,AP2 # =&  O'1\ +ATE
M "T>+  K'C, *AX[ "D?0P G'TT )A]7 "0?9  B'W( (!^$ !\?EP ='ZL
M&Q_# !L?YP ;'_T '1__ !X>_P")(   =2(  &4C  !9)   3R4  $<E  !!
M)   /",  #@C   U(@  ,R   # @ 0 N(0H +"$0 "LA%0 J(AP *"(C "<B
M*0 F(S  )2,X ",C00 B)$H (215 !\D80 =)'  &R2" !DDE0 7)*H %B3!
M !4DY0 6)/P %R/_ !DC_P"%(@  <20  &(F  !6)P  3"<  $0G   ^)P
M.28  #4F   Q)0  +B0  "LE   I)0< )R8. "4F$P D)QD (R<@ "(G)P A
M*"X ("@V !XH/@ =*$@ &RE3 !DI7P 8*6X %BF  !0IE  2*:@ $2G  !$H
MY  1*/L $RC_ !0G_P" )0  ;B<  %\H  !3*0  22H  $(I   [*0  -BD
M #(H   N*   *B@  "8I   D*@0 (BL, " K$0 ?+!8 '2P= !PL)  ;+2L
M&BTS !@M/  7+44 %BY0 !0N70 2+FP $2Y^ ! ND@ .+J< #2V]  TMWP -
M+?D #BS_ ! L_P!\*   :BH  %LK  !0+   1BP  #\L   Y+   -"L  "\K
M   K*P  )BP  "(N   ?+P  '# ) !HQ#@ 9,1, %S$: !8R(0 5,B@ %#(P
M !,R.0 2,T, $3-. ! S6P .,VD #3-Z  PSC@ *,Z( "#*Y  @RV0 (,O0
M"C'_  LQ_P!W*P  9BT  %@N  !-+P  0R\  #PN   V+@  ,2X  "TN   I
M+@  (S   !\R   ;,P  %S4% !0V#  2-Q$ $3<6 !$W'0 0."0 #S@L  XX
M-0 -.#\ ##A*  LX5P ).&4 !SAV  4XB@ #.)\  3>U  $WTP "-_$  S;_
M  4V_P!S+@  8C   %0Q  !),0  03$  #DQ   T,0  +S   "LP   E,@
M(#,  !LV   7.   $SH" ! \"0 -/0X ##T3  L]&0 */2$ "3TI  @],0 &
M/CL !3Y&  ,^4@ !/F$  #YR   ^A@  /9P  #VR   ]T   //   #S_   \
M_P!M,@  73,  % T  !&-   /C0  #<T   R,P  +3,  "<T   B-@  '3@
M !@Z   4/0  $#\"  U!"  )0PT !D01  -$%@ "1!T  $0D  !$+0  1#8
M $1!  !$3@  1%P  $1M  !$@0  1)@  $.O  !#S0  0O   $+_  !"_P!H
M-@  6#<  $PX  !#.   .S<  #4V   P-@  *3<  ",Y   >.P  &#T  !-
M   00@  #44!  A'!P #20P  $D/  !*$P  2QD  $L@  !+*   2S(  $L]
M  !,20  3%<  $MH  !+?0  2Y0  $JL  !*R@  2>\  $G_  !)_P!B.@
M5#L  $D[  ! .P  .3H  #,Y   L.@  )3P  !\_   900  $T0  !!'   ,
M20  "$P   )/!0  4 H  % -  !1$   4A4  %0;  !4(P  5"P  %0W  !4
M1   5%(  %1C  !4=P  5(\  %.H  !2Q@  4NT  %'_  !1_P!</P  3S\
M $4_   ^/@  -ST  "\^   G0   ($,  !E&   320  #TP   M/   &4@
M %0   !7 @  6 <  %D+  !:#@  6Q$  %T6  !>'0  7R8  %\Q  !>/0
M7DP  %Y=  !><0  78D  %VC  !<P0  6^L  %K_  !:_P!61   2T,  $-"
M   \00  ,D(  "E%   A2   &DL  !-.   .4@  "E4   -9    6P   %X
M  !@    8@(  &,&  !E"@  9@X  &@1  !J%P  :Q\  &LI  !K-@  :T4
M &M6  !J:@  :H(  &F=  !HNP  9^<  &;_  !E_P!12   2$@  $%&   W
M1P  +$H  "--   ;40  $U4   Y9   (70   6$   !D    9P   &H   !L
M    ;@   '    !R!0  <PD  '4-  !W$0  >A@  'LA  ![+@  >CT  'I.
M  !Y8@  >7D  'B6  !WLP  =>   '3\  !S_P!.30  1TP  #M-   P3P
M)E,  !Q8   37   #6$   9F    :@   &\   !R    =@   'D   !\
M?0   '\   "!    @P(  (8'  "(#   BQ$  (X8  ".)   CC,  (U$  ",
M6   BV\  (J,  ")J@  B,\  (;W  "%_P!-40  05,  #15   I6@  'E\
M !1E   -:@  !7    !V    >P   '\   "#    AP   (H   "-    C@
M )$   "3    E0   )@   ":!0  G0P  * 1  "C&@  HR@  *(Z  "A3@
MH&4  *"!  ">H   G<$  )ON  ":_P!&60  .5P  "UA   A9P  %FX   YU
M   %>P   ($   "'    C0   )(   "6    F@   )T   "?    H0   *0
M  "F    J    *L   "N    L0,  +0+  "X$0  N1X  +DO  "X0P  MUH
M +5V  "TEP  M+4  +'B  "P_  _9   ,6D  "5O   8=P  #W\   :'
MC@   )0   ":    H    *4   "J    K@   +$   "R    M0   +<   "Z
M    O    +\   ##    Q@   ,D   #."@  TA,  -(C  #1-P  T$\  ,YJ
M  #-B@  RJL  ,O+  #+[P W<0  *7@  !V    1B0  ")$   ":    H0
M *<   "M    LP   +D   "^    P@   ,4   #&    R0   ,P   #.
MT@   -4   #:    W@   .$   #E    Z@L  .L7  #J*P  ZD,  .I>  #J
M>@  ZYD  .NU  #KU0#_    _P   /\  0#_  < _P - /\ $@#_ !L _P E
M /\ +P#_ #H _P!# /\ 2P#_ %, _P!: /T 8 #[ &8 ^@!K /@ <@#V '@
M] "  /$ B0#O )( [ "= .D J@#F +P XP#< -\ ]P#= /\ S #_ +X _P"U
M /\ L #_ *T _P#_    _P   /\   #_    _P & /\ #0#_ !0 _P ? /\
M*0#[ #, ]P ] /, 10#O $T [ !3 .@ 60#E %\ XP!E .  :@#= '$ V@!X
M -8 @ #2 (H SP"5 ,P H@#( +( Q0#) ,( [0#  /\ NP#_ +  _P"H /\
MI #_ *$ _P#_    _P   /T   #Z    ^    /  "0#L !$ Z  9 .< (P#E
M "T W@ V -8 /@#1 $8 S0!, ,H 4@#( %@ Q0!= ,, 8P#  &D O@!P +P
M> "Y ($ MP"- +0 F@"Q *D K@"\ *P X0"J /P J #_ *  _P"9 /\ E@#_
M )0 _P#_    ^0   /(   #G    VP   -$ ! #*  T QP 4 ,0 '0#" "8
MOP O +L -P"W #\ M !% +$ 2P"N %$ K !6 *H 7 "H &$ I@!H *, < "A
M 'D GP"$ )T D0": *  F "Q )8 S "5 /$ E #_ )$ _P"+ /\ B #_ (8
M_P#W    [    -X   #)    O    +0   "O  H JP 0 *D %P"H "  IP H
M *( , "? #@ G  ^ )H 1 "8 $H E@!/ )0 50"3 %H D0!A (\ : "- '$
MBP![ (D B "' )< A0"H (, O@"! .0 @ #_ (  _P!\ /\ >P#_ 'D _P#I
M    UP   ,$   "Q    I@   )T   "7  4 E  - )( $@"0 !H CP B (X
M*@"+ #$ B0 X (< /@"% $, @P!( ($ 3@!_ %0 ?@!: 'P 80!Z &D > !S
M '8 ?P!U (X <P"? '$ LP!P -  ;P#V &\ _P!O /\ ;0#_ &P _P#:
MOP   *P   ">    DP   (P   "%    @@ ) '\ #P!^ !4 ?0 < 'P ) !Z
M "L =P Q '4 -P!T #T <@!" '$ 2 !O $T ;@!3 &P 6@!K &( :0!L &<
M> !F (8 9 "7 &( J@!A ,( 8 #K &$ _P!A /\ 80#_ &  _P#%    K0
M )L   "-    @P   'P   !W    <@ % '  # !N !$ ;  7 &P '@!K "4
M:0 L &< ,0!F #< 9  ] &, 0@!B $@ 8 !. %\ 50!= %T 7 !F %H <@!9
M (  5P"0 %8 HP!5 +D 5 #> %0 ^P!4 /\ 50#_ %4 _P"V    GP   (T
M  !_    =0   &X   !I    9@ ! &, "0!A  X 8  3 %\ &0!> "  70 F
M %L + !: #( 6  W %< /0!6 $, 50!) %, 4 !2 %@ 40!A $\ ; !. 'H
M3 "* $L G !* +$ 20#. $D \P!) /\ 20#_ $H _P"J 0  E 4  (('  !T
M"   :@@  &,&  !>!   6P   %D !0!7  P 5@ 0 %0 %0!3 !L 4@ B %$
M* !0 "T 3@ S $T . !, #X 2P!% $H 3 !( %0 1P!= $8 : !$ '4 0P"%
M $$ F !  *L 0 #% #\ Z@ _ /\ 0 #_ $  _P"@"   B@L  'D-  !L#0
M80T  %H-  !5"P  4@D  % &  !/ @@ 3@ - $P $@!+ !< 2@ > $D (P!'
M "D 1@ O $4 - !$ #H 0@!! $$ 2 !  %  /@!: #T 9  \ '( .@"" #D
ME  X *< -P"^ #8 XP V /D -@#_ #< _P"8#0  @PX  '(0  !E$0  6Q$
M %,0  !.$   2@X  $@-  !'"@, 1P<* $4$#@!$ A, 0@(: $$"( !  R4
M/@,K #T$,0 \!#< .P0^ #H%10 Y!4X -P57 #8%8@ T!G  ,@:  #$&D@ P
M!J4 +P6[ "X%W0 N!O4 +0?_ "X'_P"1$   ?1$  &P3  !?%   510  $X4
M  !($P  1!(  $$0  ! #@  0 T& $ *#  ^"1  / D6 #L*'  Y"B( . HH
M #<++@ V"S4 -0L[ #,+0P R#$P , Q6 "\,80 M#&\ *PQ_ "H,D@ H#*4
M)PR[ "4,W0 E#?4 )@W_ "<-_P"+$@  =Q0  &<6  !;%P  41@  $D7  !#
M%P  /Q4  #P4   Z$@  .1$! #D/"  X#@T -PX2 #4.&  T#A\ ,@XE #$/
M+  P#S( +Q Z "T00@ L$$L *A!5 "@080 F$&\ )!"  ",0DP A$*< 'Q"]
M !X0X  >$?< 'Q#_ " 0_P"&%   <Q<  &,9  !7&@  31L  $4:  ! &@
M.QD  #@8   U%@  -!0  #,2!  R$@L ,1(0 "\2%0 M$AP +!,B "L3*0 J
M$S  *!,W "<4/P F%$@ )!13 "(47P @%6T 'Q5^ !T5D0 ;%:4 &16[ !@5
MW@ 8%?@ &13_ !H4_P""%P  ;QH  %\<  !3'0  2AT  $(=   \'0  -QP
M #0;   Q&@  +QD  "X6   L%P@ *Q8. "D7$P H%QD )Q@@ "48)@ D&"T
M(Q@T "(9/0 @&48 'AE1 !T970 ;&FL &1I\ !<:CP 5&J, %!FZ !(9VP 3
M&?8 %!G_ !48_P!]&@  :QT  %P?  !0(   1R   #\@   Y'P  -!\  #$>
M   M'0  *QP  "D;   G&P4 )1L, "0<$0 B'!8 (1P= " =(P ?'2H 'ATR
M !P>.@ ;'D0 &1Y. !<>6P 6'FD %!]Z !(>C0 1'J( $!ZX  X>V  /'O4
M$!W_ !$=_P!Z'0  9Q\  %DA  !-(@  1"(  #PB   V(@  ,B$  "XA   J
M(   )R   "0?   B( ( (" * !XA#P =(10 '"$: !LB(0 9(B< &"(O !<B
M.  5(T$ %"-, !(C6  1(V< $"-X  XCBP -(Y\ #".T  LCT  +(O  #"+_
M  TA_P!V'P  9"(  %8C  !+)   020  #HD   T)   +R,  "LC   H(P
M)",  " C   =)   &R4' !DF#0 7)A$ %B87 !4G'@ 4)R4 $R<L !(G-0 1
M*#\ $"A*  XH5@ -*&0 #"AT  HHAP )*)L !R>Q  4GS  &)^P !R;^  @F
M_P!Q(@  8"0  %,F  !()P  /R<  #<F   Q)@  +28  "DE   E)0  (B4
M !TG   9*   %BH$ !0K"P 2+!  $2P4 ! L&P 0+"( #BPI  XM,@ -+3L
M"RU&  HM4@ (+6  !BUP  0M@P "+9@  "RN   LR0  +.L  2O\  (K_P!M
M)0  72<  $\H  !%*0  /"D  #4I   O*   *R@  "<G   C)P  'R@  !LJ
M   7+   $RX" ! P"  .,0T #3$2  PQ%P +,1X "C$F  @R+@ ',C< !3)"
M  ,R3@ !,EP  #)L   R?P  ,I4  #&L   QQP  ,.H  ##\   P_P!H*0
M6"H  $PK  !!+   .2P  #(K   M*P  *2H  "4J   @*P  '"P  !<N   3
M,   $#("  XT!P *-PP !S<0  4W%  #-QL  C<B   W*@  .#,  #@^   X
M2@  .%@  #AH   X?   -Y(  #>I   VQ0  -NH  #;]   U_P!C+   5"X
M $@O   ^+P  -BX  # N   K+0  )RT  "(M   =+P  &#$  !0S   0-0
M#C<!  HZ!P &.PL  CP.   ]$@  /A<  #X>   ^)@  /B\  #XZ   ^1@
M/E0  #YD   ^=P  /H\  #VG   ]PP  /.D  #S]   [_P!>,   4#$  $0R
M   [,@  -#$  "XP   I+P  )#   !XR   9-   %#8  ! Y   -.P  "CT
M  5 !0  00H  $(-  !#$   1!0  $4:  !&(@  1BL  $8U  !&00  1D\
M $9?  !&<P  18H  $6D  !$P   0^@  $/^  !"_P!8-   2S4  $$U   Y
M-0  ,C0  "TS   F-   (#4  !HX   4.@  $#T   U    )0@  !$4   !'
M P  2 <  $H+  !+#@  3!$  $X5  !/'   3R4  $\O  !//   3TH  $]:
M  !.;0  3H4  $V@  !,O   2^<  $O^  !*_P!3.0  1SD  #XY   W.
M,3<  "DW   A.0  &SP  !4_   00@  #$4   =(   "2@   $T   !/
M400  %('  !4"P  50X  %<1  !9%P  6A\  %DI  !9-@  640  %E4  !8
M9P  6'\  %>:  !6MP  5>,  %3]  !4_P!./0  0ST  #P\   U.P  +#P
M "0^   <00  %40  !!(   +2P  !4X   !1    5    %<   !9    6P
M %T"  !>!@  8 L  &(.  !D$@  9Q@  &<B  !F+@  9CP  &9-  !E8
M97<  &23  !CL0  8=T  &#\  !?_P!)0@  04$  #H_   P0   )D,  !Y&
M   52@  $$X   I2   #5@   %H   !=    8    &,   !E    9P   &D
M  !K 0  ;04  &\*  !R#@  =1(  '<;  !V)@  =C4  '5&  !T60  =&\
M '.+  !RJ0  <,T  &_W  !N_P!&1@  0$4  #5&   J2   ($P  !=1   0
M5@  "5H   %?    8P   &@   !K    ;P   '(   !U    =P   'D   ![
M    ?0   ( #  "#"   A@T  (D3  "*'0  BBL  (D\  "(3P  AF8  (6!
M  "$H   @L(  ('P  !__P!&2P  .DP  "Y/   C4P  &%@  !!>   )9
M &D   !O    =    '@   !\    @0   (0   "'    B    (L   ".
MD    ),   "6    F0<  )T-  "A%   H"$  * Q  ">1   G5L  )QV  "9
ME@  F;4  );E  "5_@ _4@  ,E4  "9:   ;8   $6<   EM    =    'L
M  "!    A@   (L   "0    E    )<   "9    G    )\   "A    I
M *<   "J    K0   +$&  "U#0  N!8  +<F  "V.0  M5   +1J  "RB0
ML*H  *[/  "M]0 W7   *V$  !YH   3<   "W@   "     AP   (X   "5
M    F@   )\   "D    J    *P   "M    L    +,   "U    N    +L
M  "_    PP   ,<   #+!0  T0X  -$;  #0+@  ST4  ,U?  #+?@  R9X
M ,B^  #%Z0 O:0  (W   !9Y   -@0   8L   "3    FP   *(   "H
MK@   +0   "X    O0   ,    #"    Q0   ,@   #+    S@   -$   #6
M    VP   -\   #D    Z 8  .L1  #J(P  ZCH  .E4  #G<@  Y9,  ..S
M  #CU #_    _P   /\   #_  0 _P + /\ $ #_ !< _P A /\ *P#_ #4
M_P ^ /\ 1P#_ $X _P!5 /P 6P#Z &$ ^ !F /8 ;0#T ', \@![ .\ A #M
M (X Z@"9 .8 IP#C +D WP#5 -L ]P#6 /\ P #_ +( _P"J /\ I0#_ *(
M_P#_    _P   /X   #\    _  # /X "P#_ !$ _P : /T ) #Y "X ]  X
M /  0 #L $@ Z0!. .8 5 #B %H WP!? -P 90#8 &L U !R -  >P#- (4
MR@"1 ,< G@## *X P #% +T ZP"[ /\ L #_ *0 _P"< /\ F #_ )4 _P#_
M    ^@   /0   #Q    \@   .H !0#G  X X@ 5 .$ '@#A "@ V  Q -
M.0#+ $  R !' ,4 30#" %, OP!8 +T 7@"[ &0 N0!K +8 <P"T 'P L0"(
M *X E0"K *0 J "X *8 W "C /L GP#_ )4 _P"/ /\ BP#_ (D _P#Y
M[P   .<   #?    SP   ,@   #!  H OP 1 +P & "[ "$ N0 J +0 ,@"Q
M #H K@!  *L 1@"H $P I@!1 *, 5@"A %P GP!C )T :@"; ', F0!^ )8
MC "4 )L D@"M )  QP". /  C0#_ (8 _P"  /\ ?0#_ 'P _P#M    X
M -$   "_    LP   *H   "F  4 H@ - *$ $P"@ !L GP C )L *P"8 #(
ME0 Y ), /P"1 $0 CP!* (X 3P", %4 B@!; (@ 8P"& &L A !V (( @@"
M )( ?@"C 'P N@!Z .$ >0#_ '< _P!R /\ < #_ &\ _P#=    RP   +8
M  "G    G0   )0   ".  $ BP * (D $ "( !4 AP = (< )0"$ "P @@ R
M '\ . !] #T >P!# 'D 2 !X $X =@!4 '4 6P!S &, <0!N &\ >@!M (D
M; ": &H K@!I ,P : #V &< _P!E /\ 9 #_ &, _P#*    M    *$   "3
M    B0   ((   ![    >  % '8 # !U !$ =  8 ', 'P!R "4 <  L &X
M,@!L #< :@ \ &D 0@!H $@ 9@!. &4 50!C %T 8@!F &  <@!> (  70"2
M %L I0!: +X 60#I %D _P!9 /\ 6 #_ %@ _P"Y    H@   )    "#
M>0   '$   !M    :0 ! &8 "0!E  X 9  3 &, &0!C "  80 F &  + !>
M #$ 7  W %L / !: $( 6 !( %< 3P!6 %< 5 !@ %, ; !1 'D 4 "* $\
MG@!. +0 30#: $T ^P!- /\ 30#_ $T _P"J    E    ((   !U    :P
M &0   !@    70   %H !0!8  P 5P 0 %8 %0!6 !L 50 A %, )P!2 "P
M40 Q $\ -P!. #T 30!# $P 2@!* %( 20!; $@ 9@!& ', 10"$ $0 EP!#
M *P 0@#) $( \0!" /\ 0P#_ $, _P">    B0   '@#  !J!   800  %H#
M  !5 0  4@   %   @!.  D 30 - $P $0!+ !< 2@ < $D (@!( "< 1P M
M $4 ,@!$ #@ 0P ^ $( 10!! $T /P!6 #X 80 ] &X .P!^ #H D0 Y *8
M. "_ #@ Z  X /\ .0#_ #D _P"5 P  @ <  &\)  !B"@  6 L  %$*  !,
M"   208  $<#  !&  8 1  + $, #P!" !, 00 8 $$ '@ _ ", /@ I #T
M+@ [ #0 .@ Z #D 00 X $D -P!2 #8 70 T &H ,P!Z #( C  Q *$ , "X
M "\ W@ O /D +P#_ #  _P","0  > P  &@-  !<#@  4@X  $L.  !%#0
M00P  #\*   ^" ( /00( #P!#0 [ !  .@ 5 #D &@ X "  -@ E #4 *P T
M #  ,P W #( /@ Q $8 +P!0 "X 6@ M &< *P!W "H B0 I )T * "S "<
MT0 G /( )P#_ "< _P"&#   <@X  &,0  !6$0  31$  $41  ! $   / \
M #D.   W#0  -@L$ #8("@ U!@X - 42 #($%P Q!1P , 4B "\%*  N!BX
M+08T "L&/  J!D0 *0=. "<'60 F!V4 ) =U ",'AP B!YL ( :P " &RP ?
M!>T 'P;^ !\'_P" #@  ;1$  %X2  !2$P  2!,  $$3   [$P  -Q(  #01
M   R$   , \! # -!@ P"PL +PH0 "T*%  L"QD *@L? "D+)0 H#"L )PPR
M "8,.@ D#$, (PQ- "$-6  @#64 '@UU !P-B  :#9P &0VQ !@,R@ 7#.L
M%PW\ !@,_P![$0  :1,  %H5  !.%@  118  #T6   X%0  ,Q4  # 4   M
M$P  *Q(  "H0 P J#P@ *0X- "@.$0 F#A8 )0\= "0/(P C#RD (1 Q " 0
M.0 >$$( '1!, !L06  9$&8 %Q!V !40B0 4$)X $A"S !$0S@ 1$.X $A#^
M !(0_P!W$P  914  %<7  !+&   0AD  #H9   T&   ,!<  "P7   I%@
M)Q4  "84 0 E$@0 (Q(+ "(2#P A$A0 (!(: !X3(  =$R< '!,N !H3-@ 9
M%$  %Q1* !845@ 4%&0 $A1T !$4AP 0%)P #A2Q  T4R@ -%.L #A/^  X3
M_P!S%0  81@  %,:  !(&P  /QL  #<;   R&@  +1H  "D9   F&   )!@
M "(7   @%@$ 'A8( !T6#0 ;%Q( &A<7 !D7'0 8&"0 %A@K !48-  4&#T
M$AE( !$95  0&6( #AER  T9A  ,&9@ "AFM  D8Q@ )&.< "1CZ  H7_P!O
M&   7AH  % <  !%'0  /!T  #4=   O'0  *AP  "8;   C&P  (1H  !X:
M   <&@  &AL% !@;#  6'!  %1P5 !0<&P 3'"( $ATI !$=,0 0'3L #AU%
M  T>40 ,'EX "AYM  D>@  ''I0 !1VJ  ,=P@ #'>8 !!SX  4<_P!K&@
M6QT  $T>  !"'P  .A\  #(?   M'P  *!X  "0>   A'0  'AT  !P=   8
M'@  %1\" !,@"0 2(0X $"$2 ! A&  .(1\ #B(F  TB+@ ,(C< "B)!  DB
M30 '(EH !2)I  ,B?  !(I$  "*H   AP   (>4  "#X   @_P!G'0  5Q\
M $HA  ! (0  -R(  # A   J(0  )B   "(@   ?'P  '!\  !D@   6(0
M$B," ! D!P .)@P #"80  LF%0 *)AP "28B  @F*@ &)S, !"<]  ,G20 !
M)U8  "=F   G>0  )X\  ":F   FOP  )>0  "7Y   D_P!C(   5"(  $<C
M   ])   -"0  "XC   H(P  )"(  "$B   >(0  &B(  !<C   3)   $"8"
M  XH!P +*@L ""L.  8K$P $*Q@  BL?  $L)P  +#   "PZ   L10  +%,
M "QC   L=@  +(P  "ND   KO@  *N0  "KZ   I_P!?(P  4"4  $0F   Z
M)@  ,B8  "LF   F)0  (R0  !\D   ;)   %R4  !0G   1*0  #BL"  LM
M!@ '+PL !# .   P$0  ,14  #$<   Q(P  ,BP  #(V   R0@  ,D\  #)?
M   R<@  ,8D  #&B   PO   ,.0  "_[   O_P!:)P  3"@  $ I   W*0
M+RD  "DH   E)P  (28  !PG   8*   %"H  !$L   .+@  "S !  <R!0 #
M- D  #4,   V#P  -Q(  #@8   X(   ."@  #@R   Y/0  .4L  #E;   X
M;@  .(4  #>?   WN@  -N0  #7\   U_P!5*@  2"P  #TL   T+   +2L
M "@J   D*0  'BH  !DK   4+0  $2\   TQ   *-   !S8   (X!   .@<
M #L*   ]#0  /A   $ 4  ! &P  0"0  $ N  ! .0  0$<  $!6  ! :0
M0(   #^;   ^MP  />,  #S\   \_P!0+P  0R\  #DO   R+P  +"T  "<L
M   @+0  &B\  !4Q   1,P  #38   DX   %.P   #T   !  0  000  $,'
M  !%"P  1@X  $@1  !*%@  2AX  $HH  !*-   24(  $E1  !)9   2'L
M $B7  !'M   1N   $7\  !$_P!*,P  /S,  #8S   P,0  *C   ",Q   <
M,P  %C4  !$X   -.P  "#X   -!    0P   $8   !(    2@   $P$  !.
M!P  3PL  %$.  !4$@  51D  %4B  !4+@  5#P  %1+  !37@  4W0  %*0
M  !1K@  4-<  $_[  !._P!%-P  /#<  #4V   O-   )C4  !XW   7.@
M$3T   Q!   '1    $@   !*    30   %    !3    50   %<   !8 @
M6P8  %T+  !?#@  8A,  &(;  !B)P  8C0  &%%  !@5P  8&T  %^)  !=
MIP  7,P  %KX  !9_P!!/   .CL  #0Y   J.@  (3P  !A    10P  #$<
M  9+    3P   %,   !6    60   %P   !?    80   &,   !E    9P$
M &H%  !M"@  < X  ',5  !R(   <BT  '$]  !P3P  ;V4  &Z   !MGP
M:\$  &GQ  !H_P _0   .3X  "X_   D0@  &D8  !)*   ,3P  !%0   !8
M    70   &$   !E    :    &L   !N    <0   ',   !U    >    'L
M  !^ P  @0H  (4/  "'%P  AB0  (4T  "$1@  @ET  (%V  !_E@  ?K8
M 'SG  !Z_P _1   ,T4  "A(   =3   $U(   Q7   #70   &,   !H
M;0   '$   !V    >@   'X   "!    @P   (8   ")    BP   (X   "2
M    E0$  )D)  ">$   GAH  )TI  "</   FE(  )AL  "6BP  E*H  )+4
M  "0^@ X2P  +$X  "!3   560  #6    -G    ;@   '0   !Z    @
M (0   "*    C@   )(   "5    EP   )H   "=    H    *,   "G
MJP   *\   "T"0  N!   +<>  "U,   LT8  +%@  "O?@  K*   *O!  "I
M[@ Q50  )%L  !AA   .:0  !7$   !Y    @0   (@   "/    E    )H
M  "?    I    *@   "I    K    *\   "S    M0   +D   "]    P0
M ,8   #+    T0H  -,4  #1)0  T#L  ,U4  #*<0  R)(  ,6S  ##W@ I
M8@  '&D  !%Q   '>P   (0   "-    E0   )T   "C    J0   *\   "T
M    N0   +P   "^    P@   ,4   #(    S    -    #4    V@   -\
M  #D    Z@   .X,  #M&@  ["\  .I)  #H90  YH8  .2E  #BQ@#_
M_P   /\   #\  $ _  ( /X #@#_ !0 _P = /\ )@#_ #  _P Z /\ 0@#_
M $D _@!0 /L 5@#Y %P ]@!B /0 : #R &\ \ !V .T ?P#J (D YP"5 .0
MHP#@ +4 VP#0 -4 ]@#* /\ M@#_ *@ _P"? /\ F@#_ )8 _P#_    ^P
M /8   #S    \P   /8 "0#Z  X _0 6 /L ( #W "H \@ S .T .P#I $,
MY@!) .( 3P#> %4 VP!; -8 8 #2 &< SP!N ,P =@#) (  Q@", ,( F@"_
M *H NP#! +@ Z0"V /\ IP#_ )H _P"2 /\ C0#_ (H _P#Z    \0   .H
M  #G    YP   .0  0#@  L VP 1 -H &@#; ", T0 L ,H - #& #L P@!"
M +\ 2 "\ $X N@!3 +@ 60"V %\ LP!F +$ ;@"N '< K "# *D D0"F *$
MHP"U *  V "> /L E0#_ (L _P"% /\ @ #_ 'X _P#O    XP   -H   #3
M    Q@   +\   "Y  8 MP . +0 % "T !T LP E *X +0"K #0 IP [ *0
M00"A $8 GP!, )T 40"; %< F0!> )< 90"5 &X DP!Y )  AP". )< C "I
M (D Q "( .\ A0#_ 'P _P!V /\ <P#_ '( _P#@    T    ,8   "V
MJ0   *$   "=  $ F0 * )@ $ "8 !8 EP > )0 )@"1 "T CP T (P .@"*
M #\ B !% (< 2@"% %  @P!6 ($ 7@"  &8 ?@!Q 'P ?0!Y (T =P"@ '4
MM@!S -\ <@#_ &X _P!I /\ 9P#_ &4 _P#,    O@   *L   "=    DP
M (H   "%    @@ % (  #0!_ !$ ?P 8 (  ( !] "8 >@ M '< ,P!U #@
M=  ^ '( 0P!P $D ;P!/ &T 5@!L %X :@!H &@ =0!G (0 90"6 &0 JP!B
M ,D 80#V &  _P!< /\ 6P#_ %H _P"]    J0   )<   ")    ?@   '@
M  !S    ;P ! &T "0!L  X :P 3 &L &0!J "  :  F &8 + !E #( 8P W
M &( / !@ $( 7P!( %T 3P!< %< 6@!A %D ;0!7 'L 5@". %4 H@!3 +L
M4@#I %( _P!0 /\ 3P#_ $\ _P"M    F    (8   !X    ;@   &<   !C
M    8    %T !0!<  L 6P 0 %L %0!; !L 6@ A %@ )@!6 "P 5  Q %,
M-@!2 #P 40!" $\ 20!. %$ 30!; $L 9@!* '0 20"% $@ F0!' +$ 1@#8
M $8 _ !% /\ 10#_ $4 _P"?    B0   '@   !L    8@   %L   !6
M4P   %$  @!/  @ 3P - $X $0!. !8 30 < $P (0!* "8 20 L $@ ,0!'
M #< 10 ] $0 1 !# $P 0@!5 $  8  _ &X /@!^ #T D@ \ *D .P#' #L
M\P [ /\ .P#_ #P _P"3    ?@   &X   !A    6    %$   !,    20
M $<   !%  4 1  + $, #@!# !( 0P 7 $( '0!  "( /P G #X +  ] #(
M.P X #H /P Y $< . !0 #< 6P U &@ - !X #, C  R *( ,0"\ #$ YP Q
M /\ ,@#_ #, _P")    =@,  &8%  !9!P  4 <  $D&  !#!0  0 ,  #X!
M   \  , .P ( #H #0 Z !  .0 4 #D &0 W !X -@ C #4 *  T "X ,P T
M #( .P P $, +P!, "X 5P M &0 + !S "L AP J )P *0"U "D W  I /L
M*0#_ "H _P"!!   ;@@  %\*  !3"P  2@L  $(+   ]"@  .0D  #8(   U
M!0  - (& #, "@ R  X ,0 1 #$ %0 P !H +P ? "X )  L "H *P P "H
M-P I #\ * !) "< 5  F &  ) !O ", @@ B )< (0"N "$ S  A /, (0#_
M "( _P!["0  : P  %H-  !.#@  10X  #T.   X#0  ,PT  # ,   N"P
M+0D# "T&"  L! P *P(/ "H!$@ I 1< * $< "< (0 F "< )0 M "0 -  C
M 3T (@%& "$!40 ? 5T '@%L !P!?P ; )0 &@"J !H Q0 : .L &0#_ !H
M_P!U#   9 X  %4/  !*$   0!   #D0   S$   +P\  "P.   I#@  )PT!
M "<,!0 G"@H )@@- "4'$  D!A0 (@89 "$&'P @!R0 'P<K !X',@ =!SH
M' A$ !H(3P 9"%P %PAK !8(?0 5!Y$ % >G !,&OP 2!>0 $@7Z !(%_P!Q
M#@  7Q   %$1  !&$@  /1(  #82   P$@  *Q$  "@1   E$   (Q   "(.
M!  A#0< (0P+ " +#@ ?"Q( '0L7 !P,'  ;#"( &@PI !D,,0 8##D %@U#
M !4-3P 3#5P $@UK ! -?@ /#9( #@VG  T,O@ -#.  #0SU  T,_P!M$
M7!$  $X3  !#%   .A0  #(4   M%   *!,  "43   B$@  (!$  !X1 P <
M$ 4 ' \( !L/#  :#A  &0\4 !</&@ 6#R$ %1 H !00,  2$#D $1!$ ! 0
M4  .$%T #1!K  P0?  +$)  "1"E  @0O  '$-\ !Q#T  </_P!I$0  6!0
M $L5  ! %@  -Q8  # 6   J%@  )A4  "(5   ?%   '1,  !H3 @ 9$@0
M%Q(& !82"@ 5$@X %!(2 !(2&  1$QX $1,E ! 3+@ .$S< #11   P42P +
M%%@ "11G  <4>  &%(T !!2C  ,3NP "$]T  1+T  (2_P!E$P  518  $@7
M   ]&   -!@  "T8   H&   (Q<  " 7   =%@  &A4  !@5 @ 6%00 %!4%
M !(6"  1%@T $!<0  X7%0 .%QL #1<B  P7*0 +&#( "1@\  <81P %&%0
M!!AC  (8=0 !&(L  !>A   7N0  %]T  !;U   6_P!A%@  4A@  $4:   [
M&@  ,AH  "L:   E&@  (1D  !X8   ;&   &!<  !87 @ 4%P, $A@% ! 9
M!P .&PL #!L/  L;$P *&Q@ "!P?  <<)@ %'"\ !!PX  (<1   '5$  !U@
M   =<@  '(@  !R@   ;N0  &]X  !KV   :_P!>&   3QH  $(<   X'
M+QT  "D<   C'   'QL  !P:   9&0  %QD! !09 @ 2&@, $!L$  X=!P ,
M'@L "1\.  8@$0 %(!8  R <  $A(P  (2L  "$U   A0   (4X  "%=   A
M;P  (88  "">   @N   ']X  ![X   >_P!:&P  2QT  #\>   U'P  +1\
M "<>   B'0  'AT  !L<   8&P  %1L  !(<   0'0( #A\$  PA!@ )(@H
M!2,-  (D$   )1,  "49   F(   )B@  "8R   F/0  )DH  "9:   F;
M)H,  "6<   EMP  )-\  "/Y   C_P!5'@  1R   #PA   R(0  *R$  "4@
M   @'P  '1X  !H=   6'@  $QX  ! @   .(0  #","  @E!0 %)PD  "@+
M   J#@  *Q$  "P6   L'0  +"4  "PN   L.@  +$<  "Q6   L:0  +(
M "N:   JM0  *=\  "G[   H_P!1(@  1",  #@D   O)   *",  ",B   ?
M(0  '"   !<@   3(0  $",   XD   +)@  ""@   0J!   + <  "X)   P
M#   ,0\  #,3   S&0  ,R$  #,J   S-0  ,T,  #-2   S90  ,GL  #*7
M   QLP  ,-X  "_[   N_P!,)0  /R8  #4G   M)@  )R4  "(D   >(P
M&2,  !0D   1)@  #B@   LJ   '+    R\    Q @  ,P0  #4'   W"@
M.0T  #H0   [%0  .QT  #LF   [,0  .SX  #M.   [8   .G<  #F2   X
ML   -]L  #;\   U_P!'*0  .RH  #(J   K*0  )2<  "$F   ;)P  %2@
M !$J   .+   "B\   8Q   !-    #8    X    .P$  #T$   _!P  00H
M $,.  !%$0  11@  $4A  !%+   1#D  $1(  !$6P  0W$  $*-  !!JP
M0-(  #_Z   ^_P!"+0  ."X  "\M   I*P  )"H  !TJ   7+   $2X   TQ
M   )-   !#<    Z    /    #\   !!    1    $8   !( P  2@<  $P+
M  !.#@  4!,  % <  !0)P  3S0  $]#  !/50  3FH  $V&  !,I   2LH
M $GX  !(_P ^,@  -3$  "XO   I+@  ("X  !DQ   2,P  #C<   DZ   "
M/0   $    !$    1P   $D   !,    3P   %$   !3    50$  %@&  !:
M"P  70X  %\5  !>(   7BP  %T\  !<3@  6V,  %I^  !8G0  5\   %7R
M  !4_P Z-@  ,S0  "TR   D,P  &S8  !,Y   ./0  "$$   !%    20
M $P   !0    4P   %8   !9    6P   %T   !@    8@   &4   !H!0
M:PL  &\0  !O&   ;B4  &TT  !M1@  :UL  &IU  !HE   9K8  &3I  !B
M_P X.0  ,C<  "@Y   >.P  %3\   Y$   '20   $T   !2    5@   %H
M  !>    8@   &4   !H    :P   &T   !P    <P   '8   !Y    ?00
M ($+  "%$0  A!T  ((L  " /@  ?E0  'YK  ![B@  >JH  '?6  !U_0 X
M/0  +#X  ")!   71@  #TL   =1    5P   %P   !B    9@   &L   !O
M    =    '@   ![    ?@   (    "#    A@   (H   "-    D0   )8#
M  ";#   G1,  )LA  ":,P  ETD  )1B  "3?P  D*   ([%  ",\P Q1
M)4@  !I-   04P  "%H   !A    :    &X   !T    >0   '\   "$
MB0   (T   "1    DP   )8   "9    G0   *    "D    J    *P   "R
M P  MPT  +<7  "U*   LCX  +!6  "L<P  JI0  *FT  "EY0 J3P  'E0
M !);   *8@   &H   !S    >P   ((   ")    C@   )0   ":    GP
M *0   "F    J0   *T   "P    LP   +<   "[    P    ,4   #+
MT00  -4.  #3'0  T#(  ,U+  #*9@  QH<  ,*I  #!RP B6P  %F(   QK
M   !=    'T   "'    D    )<   ">    I    *L   "Q    M@   +H
M  "\    P    ,0   #(    RP   ,\   #4    V@   .    #F    ZP
M /$&  #P$P  [B<  .P_  #J6P  YWH  .2;  #@NP#_    ^P   /8   #S
M    ]  % /8 # #Z !$ _P 9 /\ (@#_ "P _P U /\ /0#_ $4 _ !, /H
M4@#W %@ ]0!> /, 9 #Q &H [@!R .P >@#I (4 Y0"1 .$ H #= +( V #.
M -( ]@#! /\ K0#_ )X _P"6 /\ D #_ (P _P#Z    \@   .P   #I
MZ0   .P !0#R  P ^  2 /< &P#U "4 \  N .L -P#F #X X@!% -T 2P#8
M %  TP!6 -  7 #- &( R@!J ,@ <@#% 'P P@"( +X E@"Z *@ MP"_ +0
MZ "N /\ G0#_ )  _P"( /\ @P#_ (  _P#P    Y0   -X   #:    VP
M -P   #8  < T0 . -$ %0#2 !X RP G ,4 +P#  #< O0 ] +H 1 "W $D
MM0!/ +( 50"P %L K@!A *P :0"I ', IP!_ *0 C0"A )X G@"R )L U0"9
M /P C #_ (( _P![ /\ =@#_ '0 _P#B    TP   ,H   #'    O    +8
M  "P  $ KP + *P $0"M !@ K0 @ *@ * "D "\ H  V )T / "; $( F0!'
M )< 30"5 %, DP!9 )$ 80"/ &H C !U (H @P"( )0 A@"G (, P@"" /
M? #_ ', _P!M /\ :@#_ &@ _P#/    P0   +D   "M    H    )@   "4
M    D0 & )  #0"0 !( CP 9 (X (0"+ "@ B  O (8 -0"$ #H @@!  (
M10!^ $L ? !2 'H 60!X &( =@!L '0 >0!R (D <0"= &\ M !M -\ ; #_
M &4 _P!@ /\ 7@#_ %P _P"^    L0   *    "2    B0   ((   !\
M>@ ! '@ "0!W  X >  4 '< &@!T "$ <@ G '  +0!N #, ;  X &L /@!I
M $0 : !* &8 40!D %H 8P!D &$ < !? '\ 7@"3 %T J0!< ,@ 6P#W %<
M_P!4 /\ 4@#_ %$ _P"P    GP   (T   !_    =    &X   !J    9@
M &4 ! !C  L 8P 0 &, %0!C !L 80 A %\ )P!= "P 7  R %H -P!9 #T
M5P!# %8 2P!5 %, 4P!< %( : !0 '< 3P") $X GP!- +H 3 #I $L _P!)
M /\ 1P#_ $< _P"B    C0   'P   !N    90   %X   !9    5P   %4
M 0!4  < 4P - %, $0!4 !8 4@ ; %$ (0!/ "8 3@ K $P ,0!+ #< 2@ ]
M $D 1 !' $P 1@!6 $0 80!# '  0@"! $$ EP!  *\ /P#7 #\ _P ^ /\
M/0#_ #X _P"4    ?P   &\   !C    60   %$   !-    2@   $@   !'
M  0 1P * $8 #@!& !$ 1P 6 $4 ' !$ "$ 0@ F $$ *P!  #$ /@ W #T
M/@ \ $< .@!0 #D 6P X &D -P!Z #8 CP U *< -0#& #0 ]0 T /\ - #_
M #4 _P"(    =    &4   !8    3P   $@   !#    /P   #T    \  (
M/  ' #L #  [  \ .P 2 #H %P Y !P -P A #8 )@ U "P -  R #, .0 Q
M $$ , !+ "\ 5@ N &, +0!S "P B  L *  *P"[ "L Z@ K /\ *P#_ "P
M_P!_    ;    %T!  !1 @  2 ,  $ #   [ @  -P   #0    S    ,@ %
M #( "0 R  T ,0 0 #$ $P P !@ +P = "T (@ L "@ *P N "H -0 I #T
M* !& "< 40 F %X )0!N "0 @@ C )D (P"S "( W@ B /\ (P#_ "0 _P!W
M    900  %8&  !+!P  0@@  #H(   U!P  , 8  "T%   L P  *P # "H
M!P I  L *0 . "D $0 H !4 )P 9 "8 '@ E "0 )  J ", ,0 B #D (0!#
M "  3@ ? %H '@!I !T ?  < ), &P"L !L S0 ; /8 &P#_ !P _P!P!0
M7P@  %$*  !&"P  /0L  #4+   P"P  *PH  "@)   E"   ) <" ",$!@ C
M @D (@$, "( #P A !( (  6 !\ &P > "  '0 F !P +@ ; #8 &@ _ !D
M2@ 8 %< %P!F !8 >  5 (\ %0"F !0 PP 4 .X % #_ !4 _P!K"   6PL
M $T,  !"#0  .0T  #$-   L#0  )PT  ",,   A#   'PL! !X*!0 =" @
M'08+ !P%#0 <!!  &P04 !D$&  9!!X & 0C !<$*P 6!#, %00\ !0$1P 3
M U0 $@-C !$#=0 0 HH $ &B  \ O  / .4 #P#^ !  _P!G"P  5PT  $D.
M   ^#P  -0\  "X/   H#P  ) X  " .   =#@  &PT! !D-!  8# < & L)
M !<)#  7"0X %@D2 !4)%@ 4"1L $PDA !()*  2"3  $0DZ ! )10 /"5(
M#@EA  T)<P ,"(@ "PB?  H'MP *!ML "@7V  H$_P!C#0  4PX  $80   [
M$0  ,A$  "L1   E$   (1   !T0   :#P  & \! !8.!  5#@< % T) !,-
M"P 3# T $@P0 !$,%  0#!D $ P?  \,)P .#2\ #0TY  P-10 +#5$ "0U@
M  @-<0 &#88 !0V=  0,M  ##-(  @SQ  (+_P!?#@  4!   $,1   X$@
M+Q(  "@2   C$@  'A$  !L1   8$0  %1 " !00!0 2$ < $0\) ! /"@ 0
M#@P #@X.  X/$@ -#Q< #! =  P0)  *$"P "1 V  @000 &$$X !1!=  ,0
M;P !$(0  !"<   /M   #M0   [S   ._P!<$   31(  $ 3   V%   +10
M "84   A$P  '!,  !D2   6$@  %!$# !(1!@ 1$0@ $! *  X0"P -$0L
M#!$-  L2$0 *$A4 "1(:  @2(0 &$RD !1,S  ,3/@ "$TL  !-:   3;
M$X(  !*;   2M   $=<  !'U   1_P!8$@  210  #T5   S%@  *Q8  "05
M   ?%0  &A0  !<4   4$P$ $Q($ !$2!P 0$@D #A()  T2"0 +$PH "10-
M  <5#P &%A, !!88  ,6'P "%B<  !<P   7.P  %T@  !=8   7:@  %H
M !:9   5M   %=D  !3W   3_P!5%   1A8  #H7   P&   *!@  "(7   =
M%@  &18  !85   3% , $A,& ! 3!P /$P< #10'  L5"  )%@D !A@,  ,:
M#@ !&A$  !H6   ;'   &R0  !LM   ;.   &T8  !Q5   ;9P  &WT  !N7
M   :LP  &=L  !CY   7_P!1%@  0Q@  #<9   N&@  )AH  " 9   ;&
M&!<  !46 0 3%04 $14$  \5!  -%@0 "Q<%  D9!@ &&@@  AP*   >#0
M(!   " 3   @&0  ("$  "$J   A-0  (4(  "%2   @9   ('H  !^5   ?
ML0  'ML  !WZ   <_P!-&0  /QL  #0<   K'   )!P  !X;   :&@  %Q@
M !07 @ 2%P( $!@!  T9 0 +&@( "!P#  4=!  "'P8  "$(   C"P  )0X
M "81   F%@  )AX  "<G   G,@  )S\  "9.   F8   )G<  "62   DKP
M(]H  "+[   A_P!('0  /!X  #$?   H'@  (AX  !T<   9&P  %AH  !(:
M   0&P  #1P   L=   ('P  !"$   $C @  )00  "<&   I"0  + P  "X/
M   N$P  +AH  "XC   N+@  +CL  "Y*   M7   +7(  "R.   KK   *M0
M "G[   H_P!$(   ."$  "XA   F(0  ("   !P>   8'0  %!T  ! >   .
M'P  "R$   <C   #)0   "<    I    + $  "X#   P!@  ,PH  #4-   V
M$0  -A<  #8?   V*0  -C8  #9%   U5P  -6T  #2)   RJ   ,<\  ##Z
M   O_P _)   -"0  "LD   D(P  'R$  !L@   6(   $2$   XC   *)0
M!B@   (J    +0   "\    R    -    #<    Y P  .P8  #X*  ! #@
M01(  $$:  ! )0  0#$  $!    _4@  /F<  #V"   \H@  .L<  #GX   X
M_P Z*   ,"@  "DG   C)0  'R,  !@D   2)0  #B@   HJ   %+0   #
M   S    -@   #@    [    /@   $    !"    10(  $<&  !*"@  30X
M $T5  !,'P  3"L  $LZ  !*3   26$  $A\  !'FP  1;\  $/S  !"_P V
M+   +2L  "<I   C)P  &R@  !0J   .+0  "C    0S    -P   #H    ]
M    0    $,   !&    2    $L   !-    4    %,!  !6!@  60L  %L0
M  !;&0  6B4  %DT  !81@  5UH  %5T  !4DP  4K4  %#J  !/_P S,
M+"X  "<L   >+0  %B\  ! R   *-@   SH    _    0@   $8   !)
M3    $\   !2    50   %@   !:    70   &    !C    9P8  &L,  !L
M$@  :QX  &LL  !I/0  9U(  &9J  !DB0  8:L  %_<  !=_P Q,P  +#$
M "(R   9-0  $3D   H]   "0@   $<   !,    4    %0   !8    6P
M %\   !B    90   &@   !K    ;@   '$   !U    >0   'T&  ""#0
M@A8  ( D  !^-0  ?$D  'MA  !X?P  =I\  '/&  !P]P Q-@  )C@  !P[
M   20   "T4   )+    40   %8   !;    8    &4   !I    ;@   '(
M  !V    >0   'P   !^    @@   (4   ")    C@   ),   "8!@  G X
M )L:  "8*P  ED   ))9  "1<P  C94  (NU  "(Z  K/@  ($$  !5'   -
M30   E0   !;    80   &@   !N    <P   'D   !^    @P   (@   ",
M    CP   )(   "5    F0   )T   "A    I0   *H   "P    MP<  +@1
M  "U(0  LC4  *]-  "J:0  J(@  *:H  "BT0 C2   &$X   Y4   $7
M &0   !M    =0   'P   "#    B0   (\   "5    FP   *    "C
MI@   *D   "M    L0   +4   "Y    O@   ,0   #*    T@   -H*  #6
M%@  TBD  ,Y!  #*7   Q7P  ,*=  #!O0 <50  $5P   =E    ;@   '<
M  !_    B    )    "8    GP   *4   "M    LP   +@   "Z    O@
M ,(   #&    R@   ,X   #3    V@   .    #G    [0   /,   #T#@
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M_____________________________________________________P
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M]/7V]_CY^OO\_?[_;69T,0     #!"$   $                    !
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M ,;4"0"X]Q0$J_\I#I[_-!B0_SHAA/]!*7K_23!R_U(V;/]>.FC_:#UD_V]
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MC340_Y@[%_^@1"'_IDXM_Z=9//^E9$S_H6Y;]YMX:NZ5@7?GCHF"X8:/B]R
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M6_B;7EOXFUY;^)M>6_B;7EOXFUY;^)M>6_B;7EOXFUY;^)M>^KD. ,W+"0#
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M7C'_B6L\_X5W1O^!@T[_?8]6_WF87/QUH&'Y<J9E]V^M:?5LLVSS:KEO\FC
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M8E#VRF)0]LIB4/;*8E#VRF)0]LIB4/;*8E#VRF)0]LIB_Z,+ -:X!@#&Q <
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MD]B)_WP8 O^$' /_E1\#_Z,E!/^O+ ;WNC,)[,0[#^+.0AC3SD@LQL=20+G
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M?E3#X7U4P^%]5,/A?53#X7U4P^%]5,/A?53#X7U4P^%]_X<3 ?^<$@'_KA$
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M_ZD8 ?:X&P'GQQH!V]D< <W6, O TC\=M,U*+ZC(4C^=PUI-DK]A6(F[9V*
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M_%BW8_Q8MV/\6+=C_%BW8_Q8_V,? _]F(P3_<B($_WTG!O^%+@G_BC<._XU
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M,=*:7D#(DV=-P(QO6+F'=V&S@G]HKGV';JEZCG.D=Y9XH'2?>YUSJ'Z:<;2
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M:EVD[VI=I.]J7:3O:EVD[VI=I.]J_WD1 ?^,#@#_G@T W*X( -*["0#,R D
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MEQLP_Z$;+_^J'"__M1PN_[\<+O^_'"[_OQPN_[\<+O^_'"[_OQPN_[\<J;4
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M7VZ,]U]NC/=?;HSW7VZ,]U]NC/=?_VP3 ?]]#P'_C1  _YL0 /2H#P#EM0T
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MLSA"\,0X0?#?.4'O[SA [?TX0.S_.$#L_SA [/\X0.S_.$#L_SA [/\XRZ
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M%BC_LQ8G_\(6)__'%B?_QQ8G_\<6)__'%B?_QQ8G_\<6I+0  );   "'S
M>MH  &WK  !D_P4 7/\. 53_% %-_QP"2/\D!$+_+ 4^_S,&.O\Y!S;_0 @S
M_T4(,/]+"2[_40HK_U<**?]="R?_9 LD_VP,(O]V#2#_@ T>_XP.'?^7#AS_
MH0X;_ZP/&_^N#QO_K@\;_ZX/&_^N#QO_K@\;_ZX/E[P  (C)  !YU@  :^,
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M5L57[%7#6_E/PE[_2L!?_T:]8/]"NF#_0+I@_T"Z8/] NF#_0+I@_T"Z8/]
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M47Y]_U%^??]1?GW_47Y]_U%^??]1_V,4 ?]R#P'_@1  _XT1 /R8$@#LH1,
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MH?]0_W<' /")  #6F   RZ0# ,&M! "YM@, LL $ *O%% "CQ2@$F\(W#I'
M0QF)O4PD@+I5+GFX7#9RMF,];;1J0V>S<4ABL7E,7K"!4%JOBU16KY=64ZZC
M6%"NLEE/KL993Z[D6%&N]E13KO]05*S_352L_TU4K/]-5*S_352L_TU4K/]-
M_WT  -^/  #.G0  PZ@" +FP @"PN@( J,0% *',#P";S","DLHS"HG(/Q6!
MQDD?><12*'+"6C!KP6$W9K]H/&&^<$%<O7A%6+R!252\BTQ1NY9/3KNC44R[
MLU)*N\922KOD44R[]DY-NO]+3KG_24ZY_TE.N?])3KG_24ZY_TE.N?])[X4
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M+CWJ[RX]Z/PN/>?_+3WG_RT]Y_\M/>?_+3WG_RT]Y_\MQ9\  +6I  "HL0
MG+P  )#'  "$T@$ >M\& '3T$P!M]" "9O0J!%_T- A:]3T+5/5%#T_U3!),
M]5442?9=%T;V91A$]FX:0?9W'#_W@1T]]XT?._>9(#GXIB$X^+4B-_G((C;Y
MXR(V^/,B-O?\(C;W_"(V]_PB-O?\(C;W_"(V]_PBMZ8  *FN  "<N0  D,0
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M"A3_LPH4_[,*%/^S"A3_LPH4_[,*D[L  (3'  !UTP  9^$  %CH  !.^P
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M_W(9 ?]Y'P+_?B<#^8 P!?"!.0KG@$,1X'Q0&M9W6R3/<F8NR6UO-<1J>#O
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M&0'[AR ![XPG N2., 7:C3T,SX=*&,>"52._?5\MN7AH-;-T<#RO<7A"JVZ
M1J=LB$JD:9!.H&B849UFH5.;9:M5F&2X5Y9DR%B49.%8E6CT4)9K_TJ7;/]%
MEFW_099M_T"6;?] EFW_0)9M_T"6;?] _UD5 ?]F$ '_<A  _WT2 /^%%@#V
MC!L!ZI$B =^4*P/3D3H+R8Q'%\"'4R*Y@EPLLGUE-:UY;3RH=75"HW-]1Z!P
MA$N<;HQ.F6R54I5KGE22::A7D&FT68YHPUF,:-Q:C6SR4X]N_TR0</]'CW'_
M0X]Q_T&/<?]!CW'_08]Q_T&/<?]!_UL4 ?]H#P#_=0\ _X 1 /^)$P#RD!<
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M14FV\D-*M?]!2[7_/DNT_SU+M/\]2[3_/4NT_SU+M/\]XH,  ,V2  #!GP
MM*<  *JO  "@N   EL # (S*!P"&S10 @<TF GK,-0ASRT$/;,I*%V;)4QUA
MR%LC7,=B*%C&:BQ4QG(P4,5\,TW%AC9*Q)(Y1\2?.T7$KCQ$Q<$\0\7?/$3$
M\SM$P_\Y1<+_-T7!_S=%P?\W1<'_-T7!_S=%P?\WU8L  ,6:  "WI   JZP
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M&3'Q_QDQ\?\9,?'_&3'Q_QDQ\?\9LJ0  *6K  "8M@  B\   '[*  !QU0
M9=X  %[U"@!9_!, 4_P> 4[\)P)*_3 #1?TY!4']0 8^_D@'._Y/"3C_5PHV
M_UX+,_]G##'_< TN_WP.+/^)#RO_EA I_Z00*/^T$2?_QQ$G_^$1)O_R$2;_
M]A$F__81)O_V$2;_]A$F__81IZD  )FS  "+O@  ?LD  '#3  !DW@  6.<
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M2U>2[T=:DOU"7)/_/EV3_SM=D_\[79/_.UV3_SM=D_\[_VX  .!^  #.BP
MQ)4  +J=  "QHP  J:D  *&N"P";KQT!E*XN!(RL.PR%JD85?JA.''BF5B-R
MI%TJ;:)D+VFA:S1DGW,X8)Y[/%R=A3]9G(]"59N<15.;JD=1F[I'4)O11U&;
M[D13F_Q 59O_/%:;_SI6F_\Z5IO_.E:;_SI6F_\Z\70  -F#  #(D   OIH
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M+D&\_RU!O/\M0;S_+4&\_RU!O/\MSHH  +^8  "QH   IJ@  )NP  "0N
MA;\  'K'! !OSPD :]$5 &?1)@%CT30$7M! "%G02@Q5SU,04<];%$[/8QA+
MSFL;2,YU'D7.?R!"SHPB0,Z9)#[.J"8\SKHF/,_4)CS-[R4[S/LE.\O_)3O*
M_R4[RO\E.\K_)3O*_R4[RO\EPY,  +6>  "HI@  G:X  )&V  "%OP  ><<
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M"B#\_ H@_/P*HJ<  )6Q  "'NP  ><8  &S/  !?V0  4M\  $CH  !#_P@
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M169Y[D!H>_TZ:GO_-FM\_S)K?/\R:WS_,FM\_S)K?/\R_V$  .IO  #9>@
MS(0  ,.+  "[D0$ M)4! *R7#@"EER$!GI8Q!9>3/@R0D$@4BHY1&X2+62%_
MB6 G>X=G*W>%;C!SA'4T;X)]-VN!ASMH@)$^97^<06)^J4-@?KE$7W[/1&!_
M[$!B@/PZ9(#_-F6!_S-F@?\R9H'_,F:!_S)F@?\R_V0  .5R  #3?@  QX<
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M,U*6_S!2EO\P4I;_,%*6_S!2EO\PYG(  -"   #"C   N)8  *V<  "CH0
MF:8  (ZM  "(KA$ @ZXB 7VM,01WK#T*<JI'$&RI3Q9GJ%<;8Z=>'U^F921;
MI&TG6*1U*U2C?RY1HHDQ3J&6-$NAI#9)H;0V2*'(-TB@YS5)H/DR2I__,$N?
M_RY+G_\M2Y__+4N?_RU+G_\MW7D  ,F&  "\D@  L9H  *:@  "<I@  D:P
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M'#;$_QPVQ/\<OI$  +";  "DHP  F*H  (RR  " N0  =,   &C'  !=S04
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M> (1_X@"$/^: A#_JP,._[X##O_5 P[_[0,.__ ##O_P P[_\ ,.__ #DZX
M (2X  !VP@  9\P  %K5  !,W   /^$  #7F   M]   *O\" ";_"P C_Q$
M(/\7 !W_'0 9_R, %O\I !3_+P 2_S4 $/\]  [_10$,_TX!"O]8 0?_90$%
M_W0! _^% 0+_E@$!_Z8! /^U 0#_Q@$ _\H! /_* 0#_R@$ _\H!AK<  '?!
M  !HS   6M<  $O>   ^Y   ,ND  "?M   C_P  '_\  !O_!0 7_PP %/\0
M !'_%  /_Q@ #?\=  O_(@ (_R@ !?\N  +_-0  _ST  /]'  #_4@  _UX
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M.G-G[39T:?TP=6K_+'9K_REW:_\G=VO_)W=K_R=W:_\G_U<  /9C  #?;0
MT74  ,A[  #!?P( NX # +2!$ "L@B,!I8$R!)Y^/PF8>TH0DGE3%HUV6QN)
M=&(@A7)I)(%Q<"=^;W<K>VY_+GAMB#%U;)(T<VN>-W!JJCEN:KDZ;6K..FUK
MZS=O;?PQ<&[_+7%N_RIQ;_\H<6__*'%O_RAQ;_\H_UD  .ME  #;<   S7@
M ,1^  "\@@$ MH0! *Z%#@"GAB  H(4P YJ"/0B3@$@/CGU1%8E[61J$>6 ?
M@'=G(WQU;B=Y='4J=G-]+G-RAC%P<9 T;7"<-VIOJ#EH;[<Z9V_+.F=PZ3=I
M<?HR:W+_+6QS_RIL<_\H;'/_*&QS_RAL<_\H_UP  .=H  #5<P  R7L  ,""
M  "XA@  L8@  *F)#0"BBAT G(DN I6'.P>/A44.B8)/%(2 5QE_?EX>>WQE
M(GA[;"9T>7,J<7A[+6YWA#!K=HXS:'6:-F5TICAC=+4Y873).F%TYSAC=ODR
M97;_+F9W_RMG=_\I9W?_*6=W_REG=_\I_U\  .-L  #0=@  Q7\  +R%  "T
MB@  K(P  *.."@"=CAH EXXK I",. :*BD,,A(=,$G^%51AZA%P==H)C(7.
M:B5O?W$I;'YY+&A]@B]E?(PR8GN8-5]ZI#==>K,X7'K'.5QZY3=>>_@R7WO_
M+F!\_RMA?/\I87S_*6%\_REA?/\I]6(  -YO  #,>@  P(,  +>)  "OC@
MII$  )V2!@"7DQ< D9,H 8N2-@6%D$$+?XY*$7J,4A9UBEH;<8AA'VV':"-J
MAF\G9H1W*V.#@"Y@@HHQ78&6-%J!HS98@+(W5H#%-U: XS98@?<Q68'_+5N"
M_RI;@O\I6X+_*5N"_RE;@O\I[&8  -AS  #'?@  O(<  +..  "ID@  H)4
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M)$>:_R1'FO\DU'<  ,*$  "VCP  JY8  *&<  "6H   BZ4  '^J  !TK@4
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MF DMTZD)+-.^"BS3WPDKT?,**L_^"RG._PPIS?\-*<W_#2G-_PTIS?\-KI@
M **?  "6I@  B:X  'RV  !OO0  8\,  %?(  !,S0  0M(# #G9"0 UWQ
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M 0G_I@$(_[H!!__4 0?_ZP$&__8!!O_V 0;_]@$&__8!CZP  ("V  !ROP
M8\D  %;1  !(V   .]T  ##B   FY@  '_   !S_   9_PD %O\. !3_$P 1
M_QD #_\>  W_)  +_RL "?\R  ;_.P #_T0  /]/  #_7   _VL  /]]  #_
MD   _Z,  /^T  #_Q@  _]8  /_6  #_U@  _]8 @K4  '._  !DR0  5M,
M $?;   ZX   +N4  "/I   :[0  %?T  !+_   0_P( #O\)  O_#0 (_Q
M!/\3  '_&   _QX  /\D  #_*P  _S,  /\]  #_20  _U8  /]F  #_>
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M+(-7[RF#6/XD@UG_((1:_QZ$6O\<A%K_'(1:_QR$6O\<_TX! /]7  #E7P
MV&8  ,YJ  #'; , PVL% +QL$@"T;24 K6PU Z=J0@>A9TT,G&56$9AC7A64
M8F48D6!L&XY?=!Z,7GLAB5V#)(9<C":$6Y4H@5J@*G]:K"Q]6KLM?%K/+GM;
M["M\7/PF?%W_(GU>_Q]]7O\=?5[_'7U>_QU]7O\=_U   /59  #A8P  TFH
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M)6QI_R)L:O\@;&K_(&QJ_R!L:O\@_U<  .1B  #2;   QG,  +UX  "U>P
MK7P  *5\"@"??1H F7PJ 9-[. 2->4,)B'=,#H-U5!)_<UL6>W)B&7AP:1UU
M;W @<FYX(V]M@29L;(LI:FR7+&=KHRYE:[(O9&O$,&)KX2]D;/8J9FW_)F9M
M_R-G;O\@9V[_(&=N_R!G;O\@]ED  .!E  #.;P  PG8  +E\  "Q?P  J8
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M(%=\_R!7?/\@Y60  ,]P  #!>@  MH,  *V)  "CC   F8X  (V/  "&D X
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MEQH]HZ<;/*.Y'#NCTAL[HN\;.Z#^&CN?_QD\G_\8/)__&#R?_Q@\G_\8Q'P
M +:)  "JD@  GY<  )6<  ")H0  ?:8  '&J  !DK@  6K$( %>Q% !5LB,
M4[(P 5"R.P)-LD0#2[%-!4BQ50=%L5T)0[%E"T"P;PT^L'H/.["'$3FOEA,W
MKZ84-J^X%#6PT10UKN\4-*W^%#2L_Q0TJ_\4-*O_%#2K_Q0TJ_\4NX4  *^0
M  "CEP  F)T  (RC  " J   =*T  &BR  !<M@  4+H! $F\#0!(O!D 1KTG
M $6],P!#O3T!0;U' 3^]4 (]O5@#.KUA!3B]:P8VO7<(-+V$"3*]DPHPO:0+
M+[VW#"Z^T LNO.X,+;K^#2RY_PTLN/\.++C_#BRX_PXLN/\.LX\  *:7  ";
MG0  CZ,  (.J  !VL   :K4  %ZZ  !2O@  1\(! #W'!@ XR1  -\D; #;*
M)P URC, -,L] #/+1P QRU$!,,M; 2[,90(LS'$"*LQ_ RG,D 0GS*$$)LVT
M!"7-S@0ER^X$),G\!B/(_P<CQ_\'(\?_!R/'_P<CQ_\'J98  )Z=  "2HP
MA:L  'BR  !KN   7[X  %+"  !'Q@  /<H  #3/!  KU D )MD/ "79&0 E
MVB4 )-HP "/;.P CVT4 (MQ0 "'=6P @W6@ 'MYV !W>AP$<WYD!&M^L 1G?
MQ $8WN<!&-SX 1C;_P(7VO\"%]K_ A?:_P(7VO\"H)P  )2C  "'JP  >;,
M &RZ  !?P0  4L8  $;*   [S@  ,=,  "G9   AW@4 'N@. !WH%0 ;Z1X
M&>DG !CJ,  6ZCD %>M# !3L3@ 2[%H $>UG !#N=P 0[HH #N^>  [PLP -
M\,T #._L  SM_  ,Z_\ #.O_  SK_P ,Z_\ EZ,  (FK  ![M   ;;P  %_$
M  !2R@  1<X  #G3   OV   )=T  !WA   8[ ( %O<+ !3W$0 1^!< $/@>
M  [Y)0 -^2T "_HU  G[/P '^TH !/Q7  /]9@ "_G<  /V+  #]GP  _+4
M /S1  #\[0  _/P  /S]  #\_0  _/T BZL  'VT  !NO0  8,8  %+-  !$
MT@  -]@  "S=   BX0  &>4  !/J   0^@  #O\&  W_#  *_Q  !_\4  3_
M&@ !_R   /\G  #_,   _SH  /]%  #_4P  _V(  /]U  #_B@  _Y\  /^S
M  #_QP  _^4  /_E  #_Y0  _^4 ?[0  '"]  !AQP  4]   $/6   VW0
M*N(  !_F   6Z@  $.T   SZ   )_P  !O\   +_!   _PD  /\-  #_$
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M.-<0M3CL$+(Y^P^P.O\.KSK_#:XZ_PRM.O\+K3K_"ZTZ_PNM.O\+_SP- /]
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M&IM$\Q>91?\5F$;_$YA&_Q&81O\0ET;_$)=&_Q"71O\0_T(% /]'  #W3P
MY5,  -U5 0#7508 U5(+ ,M3&0##5"L O%0[ ;922 2Q45('K5!<"JE.9 VF
M36P/I$QT$:%+>Q.?2H(5G4J*%YM)DQB929P:ETBF&Y5(LAR42,$=DDC8'9!)
M[QN/2OX8CTO_%HY+_Q2.3/\2CDS_$HY,_Q*.3/\2_T4  /]+  #I4P  WE@
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M&W=9_QEW6?\7=UG_%G=9_Q9W6?\6_TP  .E6  #97P  RV4  ,%H  "Z:0
MM&@  *UG#0"F:!P H&@M 9IG.@.5944&D&-."HQB5PV)85X0AE]E$X->;!:
M77,8?EQ[&GM<@QUY6XT?=EJ8(71:I"-R6K(D<5K$)6]:X25P6_8@<5S_''%=
M_QIQ7?\8<5W_%W%=_Q=Q7?\7_4\  .59  #38@  QV@  +UL  "V;0  KVP
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M&6)H_QEB:/\9[%<  -EB  #':P  O'(  +-W  "J>0  H7D  )=W 0"0>!$
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MEAY,?Z4@2G^V(4E_S"%)?NL?2G[\'$M^_QI+?O\93'[_&$Q^_QA,?O\8U6<
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M$S>>R!,WG>@2-IOZ$C::_Q(VF?\1-YG_$3>9_Q$WF?\1OGL  +&'  "ECP
MFY0  )"8  "$G   =Z   &ND  !?IP  4JH  $VK#@!+JQH 2JLG $BK,P!&
MJST!1*M& 4*K3@) JU8#/JM?!3NK: 8YJG,(-ZJ "32JCPLRJI\,,:JP##"J
MQPPPJ><,+Z?Z#2^F_PTOI?\-+Z7_#2^E_PTOI?\-MH0  *J.  ">E   E)D
M (>>  ![HP  ;Z@  &.L  !7KP  2[(  $&U!@ ^MA$ /;8> #NV*0 ZMS0
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M !#3_P 0TO\!$-'_ 1#1_P$0T?\!G)H  )&A  "#J   =;   &BW  !;O0
M3L$  $+%   WR   +<P  "30   <U0  %=H% !#B"P 0XQ$ #N0:  [D(P -
MY2T #.4W  OF0@ *YD\ ">==  CG;0 &YH  !>:5  3FJP "YL0  >;F  #G
M^0  Y_\  .;_  #F_P  YO\ DZ$  (6I  !WL0  :;D  %O   !.Q@  0<H
M #7.   JT@  (=8  !G;   2WP  #>,   OQ"  )\PX !_,3  3R&@ "\B(
M /(J  #R-   \C\  /),  #R7   \FT  /*"  #RF   \ZT  //&  #TY0
M]/8  /3[  #T^P  ]/L AZD  'FR  !JN@  7,(  $[)  ! S@  ,],  "C8
M   >W0  %>$   _D   *Z   !?,   /] 0  _ @  /L-  #[$0  ^Q8  /P>
M  #\)@  _#   /T\  #^20  _EH  /YM  #_@@  _Y@  /^L  #_P   _]@
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M ,( _P#- /\ WP#_ .P _P#X /\ _P#] /\ _0#_ /T _P#] /\ _0#_ /T
M_P#] /\ _Q\C /\?(0#_'B$ _QDC /\3*0#_#C( _PQ  /\)30'_!UH!_P1G
M ?\#<P'_ WT!_P.' ?\#CP#_ I8 _P*< /\"H@#_ J@ _P*O /\!M@#_ ;X
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M!;HK^0:X+/\&MBS_!;4L_P6T+/\%M"S_!;0L_P6T+/\%_S0, /\V!0#_.0,
M_SP( /\\#0#].Q, \3@= .@U*0#@-#< V3-& -$T4@'-,UT!R3-G L8S< /$
M,G@$P3* !+\RAP6^,H\&O#*6!KHQG@>X,:8'MS&P"+4RO BS,LP)L3+E":TS
M]0FK,_\)JC/_"*@S_P>H,_\'IS/_!Z<S_P>G,_\'_S<' /\Z  #_/@  ^D$!
M /%!!@#Q/PT YCP2 -LZ'P#0.S$ RCQ  ,0\30' /%@"O#MA [D[:@6V.G(&
MM#IZ![(Y@0BP.8@)KSF0"JTXF JK.*$+J3BJ#*@XM@VF.,4-I#C>#J$Y\0V?
M.O\,GCK_"YTZ_PJ<.O\)G#K_"9PZ_PF<.O\)_SL" /\^  #W1   YD<  -](
M 0#:1@8 V4 + ,U"&0#%1"L OD0[ +E$2 &U0U,#L4)<!*Y"90:K06P'J4!T
M":9 >PJD/X,+HS^*#:$^DPZ?/IP/G3ZE$)L^L1&:/K\1F#[4$I8_[1&4/_P/
MDT#_#I) _PR20?\+DD'_"Y)!_PN20?\+_ST  /]#  #I20  WDX  --/  #-
M3@, RDD( ,))% "[2B8 M4LV *]+0P*K2DX#ITE7!:1(8 >A1V<)GD9O"IQ&
M=@R:17T.F$6%#Y9$CA"41)<2DD.A$Y!#K!2/0[H5C4/-%8M$Z!6*1?H2B4;_
M$(E&_PZ(1O\-B$;_#8A&_PV(1O\-_T   /)'  #C3P  U%,  ,M5  #$5
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M$6Q8_Q%L6/\1\4L  -]6  #,7@  P&0  +=G  "N:   IV8  )]B!@"88Q0
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MEAI89Z0<5F>T'55GRAU59^@;5F?[&%=G_Q97:/\46&?_$UAG_Q-89_\3X5@
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M=   JWL  *)_  "7@0  C($  'I^  !S?P( ;G\1 &N '@!H@"P 98 W 6*
M0 -??T@$7'Y0!EE^5PA7?5X+5'QF#5%\;@]/>W@13'N#%$IZD19(>I\71GJO
M&$5ZQ!A$>N0817GX%D9Y_Q1&>/\21WC_$4=X_Q%'>/\1S64  +UP  "Q>0
MIX   )R$  "2A@  AH8  '>&  !KA@  9H<- &.'&0!@B"< 7H@S 5N(/ )8
MAT4#5H=-!%.&5 90AEL(3H5C"DN$; Q)A'8/1H.!$42#CQ-"@YT40(*N%3^#
MPA4^@N(5/X'W$S^!_Q) @/\10(#_$$" _Q! @/\0QFL  +=V  "L?P  HH4
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M!RFA_P<IH/\(*9__""F?_P@IG_\(L8(  *6+  ":D0  D)8  (.:  !VGP
M:J(  %ZF  !2J0  1JL  #RM   UKPP ,[ 5 #*P(0 QL"L +[ U "ZQ/@ M
ML4@ ++%1 "NQ6P IL6<!)[%T 2:Q@P$DL90"([&F B*RNP(ALML"(:_S R"N
M_P,@K?\$'ZS_!!^L_P0?K/\$JHL  )V1  "3EP  AYP  'JB  !MIP  8*L
M %6O  !)L0  /K0  #.W   JN@, )+P- "*]%0 AO2  (;TJ ""],P ?OCT
M'KY' !V^4@ <OUX &K]L !F_?  8OXX %\"A !; M@ 4P-, %;[Q !6\_P$5
MN_\!%+K_ A2Z_P(4NO\"H9(  ):8  "*G@  ?:0  &^J  !BKP  5K0  $JW
M   ^N@  ,[T  "K    AQ   &<<% !/+"P 1S!( $<P; !#,)0 /S2\ #LTZ
M  [-1@ -S5( #<Y@  S.<  +SH, "LZ7  G.K  (SL8 ",[H  C-^P )R_\
M"<O_  G+_P )R_\ F)@  (V>  !_I0  <:P  &2S  !7N0  2KT  #[    R
MPP  *,8  !_*   7S0  $=$   S6!0 (V0P !MD2  7:&P $VB0  ]LN  ';
M.0  W$4  -U2  #>8@  WG,  -Z(  #?G0  W[,  -_.  #@[@  W_H  -__
M  #?_P  W_\ CY\  (&F  !SK@  9;4  %B]  !*P@  /<4  #')   FS
M'=   !34   .V0  "=T   /A    XP<  .,-  #D$@  Y1D  .8B  #G*P
MZ38  .M#  #L4@  [&(  .UV  #NC   [J$  .^W  #OT0  [^L  /#V  #P
M]@  \/8 A*<  '6O  !GMP  6;\  $O&   \R@  +\X  "32   :V   $MP
M  S@   %XP   .<   #K    ZP   .T%  #N"P  \!   /$5  #S'@  ]"<
M /<S  #Y0   ^E$  /MC  #\=P  _8T  /VC  #^M@  _LD  /_?  #_WP
M_]\ =[   &BY  !:P0  3,H  #S/   NU   (MH  !?>   0X@  ">8   #I
M    [    /    #V    ]@   /<   #X    ^@<  /L-  #]$0  _QD  /\C
M  #_+P  _SX  /]/  #_8@  _W<  /^-  #_GP  _ZX  /^Z  #_N@  _[H
M_Q8C /\5(0#_$B$ _PXD /\&*@#_ #, _P!! /\ 3@#_ %P _P!H /\ = #_
M 'X _P"' /\ CP#_ )8 _P"< /\ H@#_ *@ _P"N /\ M0#_ +T _P#' /\
MU@#_ .< _@#S /X _@#] /\ _ #_ /L _P#[ /\ ^P#_ /L _P#[ /\ _QH@
M /\9'@#_%AX _Q @ /\*)0#_!#  _P ] /\ 2P#_ %@ _P!D /\ < #_ 'H
M_P"# /\ BP#_ )( _P"8 /\ G@#_ *0 _P"J /\ L0#] +D ^P## /H T #X
M ., ]P#Q /8 _ #T /\ ] #_ /, _P#S /\ \P#_ /, _P#S /\ _QT< /\<
M&0#_&1D _Q0; /\._^+_XDE#0U]04D]&24Q%  @)(0#_#"P _PDY /\%1@#_
M E, _P!? /\ :P#_ '4 _P!^ /\ A@#_ (X _P"4 /X FP#\ *$ ^@"G /@
MK@#U +4 \P"_ /$ RP#P -\ [@#N .P ^0#K /\ Z@#_ .H!_P#I ?\ Z0'_
M .D!_P#I ?\ _R 7 /\?% #_'!, _Q<5 /\6'0#_$R@ _Q T /\-00#_#$X
M_PE: /\(9@#_"'  _@=Y /P'@0#Z!XD ^ >0 /8&E@#S!IT \0:C .\&J@#M
M!K( Z@:[ .@&R #F!MP Y ;L .((^@#@"O\ W@O_ -T+_P#=#/\ W S_ -P,
M_P#<#/\ _R,2 /\C$ #_(0X _QX0 /\>& #_'", _Q@O /\4.P#_$DD _!!5
M /@/8 #T#VH \0]T .\.? #M#H0 ZPZ+ .D.D@#G#ID Y@Z@ .0.IP#B#J\
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M /\O  #_,@  _S," /DR" #W+PX ZRL6 .$G(@#8)S( T"E! ,LJ3@#&*ED
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M"Y$YY0N/.O<*C3K_"8P[_PB,._\'C#O_!XP[_P>,._\'_S@  /$^  #C10
MU$D  ,M*  #%1P  P4$$ +H_$0"S02$ K4(Q *A#/@"D0TD!H$)3 IU!6P.;
M06($F$!J!99 <0:4/W@'DC]_") _B J//I$+C3Z;#(L^I@V)/K,-B#[$#H8_
MX Z$/_0-@T#_"X- _PJ"0/\)@D'_"()!_PB"0?\(_SP  .M#  #<2@  S$\
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M$&Q/_PYL3_\,;$__"VQ/_PML3_\+[D4  -Q0  #)5P  O5P  +1>  "L7@
MI%L  )Q6! "55A( D%<A (M8+P"'5SL!@U9$ G]630-\550%>E1;!G=48@AU
M4V@)<U-P"W%2> UO4H(/;5&-$6M1F1)I4:849U&V%691RQ5E4ND495+[$693
M_P]F4_\-9E/_#&93_PQF4_\,ZDD  -53  #%6@  NE\  +!B  "H8@  GU\
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M#5=>_PU77O\-WE,  ,A=  "[9   L&H  *9M  "=;@  DVT  (5G  !^9PD
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M' !F<B@ 8W(T &!R/0%><D4"6W%- UEQ5 57<%L&5'!C"%)O:PI0;W0,36Z
M#DMNC1!);IL11VVK$D9NOA-%;MP21FWT$49M_P]';?\.1VS_#4=L_PU';/\-
MS%\  +QI  "P<0  I7<  )Q[  "1?   AGL  '5X  !K=P  97<, &%X%P!?
M>"0 77DP %IY.@%8>4("5GA* E-X4011=U@%3W=@!TQV: A*=G(*2'5]#$5U
MB@Y#=9D/0G6I$$!UO!! ==D00'3S#T!T_PY!<_\-07/_#$%S_PQ!<_\,QF0
M +=N  "K=@  HGP  )=_  ",@0  @8$  '*   !E?P  77\( %E_$P!7@"
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M!BV2MP8LDM$&+)'O!BN/_P8KCO\&*XW_!RN-_P<KC?\'LW@  *>"  "<B
MD8P  (>0  !ZDP  ;94  &&7  !5F0  29L  #^< 0 YG0X -YT7 #:>(@ T
MGBP ,YXU #*>/@ QGD< ,)]0 "Z?6@ MGV0!*Y]Q 2F>?P(GGI ")IZA B2>
MM0(CGLX"(YWN R.;_@,BFO\$(IG_!"*9_P0BF?\$K($  *"(  "5C@  BY(
M '^6  !RF@  99T  %F@  !.HP  0J0  #>F   NJ 4 *:D/ "BI&  GJB(
M)JHL "6J-0 DJC\ (ZI( "*K4P AJUX (*MJ !ZK>0 =JXL &ZN= !JKL0 9
MJ\H &:KL 1FH_0$8I_\"&*;_ ABF_P(8IO\"I8D  )F/  "/E   @YD  '6>
M  !HH@  7*8  %"I  !$K   .:X  "^P   FLP  'K4& !FW#P 8MQ< %[<A
M !:W*@ 5MS0 %+@^ !.X20 2N%0 $KEB !&Y<0 0N8, #[F7  ZYK  -N<0
M#;CG  ZV^P .M?\ #K3_  ZT_P .M/\ G)   )*5  "&FP  >:   &NF  !>
MJP  4J\  $:R   ZM0  +[<  "6Z   =O0  %<   !##!@ +Q@X "L45  G%
M'@ (Q2@ !\4R  ;&/0 %QDD !<97  /&9@ "QG<  <:+  #&H   Q;8  ,;2
M  #%[P  Q?P  ,7_  #%_P  Q?\ E98  (F<  ![HP  ;:D  &"O  !3M
M1K@  #J[   NO@  ),$  !O$   3QP  #LH   C. 0 !T H  - 0  #0%@
MT1X  -(G  #3,0  U#P  -5)  #66   UFD  -9\  #6D@  UJ<  -:_  #6
MX   UO,  -;^  #6_P  UO\ C)T  'ZD  !OJP  8;(  %2Y  !&O0  .<$
M "W$   BQP  &<L  !'.   ,T@  !=4   #;    W ,  -T*  #>#P  WQ0
M .$<  #B)   Y"X  .8Z  #G20  Z%D  .AK  #I@0  Z9@  .FM  #IQ0
MZ>(  .GR  #I]0  Z?4 @*4  '&M  !CM0  5;P  $?"   YQ@  +,H  "#.
M   6T@  #]8   C;    WP   .,   #E    YP   .@!  #J!P  ZPT  .T1
M  #O&   \2$  /,K  #V.   ]T@  /A:  #Y;0  ^H0  /J;  #ZKP  ^L(
M /K:  #ZWP  ^M\ =*X  &6V  !6O@  2,8  #G+   KT   ']0  !3:   -
MWP  !>,   #F    Z0   .T   #O    \0   /,   #U    ]@(  /@)  #Z
M#@  _1,  /\<  #_*   _S8  /]'  #_6@  _VX  /^%  #_F@  _ZL  /^Y
M  #_O   _[P _Q$@ /\0'@#_#!X _P0A /\ )P#_ #  _P ^ /\ 3 #_ %D
M_P!E /\ < #_ 'H _P"# /\ BP#_ )( _P"8 /\ G@#_ *0 _P"J /\ L #_
M +@ _P#" /\ S@#_ .( _@#P /T ^P#[ /\ ^P#_ /L _P#Z /\ ^@#_ /H
M_P#Z /\ _Q0< /\2&@#_#AH _P@< /\ (0#_ "T _P Z /\ 2 #_ %4 _P!A
M /\ ; #_ '8 _P!_ /\ AP#_ (X _P"4 /\ F@#^ *  _0"F /P K #[ +0
M^0"] /@ R0#W -P ]0#L /, ^ #S /\ \@#_ /$ _P#P /\ \ #_ /  _P#P
M /\ _Q<8 /\5%@#_$14 _PP7 /\%'0#_ "@ _P V /\ 0P#_ %  _P!< /\
M9P#_ '$ _P!Z /P @@#Z (D ^ "0 /< E@#U )P ] "B /, J #Q +  \ "X
M .X PP#L -, Z@#G .D ]0#G /\ Y@#_ .4 _P#E /\ Y0#_ .4 _P#E /\
M_QH3 /\8$0#_%!  _P\1 /\-&0#_"B0 _P4P /\!/@#_ $L _P!7 /X 8@#Z
M &P ]0!U /( ?0#P (0 [@"+ .P D0#K )< Z0"> .< I #F *P Y "T .(
MOP#@ ,T W@#C -P \@#: /T V #_ -8 _P#5 ?\ U0'_ -4"_P#5 O\ _QX0
M /\<#0#_%PL _Q4. /\4%0#_$1\ _PXJ /\+. #]"$4 ^ 91 /0$7 #N!&8
MZ@1O .8#=P#D!'\ X@2& . $C #>!), W06: -L%H #8!:@ U06Q -(%NP#0
M!LD S@?@ ,P(\0#)"O\ QPO_ ,8,_P#%#/\ Q0S_ ,4,_P#%#/\ _R$, /\@
M!@#_' , _QT* /\;$ #_&!@ _Q0C /81, #O#CX Z@Y* .4-5@#A#6  W0UI
M -D-<0#5#7D TPV! -$-B #/#8\ S0Z6 ,L.G0#*#J4 R ZN ,8/N0#$$,@
MPA#? +X1\@"[$O\ N1/_ +<3_P&V$_\!MA/_ ;83_P&V$_\!_R4& /\C  #_
M(P  _R0# /\A"@#]'1$ \1H; .@6)P#A%#4 VA-# -,43P#.%5D RQ5C ,@6
M:P#%%G, PQ=[ ,$7@@# &(D OAB0 +P8F "[&:  N1FI +<9M "U&L( M!K6
M + ;[0&M'/P!JQW_ :D=_P&I'?\!J!W_ :@=_P&H'?\!_R@  /\G  #^*@
M[RH  .<G 0#G(@D Y!T0 -D;'0#/'2T R1X\ ,0@20"_(%, O"%= +DA90"W
M(FT M2)T +,B? "Q(H,!L"** :XBD@&L(YL!JR.D :DCKP&G([P!IB3. :,D
MZ *@)?D"GB7_ ITE_P*<)?\"FR7_ ILE_P*;)?\"_RP  /\M  #M,@  XC0
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M!WP[_P9\._\%?#O_!7P[_P5\._\%]#<  .5   #21P  Q4H  +Q+  "U20
MKT,  *D^"P"B/Q< G4 F )A!- "403\ D4%) 8Y!40&+0%D"B4!@ X= 9P.%
M/VT$@S]U!8$_?09_/H<'?3Z1"'L^G EZ/JD)>#ZX"G<_S0IU/^H*=$#\"'1
M_P=T0/\&<T#_!G- _P9S0/\&\3L  -]%  #,3   OT\  +90  "N3P  ITH
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M"&!._PA@3O\(XT<  ,U0  "^5P  LUL  *I=  "A70  F%H  (U3  "&4@P
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M'P!N7"L :UPV &A;/P%E6T<!8UM. F%:50-?6EP$75IC!5M::P99674(5UF
M"E59C M469H-4EFJ#E%9O Y06=@.4%GR#5%9_PM16?\*45G_"5%9_PA16?\(
MU%$  ,):  "T80  JF8  *!H  "7:0  C&<  'U@  !U7P, ;U\0 &M?' !H
M8"@ 9F S &-@/ %A8$0!7U], EQ?4P-;7UH$65]A!5=>:0957G,(4UY^"5%=
MB@M/79D,35VH#4Q>N@Y+7M0.2U[Q#$Q>_PM,7?\*3%W_"4Q=_PA,7?\(SU0
M +Y>  "Q90  IVH  )UM  "4;0  B6P  'AE  !O9   :60. &5D&0!B9"4
M8&4P %YE.@!<94(!6F5* EAD40)69%@#5&1?!%)D9P508W$'3F-["4QCB I*
M8Y<+2&.F#$=CN U&8]$-1F/O#$9B_PI'8O\)1V+_"4=B_PA'8O\(RE@  +IB
M  "N:0  HVX  )IQ  "0<@  A'$  '1K  !I:0  8VD+ %]I%0!<:B$ 6FHM
M %AK-@!6:S\!56M' 5-J3@)1:E4#3VI=!$UJ905*:6X&2&EY!T9IA@E$:94*
M0VBE"T%IMPQ :<\,0&CN"T%H_PI!9_\)06?_"$)G_PA"9_\(Q5T  +9F  "J
M;0  H',  )9V  "+=P  @'8  '!R  !E<0  7' ' %AP$0!6<!T 5'$H %)Q
M,P!0<3P 3W)$ 4UQ2P%+<5,"27%: T=Q8@1%<&P%0W!W!D%PA <_<),(/6^C
M"3MPM0H[<,T*.F_L"3MN_@@[;O\(.VW_!SMM_P<[;?\'OV(  +%K  "F<P
MG7D  ))[  "'?   >WP  &UZ  !@>   5G<! %!W#@!.>!@ 3'@D $MY+@!)
M>3< 2'E  $9Y2 %$>4\!0GE7 D%Y8 (_>&D#/'AT!#IX@@4X>)$&-WBA!S5X
MLP<T>,L'-'?K!S1V_0<T=?\'-77_!C5T_P8U=/\&N6@  *UQ  "B>0  F'X
M (V   ""@0  =H(  &F!  !;@0  48$  $B "@!%@1, 0X$> $*"*0!!@C(
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M 1R5^@$;E/\!&Y/_ AN3_P(;D_\"IW\  )R&  "1BP  AX\  'J2  !ME0
M89@  %6;  !)G0  /9X  #.?   JH0  (:,* !^C$0 >HQH ':0D !RD+0 ;
MI#8 &J0_ !FD2@ 8I%4 %J5A !6E<  4I8$ $Z64 !*EJ  1I;\ $*3B !&B
M^  1H?\ $:#_ 1&@_P$1H/\!H(8  )6,  ",D0  ?Y4  '&:  !DG@  6*$
M $RD  ! I@  -:<  "JI   BK   &:X  !*P"0 0L1  $+$8  ZQ(@ .L2L
M#;$U  VQ0  ,L4L "[%8  JQ9P (L7@ ![&+  6QH  $L+4 !+#0  2P[P %
MK_X !J[_  :N_P &KO\ F(X  (^3  ""F   =9T  &>B  !:IP  3JL  $&M
M   UKP  *[$  "&T   8M@  $;D   V\ P 'O@P  [T2  &]&0  OB(  +XK
M  "^-@  OD$  +].  "_7   OVT  +^   "^E0  OJH  +["  "]Y   O?8
M +W_  "]_P  O?\ DI0  (6:  !XH   :J8  %RK  !/L   0K,  #6V   J
MN   (+L  !>^   0P0  "\0   3'    R0<  ,D-  #)$@  RAD  ,LB  #+
M*P  S34  ,Y!  #.4   SV   ,]R  #/AP  SYT  ,^S  #/S@  S^L  ,[X
M  #._@  SOX B)L  'JB  !LJ   7J\  %"U  !"N0  -;P  "F_   >P@
M%<8   [)   (S    -    #3    U0   -8&  #8#   V1$  -L6  #<'P
MWB@  . T  #B00  XE$  .-C  #C=P  Y(X  .2D  #DN@  Y=0  .7J  #E
M\P  Y?, ?*,  &ZJ  !@L@  4;D  $.^   UP@  *,8  !S)   3S0  #-$
M  35    V@   -X   #A    X@   .0   #E P  YPD  .D.  #K$@  [1H
M .\D  #R,0  ]$$  /13  #U9@  ]7P  /:3  #VJ0  ][P  /?.  #WWP
M]]\ <*P  &&T  !3NP  1<,  #;'   GS   &]   !'5   *VP   -\   #B
M    Y0   .D   #L    [0   /    #Q    \P   /4$  #W"@  ^A   /P6
M  #_(0  _RX  /]   #_4P  _V@  /^   #_E@  _Z@  /^V  #_OP  _[\
M_PT< /\*&P#_ AL _P > /\ ) #_ "X _P \ /\ 2@#_ %8 _P!C /\ ;0#_
M '< _P!_ /\ AP#_ (X _P"4 /\ F@#_ *  _P"F /\ K #_ +0 _P"] /\
MR0#^ -T _0#M /P ^@#[ /\ ^@#_ /D _P#Z /\ ^@#_ /H _P#Z /\ _Q 9
M /\-%P#_!A8 _P 8 /\ '@#_ "H _P W /\ 10#_ %( _P!> /\ :0#_ '(
M_P![ /\ @@#_ (D _P"0 /X E@#] )P _ "A /L J #Y *\ ^ "X /8 PP#T
M -( \P#G /( ]@#P /\ [P#_ /  _P#O /\ [P#_ .X _P#N /\ _Q(4 /\/
M$@#_"Q( _P 2 /\ &@#_ "4 _P S /\ 0 #_ $T _P!9 /\ 9 #] &T ^P!V
M /D ?0#W (0 ]0"+ /0 D0#S )< \0"= /  HP#N *H [ "S .H O0#H ,L
MYP#A .4 \0#C /T XP#_ .( _P#A /\ X0#_ .  _P#@ /\ _Q00 /\1#@#_
M#0T _P</ /\"%0#_ "  _P M /\ .@#_ $< ^0!3 /4 7@#R &@ \ !P .T
M> #K '\ Z0"% .@ C #F )( Y0"8 ., GP#A *8 WP"N -P N #: ,4 U@#9
M -0 [ #2 /D T0#_ ,\ _P#. /\ S@#_ ,X _P#. /\ _Q<, /\4" #_#P4
M_PX+ /\,$0#_!QH _P$F /P - #T $$ [0!- .D 6 #F &( XP!J .  <@#>
M 'D VP"  -D A@#6 (T TP"3 -$ F@#/ *$ S0"J ,L LP#) +\ Q@#0 ,4
MZ ## /8 P0#_ , "_P"_ _\ OP/_ +\#_P"_ _\ _QL& /\7  #_%   _Q,%
M /\1#0#_#A0 ^0H? / &+ #F SD X -& -P#40#6!%L T@1D ,\%; #,!7,
MR@5Z ,@%@0#&!8< Q0:. ,,&E@#!!IT OP:F +T&L "[![P N0C- +@*Y0"U
M"_< LPW_ +$-_P"P#?\ L [_ *\._P"O#O\ _QX  /\;  #_&P  ^AH  /46
M!0#V$0T ZPX5 .(+(@#8"S$ T P^ ,L-2@#'#54 Q Y> ,$.9@"_#FT O0YT
M +L/>P"Y#X( MQ"* +80D0"T$)H LA"C + 1K0"O$;H K1'* *H2Y0"G%/<
MI17_ *,5_P"B%?\ HA7_ *(5_P"B%?\ _R(  /\@  #P(P  YB0  . A  #<
M&04 VQ , - 1&0#($RD PA4W +T61 "Y%TX M1=7 +,88 "P&&< KAAN *P9
M=0"K&7P J1F$ *@:C "F&I0 I!J> *,;J "A&[0 GQS% )X<WP":'?,!F![_
M 9<>_P&6'_\!E1__ 94?_P&5'_\!_R8  /0G  #F+0  VB\  ,\M  #*)P
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M VTZ_P-M.O\#ZCD  -5"  #$2   N4L  *]+  "G20  GT0  )@^ 0"1/!
MC#T= (@^*@"$/S4 @3\_ 'X_2 !\/T\!>C]6 7@_70%V/F0"=#YK G(^<P-P
M/GP#;SZ'!&T^DP5K/J &:CZN!FD_P =G/]X'9S_U!F9 _P5F0/\$9D#_!&8_
M_P1F/_\$Y3T  ,]&  "_3   M$\  *I0  "B3P  F4H  )%$  "*00T A$(9
M (!#)@!]1#( >D0\ '=$1 !U1$P!<D13 7!#60%O0V ";4-G FM#;P-I0WD$
M:$.#!69#CP9D0YT'8T.K!V%#O0A@1-D(8$3S!V!$_P9?1/\%7T3_!&!$_P1@
M1/\$X$$  ,I*  "[4   L%,  *=5  ">4P  E4\  (M)  "#1PL ?4<5 'E'
M(@!V2"X <T@X '%(00!N2$D!;$A0 6I(5@%H2%T"9D=D F5'; -C1W8$84>
M!6!'C09>1YH'7$>I"%M(NPA:2-0(6DCQ!UI)_P9:2?\%6DC_!5I(_P1:2/\$
MVT0  ,9-  "X4P  K5<  *-9  ":6   D50  (9.  !]2P@ =TL2 '-,'P!P
M3"L ;4PU &M,/@!H3$8 9DQ- 61,4P%B3%H"84QB E],:@->3',$7$M^!5I+
MB@982Y@'5TRG"%9,N0E53-$)5$SO"%1-_P953/\&54S_!55,_P553/\%U4@
M ,)1  "U5P  JEL  *!<  "77   C5D  (%3  !W3P0 <4\0 &Y0' !J4"@
M:% R &50.P!C4$, 85!* 5]040%=4%@"7%!? EI09P-84'$$5U![!550B 93
M4)8'4E"E"%!0MPE04,X)3U#M"%!0_P=04/\&4%#_!5!0_P504/\%T$L  +]4
M  "R6@  IUX  )U@  "48   B5T  'Q7  !R5   ;%,. &A4&0!E5"0 8E0O
M &!4. !>5$  7%1( 5I43P%95%8!5U1= E5490-45&X$4E1Y!5!4A@9.5)0'
M352D"$M4M0A+5,P)2E3K"$M4_@=+5/\&2U3_!4M4_P5+5/\%S$X  +M7  "N
M7@  I&(  )ID  "19   AF(  '=;  !M6   9E@, &)8%@!?6"( 75DL %M9
M-@!963X 5UE& %9930%4650!4EE; E%98P-/66P#35EW!$M8A 5)6)('2%BB
M!T=9LPA&6<H(15GJ"$99_09&6/\&1EC_!4=8_P5'6/\%QU(  +A;  "K80
MH68  )AH  ".:0  @V<  ')@  !H7@  85T) %Q=$P!:71X 5UTI %9>,P!4
M7CL 4EY# %%>2@%/7E(!3EY9 DQ>80)*7FH#2%YU!$9>@@5$79 &0UZ@!T%>
ML0= 7L@'0%[H!T!=_ 9!7?\%05W_!4%<_P5!7/\%PU8  +1?  "H9@  GFH
M )5M  "*;0  ?VP  &]G  !D9   6V(% %9B$ !48AL 4F,E %!C+P!.9#@
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M RYQ^ ,N</\#+F__ RYO_P,N;_\#LV8  *=O  "==@  DWH  (A\  !^?0
M<GT  &1\  !7>P  3'H  $)Y P \>0X .GH7 #EZ(0 X>BH -WLS #9[.P T
M>T0 ,WM, #)[50 P>U\ +WMJ 2U[=P$K>X<!*GN8 BA[J@(G>[\")GOA B9Z
M]P(F>/\")GC_ B=W_P(G=_\"KFP  *-V  "9?   CG\  (2"  !X@P  ;(0
M %^$  !1A   1X0  #R$   SA D ,(01 "^$&@ MA"0 +(4M "N%-0 JA3X
M*85' "B&4  GAEH )H9F "2&<P CAH, (8:5 ""&IP$>AKP!'H;> !Z$]0$>
M@O\!'H+_ 1Z!_P$>@?\!J'0  )Y]  "3@@  B84  'Z(  !QB@  98L  %B,
M  !,C0  0(X  #:.   LCP  )9 , ".0$P BD!P (9 E ""1+@ ?D38 'I%
M !V120 <D50 &I%@ !F1;@ 8D7X %I*0 !62I  4D;D $Y'8 !./]  4CO\
M%(W_ !2,_P$4C/\!HWT  )B#  ".B   A(P  '>/  !ID0  79,  %"5  !%
MEP  .9@  "Z9   EF@  '9L" !:=#  5G1, %)T; !.=)  2G2T $9XW !&>
M00 0GDP #YY8  Z>9P -GG< #)Z*  N=G@ *G;( "9W,  F<[  *F_X "YK_
M  N9_P +F?\ G(0  )&*  "(C@  >Y(  &V6  !@F0  5)P  $B?   \H
M,*$  ":C   =I0  %:<  !"I!0 +JPT "*H3  >J&P &JB0 !:HN  2J.  "
MJD0  :I0  "J7@  JFX  *J!  "JE0  J:H  *G!  "HY   J/8  *?_  "G
M_P  I_\ E8L  (R0  !_E0  <9H  &.>  !6H@  2J8  #VH   QJ@  )JL
M !VM   4L   #K(   FU 0 "M@H  +8/  "V%0  MQT  +<E  "W+P  N#D
M +A&  "X5   N&0  +AV  "XBP  MZ   +>V  "WTP  MN\  +;\  "V_P
MMO\ CY(  (*7  !TG0  9J(  %BG  !+K   /J\  #&Q   FLP  '+8  !.X
M   -NP  !KX   #!    P@0  ,(+  ##$   Q!4  ,0<  #%)   QBX  ,@Z
M  #)1P  R5<  ,EI  #)?0  R90  ,BJ  #(PP  R.0  ,CT  #(_0  R/T
MA9D  '>?  !HI@  6JL  $VQ   _M0  ,;@  "6Z   :O0  $<    O#   #
MQP   ,H   #-    S@   ,\#  #0"0  T0X  -,2  #5&0  UR(  -HM  #=
M.0  WDD  -Y:  #?;@  WX4  -^<  #?L@  WLL  -[F  #?]   W_0 >:$
M &NH  !<KP  3K4  $"[   QO@  ),$  !G%   0R   "<P   #/    TP
M -D   #<    W0   -\   #A    X@4  .0+  #F$   Z!8  .H@  #M*P
M\#H  /%+  #Q7@  \G,  /.+  #SH@  \[8  //)  #SX0  \^$ ;:H  %ZQ
M  !0N0  0;\  #+$   DR   %\P   [0   &U0   -H   #>    X@   .8
M  #I    Z@   .P   #N    \    /(   #T!@  ]@P  /D2  #\'   _RD
M /\Z  #_30  _V(  /]X  #_D   _Z,  /^S  #_P0  _\$ _P<9 /\!%P#_
M !< _P : /\ (0#_ "L _P Y /\ 1P#_ %0 _P!? /\ :@#_ ', _P![ /\
M@P#_ (H _P"0 /\ E@#_ )L _P"A /\ J #_ *\ _P"X /\ Q #^ -4 _ #J
M /L ^ #Z /\ ^0#_ /@ _P#X /\ ]@#_ /, _P#Q /\ _PL5 /\%$P#_ !,
M_P 4 /\ &@#_ "< _P T /\ 0@#_ $\ _P!; /\ 90#_ &X _P!V /\ ?@#_
M (4 _@"+ /T D0#[ )< ^@"= /@ HP#W *L ]@"S /0 O@#S ,P \0#C .\
M\P#N /\ [0#_ .P _P#K /\ [ #_ .P _P#K /\ _PT1 /\)$ #_  \ _P 0
M /\ %@#_ "( _P O /\ /0#_ $H _P!5 /T 8 #Z &D ^ !Q /8 >0#T '\
M\P"& /$ C #O )( [@"8 .P GP#K *8 Z0"N .< N #E ,4 XP#: .$ [0#?
M /L W@#_ -T _P#= /\ W0#_ -T _P#= /\ _P\- /\,"P#_ PD _P , /\
M$@#_ !T _P I /L -P#X $0 ]0!0 /( 6@#N &, [ !K .D <P#G 'H Y0"
M ., A@#A (P WP"3 -T F0#; *$ V0"I -4 L@#2 +X T #. ,X Y@#, /8
MR@#_ ,H _P#) /\ R #_ ,@ _P#( /\ _Q$( /\- @#_!P  _P4( /\ #@#_
M !8 ]P B .\ , #K #T Z !) .0 5 #@ %T W0!E -D ;0#5 ', T@!Z -
M@ #. (< S "- ,H E #( )L Q@"D ,0 K0#" +@ P #' +T WP"\ /$ NP#^
M +D _P"X /\ N #_ +@ _P"X /\ _Q0  /\/  #_#0  _PP  /\'"0#X 1
MZ  : ., * #= #8 V !" -( 30#. %< R@!? ,< 9@#% &T PP!T ,$ >@"_
M ($ O0"( +L CP"Y )< MP"? +4 J "S +, L0#" *\ V "N NT K /[ *L%
M_P"J!O\ J0;_ *D&_P"I!O\ _Q8  /\2  #W$@  [!$  .8.  #E!@@ W0,2
M -0#( #-!"T R 0Z ,,%1@"_!5  O 98 +D&8 "W!V< M0=N +,'=0"Q"'L
MKPB" *X)B@"L"9( J@F; *@*I0"F"K  I0N_ *,,U "A#>T GP[^ )T._P"<
M#_\ FP__ )L/_P";#_\ _QH  /<9  #J'@  WQX  -4:  #0$P( S@P+ ,<+
M%@# #24 N@XR +8./P"R#TD KQ!2 *P06@"J$&$ J!%H *81;P"D$78 HA%]
M *$1A0"?$HX G1*7 )P2H@":$ZT F!.\ )<4T "4%>P DA;] ) 7_P"/%_\
MCA?_ (X7_P".%_\ ^AT  .XC  #?*   T"H  ,<G  #!(0  O1D% +D2$ "R
M%1X K18L *@7. "D&$, H1E, )\95 "<&EP FAIB )D::0"7&W  E1MW )0;
M?P"2'(@ D!R2 (\<G0"-':D BQVW (H>R@"('^< AB#Z (0@_P&#(/\!@R#_
M 8(@_P&"(/\!]20  .4L  #3,0  QC,  +PQ  "V+0  L"4  *P=# "F'A@
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MC )E.)D#9#FH V(YN0-A.M #8#KN V Z_P-?.O\"7SK_ E\Z_P)?.O\"W3L
M ,=#  "Y20  KDL  *1,  ";2@  DD4  (D_  "!.@D >SH4 '<[( !T/"L
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M!%!'L01/1\<$3D?G!$Y'^P1.1_\#3D?_ T]'_P-/1_\#S$8  +M.  "O5
MI%<  )I8  "15P  AE0  'M.  !P2@  :4@- &5(%@!B22$ 7TDK %U)- !;
M23P 64E# %=)2@!625( 54I9 51*80%22FH!44IU D]*@0-.2H\#3$N?!$M+
ML 1*2\4$24OF!$E+^@1)2_\#2DO_ TI+_P-*2_\#R$D  +A1  "L5P  H5L
M )A<  ".7   @UD  '93  !K3@  9$T* %],$P!<31X 6DTH %A-,0!633H
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M SI8]P,Z6/\#.U?_ SM7_P,[5_\#O%0  *Y<  "C8P  F6<  )!I  "%:0
M>6<  &MB  !@8   55T  $Y;# !+6Q0 25P? $=<* !&73$ 15TY $-=00!"
M74@ 05Y0 $!>6  ^7F$!/%YL 3M>> (Y7H<"-UZ7 C9>J0,U7KT#-%_= S1>
M]0,U7?\"-5W_ C5<_P(U7/\"N%D  *IA  "@9P  EFP  (QN  "!;@  =FP
M &=I  !<9@  460  $AB"0!$8A$ 0F(; $%C)  _8RT /F,U #UD/0 \9$4
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M 2!Q_P$@<?\!J6L  )YS  "4>0  BGP  (!^  !T?P  9W\  %I_  !-?@
M0WX  #A]   O?0( *'T- "9]%  D?1P (WXE ")^+0 A?C8 (7X_ !]_2  >
M?U( '7]> !Q_:P :?WH &7^, !=_GP 6?[, %7_. !5^[P 6?/\ %GO_ !9[
M_P 7>_\ I'(  )IZ  "/?P  A8(  'N$  !MA@  8(<  %2'  !(B   /(@
M #*(   HB   ((@% !J)#@ 9B14 &(D= !>*)@ 6BBX %8HW !2*00 3BDP
M$HM8 !&+90 0BW4 #XN'  Z*FP -BJ\ #(K(  R)Z@ -A_P #H?_  Z&_P .
MAO\ GWL  )2!  "*A0  @(@  '.+  !EC0  68\  $R0  !!D@  -)(  "J2
M   ADP  &90  !*6!@ .EPX #9<5  R7'0 ,ER8 "Y<O  J7.0 )ET0 ")=0
M  :77@ %EVX  Y:   &6E   E:@  )6^  "4X   E/0  )/_  &2_P !DO\
MF((  (Z(  "%C   =X\  &J2  !=E0  4)@  $2:   XFP  +)P  "*=   9
MG@  $J    VB @ 'HPL  :,0  "C%P  HQ\  *,G  "C,0  I#P  *1(  "D
M5@  I&4  *-W  "CBP  HZ   **V  "AT@  H?   *#[  "@_P  H/\ D8H
M (F.  ![D@  ;9<  &";  !3G@  1J$  #FC   MI   (Z8  !FH   1J@
M#*P   6N    KP<  *\-  "O$0  L!@  + @  "Q*   L3(  +(^  "R3
MLEL  +)L  "R@0  L9<  +&L  "PQ@  L.@  *_W  "O_P  K_\ C)   '^5
M  !QF@  8Y\  %6D  !'J   .JH  "VL   BK@  &+   !"S   *M0   K@
M  "[    NP   +P'  "\#0  O1$  +X6  "_'@  P"<  ,$R  #"0   PT\
M ,-@  ##=   PXL  ,.A  ##N   PM<  ,+O  #"^@  P?X @9<  '.=  !E
MHP  5Z@  $FM   [L0  +;,  "&V   6N0  #KL   >^    P0   ,4   #'
M    R    ,D   #*!0  RPL  ,T/  #.%   T!P  -,F  #6,@  V$$  -A3
M  #99@  V7P  -F4  #9JP  V<,  -GA  #9\   V?0 =I\  &>F  !9K
M2[(  #RW   NN@  (;T  !7    -Q   !<<   #*    S@   -(   #5
MU@   -D   #;    W0   -\'  #A#   XQ$  .89  #I)   [#(  .U#  #N
M5@  [VL  .^$  #OG   [[(  ._&  #OW0  [^0 :J@  %NO  !,M@  /KP
M "_    @Q   %,@   S,   "T    -0   #9    W@   .(   #E    Y@
M .@   #I    [    .X   #P @  \@D  /4/  #X%P  _",  /\S  #_1@
M_UH  /]Q  #_B0  _Y\  /^Q  #_P   _\8 _P 5 /\ % #_ !0 _P 7 /\
M'0#_ "@ _P W /\ 1 #_ %$ _P!< /\ 9@#_ &\ _P!W /\ ?@#_ (4 _P"+
M /\ D0#_ )< _P"= /\ I #_ *L _P"T /X OP#] ,X ^P#F /D ]@#X /\
M]P#_ /< _P#W /\ \ #_ .P _P#I /\ _P,2 /\ $ #_ !  _P 1 /\ %P#_
M "0 _P R /\ /P#_ $P _P!7 /\ 80#_ &H _P!R /\ >0#] (  _ "& /H
MC #Y )( ^ "8 /8 GP#U *8 ] "N /( N0#P ,8 [@#> .T \ #K /X Z@#_
M .D _P#I /\ YP#_ ., _P#@ /\ _P<. /\ #0#_  L _P , /\ $P#_ !\
M_P L /\ .@#_ $8 _@!2 /L 7 #X &4 ]0!L /, = #Q 'H [P"! .X AP#L
M (T Z@"3 .D F@#G *$ Y@"I ., LP#A +\ WP#0 -T Z0#: /D V0#_ -<
M_P#5 /\ U0#_ -4 _P#4 /\ _PD* /\!!0#_  , _P ) /\ $ #_ !D ^P F
M /< - #T $  \@!, .X 5@#J %\ YP!G .0 ;@#B '0 X ![ -X @0#< (<
MV@"- -8 E #4 )L T0"C ,\ K0#, +@ R@#' ,@ X #& /, Q0#_ ,, _P##
M /\ PP#_ ,, _P## /\ _PL! /\#  #_    _P # /\ "P#S !( [@ ? .H
M+0#F #H X@!% -X 3P#9 %@ U !@ -$ : #. &X S !T ,H >P#( ($ Q@"'
M ,0 C@#" )8 P "> +X IP"[ +( N0#  +< U "U .P LP#[ +, _P"R /\
ML@#_ +$ _P"Q /\ _PT  /\&  #_ P  ]P   /0  P#G  T X  8 -H )0#3
M #( S@ ^ ,H 20#& %( PP!: ,  80"^ &@ O !N +H = "X 'L M@"! +0
MB "R )  L "9 *X H@"L *T J@"Z *@ RP"F .8 I0#W *0 _P"C /\ H@#_
M *( _P"B /\ _Q   /L,  #O#@  Y@T  -\)  #:  8 T  1 ,D '0#$ "H
MOP W +L 0@"W $L M !4 +( 6P"O &( K0!H *L ;@"I '4 J ![ *8 @P"D
M (L H@"4 *  G@"> :@ G *U )L#Q@"9!>( F ;T )8(_P"5"?\ E G_ )0)
M_P"4"?\ _!$  /$5  #C&0  UAD  ,P5  #'$   Q <* +T#% "W!"$ L@8N
M *X(.@"J"40 IPE- *0*50"B"EP H IB )X+:0"<"V\ FPMV )D,?@"7#(8
ME@R0 )0,F@"2#:8 D0VS (\-Q0"-#N( BQ#V (D0_P"($?\ AQ'_ (<1_P"'
M$?\ ]AD  .<@  #6)   R"4  +\B  "Y'   M!0! +$-#@"J#AD I0\G *$0
M,P"=$3X FA%' )@23P"5$E8 DQ)< )$28P"0$VD CA-P (P3> "+$X$ B12+
M (<4E@"&%:( A!6P (,6P0"!%]T ?QCT 'T9_P!\&?\ ?!G_ 'L9_P![&?\
M[R$  -TI  #*+0  OB\  +4L  "N)P  J"   *,7" ">%A, F1<A )09+0"1
M&C@ CAI! (L;20")&U  AQM7 (4<7@"$'&0 @AQK ( <<P!_'7P ?1V& 'P>
MD0!Z'IX >!^K '<?O !V(-0 ="'P '(A_P!Q(O\ <2'_ '$A_P!Q(?\ Z"@
M -(P  #"-0  MS<  *TU  "E,0  GBL  )@C @"2'A  C2 ; (DA)P"&(C(
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M 5PSL0%;-,8!6C3F 5DU^P%9-?\!633_ 5DT_P%9-/\!TC@  ,!   "S10
MJ$@  )Y(  "51@  BT   (([  !Y-00 <S,0 &\T&@!L-"4 :34O &<U-P!E
M-C\ 8S9& &(V30!@-E0 7S9; %TW8P!<-VL 6S=V 5DW@@%8.(\!5CB> 54X
MKP)4.<,"4SGD E,Z^0%3.?\!4CG_ 5,Y_P%3.?\!S3P  +Q$  "O20  I$P
M )I,  "12P  AT8  'U   !S.P  ;#@- &@Y%P!E.2( 8SHK & Z- !>.CP
M73I# %LZ2@!:.U  6#M8 %<[8 !6.V@ 53QS 5,\?P%2/(T!4#V< 4\]K ).
M/L$"33[A DT^^ )-/O\!33[_ 4T]_P%-/?\!R4   +A(  "L30  H5   )=1
M  ".3P  A$L  'E%  !N0   9CT+ &(]% !?/1X 7#XH %H^,0!8/C@ 5SY
M %4_1@!4/TT 4S]5 %) 70!00&8 3T!P 4Y ? %,08H!2T&: DI!JP))0KX"
M2$+> DA"]@)(0O\"2$+_ 4A!_P%(0?\!Q40  +5+  "I4   GE0  )54  "+
M4P  @%   '5*  !J1@  84(( %Q!$0!90AL 5T(E %5"+@!30C4 44(] $]"
M0P!/0TL 3D-2 $U$6@!+1&, 2D1N 4E%>@%'18@!1D68 D5&J0)$1KT"0T;<
M D-&]0)#1O\"0T;_ 4-%_P%#1?\!P4<  +)/  "F5   G%<  ))8  "(6
M?E4  '%/  !F2@  7$8% %=&#P!41A@ 448B $]&*P!.1C, 3$<Z $M'00!*
M1TD 24A0 $A(6 !'2&$ 14EL $1)> %"288!04F6 4!*IP(_2KL"/DO8 CY*
M\P(^2O\"/DG_ 3])_P$_2?\!O4H  *]2  "C6   F5L  )!=  "&7   >UD
M &U3  !B3P  5TP! %%*#0!.2A4 3$L? $I+* !)2S  1TLX $9,/P!%3$8
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M 2Y7_P$N5O\!LE<  *5?  ";90  D6D  (=J  !\:@  <6@  &-E  !88@
M35\  $-= @ \6PT .EP4 #A<'0 W7"8 -5TN #1=-@ S73X ,EU& #%>3@ P
M7E< +UYB "U>;@ L7WT *E^. "E?H  H7[,!)U_, "=?[0$G7O\!)UW_ 2A=
M_P$H7/\!K5P  *)D  "8:@  CFX  (-O  !Y;P  ;FX  &!K  !4:0  26<
M #]E   U8PD ,F,1 #!C&0 O9"$ +F0I "UD,0 L9#D *V5" "IE2@ H950
M)V5? "9F:P D9GH (V:+ ")FG0 @9K$ 'V;) !]FZP @9?X (&3_ "!C_P$A
M8_\!J6(  )YJ  "5<   BG,  (!U  !U=0  :70  %QR  !/<0  1&\  #IN
M   P;0, *6P- "=L%  F;!P )6TD "1M+  C;30 (FT] "%N1@ @;E  'FY;
M !UN9P <;G8 &FZ' !EOF@ 8;ZX %F_& !9NZ0 7;?P &&S_ !AK_P 8:_\
MI&D  )IQ  "0=@  AGD  'Q[  !Q>P  9'L  %=Z  !*>0  /W@  #5X   K
M=P  (G8' !UV#P <=Q8 &W<> !IW)@ 9=RX &'<W !=X0  5>$H %'A6 !-X
M8P 2>'( $7B# !!XEP />*L #GC#  YWY@ .=OH #W7_ !!U_P 0=/\ GW$
M )5X  "+?   @G\  '>!  !J@@  78(  %""  !$@@  .((  "Z"   D@@
M'((  !2""0 1@Q  $(,6 !"#'@ .@R< #H,P  V#.0 -@T0 #(-0  N#70 )
M@VP "(-^  :#D0 %@J4  X*[  2!VP $@?( !8#_  9__P &?_\ FGD  )!^
M  "&@P  ?84  &^'  !BB0  58H  $F+   ]C   ,8P  ":,   =C0  %8X
M  ^/ P *D P !I 1  2/&  #CR   8\I  "/,@  D#T  )!)  "/5@  CV4
M (]V  "/B@  CI\  (ZT  "-SP  C.X  (S[  "+_P  B_\ E(   (N%  ""
MB0  =(P  &:/  !9D0  3),  $"5   TE@  *)8  !Z7   5F   #YH   J;
M   "G D  )P.  "<$P  G!H  )PB  "=*P  G34  )U   "=3@  G5P  )UN
M  "<@0  G)<  )RL  ";Q@  FN@  )GY  "9_P  F/\ CH@  (:,  !XD
M:I0  %R7  !/F@  0IT  #:>   IGP  'Z$  !6B   .I   "*8   "H
MJ00  *D*  "I#@  J1,  *H:  "J(@  JRL  *PV  "L1   K%,  *QC  "L
M=P  JXX  *ND  "KO   JMX  *GT  "I_0  J?\ B8X  'N3  !MEP  7YP
M %&@  !$I   -J8  "JH   >J0  %*L   VN   &L    +(   "U    M0
M +4#  "V"0  MPX  +@2  "X&0  NB$  +LK  "\.   O4<  +U8  "]:P
MO8$  +V9  "]L   O<P  +SJ  "\]P  N_X ?I4  '";  !BH   4Z4  $:J
M   XK0  *J\  !ZQ   3M   #+<   .Y    O    +\   #"    P@   ,,
M  #$    Q@8  ,<,  #($   RA8  ,P@  #/*P  T#H  -%+  #17@  TG,
M -*+  #2I   T[L  -/8  #3[0  T_8 <YT  &2C  !6J0  1Z\  #FS   J
MM@  ';D  !*\   *OP   ,,   #&    R0   ,T   #/    T    -(   #4
M    U@   -D"  #;"   W@X  .$3  #D'0  Z"H  .@\  #I3P  Z60  .I\
M  #KE0  ZZP  .O"  #LU0  [.4 9J8  %BL  !)LP  .[D  "N\   =P
M$<0   G(    S    ,\   #3    V0   -T   #@    X0   .,   #E
MYP   .H   #L    [@0  /$+  #U$@  ^!P  /LK  #]/@  _E,  /YJ  #_
M@P  _YL  /^N  #_O@  _\H _P 2 /\ $ #_ !$ _P 3 /\ &0#_ "8 _P T
M /\ 00#_ $T _P!8 /\ 8@#_ &L _P!S /\ >@#_ ($ _P"' /\ C0#_ ),
M_P"9 /\ H #_ *< _@"O /P N@#Z ,D ^0#A /@ \P#W /\ ]@#_ /4 _P#Q
M /\ Z0#_ .0 _P#A /\ _P / /\ #0#_  T _P . /\ % #_ "$ _P N /\
M/ #_ $@ _P!3 /\ 70#_ &8 _@!M /P =0#[ 'L ^0"" /@ B #W (X ]@"4
M /0 FP#S *( \0"J .\ M #M ,$ ZP#5 .H [ #H /P YP#_ .4 _P#F /\
MX #_ -D _P#4 /\ _P + /\ " #_  8 _P ) /\ $ #_ !P _P I /\ -@#_
M $( ^P!. /< 5P#T &  \@!H .\ ;P#M '8 [ !\ .H @@#H (@ YP". .4
ME0#C )P X0"D -\ K@#= +D V@#* -< Y #4 /8 T0#_ -  _P#0 /\ SP#_
M ,L _P#' /\ _P # /\   #_    _P $ /\ #0#Z !8 ]@ C /, , #P #P
M[0!' .D 40#E %H X@!B -\ :0#= &\ V@!V -@ ? #4 (( T@"( -  CP#-
M )8 RP"> ,D J #' +, Q0#! ,( V #  .\ OP#^ +X _P"] /\ O #_ +P
M_P"\ /\ _P(  /\   #_    _P   /0 !P#M !$ Z  < ., *0#? #4 VP!!
M -8 2P#1 %0 S0!< ,H 8P#( &D Q@!O ,, =0#! 'L OP"" +X B "\ )
MN@"8 +@ H@"U *P LP"Y +$ RP"O .< K@#X *P _P"K /\ K #_ *P _P"K
M /\ _P0  /\   #V    [@   .<   #?  P U@ 5 ,\ (@#* "X QP Z ,,
M1 #  $T O !5 +D 7 "W &, M0!I +, ;P"Q '4 KP![ *T @@"K (H J0"2
M *< G "E *8 HP"S *$ PP"? -X G@#R )T _P"< /\ G #_ )L _P"; /\
M_P<  /8)  #I"P  WPH  -4$  #.  4 Q@ 0 ,  &@"[ "< MP R +, /0"P
M $8 K0!/ *H 5@"H %P I@!C *0 : "B &\ H0!U )\ ? "= (0 FP"- )D
MEP"7 *( E0"N ), O0"1 -, D #M (\ _ ". /\ C0'_ (T!_P"- ?\ ^0X
M .H2  #<%0  S14  ,01  "^#   N@(* +0 $@"N !X J@ J *8 -0"B #\
MH !( )T!4 "; E8 F0)< )<#8P"5 VD DP-O )$$=@"0!'\ C@6( (P%D@"*
M!IX B :J (8'N@"%",\ A KK ((+_ "!#/\ @ S_ ( ,_P" #/\ \14  . =
M  #-(   P2$  +@=  "Q%P  K!   *@)#0"B!Q8 G0DC )D*+@"5"S@ DPQ!
M ) ,20".#5  C U7 (H-70"(#6, APUJ (4.<0"##GH @@Z$ ( .CP!^#YL
M? ^H 'L0N !Z$,X >!'L '82_P!U$O\ =!/_ '03_P!T$_\ Z!X  -,F  ##
M*@  N"H  *XH  "G(P  H!P  )L3 P"6#Q  D! ; (P1)P")$C( AA,[ (03
M0P""%$L @!11 'X45P!\%%X >Q5E 'D5; !W%70 =A9^ '06B@!R%Y8 <1>D
M &\8M !N&,D ;1GH &L:_ !J&_\ :AO_ &H;_P!J&_\ X"8  ,HM  "\,0
ML#,  *<Q  "?+   ER8  ) ?  "*%PP A1@6 ($9(@!^&BP >QLV 'D;/@!W
M'$4 =1Q, ',<4P!Q'5D <!U@ &X=9P!M'G  :QYZ &H>A0!H'Y( 9Q^@ &4@
ML !D(<4 8R'D &(B^@!A(O\ 82+_ &$B_P!A(O\ URP  ,,T  "V.   JCD
M *$X  "8-0  D"\  (@H  " (0@ >R 2 '<A'0!T(B< <2(Q &\C.0!M(T$
M:R-( &DC3@!H)%4 9B1; &4D8P!C)6L 8B5U &$E@0!?)HX 7B:= %TGK0!;
M*,$ 6RC@ %HI]P!9*?\ 62G_ %DI_P!9*/\ SS(  +XY  "Q/0  IC\  )P_
M  "3/   BC8  ($P  !Y*@, <B8/ &XG&0!K*", :2@L &8I-0!E*3P 8RE#
M &$J2@!@*E$ 7BI7 %TJ7P!<*V@ 6BMR %DL?0!8+(L 5BV: %4MJ@!4+KT
M4R[< %(O]0!2+_\ 4B[_ %(N_P!2+O\ RC8  +H]  "M0@  HD0  )A$  "/
M00  A3P  'LW  !R,0  :RP, &<M%0!D+1\ 82XH %\N,0!=+CD 7"]  %HO
M1@!8+TT 5R]4 %8P7 !5,&0 4S%N %(Q>@!1,8@ 4#*7 $XRJ !-,[L 3338
M $PT\P!,-/\ 3#3_ $PS_P!,,_\ QCH  +9"  "I1@  GDD  )5)  "+1P
M@4(  '<]  !M-P  9#() & R$@!=,AP 6C(E %@S+0!6,S4 53,\ %,T0P!2
M-$H 4311 % T60!/-6$ 335L $PV=P!+-H4 2C>5 $@WI@!'.+@!1SC3 48X
M\0%&./\!1CC_ $8X_P!&-_\ P3X  +)%  "F2@  G$T  ))-  "(2P  ?D<
M '-"  !I/0  7S<& %HV$ !7-Q@ 5#<B %(W*@!0-S( 3S@Y $TX0 !,.$<
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M 3A$_P$X0_\ MTD  *E0  ">50  E%@  (M9  " 6   =E8  &A0  !=3
M4T@  $I%"0!&1!$ 1$09 $)$(@!!12D /T4Q #Y%.  ]13\ /$9' #M&3P Z
M1U@ .4=B #A(;@ V2'P -4B- #1)G@ S2;$ ,DG) #%)ZP R2?X ,DC_ #)(
M_P S2/\ M$P  *=4  "<60  DEP  (A=  !^70  <UH  &55  !;4@  4$X
M $9*!0! 20X /DD6 #U)'@ [2B8 .DHN #E*-0 X2ST -TM$ #9+30 T3%8
M,TQ@ #),;  Q37H ,$V+ "Y-G  M3J\ +$[' "Q.Z0 L3?T +4W_ "U,_P M
M3/\ L%   *18  "970  CV$  (9B  ![80  <%\  &);  !86   3E4  $-1
M 0 [3PP .$\3 #9/&P U3R, -% K #-0,@ R4#H ,5!" #!12@ N45, +5)=
M "Q2:0 K4G@ *5*( "A3F@ G4ZT )E/% "93YP F4_P )U+_ "=1_P G4?\
MK%4  *!<  "68@  C68  (-G  !X9@  ;64  &!A  !57@  2EL  #]8   U
M5@@ ,540 #!6%P N5A\ +58G "Q6+P K5S8 *E<^ "E71P H5U  )EA: "58
M9P D6'4 (UF& "%9F  @6:L 'UG" !]9Y0 ?6/H (%C_ "!7_P A5_\ J%H
M )UB  "39P  BFL  ']L  !U;   :FL  %UH  !190  1F,  #M@   Q7@,
M*ET- "A=$P F71L )5XC "1>*@ C7C( (EXZ "%>0P @7TP 'U]7 !Y?8P <
M8'$ &V"" !E@E0 88*D %V#  !9@X@ 77_D &%[_ !E>_P 97?\ I&   )EH
M  "0;@  AG   'QR  !R<@  9G$  %AN  !,;   06L  #9I   M9P  (V8(
M !]F#P =9A4 '&8= !MF)0 :9BT &6<U !AG/@ 79T@ %F=3 !5H7P 3:&X
M$FA_ !%HD@ 0:*8 #VB]  YHX  09_< $&;_ !%E_P 19?\ GV<  )9O  ",
M<P  @G8  'AX  !M>   8'<  %-V  !&=   .W,  #%R   G<0  'G$  !9P
M"@ 3<!  $W 7 !)P'P 1<2< $'$O !!Q.  .<4( #G%.  UQ6P ,<6D "W%Z
M  IQC0 (<:$ !G&V  9PT@ '<.\ "&__  EN_P );O\ FV\  )%U  "'>0
M?GP  '1^  !F?@  67X  $U^  ! ?0  -7T  "I\   A?   &'P  !%\!  ,
M? P "GP1  E\&0 (?"$ !WPI  9\,@ $?#T  WQ(  %\50  ?&,  'QT  !\
MAP  >YP  'NQ  !ZRP  >>L  'GZ  !Y_P  >/\ EG<  (Q\  "#@   >8,
M &R$  !>A0  488  $6'   YAP  +8<  ".'   :AP  $H<   V( 0 &B0H
M 8D/  ")%   B!L  (@C  ")+   B38  (E"  "(3@  B%T  (AM  "(@0
MAY4  (>K  "&Q   A>8  (3X  "$_P  A/\ D'X  (>#  !^AP  <8D  &.+
M  !6C0  28\  #R1   PD0  ))$  !J2   2DP  #90   :5    E@8  )8,
M  "5$   EA4  )8=  "6)   EBX  )8Y  "61@  EE4  )9E  "6>   E8X
M )6D  "4O   D]\  )/U  "2_P  DO\ BX8  (.*  !UC0  9Y   %F4  !,
MEP  /YD  #*:   FFP  &YP  !*=   ,GP  !*    "B    HP$  *,'  "C
M#   HQ   *05  "D'   I24  *8O  "F/   IDL  *9;  "F;@  I80  *6;
M  "DLP  H]   */O  "B_   HO\ AHT  'B1  !JE0  7)D  $Z=  !!H
M,Z(  ":C   ;I0  $:<   JI   !JP   *T   "O    L    +    "P!0
ML0L  +(/  "S%   M!L  +4D  "W,   MS\  +=0  "W8@  MW@  +>0  "V
MJ0  ML(  +;D  "V]0  M?X >Y,  &V8  !?G0  4*(  $*F   TJ0  )JL
M !JM   0KP  ";(   "T    MP   +H   "\    O0   +X   "^    P (
M ,$(  #"#0  Q!(  ,89  #))   RC(  ,M#  #+50  S&H  ,R#  #,G
MR[4  ,S.  #,Z0  S/8 <)L  &&A  !2I@  1*L  #:P   GL@  &K4  !"X
M   'NP   +X   #!    Q    ,@   #+    RP   ,T   #.    T    -(
M  #5 P  V H  -L0  #>&   XB0  .,U  #D2   Y5P  .9S  #FC0  YJ4
M .:\  #FTP  Y^< 8Z0  %6J  !&L   .+4  "BY   :O   #\    7$
MQP   ,L   #/    U    -@   #<    W0   -\   #A    XP   .4   #H
M    Z@   .T&  #Q#@  ]18  /@E  #Y.   ^4T  /IC  #[?   _)4  /RJ
M  #\NP  _<L _P / /\ #@#_  X _P 0 /\ %@#_ ", _P P /\ /0#_ $D
M_P!4 /\ 7@#_ &8 _P!N /\ =@#_ 'P _P"" /\ B0#_ (\ _P"5 /X FP#]
M *, ^P"K /H M0#Y ,, ]P#; /8 \ #T /\ \P#_ /( _P#L /\ X@#_ -P
M_P#6 /\ _P , /\ "0#_  @ _P * /\ $@#_ !X _P K /\ . #_ $0 _P!/
M /\ 60#^ &$ _ !I /H < #X '< ]P!] /8 @P#T (D \@"/ /$ E@#O )T
M[0"E .P KP#J +P Z #- .8 Z #D /H XP#_ .( _P#@ /\ U0#_ ,X _P#+
M /\ _P & /\  0#_    _P $ /\ #@#_ !D _P E /T ,@#[ #X ]P!) /,
M4P#P %P [@!C .P :@#J '$ Z !W .8 ?0#D (, X@") .  D #> )< W "?
M -D J0#6 +0 TP#$ -  W@#. /, S #_ ,L _P#* /\ R #_ ,( _P"^ /\
M_P   /\   #_    _P   /L "P#V !, \0 @ .T + #J #@ YP!# ., 30#@
M %8 W != -D 9 #5 &L T@!Q -  =@#. 'P S "# ,H B0#( )$ Q@"9 ,0
MHP#! *T OP"[ +T SP"[ .L N0#\ +< _P"W /\ M@#_ +0 _P"Q /\ _P
M /\   #_    ]@   .X !0#G  \ X0 9 -L )0#5 #$ T@ \ ,X 1@#* $\
MQP!7 ,0 7@#! &0 OP!J +T < "[ '8 N0!\ +@ @P"V (H LP"3 +$ G "O
M *< K0"S *L Q0"I .$ IP#U *8 _P"E /\ I #_ *0 _P"D /\ _P   /P
M  #Q    Z    .    #4  L S  3 ,< 'P#" "H OP U +P /P"X $@ M0!0
M +, 5P"P %X K@!D *P :0"K &\ J0!U *< ? "E (0 HP", *$ E@"? *$
MG0"M )H O "8 -( EP#N )4 _@"4 /\ E0#_ )4 _P"5 /\ _ $  / %  #C
M!P  U04  ,P   #%  0 O@ . +@ %P"S ", KP N *L . "I $$ I@!* *,
M40"A %< GP!= )T 8P"; &D F@!O )@ =@"6 'T E "& )( D "0 )L C@"G
M (P M@"* ,D B #G (< ^0"' /\ A@#_ (8 _P"& /\ ] P  .00  #1$@
MQ1$  +T.  "V"   L0 ( *L $0"F !L H0 F )X ,0": #H F !# )4 2@"3
M %$ D0!7 (\ 70". &, C !I (H < "( '< A@"  (0 BP"" )8 @ "C 'X
ML0!] ,0 >P+A 'H#]0!Z!?\ >07_ '@&_P!X!O\ ZA,  -8:  #&'0  NAP
M +$9  "J$P  I T  )\%# "9 !0 E0 ? )$"*0"- S, BP0\ (@%1 "&!DL
MA 91 (('5P"!!UT ?P=C 'T(:@!["'( >@A\ '@)A@!V"9( = J@ ',*KP!Q
M"\$ < S? &\-]@!N#O\ ;0[_ &T._P!M#O\ X1P  ,LC  "\)@  L28  *@D
M  "@'@  F1@  ),0 @"."PX B L7 (0,(@"!#2P ?@TU 'P./0!Z#D4 > Y+
M '<.40!U#U@ <P]> '$090!P$&X ;A!W &P0@@!K$(\ :1&= &@1K0!F$L
M91+? &03]@!C%/\ 8Q3_ &(4_P!B%/\ UB0  ,,J  "U+@  JB\  * M  "8
M*   D"(  (D;  ""$P@ ?1$2 'D2' !V$R< <Q0P '$4. !O%3\ ;15& &P5
M3 !J%E, :!99 &<680!E%FD 9!=R &(7?@!A&(L 7QB9 %X9J0!<&;P 7!K8
M %H;\P!:'/\ 61S_ %D<_P!9'/\ S2H  +TQ  "O-0  I#8  )LT  "2,0
MB2L  ($E  !Y'0, <Q@. &\9& !L&B( :1LK &<;,P!E'#L 9!Q! &(=2 !@
M'4X 7QU5 %T=7 !<'F0 6QYN %D?>0!8'X< 5B"6 %4@I@!4(;@ 4R'2 %(B
M\0!2(_\ 4B/_ %(B_P!2(O\ R"\  +@V  "K.@  H#P  )8[  "-.   @S(
M 'HM  !R)@  :B , &8@$P!C(1T 82$F %\B+P!=(C8 6R(] %HC1 !8(TH
M5R-1 %4C6 !4)&$ 4R1J %$E=@!0)8, 3R:3 $XGHP!,)[4 3"C. $LH[@!+
M*?\ 2RC_ $LH_P!+*/\ PS0  +,[  "G/P  G$$  ))   ")/@  ?SD  '4S
M  !L+0  8R<( %XF$0!<)AD 62<B %<G*P!5*#( 5"@Y %(H0 !1*$8 4"E-
M $XI50!-*5T 3"IG $LJ<P!)*X  2"N0 $<LH0!&+;, 12W+ $4N[ !$+O\
M1"[_ $4M_P!%+?\ OC@  + _  "D0P  F44  (]%  "%0P  >SX  '$Y  !G
M-   7BX$ %@K#@!5*Q8 4BP? % L)P!/+"\ 32TV $PM/ !*+4, 22U* $@N
M4@!'+EH 1B]D $4O< !#,'X 0C"- $$QG@! ,K$ /S+( #\SZ@ _,_X /S+_
M #\R_P _,O\ NSP  *U#  "A1P  EDD  (Q)  "#2   >$0  &T^  !C.0
M6C0  %(P# !/,!, 3# < $HP) !),2L 1S$R $8Q.0!$,4  0S)' $(R3P!!
M,U@ 0#-B #\T;0 ^-'L /36+ #PVG  [-J\ .C?& #DWZ  Y-_P .C?_ #HV
M_P Z-O\ MT   *I&  ">2P  E$T  (I.  " 3   =4@  &I#  !@/@  5CD
M $TU"0!)-!$ 1S49 $4U(0!#-2@ 034O $ U-@ _-CT /C9% #TW30 \-U4
M.SA@ #HX:P Y.7D .#F) #<ZFP U.JT -3O$ #0[Y@ T._L -3O_ #4Z_P U
M.O\ M$,  *=*  "<3@  DE$  (A2  !^4   <TT  &=(  !<1   4C\  $@Z
M!@!$.0\ 03D6 #\Y'@ ^.28 /#DM #LZ-  Z.CL .3M" #@[2@ W/%, -CQ=
M #4]:0 T/7< ,SZ' #$^F0 P/ZL +S_" "\_Y  O/_H ,#__ # ^_P P/O\
ML4<  *1-  "94@  CU4  (96  !\50  <5(  &1,  !920  3T4  $5  P _
M/@T /#X3 #H^&P Y/B, -SXJ #8_,0 U/S@ -#]  #- 2  R0%$ ,4%; #!!
M9P N0G4 +4*% "Q#EP K0ZH *D/  "E$X@ J0_D *D/_ "M"_P K0O\ KDH
M *%1  "75@  C5D  (-:  !Y6@  ;E<  &%2  !73@  34L  $-'   Z0PH
M-D,1 #1#&  S0R  ,D0G #%$+P P1#8 +T4] "U%1@ L14\ *T99 "I&9  I
M1W( *$># "9'E0 E2*@ )$B^ "-(X  D2/< )4?_ "5'_P F1_\ JD\  )]5
M  "46@  BUX  (%?  !W7@  :UP  %]8  !550  2U$  $!-   U2@< ,$D.
M "Y)%0 M21T +$DD "M**P J2C, *$H[ "=+0P F2TP )4M6 "1,8@ C3'
M(4R  "!-DP ?3:8 'DV[ !U.W0 >3?8 'DS_ !],_P @2_\ IU,  )Q:  "2
M7P  B&,  'YD  !T8P  :6$  %Q>  !26P  1U@  #Q5   R4@( *E , "=/
M$@ F4!D )5 @ "10*  C4"\ (E$W "%10  @44D 'E)3 !U27P <4FT &E-]
M !E3D  84Z0 %E.Y !53V0 64_0 %U+_ !A1_P 94?\ HUD  )A@  "/90
MA6@  'MI  !Q:0  9F<  %ED  !-80  0E\  #A<   N6@  )5@( "!7#@ >
M5Q0 '5<< !Q8(P ;6"L &E@S !E8/  86$4 %EE0 !596P 466D $UIZ !):
MC0 16J$ $%JW  Y:U0 06?, $%G_ !%8_P 16/\ GU\  )5F  ",:P  @FT
M 'AN  !N;P  8FT  %5J  !(:   /F8  #-E   I8P  (&$! !A@"P 58!
M%& 7 !-@'@ 28"8 $F N !%A-P 084  #V%+  YA6  -868 #&)V  MBB0 *
M89T "6&R  AARP (8>L "6#]  I?_P +7_\ FV8  ))M  "(<0  ?G,  '5U
M  !J=   7',  $]R  !#<   .&\  "UN   D;   &VL  !-K!  .:@P #6H2
M  QJ&0 +:B$ "FHI  EJ,@ (:CP !VM'  5K4P $:V$  FMQ  !JA   :I@
M &JM  !IQ@  :><  &GX  !H_P  :/\ EVT  (US  "$=P  >WH  '![  !C
M>P  5GH  $EZ   ]>0  ,7@  "=W   ==@  %78   ]V @ )=@H !'8/  !V
M%0  =AP  '8D  !U+   =38  '5!  !U3@  =5P  '5L  !U?@  =),  '2H
M  !SP   <^,  '+W  !R_P  <?\ DG4  (EZ  " ?@  =H   &F!  !;@@
M3H(  $&"   U@P  *8(  !^!   6@0  $((   J"   "@P<  ((-  ""$0
M@A<  ((>  "")@  @B\  (([  ""1P  @E4  (%E  "!>   @8T  ("B  !_
MN@  ?]T  '[T  !]_P  ??\ C7P  (2!  ![A   ;H8  &"(  !2B@  18L
M #F,   LC   (8P  !>,   0C0  "8X   */    D ,  (\)  "/#@  CQ(
M ) 8  "0'P  D"@  ) R  "0/P  D$T  )!=  "/<   CX4  (Z<  ".LP
MC=   (SP  "+_@  B_\ B(0  ("(  !RBP  9(T  %:0  !(DP  .Y4  "Z6
M   BE@  %Y<   ^8   (F0   )L   "=    G0   )T#  "="0  G0T  )X1
M  ">%P  GQ\  )\I  "@-0  H$,  *!4  "@9@  GWL  )Z3  ">JP  G<8
M )WI  "<^0  G/\ @XL  '6.  !GD@  698  $N9   ]G   ,)X  ".?   7
MH   #J(   >D    I@   *@   "J    J@   *H   "K 0  JP<  *P,  "M
M$   KA8  *\>  "Q*0  L3@  +%(  "Q6@  L6\  +&(  "QH   L+H  *_=
M  "O\@  K_T >)$  &J6  !<F@  39\  #^C   QI@  (Z<  !>I   .JP
M!:X   "P    L@   +4   "W    MP   +@   "Y    N@   +P#  "]"0
MO@X  , 4  ##'@  Q2L  ,4\  #&3@  QF(  ,9Z  #&E   QJT  ,;(  #%
MY0  Q?, ;)D  %Z>  !/I   0:@  #*L   DKP  %K$   VT   #MP   +H
M  "]    P    ,0   #&    Q@   ,@   #)    RP   ,P   #.    T 8
M -,-  #8$P  W!X  -XM  #?0   X%0  .%K  #AA0  X9\  .&W  #ASP
MX>8 8*$  %*G  !#K0  -+(  "6U   7N0  #;P   &_    PP   ,<   #*
M    SP   -,   #6    UP   -H   #<    WP   .$   #C    Y@   .D!
M  #L"P  \!(  /,?  #T,0  ]D8  /=<  #X=   ^(\  /FF  #YN   ^,D
M_P - /\ "P#_  L _P . /\ $P#_ !\ _P L /\ .0#_ $4 _P!0 /\ 60#_
M &( _P!J /\ <0#_ '< _P!^ /\ A #^ (H _0"0 /P EP#Z )X ^0"G /<
ML0#V +X ]0#2 /, [ #Q /X \ #_ /  _P#F /\ W #_ -( _P#- /\ _P '
M /\ ! #_  ( _P & /\ $ #_ !L _P G /\ ,P#_ #\ _P!* /X 5 #[ %T
M^0!D /< :P#U '( \P!X /( ?@#P (0 [P"* .T D0#L )D Z@"A .@ JP#F
M +8 Y #' .( XP#@ /< W@#_ -T _P#9 /\ S #_ ,4 _P#! /\ _P   /\
M  #_    _P ! /\ #0#_ !8 _  B /D +@#V #D \P!% .\ 3@#L %< Z0!>
M .8 90#D &P X@!R .  =P#? 'X W0"$ -L BP#8 )( U0"; -( I #/ *\
MS0"^ ,L U0#) .\ QP#_ ,4 _P#$ /\ O@#_ +@ _P"U /\ _P   /\   #_
M    _@   /< "0#Q !$ ZP < .< * #D #, X0 ^ -T 2 #8 %$ TP!8 -
M7P#. &4 S !K ,H <0#( '< Q@!] ,0 A #" (P P "4 +X G@"[ *@ N0"V
M +< R "U .8 LP#Z +$ _P"P /\ L #_ *P _P"I /\ _P   /\   #Z
M\0   .@  P#@  T V  6 -$ (@#- "T R@ W ,8 00#" $H OP!2 +T 60"Z
M %\ N !E +< :@"U '  LP!V +$ ?0"O (4 K0"- *L EP"I *$ IP"N *4
MO@"B -@ H #R )\ _P"> /\ G@#_ )X _P"< /\ _P   /<   #K    X0
M -8   #+  D Q0 1 +\ &P"[ "8 MP Q +0 .@"Q $, K@!+ *L 4@"I %@
MIP!> *8 9 "D &D H@!P *  =@"> 'X G "& )H D "8 )L E@"G )0 M@"2
M ,H D #I (\ _ ". /\ C0#_ (P _P"- /\ ^    .D"  #; P  S $  ,0
M  "]  ( M@ - +  %0"K "  IP J *0 - "A #P G@!$ )P 2P": %( F !8
M )8 70"5 &, DP!I )$ < "/ '< C0"  (L B@") )4 AP"A (4 KP"# ,$
M@0#@ (  ]0!_ /\ ?P#_ '\ _P!_ /\ [@H  -P.  #*$   O@X  +4+  "O
M P  J0 ' *, $ "> !@ F0 C )8 + "3 #4 D  ^ (X 10", $L B@!1 (@
M5P"& %T A0!C (, :@"! '$ ?P!Z 'T A ![ (\ >0"< '< J@!U +L = #4
M '( \ !R /\ <@#_ '$ _P!Q /\ XQ$  ,T7  "_&0  LQD  *H5  "C$
MG0H  )<!"@"1 !( C0 ; (D )0"% "\ @P W (  /@!^ $4 ?0!+ 'L 40!Y
M %< > != '8 9 !T 6L <@%T ' "?P!N HL ; .8 &L#I@!I!+< : 7. &<'
M[ !F"/T 9@G_ &4)_P!E"?\ UAH  ,0@  "V(P  JR,  *$@  "9&P  DA0
M (P. 0"&!PT @ 04 'P&'@!Y!R@ =@@P '0(. !R"3\ < E% &\*3 !M"E(
M; I8 &H+7P!H"V< 9PMP &4,>@!C#(< 8@R5 & -I !?#;8 7@W. %P.[0!<
M#_\ 6Q#_ %L0_P!;$/\ S2$  +PH  "O*P  I"L  )HI  "2)   B1\  ((8
M  ![$04 =0T/ '$-%P!N#B$ :PXJ &D/,@!G$#D 91!  &001@!C$$T 81!3
M %\16@!>$6( 7!%K %L1=@!9$H, 6!*2 %83H@!5$[0 5!/+ %,4[ !2%?\
M4A;_ %(5_P!2%?\ QB@  +8N  "I,@  GS(  )4Q  ",+0  @R<  'HA  !R
M&@  :Q,+ &<3$P!D%!P 810E %\5+0!=%30 7!4[ %L60@!9%D@ 6!9/ %87
M5@!5%UX 4Q=G %(8<@!0&'\ 3QF. $X:GP!,&K  2QO' $L;Z0!*'/T 2AS_
M $H<_P!*'/\ P2T  +$T  "E-P  FC@  ) W  "'-   ?2\  '0I  !L(P
M9!P' %X9$ !;&A@ 61LA %<;*0!5&S  5!PW %(</0!1'$0 3QU+ $X=4@!-
M'5H 2QYC $H>;@!)'WP 1Q^+ $8@G !%(:X 1"'$ $,BY@!#(OP 0R+_ $,B
M_P!#(O\ O#(  *TX  "A/   ESX  (T]  "#.@  >34  &\P  !F*@  7B0"
M %<@#0!4(!0 42 = $\A)0!.(2P 3"$S $LB.@!)(D  2")' $<B3@!&(U<
M1"-@ $,D:P!")'D 026( #\FF0 ^)JL /2?! #TGXP ]*/H /2C_ #TG_P ]
M)_\ N#8  *H]  ">0   E$(  (I"  " /P  =CL  &PV  !B,   62H  %$E
M"P!-)1$ 2R49 $DE(0!')B@ 128O $0F-@!#)CT 0B=$ $$G2P _*%0 /BA=
M #TI:0 \*78 .RJ& #DKEP X*ZD -RR_ #<LX  W+/@ -RS_ #<L_P X+/\
MM3H  *=   "<1   D48  (=&  !]1   <T   &@[  !?-@  53$  $PK!P!'
M*0\ 12H6 $,J'@!!*B4 /RHL #XK,P ]*SD /"M! #LL2  Z+%$ .2U; #@N
M9@ V+G, -2^# #0OE0 S,*< ,C"] #$QW@ Q,?< ,C'_ #(P_P S,/\ L3X
M *1$  "92   CTH  (5*  ![20  <$4  &5   !;.P  4C8  $@Q! !"+@T
M/RX3 #TN&P [+B( .2\I #@O+P W+S8 -C ^ #4P1@ T,4\ ,S%9 #(R9  Q
M,G$ ,#.! "\TDP N-*8 +#6[ "PUVP L-?4 +37_ "TT_P N-/\ KD$  *)(
M  "73   C4X  (-.  !Y30  ;DH  &)%  !80   3CP  $4W   ],PL .3,1
M #<S&  V,Q\ -#,F #,S+0 R-#0 ,30\ # U1  O-4P +C96 "TV8@ L-V\
M*S=_ "HXD0 H.*0 )SFY "8YV  G.?0 *#G_ "@X_P I./\ JT4  )]+  "4
M3P  BU(  (%3  !W4@  ;$\  %])  !61@  3$(  $(]   X. @ -#@/ #(X
M%0 Q.!T +S@D "XX*P M.3( +#DY "LZ00 J.DH *3M4 "@[7P G/&T )3Q]
M "0]CP C/:( (CVW "$^U  A/O, (CW_ ",]_P C//\ J$D  )U/  "24P
MB58  ']7  !U5@  :E,  %U/  !33   2D@  $!$   V0 4 +ST- "T]$P K
M/1H *CXA "D^*  H/B\ )SXW "8_/P D/T@ (T!2 ") 70 A06H ($%Z !Y!
MC0 =0J  '$*U !M"T0 ;0O$ '$+_ !U!_P >0?\ I4T  )I3  "06   AEL
M 'U<  !R6P  9U@  %M4  !14@  2$X  #U*   S1P  *D,+ "9#$  E0Q8
M)$,> "-$)0 B1"P (40T "!%/  >144 '45/ !Q&6@ ;1F@ &49X !A'B@ 7
M1YX %D>S !1(S@ 51^\ %D?_ !=&_P 71O\ HE(  )=8  "-70  A&   'IA
M  !P8   95X  %E:  !/6   1%0  #E1   O3@  )DL& "!*#@ >2A, '4H:
M !Q*(0 ;2R@ &DLP !E+.  72T( %DQ, !5,5P 43&4 $TUU !)-B  139P
M$$VQ  Y.S  /3>X $$W_ !%,_P 13/\ GE<  )1=  "+8@  @64  '=F  !M
M9@  8V0  %9A  !*7@  /UL  #58   K5@  (E0! !I2"@ 64A  %5(6 !12
M'0 34B0 $E(L !%2-  14CX $%-(  ]35  .4V( #51R  Q4A  +5)@ "52M
M  A4Q0 )5.< "E/[  M2_P +4O\ FUT  )%D  "(:   ?FL  '1L  !K;
M7VH  %)G  !%9   .F(  #!@   F7@  '5T  !5;!0 06@P #EH1  Y:&  -
M6R  #%LG  M;,  *6SH "5M%  =;40 &6UX !%MM  -;@  !6Y0  %NH  !;
MP   6N(  %KV  %:_P "6?\ EV0  (YK  "$;@  >W   ')R  !G<0  67
M $QN  ! ;   -6L  "II   A9P  &&8  !%F 0 ,90H !V4/  1E%  #9!L
M F0C  !D+   9#4  &1   !D3   9%H  &1I  !D>P  9(\  &.D  !CNP
M8MT  &+T  !B_P  8?\ DVP  (EQ  " =0  >'<  &UX  !@=P  4G8  $9U
M   Y=   +G0  "-R   :<0  $G$   UQ   &<0@  ' -  !P$@  <!<  &\?
M  !O)@  ;S   &\[  !O1P  ;U0  &]D  !O=0  ;HH  &V@  !MM@  ;-8
M &OR  !K_P  :_\ CG,  (5X  !]>P  <WT  &5^  !8?@  2WX  #Y^   R
M?@  )GT  !Q\   3?   #7P   9]    ?04  'P+  !\#P  ?!,  'P9  !\
M(0  ?"D  'PT  ![0   >TX  'M>  ![;P  >H0  'J:  !YL0  >,X  '?O
M  !V_@  =O\ B7H  (%_  !X@@  :X,  %V%  !/A@  0H<  #6(   IAP
M'8<  !2'   -B   !HD   "*    B@   (D&  ")#   B0\  (D3  ")&@
MBB(  (HL  "*.   BD8  (E6  "):   B7P  (B4  "'JP  AL8  (7J  "%
M^P  A/\ A8(  'V&  !OB   88L  %.-  !%CP  .)$  "N1   ?D@  %)(
M  V3   $E    )8   "7    F    )<   "7!0  EPL  )@.  "8$P  F1H
M )DB  ":+@  FCT  )E-  "97@  F7,  )B+  "8HP  E[P  );B  "6]P
ME?\ @(D  '*,  !DCP  5I,  $B6   ZF0  +)H  !^;   4G   #)X   .?
M    H0   *,   "E    I0   *4   "E    I@(  *<(  "G#0  J!$  *D9
M  "K(P  JS$  *M!  "L4P  K&<  *N   "JF@  JK,  *K0  "I[P  J?L
M=8\  &>4  !9F   2IP  #R?   MH@  (*,  !.E   +IP   :D   "K
MK@   +$   "R    L@   +,   "T    M0   +8   "X!   N0L  +L0  "]
M&   OR0  +\U  # 1P  P%L  ,!R  # C0  P:8  ,#!  "_XP  OO, :I<
M %N<  !-H0  /J4  "^I   AJP  $ZT   NP    LP   +4   "X    O
M +\   #!    P0   ,,   #$    Q@   ,<   #)    RP   ,X(  #1#P
MU1@  -@G  #9.0  VDT  -MD  #;?@  W)D  -RP  #<R0  W., 79\  $^E
M  ! J@  ,J\  "*R   4M0  "K@   "[    OP   ,,   #&    RP   ,X
M  #1    T0   -0   #6    V0   -L   #>    X    .0   #G!@  ZPX
M .\9  #P*@  \C\  /-5  #T;0  ](@  /2A  #TM@  ],< _P ) /\ !@#_
M  < _P , /\ $0#_ !P _P H /\ - #_ $$ _P!, /\ 50#_ %T _P!E /\
M; #_ '( _@!X /P ?@#[ (0 ^@"+ /D D@#W )D ]@"B /0 K #S +D \0#+
M /  Z #N /L [0#_ .P _P#A /\ T@#_ ,D _P#$ /\ _P ! /\   #_
M_P $ /\ #@#_ !< _P C /\ +P#_ #L _0!& /H 4 #W %@ ] !? /( 9@#P
M &P [P!R .T > #L 'X Z@"% .D C #G ), Y0"< ., I@#A +$ WP#! -T
MW0#; /0 V0#_ -8 _P#/ /\ Q #_ +T _P"Y /\ _P   /\   #_    _P
M /\ "P#\ !, ]P > /0 *@#R #4 [@!  .D 2@#F %( XP!9 .  8 #> &8
MW !L -H <@#7 '@ U !^ -( A0#0 (T S@"5 ,P GP#) *H QP"X ,4 S0##
M .L P #^ +\ _P"^ /\ M@#_ +  _P"M /\ _P   /\   #_    ^0   /(
M!@#K  \ Y@ 9 .$ ) #> "\ V@ Y -, 0P#/ $P S !3 ,D 6@#' &  Q0!F
M ,, :P#! '$ OP!W +T ?@"[ (8 N0". +< F "U *, LP"P +$ P@"N .
MK #W *L _P"J /\ J #_ *, _P"@ /\ _P   /\   #U    ZP   .$   #6
M  P SP 3 ,H '@#& "D P@ S +\ /0"[ $4 N !- +8 5 "S %H L0!? +
M90"N &H K !P *L =P"I '\ IP"' *4 D0"C )P H "I )X N "< ,X F@#N
M )D _P"7 /\ E@#_ )8 _P"3 /\ _0   /$   #E    V0   ,T   #$  8
MO0 / +< & "S "( L  L *T -@"I #X IP!& *0 30"B %, H !9 )\ 7@"=
M &0 FP!J )H < "8 '< E@"  )0 B@"1 )4 CP"B (T L "+ ,, B0#C (@
M^0"& /\ A@#_ (8 _P"& /\ \P   .,   #1    Q0   +T   "V    K@ +
M *@ $@"D !P H  F )P +P": #< EP _ )4 1@"2 $P D0!2 (\ 6 "- %T
MBP!C (H :@"( '$ A@!Y (0 @P"" (\ ?P"; 'X J0!\ +L >@#5 '@ \@!X
M /\ =P#_ '< _P!W /\ YP<  -$,  ###0  N P  *X(  "H    H@ % )L
M#@"6 !4 D@ ? (X * "+ #$ B  Y (8 0 "$ $8 @@!, (  4@!_ %< ?0!=
M 'L 8P!Z &L > !S '8 ?0!T (@ <0"5 '  I !N +0 ; #* &L Z@!J /P
M:@#_ &H _P!J /\ VA   ,84  "X%@  K14  *02  "<#@  E@<  )  "0"*
M !  A0 8 ($ (0!^ "H >P R 'D .0!W $  =0!& ', 3 !R %$ < !7 &X
M7@!M &4 :P!N &D =P!G (, 90"1 &, GP!B *\ 8 #$ %\ Y !? ?@ 7@+_
M %X"_P!> O\ SA@  +T=  "P(   I1\  )L<  "3%P  BQ$  (0,  !^! L
M>0 2 '4 &P!R ", ;P K &T!,P!K 3H :0)  &<#1@!F TP 9 12 &,$60!A
M!&  7P5I %X%<P!<!G\ 6@:- %D'G !7"*T 5@C! %4)X0!4"_8 5 O_ %0+
M_P!4"_\ QA\  +8E  "I*   GB@  )0E  "+(0  @QL  'L4  !T#@, ;@D-
M &D(% !F"1T 9 HE &(*+0!@"S0 7@LZ %T+0 !;#$< 6@Q- %@,5 !7#5P
M50UD %0-;P!2#7L 4 Z* $\.F@!.#JP 3 _" $P0XP!+$/D 2Q#_ $L1_P!+
M$/\ OR8  + K  "D+P  F2\  (\M  "&*0  ?20  '0>  !L%P  91$' %\.
M$ !<#Q< 6A ? %@0)P!6$"X 5! U %,0.P!2$4( 4!%( $\14 !.$5< 3!)@
M $L2:P!)$G@ 2!.' $83EP!%%*D 1!2^ $,5WP!#%O@ 0Q;_ $,6_P!#%O\
MNBL  *LQ  "@-   E34  (LT  "!,0  >"L  &\F  !F(   7AD! %<4#0!4
M%!, 410; $\5(P!.%2H 3!4Q $L6-P!)%CX 2!9$ $<73 !%%U0 1!== $,8
M9P!!&'0 0!F# #\:E  ]&J8 /!N[ #L;VP ['/8 /!S_ #P<_P \'/\ M3
M *@V  "<.0  D3L  (<Z  !^-P  <S(  &HM  !A)P  62$  %$;"0!,&1
M2AH7 $@:'P!&&B8 11LM $,;,P!"&SH 01Q! $ <2  ^'%  /1U9 #P>9  [
M'G$ .1^  #@?D@ W(*0 -B"X #4AU@ U(?0 -2+_ #4A_P V(?\ LC0  *0Z
M  "9/@  CS\  (4_  ![/   <#@  &<R  !=+0  5"@  $PB!0!&'PX 0Q\4
M $$?&P _'R( /B I #T@,  [(#8 .B$] #DA10 X(DT -R)7 #8C8@ T(VX
M,R1^ #(DCP Q):( +R6V "\FT@ O)O( +R;_ # F_P P)O\ KS@  *(^  "6
M0@  C$,  ()#  !X00  ;CT  &,X  !:,P  42X  $@H 0! ) P /2,1 #LD
M&  Y)!\ ."0F #8D+  U)3, -"4Z #,F0@ R)DH ,2=4 # G7P O*&P +BA[
M "PIC0 K*J  *BJT "DJSP I*_  *BO_ "HJ_P K*O\ K#P  )]"  "41@
MBD<  (!'  !V10  ;$(  &$]  !7.   3C,  $0N   \*0D -R@0 #4H%0 S
M*!P ,B@C # H*0 O*3  +RHW "XJ/P M*T@ +"M2 "LL70 J+&H *"UY "<M
MBP F+IX )2ZS "0OS0 D+^X )2__ "4O_P F+O\ J3\  )U%  "220  B$L
M 'Y,  !T2@  :D<  %Y"  !4/0  2SD  $$T   X+P8 ,BT- # M$P N+1D
M+2T@ "LM)P J+BX *2XU "DO/0 H+T8 )S!/ "4P6P D,6@ (S%W "(RB0 A
M,IT 'S.Q !XSRP >,^T 'S/_ " S_P A,O\ ID,  )I)  "030  AD\  'Q0
M  !S3P  :$P  %Q&  !20P  23\  #\[   V-@( +C(, "LR$0 I,A< *#(>
M "8R)  E,RL )#,R ",T.@ B-$, (35- " U6  ?-F4 'C9U !PWAP ;-YL
M&C>O !DXR  9..L &CC_ !LW_P ;-_\ HT<  )A-  ".40  A%,  'M4  !Q
M4P  9E   %I,  !020  1T4  #U!   S/0  *CD) "4W#@ C-Q0 (C@; "$X
M(@ @."@ 'S@P !XY.  =.4$ '#I+ !HZ5@ 9.V, &#MR !8[A0 5/)D %#RM
M !,]Q@ 3/>D %#S] !4\_P 6._\ H$L  )51  "+50  @E@  'E9  !N6
M9%8  %A1  !.3P  14L  #I'   P0P  )T % " ^#0 =/A$ '#X7 !L^'@ :
M/B4 &3XM !@_-0 6/SX %3]( !1 4P 30&  $D%P !%!@@ 009< #T&L  Y"
MQ  .0N< #T'\ !!!_P 00/\ G5   )-6  ")6@  @%T  '9>  !L70  8EL
M %97  !,50  05$  #9.   L2P  (T@  !M%"0 71 \ %404 !1%&P 312(
M$D4I !%%,0 113L $$9%  ]&4  .1UX #4=M  Q'?P +1Y, "4>G  A'O@ (
M1^  "4?V  I&_P +1O\ FE4  )!;  "'8   ?6(  '-C  !J8@  8&$  %->
M  !'6@  /%<  #)5   H4@  'U   !=.!  13 P #TP1  Y,%P .3!X #4TE
M  Q-+@ +33< "DU"  E-30 '3EH !DYI  1.>P "3H\  4ZD  !-N@  3=L
M 4WR  %-_P "3/\ EEL  (UB  "$9@  >F@  '%I  !H:0  7&<  $]D  !"
M80  -U\  "U<   C6@  &E@  !)7 0 -5@D "54.  =5$P &51H !%4B  -5
M*@ "530  %4^  !52@  5E<  %9E  !5=P  58L  %6@  !5M@  5-0  %3Q
M  !3_0  4_\ DV(  (IH  " ;   =VX  &]O  !C;@  5FP  $EJ   ]:
M,F8  "=E   =8P  %6(   YA   )8 @  V -  !?$0  7Q<  %\>  !?)@
M7R\  %\Z  !?10  7U,  %]A  !><@  7H<  %V<  !=L@  7,\  %SO  !;
M_0  6_\ D&H  (9O  !]<@  =70  &IU  !==   3W,  $)R   V<   *V\
M "!N   7;0  $&P   IL   ":P8  &L+  !J#P  :A0  &H:  !J(0  :2H
M &DT  !I0   :4X  &E<  !I;0  :((  &B8  !GK@  9LH  &7M  !E_
M9/\ BW$  ()V  !Z>0  <'L  &)[  !5>P  2'H  #MZ   O>@  (WD  !EX
M   1=P  "G<   -W    =P(  '<(  !V#0  =A   '85  !V&P  =B,  '8N
M  !U.@  =4<  '56  !U:   ='P  '22  !SJ@  <L0  ''I  !P^P  </\
MAGD  ']]  !V?P  :($  %J"  !,@@  /X,  #*$   E@P  &H,  !&#   *
M@P   H,   "$    A0   (0#  "#"   @PT  (,0  "#%0  A!P  (0F  "$
M,@  A#\  (-/  "#8   @G4  (*,  "!I   @+T  '_C  !^^0  ?O\ @H
M 'J$  !LA@  7H@  %"*  !"BP  -8T  ">-   ;C0  $8X   J.    CP
M )$   "2    D@   )(   "2 0  D@<  )(,  "2$   DQ4  ),=  "4*
ME#8  )1%  "35P  DVL  )."  "2G   D;8  )#8  "/\P  C_\ ?H<  '"*
M  !AC0  4Y   $63   WE0  *98  !R7   1F   "9D   ";    G    )X
M  "@    H    *    "@    H0   *$$  "B"0  HPX  *04  "E'0  IBH
M *8Z  "F3   I6   *5X  "ED@  I*P  *3)  "CZP  HOH <XX  &21  !6
ME0  1YD  #F<   JG@  ':   !&A   (HP   *4   "G    J0   *P   "N
M    K@   *X   "O    L    +$   "R    LP8  +4-  "W$P  N1X  +DN
M  "Z0   NE0  +MJ  "ZA0  N:$  +F[  "ZW@  N?( 9Y4  %B9  !*G@
M.Z(  "RF   =J   $:H   >L    KP   +$   "T    N    +L   "\
MO    +X   "_    P    ,(   #$    Q@   ,@#  #+"P  SQ(  -$@  #1
M,@  TD8  --=  #4=@  U)(  -6K  #5Q   U.( 6YT  $RB   ]IP  +ZP
M !^O   1L0  ![4   "X    NP   +X   #"    QP   ,H   #,    S
M ,X   #0    T@   -4   #8    VP   -\   #B    Y@L  .L3  #L)
M[3@  .Y.  #O9P  \((  /"<  #PL@  \<4 _P # /\  0#_  0 _P ) /\
M#P#_ !@ _P D /\ , #_ #P _P!' /\ 40#_ %D _P!@ /T 9P#\ &T ^@!S
M /D >0#X '\ ]@"% /4 C #S )0 \@"= /  IP#N +, [ #$ .L X0#J /@
MZ0#_ .< _P#9 /\ RP#_ ,( _P"] /\ _P   /\   #_    _P   /\ # #_
M !0 _P @ /\ *P#^ #< ^@!" /8 2P#R %, \ !; .X 80#L &< Z@!M .@
M<P#G 'D Y0!_ ., A@#A (X WP"6 -T H #; *P V "[ -0 T0#3 /  T #_
M ,X _P#( /\ O0#_ +8 _P"R /\ _P   /\   #_    _P   /T " #W !
M\P : .\ )@#M #$ Z  [ ., 10#@ $T W !5 -D 6P#6 &$ TP!G -$ ; #/
M '( S0!X ,L ?P#) (< QP"0 ,4 F@## *4 P "R +X Q0"\ .4 N@#[ +@
M_P"W /\ L #_ *D _P"E /\ _P   /\   #^    ]0   .P  P#E  T WP 5
M -H ( #4 "H T  U ,L /@#( $< Q0!. ,( 50#  %L O@!A +P 9@"Z &P
MN !R +8 > "U (  LP"( +$ D@"N )X K "J *D NP"H -4 I@#S *0 _P"C
M /\ H0#_ )L _P"8 /\ _P   /L   #P    Y0   -@   #.  D QP 1 ,(
M&@"^ "0 NP N +< . "T $  L0!( *X 3@"L %0 J@!: *D 7P"G &4 I0!K
M *0 <0"B '@ H "! )X BP"< )8 F0"C )< L@"6 ,< DP#H )( _@"1 /\
MD #_ (T _P"+ /\ ^0   .L   #=    SP   ,8   "\  0 M0 - +  %0"L
M !X J  H *4 ,0"B #D GP!! )T 2 "; $X F0!3 )< 60"6 %X E !D )(
M:@"0 '$ C@!Z (P @P"* (\ B "< (8 J@"$ +P @@#< ($ ]@"  /\ ?P#_
M '\ _P!^ /\ [    -H   #)    O@   +8   "N    IP ) *$ $ "< !@
MF  B )4 *@"2 #( D  Z (T 00"+ $< B0!- (< 4@"& %@ A != (( 9 "!
M &L ?P!S 'T ?0![ (@ > "5 '8 HP!U +0 <P#, '$ [0!P /\ < #_ '
M_P!P /\ WP4  ,H*  "\"P  L0D  *@$  "A    FP # )0 # "/ !, B@ ;
M (< ) "$ "P @0 S '\ .@!] $$ >P!' 'D 3 !W %( =@!7 '0 70!R &0
M< !M &\ =@!L (( :@"/ &D G0!G *X 90## &0 Y !C /H 8P#_ &( _P!C
M /\ T X  +\2  "R$P  IQ(  )T0  "5"P  CP,  (D !P""  X ?@ 5 'H
M'@!V "4 =  M '$ - !O #H ;@!  &P 1@!J $P :0!2 &< 6 !F %\ 9 !G
M &( <0!@ 'P 7@") %P F !; *D 60"\ %@ W !8 /0 6 #_ %< _P!7 /\
MQA8  +8:  "J'0  GQP  )49  "-%   A0\  'X)  !W 0H <@ 0 &X %P!J
M !\ :  G &4 +@!D #0 8@ [ &  0 !? $8 70!, %P 4P!: %H 6 !B %<
M; !5 '< 4P"% %( E !0 :4 3P&X $X"T@!-!/  307_ $T%_P!-!?\ OQT
M + B  "C)0  F24  (\B  "%'0  ?1@  '42  !N#0( 9P8, &,#$0!? AD
M70,A %L$* !9!"\ 5P4U %8%.P!4!D$ 4P9' %$&3@!0!U4 3@=> $T(9P!+
M"', 20F! $@)D@!'"J, 10JV $0+T !$#.\ 0PW_ $,-_P!$#?\ N20  *HI
M  ">+   E"P  (HJ  " )@  =R$  &X;  !F%   7P\% %D+#0!5"A, 4PL;
M %$+(@!/#"D 30PO $P,-@!+#3P 20U" $@-20!&#5$ 10Y: $0.9 !"#G
M0 Y_ #\/D  ^$*( /!"V #L0T0 [$?$ .Q'_ #L1_P \$?\ M"D  *8O  ":
M,@  D#(  (8Q  !\+0  <B@  &DC  !A'0  618  %$1" !,#Q  2A 6 $@0
M'0!&$"0 11 K $,1,0!"$3< 01$^ $ 110 ^$DT /1)6 #P280 Z$VT .1-\
M #<4C0 V%)\ -16S #05S0 S%NX -!;_ #06_P T%O\ KRX  *(T  "7-P
MC#@  ((V  !X-   ;BX  &4J  !<)   5!X  $P8! !&% T 0A02 $ 4&0 _
M%"  /14G #P5+0 [%30 .18Z #@60@ W%DH -A=3 #477@ S&&H ,AEY # 9
MB@ O&IT +AJQ "T;R@ M&^P +1S_ "X;_P N&_\ K#(  )\X  "4.P  BCP
M ( \  !V.0  :S0  &(O  !9*@  4"4  $<?  ! &@H /!D0 #H9%@ X&1T
M-AHC #4:*0 T&C  ,QHW #(;/@ Q&T< +QQ0 "X=6P M'6< +!YV "H>B  I
M'YL *!^N "<@QP F(.H )R#^ "@@_P H(/\ J38  )T\  "2/P  AT$  'U
M  !T/@  :3H  %\U  !6,   32L  $0E   [( < -AX. #,>$P R'AD ,!X@
M "\>)@ N'RT +1\T "P@.P K($0 *B%. "DA6  G(F4 )B)T "4CA0 C(YD
M(B2M "$DQ0 A)>@ (B7] "(D_P C)/\ ICH  )H_  "/0P  A44  'M$  !R
M0P  9S\  %TZ  !3-@  2C$  $$L   X)@, ,2,, "XB$0 L(A8 *B(= "DB
M(P H(RH )R,Q "8D.0 E)4$ )"5+ ",F5@ B)F, (2=R !\G@P >*)< '2BK
M !LIPP ;*>8 '"G[ !TI_P >*/\ HSX  )A#  "-1P  @TD  'I)  !P1P
M9D0  %H_  !1.P  1S<  #XR   U+0  +"@) "@G#P G)Q0 )2<: "0G(0 C
M*"< (B@N "$I-@ @*3\ 'RI) !XJ5  =*V  &RMO !HL@0 9+)4 %RVI !8M
MP0 6+>0 %RWZ !@M_P 9+?\ H4$  )5'  "+2P  @DT  'A-  !N3   9$D
M %A$  !/0   1CT  #TX   S-   *B\& "0L#0 A+!( ("P8 !\M'@ >+24
M'2TL !PN-  ;+CP &B]& !@O40 7,%X %C!M !4Q?P 3,9, $C&H !$ROP 1
M,N( $C+Y !,Q_P 3,?\ GD4  )-+  ")3P  @%$  '92  !M4   8DX  %9)
M  !-1@  1$,  #L_   Q.@  )S8# !\R"P <,A  &S(5 !DR&P 8,B( %S,I
M !8S,0 5-#H %#1$ !,T3P 2-5P $35K ! V?0 /-I$ #C:F  TWO  --]T
M#3;V  XV_P /-O\ FTD  )%/  "'4P  ?E8  '56  !J50  8%,  %5/  !,
M3   0DD  #A%   N00  )#T  !PZ"  6. X %3@2 !0X&  3.1\ $CDF !$Y
M+@ 0.3< #SI!  XZ3  -.UD #3MH  L[>@ *.XT "3RB  <\N  '/-4 "#SP
M  D[_P *._\ F$X  (Y4  "%6   ?%L  ');  !H6@  7E@  %-5  !)4@
M/DX  #1+   J1P  (40  !A" P 20 L $#\0  X_%0 ./QP #4 C  Q *P +
M0#0 "D ^  E!2@ '058 !D%E  1!=@ #08H  4&?  !!M   0=   4'N  %!
M_  "0/\ E50  (Q9  "#7@  >6   '!@  !F8   75X  %%;  !%5P  .E0
M "]1   E3P  '$P  !1*   .2 @ "T<.  A'$@ '1QD !D<@  5(*  #2#$
M D@[  !(1P  2%,  $AB  !(<P  2(8  $B;  !(L0  1\P  $?M  !'^P
M1_\ DEH  (E@  " 8P  =V4  &YF  !E9@  660  $Q@  ! 70  -5L  "I9
M   @5P  %U4  !!3   +4@< !5$-  %0$0  4!8  % =  !0)0  4"X  % X
M  !00P  4%   %!>  !0;P  4(,  $^8  !/K@  3LD  $[K  !-^P  3?\
MCV$  (9F  !]:0  =&P  &QM  !A:P  4VD  $9G   Z9   +V,  "1A   :
M7P  $EX   Q<   &7 8  %L+  !:#P  6A,  %H9  !9(0  62D  %DS  !9
M/P  64P  %E:  !9:P  6'X  %B4  !7JP  5\4  %;I  !5^P  5?\ C&@
M ()M  !Z<   <G(  &=R  !:<0  3'   #]N   S;0  *&L  !UJ   4:
M#6<   =G    9@,  &8)  !E#0  91$  &05  !D'   9"0  &0N  !D.@
M8T<  &-5  !C9@  8WH  &*0  !AIP  8,$  %_F  !?^@  7O\ AV\  ']T
M  !X=P  ;G@  &!X  !2=P  17<  #AV   K=@  ('0  !9S   .<P  !W(
M  !R    <@   '$%  !Q"@  <0X  ' 1  !P%P  <!X  ' G  !P,P  ;T
M &]0  !O8   ;G0  &Z+  !MH@  ;+P  &OB  !J^   :?\ @W<  'Q[  !S
M?0  97X  %=_  !)?P  /'\  "^    B?P  %WX   ]^   '?@   '\   !_
M    ?P   'X   !^!0  ?@H  'X-  !^$0  ?A<  'X@  !^*P  ?3D  'U(
M  !]60  ?&T  'R$  ![G   >K8  'G:  !X]0  =_\ @'\  '>"  !I@P
M6X4  $V&   _B   ,HD  "2)   8B0  #XD   >*    BP   (P   "-
MC0   (P   ",    C ,  (P(  "-#0  C1$  (T7  ".(@  CB\  (X_  "-
M4   C60  (Q[  ",E0  BZX  (K-  ")[P  B?\ >X4  &V(  !>B@  4(T
M $*/   TD0  )I(  !F3   .E   !I4   "6    F    )H   ";    FP
M )L   ";    FP   )P   "=!0  G0L  )X0  "?%P  H"0  * T  "@1@
MH%D  )]P  "?B@  GJ4  )["  "=Z   G/D <(P  &&/  !3D@  1)8  #:9
M   GFP  &9P   ^=   %GP   *$   "C    I0   *@   "I    J0   *D
M  "J    JP   *P   "M    K@$  + )  "R#P  LQ@  +0G  "T.0  M4T
M +1D  "T?@  LYH  +.T  "SU0  L_  9),  %67  !'FP  .)\  "FB   :
MI   #J8   2H    JP   *T   "P    M    +8   "X    N    +D   "Z
M    O    +T   "_    P    ,,   #%!P  R0\  ,H:  #++   S$   ,U6
M  #.;P  S8L  ,RH  #,P@  S.( 6)L  $F@   ZI0  +*D  !RK   /K@
M!+$   "T    MP   +H   "^    PP   ,8   #(    R    ,H   #+
MS0   ,\   #2    U0   -D   #=    X04  .8/  #G'@  Z#(  .E(  #J
M8   ZWL  .N7  #LK@  [,( _P   /\   #_    _P & /\ #0#_ !4 _P A
M /\ + #_ #@ _P!# /\ 3 #^ %0 ^P!; /H 8@#X &@ ]@!N /4 = #T 'H
M\@"  /$ AP#O (\ [0"7 .L H0#I *T YP"] .4 V #D /, X@#_ .  _P#0
M /\ Q #_ +P _P"V /\ _P   /\   #_    _P   /\ "0#_ !$ _P < /T
M)P#Y #( ]0 ] /$ 1@#M $\ ZP!6 .@ 7 #F &( Y !H ., ;@#A ', WP!Y
M -T @ #: (@ V "1 -0 FP#2 *8 SP"T ,P R0#) .D R #_ ,< _P#! /\
MMP#_ *\ _P"K /\ _P   /\   #_    _P   /@ !0#R  X [@ 7 .H (@#F
M "P X0 W -T 0 #8 $D TP!0 -  5@#. %P S !B ,H 9P#( &T Q@!S ,0
M>0#" ($ P "* +X E "\ )\ N0"L +8 O@"T -T LP#W +$ _P"P /\ J #_
M *( _P"> /\ _P   /\   #Y    [P   .8   #?  L U@ 2 -  ' #, "8
MR  P ,0 .@#  $( O0!* +L 4 "X %8 M@!; +4 80"S &8 L0!L +  <@"N
M 'H K "" *D C "G )@ I0"E *, M "@ ,L GP#N )T _P"< /\ F0#_ )0
M_P"1 /\ _P   /8   #J    W0   ,\   #'  8 P  / +L %P"W "  LP J
M +  ,P"M #L J@!# *< 20"E $\ HP!5 *( 6@"@ %\ G@!E )T :P"; '(
MF0![ )< A0"4 )  D@"= )  K ". +\ C #B (L ^@") /\ B0#_ (8 _P"#
M /\ ]    .0   #4    R    +\   "U  $ K@ + *D $@"E !L H0 C )X
M+ "; #0 F  \ )8 0P"4 $D D@!. )  4P". %D C0!> (L 9 ") &L AP!S
M (4 ?0"# (@ @0"5 '\ I !] +4 >P#/ 'D \0!X /\ =P#_ '< _P!U /\
MY0   -$   ##    N    *\   "H    H  & )H #@"5 !4 D0 > (X )@"+
M "T B  U (8 / "$ $( @@!' (  30!_ %( ?0!8 'L 7@!Y &4 > !M '8
M=@!S ($ <0". &\ G0!M *X ; #$ &H YP!I /T : #_ &@ _P!I /\ U0,
M ,,'  "V"   JP8  *(   ";    E    (T "@"( !  @P 8 '\ ( !\ "<
M>@ N '< -0!U #L = !! '( 1P!P $P ;P!2 &T 6 !K %\ :0!F &< < !E
M 'L 8P"( &( EP!@ *< 7@"[ %T W !< /8 7 #_ %L _P!; /\ R0T  +D0
M  "L$0  H1   )<-  "/"   B    (( !0![  T =P 2 ', &@!O "$ ;  H
M &H +P!H #4 9P [ &4 00!C $8 8@!, &  4@!? %D 70!A %L :@!9 '4
M5P"" %4 D0!4 *( 4P"U %$ SP!0 .\ 4 #_ %  _P!0 /\ OQ0  + 8  "D
M&@  F1D  (\6  "'$0  ?PT  '<&  !Q  @ :P . &< % !D !L 80 B %X
M*0!= "\ 6P U %D .P!8 $$ 5@!& %4 30!3 %0 4@!< %  90!. '  3 !]
M $L C0!) )X 2 "P $< QP!& .D 1@#[ $8 _P!% /\ N!L  *H@  ">(@
MDR(  (D?  " &@  =Q4  &\0  !H"P  800* %T $ !9 !8 5@ = %0 (P!2
M "H 4  P $\ -0!. #L 3 !! $L 2 !) $\ 1P%7 $8!80!$ FP 0P)Y $$#
MB0!  YH /@2M #T$Q  \!>4 / ?X #P'_P \!_\ LB(  *4G  "9*0  CBD
M (0G  ![(P  <1X  &D8  !A$@  6@T# %,(# !/!1$ 3 47 $H&'@!(!B0
M1P8J $4', !$!S8 0P@] $$(0P! "$L /@E3 #T)70 ["F@ .@IV #@+AP W
M"YD -0NL #0,P@ S#.0 ,PWY #,-_P T#?\ K2<  * L  "5+P  BR\  ( N
M  !W*@  ;24  &0@  !<&@  5!0  $P/!@!&# T 0PP2 $$,&  _#!\ /@PE
M #P-*P [#3( .@TX #@-/P W#D< -@Y0 #0.6@ S#F8 ,0]T # /A0 N$)@
M+1"K "P0PP K$>4 +!'Z "P1_P M$?\ JBP  )TQ  "2-   AS4  'TT  !T
M,0  :BL  & G  !8(0  3QL  $<6  ! $0D .Q / #D0%  W$!L -A A #00
M)P S$2T ,A$T #$1.P P$4, +A)- "T25P L$F, *A-Q "D3@@ G%)4 )A2I
M "45P  D%>, )1;Z "86_P F%?\ IC$  )HV  "/.0  A3H  'LY  !Q-@
M9S$  %TM  !4*   3"(  $,=   [%P4 -10- #(3$0 Q%!< +Q0= "X4)  L
M%"H *Q4Q "H5.  I%D  *!9* "<75  F%V  )!AO ",8@  A&9, (!FG !\9
MO@ >&N  'QKX " :_P @&O\ HS0  )@Z  "-/0  @SX  'D]  !O.P  93<
M %LR  !2+0  22@  $ C   X'@$ ,!D* "P8#P J&!0 *1@: "<8(  F&2<
M)1DM "0:-0 C&CX (AM' "$;4@ @'%X 'QUL !T=?@ <'9$ &AZE !D>O  8
M']T &1_V !H?_P ;'O\ H3@  )4]  "+00  @4(  '="  !M0   8SP  %DW
M  !/,P  1BX  #TI   U)   +2 ' "<=#0 E'1( (QT7 "$='0 A'20 (!XK
M !\>,@ >'SL '1]% !P@3P :(5P &2%J !@B>P 6(H\ %2*C !0CN@ 3(]H
M%"/U !4C_P 6(_\ GCP  )-!  ")1   ?T8  '5&  !L1   8D$  %<\  !-
M.   1#0  #PP   S*P  *B8# ",B"P @(1  'B$5 !PB&P ;(B$ &B(H !HC
M,  9(S@ &"1" !8E30 5)5D %"9H !,F>0 2)HT $2>B ! GN  .)]8 $"CT
M !$G_P 1)_\ G$   )%%  "'2   ?4H  '1*  !J20  8$8  %5!  !,/@
M0SH  #HV   Q,@  *"T  " I"0 ;)PX &2<2 !@G&  6)Q\ %2@E !0H+0 3
M*#8 $BE  !(I2P 1*E< $"IF  XK=P .*XL #2R?  PLM0 ++,\ #"SO  TL
M_P -*_\ F40  (])  "%3   ?$X  '-/  !I3@  7DL  %-'  !*1   0D
M #D]   O.   )30  !TP!0 6+0P %"P0 !,M%0 2+1P $2TC ! M*@ /+C,
M#BX]  TO2  -+U4 ##!C  HP=  ),(@ "#&<  8QL0 &,<L !C'K  <P_  (
M,/\ ET@  (U-  "#40  >E,  '%4  !G4@  75   %),  !)2@  0$8  #5"
M   K/@  (CH  !HW 0 2- D #S,.  XS$P -,QD #3,@  PT*  +-#$ "C4[
M  @U1@ '-5( !39@  0V<0 "-H0  #:9   VKP  -L@  #;H   V^0 !-?\
ME$T  (I2  "!5@  >%@  &]9  !E6   6U4  %%2  !'3P  /$P  #%(   G
M1   'D$  !8_   0/ < "SH-  DZ$0 (.Q< !CL>  4[)@ $.RX  CLX  $\
M0P  /$\  #Q>   \;@  /($  #R7   \K   .\4  #OG   [^   ._\ D5(
M (A8  !_7   =ET  &U>  !C70  6EP  $Y8  !"5   -U$  "U.   C2P
M&DD  !)&   -1 8 !T,,  -#$   0Q4  $,;  !#(P  0RL  $,U  !#0
M0TT  $-;  !#:P  0WX  $.4  !"J@  0L,  $'F  !!^0  0?\ CE@  (9>
M  !]80  <V,  &MD  !B8P  5V$  $E=   ]6@  ,E@  "=5   >4P  %5$
M  Y/   )304  DT+  !,#@  3!,  $L8  !+'P  2R@  $LR  !+/0  2TD
M $M7  !+9P  2GL  $J0  !)IP  2<   $CD  !(^   1_\ BU\  (-D  !Z
M9P  <6D  &EJ  !>:0  4&8  $-D   W80  +%\  "%=   86P  $%D   I8
M   #5P,  %<)  !6#0  51   %45  !4&P  5",  %0M  !4.0  5$4  %13
M  !49   4W<  %.-  !2I   4;T  %#B  !0^   3_\ B&<  ']K  !W;@
M;W   &5P  !7;@  2FP  #UK   P:0  )6@  !IF   19   "V,   1B
M8@$  &$&  !@"P  8 X  %\2  !?%P  7QX  %XH  !>,P  7D   %Y/  !>
M7P  77(  %V(  !<H   6[D  %K?  !9]P  6/\ A&X  'QR  !U=0  :W8
M %UU  !/=   0G,  #5S   H<@  '7   !-O   ,;@  !&X   !N    ;@
M &P"  !L!P  :PL  &L.  !K$@  :AD  &HB  !J+0  :CH  &E)  !I6@
M:6P  &B#  !GFP  9K4  &78  !D]0  9/\ @'4  'IY  !P>P  8GL  %1\
M  !&?   .7P  "Q\   ?>P  %'H   UZ   $>@   'H   !Z    >@   'D
M  !Y 0  > 8  '@+  !X#@  >!,  '@:  !X)0  >#(  '=!  !W4@  =V4
M '9\  !UE0  =*\  '/.  !R\0  <?\ ?GT  '6   !G@0  6((  $J#   \
MA   +H4  "&%   5A0  #84   .%    A@   (<   "(    B    (<   "'
M    AP   (<$  "'"0  APX  (@3  "('   B"D  (@X  "'2@  AUT  (9S
M  "&C0  A:<  (3%  "#[   @OX >(0  &J&  !<B   38H  #^,   QC@
M(X\  !:/   -D    I$   "2    DP   )4   "6    E@   )8   "6
ME@   )<   "7    EP<  )@-  "9$P  FA\  )HM  ":/P  FE(  )IH  "9
M@P  F9\  )BZ  "7X@  EO@ ;8H  %^-  !0D   09,  #.6   DEP  %I@
M  V9   !FP   )T   "?    H0   *0   "E    I    *4   "E    I@
M *<   "H    J0   *H$  "L#   KA,  *XA  "N,P  KD<  *Y=  "N=@
MKI,  *ZN  "MS0  K.\ 89$  %.5  !$F   -9P  ":?   7H0  #:,   "E
M    IP   *H   "L    L    +(   "T    LP   +0   "U    MP   +@
M  "Y    NP   +T   "_ 0  PPL  ,45  #%)0  QCD  ,=/  #':   QH4
M ,:B  #&O   QMX 59D  $>=   XH@  *:8  !FH   -JP   *T   "Q
MM    +<   "Z    OP   ,$   #$    PP   ,4   #&    R    ,H   #-
M    SP   -(   #6    VP   . ,  #A&   XRL  .1!  #E6@  YG0  .:1
M  #EK   Y<0 _P   /\   #_    _P ! /\ "@#_ !( _P = /\ * #_ #0
M_P ^ /T 2 #Z %  ]P!7 /4 70#T &, \@!I /  ;P#O '0 [0![ .L @0#I
M (D Z "2 .8 G #D *@ X@"W -\ S0#< .X V0#_ -D _P#* /\ O@#_ +4
M_P"P /\ _P   /\   #_    _P   /\ !@#_  \ _  8 /@ (P#T "X \  X
M .L 0@#H $H Y0!1 .( 6 #@ %T W@!C -P : #9 &X U@!T -0 >P#1 ((
MSP"+ ,T E0#* *$ R "O ,4 P0#" ., P #[ ,  _P"[ /\ L #_ *@ _P"D
M /\ _P   /\   #_    ^P   /,  0#M  P Z  3 ., '@#@ "@ V@ R -,
M/ #/ $0 S !+ ,D 40#& %< Q != ,( 8@#! &< OP!M +T = "[ 'L N0"$
M +< C@"T )D L@"G *\ MP"M -  JP#R *H _P"I /\ H0#_ )L _P"7 /\
M_P   /\   #T    Z0   .    #5  @ S@ 0 ,D & #% "( P0 K +P -0"Y
M #T M@!% +, 2P"Q %$ KP!6 *X 6P"L &$ J@!F *D ;0"F '0 I !\ *(
MA@"@ )( G@"? )P K@"9 ,, EP#G )8 _P"5 /\ D@#_ (T _P"* /\ _
M /    #C    U    ,@   "_  , N0 - +, $P"O !P K  E *D +@"E #8
MHP ^ *  1 "> $H G0!0 )L 50"9 %H EP!? )8 9@"4 &P D@!U )  ?@".
M (H BP"7 (D I@"' +@ A0#6 (0 ]@"" /\ @0#_ 'X _P!\ /\ [0   -T
M  #,    P0   +@   "N    IP ) *( $ "> !< F@ ? )< )P"4 "\ D0 W
M (\ /0"- $, BP!) (D 3@"( %, A@!9 (0 7P"" &4 @ !M 'X =P!\ ((
M>@"/ '@ G@!U *\ <P#' '( [ !Q /\ < #_ '  _P!N /\ W0   ,D   "\
M    L0   *D   "A    F0 # ), # ". !( B@ 9 (< (0"$ "D @0 P '\
M-P!] #T >P!" 'D 2 !X $T =@!2 '0 6 !R %\ <0!G &\ < !L 'L :@"(
M &@ EP!F *@ 90"\ &, X0!B /H 80#_ &$ _P!A /\ S0$  +P%  "O!0
MI0(  )P   "4    C0   (8 " "!  X ?  4 '@ &P!U ", <@ I '  , !N
M #8 ;0 \ &L 00!I $< : !, &8 4@!D %D 8P!@ &$ :0!? '0 70"! %L
MD !9 *$ 5P"T %8 T !5 /( 50#_ %0 _P!5 /\ P0P  +(.  "F#P  FPX
M )(+  ")!0  @@   'L  @!U  L <  0 &P %@!H !T 9@ C &, *@!A #
M8  V %X .P!= $$ 6P!& %H 3 !8 %, 5@!; %0 9 !2 &X 40![ $\ B@!-
M )L 3 "N $L Q@!* .H 20#^ $D _P!) /\ N1(  *H6  ">%P  E!8  (H3
M  "!$   >0L  '$#  !K  8 90 - &$ $0!= !@ 6@ > %@ ) !6 "H 5  P
M %, -@!1 #L 4 !! $X 1P!- $X 2P!6 $D 7P!' &D 1@!V $0 A0!# )<
M00"I $  OP _ .( /P#X #X _P _ /\ LAD  *0>  "8'P  CA\  (0<  !Z
M&   <A(  &H.  !B"   7 $( %< #@!3 !, 4  9 $X 'P!, "4 2@ K $@
M, !' #8 1@ \ $0 0@!# $D 00!1 #\ 6@ ^ &4 / !R #H @0 Y ), . "E
M #8 N@ V -L -0#T #4 _P U /\ K"   )\D  "4)@  B28  '\D  !U(
M;!L  &05  !<$   5 P! $X&"@!* @\ 1P 4 $0 &@!" "  0  E #\ *P ^
M 3$ / $W #L"/@ Y D4 . -- #8#5@ U!&$ ,P1N #$%?@ P!9  +P6C "T&
MN  L!M0 + ?P "P(_P L"/\ J"4  )LJ  "0+   ABT  'LK  !R)P  :"(
M %\=  !7%P  3Q(  $@.! !!"@L /@<0 #L&%0 Y!QL . <A #8()@ U""P
M,P@R #().0 Q"4$ +PE) "X*4P L"EX *PML "D+?  H#(\ )@RB "4,MP D
M#-, (PWP "0-_P E#?\ I"H  )@O  "-,@  @S(  'DQ  !O+@  92D  %PD
M  !3'P  2QD  $,3   \$ 8 -0T, #,,$0 Q#!8 +PP< "X-(@ M#2@ *PTN
M "H--0 I#3T )PY& "8.4  D#EP (P]J "(/>P @$(X 'Q"B !T0MP <$-0
M'1'R !T1_P >$?\ H2\  )4S  "*-@  @#<  '8V  !M,P  8R\  %DJ  !0
M)0  2"   #\:   X%0  ,!$( "P0#@ J$!( *! 8 "<0'@ E$"0 )! J ",1
M,@ B$3H (1%# " 23@ >$EH '1-H !L3>  :$XL &!2@ !<4M0 6%-$ %A7Q
M !<5_P 8%/\ GC,  ),W  "(.@  ?CL  '0[  !K.   830  %<O  !.*P
M128  #TA   T'   +1<% "83#  C$Q  (A,5 " 3&@ ?$R$ 'A0G !T4+P <
M%3< &Q5! !H62P 9%E< %Q=E !87=@ 4&(D $QB> !(8LP 1&<X $1GO !(9
M_P 3&?\ G#8  )$[  "&/@  ?#\  ',_  !I/0  7SD  %4U  !,,   0RP
M #HG   R(@  *AX! "(9"0 >%PX '!<2 !H7%P 9&!X &1@D !@9+  7&30
M%AH^ !4:20 3&U4 $AMC !$<=  0'(< #QV<  X=L0 -'<L #1WL  X=_P /
M'?\ F3H  (\_  "$0@  >T0  '%#  !H0@  7CX  %,Z  !*-@  03(  #DM
M   Q*0  *"4  " @!@ :'0P %QP0 !4<%0 4'1L %!TB !,=*0 2'C( $1\\
M ! ?1@ 0(%, #B!A  TA<0 ,(84 "R*9  HBK@ )(L< "2+G  HB^P +(?\
MESX  (Q#  "#1@  >4@  '!(  !G1@  7$0  %(_  !).P  0#@  #@T   O
M,   )RP  !XG P 6(PH $B$. !$A$P 0(AD $"(@  \B)P .(R\ #20Y  PD
M1  +)5  "B5>  DF;P ')H( !B:6  0FK  #)L0 !";E  0F]P &)O\ E4(
M (I'  "!2@  >$P  &],  !E2P  6T@  %!$  !'00  /SX  #<[   M-@
M)#$  !LM   3*@< #R@-  TG$0 -*!8 #"@=  LH)0 **2T "2DW  <J0@ &
M*DX !"M<  ,K;  !*W\  "N4   KJ0  *\$  "OC   K]@  *O\ DD8  (A+
M  !_3P  =E$  &U1  !C4   6DT  $]*  !'1P  /D0  #-    I/   (#@
M !<T   1,04 #"\,  DN$  '+A4 !B\;  4O(P #+RL  C U   P/P  ,$P
M #%9   Q:0  ,7P  #&1   QIP  ,+\  ##A   P]0  +_\ D$L  (90  !]
M5   =58  &M6  !B50  6%,  $Y0  !%30  .DD  "]%   E0@  '#X  !0[
M   ..04 "3<+  0V#P !-A,  #89   V(   -BD  #8R   W/0  -TD  #=7
M   W9P  -WD  #>/   VI0  -KT  #;@   U]0  -?\ C5   (16  !\6@
M<EL  &E;  !@6P  5UD  $Q6  ! 4@  -4X  "I+   @2   %T8  !!#   +
M000 !$ *   _#@  /A$  #X6   ^'0  /B8  #XO   ^.@  /D8  #Y4   ^
M9   /G8  #V,   ]HP  /+L  #S>   []0  ._\ BE<  ()<  !Y7P  <&$
M &AA  !?80  5%X  $=;   Z5P  +U4  "52   ;4   $DT   Q+   &2@,
M $D)  !(#0  1Q   $<4  !&&@  1B(  $8L  !&-P  1D,  $91  !&8
M17,  $6)  !$H   1+@  $/<  !"]0  0O\ B%T  ']B  !W90  ;F<  &=H
M  !;9@  3F,  $%A   T7@  *5P  !]:   55P  #E8   =4    4P$  %(&
M  !1"P  40X  % 1  !/%@  3QX  $\G  !/,@  3S\  $]-  !.70  3F\
M $Z%  !-G0  3+4  $O8  !*]0  2O\ A64  'QI  !T;   ;6X  &)M  !4
M:P  1VD  #IG   M90  (F0  !AB   08   "5\   !>    7@   %T#  !<
M"   6PP  %H/  !:$P  61D  %DB  !9+0  63H  %E(  !86   6&L  %>!
M  !7F0  5K(  %72  !4]   4_\ @6P  'EP  !S<P  :',  %IR  !,<0
M/W   #)O   E;@  &FP  !%K   ):@   &H   !I    :0   &@   !G P
M9@@  &8,  !F#P  910  &4<  !E)P  9#0  &1#  !D4P  9&4  &-[  !B
ME   8:T  &#-  !?\0  7O\ ?70  '=W  !N>0  7WD  %%Y  !#>0  -G@
M "EX   <=P  $78   IU    =0   '4   !V    =0   '0   !T    <P(
M ','  !S#   <A   '(5  !R(   <BP  '([  !Q3   <5\  '%T  !PC@
M;Z@  &[&  !L[0  :_\ >WL  ')^  !D?@  57\  $>    Y@0  *X(  !Z!
M   2@0  "H$   "!    @@   (,   "#    @P   ((   ""    @@   ((
M  ""!0  @@H  ((/  ""%P  @B,  ((R  ""0P  @58  (%L  " A@  ?Z$
M 'Z]  !]Y@  ?/P =H(  &B#  !9A0  2X<  #R)   NB@  ((L  !.+   *
MBP   (P   "-    CP   )$   "2    D0   )$   "1    D0   )$   "2
M    D@(  ),)  "4#P  E!D  )0G  "4.   E$P  )-B  "3?   DY@  )*S
M  "1V   D/8 :H@  %R*  !-C0  /Y   #"2   AE   %)4   J6    EP
M )D   ";    G0   )\   "@    H    *    "@    H0   *(   "C
MI    *4   "F!P  J!   *@<  "H+0  J4   *E6  "I;P  J8L  *BH  "G
MQP  INP 7X\  %"2  !!E@  ,YD  ".<   4G0  "I\   "A    HP   *8
M  "H    K    *X   "O    KP   +    "P    L@   +,   "T    M@
M +<   "Z    O0<  +\0  "_'P  P#,  ,!)  # 8@  P'X  ,";  # MP
MO]@ 4Y<  $2;   UGP  )J,  !:E   +IP   *H   "M    L    +,   "V
M    NP   +T   #     OP   ,$   #"    Q    ,8   #(    R@   ,P
M  #/    TP   -H'  #;$P  W24  -X[  #?4P  X&X  -^,  #=J0  W<(
M_P   /\   #_    _P   /\ !P#_ !  _P 9 /\ ) #_ "\ _  Z /D 0P#U
M $L \P!2 /$ 60#O %X [0!D .L :0#I &\ YP!U .8 ? #D (0 X@"- .
MEP#= *( V@"Q -4 Q0#2 .@ T #_ ,\ _P#$ /\ N #_ *\ _P"I /\ _P
M /\   #_    _P   /\  @#[  T ]P 5 /, 'P#O "D Z@ T .8 /0#B $4
MW@!, -L 4P#8 %@ U !> -( 8P#0 &D S@!N ,P =0#* 'T R "% ,8 D #"
M )L P "I +X N@"[ -D N0#W +@ _P"T /\ J0#_ *( _P"= /\ _P   /\
M  #_    ]@   .X   #G  H X0 1 -P &@#7 ", T  N ,L -P#' #\ Q !&
M ,$ 30"_ %( O0!8 +L 70"Y &( N !H +8 ;@"T '4 L0!^ *\ B "M ),
MJ@"A *@ L0"F ,@ I #M *( _P"B /\ FP#_ )4 _P"1 /\ _P   /P   #N
M    XP   -@   #-  4 Q@ . ,$ %0"] !X N0 G +4 , "R #@ KP!  *P
M1@"J $P J !1 *< 5@"E %L HP!A *$ 9P"? &X G@!V )L @ "9 (P EP"9
M )0 J "2 +P D #? (X ^P". /\ BP#_ (8 _P"# /\ ^    .D   #<
MS    ,$   "X    L@ * *P $0"H !@ I0 A *( *0"> #( G  Y )D /P"7
M $4 E0!* )0 4 "2 %4 D !: (\ 8 "- &< BP!O (D > "& (0 A "1 ((
MH "  +( ?0#, 'P \0![ /\ >@#_ '< _P!U /\ Y@   -,   #&    NP
M +$   "G    H0 % )L #0"7 !, DP ; )  (P", "L B@ R (@ . "& #X
MA !$ (( 20"! $X ?P!3 'T 60![ &  >0!H '< <0!U 'P <P") '  F !O
M *D ;0"_ &L Y@!J /\ :0#_ &D _P!G /\ TP   ,,   "U    JP   *,
M  ";    D@   (P "@"' !  @P 6 '\ '0!] "0 >@ K '@ ,@!V #@ =  ]
M '( 0@!Q $@ ;P!- &T 4P!L %D :@!A &@ :@!F '0 9 "! &$ D0!? *(
M7@"V %P U0!; /< 6P#_ %H _P!: /\ Q0   +8"  "I @  GP   )8   ".
M    AP   (  !0!Z  P =0 1 '$ & !N !X :P E &D *P!G #$ 9@ W &0
M/ !C $$ 80!' %\ 30!> %, 7 !; %H 9 !8 &X 5@![ %0 B@!2 )L 40"N
M %  R !/ .X 3@#_ $X _P!- /\ NPH  *P-  "@#0  E0P  (P(  "# @
M?    '4   !N  @ :0 . &4 $P!B !D 7P ? %T )0!; "L 60 Q %@ -@!6
M #L 50!! %, 1P!1 $X 4 !5 $X 7@!, &@ 2@!U $@ A !' )4 10"H $0
MOP!# .0 0@#\ $( _P!" /\ LA$  *44  "9%0  CA,  (01  ![#0  <P@
M &P   !E  , 7P + %L #P!7 !0 5  : %$ 'P!/ "4 3@ K $P , !+ #8
M20 \ $@ 0@!& $@ 10!0 $, 60!! &, /P!O #X ?@ \ )  .P"C #H N  Y
M -D . #U #@ _P X /\ K!<  )\;  "3'0  B1P  '\9  !U%0  ;!   &0,
M  !=!@  5@ & %$ # !- !  2@ 5 $< &@!% "  1  F $( *P!! #$ /P V
M #X /0 \ $0 .P!+ #D 5  W %\ -@!K #0 >@ R (P ,0"> #  LP O ,X
M+P#O "X _P N /\ IQX  )HB  "/)   A"0  'HA  !Q'0  9Q@  %\3  !7
M#@  4 H  $D#" !%  T 00 1 #X %@ \ !L .@ A #D )@ W "P -@ R #0
M.  S #\ ,0!' #  4  N %L +0!G "L =@ J (@ * "< "< L  F ,D )0#J
M "4!^P E ?\ HB,  )8H  "+*@  @2H  '<H  !M)0  9"   %L;  !2%0
M2Q   $,, @ ]!PD .0,. #8!$@ S 1< ,0$< # !(@ O B< +0(M "P#-  J
M SL *01# "@$30 F!5@ )05E ",&=  B!H8 ( :: !\'K@ >!\8 '0?G !T(
M^  ="?\ GR@  ),M  "(+P  ?B\  '0N  !J*P  828  %@A  !/'   1Q<
M #\2   X#@0 ,0L* "X(#@ K!Q( *0<7 "@('0 G"", )0@I "0),  C"3<
M(0I  " *2@ ?"U4 '0MB !L,<@ :#(4 & R9 !<,K0 6#,8 %0WF !4-^0 6
M#?\ G"T  ) Q  "&-   ?#0  '(S  !H,0  7RP  %4G  !,(P  1!T  #P8
M   T$P  +1 & "8-"P D# \ (@P3 "$,&0 ?#!\ '@TE !T-+  ;#30 &@X]
M !D.1P 7#E, %@YA !0/<0 3$(0 $A"8 !$0K@ 0$,8 $!#H ! 0^P 1$/\
MF3$  (XU  "$.   >CD  ' X  !G-@  73(  %,M  !**   0B0  #D?   Q
M&@  *A4! ",1!P =$ T &P\0 !D/%0 8$!L %Q A !80*0 5$#$ %!$Z !,1
M10 2$E$ $1)? ! 2;P .$X( #A.6  T3JP +$\( "Q3C  P4^@ -$_\ ES4
M (PY  ""/   >#T  &\]  !E.@  6S<  %(R  !)+@  0"H  #<E   O(0
M*!P  " 8 P 9% H %1(. !02$@ 3$Q@ $A,? !$4)@ 1%"X $!0X  \50@ .
M%D\ #19<  P7;  +%W\ "1B3  @8J  &&+\ !QC@  <8]0 )&/\ E3@  (H]
M  " 0   =T$  &U!  !D/P  6CP  % X  !',P  /C   #8K   N)P  )R,
M !\?   7&@@ $A<- ! 7$0 /%Q8 #A@<  X8(P -&2P #!HU  L:0  *&TP
M"1M:  <<:0 %''P !!V1  (=I@ !';P  AS=  (<\@ #'/\ DSP  (A!  !_
M1   =44  &Q%  !C1   64$  $\]  !&.0  /C8  #4R   N+@  )2H  !TE
M   4(00 #QT+  T=$  ,'10 "QT:  H>(@ ('BH !Q\S  8@/@ $($H  R%7
M  $A9P  (7D  "&.   AI   (;H  "';   A\@  (/X D$   (9%  !]2
M=$H  &M*  !B20  6$8  $Y"  !%/P  /3P  #4Y   K-   (B\  !DK   2
M* 0 #20*  DC#@ &(Q( !2,9  0D(  ")"@  24Q   E/   )4@  "95   F
M90  )G<  ":,   FH@  )KD  ";9   E\@  )?X CD4  (1)  ![30  <T\
M &I/  !@3@  5TL  $U(  !$10  /$(  #$]   G.0  'C4  !4R   /+@,
M"BP*  4K#@ !*A$  "H6   J'@  *B8  "LO   K.0  *T4  "Q3   L8@
M+'4  "R*   KH   *[<  "O6   J\@  *O\ C$D  ().  !Z4@  <50  &A4
M  !?4P  5E$  $Q.  !#2P  -T<  "U#   C/P  &CP  !(X   ,-@, !C,)
M   R#0  ,A   #$4   Q&P  ,2,  #$L   R-P  ,D,  #)0   R8   ,G(
M #*'   QG@  ,;4  ##4   P\@  +_\ B4\  (!4  !X5P  ;UD  &99  !>
M60  55<  $E3   ^3P  ,DP  "A(   >10  %4(   Y    (/0(  3P(   [
M#   .@\  #D2   Y&   .2   #DI   Y-   .4   #E.   Y70  .6\  #B%
M   XG   -[,  #?2   V\@  -?\ AU4  ']:  !V70  ;5\  &5?  !=7P
M4EP  $18   X50  +5(  ")/   83   $$H   I(   #1@$  $4&  !$"@
M0PT  $(0  !!%0  01T  $$F  !!,0  03T  $%*  !!6@  06P  $"!   _
MF0  /[$  #[0   ]\@  //\ A%P  'Q@  !S8P  ;&4  &1F  !99   2V$
M #Y>   R6P  )ED  !Q6   25   #%(   11    3P   $X#  !-"   3 P
M $L.  !+$@  2AD  $HB  !*+   2CD  $I'  !*5@  26@  $E^  !(E@
M1Z\  $;-  !%\0  1/\ @6,  'EG  !R:@  :VP  &!K  !2:0  1&8  #=D
M   J8@  'V   !5>   -70  !EL   !:    60   %@   !7!   5@@  %8,
M  !5$   5!0  %0=  !4)P  5#0  %1"  !34@  4V0  %)Y  !2D@  4:L
M %#*  !/[P  3O\ ?FH  '=N  !P<0  9G$  %AP  !*;P  /&T  "]L   B
M:@  %VD   YG   &9@   &4   !E    90   &,   !B    8@0  &$(  !A
M#0  8!   & 7  !@(0  7RX  %\\  !?30  7EX  %YT  !=C0  7*<  %O%
M  !:[0  6?\ >W(  '5V  !K=P  778  $]V  !!=0  ,W4  "9T   9<P
M$'(   =Q    <0   '$   !Q    <0   &\   !O    ;@   &X"  !N"
M;0P  &T1  !M&@  ;28  &PU  !L1@  :U@  &MM  !JA@  ::$  &B^  !G
MZ   9OX >7H  '!\  !A?   4WT  $1]   V?@  *'X  !M]   0?0  !WT
M  !]    ?0   'X   !_    ?@   'T   !]    ?    'P   !\    ? 8
M 'P,  !\$@  ?!T  'PL  !\/   ?$\  'ME  ![?@  >IH  'FV  !XWP
M=_H <X   &6!  !6@P  2(0  #F&   KAP  '8<  !&'   'B    (@   ")
M    B@   (P   "-    C0   (P   ",    C    (P   ",    C0   (T$
M  ".#   CA,  (\A  ".,@  CD8  (Y;  "-=   C9   (RM  "+S@  BO,
M:(8  %J(  !+BP  /(T  "V/   >D   $9$   >2    DP   )4   "7
MF0   )L   "<    FP   )L   "<    G    )T   ">    G@   )\   "A
M P  H@P  *(6  "C)@  HSH  *-/  "C:   HH8  **B  "BP   H>@ 7(T
M $V0   _DP  ,)8  "&9   2F@  !YL   "=    H    *(   "D    J
M *H   "K    J@   *L   "L    K0   *X   "O    L0   +(   "T
MMP$  +D-  "Y&@  NBT  +I#  "Z6P  NG<  +N4  "[L0  N=( 4)4  $&8
M   RG   (Z   !.B   (I    *<   "J    K    *\   "R    MP   +D
M  "[    N@   +P   "]    OP   ,    #"    Q    ,8   #)    S0
M -(!  #4#P  U1\  -<U  #830  V&D  ->&  #7HP  UKT _P   /\   #_
M    _P   /\  P#_  T _P 5 /\ ( #\ "L ^  U /0 /P#P $< [@!. .L
M5 #I %H YP!? .4 9 #C &H X0!P -\ =@#= 'X VP"' -@ D0#3 )T SP"K
M ,T O0#+ .  R0#[ ,< _P"] /\ L0#_ *D _P"C /\ _P   /\   #_
M_P   /P   #V  L \0 1 .T &P#I "4 Y  P -\ .0#: $$ U0!( -$ 3@#/
M %0 S0!9 ,L 7@#) &, QP!I ,4 ;P## '< P !_ +X B@"[ )4 N "C +8
MM "T ,T L@#R +  _P"L /\ HP#_ )P _P"7 /\ _P   /\   #Z    \0
M .@   #@  8 V0 . -( %@#. !\ R  I ,0 ,@#  #H O0!! +H 2 "X $T
MM@!3 +0 6 "R %T L !B *X :0"L &\ J@!X *@ @@"F (X I "; *$ JP"?
M ,  G0#F )L _P": /\ E #_ (X _P"* /\ _P   /8   #H    W    ,X
M  #&  $ OP + +H $0"V !H L@ B *X *P"J #0 J  [ *4 00"C $< H0!,
M )\ 40"> %8 G !< )H 8@"9 &@ EP!P )4 >@"2 (8 D "3 (T H@"+ +4
MB0#3 (< ]P"& /\ A #_ '\ _P!\ /\ \@   .,   #2    Q0   +H   "Q
M    JP ' *4 #@"A !0 G@ < )H )0"7 "T E  T )( .@"0 $  C@!% (T
M2@"+ %  B0!5 (@ 6P"& &$ A !I (( <@!_ 'T ?0"+ 'L F@!X *L =@#$
M '0 ZP!S /\ <P#_ '  _P!N /\ WP   ,P   "_    M    *L   "A
MF@ " )0 "P"0 !  C  7 (@ '@"% "8 @P M ($ ,P!_ #D ?0 _ 'L 1 !Y
M $D > !. '8 5 !T %H <P!B '  :P!N '4 ; "# &H D@!H *, 9@"X &0
MW@!C /L 8@#_ &( _P!@ /\ S    +P   "O    I0   )T   "4    C
M (8 !P"!  T ?  2 '@ &0!U !\ <P F '$ +0!O #( ;0 X &L /0!J $(
M: !( &< 3@!E %0 8P!; &$ 9 !? &X 70![ %L B@!9 )L 5P"O %8 RP!5
M /( 5 #_ %0 _P!4 /\ O@   +    "D    F0   )    "(    @0   'D
M @!S  H ;P / &L % !G !H 90 @ &, )@!A "P 7P R %X -P!< #P 6P!"
M %D 1P!7 $X 5@!5 %0 7@!2 &@ 4 !T $X @P!, )4 2@"H $D P !( .@
M1P#_ $< _P!' /\ M D  *8+  ";#   D H  (8%  !^    =@   &\   !H
M  4 8P , %\ $ !; !4 6  : %8 (0!4 "8 4P L %$ ,0!0 #8 3@ \ $T
M0@!+ $@ 20!0 $@ 6 !& &( 1 !N $( ?0!  (X /P"B #T N  ] -T / #X
M #P _P \ /\ K!   )\2  "4$@  B1$  '\/  !V#   ;@4  &8   !@  $
M60 ( %4 #0!1 !$ 3@ 6 $L &P!) "$ 2  F $8 *P!% #$ 0P V $( / !
M $, /@!+ #T 4P [ %T .0!I #< >  V (D - "< #, L0 R ,X ,@#Q #$
M_P Q /\ IA8  )H9  ".&@  A!H  'H6  !P$@  : X  %\*  !8 P  40 $
M $P "@!(  X 1  2 $$ %@ _ !L /0 A #P )@ Z "P .0 Q #< -P V #X
M- !& #, 3P Q %D +P!E "X <P L (4 *P"8 "H K0 I ,8 * #J "@ _@ H
M /\ H1P  )4@  "*(0  ?R$  '4?  !L&@  8Q8  %H1  !2#0  2P<  $0
M!@!   L /  / #@ $@ V !< -  < #, (0 Q "< ,  L "X ,P M #H *P!"
M "H 2P H %4 )@!A "4 <  D ($ (@"5 "$ J0 @ ,$ ( #D !\ ^0 ? /\
MG2(  )$F  "&*   ?"<  '(E  !I(@  7QT  %<8  !.$P  1@X  #\+   X
M!0< -  , #$ $  N !, +  8 "H '0 I "( )P H "8 +@ D #8 (P ^ "(
M1P @ %( 'P!> !T ;0 < 'X &@"2 !D IP 8 +T %P#? !<!]0 7 O\ FB<
M (XK  "$+0  >2T  ' K  !F*   720  %0?  !+&@  0Q0  #L0   T#0(
M+0D) "D%#0 F Q  ) $3 "("&0 A AX ( (D !X#*@ = S( &P0Z !H%1  9
M!4\ %P9< !8&:@ 4!WP $P>0 !('I0 1![L $ ?; ! (\@ 0"?\ ERL  (PO
M  "!,0  =S(  &XQ  !D+@  6RH  %$E  !)(   0!L  #@6   Q$@  *0X$
M ",,"0 ?"0T '0<0 !L'%0 9"!H & @@ !<))P 6"2X %0HW !,*00 2"TT
M$0M: ! +:0 .#'L #@R0  T,I0 ,#;L "PW9  L-\0 ,#?\ E2\  (HS  !_
M-@  =C8  &PU  !C,P  62\  % K  !')@  /B$  #8=   N&   )Q,  " 0
M!0 9#@H %0P. !0,$0 3#!8 $@P< !$-(P 0#2L #PTT  X./P -#DH # ]8
M  L/9P *$'D "!"-  <0H@ &$+@ !1#4  40[P &$/\ DC,  (@W  !^.@
M=#L  &LZ  !A.   6#4  $XP  !%+   /2<  #4C   M'P  )AH  !X6 0 7
M$P8 $1 +  X.#@ .#Q, #1 9  T0(  ,$"@ "Q$R  H1/  ($D@ !Q)5  83
M90 $$W8  Q.+  $4H   $[8  !/1   3[@  $_L D#8  (8[  !\/@  <S\
M &H_  !@/0  5SD  $TV  !$,0  /"X  #0J   L)@  )2(  !X>   6&@(
M$!4)  P3#@ *$Q( "107  @4'P '%28 !A4O  06.@ #%D8  1=3   78@
M&'0  !B)   8GP  &+4  !?0   7[0  %_L CCH  (0_  ![0@  <D,  &A#
M  !?0@  5C\  $P[  !#-P  .S0  #,P   L+   )"D  !LD   3'P( #1L)
M  D9#0 &&1$ !!D6  (9'0 !&B0  !HM   ;.   &T0  !Q1   <8   '7(
M !V'   <G0  '+,  !S.   ;[0  &_P C#X  ()#  !Y1@  <$@  &A(  !>
M1@  540  $M   !#/0  .SH  #,W   J,@  ("T  !<I   0)0( "R()  4@
M#0 !'Q   !\4   ?&P  ("(  " K   A-@  (4$  "%/   A7@  (G   "*%
M   AFP  (;(  "'-   @[0  '_P BD,  (!(  !X2P  ;TP  &9-  !=2P
M5$D  $I&  !"0P  .D   "\[   E-P  '#,  !,O   -+ ( !RD(  $G#
M)@X  "42   F&0  )B$  "8I   F,P  )S\  "=-   G7   )VT  ">"   G
MF0  )K   "7,   E[@  )/T B$@  '],  !V4   ;E$  &52  !<40  4T\
M $I,  !!20  -40  "M    A/   %SD  ! V   *,@$  S '   O"P  +@X
M "T1   M%@  +1X  "TG   M,0  +3T  "U*   M60  +6L  "V    LEP
M+*\  "O+   J[@  *OX A4T  'U2  !U50  ;%<  &-7  !;5@  4U4  $=1
M   [30  ,$D  "5&   <0P  $S\   T]   &.@   #@%   W"0  -@T  #4/
M   T%   -!L  #0D   T+@  -#H  #1'   T5P  -&@  #1]   SE0  ,JT
M #'*   Q[@  ,/\ @U,  'M8  !S6P  :ET  &)=  !;70  3UH  $)6   V
M4@  *D\  "!,   620  #D<   A$    0@   $$#   _!P  /@L  #T.   ]
M$0  /!@  #PA   \*P  /#<  #Q$   \4P  /&4  #MZ   ZD@  .JL  #G(
M   X[0  -_\ @5H  'E>  !Q80  :6,  &)D  !78@  25X  #Q;   O6
M)%4  !E3   040  "D\   %-    3    $H   !)!   2 @  $<,  !&#P
M1A0  $4<  !%)P  13,  $5   !%4   1&$  $1V  !#CP  0J@  $'&  !
M[   /_\ ?F$  '9E  !O:   :&H  %UI  !/9@  0F0  #1A   H7P  '5T
M !);   +60   E@   !6    5@   %0   !3    4@0  %$)  !0#0  4!
M $\8  !/(@  3RX  $\\  !/2P  3ET  $YR  !-BP  3*4  $O"  !)Z@
M2/\ >VD  '1L  !N;P  9&\  %5M  !';   .6H  "QI   @9P  %&4   UD
M   #8@   &(   !A    8    %\   !>    70   %P$  !<"0  6PT  %L2
M  !;'   6B@  %HV  !:1@  65@  %EM  !8A0  5Z   %:]  !5Z   4_X
M>7   '-T  !I=0  6W0  $QS   ^<P  ,'(  "-Q   6;P  #6X   1M
M;0   &T   !M    ;    &L   !J    :0   &D   !I P  : D  &@.  !H
M%0  9R$  &<O  !G/P  9E(  &9F  !E?P  9)H  &.W  !BX0  8?P =W@
M &UZ  !?>@  4'H  $)Z   S>P  )7L  !AZ   .>0  !'D   !Y    >0
M 'H   !Z    >@   '@   !X    =P   '<   !W    =P$  '<(  !W#@
M=Q@  '<F  !V-@  =DD  '5?  !U=P  =),  '.O  !RTP  <?< <7X  &-_
M  !4@   18(  #:#   HA   &H0   Z#   $A    (0   "%    A@   (@
M  ")    B    (<   "'    AP   (<   "'    B    (@   "(!P  B1
M (D<  ")+   B#\  (A5  "(;0  AXD  (:G  "%QP  A.\ 9H0  %>&  !(
MB   .8H  "J,   ;C0  #XT   2.    D    )$   "3    E0   )<   "8
M    E@   )<   "7    EP   )@   "8    F0   )H   ";    G0<  )T1
M  "=(0  G3,  )U)  "<8@  G'\  )R<  "<N0  F^( 6HL  $N.   \D0
M+9,  !Z5   0E@  !)@   ":    G    )X   "A    I    *8   "G
MI@   *<   "G    J    *D   "J    K    *T   "O    L0   +,)  "S
M%0  M"<  +0]  "U50  M7   +2.  "TK   M,P 39(  #^6   OF@  ()T
M !&?   %H0   *,   "F    J0   *P   "O    LP   +4   "W    M@
M +<   "X    N@   +L   "]    OP   ,$   #$    QP   ,L   #-#
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M^_S^______________________________________________________\
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M\/'R\_3U]O?X^?K[_/W^_VUF=#$      P$A   !
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M___________;D%L]9:CV__________________________________Z\=30
M5)OK_________________________________].4?DDL3IKL____________
M____________________V-3*LWYE;:7Y____________________________
M________],6NK\G_____________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________#6QNS____________________________________FNY%T
M8ZOW________________________________]L2:<T4F-'W,____________
M____________________M8!5, H &6"R____________________________
M___/=#4+    "E*G______________________________^6-        $^G
M______________________________9I'0  "0P&"5*Q________________
M_____________\L[#A,U3%M-3%[#_____________________________ZE@
M-F"&G[:LJ;C9_____________________________^"7C;[E____________
M___________________________M^?______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________Z]G*O,?_____________
M_____________________\^:@6U:1HCJ____________________________
M____Q'P^)A   %2P_______________________________@@SP      "Z'
M[?____________________________^L4Q       !=MUO______________
M______________N ,0        EAS/___________________________]):
M @        !=S/___________________________Z@U          !<T___
M_________________________WT-          !4UO__________________
M________[GU%          !$U/___________________________*ID+P(
M  0B-TE8SO___________________________^FD:T$H/V-_E:>ZVO______
M________________________U;*LLLSD^O__________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________Y;N7=V+(_________________________________]N>9S8*  *,
M________________________________R'\_!0    !>S_______________
M_______________9@3D        \JO____________________________^>
M3          CD/___________________________]QO&@         0??G_
M_________________________Z](            ;^[_________________
M_________X03            9.;_________________________[%$
M        5][_________________________N!4             2-;_____
M____________________=!0             .,______________________
M___YHEH3            (\7_________________________WYM<+
M    #;K__________________________^^Q?54Y(A$' 0(1(K+_________
M_____________________]^_I9F8FJ"LO=K_________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________^.^G8!\^_______________
M__________________*WA%<P#@ =K/______________________________
MTHI,%0      <O/____________________________6?S8         2\G_
M__________________________J1/@          +ZO_________________
M_________\!:            &I7__________________________XTD
M        "(3_________________________YUX              '?_____
M____________________M"4              &K_____________________
M____?0               %OT_______________________]*P
M     $SK______________________^E                 #SA________
M______________\P#                "W9_____________________YF*
M82<              "?7_______________________MOHE5)P
M "7<__________________________[*G79=2CPR+2PP.4?>____________
M___________________]YMW6TM#3V>3_____________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________[]2[UO_________________________________GN(]J2R\5;___
M____________________________Y*%G- <     /,G_________________
M___________6@CL         $I?__________________________^V%,0
M         &___________________________Z9"             %#A____
M____________________[&D              #?)____________________
M____LR\              "*V________________________>0
M     !"G_______________________R-                 "9________
M______________^I                  ",______________________]&
M                  !______________________]\
M  !T_____________________Y<                   !J____________
M_________\X                   !C______________________\I(@$
M              !A______________________^YHX!7-Q<           !H
M___________________________ZTZZ4AGQU<7!R=X&4________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________]NZG8)I:=/______________________________\B3
M93T9    '9[____________________________;CDP3         &[_____
M_____________________]M\+            $77____________________
M_____XLJ             "*T________________________PD0
M      .7________________________?0$               !_________
M_______________G-@                !J______________________^=
M                  !8______________________]&
M  !'^/___________________^D                    UZ?__________
M_________Y8                    EV____________________[P
M               8SO___________________^L                    /
MPO____________________\                    *N?______________
M______\G                   *M?____________________]P
M           -N?_____________________@G(QP54(S)AL4#PT.$AHFO___
M__________________________GDV-+.S,O,S];@_/__________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________^O3O./_____
M___________________________2J85E2"P2 87_____________________
M_______QJW$\#P       $_@_________________________]5_-0
M     !^R________________________XW4=              ")________
M________________D",               !G_______________________5
M0P                !(]O____________________^*
M   NW?____________________\X                   7R/__________
M_________[X                    $MO___________________YP
M                I?___________________[H
MD____________________]P                     @O______________
M______\                     =/____________________\3
M            :/____________________]"                    8/__
M__________________]Z                    7?__________________
M___1                    8?______________________)
M        9O______________________R:R9B7UV<6QI9V9G:W!ZC/______
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________________^+%
MJI%Y87?_____________________________W:9W4"P,     #'$________
M_________________^"23A,           "/________________________
MTG =              !@_______________________N;P\
M   WXO____________________^6'                  4P/__________
M__________]                     H____________________ZX
M                B?___________________YX
M<O___________________[P                     7_______________
M_____]H                     3?____________________H
M            ._____________________\.                    *OG_
M__________________\S                    &^G_________________
M__]>                    #]O___________________^/
M        !M#____________________0                     ,K_____
M________________*P                   ,C_____________________
M@                    ,O_____________________]Q8!!04# 0
M 08-&,O_______________________SKX=C/S,W/T-+4U]SBZO__________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________________QVL;_________________________
M______'&HX1H33(8 !6K__________________________^Y?$88
M  !Q________________________UWPO               [X___________
M___________?9 D                ,M?____________________]T P
M                C?___________________\45
M:O___________________YD                     2_______________
M_____[8                     ,/W__________________]<
M            &>?___________________8                     !=/_
M__________________\.                     ,'_________________
M__\O                     *____________________]2
M         )[___________________]Y                     ([_____
M______________^E                     (#____________________8
M                     '3_____________________-@
M     &W_____________________?                    &G_________
M____________UPT                  &C______________________W
M                 &'_______________________]0/$9.5%E=861H;'!V
M?HG_________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________________^_5NZ.+<UJ5____________
M_______________XOXYD02$%      !2_/______________________]YU6
M&              7P?_____________________E;!8
MC?____________________]C                    7O______________
M_____YT                     -?S__________________Z$
M            $=G__________________\H                      +O_
M_________________^X                      *'_________________
M__\,                     (K___________________\M
M         ';___________________]-                     &3_____
M______________]O                     %+___________________^4
M                     $#___________________^\
M     ##____________________J#@                   "+_________
M____________1                    !7_____________________@0
M                  OU____________________R L
M  +L_____________________UX                   #E____________
M_________\D<                  #:______________________^= 0
M           '#A?%________________________U;F\P<?.U=OAYNWT^___
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________^-_/_____________________________^S&I8AM5#LA!P R
MWO_______________________]>262D             H/______________
M________B38                 9_____________________]F
M            ,O;__________________Y4                      \C_
M_________________Z<                      *#_________________
M_]<                      'S___________________\
M         %[___________________\E                     $/_____
M______________](                     "S___________________]J
M                     !C___________________^+
M      7S__________________^O                      #A________
M___________5                      #/____________________)
M                  "^____________________5
M  "N____________________BP                    "?____________
M________RPX                   "2_____________________U<
M              "&_____________________ZH*                  !Y
M______________________]M                  !F________________
M_______W50                !%_________________________VHC*S4_
M2E5@:G5^AY&<________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________HS[:=@VE.N?_________________________LLH-<
M.AT"        >_______________________Q6TI                0/__
M__________________^#&P                  !\O_________________
M_Y(                      )C__________________Z0
M         &K__________________]T                      $'_____
M______________\.                     !W___________________\Y
M                      #H__________________]@
M      #.__________________^%                      "W________
M__________^H                      "C___________________+
M                  "0___________________O%@
M  !]____________________/@                    !L____________
M________:0                    !:____________________F0
M              !)____________________TA8                    Y
M_____________________U@                    I________________
M_____Z(                    9______________________56
M           $______________________^[+P                  ^/__
M____________________JRD                 S___________________
M_____\E'      <3("X^4FB$[?__________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________________________________35R?__
M__________________________K2L))W74(H#   2O__________________
M_____\5]11<             $=C____________________$4
M         )___________________Z(,                     &C_____
M_____________Y0                      #;__________________]H
M                      ?L__________________\5
M      #$__________________](                      "B________
M__________]U                      "#__________________^=
M                  !I___________________#
M  !2___________________G#P                     ^____________
M________,P                     K____________________6
M               8____________________@0                     %
M____________________K                       ________________
M____WB(                     \O___________________UP
M            W____________________Y\                     S/__
M_________________^A*                    M___________________
M__^@%@                  G/______________________>@(
M        =________________________WH+               %3/______
M__________________^B5VAT@(V<J[S0Y___________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______MX___________________________TJ-Z6#HI(QP6#@8  )______
M________________K%(.                 &G__________________^1#
M                     #3__________________WD
M      #C_________________\T                       "R________
M__________\3                      "%__________________]/
M                  !=__________________^#
M   Z__________________^R                       <____________
M_______; P                     "____________________*@
M                ^___________________3P
MY___________________=                       U/______________
M____FP                      P/__________________Q <
M            K?__________________\#,                     FO__
M_________________V<                     AO__________________
M_Z,                     <O___________________^-$
M        7/____________________^1!@                  0?______
M_______________K7P                  '?______________________
MRDL                  /_______________________\M7   ,&"0Q/TY@
M=(NGQ___________________________U^?R________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________________Z]3-Q\*^NK>S
ML*VIJ*7____________________=?E,_,",9$0D"          #;________
M_________W8                       "G_________________[H
M                  !U__________________\'
M  !&__________________].                       :____________
M______^,                        _?_________________!
M                V__________________Q&0
MOO__________________1                       I/______________
M____:P                      C?__________________D0
M            >?__________________MP                      9O__
M________________WB$                     4___________________
M_TH                     /____________________W<
M        *____________________ZP*                    %O______
M_____________^=%                     /____________________^*
M                     /_____________________630
M     /W_____________________IRX                  -7_________
M_____________Y@J           &&"U%8.#_______________________^H
M8W2!CYRKN\WB^O______________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________________________________________Y\NWJ9V5CHF$@'QX='!L
M:&60_________________[QJ2"T9"@                 Q____________
M______\                        #__________________]"
M                W/________________^.
MLO_________________.                        C?______________
M____*0                      :___________________6@
M            3O__________________A@                      -/__
M________________K@                      'O__________________
MU!<                     "O__________________^CT
M         /___________________V4                      /______
M_____________XX                      /___________________[P9
M                     .____________________%.
M     -C___________________^+                     +__________
M___________,0P                   *'_____________________D1D
M                 'K_____________________\G0*
M$5_______________________^AT$Q\L.$538G*%F[32]?______________
M____________U^CT____________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___[]_/Q[NSKZ^SQ___________________9LIF'>6UD75912T9!/#@R+2@C
MQ/________________]+)0L                     DO______________
M__^(                        9O_________________7
M            /?__________________,P                      &/__
M________________;                        /__________________
MG0                       /__________________R0P
M         /;_________________\34                      -______
M_____________UL                      ,O__________________X(
M                     +?__________________ZD&
M     */__________________],O                     (W_________
M__________]>                     '?___________________^3!P
M                 %[____________________-0P
M $#_____________________AQ                   !S_____________
M________V%X                   #______________________[].
M   .'"P^4FJ&I<C________________________"?(R:I[;%UNC]________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M___________________________________________________NX=?/R<.^
MNK:QK:FGIJ:GKO________________^^AFU;3$ W+R@B'!80"P0     %/__
M_______________7!0                       /__________________
M-                        /;_________________=@
M         -+_________________L                        ++_____
M____________X20                      );__________________U$
M                     'S__________________WD
M     &;__________________Z                       %'_________
M_________\<C                     #S__________________^Y+
M                 "?___________________]T
M !#___________________^C%@                    #_____________
M_______83                     #_____________________B \
M              #_____________________RU,                   #_
M_____________________Z4X           )'31.:XS_________________
M______^9.4-17VY]CJ"UR^7_____________________________Z_G_____
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________Z\RYK*&9D8N&@7QX
M='!K:&9F:/'_________________844R(Q@.!@               )[_____
M____________?@                       '7_________________PP
M                     %+_________________^S<
M     #+__________________VH                      !;_________
M_________Y8                       #__________________[\;
M                  #__________________^9"
M  #___________________]I                      #_____________
M______^0 @                    #___________________^Y+
M              #T___________________H7                     #9
M____________________D1@                   "\________________
M____RE,                   "=_____________________Y@N
M     ! I1F;$_____________________^Y_'0P:*#=&5VE^E:_,[O______
M___________________GH*JYR-CI_/______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M__WU\.OFXM_;V-32T=#2U^#_________________SIZ*?'%I85M644Q(0SXZ
M-C(O+C'_________________TB41 P                    #_________
M_________T(                       #__________________WT
M                  #__________________[ +
M  #V_________________]TY                      #<____________
M______]B                      #%__________________^)
M              "O__________________^O(@                    "9
M___________________62                     ""________________
M____<@                    !I____________________H2@
M          !.____________________TUP                    S____
M_________________Y8N               5,E)W____________________
M_^!R$P   0\?+T)8<(NHR.S________________________*;VY^CIZPP]CO
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________________________________G@TLC
MNK6PK*BEHI^=FYN<H*?__________________X)D5DM#/#8P*R<B'1@3#@D$
M  #4_________________Y(                       "M____________
M_____\P>                      "+__________________M2
M              !M__________________^                       !1
M__________________^I&P                     Z________________
M___00@                     C___________________U:
M           ,____________________CQ0                     ____
M________________N#X                     ____________________
MY6T#                    _____________________Y\W
M   0+U!T_____________________]UR%      &%RI!6G64MMK_________
M______________^\6$149'6&FJ_(X_______________________________
MTLWA\?______________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________/OZ^_W______________________^ZYJ)V6CXJ&
M@G][>'9T<G-U>'^0_________________^M/.C H(1L5$ L' @         C
M__________________]I                        ________________
M__^;"@                      ___________________(.0
M            ___________________P8P                      ____
M________________B@X                     ____________________
ML#0                     ____________________U5L
M        _____________________X4:                   #[/______
M_____________[%)               8.5V!_____________________^5[
M'@      #"$X4F^/L]G_______________________^[6"DY25IL@)>PS>W_
M____________________________LYZTQ=?K________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____^N_GX=S9UM32T-#0T=/9X.OW__________________^XBGYW<6QH9&%>
M6UE85U=97F5Q__________________^_,1\6$ H%                ____
M_______________M5@                      Z/__________________
M@@0                     S/__________________JR\
M        L___________________TE<                     F_______
M____________]WP0                    A?___________________Z(W
M                  4KE/___________________\MA @            PL
M4':>T?____________________6-,       #2,[5W:9ON7_____________
M___________#8Q@J.TQ?=(VGQN?_____________________________J'^6
MJ+O0Y_____________________________________W_________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
MW<[%O[RYMK2SL;*RM;G R=7C____________________EVQD7EE544],2DA'
M1DA+4%EFH?__________________IR8.!P(                 5O______
M____________SE                      .O__________________]'D+
M                    (?___________________Y\R
M    #O___________________\18                "#%:A/__________
M_________^E_'P          !B=+<9K"Z?____________________^G20
M   "%R]*:(JNU?S________________________3=1XF.$I>=8^KR^______
M________________________KG*%F*S"V_;_________________________
M_________]_O________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________________________________________[^R
MJJ:CH:"?GZ&CIJRTP,W=[/___________________XI:4T]+2$9$0T)!0D-'
M3EEI??___________________YXN!@                   /__________
M_________\-6                   50?___________________^=[&@
M           )-&"+M/____________________^?/P         $)4IQF<+K
M_______________________&9@\    3*D1B@Z?-]?__________________
M_______KCC4K/E%H@9V\WO______________________________OG9_E*G!
MW/G__________________________________]+8\___________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________]O+P[^_O\?/X_?____________________________BPGYJ7
MEI:6F)N?I*RVPM'A[O____________________Z.4$I'141$1$5&1TM16FB#
MJ?____________________^F00$           <V8X^ZX?______________
M_______&90H       0G3'.<Q.S________________________EB"\  !,J
M1&*"ILST____________________________JU V2F%[EK36^O__________
M____________________TH=\F+'+Z?______________________________
M_____]3.[?__________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M________[>7CX^3FZ.WQ^?_____________________________]L922DI69
MG:.ILKS0[?__________________________G5-'24U15F!SBJ_6_/______
M____________________LE8 &C50;8NNTO?_________________________
M____S6\^7WN9M]?Y________________________________[I^#IL+A____
M_________________________________^/.Z_______________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_____________________________P
M
M
M                    ________________________________________
M____________________________________________________________
M____________________________________________________________
M__________\   #_[@ A061O8F4 9$     " P 0 P($"
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M-R];E_@
M
M                               "[77[W6VJT&;T]L8H\M\3)KHUCH57
M\<_& !2/)P<N-/=H_>PXJ,?]/ 6K1?V<$*K&?7\?ZX_T
M
M
M !S?'TSHQ\N\SKQZN\\GN]9JPR\QY6+N%$ !=#@[O7S7IDB\O8S1Y;X>R2BR
M_P .J/CFXP  "@^7J\VK:NPNH-.TB@%36![=+[@
M
M                                                     !6="JC?
M/KLS$;[]=&8[)6U<\ %*5BG(DNYS6RTS9SXM@  KKB[/#M[CT]IO=!&[A4O6
M_%V>$   Z?[\_P!U85V%5#HHE-LZMM+V.CV0
M
M                                                #<A@[E"E*ZBM
MA*_-NYB   *=J?10%?1MIM8VW2@@   N;P=S@D 1.Z5&[/Z',_     HSDZ_
M+H0E=L*PU+2""U'_
M
M                            !7% JR6/IMV/-S^"N4X     BQ[>=>:/
M[LBPP    !M)H4TI^1!$+L474?QR\8   &M2M0_W8Y,QM+6]*<G!R
M
M
M  &0-MIHFCZ)=J+-:P]U@     $8C;)@$CL;-\(0    !EW3Z]YLH.#7GH&Y
MW#W.N   !BAWZ'Z,7*<V7K^U_/TNP
M
M                                    !DI:R=INV@O;*R4M7.P
M'6Y>-!"]#FG]A/?JU      #(_IU?HRIH'>RWUU^#O=8   #&CNT?OQ3YY9&
MX5NN;J<X
M
M              7C@\H3E?/UMP936AN&      ZO-QHNVV[7TCZ;)\+0
M  !E!T:UT)6<#O=;RN>+L\(   &$E3CGJQ7YW92X/G?OQ^@
M
M                                                   #U>GV4V_0
M?MA;&L8+X@    "W,HH;4)FKC.T'[&,-V"60UH         9XTJ3>1*-@UZ;
M?][\^OX   !H]D]MZLT:RBVU6
M
M                              $FC5'GPD;:P,XP   'Y_36YE)8EHBV
M&X@-1>:>-*EZM3P          ;H(W<*E]]D4N?1X   'C?7'^X>UQ+!W+LKV
M:=V@
M
M       ,Y<?KN)U/GNV\O0ZW,  #@Y/EI^S9QD1R]G^#C!V_]I
M   <C]2C(->B@,_*3*/&    T<R>V]6:.91;:K
M
M                                         #^_A. T#;:6QW%Z^0
M-=>3=D$6';WKR8)Y"V@              !>'K=_K2\[?7YMM7'%V>$   U>U
MR&>_&UF=H:Y
M
M              -GN)F0";#H7VM@ *+KM*1>=MNOQHAV'8?.'[^0
M       &V:@3FG)$T/NQ10  !HZD]MZLT<2BVU6
M
M                                          $T+11M/;7,.\C !B1>
M>VJ&MO)U=,0;UVS                 '*_4H&#WFH#8-2)5XP %N^;J<\1"
MX-A[D6F['1[(          !=>'2-E?9RXRZ$2D#GX_M1];IBPMQ8<Q=NY;YY
MW9X
M                                                 %ZX%*WT)/-5
MNJ=_K<P-=63ED$,/>GJR6REE                   !4'QR_C?1%;G4AM=H
M$XIVHOCE_&%=3COJ1[)=:NM,7^]1>^         !W.#E;Q]?V6[?;KIS&9M6
M$NPY/G]  !HRV"8C(EVY?6Z
M
M         WD:_<N$M;3-LC!KQR9LDA1[Y=4RBZ[2@
M =O\^OYZ/Y]?GP_KC_8          5)2^\F6Z--H[:;B'D,    "/YLCPP19
M-O&O,                  %:\78XLTJ;(O+R>Z-9\^[?7[_ %O<^>7\^)]<
M7ZM=S]+L8Z=VD][#2HQ[T[2]CH]D
M                                                )=FEG9:W98%9
M7,8[L0!!5]".H9:>91P         !N(PBR>2>=3.?P  */K=,0+O11IV
M              !*2U&;"4@S6OFD     (W>TC!9&EVIX&@
M   #.&ER3R=RT<N#3&P*D2GQO3_/O\@   ?D8@5&@>GJ0D$%J/5K7(54'F_7
MQ^@
M                     GD^=S<,S"LE<Y!L] FH]@/D99L          &\3
M #+9+:TQ[)0  417Z2^<QZ?-'0                 "Z\.D;Z$OFHW5JBIG
M=     $7K;9K\1YME^$X               "X'#VN&1#$+KT5LKHLP\(
M   #'/N4GO1SIC:6ML,*E'O4
M                                          ^C#YAMX;1?L&Q$1;MN
M>O<           ;Q, ,MDMK3'LE  !1%?I+YS'I\T=
M-S.#&4B8+I+V;@  #^#':YT(6_DE%9(6NG2+EMPU\-%&PK$(
M   7?Z_?ZTJ:"7MM[D/TZKT@        "C.3K\L.FXM@;FV\YNIS
M
M        !ZW3[+Z)/F3W<OGY^DG2^M9+XZ           -XF &6R6UICV2@
M HBOTE\YCT^:.@                 $F?5)GND;ZO\ .0  %)5FFH5&^/5.
MURY/V.!ZO3[*LZ%5%MY30@              >Q\\GYEB0&^-NLL.A7/.
M     //_ 'Y_48^;V;KS7G5XI[0                           &UV@SB
MG=D5%EWA@ !KCK,2]S4Y7X-40
M        %44BH)/>IG/]%<V^Z\            &\3 #+9+:TQ[)0  417Z2^
M<QZ?-'0                 "6GIGV1MY>OS+@  &D;/G$Y$:W1:U0
M           &ZJ-7$I;?%%;FT@         <;\1Q9E:6N-6-=A-0
M                    !OQBESZ/W-QNX5+@ !IKD=OJGT#RRU]8@
M                                    <OQ],X+ W:8-9 VC
M    ;Q, ,MDMK3'LE  !1%?I+YS'I\T=                  )?.E'9DW2X
M)94@  C';8,!$=+9W@^                 ._\ GU_)E=N,@K872X.[UP
M"U_/TNQJKKL)J'#FI1_TZ,Y.ORW<Z_?ZV<5,DGD[,J),?!JWCY^,-!<KM?6.
MF>26^J<                             WXQ2Y]'[FXW<*EP  TUR.WU3
MZ!Y9:^L0                                       ,HNC6O/NKU^[P
M=3]_'9?O\P/JL9]CB?@ #*3HUKS\A>G5>ECYW*7W<6>]1/0         -XF
M&6R6UICV2@  HBOTE\YCT^:.@                 $O[2?LT;H,%,IP  1<
M-N6O='PV4X6                 #-.FR+RI7,"O?;P   PKJ4=]6+].+,U]
M1'+UN4  +E\'<X)',.NW1&,'>HW?T-2JV-7@
M     ;\8I<^C]S<;N%2X  ::Y';ZI] \LM?6(
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MCX;*<+                 !N[C%QZ4WHQ>Y5)   $-VXV/]SK*]FG=H
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MU@YQ   U-9E8X(MFW37L#='&KATOOIBMSJ/   -"LKMC6&EV26\J@
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M_K\J\6]FMN+L\4U:VN1%K    (3MR\=;J4KR<'(       ;Q, ,MDMK3'LE
M !1%?I+YS'I\T= "X,:K3Z+OF)W@@  P/R(L^B:[D];Z:WH:VM+OPF3
MQ&O1;5!_W]:EUFIS%@3$=(FSMN-P?R@        417Z2^<QZ?-'3=!@IE.E_
M:3]F@  -9V5EA4)+??J>   $@_6MFFE'ZC=A   -+^=>+"(#NPUE@V04:7>'
M)LA-XZ#   .G^_/]TC2:W-5Z8Y);VJ*4Y.#D      V:T28^#)7A=X*%   (
MC=P+$W(Q7[]$]    #8W1I;XDG&$WDH(  +#]JF=R'A<6P5S.)^,TJ;(?+DN
M0J\-"7>Z_?ZP     %)\G!R1]);:NL]55>A-0[CHY<"F-_T3NC1P
M6JY^EV(9%R,>[H  !GQ291X\B"(76HJ^G5J?4      L-VJ9W(R\VLY7F*G?
MHGH  !*&@UYZ V#4F5>,  $1&X-A[D[^HG=&CL]*5)_'    #&_N4CO14YY9
M*X5NN;J<\E2%W?H79;19AX0    >5]?'ZC/36SM=ZZ:Q$_;#)[HUGH78Z_>Z
MW6_?S^\C]8)56,^OQOQZ/S]_F;I;+(VU7._?X   1![A6&N5C7W:/W@
M #>)@!ELEM:8]DH  *(K])?.8]/FCH 7!C5:?1=\Q.\$  &)EY;<*KH]19$6
MRFP     #4=FAC6AI;R]7 )B.D39VW&X/Y0        *(K])?.8]/FCIN@P4
MRG2_M)^S0  &L[*RPJ$EOOU/   "0?K6S32C]1NP@  &E_.O%A$!W8:RP5QQ
M=GBF:6XR#M?4'QR_@   "C.3K\NMBM1#W=<59B/MX'U6,^O37WP\@   'H?G
MU_)B]N;_ -LKR]>H=4  -/DB@-2Q]I;:RLP   ))4,N[0VT*AS3P   T52FV
ME6Z2)-;FJ\I>A6O/E?P*^-NZH^.;C       ,<>Y2.]$DN!8NX^VN/SJF]_T
M3NC1P        6JY^EV(9%R,>[H  ;EHY<&F-^$3N?1_,_?X       41R];
MEBF3RR-P\7>]1?0  E#0:\] ;!J3*O&  # FJQCV,]J5)_'      UY5>*>U
MB-4*%Z6\:,7(I,     "C>3K\L/^X=A+E6E['1[(    3%;=7^MG??JU/I@
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MDMY5       !O$P RV2VM,>R4  %$5^DOG,>GS1T +@QJM/HN^8G>"
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M8.]1N^$H:#7GH#8-295XP  >#]<7[B W#L+<JQ_:IO;  DG0N[U#;/J),_
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M,-NY0X  ?P0T+CX^W/M'V.AV0  F(6[O[;._G4JG3  "+M.++U_K\J\6]D
M  +^=2J=.7_;R_5M?1_/O\@ !'JEUJJTU$2&!U(      &\3 #+9+:TQ[)0
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M55HCE5LZN"4-!KST!L&I,J\8  -$<IMG5VD^36ZJH  ,\:5)O(E-P6]=O@
MM1S]'L0RKD8^70   ):$ OG;K+RGU[S   C#S>S5>ZZZQ$_;     )!<1NI1
MFX&/3VF@  P:JD:]:*Q.[)W"      #>)@!ELEM:8]DH  *(K])?.8]/FCH
M7!C5:?1=\Q.\$   ?.>]/&CU04CHP  ,O;*7,3X?.?N/  !;^245\Z'T[Z/@
M  2_M)^S1N@P4RG  !%PVY:]T?#93A8  #=!@IE.E_:3]F@  -9V5EA4)+??
MJ>   $@_6MFFE'ZC=A   -+^=>+"(#NPUE@       .1^MI-"FE/R&8A=:BZ
MF^.;C   (B=P;#W)Q?[U&[X<_P"?O\F!6\OW;7(/J57I  !&#F]F:^UWUB*>
MU[OQR?B9_;?(6U]8<?8X@ ,(ZG'/5BGSRR-PP -W,9N-2F].+7+I(
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M<T\  "B>3K\L,RY&/=T*<^^+]@  &1/3JW2V[1Z>4WL=H\M\.^'5J74
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M0  :7\Z\6$0'=AK+  !M&H<TI^_'4J?4T@R>W%5@   !DMTJQT)>UO;\VV
M (H$]L?<3#*I1[U  -_D3NC1VY".7 I@  -'$GMM5FY>.7!IBL./L<0 &HJ0
M02I(]$OM36@     %\.K4NIF33I!YF:%-D/E[#*/*_%OOU:GTP  #%_O4;T(
MB=P;#W(  WXQ2Y]'[FXW<*EP  U"2&!U+'NEUJJS   -F5$F/@R6H7>"A0
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M2GQI/$(O+07I?GW^=3=?@U1Z$)7;"L*&Y>MR@ !7'%V>*3O"+RT#F[3)'Y0
M =;]_/["RN3CQ=*B>7K<H %^NI4^G,)MW?VVG9?O\  \O]^/UZGY]_D  (E,
M_L7<;$FH4+T@   ,A.G5>E8WM4WM^;]?'Z  YOS]_F\J+W)I/=Y&;CTH  %&
M\G7Y84MR\=KI@ ;\8I<^C]S<;N%2X  8'U6,^O%CG5E+@@  %P^'M\,S>V^0
M=K_2_/O\@ >']<?[B!W#L)<JQ?:IO;   .Y^?7\W"QV?4SJ1D$$J2G/OB_8
M !*&@UYZ V#4F5>,  $=:86GK;4Y7X-40  9QTN2>3*I@E[;>@ !CEW*3WH@
M%P["7*   )9L OG;K+^GU[S   C$3>S5>ZZJQ$_;       .[^?7\D:PZ[5$
M;2J%-:? .,19IU92X."%5C/K@   !O$P RV2VM,>R4  %$5^DOG,>GS1T +@
MQJM/HN^8G>"   /G'^H'1LI&M4T  &7-E[E)\OG,W(@  M_)**^=#Z=]'P
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M7MMZ  &.7<I/>B 7#L)<H   EFP"^=NLOZ?7O,  ",1-[-5[KJK$3]L
M  #E?K>5%[DTENXC%QJ5Y7[_  +2=CH]F)//[%7&M-V.CV0   -XF &6R6UI
MCV2@  HBOTE\YCT^:.@!<&-5I]%WS$[P0  !\X_U Z-E(UJF@  RYLO<I/E\
MYFY$  %OY)17SH?3OH^  !+^TG[-&Z#!3*<  $7#;EKW1\-E.%@  /[^'T)O
M-1NL7WMY+P          :7\Z\6$0'=AK+!DCTJOT96\#O?;RXG#V^
M    (RLVLY7FMVLQ'W   #.>ER7R94L$O9;T     CXRZU=9Z@9# JE   +E
M</<X)7<"OA;O(?IU7I!:OGZ78U0U^#U%B-4*#Z7F_OQ^L@>I5>EM]CT]IJ__
M %*ITP  PAJ<<]:*C/+(W"  W1QNX=+[Z8I<ZCP   ,?^W2^[;'GZ7/7_#VN
M&L>/L<4-&X^/MSPR#ZE5Z4NNWM][;^]\\OX  "W_ "]7FU,R"#5'AU48_P"G
MU/WY_N5'0K?G[8J!.:=O9UJCU "GOOB_>@&66MK+4G((+4?\ !*&@UYZ V#4
MF5>,  $=:86GK;4Y7X-40  9QTN2>3*I@E[;>@ !CEW*3WH@%P["7*   )9L
M OG;K+^GU[S   C$3>S5>ZZJQ$_;         ,^J3*/'D5P^[-$WGZU0ZH8F
M]^A^C%;G=D[A43R];E   -XF &6R6UICV2@  HBOTE\YCT^:.@!<&-5I]%WS
M$[P0  !\X_U Z-E(UJF@  RYLO<I/E\YFY$  %OY)17SH?3OH^  !+^TG[-&
MZ#!3*<  $7#;EKW1\-E.%@   E8Z>MBK?;KIS&          !I?SKQ81 =V&
MLM>3K5#JROH%?"WEZNM4>H          &O2KQ3VHP$XLS7WY   !_1+FM]?>
MV^4O1K7G@   >!]<7[AG7(Q]N?0?+U>8  *IX^;CE202]MO<OZ?7O-
M  ".O,+3UMJ;K\&J( #-.FR+RY7,"O?;L     "U7/TNQ#(N1CW=  VT4"<T
MY(DA]V**          CQR^U-:ZCY!!*C )0T&O/0&P:DRKQ@  CK3"T];:G*
M_!JB  #..ER3R95,$O;;T  ,<NY2>]$ N'82Y0  !+-@%\[=9?T^O>8  $8B
M;V:KW756(G[8         %5\?/Q[HXW<.EMQL<G],UCQ]CBQ(J%"]*+[.+,5
M]:SGZ78  #>)@!ELEM:8]DH  *(K])?.8]/FCH 7!C5:?1=\Q.\$   ?./\
M4#HV4C6J:  #+FR]RD^7SF;D0  6_DE%?.A].^CX  $O[2?LT;H,%,IP  1<
M-N6O='PV4X6   #)^TMP$]?SJ;BU44FH      -9.5]@FS;%"_H  -+^=>+"
M(#NPUEKC</;X),\)O%0F;],DGD@         8CU"A>E%CG5E+@4/R];F
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M(J&/G+;65G2O)P<@    ![WQR_B9);G("V-RN'N<   !%8G=D[A8-52->L
M 7RZM2ZDD:&7=H?-2FR+R@      #6G6H?[L<V8VEK>D>3@Y   "_/4J?3E3
MP2]MOKV=:H]0    +5<_2[$,BY&/=T   S_I,I\:0]#[K47>_K5+J      4
MW]\/)HWE%MJLTRR.WU3\/[^?T "4-!KST!L&I,J\8  (ZTPM/6VIROP:H@
MSCI<D\F53!+VV]  #'+N4GO1 +AV$N4   2S8!?.W67]/KWF  !&(F]FJ]UU
M5B)^V             7 X>UPY?T^O^;BUWJ)Z%I>QT>P ;B,(LGDGG4SG\
M"CZW3$"[T4:=@!7$?JR>3YW-PP   @3>BS3FI>KT\  &4%I+@)L.A?:X  "A
MY!2$#;T1Z>@  2F=1&PMMHPSR1  !''V@X--&VP+$@    &Q3&.]Z39JASY;
M&<8;XN7X^@ %@;CPU'9V;X0M"&Q?#AF-8^Z"9AHRVD   U+YF8W(LVW?7H
MNOU^]U]PD>GU,[3*%-:?O+UJAU0    \+ZX_WKLK$3]O3/)+>U/AW4:!Z8
M    !O5BURZ2W;QFXU*  !C_ -NE]V'O<2P=R^-^    .0;$J/+/$VR4"<T[
MG=2I-Y%2?'-Q@  %$\O7Y=?]6BWLZBY! ZDP=JD;]8     N!P]KAW<QFX]*
M;4*%-:?N'P]O@   ,3^_0_1B1W L5<<   ]OYY/QM-H,VI_:G0IM3V8].K_F
M=K\^OX  %E.S3NWJ_KD,][3U(H#4UH^QT.R   2,8==JB<XZ7)/)  #0_*K9
M5?K+K<.]T  ,Q:=7_,DGPN[]#  !83MTSN19IU92X   !)NA%XZ#RFZ-;\\
M ([<PM/6N!]5C/K@
M       7G@LJ9IV(NHN["I*\[M<+%V[=OF$U^[3NIS<8         _8R;Z-9
MZ&7-/KWFWZZE3Z=?\7;X>[^?O\I7[X>2SG9I_9Q?[U%]##6I1_TZ9^^'D
M     #=;&KBTMO?BMS*0  #1#*;9U=I1DUNJJ      #TOG[_.1O3JW2O;UJ
MEU*QXN?BZ_[^?VA.7K<UC>U3>W8#MTKN=;]_/Z       !V_SZ_F2G2J_1OK
MU:GTZJX^?CZ?[\_VWW-U.?'ON4KN62[-.[8     %8<?8XLG.C6>A=SK][K>
MK\\GYH?EZW-CIW*1W;#=NF=S^
M
M             #F_/U,(MY?RV=_NI5.F !T?WY_L-RXV/USK2=CH]D
M
M
M                   V)4>6>+)ZA%Y:!  #756(G[<8B;V:KT
M
M
M               NUU^]UI6T#O?;R_G4JG3  ",--[-5[KLK$3]L
M
M
M              -[\5N92/;_ #Z_GJ?/W^;K<'>Z^P*D2GQ:VX^SQ  !9OLT
M_M0X[BV N;T_WY_H
M
M                                      3=[8Y'6I]7\^_R     :&)
M5;&K]+4EMY5(
M
M                                  !-WMCD=:GU?S[_ "    %GNQT.
MU#]N'82Y5+<G!R
M
M                                     $W>V.1UJ?5_/O\ (   'C?7
M'^HN4YLO<#!FJ1KU@
M
M                                        )N]L<CK4^K^??Y   ,8N
M]1N_'AE]J:UPNJ4=]0
M
M                                          )"T0NK1?=_/K^!^!2O
M)P<MD>U3NUAI48]ZF(M1H/I?@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M  '+\?3*RSUQ57T6IL8;LP!;V2T0   !^OS]71B,@4E6J:IFJ]    >]3NXK
M6@U4  %LY707!R?  K"B5-4=+[P #B^_E;&64          <OQ],K+/7%5?1
M:FQANS %O9+1   >GU.PN!&ZRH:04AXO?ZH "XL8K;K<OPH.14<   !<B+5U
MY7<ZRC*[2P  !Z/5YUPHU6@!U^7X6XE%#<?U\@  NG$)"   */K=,4Y5.B
M    #T.MS+AQFM@  "WTEHKS>UP "O8Y6'K=/L@"CJY3%.U/H@  "Y\2K[H]
MCB6^DM%!R_'TN=$Z^\.H=11%?I(  *DI?>9:69N2\KN==BI>"W3Q^]U0 %84
M2IJCI?>  !T>QQ+=2>A@#M</(N3%JZ  "C:[2U/5+I #F^/I<V)U\'Y_?Q0<
MBI#RNYU@  !=N&21<Z)R!:>8QQ;^245=&(R%9V<1<
M   &3=J)\F<Z+=IC,JQMT0>?V>%JGS"QT0[=W>L13=5Z   -FF*-_$VK0EM?
M:D\S<;4,W>=JV   &ZG _*M+UTJ;,   ?/'],6DU9F<Q8 2K-/NQ-ORUS9D
M +:RJA/G5^G'2"        #)NT\^3.=%VTQF58VZ(//[/"U39A8Z(=V[S6&I
MNJ=$ ;,L4K]IMFA'; TSYS8MH?.[760 ,UK#763LO/3M\:[\FK)(0^_74T
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M*]&NT9@!DA9EU^7C4]4^DWKZ],O4"CT5Z='X^OP
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M7J4                      F/Z/-H+;WA3DRBE[A]=#3MF[C"M%-8T
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MQV[UIRS@Q?0[MW>L0 !(.UK9J)0FI38$[G!RJ.KE+:5<\,547C;;KZ4'(J.
M #8MC%>].(T [;$9[:Q@4CA;0\&0  9*6LG;Z!7FWW0   ^=IZ;-(JUDOCP
MNG$)"^B7YD]W32_G7BPB [L-98 ^B/YE=W#&ZZ4%02?0QJ!
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MZ4=F;='@EE0^?SZ1=,+&>ZT" $B_6'G"DWZH,^@  8\W,A+Y_GI#TQ/*[G7
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MQ:IL]F]C7KEZB^;:]?J/)LPPF!>&$2=;:4T)X_>ZH
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MP\LK -".Q?#EY/<ZP  ,J;/W$2*-9&;S49FEC2U0YBXY@  NU#)(D[ZF\_@
M :D<S\;&IS,C'  5G0JHE/:A=AP/Q]?*U4PCK6;E981J\RWQ^<?U\@KF/U=+
MFTN;*FJ',;')H^S]Q+
M
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M?(K!3Y:3(L$'!4C9#:$*EAJNP$==@(Z[ 1UN#A! WSAVWRY<9H=@(Z[ 1UV
MCJ1$E*>MPOH5#A+ZEXMR3PA#MZ==8! Z!:%!$% GS22@.1K*FP3@7%?*^[,0
MHYGLYV%>,>].0H9;W!/2_7^4C"E 4F#T!LF <#I134S9<N$5"XSE*>ORTZ_+
M3K\M.G%*4A86[*4QORTZ_+3K\M.ORTZ_"7%=->^-0HR92'1"J)])T&<IRG 1
M,3*FN*YWC$3)#G1"R*2 E2"#1*L $21]##JIG*<IQ?[T109UR"(DP9?DH_ P
MF$C,E!/%("1%1/>EHQ@J1@A0Z@1(2(ON#G,W&>C,+4\4\7GX/BQ LD!>2YP8
M88(<&;=H"EL;K0XSJ7PF_P!#N%]=8=MOPA#N%]"H<)?4O%N2>$(=O3KK$<2R
MAS1I$. :G*=,^61."$APA:!P^"B6[64AE.<ID3':BO$2ND.@82H86 J!49,4
MTRHITXOVD)(S,H9 , F0^:X_U86Y^M$8%D !55575 F%I&SD:V7D >A31O?D
M>"YWC"'14+63*ADP(%TK($U$@D95S@/%J397_4215^9.Y"^5]V/$2&[05Y>X
MST9A:GBGB\_!\6!3*";5C(=P9JAK-E8;3&NQ74AW"^NL.VWX0AW"^A4.$OJ7
MBW)/"$.WIUUY Y0L9D.W@JM#I)XOJ<IRGR6^;G*KBL%>S'(6\9_"KBN&/<DH
M6\6_&O@N!SK3X@AA0*@7 ;HT$X"E>@E D-K_ 'RG'^K"W/UHEX7W9&%$,E2M
M?QA-U\83=?&$W7QA-U\83=?&$W7QA-TMFRQNJ%O"?F*<%SO&%"!D*=A< ?YB
M<10&1<M"?#]V=A0Y_BG<@\5D;+54U450MX?\Y?E[C/1F%J>*>+S\'Q6+2*$*
MS$.6J?2IXZ0L2OW;WAW"^NL.VWX0AW"^A4.$OJ7BW)/"$.WIUUY8Y0L9D8;P
M-6C2<;*<@N-,N/*<JI<%HKV@G"4'F5,TSE5+@O&/>G(2!?LI3@.%2."('4$)
MR0C)@#0"^;#T5629GD./]6%N?K1..O\ _?L;<J_\^"YWC"W*/_"%:E^*;"4I
M_.:B5>\(4+N_DKQ+W8D*.8[.>Y>XST9A:GBGB\_!\3/ D6:4.1]%-=A86;XO
MAW"^NL.VWX0AW"^A4.$OJ7BW)/"$.WIUUYLY?CH\B CR$#$!KB31/>D.$Y2G
M(\6F4-0HAGWY+0E=(= PE0PL"06[2=@7$^=7-(JIDG,J;!.!0N/]6%N?K1.*
M?_U>QMV?_P!/!<[QA;LO_EA6>[84_P#?1*O>$*%W?R1P:# 1HL(4'@E.<ID3
M$C17E;C/1F%J>*>+S\'Q-OP[#D9T'A9OB^'<+ZZP[;?A"'<+Z%0X5U2HR9BW
M)QI4MN';TZZ\]<)4C 1(<_Q3N+@*_G"A0S/N#FEPQ[DE"@EO=%8/]Z442?XU
M4SIGRR9L4D, ,&8"@<?ZL+<_6B<4O_K]C;O[O@N=XPM[]I"L]VPIW[Z)5[PA
M0N[^4K)_; 9RG*<#?-?D$Y6XST9A:GBGB\_!\3;\.PY&=!X6;XOAW"^NL.VW
MX0AW"*/S6'AQ04*4S(B+<G5Z!5V';TZZ\\:F58,2%+\$_B*%2,$,%4 +!35.
MBHJ/(R77C'O3D (50XP8=(0<1H@5.2,-X6G0Q(V7Y;>-3_&!Q_JPMS]:)QT?
M_N&@(0379C.NS&==F,Z[,9UV8SKLQG79C.NS&==F,Z[,9UV8SKLQG79C.D (
M4,UP7.\86]^TA6>[84[]]$J]X0H7=_+6TV$,2L(0J8H- <G<9Z,PM3Q3Q>?@
M^)M^'8<C.@\+-\7P[A?76';;\(0Y[EO?X^0L5Q5-![ #@F@(<VGJ$\;_ ,.W
MIUUA5U216E'5N2HCR+$XDBC\B= X"OY1(4$Y30",)4,+ WRWYQ^4*2*#Z%0"
M5>A6Z/3HP1-%8TP681^!Q_JPMV?_ -,2\%[PC"@CR"-^P+G>,+>_:0K/=L*=
M^^B5>\(4+N_E_P"]*R7,M5 AGO<C<G<9Z,PM3Q3Q>?@^)M^'8<C.@\+-\7P[
MA?76';;\(0YEILU/&Z+"Z[Q2Y5HX+^WB2+)VZ/GCBH>AV].NL"HI4D@ZJJJZ
MM)ZW6!($<(Q1",,$7#4U&H\)#*4YS!#D"# >+2-E9RG*<%-55,266[*2C-G@
M"5--5-=,$Y2G)82@PPX09_@- X_U848:0)^(P#(<"JF=%4%%=0=9,U0<+Q3G
M*F4G 'VH,2@6B)<[QA;W[2%9[MA3OWT2KWA"A=W\R<I5254FHM/C_K22?D=
MY&XST9A:GBGB\_!\3;\.PY&=!X6;XOAW"^NL.VWX0AO&@5.FT\5L;G.VT;MM
M1FU9VX!--<;>6059X-) "N?G'9EBE;N7A>MZ71%MZ==>*BH4$0A11!A.(0XP
M%0#@,42#7R56OC2;JM>(4Z'<0DY#F1S-<207[0>B6RON#G)3"W:CD9PV$2!-
M&138R8JUDYA#!#T0*@M 1"$O3^<Q X_U(93G*::JA&Z.(QD "?!=*^Y-0IY\
M0B*7,@F@X!!* J%16J-\"1\P1K)*!<]1"N=XPM[]I"L]VPIW[Z)5[PA0N[^;
M.4IR4D2>IRG*? J9$*#EC(1L&/<9Z,PM3Q3Q>?@^)M^'8<C.@\+-\7P[A?76
M';;\(0SE*<KM,^M@7-]AV].NO \="(@CCBF1?840GV<K$KE>TD^2WRWY 8C!
M@(L$=.BG1N!<T.5K <54I4KQ"K4UQ/EH9Q RD;.F#M<*.#[Y0@<='XAQAGSH
M,OBZCJM1/":+3G,WP/%*3A82BL*N$$<8O6 XJY2I7B%4JEU/EH=Q2_ R<,&Z
MN(8E85:<MT#0KG>,+>_:0K/=L*=^^B5>\(4+N_GGTD YHR4,%*^">?$(B@C!
MF XMQGHS"U/%/%Y^#XFWX=AR,Z#PLWQ?#N%]=8=MOPA%N'VV$1WS[#MZ===&
MC01,$V:%.#>PI"?,X-R%(KV0W&'14)6 #2 #"**&"&HJ AX7G()280$"N!V@
MCRBO[KBLILQZ?8$&LY6%Q7.\86]^TA6>[84[]]$J]X0H7=_L H08U!Q GH4$
M4"O2>H"D1"YD$T%#N,]&86IXIXO/P?$V_#L.1G0>%F^+X=POKK#MM^$(KX6L
M3[R6U7D)6;"URK<V$%/6&AV].NNARX1D)02QB-7L">GBGA 00RX7(7ROO2\:
M"6]Z:B7#1BLQSDQ.J.BRE*F4'^]*9*9(SR2O[J!51_>3G*<I\U,2:S<Z:::*
M>*YWC"WOVD*SW;"G?OHE7O"%"[O]B%!"'I,M\&O0Z2>+Z+&C!(4@JESLH-QG
MHS"U/%/%Y^#XFWX=AR,Z#PLWQ?#N%]=8=MOPA'E]BM.ZQ4X3-IQOD8O8GK=X
MU')Y,3T7&6';TZZ\)TRJD>095:$#$"KYI!$%'F$$&#1R1**1*#(%18>)'+=G
M)1&R8!P,\EF24^8GHPQJ8008 <1PF$=!-E!B8O(*_NH3Z2 <T:)F"=?*##$%
MK((4J-2E*4H%SO&%O?M(5GNV%._?1*O>$*%W?[**7 &D(B$*YEP1 :>.>;1=
M;SM-Y"WPUY"WPUY"WPUY"WPUY"WPTVK%WJ+N/B[ !C+6\A;X:\A;X:\A;X:\
MA;X:\A;X:\A;X:0 A $&&_28HK5E_(6^&O(6^&O(6^&O(6^&O(6^&FG8R]19
MTPYT6PN0\;S>0M\->0M\->0M\->0M\->0M\-8!,EY,IK<B^N*MNKWT7/Q O9
M;,40,0*N!@VBN3= W9# - ;@Q<N7)E\FD97<%B/(6^&O(6^&O(6^&O(6^&O(
M6^&L%[87(9UYH#!4N:I,MZJ6AR9DM/D4!UB5%D(V-HHEE"?-<)7\)PD2_:C?
M^N1_O1I$*&-&$0\#JL,0*<00 PTRZ"<%T42"A7E#  F S;?$IF,7' G$1*&1
M1XJZ*!*32 7$T.D'P-3E.F<(!,T9T6;U<]%RI<K3$L%3(I_L)W783NNPG==A
M.Z["=TA B@E858.L5/["=UV$[KL)W783NNPG=$29N@Y$IE#0A[L)W783NNPG
M==A.Z["=TC!B!$?\/==L+<OG2QA'CBK5#[?%AQ:B6W_8(K6U\6,?VC67+%R8
M'L R:1'T(WR=6JFY/4VZ9U\NFM4MP75#<!EH)%3PM!A!A2YSA,_A3"WBWX4\
MNJFFN0B:0$U4AI]6IM\CJ2 1EJE$3J=!IY(/4I2E+FSE*J0B:0%U4A)]6OE\
MCJ2 0EJE%3J=!DB@/+$!"%E6D)PFJD$A/7R^1U2AIU.@R),'[I9SE*1XQ,T:
M@IIG544 D6+_ 'MK1OLY2%$+>_._>V9- E SIL0Z/"B%O<$_O7FXA)3^8Q-3
M<8VA%\]7(484>N$H7F:,TRE3+[UZO_;DM\I^6C[V*O\ VY!0M6;'"#H!#^]B
MK_VCHHJ$J2TZ1$+[V:O_ &B*)QHY,@F $9?>U-O&IS^73>OETWKY=-:I;@N@
MVZ!+0*40 U_K_P#':$$#"#7,AK'-P8IE-CV=$;KT9[N"CJJE3+S!8.DI>0UV
MB)35TE$+^8+!UY@L'7F"P=>8+!UY@L'0(P1@+BJ.9MH8OF"P=>8+!UY@L'7F
M"P=!OUBC"<\00,(-<R&L<W!BF4V/9T1NO1GNX*$\?(IA7S!8.DU53%@M ;>S
M,(&4]WM-7-1F7RRB9A+=#97!XCATFG%?,%@Z\P6#KS!8.@7VR# E%= E$,[@
ML*6O,%@Z\P6#KS!8.O,%@Z\P6#I+6T5<"Y9PX33RWF"P=>8+!UY@L'7F"P=>
M8+!UY@L'1(\24RO%0>#2237F"P=>8+!UY@L'2<MHRQ3$(_F*%62>;/4S7 00
M,$/S!8.DUUM99,PK"XBMXD?RAQ]314O).PJR(G*::KE8%1S-M#%\P6#KS!8.
MO,%@Z\P6#KS!8.BCV9A\SQ,&"Y0OY@L'7F"P=>8+!UY@L'7F"P=):RCK@'$4
M4,$/S!8.O,%@ZIN PZIDE%/4@HGG<5BV\*->_P#99YG7>_66P"9$Z34B3IN4
MP&0>^P[S7?;-DV1=[(BY]YS_  )G3B<9M+FU>1A&4-1'5T6',FZGEE9C6#MU
M/+^\,6X?T-AMATTX[D'42!B^-N=>:[[9LFR+NY#W/O,H<"9TXG&;2YM7D81E
M#41U=&XYLG.R8UZP@OQY;OCCD9><C9"VRBHGE=0PL.=CR4BO/<8I:>V1X\;4
MSN/ESQ;179"%"'"ARQ].T#(NG<6W!O%W,0I=PW /^O#MP]-.7E+Z>XL0?3AQ
MS>]2O$H<-IYBR^;5T+=GF:\&\_FS \O%^(7J/X/KP1K;\Z]P9696%[*%WB^W
MC<!6X-AYNUE'\6LQ;DOIX<=R#J)#C/U^XWTZ)0[<O2#C<'P#Q3U)123-M\S;
MXV^'L1DTP+[$X+XF$18R\0\1L7+IFMQKLZ<R\)+\EBS.O/=5<NO<VFJFNG["
MW!GL=6[P4TU556PV[$PVAJ>W39XP7NA@/=1F 808V&5==BS=NIYAWCT7,#E!
M[#7, NY:J'</Z&ZQWQ!$OXR/XTA]?QI#Z_C2'TUT6;;;/'<@ZB:M[M_C/QB_
MQI#Z_C2'TA;<HR*N<[<%>QU<O#33575;';L3#2&I[=-GS!>Z& ]U&6!A!C89
M5UV#/PYV7'_4ISE/#F^\KO6]T9,ER9?*"]YB]UR=8N'.PY!Q;B%U/B*_PPEN
MIYBV;ARQ].VL;,<*\AC7\:0^E#;660RUT+6O&T#J2E100U2V;P#N!;WC7MJ#
MUU_QI#ZR#LK58=]:;>W4,X6[_&D/K&ZP5>/S9Y=U&/.Y5O/XTA]?QI#ZN$TI
ML-],9LS>CV_C2'U_&D/JS]O9VJMMQS>]2M%/YZ_XTA]3VTA_PO-A'<:U#>UM
MS7$.!K,#R\7XA>H_@^O!&MOSKWQ$KH"HN*\E"X3ZM;;5PW;?"#MS6K*DW+MP
M,$R7NUBA>"T>L1,>@[,,KCDEBB)D$X_XTA]7CP9%M);;6-F,E>0X/\:0^K98
M#"VZN!QOIT2UCG8>O(!V?QI#Z_C2'U_&D/K'"Q-=@&?QN#X!UCY96J_#Z$VT
MS<J7?MZW?1"[B;3@:*NWW LM5:QTO.3OC;;C? WB<^GG?)EL"Q+PS]7#ZXW<
MU,?UA'>>6=H2%FK/M4WV]L?86?3<-H]^Z*Z@Z[0;@#%64UIW'8#["CR N<%:
M*TXPPI@7%>P%-WVG716'7MZ74^"/"'</Z&ZV[.A\>Y!U$UCZLI -C?CJ)KXZ
MB:+*2<<KYV?+<-H]_**ZPZ[0;@#%64UIW'8#["BW&#GNK.Z&*F2X=F+J+-F[
MA-AR(SQ;V>M^/EQ!T8+&2@ECSG8+SPNUSI;+:[V=JJ_'=AY:<C=B[CV:I]C/
M##.ZGEI>>'+'T[:VU>].&Y$M(AIU:Q( ,%\<X=POKKJVW3OV#(;KK8OK;%F]
MZE0/U^%S%I$;UO-8" &!<@8'EXOQ"]1_!]>"-;?G7OB,%0."Y4$\UG%9ZZ2S
M9M_V]S<L6]P4=<1'"3CS*]-6MM3]E#?3HEK;M.%"=UOCJ)KXZB:^.HFJ:J:Z
M>-P? .MO3KKPRHL2DWDMWK;Y?0Z#=[C='#6S-TUEA8'679BW>;&UB7S51001
MY7KL(S+\IR$D%V^B?862]@$^_;*>["=]N%[0 XY4:UV95ZK;C6/O\Q[[(4.X
M3=3X^]]8G6\\N+%Y;V[G;F^C5<BHSG*Q7@EW 9T&X?T-TW;DW%9Y'STO;KST
MO;K$F[%TW)D)!N0=1(-N;K-SLF,?T^_;*>["=]N5[0 XY4:UV95ZK;C60OZQ
M[[(,&Y*<_(T]'+&^8.$FL5,L"UG6J[W6MOESXX6<-7KN?F&0*I>1C).?#GG#
MN&W4^#M36WU;R;;M3N#V[FW;HTU5458VW2IN[:"#+'T[:M=>RXMFAOKBR2TH
M9J9)*!=65U5>4K?,5>N4\6JW4]H-F'<+ZZZMMT[]@R&ZZV+ZVQ9O>I6FJ=-7
MUQ9):GG#DE.5P[YW9NJ%K;VM&?04*!Y>+\0O4?P?7@C6WYU[@S&Q,5WDI&2Q
MDD8T@.9QM0_9S/U[MPRTW8W7RWH<RO35K;4_90WTZ)0V^\ \;@^ =;>G77C<
M1/ 2;@8J&A2>0_V8[V,SW\EO;;PM8MUW!P.O6S@CA,VGFK37+7+2/U*4R:TE
M\;@/-+MVRG*X51VN&WM#4K?%.<F-]%.9UX;)WH1];=UU.VHT&X?T-U:W&BZ]
MXF]]".1.OH1R)UC;B7>BVMZH-R#J)IA8"N-]LK^-ETZ_C9=.L9L2EFPCXY[O
M8S/?Z6]MO"UBW7<' ^];.".$S:>:M+<M<M(_4I3)K27QW*SGYC>L1"T@,;\N
M[%56:N-H((4<7%2QX5E+:YQ%_<Y)!"5@BE1Z#1;B:,ER1:^=RS%V[I%PPA3#
M2S!Q>9C7RIR$Q]O1:C6W_=3Y6N-!ECZ=M-.W[X?E?T\WUT*$( );YJ /EZV)
MQQ8EATV+<+ZZZMMT[]@R&ZZV+ZVQ9O>I64ISG]/-]=.RW;[8?#$7$]C7/0RI
M4L2+0/6BH-Y8BUTT9&\'Y530QM;?=,YWZAN38.TUV9/+;?11]72Q7O-:4OK
MB[J@U[CPYE>FK6VI^RAOIT2UC_8I0OZZ/XV73K^-ETZ_C9=.FVE5H3=XW!\
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M45WR>=+YN7['AOU)A7^XO;,/Z?RVMAS3,55*/M=%%0E:<2H3R,1U1))P1U_
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M&_4F%?[BXMOQ%'>+)='8)ERWKNBZQ15-2&K0KCOUM"V=RG^-GHLJTB2E:#5
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M->*2>U35373RUE(+K),T6&)F." HS2U24Y3E!.4IR62$TQ3X@A5CC%"]!0K
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M<YU3@9G<,+][UA:'B*%>[EB:_<,+U[]]E+'CI.8#Q7 I'C8!ROCBDX4%MO\
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MIGR1E-/<<*B_X%]9"CS%O/CU=2FY#-T((&$'?JZ%=S'KB\+[RRXE%(M X50
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MB[%#CCFA]8B86OS*1=LS8FU]@FKRGNQ&=<EMYF[<*[9POK9SZE<Z^W1"'$_
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MO)OMT0@P.W$J&F7+F #8'-S<S[;E@D]<7%ARK''; ]($.\!Z@H=MSUI0Y?\
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M+\S?1]%L[?\ 'Q712)1_#?M^ZELX;?DIV(PSQBQH,ZWULHT5ZO."TW2O=/\
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M9_?@R29X5B]ZK$*ZQE*54M<3<G\>F=E%9)RMY6:+CX_U[DKW:7K=,4:CF?\
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MPU555U<MM&IRKY#B ]V>B; GXA?XD)10+0J)8A 3F &!RU9%Q2GJ@2@6CB9
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M% G2>*B!UA"0@&!RU9=RUTRH<*=5*IP)M,AW-+\#1TR<JXAB"!5IJ\&/"O\
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M'<-Q+#PU/A.;@N(UWRW-S"6@]K$YX,C?] \7M\15 "Z(Q6>('5SMO($GBJ=
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M^M@CFAV3WLOS0[)[V6B->R?[,J*%7B&GMDCM9;<S%CPYR0#UQT\6LGL9!5T
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MW,/^F6WQF7VYA_TRV^,R^W,/^F6WQF7VYA_TRV^,R6*+&K!G8@*HO+<DDF@
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M(VMY(J[12"XBE8*"!M%8W8A:D"I%*D#61GO>XA,D$,8J\DCJB**TJSL0JBI
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MQQ>RFFD(5$CNH'=F.H*JR%F)W  3F/=W;K%%$K.[NP5$102S,Q("JH!+,2
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M%N(-H<[;RC4T<J@J0?4MLNI5U5@"-WK?2_SO?_6),NAWGS"?K]OGX_XF'_\
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M"S.5BB<J=#"-Y%<J=!"D'0<IL6Q>=[FZN7:2665B\DCL:L[NQ)9B=)).4/\
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MISE)_,+^84D38NT30VUM"W.):I)02R22@!7G=1S:K'M1I&S^'(T@$?\ 7?\
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M-=T LX!"'*.SM$6.*)51$4 *J* JJH&@*H   T "F<TLK!54$DDT  TDDG0
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M!1550%50%4!0!_0.TA(.^-&5)'+<9)[OH*'"<*B:>YN'6..-!5G=C0 <NZ:
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M%&HU*D:A$4<2@#K6!6OL(+AO=R1C_!Z*%M:(7<[@W!ODZ@!OG(3WE)IM>D>
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M\FWHW'\68:7>UA4[VPL[L.7;2O$,ZXQO%9!%;6L;2R.?6H@+$TUDT% !I8T
M!)&4MO'-)9834B*TC8J&3<:X*D<\["A*L3&AT(NMFZBW=C*\,J&JO&S(ZG?#
M*00>(Y17O2.\EO9H8EA229B[B-6=U4N?":C.QJQ+:=>KT0L,0VF<@ #62= &
M0B%#*]#(V^=X>U74.4[OH R2$*JBI)T  :R3E\GMR1;H= U;9]D>#V(W-9TG
M1_1<SWJEBC*!1B-8-=67J&]VV7J&]VV7J&]VV7J&]VV7J&]VV4,EDI4NQ!JQ
M.@ '=_\  ELYW)8SV'&5ET%LWI)B#\_. ?\ (A;X-2-Z2;PAPP'?]"8AYLE^
MM6F=>_H)O)MZ-Q&YW7Q&1>1+:U([;G.M< MVV6Q2Y ?VT-NO.,/UI@/$"-WT
M:V+3#0M5CX_7-R#P1QG='H"IT 9&PLF^ 4^$1_F$?X1N;YT[W]&W/C)W#G6_
MCMW!_P"! ZZP01QC+$<7@;:MXF6W@TU'-0#8JI]B\G.2#Q_0F(>;)?K5IG7O
MZ";R;>C;@[^(SG_T+4>EG='[3UJ1W;\KM;@^\'HP1H*LQ  WR= RBLH]4:@<
M9UL>4U/+G\[>R",;E=9X@-)Y <BN'P%_;.=D>Y%21QD'@RJA2/Q4K[XME4S@
M_B1_DY?#)'(.(J>R#3M9!;Q&A._ZM>R &_NG(36KK(IW5((_L/ =/5;"\/;P
M!HD<>N]JI]COGUVK5K_HVY\9.X<ZW\=NX/Z>:ZE98+=/52OH'$H]<> ;NBM:
M9;$<,MX1ZYG,2GB"^%3QA7+9EP\QCV23,2.1@ >7)I\ F,I45,+@+*!P4T/R
M<0J=&6RV@C-#P0-LGUS40<8VB*CBKE7X/BV_[*=O(O/ VR/7+1QR[)-.6GH#
M$/-DOUJTSKW]!-Y-O1L_G"?R-MG8'\VG\JOHR -J0ES^**C^]3/&P TTE=A=
MP;[-P#>W3HWR#<7;EW;=/<&X -P#0,X3V<A1N#4> C41P$9?)YP([@#5N/OE
M?376-8J*T;"L/;PM4CC<WT4[_LCN:M=:?T=<^,G<.=;^.W<'].B*4[,2 O(V
M\BZ3V=0WJUW,K6U"[-HLL:)%ZW8VP-(W2PU\=,C/<01HBTJS: *F@TUWS3(P
MVRPNU*T1M--_P6!Y<HK[#G948^":^$C#32NZ"*TKN @UW5QZ!0LJD)<*-6T?
M4R ;@;4>$TU@D]1;:W4N[F@ W?PW3J TG)9[D"6?74Z54[R@[WLCIWJ:LQKF
MR CN!IT:%?@8:@3[+W5=QHI059200=8(U@]>Q#S9+]:M,Z]_03>3;T;/YPG\
MC;9V"?-I_*KZ,GF]C'3W3 _X<^=R=$;&-> (::.,U/+U@2Q,5934$&A!WP1J
MRJ?Z/N?&3N'.M_';N#^G;VY7U4KQQ5WAZIAR@T.5I^FB]^N4EC&P5GV=)U#9
M96W.+);^>8,4!HJ@BI8%=).X =5->4>&VS!RC;3D:0" 5"UW3I-=[0-=:7E@
MWJ9H'/XR:5/)IZIQ28?"2U"<" Z^-B.P!36<Y<7A&LA9./UK=K9/XO7L0\V2
M_6K3.O?T$WDVZ]\FZ/6-Q?2#6((9)2*^RV%.R.$T&[D)#A8ME.[/<0(>5!(T
M@Y4&52]BO ;A_2@([>58H;6;@2Y4'_U%C';R+WF!7#@::P<W<Z.*W>4]JN36
MF(0O!*NM)$9''&K $<HZU/YPG\C;9V"?-I_*KZ,NSP1_^YGW,;:Q*_8VB0>4
M:?Z)K;02.#NA33LTIV\JF$+XSIW 2<M)C'XQ_)RT<V>)SZ:C*O,;0]JZ'M;0
M/:RK<6\B#?*FG9I3M]:N?&3N'.M_';N#K^S;1M(=Y5+=P'*JVS#QBJ]IB#EI
M"+QOW@<M<?NC^3EX,2OQ.OID95N+>10-W9)'9%1V_081 23J TG*L=LP!]E1
M/?$'*I$:\;]X'+1S;<3]\#*K6[,/:E7[2DGM9<W,I1AN,"#V#GA5%2=P:\JQ
M6ST/LJ)[\KEX2HO&X]*N6N,_C'\G*HB#^*Z^F0<O^;A>,;Y4T[.KMYM[;+ZJ
M)XY:;X]2QY *G*T_31>_7*:[M&V9%V*&@.MU!T$$:B=S*5;TAI(BND "H8&E
M0-&@@Z@-S(31#9$R;1I[($ACRBA/"2<KR_;U,,#C\9]"CET]0*-9T91V\?J8
MU"CB IG3VI%2R&GC#2O]X#KV(>;)?K5IG7OZ";R;9EE#,H='GA5E(J"#(H((
M.@@C00=8R^[N'?0[?XO+[NX=]#M_B\ON[AWT.W^+R^[N'?0[?XO+[NX=]#M_
MB\L:Q/"<$L;:XAA!26*UA21#SL8JKJ@930D5!U'J#".BUJT[BADD/@PPJ3ZN
M60^"@T&@TNU"$5FT9)>],#_O%X*$H:I:(=Y8P0TM-596*,-/,J<ELL,@CMX4
M%%CB18T4;RH@"@<0S38](K&"]B]C-&DE.%2P)4[S*01K!RDQ'^74YLI])^2S
MLSP/[6.4[4L1.YMF52:#P!IRDP/I':O:747JD<:QN,K"JNC>M="R,-()S#B/
M2#"+.]N/EDZ<Y/;Q2OLJL1"[3J3LBIH*T%3E]W<.^AV_Q>7W=P[Z';_%Y?=W
M#OH=O\7D</Z/6<-C 6+F."-(D+D %ME !M$*H)I4@#>SHY^DF&6M^\0*HUQ!
M'*4!-2%+JQ )TD#=R^[N'?0[?XO+[NX=]#M_B\ON[AWT.W^+RNY8NC^'*RPR
MD$6< ((1B""$T$'2#U)L/Z0V<-] +&9Q'/&DJ!Q+;@-LN"-H!F -*@$[^7W=
MP[Z';_%Y?=W#OH=O\7E]W<.^AV_Q>7W=P[Z';_%Y?=W#OH=O\7EBN*X)@UE:
M7,1M=B6&VACD7:O($;9=4##:5BIH=()!T'/QB#I)86]^D5O"R+<1)*$8R,"5
M#JP!(T$C6,ON[AWT.W^+R^[N'?0[?XO+[NX=]#M_B\ON[AWT.W^+R^[N'?0[
M?XO*'$.CV$VEC.;Z%#)!;Q1.4,5P2NTB@[)*J2*T) WNK<Q;ZH>P6'^+/_WB
MW%5:@DIN$: W$10'>(&_UU)9+:(R)X#_  :U)&HG1ZX4)._7+]EB_5KWLOV6
M+]6O>R_98OU:][+]EB_5KWLOV6+]6O>RE%G B2J-I2J@$E=-- ]<*BF^1UE(
M(Q5G(4<9-!V\DB-M&Q4 5**2:"E22-).LY?LL7ZM>]E^RQ?JU[V7[+%^K7O9
M?LL7ZM>]E^RQ?JU[V4D=E&L<<7@ *H4$KZHZ-9VJBN\!U1!:(9'.X!7E.\.$
MZ!D),5DV?:)KY6.CC !X&R'R6!01ZXC:;W35/8.>?E4",3NTHWNA1NWD7PR4
MJ?8/I'(PTCE!X\N:O8RAW#K!XF&@\AT;O5G6[B64*@(#*&IIW*Y?LL7ZM>]E
M^RQ?JU[V7[+%^K7O9%;2)8@VO94+7CH,X+=Q+*%TC:4-3BJ,OV6+]6O>R_98
MOU:][+]EB_5KWLOV6+]6O>RG=+:(,L;D$(M00IH1HW,\10J78Z@ 23Q 9"2_
M80+['U3]X=DD;HR!$7.L-V3PNUZG^[D$C 4#< H,X_*X58GUP%&]T*'MTR,N
M%2;8]@] >1M /$0./(P7*%'76"*'\.'=SXYKF".1RSZ612=#&FDC+]EB_5KW
MLOV6+]6O>R_98OU:][+]EB_5KWLOV6+]6O>RN8H@%597  %  &- !N 9".,%
MF.@ "I)W@,A/BS% =/-KZK\8ZAQ"IX0<MBSB6/A TGC8U)Y3F\U=1K(N\P![
M%=7&,C+A+<VWL&)*GB;21RU'%D;>Z0HZZP>Z-PC>(T'<ZH514G0 -9.0N,6)
MC4Z1&/5GQCJ7BTGQ3ELV42Q\('A'C8U8\IS:'(L$YF0^N31IX5]2>'17ARVI
M1MQ$Z)%U<3#UIX#H.X3U1-(-J)P4D7V2-H/8UC?I3=RMKT-M6;21NDHJ1L!@
MQ!IIVE TBE330-S*:TM)MN1MB@V'%:.I.EE U [N4AO6V(Y$I6A/A @C0H)U
M5W,H(\*D,MPK$! C@E6&G2R@:"H.DZ!4Y+@%NP:0G;N&&K:W(P=T+N\(&HU
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M@'6^:NTJ1ZEAH9>(^D:@[HRV9?"C;U+C4> [S;X[!(SH_&?WQSKB"!2SO,X
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MGP3R,:?C<'6\0\V2_6K3.O?T$WDVS+#YS!Y5<^[_ $TOOVSNCWS^V\HN=?\
MS:?R39T_G"?R-MG8)\VG\JN=*-^PN!_ZMN?2SL>A45V;<2<D4L<I/($KGX_B
MI&B66UB!X8DF=A_ZRUY,Z#SA!Y&Y] 12IK5U(XP0<]QO(G<KZ>8EU":-&P8<
MAKV#J/!E'=P^ID4,.7<XQJ/#FF.055@01O@Z",I;)_\ +8@<(UJ>52#RY&[8
M>%.U?Q5\$=O:/$<V2[E]3&I8\@U<9U#AR>XE-6=BQXR:G/\ ^4D(7=0Z4/(=
M7&*'AR"8C$8S[)/"7L'PAR;60^2SHQ.Y6C>Y-&[76XL4C&D'8?BTE3R:17A
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MZU<?HY/>G-7#L4;P-22'UN\K>UWFW-1T:0&4U!Z\;2S(>X/*(^%M]MY>5M%
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M-1^'!N==J<FM\-I-+JVM:+R^N/ -&^=S)KBY8N[:23^&K> T#4.M+/$:,A#
M[Q!J,HKR+5(H/$=T<AJ.3/DV35(?@U_%]4>5JZ=ZF?S]HU*^J4^I8;Q'<.L;
MAR$8/-S;J,=?BG4P[>^.NFWLB)I]6C2BGVQ&L^U'*1DUS<L7=C4D_AH W -
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MX-P<)/\ 6TO$.YGGY3("^XBZ7/)N<;$#+8;X.$'0@/;8^N/:&X-W^ML*89=
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MXMA#K3;=F*T+*A)4 W]AA\\>Z%CN(VY&^4.!RH<DL>DL;X+</0!I&$ML2?\
MSU563CDB1%&N3+_^/^BEPKSWT:M=S1L&"6T@!6)64D%KA2&8@Z("!I$P*YB2
M_P"C9W+]G8C_ ,?4H<CB6%1[.%8H6DAH/!AEK66WW@%)VXAH'-L%%3&QZB6]
MNI>21@JJH)9F8T"J!I))(  TDZ,H[&X4?[C>;,UXXH?A"/!A!W4@4[ H2"YD
M<>KIU,?BUTM6?]6RR?X<^]_F%?)\)=DVUL2-4,; S.."24+'O@PL-1ZLN)6B
M;-GC -U'0>")2:7*#A$AYV@T!9E&YG8#^G;R,G4P^=L..(?+VF6@GYC8YD1&
MOYF;:VN<]K2F[71]VS]/'[ED%O\ H])''72T=XLC <"M;Q G@+CCR3I%T9E,
MD+$HRL-F2*0 %HY4J=EP"#H+*P(9692"9L-Q",2P7"-'(C:5='4JRG@*D@Y8
MET98EA97$L2L=;(KD1L?'39;ES O_P ;.@4_;Q^YY?=L_3Q^Y9/TF6R^0;%Q
M)!S?.\]782-]K;YN+7SE-G9T4K4UT97>$GHZ9/DLTL.U\N"[7-NR;6S\C-*[
M-:5-*TJ=>7W;/T\?N65IC"V!P_Y+!S.P9N?VOA&?:VN:BIZJE*'56NYUS#^E
M1@^4_(91)S6WS>W0$;.WLOLZ]>RW%E]VS]/'[EE]VS]/'[EEA_281<Q\OMXI
M^;VMO8YU ^SM[*;6S6FULK77098CTC,7/?[?:W%SS>UL<YS$3R[&WLML[6SL
M[6RVS6NR:4R^[9^GC]RR^[9^GC]RRO\ I<+?Y*+UD;FMOG-C9C2.FWL1[5=B
MOJ%UTW*YF$^-=_7)\BV\*Y?=L_3Q^Y9:>C9^GC]SRBZ/7EO+A=[<'9A$C+)#
M*YU1K*H4B1M2J\:AC158N54Y8;T[MT FCD^1S$#2Z.KRPEOT;)(H/_F ;@S;
M#YM!Y)<L=_11?68>KAOSJW\JG47Y];^\FS B"I)H!PG*PZ,V0 CLH$CT>N8#
MX1S[:20L['=9B<KGI5C>T8;<"B( 7D=R%2- 2!5F(%2:**L= .3'!L-L;:&O
M@K*)YY -RKK+"IY(QD!TAPFTN8]WY.TMN]-^LC7"D\% #JJ->0M;*Z^17M*F
MVNMF)S05/-OM&*4:":(^V%&TR*,O]MPB0_[/AS,L%- GD]2]R1NAM*PUTK'X
M5%:1QF7F$MA1Q#Y5,)MH7/,;-$5-G9YB7:U5K4;U-W+[MGZ>/W+*QZ'C S:&
M],@YWY8)=CFX9)?4?)8]JO-[/JQ2M=-*'+#HVPPXA_N G.BXYCF^9,0_T9MK
M:YWVM-G=KH^[9^GC]RRQ#HN,!-O\NA>'G?EHDV-H>JV/DJ;5-[:6N_F='/.F
M'_6XNI;8XUC\O^47 @V!-S&S6.23:VN:EK^;IL[(UUKHH?NV?IX_<LONV?IX
M_<LONV?IX_<LK;'UL?D'R>V6WV#-S^ULRRR;>US45*\Y39V3JK730=7"_G=M
MY9.HG29K+Y?MW$<'-\[S--M)'VMOFY=7-TV=G36M133\)T<8#@O@>T;0=W);
M?'+:ZPTMZ]E6>%>-HCSO8A.4>+8'<QW=M**I)$P=#OBH.@C4RFC*:A@"*93X
M/C$*W%K<H4DC<55E.L'=!&L$4*D!E((!RFP*IDM)1SUK(=;P,2 K'5SD; QO
MJJ5#T"NHS/\ YC_+N">7#)Y65H519UE*4#2+:FLA4FL9F@4-5"I8!<L0PG^:
MO1WY%& D?PL,L45TKAML+!<5D4Q[*G;5V&TP*E&73TQALGYR"&YMX(GK7:CB
M>] :NH[2E37*]Z*=*IE5L'62[ADEU?(U8R/KJ:VKFH.L1L@44C.72W'YZK%(
MEDMM&?\ +MH7NEC7@8[9D>FCG'<C0<KVUU<U/,GN9&'I?T''AL;?"8?<SQ.N
MZ!(WRA33>/.D ZB58;AR*,*@Z"-\'*:__E^Z8A9LQ9;=W6*YC!-=@,Y6*55&
M@-MHYT#8)TGF^D>&W-EIH#-"Z(?%<C88<*L1UC#^C94F!GYRX(];;Q>'+IW"
MX C4[CNN2Q1*%50  !0  4  &@ #0 -671FPMY-D278N+L#7\C4&!E(W0_.R
M.OMX =S(.A!!%01I!!U$'>RM>GMDE9L.80W! TFVE;P&/!%,: ?^>Q.K.N?-
MT_UBUZEGYL@^LWG6,7^>+Y!.IT@DC@D93B%T00C$$<\VD$#2,OV:7]6_>R_9
MI?U;][(/<1/&":59645WJD#3U^/#8V'.8?<W$3KN@2-\H4TWCSI .HE6&X<B
MCBH(H1O@Y2W_ $ =,0LV)9;=W6*YC!).P&D(BE51H#;:.= YLG2>;Z1X;<V6
MF@,T+HA\5R-AAPJQ&?B%T=4>'2+RO<VWI*>H\<3AFB;9< @E6*JX5AN'8=6H
M=.RRG41E==%\0HIE&U#)2IAG0$Q2C=H"=EP*%HV=*C:RN<"Q>,Q7-I(T4B'<
M930T.ZIUJPT,I#"H(R/\Q\;BK:V+%+-6&B2Y'JIJ'6L -%.KGB""&A(ZAD@<
M.H9E)4@C:1BCK4;JNK*PUA@0=(RZ06^LMAU[3C^32%>W3.M.C^&+M7%Y*D*#
M<VG8+4[RK7:8Z@H).@9671O#!2"RA2)=%"VP "[>V=JNQW68G(W.%2<U?7D\
M4,##6NRW/2M37L\W&4.\9%W\K'I'8_FKV".916NSSB!BI]LA)5MX@C*XGM4V
MKS"JW<-!X15%//QC=\**K!1I:2.,9V _IV\C)U.CWZ2]][;=7&\4N%86ES-;
MI#6H#/"LW/,N^*21*2-%5(UJ:98Z\&H3(I\98(E?^\#7ASI_.$_D;;J8M\\N
MO+OZ!Z/>;[7R*9=(_->(?5)<_"?&N_KD^3<1[G5PS#<&5FNI;F$1[-:JPD5M
MNHU! "[-J55+$@ ]1TDUO=VRKXU7;1^*K<F;8?-H/)+ECOZ*+ZS#U<-^=6_E
M4ZB_/K?WDV8LJ:U((XP:C*UQNR.U#=PQS(?:RH'7M'*YZ*8F[0K/LLDJ %HI
M$8,CA3H8 BC*2-I"RAE)#!WL;48M;+JDM&VG(W-JW;9FVJ:PBR*#H#G02;/%
MK:6UF76DT;QN.-7"L.QUC _&N?J=QU.CGBWW=M,[HYYTP_ZW%U,-2W1I",04
MD*I8T^3W&F@!T9?LTOZM^]E^S2_JW[V7[-+^K?O9%6%"-8S,+^=VWEDZD'G"
M#R-SU8(II3_M5](D5U&2=A0Q"K< :E>$D,2!5HPR'6I7*'I*B_#85<)5J?Y-
MP1$Z\LO,'D._F18+:R07MG H2**YC+<V@U*DD3Q24'K0[.%%  !HRDPJS6VP
MQ)5*O);K)SQ4BA"R22.$J-&TBJXUJX.5YA_1V&UD6^96D:>.5V!164;!CFB
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M9D]39RR*G*!><Q*4=4P&V&_DMF5%>=C28SK;\>0PXME]A]E8<:>9=;(4E:5
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M;],8&#,"BT* W3*9#;[S;+2$X\^&)[5YMU'S8^0V3?U2R8^E]EJ[3XN;#O\
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M"3UJ2E;55MVX*;+H]=H=0ETJKTJ>RN/-I]1@OJC2X<IE?%*VUI*5#O=NU/\
M[NES?I+M3>U!]I%U_B&1\FW%[_%\>Y.WM[S=?>_O+W1QODS5*YU(S*HFFT>B
MMDIQ#:[CN:++*DD\BLM-4D'EP*AR$[^JM1DR7':=:=PS-/+>CE94Q#I-E27*
M,XF+CR(D3$2YI[JWU$<" -^GUV@52H42M4F4S.I=6I,R13ZE3IL=>=B7"FQ5
M(<:<01BE:% CF.RW75K===6IQQQQ2EN..+5F6M:U8DDDDDDXD_J?K?[:[0_%
M$O>T6]N5S?B1G]7?.AO: 2U6=0KVTXT>:G(X/1**UGN6X(K2^9$V,ZJ.^G$Y
MDY>&(!V\WGW\M)O=[3]KUTFHE8I] J=T.6RN-5:JS)?@Q10KM@W$\'VH@+AS
MMQ%-IRC@I0)X8[4/5N[-3:57G;8A5QJDT*W*34(K4N97:-(H#KM3GSW$GJ6F
M)+JTLH9)4YD)6D((7:&B%BUNGW5.MJ['+NO&K4B0U-I5(J4&DRJ'3* S46"I
MI^1EFRG)B6E$,E#:%'K"M#?G)Z13/5:-J1YN=]RDQE<6D779*$5JTZJI!Q!5
M%4N2I'#'%0P([+^OUR4]"[MU"3+I]H*DM8NT2QX<HQGI4=*P"AVJ26EK4O#C
M&:8*%!+S@5NT#SCK8@)9<G2HEH:DHC- )?DE@IM6YI 3R**&E4Z0X>7"(D#'
M,3VW4_\ NZ7-^DNU-[4'VD77^(9';E4C2[3>^=1*DVI"'XEEVK6[E=B]9Z5<
MWV(8=#",.)<=*4@8DD $[-2EZ-1[3AO92A^\KXLFD/8*XDNTIF>_.;PYPY%2
M>YCQP"W)VBL57#U)^_*RIP<.<QJ.XG_*V4N'0]-+@4E)4&J1J)!9<6</2)->
M8A)Q^R4!W]GGZ[YMM^5!AA*G%.64:'J,5-IXE:&+ F5)WDXX%O,.<#:11+HH
M59MNM1"!+I%?IDVCU2*3R"1 J*&W4'A],@=JN+W^+X]R=O;WFZ^]_>7NCC?)
MGG$/G#.W$TK93P&.1]ZXEKP/A;3COZW46<A:)$+5:_<"L$%Z-(N:3*A2ACQR
MO,K;=2><*!_4EE^R=(=0[AAOA):JD*U*P*,H+XH)K4AI$1./*,SPQ''DV0Z]
MIM H#+@!0NNWK9S*\#SKBP)LE]'@6T#WM@IR1I?%4?\ -OW=45+'A,:FN)]!
M6V9DZ:SC@3DBWA*0K'ZG&= 93CX\._LMU.EC-:8;!*G:'>5DS%</J(;U0:D*
MQY@ED[.O7GI#J-;T1D*+E2J%HUM-) 1Z<IK#;*HJL.4Y7C@./:M;_;7:'XHE
M[VBWMRN;\2,]O,*RK-NJ\)B5)0J+:]O5>OR4K5Z5*F*4RZH$\P(V0[ T4N"
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M8T2&P[)E2'5>E:8CLA2UJ/,E()V9?H&B%Z-1WTA;,FY8T*RF'&CQ#K;MY/0
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M$;^NU/U9TTL74J#1;(M291X=\VM1KHC4N7*KS[$F3 8K++R6G'$)2E:T $@
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MQ)4_%3&EH;3@$B-(6>*CO7MIO70GV,O.VZI07GB@.*A/38RD0JFR@\.MBO\
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M_5JG_P ?*_=[?]6J?_'ROW>Q2JJU(@@@@SI1!!X$$%78N+WA[X]UEO;VO/\
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M:0IJFT:FM+4J%1*'!*E)CQ(X40VV"225..*6ZMQQ7948[[S!4 %%EU;14!Q
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M"90:$"HXGJK>M\Q8*.X,L<<.&WE0K]:$H',)(JDX/A6..;KNLS8X\<<=HK]
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M=:Q)03OPJ52X4JHU.I2XT"G4^"P[*FSITQX1XD.'%8"EN.NN*2AMM"2I2B
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M?HHKN]K][U5Y?B9W?T/]K=2]U$_>N'VFV3^*?D-JY-.[ON"S:VWE29] J4F
MN0TE6;R:<TTKJY#)/IF'T+;5],D[1:7K59=+O^"@(:=N>V%,VO= 2/3R9E,R
MJILM?<;81"3W5=V,Q3]2H%H5F0$ T'45 LZ:VXOTC J,]1ICSA/1"(T]TD\
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M6GUD3 XRY:5C*DTY,Z(OH]37:\M:ITP*3T76@ZW'7SQQVJ'>>FUTU.U+AA]
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M%29<8I(Z3*@<-A7-4KVK%T/M..+@4]]U$6A4<.<%-T:@00W#C C!*E-,A:\
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M;)3,NZUJ^4C KJUC6ZRI??4*$U"'[4#8)72=)9!&.*WK3KR5*X8<0Q6$#O\
M ;*2U#TMAE7(N-:-44I'##HB74W1W^(.RFXVH=(H25XA7L-8UG9\I^E2[584
MI:?"E0/?V<:K^N6I+T=X%+T.FW-/M^ ^E7*AZ!;ZHK*T_6J;([VSTR?*DS9D
MA9<D2I;[LF2^X>5;S[Q4I1[ZB3VYB?39LNG3HRPY&FP9#T27'< P#C$F.4K0
MKOI(.S35!UROMQED ,L7%4&;SCM(3P2VVQ>+4] 0.0("<H' #9(F7%9U>*0
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M1CB.(X;T6C6_2:G7:Q.4XB%2J/ E5.I3%M-*?=3%@PD+=<*6T*6H(0<$@D\
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M\W>_#</'V"" 00001B"#P((.SMW672O)=%M8I51N"T41&<L"T[D#@D7/8IR
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M+>>9+IU(AJ1>U"9*05J$FE]=(;80"79,:,D#'>\VOV[S/<M4.QYK/_?-7?\
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MWLMM8Q0M*D*&)&*5#*H8CO;?F@KGPHZF_P!+; G1^MJ ()2=4=3L% 'D.6K
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M@5JB5)" \PYE#K$B.^R5-2([[:D/1I3"UM/-*2XTM2%!1W?-U_[EJ!^B6O\
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MHQYQ]XTJXHU]VW/.G4Z/:]L6PN!>-OH55WJ2XNWHL1+J)]/1+*2^5D/,,MM
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M.L1^SA\MSRQI/JK"?5 .5;/+CX4\O@Q[@WY,DCA@EA![O'.Y_P"GY;A!&(/
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M$E3GI >XGEV_"A]R?_<[?A0^Y/\ [G;\*'W)_P#<[?A0^Y/_ +G;\*'W)_\
M<[?A0^Y/_N=OPH?<G_W.T549T.E >2YT%IP!*2CTX'?Y-YYLG$MOD@=Q+B 1
M\T'LO?8,_>QO=81BF.VIP=S.KU-/SR?%O(<PXM/H./<2M)21Z.&^PP!AU;20
MK#G61BX?&HD[TM & $AT@=Q*E9DCT#O,]Y;P_P#N$_L]I=8. 4H9FU'Z5Q/%
M!_8/>QV4A0*5(44J2>4*2<"#O/1R>DRYG2/]6[S =Y0/H_K:P?8;<YLRDC./
M L=(>([%45Y31_T;GJB/ %#!0\>.Q+S)ZO\ TK?3;\:AR?XP':&7TXXM.)7@
M.< ])/C&(V"DG%*@"".<$8@]E3B1BY&)=3W2C#!U/H=+Q;S$@8^IN J YT'H
MN)\:21L%).*5 *21R$$8@CLI9!Q3&;"3_".=-?S,H\6\PSA@H("G/X1?27Z!
MX>+LNLJ]*ZVMLGN9DX8CP<NRVG!@MM:D*'<4DX'M7J#[K7>0M02?"GD/C&P#
MZ6Y"><D=6YAWE(X>BG8)4LQW#PR/8!)/<2X.'HX=HB?P;OVPWI7\$C[<[\-O
MN!Y9\92E/SC\B3$=U+*_VI4#\_LO?8,_>QO3'.ZIE _Q0I1^>-Z0>X63_P#?
M2/V=Z*V>1<AE!\"G #OR_LT_-;!WD?PKOVW:A-;3T'B$O #TKO,L_9#YH[^\
MUB<$/^H+[G3/0/[;#];F!X@\"#S[*<BA+#W$Y!P9</<*1Z4]\<.]S[*:=0I#
MB#@I*AQ!_P .0[\19Y>I"#_LCU?['9((Q!!!!Y"#P(.SS&!RA69L]UI?21Q\
M' ]\;R6R<5QCU1[N3E:/H</%V%N+."&T*6H]Q*!F4?0V=>7Z9UQ;A[Q4K' >
M#=:"ABVSZNON$((R ^%6'BW3/93B0 )*0.."1@EWQ#@KQ'N]M2G$O1P>+*SR
M#_5JY4_.[VP=85B.1:3P6VKZE:?\,>;>B?P;OVPWI7\$C[<[[">Y&!]%U0_8
M^1) [L?'T'!]'LO?8,_>QO/GNR2/0:2?V=Z5_L/^81O0_P"4-?,7COR_LT_>
MT[R/X5W[;M3C#HQ0XDI/='<4,><'B-G([HZ2#P5AP6@\4K3WB/H;H()!!Q!'
M @CD(.S#^/24@!SO.)Z+G#PC$=[];IE(2 ]'&*B!Q6SCT@?L>4=['?:'U+CP
M_P#N%7[.XW+2.DR>K<[[2ST2? KY^\&U'!$E/5'N!P=)H^CT1X>PIL'!<A:6
MAW<@Z;A] 8>/>5(4.G)5B.Z&F\4I]$XGT-W \0>!!Y]E/P$X@XE<;G!Y26<>
M;ZWT.X"E0*5).!2H$$$<H(/;$O-'$< XV3T7$8\4G]@\QV;?:.+;B0I)Y^X0
M>^#P.[$_@W?MAO2OX)'VYWV#W8P'H.J/[/R(_P#R8_?4]E[[!G[V-Y[^5*^]
M(WI7^P_YA&]#_E#?VV_+^S3][3O(_A7?MNUYVQ_&602WR8N)Y5-$_-3W_"=B
M"""#@0>!!'*"-UR&L]%WU1K'_2)'32/"GCXOUNO(5Q2MIQ)'>4@@[Z.^ZZ?\
MK#]C<<96,4.H4A7=P4,,1WQRC9UE?IVEJ0>X<IPQ'>/*-U*TDA25!22.4*2<
M01LS(3_G6PHCN+Y%I\1!&R60<4QFPD_PCG37\S*/%NM,(],ZM*!WLQPQ/@Y3
MLVT@8(;0E"1]:D91O^KM KPP#J>BZGN8+'+X#B-BJ*\EU/U#OJ:^\ H8@^/#
M8]=&=0!]-E*D?=$XI^;VMZ&H\".N:QYB,$N)'AX'T=V)_!N_;#>E?P2/MSOP
MW.ZEY!/@*5)^>=X]4TXYEPS=6A2\,>3'*-OP:1]Q<^AM^#2/N+GT-OP:1]Q<
M^AM^#2/N+GT-OP:1]Q<^AM^#2/N+GT-OP:1]Q<^AM^#2/N+GT-OP:1]Q<^AM
M^#2/N+GT-OP:1]Q<^AM^#2/N+GT-OP:1]Q<^AL\7&76P8Y *VUH!/6). *AV
M7OL&?O8WGOY4K[TC>E?[#_F$;T/^4-_;;\O[-/WM.\C^%=^V[8J='3PXF2A/
M-_K@/MO1[NZVZV<%MK2M)[BDG$8[-2$<CB02.7*L<%H/@.(_6D8T=6,E8Z2A
M_F$D<OV1YAS<O<V3#EKXXX,/+...)X-+4?\ ))\'<[3(<)P46U-M]TN.#*G#
MP<O@&_%'.4K7^W=4L?,.ZU,2.BZ.J=P_TB1BA1\*>'BWI3#JL$L)5)3WFP/5
ML/ <#X]G7E^F=<6X>\5*QP'@W7)2AT6$Y$?PK@P)'@3CCX>UGK8S*R>560)7
M^W3@?F['JR\P>8)7G2/"',3\W8EB0TZ.XXE32O ,,P^=MB^PM"?JP MO]NC$
M?-WXB^Z\EL^!WU(_/W8G\&[]L-Z0GG+ /B2X ?G[_6 <6'4+/V*O4S\TC>4R
MHX)DMY1_"(Z2/F9A\@O?8,_>QO/?RI7WI&]*_P!A_P PC>A_RAO[;?E_9I^]
MIWD?PKOVW;,#Q!X$'GV,F.G&,H]- _S"B>3[$\W<Y.YNF(ZK!J0H=63R(?Y
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M>#BGQ=H0T@8K<6E"1W5*.4#9IA'I6FTH'?P'%1[Y/$[RW75!#:!F4H\@'^'
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M(/U?3<P[S:3\\C8*0CK'1QZYW!2@?K!R)\7'O]M9F)'IO47<!SC%3:CXL0?
M-YAC#HJ7F<_@T=)?'O@8#O[8#@!P '-VC \0>!!Y]BML&,X>=H#JR>^T>'[7
M#8EM*9"!SM*Z6'?;5@<>\,=LKK:VU?4N)4@\.\K?RLM..GN-H4O#PY1L"\41
MD'ZHA;GB0@_/(V"\G7.C_..X*P/=0CD'S^_VHM/MI<0>90X@]U*AQ![X.Q7#
M<#J>7JG"$N#O)7Z4^/#;*^RXT?KTD _8JY#XCOQW&V'5-I>:6IS*0V$I6"3G
M5@.3O[Y0XA+B%<%)6D*2?"#L515F.KER'%QHGO8G$>B?!L<6"ZD?3L>JC]J.
MEZ(V(4"DCE!!!'A!WAU$=Q8/T^7*WXW%8)^;L%3'@@?Z)GI*\;BA@/$#X=LD
M=I+8YR!BM7V2SQ/C.^ZXU&?<04- +0TM:3@V <%)&WX%*^X._0V_ I7W!WZ&
MWX%*^X._0V_ I7W!WZ&WX%*^X._0V=2\TXTHR5*"7$*02GJD#$!7-P.]);:0
MMQ:NIRH0DJ4<'TJ."1QY!CM^!2ON#OT-OP*5]P=^AM^!2ON#OT-OP*5]P=^A
MM^!2ON#OT-HJUQ)*$)?;*E*9<"4@*XDDCAOR7&XLAQ"EI*5H9<4E6#8'!0&W
MX%*^X._0V_ I7W!WZ&WX%*^X._0V_ I7W!WZ&WX%*^X._0V2AUM;2PXZ2AQ*
MD*P*N!P5^N8ER*UB>538+2L>Z2UA\W8EMQ]KO9D+2/ %#'YNW0F ]Y;)'S0H
M_.VX2&".^'!\X';B_'_^[^YVZ<MM/V+:E?/(V]5E.K_@T(;^VS[8EDND<[JU
M*_R1@GYFV5IMMI/U+:$H'H)[>S$2>*CUS@^M3T6P?"<3XAO/2U#BH]2V?K1T
MG"/"<!XCVPI6E*TGE2H!0/A!VZ41D8_4)ZK[WAMP;<1]B\LX?M\=O321_M$?
MLIVY9!\+B>/H)VXL*7]DZ[\Y)&W0B,8CD*FPLCP%>)V    Y !@!X .W$* 4
M#R@@$'P@[8KB,XGE* 6CZ+1&W!#J/L75'[?';TTD?[1'[*=N60?"XG]A(VXL
M%9^N==^<% ;8M16$D<BNK25?MCQ^;VO!YIIT=QQ"5_; [<8J4GNMK<;P\2"!
M\S;@'T_8N_N@=O323_M$?L)VXM+7]F\Y_P"@C8%J*PDCD5U:5+'@6K$_-^5*
M23@!Q)/  #E).S[^)RJ60WWFT=%'#P#$]_=2E()4HA*0.4J)P &S,=/^;0 2
M.=9XK5XR2?EN*:2?59.+21SAO#U57H='Q[R7%#%$8=:>YGQP:'H]+Q?+<+KZ
MPD#'*GAG<4!Z5"><_P"!V4^YP'I6T8XAML>E2/GD]W>2XH=.2>M/>1R-#T.E
MX_EL$>2(X$C]^5S'[';\#1]V5^YVZ,5D>%:S\[#8A"6&NX4-J4H?="1\S8N/
MN+=6?IEDG =P#F'>&\S'3CZHL9B/I6QTG%>(8[!*1@E("4@<@ &  ^6PK[)7
MS^U.35CBO%IG'Z@'%Q8\)P'B/RV5?9*^?VEN.WRK/25S(0.*UGP#Z&S;+8P0
MVA*$CO)&''O]WY;*OLE?/[0EMM)6M9"4I2,2HGD &V*\#)= +JAQ"1RAI)[@
MYSSGO8?+:5]DKY^^.J:(;)XO.8I:'=P4>7P)QVS#U601@IY0Y.ZEM/TH^:><
M_+;)Z^-Q)/*[SG[';]_C>B[^YV_?XWHN_N=OW^-Z+O[G;IRVT_8MJ5\\C;U6
>2\O[!*&_MLVP*8Z%J'TSN+IQ[N"\0/$/_P"M.__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648579416248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001337013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INFUSYSTEM HOLDINGS, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-3341405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3851 West Hamlin Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rochester Hills<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">48309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">291-1210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INFU<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,540,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648579508632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">16,392<span></span>
</td>
<td class="nump">15,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">3,878<span></span>
</td>
<td class="nump">3,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,585<span></span>
</td>
<td class="nump">2,535<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">23,260<span></span>
</td>
<td class="nump">22,065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentHeldForSaleOrRental', window );">Medical equipment for sale or rental</a></td>
<td class="nump">1,987<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation', window );">Medical equipment in rental service, net of accumulated depreciation</a></td>
<td class="nump">39,113<span></span>
</td>
<td class="nump">39,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property &amp; equipment, net of accumulated depreciation</a></td>
<td class="nump">4,375<span></span>
</td>
<td class="nump">4,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,710<span></span>
</td>
<td class="nump">3,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">10,219<span></span>
</td>
<td class="nump">10,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="nump">3,916<span></span>
</td>
<td class="nump">4,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">10,277<span></span>
</td>
<td class="nump">10,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,380<span></span>
</td>
<td class="nump">471<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">98,237<span></span>
</td>
<td class="nump">97,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,242<span></span>
</td>
<td class="nump">7,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">5,543<span></span>
</td>
<td class="nump">4,685<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">13,941<span></span>
</td>
<td class="nump">12,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">34,792<span></span>
</td>
<td class="nump">32,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">3,451<span></span>
</td>
<td class="nump">3,670<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">52,184<span></span>
</td>
<td class="nump">49,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value: 200,000,000 shares authorized; 20,540,143 shares issued and outstanding as of March&#160;31, 2022 and 20,699,546 shares issued and outstanding as of December&#160;31, 2021</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">103,373<span></span>
</td>
<td class="nump">101,905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">955<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained deficit</a></td>
<td class="num">(58,277)<span></span>
</td>
<td class="num">(53,903)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">46,053<span></span>
</td>
<td class="nump">48,272<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 98,237<span></span>
</td>
<td class="nump">$ 97,586<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentHeldForSaleOrRental">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment held for sale or rental as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentHeldForSaleOrRental</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648579433000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock,, authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">20,540,143<span></span>
</td>
<td class="nump">20,699,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">20,540,143<span></span>
</td>
<td class="nump">20,699,546<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582290008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">$ 26,763<span></span>
</td>
<td class="nump">$ 24,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="nump">11,396<span></span>
</td>
<td class="nump">9,887<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">15,367<span></span>
</td>
<td class="nump">14,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Selling, general and administrative expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">47<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">1,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">3,319<span></span>
</td>
<td class="nump">2,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">11,816<span></span>
</td>
<td class="nump">10,354<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total selling, general and administrative</a></td>
<td class="nump">15,892<span></span>
</td>
<td class="nump">13,703<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="num">(525)<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(277)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before income taxes</a></td>
<td class="num">(830)<span></span>
</td>
<td class="nump">482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (368)<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net (loss) income per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">20,609,372<span></span>
</td>
<td class="nump">20,338,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">20,609,372<span></span>
</td>
<td class="nump">21,937,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (368)<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent', window );">Unrealized gain on hedges</a></td>
<td class="nump">905<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent', window );">Provision for income tax on unrealized hedge gain</a></td>
<td class="num">(218)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net comprehensive income</a></td>
<td class="nump">$ 319<span></span>
</td>
<td class="nump">$ 819<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576525768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Retained Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,518<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 40,752<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 84,785<span></span>
</td>
<td class="num">$ (44,035)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Employee stock purchase plan</a></td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</a></td>
<td class="num">(565)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(565)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,518<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">42,949<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">86,163<span></span>
</td>
<td class="num">(43,374)<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">48,272<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">101,905<span></span>
</td>
<td class="num">(53,903)<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Stock-based shares issued upon vesting - gross</a></td>
<td class="nump">239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Employee stock purchase plan</a></td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation</a></td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common stock repurchased as part of share repurchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock repurchased as part of share repurchase program</a></td>
<td class="num">(4,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(368)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(368)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balances (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 46,053<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 103,373<span></span>
</td>
<td class="num">$ (58,277)<span></span>
</td>
<td class="nump">$ 955<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580284040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (368)<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">47<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,706<span></span>
</td>
<td class="nump">2,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Loss on disposal of and reserve adjustments for medical equipment</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">(Gain) loss on sale of medical equipment</a></td>
<td class="num">(228)<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">1,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred debt issuance costs</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,047<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(462)<span></span>
</td>
<td class="num">(180)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets - (increase)/decrease:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,278)<span></span>
</td>
<td class="num">(420)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">61<span></span>
</td>
<td class="num">(154)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Changes in liabilities - increase/(decrease):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="nump">1,641<span></span>
</td>
<td class="num">(2,889)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="nump">4,078<span></span>
</td>
<td class="nump">2,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,204)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchase of medical equipment</a></td>
<td class="num">(2,931)<span></span>
</td>
<td class="num">(2,336)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(138)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from sale of medical equipment, property and equipment</a></td>
<td class="nump">966<span></span>
</td>
<td class="nump">876<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">(2,143)<span></span>
</td>
<td class="num">(2,802)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Principal payments on long-term debt</a></td>
<td class="num">(10,696)<span></span>
</td>
<td class="num">(40,093)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Cash proceeds from long-term debt</a></td>
<td class="nump">12,529<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(565)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchased as part of share repurchase program</a></td>
<td class="num">(4,006)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Cash proceeds from stock plans</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED IN FINANCING ACTIVITIES</a></td>
<td class="num">(1,716)<span></span>
</td>
<td class="num">(6,736)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">219<span></span>
</td>
<td class="num">(6,887)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">9,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">$ 2,761<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PaymentsToAcquireMedicalEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cash paid during the period to acquire medical equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PaymentsToAcquireMedicalEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585628056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies<div style="margin-top:12pt;padding-right:7.2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The terms &#8220;InfuSystem&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221; and &#8220;us&#8221; are used herein to refer to InfuSystem Holdings, Inc. and its subsidiaries. InfuSystem is a leading provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care. The Company provides products and services to hospitals, oncology practices and facilities and other alternative site health care providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial information. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) for complete financial statements. The accompanying unaudited condensed consolidated financial statements include all adjustments, composed of normal recurring adjustments, considered necessary by management to fairly state the Company&#8217;s results of operations, financial position and cash flows. The operating results for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 as filed with the SEC on March&#160;15, 2022.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires the use of estimates, judgments and assumptions that affect the amounts of assets and liabilities at the reporting date and the amounts of revenue and expenses in the periods presented. The Company believes that the accounting estimates employed are appropriate and the resulting balances are reasonable; however, due to the inherent uncertainties in making estimates, actual results could differ from the original estimates, requiring adjustments to these balances in future periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582108904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Pronouncements and Developments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recent Accounting Pronouncements and Developments</a></td>
<td class="text">Recent Accounting Pronouncements and DevelopmentsIn June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. 2016-13, &#8220;Financial Instruments (Topic 326) Credit Losses&#8221;. Topic 326 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investments in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. Topic 326 was originally effective as of January 1, 2020, although in November 2019, the FASB delayed the effective date until fiscal years beginning after December 15, 2022 for SEC filers eligible as of the FASB's deferral date to be smaller reporting companies under the SEC&#8217;s definition. The Company qualified as a smaller reporting company in November 2019 when the FASB delayed the effective date of Topic 326. Early adoption is permitted. The Company is currently evaluating the impact of Topic 326 on its consolidated balance sheets, statements of operations, statements of cash flows and related disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648586358280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Acquisitions Accounted for Using the Purchase Method</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On January&#160;31, 2021, the Company acquired the business and the majority of the assets of FilAMed, a privately-held biomedical services company based in Bakersfield, California. In becoming a part of the Company&#8217;s Durable Medical Equipment Services ("DME Services") segment, this acquisition supplements the Company's existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April&#160;18, 2021, the Company acquired the business and substantially all of the assets of OB Healthcare Corporation (&#8220;OB Healthcare&#8221;), a privately-held biomedical services company based in Mesquite, Texas. OB Healthcare specializes in on-site repair, preventative maintenance, and device physical inventory management to hospitals and healthcare systems nationwide. The acquisition further develops and expands InfuSystem&#8217;s DME Services segment and complements the Company&#8217;s purchase of FilAMed.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The results of operations for FilAMed and OB Healthcare are included in the Company&#8217;s consolidated statements of operations from the respective closing dates.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Final Purchase Price Allocation </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to FASB Accounting Standards Codification (&#8220;ASC&#8221;) Topic 805, &#8220;Business Combinations,&#8221; the purchase price for each of the acquisitions was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the respective acquisition dates. The purchase price allocations were primarily based upon a valuation using management&#8217;s estimates and assumptions. The purchase price allocation was completed for FilAMed and OB Healthcare as of December&#160;31, 2021. The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FilAMed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consideration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,650&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Working capital adjustment, paid in cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - consideration</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FilAMed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment held for sale or rental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - purchase price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The amount of acquisition costs for both transactions was less than $0.1 million for the three months ended March 31, 2021 and was included in general and administrative expenses.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company fully paid all consideration for FilAMed as of December&#160;31, 2021. On the OB Healthcare acquisition date, the Company made an initial cash payment of $6.1&#160;million with subsequent cash payments totaling $0.4&#160;million during the year ended December 31, 2021 and had an additional estimated amount due to the seller for contingent consideration of $0.8&#160;million, which was recorded in the balance sheet under the heading for other current liabilities. The contingent consideration arrangement, as amended, required the Company to pay OB Healthcare $0.8&#160;million if certain written contracts were executed.  As of March&#160;31, 2022, the Company had a $0.8&#160;million remaining liability relating to this acquisition. However, the requirement under the contingent consideration arrangement was satisfied on April 28, 2022, and the Company paid the remaining payment shortly thereafter.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted-Average</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization Period</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Years)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,300&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.2</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The goodwill acquired consists of expected synergies from combining operations of FilAMed and OB Healthcare with the DME Services segment as well as their respective assembled workforce who have specialized knowledge and experience. All of the goodwill is deductible for tax purposes. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Unaudited Pro Forma Financial Information </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The unaudited pro forma financial information in the table below summarizes the combined results of operations of the Company, FilAMed and OB Healthcare as though the companies&#8217; businesses had been combined as of January 1, 2021. The pro forma financial information for the three months ended March&#160;31, 2021 was adjusted by less than $0.1 million for the tax effected amount of acquisition costs and non-recurring expenses directly attributable to the FilAMed and OB Healthcare acquisitions. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place at the beginning of the period presented nor is it indicative of future results. The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the three months ended March&#160;31, 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,679&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582101640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the Company&#8217;s disaggregated revenue by offering type (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of Total Net Revenues</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of Total Net Revenues</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Third-Party Payer Rentals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">50.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">52.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Direct Payer Rentals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,763&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-Party Payer Rentals are entirely attributed to revenues of the Integrated Therapy Services (&#8220;ITS&#8221;) segment. For the three months ended March&#160;31, 2022, $3.2 million and $4.8&#160;million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2021, $3.1 million and $4.3 million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2022, $0.1 million and $3.6 million of Product Sales were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2021, all Product Sales were entirely attributed to the DME Services segment. For the three months ended March&#160;31, 2022 and 2021, all Services revenues were entirely attributed to the DME Services segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582081208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAbstract', window );"><strong>Medical Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAndPropertyDisclosureTextBlock', window );">Medical Equipment</a></td>
<td class="text">Medical Equipment<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medical equipment consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,788</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental - pump reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(44)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(46)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental - net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,987</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,742</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">92,630</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">91,891</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service - pump reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,246)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,074)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(52,271)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(50,946)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service - net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,113</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,871</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,613</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation expense for medical equipment for the three months ended March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was $2.4 million, compared to $2.3 million for the same prior year period. This expense was recorded in &#8220;cost of revenues&#8221; for each period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAndPropertyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for medical equipment and property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAndPropertyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585627336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accumulated</span></div><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accumulated Depreciation</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture, fixtures, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,924</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,703)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,812</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,528)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,284</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Automobiles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">110</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(104)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">110</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(103)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,449</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,301)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,148</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,444</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,212)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,232</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,108)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,366</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,843)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,523</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation expense for property and equipment for the three months ended March&#160;31, 2022 was $0.3 million, compared to $0.2 million for the same prior year period. This expense was recorded in &#8220;general and administrative expenses&#8221; for each period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585600472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill &amp; Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text">Goodwill &amp; Intangible Assets<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The changes in the carrying value of goodwill by segment for the three months ended March&#160;31, 2022 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services (a)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) The ITS segment has no recorded goodwill. </span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The carrying amount and accumulated amortization of intangible assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Assets</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Assets</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Nonamortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(23)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(23)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Physician and customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,834</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,033)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,801</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,834</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(31,401)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,433</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(90)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">382</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(67)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">405</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">943</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(157)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">786</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">943</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(123)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">820</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,530</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,280)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,530</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,258)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">272</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total nonamortizable and amortizable intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(43,583)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,219</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(42,872)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,930</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three months ended March&#160;31, 2022 was $0.7&#160;million, compared to $1.0&#160;million for the same prior year period. This expense was recorded in &#8220;amortization of intangibles expenses&#8221; for each period. Expected remaining annual amortization expense for the next five years for intangible assets recorded as of March&#160;31, 2022 is as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2027 and thereafter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,783</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">990</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">990</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">810</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">524</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,219</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582111704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">February&#160;5, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the Company entered into a Credit Agreement (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2021 Credit Agreement&#8221;) with JPMorgan Chase Bank, N.A., as administrative agent (the &#8220;Agent&#8221;), sole bookrunner and sole lead arranger, and the lenders party thereto. The borrowers under the 2021 Credit Agreement are the Company, InfuSystem Holdings USA, Inc. (&#8220;Holdings&#8221;), InfuSystem, </span><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inc. (&#8220;ISI&#8221;), First Biomedical, Inc. (&#8220;First Biomedical&#8221;), and IFC LLC (&#8220;IFC&#8221; and, collectively with the Company, Holdings, ISI and First Biomedical, the &#8220;Borrowers&#8221;).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Credit Agreement provides for a revolving credit facility (the &#8220;Revolving Facility&#8221;) of $75.0 million that matures on February 5, 2026. The Revolving Facility may be increased by $25.0 million, subject to certain conditions, including the consent of the Agent and obtaining necessary commitments. The lenders under the 2021 Credit Agreement may issue up to $7.0 million in letters of credit subject to the satisfaction of certain conditions. On February&#160;5, 2021, the Borrowers made an initial borrowing of $30.0 million under the Revolving Facility. Proceeds from the loan, along with approximately $8.2 million in cash, were used to repay all amounts due under the Company&#8217;s then existing credit facility dated March 23, 2015 (the &#8220;2015 Credit Agreement&#8221;).</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Credit Agreement has customary representations and warranties. The ability to borrow under the facility is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations on indebtedness, liens, mergers, acquisitions, investments, asset sales, affiliate transactions and restricted payments, as well as financial covenants, including the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a minimum fixed charge coverage ratio (defined as the ratio of consolidated EBITDA (as defined in the 2021 Credit Agreement) less 50% of depreciation expense), to consolidated fixed charges (as defined in the 2021 Credit Agreement)) for the prior four most recently ended calendar quarters of 1.20 to 1.00; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">a maximum leverage ratio (defined as total indebtedness to EBITDA for the prior four most recently ended calendar quarters) of 3.50 to 1.00.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Credit Agreement includes customary events of default. The occurrence of an event of default will permit the lenders to terminate commitments to lend under the Revolving Facility and accelerate payment of all amounts outstanding thereunder.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Simultaneous with the execution of the 2021 Credit Agreement, the Company entered into a Pledge and Security Agreement to secure repayment of the obligations of the Borrowers. Under the Pledge and Security Agreement, each Borrower has granted to the Agent, for the benefit of various secured parties, a first priority security interest in substantially all of the personal property assets of each of the Borrowers, including the shares of each of Holdings, ISI and First Biomedical and the equity interests of IFC.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February&#160;5, 2021, in connection with the execution and closing of the 2021 Credit Agreement, the Company, along with its wholly owned subsidiaries as borrowers, terminated the 2015 Credit Agreement. All outstanding loans under the 2015 Credit Agreement were repaid and all liens under the 2015 Credit Agreement were released, except that a letter of credit originally issued under the 2015 Credit Agreement in the amount of approximately $0.8 million was transferred to the 2021 Credit Agreement.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The 2021 Credit Agreement was accounted for as a debt modification. As of March&#160;31, 2022, the Company was in compliance with all debt-related covenants under the 2021 Credit Agreement.  </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April&#160;15, 2019, the Company sold for $2.0 million and immediately leased back certain medical equipment in rental service to a third party specializing in such transactions. The leaseback term is 36 months. Because the arrangement contains a purchase option that the Company is reasonably certain to exercise, this transaction did not qualify for the sale-leaseback accounting under ASC 842. The medical equipment remains recorded on the accompanying condensed consolidated balance sheet and the proceeds received have been classified as an other financing liability, which is being paid off monthly over the term of the lease. The balance of other financing as of March&#160;31, 2022 was $0.2&#160;million.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As referenced above, the Company executed and closed the 2021 Credit Agreement during the first quarter of 2021, and in connection with entering into that agreement, terminated the 2015 Credit Agreement. The following table illustrates the net availability under the Revolving Facility as of the applicable balance sheet date (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 66.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">December 31,<br/>2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross availability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding draws</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(35,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,974)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Letter of credit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(600)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(600)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Availability on Revolving Facility</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,400</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,426</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company had future maturities of its long-term debt as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2026 and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">thereafter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other financing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,230</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a breakdown of the Company&#8217;s current and long-term debt (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Current </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Long-Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Long-Term </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,974</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,974</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other financing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">423</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">423</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">423</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,974</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33,397</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unamortized value of debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(74)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(208)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(282)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(74)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(226)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(300)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">156</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34,792</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34,948</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">349</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33,097</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March&#160;31, 2022, amounts outstanding under the Revolving Facility provided under the 2021 Credit Agreement bear interest at a variable rate equal to, at the Company&#8217;s election, a LIBO Rate for Eurodollar loans or an Alternative Base Rate for ABR loans, as defined by the 2021 Credit Agreement, plus a spread that will vary depending upon the Company&#8217;s leverage ratio. The spread ranges from 2.00% to 3.00% for Eurodollar Loans and 1.00% to 2.00% for base rate loans. The weighted-average Eurodollar loan rate at March&#160;31, 2022 was 2.37% (LIBO of 0.37% plus 2.00%). The actual ABR loan rate at March&#160;31, 2022 was 4.25% (lender&#8217;s prime rate of 3.25% plus 1.00%).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585576520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments and Hedging Activities</a></td>
<td class="text">Derivative Financial Instruments and Hedging Activities<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In February 2021, the Company adopted a derivative investment policy which provides guidelines and objectives related to managing financial and operational exposures arising from market changes in short term interest rates. In accordance with this policy, the Company can enter into interest rate swaps or similar instruments, will endeavor to evaluate all the risks inherent in a transaction before entering into a derivative financial instrument and will not enter into derivative financial instruments for speculative or trading purposes. Hedging relationships are formally documented at the inception of the hedge and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is exposed to interest rate risk related to its variable rate debt obligations under the 2021 Credit Agreement. In order to manage the volatility in interest rate markets, in February 2021, the Company entered into two interest rate swap agreements to manage exposure arising from this risk. On a combined basis, the agreements have a constant notional amount over a five-year term that ends on February 5, 2026. The agreements both pay the Company 30-day LIBOR on the </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">notional amount and the Company pays a fixed rate of interest equal to 0.73%. These derivative instruments are considered cash flow hedges. The Company does not have any other derivative financial instruments.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The tables below present the location and gross fair value amounts of our derivative financial instruments and the associated notional amounts designated as cash flow hedges as of the applicable balance sheet date (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.302%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,260</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.302%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">355</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2021</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on cash flow hedges - interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">268</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized gain recognized in AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">877</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">148</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amounts reclassified to interest expense (a)(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(218)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">955</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">158</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) Positive amounts represented interest expense. Total interest expense as presented in the condensed consolidated statement of operations and comprehensive income for the three months ended March&#160;31, 2022 and 2021 were $0.3 million and $0.3 million, respectively.</span></div></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(b) As of March&#160;31, 2022, $0.2 million of income is expected to be reclassified into earnings within the next 12 months.</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company did not incur any hedge ineffectiveness during the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648586334904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company recorded a benefit from income taxes of $0.5 million and $0.2 million during the three months ended March&#160;31, 2022 and 2021, respectively. The income tax benefit during 2022 relates principally to a pre-tax loss whereas the benefit during 2021 relates to excess tax benefits on exercises of stock options and vesting of restricted stock during the period. Other differences in the effective tax rate include the estimate of the Company&#8217;s annual state and local taxes and taxes relating to its foreign operations in Canada. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (&#8220;CARES&#8221;) Act was enacted in response to the COVID-19 pandemic. The CARES Act among other things, allows employers to defer the deposit and payment of the employer's share of Social Security taxes. Under the CARES Act, the Company deferred paying $0.7 million of applicable </span></div>gross payroll taxes as of December&#160;31, 2020, which was included in other liabilities. The $0.7 million balance of the deferred Social Security taxes was expected to be paid in two equal annual installments during the years ending December&#160;31, 2021 and 2022, respectively. In December 2021, the Company made the first of these two equal annual installment payments. As of March&#160;31, 2022, the remaining balance of approximately $0.3&#160;million is included in other liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582067032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments, Contingencies and Litigation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments, Contingencies and Litigation</a></td>
<td class="text">Commitments, Contingencies and Litigation<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time in the ordinary course of its business, the Company may be involved in legal and regulatory proceedings, the outcomes of which may not be determinable. The results of litigation and regulatory proceedings are inherently unpredictable. Any claims against the Company, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. The Company is not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable, primarily for the following reasons: (i) many of the relevant legal proceedings are in preliminary stages and, until such proceedings develop further, there is often uncertainty regarding the relevant facts and circumstances at issue and potential liability; and (ii) many of these proceedings involve matters of which the outcomes are inherently difficult to predict. The Company has insurance policies covering potential losses where such coverage is cost effective.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is not at this time involved in any proceedings that the Company currently believes could have a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582120248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(Loss) Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">(Loss) Earnings Per Share</a></td>
<td class="text">(Loss) Earnings Per Share<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic (loss) income per share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted (loss) income per share assumes the issuance of potentially dilutive shares of common stock during the period. The following table reconciles the numerators and denominators of the basic and diluted (loss) income per share computations:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Numerator </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">:</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(368)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">661</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,609,372</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,338,160</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dilutive effect of common stock equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,599,479</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,609,372</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,937,639</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.02)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.03</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.02)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.03</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months ended March 31, 2022, all outstanding options and unvested restricted stock units were anti-dilutive due to the Company's net losses for the period and therefore are not included in the calculation. For the three months ended March&#160;31, 2021, less than 0.1 million of outstanding options and unvested restricted stock units with an exercise price above the current market value of the Company&#8217;s common stock were not included in the calculation because they would have an anti-dilutive effect.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Share Repurchase Program</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 30, 2021, our Board of Directors approved a stock repurchase program (the &#8220;Share Repurchase Program&#8221;) that authorizes the Company to repurchase up to $20.0 million of the Company&#8217;s outstanding common stock through June 30, 2024. Repurchases under the Share Repurchase Program are subject to market conditions, the periodic capital needs of the Company&#8217;s operating activities, and the continued satisfaction of all covenants under the Company&#8217;s existing 2021 Credit Agreement. Repurchases under the Share Repurchase Program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase Program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. As of March&#160;31, 2022, the Company had repurchased approximately $4.6 million, or 343,514 shares, of the Company's outstanding common stock under the Share Repurchase Program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585580328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next ten years. The Company&#8217;s leases do not contain any restrictive covenants. The Company&#8217;s office leases generally contain renewal options for periods ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMzUz_c5ee57a4-2e68-4541-8653-b24cb86c7ae1">one</span> to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#8217;s office leases do not contain any material residual value guarantees. The Company&#8217;s equipment leases generally do not contain renewal options.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Payments due under the Company&#8217;s operating leases include fixed payments as well as variable payments. For the Company&#8217;s office leases, variable payments include amounts for the Company&#8217;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#8217;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease costs for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">329&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">348&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Supplemental cash flow information and non-cash activity related to the Company&#8217;s leases are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurement of lease liabilities and right of use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flow from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right of use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average remaining lease terms and discount rates for the Company&#8217;s operating leases are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.6</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.7%</span></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Future maturities of lease liabilities as of March&#160;31, 2022 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operating</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Leases</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">869&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027 and thereafter</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,747&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582094760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment Information</a></td>
<td class="text">Business Segment Information<div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s reportable segments are organized based on service platforms, with the ITS segment reflecting higher margin rental revenues that generally include payments made by third-party and direct payers and the DME Services segment reflecting lower margin product sales, direct payer rental and services revenues. Resources are allocated and performance is assessed for these segments by the Company&#8217;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker. The Company believes that reporting performance at the gross profit level is the best indicator of segment performance.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The financial information summarized below is presented by reportable segment for the three months ended March&#160;31, 2022 and 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate/</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,641</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,763</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,488</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,488)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,641</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,610</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,488)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,763</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,738</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,629</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,367</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,892</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,892</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(277)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(277)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(28)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(28)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">462</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">462</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(368)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">61,991</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34,246</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">98,237</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,511</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,420</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,931</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,398</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,416</span></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate/</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,911</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,552</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,463</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,446</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,446)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,911</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,998</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,446)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,463</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,573</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,576</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,703</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,703</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(322)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(322)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(69)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(69)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">179</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">179</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">661</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">62,508</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,079</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">90,587</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,621</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">715</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,336</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,696</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">874</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,570</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582053528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVID-19<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_Covid19Abstract', window );"><strong>Covid-19 [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_EffectOfCovid19PandemicTextBlock', window );">COVID-19</a></td>
<td class="text">COVID-19On March 11, 2020, the World Health Organization declared the outbreak of coronavirus (&#8220;COVID-19&#8221;) as a pandemic, which has spread globally and throughout the United States. During the period of the pandemic, we took a number of precautionary and preemptive steps to protect the safety and well-being of our employees while ensuring continuity of service to our clients, including, transitioning our employees to a remote work environment, suspending employee travel, canceling participation in industry events and in-person group meetings, promoting social distancing and enhanced cleaning and sanitization efforts across office locations, and implementing protocols to quarantine employees who may have been exposed to COVID-19, or showed relevant symptoms. We also undertook preparedness plans at our facilities to maintain continuity of operations, which provide for flexible work arrangements without any significant disruptions to our business or control processes. Our management team continues to actively monitor the situation and is in constant communication with our workforce, customers and vendors. During the three months ended March&#160;31, 2022, outbreaks of COVID-19, including the Delta and Omicron variants, unfavorably impacted our revenue growth initiatives in certain product lines including Pain Management and NPWT. The impacts included scattered restrictions on elective surgeries and delayed ramp-up in treatment volumes for new customers, both of which unfavorably impacted the Pain Management business, and restricted physical access to our customers facilities, which unfavorably impacted both the Pain Management and NPWT businesses. While the COVID-19 pandemic has not had any material unfavorable effects in our financial results for the three months ended March&#160;31, 2022, beyond this delay to our revenue growth plans, the extent of any future impact will depend on future developments, which are highly uncertain, cannot be predicted and could have a material adverse impact on our financial position, operating results and cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_Covid19Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Covid-19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_Covid19Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_EffectOfCovid19PandemicTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for effects of COVID-19 pandemic.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_EffectOfCovid19PandemicTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582077176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives Accounting Policy</a></td>
<td class="text">In February 2021, the Company adopted a derivative investment policy which provides guidelines and objectives related to managing financial and operational exposures arising from market changes in short term interest rates. In accordance with this policy, the Company can enter into interest rate swaps or similar instruments, will endeavor to evaluate all the risks inherent in a transaction before entering into a derivative financial instrument and will not enter into derivative financial instruments for speculative or trading purposes. Hedging relationships are formally documented at the inception of the hedge and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648586505656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FilAMed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consideration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,650&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Working capital adjustment, paid in cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - consideration</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FilAMed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment held for sale or rental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - purchase price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">FilAMed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consideration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,250&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,650&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Working capital adjustment, paid in cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - consideration</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FilAMed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OB</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment held for sale or rental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(288)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total - purchase price</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,325&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,725&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock', window );">Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Acquisition Date</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fair Value</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Thousands)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted-Average</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization Period</span></div><div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Years)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,300&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total intangible assets (a)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11.2</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text">The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the three months ended March&#160;31, 2021 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,679&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580463096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table presents the Company&#8217;s disaggregated revenue by offering type (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of Total Net Revenues</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Net</span></div><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenues</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Percentage of Total Net Revenues</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Third-Party Payer Rentals</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">50.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">52.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Direct Payer Rentals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Product Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,763&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,463&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582119416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAbstract', window );"><strong>Medical Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ScheduleOfMedicalEquipmentTableTextBlock', window );">Schedule of Medical Equipment</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medical equipment consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.767%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,788</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental - pump reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(44)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(46)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment for sale or rental - net</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,987</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,742</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">92,630</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">91,891</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service - pump reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,246)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,074)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(52,271)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(50,946)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Medical equipment in rental service - net</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,113</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,871</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,613</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ScheduleOfMedicalEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of medical equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ScheduleOfMedicalEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585638760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accumulated</span></div><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accumulated Depreciation</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture, fixtures, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,924</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,703)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,812</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,528)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,284</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Automobiles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">110</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(104)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">110</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(103)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,449</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,301)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,148</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,444</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,212)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,232</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,483</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,108)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,366</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,843)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,523</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648683651288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill &amp; Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text">The changes in the carrying value of goodwill by segment for the three months ended March&#160;31, 2022 are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services (a)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of December 31, 2021</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Goodwill acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Balance as of March 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,710</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) The ITS segment has no recorded goodwill. </span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock', window );">Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The carrying amount and accumulated amortization of intangible assets consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Assets</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Assets</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Nonamortizable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(23)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(23)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Physician and customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,834</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,033)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,801</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,834</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(31,401)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,433</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(90)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">382</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">472</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(67)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">405</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unpatented technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">943</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(157)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">786</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">943</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(123)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">820</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,530</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,280)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,530</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,258)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">272</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total nonamortizable and amortizable intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(43,583)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,219</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(42,872)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,930</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text">Expected remaining annual amortization expense for the next five years for intangible assets recorded as of March&#160;31, 2022 is as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.581%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2027 and thereafter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amortization expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,783</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">990</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">990</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">810</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">524</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,219</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount and accumulated amortization of identifiable intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648583088520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Line of Credit Facilities</a></td>
<td class="text">The following table illustrates the net availability under the Revolving Facility as of the applicable balance sheet date (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 66.77pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">December 31,<br/>2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross availability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">75,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding draws</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(35,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,974)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Letter of credit</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(600)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(600)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Availability on Revolving Facility</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,400</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">41,426</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company had future maturities of its long-term debt as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2026 and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">thereafter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other financing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,230</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a breakdown of the Company&#8217;s current and long-term debt (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.660%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Current </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Long-Term</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Long-Term </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Portion</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revolving Facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,974</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,974</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other financing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">423</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">423</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,230</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">423</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,974</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33,397</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unamortized value of debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(74)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(208)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(282)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(74)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(226)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(300)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">156</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34,792</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34,948</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">349</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33,097</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648586324936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The tables below present the location and gross fair value amounts of our derivative financial instruments and the associated notional amounts designated as cash flow hedges as of the applicable balance sheet date (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.302%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">March&#160;31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,260</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.302%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">December&#160;31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Balance Sheet Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Fair Value Derivative Assets</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Derivatives designated as hedges:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">355</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.102%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2021</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Gain on cash flow hedges - interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">268</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unrealized gain recognized in AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">877</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">148</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Amounts reclassified to interest expense (a)(b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Tax provision</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(218)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">955</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">158</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(a) Positive amounts represented interest expense. Total interest expense as presented in the condensed consolidated statement of operations and comprehensive income for the three months ended March&#160;31, 2022 and 2021 were $0.3 million and $0.3 million, respectively.</span></div></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(b) As of March&#160;31, 2022, $0.2 million of income is expected to be reclassified into earnings within the next 12 months.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582084200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(Loss) Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The following table reconciles the numerators and denominators of the basic and diluted (loss) income per share computations:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Numerator </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">:</span></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(368)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">661</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,609,372</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,338,160</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dilutive effect of common stock equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,599,479</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20,609,372</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">21,937,639</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (loss) income per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.02)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.03</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.02)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.03</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582092360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The components of lease costs for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">329&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">348&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Variable lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Supplemental cash flow information and non-cash activity related to the Company&#8217;s leases are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurement of lease liabilities and right of use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flow from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right of use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average remaining lease terms and discount rates for the Company&#8217;s operating leases are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.6</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.7%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Future maturities of lease liabilities as of March&#160;31, 2022 are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operating</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Leases</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">869&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027 and thereafter</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total undiscounted lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,747&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: Imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2,374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,373&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582056888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The financial information summarized below is presented by reportable segment for the three months ended March&#160;31, 2022 and 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate/</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,641</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,122</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,763</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,488</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,488)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">16,641</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,610</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,488)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,763</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,738</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,629</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,367</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,892</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,892</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(277)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(277)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(28)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(28)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">462</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">462</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(368)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">61,991</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">34,246</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">98,237</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,511</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,420</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,931</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,398</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,416</span></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">ITS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DME Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Corporate/</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eliminations</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - external</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,911</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,552</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,463</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net revenues - internal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,446</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,446)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,911</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,998</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,446)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">24,463</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,573</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">14,576</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,703</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,703</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(322)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(322)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(69)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(69)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Benefit from income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">179</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">179</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">661</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">62,508</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">26,079</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">90,587</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Purchases of medical equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,621</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">715</span></td><td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,336</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Depreciation and amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,696</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">874</span></td><td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,570</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648582326360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 18, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition costs and non-recurring expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember', window );">OB Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="nump">$ 6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability', window );">Contingent consideration and working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember', window );">OB Healthcare | Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense', window );">Pro forma acquisition cost and non-recurring expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma acquisition cost and non-recurring expense for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration and Working Capital, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580238856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 18, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_WorkingCapital', window );">Working capital adjustment, paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total - consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember', window );">FilAMed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_WorkingCapital', window );">Working capital adjustment, paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total - consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember', window );">OB Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments', window );">Cash</a></td>
<td class="nump">$ 6,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_WorkingCapital', window );">Working capital adjustment, paid in cash</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total - consideration</a></td>
<td class="nump">$ 7,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Business, Excluding Working Capital Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital adjustments incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576580328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Assets Acquired and Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 18, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental', window );">Medical equipment held for sale or rental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,710<span></span>
</td>
<td class="nump">3,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(288)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total - purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember', window );">FilAMed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental', window );">Medical equipment held for sale or rental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(281)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total - purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember', window );">OB Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental', window );">Medical equipment held for sale or rental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right of use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total - purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of medical equipment in rental service recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating lease right of use asset recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_FilAMedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=infu_OBHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576565288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Intangible Assets Acquired (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 4,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">11 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Physician and customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Unpatented technology</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquisition date fair value</a></td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585712712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Pro Forma Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 24,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 639<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580121000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">$ 26,763<span></span>
</td>
<td class="nump">$ 24,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember', window );">ITS | Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember', window );">DME Services | Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_DirectPayerRentalsMember', window );">Direct Payer Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">7,962<span></span>
</td>
<td class="nump">7,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_DirectPayerRentalsMember', window );">Direct Payer Rentals | ITS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_DirectPayerRentalsMember', window );">Direct Payer Rentals | DME Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_DirectPayerRentalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=infu_DirectPayerRentalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576675160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">$ 26,763<span></span>
</td>
<td class="nump">$ 24,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_ThirdPartyPayerRentalRevenueMember', window );">Third-Party Payor Rental Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">13,368<span></span>
</td>
<td class="nump">12,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_DirectPayerRentalsMember', window );">Direct Payer Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">7,962<span></span>
</td>
<td class="nump">7,398<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_ProductSalesMember', window );">Product Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">3,744<span></span>
</td>
<td class="nump">3,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="nump">$ 1,689<span></span>
</td>
<td class="nump">$ 688<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue Benchmark | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue Benchmark | Customer Concentration Risk | Third-Party Payor Rental Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">52.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue Benchmark | Customer Concentration Risk | Direct Payer Rentals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">29.70%<span></span>
</td>
<td class="nump">30.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue Benchmark | Customer Concentration Risk | Product Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">14.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue Benchmark | Customer Concentration Risk | Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_ThirdPartyPayerRentalRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=infu_ThirdPartyPayerRentalRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_DirectPayerRentalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=infu_DirectPayerRentalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=infu_ProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=infu_ProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585673288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Equipment (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAbstract', window );"><strong>Medical Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DepreciationExpenseRelatedToMedicalEquipment', window );">Depreciation expense related to medical equipment</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DepreciationExpenseRelatedToMedicalEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of depreciation expense related to medical equipment recorded during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DepreciationExpenseRelatedToMedicalEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576522536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Medical Equipment - Summary of Medical Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentAbstract', window );"><strong>Medical Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentHeldForSaleOrRentalGross', window );">Medical equipment for sale or rental</a></td>
<td class="nump">$ 2,031<span></span>
</td>
<td class="nump">$ 1,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentForSaleOrRentalReserve', window );">Medical equipment for sale or rental - pump reserve</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentHeldForSaleOrRental', window );">Medical equipment for sale or rental - net</a></td>
<td class="nump">1,987<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServicesGross', window );">Medical equipment in rental service</a></td>
<td class="nump">92,630<span></span>
</td>
<td class="nump">91,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServicesReserve', window );">Medical equipment in rental service - pump reserve</a></td>
<td class="num">(1,246)<span></span>
</td>
<td class="num">(1,074)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(52,271)<span></span>
</td>
<td class="num">(50,946)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation', window );">Medical equipment in rental service - net</a></td>
<td class="nump">39,113<span></span>
</td>
<td class="nump">39,871<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_MedicalEquipmentNet', window );">Total</a></td>
<td class="nump">$ 41,100<span></span>
</td>
<td class="nump">$ 41,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentForSaleOrRentalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of reserve associated with medical equipment for sale or rental, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentForSaleOrRentalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentHeldForSaleOrRental">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment held for sale or rental as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentHeldForSaleOrRental</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentHeldForSaleOrRentalGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment held for sale or rental as of the balance sheet date, before reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentHeldForSaleOrRentalGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of accumulated depreciation related to medical equipment in rental services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServicesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the gross amount of medical equipment in rental services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServicesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentInRentalServicesReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of medical equipment in rental services reserve, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentInRentalServicesReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_MedicalEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the net amount of medical equipment, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_MedicalEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585710952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Textual) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationNonproduction', window );">Depreciation</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationNonproduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationNonproduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580166392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Assets</a></td>
<td class="nump">$ 8,483<span></span>
</td>
<td class="nump">$ 8,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="num">(4,108)<span></span>
</td>
<td class="num">(3,843)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property &amp; equipment, net of accumulated depreciation</a></td>
<td class="nump">4,375<span></span>
</td>
<td class="nump">4,523<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures, and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Assets</a></td>
<td class="nump">4,924<span></span>
</td>
<td class="nump">4,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="num">(2,703)<span></span>
</td>
<td class="num">(2,528)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property &amp; equipment, net of accumulated depreciation</a></td>
<td class="nump">2,221<span></span>
</td>
<td class="nump">2,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Assets</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property &amp; equipment, net of accumulated depreciation</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross Assets</a></td>
<td class="nump">3,449<span></span>
</td>
<td class="nump">3,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="num">(1,301)<span></span>
</td>
<td class="num">(1,212)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property &amp; equipment, net of accumulated depreciation</a></td>
<td class="nump">$ 2,148<span></span>
</td>
<td class="nump">$ 2,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648585654648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill &amp; Intangible Assets (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">$ 710<span></span>
</td>
<td class="nump">$ 1,043<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580199608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill &amp; Intangible Assets - Goodwill (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 3,710,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">3,710,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember', window );">DME Services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">3,710,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">3,710,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember', window );">ITS</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648578938808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill &amp; Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Trade names</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(43,583)<span></span>
</td>
<td class="num">(42,872)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">8,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total nonamortizable and amortizable intangible assets</a></td>
<td class="nump">53,802<span></span>
</td>
<td class="nump">53,802<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">10,219<span></span>
</td>
<td class="nump">10,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets:</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=infu_PhysicianAndCustomerRelationshipsMember', window );">Physician and customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets:</a></td>
<td class="nump">38,834<span></span>
</td>
<td class="nump">38,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(32,033)<span></span>
</td>
<td class="num">(31,401)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">6,801<span></span>
</td>
<td class="nump">7,433<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets:</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Unpatented technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets:</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(157)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">786<span></span>
</td>
<td class="nump">820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets:</a></td>
<td class="nump">11,530<span></span>
</td>
<td class="nump">11,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(11,280)<span></span>
</td>
<td class="num">(11,258)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=infu_PhysicianAndCustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=infu_PhysicianAndCustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576578584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill &amp; Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 1,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter', window );">2027 and thereafter</a></td>
<td class="nump">3,122<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 8,219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648575613960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details Textual)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 15, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,230,000<span></span>
</td>
<td class="nump">$ 33,397,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="nump">32,974,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="nump">32,974,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PercentageOfTotalDepreciationExpense', window );">Percentage of total depreciation expense</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio', window );">Debt instrument, covenant, minimum fixed coverage ratio</a></td>
<td class="nump">1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_DebtInstrumentCovenantMaximumLeverageRatio', window );">Debt instrument, covenant, maximum leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LIBORRate', window );">LIBOR rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | ABR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LenderPrimeRate', window );">Lender prime rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Base Rate | ABR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Minimum | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Minimum | Base Rate | ABR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Maximum | London Interbank Offered Rate (LIBOR) | Eurodollar Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Maximum | Base Rate | ABR Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions', window );">Revolving credit facility</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Borrowings under revolving credit facility</a></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember', window );">The 2021 Credit Agreement | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2015CreditAgreementMember', window );">The 2015 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_The2015CreditAgreementMember', window );">The 2015 Credit Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayments</a></td>
<td class="nump">$ 8,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember', window );">Financing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 230,000<span></span>
</td>
<td class="nump">$ 423,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember', window );">Financing Agreement | Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DebtInstrumentCovenantMaximumLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum leverage ratio required by the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DebtInstrumentCovenantMaximumLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_DebtInstrumentCovenantMinimumFixedCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum fixed coverage ratio required by the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_DebtInstrumentCovenantMinimumFixedCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LIBORRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the LIBOR rate as of the specified date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LIBORRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LenderPrimeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the lender's prime rate as of the specified date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LenderPrimeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional borrowing capacity under the credit facility subject to certain conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PercentageOfTotalDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of total depreciation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PercentageOfTotalDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_The2021CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=infu_EurodollarLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=infu_EurodollarLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=infu_ABRLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=infu_ABRLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_The2015CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_The2015CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralAxis=infu_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralAxis=infu_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580276008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details) - Revolving Credit Facility - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Gross availability</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding draws</a></td>
<td class="num">(35,000)<span></span>
</td>
<td class="num">(32,974)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit</a></td>
<td class="num">(600)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Availability on Revolving Facility</a></td>
<td class="nump">$ 39,400<span></span>
</td>
<td class="nump">$ 41,426<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580334024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Future Maturities of Loans (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">35,230<span></span>
</td>
<td class="nump">$ 33,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember', window );">Financing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 32,974<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year and after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576660792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Company's Current and Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">32,974<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">35,230<span></span>
</td>
<td class="nump">33,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_UnamortizedDebtIssuanceExpenseCurrent', window );">Unamortized value of the debt issuance costs, current portion of long-term debt</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_UnamortizedDebtIssuanceExpenseNoncurrent', window );">Unamortized value of the debt issuance costs, long-term debt</a></td>
<td class="num">(208)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized value of the debt issuance costs, Total</a></td>
<td class="num">(282)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">34,792<span></span>
</td>
<td class="nump">32,748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">34,948<span></span>
</td>
<td class="nump">33,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember', window );">Financing Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongtermDebtGrossCurrent', window );">Current Portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LongTermDebtGrossNoncurrent', window );">Long-Term Portion</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">32,974<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 32,974<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LongTermDebtGrossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt, excluding the current portion. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LongTermDebtGrossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LongtermDebtGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of the current portion of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LongtermDebtGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_UnamortizedDebtIssuanceExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of unamortized debt issuance expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_UnamortizedDebtIssuanceExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_UnamortizedDebtIssuanceExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of unamortized debt issuance expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_UnamortizedDebtIssuanceExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=infu_FinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648579037368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities (Details Textual) - Interest Rate Swap - Designated as Hedging Instrument - Cash Flow Hedging<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 05, 2021 </div>
<div>numberOfAgreement</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Interest rate swap | numberOfAgreement</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Term of contract (year)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Fixed interest rate</a></td>
<td class="nump">0.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss', window );">Net hedge ineffectiveness gain (loss) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNetHedgeIneffectivenessGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the ineffectiveness of the hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNetHedgeIneffectivenessGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648579509032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details) - Cash Flow Hedging - Interest Rate Swap - Designated as Hedging Instrument - Other Noncurrent Assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Fair Value Derivative Assets</a></td>
<td class="nump">$ 1,260<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576398376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments and Hedging Activities - Derivative Financial Instruments Designated as Hedging Instruments in AOCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 48,272<span></span>
</td>
<td class="nump">$ 40,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">46,053<span></span>
</td>
<td class="nump">42,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Reclassified within twelve months</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Gain/(loss) on cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Unrealized gain recognized in AOCI</a></td>
<td class="nump">877<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified to interest expense</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Tax provision</a></td>
<td class="num">(218)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 955<span></span>
</td>
<td class="nump">$ 158<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576567512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">$ (462)<span></span>
</td>
<td class="num">$ (179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent', window );">Payroll taxes</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580303000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(Loss) Earnings Per Share (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareRepurchaseProgramCumulativeSharesRepurchased', window );">Cumulative shares purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares', window );">Cumulative shares purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Repurchase Program, Cumulative Shares Purchased, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_ShareRepurchaseProgramCumulativeSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Repurchase Program, Cumulative Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_ShareRepurchaseProgramCumulativeSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648575571960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>(Loss) Earnings Per Share - Calculation of Basic and Diluted EPS (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (368)<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">20,609,372<span></span>
</td>
<td class="nump">20,338,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of common stock equivalents (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,599,479<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">20,609,372<span></span>
</td>
<td class="nump">21,937,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.02)<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648586373048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details Textual)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term (year)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term (year)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648575553192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 329<span></span>
</td>
<td class="nump">$ 348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flow from operating leases</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term:</a></td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate:</a></td>
<td class="nump">7.60%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648580479624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">1,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">1,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">2027 and thereafter</a></td>
<td class="nump">1,783<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">6,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(2,374)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 4,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139648576210008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesExternal', window );">Net revenues - external</a></td>
<td class="nump">$ 26,763<span></span>
</td>
<td class="nump">$ 24,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesInternal', window );">Net revenues - internal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net revenues</a></td>
<td class="nump">26,763<span></span>
</td>
<td class="nump">24,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">15,367<span></span>
</td>
<td class="nump">14,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Selling, general and administrative expenses</a></td>
<td class="nump">15,892<span></span>
</td>
<td class="nump">13,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(277)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(368)<span></span>
</td>
<td class="nump">661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">98,237<span></span>
</td>
<td class="nump">90,587<span></span>
</td>
<td class="nump">$ 97,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchases of medical equipment</a></td>
<td class="nump">2,931<span></span>
</td>
<td class="nump">2,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">3,416<span></span>
</td>
<td class="nump">3,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=infu_CorporateAndEliminationsMember', window );">Corporate/ Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesExternal', window );">Net revenues - external</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesInternal', window );">Net revenues - internal</a></td>
<td class="num">(1,488)<span></span>
</td>
<td class="num">(1,446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net revenues</a></td>
<td class="num">(1,488)<span></span>
</td>
<td class="num">(1,446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Selling, general and administrative expenses</a></td>
<td class="nump">15,892<span></span>
</td>
<td class="nump">13,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(277)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchases of medical equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember', window );">ITS | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesExternal', window );">Net revenues - external</a></td>
<td class="nump">16,641<span></span>
</td>
<td class="nump">15,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesInternal', window );">Net revenues - internal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net revenues</a></td>
<td class="nump">16,641<span></span>
</td>
<td class="nump">15,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">10,738<span></span>
</td>
<td class="nump">10,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">61,991<span></span>
</td>
<td class="nump">62,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchases of medical equipment</a></td>
<td class="nump">1,511<span></span>
</td>
<td class="nump">1,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">2,398<span></span>
</td>
<td class="nump">2,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember', window );">DME Services | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesExternal', window );">Net revenues - external</a></td>
<td class="nump">10,122<span></span>
</td>
<td class="nump">8,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_RevenuesInternal', window );">Net revenues - internal</a></td>
<td class="nump">1,488<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total net revenues</a></td>
<td class="nump">11,610<span></span>
</td>
<td class="nump">9,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">4,629<span></span>
</td>
<td class="nump">4,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">34,246<span></span>
</td>
<td class="nump">26,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_infu_PaymentsToAcquireMedicalEquipment', window );">Purchases of medical equipment</a></td>
<td class="nump">1,420<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">$ 1,018<span></span>
</td>
<td class="nump">$ 874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_PaymentsToAcquireMedicalEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cash paid during the period to acquire medical equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_PaymentsToAcquireMedicalEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_RevenuesExternal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of external net revenues recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_RevenuesExternal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_infu_RevenuesInternal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of internal net revenues recognized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">infu_RevenuesInternal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>infu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=infu_CorporateAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=infu_CorporateAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_ITSSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=infu_DMEServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>infu-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:infu="http://infusystem.com/20220331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="infu-20220331.xsd" xlink:type="simple"/>
    <context id="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1afb9f64c12245cfbcdf7e70f7a26741_I20220429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2022-04-29</instant>
        </period>
    </context>
    <context id="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i01f05e29baa14bd0a757fcfc29360491_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25f33d209715440fbb5be414480b1768_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5fb95b32e4654392b07c0102083ff1de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e27a3a029534186a1f04cd4900ea788_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7f89d0d1f4445978bf16c0f5f8792ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95bc362b5d314368999d043bce1b654a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if785a73c71834ed59f0446734c77df79_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaf436762a17484ebfcec7f989d83620_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30e45981adc34974b1489e559c4a7b7b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if578c620ff804879877d88b6707147d7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i100e31c2a3f141098462c1bae67f7c14_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icd4cfb7b4b0a448ea084cf971ba89514_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if8f287da32c34a4382931967c22f2986_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8b643b684c364bcd8ec30529ba06e134_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i90ca1cca292344a08bf352fbd442ee45_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia2be1d671b114cf08009f612708ee32e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i247580c074ba4302b7e3c71ddea3bae5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i963ea4ed6904434cba81f9b35544822a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i99185486b44a43db8dee855c0e2e3a15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie03f91b078594271bd4e14d68978bf06_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4c341c2ae934d3897c08cd614b84edb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c477f12061c46b79bd5fb63d4373a4e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia35e3080b1b8404cba8a212ab094986f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ef62092fb404ae79ccb143d6c18f047_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if8003ee2c2474deca1adb94e55f98442_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i19444b1c10474d8490f92d04a10e148f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id2aa136b42f543bb8d61228fb3ab265f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib951efad10c64237873bd1580ccacf5b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7876b1efc8a54b39b1afc22d1abf2ec0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2cf5aee4ba8347b58d13695506bc288c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i42616323608f4b44a460de02c3482936_D20210131-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:FilAMedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-31</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-18</startDate>
            <endDate>2021-04-18</endDate>
        </period>
    </context>
    <context id="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i751082717be544698a176938b3add8c3_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:FilAMedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-18</instant>
        </period>
    </context>
    <context id="i9ede16521fc64b74b1f49fe77c8a9798_D20210419-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-19</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7797bc0f95b940b39aa0182a7088eb53_I20210418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-18</instant>
        </period>
    </context>
    <context id="id6070f50a0324f03942b82573c417cdf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">infu:OBHealthcareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia4990fd3a38c4f3eb1d7099fb3c52dff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id82fee9ebb5a42a9890e2723157a39ae_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9fffd8c4d1c944babfd356c6577863a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie996aa5ccd674a0d8c3da996d58461d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9485abe60939498a8c78a8987d9934b6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d5f226368ed474b99f5057977d175c1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fbe9dbc0da14959be7205dd13d84c0b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0e029b8ec12f40869e606cbefce19746_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia2e5ce00d4ed4d9a97f7aed53faa1ff6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ThirdPartyPayerRentalRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if49785589581493ebb90d7a0199ea525_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ThirdPartyPayerRentalRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if8ef7499ada54e7e9ad7851db5747696_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ThirdPartyPayerRentalRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifb56702f67294df0b173f365472c73ca_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ThirdPartyPayerRentalRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4982a0329516423a9136efc7957f9aab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i29edb7af843f4319acdf73d40cbd3a19_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ff148b282eb4181803b5f6562d8734a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i447d77e0640e4266805ed52d0e06d21b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i44bc98dc84754947aca9ffc1d3e8bbf0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i76aeb4498a0b4c5889d9b44b13e75ebb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib3db6d103273445e8e1f89920aa09ed6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3dca92952a174b78b27dc46eeaa65d99_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia7f79ccd7d5f40ae837e2fafc736606e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1a7c684f949741a3981a761e9bbcbf9d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idf3c886d74bc45548114cbfdf0c6983b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iea3ee5aa2d194f4c8a4c459c8fc91b98_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i27169791ade7453ea172c0da7b9f2a47_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib1822b59343e4f53b58f3e3f7280600e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if4fd38174ba44b03a584466ebe9ab057_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i60c58188de1b4fc3af027ccbcd0a1fb3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8204bc432ee142d3bad5b48145ed8618_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i55927c5429ab4da4b5c134d3ea056150_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">infu:DirectPayerRentalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5095ccbbd602407d910da1f13f5d8d6d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3a16fc3aeb5143d2908ebc833b38ed1d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iab9576cec45e4a449fa940366d43de5c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4bb1bc7267ab4f3b8a2ba31c8f332d5f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibef9d8e70d0d44f6881d0cc953b6c86c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5d32500896b341cb86356b976a1a7e6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc6296cc506a4da2b9d7da01f0ce124c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i16ee9bf588434522bd80adcc901d4ef9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic700dbf08af94b2eae2ba16cb3c059e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd7edbf7b2bd4b21aa91040e49a07b37_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d3f2b23fb394007a3aae9607cd8f47d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i53c7ee1171d34f9ead27a9700cd1fcf4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i69120393fdcf4f98b5f3643efcf1ba48_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idfb5ef2d8f814683800aefa4d847067f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2007dc85e9fb4c4eb7d1a818c44c551b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3955a41377c6464b8b96323f2127c3ac_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">infu:PhysicianAndCustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f1511ac8ff546a283d31d4c98b6133f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2ed66385f90b4519b38d4183d11d53b9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic5adc6accdfb4947bc052bfbd05a41a4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5b34086db73244b8b360acb9f538d2ac_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="i9db5ef6e072245c6836ab464e21b81d6_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="i280422ec877d4871b85139ef7dab2895_D20210205-20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="i88c67caf15574e31981968dbcfd092ba_D20210205-20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2015CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="i11787656cdd7485983ece34ada8d626d_D20210205-20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="i5755350e04f34d40bf1835b45c2e72c7_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="ibdfe551e6db54288aab0d8b7eaf87872_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2015CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="i0c5050671c134292bc772cc44ffea56a_I20190415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-15</instant>
        </period>
    </context>
    <context id="i3149a0ad24134e48ad364d402109026e_D20190415-20190415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-15</startDate>
            <endDate>2019-04-15</endDate>
        </period>
    </context>
    <context id="i33b5522177ae46f8a72045d13d78d239_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">infu:MedicalEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3266fe0bfd5844249bf77f4e1b271d97_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6c1fe4e839584747a8e98242a4f539a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if15ae0b27a6244e18335b6d84819ccdd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:FinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7be2e6385d2e4a1f81cede9f9325baf4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id6870ed273a94fee99d887c2cff01c3b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i31619f4fd16547b6a88ad77ca83de2b5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i621754a0bc234c319f31862d80d9e6bf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i648fe53f400e4a9fa1260cef7c260580_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia4114f950c2d4190904d6635dfffe982_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:EurodollarLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibcc44660e52943efa3af89d8516b33e7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4cfd39a0ac8040ccb08858cf8fa5bf15_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">infu:The2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">infu:ABRLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i46375b7fb651451ea71759de00ad04f8_I20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="i18d15197765c4fbe87a2fbc20e38f379_D20210205-20210205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="i718b8b354a364afc9026b010eb60129b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i11453ba9eaac46c4bb4e7d291baadf1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i93ef1df061524c8b9663782244eb5d30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf2eab998bda4fbd8fbc14723f4850ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i085e4370af544db9a0d15a2675df534e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9cdfd77a386045118c342ea3d171f086_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0066368dfe234730a0ec98982a4f6be1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib91337cd039b4e1fb73ba260c56f4232_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4b1ca0fa1a4549d0b3d620aeaa0f1a50_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i97d7dd5690f147b482bf2fe489cfcf4a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1c35755c8447450b8e419647303eac4d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17cfc9c479c543688ef515f286847c44_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0649b764378d49608401c1e982e219f9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9ad5338f58cd45369e7740b50719ff1d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icfcd91dfbd3b4861afdcf33774cf868a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9823e66bcb094044aa90984c93101af3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib3eb1c6975d549109036d441a4208693_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7948825b6e95471c8a412984f797602e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i814be89047894da9a58c9f276f7bd602_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i91e9dc825e4341c0b5c96f30ce2f3772_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i16b961b3af684edb8219f8ad50fba90b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:ITSSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8f1cbecf89194e0ebc676764e029ed03_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">infu:DMEServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic7ace98423094ec1812718f76386b5e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001337013</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">infu:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="numberofagreement">
        <measure>infu:numberOfAgreement</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY18zLTEtMS0xLTkwNjY1_86ef5074-17f9-4867-bc06-331c331e527f">0001337013</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY180LTEtMS0xLTkwNjY1_3c63fa86-83c4-4a59-9db8-509fd0fe9302">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY181LTEtMS0xLTkwNjY1_66854a5a-0c1b-4bab-aae1-3b4eae374522">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY182LTEtMS0xLTkwNjY1_ddfaff17-7de0-4353-aff0-14d280add087">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180L2ZyYWc6MmFiZjFmMTM4MjhmNDg1YzkxMzgzNDAxNGVkZTU2ZjUvdGFibGU6YTc0OGE2OWZkYjg4NDg0MDhkODJmODA3YjVmMzdhYmMvdGFibGVyYW5nZTphNzQ4YTY5ZmRiODg0ODQwOGQ4MmY4MDdiNWYzN2FiY183LTEtMS0xLTkwNjY1_91b2894f-adcf-451d-b2f1-d853eed5e263">2022</dei:DocumentFiscalYearFocus>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="icfcd91dfbd3b4861afdcf33774cf868a_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMzUz_c5ee57a4-2e68-4541-8653-b24cb86c7ae1">P1Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <dei:DocumentType
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg5_f6c09de6-a419-4d28-9957-371ee183753a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTkw_fb1c2a36-8acf-43f6-8386-a7a0d76b559b">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTQ_f046ff34-b6fe-4b73-bd95-19a4e8619dc2">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTkx_9567b53b-ec63-4011-ae49-061ca3e1026c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk0_48054590-965c-4eaf-ad7a-a2a7588d8e7d">001-35020</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk1_33cdc0a1-9361-4cb4-99f7-2ae742484944">INFUSYSTEM HOLDINGS, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDc2MDI2M2FiNzg3NDE3YmFkODg3OGM3ZGQ1YTdmOTcvdGFibGVyYW5nZTowNzYwMjYzYWI3ODc0MTdiYWQ4ODc4YzdkZDVhN2Y5N18wLTAtMS0xLTkwNjY1_f2dad4fd-e65a-40c2-b4a7-4b7b5445aa5a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDc2MDI2M2FiNzg3NDE3YmFkODg3OGM3ZGQ1YTdmOTcvdGFibGVyYW5nZTowNzYwMjYzYWI3ODc0MTdiYWQ4ODc4YzdkZDVhN2Y5N18wLTEtMS0xLTkwNjY1_1ddfe07d-823c-4a51-83c6-15a7c3a61535">20-3341405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg1_3aac69d2-77f0-4790-8d06-aacf70c8a0d2">3851 West Hamlin Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk2_3c01c8e3-fae5-4052-9386-b6b8246714c0">Rochester Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTkz_05657b67-1faa-46b1-9000-1ffa6a161800">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk3_14d4dc63-a1b9-4c9a-b2dc-bcd9b1b4a509">48309</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk5_9887480d-38bd-461c-b9be-7891f1830c7b">248</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg2_9ca12c93-5cb8-4fe4-9f55-2b4d2958b4b4">291-1210</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDA4NmUzMGY1YzkwNDViYmEwMTliMGRlZmQwNTRhZDIvdGFibGVyYW5nZTowMDg2ZTMwZjVjOTA0NWJiYTAxOWIwZGVmZDA1NGFkMl8xLTAtMS0xLTkwNjY1_906d15e0-8e96-4795-9c75-c8f159cf85c7">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDA4NmUzMGY1YzkwNDViYmEwMTliMGRlZmQwNTRhZDIvdGFibGVyYW5nZTowMDg2ZTMwZjVjOTA0NWJiYTAxOWIwZGVmZDA1NGFkMl8xLTEtMS0xLTkwNjY1_a109a582-c480-4250-9975-11f9e274aa7c">INFU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6MDA4NmUzMGY1YzkwNDViYmEwMTliMGRlZmQwNTRhZDIvdGFibGVyYW5nZTowMDg2ZTMwZjVjOTA0NWJiYTAxOWIwZGVmZDA1NGFkMl8xLTItMS0xLTkwNjY1_6581aecf-c451-4c7a-9a8d-f1baab4f98db">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTk4_2eb42296-0e33-43cc-ae0a-8b76fcd7b489">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg3_64bf6af2-350d-483e-a3e5-f8ea3116b5ad">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6Njc4NTNhOWRiYTgxNGMwM2I2ODJjMzA4NDA5MWFjNDkvdGFibGVyYW5nZTo2Nzg1M2E5ZGJhODE0YzAzYjY4MmMzMDg0MDkxYWM0OV8wLTQtMS0xLTkwNjY1_973a9c3b-1272-47db-ac38-2fa0065dc322">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6Njc4NTNhOWRiYTgxNGMwM2I2ODJjMzA4NDA5MWFjNDkvdGFibGVyYW5nZTo2Nzg1M2E5ZGJhODE0YzAzYjY4MmMzMDg0MDkxYWM0OV8wLTctMS0xLTkwNjY1_753a2cff-b0da-4896-9361-fded6ec9fda9">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGFibGU6Njc4NTNhOWRiYTgxNGMwM2I2ODJjMzA4NDA5MWFjNDkvdGFibGVyYW5nZTo2Nzg1M2E5ZGJhODE0YzAzYjY4MmMzMDg0MDkxYWM0OV8yLTEtMS0xLTkwNjY1_ae3617d2-201b-4347-8c89-7ecc2137296d">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMTg4_44444032-4def-4c86-93e9-11e1fa51e837">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1afb9f64c12245cfbcdf7e70f7a26741_I20220429"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xL2ZyYWc6NjgzODkxMzBiZjQyNDFjOWJhMWJmYzQ1ODZhYjc2OWMvdGV4dHJlZ2lvbjo2ODM4OTEzMGJmNDI0MWM5YmExYmZjNDU4NmFiNzY5Y18yMDk0_29b6b7a9-6f2f-4263-8508-03f2cb87ce94"
      unitRef="shares">20540143</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNS0xLTEtMS05MDY2NQ_609176f6-38ad-4e94-b2b1-00870c39d212"
      unitRef="usd">405000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNS0zLTEtMS05MDY2NQ_f313ec8a-801f-48b1-b1cd-dc7bd1f4a3ef"
      unitRef="usd">186000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNi0xLTEtMS05MDY2NQ_5c75fd94-7713-4107-aa00-73de703c2987"
      unitRef="usd">16392000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNi0zLTEtMS05MDY2NQ_1b46c591-72d4-405b-afe4-94baf80ee54e"
      unitRef="usd">15405000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNy0xLTEtMS05MDY2NQ_54a1351d-f267-407c-a69f-1c71b6fc3c42"
      unitRef="usd">3878000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNy0zLTEtMS05MDY2NQ_d218ba42-9714-466c-8f4c-f7b466fc7bb0"
      unitRef="usd">3939000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfOC0xLTEtMS05MDY2NQ_335ff290-9da6-4995-b714-fd9dc54b5a42"
      unitRef="usd">2585000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfOC0zLTEtMS05MDY2NQ_d519ee30-3fd4-402f-8428-92a55da9ffd2"
      unitRef="usd">2535000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTAtMS0xLTEtOTA2NjU_fbdbd219-f9c8-4d5c-9642-e461c2f61bc5"
      unitRef="usd">23260000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTAtMy0xLTEtOTA2NjU_f2fc8e53-c1e6-4363-829a-453c28b3af74"
      unitRef="usd">22065000</us-gaap:AssetsCurrent>
    <infu:MedicalEquipmentHeldForSaleOrRental
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTEtMS0xLTEtOTA2NjU_73a3e3f3-58c5-4c9c-b530-3ce313a060f5"
      unitRef="usd">1987000</infu:MedicalEquipmentHeldForSaleOrRental>
    <infu:MedicalEquipmentHeldForSaleOrRental
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTEtMy0xLTEtOTA2NjU_83f04904-55ef-48ec-af39-2b1ce5da18b2"
      unitRef="usd">1742000</infu:MedicalEquipmentHeldForSaleOrRental>
    <infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTItMS0xLTEtOTA2NjU_86aaf035-57c3-4261-8f22-1492518f6730"
      unitRef="usd">39113000</infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation>
    <infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTItMy0xLTEtOTA2NjU_1f5e0ad9-1573-403d-8ff4-fc7eef7aa6ac"
      unitRef="usd">39871000</infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTMtMS0xLTEtOTA2NjU_d0e4643c-2c6b-4322-8cd7-1b62adeddb82"
      unitRef="usd">4375000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTMtMy0xLTEtOTA2NjU_940ad6d6-1703-46fa-8f5f-cc8a55dd4c8c"
      unitRef="usd">4523000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTQtMS0xLTEtOTA2NjU_2548af0d-9071-4d2a-9a15-38a6d99ed3af"
      unitRef="usd">3710000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTQtMy0xLTEtOTA2NjU_892d4d9d-f537-4797-930b-5c280f03034e"
      unitRef="usd">3710000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTUtMS0xLTEtOTA2NjU_970f8880-66ed-432b-8b9c-3a4ae2568744"
      unitRef="usd">10219000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTUtMy0xLTEtOTA2NjU_0c16d4f1-3437-4569-add2-489546e7d639"
      unitRef="usd">10930000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTYtMS0xLTEtOTA2NjU_6bc0fe55-219e-4890-b434-fa96be3945ca"
      unitRef="usd">3916000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTYtMy0xLTEtOTA2NjU_07a48c1e-ec72-4c88-8d87-5c020038d35d"
      unitRef="usd">4241000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTctMS0xLTEtOTA2NjU_cfd0afd0-0045-44ba-9a0d-7dc118981775"
      unitRef="usd">10277000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTctMy0xLTEtOTA2NjU_57afc885-763e-487c-accc-abd9ff534da7"
      unitRef="usd">10033000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTgtMS0xLTEtOTA2NjU_863b8e78-1ebe-417b-ae38-037aee5028d2"
      unitRef="usd">1380000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMTgtMy0xLTEtOTA2NjU_9381bfdb-2fad-4a02-918c-d963ff373068"
      unitRef="usd">471000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjAtMS0xLTEtOTA2NjU_8135d2be-7ae4-4412-aa38-f515f020781b"
      unitRef="usd">98237000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjAtMy0xLTEtOTA2NjU_08e6f695-e136-460d-8259-774a85dae4fc"
      unitRef="usd">97586000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjQtMS0xLTEtOTA2NjU_453a1282-4920-4990-8585-bb035d0fe132"
      unitRef="usd">8242000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjQtMy0xLTEtOTA2NjU_157ae14d-eef0-44d7-ae4b-71dca4dbdda6"
      unitRef="usd">7862000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjUtMS0xLTEtOTA2NjU_079881b8-4036-4c05-a79f-50be9034ae66"
      unitRef="usd">156000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjUtMy0xLTEtOTA2NjU_53e09b52-c0dd-424e-91e6-7aec5e0bb3e4"
      unitRef="usd">349000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjYtMS0xLTEtOTA2NjU_6f15e147-31d8-45ee-babf-cc87377a74fa"
      unitRef="usd">5543000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjYtMy0xLTEtOTA2NjU_174636b8-a73c-47c9-aba8-cea5cfee97ae"
      unitRef="usd">4685000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjgtMS0xLTEtOTA2NjU_f98e4986-c1ba-458e-82c4-2a624d48b38a"
      unitRef="usd">13941000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjgtMy0xLTEtOTA2NjU_03259216-8edd-450a-8050-77813a130e87"
      unitRef="usd">12896000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjktMS0xLTEtOTA2NjU_1c0e596f-8631-468e-8c19-1de2c18cc1ef"
      unitRef="usd">34792000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMjktMy0xLTEtOTA2NjU_5fff6592-c38c-47cf-905e-c071b134a31e"
      unitRef="usd">32748000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzEtMS0xLTEtOTA2NjU_754babbf-c78a-4656-8ec5-6f2c015583d2"
      unitRef="usd">3451000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzEtMy0xLTEtOTA2NjU_b5b8c836-d195-4a63-bbe5-c3e0257026ae"
      unitRef="usd">3670000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzMtMS0xLTEtOTA2NjU_67c5801b-0158-4535-aa63-a4c1672a7c4e"
      unitRef="usd">52184000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzMtMy0xLTEtOTA2NjU_2c4edd79-8642-4e9c-9376-0504466e869c"
      unitRef="usd">49314000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV8yMQ_3d3dac30-28ea-4fcd-92b8-c96474249229"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV8yMQ_def5e16c-d455-43b9-946e-c6b3ea3bde17"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV80Ng_3938d12c-d72e-4dc6-8ab4-597c2a682530"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV80Ng_d8c9c00f-7d03-47f1-ad5e-3f770d099ea4"
      unitRef="shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV81Nw_70f6b2be-6881-47bd-80ae-29e710ecac58"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjplNzIxOWIyODlkYTI0YzUxYTY2NTlhNWQ5OGMyMmU5MV81Nw_a91e83bf-5e46-4f2c-bfc9-25c4a64e9c23"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMS0xLTEtOTA2NjU_44254a10-dd3a-4419-b17f-13c7c6c1479b"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzYtMy0xLTEtOTA2NjU_3679b09d-8655-4ebc-bc7c-27e0450f3321"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF8xOA_7eac2b7f-09bb-4a15-ad7f-55ad2e62345f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF8xOA_f6689456-6268-4d43-9d29-d81368cd4c7a"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF80Mw_14fcdcf5-3d2d-4118-a880-6a411c619706"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF80Mw_a01c9329-cf4c-4960-be6f-606749fa31e9"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF83Nw_90c9c187-f800-4401-b3cb-b59f01ec2d40"
      unitRef="shares">20540143</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF83Nw_e2988d46-be32-4d2d-b456-97d019fd91e6"
      unitRef="shares">20540143</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF8xMzk_3bfe2a83-48ff-4c44-a2d7-6c63839a677f"
      unitRef="shares">20699546</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjo4MjA1ZTViNmJkZDE0OTBiOTc4ZDcwZjdhNjU5MjA4MF8xMzk_90994a86-ebc8-45ff-9cbc-04ccbc2bcf9d"
      unitRef="shares">20699546</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMS0xLTEtOTA2NjU_bafc0227-8cb7-4af0-ae21-a92004986b20"
      unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzctMy0xLTEtOTA2NjU_96e994a4-0ed0-4d70-8f72-7fd354b45064"
      unitRef="usd">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzgtMS0xLTEtOTA2NjU_611ecbf5-b5dc-4abe-af4a-5df4702e2dfb"
      unitRef="usd">103373000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzgtMy0xLTEtOTA2NjU_74e5ec39-c0f1-4069-a7ba-86c1873c2927"
      unitRef="usd">101905000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzktMS0xLTEtOTA2NjU_9c5c93e8-5e0d-489a-aa30-cff1c57d5dbd"
      unitRef="usd">955000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfMzktMy0xLTEtOTA2NjU_9b6cba1d-9b17-479e-843d-510f7df790d5"
      unitRef="usd">268000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDAtMS0xLTEtOTA2NjU_61538889-b666-41d5-8bfd-befb795eda9d"
      unitRef="usd">-58277000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDAtMy0xLTEtOTA2NjU_ce00e52a-d5c2-4dec-89bf-f94165b95b97"
      unitRef="usd">-53903000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDItMS0xLTEtOTA2NjU_83584b98-114a-4cb4-be84-40c37bb79a81"
      unitRef="usd">46053000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDItMy0xLTEtOTA2NjU_044ebe86-7a00-4b5e-aadc-1d5768f306a6"
      unitRef="usd">48272000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDQtMS0xLTEtOTA2NjU_06297913-216b-472f-aa8a-f295280c3df9"
      unitRef="usd">98237000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xNi9mcmFnOmI0ZWE5ZTRjYTBiYjQ0MDJiZjMyNjI2NTEzMTdhOTY4L3RhYmxlOjM2YzNmZDI4ZTY5NzRhYzdiODA1ZGEyMjNhZTUzMjg3L3RhYmxlcmFuZ2U6MzZjM2ZkMjhlNjk3NGFjN2I4MDVkYTIyM2FlNTMyODdfNDQtMy0xLTEtOTA2NjU_cc6eeaea-a5a5-4312-883c-42921d1a72fa"
      unitRef="usd">97586000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMy0xLTEtMS05MDY2NQ_9e7d5c58-78fb-470e-95f6-1df83bda63bc"
      unitRef="usd">26763000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMy0zLTEtMS05MDY2NQ_25fabb09-8953-4162-8541-ffeba4bb3f7b"
      unitRef="usd">24463000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfNC0xLTEtMS05MDY2NQ_f075dcce-18db-491e-8543-edf82fa565d7"
      unitRef="usd">11396000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfNC0zLTEtMS05MDY2NQ_e4abbe12-9b34-4418-a9ee-09362fb09306"
      unitRef="usd">9887000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfNS0xLTEtMS05MDY2NQ_d1029787-7006-4787-9d92-b8b976cea0e4"
      unitRef="usd">15367000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfNS0zLTEtMS05MDY2NQ_49c5941d-3f47-4583-84ae-0ed9e7d3acbd"
      unitRef="usd">14576000</us-gaap:GrossProfit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfOC0xLTEtMS05MDY2NQ_2f21af91-d848-47cf-adc3-91ee372cec34"
      unitRef="usd">47000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfOC0zLTEtMS05MDY2NQ_8d4b8eaa-a1a2-4020-abe0-bae21e011a04"
      unitRef="usd">-70000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfOS0xLTEtMS05MDY2NQ_4f82d6f3-3fab-43ec-bcac-59fdf353c3ac"
      unitRef="usd">710000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfOS0zLTEtMS05MDY2NQ_f66deac8-26c6-47de-9f8f-00eeb0232995"
      unitRef="usd">1043000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:SellingAndMarketingExpense
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTAtMS0xLTEtOTA2NjU_1dfb7f84-db86-4c12-a7c5-501687ffa054"
      unitRef="usd">3319000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTAtMy0xLTEtOTA2NjU_c1f4039b-b8c1-47d5-93c9-b944388b8fe5"
      unitRef="usd">2376000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTEtMS0xLTEtOTA2NjU_f4e9be76-cc87-4b0c-a6ad-99a1f9d28ce4"
      unitRef="usd">11816000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTEtMy0xLTEtOTA2NjU_7c8309a1-1022-4e78-9eba-1c0727d45fda"
      unitRef="usd">10354000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTMtMS0xLTEtOTA2NjU_7ac53f72-55f1-4190-8eeb-cabcabf2ea2d"
      unitRef="usd">15892000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTMtMy0xLTEtOTA2NjU_6757be46-30d6-4e70-b56b-b3b5eb1420cd"
      unitRef="usd">13703000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTUtMS0xLTEtOTA2NjU_c63d3c88-cd7a-4d06-a64a-b281f5603143"
      unitRef="usd">-525000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTUtMy0xLTEtOTA2NjU_57f6b05f-5394-4263-b906-1dbf6932a179"
      unitRef="usd">873000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTctMS0xLTEtOTA2NjU_e0e5f54a-d16e-4fd8-9526-3cf383fc496f"
      unitRef="usd">277000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTctMy0xLTEtOTA2NjU_bda41e6c-c20b-4cba-95fd-7bd057c9be8b"
      unitRef="usd">322000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTgtMS0xLTEtOTA2NjU_63060600-db78-4aa7-ba52-e352ebe431ad"
      unitRef="usd">-28000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMTgtMy0xLTEtOTA2NjU_704e223c-c1ad-4d9f-93e2-3a0d586b4b99"
      unitRef="usd">-69000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjAtMS0xLTEtOTA2NjU_ca34d7fe-2d1f-4b99-9294-e3acb7adf30e"
      unitRef="usd">-830000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjAtMy0xLTEtOTA2NjU_a0ba5cf4-fef0-4365-9fb7-aac7164e3146"
      unitRef="usd">482000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjEtMS0xLTEtOTA2NjU_451a92a3-f57e-48ac-8c30-131731e961e9"
      unitRef="usd">-462000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjEtMy0xLTEtOTA2NjU_b7943e31-6339-405e-9e44-1c71179a7ab1"
      unitRef="usd">-179000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjItMS0xLTEtOTA2NjU_366bae70-cfae-40d3-9891-2ba7df6a6260"
      unitRef="usd">-368000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjItMy0xLTEtOTA2NjU_38f99c3d-5193-4adb-b584-0d131d8d8bcd"
      unitRef="usd">661000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjQtMS0xLTEtOTA2NjU_4a7da7ca-9469-48ca-bb14-879f00ab2552"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjQtMy0xLTEtOTA2NjU_48876e09-5d8c-4296-8760-08f0bdfa6d8b"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjUtMS0xLTEtOTA2NjU_cc674984-6814-4487-a45e-ff16abf8c0bb"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjUtMy0xLTEtOTA2NjU_a108e519-3cdb-477d-ae73-836dc88ebb70"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjctMS0xLTEtOTA2NjU_1f60d10d-8371-4415-9523-5cb062e1cc1c"
      unitRef="shares">20609372</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjctMy0xLTEtOTA2NjU_cc552ec5-e3f6-43e3-996a-87296cd4824d"
      unitRef="shares">20338160</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjgtMS0xLTEtOTA2NjU_09f028ac-627f-441f-bfa2-bf7898c26311"
      unitRef="shares">20609372</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMjgtMy0xLTEtOTA2NjU_7561116b-c7d4-476a-b7c2-34ff338cc3b2"
      unitRef="shares">21937639</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzEtMS0xLTEtOTA2NjU_60256dc6-133f-45f4-a08e-715477e860a0"
      unitRef="usd">-368000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzEtMy0xLTEtOTA2NjU_74298e4a-97a6-4d00-86d4-fec499d691ef"
      unitRef="usd">661000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzMtMS0xLTEtOTA2NjU_218f38bf-7489-4cfe-8617-a03115bb11b6"
      unitRef="usd">905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzMtMy0xLTEtOTA2NjU_3b16794f-05ec-4e08-a501-a3b6672a20a8"
      unitRef="usd">158000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzQtMS0xLTEtOTA2NjU_22415b58-8e39-4b2e-aa9b-d76dceef729b"
      unitRef="usd">218000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzQtMy0xLTEtOTA2NjU_29202c52-5a07-4141-82d3-c7217b8d7e07"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzUtMS0xLTEtOTA2NjU_8787f2ba-ca24-4d8d-9b8f-8a664bd49f6a"
      unitRef="usd">319000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18xOS9mcmFnOjRmNDQwOWQyMDI5ZTQxZjZhN2RhNDlmOTJhNDc1NTcwL3RhYmxlOjdlZGJjMzkxY2Y2YjRmOGI5YmVkZmRhNWYzMDM1N2VhL3RhYmxlcmFuZ2U6N2VkYmMzOTFjZjZiNGY4YjliZWRmZGE1ZjMwMzU3ZWFfMzUtMy0xLTEtOTA2NjU_7abb9620-9a79-4e49-95f0-894e92cf59e2"
      unitRef="usd">819000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i5fb95b32e4654392b07c0102083ff1de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0yLTEtMS05MDY2NQ_62b3714f-1d52-44cf-830d-4a7096cca45c"
      unitRef="shares">23816000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5fb95b32e4654392b07c0102083ff1de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi00LTEtMS05MDY2NQ_f1fa6453-4895-4a19-a4aa-3b00761e3544"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e27a3a029534186a1f04cd4900ea788_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi02LTEtMS05MDY2NQ_75bfec09-a4cc-4686-b534-36d6329d4f90"
      unitRef="usd">84785000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if7f89d0d1f4445978bf16c0f5f8792ae_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi04LTEtMS05MDY2NQ_a9dad9f1-2316-403c-b1b7-ee45cf4490c6"
      unitRef="usd">-44035000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i95bc362b5d314368999d043bce1b654a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0xMC0xLTEtOTA2NjU_4c1ae0bd-42c6-4d25-84ad-66ff8da102c2"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="if785a73c71834ed59f0446734c77df79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0xMi0xLTEtOTA2NjU_b60d26f5-801b-4c66-bd2c-00aae6dac794"
      unitRef="shares">3518000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if785a73c71834ed59f0446734c77df79_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0xNC0xLTEtOTA2NjU_b006c7ac-e2a7-410e-9ff6-e2aa787f4bf1"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idaf436762a17484ebfcec7f989d83620_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMi0xNi0xLTEtOTA2NjU_4c2f5668-1d19-4369-8827-e6ca7dc60d58"
      unitRef="usd">40752000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="i30e45981adc34974b1489e559c4a7b7b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMy0yLTEtMS05MDY2NQ_9ae951a1-9088-43ef-bf33-7139923eae05"
      unitRef="shares">129000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="if578c620ff804879877d88b6707147d7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMy02LTEtMS05MDY2NQ_1439955b-b226-4137-abba-ed2449d17185"
      unitRef="usd">139000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMy0xNi0xLTEtOTA2NjU_43f2af56-c6e6-4a3f-a013-669a68d8b341"
      unitRef="usd">139000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if578c620ff804879877d88b6707147d7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNC02LTEtMS05MDY2NQ_ae0e608c-3f40-4ee4-9364-d4fea4e14c3b"
      unitRef="usd">1635000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNC0xNi0xLTEtOTA2NjU_57457a90-e4f2-4ef0-9874-ff237aae62a4"
      unitRef="usd">1635000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="if578c620ff804879877d88b6707147d7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNS02LTEtMS05MDY2NQ_e0fe7f96-4247-4756-9ace-c9de78cf7ff1"
      unitRef="usd">169000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNS0xNi0xLTEtOTA2NjU_21ea3def-a4d2-4d64-b1c2-e2ef2260e4aa"
      unitRef="usd">169000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i30e45981adc34974b1489e559c4a7b7b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNi0yLTEtMS05MDY2NQ_aa9fc580-9f12-4d7b-b7e5-ffb7d36686b3"
      unitRef="shares">30000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if578c620ff804879877d88b6707147d7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNi02LTEtMS05MDY2NQ_97ecf72d-010f-4f66-b20d-a0aa6c169690"
      unitRef="usd">565000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfNi0xNi0xLTEtOTA2NjU_fc2f90b1-52b5-40b9-9609-ae52fe281b7a"
      unitRef="usd">565000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i100e31c2a3f141098462c1bae67f7c14_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfOC0xMC0xLTEtOTA2NjU_a180360d-ddd9-4fdb-bc47-c088dd2f02ab"
      unitRef="usd">158000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfOC0xNi0xLTEtOTA2NjU_7c0fd0aa-4eff-4df9-b0e2-33933879e135"
      unitRef="usd">158000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="icd4cfb7b4b0a448ea084cf971ba89514_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfOS04LTEtMS05MDY2NQ_084b9e0d-13bc-48d8-87b2-22f3b1be6754"
      unitRef="usd">661000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfOS0xNi0xLTEtOTA2NjU_36f96ae0-176f-4d91-b04e-76ad5ae91da3"
      unitRef="usd">661000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="if8f287da32c34a4382931967c22f2986_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMi0xLTEtOTA2NjU_d082ff59-92b2-4db2-b467-62d1b894e676"
      unitRef="shares">23915000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="if8f287da32c34a4382931967c22f2986_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtNC0xLTEtOTA2NjU_c34ed137-5dcf-403f-a591-3f1b9beb259f"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8b643b684c364bcd8ec30529ba06e134_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtNi0xLTEtOTA2NjU_4f861526-50ad-4d77-ac7b-4a0835933a8b"
      unitRef="usd">86163000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i90ca1cca292344a08bf352fbd442ee45_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtOC0xLTEtOTA2NjU_98fdfe00-4242-43e2-9b81-203eee8dbba3"
      unitRef="usd">-43374000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia2be1d671b114cf08009f612708ee32e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMTAtMS0xLTkwNjY1_5d602b59-923d-434a-9079-7a28b92ab481"
      unitRef="usd">158000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i247580c074ba4302b7e3c71ddea3bae5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMTItMS0xLTkwNjY1_769ea5ae-4a28-4f80-a4f3-eec1cd3a7bf3"
      unitRef="shares">3518000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i247580c074ba4302b7e3c71ddea3bae5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMTQtMS0xLTkwNjY1_1b958e76-c9ff-4f81-af96-f3e50abd13d1"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTAtMTYtMS0xLTkwNjY1_2d7b8d02-16df-4736-88c6-f1fabcd044e7"
      unitRef="usd">42949000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i99185486b44a43db8dee855c0e2e3a15_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMi0xLTEtOTA2NjU_bf1784a9-87ec-42a1-b886-daf773d3c465"
      unitRef="shares">20700000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i99185486b44a43db8dee855c0e2e3a15_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItNC0xLTEtOTA2NjU_53384ccb-3b2a-4025-855d-fa6c563c4ff6"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie03f91b078594271bd4e14d68978bf06_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItNi0xLTEtOTA2NjU_0949df24-c0b4-4cd7-afe7-c4f33bf4a3be"
      unitRef="usd">101905000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4c341c2ae934d3897c08cd614b84edb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItOC0xLTEtOTA2NjU_351d25e9-7d8a-4c8a-ba8e-0b0a8fc8bd0a"
      unitRef="usd">-53903000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4c477f12061c46b79bd5fb63d4373a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMTAtMS0xLTkwNjY1_0a3e67a2-a01b-495c-ad0b-0b934f6a0698"
      unitRef="usd">268000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ia35e3080b1b8404cba8a212ab094986f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMTItMS0xLTkwNjY1_da8ecb3c-31ad-4444-a551-192f00d092a5"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia35e3080b1b8404cba8a212ab094986f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMTQtMS0xLTkwNjY1_9211c5a8-86d5-42f5-9191-a8789bc07bc9"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTItMTYtMS0xLTkwNjY1_337551df-1321-4d36-b070-e38f12fcb884"
      unitRef="usd">48272000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross
      contextRef="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTMtMi0xLTEtOTA2NjU_dbeb5494-781d-4e64-8e9e-ad429325857e"
      unitRef="shares">125000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTMtNi0xLTEtOTA2NjU_d494c24f-cb34-428b-990c-9e21f02d4693"
      unitRef="usd">239000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTMtMTYtMS0xLTkwNjY1_21cfb6d9-32fd-4db4-87f2-f1a1efff08d2"
      unitRef="usd">239000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTQtNi0xLTEtOTA2NjU_8dd291e1-78b3-436c-b95c-5461abbd9645"
      unitRef="usd">1047000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTQtMTYtMS0xLTkwNjY1_76eccf81-01b9-4c66-9f10-c065ad11ad2f"
      unitRef="usd">1047000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTUtMi0xLTEtOTA2NjU_81c9b461-db87-4e09-8943-9c93d1383346"
      unitRef="shares">28000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTUtNi0xLTEtOTA2NjU_0a2f1652-a0c8-4cce-ade0-1c123c0a5e4b"
      unitRef="usd">236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTUtMTYtMS0xLTkwNjY1_93c11ff0-8883-4b81-9117-143d5af889aa"
      unitRef="usd">236000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTYtMi0xLTEtOTA2NjU_95fce083-a0c6-4e66-b99c-600349abb763"
      unitRef="shares">3000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4e2a6242a59e436d9b3a05aa07bac012_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTYtNi0xLTEtOTA2NjU_bb445a00-bd0b-41f2-a7cd-2fb246de28c6"
      unitRef="usd">54000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTYtMTYtMS0xLTkwNjY1_0bb24e83-af43-49da-aa6d-2d8e79f5660b"
      unitRef="usd">54000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="if6a5516a5ec1489aace344e1152efa0c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMi0xLTEtOTEzMDU_35a4f3de-4fca-4ac4-a780-567531359846"
      unitRef="shares">310000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i9ef62092fb404ae79ccb143d6c18f047_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtOC0xLTEtOTEzMDU_ee456b5c-db3a-40d1-a8ee-8fb3f3ce4d00"
      unitRef="usd">4006000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTYtMS0xLTkxMzA1_aea52b22-57e5-4eda-bf59-5111b61cdf4b"
      unitRef="usd">4006000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if8003ee2c2474deca1adb94e55f98442_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTgtMTAtMS0xLTkwNjY1_85094d8a-54c8-4ff9-83e6-1b3973fb7d92"
      unitRef="usd">687000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTgtMTYtMS0xLTkwNjY1_62d6a018-aff9-4f3d-b149-12a47c6ec213"
      unitRef="usd">687000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i9ef62092fb404ae79ccb143d6c18f047_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTktOC0xLTEtOTA2NjU_36ea996a-650e-4f65-b550-c99095818456"
      unitRef="usd">-368000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMTktMTYtMS0xLTkwNjY1_88f40d37-c98a-4e0b-bfc2-0107803e8fe1"
      unitRef="usd">-368000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i19444b1c10474d8490f92d04a10e148f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMi0xLTEtOTA2NjU_b0036648-8965-49d9-8a93-1d8085fbffc9"
      unitRef="shares">20540000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i19444b1c10474d8490f92d04a10e148f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtNC0xLTEtOTA2NjU_bb64ec3c-0c12-4aa2-9c42-48d0e98cab31"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id2aa136b42f543bb8d61228fb3ab265f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtNi0xLTEtOTA2NjU_e5ac6efe-2f7a-43ee-abc9-28a21e3911ff"
      unitRef="usd">103373000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib951efad10c64237873bd1580ccacf5b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtOC0xLTEtOTA2NjU_1304e75b-ed8f-45dc-946a-d25e0a21e365"
      unitRef="usd">-58277000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7876b1efc8a54b39b1afc22d1abf2ec0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTAtMS0xLTkwNjY1_2470e8fb-aed5-4dcf-9563-a5cf938d4544"
      unitRef="usd">955000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i2cf5aee4ba8347b58d13695506bc288c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTItMS0xLTkwNjY1_edbf74b9-488d-4a47-9f52-a8855cd95cb0"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2cf5aee4ba8347b58d13695506bc288c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTQtMS0xLTkwNjY1_1b0abf9d-6a74-4886-b78f-fb6d9823cb8c"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yMi9mcmFnOjIxNTBhOTBhMzI2NDQ2OGJhNTcyNGNmYjVlOTM1YjZjL3RhYmxlOjk5Yjc0NTBiNzhjMTQxNmJhNDNlNmIwZWIyYzEyMWUwL3RhYmxlcmFuZ2U6OTliNzQ1MGI3OGMxNDE2YmE0M2U2YjBlYjJjMTIxZTBfMjAtMTYtMS0xLTkwNjY1_6dc1c499-9112-4422-bb97-c24026421349"
      unitRef="usd">46053000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNC0xLTEtMS05MDY2NQ_0efab052-4e06-46c8-89fb-cfd0ee4cbb2b"
      unitRef="usd">-368000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNC0zLTEtMS05MDY2NQ_144a80f1-2895-4c69-8c85-1b2e55965f0a"
      unitRef="usd">661000</us-gaap:NetIncomeLoss>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNi0xLTEtMS05MDY2NQ_e183a94d-49af-457a-9e26-10ebebc3620b"
      unitRef="usd">47000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNi0zLTEtMS05MDY2NQ_004c50e4-a900-4ce9-96f4-dc8bbf07bec9"
      unitRef="usd">-70000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:Depreciation
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNy0xLTEtMS05MDY2NQ_6df4aa6f-0d95-4a70-9828-401dc9d51325"
      unitRef="usd">2706000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNy0zLTEtMS05MDY2NQ_56e1aa14-9130-4a68-a493-76bb664cbabf"
      unitRef="usd">2527000</us-gaap:Depreciation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfOC0xLTEtMS05MDY2NQ_49336dc0-1a67-474a-b67b-614f5e88275d"
      unitRef="usd">275000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfOC0zLTEtMS05MDY2NQ_124deaa1-499d-4f56-8bd4-8e8f16549155"
      unitRef="usd">597000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfOS0xLTEtMS05MDY2NQ_6c928cb2-0a14-485a-b0e9-f8ce24e1d9a8"
      unitRef="usd">228000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfOS0zLTEtMS05MDY2NQ_7220402a-ecf5-40b0-89a1-dfd18990117f"
      unitRef="usd">-89000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTAtMS0xLTEtOTA2NjU_df8fd00d-cef9-494c-b756-359d2f4d704c"
      unitRef="usd">710000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTAtMy0xLTEtOTA2NjU_415d8e36-6766-4842-9162-c491a470ee07"
      unitRef="usd">1043000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTEtMS0xLTEtOTA2NjU_72c6ec3a-ec66-41d8-b5b8-5509b0bd6636"
      unitRef="usd">18000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTEtMy0xLTEtOTA2NjU_73896797-a76a-4b56-a284-a82d77c36883"
      unitRef="usd">96000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTItMS0xLTEtOTA2NjU_68c56009-d838-4959-8809-5bb147cd0993"
      unitRef="usd">1047000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTItMy0xLTEtOTA2NjU_5e12caec-5437-4c67-8cf3-62a17ed1abbd"
      unitRef="usd">1635000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTMtMS0xLTEtOTA2NjU_1d6cc864-7dc6-40bf-a626-552823739e7c"
      unitRef="usd">-462000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTMtMy0xLTEtOTA2NjU_dc657c58-36df-4f29-b090-0bfcdf19c5fb"
      unitRef="usd">-180000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTUtMS0xLTEtOTA2NjU_319d2104-2a8f-40c3-88c8-0dd2bb33192b"
      unitRef="usd">1278000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTUtMy0xLTEtOTA2NjU_20f8cda5-6bea-4306-9125-6905b5c84795"
      unitRef="usd">420000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTYtMS0xLTEtOTA2NjU_ab85dc4c-dfba-463d-8481-d9321822e4a0"
      unitRef="usd">-61000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTYtMy0xLTEtOTA2NjU_3699dfad-710a-4404-b989-2342d2c1f576"
      unitRef="usd">154000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTctMS0xLTEtOTA2NjU_ed8cefb7-c873-4079-b221-44d49ada0af7"
      unitRef="usd">50000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTctMy0xLTEtOTA2NjU_83a0c9c6-94b4-40e2-bc01-dcd57acced9d"
      unitRef="usd">244000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTgtMS0xLTEtOTA2NjU_a7040dc7-6ccd-40e2-b9be-8d823234671a"
      unitRef="usd">41000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMTgtMy0xLTEtOTA2NjU_cc218a7f-0ca7-4227-82a5-23f5afb673ab"
      unitRef="usd">40000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjAtMS0xLTEtOTA2NjU_ca007b31-48ff-4691-b6e9-97f1f7e7a288"
      unitRef="usd">1641000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjAtMy0xLTEtOTA2NjU_fd73d5da-6236-4c6d-9da0-5eaf0674ab3e"
      unitRef="usd">-2889000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjEtMS0xLTEtOTA2NjU_74c6ad7d-6370-4f2d-8964-e8935ed640be"
      unitRef="usd">4078000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjEtMy0xLTEtOTA2NjU_3ccfc9e9-2cc7-4fe0-8dc7-11876bb70648"
      unitRef="usd">2651000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjQtMS0xLTEtOTA2NjU_fc8248c9-bcb1-4545-a768-e7e7d2fcc87c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjQtMy0xLTEtOTA2NjU_391a6e90-9b99-4942-928e-9ac80a197470"
      unitRef="usd">1204000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjUtMS0xLTEtOTA2NjU_42414376-1a9f-4ded-a812-0c76a9e426f3"
      unitRef="usd">2931000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjUtMy0xLTEtOTA2NjU_31b9158a-19c0-485c-bc35-51d81fa65fad"
      unitRef="usd">2336000</infu:PaymentsToAcquireMedicalEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjYtMS0xLTEtOTA2NjU_c230ea03-87a2-4043-90e3-bdb980b2140a"
      unitRef="usd">178000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjYtMy0xLTEtOTA2NjU_fe5a6003-e8e8-4131-9488-bc9dc97ec2c2"
      unitRef="usd">138000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjctMS0xLTEtOTA2NjU_a7842cff-2968-463b-bf9c-8095fc4648da"
      unitRef="usd">966000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjctMy0xLTEtOTA2NjU_cda70e6c-3411-42cd-841a-ec0c1c8d0d44"
      unitRef="usd">876000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjgtMS0xLTEtOTA2NjU_739a47e8-f89c-46de-8c64-548e62a08191"
      unitRef="usd">-2143000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMjgtMy0xLTEtOTA2NjU_5414ac69-4ab5-4204-b0d6-b2f394ae7a7c"
      unitRef="usd">-2802000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzEtMS0xLTEtOTA2NjU_96b03628-7019-4039-b5ce-b84fdd9b68cf"
      unitRef="usd">10696000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzEtMy0xLTEtOTA2NjU_0a3022a1-6ae4-4093-98cd-b313a5e5320b"
      unitRef="usd">40093000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzItMS0xLTEtOTA2NjU_fbb4312d-f982-44be-8299-e5a642ed2552"
      unitRef="usd">12529000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzItMy0xLTEtOTA2NjU_7ecef313-f064-460b-a545-8d74a4a32a20"
      unitRef="usd">34000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzMtMS0xLTEtOTA2NjU_31759277-9d1a-48d0-9e7d-a97da7c11015"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzMtMy0xLTEtOTA2NjU_16f6d9be-0454-4a8b-a6ab-a98465891b5a"
      unitRef="usd">386000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzQtMS0xLTEtOTA2NjU_42d769d7-62b5-4c00-ab67-a652304473ee"
      unitRef="usd">54000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzQtMy0xLTEtOTA2NjU_639bfeff-a155-418c-9a09-b40ab8300147"
      unitRef="usd">565000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzUtMS0xLTEtOTE0MDc_88cee5cd-cad8-404c-a3ba-1005c06df22c"
      unitRef="usd">4006000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzUtMy0xLTEtOTE0MTQ_ade45cde-cff4-423a-baa0-a969f1621fe1"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockPlans
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzUtMS0xLTEtOTA2NjU_4e24e086-2e9e-4f75-9f3d-de8178e3af38"
      unitRef="usd">511000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzUtMy0xLTEtOTA2NjU_43ac843f-dd3d-4bfe-8fe0-4571a4282bd6"
      unitRef="usd">308000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzctMS0xLTEtOTA2NjU_e8112669-9717-426c-a060-8c7328bc0cd2"
      unitRef="usd">-1716000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzctMy0xLTEtOTA2NjU_a20a0ae7-8fb9-4e68-8892-c25825a4f54b"
      unitRef="usd">-6736000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzktMS0xLTEtOTA2NjU_2f8f461e-c84f-460e-8ed4-e53b5a47e5bd"
      unitRef="usd">219000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfMzktMy0xLTEtOTA2NjU_92cb5fa6-efcb-4b27-8f09-2cb3dde8f179"
      unitRef="usd">-6887000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNDAtMS0xLTEtOTA2NjU_235308d3-a86f-4356-9807-7d0c4758ea26"
      unitRef="usd">186000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idaf436762a17484ebfcec7f989d83620_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNDAtMy0xLTEtOTA2NjU_a3628b1d-6ff4-40c6-b92e-c0da5e9c5b57"
      unitRef="usd">9648000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNDEtMS0xLTEtOTA2NjU_d5948e20-8a72-44a7-91e4-8fec0d2b45e8"
      unitRef="usd">405000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18yNS9mcmFnOjQxNDc5MGVlYTM4MDRiNWViYWU1ZjM2NzE5MTVmNTRlL3RhYmxlOjhiNzNlNTBiZDNhNjQ4ZDU5NjA2YmI4MDNmZjc1ZGU2L3RhYmxlcmFuZ2U6OGI3M2U1MGJkM2E2NDhkNTk2MDZiYjgwM2ZmNzVkZTZfNDEtMy0xLTEtOTA2NjU_349120a9-bfec-4bf9-af7e-da8069a2cab9"
      unitRef="usd">2761000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BasisOfAccounting
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zMS9mcmFnOjJkMDRjODczMWZhMjQ3N2Y5NThiYzcxNDYxZjYzZjNkL3RleHRyZWdpb246MmQwNGM4NzMxZmEyNDc3Zjk1OGJjNzE0NjFmNjNmM2RfMzgyMw_a03935d5-7023-415d-80c8-8549e9ca5b49">Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies&lt;div style="margin-top:12pt;padding-right:7.2pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The terms &#x201c;InfuSystem&#x201d;, the &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;our&#x201d; and &#x201c;us&#x201d; are used herein to refer to InfuSystem Holdings, Inc. and its subsidiaries. InfuSystem is a leading provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care. The Company provides products and services to hospitals, oncology practices and facilities and other alternative site health care providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim financial information. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) for complete financial statements. The accompanying unaudited condensed consolidated financial statements include all adjustments, composed of normal recurring adjustments, considered necessary by management to fairly state the Company&#x2019;s results of operations, financial position and cash flows. The operating results for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 as filed with the SEC on March&#160;15, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires the use of estimates, judgments and assumptions that affect the amounts of assets and liabilities at the reporting date and the amounts of revenue and expenses in the periods presented. The Company believes that the accounting estimates employed are appropriate and the resulting balances are reasonable; however, due to the inherent uncertainties in making estimates, actual results could differ from the original estimates, requiring adjustments to these balances in future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNC9mcmFnOjM0ZDhlM2E3M2U3MTQ1ZmZiNzg5ZmEwMmQ5YjY0MzhhL3RleHRyZWdpb246MzRkOGUzYTczZTcxNDVmZmI3ODlmYTAyZDliNjQzOGFfMTI5Ng_8d8a22e5-f154-4bd1-8402-be4a9154362d">Recent Accounting Pronouncements and DevelopmentsIn June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update No. 2016-13, &#x201c;Financial Instruments (Topic 326) Credit Losses&#x201d;. Topic 326 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investments in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. Topic 326 was originally effective as of January 1, 2020, although in November 2019, the FASB delayed the effective date until fiscal years beginning after December 15, 2022 for SEC filers eligible as of the FASB's deferral date to be smaller reporting companies under the SEC&#x2019;s definition. The Company qualified as a smaller reporting company in November 2019 when the FASB delayed the effective date of Topic 326. Early adoption is permitted. The Company is currently evaluating the impact of Topic 326 on its consolidated balance sheets, statements of operations, statements of cash flows and related disclosures.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAyMQ_e2fd18ab-4709-420a-be96-66324c57f570">Business Combinations&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Acquisitions Accounted for Using the Purchase Method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On January&#160;31, 2021, the Company acquired the business and the majority of the assets of FilAMed, a privately-held biomedical services company based in Bakersfield, California. In becoming a part of the Company&#x2019;s Durable Medical Equipment Services ("DME Services") segment, this acquisition supplements the Company's existing biomedical recertification, maintenance and repair services for acute care facilities and other alternate site settings including home care and home infusion providers, skilled nursing facilities, pain centers and others. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April&#160;18, 2021, the Company acquired the business and substantially all of the assets of OB Healthcare Corporation (&#x201c;OB Healthcare&#x201d;), a privately-held biomedical services company based in Mesquite, Texas. OB Healthcare specializes in on-site repair, preventative maintenance, and device physical inventory management to hospitals and healthcare systems nationwide. The acquisition further develops and expands InfuSystem&#x2019;s DME Services segment and complements the Company&#x2019;s purchase of FilAMed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The results of operations for FilAMed and OB Healthcare are included in the Company&#x2019;s consolidated statements of operations from the respective closing dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Final Purchase Price Allocation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Pursuant to FASB Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 805, &#x201c;Business Combinations,&#x201d; the purchase price for each of the acquisitions was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the respective acquisition dates. The purchase price allocations were primarily based upon a valuation using management&#x2019;s estimates and assumptions. The purchase price allocation was completed for FilAMed and OB Healthcare as of December&#160;31, 2021. The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;FilAMed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Working capital adjustment, paid in cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;FilAMed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment held for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The amount of acquisition costs for both transactions was less than $0.1 million for the three months ended March 31, 2021 and was included in general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company fully paid all consideration for FilAMed as of December&#160;31, 2021. On the OB Healthcare acquisition date, the Company made an initial cash payment of $6.1&#160;million with subsequent cash payments totaling $0.4&#160;million during the year ended December 31, 2021 and had an additional estimated amount due to the seller for contingent consideration of $0.8&#160;million, which was recorded in the balance sheet under the heading for other current liabilities. The contingent consideration arrangement, as amended, required the Company to pay OB Healthcare $0.8&#160;million if certain written contracts were executed.  As of March&#160;31, 2022, the Company had a $0.8&#160;million remaining liability relating to this acquisition. However, the requirement under the contingent consideration arrangement was satisfied on April 28, 2022, and the Company paid the remaining payment shortly thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;(Thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unpatented technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total intangible assets (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The goodwill acquired consists of expected synergies from combining operations of FilAMed and OB Healthcare with the DME Services segment as well as their respective assembled workforce who have specialized knowledge and experience. All of the goodwill is deductible for tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Unaudited Pro Forma Financial Information &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The unaudited pro forma financial information in the table below summarizes the combined results of operations of the Company, FilAMed and OB Healthcare as though the companies&#x2019; businesses had been combined as of January 1, 2021. The pro forma financial information for the three months ended March&#160;31, 2021 was adjusted by less than $0.1 million for the tax effected amount of acquisition costs and non-recurring expenses directly attributable to the FilAMed and OB Healthcare acquisitions. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisitions had taken place at the beginning of the period presented nor is it indicative of future results. The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the three months ended March&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAxOA_1414e70b-6cba-4516-aaf3-35f0f48eeda9">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;FilAMed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Working capital adjustment, paid in cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;FilAMed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment held for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAyMg_2abd70d9-f4de-4c0f-9e55-6cf314d5c650">The following table summarizes the consideration paid and the allocation of the purchase price to the fair values of the assets acquired and liabilities assumed as of the respective acquisition dates for both FilAMed and OB Healthcare (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;FilAMed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Consideration&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Working capital adjustment, paid in cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;FilAMed&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:19.87pt;padding-right:19.87pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;OB&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Healthcare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment held for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total - purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments
      contextRef="i42616323608f4b44a460de02c3482936_D20210131-20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMS0xLTEtMS05MDY2NQ_cd55e7f8-4cb6-4a91-9176-ba2ab54c9f07"
      unitRef="usd">1400000</infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments>
    <infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments
      contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMS0zLTEtMS05MDY2NQ_a9881356-6c26-4785-94b1-6821c6ede4be"
      unitRef="usd">6250000</infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments>
    <infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments
      contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMS01LTEtMS05MDY2NQ_8768a788-266b-4c05-b9ac-19e4e2e60255"
      unitRef="usd">7650000</infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments>
    <infu:WorkingCapital
      contextRef="i42616323608f4b44a460de02c3482936_D20210131-20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMi0xLTEtMS05MDY2NQ_416a22a8-bf84-474f-a0a4-fe46db1d121d"
      unitRef="usd">0</infu:WorkingCapital>
    <infu:WorkingCapital
      contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMi0zLTEtMS05MDY2NQ_b5f5c19d-6fa0-4be1-b17e-0621f5d7a13e"
      unitRef="usd">325000</infu:WorkingCapital>
    <infu:WorkingCapital
      contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMi01LTEtMS05MDY2NQ_9fbf5e9d-b25a-4575-b045-9263efa199eb"
      unitRef="usd">325000</infu:WorkingCapital>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i42616323608f4b44a460de02c3482936_D20210131-20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMy0xLTEtMS05MDY2NQ_70a93421-a03a-4c56-852f-a045af98b373"
      unitRef="usd">0</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMy0zLTEtMS05MDY2NQ_be250253-f366-4116-9301-ae96626dcadf"
      unitRef="usd">750000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfMy01LTEtMS05MDY2NQ_d812dd16-7709-4a6d-8e4b-3f378d8aa84e"
      unitRef="usd">750000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i42616323608f4b44a460de02c3482936_D20210131-20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfNC0xLTEtMS05MDY2NQ_55060e17-ebe6-4873-9571-dc8f9060ff80"
      unitRef="usd">1400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfNC0zLTEtMS05MDY2NQ_3c7d3ec9-b356-424c-ad87-05655243b934"
      unitRef="usd">7325000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjVjN2E0MTdmNDBlNDRlZDBhMTRhMGExOWVhMjU0MjdjL3RhYmxlcmFuZ2U6NWM3YTQxN2Y0MGU0NGVkMGExNGEwYTE5ZWEyNTQyN2NfNC01LTEtMS05MDY2NQ_dfcd56b5-04ba-4b87-90ac-576a6fa2ef40"
      unitRef="usd">8725000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMS0yLTEtMS05MDY2NQ_dd329d48-da6c-4ecf-8bab-dc1baac2cf28"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMS00LTEtMS05MDY2NQ_5fc89bb0-7f10-443a-8b47-59c463c7d254"
      unitRef="usd">725000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMS02LTEtMS05MDY2NQ_ac431ca4-8949-413c-96ad-e7cfbb6bdd59"
      unitRef="usd">725000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMi0yLTEtMS05MDY2NQ_b1431e0f-0b0b-435b-9e87-d52cf40c9c55"
      unitRef="usd">74000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMi00LTEtMS05MDY2NQ_0aafffe6-702c-453a-9d41-6304650d9e1e"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMi02LTEtMS05MDY2NQ_740bc2d6-9644-4951-baa6-17df7ce12d74"
      unitRef="usd">74000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMy0yLTEtMS05MDY2NQ_c0f74f3f-a455-4b2c-aed4-dbf6bc1458af"
      unitRef="usd">40000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMy00LTEtMS05MDY2NQ_5efd6fb0-8b38-4fb6-b099-26f4d9a66685"
      unitRef="usd">0</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfMy02LTEtMS05MDY2NQ_69d3d533-5ce5-4c9f-8223-befc71d59229"
      unitRef="usd">40000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNC0yLTEtMS05MDY2NQ_9645903f-33a4-46fe-bcd1-d8b589f849ce"
      unitRef="usd">102000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNC00LTEtMS05MDY2NQ_e3019556-73fd-44ae-80d9-1b51f37da276"
      unitRef="usd">59000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNC02LTEtMS05MDY2NQ_50b7afee-c19f-4536-84ae-237cf87dbb64"
      unitRef="usd">161000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNS0yLTEtMS05MDY2NQ_eb3eaa35-534d-4430-aa7c-61807d7a7f8b"
      unitRef="usd">1015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNS00LTEtMS05MDY2NQ_92ac87b8-e8f8-4465-b3dc-b13adbd17283"
      unitRef="usd">3000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNS02LTEtMS05MDY2NQ_9a62ca03-f9c0-417f-b5e8-438893a6ec93"
      unitRef="usd">4015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNi0yLTEtMS05MDY2NQ_3dbf946e-ee2b-450f-b155-45ab1d4f5084"
      unitRef="usd">169000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNi00LTEtMS05MDY2NQ_d4f047e2-91b8-4d0b-bcd0-04789f34f470"
      unitRef="usd">3541000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNi02LTEtMS05MDY2NQ_f818c5aa-5bb4-48ae-b50b-8a9fcf870d25"
      unitRef="usd">3710000</us-gaap:Goodwill>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNy0yLTEtMS05MDY2NQ_55c0fdf0-41d9-4db0-aef0-733dcc4dc4fc"
      unitRef="usd">281000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNy00LTEtMS05MDY2NQ_0d1d2194-810f-4dd0-b404-2355b5ab4411"
      unitRef="usd">7000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfNy02LTEtMS05MDY2NQ_e0617907-9944-49af-9177-9ca73fa40545"
      unitRef="usd">288000</infu:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOC0yLTEtMS05MDY2NQ_8c4fefe3-a02e-4727-a8e2-93ceacad6519"
      unitRef="usd">281000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOC00LTEtMS05MDY2NQ_d33a609a-b572-4890-a49e-8909a7ef73a1"
      unitRef="usd">7000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOC02LTEtMS05MDY2NQ_df187bd2-82f2-41ff-8025-eea2dc8bd830"
      unitRef="usd">288000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i751082717be544698a176938b3add8c3_I20210131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOS0yLTEtMS05MDY2NQ_2d243007-fc1f-48c2-b89a-cd898bedc6d3"
      unitRef="usd">1400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ia1ddd0ea388f43e1aa5c2412884249a5_I20210418"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOS00LTEtMS05MDY2NQ_66b3b5a5-03af-4ac6-a17a-904bdc13ae7e"
      unitRef="usd">7325000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjA5NWQ1ZTU5N2VmZjQwOWJiNmM1YTEwMzVlZGY4ODk0L3RhYmxlcmFuZ2U6MDk1ZDVlNTk3ZWZmNDA5YmI2YzVhMTAzNWVkZjg4OTRfOS02LTEtMS05MDY2NQ_05908de4-01e9-4e85-80d7-f0eedb550457"
      unitRef="usd">8725000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMjM4MA_f12f2636-ced3-4892-a99c-b09b44ca288b"
      unitRef="usd">100000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i4e5048f55b7f4cb2ada78dde958c8dc8_D20210418-20210418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMjk0Nw_75f87d1c-f7e4-4815-b2cc-56b739b460f8"
      unitRef="usd">6100000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i9ede16521fc64b74b1f49fe77c8a9798_D20210419-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMjk4NA_15098578-150d-4df1-a716-6ad1e9cb2a46"
      unitRef="usd">400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7797bc0f95b940b39aa0182a7088eb53_I20210418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMzE2OA_072b2b4a-c393-40c9-ab32-a31c28230802"
      unitRef="usd">800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7797bc0f95b940b39aa0182a7088eb53_I20210418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMzM1Mw_072b2b4a-c393-40c9-ab32-a31c28230802"
      unitRef="usd">800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <infu:BusinessCombinationContingentConsiderationAndWorkingCapitalLiability
      contextRef="id6070f50a0324f03942b82573c417cdf_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfMzQ5Ng_85fad16d-23d4-4956-b855-ed961fc7ce29"
      unitRef="usd">800000</infu:BusinessCombinationContingentConsiderationAndWorkingCapitalLiability>
    <us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAxOQ_4ec9ab6a-c475-4e6d-b3ab-cf0ecc5ec4e8">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table shows the breakdown of the identified intangible assets acquired into major intangible asset classes for both acquisitions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Acquisition Date&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;(Thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amortization Period&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.72pt;padding-right:4.72pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;(Years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unpatented technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total intangible assets (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) There was no residual value, renewal terms or extensions associated with any intangible assets acquired.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia4990fd3a38c4f3eb1d7099fb3c52dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMS0yLTEtMS05MDY2NQ_69b9fc8d-6fa1-411d-be98-d137ce6843bb"
      unitRef="usd">2300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id82fee9ebb5a42a9890e2723157a39ae_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMS00LTEtMS05MDY2NQ_f2cfa7ee-eaee-4688-a362-8f3320a47ffe">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9fffd8c4d1c944babfd356c6577863a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMi0yLTEtMS05MDY2NQ_9310fdbe-fba3-4434-a71b-a6e023d47b35"
      unitRef="usd">943000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie996aa5ccd674a0d8c3da996d58461d4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMi00LTEtMS05MDY2NQ_e20ea398-b1b5-46a2-9d75-e9d3a3c477d2">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMy0yLTEtMS05MDY2NQ_12ca55de-7c21-4d4a-a276-d8c8a371365b"
      unitRef="usd">472000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9485abe60939498a8c78a8987d9934b6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfMy00LTEtMS05MDY2NQ_06c6872e-4134-4968-ad66-680f620479ef">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9d5f226368ed474b99f5057977d175c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfNC0yLTEtMS05MDY2NQ_0d2b92f1-ae84-42fc-b354-6bb274b7d0ef"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5fbe9dbc0da14959be7205dd13d84c0b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfNC00LTEtMS05MDY2NQ_6e72ef6e-d337-4ddb-8260-c64f9ac6abcc">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfNi0yLTEtMS05MDY2NQ_7deb1c0e-9c88-4ab9-9bc8-29ff2a9336ab"
      unitRef="usd">4015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOjYyYzQ3NjAzYjEyNjRhYTRhZGJlMDIxM2U2MTgxZTRmL3RhYmxlcmFuZ2U6NjJjNDc2MDNiMTI2NGFhNGFkYmUwMjEzZTYxODFlNGZfNi00LTEtMS05MDY2NQ_70a8c4e1-6c47-4ec5-847a-9972d49081ea">P11Y2M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <infu:BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense
      contextRef="i0e029b8ec12f40869e606cbefce19746_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNDMyNQ_ec1efa0a-c23d-4a4a-bf5a-a005b3a1bf95"
      unitRef="usd">100000</infu:BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RleHRyZWdpb246MmZiYTVhNzQ5NTRkNGY3MGEwYTM1OTExOWQyZTBjZWRfNTAyMA_559882d7-5297-4b69-9f4a-457d92e7efb1">The following pro forma financial information presented also includes the pro forma depreciation and amortization charges from acquired tangible and intangible assets for the three months ended March&#160;31, 2021 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 77.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOmMyYmQ0ZWYzNjQyMDQ0YjRiMmE4NDNkOGI5YmE0ZjFiL3RhYmxlcmFuZ2U6YzJiZDRlZjM2NDIwNDRiNGIyYTg0M2Q4YjliYTRmMWJfMi0zLTEtMS05MDY2NQ_3b013e05-f0fb-4eca-82a8-1502e0b46139"
      unitRef="usd">24679000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM18zNy9mcmFnOjJmYmE1YTc0OTU0ZDRmNzBhMGEzNTkxMTlkMmUwY2VkL3RhYmxlOmMyYmQ0ZWYzNjQyMDQ0YjRiMmE4NDNkOGI5YmE0ZjFiL3RhYmxlcmFuZ2U6YzJiZDRlZjM2NDIwNDRiNGIyYTg0M2Q4YjliYTRmMWJfMy0zLTEtMS05MDY2NQ_5ff8a3fd-36a9-4206-82e3-114d4a874f1a"
      unitRef="usd">639000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfODQ1_4f4e8202-2638-43e9-8dd5-6946b8dd9bd3">Revenue Recognition&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table presents the Company&#x2019;s disaggregated revenue by offering type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of Total Net Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of Total Net Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Third-Party Payer Rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Direct Payer Rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Product Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Third-Party Payer Rentals are entirely attributed to revenues of the Integrated Therapy Services (&#x201c;ITS&#x201d;) segment. For the three months ended March&#160;31, 2022, $3.2 million and $4.8&#160;million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2021, $3.1 million and $4.3 million of Direct Payer Rentals were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2022, $0.1 million and $3.6 million of Product Sales were attributed to the ITS and DME Services segments, respectively. For the three months ended March&#160;31, 2021, all Product Sales were entirely attributed to the DME Services segment. For the three months ended March&#160;31, 2022 and 2021, all Services revenues were entirely attributed to the DME Services segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfODQ3_1d9f2fea-f880-46c3-b067-c1c537b65814">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table presents the Company&#x2019;s disaggregated revenue by offering type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of Total Net Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total Net&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Percentage of Total Net Revenues&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Third-Party Payer Rentals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;52.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Direct Payer Rentals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;29.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Product Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 68.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="ia2e5ce00d4ed4d9a97f7aed53faa1ff6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNC0xLTEtMS05MDY2NQ_03196c72-ccce-4ba6-90f0-7baaaae0f107"
      unitRef="usd">13368000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if49785589581493ebb90d7a0199ea525_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNC0zLTEtMS05MDY2NQ_c66598ce-e5e3-44d3-bdbe-c29b1e1279a4"
      unitRef="number">0.500</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="if8ef7499ada54e7e9ad7851db5747696_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNC01LTEtMS05MDY2NQ_d2618e1e-efbd-4095-a351-fe4dfc33f450"
      unitRef="usd">12794000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifb56702f67294df0b173f365472c73ca_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNC03LTEtMS05MDY2NQ_103180e7-21bd-4313-bfab-739a889be94c"
      unitRef="number">0.523</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i4982a0329516423a9136efc7957f9aab_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNS0xLTEtMS05MDY2NQ_f009bc52-ff5f-4b5c-b0b3-eb8855d07bfb"
      unitRef="usd">7962000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i29edb7af843f4319acdf73d40cbd3a19_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNS0zLTEtMS05MDY2NQ_5dea8368-9a43-410d-b0e0-50c747848610"
      unitRef="number">0.297</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i3ff148b282eb4181803b5f6562d8734a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNS01LTEtMS05MDY2NQ_11dd6d8c-c0e4-4ba7-933c-8868fbbfe079"
      unitRef="usd">7398000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i447d77e0640e4266805ed52d0e06d21b_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNS03LTEtMS05MDY2NQ_8c159310-6d8d-4b4d-8415-900f505b3939"
      unitRef="number">0.302</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i44bc98dc84754947aca9ffc1d3e8bbf0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNi0xLTEtMS05MDY2NQ_cdc974cb-fbb9-4944-ac9d-a46503dc9120"
      unitRef="usd">3744000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i76aeb4498a0b4c5889d9b44b13e75ebb_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNi0zLTEtMS05MDY2NQ_38b04787-ef70-4f7c-897d-24709c3737bb"
      unitRef="number">0.140</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="ib3db6d103273445e8e1f89920aa09ed6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNi01LTEtMS05MDY2NQ_af7b1da8-cf23-4058-a9a0-4495b60dd742"
      unitRef="usd">3583000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3dca92952a174b78b27dc46eeaa65d99_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNi03LTEtMS05MDY2NQ_fff19d93-6c2a-4c4d-9a73-bf34271f0cd3"
      unitRef="number">0.147</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="ia7f79ccd7d5f40ae837e2fafc736606e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNy0xLTEtMS05NDYzNw_ea1497d5-5c6c-4c42-9149-91ea95653871"
      unitRef="usd">1689000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1a7c684f949741a3981a761e9bbcbf9d_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNy0zLTEtMS05NDY0NA_eb41f225-46eb-45f7-a364-54a749053ae7"
      unitRef="number">0.063</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="idf3c886d74bc45548114cbfdf0c6983b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNy01LTEtMS05NDY1MQ_783b36ea-7f52-4b47-9a8a-b49193e53ecb"
      unitRef="usd">688000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iea3ee5aa2d194f4c8a4c459c8fc91b98_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfNy03LTEtMS05NDY1OA_636d6eb3-bb8d-4fb6-a24f-1816dfe9dc0a"
      unitRef="number">0.028</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfOC0xLTEtMS05MDY2NQ_3e645914-fdde-40de-b924-a2126dd6ac52"
      unitRef="usd">26763000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i27169791ade7453ea172c0da7b9f2a47_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfOC0zLTEtMS05MDY2NQ_2966f990-e3f6-4267-8a9a-7608f4cdf7b3"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfOC01LTEtMS05MDY2NQ_6db9f639-af91-4d9b-8105-3cf6cd0d262e"
      unitRef="usd">24463000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib1822b59343e4f53b58f3e3f7280600e_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RhYmxlOmM1ZTgwOTkyZDdhODRlNTY5MWQ2MTNlN2JhM2FkMDNkL3RhYmxlcmFuZ2U6YzVlODA5OTJkN2E4NGU1NjkxZDYxM2U3YmEzYWQwM2RfOC03LTEtMS05MDY2NQ_eec95a9a-57f3-4cd5-b7fe-53e9b9a1e3aa"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues
      contextRef="if4fd38174ba44b03a584466ebe9ab057_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfNjE0_6773effb-45ba-4ba9-97ac-df1dd2f608c9"
      unitRef="usd">3200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60c58188de1b4fc3af027ccbcd0a1fb3_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfNjIx_0dec59ed-66b9-4935-b5ef-8b9e5e9ba398"
      unitRef="usd">4800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8204bc432ee142d3bad5b48145ed8618_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfNzQ0_901ec036-26bd-469e-baf1-6795d0205604"
      unitRef="usd">3100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i55927c5429ab4da4b5c134d3ea056150_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfNzUx_44120df4-b2c3-4d1a-88d2-bb88c06f8f24"
      unitRef="usd">4300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5095ccbbd602407d910da1f13f5d8d6d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfMTA5OTUxMTYyOTc2OQ_ac1f8cfe-4549-417d-a547-3a7c52ddba73"
      unitRef="usd">100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a16fc3aeb5143d2908ebc833b38ed1d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180MC9mcmFnOmY4NmE2MzcyMjQ1ZDQ3YmU5ZGIxYjIyZjY0M2YyNmZhL3RleHRyZWdpb246Zjg2YTYzNzIyNDVkNDdiZTlkYjFiMjJmNjQzZjI2ZmFfMTA5OTUxMTYyOTc4NQ_3e455716-2752-4fab-a01c-239459a837a9"
      unitRef="usd">3600000</us-gaap:Revenues>
    <infu:MedicalEquipmentAndPropertyDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RleHRyZWdpb246YjljMGFmMzhkZDk2NGJkN2JiMDE1NjgyNjczZjBmZTBfMzA1_85e9998f-f069-45f0-abdd-8aec065cb154">Medical Equipment&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Medical equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,788&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment for sale or rental - pump reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment for sale or rental - net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,987&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,742&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment in rental service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;92,630&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;91,891&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment in rental service - pump reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,246)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,074)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(52,271)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(50,946)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment in rental service - net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,113&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,871&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;41,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;41,613&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Depreciation expense for medical equipment for the three months ended March&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;was $2.4 million, compared to $2.3 million for the same prior year period. This expense was recorded in &#x201c;cost of revenues&#x201d; for each period.&lt;/span&gt;&lt;/div&gt;</infu:MedicalEquipmentAndPropertyDisclosureTextBlock>
    <infu:ScheduleOfMedicalEquipmentTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RleHRyZWdpb246YjljMGFmMzhkZDk2NGJkN2JiMDE1NjgyNjczZjBmZTBfMzA0_847a3f1b-4e44-4677-918d-5bffce5ea5d3">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Medical equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment for sale or rental&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,788&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment for sale or rental - pump reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment for sale or rental - net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,987&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,742&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment in rental service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;92,630&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;91,891&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment in rental service - pump reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,246)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,074)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(52,271)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(50,946)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Medical equipment in rental service - net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,113&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,871&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;41,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;41,613&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</infu:ScheduleOfMedicalEquipmentTableTextBlock>
    <infu:MedicalEquipmentHeldForSaleOrRentalGross
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMS0xLTEtMS05MDY2NQ_59b8d157-465a-4122-9b38-f37f527289b6"
      unitRef="usd">2031000</infu:MedicalEquipmentHeldForSaleOrRentalGross>
    <infu:MedicalEquipmentHeldForSaleOrRentalGross
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMS0zLTEtMS05MDY2NQ_4060053b-d2c7-4d9d-a33a-c4c55008bff7"
      unitRef="usd">1788000</infu:MedicalEquipmentHeldForSaleOrRentalGross>
    <infu:MedicalEquipmentForSaleOrRentalReserve
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMi0xLTEtMS05MDY2NQ_97e921da-bde4-442f-ac37-56108478509b"
      unitRef="usd">44000</infu:MedicalEquipmentForSaleOrRentalReserve>
    <infu:MedicalEquipmentForSaleOrRentalReserve
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMi0zLTEtMS05MDY2NQ_d07241e6-f31c-4c03-be53-4b67fa2bb548"
      unitRef="usd">46000</infu:MedicalEquipmentForSaleOrRentalReserve>
    <infu:MedicalEquipmentHeldForSaleOrRental
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMy0xLTEtMS05MDY2NQ_844fd341-c3e6-481b-b5dc-739a6ec3be79"
      unitRef="usd">1987000</infu:MedicalEquipmentHeldForSaleOrRental>
    <infu:MedicalEquipmentHeldForSaleOrRental
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMy0zLTEtMS05MDY2NQ_03c23eea-15b0-47c0-ac94-47737dd94059"
      unitRef="usd">1742000</infu:MedicalEquipmentHeldForSaleOrRental>
    <infu:MedicalEquipmentInRentalServicesGross
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNS0xLTEtMS05MDY2NQ_2df87c5a-f23a-4d54-88c1-6c6c23a5485b"
      unitRef="usd">92630000</infu:MedicalEquipmentInRentalServicesGross>
    <infu:MedicalEquipmentInRentalServicesGross
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNS0zLTEtMS05MDY2NQ_a4f9806a-dc4e-4447-a42e-fce794e0d8a8"
      unitRef="usd">91891000</infu:MedicalEquipmentInRentalServicesGross>
    <infu:MedicalEquipmentInRentalServicesReserve
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNi0xLTEtMS05MDY2NQ_01063c3e-5135-4653-940d-f3ef0fbf6315"
      unitRef="usd">1246000</infu:MedicalEquipmentInRentalServicesReserve>
    <infu:MedicalEquipmentInRentalServicesReserve
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNi0zLTEtMS05MDY2NQ_1dfe9607-1d3c-49fd-b35e-7ef8f2c359d7"
      unitRef="usd">1074000</infu:MedicalEquipmentInRentalServicesReserve>
    <infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNy0xLTEtMS05MDY2NQ_e54e9b08-347b-46a0-bf65-d8f872c7b952"
      unitRef="usd">52271000</infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation>
    <infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfNy0zLTEtMS05MDY2NQ_37666d33-b0c2-4443-b457-bac94163f3ea"
      unitRef="usd">50946000</infu:MedicalEquipmentInRentalServicesAccumulatedDepreciation>
    <infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfOC0xLTEtMS05MDY2NQ_780d35bc-350f-4202-beec-d629764f5024"
      unitRef="usd">39113000</infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation>
    <infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfOC0zLTEtMS05MDY2NQ_a28094b2-9f38-464d-ae64-d9e2d308ccd9"
      unitRef="usd">39871000</infu:MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation>
    <infu:MedicalEquipmentNet
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMTAtMS0xLTEtOTA2NjU_6bd0cde9-6576-4f4e-aad3-d3ea5690dac3"
      unitRef="usd">41100000</infu:MedicalEquipmentNet>
    <infu:MedicalEquipmentNet
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RhYmxlOjdmZjU3MzMwNDc2ODQ4OTA4NGNhNzNhYTkxNGI3ZTU4L3RhYmxlcmFuZ2U6N2ZmNTczMzA0NzY4NDg5MDg0Y2E3M2FhOTE0YjdlNThfMTAtMy0xLTEtOTA2NjU_2c90b28d-dcdd-4914-b1e1-c9b4999e1e65"
      unitRef="usd">41613000</infu:MedicalEquipmentNet>
    <infu:DepreciationExpenseRelatedToMedicalEquipment
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RleHRyZWdpb246YjljMGFmMzhkZDk2NGJkN2JiMDE1NjgyNjczZjBmZTBfMTQ3_833be254-b057-4bd9-aaa7-0be3820a2af7"
      unitRef="usd">2400000</infu:DepreciationExpenseRelatedToMedicalEquipment>
    <infu:DepreciationExpenseRelatedToMedicalEquipment
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180My9mcmFnOmI5YzBhZjM4ZGQ5NjRiZDdiYjAxNTY4MjY3M2YwZmUwL3RleHRyZWdpb246YjljMGFmMzhkZDk2NGJkN2JiMDE1NjgyNjczZjBmZTBfMTg0_7ecfa580-4e11-4afe-b3f5-49f049a74b3d"
      unitRef="usd">2300000</infu:DepreciationExpenseRelatedToMedicalEquipment>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RleHRyZWdpb246MzJhYjM5Y2YwOGZhNDgwNGI0ZjJkOTUwMTc3Njg2NjRfMzM4_a0b3351a-c955-425d-9094-f3157aed13d4">Property and Equipment&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accumulated Depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Furniture, fixtures, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,924&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,703)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,221&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,812&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,284&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,449&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,301)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,148&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,444&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,212)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,232&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,483&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,108)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,366&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,843)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,523&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Depreciation expense for property and equipment for the three months ended March&#160;31, 2022 was $0.3 million, compared to $0.2 million for the same prior year period. This expense was recorded in &#x201c;general and administrative expenses&#x201d; for each period.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RleHRyZWdpb246MzJhYjM5Y2YwOGZhNDgwNGI0ZjJkOTUwMTc3Njg2NjRfMzM5_9663e36b-02bf-48ee-b980-b5e91885f096">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.57pt;padding-right:4.57pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accumulated Depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Furniture, fixtures, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,924&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,703)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,221&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,812&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,284&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Automobiles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;110&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,449&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,301)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,148&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,444&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,212)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,232&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 50.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,483&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,108)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,366&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,843)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,523&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iab9576cec45e4a449fa940366d43de5c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi0xLTEtMS05MDY2NQ_6cb88201-5e28-4a87-8b5c-86fab8586ad2"
      unitRef="usd">4924000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iab9576cec45e4a449fa940366d43de5c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi0zLTEtMS05MDY2NQ_63a369cf-cc10-4ba1-882b-474928bbeb52"
      unitRef="usd">2703000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iab9576cec45e4a449fa940366d43de5c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi01LTEtMS05MDY2NQ_232c0a19-de74-457a-97ae-73abb4298009"
      unitRef="usd">2221000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4bb1bc7267ab4f3b8a2ba31c8f332d5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi03LTEtMS05MDY2NQ_f665b69b-5ec5-4121-aed1-29f504753bcd"
      unitRef="usd">4812000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4bb1bc7267ab4f3b8a2ba31c8f332d5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi05LTEtMS05MDY2NQ_d153ded1-90d5-4080-b93d-0bc6e9dc9497"
      unitRef="usd">2528000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4bb1bc7267ab4f3b8a2ba31c8f332d5f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMi0xMS0xLTEtOTA2NjU_b919544d-f679-4c79-8c90-79b8b1de5930"
      unitRef="usd">2284000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibef9d8e70d0d44f6881d0cc953b6c86c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy0xLTEtMS05MDY2NQ_a5b7a213-864d-4ea7-ac55-b3c65ec6865a"
      unitRef="usd">110000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ibef9d8e70d0d44f6881d0cc953b6c86c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy0zLTEtMS05MDY2NQ_042c207d-6e70-4b15-b2bf-577a0f5bf1da"
      unitRef="usd">104000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibef9d8e70d0d44f6881d0cc953b6c86c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy01LTEtMS05MDY2NQ_f0cd5688-b436-4fb8-b297-5f0ad871a440"
      unitRef="usd">6000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5d32500896b341cb86356b976a1a7e6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy03LTEtMS05MDY2NQ_d65195e7-750e-4e19-9efe-f4025fbed551"
      unitRef="usd">110000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5d32500896b341cb86356b976a1a7e6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy05LTEtMS05MDY2NQ_6dfc5d4c-5b66-4729-a5eb-8e6342750414"
      unitRef="usd">103000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5d32500896b341cb86356b976a1a7e6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfMy0xMS0xLTEtOTA2NjU_4e594203-06c0-46aa-a3e7-dc9bd8b201a8"
      unitRef="usd">7000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifc6296cc506a4da2b9d7da01f0ce124c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC0xLTEtMS05MDY2NQ_f41fdcce-db70-4be2-847a-8a1364ebe2b0"
      unitRef="usd">3449000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ifc6296cc506a4da2b9d7da01f0ce124c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC0zLTEtMS05MDY2NQ_5318e527-c35e-4289-be0a-db096efaca78"
      unitRef="usd">1301000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ifc6296cc506a4da2b9d7da01f0ce124c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC01LTEtMS05MDY2NQ_4a5bac8e-51a3-4842-a15e-f31385403338"
      unitRef="usd">2148000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i16ee9bf588434522bd80adcc901d4ef9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC03LTEtMS05MDY2NQ_c2ac419c-250f-4427-b645-d4da8a888480"
      unitRef="usd">3444000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i16ee9bf588434522bd80adcc901d4ef9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC05LTEtMS05MDY2NQ_6bf3f14f-de9c-4ffa-9c89-893e87a7fd65"
      unitRef="usd">1212000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i16ee9bf588434522bd80adcc901d4ef9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNC0xMS0xLTEtOTA2NjU_086e3965-2767-495f-90be-dff47ce5ea66"
      unitRef="usd">2232000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi0xLTEtMS05MDY2NQ_6b1ed1fe-5b50-4cea-9a81-0096ccb3acea"
      unitRef="usd">8483000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi0zLTEtMS05MDY2NQ_3e2ebb55-f7c3-4205-a3c1-b2f58ce74808"
      unitRef="usd">4108000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi01LTEtMS05MDY2NQ_6044eb16-d84e-4670-bb02-a3e6c8ab72b8"
      unitRef="usd">4375000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi03LTEtMS05MDY2NQ_2e6b0fb6-2266-4c6b-a642-d1bb3ec1f58f"
      unitRef="usd">8366000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi05LTEtMS05MDY2NQ_94b92b2c-1f69-48d1-9edd-461f868b36ff"
      unitRef="usd">3843000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RhYmxlOmFhMGZhYWY4NWRlZTQzM2ZiNjJjODBlODViN2UxZGQ3L3RhYmxlcmFuZ2U6YWEwZmFhZjg1ZGVlNDMzZmI2MmM4MGU4NWI3ZTFkZDdfNi0xMS0xLTEtOTA2NjU_bd7db455-5cac-461d-b7fd-738e2f166aad"
      unitRef="usd">4523000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationNonproduction
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RleHRyZWdpb246MzJhYjM5Y2YwOGZhNDgwNGI0ZjJkOTUwMTc3Njg2NjRfMTYy_0fd17dbe-6d07-418f-84cd-df775b0dccc1"
      unitRef="usd">300000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180Ni9mcmFnOjMyYWIzOWNmMDhmYTQ4MDRiNGYyZDk1MDE3NzY4NjY0L3RleHRyZWdpb246MzJhYjM5Y2YwOGZhNDgwNGI0ZjJkOTUwMTc3Njg2NjRfMTk5_dc6730ba-d9b9-425a-bb18-9b5a50e8a0df"
      unitRef="usd">200000</us-gaap:DepreciationNonproduction>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfNjI3_1eeca677-4e39-4a73-8112-bcfe797db11a">Goodwill &amp;amp; Intangible Assets&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The changes in the carrying value of goodwill by segment for the three months ended March&#160;31, 2022 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;DME Services (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) The ITS segment has no recorded goodwill. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The carrying amount and accumulated amortization of intangible assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Nonamortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Physician and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,834&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(32,033)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,834&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(31,401)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,433&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;472&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;382&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;472&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;405&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unpatented technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;943&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;786&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;943&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;820&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(11,280)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(11,258)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;272&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total nonamortizable and amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(43,583)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,219&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(42,872)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,930&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for the three months ended March&#160;31, 2022 was $0.7&#160;million, compared to $1.0&#160;million for the same prior year period. This expense was recorded in &#x201c;amortization of intangibles expenses&#x201d; for each period. Expected remaining annual amortization expense for the next five years for intangible assets recorded as of March&#160;31, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2027 and thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,783&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;810&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;524&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,219&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfNjI4_8e008396-b859-4076-bf97-547663ef9891">The changes in the carrying value of goodwill by segment for the three months ended March&#160;31, 2022 are as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;DME Services (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Goodwill acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) The ITS segment has no recorded goodwill. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ic700dbf08af94b2eae2ba16cb3c059e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmFiMjc2NmYyYjFjZjQzMzk4NDIzM2YyOGYxZjQyMDNiL3RhYmxlcmFuZ2U6YWIyNzY2ZjJiMWNmNDMzOTg0MjMzZjI4ZjFmNDIwM2JfMS0yLTEtMS05MDY2NQ_b7755017-af64-49be-b0b9-a60997a33b6c"
      unitRef="usd">3710000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifd7edbf7b2bd4b21aa91040e49a07b37_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmFiMjc2NmYyYjFjZjQzMzk4NDIzM2YyOGYxZjQyMDNiL3RhYmxlcmFuZ2U6YWIyNzY2ZjJiMWNmNDMzOTg0MjMzZjI4ZjFmNDIwM2JfMi0yLTEtMS05MDY2NQ_df820537-56b3-4174-91dc-3b4344d1fa10"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i7d3f2b23fb394007a3aae9607cd8f47d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmFiMjc2NmYyYjFjZjQzMzk4NDIzM2YyOGYxZjQyMDNiL3RhYmxlcmFuZ2U6YWIyNzY2ZjJiMWNmNDMzOTg0MjMzZjI4ZjFmNDIwM2JfMy0yLTEtMS05MDY2NQ_8b9d557a-dd68-40ab-8b56-ff352c91a84a"
      unitRef="usd">3710000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i53c7ee1171d34f9ead27a9700cd1fcf4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmFiMjc2NmYyYjFjZjQzMzk4NDIzM2YyOGYxZjQyMDNiL3RhYmxlcmFuZ2U6YWIyNzY2ZjJiMWNmNDMzOTg0MjMzZjI4ZjFmNDIwM2JfNS0wLTEtMS05MDY2NS90ZXh0cmVnaW9uOmNlYjg4MzQ1YjdjODQ5ZGViYjgwMThjMDRmNjM0ZWYyXzk_7d558179-8f49-4cf5-8266-429d97b9bc37"
      unitRef="usd">0</us-gaap:Goodwill>
    <infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfNjMw_87da29ee-cb7f-4125-adb6-ce1e36c28a18">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The carrying amount and accumulated amortization of intangible assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Nonamortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Physician and customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,834&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(32,033)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;38,834&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(31,401)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,433&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;472&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;382&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;472&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;405&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unpatented technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;943&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;786&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;943&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;820&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(11,280)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(11,258)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;272&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total nonamortizable and amortizable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(43,583)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,219&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(42,872)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,930&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMy0xLTEtMS05MDY2NQ_49af0cfc-c609-4796-aa03-dfc319a761ed"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMy01LTEtMS05MDY2NQ_75cfc3aa-879f-4c61-ab21-3480d081265e"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMy03LTEtMS05MDY2NQ_cf8f7137-e16a-4557-a808-50f8b7caf18d"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMy0xMS0xLTEtOTA2NjU_0822b0e3-54b7-48cd-b3c4-fa56b670d566"
      unitRef="usd">2000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i69120393fdcf4f98b5f3643efcf1ba48_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS0xLTEtMS05MDY2NQ_29052631-22aa-4beb-b631-acd647f5b0e3"
      unitRef="usd">23000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i69120393fdcf4f98b5f3643efcf1ba48_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS0zLTEtMS05MDY2NQ_7f002053-cbef-4604-a351-3f24c8ac3990"
      unitRef="usd">23000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i69120393fdcf4f98b5f3643efcf1ba48_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS01LTEtMS05MDY2NQ_3e8fbadf-3f7b-4666-a14d-b9f39b38d10e"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idfb5ef2d8f814683800aefa4d847067f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS03LTEtMS05MDY2NQ_2c2cebff-f2a6-4d4f-9e82-95553dee75e0"
      unitRef="usd">23000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idfb5ef2d8f814683800aefa4d847067f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS05LTEtMS05MDY2NQ_1bf85b1c-5689-4cf1-80f0-a64f108bc383"
      unitRef="usd">23000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idfb5ef2d8f814683800aefa4d847067f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNS0xMS0xLTEtOTA2NjU_e352c69e-c888-40e9-89d2-4d7b36190ef2"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2007dc85e9fb4c4eb7d1a818c44c551b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi0xLTEtMS05MDY2NQ_8fd5c83a-2eef-490b-ae83-b1d75ab8861a"
      unitRef="usd">38834000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2007dc85e9fb4c4eb7d1a818c44c551b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi0zLTEtMS05MDY2NQ_150e0cd6-4ab9-4747-bec4-15b2cba56499"
      unitRef="usd">32033000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2007dc85e9fb4c4eb7d1a818c44c551b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi01LTEtMS05MDY2NQ_a35152f6-d2cb-4955-ba5e-0a45dca8d03e"
      unitRef="usd">6801000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3955a41377c6464b8b96323f2127c3ac_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi03LTEtMS05MDY2NQ_45f7730c-933f-4e37-8df6-647017d6d333"
      unitRef="usd">38834000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3955a41377c6464b8b96323f2127c3ac_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi05LTEtMS05MDY2NQ_9e1b5c58-246f-4eaa-9b43-c85ee8cce024"
      unitRef="usd">31401000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3955a41377c6464b8b96323f2127c3ac_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNi0xMS0xLTEtOTA2NjU_b47cfe56-a3d0-403f-aa15-b08dca78ca02"
      unitRef="usd">7433000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6f1511ac8ff546a283d31d4c98b6133f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy0xLTEtMS05MDY2NQ_eec37577-1e0e-4d21-8bee-09e8190d2ef4"
      unitRef="usd">472000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6f1511ac8ff546a283d31d4c98b6133f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy0zLTEtMS05MDY2NQ_3aaa148b-231d-4058-8336-daa2b42138a7"
      unitRef="usd">90000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6f1511ac8ff546a283d31d4c98b6133f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy01LTEtMS05MDY2NQ_411c20cc-65c1-440c-8262-edf389790753"
      unitRef="usd">382000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy03LTEtMS05MDY2NQ_4a84240a-7d96-4661-a60e-9ff553ded510"
      unitRef="usd">472000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy05LTEtMS05MDY2NQ_f63b7fb9-004c-4019-a83d-2b8d231c3c6d"
      unitRef="usd">67000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic208eb5d034e43d0bb1b04e0e53c6f9f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfNy0xMS0xLTEtOTA2NjU_54920880-3d3a-4761-bb25-03fbcdc1ba21"
      unitRef="usd">405000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2ed66385f90b4519b38d4183d11d53b9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC0xLTEtMS05MDY2NQ_c8d49901-8e27-42d8-997b-86ac65061819"
      unitRef="usd">943000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2ed66385f90b4519b38d4183d11d53b9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC0zLTEtMS05MDY2NQ_4ddb5bc5-c092-4fab-9cce-b9869a64d44d"
      unitRef="usd">157000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2ed66385f90b4519b38d4183d11d53b9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC01LTEtMS05MDY2NQ_f85a4206-a630-4325-9b37-4a4722fc1802"
      unitRef="usd">786000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9fffd8c4d1c944babfd356c6577863a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC03LTEtMS05MDY2NQ_63bd689d-e1c7-447e-bd22-85f9d279dcb3"
      unitRef="usd">943000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9fffd8c4d1c944babfd356c6577863a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC05LTEtMS05MDY2NQ_d92c2b91-c56a-42af-ad17-8c3c3306fcc4"
      unitRef="usd">123000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9fffd8c4d1c944babfd356c6577863a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOC0xMS0xLTEtOTA2NjU_5b98db27-5dce-466f-8691-a2a650f5526a"
      unitRef="usd">820000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic5adc6accdfb4947bc052bfbd05a41a4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS0xLTEtMS05MDY2NQ_9b7e1e00-cd67-452b-9d4f-945328e74662"
      unitRef="usd">11530000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic5adc6accdfb4947bc052bfbd05a41a4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS0zLTEtMS05MDY2NQ_463fd9ea-349b-4a67-af92-61a4401b55df"
      unitRef="usd">11280000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic5adc6accdfb4947bc052bfbd05a41a4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS01LTEtMS05MDY2NQ_3c726375-e864-430d-84ab-ea59070a7f93"
      unitRef="usd">250000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9d5f226368ed474b99f5057977d175c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS03LTEtMS05MDY2NQ_3abffaf4-d89f-44de-9b15-4a0a4f3cb3ef"
      unitRef="usd">11530000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9d5f226368ed474b99f5057977d175c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS05LTEtMS05MDY2NQ_a561106f-2006-4f7e-ba2b-a152bae6b103"
      unitRef="usd">11258000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9d5f226368ed474b99f5057977d175c1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfOS0xMS0xLTEtOTA2NjU_be395217-c4b8-444c-aaa1-39ee131ba719"
      unitRef="usd">272000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtMS0xLTEtOTA2NjU_2efcc8c1-d681-4215-8a93-6a3c1744b19d"
      unitRef="usd">53802000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtMy0xLTEtOTA2NjU_5f54e6d0-51e8-4a06-8eba-4eadf65e5ce9"
      unitRef="usd">43583000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtNS0xLTEtOTA2NjU_4152e3c9-2350-4bad-a720-9586dc5b87ce"
      unitRef="usd">10219000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtNy0xLTEtOTA2NjU_55763767-be2f-4601-8cbb-2dbea02298ef"
      unitRef="usd">53802000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtOS0xLTEtOTA2NjU_466310e7-e1c4-4489-875f-60570e16ad9a"
      unitRef="usd">42872000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmJlMDlkYTc4YzZiMjRkYWE5NGUzOWU5YjAyNmI3OWMxL3RhYmxlcmFuZ2U6YmUwOWRhNzhjNmIyNGRhYTk0ZTM5ZTliMDI2Yjc5YzFfMTEtMTEtMS0xLTkwNjY1_43823338-da4a-42a6-ad36-bdd75ca27781"
      unitRef="usd">10930000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfMzA2_75f68240-e8db-4ff8-aad8-2728c6883f44"
      unitRef="usd">700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfMzQz_d7ead1da-3242-4633-afe7-d259c3d6c39b"
      unitRef="usd">1000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RleHRyZWdpb246YmEyZTM3ZDNlODRkNDY3NjhmNDRlMmVlOGM1MDY5YzhfNjI2_45eb3f13-cf80-4909-a46a-d15e6bdfec52">Expected remaining annual amortization expense for the next five years for intangible assets recorded as of March&#160;31, 2022 is as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:2.28pt;padding-right:2.28pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2027 and thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,783&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;810&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;524&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,219&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi0xLTEtMS05MDY2NQ_9cf4e824-ce05-4b2d-a145-80b7c7d17478"
      unitRef="usd">1783000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi0zLTEtMS05MDY2NQ_5f8acd67-9407-46a8-8834-da313c41b827"
      unitRef="usd">990000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi01LTEtMS05MDY2NQ_91bb1e30-4d59-4a6b-9de4-d557ef03d7cd"
      unitRef="usd">990000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi03LTEtMS05MDY2NQ_5e3d7c81-de38-4485-ac27-6ce7b846e2b3"
      unitRef="usd">810000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi05LTEtMS05MDY2NQ_0dd98a5b-6fff-42cb-b0f1-7187a23e34a6"
      unitRef="usd">524000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <infu:FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi0xMS0xLTEtOTA2NjU_fb250fbb-9472-4eb4-8311-b9b7780415c4"
      unitRef="usd">3122000</infu:FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM180OS9mcmFnOmJhMmUzN2QzZTg0ZDQ2NzY4ZjQ0ZTJlZThjNTA2OWM4L3RhYmxlOmY5YzEzZTkxMzExYTQ3NTk5YjVmMmE5MTEwYWY5Mzc0L3RhYmxlcmFuZ2U6ZjljMTNlOTEzMTFhNDc1OTliNWYyYTkxMTBhZjkzNzRfMi0xMy0xLTEtOTA2NjU_5b71b9a5-9dfa-492b-86ff-5869bc9e56e9"
      unitRef="usd">8219000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjg0NA_021bc7ec-70ce-4d6b-b6aa-e269bb830f78">Debt&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;February&#160;5, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;the Company entered into a Credit Agreement (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2021 Credit Agreement&#x201d;) with JPMorgan Chase Bank, N.A., as administrative agent (the &#x201c;Agent&#x201d;), sole bookrunner and sole lead arranger, and the lenders party thereto. The borrowers under the 2021 Credit Agreement are the Company, InfuSystem Holdings USA, Inc. (&#x201c;Holdings&#x201d;), InfuSystem, &lt;/span&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Inc. (&#x201c;ISI&#x201d;), First Biomedical, Inc. (&#x201c;First Biomedical&#x201d;), and IFC LLC (&#x201c;IFC&#x201d; and, collectively with the Company, Holdings, ISI and First Biomedical, the &#x201c;Borrowers&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The 2021 Credit Agreement provides for a revolving credit facility (the &#x201c;Revolving Facility&#x201d;) of $75.0 million that matures on February 5, 2026. The Revolving Facility may be increased by $25.0 million, subject to certain conditions, including the consent of the Agent and obtaining necessary commitments. The lenders under the 2021 Credit Agreement may issue up to $7.0 million in letters of credit subject to the satisfaction of certain conditions. On February&#160;5, 2021, the Borrowers made an initial borrowing of $30.0 million under the Revolving Facility. Proceeds from the loan, along with approximately $8.2 million in cash, were used to repay all amounts due under the Company&#x2019;s then existing credit facility dated March 23, 2015 (the &#x201c;2015 Credit Agreement&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The 2021 Credit Agreement has customary representations and warranties. The ability to borrow under the facility is subject to ongoing compliance with a number of customary affirmative and negative covenants, including limitations on indebtedness, liens, mergers, acquisitions, investments, asset sales, affiliate transactions and restricted payments, as well as financial covenants, including the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;a minimum fixed charge coverage ratio (defined as the ratio of consolidated EBITDA (as defined in the 2021 Credit Agreement) less 50% of depreciation expense), to consolidated fixed charges (as defined in the 2021 Credit Agreement)) for the prior four most recently ended calendar quarters of 1.20 to 1.00; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt"&gt;a maximum leverage ratio (defined as total indebtedness to EBITDA for the prior four most recently ended calendar quarters) of 3.50 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The 2021 Credit Agreement includes customary events of default. The occurrence of an event of default will permit the lenders to terminate commitments to lend under the Revolving Facility and accelerate payment of all amounts outstanding thereunder.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Simultaneous with the execution of the 2021 Credit Agreement, the Company entered into a Pledge and Security Agreement to secure repayment of the obligations of the Borrowers. Under the Pledge and Security Agreement, each Borrower has granted to the Agent, for the benefit of various secured parties, a first priority security interest in substantially all of the personal property assets of each of the Borrowers, including the shares of each of Holdings, ISI and First Biomedical and the equity interests of IFC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On February&#160;5, 2021, in connection with the execution and closing of the 2021 Credit Agreement, the Company, along with its wholly owned subsidiaries as borrowers, terminated the 2015 Credit Agreement. All outstanding loans under the 2015 Credit Agreement were repaid and all liens under the 2015 Credit Agreement were released, except that a letter of credit originally issued under the 2015 Credit Agreement in the amount of approximately $0.8 million was transferred to the 2021 Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The 2021 Credit Agreement was accounted for as a debt modification. As of March&#160;31, 2022, the Company was in compliance with all debt-related covenants under the 2021 Credit Agreement.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April&#160;15, 2019, the Company sold for $2.0 million and immediately leased back certain medical equipment in rental service to a third party specializing in such transactions. The leaseback term is 36 months. Because the arrangement contains a purchase option that the Company is reasonably certain to exercise, this transaction did not qualify for the sale-leaseback accounting under ASC 842. The medical equipment remains recorded on the accompanying condensed consolidated balance sheet and the proceeds received have been classified as an other financing liability, which is being paid off monthly over the term of the lease. The balance of other financing as of March&#160;31, 2022 was $0.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As referenced above, the Company executed and closed the 2021 Credit Agreement during the first quarter of 2021, and in connection with entering into that agreement, terminated the 2015 Credit Agreement. The following table illustrates the net availability under the Revolving Facility as of the applicable balance sheet date (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 66.77pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revolving Facility:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross availability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;75,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;75,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding draws&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(35,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(32,974)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Letter of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Availability on Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;41,426&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company had future maturities of its long-term debt as of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;2026 and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,230&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following is a breakdown of the Company&#x2019;s current and long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Current &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Long-Term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Long-Term &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,974&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;423&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;423&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;423&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;33,397&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unamortized value of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;156&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34,792&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34,948&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;349&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;33,097&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;March&#160;31, 2022, amounts outstanding under the Revolving Facility provided under the 2021 Credit Agreement bear interest at a variable rate equal to, at the Company&#x2019;s election, a LIBO Rate for Eurodollar loans or an Alternative Base Rate for ABR loans, as defined by the 2021 Credit Agreement, plus a spread that will vary depending upon the Company&#x2019;s leverage ratio. The spread ranges from 2.00% to 3.00% for Eurodollar Loans and 1.00% to 2.00% for base rate loans. The weighted-average Eurodollar loan rate at March&#160;31, 2022 was 2.37% (LIBO of 0.37% plus 2.00%). The actual ABR loan rate at March&#160;31, 2022 was 4.25% (lender&#x2019;s prime rate of 3.25% plus 1.00%).&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5b34086db73244b8b360acb9f538d2ac_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjE3_526256d5-19ab-4048-8aed-9ab2f3348ce5"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <infu:LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions
      contextRef="i5b34086db73244b8b360acb9f538d2ac_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjk0_91381c02-b2c4-47c7-833c-fa3faf0af59c"
      unitRef="usd">25000000</infu:LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9db5ef6e072245c6836ab464e21b81d6_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfODYx_c7641bd6-d523-4f65-924b-1024f9dcd84b"
      unitRef="usd">7000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i280422ec877d4871b85139ef7dab2895_D20210205-20210205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfOTg2_e8a29329-bb8e-406f-a2f2-383e706298aa"
      unitRef="usd">30000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i88c67caf15574e31981968dbcfd092ba_D20210205-20210205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMTA2OA_fa0b45e1-78ce-4d0b-9075-15dcbdcbe1e7"
      unitRef="usd">8200000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <infu:PercentageOfTotalDepreciationExpense
      contextRef="i11787656cdd7485983ece34ada8d626d_D20210205-20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMTc1Ng_e5033731-7dba-4c3d-baf4-f649868e1c0e"
      unitRef="number">0.50</infu:PercentageOfTotalDepreciationExpense>
    <infu:DebtInstrumentCovenantMinimumFixedCoverageRatio
      contextRef="i5755350e04f34d40bf1835b45c2e72c7_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMTkxOA_9a058775-fc5b-44e0-bc56-cf0471d5daf3"
      unitRef="number">1.20</infu:DebtInstrumentCovenantMinimumFixedCoverageRatio>
    <infu:DebtInstrumentCovenantMaximumLeverageRatio
      contextRef="i5755350e04f34d40bf1835b45c2e72c7_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMjA2MQ_e1014d5b-3294-498a-95c7-e8c6770bd469"
      unitRef="number">3.50</infu:DebtInstrumentCovenantMaximumLeverageRatio>
    <us-gaap:LineOfCredit
      contextRef="ibdfe551e6db54288aab0d8b7eaf87872_I20210205"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfMzI3NQ_ef617719-a153-45b5-b724-e528c1f00977"
      unitRef="usd">800000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0c5050671c134292bc772cc44ffea56a_I20190415"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNDg0NA_f343adb8-66f3-4309-959a-149b2e29bc04"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i3149a0ad24134e48ad364d402109026e_D20190415-20190415"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNDk5Mw_e1141b0f-c2dd-4d72-8da5-c3dbb4b4e0af">P36M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i33b5522177ae46f8a72045d13d78d239_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNTQ2Mg_57551d2a-c5f4-4cc0-b0ec-f24b0e8fa47f"
      unitRef="usd">200000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgzMA_4939a600-4f7c-4154-8dd7-219432b9e4b5">The following table illustrates the net availability under the Revolving Facility as of the applicable balance sheet date (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 66.77pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;March 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revolving Facility:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross availability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;75,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;75,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding draws&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(35,000)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(32,974)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Letter of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Availability on Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;41,426&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfMy0xLTEtMS05MDY2NQ_e7556d02-384a-45c9-8e61-1061ef490469"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfMy0zLTEtMS05MDY2NQ_21bdc9b6-9ca0-44e1-9aae-9fd012185d54"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNC0xLTEtMS05MDY2NQ_0f3aad02-608d-4c76-bdc3-b9c307b9234d"
      unitRef="usd">35000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNC0zLTEtMS05MDY2NQ_d0b30c6e-f8c5-4a68-b6e3-a2b8dac142f8"
      unitRef="usd">32974000</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNS0xLTEtMS05MDY2NQ_41564da1-238e-49e8-a682-44483bc75c8a"
      unitRef="usd">600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNS0zLTEtMS05MDY2NQ_7e2e09a1-05d3-4207-8577-51c526803b0c"
      unitRef="usd">600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNy0xLTEtMS05MDY2NQ_a9134561-d20e-4af5-8246-0b8de1ab894d"
      unitRef="usd">39400000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjk1YmQzYmExNDgxMDQ1M2E4N2MzNmJlYWQzMzcwNzEzL3RhYmxlcmFuZ2U6OTViZDNiYTE0ODEwNDUzYTg3YzM2YmVhZDMzNzA3MTNfNy0zLTEtMS05MDY2NQ_f45c4b0f-1dbf-4888-b37a-e46f7c04eece"
      unitRef="usd">41426000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgzMQ_a2dfb4c8-8fbe-49d8-8a7c-36e9ef2f1fe7">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company had future maturities of its long-term debt as of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;2026 and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,230&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS0xLTEtMS05MDY2NQ_c3934a65-a406-462f-9407-2b19d2aa932f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS0zLTEtMS05MDY2NQ_19342f83-1934-41c1-ae90-13f5ed9f04d2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS01LTEtMS05MDY2NQ_950cec9f-15d5-4694-8092-d3c45ebd21b9"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS03LTEtMS05MDY2NQ_d9da6b5e-e7ae-4708-9325-4481f538728a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS05LTEtMS05MDY2NQ_15f331cf-221b-448a-a725-129599025726"
      unitRef="usd">35000000</infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMS0xMS0xLTEtOTA2NjU_8fce2874-fcb7-4480-be7f-d4fc402491c7"
      unitRef="usd">35000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi0xLTEtMS05MDY2NQ_89a59175-244e-459f-8eec-4db2cf6efdb9"
      unitRef="usd">230000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi0zLTEtMS05MDY2NQ_d593191a-caa2-4406-9011-72556fdde4ed"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi01LTEtMS05MDY2NQ_d5fe4b1a-36f4-4416-a13a-78a28c96d5ee"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi03LTEtMS05MDY2NQ_03f8827a-326c-4be4-b3f2-2ea7758bc88a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi05LTEtMS05MDY2NQ_bc610837-1681-4f0b-877a-06efb2e7a3f5"
      unitRef="usd">0</infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMi0xMS0xLTEtOTA2NjU_6d667336-93ff-499c-b091-11f4c590073a"
      unitRef="usd">230000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy0xLTEtMS05MDY2NQ_6aa6049f-0eb6-49b4-9df6-16f705915d6d"
      unitRef="usd">230000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy0zLTEtMS05MDY2NQ_aa7f4194-b6d3-4a51-b2a1-3f4f2cdec3a4"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy01LTEtMS05MDY2NQ_f2062505-1cec-48e8-82d5-3e3aa38c9212"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy03LTEtMS05MDY2NQ_5d16bd57-829f-4400-93be-532fded38f91"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy05LTEtMS05MDY2NQ_da128d98-1b62-428b-8cc4-e7273013c5f9"
      unitRef="usd">35000000</infu:LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOmE0ODI2Mzk5YzcyNDQ2NGM5OGZiNzdlY2M5OGYzNGFjL3RhYmxlcmFuZ2U6YTQ4MjYzOTljNzI0NDY0Yzk4ZmI3N2VjYzk4ZjM0YWNfMy0xMS0xLTEtOTA2NjU_49481310-e9c4-4bd0-b273-5047f6e8fde5"
      unitRef="usd">35230000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgzNA_90da996c-5fff-4c5c-a6ed-5b75ba725670">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following is a breakdown of the Company&#x2019;s current and long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Current &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Long-Term&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Long-Term &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Portion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Revolving Facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,974&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;423&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;423&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;35,230&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;423&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;33,397&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unamortized value of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(282)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;156&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34,792&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34,948&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;349&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:0.75pt solid #000000;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;33,097&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <infu:LongtermDebtGrossCurrent
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi0xLTEtMS05MDY2NQ_e8693ff9-3999-4b03-a838-3f0a9eaf6940"
      unitRef="usd">0</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi0zLTEtMS05MDY2NQ_056192db-a0d1-43b0-a8f5-47cf87d6e374"
      unitRef="usd">35000000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3266fe0bfd5844249bf77f4e1b271d97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi01LTEtMS05MDY2NQ_7e266f1a-76b6-45be-ac0c-4fa2b90f0640"
      unitRef="usd">35000000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi03LTEtMS05MDY2NQ_685e087b-6188-4483-9c2c-8a85d28e4484"
      unitRef="usd">0</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi05LTEtMS05MDY2NQ_5d87754b-47b2-400e-87fd-b2c2b5349498"
      unitRef="usd">32974000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6c1fe4e839584747a8e98242a4f539a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfMi0xMS0xLTEtOTA2NjU_7ab83ed4-835f-427c-a6ab-9825f00e5550"
      unitRef="usd">32974000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi0xLTEtMS05MDY2NQ_13087b72-a240-406a-adae-e72129586421"
      unitRef="usd">230000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi0zLTEtMS05MDY2NQ_5198f8cd-ef86-4964-81ed-a0d69daab9be"
      unitRef="usd">0</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5d3f82fb3bdb4702975f2610e732cdb1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi01LTEtMS05MDY2NQ_83c6aa7e-d9e3-40a3-972e-549ac5023ea1"
      unitRef="usd">230000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="if15ae0b27a6244e18335b6d84819ccdd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi03LTEtMS05MDY2NQ_9666c8fb-1d8d-40f6-9dcb-b80ca13f1bf6"
      unitRef="usd">423000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="if15ae0b27a6244e18335b6d84819ccdd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi05LTEtMS05MDY2NQ_d6664f22-a22e-4fbd-b866-3572da75841a"
      unitRef="usd">0</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if15ae0b27a6244e18335b6d84819ccdd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNi0xMS0xLTEtOTA2NjU_23926965-0e21-4037-b467-7c433dc6430c"
      unitRef="usd">423000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy0xLTEtMS05MDY2NQ_a637e082-ca41-40e5-993a-43c4716450ea"
      unitRef="usd">230000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy0zLTEtMS05MDY2NQ_c697294a-9c54-42fd-97f9-a1e9951e5f0e"
      unitRef="usd">35000000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy01LTEtMS05MDY2NQ_9562b9dc-aa72-474a-b80b-4bcf7fd20453"
      unitRef="usd">35230000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:LongtermDebtGrossCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy03LTEtMS05MDY2NQ_03475ec3-b032-4ac8-9b54-41eb1c8fbb06"
      unitRef="usd">423000</infu:LongtermDebtGrossCurrent>
    <infu:LongTermDebtGrossNoncurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy05LTEtMS05MDY2NQ_6661a590-c4c9-455d-bbab-f6b49b466540"
      unitRef="usd">32974000</infu:LongTermDebtGrossNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfNy0xMS0xLTEtOTA2NjU_b75bcd6c-5fae-425d-9db7-e6a74d2fe7dc"
      unitRef="usd">33397000</us-gaap:DebtInstrumentCarryingAmount>
    <infu:UnamortizedDebtIssuanceExpenseCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC0xLTEtMS05MDY2NQ_799320bb-c098-4cdd-9d55-76e7a7a70c10"
      unitRef="usd">74000</infu:UnamortizedDebtIssuanceExpenseCurrent>
    <infu:UnamortizedDebtIssuanceExpenseNoncurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC0zLTEtMS05MDY2NQ_5ff2a749-2793-488e-aaef-a9810c987133"
      unitRef="usd">208000</infu:UnamortizedDebtIssuanceExpenseNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC01LTEtMS05MDY2NQ_6bfb3e0f-0de9-403c-a001-0c23e59ad8cc"
      unitRef="usd">282000</us-gaap:UnamortizedDebtIssuanceExpense>
    <infu:UnamortizedDebtIssuanceExpenseCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC03LTEtMS05MDY2NQ_6f63b3cd-d1c0-4c63-aa9e-59a32988828c"
      unitRef="usd">74000</infu:UnamortizedDebtIssuanceExpenseCurrent>
    <infu:UnamortizedDebtIssuanceExpenseNoncurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC05LTEtMS05MDY2NQ_242558bc-6c49-48ea-aca8-dba9974c788b"
      unitRef="usd">226000</infu:UnamortizedDebtIssuanceExpenseNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOC0xMS0xLTEtOTA2NjU_41602a0d-286a-4e8e-a446-acd3fdd672e4"
      unitRef="usd">300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebtCurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS0xLTEtMS05MDY2NQ_fc7c8118-e2fa-4e61-8dae-ec883b03846a"
      unitRef="usd">156000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS0zLTEtMS05MDY2NQ_6989dbed-a51e-49c8-805e-a001a599d67c"
      unitRef="usd">34792000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS01LTEtMS05MDY2NQ_4b30bb2d-e299-488a-bd2a-34bff7f5ef6a"
      unitRef="usd">34948000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS03LTEtMS05MDY2NQ_1c45bad8-0870-4a1b-aeb4-d6897d65b126"
      unitRef="usd">349000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS05LTEtMS05MDY2NQ_44e93d92-235b-4ae9-b6ff-46d4cee6d142"
      unitRef="usd">32748000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i01f05e29baa14bd0a757fcfc29360491_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RhYmxlOjc3YzNmMDNmOTYzYjQyYTE5NmI2ZWE0M2E5NGMzNmVmL3RhYmxlcmFuZ2U6NzdjM2YwM2Y5NjNiNDJhMTk2YjZlYTQzYTk0YzM2ZWZfOS0xMS0xLTEtOTA2NjU_4ba904f4-23fa-4da8-acae-df884c969767"
      unitRef="usd">33097000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7be2e6385d2e4a1f81cede9f9325baf4_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjYxNg_f513fd94-ecba-45fb-9c5b-77849abd02c1"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id6870ed273a94fee99d887c2cff01c3b_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjYyMg_68f713c7-1835-4e16-9ed2-194f9620f124"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i31619f4fd16547b6a88ad77ca83de2b5_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjY1MA_2383e18e-af7d-4dc2-bcdf-eeedebb53763"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i621754a0bc234c319f31862d80d9e6bf_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjY1Ng_56e8101c-58c7-4085-bec9-c31324054f52"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i648fe53f400e4a9fa1260cef7c260580_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjczMg_4e4d612f-c42b-47aa-92bb-3ed9a5575184"
      unitRef="number">0.0237</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <infu:LIBORRate
      contextRef="i648fe53f400e4a9fa1260cef7c260580_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjc0NA_85ffb0f5-a2be-4ac3-a5c0-f83f9058b55c"
      unitRef="number">0.0037</infu:LIBORRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia4114f950c2d4190904d6635dfffe982_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjc1Mg_311a65d7-48e7-41df-8b2d-6c3e07c0855b"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ibcc44660e52943efa3af89d8516b33e7_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjc5Mg_1b244a65-883a-4aff-b2b8-7ac880fcd3a8"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <infu:LenderPrimeRate
      contextRef="ibcc44660e52943efa3af89d8516b33e7_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgxOQ_b027ac88-d134-4190-a214-cbcd7b3b1a3e"
      unitRef="number">0.0325</infu:LenderPrimeRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i4cfd39a0ac8040ccb08858cf8fa5bf15_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181Mi9mcmFnOjUyMTc2ZGE3MGQ5YjQ2OTViYWFiNTFlZGNjMThkMTljL3RleHRyZWdpb246NTIxNzZkYTcwZDliNDY5NWJhYWI1MWVkY2MxOGQxOWNfNjgyNw_59a457c8-fbbe-4b6e-81a5-b0558416c400"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTk5OQ_db8aa664-7dcd-4e52-b553-9102e3ff3d6b">Derivative Financial Instruments and Hedging Activities&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In February 2021, the Company adopted a derivative investment policy which provides guidelines and objectives related to managing financial and operational exposures arising from market changes in short term interest rates. In accordance with this policy, the Company can enter into interest rate swaps or similar instruments, will endeavor to evaluate all the risks inherent in a transaction before entering into a derivative financial instrument and will not enter into derivative financial instruments for speculative or trading purposes. Hedging relationships are formally documented at the inception of the hedge and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is exposed to interest rate risk related to its variable rate debt obligations under the 2021 Credit Agreement. In order to manage the volatility in interest rate markets, in February 2021, the Company entered into two interest rate swap agreements to manage exposure arising from this risk. On a combined basis, the agreements have a constant notional amount over a five-year term that ends on February 5, 2026. The agreements both pay the Company 30-day LIBOR on the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;notional amount and the Company pays a fixed rate of interest equal to 0.73%. These derivative instruments are considered cash flow hedges. The Company does not have any other derivative financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The tables below present the location and gross fair value amounts of our derivative financial instruments and the associated notional amounts designated as cash flow hedges as of the applicable balance sheet date (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair Value Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,260&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair Value Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Gain on cash flow hedges - interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;268&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unrealized gain recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;148&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amounts reclassified to interest expense (a)(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;955&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;158&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) Positive amounts represented interest expense. Total interest expense as presented in the condensed consolidated statement of operations and comprehensive income for the three months ended March&#160;31, 2022 and 2021 were $0.3 million and $0.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(b) As of March&#160;31, 2022, $0.2 million of income is expected to be reclassified into earnings within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company did not incur any hedge ineffectiveness during the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMjc0ODc3OTA3MTYyNQ_9b4d8a66-ea51-455b-927c-69152510d4e2">In February 2021, the Company adopted a derivative investment policy which provides guidelines and objectives related to managing financial and operational exposures arising from market changes in short term interest rates. In accordance with this policy, the Company can enter into interest rate swaps or similar instruments, will endeavor to evaluate all the risks inherent in a transaction before entering into a derivative financial instrument and will not enter into derivative financial instruments for speculative or trading purposes. Hedging relationships are formally documented at the inception of the hedge and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i46375b7fb651451ea71759de00ad04f8_I20210205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTEyMQ_c12cd4c7-5a7f-4e97-a690-b85b8c4ee9f8"
      unitRef="numberofagreement">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeTermOfContract
      contextRef="i18d15197765c4fbe87a2fbc20e38f379_D20210205-20210205"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTk5Ng_311b344c-1d10-4e47-8caf-9883fb7d31b6">P5Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i46375b7fb651451ea71759de00ad04f8_I20210205"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTQ0Mw_201f6220-eedb-4207-8ad5-10da4b784289"
      unitRef="number">0.0073</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTk5Nw_518a3835-a24d-41f5-bef4-5fbcfdb66c61">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The tables below present the location and gross fair value amounts of our derivative financial instruments and the associated notional amounts designated as cash flow hedges as of the applicable balance sheet date (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair Value Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,260&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Fair Value Derivative Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Derivatives designated as hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 41.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i718b8b354a364afc9026b010eb60129b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOjBiZDQzYjdjZTZmMDQ3ZDE5NmUzOTE5ZmY0YjU2ZjA5L3RhYmxlcmFuZ2U6MGJkNDNiN2NlNmYwNDdkMTk2ZTM5MTlmZjRiNTZmMDlfNC00LTEtMS05MDY2NQ_a335bb22-f64a-4345-89c3-9ed1445c7913"
      unitRef="usd">20000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i718b8b354a364afc9026b010eb60129b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOjBiZDQzYjdjZTZmMDQ3ZDE5NmUzOTE5ZmY0YjU2ZjA5L3RhYmxlcmFuZ2U6MGJkNDNiN2NlNmYwNDdkMTk2ZTM5MTlmZjRiNTZmMDlfNC02LTEtMS05MDY2NQ_9e21b111-41da-4402-befc-ae423e7a28b9"
      unitRef="usd">1260000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i11453ba9eaac46c4bb4e7d291baadf1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOjExNzkyODRiNDc4NDQzYmVhZDIwYTRhNGE5MWQ2MzFiL3RhYmxlcmFuZ2U6MTE3OTI4NGI0Nzg0NDNiZWFkMjBhNGE0YTkxZDYzMWJfNC00LTEtMS05MjU5OA_6267d35b-6613-4ba5-83fe-64de71b4f44d"
      unitRef="usd">20000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i11453ba9eaac46c4bb4e7d291baadf1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOjExNzkyODRiNDc4NDQzYmVhZDIwYTRhNGE5MWQ2MzFiL3RhYmxlcmFuZ2U6MTE3OTI4NGI0Nzg0NDNiZWFkMjBhNGE0YTkxZDYzMWJfNC02LTEtMS05MjYwNQ_8ceef931-4ddb-4dbe-8833-7b0590f51fc2"
      unitRef="usd">355000</us-gaap:DerivativeAssets>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTk5OA_3740cb5b-fc03-479d-bab2-6c5d05fce20c">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The table below presents the effect of our derivative financial instruments designated as hedging instruments in AOCI (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Gain on cash flow hedges - interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;268&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Unrealized gain recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;148&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Amounts reclassified to interest expense (a)(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Tax provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;955&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;158&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(a) Positive amounts represented interest expense. Total interest expense as presented in the condensed consolidated statement of operations and comprehensive income for the three months ended March&#160;31, 2022 and 2021 were $0.3 million and $0.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(b) As of March&#160;31, 2022, $0.2 million of income is expected to be reclassified into earnings within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i93ef1df061524c8b9663782244eb5d30_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMi0yLTEtMS05MDY2NQ_f1c0a9cf-1427-46e0-9d72-ba0e42cfc438"
      unitRef="usd">268000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idf2eab998bda4fbd8fbc14723f4850ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMi00LTEtMS05MDY2NQ_ae208bf2-4a4d-4f2e-bace-e7aa3570b22f"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i085e4370af544db9a0d15a2675df534e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMy0yLTEtMS05MDY2NQ_57125c86-add0-465c-90e1-4069a2b30764"
      unitRef="usd">877000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i9cdfd77a386045118c342ea3d171f086_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMy00LTEtMS05MDY2NQ_7bc78034-2251-46af-8fb5-dafe7fa38c13"
      unitRef="usd">148000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i085e4370af544db9a0d15a2675df534e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNC0yLTEtMS05MDY2NQ_e645f4c8-1fdb-4493-bedd-b232166b157e"
      unitRef="usd">-28000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i9cdfd77a386045118c342ea3d171f086_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNC00LTEtMS05MDY2NQ_64bbd935-33a3-4c8f-8c08-91060b65e5dd"
      unitRef="usd">-10000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i085e4370af544db9a0d15a2675df534e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNS0yLTEtMS05MDY2NQ_9f12fcfe-2e04-4154-a1b4-7e23f876727e"
      unitRef="usd">218000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i9cdfd77a386045118c342ea3d171f086_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNS00LTEtMS05MDY2NQ_cdc012a8-f03a-48a5-ad97-fe327b2f672d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity
      contextRef="i0066368dfe234730a0ec98982a4f6be1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNi0yLTEtMS05MDY2NQ_7c41e5c2-0bba-43e4-b68c-51548934799b"
      unitRef="usd">955000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib91337cd039b4e1fb73ba260c56f4232_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfNi00LTEtMS05MDY2NQ_a9b9b3f8-3499-450e-9288-f9433e984236"
      unitRef="usd">158000</us-gaap:StockholdersEquity>
    <us-gaap:InterestExpense
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfOS0wLTEtMS05MDY2NS90ZXh0cmVnaW9uOjUzMDIxNDFmOGY3NDQ5MGJiNGJiNmE0Y2UwYzljYTdmXzE1NQ_c79ddb81-24ad-4f40-b59f-75a49ca5bcfd"
      unitRef="usd">300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfOS0wLTEtMS05MDY2NS90ZXh0cmVnaW9uOjUzMDIxNDFmOGY3NDQ5MGJiNGJiNmE0Y2UwYzljYTdmXzEwOTk1MTE2MjgwMTE_e7312163-6ecb-4052-b2d7-9a27b9c43d60"
      unitRef="usd">300000</us-gaap:InterestExpense>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i4b1ca0fa1a4549d0b3d620aeaa0f1a50_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RhYmxlOmIyZmQxNzc3MjcxNjQ5NzJiODNkMmYwNzlhOWU5MjBkL3RhYmxlcmFuZ2U6YjJmZDE3NzcyNzE2NDk3MmI4M2QyZjA3OWE5ZTkyMGRfMTAtMC0xLTEtOTA2NjUvdGV4dHJlZ2lvbjozMWFiMTQwOTIwNzg0MzZiOTcxMWJmYzQzYTk4MTIwOV85_60090b7d-4cb5-44f3-b7eb-e2a5091cd026"
      unitRef="usd">-200000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss
      contextRef="i4b1ca0fa1a4549d0b3d620aeaa0f1a50_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTkyMw_302d621d-d7d4-44aa-b4c3-4c86e7e94ec9"
      unitRef="usd">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
    <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss
      contextRef="i97d7dd5690f147b482bf2fe489cfcf4a_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181NS9mcmFnOjkxODVlYTk5NjZjNTQxMzJiNzJjMGZlMGY1ODFkNDhkL3RleHRyZWdpb246OTE4NWVhOTk2NmM1NDEzMmI3MmMwZmUwZjU4MWQ0OGRfMTkyMw_43c2b6fc-c581-4154-9d80-b3bd693f72bf"
      unitRef="usd">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfMTAzMA_6b375825-8ec7-4011-8b85-6169af2929aa">Income Taxes&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company recorded a benefit from income taxes of $0.5 million and $0.2 million during the three months ended March&#160;31, 2022 and 2021, respectively. The income tax benefit during 2022 relates principally to a pre-tax loss whereas the benefit during 2021 relates to excess tax benefits on exercises of stock options and vesting of restricted stock during the period. Other differences in the effective tax rate include the estimate of the Company&#x2019;s annual state and local taxes and taxes relating to its foreign operations in Canada. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (&#x201c;CARES&#x201d;) Act was enacted in response to the COVID-19 pandemic. The CARES Act among other things, allows employers to defer the deposit and payment of the employer's share of Social Security taxes. Under the CARES Act, the Company deferred paying $0.7 million of applicable &lt;/span&gt;&lt;/div&gt;gross payroll taxes as of December&#160;31, 2020, which was included in other liabilities. The $0.7 million balance of the deferred Social Security taxes was expected to be paid in two equal annual installments during the years ending December&#160;31, 2021 and 2022, respectively. In December 2021, the Company made the first of these two equal annual installment payments. As of March&#160;31, 2022, the remaining balance of approximately $0.3&#160;million is included in other liabilities.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfNzg_032cc8d4-cbcb-4bdb-9ea0-7e88df155ef0"
      unitRef="usd">-500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfMzg0ODI5MDcwMDgxMg_810303bb-5c0d-45dc-8b3b-8cab13144f9c"
      unitRef="usd">-200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent
      contextRef="i1c35755c8447450b8e419647303eac4d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfNzc3_7dc3d26e-c010-4e8c-adbb-3fc9e83f0347"
      unitRef="usd">700000</us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent>
    <us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent
      contextRef="i17cfc9c479c543688ef515f286847c44_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfNzc3_e70f3cc2-8cc4-4e40-a13f-e1c7a74cb14a"
      unitRef="usd">700000</us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent>
    <us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent
      contextRef="i1c35755c8447450b8e419647303eac4d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfODc2_7dc3d26e-c010-4e8c-adbb-3fc9e83f0347"
      unitRef="usd">700000</us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent>
    <us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent
      contextRef="i17cfc9c479c543688ef515f286847c44_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfODc2_e70f3cc2-8cc4-4e40-a13f-e1c7a74cb14a"
      unitRef="usd">700000</us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent>
    <us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent
      contextRef="i0649b764378d49608401c1e982e219f9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM181OC9mcmFnOjMxODkwMmU1OTRkOTQyNDM4ODNmMWI5OGFjMzE0YjBjL3RleHRyZWdpb246MzE4OTAyZTU5NGQ5NDI0Mzg4M2YxYjk4YWMzMTRiMGNfMjc0ODc3OTA3MzAxMw_a5586a96-821b-48a3-a586-261ae18beac5"
      unitRef="usd">300000</us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182MS9mcmFnOjlhMGI4MjhjNTYxMDRkZTQ4ZjcyZGNkOTQyMGI1YTBhL3RleHRyZWdpb246OWEwYjgyOGM1NjEwNGRlNDhmNzJkY2Q5NDIwYjVhMGFfMTM0Ng_888993bf-5bd1-4a28-b124-843c4211d2ab">Commitments, Contingencies and Litigation&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;From time to time in the ordinary course of its business, the Company may be involved in legal and regulatory proceedings, the outcomes of which may not be determinable. The results of litigation and regulatory proceedings are inherently unpredictable. Any claims against the Company, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. The Company is not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable, primarily for the following reasons: (i) many of the relevant legal proceedings are in preliminary stages and, until such proceedings develop further, there is often uncertainty regarding the relevant facts and circumstances at issue and potential liability; and (ii) many of these proceedings involve matters of which the outcomes are inherently difficult to predict. The Company has insurance policies covering potential losses where such coverage is cost effective.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is not at this time involved in any proceedings that the Company currently believes could have a material effect on the Company&#x2019;s financial condition, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTkwNQ_9c431ec9-485c-4114-aefb-7203d1357eca">(Loss) Earnings Per Share&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Basic (loss) income per share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted (loss) income per share assumes the issuance of potentially dilutive shares of common stock during the period. The following table reconciles the numerators and denominators of the basic and diluted (loss) income per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Numerator &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;661&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,609,372&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,338,160&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dilutive effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,599,479&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,609,372&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;21,937,639&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net (loss) income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;For the three months ended March 31, 2022, all outstanding options and unvested restricted stock units were anti-dilutive due to the Company's net losses for the period and therefore are not included in the calculation. For the three months ended March&#160;31, 2021, less than 0.1 million of outstanding options and unvested restricted stock units with an exercise price above the current market value of the Company&#x2019;s common stock were not included in the calculation because they would have an anti-dilutive effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On June 30, 2021, our Board of Directors approved a stock repurchase program (the &#x201c;Share Repurchase Program&#x201d;) that authorizes the Company to repurchase up to $20.0 million of the Company&#x2019;s outstanding common stock through June 30, 2024. Repurchases under the Share Repurchase Program are subject to market conditions, the periodic capital needs of the Company&#x2019;s operating activities, and the continued satisfaction of all covenants under the Company&#x2019;s existing 2021 Credit Agreement. Repurchases under the Share Repurchase Program may take place in the open market or in privately negotiated transactions and may be made under a Rule 10b5-1 plan. The Share Repurchase Program does not obligate the Company to repurchase shares and may be suspended, terminated, or modified at any time. As of March&#160;31, 2022, the Company had repurchased approximately $4.6 million, or 343,514 shares, of the Company's outstanding common stock under the Share Repurchase Program.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTkwNg_3b25abf4-0b9b-463e-be97-8e550e1c349c">The following table reconciles the numerators and denominators of the basic and diluted (loss) income per share computations:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Numerator &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%"&gt;(in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;661&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,609,372&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,338,160&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dilutive effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,599,479&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20,609,372&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;21,937,639&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net (loss) income per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.07pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfMi0xLTEtMS05MDY2NQ_f8668f69-3719-4ac0-8bec-5ee21827b3a5"
      unitRef="usd">-368000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfMi0zLTEtMS05MDY2NQ_b95bc7c9-d6d9-4444-b2b6-3724563d8d15"
      unitRef="usd">661000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNS0xLTEtMS05MDY2NQ_99777740-09bf-4ff8-8ab0-a500a0bf6550"
      unitRef="shares">20609372</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNS0zLTEtMS05MDY2NQ_447b2765-0467-488d-a5a1-9afad2d1257a"
      unitRef="shares">20338160</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNi0xLTEtMS05MDY2NQ_aec17e68-8be8-471b-940b-cec37b291d08"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNi0zLTEtMS05MDY2NQ_cc08ed80-78eb-4d10-a0e3-68904c89aec9"
      unitRef="shares">1599479</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNy0xLTEtMS05MDY2NQ_e7c3621b-ea6d-4dd2-b0a7-1f75dc16eb87"
      unitRef="shares">20609372</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfNy0zLTEtMS05MDY2NQ_500c5825-5dc0-45e5-a9df-8b9e225205d1"
      unitRef="shares">21937639</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfOS0xLTEtMS05MDY2NQ_8717a99a-9ed8-4439-bdfe-5ca8fd19314a"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfOS0zLTEtMS05MDY2NQ_9ebbcc2b-6242-42ad-b27c-c37608eeb247"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfMTAtMS0xLTEtOTA2NjU_b2a10771-a60b-4ef2-aae0-f6e6e0853429"
      unitRef="usdPerShare">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RhYmxlOmYwYjY4ODJmZGEyMzRiNmNhMWNiMzAxNzdmMDQ1MWNiL3RhYmxlcmFuZ2U6ZjBiNjg4MmZkYTIzNGI2Y2ExY2IzMDE3N2YwNDUxY2JfMTAtMy0xLTEtOTA2NjU_c6ca23c9-76d6-410c-89e2-6108f6d9e492"
      unitRef="usdPerShare">0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTA5OTUxMTYzMTAzOQ_fe3f353e-f643-4504-8274-e89de9c91228"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i9ad5338f58cd45369e7740b50719ff1d_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTI0MQ_8bb9635a-3630-4f8d-8865-4bea3738a402"
      unitRef="usd">20000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <infu:ShareRepurchaseProgramCumulativeSharesRepurchased
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTY0OTI2NzQ0NDI5MA_8233e7a6-a3d9-4b14-a9e5-8b28bcd5042e"
      unitRef="usd">4600000</infu:ShareRepurchaseProgramCumulativeSharesRepurchased>
    <infu:ShareRepurchaseProgramCumulativeSharesPurchasedShares
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182NC9mcmFnOmE1YjRkN2Y3M2U4ODQ2NTU4YTYwNjRiN2NjMzRmMTNmL3RleHRyZWdpb246YTViNGQ3ZjczZTg4NDY1NThhNjA2NGI3Y2MzNGYxM2ZfMTY0OTI2NzQ0NDMwMg_f38e6318-fb8e-4029-96d2-00e38f60f890"
      unitRef="shares">343514</infu:ShareRepurchaseProgramCumulativeSharesPurchasedShares>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMTU5MA_229bc179-25a9-4d50-8304-623b8e687e9d">Leases&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next ten years. The Company&#x2019;s leases do not contain any restrictive covenants. The Company&#x2019;s office leases generally contain renewal options for periods ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMzUz_c5ee57a4-2e68-4541-8653-b24cb86c7ae1"&gt;one&lt;/span&gt; to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company&#x2019;s office leases do not contain any material residual value guarantees. The Company&#x2019;s equipment leases generally do not contain renewal options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Payments due under the Company&#x2019;s operating leases include fixed payments as well as variable payments. For the Company&#x2019;s office leases, variable payments include amounts for the Company&#x2019;s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company&#x2019;s equipment leases, variable payments may consist of sales taxes, property taxes and other fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease costs for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Supplemental cash flow information and non-cash activity related to the Company&#x2019;s leases are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash paid for amounts included in the measurement of lease liabilities and right of use assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating cash flow from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Right of use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average remaining lease terms and discount rates for the Company&#x2019;s operating leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Future maturities of lease liabilities as of March&#160;31, 2022 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2027 and thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMjc0ODc3OTA3MTA1MA_a62c60df-b4c9-4c7e-920f-562a09aa3c0a">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i9823e66bcb094044aa90984c93101af3_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMTU4Nw_8d141d24-5a58-47c1-a90a-c0cf0a626c80">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMTU4OA_0db8aaa9-4315-4e92-9cd5-15ffc8a5f5c8">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The components of lease costs for the three months ended March&#160;31, 2022 and 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Supplemental cash flow information and non-cash activity related to the Company&#x2019;s leases are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 3.28pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash paid for amounts included in the measurement of lease liabilities and right of use assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating cash flow from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Right of use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average remaining lease terms and discount rates for the Company&#x2019;s operating leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfMi0yLTEtMS05MDY2NQ_1361ba2c-5b42-450e-810d-2facf3162b9b"
      unitRef="usd">329000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfMi00LTEtMS05MDY2NQ_dd578f19-27c6-46d6-815c-7b6c89875c35"
      unitRef="usd">348000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfMy0yLTEtMS05MDY2NQ_f8661938-1074-4874-a20f-c8cd03ca9e7e"
      unitRef="usd">74000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfMy00LTEtMS05MDY2NQ_ffb86dd5-0216-424c-905b-8476ee3c20ee"
      unitRef="usd">57000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfNC0yLTEtMS05MDY2NQ_5bb1c756-9097-41a7-96f2-2717d57da0d0"
      unitRef="usd">403000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjhhMWU5ZmY1MDU1ZjRlZGFiYzQzNzllYjdmZTRiNjAwL3RhYmxlcmFuZ2U6OGExZTlmZjUwNTVmNGVkYWJjNDM3OWViN2ZlNGI2MDBfNC00LTEtMS05MDY2NQ_178d2557-4864-41e3-87a9-ca6ab0d45261"
      unitRef="usd">405000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjkwNmJkNDgyZTQ4ZjRjNmZiYjEzZjE3N2E1YWUzYTc1L3RhYmxlcmFuZ2U6OTA2YmQ0ODJlNDhmNGM2ZmJiMTNmMTc3YTVhZTNhNzVfMy0yLTEtMS05MDY2NQ_9aede945-a332-439b-92a8-4a7bb3e82676"
      unitRef="usd">359000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjkwNmJkNDgyZTQ4ZjRjNmZiYjEzZjE3N2E1YWUzYTc1L3RhYmxlcmFuZ2U6OTA2YmQ0ODJlNDhmNGM2ZmJiMTNmMTc3YTVhZTNhNzVfMy00LTEtMS05MDY2NQ_5f5703f5-3d16-41ca-83fa-f2381ddf00c3"
      unitRef="usd">375000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjkwNmJkNDgyZTQ4ZjRjNmZiYjEzZjE3N2E1YWUzYTc1L3RhYmxlcmFuZ2U6OTA2YmQ0ODJlNDhmNGM2ZmJiMTNmMTc3YTVhZTNhNzVfNi0yLTEtMS05MDY2NQ_8c817ecd-69f9-40ac-8c85-1d4dc56fb228"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjkwNmJkNDgyZTQ4ZjRjNmZiYjEzZjE3N2E1YWUzYTc1L3RhYmxlcmFuZ2U6OTA2YmQ0ODJlNDhmNGM2ZmJiMTNmMTc3YTVhZTNhNzVfNi00LTEtMS05MDY2NQ_105829df-0b1a-4bc5-b066-bd62e39eb355"
      unitRef="usd">281000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjNiYWU3ZTZkZWVkNjQ1MDhiZjM1NmE4ZjU3OGQ5NWEzL3RhYmxlcmFuZ2U6M2JhZTdlNmRlZWQ2NDUwOGJmMzU2YThmNTc4ZDk1YTNfNC0yLTEtMS05MDY2NQ_2c4abc2a-95d2-4899-82f9-9c96c96f64a5">P6Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjNiYWU3ZTZkZWVkNjQ1MDhiZjM1NmE4ZjU3OGQ5NWEzL3RhYmxlcmFuZ2U6M2JhZTdlNmRlZWQ2NDUwOGJmMzU2YThmNTc4ZDk1YTNfNC00LTEtMS05MDY2NQ_537d847f-c58e-467a-968a-e8a4ec71a37e">P6Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjNiYWU3ZTZkZWVkNjQ1MDhiZjM1NmE4ZjU3OGQ5NWEzL3RhYmxlcmFuZ2U6M2JhZTdlNmRlZWQ2NDUwOGJmMzU2YThmNTc4ZDk1YTNfNy0yLTEtMS05MDY2NQ_c944446d-bb86-4e7f-8095-8e6858f1522a"
      unitRef="number">0.076</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOjNiYWU3ZTZkZWVkNjQ1MDhiZjM1NmE4ZjU3OGQ5NWEzL3RhYmxlcmFuZ2U6M2JhZTdlNmRlZWQ2NDUwOGJmMzU2YThmNTc4ZDk1YTNfNy00LTEtMS05MDY2NQ_7c1ec0eb-03f9-467b-89eb-9e127d08ae8b"
      unitRef="number">0.077</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RleHRyZWdpb246MmFlZjIzZTQ2YzFkNGVlODhhYTVkZjA1ZTIyMGM3N2VfMTU4OQ_3ce9722b-cbab-4ed6-bdfc-9372adb943d5">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Future maturities of lease liabilities as of March&#160;31, 2022 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Operating&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2027 and thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfMS0yLTEtMS05MDY2NQ_6f6983e4-6b39-4f87-98e2-fcd43b1808c4"
      unitRef="usd">869000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfMi0yLTEtMS05MDY2NQ_c68e92aa-44f7-4add-bb00-4c727997d857"
      unitRef="usd">1065000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfMy0yLTEtMS05MDY2NQ_62624b5e-6302-4bd3-884c-160487c7462d"
      unitRef="usd">1060000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfNC0yLTEtMS05MDY2NQ_1271b1fe-d351-4a04-942f-91f5d2fbe2a7"
      unitRef="usd">1029000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfNS0yLTEtMS05MDY2NQ_cb4655a4-4bb4-4b1b-9c79-af346e1ea10d"
      unitRef="usd">941000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <infu:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfNi0yLTEtMS05MDY2NQ_1e3461f1-b3ad-4fb1-b5ae-84a5cfd9bba4"
      unitRef="usd">1783000</infu:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfNy0yLTEtMS05MDY2NQ_24dcfdb1-25b9-4120-a1f8-ef889e130384"
      unitRef="usd">6747000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfOC0yLTEtMS05MDY2NQ_17d91ae6-1a8b-48cc-ae23-583585f5c8ff"
      unitRef="usd">2374000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM182Ny9mcmFnOjJhZWYyM2U0NmMxZDRlZTg4YWE1ZGYwNWUyMjBjNzdlL3RhYmxlOmY4NmU3MDViMDVmYTQ3OTE5MjA4NjQ5ODI2ZDBlMTVlL3RhYmxlcmFuZ2U6Zjg2ZTcwNWIwNWZhNDc5MTkyMDg2NDk4MjZkMGUxNWVfOS0yLTEtMS05MDY2NQ_d1edaa8d-e049-44f1-a2af-33df35351402"
      unitRef="usd">4373000</us-gaap:OperatingLeaseLiability>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RleHRyZWdpb246MzQ2N2U2ZTBkZTFmNDk5MWExOWZhNmM0NjAyYzZjYjdfODg1_1fea7f43-aaf0-47e8-8c6d-7772b4764caf">Business Segment Information&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company&#x2019;s reportable segments are organized based on service platforms, with the ITS segment reflecting higher margin rental revenues that generally include payments made by third-party and direct payers and the DME Services segment reflecting lower margin product sales, direct payer rental and services revenues. Resources are allocated and performance is assessed for these segments by the Company&#x2019;s Chief Executive Officer, whom the Company has determined to be its chief operating decision-maker. The Company believes that reporting performance at the gross profit level is the best indicator of segment performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The financial information summarized below is presented by reportable segment for the three months ended March&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Corporate/&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;16,641&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,763&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,488&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,488)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;16,641&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,610&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,488)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,763&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,738&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,629&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,367&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,892&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,892&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(277)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(277)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;462&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;462&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;61,991&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34,246&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;98,237&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,511&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,931&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,398&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,416&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Corporate/&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,911&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,552&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,463&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,446&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,446)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,911&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,998&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,446)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,463&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,573&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,576&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;179&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;179&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;661&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;62,508&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,079&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;90,587&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,621&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;715&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,336&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,696&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;874&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,570&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RleHRyZWdpb246MzQ2N2U2ZTBkZTFmNDk5MWExOWZhNmM0NjAyYzZjYjdfODg2_e94688fe-adf7-4ccc-8181-c117c406a87e">&lt;div style="margin-top:12pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The financial information summarized below is presented by reportable segment for the three months ended March&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Corporate/&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 32.57pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;16,641&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,763&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,488&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,488)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;16,641&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,610&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,488)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,763&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,738&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,629&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,367&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,892&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,892&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(277)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(277)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;462&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;462&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(368)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;61,991&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;34,246&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;98,237&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,511&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,931&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,398&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,416&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:114%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;ITS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;DME Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Corporate/&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Eliminations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net revenues - external&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,911&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,552&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,463&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net revenues - internal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,446&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,446)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,911&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,998&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,446)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;24,463&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10,003&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,573&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;14,576&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;179&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 5.57pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;179&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;661&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 32.57pt 0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;62,508&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;26,079&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;90,587&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Purchases of medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,621&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;715&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,336&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Depreciation and amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 32.57pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,696&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;874&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 5.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 32.57pt 0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.57pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,570&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <infu:RevenuesExternal
      contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMy0yLTEtMS05MDY2NQ_5a16aa87-6c33-43dd-978c-f1e3d5676648"
      unitRef="usd">16641000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMy00LTEtMS05MDY2NQ_9356397b-3fb5-4885-b61e-38a5144b1a44"
      unitRef="usd">10122000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMy02LTEtMS05MDY2NQ_bc67c930-b404-4340-8818-74a97a92e9c2"
      unitRef="usd">0</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMy04LTEtMS05MDY2NQ_907d7cf4-9571-40f0-93c6-4afa73c0da7d"
      unitRef="usd">26763000</infu:RevenuesExternal>
    <infu:RevenuesInternal
      contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNC0yLTEtMS05MDY2NQ_700f3228-55ee-4759-a444-410cbe40a8db"
      unitRef="usd">0</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNC00LTEtMS05MDY2NQ_ad8a205b-b10d-4a69-a37d-32b454d71d06"
      unitRef="usd">1488000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNC02LTEtMS05MDY2NQ_29b4414b-3e13-4138-9838-25c89e2cdef3"
      unitRef="usd">-1488000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNC04LTEtMS05MDY2NQ_6f760d32-94b5-40e7-8350-5e6d46b0c054"
      unitRef="usd">0</infu:RevenuesInternal>
    <us-gaap:Revenues
      contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNS0yLTEtMS05MDY2NQ_352ccfc4-1b34-4770-add9-9fcaacb55e3e"
      unitRef="usd">16641000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNS00LTEtMS05MDY2NQ_df857214-c486-4504-a5f9-8dede42cdbc2"
      unitRef="usd">11610000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNS02LTEtMS05MDY2NQ_41749289-a9b0-4fd5-9ef1-39c867bca4f6"
      unitRef="usd">-1488000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNS04LTEtMS05MDY2NQ_b9585b65-4548-4de4-9428-2fc73ff5ca13"
      unitRef="usd">26763000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNi0yLTEtMS05MDY2NQ_276442dc-0635-47ed-befd-b9155225bf39"
      unitRef="usd">10738000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNi00LTEtMS05MDY2NQ_069c867a-aae4-4a91-ad97-4c9ef379c203"
      unitRef="usd">4629000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNi02LTEtMS05MDY2NQ_f5348626-d5c6-45f9-96e4-266666df2e0e"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfNi04LTEtMS05MDY2NQ_eda45e29-8bc7-4e2d-8014-a8ee5d68b7e9"
      unitRef="usd">15367000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfOC02LTEtMS05MDY2NQ_75de3372-376c-4faa-869e-7505661fb324"
      unitRef="usd">15892000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfOC04LTEtMS05MDY2NQ_7a55103e-6800-482c-8dcd-7232f729af77"
      unitRef="usd">15892000</us-gaap:OperatingExpenses>
    <us-gaap:InterestExpense
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfOS02LTEtMS05MDY2NQ_dee0b917-edce-4337-8581-4798314f67d4"
      unitRef="usd">277000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfOS04LTEtMS05MDY2NQ_1559d21c-8612-46b7-8909-7c1aac4ca23f"
      unitRef="usd">277000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTAtNi0xLTEtOTA2NjU_fefcde72-7364-4a75-ae7b-c6e76d7ac9f7"
      unitRef="usd">-28000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTAtOC0xLTEtOTA2NjU_c7b59a46-6729-45d6-a175-6d4a3bb7eeaf"
      unitRef="usd">-28000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTEtNi0xLTEtOTA2NjU_2c49ab5e-5290-432f-9b33-496b9f87c921"
      unitRef="usd">-462000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTEtOC0xLTEtOTA2NjU_2f481cc9-487c-410d-813c-10374c5ef441"
      unitRef="usd">-462000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTMtOC0xLTEtOTA2NjU_f251dd11-ef4c-4a84-8cc5-32ae89e11bac"
      unitRef="usd">-368000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets
      contextRef="i7948825b6e95471c8a412984f797602e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTUtMi0xLTEtOTA2NjU_dfe5e56c-db7b-49cb-a8a5-b60e3ccbd72c"
      unitRef="usd">61991000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i814be89047894da9a58c9f276f7bd602_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTUtNC0xLTEtOTA2NjU_e1d4025f-d308-4597-a1b5-1ecae4cf98f0"
      unitRef="usd">34246000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i91e9dc825e4341c0b5c96f30ce2f3772_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTUtNi0xLTEtOTA2NjU_7d8531e2-cd1b-4bc3-b45e-c87b2bdeee07"
      unitRef="usd">2000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i670dd04a7e7b4ccfa103e1c4216749f4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTUtOC0xLTEtOTA2NjU_51f7d73d-4218-42e4-898f-15e7965e680f"
      unitRef="usd">98237000</us-gaap:Assets>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTYtMi0xLTEtOTA2NjU_c0c13f54-deb4-4f2b-8cb4-568192f378e2"
      unitRef="usd">1511000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTYtNC0xLTEtOTA2NjU_23ff4eb7-62b3-48f5-a3f3-54804cb022a0"
      unitRef="usd">1420000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTYtNi0xLTEtOTA2NjU_bad7e2e0-c1e1-4882-82ff-25e11e3ce7bc"
      unitRef="usd">0</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTYtOC0xLTEtOTA2NjU_b678ecd7-799d-4298-8690-ff37f0779f4e"
      unitRef="usd">2931000</infu:PaymentsToAcquireMedicalEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib00d39cd5195487c9dcb9a5c8d740c03_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTctMi0xLTEtOTA2NjU_ca0d43c2-2161-4c99-93d5-7627e9c22ab9"
      unitRef="usd">2398000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib3eb1c6975d549109036d441a4208693_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTctNC0xLTEtOTA2NjU_e4b5b70a-2563-4263-b745-19487caf3e5b"
      unitRef="usd">1018000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic4b6f761a25b4892a7d404d4b02c4da9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTctNi0xLTEtOTA2NjU_46d2d8c6-bfb4-4bba-abf3-88fc74c6ab49"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOjEzZmFhMDk0NzY1YjQ2ZTRiYWJhZmI2YTA4ZjE5ZDc3L3RhYmxlcmFuZ2U6MTNmYWEwOTQ3NjViNDZlNGJhYmFmYjZhMDhmMTlkNzdfMTctOC0xLTEtOTA2NjU_5c83252c-33e1-4928-ac17-139c7f8b8495"
      unitRef="usd">3416000</us-gaap:DepreciationAndAmortization>
    <infu:RevenuesExternal
      contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMy0yLTEtMS05MDY2NQ_f0419267-b6a5-495d-9148-b98ad68b4bc9"
      unitRef="usd">15911000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMy00LTEtMS05MDY2NQ_cdd99bca-bf02-4d6e-97d5-1cd72cd56ded"
      unitRef="usd">8552000</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMy02LTEtMS05MDY2NQ_2647e168-f9d6-4855-8622-297264175c87"
      unitRef="usd">0</infu:RevenuesExternal>
    <infu:RevenuesExternal
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMy04LTEtMS05MDY2NQ_edca2c8a-e61e-4170-ac59-f8e9d20bfd79"
      unitRef="usd">24463000</infu:RevenuesExternal>
    <infu:RevenuesInternal
      contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNC0yLTEtMS05MDY2NQ_1a064282-6d51-4f7f-8358-dd6bc261152f"
      unitRef="usd">0</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNC00LTEtMS05MDY2NQ_a70dcd9f-6f22-4ce8-9bd7-1d0e9ca64aae"
      unitRef="usd">1446000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNC02LTEtMS05MDY2NQ_31baef3f-c25e-407b-9393-ede8774beed1"
      unitRef="usd">-1446000</infu:RevenuesInternal>
    <infu:RevenuesInternal
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNC04LTEtMS05MDY2NQ_2b256976-9a5f-4878-a28e-6dbe3347d7dc"
      unitRef="usd">0</infu:RevenuesInternal>
    <us-gaap:Revenues
      contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNS0yLTEtMS05MDY2NQ_25310357-d514-49c7-9e24-7cfcbc3f4c40"
      unitRef="usd">15911000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNS00LTEtMS05MDY2NQ_e167350b-07cb-4e79-96c2-4117a12f977d"
      unitRef="usd">9998000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNS02LTEtMS05MDY2NQ_9c3c7e1f-5c9e-4bea-8594-ff9ded2c6299"
      unitRef="usd">-1446000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNS04LTEtMS05MDY2NQ_1d3e10fd-5c1d-4ff7-a1d6-5a905b50c4d5"
      unitRef="usd">24463000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNi0yLTEtMS05MDY2NQ_2e455f76-84fb-41a4-ab44-3ef97b296de2"
      unitRef="usd">10003000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNi00LTEtMS05MDY2NQ_515e76eb-63f8-4541-abba-22e555b2b05e"
      unitRef="usd">4573000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNi02LTEtMS05MDY2NQ_46ccf40f-6e1e-45f6-a18b-c1c1fbbb6b01"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfNi04LTEtMS05MDY2NQ_4f2e5363-db61-424c-897a-709fbc18fcdf"
      unitRef="usd">14576000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfOC02LTEtMS05MDY2NQ_b0ebc284-0d6d-44da-87f0-72c9be268ef5"
      unitRef="usd">13703000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfOC04LTEtMS05MDY2NQ_b439d3d3-f695-449e-a2d8-e7ef80227039"
      unitRef="usd">13703000</us-gaap:OperatingExpenses>
    <us-gaap:InterestExpense
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfOS02LTEtMS05MDY2NQ_6794c746-70da-495a-8505-7172f87be884"
      unitRef="usd">322000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfOS04LTEtMS05MDY2NQ_847e8a5e-1afb-4646-a6bd-981ca3880af2"
      unitRef="usd">322000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTAtNi0xLTEtOTA2NjU_42c8a478-975a-44dc-b057-4386cf38845f"
      unitRef="usd">-69000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTAtOC0xLTEtOTA2NjU_bb07aa03-d644-4ff4-8bac-6102cf2d9a7b"
      unitRef="usd">-69000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTEtNi0xLTEtOTA2NjU_15a32639-e57c-48dd-8d9d-ed434c6aa15b"
      unitRef="usd">-179000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTEtOC0xLTEtOTA2NjU_77423193-96a1-4a0f-9d4e-5d0001472d4c"
      unitRef="usd">-179000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTMtOC0xLTEtOTA2NjU_261a2bda-a283-4445-b02e-e58bea570ee5"
      unitRef="usd">661000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets
      contextRef="i16b961b3af684edb8219f8ad50fba90b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTUtMi0xLTEtOTA2NjU_ec07c7cd-6186-4562-8df1-61bdf0c897ac"
      unitRef="usd">62508000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8f1cbecf89194e0ebc676764e029ed03_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTUtNC0xLTEtOTA2NjU_92967ead-7fa6-4cd3-9970-39e170963185"
      unitRef="usd">26079000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic7ace98423094ec1812718f76386b5e1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTUtNi0xLTEtOTA2NjU_cbcb8623-c7dd-4019-9381-d6495d39eb26"
      unitRef="usd">2000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i963ea4ed6904434cba81f9b35544822a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTUtOC0xLTEtOTA2NjU_558dd4a1-cad2-41a3-925c-d9bde321fb56"
      unitRef="usd">90587000</us-gaap:Assets>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTYtMi0xLTEtOTA2NjU_67a1a100-6e4c-436d-b453-d27fe434aeab"
      unitRef="usd">1621000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTYtNC0xLTEtOTA2NjU_ce23aae1-e51f-44ba-a404-853520367ab9"
      unitRef="usd">715000</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTYtNi0xLTEtOTA2NjU_e7b1f136-03f5-4c59-8f1f-ef559e78425a"
      unitRef="usd">0</infu:PaymentsToAcquireMedicalEquipment>
    <infu:PaymentsToAcquireMedicalEquipment
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTYtOC0xLTEtOTA2NjU_a4f56efd-6697-4527-bf4d-6083ab2c70d4"
      unitRef="usd">2336000</infu:PaymentsToAcquireMedicalEquipment>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6e56d96463c64ea597b2af038bbde80b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTctMi0xLTEtOTA2NjU_8bc1aba3-bae3-4aea-92d0-0d007ef62c33"
      unitRef="usd">2696000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i510be7c0c4a34576ab2e82900448e329_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTctNC0xLTEtOTA2NjU_91b2e999-a563-45f1-a10e-0110a38b05d9"
      unitRef="usd">874000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i26fb730bc2cd4f62bc753cf8f8cfc55c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTctNi0xLTEtOTA2NjU_f4c9e33e-bdee-4a73-b522-f5fd5dde9e5a"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i25f33d209715440fbb5be414480b1768_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183MC9mcmFnOjM0NjdlNmUwZGUxZjQ5OTFhMTlmYTZjNDYwMmM2Y2I3L3RhYmxlOmUwZDI2NTFjNWU2ZTRjYzQ5NGNjY2Y0NDcxN2QyMDkzL3RhYmxlcmFuZ2U6ZTBkMjY1MWM1ZTZlNGNjNDk0Y2NjZjQ0NzE3ZDIwOTNfMTctOC0xLTEtOTA2NjU_97daf4ab-c8f0-4215-8bf4-613992c7c43b"
      unitRef="usd">3570000</us-gaap:DepreciationAndAmortization>
    <infu:EffectOfCovid19PandemicTextBlock
      contextRef="if9fd90e0c75a405283198b794bbb93da_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmY3ZTU2ZjBkNmVlYjRmYWZhOWQ2ZDM4OTYzNzY5YWMzL3NlYzpmN2U1NmYwZDZlZWI0ZmFmYTlkNmQzODk2Mzc2OWFjM183My9mcmFnOmE3NGY3N2Q3NTliYTQ0ZGRiOGM4OTU1ZmRiOTYxZDZmL3RleHRyZWdpb246YTc0Zjc3ZDc1OWJhNDRkZGI4Yzg5NTVmZGI5NjFkNmZfMTQ5Mg_83aff6d0-b3c1-41c5-91de-41b472c116b5">COVID-19On March 11, 2020, the World Health Organization declared the outbreak of coronavirus (&#x201c;COVID-19&#x201d;) as a pandemic, which has spread globally and throughout the United States. During the period of the pandemic, we took a number of precautionary and preemptive steps to protect the safety and well-being of our employees while ensuring continuity of service to our clients, including, transitioning our employees to a remote work environment, suspending employee travel, canceling participation in industry events and in-person group meetings, promoting social distancing and enhanced cleaning and sanitization efforts across office locations, and implementing protocols to quarantine employees who may have been exposed to COVID-19, or showed relevant symptoms. We also undertook preparedness plans at our facilities to maintain continuity of operations, which provide for flexible work arrangements without any significant disruptions to our business or control processes. Our management team continues to actively monitor the situation and is in constant communication with our workforce, customers and vendors. During the three months ended March&#160;31, 2022, outbreaks of COVID-19, including the Delta and Omicron variants, unfavorably impacted our revenue growth initiatives in certain product lines including Pain Management and NPWT. The impacts included scattered restrictions on elective surgeries and delayed ramp-up in treatment volumes for new customers, both of which unfavorably impacted the Pain Management business, and restricted physical access to our customers facilities, which unfavorably impacted both the Pain Management and NPWT businesses. While the COVID-19 pandemic has not had any material unfavorable effects in our financial results for the three months ended March&#160;31, 2022, beyond this delay to our revenue growth plans, the extent of any future impact will depend on future developments, which are highly uncertain, cannot be predicted and could have a material adverse impact on our financial position, operating results and cash flows.</infu:EffectOfCovid19PandemicTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>74
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MC!=NXJ_6\6Q/?$#N96:6F@RS2$0?XSU@*8'8%NB*H8+W7!V3@!X1YC-6PS/
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MZ=J?I<PP/VX08><4.C.*V3&K*@3#S?TY-E ;Y)Q0]MOL=S(58:$@6[58N-)
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M3^'V:KVTM]XQ,G>K8S-IC$S=YE+P2"A[ 9R?2VFV._8&Y0+KY7]02P,$%
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MLO@JK[9"UJ8"^C_>+,+:)D"S3_B^=A%J+ )J$YG:(T"S2?AVQPA5J4>*9>P
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M]E#,GN@^E=_YRU=6&S12^B*>BO(O>JEEO1Z*]D+RK%X,"+(DK_[3W[4C6@M
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MUP"JL70V>?)X)'QYMI6/Z+K\5%JYB$M!_HFK",22#3!?.[1B_\$;#&_GT[\
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MC-X<#LBUKXSV(]@ZW>PK&_!.2,,2#S-VT0#KA;5A]Q$#]$^]Q5]02P,$%
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M?<1&*L!*$%>MV)W!AXN/W>5@%PHMB8),H'W<>Q,<OJXJH^BA[TO[AQ?J3OM
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MP>9[_XSHC)S8@=,M>Q'PGML)E$4*+&?L!;QRS+&,>.5K<X2/-VOG+=V(3R_
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M-IXF;-RV]*2A#0:DWQCC#X<08'PD5W\#4$L#!!0    ( .U]I50!41D]-0,
M !\'   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;*55VV[;.!#]E8$V
M6"2 8$F4G*BI;<!I>@.V@)&TNP]%'VAI;!&E2)6DZN3O=TC):E*T6;3[(I)S
M.7-FR!DM#MI\M@VB@[M6*KN,&N>ZRR2Q58,MMS/=H2+-3IN6.SJ:?6([@[P.
M3JU,6)J>)RT7*EHM@FQC5@O=.RD4;@S8OFVYN;]"J0_+*(N.@ANQ;YP7)*M%
MQ_=XB^Y#MS%T2B:46K2HK- *#.Z6T3J[O"J\?3#X6^#!/MB#SV2K]6=_>%LO
MH]030HF5\PB<EJ_X J7T0$3CRX@932&]X\/]$?U5R)URV7*++[3\1]2N649E
M!#7N>"_=C3Z\P3&?N<>KM+3A"X?!MJ"(56^=;D=G.K="#2N_&^OPP*%,?^+
M1@<6> ^! LMK[OAJ8?0!C+<F-+\)J09O(B>4OY1;9T@KR,^M-H;NU[A[X*J&
MEU]ZT5'%W2)QA.TMDFK$N1IPV$]P<GBGE6LLO%0UUH_]$^(T$6-'8E?L2<!W
MW,P@SV)@*6-/X.53HGG R_\CT1@VDBOW.%_XN-Y:9^B)?'HB5#&%*D*HXG_7
M]'=PX)$8)W&EJ5.LPQKT#ER#L-.26DZH/9P*11+=6_*P9Y= M:V:J;APC16V
M6S1'20:OC;86UM:BHZ6J^K:7W$-?([5^)7CHJ/?:<?E+MJ]ZHX3K#<:P$W=^
M8^/OTCB!(G[&"EI/67R1YF>T8S$C4EY39FS0S%DY:LH"UCVUB=X*B1:R+(73
M+"W.X/RX)XP+^ NI=QLM:Q!M9_17]-$LY'%1/".C.$^S,X++BC+("B]C&?,R
MEK.1_PF4<5'FGD(19VF@4,3YQ3QH\O-SK\GCLL@'S9SEC\N =S1-K;\; ]V/
M[]&K_/6YQB!".W05^J[Z_MX.W,)).LMI+DA)Z#&]@;;CABR=]AIVU$R@EK=(
M@04=[Y$3!Z1]/8/WC; 3.8]+E+7Q,>GI_/E'R5CZ?(\*#17!T^4US2+A6\8/
MU:.G#9;9\Q ..7$=\7_45,F#H=6BV8?1;"F%7KEA?DW2:?JOAZ'WS7SX=5!=
M]D)9D+@CUW1V,8_ #.-X.#C=A1&XU8Y>2M@V] =#XPU(O]/:'0\^P/1/7/T+
M4$L#!!0    ( .U]I529 <'$:@0  *,*   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;)U6W6_;-A#_5PZ>4=B %DN4%,N)8\!ITBX/*8(FW1Z&/= R
M;1&E2)6DXGA__8Z4I=CY\+J]D")Y][OOTTTW2G\W!6,6GDHAS46OL+8Z&XU,
M7K"2FA-5,8DO*Z5+:O&HUR-3:4:7GJD4(Q*&IZ.2<MF;3?W=G9Y-56T%E^Q.
M@ZG+DNKM)1-J<]&+>NW%5[XNK+L8S:857;-[9K]5=QI/HPYER4LF#5<2-%M=
M].;1V67BZ#W![YQMS-XW.$L62GUWAYOE12]T"C'!<NL0*&Z/[",3P@&A&C]V
MF+U.I&/<_V[1/WG;T98%->RC$G_PI2TN>ED/EFQ%:V&_JLUO;&=/ZO!R)8Q?
M8=/0IG$/\MI85>Z848.2RV:G3SL_[#%DX3L,9,= O-Z-(*_E%;5T-M5J ]I1
M(YK[\*9Z;E2.2Q>4>ZOQE2.?G7U6:KGA0L '6E;G<",ME6N^$ SFQC!KIB.+
M4ASM*-\A7C:(Y!W$&&Z5M(6!:[EDRT/^$6K7J4A:%2_)4<!;JD\@C@(@(2%'
M\.+.Y-CCQ?]F,I7+UP;#%3>Y4*;6#/Z<+XS5F#A_'1&;=&(3+S;Y7V+?\O-/
MXKT3.7@H&.0%7C(#7()U1ZKUELLU/%)1,U K6+<HBRT8ML9RLX"E[JEMH1F#
MLHDF<]$$C$5>=,$ BDZB!AD$%K>!@1>C:H,FFN$97-U>PSW3CSQ'%09T")=4
M4)E['I1]Q7)6+IAN\2+H0QR,HQ">?97_J+E&P1]^R4A$SE\@O%"G97>BG/4W
M#_>=405R2(5])%?:6=(:?M+XJ74,+56-U"Y&-,_KLA;4(C5>:\O_IKZ3H&#^
M[&W:>#M7V*B,H\5GY[W&*0[SI5M>:/W:#9^U,J8-XWQ/C?F^&E^P9?\\Y1<E
M6R.<UJ\->-!TR0"),%9]($$8AKBW?G^^>>]E?@S][ ">Q# @\;"#>'F^*[:&
MYYQ*'X>F"Z)_-!/>'E/PRD"<!5F<P"!&\3$RGP99&#W?1D$21D,8!TD<.^-_
MS559,<N;?\$:,]NEA8%D3& P"8?(29K#Z7@(29C"-UFA*Z7SIF5Y(950ZRU,
M$E0V2I%FG)WN3D[WC(1PKU9VXVHBBH(TQCS$G62(3=+PX"[-\ YE/2A+!:;E
M06A\[AT-51_2&*UU"3](XB#-4'X?HC @T>3PD039F.P>)W%XF!;L"7_MAOV'
M>M]@$?7#DS'^B81 B "<5ZDK4*N@'YV$[4L':C#B4&F.QRVC&BJ&WTM7==QT
M&CC<KC*Q6EPBD/#\_:KK6(TGC<Z]/$91V5; -1+D+GB:N>'$%[>4-?J;'G."
M9$_8 7%2\.H:?_\Z IVR;_8AM.Q(5_0DN,1N2=R2NN74+6,??=0#!ZR5Q9QO
M,N3-L&%0@W$6XSZ9A-V:16Y-$=AUP\AWQ<PEQEN_L-'>X( 5MO;CD>MEV .;
M&:*[[2:P>3-X/),WXQNZ8,VE <%6R(HYDO9 -R-1<["J\F/(0EDL9_]9X!3)
MM"/ ]Y52MCTX =U<.OL'4$L#!!0    ( .U]I50,3&#2_PH  (D=   9
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MUK!KPW>[4C5#[:G[4V;]JL,A72*+,_"?,SF7Z@A9I@GBJQ9?_Q+7?FMWQ2(
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M+3L\MLBS +XW#ED:-VQ@>KYM_@)02P,$%     @ [7VE5$T' K]:!0  4PT
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M;[\YS-+LA*7#_:.CX>3@:)WI3>QT>)0?#*?YT3,.K8.W(@4/DU&2D8MXYFO
MI_W8=6-V?(QRTT59/(DRA7+(()\M@9HV9BBF-.B%<(2/&'DK2VIV?@8MX>%2
MD#RAP3=K_54!5DTT?H6$<_WPG8LE1(XATK.>6:?": 6O.$X,0>&GC2?W52"R
M,?M(%E=E4%$ZHW_M&_ZA8Q(RUXA*BB- *3K-D+.O=ECZ&A.9N!>VE YN8!)X
M%V8A.J;!6B0?QXR]@].00A"K4NGC$65Q<.*VA1-#^07?62%*'ERT]( C.ZB*
MU1 T,=K.0J?.4;_OW8HV(# X@-F--7/+&_:+9C\%+5B>K&)E@F67AMN*Z%Y+
M[ 1=W;>MA7/(5$_4/H*U/=@>\22WLN1DE\4XG)Z\IG1XQ@.*VLJ_^WVFCPP)
M9P,^M-3Q*H.B-W/W7"@W\[D55HC$A'F]Y>QDM,'/(;.5Z!2U,UK4[4+Q%U4\
M*/7)Q599R:B=X8:D4:4E;Z7G"K(7E=M)N:4MC@C'VQ6 !'#Z>B!LC 62'R:Y
M&>\N8L"B>BV1$<UICWDD_Q1?W$L7X>-F>64%N+*+.6H&]T+_GT/0<*2'W\%+
MQ:'X7IQTP5V% V6)7A3$@GN!(TF+N<'I1"6$:X)VG0M=G1%:@>+EE>B-<W8;
M< "E2;'_)B4CNCNA=A*J#(A3P9A"R3G,O*"D?I??L.R":^.>@=0)&X\):L.'
M!BF<21(\9$I(N$>/V$7,X].]<]-BS:L-DU57./>RZ8+Q:C*:KD0<S>23?+B?
M3GIJPR<J^>X%27\Y6:/G+F3CC8LN3M=YO,[3)A2T[^Z\Z][U%\-%=U%^G-Y]
M;B ,<XE,*C'#TF1TL#]@MKO"=R_>M/':7!B/2WALUOCJ$98F8'QF<'7I7\C
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MS?E-=V&\%^^NW5?^&VKQ%5A!-3S*9Q-ANJML-W%ZXZ^/"^UP&?6O%6[_9%@
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M%*B>_(R,D^3[W+JW/N$AR$.-EY>#&&"_\3X=)Q)@>LLW_P-02P,$%     @
M[7VE5(*0@=)Y!0  Z1   !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M[5A;;]LV%/XKA%<,">#$EFS'298$<+)E#=!+D*8MAF$/M'1L<:5$E:3BIK]^
MWZ%D6<W%Z][VT ?K0IX;S_G.)](G*V,_N8S(BR^Y+MQI+_.^/!X,7))1+MV^
M*:G S,+87'J\VN7 E99D&I1R/8B'PX-!+E71.SL)8]?V[,147JN"KJUP59Y+
M>W].VJQ.>U%O/7"CEIGG@<'922F7]([\^_+:XFW06DE53H53IA"6%J>]671\
M/F7Y(/!!T<IUG@6O9&[,)WZY2D][0PZ(-"6>+4C<[NB"M&9#".-S8[/7NF3%
M[O/:^F58.]8REXXNC/ZH4I^=]@Y[(J6%K+2_,:N7U*QGPO82HUVXBE4C.^R)
MI'+>Y(TR(LA54=_EER8/WZ,0-PIQB+MV%*+\57IY=F+-2EB6AC5^"$L-V@A.
M%5R4=]YB5D'/GYU7#B/.B0N3SU4A.55.[-S*N2:W>S+P\,&2@Z2Q=U[;BY^Q
M-Q*O3>$S)WXK4DJ_U1\@MC; >!W@>;S5X&MI]\4HZHMX&,=;[(W:!8^"O=%_
M6+"012IFSJ$'9LGG2CD51O^<S9VWP,U?6_R.6[_CX'?\C-]W:*>TTB3,0K0Q
M=+RYOIC?=P>>ROU6%]R_QZZ4"9WVT*".[!WUSFXS$@NCT7RJ6 K/=6TZ4'TE
M)SRF$WA7*=DZ%Z54:4@(3TDH)O4XXN:1LK))AC80I54)"6_"Z$(J*^ZDKF"R
M$92<3X>VPXHLU2:UDG.EL3R(8;[*>;S50,PEA2ZMM9HRI-)#'/PCYL9GXE+I
MV>O&WMMS\9*D]EDB+8D=5<".J1RFW.YQ*_FMU*WQ4J/ZW35?2)>)%R+JCX=#
MW _Z\83OT_X![A]!*YR[1):*567Z-_H2Q.3[=;+@-F$#/_]T&$?Q+V(43\(/
M/CP4(?@@Q6O!*:SSKPYI[X'4)IYIG\V]$(?]*>[;EM6%+_B Q"47Y@,7!G.)
MJ0J4Q%)"ZBX@X44;"[P$'WR]*NX0M+%<INEX$^Y8P*]*X(?@IN04B(QT&HKC
M)(/;PGK!D8R'K1X>KRT^(];?AZIME*-A+"9'(CJ(X-/+8JDXJ 8Y47\8(9']
M(7(P#L^_&Y.NE-90.,+$9!SA.HV&XFT9DH8B:6)L6N9BAE7E6G/Q822FN!X^
MDNZB<@=BNV)GNLM/A[MM:1[ _KG:;"&*24L4D^\FBAM*S+) HZ;B*D7"U$)1
MPU0->:P[ZU5G#;.ZLYXBD*VN?Q#(#P+Y02#_6P(Y: GD8"N!7*I">=I[A3:H
M07Z%K=BB.]A)U2,N<>):6O_-+J6S4WJ*4[9'\R1]9&95,\<<!XE/J5FU[* V
M-*<>%;2E DP9[(+_!EH>2HE$\[W3[QTJ<,=; ;YSVS:_^!CV\Y3NS>Y0["4R
ME1OKU=>ZM:[)*I.*G3](6@A?A(TZ,79UO87.5.E0U+@_0I&!O/=%"6<%# I/
M2588;9;WXF@\ J3>F&(O,7E)O@Y++BT1P]N)\13XYGJ1+:3>8S0ZL_ K;EBV
M/&GP]3A7.W(7_FO81]%^' 90#"BN4.3",%NJM()RH-T^]QVM\ I?N>-&I"^^
M/GT%KC6)DAS^2G%.B_LM]=G?@N)IB^+I5MP\M4?N,PV(<!I#3NH3Z3.@W&K\
M>SYT)3P%#P*M(PLLGK/<^A1!+]13:F<PE>@J;;Z'&]V4(,>)6Y\R9!=%( 2[
M9*A:DV_ O<EJ\503,*[9B<^ $I'7IRWBTY; 62G)UH>EZ-'G[/9?-6X(O%TQ
M.\7C_L'T2+Q!0V%IP#9_U49'3_+3H'/\1!,LPR';B?"QJ$^B[6A[CI_5Q]>-
M>/TG .)9*N!-TP*JP_TI-BRV/EC7+]Z4X3"+SD;'A<>,)#YY+(#YA3%^_<(.
MVG\WSOX!4$L#!!0    ( .U]I51>E*<'T0(  !@&   9    >&PO=V]R:W-H
M965T<R]S:&5E=#(T+GAM;)U5W6_:,!#_5TY9-[521D(2('2 U(]-VT,G!&Q[
MF/9@DB.QFMC,=DKY[W=V@-*I1=I>B,_^?=PYN6.TD>I>EX@&'NM*Z+%7&K.^
M# *=E5@SW9%K%'2RDJIFAD)5!'JMD.6.5%=!%(;]H&9<>).1VYNJR4@VIN("
MIPIT4]=,;:^QDINQU_7V&S->E,9N!)/1FA4X1_-M/544!0>5G-<H-)<"%*[&
MWE7W\CJQ> ?XSG&CC]9@*UE*>6^#+_G8"VU"6&%FK *CQP/>8%59(4KC]T[3
M.UA:XO%ZK_[)U4ZU+)G&&UG]X+DIQU[J08XKUE1F)C>?<5=/S^IELM+N%S8M
M-B;'K-%&UCLRQ347[9,][N[AB)"&KQ"B'2%R>;=&+LM;9MADI.0&E$63FEVX
M4AV;DN/"OI2Y473*B6<F,WQ T2#,,).%X.ZFSA=L6:&^& 6&'"PNR'9JUZU:
M](I:#'=2F%+#1Y%C_IP?4&:']*)]>M?12<$[ICH0=WV(PB@ZH1<?RHV=7OP/
MY?Z\6FJCZ//X=<(@.1@DSB!YQ>"6:U84"@OFM.4*=I8O7>9IJ46)L)(5M0T7
M!1C[3H :3Z,P&@P=WLAZS<3VW9LTZ@X^:,B?O#&GCFE+76XIBQ4J)[)=(YQS
M0739:"9R?7$)BU(A/GMQ[K;M3Q<6TK *OM)TV-6A88HJHQRH96UY+P#^BU-R
ME;^?,F6V,&5;5'1$^$K#&71C/^ZGT L[(;RU<>0/A@GTHDY,\2U7U.%_D0;^
ML$\5##L#0@S\>)A"''8B"J9*Y@WAYXP^<8C]09) -W'*L=]+8QM8TAS5 \\(
MTO7[Z1#ZSJN?IA!U4EJU)9Q!U/<'?2*%^^2BQ$^>-E[ZHH*C;JU1%6XF:<AD
M(TS;N(?=P]B[:KO]"=[.3&J/@@L-%:Z(&G8&/0]4.X?:P,BUZ_VE-#1)W+*D
MT8W* NA\):79!];@\&<P^0-02P,$%     @ [7VE5';%+Z6O @  1@8  !D
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MA,87DU% =#NU6L.JVD^*C;(X=_RVQ$$/VCG@_58IVQDN0/_7L?P#4$L#!!0
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MU/3P>!R!Z9^@7G%Z$]9^J1T-*8@UO=IH? #Y5UJ[O>(+#/\#LY]02P,$%
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M85G2<(J6!>@^-\9O-FR@&W=G_P!02P,$%     @ [7VE5&*9!:OK @  3 8
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M%2O08D&2MAB&?:#ELT64(E62BN-_OR,ERW;BN@/VP?11O'OXW!O)Z4;I;Z9
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MC#U>?-[#OZ\6QFHJ@G_.8"8=9N(QDW.8/;A1QIZ*V'GCAP(A5V6E)$IK0*U
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MD74J]0MW,BK0&B^P?"CF7*W<DB4A&<X%83G@>#5VIO!R!H<:8$Y\(7@K:L]
ME[)D[$DO;I*QX^F,,,6QU!1(_3SC"%.JF50>/RRI4\;4P/KS*_N5*5X5LT0"
M1XP^DD2F8V?H@ 2OT(;*.[:]QK:@GN:+&17F+]C:LYX#XHV0++-@E4%&\MTO
M>K&-J %@T #P+< _%-"U@.ZA@, " M.972FF#S,DT63$V19P?5JQZ0?33(-6
MY9-<W_M"<K5+%$Y.PHU0;X0 $<N6)$?Z,@0X!_,-CU/53S#G),9@2BF+S28X
MF6&)"!6GZM3#8@9./IR"#X#DX#YE&X'R1(Q<J3+3_&YLLPAW6?@-64P+W@%P
M> 9\SX=[X%$[_"/*.Z +&^&S=O@,QTUP5[6S[*E?]M0W?-T&OH5$$JMO0X*O
MG]06N%$K\:V%N%L2=PUQT$ <(9'N*V^'ZAN4_M"?)X-^SQNYSWMB!66LH#76
MH_I<2;X&,2J(1!2@Y+M2HZ[J#!2()/K&XX9\=LR]6CY=O[<_G5Z93J^]=)9+
ME8YN:JP42A+,C1SWA>^]"3]HZD:_#-]O#7_/= _.WX_=?W,5PT%3[8,R^* U
M^!6ATUN<M AH6#(-CZO,BY+XXF^4&5V\:0<,O(:[@%[E6=[_TF9DJ>OJ:,JG
MYJ'P6.*,+-4A\2N_@?Y1U!E9G@/OH[(EV.Y+GT-PC1&5:8PX;E$3K,P'!L<5
M*JR,!+[C)/N%$5I8O3=]O\DW8&4<L-TY_D&KH:4^R$AAY2:PW4[^0*VAI3K(
M2V'E0G!X%+V&EN>W_VQO.^#6QA\]K-XBOB9JBJ%XI6!>9Z#2Y[OY;[>0K# 3
MT9))-5^9QU3-S)CK VI_Q9A\7>@AJYS")[\ 4$L#!!0    ( .U]I53QY:.;
M<00  +43   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;*V878^;.!2&
M_XH5]:*5M@,VY&.J)%)FH-M9==11I^U>K/;" 2>Q:G!JFTG[[]<F#&8*]C)J
M;P(VO.>\/L8/Q,L3%U_E@1 %OA>LE*O)0:GCFR"0V8$46%[P(RGUE1T7!5:Z
M*?:!/ J"\UI4L "%X2PH,"TGZV7==R?62UXI1DMR)X"LB@*+'U>$\=-J B>/
M'1_I_J!,1[!>'O&>W!/U^7@G="MHH^2T(*6DO 2"[%:3#7R31I$1U'=\H>0D
M.^? #&7+^5?3N,E7D] X(HQDRH3 ^O! K@EC)I+V\:T).FES&F'W_#'ZVWKP
M>C!;+,DU9W_37!U6D\4$Y&2'*Z8^\M,[T@QH:N)EG,GZ%YR:>\,)R"JI>-&(
MM8."EN<C_MX4HB. L4. &@$:*X@:0316$#>">*Q@V@CJH0?GL=>%2[#"ZZ7@
M)R#,W3J:.:FK7ZMUO6AI'I1[)?15JG5J?55)W2,EN.;%EI;8S)X$K\%&2J(D
MV&3?*BI(#G"9@_<4;RFCBA)IKE>%[G^9$(4IDZ^TYO-] EZ^> 5> %J"3P=>
M2:V2RT!IGR9;D#6>KLZ>D,/3+187(()_ !0B-""_]LL3DK5R."!/_/+-46>'
M"Z<\]<O_PJ4K>Z#GIIT@U$X0JN-%CGCW"BNB5Z8"_[S7E\"-;LE_/8&C-G!4
M!XY=X\PR7I5ZC@7)"'W 6T:&:GT.,JN#&.H\K.=HN@P>!C+';>;8F_FF?-#C
MX4(_1T,9S^)I-V,\G'#:)IQZ$]Z2G&:8 :(?YF-=RP-A.="8!1(S O11Z%[,
MANQ,>W;B<-C.K+4S\]JY$YKS0OVH%U7K:2CWK)<;SN!P\GF;?/X_Q5>XW%,]
MVP#7:WPH[WQ@S- QZXLV\<*;^$_.\Q-E0S6^6O0>LF@.;97/IA8]4T]N>F+J
MLC5UZ37U04^$9EZY!XSHUPT0YKT"^ Y4TE>?RYX5M%@,.X&A)7'X+"_,XG80
M@F'/Q&NWB\[[ 'I=?.)Z'6B8'RN1'8R-HZ#9(!F:0-U96SC9 "WO(/(:>$O9
M1B]8#^&@11R,?B\\H648]$-L'#[3)DJW2(Y'%EJ:03_._/Q,89]8+H!"BRSH
M9]:O(#2%?8ZY& HMQZ ?9*,IFL(^SF"('/DMSJ"?9V- FL(^M*"3I-!2"_JQ
MY6%I"OMP@K/+X8S(P@D]#T[C0)FB/J30PO$&0Y91R,^HYY$R;:+]1$J7B\Z'
MF1]4HTF9-H&Z$(!QZ%@!R-(-^;_@/ER!=P0S=<BP(+Y/30LU%/]>7B(++>2'
MUCA>)DV44=^;R-(+^>GE)V:"^GQR38[%$_+CZ5> F: ^L5R&+*^0GU>C>9F@
M/K2F+H!89"$_LL;@,D%]=D6A:Z%$%EZ1'UX>7"91GU#1-'; (;*(BIZ'J'&\
M3*(^JN8.*Y93D9]3SZ-ETD1[0DN7A\Y_33^J1K,RB0;^<$8] @2='0^SH76+
MQ9Z64H]PIV7AQ5S;%^<]HG-#\6.]";+E2O&B/CT0G!-A;M#7=YRKQX;95VEW
MZM;_ 5!+ P04    " #M?:54H83A'TL#  ">#   &0   'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6RU5UM/VS 4_BM6Q -(@\3N#5!;B<*F(8T)T3$>ICVX
MR6ECD=C!=EJZ7S_;"4DG6C.D\M+&E_.=RV=_.1FNA'Q4*8!&SWG&U2A(M2[.
MPU#%*>14G8@"N%F9"YE3;89R$:I" DV<49Z%)(KZ84X9#\9#-W<KQT-1ZHQQ
MN)5(E7E.Y7H"F5B- AR\3-RQ1:KM1#@>%G0!4]#WQ:TTH[!!25@.7#'!D83Y
M*+C YQ/B#-R.GPQ6:N,9V51F0CS:P74R"B(;$600:PM!S=\2+B'++)*)XZD&
M#1J?UG#S^07]BTO>)#.C"BY%]L 2G8Z"TP E,*=EIN_$ZBO4"?4L7BPRY7[1
MJMH[Z <H+I46>6UL(L@9K_[I<UV(#0.RRX#4!L3%73ER45Y13<=#*59(VMT&
MS3ZX5)VU"8YQR\I42[/*C)T>3TIE9I1"ER*?,4YMJ10Z1M=<4[Y@LPS0A5*@
M%;J(GTHF(4&'5Z IR]01.D",HQ^I*!7EB1J&V@1D8<.X=CZIG),=SC%!-X+K
M5*'//('D7X#09-*D0U[2F1 OXA7$)ZB#/R$2$7P_O4*'!T<>V$Y3I8Z#[>R
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M$-KO39!?-^/5&%:5_DIOE<4!\<L<7R30+@#W=TK9H^$(NC<N^0502P,$%
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MH^$1@>L*@[M+3)O ^HSJZ]V5>UTE</_,,M<%!(>GR1P>GE"_<4)+F5NLCA8
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M7I[8E /)UL6AQS.3RO;B,J(DI#R?H)XO&9/[0;Y ?6XV^@]02P,$%     @
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M\W.B-K9).\\'>]21G7DR-_0/V604I>'#?MW^MAE%XV0PZL(,]YYAA7KKI]-
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MM8,P GI_SKE:3XP!][.0_@502P,$%     @ [7VE5$V"T9%?!   010  !D
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MB!J]2"2Y_8V>BK;^ $7;7(FT"-89I'&V_\N>"R,J 3@X$("+ -PV@!0!I&U
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M!;0-H/V%4KB=V.;5?JM&?P!02P,$%     @ [7VE5-OS.?A/ P  D T  !D
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M/YE F 7Z^99S]3XP37GQ$3;_"U!+ P04    " #M?:54,GOESKH#   8#P
M&0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6RU5UV/FSH0_2L6JM16ZB[8
MD*\JB=0F6MV56FFU'[T/5WWP$B>Q"G:N;9)N?WUMPP()QIM6[4N"X9SAS'@\
MPTP/7'R36T(4^)YG3,Z"K5*[]V$HTRW)L;SD.\+TDS47.59Z*3:AW F"5Y:4
M9R&*HF&88\J"^=3>NQ'S*2]41AFY$4 6>8[%TT>2\<,L@,'SC5NZV2IS(YQ/
M=WA#[HAZV-T(O0IK*RN:$R8I9T"0]2SX -\OD"58Q!=*#K)U#8PKCYQ_,XOK
MU2R(C"*2D509$UC_[<F"9)FQI'7\7QD-ZG<:8OOZV?J5=5X[\X@E6?#L7[I2
MVUDP#L"*K'&1J5M^^(=4#@V,O91GTOZ"0X6- I 64O&\(FL%.67E/_Y>!:)%
M@$D/ 54$="XAK@BQ=;149MU:8H7G4\$/0!BTMF8N;&PL6WM#F=G&.R7T4ZIY
M:KXDCPI<@+MR%P%?@P7/=Y@]O99@40A!F *8K< GSC87BH@<6,:;)5&89O*M
MYC[<+<&;5V_!*T 9N-_R0FJ"G(9*RS,O"=-*RL=2"NJ1\AF+2Q##=P!%"#GH
M"S]]2=*:#H_IH0Y*'1E41P99>[$O,M=,*E'D)@K_?=( <*U(+K]ZS,>U^=B:
M3WK,/P?WA@N3SZYPE0:&UH YCOLYBJ-IN&_'I(M)4%QCCI0EM;+$J\QN];W9
M:H^VTL2@]=YX$$6GZAPH-!DE;GV#6M_ J^^>*YRY- T<FKH1<Z#B>#)R:QK6
MFH9>30\,YR98/\@*['%6$'.2U);HBJ*SB$I98)82D'*IY#M]KLN]WY7Q-=BL
M/E^&X?)NV-%]T8IDZ9L?<^39J/9L] <]>]F-45<BBL8G?KA :.AV9%P[,OZ#
MCO0FV=@A;8Q.]#M <>MP'.F?U/HG9Q6,7TJ:24<(' Q/Q'8Q<3)Q:X51TU:B
MEXN(5UIEX/B]H\EI*%TP-$K&/0);?0_^7A6I>"?Q2$Y3U 6+H[XZ INN Y%7
MUQ5E.@\IVX /&T&(:3V>;@.;=@/CO]'.8-,UH+]MG-'08+<?=.NS ]3;TF#3
M,Z"_:9S5U&"W-W34^2#'VIK> ?W-HS\5N_7<$:\NJ#]>3=6'_K)_2_8\VYLT
M7 BRH@I<X91F5#WY<J4IQ7#\5Y*QJ97PO&+IV^QNW>N$U@<Y_JAL"B,ZHS"^
ME(C(4?0<GU<N6/_W%6IJ(_K-VECQAB_I<L <NL+6V&)F1CT ;"B3("-KS8LN
M1]HQ48YAY4+QG9UD'KG2<Y&]W.K1E0@#T,_7G*OGA1F.ZF%X_A-02P,$%
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MPX(N*M0N@/8SI>QQXEI;<_5-_@!02P,$%     @ [7VE5)#,!!]W @  O 4
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M*F])Z/]$ B\(.OBLO]_=[Z$3UHD++5YX/7%__HIK9*LA5W_U( ]JY(%%'EQ
M7@$FBIM</=,,\PI=XI<0(PMA2L5Q,9@$8]3EV)2DP\H;#T]6;_@-:W[#7GZ8
MT"OD2O]A<]N1-PS/R'58!=/!M)O<J"8WZB6WY1HD*$W@!2NMZJ0W:FT<C,=G
MY-HV87!!MW%-;?Q]U![P3)+'@N[)-[*F*B5W6,SK _KMZL'M^<8F-9?)#_YZ
MIS7RM#?*!X@RJA3;,:1?,)UB&=$%9+A3;@M"5T:F[8QX7K?:OG>JK%XODU_P
M$G5O,J&PKN&%%1FE=T;I%!4%U1.KWZC>_@_6T0].V,'_KP,5QAOI1I.SC[G#
MZ)*ZI_+GA[WLGCAV+1G[%[.<H-#84D0BX79<72N==,,6DTGK['48^8/)!<*G
MJNKWE]5E+@[FTI/-#U0+9'N]8E30;U1NB=RV\2^I?"JU?G^M_4)?R%Z*(S-M
M6R>S=A7]$/@M;FVK2]1.A=;OK[37KX$*H'G]3(?#<VIM(W]XGFRWT6#E(!/;
M=RH2F8R6'40]6_>V2]O1G<VO3,]K&[<33-DP8W^ QTV1#'8(Z=V.42Q9]J#E
M0(N];>.>A<:FT+ZFV+>#- :XOA-"OP[,!O4_@<5_4$L#!!0    ( .U]I53?
MO3)/F0(  &T'   9    >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;+556V^;
M,!3^*T>H#ZVT%@(D;%6"U%RF56JUJ)?M8=J# R?!JK$SVVG2?U_;$):F*<O+
M7L"7\UW.,1SWUT(^J0)1PZ9D7 V\0NOEI>^KK,"2J NQ1&YVYD*61)NI7/AJ
M*9'D#E0R/PR"GE\2RKVT[]:F,NV+E6:4XU2"6I4ED2]#9&(]\#K>=N&.+@IM
M%_RTOR0+O$?]N)Q*,_,;EIR6R!45'"3.!]Y5YW*2V'@7\(/B6NV,P68R$^+)
M3J[S@1=80\@PTY:!F-<SCI Q2V1L_*DYO4;2 G?'6_:O+G>3RXPH' GVD^:Z
M&'B?/<AQ3E9,WXGU-ZSSZ5J^3##EGK"N8KL]#[*5TJ*LP<9!27GU)INZ#CL
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MM8%Z/F%,KB<Z0'.'&OX'4$L#!!0    ( .U]I529R5A5FP(  'P'   9
M>&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;(V56V^;,!B&_XJ%>M%*:SE#4A&D
M'C2M4BM5/6P7TRZ<8()58S/[HVG__6R3TFQQDMV ;?R]S_MR^"A60KZHAA!
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MD4BS05^OA8"/B>G8XP^W_ -02P,$%     @ [7VE5&(0ZTD\!@  P!\  !D
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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M'Y]%9YK^,Y^-_^VY>@=02P$"% ,4    " #M?:54!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .U]
MI50WA5B@[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( .U]I5297)PC$ 8  )PG   3              "
M <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ [7VE5*<1C \^
M!0  ;!4  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( .U]I527QHU-( 8  $88   8              "
M@8(-  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #M?:54
ML+=8']H"  #X"   &               @('8$P  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ [7VE5-5->(Q]!0  5Q4  !@
M     ("!Z!8  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M .U]I537F+&K" 8  /8;   8              " @9L<  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " #M?:54PKG+OO\&  "?&P  &
M            @('9(@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ [7VE5+M(\>= !@  1P\  !@              ("!#BH  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( .U]I506J9H6500  /8)
M   8              " @80P  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " #M?:54\&,CEE@*  #'&@  &               @($/-0
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ [7VE5 8&W=%[
M P  =@D  !D              ("!G3\  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " #M?:54Y$ 0K@\#   P!P  &0
M@(%/0P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( .U]
MI50!41D]-0,  !\'   9              " @95&  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ [7VE5)D!P<1J!   HPH  !D
M         ("! 4H  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    " #M?:54#$Q@TO\*  ")'0  &0              @(&B3@  >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( .U]I52/SYDY<08  *T0
M   9              " @=A9  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ [7VE5#/<J<.I P  W <  !D              ("!@&
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #M?:54Y' +
M)D$$  #*"0  &0              @(%@9   >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( .U]I51-!P*_6@4  %,-   9
M  " @=AH  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
M[7VE5%F[FD'C!   #0P  !D              ("!:6X  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " #M?:54<$#J2A8%  !;#   &0
M            @(&#<P  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( .U]I529]( +I04  %,,   9              " @=!X  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ [7VE5"<ETE6! P
MUP<  !D              ("!K'X  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " #M?:54@I"!TGD%  #I$   &0              @(%D
M@@  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( .U]I51>
ME*<'T0(  !@&   9              " @12(  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ [7VE5';%+Z6O @  1@8  !D
M     ("!'(L  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M" #M?:54A8>PM,4"   3!@  &0              @($"C@  >&PO=V]R:W-H
M965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( .U]I52,\G>X@ 0  "D+   9
M              " @?Z0  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L!
M A0#%     @ [7VE5,9R3CG> P   PH  !D              ("!M94  'AL
M+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #M?:546V2TJD<$
M  #Z"@  &0              @('*F0  >&PO=V]R:W-H965T<R]S:&5E=#(Y
M+GAM;%!+ 0(4 Q0    ( .U]I51BF06KZP(  $P&   9              "
M@4B>  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ [7VE
M5)&54J#E P  =@D  !D              ("!:J$  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " #M?:54I=5:*!<$  #B"0  &0
M        @(&&I0  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( .U]I50&PCBL# ,  ,4)   9              " @=2I  !X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ [7VE5&\ RQX< P  D0L
M !D              ("!%ZT  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " #M?:54\>6CFW$$  "U$P  &0              @(%JL
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( .U]I52AA.$?
M2P,  )X,   9              " @1*U  !X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ [7VE5'+I<<LV @  [P0  !D
M ("!E+@  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #M
M?:54P0^T7!L#  "Q"P  &0              @($!NP  >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( .U]I51JKKV9 P0  $,3   9
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M970T,RYX;6Q02P$"% ,4    " #M?:54#@)J(4T"   Z!0  &0
M    @($\S@  >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M .U]I524:HN'D0(  #@(   9              " @<#0  !X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ [7VE5$V"T9%?!   010  !D
M             ("!B-,  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    " #M?:54FNT0UGL"  "Q!@  &0              @($>V   >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( .U]I51UX#)DS 4
M #8A   9              " @=#:  !X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ [7VE5%_6F'VJ @  MP8  !D              ("!
MT^   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #M?:54
MV_,Y^$\#  "0#0  &0              @(&TXP  >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( .U]I50R>^7.N@,  !@/   9
M      " @3KG  !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ [7VE5!H;);VT @  !@<  !D              ("!*^L  'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " #M?:54D,P$'W<"  "\!0
M&0              @($6[@  >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+
M 0(4 Q0    ( .U]I512M#*=I@,  !4,   9              " @<3P  !X
M;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ [7VE5-^],D^9
M @  ;0<  !D              ("!H?0  'AL+W=O<FMS:&5E=',O<VAE970U
M-2YX;6Q02P$"% ,4    " #M?:54R;'PO+T"   Q!P  &0
M@(%Q]P  >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( .U]
MI509@%W<)0,  !H)   9              " @67Z  !X;"]W;W)K<VAE971S
M+W-H965T-3<N>&UL4$L! A0#%     @ [7VE5$;)E'<L @  A 8  !D
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M<R\N<F5L<U!+ 0(4 Q0    ( .U]I51%@TXG[@0  'DH   /
M  "  <H0 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #M?:54]4F2S $"
M  !>)   &@              @ 'E%0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " #M?:54UDS DN !  #C(P  $P
M@ $>& $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     10!% -H2   O&@$
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>145</ContextCount>
  <ElementCount>266</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>47</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Recent Accounting Pronouncements and Developments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RecentAccountingPronouncementsandDevelopments</Role>
      <ShortName>Recent Accounting Pronouncements and Developments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103103 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2114105 - Disclosure - Medical Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/MedicalEquipment</Role>
      <ShortName>Medical Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2118106 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122107 - Disclosure - Goodwill &amp; Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillIntangibleAssets</Role>
      <ShortName>Goodwill &amp; Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2134109 - Disclosure - Derivative Financial Instruments and Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2140110 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2142111 - Disclosure - Commitments, Contingencies and Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/CommitmentsContingenciesandLitigation</Role>
      <ShortName>Commitments, Contingencies and Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2143112 - Disclosure - (Loss) Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LossEarningsPerShare</Role>
      <ShortName>(Loss) Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2147113 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2152114 - Disclosure - Business Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessSegmentInformation</Role>
      <ShortName>Business Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2155115 - Disclosure - COVID-19</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/COVID19</Role>
      <ShortName>COVID-19</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2235201 - Disclosure - Derivative Financial Instruments and Hedging Activities (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesPolicies</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://infusystem.com/role/BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/BusinessCombinations</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/RevenueRecognition</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Medical Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/MedicalEquipmentTables</Role>
      <ShortName>Medical Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/MedicalEquipment</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/PropertyandEquipment</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2323305 - Disclosure - Goodwill &amp; Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillIntangibleAssetsTables</Role>
      <ShortName>Goodwill &amp; Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/GoodwillIntangibleAssets</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/Debt</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Derivative Financial Instruments and Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2344308 - Disclosure - (Loss) Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LossEarningsPerShareTables</Role>
      <ShortName>(Loss) Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/LossEarningsPerShare</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2348309 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/Leases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2353310 - Disclosure - Business Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessSegmentInformationTables</Role>
      <ShortName>Business Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://infusystem.com/role/BusinessSegmentInformation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Business Combinations (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsDetailsTextual</Role>
      <ShortName>Business Combinations (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/BusinessCombinationsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Business Combinations - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Business Combinations - Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails</Role>
      <ShortName>Business Combinations - Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Business Combinations - Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails</Role>
      <ShortName>Business Combinations - Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Business Combinations - Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails</Role>
      <ShortName>Business Combinations - Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Revenue Recognition (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RevenueRecognitionDetailsTextual</Role>
      <ShortName>Revenue Recognition (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/RevenueRecognitionTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails</Role>
      <ShortName>Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Medical Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/MedicalEquipmentDetailsTextual</Role>
      <ShortName>Medical Equipment (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/MedicalEquipmentTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Medical Equipment - Summary of Medical Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails</Role>
      <ShortName>Medical Equipment - Summary of Medical Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Property and Equipment (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/PropertyandEquipmentDetailsTextual</Role>
      <ShortName>Property and Equipment (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Goodwill &amp; Intangible Assets (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillIntangibleAssetsDetailsTextual</Role>
      <ShortName>Goodwill &amp; Intangible Assets (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/GoodwillIntangibleAssetsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Goodwill &amp; Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill &amp; Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - Goodwill &amp; Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Goodwill &amp; Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2427415 - Disclosure - Goodwill &amp; Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails</Role>
      <ShortName>Goodwill &amp; Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Debt (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtDetailsTextual</Role>
      <ShortName>Debt (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/DebtTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails</Role>
      <ShortName>Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2432418 - Disclosure - Debt - Summary of Future Maturities of Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails</Role>
      <ShortName>Debt - Summary of Future Maturities of Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - Debt - Summary of Company's Current and Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails</Role>
      <ShortName>Debt - Summary of Company's Current and Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2437420 - Disclosure - Derivative Financial Instruments and Hedging Activities (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2438421 - Disclosure - Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2439422 - Disclosure - Derivative Financial Instruments and Hedging Activities - Derivative Financial Instruments Designated as Hedging Instruments in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails</Role>
      <ShortName>Derivative Financial Instruments and Hedging Activities - Derivative Financial Instruments Designated as Hedging Instruments in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Income Taxes (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/IncomeTaxesDetailsTextual</Role>
      <ShortName>Income Taxes (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/IncomeTaxes</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2445424 - Disclosure - (Loss) Earnings Per Share (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LossEarningsPerShareDetailsTextual</Role>
      <ShortName>(Loss) Earnings Per Share (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/LossEarningsPerShareTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2446425 - Disclosure - (Loss) Earnings Per Share - Calculation of Basic and Diluted EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails</Role>
      <ShortName>(Loss) Earnings Per Share - Calculation of Basic and Diluted EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2449426 - Disclosure - Leases (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesDetailsTextual</Role>
      <ShortName>Leases (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/LeasesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2450427 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2451428 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="infu-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2454429 - Disclosure - Business Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://infusystem.com/role/BusinessSegmentInformationDetails</Role>
      <ShortName>Business Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://infusystem.com/role/BusinessSegmentInformationTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="infu-20220331.htm">infu-20220331.htm</File>
    <File>infu-20220331.xsd</File>
    <File>infu-20220331_cal.xml</File>
    <File>infu-20220331_def.xml</File>
    <File>infu-20220331_lab.xml</File>
    <File>infu-20220331_pre.xml</File>
    <File>infu-20220331xexx3111.htm</File>
    <File>infu-20220331xexx3121.htm</File>
    <File>infu-20220331xexx3211.htm</File>
    <File>infu-20220331xexx3221.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>infu-20220331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="582">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>80
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "infu-20220331.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "contextCount": 145,
   "dts": {
    "calculationLink": {
     "local": [
      "infu-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "infu-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "infu-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "infu-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "infu-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "infu-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 415,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 1,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 6
   },
   "keyCustom": 37,
   "keyStandard": 229,
   "memberCustom": 15,
   "memberStandard": 32,
   "nsprefix": "infu",
   "nsuri": "http://infusystem.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://infusystem.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Revenue Recognition",
     "role": "http://infusystem.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:MedicalEquipmentAndPropertyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114105 - Disclosure - Medical Equipment",
     "role": "http://infusystem.com/role/MedicalEquipment",
     "shortName": "Medical Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:MedicalEquipmentAndPropertyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118106 - Disclosure - Property and Equipment",
     "role": "http://infusystem.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122107 - Disclosure - Goodwill & Intangible Assets",
     "role": "http://infusystem.com/role/GoodwillIntangibleAssets",
     "shortName": "Goodwill & Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - Debt",
     "role": "http://infusystem.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134109 - Disclosure - Derivative Financial Instruments and Hedging Activities",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities",
     "shortName": "Derivative Financial Instruments and Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140110 - Disclosure - Income Taxes",
     "role": "http://infusystem.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142111 - Disclosure - Commitments, Contingencies and Litigation",
     "role": "http://infusystem.com/role/CommitmentsContingenciesandLitigation",
     "shortName": "Commitments, Contingencies and Litigation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143112 - Disclosure - (Loss) Earnings Per Share",
     "role": "http://infusystem.com/role/LossEarningsPerShare",
     "shortName": "(Loss) Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147113 - Disclosure - Leases",
     "role": "http://infusystem.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "role": "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152114 - Disclosure - Business Segment Information",
     "role": "http://infusystem.com/role/BusinessSegmentInformation",
     "shortName": "Business Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:EffectOfCovid19PandemicTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155115 - Disclosure - COVID-19",
     "role": "http://infusystem.com/role/COVID19",
     "shortName": "COVID-19",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:EffectOfCovid19PandemicTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2235201 - Disclosure - Derivative Financial Instruments and Hedging Activities (Policies)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesPolicies",
     "shortName": "Derivative Financial Instruments and Hedging Activities (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Business Combinations (Tables)",
     "role": "http://infusystem.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://infusystem.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:ScheduleOfMedicalEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Medical Equipment (Tables)",
     "role": "http://infusystem.com/role/MedicalEquipmentTables",
     "shortName": "Medical Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "infu:ScheduleOfMedicalEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - Property and Equipment (Tables)",
     "role": "http://infusystem.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323305 - Disclosure - Goodwill & Intangible Assets (Tables)",
     "role": "http://infusystem.com/role/GoodwillIntangibleAssetsTables",
     "shortName": "Goodwill & Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - Debt (Tables)",
     "role": "http://infusystem.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Derivative Financial Instruments and Hedging Activities (Tables)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables",
     "shortName": "Derivative Financial Instruments and Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "role": "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344308 - Disclosure - (Loss) Earnings Per Share (Tables)",
     "role": "http://infusystem.com/role/LossEarningsPerShareTables",
     "shortName": "(Loss) Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348309 - Disclosure - Leases (Tables)",
     "role": "http://infusystem.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353310 - Disclosure - Business Segment Information (Tables)",
     "role": "http://infusystem.com/role/BusinessSegmentInformationTables",
     "shortName": "Business Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i25f33d209715440fbb5be414480b1768_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Business Combinations (Details Textual)",
     "role": "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
     "shortName": "Business Combinations (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i25f33d209715440fbb5be414480b1768_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Business Combinations - Purchase Price Allocation (Details)",
     "role": "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails",
     "shortName": "Business Combinations - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i48d920fb8bd246e2931e1366330a78d1_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i01f05e29baa14bd0a757fcfc29360491_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Business Combinations - Assets Acquired and Liabilities Assumed (Details)",
     "role": "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
     "shortName": "Business Combinations - Assets Acquired and Liabilities Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i01f05e29baa14bd0a757fcfc29360491_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i01f05e29baa14bd0a757fcfc29360491_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Business Combinations - Intangible Assets Acquired (Details)",
     "role": "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
     "shortName": "Business Combinations - Intangible Assets Acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i01f05e29baa14bd0a757fcfc29360491_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i25f33d209715440fbb5be414480b1768_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - Business Combinations - Pro Forma Information (Details)",
     "role": "http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails",
     "shortName": "Business Combinations - Pro Forma Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i25f33d209715440fbb5be414480b1768_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Revenue Recognition (Details Textual)",
     "role": "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
     "shortName": "Revenue Recognition (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i5095ccbbd602407d910da1f13f5d8d6d_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)",
     "role": "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails",
     "shortName": "Revenue Recognition - Disaggregated Revenue by Revenue Stream (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "ia2e5ce00d4ed4d9a97f7aed53faa1ff6_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)",
     "role": "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "infu:DepreciationExpenseRelatedToMedicalEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Medical Equipment (Details Textual)",
     "role": "http://infusystem.com/role/MedicalEquipmentDetailsTextual",
     "shortName": "Medical Equipment (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "infu:DepreciationExpenseRelatedToMedicalEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "infu:ScheduleOfMedicalEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:MedicalEquipmentHeldForSaleOrRentalGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Medical Equipment - Summary of Medical Equipment (Details)",
     "role": "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails",
     "shortName": "Medical Equipment - Summary of Medical Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "infu:ScheduleOfMedicalEquipmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:MedicalEquipmentHeldForSaleOrRentalGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationNonproduction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Property and Equipment (Details Textual)",
     "role": "http://infusystem.com/role/PropertyandEquipmentDetailsTextual",
     "shortName": "Property and Equipment (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationNonproduction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)",
     "role": "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails",
     "shortName": "Property and Equipment - Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Goodwill & Intangible Assets (Details Textual)",
     "role": "http://infusystem.com/role/GoodwillIntangibleAssetsDetailsTextual",
     "shortName": "Goodwill & Intangible Assets (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i01f05e29baa14bd0a757fcfc29360491_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Goodwill & Intangible Assets - Goodwill (Details)",
     "role": "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill & Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "ic700dbf08af94b2eae2ba16cb3c059e1_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - Goodwill & Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)",
     "role": "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails",
     "shortName": "Goodwill & Intangible Assets - Summary of Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "infu:CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427415 - Disclosure - Goodwill & Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)",
     "role": "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails",
     "shortName": "Goodwill & Intangible Assets - Expected Annual Amortization Expense for Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Debt (Details Textual)",
     "role": "http://infusystem.com/role/DebtDetailsTextual",
     "shortName": "Debt (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i11787656cdd7485983ece34ada8d626d_D20210205-20210205",
      "decimals": "INF",
      "lang": "en-US",
      "name": "infu:PercentageOfTotalDepreciationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i3266fe0bfd5844249bf77f4e1b271d97_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)",
     "role": "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails",
     "shortName": "Debt - Summary of Revolver Based Upon Borrowers' Eligible Accounts Receivable and Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i3266fe0bfd5844249bf77f4e1b271d97_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i5fb95b32e4654392b07c0102083ff1de_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (UNAUDITED)",
     "role": "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i5fb95b32e4654392b07c0102083ff1de_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432418 - Disclosure - Debt - Summary of Future Maturities of Loans (Details)",
     "role": "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
     "shortName": "Debt - Summary of Future Maturities of Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:LongtermDebtGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - Debt - Summary of Company's Current and Long-term Debt (Details)",
     "role": "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
     "shortName": "Debt - Summary of Company's Current and Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:LongtermDebtGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i46375b7fb651451ea71759de00ad04f8_I20210205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "numberofagreement",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437420 - Disclosure - Derivative Financial Instruments and Hedging Activities (Details Textual)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
     "shortName": "Derivative Financial Instruments and Hedging Activities (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i46375b7fb651451ea71759de00ad04f8_I20210205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNumberOfInstrumentsHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "numberofagreement",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i718b8b354a364afc9026b010eb60129b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438421 - Disclosure - Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails",
     "shortName": "Derivative Financial Instruments and Hedging Activities - Fair Value and Notional Amounts of Cash Flow Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i718b8b354a364afc9026b010eb60129b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i01f05e29baa14bd0a757fcfc29360491_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439422 - Disclosure - Derivative Financial Instruments and Hedging Activities - Derivative Financial Instruments Designated as Hedging Instruments in AOCI (Details)",
     "role": "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
     "shortName": "Derivative Financial Instruments and Hedging Activities - Derivative Financial Instruments Designated as Hedging Instruments in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i4b1ca0fa1a4549d0b3d620aeaa0f1a50_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Income Taxes (Details Textual)",
     "role": "http://infusystem.com/role/IncomeTaxesDetailsTextual",
     "shortName": "Income Taxes (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i0649b764378d49608401c1e982e219f9_I20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i25f33d209715440fbb5be414480b1768_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445424 - Disclosure - (Loss) Earnings Per Share (Details Textual)",
     "role": "http://infusystem.com/role/LossEarningsPerShareDetailsTextual",
     "shortName": "(Loss) Earnings Per Share (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i25f33d209715440fbb5be414480b1768_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446425 - Disclosure - (Loss) Earnings Per Share - Calculation of Basic and Diluted EPS (Details)",
     "role": "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails",
     "shortName": "(Loss) Earnings Per Share - Calculation of Basic and Diluted EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449426 - Disclosure - Leases (Details Textual)",
     "role": "http://infusystem.com/role/LeasesDetailsTextual",
     "shortName": "Leases (Details Textual)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450427 - Disclosure - Leases - Lease Cost (Details)",
     "role": "http://infusystem.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451428 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "role": "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "i670dd04a7e7b4ccfa103e1c4216749f4_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:RevenuesExternal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454429 - Disclosure - Business Segment Information (Details)",
     "role": "http://infusystem.com/role/BusinessSegmentInformationDetails",
     "shortName": "Business Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "infu:RevenuesExternal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies",
     "role": "http://infusystem.com/role/BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Recent Accounting Pronouncements and Developments",
     "role": "http://infusystem.com/role/RecentAccountingPronouncementsandDevelopments",
     "shortName": "Recent Accounting Pronouncements and Developments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103103 - Disclosure - Business Combinations",
     "role": "http://infusystem.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "infu-20220331.htm",
      "contextRef": "if9fd90e0c75a405283198b794bbb93da_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 47,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://infusystem.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "infu_ABRLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the ABR loans.",
        "label": "ABR Loans [Member]",
        "terseLabel": "ABR Loans"
       }
      }
     },
     "localname": "ABRLoansMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma acquisition cost and non-recurring expense for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition Pro Forma Acquisition Cost And Nonrecurring Expense",
        "terseLabel": "Pro forma acquisition cost and non-recurring expense"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaAcquisitionCostAndNonrecurringExpense",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_BusinessCombinationContingentConsiderationAndWorkingCapitalLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration and Working Capital, Liability",
        "label": "Business Combination, Contingent Consideration and Working Capital, Liability",
        "terseLabel": "Contingent consideration and working capital"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAndWorkingCapitalLiability",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of medical equipment in rental service recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Medical Equipment Held For Sale Or Rental",
        "terseLabel": "Medical equipment held for sale or rental"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMedicalEquipmentHeldForSaleOrRental",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of operating lease right of use asset recognized as of the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Asset",
        "terseLabel": "Operating lease right of use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount and accumulated amortization of identifiable intangible assets.",
        "label": "Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets [Table Text Block]",
        "terseLabel": "Carrying Amount and Accumulated Amortization of Identifiable Intangible Assets"
       }
      }
     },
     "localname": "CarryingAmountAndAccumulatedAmortizationOfIdentifiableIntangibleAssetsTableTextBlock",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_CorporateAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding corporate and eliminations.",
        "label": "Corporate and Eliminations [Member]",
        "terseLabel": "Corporate/ Eliminations"
       }
      }
     },
     "localname": "CorporateAndEliminationsMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_Covid19Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covid-19",
        "label": "Covid-19 [Abstract]"
       }
      }
     },
     "localname": "Covid19Abstract",
     "nsuri": "http://infusystem.com/20220331",
     "xbrltype": "stringItemType"
    },
    "infu_DMEServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the DME Services segment.",
        "label": "DME Services Segment [Member]",
        "terseLabel": "DME Services"
       }
      }
     },
     "localname": "DMEServicesSegmentMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_DebtInstrumentCovenantMaximumLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum leverage ratio required by the debt agreement.",
        "label": "Debt Instrument Covenant Maximum Leverage Ratio",
        "terseLabel": "Debt instrument, covenant, maximum leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumLeverageRatio",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "pureItemType"
    },
    "infu_DebtInstrumentCovenantMinimumFixedCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum fixed coverage ratio required by the debt agreement.",
        "label": "Debt Instrument Covenant Minimum Fixed Coverage Ratio",
        "terseLabel": "Debt instrument, covenant, minimum fixed coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMinimumFixedCoverageRatio",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "pureItemType"
    },
    "infu_DepreciationExpenseRelatedToMedicalEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of depreciation expense related to medical equipment recorded during the period.",
        "label": "Depreciation Expense Related To Medical Equipment",
        "terseLabel": "Depreciation expense related to medical equipment"
       }
      }
     },
     "localname": "DepreciationExpenseRelatedToMedicalEquipment",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_DirectPayerRentalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents direct payer rental revenue.",
        "label": "Direct Payer Rentals [Member]",
        "terseLabel": "Direct Payer Rentals"
       }
      }
     },
     "localname": "DirectPayerRentalsMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_EffectOfCovid19PandemicTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for effects of COVID-19 pandemic.",
        "label": "Effect of Covid-19 Pandemic [Text Block]",
        "terseLabel": "COVID-19"
       }
      }
     },
     "localname": "EffectOfCovid19PandemicTextBlock",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/COVID19"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_EurodollarLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to the Eurodollar Loan.",
        "label": "Eurodollar Loan [Member]",
        "terseLabel": "Eurodollar Loan"
       }
      }
     },
     "localname": "EurodollarLoanMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_FilAMedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to FilAMed.",
        "label": "FilAMed [Member]",
        "terseLabel": "FilAMed"
       }
      }
     },
     "localname": "FilAMedMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_FinancingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the financing agreement (the \"Financing Agreement\").",
        "label": "Financing Agreement [Member]",
        "terseLabel": "Financing Agreement"
       }
      }
     },
     "localname": "FinancingAgreementMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Finite-Lived Intangible Asset, Amortization Expense, Year Five and After",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetAmortizationExpenseYearFiveAndAfter",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_ITSSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the ITS segment.",
        "label": "ITS Segment [Member]",
        "terseLabel": "ITS"
       }
      }
     },
     "localname": "ITSSegmentMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_LIBORRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the LIBOR rate as of the specified date.",
        "label": "LIBOR Rate",
        "terseLabel": "LIBOR rate"
       }
      }
     },
     "localname": "LIBORRate",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_LenderPrimeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the lender's prime rate as of the specified date.",
        "label": "Lender Prime Rate",
        "terseLabel": "Lender prime rate"
       }
      }
     },
     "localname": "LenderPrimeRate",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee Operating Lease Liability To Be Paid After Year Four",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional borrowing capacity under the credit facility subject to certain conditions.",
        "label": "Line Of Credit Facility Additional Borrowing Capacity Subject To Certain Conditions",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityAdditionalBorrowingCapacitySubjectToCertainConditions",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_LongTermDebtGrossNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt, excluding the current portion. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long term Debt Gross Noncurrent",
        "verboseLabel": "Long-Term Portion"
       }
      }
     },
     "localname": "LongTermDebtGrossNoncurrent",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year and after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long term Debt Maturities Repayments Of Principal Year Four And Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_LongtermDebtGrossCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of the current portion of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Longterm Debt Gross Current",
        "verboseLabel": "Current Portion"
       }
      }
     },
     "localname": "LongtermDebtGrossCurrent",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Equipment",
        "label": "Medical Equipment [Abstract]",
        "terseLabel": "Notes To Financial Statements [Abstract]"
       }
      }
     },
     "localname": "MedicalEquipmentAbstract",
     "nsuri": "http://infusystem.com/20220331",
     "xbrltype": "stringItemType"
    },
    "infu_MedicalEquipmentAndPropertyDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for medical equipment and property.",
        "label": "Medical Equipment and Property Disclosure [Text Block]",
        "terseLabel": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentAndPropertyDisclosureTextBlock",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_MedicalEquipmentForSaleOrRentalReserve": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 1.0,
       "parentTag": "infu_MedicalEquipmentHeldForSaleOrRental",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of reserve associated with medical equipment for sale or rental, as of the balance sheet date.",
        "label": "Medical Equipment For Sale Or Rental Reserve",
        "negatedTerseLabel": "Medical equipment for sale or rental - pump reserve"
       }
      }
     },
     "localname": "MedicalEquipmentForSaleOrRentalReserve",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentHeldForSaleOrRental": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 2.0,
       "parentTag": "infu_MedicalEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents medical equipment held for sale or rental as of the balance sheet date.",
        "label": "Medical equipment for sale or rental",
        "terseLabel": "Medical equipment for sale or rental",
        "totalLabel": "Medical equipment for sale or rental - net"
       }
      }
     },
     "localname": "MedicalEquipmentHeldForSaleOrRental",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentHeldForSaleOrRentalGross": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 2.0,
       "parentTag": "infu_MedicalEquipmentHeldForSaleOrRental",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents medical equipment held for sale or rental as of the balance sheet date, before reserves.",
        "label": "Medical Equipment Held For Sale Or Rental Gross",
        "terseLabel": "Medical equipment for sale or rental"
       }
      }
     },
     "localname": "MedicalEquipmentHeldForSaleOrRentalGross",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 1.0,
       "parentTag": "infu_MedicalEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date.",
        "label": "Medical equipment in rental service, net of accumulated depreciation",
        "terseLabel": "Medical equipment in rental service, net of accumulated depreciation",
        "totalLabel": "Medical equipment in rental service - net"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServicesAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 1.0,
       "parentTag": "infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of accumulated depreciation related to medical equipment in rental services.",
        "label": "Medical Equipment In Rental Services Accumulated Depreciation",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServicesAccumulatedDepreciation",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServicesGross": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 3.0,
       "parentTag": "infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the gross amount of medical equipment in rental services.",
        "label": "Medical Equipment In Rental Services Gross",
        "verboseLabel": "Medical equipment in rental service"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServicesGross",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentInRentalServicesReserve": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": 2.0,
       "parentTag": "infu_MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of medical equipment in rental services reserve, as of the balance sheet date.",
        "label": "Medical Equipment In Rental Services Reserve",
        "negatedTerseLabel": "Medical equipment in rental service - pump reserve"
       }
      }
     },
     "localname": "MedicalEquipmentInRentalServicesReserve",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents medical equipment.",
        "label": "Medical Equipment [Member]",
        "terseLabel": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_MedicalEquipmentNet": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the net amount of medical equipment, as of the balance sheet date.",
        "label": "Medical Equipment Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MedicalEquipmentNet",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentSummaryofMedicalEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_OBHealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the acquisition of OB Healthcare Corporation.",
        "label": "OB Healthcare [Member]",
        "terseLabel": "OB Healthcare"
       }
      }
     },
     "localname": "OBHealthcareMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Business, Excluding Working Capital Adjustments",
        "label": "Payments to Acquire Business, Excluding Working Capital Adjustments",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessExcludingWorkingCapitalAdjustments",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_PaymentsToAcquireMedicalEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of cash paid during the period to acquire medical equipment.",
        "label": "Payments To Acquire Medical Equipment",
        "negatedLabel": "Purchase of medical equipment",
        "terseLabel": "Purchases of medical equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireMedicalEquipment",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_PercentageOfTotalDepreciationExpense": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of total depreciation expense.",
        "label": "Percentage Of Total Depreciation Expense",
        "terseLabel": "Percentage of total depreciation expense"
       }
      }
     },
     "localname": "PercentageOfTotalDepreciationExpense",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "infu_PhysicianAndCustomerRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to physician and customer relationships.",
        "label": "Physician and Customer Relationships [Member]",
        "terseLabel": "Physician and customer relationships"
       }
      }
     },
     "localname": "PhysicianAndCustomerRelationshipsMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_ProductSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information about product sales.",
        "label": "Product Sales [Member]",
        "terseLabel": "Product Sales"
       }
      }
     },
     "localname": "ProductSalesMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_RevenuesExternal": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessSegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of external net revenues recognized during the period.",
        "label": "Net revenues - external",
        "terseLabel": "Net revenues - external"
       }
      }
     },
     "localname": "RevenuesExternal",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_RevenuesInternal": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessSegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of internal net revenues recognized during the period.",
        "label": "Net revenues - internal",
        "terseLabel": "Net revenues - internal"
       }
      }
     },
     "localname": "RevenuesInternal",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_ScheduleOfMedicalEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of medical equipment.",
        "label": "Schedule of Medical Equipment [Table Text Block]",
        "terseLabel": "Schedule of Medical Equipment"
       }
      }
     },
     "localname": "ScheduleOfMedicalEquipmentTableTextBlock",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/MedicalEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "infu_ShareRepurchaseProgramCumulativeSharesPurchasedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program, Cumulative Shares Purchased, Shares",
        "label": "Share Repurchase Program, Cumulative Shares Purchased, Shares",
        "terseLabel": "Cumulative shares purchased (in shares)"
       }
      }
     },
     "localname": "ShareRepurchaseProgramCumulativeSharesPurchasedShares",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/LossEarningsPerShareDetailsTextual"
     ],
     "xbrltype": "sharesItemType"
    },
    "infu_ShareRepurchaseProgramCumulativeSharesRepurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program, Cumulative Shares Repurchased",
        "label": "Share Repurchase Program, Cumulative Shares Repurchased",
        "terseLabel": "Cumulative shares purchased"
       }
      }
     },
     "localname": "ShareRepurchaseProgramCumulativeSharesRepurchased",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/LossEarningsPerShareDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_The2015CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the \"2015 Credit Agreement\".",
        "label": "The 2015 Credit Agreement [Member]",
        "terseLabel": "The 2015 Credit Agreement"
       }
      }
     },
     "localname": "The2015CreditAgreementMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_The2021CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the \"2021 Credit Agreement\".",
        "label": "The 2021 Credit Agreement [Member]",
        "terseLabel": "The 2021 Credit Agreement"
       }
      }
     },
     "localname": "The2021CreditAgreementMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_ThirdPartyPayerRentalRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents third-party payor rental revenue.",
        "label": "Third-Party Payer Rental Revenue [Member]",
        "terseLabel": "Third-Party Payor Rental Revenue"
       }
      }
     },
     "localname": "ThirdPartyPayerRentalRevenueMember",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "infu_UnamortizedDebtIssuanceExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtCurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current portion of unamortized debt issuance expense.",
        "label": "Unamortized Debt Issuance Expense Current",
        "negatedTerseLabel": "Unamortized value of the debt issuance costs, current portion of long-term debt"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpenseCurrent",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_UnamortizedDebtIssuanceExpenseNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The noncurrent portion of unamortized debt issuance expense.",
        "label": "Unamortized Debt Issuance Expense Noncurrent",
        "negatedTerseLabel": "Unamortized value of the debt issuance costs, long-term debt"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpenseNoncurrent",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "infu_WorkingCapital": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of working capital adjustments incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Working capital",
        "terseLabel": "Working capital adjustment, paid in cash"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://infusystem.com/20220331",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r98",
      "r144",
      "r157",
      "r158",
      "r159",
      "r160",
      "r162",
      "r164",
      "r168",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r232",
      "r234",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r98",
      "r144",
      "r157",
      "r158",
      "r159",
      "r160",
      "r162",
      "r164",
      "r168",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r232",
      "r234",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r240",
      "r274",
      "r306",
      "r308",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r489",
      "r491",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r240",
      "r274",
      "r306",
      "r308",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r489",
      "r491",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r170",
      "r290",
      "r292",
      "r454",
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r170",
      "r290",
      "r292",
      "r454",
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r240",
      "r274",
      "r304",
      "r306",
      "r308",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r489",
      "r491",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r240",
      "r274",
      "r304",
      "r306",
      "r308",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r489",
      "r491",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r29",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r18",
      "r175",
      "r176"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent": {
     "auth_ref": [
      "r466",
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs.",
        "label": "Accrued Payroll Taxes",
        "terseLabel": "Payroll taxes"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r27",
      "r207"
     ],
     "calculation": {
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated Depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r49",
      "r56",
      "r57",
      "r58",
      "r59",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Gain/(loss) on cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r46",
      "r48",
      "r49",
      "r478",
      "r496",
      "r499"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r45",
      "r49",
      "r56",
      "r57",
      "r58",
      "r100",
      "r101",
      "r102",
      "r373",
      "r492",
      "r493",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19",
      "r315",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r311",
      "r312",
      "r313",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r309",
      "r310",
      "r316",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r68",
      "r87",
      "r260",
      "r425"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r87",
      "r192",
      "r198"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangibles",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/GoodwillIntangibleAssetsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LossEarningsPerShareDetailsTextual"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r93",
      "r152",
      "r159",
      "r166",
      "r180",
      "r222",
      "r223",
      "r224",
      "r226",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r235",
      "r236",
      "r370",
      "r374",
      "r411",
      "r444",
      "r446",
      "r462",
      "r476"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r41",
      "r93",
      "r180",
      "r222",
      "r223",
      "r224",
      "r226",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r235",
      "r236",
      "r370",
      "r374",
      "r411",
      "r444",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AutomobilesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vehicles that are used primarily for transporting people.",
        "label": "Automobiles [Member]",
        "terseLabel": "Automobiles"
       }
      }
     },
     "localname": "AutomobilesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails",
      "http://infusystem.com/role/IncomeTaxesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r384",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails",
      "http://infusystem.com/role/IncomeTaxesDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BasisofPresentationNatureofOperationsandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r305",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r305",
      "r307",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r345",
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r345",
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition costs and non-recurring expenses"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r359",
      "r360",
      "r362"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Total - consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r357",
      "r359",
      "r360",
      "r364"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r358",
      "r361",
      "r365"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "auth_ref": [
      "r350"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease obligation assumed in business combination.",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "negatedLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r350"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r350"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Acquisition date fair value"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r350"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total - purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSegmentAllocationTable": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about goodwill in a business combination.",
        "label": "Business Combination, Segment Allocation [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "BusinessCombinationSegmentAllocationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r25",
      "r89"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r84",
      "r89",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r84",
      "r415"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "negatedLabel": "Reclassified within twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollateralAxis": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Axis]",
        "terseLabel": "Collateral Held [Axis]"
       }
      }
     },
     "localname": "CollateralAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollateralDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Domain]",
        "terseLabel": "Collateral Held [Domain]"
       }
      }
     },
     "localname": "CollateralDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r219",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments, Contingencies and Litigation"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CommitmentsContingenciesandLitigation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r100",
      "r101",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock,, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r17",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r17",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value: 200,000,000 shares authorized; 20,540,143 shares issued and outstanding as of March\u00a031, 2022 and 20,699,546 shares issued and outstanding as of December\u00a031, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r55",
      "r64",
      "r469",
      "r484"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Net comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Comprehensive income:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r193",
      "r196",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r173",
      "r409",
      "r410",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r173",
      "r409",
      "r410",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r173",
      "r409",
      "r410",
      "r500",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r138",
      "r139",
      "r173",
      "r409",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r173",
      "r409",
      "r410",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r290",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r290",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r70",
      "r454"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r137",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Physician and customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r91",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r254",
      "r261",
      "r262",
      "r264",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r92",
      "r98",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r268",
      "r269",
      "r270",
      "r271",
      "r426",
      "r463",
      "r464",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r15",
      "r265",
      "r464",
      "r475"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding borrowings",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r35",
      "r267",
      "r424",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r36",
      "r92",
      "r98",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r268",
      "r269",
      "r270",
      "r271",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r36",
      "r92",
      "r98",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r244",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r263",
      "r268",
      "r269",
      "r270",
      "r271",
      "r276",
      "r277",
      "r278",
      "r279",
      "r423",
      "r424",
      "r426",
      "r427",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r318",
      "r319"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r87",
      "r94",
      "r327",
      "r336",
      "r337",
      "r338"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r87",
      "r205"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r87",
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationNonproduction": {
     "auth_ref": [
      "r87",
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.",
        "label": "Depreciation, Nonproduction",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationNonproduction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r377",
      "r378",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r42",
      "r43",
      "r44",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Fair Value Derivative Assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Fixed interest rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r44",
      "r385",
      "r386",
      "r391",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r402",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Financial Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r382",
      "r385",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNetHedgeIneffectivenessGainLoss": {
     "auth_ref": [
      "r390",
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from the ineffectiveness of the hedge.",
        "label": "Derivative, Net Hedge Ineffectiveness Gain (Loss)",
        "terseLabel": "Net hedge ineffectiveness gain (loss)"
       }
      }
     },
     "localname": "DerivativeNetHedgeIneffectivenessGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r378",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r376",
      "r379",
      "r380",
      "r382",
      "r383",
      "r388",
      "r391",
      "r395",
      "r397",
      "r400",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Term of contract (year)"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r97",
      "r376",
      "r379",
      "r382",
      "r383",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives Accounting Policy"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r65",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r120",
      "r122",
      "r127",
      "r128",
      "r129",
      "r133",
      "r134",
      "r405",
      "r406",
      "r470",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net (loss) income per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r65",
      "r109",
      "r110",
      "r111",
      "r112",
      "r113",
      "r122",
      "r127",
      "r128",
      "r129",
      "r133",
      "r134",
      "r405",
      "r406",
      "r470",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "(Loss) Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LossEarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r56",
      "r57",
      "r58",
      "r100",
      "r101",
      "r102",
      "r106",
      "r114",
      "r116",
      "r136",
      "r181",
      "r275",
      "r280",
      "r311",
      "r312",
      "r313",
      "r329",
      "r330",
      "r404",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r492",
      "r493",
      "r494",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.",
        "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted average amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      },
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r193",
      "r194",
      "r197",
      "r201",
      "r455",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r197",
      "r459"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Amortizable intangible assets:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r193",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r197",
      "r455"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsExpectedAnnualAmortizationExpenseforIntangibleAssetsDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, fixtures, and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r87",
      "r204",
      "r209"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "(Gain) loss on sale of medical equipment"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r186",
      "r187",
      "r446",
      "r461"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsAssetsAcquiredandLiabilitiesAssumedDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r69",
      "r93",
      "r152",
      "r158",
      "r162",
      "r165",
      "r168",
      "r180",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r235",
      "r236",
      "r411"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r382",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r87",
      "r203"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Loss on disposal of and reserve adjustments for medical equipment"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r152",
      "r158",
      "r162",
      "r165",
      "r168",
      "r460",
      "r467",
      "r472",
      "r486"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "(Loss) income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r210",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r322",
      "r323",
      "r325",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r95",
      "r321",
      "r324",
      "r326",
      "r334",
      "r339",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r115",
      "r116",
      "r150",
      "r320",
      "r335",
      "r340",
      "r487"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Benefit from income taxes",
        "negatedTerseLabel": "Benefit from income taxes",
        "terseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/IncomeTaxesDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in assets - (increase)/decrease:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Liabilities [Abstract]",
        "terseLabel": "Changes in liabilities - increase/(decrease):"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r129"
     ],
     "calculation": {
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of common stock equivalents (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r200"
     ],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Total nonamortizable and amortizable intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r191",
      "r195"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r60",
      "r146",
      "r422",
      "r425",
      "r471"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDetailsTextual",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r39",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r439",
      "r441"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term (year)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesDetailsTextual"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "negatedLabel": "Letter of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r32",
      "r93",
      "r160",
      "r180",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r235",
      "r236",
      "r371",
      "r374",
      "r375",
      "r411",
      "r444",
      "r445"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r93",
      "r180",
      "r411",
      "r446",
      "r465",
      "r480"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r93",
      "r180",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r235",
      "r236",
      "r371",
      "r374",
      "r375",
      "r411",
      "r444",
      "r445",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r15",
      "r464",
      "r475"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "negatedLabel": "Outstanding draws",
        "terseLabel": "Long-term line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "totalLabel": "Gross availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Availability on Revolving Facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r15",
      "r251",
      "r266",
      "r268",
      "r269",
      "r464",
      "r477"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt",
        "totalLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r98",
      "r220",
      "r256"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r98",
      "r220",
      "r256"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r98",
      "r220",
      "r256"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r36",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r84",
      "r85",
      "r88"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r50",
      "r53",
      "r58",
      "r63",
      "r88",
      "r93",
      "r105",
      "r109",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r126",
      "r152",
      "r158",
      "r162",
      "r165",
      "r168",
      "r180",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r235",
      "r236",
      "r406",
      "r411",
      "r468",
      "r483"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net (loss) income",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED",
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r1",
      "r103",
      "r104",
      "r107",
      "r108",
      "r117",
      "r118",
      "r119",
      "r178",
      "r179",
      "r182",
      "r183",
      "r299",
      "r300",
      "r301",
      "r302",
      "r314",
      "r331",
      "r332",
      "r333",
      "r403",
      "r412",
      "r413",
      "r414",
      "r443",
      "r456",
      "r457",
      "r458",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "Recent Accounting Pronouncements and Developments"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RecentAccountingPronouncementsandDevelopments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-competition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Unrealized gain recognized in AOCI"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Selling, general and administrative expenses",
        "totalLabel": "Total selling, general and administrative"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r152",
      "r158",
      "r162",
      "r165",
      "r168"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating (loss) income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r433",
      "r441"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r430",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flow from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right of use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r438",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate:"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r437",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term:"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r162",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r40",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent",
        "terseLabel": "Unrealized gain on hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent",
        "negatedLabel": "Provision for income tax on unrealized hedge gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r51",
      "r54",
      "r368",
      "r369",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "auth_ref": [
      "r368",
      "r369",
      "r372"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "negatedLabel": "Tax provision"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r33",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r384",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/IncomeTaxesDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesFairValueandNotionalAmountsofCashFlowHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Common stock repurchased as part of share repurchase program"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r74",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "verboseLabel": "Payments to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of business"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r16",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r16",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Borrowings under revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r78",
      "r83"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Cash proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "terseLabel": "Proceeds from sale of medical equipment, property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Cash proceeds from stock plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r27",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r212",
      "r503",
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r26",
      "r206"
     ],
     "calculation": {
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross Assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r11",
      "r12",
      "r208",
      "r446",
      "r473",
      "r481"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property &amp; equipment, net of accumulated depreciation",
        "totalLabel": "Property &amp; equipment, net of accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r11",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r11",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r67",
      "r184"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "negatedLabel": "Amounts reclassified to interest expense"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.",
        "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security",
        "negatedLabel": "Principal payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "terseLabel": "Repayments"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r280",
      "r315",
      "r446",
      "r479",
      "r495",
      "r499"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r100",
      "r101",
      "r102",
      "r106",
      "r114",
      "r116",
      "r181",
      "r311",
      "r312",
      "r313",
      "r329",
      "r330",
      "r404",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r138",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r291",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r61",
      "r93",
      "r143",
      "r144",
      "r157",
      "r163",
      "r164",
      "r170",
      "r171",
      "r173",
      "r180",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r231",
      "r233",
      "r235",
      "r236",
      "r411",
      "r472"
     ],
     "calculation": {
      "http://infusystem.com/role/BusinessSegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net revenues",
        "totalLabel": "Total net revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual",
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual",
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails",
      "http://infusystem.com/role/DebtSummaryofFutureMaturitiesofLoansDetails",
      "http://infusystem.com/role/DebtSummaryofRevolverBasedUponBorrowersEligibleAccountsReceivableandInventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r436",
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsDetailsTextual",
      "http://infusystem.com/role/BusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.",
        "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LossEarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Line of Credit Facilities"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r27",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r152",
      "r155",
      "r161",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r152",
      "r155",
      "r161",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r140",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r157",
      "r158",
      "r159",
      "r160",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r168",
      "r173",
      "r214",
      "r215",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r152",
      "r156",
      "r162",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r172",
      "r173",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, General and Administrative Expense [Abstract]",
        "terseLabel": "Selling, general and administrative expenses:"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/RevenueRecognitionDisaggregatedRevenuebyRevenueStreamDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balances (in shares)",
        "periodStartLabel": "Balances (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r140",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r157",
      "r158",
      "r159",
      "r160",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r168",
      "r173",
      "r189",
      "r211",
      "r214",
      "r215",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessSegmentInformationDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsGoodwillDetails",
      "http://infusystem.com/role/RevenueRecognitionDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r38",
      "r56",
      "r57",
      "r58",
      "r100",
      "r101",
      "r102",
      "r106",
      "r114",
      "r116",
      "r136",
      "r181",
      "r275",
      "r280",
      "r311",
      "r312",
      "r313",
      "r329",
      "r330",
      "r404",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r492",
      "r493",
      "r494",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r136",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r16",
      "r17",
      "r275",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Stock-based shares issued upon vesting - gross (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Stock-based shares issued upon vesting - gross"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LossEarningsPerShareDetailsTextual"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r16",
      "r17",
      "r275",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Common stock repurchased as part of share repurchase program (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r16",
      "r17",
      "r275",
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Common stock repurchased as part of share repurchase program"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r17",
      "r22",
      "r23",
      "r93",
      "r177",
      "r180",
      "r411",
      "r446"
     ],
     "calculation": {
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED",
      "http://infusystem.com/role/DerivativeFinancialInstrumentsandHedgingActivitiesDerivativeFinancialInstrumentsDesignatedasHedgingInstrumentsinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Unpatented technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/BusinessCombinationsIntangibleAssetsAcquiredDetails",
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/GoodwillIntangibleAssetsSummaryofCarryingAmountandAccumulatedAmortizationofIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r37",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTotalLabel": "Unamortized value of the debt issuance costs, Total"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtSummaryofCompanysCurrentandLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r434",
      "r441"
     ],
     "calculation": {
      "http://infusystem.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/DebtDetailsTextual"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r121",
      "r129"
     ],
     "calculation": {
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r120",
      "r129"
     ],
     "calculation": {
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://infusystem.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUNAUDITED",
      "http://infusystem.com/role/LossEarningsPerShareCalculationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r508": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r509": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r510": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r511": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r512": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r513": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001628280-22-012595-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-012595-xbrl.zip
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M1RD,A19Z DEN*Y9?6;;WSB/., K1JS%I7T&@*G@A(HQ60GVS$&IJBF41:?.
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M0S/+"S.[/&8V$G7[\B0S65&D=#E%ECQ63GL>K.N\[9!9]O&]&,T+K3Y/6IW
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M)Y(5V"FP\Q@S,LNI1H.])=Y;:BCC>=.ZQ 1-+G!.8^3B>MSIPF/";P6 'A>
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M&B@F%R_T]8@&Y$\-=/X%#1Y\%/9@L_H;#*]6MB':WZO:^)7],IC:9C6UP&:
M#L,W;#6"H?DT&.%@V*,/ (?L#XCV2+'"K8&$_*SX%$RV&_GS*I9]>8+RL(;#
M/Q^YMYU.92 -'MV.<Z!KGR<STRNN/[XUO@.E'>E\,"%BQ:^R!6&KT?W'@KR
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M(4HB9\'(%MR;A%5NS@+;::I*S-6,<)[21&8OO/0$5;@*-JX<-D:!N4Y".)5
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MZ H7B**:K6VR=3RWEO %&!80&!;1PBG \)C ,&D&&2NIMYBA9#Q&G*B$G(@
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M2(MLL+GI(<U-Q+3DE%2M.9X[Y<PER5=V@[L2U:1?1!"CD_8!Q:1S74$)?)7
MWEH<I G6.N.J!@#/F;!>3RWDQR.B23._9EY:JR(*)C+@3)8AHVA$@AOK!:8L
MVHHS/14!)2)LQ(XJ*W-/+Z(9$TX&S34QWH=P3W-V13FWH9Q)L[614GJ='")!
M!Z"<))$)WB&GL;>$)>*27'G+*:LHYQE33B73/2A1396Y :+BB69%"9@03RX
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M?,S7UZGN:;D\J.;](ES8MM\7AU+"R]4^6>.XD"*'*']XO5^$^A91\3>6(ZQ
M9P[0F;8CVNB)BE)GZZ%&7!&'#,<.^>@9P)$A >LYNV<]H>;RLJEQT2Q_T=18
MR0'W(LE).<![K&,N*:IT=(@' C(XC@Q);3#WVMBBBBQ9%<:L<F4>Q0;WO,2
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M'ZI,;T583RSF5(2U&,*:E&]HXIIX#Z(-$%&N!!>0)LPC@IGB7L3$^3R$M9!
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MCU @+7\&6D"(,F3Y<Z4^+G^..CG9%2O?@'(,9UC^%!1QD%;+GZ($7=G)MSG
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M0.>&D&L9_Z/@)%+)$@3I@#PM+1.!:TX&V"BP$534@P0^)C<&0T7,Y[F4*/@
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M5?Q=0:B"V1)\!#"$XQ6T-:9] -D]3T7LH()K#25(.J%(PK<:ECUV5E_[%H1
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MU9E%;L#&DKVJ-Z-TPY69AM*2H^(_5=GQ7;<KB^QJ"8@92$#<1T)%!F!/\F\
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M@K&!DNLCE[Y,.1G;?>T\UCYP-P6.MM"<GI0LUX*.5;8DT#BNDA5N!@@NG1?
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MH*M5PR#YTJ[O<IDS,%Q*%.CZ+N]C+P_6=WF]%-X3L@$_PB;OQ#4%4>-)D!T
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M85+9VCH!^3VRP29HN-RCQ+RU5]KD=8JZ:J0)QGF '+\G7*SRU](/?/-YL^K
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M!L/4#MYLZK,"AGVEB&^)P"X@<+--G2%JW-\FV**16HV46(:9/U?4;TS<96V
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MV:1SX<7ZF(P]K/YH._C%;0/GRA5IK =;) -5R!=PT1;@QM0>?E$6'5L,_#8
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M8:W<X.O8(C-&&I[ NTP1O"1LSGH+C*5,:R!I9?I4%FZ&KZ.F7L<%5I?,11;
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M(N1K/ EC,BKS>@_*@@195]6H7C\9BLA@@Z@)C=IDV60)FH9#+DT4W/;)XC<
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M17*H(Z,HUP6ILY3"M.%Y[,9S"F;0@Z0;L'^?Q'A^=KXZ!=J7SUH#+089 ;7
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MWL-A/MJ>-SQ:_?4BLA[GW6*^'+V9S])Y7+Z>KY&M5I18*7<R>+ EUQK^14!
MAN"$9LHH3-$<U(&77G!IF:6?MI?8?0A.QM'J1<0]EK:[A&?Q9)HVYKBV[$-
M'>-C':/_ZW"&];'ZT=1UM?<DYC;3?@<X8X2RJB"84KM=9E? ,RLAF,B9EC'Z
MP_+##U'W>]RL 55_C'0;>-1K8)N.#H5"?4<C\UFL#D\B;61U _+*9I-L+-CF
M//$*C.&V\QY5,^M+KD.TR]YQ,O]]G\MI_>?P=?W-N^4\XUF'VZZ=WM>"Y7#'
MT6[??TU&^,!KJ22FI&=H+=<Z"V:]X+[@+@;$X6]NS(ZPC*!SI2$%Z4!%'BE(
M5!F,"$PK]-HTJNHU&#LBE&!%%JM.0PR4LQP"([>/669#B$9JVX:U_H#9$<=H
M?2\[XAC!-D@4/YM-8ZXY\M7%U_'B'V_(GZ^9[ ^9CZRR6EO"9DPP0+/2UXPX
M@Z I=!*L(&]DUC>A.C%#Z$T!#1R:&P,V'8(N5I'-^AA!E7K!V<D"5@ICM%/(
MMS,1/Q)UIHM)]";V!T2=N6KC3[\^S=/X\0SG_UB% MXX5I16()-PM8^=!)^T
M (ODWCD,A>LV[,+;D#W(5,E1)G#;<M-%%6VX#5OX-NC6@<0A^%H396Y$>&\4
MF1[U>JO1]*"4^S >A]G%E"T8QD/-!]=5N4:AT2>"::UI5%[_?HSF=C+,/=K,
M,;IH8"OK%?57DLHNDLBF-II@J@1G@.5:E$-)!"^00^WB;6U1T6;5,NRY&=Z]
M\&EZU.KNF*A'E0P1,#W]^I[^Z7J^%"]]42"2K?-%&G#1.(@F2:>LL<FT"9)O
M /4C>#!W4D"3"W%;T"JP;UOD[="&]5N^@WLP+LO=%'F;@734PA".RB6(UN:$
M%"N"=[G4K'8"ERW2<H<<8]"(:B ?I;6!'.^>-+>/8X3?L,[#-8CKO8]62BD)
M&OCH#2AM M"&*^JABO4BN<3L0=2!XVWC9F /P!&YJQ+WU';H0P-MO(_;^>O!
MH6>6/"_+F:7)X2QA3 6"SXYAQEA8,S?D<5Y"ZNB/]*N2!KT6#Z3!'X+RSTM(
MO>GY;E='[J*D^[N$Y#(RVI(C4'!627S:@U-,DP%P%XMR)J1P<J;4QR6D 2SI
M&-WT34A^_W$\3V^P-J;]?GEFO29O OUB"A;R[!"=!E4K?7E&/X8<$X\4[F>U
MM8WMH;K>_JX'>S'I*!7-VLFW=W[SOGM36C"G$@N07"%0C!RXH*(';8,2WGE$
M=BM#YG'>0;NSJGN19=_S>\W96HUS#2<8PZ,1#IS.2"N:\8"U/BY70B=$3U[Y
M80U*KS_[])3:47Y-+HRM"'T;%AZ/F5QD!"YBI6NCAI!JO;)D'):@E,R-KA!>
MAG%2>N\NZ"&*,VWZR>.E5O+OXL><SB=Y5G;]M0/7\>XOZTQT[&F<6RQ'RU6V
M)K%Z#**,LLX7Y9ERG%O.4>#H[J_MS%U>/?G-!*?+)Y<>_^I[WT/R%UPI#G0E
MLJBH%* D!Y51Y(S&"Q9"&S;8[=AZ8&[O?L/?YK/%8A25Q$S^$!2O':@0)'A,
M#EC.7@:&7J8VIX WXQI^]>O92G80O?M20X/<VY,8S\_.)Y5L_#Q_(I]KC!=U
MV&@A6XE]FIZ<S>;+\?^L?K]W,"-"R@,C=SOK>K&0"R01<1J'<JYP;TWD;;*X
M?8W@Y SO7E3;Y@;*;F"U#['*,F1R^^LMFT+A0$2:/B(!]ZY8VHMXTFT*1=^$
MZN1,J3<5M'#AUX[$Z[(7Y44^W)1DF""G,W)+..M-W!!" A-D5,F*I%DC[_Y
MA$/Q?!L;2Q.%/!36[]XA73K'9>0:>R8=^)(INDD\@RL>P686N/>69]'&T X
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M]P;!_2GWSNK8H]ZC9-G O]C@V#2;?WX^'T\_O,GS\2R-LC,V%2% ZMI.!9D
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MV##I.]#?\6Q#>ST$;M/3RB,!W\]Y9C,#.-S0>M/> S"ZD+C@V2M03I+K5DH
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M7^V Q(6S +!UT?2GFC7*"B%J8(?"H-!V*&=1=751&6F(@N@V71C<WHE+W Z
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M=^@D,'G].>X$$;VGM$-S_RNT1%E?G$7L(5%448"_6VE\FX)-ZXUAS@>179.
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M!&X_V3X)^+U=.+!2=J!I$KCG7>3\F"6[LAZZ= &GKGNL+L'WM'7$SNT'S3:
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MHX=FMIW.%B;Y.5XO YK1.SI?D4K+D",YNTGM(@CTVXE;(Q?TBXK.-BT>(K3
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M3R].<Z<J<RG<$FU'6]'_0O_YL2[(3TO<5\K_+447;8OX#646#(DQAMG^AK8
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M!M4%D9JN"_;L<^7OZO6KBKJZ_[FJH^/GVFB,(<+F/]=&<P^XI P1:!36!8X
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MO3WI&;V&/NCX]S>*O*DQ7E4D:E'DKJ1$ZH(P93]%2D)PXNGM% .VNND[RIK
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MP"5Q.G_=9*FCS_DJVX1N;T[)?68B-3,_&'N?\BJKWM*68I.6HM7D-9#\04+
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M?1CFON+PK#X,2[CM5BSDY:#HR'[8I)Z,+B'<MMU;/XKP:MK 0""S:@WE")3
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M6+3CH7HOK,)R2?U2W.&_BO)]\#WI-QS::R:9"K9TEI"RDWQ:2TE)X>Z-!TC
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M9$<48A-N4+<-*<7[TE&H"_C1LJ.8&83XN)=87\*5=:6XI<3@66=P!PCMEQ^
M64R'_750>T9)6S],3S^@.84 T*-HBY'9M!>E2E0/S;CC.OHQ+=H7A-E-?3MS
M'W83==FEA< 7DNB]E\$2D:SE#72AX)TZ$*;EHRE=B!D\[Y)4)(8[*?84JH_]
MP(>&1K!NSKB"_LCTND H5^FAHT&@4,VIYB3P%56(L@.:+;],3H ]D*J*5R"R
MQ?*8,\@Z8=/:>E2DP&[&#-0E3M-YES)!G6GW2Z!_M7.3!>BLJ461!\DTQ),6
M0Y]IW8NFP4M5(=L?(@;D#=[WD"'2,S9%R(?\&>=L2X<[+^VZ75[2*FAX"?S>
MN$H>!6;7/"7:0>TJGQ2ZP,P5/ML7PI]IWWH'(M(U\Z9?1]KSNLY&ECKMLMTU
MJ^SDP(2&Z<#$KH.R;-"55AUA#:2\X4A!*O1;#7@;#+ZY\IA7"UQ;(9M>@L#S
M\L\,E^P^DCM"*\O;1Z[/*[\Q4B U@F+Z<O%@\(V.L_F-T-+FM]%G8!T-<5Z+
M8"_-;Z9/AW_EK3B1CG\$% Z2"87@;;7["4\@+Z46Q%(8"I],? /_D=]/(B&I
MT1?(MJ@W:^Z3SV$<K0.HA1B_8\^QSS ;!E)Q<LRCFCJ\!Y8I?H4_A%N&"R-D
MX4[D=1+^X E1UXDUA$6>GTE1!-DT(+F;T'2T".-.>]37@7E"XU8OQJIIJT5(
MW&;J,\P'W&?J<"X;WT[5;3U+2*<B/:T(CZFA4P=(/I0KAR^BZH6$7FLT4.!C
MQF%<>1^$$S&/N(?0-=@.SMZ<'!R.?2[R,MZ#]=;#"V]D^4Y=2'C&P![*0&9I
MYG9K4>[*+Y634._DU_E:]*#T-*H(PQ??S]Z*+19Y1+S&+1&85H-P"+Y@BA)_
MBJT\N!R1476@*Q^YVG35> ;YP7"'5XH:U7Y"1J.U:I^L;1B4HB/"'NLK$Z[:
M@P5*"5.6X6ZS:0=6P:6ME,YB1%[CJ8K32.?:[]Q2Y)LJ'T06ZJRQ+9.,[M9C
MMI1CRC3G5ZW&<-6I5H=P"]BA^R&P;P,Q'77PH]W7#3\0]'9OC@09WJ2$<U$N
M=3$9>]"SJT3A9]#'3?O<.]!'#<Y6."R&;;/O'4RU?WW' GCV[HF&!,34 3[[
M"F*TVQ%V&:EO6Y7AB&(U30D/0@?5SW)W1SL;&59!F"^L1[L@#%6YL<6;X0_"
M:5_2OT/<67CZ>>A>Z$_Z,#PF'48?0ES?3*/?1D6Z36+0T8F3-S!W8<0CVVE[
M4+W-LVABM%C32RO"I#!WT+9A%T >T\*PMW?":'&XAC E#8=/7^E)^XD_-ND8
M8SKAPO!BZ@S*Z<8#E.^40;6.<I=B9"RG7*-PP&<IMRC,-#SE&T6\:83J2E&X
M0J@2"FE2/DU.40SN)JMXEQLRR1SN&]4,,HGSFW:<3.?8@F1D,WM[:A[Y%$L7
M>HK\A_G%I8D2SF1-FDK=2K\T ";M5-ROMR;%R?T5>TEQ4BJ51<H2'P-B2321
M1THI:51P-.0WZ1-?MN(/V8YO.7&4LH;!ZT\FYINFUWXD9AMJY4W$;)TC!4V$
MJ"O*\42U<D.R@'A6[A@209HJ1:\H)<V4 B92R)L8F7UH0F5CU%A*-M6YR'83
M]%67R0)"HXE75D6X9$ GG2'.T>X-;B,&JX\L?T5T5RV9&$4B,P)Z3Q&LNZMJ
MT@C3VX](O^'_-'>2#A FU>M+;Q&\JV\G+2+@*T>"%Q)JC8^64PGENH2)CL3;
MC,6]F?C&W4NJ+^ ;!W72%+RX9Y0T#\]L?UX:@&]JUB:*\&\:-FW4$A;5DI9;
MXT_K<BQ^$K,9D]JN"?>4W3!^%]" NX2_^!0P#+^/UPR=4ES&?0_3Q;_BYB.6
M!SWC+D&REW9S/Z-BQS(L';N\]:/  EEDM.)]0R4+WO"FH]?BAKDAF"E%<(X8
M\R#>BF.)W1TTF[T/AUORA5...SJ6I-1$VY9WO'+23<-E+I'TG7^=HR-;8TWL
M&^2EA7"V+SDBSHTU1$8'QK,09/V29-8GLFPL$SVA")K/<[YPTO5UG)GL09Z,
M'<P&8(0L#BNQ ,]\S3RX(Y.)9T8%-##]&0^=CC!UC+'S P-* S35LP]*;^IT
MK'L2 9?)6B!>ALYGE@@'\J&,*X+"6" #S8_VO\]8RX,XK644\\;.&W1/&J"Q
ME7553]%JF#^T% Z=Z:7.1$$9-*5/GHC^7NX5TT+G2''^6^A;) F._?0T\>VQ
M76\)#=#P@+6X=JWF&'-+%8_=SL"8VI!CNY'A1.XANI_.)09 .ZW^X'>4AE&-
M.,;30(K4OWME0S13VCY%X\P8;1YA?:,_;7!!W*>[U(ARY]"TYI3MB;0 XW4_
M/^K=BGZ';]1&5?A?5?^0Z3&X2%W'R.WU867321TO$1MHS2U5.23:K(:WVZY2
M.^L(ZT]3TZKQ#I54&Y757U79H'8LBY5>4KH G:EOY'C0)<@IV41(>:98T@7]
M$C53;(*C?*Z(9R%Z%G(E-8@O8R,_G[#;]$JI0J1+Y\N/(6.H\V2N*!_P#TD;
M>E[&(7$:^OO69-$6S'6?E<)VK,#NEQB 98Z-837%R62GF$N,E<R2Y1/)E*62
M(\1&,$"<1KR6?D]D0[*+E @GD'+64@0%)+D=14@B@<9ZF$X#&!?*!EFK1+^D
MULQ>TA<QA;D.-%4TBS&T\X?@"B,MX@S_(F.J]V.^%_VTW6S!'/KUO\]5X2)E
MB5>+ .('HEG$;Z)LP7/@%,$7_MZ='OQ^7D_$8MXH]Y;W3MX";MR"+MX1;MI?
M94B05&GBA2%B2Y6.Z">D* Z5KQ/,D[U+R^9=ED9L 7,OB=][G>2ZB6,61'';
M1)/_*GV=^*V9(>"*TDU>!+S@M*&_C,#/UFU,;><MU4P+O\Q=K,KPRN:D*C_-
M_\/ID8K'U6)Q:=,I_F?AM?KG^%N"\)K3I;=XQ\V#J7.X/-/,\%".L")JS1/V
M'H/;_%'V?6G>7Z7;(Y[2D\)G"8D=[_$I_%NM :6QO(1&68J<:UFGVGR9,ZGF
MRQH.V]_L,!_(WBH=/V/+KE7>+SW%N&K<7BY&WC58@'P+#FG?@@\G<#76T*B0
M5RH.K'M5M/(9O'<62','ON9_BGQ.%FH2PPL86RMF(>*1&W0'D8$%+II:U++X
M=ZH!]/20(J4[^KG[104:0YCEK_J,_O"W+:G.N!1_G8[6CQ#F(,A:,"$F/U>=
M2%#';U26$YX'GY3?)X:Z[Y0O)L)G62K7$%?\59*SAE.,C32%#D*_"6=I/.CX
M/)EJ+MTECJCPH[T(=I?UT@ZXW9$^H#7/O"!7T%K&%4#?)VBB'M'NY _#^M0.
MO*.Y?4HK[IT=5^2+N=,W5DBK. 0WK&0_)WAFNVP^>SP[B)-U1Y21U 4:G/PD
M;()J@RPT=YK"23*RPT?F(\[=N$)B%I6[+1,/B+)F"B7[^/*_2G1$9U?QE6)0
MG]5_@S*4?.VE'((\5ST<6RE%*]]OJ!<_4)Q>>59T37%X9IG8) ".JV2MOFXO
M99DZH68S%*"<:%9F?Y&=-KZ/=9#<,ES:X"+>H;^U$BCRURV:N4W4)AA? 403
MM!O;#Y$/JCZUW(+(%8;&IFR&+*5.'M,GR:B)#SHK.E+U>:63L+-BZ<S%PN\"
MO[^*R6^>6^J'V5#_I>Q>J6VM(Q"7]J *!_J]55@Y X)8WV-<!QU<EEWQ$)8^
M)<W4"5LRKN8T?H"5H._478%'EK17/T6L3J.;79'SMWH96Y&_UY<8#J).+EME
MB$0[3J%5H-#>?Q5#TZ#!E:)#:GFXFI)E54K<X]2WI@OXC9%=%4GXJO4 ?0G^
M]]*7NE,$VRDF?0FA<5P!ZL-H<2A932 -4)QCCJ4.I,8:151&Y&*#';5LG5#G
M1LU96JU%4].F=&B%5.5?12^L6\&+1+ZK7L[%%?57;N"TIY@K\.SW$1K=#W;F
M.GOM3+;%TG1-&'O>E-WJN\SS?Q7M6NTV60ZRM"I6NK#(TY0G/IEB:]")I!%S
M=7.$/-]C&BO!^Z6KU,N%^5-.J7+9'\<5N$:FXR*^FO6:,X5#QB:U1;))?T,9
MLZ5!&R__X(M5;Y!G++55.<J>37F@G,&Q&%?S:N95740<--M7#A=2C N,X.1X
M_6J#_Y8XC5K7X+M )='E+3FBA*JI4YXI !S+\4K%^>K=S9D(<N5@PZM"SXJ&
MNK5)/W3MU?5;+#0V51X^UY4_*TE+](IKFFE3'LJ#_FL+T]>[OX1:]KG+OVQ*
M)JWM<;DHUJYY-\@BF-OP )SIL;'N)01H-UROA8 F\&M:8/^I])YST(2R$YTK
M80Z9J:T-L.\QWYN2X+>#8?79B-T>@;51R'*[A[6-R(@)OZO\T..K#69Z-PGS
MK"RW_1K6/M.B)1*;&U/5\!)[,'AE[2N<A\>LZJ,XEMV;ZN>X)(MLTW?"^"J*
M;NMRH&25/F\C4^9G8)L^DF_'^-:KR <W'JW1DX^L/E=53CYO][0JG;S;HJWB
M!Z5S7(5W?&+?+Z6VIK$],R8WGF5QMP_6@9D?-R*J"YG2U3+S6B;0[GKE5^9>
MB]>&(/H_?Q7J4<=<L:!T90M:A$CO;'@H3-N>4XL7I&UTK"KE&U;G5-KQ2^TN
MF ;XS(G.N@&&T[A2M1>I-Y8\:=ZO/)$.:7!6;-YN5],NN[/ADMD@?;/:RQ0D
ML[*[851+=DY,T98SPL955MM5DT5)=[-'15#ZVGJ./F7;M1I+;>T&5>4K3?^J
MET:E!F.WJ^*(;'@B7Y/(*!Q7GFV4^@4E?4VCM0O3/>M^5IW;-E2=57E\ ['2
MS?1QU<N*T0JEW7G#!]FQB6UJ$8/T5Y6OW3NQN"_KS*[0TAEQ#P<U9;#-SGV3
MRX_XNG<] WYR=NH,!M7,6-J]%?@0 #!/0G;]566O1S="UF:='0F 7(O[/! &
M-6[>TH.%07PS.CWAWL[(]FBX<49_QS/8$P# M _G-JY.[WZ*+LPR#=U T^(N
M]YU%#VUVZ7J-6>@;WR[#D)SEK3Q,Q\S%;<<P+@" D4]:-JZ:=B%(P*R\P6*2
M8QRW-XOX/.Q#)Y9XQ]>C;1[QG;.R^0/QV\R2E@?$:P! 12FU>EP11KR9U*QU
M \Z,&W$I/;:,;6%]':OH5WWGM0S2#<ZJ)C:]<F9SLQ>] P P@&B <14[O$&P
M*\NQ?S'_>%QX-X!W*ZRRW88WR^=GLYRK<#8U!G+WS7S2V,H9.^/I9?^OW(:H
M\M]9\_HB9<?B0KKLI(PP59N]!.3SOJE"?-^YL6&M9,NL90T[!<\! -W=_U<V
M@Q_U.[,6]%9JG\2%=^[4)(<I6F/44WP>-1Y5#3@;Z[.5IV:%U.\4_!Q36_]3
MI3\&I54OLYQ[YYJCXN([^DVD,$U+A7&%S_-&ZPJ(<W>=2K=L5DH=4S@= -#V
M_*=.QX' Q>'#3R%>I>CZB]!KY3+9/7@!2$6<@;@+$1<FHW; R-M!Z#I$G'<[
MIAEYQ>8HSALY<#*S[ T\:2@-^!114@<&#R"Q4C.T!,7!/X1;HK4%P0@-IGY;
M'O('ML*K&W4+ESS]"0:%?7R<5W*<E#L@+[M%RJRY#SQ)RI&X@/4D,DX.32&U
MY,^!_2'=B=Z)@)(GK3F"7$6>-'TIZ@V)>717T0-N7-^!TFF<N&K[<FMVKL@
M_,#B8MW!IYD7<V]"1<PU44GPR0RQYW.XGO[2&H.LH T=L2N,4/CVNA639$EF
M9JE80A'.+&>*=J&O@B#"!3D]D,W\FJVYT .\39Z.L%5<IVF/$#A6PJ'#!0#3
MTN[;12$&6*5_2;*VGW^B+%$]#=4 C%2PL^O!2V4^D0Q(@\3-HPSR1'1X6BF<
MQ9UZ<"#O5]/<KDN%H75:DWMQ<M4/WJ[2)!,0V5R>8)B;=0SDH_D3<13<K4I:
M?0%\4O%QF@5LF'/HP.N\#;U3NVP*J!V'C(E%XI;MW)LE[/J;B!-EK.JAS#]
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M_BI0==,+W)3<SH:)N,3$7[6K<<:(\BH"[JT?O]('O\GEMO$6'C1'6[D6]QD
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M-=LGVBZ1=3B57!T,-3XOZ^NW$QT N2T?(*Z'\#NS@6<K#K:5IGZ$[V\9'W(
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MB),8+Q33,QZCQM1-3B#98T9CRRR,@E0*@R:S-P*!L#LX7_ \)!Q8#NU!'\K
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M$/Y6.LEFY.C\TMW_4$7>[.45'S,".2;XC]AB;A'R84@I]S.ZQ4/#$V,>S[S
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M[=[R^RL>K'JX_M'FQ]N?['JZ]]F!YQ=?/'KY\1^KU]/>N+SU>;?T?<*'[(^
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M'U(.[X@PU<NX25=T#'%:^#>EGV".][_B$<Y!AQ+N%Z32Y-8[U-@EOMI!J=L
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M9ZB\)]!_,'X^?()-X/+._H<KX2S:C>"9["-6.D&)- F<B;UP)WZ$]! ZO;V
MLA9\&.--5;(^K</0XX''#QRJ?RJ$9]9A5\LF#ES&18EMYE_X:F$9[SJAC5^*
M,Q._<+&Y='(Z6K()H#Q @KQ>TSK!GGL*S',3Y51#S6S]A_XX;)B&8Q+@2,IP
MKAA_1#8?RR<ZB2=OLY*L_"O1MR@;.=N]*+0U<.[=,,SLEK23F=6AMFM]8VHJ
M+3MJ-V/;C!,X&/PXS8$:E$!4T'*ND29(%D1'D8?Y6[T64MN11W><JRKZ%YZ(
MQ6@Z;3UOJP^UK#"&8<?4-Z-,7*$INGHO_JGV2HX]D:6PBSI!CA7-]3Q)C48#
M;R=7?A@9.D[ +-Z3T#.S.J1GP)!30VY;R*['/K")JL?B,;7OLW7$!9I143FD
M5Q*%)YOR@5-TJ[?2=FKUL9M5QP[U=._ W-D[1F^HF=X;B+S$XEL9F#S\Y+K&
M[-F$?7IBY!>207;,,XG2R=UQ;05S;LVBPSKF0JQ_)\!TP&W6G61NP!<C+<P"
M@AJ3SU01GV2O8UXG;XY:!H10/GDR@+NT7U?JZ$4T[:$:.I^FZRBF]]+JM+OI
M#VD'X5K&,MJ/JA)&!7U+5A+C(KTGLHBYC;'><Q2PDO'X\FKJ!W3.@6LT!_:X
MMG]I><@833*M&7: "NFCH;+*'#H&/)193?\/7!"QFZ%A83RD3#S0=ZF6TB/%
MC410WHI+6O.H/L)*U2>J@"\ W6BCN9<KTFA<CEV&B6['+HI82G\&\SW<&;?!
M71?=R$WZ8_OND%]JSC;_IO@K[RBM%*/L)VL\=:G$M3R;>D"(2[]#P_+4&R7T
M>)3E?I.1!GTY_XUTHV'6<!MYJ=6CZ1*YHC9< 9&OZ[* ,90"%;V,2)TA,Z2[
M4F^(:C?.IIW@Q;C+Z ^1'>=^D7RZXO?VDBBM],9KI.,- KF([&U1,.W)IPT-
MI0<IL-JV54/=*JL(;Z6E"VZXI]-9;-,Y?^+P4/'06]*HOI;&B:3HC@[9,*FS
M2<_808ZSBDH74F8;*K8NH/RG&A>>3/TN=G1?2_= N\]V$DN/Y [E$-OV-31L
M)SX?4,@FDB([L^A[2/>;UI1PR9WFJVGU%)TV*.P/M4OJYO:']I:C/#$)O50]
M?B" _;PFJFZ0O1Q+D!"0*ESC_Q,[AW]7? \.).:DV4'=I)=A*+21,NQ&!;_1
MOAV[S8ZF/.GW1AC4Y=9&^"0U2XR#':DVZEE(3YM</!I:2>.G;@?[Z"LVO &+
MZ+?=[,$ QNFCO? #^%3?*-@5'F.Q0BPH7)0%?@)K*4=!,KAHUV)P/JLMQ<0Z
MQ8K8L(-E!)ZZWF6) .A(%F03B7JTX$?!8_,J,),?))S*NLUM))M83(YOD3W+
MCWTN^2%K+)(;>A=X UUW-0*?P66'IX/UF@W=FUF?E?MK[[,*Y;[\6\![21=)
M"=2*? OC@&K^/\F!0!(W.;0"2&&;78N :DAY\!/KEN535R#+JU9OO 18]6MX
MMP!O=3VQB_E"X5C 81Z0="0U,P>%BT,G,<]Q US7,__ CP_.8@6WZCLS 4UC
MON%?8)SU,_<;4UU;37C&3->^W_F$&: L3')CKI.TAPPR<_E&UQE,,WO2@0+@
M6+]31P-@US7-X,KDMUBXOLQYMDD$+\8-$VEG-..,]EKB;L8EQ:@0#'.,\)#+
M.V82.F[D7P"WW]*QC'EEMT;/8WKV+.)P&9VMV_$J1E5]9_XI1HGQ?6(V@Z[Z
M&>+%V"LVNEQCSD*O["%*.C!1S;-$3ZMEZJ_"^)H+[&7\R[B9V(N\$GSECBSN
M7X3W6Q:B-I(^>"P[D2)V;D#^HGW8S1!'D)5-+D(#^:5ZO& .92.RGM=(Z:CY
MPHVE^N8IT9_4.YO+V5TT71 7P=,YS@QX(Z-GD"+\!IYN'"?8"88J?_ >L 9@
M%R["BJN9P@D$OFT_BXX#]B><02X @J"E< =0ZIP%R8'4@6+!4<$HVRV^/\^H
M.,P]P?6%UG(PZ(OJ16@P>V#[!/8B1)S@#?^!\P/W0M\@%^< \!OK6O]F_AGE
MVOIKO(VRS_*]G!N2@^ L5"P28US8!8+BW! DF[<EW@PG<Y8&[H!RD1/.*T L
MY-N7Q9]6&U-WG\O5)\A.<%9H_%FN[%O*)55YR(!L]#8%W"YZ$+\&&N0W!\X%
M;W"\G2>!H^"*7AF/T)A6MX#SI0Z5_D$%)@%0RH[2TRI[$$=UZ;9)L*,\*FX$
M\A)]#[@.%O&*G3ZS+ BMYS-O3-<F*Y'#::V7IJ(+&_8P#R!G+ V5<^!N@S0'
M@ ZH=\5M R_)I@18P8F"7*=GK&1V?@^'V[%GI>4[QZ_7)#G$/M3>RW1$RAO%
M%2)XLZ4T9QZT0^\1-PED*8X$E+&.B*8XW63-1I>W9FD/5.TUK%8[5T\6;%8<
MKTFB7I*QL-;25Y*-^)F9]T1C",TQB_@#I"(_';> @G6<@(ZEO6Z1:Y@DEKY:
M-9KTC"^6-Y(SJ(NDA>2[I0%B=PJ<&2;X38W;I. =HKGX;>+ ]'#'O]@^#&WS
M8?5&EHN.J;@.[.?UR$ @EQ(@V0(L*JD1.3(_9&@%4YA/-LWB/F(^7/\;'6)^
M<YR(, '[IBLJ9VZ?%I ?Y:!<FY2"%I*SQ9O86XH;A;Y(9OH7OA-<%EW+G0?1
MUX^@8T&1XR3X'DO>^%GI+(O3Z&47)-LX^R1B434))RH2P+O>"K;P&M+S>)F<
M*]$^G SV^_4<]C;XF^-D. V\W>BDJ-'=4S^1+=)X<J:(KRDQQ$%AEZQY5Q"_
M3OQXZP5NNW!IU'ETF!>V/@FYC/HY3H;N0[\;F/('=2EJ7ZG8] C-$L<88HC3
MA2LTQJ)&_D+%FZT97$>I9Q0#]1$FKW= <KDACE,@)OS%]D6.:[6I6J1VC>7L
MXZ);UO<$NJ"U-K5H!:]!VY/VA'-0\3/*G7U)LF+]>/@7?^+_*7?DE$TI7]U[
M5Q4DN=9QE1TC0IM+\3\%F^M.%7;R(FKMTX2<? TV\A6;)=/ZWH+W"/B.4\"W
M;*+Q;-V4JFRQS=2/J0.^&?C5;ZH/:;'8V'QO50KN>+)4OIJ V1@KODX*\2X6
M5%.VK[5R'M >&WTM'XEU8OO:%M)T *.GDX3509H\LOV.7F4X^6GR<MD2RNGP
MMZ([U#/>87PV?<+:TYR)#,"@-9]D'A&5&D7,$N9Q71YS%4:DCF>.VK%0$<#X
MDV25KF$N"E<*/S.CO)?R>IBRM>_03<P?^H>F'O28T&A@L <9+[79R.ZJ*ZH8
M^'(>5KX)GIZT0K(1R@@/$:X%Z]?]X'YB_;#_FVUAI>I7U9X7]PD>Z&N%WQ@N
M&D"PJ6J.$LNKVWY/5L8=E]@J)J&DL(^"$N3NNOO<>-C?WHD]$^3JD-J)ZFY!
MN.ZA,H(N5!^3G:MD* 8EJ=O3I3W".XF;1+OYQ6']_"'.LW4G.?WL3?8;$ VD
MUOXTDDUB_AG=5D,E?9[:2^M8\4>Q1'DY]XYTF0S:\D+D)G8,H_%=^+O7]7'\
M.:OM4Y!U,$,K,,YLC.!G:=_6E=!,JJ.FQ J^O$&_,!<K:5(]WB(2'I)9P\)X
M1T71ZZSH9>X1^WSX ;)!ZV<XTG&3]T=K:@FB^:LJ;1LJUL@WF1?F+I)$Z3YM
MB17N4!X+F\&KEH#K^*B(O]*^$C8C]R1OVD15XZ'!)@8FG+"L7E@M*EYLUM5\
MS+QIX.&8<1I-.L$_^)3\&VF1!R0NI&Q>P^)I:;<D2*N><!,J;^02-^)/U:'$
MT[M.FA 2*9.GKR8GQJ6K(RC)P4;96VJ-!T=42KNPY@*WFU$L6=Q"9I#!IPTU
M#$=\FK6,_GE70FTY_4/F<ET>8V[<>%48(RNX0OJ=T>/!%W*8Z^SF<IXR_Q'K
MFO.0=V"B+1?^@>NT;(>7%ATQ[H *,AJTA>#YV#9E*I@0'"A=RKKBP1.,L*KM
MDCB^K,7BOYL(P@S6H7HR_S!NL9G)"RWR-$"<LQGK-1!:'9NI@-AVP=,EF?#E
M_U/3_R]@U 0&BT2-AQ5[6-%U)V40MMYT6A)7N$]_5K0X_8+Z+/]][#SY(>Z9
MH-?B!K3.0\"O0<KM.M"54(#(M7&-_@?PL,Y#NPP;8O)4.1=FZ[WD7NDTM8\D
M(.:.W%48%'1-/(ZWSD/,>X8NL;O$W@W/%%YKV%>W$&BW'C=)L1-J=^LO%<[7
M6=4_TM>KS JW&*.L3;(]J%.D%+ ])#P:1V/WAKT3/BJ4-]2TS )*K36V*S7[
M:S,MH07G=,$&=.MWU7KUO9AJ681\?9!*%"#B>0AXGMS+:\>SER/I\-Z!J,H6
MTHYNJ.IFV;&V$]5K<U\TOJU1);VRWL-Y1HXSRO%__!HU4XF?7#[*_"C!JZP"
M>]HEF-5?29A'BNW2$DAEK:W[B1-SSS:<)1Y/NF#I)>V.^&0H(]_P:U.]HBYV
MM9/:TXRKY_(]&"EP?%\"/9#XO9-.^Z^LN$5'.Y>+V&RTYTD*LX3N'G%!GT:O
M]6M0/F2L==TL6<>XM9K$RV!VPF-['6 WHKXC!THH_=;, (6YKO5\UL^D6!/$
MTD18=5M9"7YZQ4?63-<J<3;P?O59;BWP#&K_?U5F$C>V%W-K2PU-0D[4MC-U
M.G1"TL1:"?(L@J#%P7?])(H5_W]K E$M>'_-/,X?U@\HLQLO?4WXTM8J?EJ:
MTGA*^&0;VWJ9_R'QM/$T;W9$BJ:9L\&/(R]@5[G6"[_"EC7)' KX'/J[ZXFF
MEC#4-D\UJG11H[,\<=MFJ[O$FJ@V.HG&1OAJIO&+_5#9".>,ZY"PA.V^!N9,
M@WK NUTEIF4$0:M&_Z#D54.CAK9MA:5!.2VQTF"6MD3,5$M$47X463COJ>MY
MP5L47=..]L&98$?7$AM(0%H#+>:2^PT^QI)M8RV+M0L3,PR3%*\BIJI^24[Y
M0=+S@G[7AP(]IV'-6;0"?D!>=,"CLK""/G2Z"MAQKC\6<WSKY$Z@)C@VNCD'
M^S1DM_4!_N2Z4X;YQ,N.38I_*9XKO@NEM)/DZ2,E^*H*]9['^(,[GO6M(R1M
M7=4135P6N[UI#LD^Y)9%3][E/5IWG7+::8+\$*UZI5# 88209^P/H2VK8.W>
M0SV_XVK/'VK_UJGMDZ@O8M,:KM.20YZ:2VFOO1VT_?0ZIS39'@9_U51^'5-$
M'KMO+"BIR!EDL?;LL'2?9/V=]JSU&F"-#;)U Q4A3TS)0(9WI*8+R'322,\#
MC%5DWCU@#^G9WD^<?RM"!["H<@?0-<3>D3;2<A))BG6MM\%E(4]K,Z$&[SSU
M2?"ETR7I&'#3JJL\/]8(Z=C>M>*("M=^K7#7#ESG=;XVK:_Y"?=1[*JZHYSH
MD-=&,ONP-T7U"XES'B])AIZL7LUM \VDIB%$65ZQIN^%?,(.3.<2B2JMJ]E.
MY!6[HFX:_TG(1\,I;H.W7+49K7;V$N]#DE;G<P.@;231T#3]CHI5?=LTI3NP
M'2QE8EIW$R3SC5UBK11[AWPR! I"O>N5)[F9SEO%X6SN:B7G#O2=1-W39UE;
M8=_[TBC=06O_K3V0-M#X5?D\=HWED<P]=+Q^MXCKW:?,Y'UQKA ]1[FK]W/D
M,/FFK?I=A=.Q!FQ2Y9$>9UP])MVX O^R^@7:1_3 <FO6DA!\>$X_^0-Q;G0%
M54%>[=5.YU'EUP>J;I$6'IU?74;B=AVK>40>KW^,VT*6L17X_13OZE7$8,JK
M[#.DR]3.J'9*+4WA94?;0Z^_^K9R 33^<';5")C4&5&=RNK046ONLGR0=%P5
M< TSBS 'X&6])%X$@B-_D4>8'SW;J3^8QBO>Y6+A^8/&RDC!M'99U6O>3NVH
M:BGG*CP)NQ'%5_[ 3V8OR?J;\ (>B,PB?87\/".H22S*/]:R: W]P*R*B<JC
M;9,K]\D7JP68&@D"GJ@)%(VO^!>WDF_(#"4LX\Z).$J*96=XO* ,0UZ7,DIC
MZA;L/U_^MXG0<J+BI/Z$*K6*HUG-:JW>KA"4?\1NE7S. /!5PNB(4&(_-];#
M0 F$#UY,+&&UJ_>=+HMIGM8\4C&F/D.94'G49 3V8UIT;\I=:WI47NEW<#>E
M&S>>)_H*QGEDD\^S5UW@%+\=?+UO0NE #['I57EQVQY%=:5]PUWF"\P<R[0R
M4HVSWC4]#5>@G+BQBG!.1/6P)^/1E/._BR6'Q@[32E/V*IHVE7WI.R+?6]'>
M?ISI5Z5I.%MZMWJW:63K)>POS:Z-?Q,($JO[+[(+)^7T$<K"\C5[U)3:BO<-
M^Z@.54UR%^I =2IS%2T>.[7T)>T_W+VM5^FMA OA+QAB\BAW'7.0JCF51W(G
M\'?32?>)0;9V,H?X0F9/\2 9&0Z4A^2"T@G49DKXUNDT+M4K?#-=38MQ]V<\
MH\M//"> P)V!)\08@%7O3_H+<)(<)YUAOJ1])IN8(R5C*7QF0UH 5<B4A/70
MAIF0VR.&,Q-[O  _C3^E/P7_@#ML;25T<3!B#)&+>E"/DNCL&<7CR"C\.15'
M:8;^"5M+_08:W31TF.5S]!OV'Z5][SM<E^R])0XOD@R(EA&((CJE@4@5;-DU
MAU3/\TS91WZ ?MG03$U )&X9M/?@I2/G:FZ;_'N.8T<,:\QK<1;-?\)Q>(5R
M@-Q(:)0QB@*(=\0;4Q:0??CO-@10ACAI;BMI>#CJ\)V:1<U>W=>PHVP!IG78
M!Y8I@GFXZX;CI(OXKQJXD$L,47@DBTA6<4?H74H([[[K1]H41'C8OIK;.[Y[
M:4U5AT-M&3:NZ2L_'A=:9R+-P!?51A4\(>S3W$R>0_*4>X:*R=>%3J[GJ'WL
MAD,=U4[#MBY5S=2!&\:S-;>[##P+]EB+/;$*]V]=1\$V0KQQ99*5>$Z5$AI,
M1L1K7+NIE:AD7QY(+4MNNP,NJPC5<UFWJZ9P<UD=F!.$=I:@1K'S!(N$8R;-
M9-40^"$H2TBZX]++ND[5#\<  _C%K2<!E#!*MQ/83KC)B0.BB /X'B"09,U_
M T20&Q.S@6V4@R'C !UMG N9-8$.[%W+G,^XT2)@3F <TV8P_F-TH;Z,MXPZ
MW![&#T9K_A+F"L;1+7W,+,;38 ESF#G')0J(8<;L^8?>SL$U^])M**)^2J]G
M\Y O]#Y$BC72'\"=.SP8=M#ES7\85/!C\"+&=W"<RT*F%7B_6T9C2G\V?J8Q
M)?ZJ5AI?E >?H;4(J#56VF.>(2^7'LDYL3F?WL^^&S3 V *?<7[/G D2!ME4
MN9[5\)JJT[Q4-E";5?;0)>H%^9;J@[1Y$NSV.AH@E"5<IT_FZ8.VT8?1G<Z7
M&$KHPD GY7K]FX99E,<6IN(DY;WQ+/B#NEC[I7H4M5*U=/L$ZE.99T(AC21:
M%C27OH%[R'F0X0K_'IA*B>OPLQ51LIK_5<RD%-@BP(T4CKD(DT)YH =S,=0R
M%2_^,VVR-"_P*NT6_[ZSF7Z-/;K?0GX]F%[_E/RSQTE.(7]OH[/J*7,:!%6'
M*&5FQ;9OE!\Z3KR*VJ*("I33^,)N9S%=SK[66<0/+.TQ;^9^+&^29'+N5S*8
M$/H&$UWIB/Y5LSK'S';$K8Y+1Y((,0$;8 EIK^,/Z#75T,'CRK O3:4<)NZ%
M>!L*XV\S%&P3X7+%%N0$\4'V(V04>5+L'CB,$NM_ S)2]SH^@V;3*]KEG,FT
M/[6;T-GTU:)LMAT]A"Y%MM+SRZM@!5V;[0(]I3^)=84B&('^(#C"J'>\"B8S
M5[2!;!M[BM$!&4+RA([P ]A"T\#+H&=E*J@:BLB"P5M@<TPWF %.\_=A?6:5
M.!YC-0'=K3L1INBWP076"14"=^BL8 I5 ,WC59>V@Q3.[<P1<"R:%K.:I4*&
M_9ZR8N%QCGM8\\ E+038J/Y/[P\=4![@AX*?Y+F43G"CY$[)<U:W*"-S%2N$
M_\^F7N %-]BO'AA@5SEV !IH>_, ]-)\7$> YAK/\JC@)AV/_(:E5B\L\6=-
ME]=E:(!&R:I-F4"J /*K OPX5D<;X $3F^V@@F9 >PM4VG9S+[,.6WCD3:Q)
MQB7%)@#2M&1,!=P4#M$?F"_$;+\PYB6>VK&6>0LI;#H"3>B9KRT @]KIW$A6
M7E,:J1?06&\7+P.F&_/3FYC[U7>BFYA<F;??+"8DV.BH8:K8CI8GBCFEF^5O
M96/*0Q%7B6OE KQ!1*AZ7:@6'*R^DE;!GX1]&JGBQA.6^4Y"U:0&>P+R@JJW
M^,ATV-'R$$D_;B)<*'J#GX*[+PP@+"QXR1<20U-O<I^2D,CEG&#R4Y_C;!.5
M8<]!)M(SS>521ZI0%B/.HQZ%V,(ZZF_<:/X?6F2! Z^ 5I<:Q+E"7Q#1@D;0
M#3X"Y  CR%X-;V!\,5'$MZ"WTDVBA5 -B!-4@F^P:WB7P-*=!=Q$UH\4&WJ=
MI8K8R-[.\O;)A+\ 5^SK(2E04ZL4]0DR)#F"/_S5+#Y_._=6S0;N>0Z2W\])
M1'U3%K+_0SYL?(Q(X7H?%W@CM-&^"_S..F$\*[RI&!$W"=QD_P W>2+)OFJ$
M.THDRA^/\@4YR1*V!\]I(P(_1E]Z_X+:$-!^"*2 GXR.0G?C&-%//D^7#;AR
MGZMK,'<YF8K\'1CV:VE\\B)$*W+>& 0G\-Y[WX*<4:[](7 &]-70+.BT+1'A
M^3,L TPCM]CX$9.,7M1^R_N77:3\E-2 K)(^#'\-W1,.>.\'#W)3[$^P]L#_
M&+8(4MIGBZ;R!IM>,U=S_ZH/J[J"%IKB\UC(1UU24@K<IXP);X< R5IO#8CE
M7;4_R\(BJ.*1<4W)+_26;EO98XJK^D3%2-DUY<:JVFTK9#W5JLUIDAG8W:'_
M";,)HSV_\;0DO9TS>I*J5J3I[]2L0S.T'MA@LE9EP&TN2U#,PF-RZJ40H3/A
MK>A?TJS0!D$46>;YD*NFQMOM8-^B1\H'=2R*'UNI?D4!26^4V91_2LVRV]3
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MJH;LVY$$_%WM:^+=8!!YDIC:^T3R#I_2^1]M )O5NJ$@ TUII"39(,=K9Z_
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MI4CDS)=W*0Z6SE:L  +3_E+\! Y$Y -7P'0?._ 1^-G!%;: !ILV2)JQ.UI
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MHAW$(+.8.I=P92OR_N"[N&L2+N"Y_._+I^&C14S/\]@%J:7M5>RPPLKP C_
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M4FC=<P1#T1GM-J()H<%-W\6U/JRZ;=)0UQQ3B7RDW0S=',53"TO5'/!HF<U
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M0] @<5_VMW<7_D?^Q<4+]P?";#58$VBV<,$606?R/RI5"D/&%*4%X!#_AA0
MS1%#1!OP.XB-'P8EWB3V&QKO$H,E0:ML-Z+7X1"+:I2$]^>KR&B4FSY _$+1
M>!-!13,C"O%>=&:0#W8'>>*=BODCIUQ6H'7($=M;J#>RT:()G8QH\Y<1L:K8
M=)1P4+Z*E^&#R@D1)=@YXE-0.?J#F.K=C>;C22X <@\;L/V%;$9?6NQ%AE&/
MS-OMRDR;)%UK?LZUJ!_-E@4;EELTK"\YX&=?^YLRU[W4[$O=Y!!E8+$ RW?:
M,WSMHHMJ2-*:.:8U))^>>+<YHVA55%:C<]G$T/ZZG91.WQ<UTZA4]S)C$9/I
M0.JV<1NLRC0KA/\M9JDL9>D98-/^TOK$Q(:?%?F1-^I^586&!M:LHJ7[#INL
MF ;W?'T+YX?#=JV%@+0ZI+HM"5[\D7PG?Y QOB&]JB_A9-T&ZNO(Y)KSC+20
MVZ;5K)N^?$,J5^>>K/TN*'&XI=XBCK>>KAR492VA$"^ _V/?KJ+:S->&_\_>
M,\_,[#W3<>W4;>K>4J&EN+N[NR4DQ-V-H$&")(&$A B$! CN[J6%ME2HN[O_
MWG1F/_.L]_W_#Z!S\AR4M;X'G'VN"Q9K7;EO;#S8N1N29(XNV?H4N.6US+L0
M3U-JQKDTZSTN7#T\:JL]FXLH__T9$XFZM<J-+L3:+.VC_1M/]EB4[956X7 Q
MZPO8<\M\?F2Z@ZDS+QY1N6<;QPNU?*LORQ[=MOX71C@V:A6=5H=?M.PGJALA
MQUV2.8Q*=V#QU6AW2Z^,WS#?F"[A[L9,[/F"O1>KW.K&M,%)UA^DP_"5J^JI
M#PGB97X4 Q'M[L!G$GYU,,_((& LE_.^(T@.ON'L(33O?L&R)CS>NH^13K1>
MOX_63%2N.DMU(X)E?,H!TG[W;S.(U&*'13PQ%6_QF'N(^M'!*^Q$2N+N-TPB
M^?56=WHKN6J]%^TW<ORJ-Y2CY!7+FL@G2-/E>WR*796YEP,V>*VF6P1W^!4B
MEH:C@K^(84;'A3-]^N.%,:MM8U+^G?!T'S)M%K)EXP#R%>(3\7KW87]1CK/W
M;/!VZ@7_VV'-\-LAOT191N,C<+''O6_&KDZDV[0G+4J-W;<8Z@>3;YQ W$0E
ME3D[0R.Y6;GN+V+64Y)]D'$]L(+ +Q(CHD)"IU.^\OXTZB;DI,W2!"O8L,D@
MY"/D%QM/I#_'U)8@[:G)WOR++KC4_R+->/I!FM.\_.S2TB+M@M'P?5[;(AXB
M?K;FQ>E1/YJ04HYC7#>>2U^%&Q?66;]%O,H(<PQ##A$I;B6H8NAB[_/HY(CD
MP!B,HR<^W QK:OU];"#.S,0J^1@^8>,E> *AK6BCQ5T2@O>K70TIFH!R.4+R
M@IAZGB!9A"O\Y:3='J]#ATB[K0PQ)B13DQ^37I(\-UZ'C9'0!1>/.+';N(ML
MPEG=>*G38>90:K;';XRCX5_[[:"?\:"&"&@WK>#1YM1G>Q\E65)>;[P-<R"_
MS9\[O#Q'S]EOA<GJQ[UQR.>?3_W:397Q<5BYSTON)H_EP45L)ZO-47AFQ-Z3
MB1IZR,9[:>>HCOGK3=.+5[+++#\J/(@CV]L*$E)TKHP<75BX]]NLC]T?!PUD
M6%I]$GF"D[BW)7$W,V'CPS06+;P@*CC:]2WGU[!PKWA<<B3,[VC*P9BJ8)/0
MDH1OPE5N9Y,;8JPMV-"BQ%]VUZ6?@?BLWX:)16P78/P&_!-8 T'V00 ;&#H6
MEID<&)D8M2SD8NS!V'HWIT27Q!2+=:F25+_=7+@?3+'>">V*PN<V>PDC1IF_
M^.5$4]%W@W!Q>Y,6A>$3;@:/1NF3E:YI\3L@'//,Y/NPG-TVL$6(V^NC4;Z8
MRIS/W::2OJ$3O7<FWT;!_)&I@PDW@H]"I4%3$8DPCDM]K&,ZU_R'I&2D:O<W
MT*N8S]=CD7A<91;".3W=A+;$8SO"#+G+9QQI&=\5B$59!GT>%H=V=OD^6HI)
M.J).7(85[;H*N8Y[L9Z/Z"*@,U<[\ FFE">N!00H8I\7E2",N^Y/(+0%.H34
M$ZXX"Z/V$9<>"8X'Q(A=O9!OB(;U98B5I%_Y7]O]P/R"\JES)",N/=DCBZZ+
M.^@[1GL24!ML2SODO"[RW]2,(VOBOZ1<VE6=ZD_9LUZ57DJF9>RW^3*32W9T
MS.5_ Q]Q>\I#Q^I]8CDG PX&_<0^XM0:\0-39387Y\#X:5=)2@\M97U]^G9*
M"Z_<"E.03^IRV"2P@[NXUN5,Q-I[.V:Y^-\*7)EQVHD1;LN-,:N)5;)N[,*E
MN##<U[?#3U%;>>U1P6Z1)$C,D)<!UASOY?]5#"'I'\%Q?N=23H9/.ZZ%7H])
M/G0^?4>BV8ZUJ!,0TMI.7!O"CW,[]+G_3N+/$5>"!M.RHT^'!40SXZY'WO7[
M)FE-;+8#([4L,? 0 N:1ZK?C'\A06,/:!]AB%)?M%?@@8A%>'NH9=1**CZB*
M%4=EQWR;$.?K&J](-K-_F4R#[#VT!EH*\]U^"_$%8GC=$DP)IHC9[>>>,([;
M%O1#T@3D^]#.E(E(3"0>,N83%HM,F[:W2]3!7YKJ(>N19MN[X;?07>O,T:TX
M L//>S$,CKGLOP6N3;D6O"G]4D1"^ 'DM][*:"K*P:XQX6=TH6EPRGG,Z^T*
MV!T<>UTXZC5A+WVCAR?V-?J$CP8'3WX=\!!W,EP8ZH#?Z?4\<A:?8^<05TOX
M+]/?DGL(K.VYL!^(2]=A4?[$-MI>UV<T9]0;+Q[MG\FF_HNHN6$/@Z74'[RB
M(N"44MNSL2S*SH-WDB;)4]O9:8'DM'79R*/D;ZAHET]Y7B@OCS&N39+8E\CY
M9UABD#5+[GDKW)[I:PN/R6=\<U"3] UM<CL1VDNEKJM 1E"V4QX[47(?(T^X
MI^5L3_K=QR;KI]#7@=LRSGH*PGRY.ML#T2/LK(.8Q#0F9'LHU)UNL:X6^6_J
M<LIOB7RW'D1#<K+7VX2[J1!_RQ 5-#,XS^,KV'CX6^MHQ.&8@OVFJ+G$A"T:
M[!2D9C66\!R!)47$AOM_E Z-;PS*B9]+^BUL;?!X2FYDAWLP=%MLBM5E^#\3
M;??=0WZ6ZKFE N,/ZUS=B1]%Y1/N17+#[> _QKA$K8Z;B/]WS-N@<XDGXL^X
M5:2,)HU;A4'?I%[:5YD>!EN]18C^%Z)V]6M<#X:+9X4MBF>G=4=N253$"F,.
M)@\$?17ODWK3]562-.TGRX>03?"P?3#89<3HEF+D'!JQ9@?V+,X'=R#H-;06
M6A46"_LU1A#9"<<$?AF[+GW&U3ZA$VEF&952BNK<MSQ-BO';PD)<QOVZ)AC[
M$_X)]O< 3W0+1!/\!@.)K@\OQ'X58!-MA16[2.-7XDPMC3]#W!V3FU VOF8+
M$?$Y@;Z&@DDE1F+L_+XB\U.O!-XG9T5_'-I-CO.OBE20M[@LB>TDO;(H3_J)
M=-)D "(@]6XAI3N1ZM9(T)=)8G2QSU;VKZGV 4=8*5'0$#,FP7]#A#L#XEP5
M4TQ/L3B<^#L-;9*9>IR:M04/UU'$:YK1,+(&O<RK+LLA9<;O#O]-Y-O@KS*L
M_=K#CW##G+VC56RVQ6<)P<PND[!4$\8_MT3"C] .KQE'_T+A()-@G[K_5](#
MN*_WIH@EZ:/^43[32._@6D<+U/V(I68Z3&U,V^X:7&%BX49?0B_D_,HH\O>(
MHO23J;_XM25.0*:#G,*WII6%7O3Y#0Z+I#LT(")B+<U\4(3$[;L9F*Y4UXU)
M>"O8R,HVXBRJ%,Y,A(91$O*2<R(3PG:G:F)\O,VA1^,=';Z"?Y_D=_@2@I'*
MV^V*7IEV>V,Z]B$B?]6_"8,8+,PI;EG<_OC8A)R$]-"?DUXDU7OA4J-27MDG
M05]#/0]CX=VPD=TKD=6(Z(U$S!!ZWRIG_"G<MK3ET1M2+\5YQ%Z!PD)6)&3!
M/O(L3[: <^V>0I8A-AS>"-N)O+#[$T0,6KLQ"]V+K5I%QW^)-T!71I0@$;&4
MZ )4># DCH@V\7B9",%\8A>2PL:<.W04>A([M6LZW1%W<F,6ZBK^X:IZ7!CQ
M:XAG6")A*J8OLH3X:]! 3!-QCT=T_'GB$=NYY!U$WT-H2#V1LJL9[DMLVUB$
M6D]\L^H,]BAI7ZHVI(A^)69W^#-Z1I!YM#GMGOO]N%S:+EM4TK=4VJ&5J4.4
M:[LR8 **_T8QDD,>6/4:&TS>F;H_> U/&3T0IN1V!,Y$_<2)=N?'LEBG;;<F
MKF6&F3Y*_8C^8E=LVG.::",?^3/59O6/V(_((&D*,^;^8Z0#ENF]U3\9%^$?
MYKH!;QU<8R4E;(E8>V [<4O,]'9ODD-B^^_[R$+H5\M)U$\0NL0XY'(_[P@K
ME&G@%3\!.B24ZD+#4"+W6&W#ZF/_M?\N_I/$K[<[$-)2;7^/(WT'FUE^F]R!
M*D\X I.'BL.WI"^/*/!M07"C"YW[D8_C%)8R-"1Q9K\0^UWJMNW;<9-INM\Y
MA"8$=H4]28))C%\/P<3,A2U-.Q2_SZ<%=B>QP'E1>EG*)Y;?(N,@[/V'T+ZP
M'=L78</37_XNP6>@GJ\H(BIQ_XY;DRQ-^2)T5VI5:K_W96@1E.)D ^/!+"VD
MZ8+T7_8]0HXCO]KV%/,;^M??FW$,K-V*<X03>%SLP<2-Z>M"0I.3$5;>6U*+
MD%Z.!F@O*MQB#_PS-'[?&"(-T[3M(>HE[M/?CV/%^)B5/Q/6$KIB</&?X;X-
M[DEDX@J]5,G7<,\=;2#F>$?S\;1ZO'8?+=V+L'7;9=1_$=I_OX8Y1W1=:8//
M(9Z(OAQ[B-(4O#_^+D7MM2T)1PER.)?REOS0' $M(9?L.P!/( =MZT1:D+?^
M_@1C1GJU,@F_F-05G6;\F[PD:#).RJ)ZCB3Z,4D.S.17#$_S?1 #_>"^GV$R
MVL%M50@9U>GW!^A!2NA*+JZ93(J@4<ZX7?!_3'G@]<S]!^H*_XVVQZB.P=3#
M@=24B$5[/J86Q\QL=J:>3CRY)H)F"=VS=)K6BQ@(MR0F^!K\/R:>#71ULR4Y
MA+RRW4M21O0>>DS^/*9A]S09FS"W.9#RS]1]:Y246MBY91Y4*$H69HE;&I+E
M]R7N0GB9*PV?%=5DDTG8&GO[$(DPF6BYNY#(2QG:'$ *2D.LN4AV180O:Z?8
M8P)#O=!?18?XKL+\''O*18;]."'4^C[V<M++0Y_AQE-UN[WP4VG9FUT(-](S
MURXB+4&U+%]"ML=>"X$@7).6^[@@"U,^=;Z$ZDI]9&V#/@.]:2K#?@K_:/?/
M.!?$WLT6^ H4>>UVXK>8F\L322EXVV 9['+:B'=!>A)\I;,M8CP]Q:H;M1+1
M96J.)J#6[WJ)>8RNWFR-(V-MUGH2UN-N+-<0#01,T&/H$-K*ZR$L$_.YDR%]
M/49GY8)08?T/WD3MP?VP:Q)]$G=U<S"6CA]>B\:'$FJ67R(N)Y*"8B#_)/*\
M6&F?$0><8F%'B?U6OZ;#B+J# \@EQ)9=E:C;Q+.;+3!=I!_69N):24=6?$V0
MDH("7Z=DT85>:R ==">G+]+J:&66$W 4]>C! H0I=?6N;-0&2N;F0YA5E*_7
M%N,LR+P5.PD6Y*_].-P#;N%NSSEY7F3[Q9R/_-J/G&6'!&_:!V7)PX]MW\F\
M&].UOI1ID7AYY4E& ]1[21C#'7'*%\I\XW/"[4=F8P#9SHD9$&)]Y##C8L36
M?=\P_&+LMG]'/Y%0MKZ#'I.Z8M4>^F^PBTONT!Z@Y#Z%M.E@>]>#M)-AZ;8E
MM,9(O9F"AHC]WJ2&MCZA9-M-ZO44O_73U*:TO:O(U!J$S=)8:CO&R7N*?#:R
MQ@5!61KC:7.&8A+_F=EJRN[$DR9NE/4I$]LZ*)NAM]>?IYBEKUW53DE#D9=.
M4AJP ][?$C<D+'+N(JJ2UMGL)[Y-<3I<0-H!H9C\FQ2>=F%;,4F:'KK^.NDQ
M\NZJ!^0P3/:R#>3C^)^]0G&]D$#GI7@.]*9U+>%G&.;P%@(N_<>][80SB+%M
M+*(S2K[^$7$*PUV]A 3'P9?!R#\3#GKV8?0(M%,>MA%)LK; 85'P0Z?P7Z)3
M]F+Q!1CJMD3"3JQNP^>$&=S=U59$)6'E,BT)2]SE:8ZZAO-W^@FS#3=C-8U=
MA]]RB($]CZ?L/8+CX1]N.X#W(* V?$SXFOC5ZE0"(.8ONT!\0_K8XSP22EGF
M.(IZ2OG92HQ93NXX!,7<(?OM]<96D!=OB\/A2,\W_(Z/)%U?S2$02./+/R<6
MDM0N)W/?N%;8.>30/*?,H=G?^BT]<"B3'B3=>2'C5#AB4PMO=4SN6G,.)O'R
M\CS64VCJ;[\RZQ#7G$>S7GHWV7IDWO'''R'Q:X)#]^,SS,*A.Y.XFNBN3?F<
MI0FN:Y-8HM2/5WS$](!=^:V>88N2._^0\3QPQ(:7L3ETB=DT;T,$;=]-SO68
M)3N_9;/C+VU"LW8DGU^;Q;@#?;8BD'X6L6W)0?J_,(>=4-QOPR>M;W)P45*S
M'>R:V,Q]6)8Z0;1CB,E./K\IFI$*M5E;0T^ =ZY0T I0SDMJJ,^Q2L=95DCL
MN+4GZYN$E8>KF=@DEO$W4)'Z^8YR>@>T:5,0[2*<LW:"]C,R8L5M*AYCOO0;
MZC>XVX[F]'O) U;]] >I@L-'Z$70%)->VE-8R X8;7\Z9%,DE8V4KKU/>8">
M7;F.PL/]:VDXQ87PL4,K=1*6:^5$6P$_<^@R[9^(528,*A>)W>%$>8)ZN"F
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MI4%*K*LNI;56%G*ZQ'G9_<+LPJ'\3,E(-D\QFLE1#O(YZOZ%]#\&V\- :N,
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MXFQ)4G:Z/#,E.2H_+B&Q)"H6/2TQQ57RZ-KJX)C6:EET6Y4\JKU"'M7Q1Z!
M&V+1AFRM-5"DB6[OP[N@7F?_^V9#M=$V"ZW'78XZ-\YB[;I.$3Q/-U!Y=37>
M 65E_,C< G%B:DY01EQF1%YD6GQQ2')Z>6!28:4DL:9*G'BJVC^AO4H:UU$1
M$-M1_B<0C3;$J2Z&'(W54**!;F_-'=^/']G[MD7_P'"GA>K#7COM*Q=<;,^>
MP1-/-%,X5?5,:4$U+R*]S#<AOB@@/3(_-%>6$U,DS4HM\\W(J_!)KZSD9S15
M"=+;*T7)'16^26?+_^170\+!Q9"GM@K*U#9 K?K6+\U:.U^=U=O]]++%KCM]
MUH>[NYUL6LYYX.M:2.R2)KHDZQ@G++%&&!=5(4F5E<JS)<6* F%A4@FO(*>,
MG5]>X9W?B.HHYV2=+>-E_!G$;)X!R0?^A@+5%5"IN@X:5#=].*.^9;1;9_/@
M;=.MUVY9:9V[@K$Z<=$-5WG6TSNOE29.;F:%*(X+8N3UXF3)T>!,G^J(7$Y5
M0B&C(JN85E%:2JEH**54GBOQ*CY?PBCX,XA%&_Y]AK+HP'*HV;_Z9[/*VC>=
M!]<^N:&]\LY#P\T]]RPU6F\X6-1=<74OZB8PTL]313'MS."05EZDY)1OO$]S
M8"K[1'@FO3$^AWP\,Y_84%) .%Y?B&\\6T"LO5!(JOHSB$<;LO8M@-)]2Z!^
M]_)/9W8M'[ZR;\G=A^K++C\QV'IVT%*M\9Z]6?DM%VQV'XX6?XG,#^MF2*47
MN*$^YT4*UKF >*^.L&12>UP:OCTST[V]),NUO3X+V]&1Y=K2D^W>U)/S)Y"
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M 2.4RJ!A4IWL&?&$_"GA3,A3?%?H4_R-T ?$NZ$W2/=#+Y'OA77_ ?C^3T.
MS@J(,-X,,5;[(,Y1"V)=C4!!M($P+Y?O05SB)W]_KW%A*.<U+];G)2O%;Y21
M+1WQ*@H:IE3(GI+K0H8\FT*'B.WA3PB]X0/$6^&W2/WAE\EW(RY0[T:>I]Z9
M$/AMF I^!^9!D/8*B#+:#/&6>W\]%Y. -80XO#5$45V^A[ (GP)\O=[YR3BO
M!0KA"TZ2_W/OK,!A>J'L*;4B9(A<%_:$=#+B,?%<Y&-B7]0=TIVH*Y0[45W4
M?Q3MM-O19[PF]JM!C#;(CZR &,--D&2QY]<S*<E.!I#H;@6Q9.?O$0S")YG
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MR:LQH9O6GMA%NYK4QKB6U,SL2SKFW9=<P^Y+JF)?FQ!(T 8IVA"EN0R2=3=
MIM%.R#8_"#DVVI"#,?F<Y6[[-MW3]442@S04X^/],"S YTY0N.2:.$Y^29@6
MV<7+BSG/+DMH]ZY+.L,\G7*:<3'UA/?5U#KVE=0JSM744N[5E!+>Q/YO0[3&
M,DC360_9_SZ#8'H \JVTOA4X&+[/QUJ]S"$X/\WP(CQ,XM-O1?L+KH3*I1<#
M%2%GQ4E19X19<:?X14DGN%6I#>P3Z?7LL^DUG,OIY;S+Z<7\R^GY@BMI>7\
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MA90)59Y'D.SK"!(WK(R$P7QE":R8PH6-LVBP8SX.5)8X@?H*6]!>;0%&ZTS
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M+0A"-[<0M#=X@^%V,ICO]0#;@\[@I&8/[IK6X'G$ F@ZIL#2-0(??7V0&.A
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M#O3*:,.PC!9LD]6$_7(:<&9)@_@,VH_@^><1RO\#H90'"$5_XT4A((3\08+
M @6B&VB0G," RP',N&W!AH<,5%X+<.$S!0\^8_#F-X" 97H0NDP'8I9K08J
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MI?1;8.H2(!&W?SYN[QH!]* -MW<?/[HTQ(_.;!%%A[:H$W>.F/%/;')8.33
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M\H3/J6J$5VEZQ$>I%ERWDVE\U^-9PK_%<"3/1L3(GPQ-53D6G*MQ**A4^T!
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M/XLHJ0_3*.&'/DKP<1E-\N,HC?_I*'(=>?0?>M8"3,/^%V-^&M8^$OON_3.
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M:#_VEL@(WL;P1,%(:*;TFI "N97!%0K#0?5*RP);598$=*LM\I^C,>BW6'/
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M#_-;5@*4KP?(PK['8K\#,-OU"(#-"0"3,P#:%P!4+@/(_$:!Y T6\!]P@?=
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M */P'G;#6S@"K^$"O,*BO<3_7L!';#;YBV<_0.35@,@I8SL0OBH0GCX0\8E
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M.%;3B+A5P[]LPSFPIN+;=X%ZZW MX+6\ << L^/: $)1C_QFL,"KFP]3>Q3
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M61*<]Y(D./<+<7#N[^*0',5#+E'C4"ZPB8S2#O22%E*537V^YN;1_^>K(J5
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M=V+_9+V OGL>A?@L.O.GJ-:G4.E/H. ?HX(>U5_0U-_]U\F@1^_*,'9%?*%
MRFA&&4?K':7I?]"ZOZ$N7E<#',;I& -4^QC5/Z.G\<-[0L8Z_00_'D%9/HP?
M#WIV9NQ'/U^@>U',]Q"T=_'L#CRZ7>_BT5<T\<)_X?N[4F@:&3= '=F5D<"W
M,N IA*<*CB9"HHL0',3B&"IZ!MM+L;T2VVNQO5&'\>-6U/7-.I4P/ANU?0E=
MZ!K^W:ZK/>>6OJ8K8+H<5@.7^?!O'__;OI!Z4D'4G)ER1%.&5-VI'.R7X&\-
M7; %V]V>.T.NPX]KT-M7H_NOT@ILSV-W(UUXJRY%<Q]D(+N$-KD(E@OPZGPL
MGD<KG:L/T?'?X.&"!^< 8U?(__A"V^A:=WNZ83A<5EHS'OOIV,_'OAO[=;1R
M"[:[L3V@"XF/ \3I^9K%]G+LS6-W$RUQO/9I#Q&Z7WOYM'&_S"G4VLE$QAXB
MZB2B[22XC^#WOO67^WU=T1AZKJ N#E(7%]%'+E R_F=BOQ#[Y5BM(^I:L=^%
M_0'LCU+S4]B?Q?X*;*ZE%C;3(CNU@T^<@)?'TPK;L'X<I=Q"%&_6Q^"?8,&#
MEXP=*0PKMX3 S>/%QE(X?IQ-'SE3D=1H+!RI<.1@OTB[58G]>AA:A9J$HQ^.
M45I@"HXE<*RDQQY#;6S3!KPZ!DOKJ,&UM,<\T;J&%E]-KUY-CS=^']O $\;=
M. RO5S#]'0!G\OS4"*:T$#_M]HN RP97/#SI\.3!40)')1SU<+3"T:7UU,<Z
M_%A+?*RAOZR&;24E7.&W2\O\]FG._Z"6^M^@V8#[P'-:'/B!%@=]H<7!_P8+
MNM_J76Z_D*GF#+";YR<PS&[%G^-,@=H28M:F0+LV!"9I75"&YH/RM2:X5*N"
MJ[0RN$$K0MJT/*1'<R&#6AHZH26ALUH<ME*+PC9J.GR'IL+/T&3$Q1J/N%YC
M$?=IU/0<^$ CYB_!@@=W,-U>%L>T2"IT4H)W[6,CK]>3ELSCR[PE1&M,%JTT
MQ6BY*45SIBPM,;LT:W9KL;E&B\Q-FC9W:,K<ITG+B"8L,QJS+->HY1@-1YZ@
M02M18[U(_=;KU6>]5[VVY]5C^P/X6CWV!1X7=!.\%R6C]U(H?RK\/*[A]0J&
M^3E\61KMIZ6V<"VVVC1CB]>4S:$)6X[&;44:LY5KQ%:G87N+ANQ=&K0/JM\^
MH;ZHI>J)FE<WR4=G]"GJB#F@]IAKU!9[MUICGU%KW/O@*[#@P35PGNN@#DC#
MMI!ZK 7+>3Y+>CB#+U/X.!$;K/$8BT9BHC44FZS!V SUQ^:K+[9$O;%5ZHEK
M4%=<FSKC>M41/ZJV^$5J35BEEH3-:DH\28U)YZDAZ2K5)]^INN2GP;NJ2_F2
MQP6N,5[!MX]I?D>FM"%+6@EF>3[%M3%\&Z%NAI+]-9!D4E^B3=U)\>I*<J@C
M*5OM285J2W:K-;E&S<G-:DKI4F/*D!I2IU6?ND*U:1M5DW:BJAWGJ"K]"E6F
MWZ&*]"?!.^!S7B]X< BNO4SQVW*H ]+1.3#-\S&N#>%+/_72@R]=CC"UIT6J
M-2U&S8YD-3DRU.C(4[VC6'7IE:I-;U!->KNJG?VJ<DZH,F-.Y1G'R)VY4V59
M9ZDTZW*59#'B9C^NXNRW>/P[6.#Z@BZ$ZV1XM^1[=\3,@@DPE(?>X7HW]=*.
M+RV906K*-*LATZZZS 359*:I*C-;E9DN562Y59Y5*W=VB\JR>U6:,Z:2G"4J
MSEVGHKSM*LS;)U?>#U20_T/EY_\$_);G?P/_YCJZ&Y[=QCH4*>B*0F( C(!^
M7G<5D&?R?A.HS_5736Z$JG*MJLB-E3LW666Y&2K)S5-Q7HF*\ZM4E-^DPH(N
MN0I&5.!:K'S7O/(*CU=NX1G**;Q4V46W*JOH4? ;GG\&_L5UY@UX=L"YGO1S
MKI@\'PR";EZW<;T)7^I %2AWA:G,95%)892*"A-56.A006&.\HL*087RBAN4
M6]RAG))!99?,**MTM3))4C-*]\I9=E#I9;> 1^0H>X/'O\I9^AU8\.R2.A[.
M^1+:@?1S#/2!#M#,M3I0"=R@I#18A:5F%93:E%<6I]RR5.6492K+70#*E.FN
M549YFYSE_4JOF)*C8J72*K8HM?)4I51>K.3*FY14^1!XC>>?<.V?2JE8T&G8
MWE)&?W#3#N5H3M #6GG= *I *:\II@HJ_)5;&:&L*JLRJV+DK$I2>K53CNI<
MI567*+6Z2BDUS4JNZ5%2[;@2:Y<IH7:3XFM/5ES=A>!&Q=8]H)BZ5Q5;^['B
M:K]5? US)_P;X5@&QT2E=PVH$S1[UG^H?U"$5,FOD;)KT3YUH7+46Y3:8%=*
M0[R2&]*4U)BEQ,9")326*ZZQ0;%-78II&E%TTU*P05'-NV5O/B!;\_7@Q[(V
MORQ;TT>R-WTC>R/:'^YUI-ZS\(SZUH#:?&M 5: 4W@)2XIP&\NXF*;4E4(FM
M$8IOLRJN+48Q[4F*;G<JJCT/E,K>7BM;1YNL'8-@L2P=Z\!.F3O.!=?(U'&O
M(CI^QN,?9&[_"BQH&SRKX9FNHS_6?;\&5 O*05$CVK>9\B-3TMK1OTBWF.Y0
MV7O-LO7:9>V-5V1?JBQ]63+W%8)*F?J:%='7J_"^287UK5)HWS:%].U34-_E
M"NR[4X&]/U50[^_!9PKN^5:;X%E&&<?AZC-V!H$&4$692^'.ASNS _XN^)$I
M,<@VVV"0+",1BABQ*GPD6F$C20H=<2ID)$]!(V4*'*U3P&BG_$:-6VT0DJ,(
MUU%$S(AQJS_:?P21,HS6'":+'/[:<Y?:8N3Q,.@&+: .7L);A7!G(]\=?>C?
M 2D6B6)#GULF A4^':[@:8O\IYGL9YC<9IAX9K*\ \P,032#H9D![Y$GB]!X
M,XC7&434#.)IFJQQ^I=,"!^#K[22^IV$:P!T@"9C9Q)E+J;,N939B71/HCBQ
M$_"CS\V8#%L2H, YM.4R$IYE)"#+F>B7,[FM8%!?P4"_@HZ]@H9=@:$5?'$E
MHG;%"0 !N^):/HLX7/X*W_T+^-)SA]@H?+T\MG5_OP:43YDS*'/R%/SPVI"*
MYF5H\)52P!IT_SR)WUH2KG4D.^M)-(XA$=F [M_H]"[^&YUM(Y6\<=![^\U&
MVF/CZ7P&$;N!S/F8Y\&'?/=S3<,W"+HI<^.@=V>0"XF<29E39N&'UTHQ3/-H
MT&,D/S0R:1I)%IKR.)+0K?AQO,6;?&V/9=!EPM_)1+BKT+<GA;K891R-C+C?
M17OL1,3O('O>@6C=_@[XJ\;A[ >MQLX@JJUXAAA82A]< 3^\5G@C*$(0VIS$
M$CL 4Z2K3';^TBG4QZGAWGTII^/'F=3'?OPXB]@XVS@NC0 _BT*>16P:Q\+N
MISWVD[WO>PC\@L__2:.XV$5]UU/?97PLES*G$4*Q\%JW2>$[)?^3X".L9:R%
M[/<DW20^OC61 \:Z",GX1:$DY23(!XF/2XT$D1B]@MBX@C:Y@J"['*++UW/]
M-!YICQ_0'C] U5SZMOJH[V;JNP))7L!'TK>@_RFO%=ZPO=3]?A^?L1?EH/Y[
M+\I5OO6):X^LB01)-U,GM](V/R1.[\"/.XB-.VB3.^A<=U#(.S!^._WCMEL
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M;/-!99EO4:;Y$6687P,?@:^U YZU<"XF#1PA!>L&K3QO #5,=U7X4H&/;FN
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M)_Q>BW?B&XCU;OX;H" #Y5QK]1YTT4=,]!&7O0C3'O1N]PM2U\>>\X#<OGU
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M%C)W5L]9,&COI!>ZSZ'%/8C_0+U/+(;RE_Q'G2M[-GH/<D/^*QX"-MG1O_M
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MO/%W]75PT/ ?0W%S?@J,!89)R=6:US5A]69@..;P*"][G:IT+!Y4HY>2FE3
M( 4?4P0^-X]/NLKBD:X7\"@W<KCT&PQ>_O6_JSNA0<-_" V;\V/YF UW/!.3
M(]I7-6'-)G- >=3AT9SW.K6I(2P&H9$2&^4EQ%8Q^+I\(:&=+21T%@F(5W/!
M)G0^[1J-G_VW]7DH9OCWX6%S?@B.WG#'-SXYHG]%$]9N, 74AQQ>PVE/J385
MBT'4JF3$1@GX_P+PNSG@=S/!_\\'_S\;^H8FH':2!?2_K8_"T<._JQ@Z^[OP
MJ/5W_&.3(X:7U17ZM:9RPQZ[RW3":]*F5FC!K\/\?Q'XNESP_XO![RX EAPQ
MH8TN(F*^<SM)1/O;NEH1%?=-U9#9WU2.6'\W."JYQCQ776%<;0S:/RBU@>^M
MTZ95*,'_+P%?EP]^-PO\[D(IKBD76!@20@NMA-A"+B&W$DJH?UN=E5%Q=R.#
M9]VM'K;N;D5<<HWM>55EZ7*#T[;5J3>>":B 0:8F5 M5^!JV E=;I,#5Y0%+
MM@S?D"4C-%)@G)!@O!*DE+^M]JJH83=K8UZX73MD[1>1V*1:UQ1%P/6ZT6C=
MY5(:SP5DNK20&/Q_KAI7Q53AJO-5^$B.$E]#5^)K:0I"+5E!K"/*275X.:7^
M[ZJU*FIH>WWTS,[FF#7M#3&)M>6C%&;G.U:E99];8KS@%QG2ROE=_C\>\_\K
MP?^O8JCQU33P_RG01R28,P0EN0:GI/QM-46BAK0T1C_7VAJSNJ$A.M7NG:93
MV-?:199#+K[IHI=G3.OR_XN  _/_&>#_TS2$"@KX_R0-J8JH)E7UQ "J_Z[J
M:Z(&-S1%/UO7$KTAU!B-4Y7/4O!+/[1SK$?*V):+'I8IS<LTXOWY!D(@6T\H
MS](3@E0=,436D4)$'3F,UY+#."TUG*&E5?Q=U=1&#8HT1\^J:(G>:FJ/2>?7
MSF07^]>IB^R'2PNM%UT%EE1/@9G@S3$1?%E&HI]J) 7(!E* :" '" 9*.<Y
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M41TUT9,_JQ^\I+TU9K>[+88L#<Z7<4NWV5G6XV5,RV5WD3G-4PB^?ZZ1X&>
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M#+:)P/!<-X-B:7*K<#VO0K#+&)(<L ;D)[OR(,J4&4&;@APQ2DF-:C'IBE1
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M4LJ^CQ-2]WR4G+;[5FKZKIL9&3MOXC)WW"#BME^GX+==IQ-ZJTBP/U+6V'^
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M#MAPK(@F158G3E-5\=*U07:&P5><:?(P<697(<[J+,#9[ ]3%X, 8U@X >4
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M-:O:/NS84_/MT*F";R?T4KXI6T=]U'$.G#*C<U[9^S!>$/SHS^E\\J!/"&&
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MPDR0QBW?$H>MIXA/;*9)\P&NJ -IAS@X'EX #LHK@**S">BFTN!F=P1HA--
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M5:??,\'WYJ^<7V.FG)]9SQ#NV+XC]MK/DBYA9TGG<;.D]GD )]0!ASK@]DL
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MN ]",;(0B%/\[D_2^L3T,)IE<#%3]##["7*"TQ@ABS3J6.+Z''^6/HB]X#Z
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MH%VB#%HUJJ!Y3@TTNC1 XZ8FJ ]I@MI;M.IG+5#_J?55"[1F=$'KM3YHCQB
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MFYE(2?/*H2=Y5GC&>;8Q8CSO>@D9$YZ17I/NX5YOZ6%>4]0PKVG74,8,>2X
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M#0X^CSIYGH]6.O,?;W%U>W+6U?71"U>7!^CF<AL]W'Y!+_Y/Z/-?KM$,C@T
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MC:X/_)!_*P#=+P>B^[E@=#_]'S! BXE^ADP,I_X?1Y)-V)C&$<),-TG,"%#
MM&@U3$K7Q?@B8XRNLL"(!@Z&S;/[&K+8<32HW^ESX+#+QX!M;A\"#O#?^9_C
MO_*_X_XLX*7[DX O'O<"T.MZ$'J?"T6?$V'H<R@<?0[\!PRB-031_1E-\T@>
M^_])AFS,M1;$?&=QS/>5Q]P(5<Q,TL74/)/1I"E6'^+K;-_%M#B^CEK@_#*B
MU^UY^*#[7V$;/9^$[O%Z%'+2ZT'H;]YW0I][_Q8RZG<E%/U/A6/ H4@,V!.%
M 3NB,6!;S+]A,/7+,,I/T&!B!IE(LRBB_9CL*(:3O62Q)$1EM"!.YUU.IO&K
MS!*K9VG5=H^3&IT>),QSNQ>WR.-.3+_7']'K?&Y%[O"[$7$TX%K$]8!+D7\%
MGHO\''P\"D/VQ6#H]E@,W12'(>OC,7@XX=\PA'+'OIL;^SVI7%*LP\(RVH]*
M6Q&<RI?^5!F@]+HL2NNODA2CAP7Y5G=SR^U^SYSA_&MJB_N5Y"Z?2XF]_C_%
M#P:=C=L4<BIV7]B)F//A1V,?A!^(_1"Q*PXC-R5@Y+HDC!A*QHB!9 SO3\:P
M\3"4\F,I.X-Z1B%UWRFT-U6&+)QN(_1IAK/$JSH?A2<U8>KW*A,-?BO+L;A:
M-,G^XL1JU[/9#5XG,^;Z'TM;&'PH9678_N3AR+V).Z)W)1Z/V9[X1\R6I#>Q
MZY._Q@ZF?(WI2_L6O3P-HY:E8^22_X!AZK0/U+VSJ6=,HG5,I=Y=I\?\VF A
M\*;)0?1)DX?,GPV!RC?K8G4O5658GIU2Z'"\I()_J+#.9U]><^"NG,ZP[9E+
M(S>GKXX92=L4OR[U8,+:U"N)@VDO$OO3/R?T9H[&+\[Z$M>3]36V._M;](+_
M\/<:DBE[XMC_/Z!U3%-A8(,VX\,<$]:S=J[0O787B5NM?A,N-4;IGJY+L3A2
MG>>PKWPR?^?D:M\MQ0W!(P7M$<-Y/3%#.2OC![+7):W,VIVR/.M\RM*L)RF+
M<CXF+\C]E#0_;S2A(^]+_-R\K[$D9CR,4&-@*O7MPK'?NZ?N6T_K:59GO)ZG
MSWS89<G^O=M!Y.<.;X4SK>$Z1QH3+?;.R';85E/LOK&RTF]X2EW(ZDG-D7W%
M\V-["Y8E+LX?2NF9N#UM0=ZI]/D3'Z3-R_^0VE[P,;FUX%/2G,+1A.;"+W'-
M!?^&473=&91=0EVG1A:P41X^MRO#LRY-QMW%1LSKBSG"Y[H]Y(]UA&CO:XTW
MW]:883]27\!?4UOFUU]5&]);T1BUN&QN7/?D14F=):O2VHLW9[06'<V<4WPW
M8W;)^_2FD@^IC26?DAM*/B?.*AF-GU7R)6X\C*'NGT4S**7..]:]FV7@7:<\
M/%JD#+\MUV)<6FXM='()7^Y =Y#6CHX8LY'6-/NAICQ^W\Q)?LNF5X7TU,R,
MFC^U-;Z]HCMYSI25Z8UE(YDS2P]FS2C[/6O&E'<9=5/>I]65?4R97O8I:7KI
MYX3II:/QXV$<S3Y7>JSW M:3-DEXU2T-?_;*P+4!53C;9REX9+FK[.[% 1J;
M%D29KNU(MNMOS7%;.KO8M[NA(J1C1EU4Z_3F^*::^<GU5<O3ITU=EU4]=5]V
MU=1?LZ=6O<VHFOH^K:KR8TI5Q:>DJO+/"57EH_^""6._#T/94ZGW-HC#BPXQ
M^&V)*/S:+P87!Y7@Q&HS@?W]SM+;EONIKUL<83S0G<A=UIGIVMU>X#-O3EGP
MG*;:R(:&QKBZ^H[DZKJEZ173UV253=N=/7GZS^1U9NFT]VEE-1]2IE1_2II2
M]3FQO&HT83Q,IK-02)VS1@S>-XM0YQ*$J[TB<&FU*)P95H##:TW8.P=Y4B/]
M/JJ#R\.,EB^)Y_3TI#O/ZYKH-6?>Y*!9[541TUIFQ4YM;D\J:UJ<5M(PF%G8
ML#,KO^$">9E1./-]6M&,#RDE=9^22J9]3IQ4.YHP'J;262@1I;,@#'^VL>#:
M0@&XL%((SJP1IOXK!WLW&+*VK+.76#ODI;QR58C!HI6QUIW+4GDMBW,]9_64
M!$SKJ@RK[)P14SJO):&HO2<EKW4@/;MU6V9FZSGR/#U[SH?4W*:/*1,;/B7E
MS_R<4% _^B^80>>P5 @^SF3!S7E,N+!$ $X/",+1]8*P?XLT;-^BQUR_R59L
M8(.'XM+A(-WY@]$6+0/)#K-69O.G]1;Z5BR=$CQI\;3(@I[FN)SN!4D9"_I2
M4[NVI"5WG2;/4E,Z/J:DMWU*RFSYG)@U>S0ANVDT?CS,H7VH9,&?LZE[=S'@
MS'(V'!FB_K^1#=MW2,#(3FWFZATV(KU;W106; K0:ML0:=HPG,B=MB;3N6)U
MON>D@=* _+Z:T.R535%IRSOC$GM7),;U;DJ.Z3U)GB;%+OF<F-#].2&I<S0^
M9>Z7N-3V+['C83[M0RUU;^K_YQ<!'!U@P9YA)FS=RH#U^T1A<+\Z8_D^2\&>
M/<XR[;M\U1JWAQE.VQIO5;$YS:%D8Y[;Q V3O#/7506D##>$)JSMB(A>LSPZ
M8FAC;/B:$[%A0T]BPU9_B8U<\34V>LG7F-B>;S%QW=^BQ\,2-CR8"7"Y$^!$
M+\#>009LH>XWO),!_4<$8-DQ)>@^:L)N/^(HT7C(2VG:@1#M\GTQ)L5[4FSR
M=N<X9.PL=DW>,=4S;OM,WZAM\P+#MO6&!&\="0O<=CPL<.N3L(#-&!ZT#B-"
M5F-$6!]&A"_'\/&P N"W.0!G%@(<Z ?8.@RPEKK7RGU,6'1"$#K/R4+K.7UF
MPUFN2.UIOFSYJ0#5HI.1NKG'DTS2CV59)1TMLHL]4L&+/%+O%GIXKD?@X5YO
MO\,C/KZ'CY,G/EX'T-][-P;X;L5 _PT8%+#NWQ[7 5SJ #A"_7O[$%W_1LK?
M!=!SF EM9X6@X:H$S+BJP:BZ:B%0>L59O/!G7_GLRV&JJ9?BM1,N91A&7RPP
M"[]8;A5\H9[K?V&NO<^%7D>OBR-.'A=/.'E>?,+CG__JZGH6^?RCZ.&^'ST]
M=J/7>+\U YRD<[!K & =]=^5VP"Z#P"TGF+!C$M",/6.!$RYH\XHOF/*RKMM
M+YQ^VT,RZ7:P?.SM&.7(VZGJH;<GZ@3>+M/WO3W=R.MVJZG'[27F;G?66;K>
M/4SN6SK_\=G:\7?D.OZ*=KR+Z.!T#AW'.S\?8-]*@ UK /HV4_Y>@#G' :9?
M8,*4&X)0_%0&\IYJ,#*>FK"2_[(5C/W+32SB+S^IX+_"Y0*>)4SP>9:I[/FL
M2(W_;*J&R_-&;=[S+EV'%P-Z=B]W&-B^NFS ??'&@/L7&M@\12.;AVC*N8=F
MXQU>!K!I$&" SF$/[<&<HP#3S@-,O@Z0^T 0,M[+0-('=4;L!T-FQ =K=O!'
MGJ#?)P\1KT^!8NZ?HR1=/R=).XUFRSJ,ELC;CM9,L/DR1\GJZR)EBZ_#JF;?
M#JJ9XI_J)E\^JYM\1G63#ZA&U,?;2GNPBO9@X0[*/PQ0<Q:@Y!I YA\ B>\$
M(1JE(0R5&8&HR_2AWN^!7+8K.@OPT%/0'@.%N!@I;(V)(A:8)6J*)>)&6"MA
M@*V2>KA,6@='9+3QN*P6/I;3Q"]R&HC_:7 MP"*Z#UH.4OX9@.*K &F4'_40
M((2ZOS]*@B?*@QNJ,WBHSZ0*S;1!#LL2>2Q3=&<;H1];'T,%=#!60 O3!-6Q
M4$@%JX24L$5X BX55L -(O)X5$0._R0?"8J.MX3.0.M^@-I3 $57 %)O X0_
M /!]!^". ,XH O8T"QM48%C0.DQ0EV& Q@P=M&1JHBU3#9V8RNC!FH#^+#D,
M9\E@ DL*<]@2.(4MAHUL4>P1$,$U L*X6T (+Y(__Z5]#^W_2<K_^9_\,+I^
MCV< /,JW)9;(!!,4!0.4 AV:AP:J,%10DS&!UB*'1@QI-&=((H<ACHY,471G
M"J$_DTHC$S"%%)):%F [Z27KR?9_04?J>1P;)MIR6>A@1YS8:.<I@)P0(;1.
M%$'+/ DTKY!!TP9Y-.Z<@,9+E=!HE3(:;5!!H^VJ:'A #0U/D2OJ:'B/O-!
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M(8;\5&ET+5! IZE*Z-BHBO8=&FB_1 OM!K31=IT.VF[51>X^/>2>T$?N%?+
M +FOR*@!4N8W6S3X;(=&;QS0^"\>&C]P1I/QT$6?B2XFE&_$1%]C%OJ;LS'
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M!2I])I_,486HO;%$M6?6J/[$YD?(H7P' P:ZZ#&0/_9=A#$3/3@L='<50+<
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M@/S*?'JUS4?7[V$4G<54@->%U/TKJ/=.8\+I66PX-EL0#K9(P\XV7<:F%J[
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M>&B>3<#0<EN_H8UVOD,G['P&']MYK_IF[SV ]CXKT=YO&=K[+_G1W2E KT<
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MQTJ&&+8P17$%4P2W,X7Q*E,(WQ+\E\X- #,IOVPL_QSE7P7PHVMWN@M@]1#
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MBX^Z!2Z^X1:XZ#O7P 7"-7"^< WJ%BY!\_[-NYR+5^M[>H':/MBF1=H>%&M
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M?4!GN<\YW64^K^DN]OE6=^&(OW3GCQ"ZW3WHS//Y!\&X?_3FHX"/F3?\J1W
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MQGGP,G-PGMJ'N=S8PJ7/2B[#%G!)V$E/WAZAB^8H,TR/=D1#C!=J8T>C.C9
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M*289_%E"+M?<^4!8H3Y"BDP17-P'@<7],6G*4$R<,AH!)0&84!**\?^'K_<
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MR'UDHCO3B+53)FEUJK/&T_TTEA&NI9E)6IR9K=&L8BW,JM;\[":-9'=J.'O
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MIKKRB&U5Y<VV%94/VI97OF1;5OF!;5F%V<9 >3DHL^!Y.!ZNH7> (V!'-3[
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M3K,IJ<-L>AB>6SL9DP3D6\ *^!: ?IZW\'Y=MU1!D%S<-TD%_4[*&YBIW($
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MY;YHE]P6G9'KHGOELN@EN8Q^)-<%9KG-MV+$K-/4;R=8V4-?!'- *ZB&NV@
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M#R?*;3A+KL,E<AEND/-PKV8,C\II>*,<AX_(8?@VV0T] =Z2_>!7<IAKEN.
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M8#5<"XP;>JAO$X_EU#EGE#Z(^1$KI !XO2C"9;/D@$:?LIN@%]=JORT@^#Q
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MW)+[6$1X.!];YF'+D.\TS?5U49^?CWIG!:M[=K2Z9B>KPS]+[?Z%:@NH4$M
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M9N2 J',2=8X:D(*&X(?7?9'DA%RT0Z-/6D6PMP9=N8: :RUVK"/06._-)!/
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M4GX=Y;=07B?E]=,2(RPG2[66_Z_&BI58.HZGEN/)Y?2<L8G?/C;_&V,R3_Q
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M7CT'\7];@U%^'H<&UU6YF&=PF9_@4T_A,5_#7+Y C\]A.9_"?#Z&=7U QWD
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MDRD_G?*S*3\7CZR)C#J4UY">TAPO;8^']$";0?2>"7!V=7KJ!KXY@K7> \^
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M'',-W&X%OK$4/19ACU=@C/-A>/-@?B\Q><S!1V;A(S/08QKVF"+#8'B3D+4
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MM7>6:C9&9)F1Y(.L0&2%(R>&D3P)66G(RD96'K)4=J81FK7!2CTMF;Q$K)U
MKXNG]\<Q$L0Q&L8A7V&:P1KZ="4T;L'4T@ 4@7P^5W,GSN6[;/2IY&8OE9Q=
MI:*C2;(</"7#WD_2'8(ES2%2*CC$2ZICJJ0X9DF28S5)="R4!*>&$N?46F*=
MNDNTTU")<IHND4XK)-QQ+[@F80Y?2ICC"PES8KPR69<$=_"T[KM1^9<:H"K(
MYEH6WV6@3YJ[C:09'27-S4TJN)HEQ=5;DMT")-$M3!+<8B3>D"1QA@R)-521
M:$.!1!D:2(2QE80;NTNH<:@$&V=(H'&E!!CWB;_AJO@9GHB?\3GO-1F-C-YJ
M_Q%A>4/"C2*0"W+XG G2"(52^#X)?1+-=I+H[BP))J/$FSPDUN0K,>XA$NT>
M)5'N"1)A3I=P2$@H@7B(N;X$F5M)@+F'^)F'B8]YIGB;5XNG^57Q,-\$7_'^
M!6#<I/SNR&I)2%Z/<+AF +$=R.)]FI_*>1#KHU,<]\1ZVTB,I[U$>;I)I*>[
M1'AZ2[AGH(1ZA4N(5YP$>Z5*H%<E"?#.%S_O8O'U;B'>WMW$TWN(>'A/%[/W
M2C%Y[Q.C]U7P1$Q>+X F@RF[,_*:0I'J$.Y4!U!'R>!S"DA GUB^CP:1Z!/N
M:R.AOLX2XFN4(#]/"?3SDP"_$/'WCQ9?_R3Q\<\2;_]<\0RH(QX!S<0<T$5,
M 8/$&#!%# %+Q35@E[CX7P2?@5_%U4^S'%?8 5F-H$=%>@ZH(J@ $KD6BSY1
M(()[0D$P" QR$/\@@_@&F\4GV$>\@X/$*SA2/$,2Q",D7<PA5<444B3&T,9B
M".T@KJ&EXA(Z09Q"%XI#R':Q"SD+'HI]\,_B$*Q)7W4.#O(:0%=K0H^J@ R0
M N*Y%@TB^#X4! -_/ON$V8I7N(MX1IC$'.$)_,44$2:FR%@Q1J:*(3);7"-K
MB$MD W&*9*2-["UVD6/$)G(^QB0XC" 8C""F#O\9:)9]:2V15TP(G@\4?4]3
M^1\0&ZYR/R)A?!\, GCORW7/*%LQ1SN)*=8@AEBSN,7ZB&MLL+C$1HIS;*(X
MQF6*?5RNV,75%9NX%M;-^W',1''P[MC-@"@AAF SAN@EFKF3<ILAMS8A9ZZ>
M THMS_]P/0*$(C>05S^N>?&].=963/%.XI;H)LY))G%,\A+[)'^Q30H3F^0X
M'#G-NG @F3@Z&=*2#$E*AE<DSZ&#$9PG$4\GHD,B$5R")ATIMY':"Z;V8($,
MD 1BN1:%O#"5?P)^?/:F> ^HK"G)5MQ2',6I@IO8IS' I-'!TW'N=!PHG0(S
M5"*EDO4/^!F0IPSB^0QBZ71FIG1FZ31X=QHZ5'@&-&D39SV/)Y^RLU4.""3P
M.8;K$>@2S*L_G[T3D4_1)FB"6YJ-.&4XB%T6 WU%!MI*[M8!3254<S!L#C_(
MR6"0A4Q7ALA5AE_E] =P_VR(2O91?H,.%9];\C#-$ZWG\>2J=4#)UAQ0/->B
MT264UP ^>Z<@OP+\ \KFFB7B1!5M<YA@JS#9565"R64PSU.);0:T?#I1/H;+
M1]G\RM:#/?+QB7R(3#[DJ3K$)0_NGPOWK_;<LAZFD;X6J#+( ,DJ!X0NX;P&
M\MD'N1Z9R$>N2XZ(0U4F=*HG^4SN-="C #V*F&QKJ20_;5+,@%9,YRE6AQVA
ML"+V==7#;HA*ZA"=U8$HUB9RJT446X0.A9H44WYU4 FD(2\1=XKB-9C/OM!V
MCQQK_L<Y3\2N!K(+1$WFE 54/J0^>C1$CQ(WZV++9I[6C9_-(ZV)KF9P[F:T
M1U.(=%-(;!,BML80MT9O\1O\H:$F1>7G\5#/"J@=B]Q0/OOAUA[4UX!<I\(_
MR6Q@"6PH#\"5+?F05K8,,@0;[=%#G972A0F@"VW2!6?J0J&=Z1^=N+$3$6)'
MM1Z%Z+G==28IQH?6FM1 S2K4,XNF2T1N!)_]\Y%/?0TTI2-5L.1]E$R5"U'Y
M%[4G2.4EU-J0W_,AM$T?.&XI_C$0/=0D, C_'$2CEE&9@10R@!O[3[ ^KZ?O
M&29+6%4OS7H>#G9.K8X?TG2!V-F3^AKXB;W*^[32 \O.NJSR7$A_/?@=K >B
M(_1@?!R!UT3TF$I?F<X$,PW_G*H.Z:;@210TD7%B_&+N@TV,^<RR'Z<Z=L[$
M5/'8.J0^8Q!!I &SV;67/_(OI;J\\CTYY>>3J$!\FAZ0EN="U%J-1=AD&?UV
MM7IP )/!*CK92@R\G,*7]A-9S,T+B:87W".@_U5RL'5R0W46,GV@M?4,&KN>
M>CV'Z#(QGR7W,NO/<L2:"RE?%[)6_C@O1*T'4>>$'$ /M7G[,/WD(,[^*K;8
MAX ]5&(G/]A!>VS[RO),JFB&$']L;:(+.Y3I)$/54^5ZYLD?ZT'^G =1^W!V
MZK+*\R#_^_P81>!NTRYW&3=N,]"^CN/=H(&O(N0R%;G #\^])PE=Z(?(]N"R
MTVB]OG/U>J[2Z[:MO%[RQYDD?UX3HDBR6@^B#FY0YX.H/V"7YT#4@T6_8BS]
MDC;Y@@'G<5V1SW&LAS3B)YM$/KKX7SF0Y_"JY^(L+RS[8=0:#'4>1ZP>@:NU
M(#4M?YU]0>=\1B?YA0[R(ZSN>YSF.]CE-SC,ES#1QY9S21>AP@;X]$%Y!^7>
MX,ZK8CT#0ZV!4#F Y?H:B/+]'VH/QE,=/\)I?D6/W\27[\+E)R+S[XC<OR2R
M?\0@]1 ]/J+#OL< \0Y\ZDU8F7I&K/5,CF$PJ0DTQ1S,M!Q&LUV.T3BO\4LE
M?XLN6YV_J?( Z@P*E?_X5C?99SH^P1X?P&G>@5>]#8]X!RYS&UYW%19Q$3W.
M8H]3#%K69Z,TI?S6E-\1M^@A^]!C-WQB)YUF&]QJ,[QF [98*_?A=,\L^0^5
M^YBJYR#4&10J__&QWH3E^U!.69K=40YCBP.TR0':Y%7+7I047#Z+NE3%-6M0
M>BUL6A^W:2PK&#"7P8*7,(@L0H]7<&SK>:!+L,@V6N<\+OZU1;;*>PP3ZS-
M5![B ]V5E.Q#NONML[BC#66ZRE)XU5+:9 G<;B&^,1\]YJ'''/QC%FQO!OQR
M.H/X5'QD,CXRT<+V>U"_,F2-19.Y6&4MPYC*$KUOD:F>,J3V?I3G(:[K+KY#
M[P:OZ,. =0V& ^49\3(/X,_[<$J-9<A(H=Q,RK6>QSD('QF(CPS 1TK1HQ]Z
M],%/>W&']2S.Q7#Y'98GZJBG#*EU%VKOAWH"M#KY]X1>]R7Z<#=.'W;5$#P
M6Q 14Z:)X=D+!%!V.&7'4M-DRLY@*,VF[&J46Q./J,.P7D+Y+2F[,UY2RKO1
MEJ?7-I?U>,XQF/ CR[X/M=NL1(=*MR[5A]P1^O#84Q^F&=$HTX$RW=#9#'Q
M$.5',(W$4G:R-(/A-H7Y-D&/QNA1@CT:\JX!=]9#TV++B2%3T6Z9U,9C:^&;
MM1@!BI!=CC5Z_95\M222(<OR9PDU1:JILK'84JXS,%*V!_"E_& \,8+R8RD_
MF?+3*3^;\G*ED'\J$U*3FN=3B^K4*@_KYEI.E=V&-U\"3RU/Y5:H)IJE_<?I
M]5=38RNQ_JF$Z8OR"7E $;:PYA],P!/X(2,$&9'(B$-&,C(R*#,'3ZTNE?E5
M#M966:**M%P6-<S$BS-HCW1Z=#HC@'HBE3H5.M.2HV0Z9+KMP=3?FG"HD9,U
M]U' YWRNYS$%5A,[RG>F?",P(\,;!" CE%:(0DX\<E(I+\NB21I:5J 6J7A#
M"MZ8;-G--)V1;J4D,%8DR+N6%7!J1Z)Z2M=$0K'^SH0D3"U-W:Q_(JL)<OE<
MF6FO$M]51)\L6T=DN"+#1!T\@ ^R I$5AJQHY"0B)XW_9U-V=;2JBX6:6;)G
MT7AW%+TL$L^/8)2)H#=&T!XJ&ZY.B!J-G%X&ZQJ8ABK_HOY<"7+XG G2^"X5
MG5)<["3%T5F2[0V29.LNB3:>DF#C)_$VP<B*0%8<HU@*\K(DRB97(FUJ281-
M8PFS:2^A-OTDV&8\WKP0K;>#"^")96>D.JU[*#*Z(;.Y6JIMMN9?*H-,4(%K
MR7R7 .*,-A)G<) X5U>)=39*C)-9HAV])=(Q0"(<PR3<*5K"G)(DU"E#0IRJ
M2+!SH00ZETB <SOQ<^XKOLYCQ<=IOG@[;1$OQU/BZ? )^!5H4J:.ZT.>VC)?
MR]/Z)]M*( TD<2T>Q/!]%(@TV4N$T4DB#&X2[F:2,#=/"7'SDV!#L 09(B70
MD" !AG3Q-U067V.!^!A+Q,O83CR-?<5L'"?NQ@5B,FX1H^$D^ #\ #0II>QV
MZL^CA,(%:NT+R%"Y%Q#/M1@0B3[AW!/J82?!9@<)=G>6('>#!)K,$N#N+7[N
M@>+K'B$^YGCQ-J>)I[FR>)@+Q6QN)"9S>S&:^XK!/$;<S"^+BWF3.)N/BY/Y
M??"].+DS;E-V*^35(PS.AYYD@S20"*#3$@G"^#X$70*];"7 TU[\/!W%U]-5
M?#Q-XNWI*9Z>_N+A%0IBQ.R5*B:O;#%ZYXO!NYZX>;<2%^^>XN0]0AR]YXJ]
M]P:Q\SHFMEX/Q,;S>['U5,^NQA>05\?/NO=(Y8!20#R(4GD7$,+W@>CB[V,K
MOC[VXNWC()Z^SN+A:Q2SGUE,?CX@2(Q^D6+P2Q W_PQQ\:\F3OZUQ<&_F=C[
M=Q5;_Z%BXT\LZ\>,Z$<PYO< $O4#T*2S.@?'W_KG\JJ!UAQ0$H@!$="E4+X+
M O[HXNMG*]Y^=N+I[R#F "<Q!;F)(<A=W(*\Q)6;G(/#Q"DX5AR"*XA]<([8
M!A.TAS#BA3#JA\"[@PE0@XEE@] AZ#TJ1N04J%GVI94@KR:T/2?8F@-*X#4*
MA 59<S\!Z.(78"/> ;;B&6@GYB![,84XB2'435S"3.*(LSB$^XI=>+#81,#]
M(R#*$16M!U=$$+1'0!0B!@!FI?#5X#4*1X=0>%8H<R=RZB&W.N%W13T'%,?[
M2#W_$X0N_MSC SQY;PZQ%5.8O1@B',4ETE4<HHQB&VVV.F],@#5Y$ZLV$,']
M8^%7L<76/Y[&,AO%0DAB5@)X=S1!;]0O .X?:EV/5"W"N@XH"<3P.1Q=0O@N
M$#U\><7EQ,QU$]\;HFS%.<9!'.(8X.(9P!)-UHZ<K!90\8-DXOCD5#T7HS82
MJ,,,"-Z3)W ?)"$1(I" #@E$LO&:-%;KD=1>,+4.*-J: XKB6ABR@I'I![QX
M;^:ZB>_=8N'@5-,^D4$^F<DEU<4ZF*8SH&5BBTQLD<D/,A,![9$)<<V$7V42
MSV= 'C*(5-+A%6GO6?,PJ9K41^7J:B]8G'4=4)Q: X2L4&0& &_>>W#=A%PW
MBG5*AH=!$R0=KIV)'A71(UM-+@SL56B3JG2@JMBB:JSU@)FJ>=:'#%?%+ZL,
MYSZX3<Y>?O,.@Z$U#U-;[0=3Y_" I(0_<D!!O/H@UX/K)N2Z(M>1(FV@KTR6
ME .J,JGFHD=U)^NZE *3->%>I#H:MBCBAX65K0]<+B0J*8!(U81 U2!RS+_#
M[XCJ\V M4/,<FJX"KPE):A\:?J"O0?)(M>9_7)!KGXU,FI>)G-\"E0]1>0E+
M/H1)OA@]ZKM9)[Y&7M:D:R.UZ(D?E] >)>K!OWU$&M WZF_4]P7];#F;)0_W
MK:C6X52P[@4+!P%\]LQ4ZW^0CUQ;2^Y'EUE;#VY4D%.B!SR6? @V:47@T08]
MVJM)B#;I@#-UH#+M4;P=[=&6"+$-$5.K5=9S:IM_9UF+4J62?AX/ND3K^\"\
M,)\)N<XU+$'4'S++\R_EN1#+6A0]\%1!H"4_0;#1%ST&F*W/S>F/@Y4BH%0]
M$(D?]!G*/9#H'C");H_XG28YR,N@OO'Z/BRU!L=$?9V47)7W::++5&M1.OQ9
MEEAS(2HW,5 /Q,OWR8S%1R:BQU1\8TJ(]6%Q$_#-<7#N<?QH-.QAU':1X6^*
M#/U-<JAO,E]'4F<_5'6OAWQE7Y5G:J?+["%_K$,I7Q,R6@]$Z?*_YT+*]\BH
M/1R+\9$5]%FU85@]JV8Y1EY"Q192X"OC15YFS'X)TC[GJ:13YQBU#XHZF[&S
M<QL]N.TE?^1!5-W4XNOR,UK+Y?R^]D3^R(/\>9W&?O0X3)\]S&1SD$ZVG\KN
MQ:@[,=IVVF/; 9%-GTHB?A6*B3QI*E=5YSZZ754])\D?YY+\;QY$+<S_\W-[
MR\\)46M!<#=+7L*2 [&W/B/F+FWR.DYWHY[U6;T7IXN<I8 SUR02V;Y=U'.8
MZ/NJSFI]CUJ'HO[PJ\C7:EVF(H-J4X BI>7[;Y0L=0Y)^5H0M6B@/ ?R@5C/
M17T"OJ6_?$.;?$5?_0*'>XS0ST9!\%=PW['_(__P/5SB1S'(KY8U& %ZY)NL
MKP7)M3"CYW227W'6GV C/^"H3XG?O\6 7\$\OX"-/H)7?4IC?4CC/)#],*N;
M<H=2SXAU[\MJ/?=1?@ZF]1DHUCT8CW1\@1[?H<?/\)F?B(9_(&+^A@C^"7'[
M0QC-1^CQ "9WG\YZET[S.LY[ ^>]BAZ7T>,"C/LLC/PDDH[B'(?EE!R0SRW/
M8%FERU;[/R;K.8AOQ+I]Z#WYX_'#ZIDH]\5);L,E;L,C[L!EKA&[7X!-G$:/
M$]CC* /680:.@PQ4^^%U>QDL=N/,.V'UVW"H+3CQ1IQW';5>S1TKY U<][FE
MWNKLB]%Z#D(]:5@=9ZMR'VH-PB6]F0]9W,Q&]L#O=M(FN^#]N^#;6V$N&]%C
M+1/&*@;M%3 ^Q627,) L8O!ZA8'+NA>E#[*&TE4G4]^%=-LMO#N+[&\L^0^5
M^U#[/]0)M[V <B.5RCNBN[CJ7DOU;C!?'+&;$7A2;@#=(T)FH\<,])B&?TRQ
MK.;/QYY%#!7U*+\)WM":X:,+=>Q''4?2,C.E#(T'T!JE\KYEWXG*>Z@<1 <]
M#W%2=W<E>X'\L09#+4L;A2U&B(OE+,X1<,SAL*(AZ#&(=AD(I^H/^U/G<?;5
MS^/L!1/OP032C4&U*__OS%T=:9,.6*@]+=0.;VF+AZDG/ZL]("H/H<ZAV"O_
MO0=DB#XT]=&'Q^YB3WENP Q\0!!E1U!V'.4F4VX&$K.I?2YE%^"A]?".IOQK
MAXQ>>.UP/&:F-$1* [RH/EY?3ZS[/\K/H%BORQ^CRU93@9H6U)2DANOFV*(9
M_MF4-FF*;S037\H.0O\(RHZE["3*3:?<;*R02]F%E%N?*;T%[SI;LD0U92)3
M_1):;0_3_EN6_1]Y>D]7KPOU^JNIH*LN6TT7:KI2?ZY0?[:HC2UJP[EKT2:U
MT*,V>A1),#(B*#^6\I,H/YWRLBDW#V^MC:<TDLI8/H=6RJ95*^%1%?'-BI;3
M;GZPG$*4I8\Z,W3[J_JK_$>)+E?]N4:%*BITJ":VP$FJ,F94%7?@B0P_9 13
M?@3EQU)6LB7[D,G5=+1*PS(5L$6JY035P7P[ ZQ%VV/@L64%7)(^^BD;J!Q0
M>T*0QK;6D$CE/JKR7H5.*G1CQJ-T!^ "C,@P R_D^",G!!F1E!5/F:F2B#9J
M94@\%HO#HK&T; RM'(VG1UF>./0J=[]G&7W5B4C1HEF6@G9G6FG!D%Z/<*RF
M,R&;LS543>-:"B%),CHEB1WE.U&^&S !#^3X("< .:'(B>9?(N6F4WYEK%/
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MQ 2,P,W+55R\C>+DXRZ.OEYB[^LO=KYA8NM+S.:7!B +?NK@2$8_/V8@WPF
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MQ?49!""R==1#1QDCBD[1&9Y:]@15TM?AQ"58]X(%Z6N 3,AU1:Y]IE[7*GI
MDR__O1ZEGOQI;8B--0A0YY2TI9^T5>?%QE@?2-Z*'[1DK&I.Q-0,LMQ$G5/[
MV'(^;6::-8VGUN&$(M>W@MH#AGSJ:U=%#Z9JZC+_G']I(M:U*"KX^M]],CW1
MHZ_!>D!\7QRJ+X7WI@(]^5$/QJIN^$1G"&S'=RW/Z$FGGLDT6:3:AZ76X%2V
M[K^RK2G6O$]Y_J5\38C*O:AU*/^;"RE?%Z+6A%CR(.@Q"1^=1%^=0...H_ Q
M5&(T[3&"Z&T8T?S@BR(#?Y)TZAM+^P;3OI[8V0T7MJVG![8M=)F=='F]=5G_
M>S9)^7.#U1]F_^L,4_18B6^LP#^7TN"+$;" J'G^8()YQJK9M,>,SR4)OPI7
M^Z"HLY%VM6VFR_US'F2P+D_)4CD7%0BK#?EJ?4;YFI#R/(CZ0W7YN1V*O!QV
MLIX+<I!.MA];[$'(=BJSE4(VTT?7WY8H_,I?G4/33#\#6"WP+M5M.D:7.5.7
M5WY.ZEJQKLWX<QY$D;7RM2"*O*F\A"*QZHR.M^DK;](F=W#\FU3X*H(N4/A9
ME#YSPC*=>'#)J;M>9Q7DCM?KJO(@BGRNT>M6?C:(Y7G \L=:D/)S4M5^&$6@
MRW,@:B&#VMA@26S0)M_AGU_3^%_0T)\C[!,$O*^4_^__;.SL'1R=75S=C"9W
M#T\O;U\__\"@X)"P\(C(Z)C8^(3$I)34"FD9F5F5LG,J5ZV6FY=?HV9A4:W:
M=8OK-6A8TJA)TV;-6[9JW;9=^PZ=.G?IVKU'S]Y]^O;K/V!@V> A0X>/&#EJ
MS-AQ$R9.FCQUVO09LV;/>6G>R_-?6;AH\=)ERU>N6KUFW?H-&S=OV;I]Q\Y=
M>_;N>_7 P4.O'3EZ[,3)4V?.GCM_\=+E*]>NW[CU^NT[]]YX\ZW_O/W.@_?>
M_^"CCS]Y^-GGCYY\\>57WWS[W?<__/C3+[\^>_Y"^W_[W[_U__]Y_6UL58V=
M5)4-U-FL*NU#K0-4M4-5O:.H>)RJ>;*J>CIUKZ@J7T75OCK5+U#UKX,!ZBL+
M-%8F:($-VB@C=%16Z(89>BD[E"I##,(2PY0I1F.+\<H84Y0U9F*.N<H>"Y1!
MEF"1%<HD:Y5--F&4;<HJNS'+?F67P\HPQ[',:66:"\HV5S'.366=N\H\]['/
MN\I 'V*A3Y6)'BL;?8V1GBHK_:S,]-L+K;3'D'35[G:6 .Q_G>'_\OG_Y_82
M&QM;6SL[>VS@Z.3D[.R"'=P,!B.F<#>;/;"&ES?V\/7#(@&!V 2C8!7,@ETP
MC+*,Q316V_R/<2RVP33U&ZBN1$]JTZY#IR[=>O3J4SJ@;,BPD6/&39P\;>;L
MEUY>L&C)LA6KUJS;L(GNHGK+_E>II*6._U-%:QTME52UI)K4DXI24ZI*73]]
M2&T_?T1]GWQ!C;_Z^NMOJ/1W3Y]^3[U__.FGGW_^A;H_>_[\M]]>_%M_;5.,
MH[8QS:1MKN*O[2N(TH[5R]#.-"]Z<:Y#F^_.=Q_XR=E^T]XZ.G#9]?U#MI_;
M,>SPB<TCSQY>-_;:OE63[NY8/O/=34L6/?RG^%>'?W7X5X=_=?A7AW]U^%>'
M?W7XRSILUG78@@[["R*UX^APKEG1\XOMVWQ[N5O9QQ?[3'_S]( 5UUX;M//L
MOB%'C^T:?O[ MM$W=FP8?V_]ZJGO+%O^TH?_%!8=-J'#UBI^VJOH<+)>NG:A
M6=$O5]JU_?I&U[*/K_>>\<;%TI573@W<?>+0H*,']@X]MV/[B*OK-XVYO6S=
MQ/LOKYKYX)_B=QVVH\-!=#A=+_VWRTV+?KS1MNV7MSL/^O#UGC-O7^N[ZNSI
M_KL.'2Y[;>>^P6<V[!QV>?G6D3<7;!QW;^;:J??_*;0MN@X[T.%0081VIE[Z
MK]>:%#Z]W:;-X_]T&O3>F]UG7KO>9^6Q,Z4[]AP9>&C3@4$G5^X9<G[ACN%7
M9V\9?6O*QHGW_BDL.FQ&AUU5?+77:D:\.%^<]M/-)H7?O-FJS6<?=!CTYMO=
M9IR_T7OY@7/]MFX]-F#_ZD,#CR[>/^CT2[N'79RV?=35\5O&W_RGT+:BPQ9T
MV%W95SM:,_S9Q>(*W]]M7/#D0<LV'S]L5W;SG6[33]SJO73WA;Z;UI_LOV?I
MD0&'7CY8=GS&OB%G)NX><6'TSK%7_BFTK=%*!Z.VM[*/=J)FV$]7BBM\?;]1
MS8<?-V_][N=M!UY\T'7JH=N]%FVYW'?=RC.EVU\Y/F#?K"-EAZ8<'')L[/[A
MIX;O'7/VGT+;%NV@;46'5RM[OSA=,_3IC>*41P]*\C]\U+3UW<=M!YQZO^ND
M/7=[SE]WK<^JQ1=*-\T]/6#'M!-E>\<?'7QPU.'AKPTY./K8/X6V'1VV53!J
MAW*\?CE?(^3+.W63/OJX0?X[7S=I=?7+-J6'/^PR?NN;/>>NN-5GR?PKI6MF
M7!BP:=+9LFVC3PW9->S$\+UEQT:_^D^A[4"''>AP-,?SZ94:09^\73?^_N?U
M\V\^;=SR]->M^^[^I/.HM>_VG+;P7M^79]_JOV3*]8$KQUX9O';$Q:$;!I\?
ML;G_V3';_BFT7>BPMX+;L],Y[H]?K^'W]D>UXJ]_5;_&N5\:-3_XM%6/38\Z
M#UGR8<]Q<]_I.VWJ6P/FC+\W:/ZHVT,7#KTU8DG9C='+^UT?M_*?0ML39:\=
M2G'Y]G(EPX-W<[UN/*Z5>.;'>OF'M)+&VW]JU6G%UYW[SON\UY"IGY2.'O]!
MV821[PV9//3=$=,&O3UZ9O_[XV;W?7/2W'\*;5^4_:^GDAT_OE?!Z>;#JKYG
MGA8E'=#JYF[5&M9?_5O+5O-_[-QYVK>]>X__<D#_D8^'#!KZ^?"A99^-&M[_
MT[$C^WXR873OCZ>,^:?0#D;:/;D6:?OZQW%.9[^M$G#@1<W$S5JMRBNT!D4+
MM!8ETUYT:3'NUS[MAO\TL-/@'X9V'?!T1/?2[\;T[//M^%Z]OIG4I\?74_O^
M4_QX-LCFWOL>-F>_CG4[^+Q*X!8M+VZ95I@Y5ZN7.U5K7C1&ZUQOJ-:G9* V
ML$D_;6BS/B]&MNCUVYB6/9Z/;]7M^:0V79]-:_M/<>^6JYS_TM/VX+-8XU:M
M4L RK6K4'*U&\@2M.&N$UK1*F=:Q>C^M=T$O;4!1=VU([:[:\#I=M-%U.VOC
MBCMJ$XL[:%/J_5-H:R(=M%4I!FUUCH^VM4:HMJ]NDG:H:37MM?8ESP[UZ/K5
M@0'#/]HY=.;]C:.7W5PQ?O/E5Z;L.SMWQI&3,^:<.CIY_H7#XY=<.S!V[:W=
M(S?>_KOX5X=_=?A7AW]U^%>'?W7X2SJL08?M^:':J^API$DU[5B[DE^/=N_V
MY6NE(S[<.WCV&UM'KKR^9NSV"TLF'CPU?^K)HW-F7C@T?=[U_9,7W]DS<>V;
M6\:MO_MW8=%A-3JLS?;6=J## 70XA@XGVC;Z]62W;E\<[S?R@X.#YM[=-7SU
MU8VC=IU=.>[(\<63SAU^>?K5_;/GW-D]?=']S9-7O;UNTKHW_BZTM;H.Z]!A
M9WZ(=JA.DG:B<37M=)M&OY[IVOV+,WU&O7=DX+P[^X:NN[QUQ-[3ZT8?/[)B
M_*4#BZ?<VKMP[AL[YB]Y>^W,E>\NG['VK;^+WW58CPZ[T.%PG43M%#J<;=/H
ME_-=NC^YT'OT>R?[OWS[T. -%W</>_7DEI&G7]LP_LJ!==-N[5PY]XT-BQ>^
MO7S^RG<7O;3F_M^%18<UZ+ !'7:CPVOH<*91M1<76C?ZZ7*G'D^N]ASSX%SI
M_%O'RS9=.##DX(F](T\?VCG^\NXM4V]M6C?KC94KY[^]:-G*=^<M7'/_[T);
MI^NP$1WV5@_6CJ+#N495GUUNU>B':QU[/+K58\R[5_HNN'ENP.8S1P<=/+1_
MV.F=.T=?WKAU_,V5&Z?>6[AV[OVY:Y:],VOEFOM_%Q8=UJ+#YDI>VCYT.%8G
MX<7%DJH_7VO9Z+O7._3X[%ZWL6_?ZOW*Y0NEFX\>&WA@UZN#3VW8->S2\JVC
M;BS8-/[.K/73WIJR=OY_IJQ?^=;?Q>\Z;$&'5]'A1.V$YY<;5OWA9HN2K]YH
MW^.3M[N,O7NGUX(S%_MM?!7.O?G@H.,J!_**G@.9O''BO;'K9[\Y>L.B-_XN
MM/415AVV5O+4#E0/TD[5CO_E6L,JW]UM7O+XW;8]/OB@\]CK\.YCE_NNWWFR
M_YZUAP>^MFC_X--S=P^[,'7[J*OC:),1FZ??'KIIWIV_"XL.ZY+=M.WH<"@O
MZ+>SM>-_N-&P\E?_:=;PX<>MN]__J-/H"V_TF'?@:I\UF\Z4[EAV=,"!EP\.
M.C9CW]#3*@<R:N?8*T.V3[E6MFWV];\+;0,ZK$>'G14]M"-Y@;]<J!WWS>T&
M.8\^:%+_HT<MN]W\I..H$V_UF+/K>I\5:\[WV_+*R0%[9ATI.SCYT)"C8UX=
M?G+8OC%GR_9,.M]_]_2+?Q?:1G38@ Y[*IJUXWG^WU^I%?/X?H-*'WU64O_=
MKYMWO?BPXX@#;W>?N>GUWHN77NZW;NZY 5NGGBK;/>[8D/TCC@P_-/CPZ"/]
M#TXXWO? U)-_%]JF"'MM(SJ\6M']V9D\OR]OU8K\\/UZ6?>?E-2_];19E^.?
M=QBRX[UN4U;=Z_WR_)NERZ9?&;!VPH5!FT:=';)MR.D1.P>>'+VG[_$)^WL=
MF_+JWX6V&1VV)KEJKV49GU[*]?[D?E'HFP_K5KSV;</ZYW]JVG'?%^T'KONH
MV]A%[_2>/NN-_O,FO5ZV:/2-(<N'71N^JNS*R+6EE\:N[WUAXJ8>YZ=N_KO0
MMH;;:[L3G9^?RG1[=*N:^:T/:X9>_;)NQ5,_-R@^_*Q)V\W?MN^]]%'W(7,^
MZC-V\H,!4\:\/7CF\+>&SQG\QJAY ^Z.G=_O]H2%O5Z?LKC[K>E+_BZT[>%V
MVL$$QV\NISN]_2#3<.UQS8B3/]:IN%^K7VN;UKCYBI_:=WKIF^Y]IC[I5S;V
ML[)APS\9-FKP1R/'#OAPS/A^[T^8V/N]R9-[/I@^M?N[,Z?]76B[PNQ^.15C
M]_Z;D;;7/L]P/_E]C<B]6E'F1JVXQDJM<8-Y+]JWF/I+CPYCO^_?;=AW@WL-
M^GI$W_Y?C2GM]^7X 7V^F#2PY^.I@[H_GCFXZZ,Y0_XNM$/!MI_?\+:Y_C#$
M_N33=,]]6E[D!JUFA<5:G2ISM4:%4[1V]49K/1L/>=&_Q8#G@UOW>S:B;>]?
MQK3O^?/X#CU^GMRQVT_3.G7Y<6;GSC_.Z?)W\?2\N]Q\VTU./ UQVJ=E>&_0
MJH0MTJHGSM1J94[02JJ,T-KFEVD]BOIII75Z:8.+>VC#ZW?31C?HHHUOV%F;
M5-))F]JH@S:S<0=M]M_&]6LN<O*AP6:/%NJR44OS6J15#)ZN58L>HQ4F#=8:
MI/?36E7LJ76MW%7K6[6S5I;;41N:UUX;6;V=-B:_K3:^1AMM4HW6VK2:K;09
M?QO:LC ';7&2F[:(L7IM7J"VM7:LMKMQEK:G;9&VJWO+G[<-Z/7EAA$C/UXQ
M?OH["Z8NO#=[SNI;4^=OOC9AT<Y+8Y;MNS!R]<&SPS8<.3UD^_$39?M/'AFP
M[]1?Q;\Z_*O#OSK\J\/_YW58@@Y+T&$=.FRO%:/M;92E[6M3I.WMUO*GG:6]
MO]@R?/2'J\?.^L_BR4MNOS1S_;49+^VX-.F5?>?'+3E\9M3*8R>'KS]U?.CV
MLP?+=I][==">,W\55AT27;6E%3VU#;F!VDYT>+4D2SO0NI9VH&NK'_?UZ_MX
MU]"Q[V\8/?>-%1-7WE@P;>NEV;/VG9TZ[\BI"0M/'ANS_-R1D>LN'1RV[>JN
MH3LO[ABVZ_Q?A;8\S%Y;B@[+LSRU3;D!VFYT.-@P2SO<JI9VN'/K'P[VZ?=H
M_^#Q#[:.>/GNFG%KKRZ>M//\2],/_Y$#67KMP)AUMW:,V'1KT\CMES>.W'GQ
MK^)W'59D>6B;T6%/48QV&!V.MJRE'>O4^OLCO4L_.U0V\=V=PUYY?>/H#9>7
MC]]W^I4IQX_-F7GA\(R7KQV8MNSF_FD;;V\<L_'VFK';KJX>N_WR7X6V AV6
MH<-*=-A2+4#;5Q2M'6F0I1UO6>O%R8ZMOS_1L_]G1P=,>GO?D$6WMH[<?&'-
MV ,GETP\?63AK(L'YR^XMF?NTEO;9ZV[LWK2AKO+)FZ]OG32MJM_%;_KL H=
MME7SU_:CP[$&F=JI%K5^.].AS=,S/08\/%4Z^3^'!B^YL6OXUO.;1A\^N6[R
MZ4,K9E[<O6C>]:WS%]U:_]+J.\NFK[^[<-J6&Z],VWKMK^)W'59G>FC;T>%5
M=#A>/U,[T[S6L_/MVSR]T'W I^?Z3;E_K&SI]?U#=YS;->;0D4T33^U=/>WB
MUF5SKJU;M.#U%0M6W%WXTOI[\V9MOCEOUM9K?Q46'9:CPYI,L[8#'0X61FDG
MZV>^.->\Z)=+[=I\>Z7;@$\O]YGZYID!RZ\>&;+]Y-Y1AU[=-O[4]O53+JY?
M->O:BN4OWUJT9-F=>0O7WYOU\N:;L^9MO?Y7H:W4=5B+#CO1X1 ZG*J?\?QB
MLZ(?K[9K\_6-+@,_N=%KVMT+I<LO'!^\_<B!$0=W[QI[<M.621=6K9]Q;=&:
MEV[-6[GXSNR5Z^].6[3YYK2%6Z[_55AU2'#5UJ/#KJI^VF%T.%,_XY<K38N>
MWFC3YHL[G09^\'J/:3<O]UM^^E39M@.O#3^X;=^8DVMV3KRP9.NTJR]OG'-S
MUOI%MZ>N7W=GXLK--R<NWW+]KT);&6JOK4"'#>BP!QV.%$;^=JY>^H_7FQ1^
M<Z=UZ\_?[CCPG3>Z3;MRO<^RH_#=7<>&'%A_8.2)I7O&GGMYY^3+,[?-O#YY
MR_Q;XS:O?'WLQLTWQJS?>NVO0ENEZ[ IPUW;5]57.UX8\>O%>NE/;S<N>/)V
MR]8?O]]^P-UWNDX]>ZOWDGWG2[=L/#YP_]*#0XZ]M&_$V6F[QEZ<L&/2U5';
M9MT8MG7AS6';-EP?OF/KU;\*BPXKT6$+.KR*#B<+PG^X6J_"5V\VJOGPPQ8M
MW_VD;?]K[W6=?/1VKX7;+O7;L.)D_]TOOU9V>-J!(2?&[1UQ=OCN,1<'[9Q\
MI73'G*NE.Y9=Z;]SS:6_"FTU.JQ*<-&V99BT0U6\?SU;$/;-S>+4SQZ4Y'_T
MJ$G+.Y^W*3WS09<)^^[UG+_N:M_5"\_UWSKS1-G>"4>&'!IY:/C1(0=&G^B_
M?^+I/GMGG.VY=\&Y'GL7_V5H:]!A-3KL2C=J1ZMX?7^I9LCG;Q0GO?])_>IO
M?=&XQ96O6O<]_''G,5OO]YR]_%;?)7.O]%\[^7S9EM&GA^P<>F+$WH''1K_:
M[\B$0[U>F_9:M\/SCG0]-/_H7X6V%AW6Q3MK^]+<GIVN[/'%S9H![[]?._[N
MH_KY5[]MW/SD=ZUZ[7K8>?CJ!SVG+'BCW[SIMP8L'G=M\,H1EX>M&W1QY,;^
MY\=LZ7UVXK8>IZ?M[')J[J[.I^;M_JO0UH?8:9OCG+3#%5R^NY1C_/!^#>\[
M#VLE7OJF?O[)GQLUW?]#RZ[KGW0>N.CCGJ-G/2B=,O%^V>Q1]X:^/.3.R%<&
MOCYF<;^;XY?UNCYY1;=K,U9UOCIW3:<K\_XRM(WHL"O6X=G)%,>'KV<YW_VH
MFN^EKVHE'?NE.&_OBY*2S;^V;+?TV\Z]YCSI53;Y8?\1HS\:/';H^R,FECT8
M/:7TG?'3^[P]>6;/_TR;U>VMV7,ZO_GR2YW>F/^7H6T)MM,.1ME]=276[HWW
M$YPN?5$MX.C/A4F[M#I5-V@-ZB[76C:;^TOG]E.^[]-]S#<#^PS[<EC_LB>C
MRDH?C1O2]_-)PWH]G#J\QZ<S1G;]9,ZHSA_/']/IXP5_&=J.(-N?_A]V[BLJ
MS3X/]SYJ>J]/RI/>>^^F&F/OL?<N*-A 14015) B* B"B!U[[[W7J#%]-(FF
MF,3TF-[SVW<R\\YZUUY[C#F;@SGX'O-9"-S_BW5CTTJ%P=L+%#J?;9E1\U%Y
M>1Z<V9H,:H>$H',F"DRUP\#!*.B[AQGABX^UUR=_.^R'( ?,>XJ3V[LP9Y>W
M=%>G-RPWA]=<M-T8'V,W)G#_TZ!RL<*-_IFHSJ<+%:L_;IV=!T>7)\+)37Q0
MW<, [:.A8'R:" YJON"NA05O70SX&[A"D*$S4,X[09BQ ]!-['\P36U_1)G9
M?.>;6W\7_'$WVJ:A.JY-1U5]7#0I%[;.280#2Z/AV-IPY+D@@>8>7S ZA 7;
M8VA GW &K],.0#AC!X%G;2%8U09"SUE#^#DK8*A9 DO=''A(T1I_6EOG5%3E
MK:D*V?#7E"38-CL:]BP.@T,K N#D.D]0W^(*!CL<P'*W#3COM0+L?@OP.6@.
M?H=,(1")?-@$*(>-@7;D/$0<-0(F$NN/ _[*21"-?$9%'9P'8N2:E:RZ%C+T
M=D*FQ7&0.^M BJ?51RG1_:60&C#*9=+NT7GLVZ%"P0!9*KE&3$Z\[)>>VH_/
MEO?Y%&3U>I7G7, UY+=BZ@O^I/\9_F?XG^&_U"#XEX%W8![$(X94U360K;L3
M<LR/0Y:C#J1CK=\G^6.?2RBD!S$,^C S*GH@3""^&B))ND22I??YIV;W$#+S
MNGWR"SN]RDJ:L=5E==C:XC\)8A%#S);I$(.<JQ.._07I9]= GLY.R#<] ?GV
MNC^RW6W?R0F>3Y."@^^)PMB#7);H*B,Z^2)5F'F!')_?24PJ:?.35[3XYE8W
M>9?55GJ65Y=Z597_2;\,?,0@0,ZTB8@A$S$4:.^$8I,34&2G][T ;?<FQ]=[
M-)U$'8X/Y5WG,Q(NLCD9W>$QA6TA<>7-@0FU#?YIC76$W)8RKX+6 M_2NEQ\
M1=6?!,(5_S0($4,R8LA660U%6CNAS/@$E-GJ?2]ULW]=Z.W[*)L8=BLI1' E
M+BREA\O,:Z-SRYM"8^OK@N);:TAI[96!N9UY^+R.3+_B1GE ><V?],L@0 RB
MO7,AY>ABR$$,)5H[?MT+4FFC][7"Q6&LS)/P(-^//I@>).J7ALH[^1'%S2QV
M;3TCMJDV0M9604OO+ K)Z9('Y'2E!!8U)Y%*Z_ZD?QOB$$,:8LA##&6(H1HQ
MU%CK?:IQ=GQ5A?4;*<%'#F0'2OJ20K+;Q>%EC0).7564H+F4*6DOH*=TY81G
M=R>1LR](@PM:)"$E]7\2B/YE$.^9 ^F((?_,*BC7W/'S7I#O]59Z'^J='%_6
M>_C?K_!A7B\(D/;(R3DMLK"R:A&SKB0FNCF/(^K(9,JZTA@9%R2A63TB:D&;
MD%K<\"?],L1NG@X2Q" _N@@*$$.EYJ][0;XU6NJ]:W9T?-Z,";A7Z\V^4DR0
M=68%Y=0E4\O*XAEU>;%1+1G1L1W)4=+N!'9ZCY">U1,3D=\>'5'<^"?]RS -
MXG_^'N;((B@ZLQ*J$$.CX?$O+19Z;]H<G)ZTHP.&&G"<OC*\K"4W,*<R/:2L
M0!9>ER%F-2?'QG3$QXB[1;R4GFAV5B^'F=?.818U_4D0AQB$B$'Z\_<PB*$8
M,=0@AA8#Y4\=YGIC779.C[I<B0/-'E'=E3ZR^L* [)),<FEV"JTV)2&R.5[,
MZX@5B;JC8Y-ZV#%9O0QN7@<CJJCY3X*XOY5^&62[9T/VD850>GHEU&EL^]:N
MK_RAVTSO19^MT_T>9^*5-G=.6ZU70E6)7W9^;E!I6D9HK32%WAPKBVKG2F.[
M6!+9!;HDJX<FR.N@\0N;_Z1_&Q(10PYB*#^] AHTMG[NTCOVML]4]^E5:\?A
M?D=B7R>:W=C@*2VIQ&=E%@66).:&U @SPYNX:>RVR!1^9UA2?'=H<N:%X/B\
MCF!Q8?.?!&+$($(,R8@A[_ "J#S]]_=FC2T?>O2.OKIJK/-HT-)QX)I#0&>/
M&ZNZ%1N?7^>;F5(14"PN#J[BY=,:(G.8K;2LZ([@3$D7*5/>'9":UTY,*FK^
MDWX9XC9-@]3=LZ  ,52?6OZY37WSZXNZ1Y[>.J]]]XZ%_:6;=O[-EUR8I=T>
MDHP6;[FTWJ\PIBJH(K(\M(Y:0F\**HIJ]2\0M>,+4CI\\_/;?+.+FOXDD" &
M,6)(WS43B@_-_U%_:MF[+O6-SZ[I'GHX8J Y.&)FUWW'EE#S#V=Z7C]&).O$
MI<4T^>31:_U*0RI)U0%EE'K?DHA&7'%4LWM17 NF6-Z,+2NI_Y,@'C%($$/F
MSAE0?FCNY^932UY>5%O_X+;.OJ%1?<W^QZ:V30]L?$N&G6EIUS QPAY< K/=
M6TYIPN<%U 44>U>3RSTJJ55N%8P:I_+H6H=R:9U394;UGP12Q"#=.!5R=TZ'
MZH.SWW2>7/SPNMKJFR.:^_N?Z6EVO#"VJ7QJ[9EUWRDX?A##XE[!Q8;W^DB#
MNOQ2_K_?@&":J'DN#8P"QWIND5U]7+%M7>(?!0G+E2!YPQ0HVC'M<].!F4_Z
M3\R[>4=EY<4GFOO;7NMIU+XQLLP?L\(DCCKY\^]BJ(R;7LR0:_CH@,L!0I^+
M01)L+R4!?2$LT;D[,MFADYMJVR%,M^Z0_E&0B!CDZR=#Y;;)8UW[IMZ^=7#6
MQ5&5U2VO-0Y4?=91*_QH:)+ZWLI1^,(9QQKU\ ^][QT<..Q'P]\B,3P'0U@>
M_Z!QW*[3N<[7V-$.5Z/YMI=%L=:7I<(_"5*6*4+^6J5/C9N4[E_;J'3QX?ZY
M+6,J:RN^J._/_:&MDOK#0#_NJY4E^[V+$VT,ZTYZ[NM->$(D>(V2 [ /J23T
M2#C9]7YDL-,]#L7^;@S5]HZ(9CT<'_8G01IBJ%BI\*1WB4+_R"JEEK']"\J_
MG%Z7C6Q_&6B>$(*!!ANL#&C?7<Q(GW$VA ]X!Z]W@<X>;T+<T*]I&-<QNKOS
M*Q;6\2479_^"[VGS/,[;^IG4YT^"O,4*;UOGH2[?G(EJ?K5Z2MG7_0NSX/@:
M*:CLB :-0PS0/T4!2S4BN&C[ $X?"W@C# 2:N/X(,7/^3C-W_$:W</C*LK3[
MPK6R_<*WMOX<9V/U26K[)WVIGH/JZYF.:GHT6Z'DVYIIF;!_83P<71D%IS;1
M0&T7"?0.XL'\& Z<3F$ J^("OJJ.$*!F#V1U.Z!JV$"$IC5$:ED!1]L2HG7,
M0:AK!I(_JJ]Y"JKATE14\8<YBG)8.UT"NQ9PX,"R4%!>XP]G-^- 9X<K&.]Q
M!/O]MH Y: U>ARV!<,0" H^:0_ Q,PA5-H5P91-@'#<&]HGS$'W"" 0G_Z3Z
M]LFHHG],1J7!/"4)K)O.AJUS0V#/8CP<68Z!TZL=07.]%1AN,@/++2;@N,T(
M,-L-P6N' >!WZD/ +CT@(07OUH70W3H0OD<;(I'8?Q2PD?-#Y)9I$'Y@#O".
M+8(XE160J+T9$LT.@,Q1!20X?1 0K3]%T=S>1+)]GM,$@8_)DM 'Q$3Z/4(:
MZXY/%G?(JR#F%JXT]B:V6C3@T2*^CNF-[W7ID4XTN _W-<^>M3,PTE?3U#F'
MFCK]OT+U/\/_#/^W@8D8(O;/@6AD<8C_94@R/0")#BH0CS, 88#-1QX5_9K)
M]GT6Q@\:#1;31HBRR+N$-,Z0;U;T+:]\P4W/4M$ MD9\PZ-%>AES(>&"Z\0#
MS@HE8"(GS,A]<T" G/:E9U9 JM9F2#<^ *EV9R')W?![/,'N?6P(]@4WDCC*
MX%'OAPI90T'QT3<#DD4W"!GQUWSR$J]XE:1<PE6G]6-;,]K=6C.:,)TI$PVB
M$ ,+,;#VS@;1X860>/IOD&MNALSS!R#3YBRDH\]_2_9U?!-/]GX:&Q$\PF9'
M#H7S8P9"Q.*KI,2D2W[IZ7V^.5D]7D6YW;BJ@A9,75&=1U-.):Y-/M$@"CE9
ML1$#9\]L$".&9,20J;$)<HT.0*ZU*F2[&G^1>SN/)07B1\4TZAU>9-1@)"_N
M"E68?#%(FGG!/R6_$Y]5W.Y=6-Z,JZRL]J@J+_6L+RCR;LZ::,#]:4!.F%S$
M$']H :2>6@[9&O^\0Z7 2A7RG$T^YWBZO)('^#^442)NQT;PKW$XLHOA_,QN
M9"ZT$1/+6_PRJYL)Q;55WJ6UQ5X557D^M<79^,;<B?;+P$$,T<CBD"*&=,20
MJ[X)BG_>H6*A^JW(R>1# =;M18X?<22%'#DH#A-=CF:F76#P\MMI<64ME.2J
M!G)6;2VIJ+Z84%*?[5M6FT&H+DWS;\B?:,#[99@*,;MF@0PQ9)Q<#OGJ_[I#
MQ5SU2YF#Z=L2=_3S0CSI7@:)?4,6&M\72\_LB(HJ;&3$EM?0$JK+*>EU)<%Y
M#;F!Q8UI_B7UR<2J\L3 ^L*)]LL0A1@$B"'QX'S(.KD,"M4V0H7>_A^59JH?
M*^U-QRK0F,>EWD'#.0%1EY+(LLZXL,S&:%9A%3NFHH0NKLD/2Z[/IF8WRD.*
MFA(01WQ09:4XN+9HHD'T\G\:8G_^0@8Q9".&8K4-4*6[_UNMJ>K[6CO3%[5N
MF)%RS^ ;>7C>A322K%D:FED5RR@JYG$K<EG"V@R&K"$U0MZ4%%[8+ HI:HZE
M5%0)0FM+)MHO Q<Q"'_^0@8QY)Y8"J6(H49W_Y<&$]6WC3:F3QM=W.]4>81<
M*O3AM6<0$VJ30C)+Q!&%N0)VA9PKJ$UBQS=(F:G-XLB\EFA:80LOK+R:%UY3
M.M'^:4!6CVC'3$@]. _R$$/YN?50I[/O4[/QV;%6:]/15B?WF[68D-X2;UY3
MCG]"12HY,S^!5BB/8U8D"J)K)3QQ0VQ4<G,,)[N%'5G0PHHLJV%%5I=--(A!
M##S$($8,Z0?F00%BJ#SWZ\Z,#^WGS[[LLC(=Z7!PO]:(#NFL\.36YA,2BC-(
M&9G)H85)4GJY.(Y;*Q *&[A\63.+G]E"YQ:TA$>5U49PJLLFVK\-$L20<6 N
M%!W_=5?$MV;MO>^ZC52>]5F8W.FV=^]O<0UNJ<9&513[2G-SB1FI\I "27)X
M.5_&KN'$"QH88FE3>)R\)514V$+AE]:%QE253S3@(X9HQ"#=,0,R$4/)\;^@
M5G7MYW;M/:\O&IX9O6)N?/.B+>9"APNYOMZ#4U3A'2\O\I<GY)#S!1FT,DX:
MLYJ>'%U/390T!B>F-@<E%C8'2DKK2'%5Y1,-^,O^:9!MGP$YR+6S_/CB;XVJ
M:]YU:>UZ<=7@U,B Z?FK5VS0[1><@BI;,.R<6B]Q4@4A35A,RHO*#RV)R&%4
M4C*YM:2,N(: C.1&0D9^(SZEK):06%4^T4" &&(V3(6D[=,A;_]LJ%)>]*GU
M[*I7?5H[1F_JGQ@:-C'L&[!R:^AW)!5UN3'36W!QDCK?%%X5,9M>'E)$*8DH
M#RSB5!$*A;7>A4EUGH5Y=;C<\FK/S.JRB0:QB(&/&%*W38.B?;-^U!U;\*93
M9<7CJYI;[]W34;XV<MZP8\C2I?*Z/3&[WY4AZ_:(C6GW3F0T^V=0&LAYQ+KP
M8M\:=AFN6E#A7I50Y5:9B519@2ZI+9YH(%RJ!,+U4T"^=2J4[9WQJ?G8O&<7
M59;>'5+?>/VAMG+/J*%!_8B%4^&P'2%UP"5,=-6=Q[KH):%TX5/\VHB9GLW!
MN9B&\ *7>G:Q0YV@Q*Y.AI17[-C8D#_10(08)&LG0\Z6*5"]9]I8U\^[(DXO
MO#9R;M.%9]K*S<_U]4L?F]EG/+3SBK_O2N;>QM+#K_OP2)?\A/@^DA1[@9+D
MUAF>ZM3!2K=KB\FP;I-D6K:F9UJV%4TX$"]1A,0UDZ!PT^1/3;NF/+JT?]KU
M>\<7=3\]MZ7QC99R^6L]G>Q7IE:R%W9H_E,W/&,$1PX9]J7YWR1&>O\CF.-Q
MC1;M>H7!=[K,$=KU\T76%R5BBXNI$O.^W/B)!O&(0;Y*"2K7*[WHWJ1T8WCK
ME.XGRDL:WJIN+?VD>2SKHZY&T@<3D]CW=O;,UVATZ',O;^)C/S_?AZ1 W'U*
M,.9N>*C+'2;-<8@;;G=;0+>Y)6%8WDQAF@]F33A(^$L1\O]6_-"\4N'6S84*
MW8^W3J]_J[RLY/O9+1D_U \E?-<Y*_ANHLOZ;F=*_8RQ"7SO[8A_X^_F.49V
M=W])Q;D]IWLY/V/[.#SE^=H]B278/);X68XF!Y@_RB!.-$A=K "5BU$#_3-1
M%T87*M:]W3JS^+ORLG0XO4D"Y_;Q0/LX XQ5*6"G302,@0]X&V._^YMCOI(M
M7;]0K9T^T6T=/K+M[#Y$.]A^$#I:OX]WLGR7[&S^5NXRT2!_'NI&ZS14U]49
MJ-IWBY4*8=OL-#B\- Y.K&/#V1U4T#I  J-C>+ ]Y0GHLQCP4G<%/TTG"-)V
M *J.'43HV0!+WQIX!I8@,+0 L9$9))XWA33CB398,QG5WCD553TX#94'2R:G
MPO;90MC_%Q..K@J!TQO]0&,[#@SVN('E 2=P.6P/N*.V@%>V!N()2P@^:0ZT
M4V9 /VT*[-,FP#MC#+$JYR'^K"$D3;B.ALFHRK[)J)P'TQ228-F46-@RBP&[
M%@;!P64^<&(5!LZM=P3=359@NM4<[':8 GJG,7CN/@_X/49 W&L(Y+T&$+I/
M'\+WZT'D?EW@'- !_@%M$!V<:)5M2JCL:XJHA,\S%07P]^0(6#\C$+;.]82]
MBUS@Z%(;./.W&6BM.@]&:PS 8ITNV*_7!M<-6N"Q41.\-FH ?I,Z!&Q2@Z#-
MYR $B;9%%1A;S@)[ZT2#,&3CA&Z>"D'(M8)^9#YP3R\#@>8Z$)KL!('#48C&
MG0,V41_HX1;?:%R'C\$B]#NBS/,U(0W_TB<[X+EG >DIMC3XB7LU913=1'WD
MUADVXM(?,>0T0+]J?Y,QD?YG^)_A_VD(WC<+(@_/A^A32T&(&.*,=X+([B@(
M/,X!-\ 0(FE67\(YSN\IL1ZO25+?E_ZI <]\,X.>>.531K$EM(?N5>$/,(V,
M^^A.YEW7?M8-IQN<?L<!UD2"<&1G41%#Z-Y9P#XT'P0GEX)$?1TD&.V$>)MC
M(,:H@X!P_@<WQ.YC)!/SFA;C^R)8'/B$F$1Y2$@/'_'.B;R+*^(,>U3RAMP;
M8VYAN@377?N%/<Z7!1TNU[@3"2(0 PW9.+0]LX"+[ L1<K9/4%L+R08[(<E*
M&1)<-4#L8_I50'9\%T7'O61P QZ'"D,?D!(8=_U2?WX/$W/3JU X@*N47/=H
M2KB"Z4[L=NE.;''K$S=@+@LF$M 10QABB-@]$Z*1?2$YL022$$.:_DY(LU2&
M9&=-D'F9?Q$'NKSFA_D\97/(#\+X]#O!$NY-8K+P!B$S_JIW0=)E7$5:OT>3
MO-.U);,)W9%:Z]XCK<1>%$VD?QL8NV:" #%(D7V1<FX-9.KNA QS94AWU/J6
M@K7XF."/?B4*]1OE,:EW&=&<FZ$BX752HNRRGSRMSSLOJP=7GM?IT9!?CV[,
MJ_)HS2C%=245>?5*)A(PD'T1CISMF3MG@G#_7) A^R)==0WDZ.R$'#/E'UGV
MVI_D[I9O4PCN+Q)" A\(Z/3;["C^];#8A'ZR5-X3D);32<C-;\.7%S9ZUQ65
M>]05%7DV9^=Y=Z1F^UY(F$C_-K"1C1.'&)*4_X(,U=60I[T#"DR4O^;9:;_/
M05N_S/#!CB:3R'?B:*SKW$AQ7P0OI3,T+K,E*#&OGIA96.-?5%SI5U.2[UU3
MDNW3F"<GM*6G^74G3B2(1 P1B(&#;!SQOCF0HKP8LL^NAD+$4&RL_*G81OMU
MH:OUTUPOSWMI_I3KDF!>;TRXI)W%26T(%V154^+SR\AI146DW-+\P(JR#$)U
M6:I??6%20&N&++ S>2+]V\#]^2L=Q)!V;#'DJJR"8JWMW\O/*W\HM]9^6>IL
M\[  ZW5+CJ=>E)%X[4*JI($;F5H9&9U='!Y7D!>:5)P5DE4F#RXI3R)554@#
M:XLE0<U98G)'ZD0")F*@;YP"T3]_(;-W-LB/+8)\Q%"FM?UKE=&QM]66VD^K
M'&WO%;M[7\WVIG8E!_ :)2&22GY$:A&'DYT3&5L@#T\H2::EE\NH!1422F5E
M;'!-J8#2E,.GM*=-)& B.XN^80K$;)T.,L20>701%*JLA K-;9_J#(Z-U5MH
MC]8YV-XN=_.YF.=%;4WWXU8GD"7%(EIJ3@PK.XT34Y#(E)1(Z"GEHHC<2D%$
M12676EW&#6O,C0IKDT^D7P8&8A @AB3$D'UT(12?60'5FEL_-.D??=%BIO6@
MT<[F1K6K=W<1+K0A"\\M2R9)<N-#4].%C&Q9#+<@CBLJX;.3RGFL[$H.JZPJ
MDEY5'LEHR(MDM&9,)&#]RQ"+&%*0S\K<HPN@[,R*;[4:6]ZUZAUYUFFJ=;?5
MUN9RG8M76ZE':'6N3U1A>H X(S$D)3$^/"M.Q"F($<26<&(2RB-Y&941O.(J
M&J>R@L9IR _CM&9,I%^&2,0@VC(-TA!#_I$%4''Z[R\-&IM?=^H='NTUT;C=
M:6W=V^CDU5B)H905>7.RL_WBDM."DL5)M*P8*3.?)>&71(CBRZG"],H086%E
M$+^R(CBFOB XNB5S(@$;,3 1@Q@QR)'/ZR+D^EU]>MFG%O5-+WMT#SZX9*QV
MO<?*JK/5T;.F%AU24.;)3BO B^*S24E\>6@&*X61%Y[$*PZ1B<M("2D51&E>
MA5]\946 N+Z *&K)G$C 038O"]G=\<BU,W/W#"@]//=;_:FE;SO4UC^]I+/O
M[G6C<_W]%I;-7?;8LB97<E8-EB4K\Q7&%A$3V7DA\K"LB)S@#$XA,5U80DA+
M*O-)RRGW2J\N\TYNR/>5M61.I%\&SKHI($,,.;NF0\6A.1^;3_[UHE=MS8,!
M[5V#MPU4NZ^9F]?VV7H4=+B04IO<(^-JO?E1E7[2\%)R:G!Q6)9_(2O/)U]0
MB,N7%;OG9Y=@\BN+W;,;\SPR6C,F$D0M503>FLF0O&D*%.R<]KWVX*S7G2<6
M/KRJNF+HKL;.2_?T55INF9J67;5!9_8Y$>.[T!&\5D]>1!-!'%Q/2O2OH:9[
M5S.S/*KX.6Z5"7DN55GY3E45^<[ES=DN1>WI$PFXR.X6K)X$Z1LG0^F.*1^;
M]T]_?/'XW-O#IY==>JBQJ_.AKDKU71/CO%M6+DG7'0C\2ZY41A^6'7+!5^#?
M%2CQZJ FNK<S4UW:^>F.;;(,N[;,3)NVLDS;UK9TN_JNY(D$T8A!O'(29*^?
M!-5;)[WLVCMEZ.:!&9<>G/F[XYGZKKJG.F>*'ITW2ANQ=(B[Z^#)&4('TFYY
MTDB#?DS?ZV2>QQ6:P*4_,LZ^CQ=OW1N78-F3+#/OR969]=3(+'I[)1,)^,CV
MER%GRL(UBA^:-BK>O[I!Z=+(OEGMST^OK'FMOKOHE?8I^0M#O?AGEI:\IXXN
M$8_=/8-'??W\1HA!7G=#0C%#X>'.MU@,^\$8ILV F&UY(SG*_$86U_1Z&=?X
M>O.$@MC%BI"^3!$J5R@\Z?E+X?*]E8KMS_?.J7E_>E7!QW.[TMYK'8]_9Z 1
M_=;R//VMDU7(&ZQCP&L\VN<E"8=]%NKM]H2.=QKE^-L_XA-M'HA)EB.)0>8C
M\F#3^X4AQO>J)A2(%RI _B*%MZUS45<&9J+:GJ^:5/5A[_S\[R=7I7X_NSWN
MF\9A[C?],Q'?+#2#OSD9!'S#F7I_)5AZ?";9HC]2'9S?,YP<WD:YV+T1N-F\
MEJ MQQ(QYJ_D'J:O\K'&+\MP$PG2YJ%>5\]"7>R>CFJ[,Q-5\7'UE#S8MR 9
ME%?&PIG-+%#?2P6]HR0P/X4'QW.>@-7$ %['%4CZ3A!J: _T\[; ,;8&OHGE
M#[&9Q7>9N=FW= N3K[F6QE^+K2;26.$T5%_C5%13WS14V<LYBMFP=EH2[)W/
MA\/+&7!R73"<V^H'NGL\P>0@!NR/NH#[<0?P.6D' :>M(43%$L+/6@!3U0QX
MYTPA5LT$XM7/0[*&$61J&D*^UD3JKYJ$:FB=C"JY-@65\6.>4@*LGQ8-.^>&
MP_Z_ D%YA3><78<!K<V.8+3-!JQW6H++'G/ [34%_'YC"#QP'D(.&D'X(0-@
M'M8'[A$]$!S1!<E1'4@^I@T9$ZJQ3@E5=$$)E79;24$""Y1XL&X:#;;,]H?=
M"W!P>(D+G/K;%M17F8/>6F,P6V\(=AOUP&63+F W:X//%BWPWZH)0=LT('2;
M.D1L5P/F=F28[5"%V!UG(7[G1"IN44"E74&AA,^4%#BP4"D45DPAP/H9&-@V
MQQYY75C L<7G066)'F@NTP;#Y1I@OD(-;%:J@M/*L^"VZ@Q@5Y\&[]6G@+#F
M)!#7G #RFN- 7:L,#"3.NHD$I)5*X+]E"OCNGPGDPW,A_-1BB-18">SSFX%I
MOQ?H.&6@!:I""%T'@F+.0T"\.1!2;;[Y9#E\\2QP_N11YO814X-YCV[V>.O:
MA7OEU.?UW.&J]ZC=D,]]FX?X(:M'O^U_AO\F W*M"-@\!0C[9@+ET%R@GU@,
M;/65P#7<#!S;O<#T. X1 6I #=.#8)XI!(JMO_DE.WSVS7#YZ)6/>8\MQ;YU
MK_9Z@V[R&7/MPC]W[O-[['#-?\1N.."6S4C@=9N'_K\+@OYE"-@S V@'YP#K
M^&+@J:T$OOYFB+'>!UST"6 1-( >:@14MN6W8*'#)Z+,[3TA'??&)\=GS+.(
M\-*C(N YIH'TU*TS>-3E(N6^XXW00;LAZB6[NR&]]B-!OPO(B(&(G%](R#GN
MY[T@4<J+@*^Z D1ZFT%HN0_X+B>!ZZ,%K&"3'Q&1MI]#^6[O@N(]Q_Q3\"]\
M,XE/O0J"'V/+0A]AZL(>N'70[R$7\D''?[#Z'08CNQR':&U.=RF_"X*1[1^(
M&,B[9ORZ%R0:V5G"LRL@7F<S2,SW@\CI%/ ]=8!+,OO&C'!\'\[S& N)PS\/
M3"0])LA#'WKG1MS'EC+ONM=RAM$=O)NNE_D7'2_S.YVO<YI=;M'K78=HO^N7
M@808*,CN9B,;1W!LX:][8F3:FT!FNA^D#J<A#JO[E>]O^3&*ZOHFDN/]G!8;
M.!HDI8[XI4;>\<GFWL85\P<]:D7_P'1)>IU[I.TN%^.:W*[$U* '6!686_3?
M!2&((0@Q4+=/ARC$($1VEE3E;TC6V@0IQOLAR>[,UP2,_H<XO,UK?HC[<TZD
MWVA$3.C]$#%SB)@<,^";&7<%5RCKQU8G]7JT)[>Z=2;7H7NDE>Z78DNPUZ,*
ML8/,WP4AR.8-0C9OV+;IP$,VCAC9.(EG_H8TS4V08;3_>[K-F8\I;@:O$WSL
MGL4%X1[RPDC###;]>@@_II\HB;M 2$GH],E):O4J36GV;$RK\6A/*_7H2BK$
M]8ESO:[$9'O?X/PNH" &,F*@;YT&_-VS0(H84DXOATR-C9!CN.]SMM69MQG.
MAL]3/1T>QOM[WXX)H5QATMD]M"A!>[!0TD24)=;YR5.J\07I%;[5\A+OUHQ<
MKX[4+)\>:3K^DB"5<(W[NR#T7X:?]VG%(CM+=G@^I)]:!CGJ&[X7Z._[D&]Q
MYE6NH]%HAH?C<*(O_HJ01+T016.W,EB">FI,?&6P)*DT,"6M," G(\^_+#/'
MOSDK#=\J3_;K3DP,Z!<E!%R)^5V_#,&(X>?]2:)=,R'IT#S(/+44\M77?RW1
MV_NVQ.S,LV)[H_LY:.<;J=Z$7DD M95/8=>QZ;'E=&Y\(568G!,B2\\(RLA,
M(Q5EIP3694L#FK,D@9W)8E*?."[HLN!W 14QA"![\^<],6+D_9F*&+)/+H5"
MM?6?RG7WC%6:GAXMMS4:*G!UOB3WQ'?(_$+K161V>718; &++<VB\Y/3:/'R
M)$I:EC0D/T<<7)T;&]24(PCN2.6']$IB*)=B?Q=0E_W3\/-^E/B=,R#]X%S(
M.['D1\FY=1^J=/:\J#,^_:#*QO ?)<Y./=E8?%,*/K0RGL0NC T59/$BI:DL
M7G("(TX>%YZ<%4O+SHFAE>=&41N1VM,YM!XIA]8O_%U 0PP4Q/#S'HB$G=,A
M _F\+CCQU[?R<VO?UFGO>MIL=.ING97AY7(GIXY\=]]:N0^E)#& E2T.$:0*
M(N*EO*AD$4<HCV'*LJ(8F;DL1DD>@]&81Z>WR1GT"PD,^L6XW_7+$+I^,L0@
MKXG$'=,AZ\!L*#Z^^$N5ZNJQ1NV=H^V&)VXW61KT53DX-A>A?2JRO4+R4OV8
MZ3(R/T%,BQ?&LI)Y,7PYBXO\6:+DN6&<HCQJ5$->*+LU@\KNEE'9?>+?!6&(
M@;9N,@B0YR)YQS3(W3\;RHXO^EAW=M7+-JWM#[H-E:^WF>MWU=D[U)6Y>1?G
MXX(S,_',Q-1 OD@6*N'%1R8QXZ+3PV+%611!:@Z9GY]+XM?FD6):,X*BNQ/)
MO#[Q[X(P9'>'KYT,0L20NGT:Y.^?^:-2><&[)I453[LUM]SMTS]ZJ=-,K[7)
MUKZRRL4KM\2#G)+GPQ!G$J.CTY /R^2(1)HL*BU8*LHD2I*S_22Y.7A)52Y>
MW)KA)^I.]!?V27X7A",&!K+]XY"_AWS;5"C>-^-K[;%YK]O/+!OMU]AXZXKN
MD9X>$YWZ-AO;X@8G3WF5>Y"TQ(O.+_#G,7/((EIF6$)0.CO%/S56[I,BR_1,
MSL[&IE1DXU):,[QDW8G>"7WBWP41B(&U:A+$KYL$65NG0/F>:1^:CLQYUG-Z
M\;T!M357![0/M5\RUJ[LMK+.;77$)C6@B;'5GF'L<CPGK(0D""JD2OSRF8E>
MN?Q4CYR$='1.IMPUIRS#-;<]'9UQ(0&3WA?WNX".;/^H%9,@<>TDR-L\^7O-
M[BFO.@_-&+EV<M[ G;.K>X:U#C3<,-(HNF1IF7[!'B/N</6/:L:&AC?X,H-J
MB=&$:HK0LY(1CZF(EKF42Y,=RS)2[,M+4^PJVI,=BGOC'0OZA;\+&(CAY_U)
MJ6N4H&2CTONF[9,>]>^=,C!\9&[OP[-K6N]K[J\8-E3+'C W2[ABZQ)]T=F7
MWN-.)G=YAQ,Z EB>;2$\="LCUJDE.LZN62JQ;LZ(MVHIE5JVML=;-?0+K6NN
MQ/PN8/ZE"")D^V>M5/Q1M5;Q>?<ZQ<&AC9-Z'QZ>W_+T[+K*48W]>0_T59/O
MFIZ/';*QC[SIY!%RP]W/[YIWL.>5@#"WRY1(QTL,MNVE&*[EI81H\TN9,::7
MRODF5SIC3/NN<4V[;K!_%[ 7*X)LB0(4+E-XU[Q486A@/JKWX:;)S2\/+ZQX
MI;(^]X7ZOI1G.J=%3TQTV:,VYK1'+@Z!#[ 8WP<$+^P(F>!V/YSH>#\JR/:^
M,,3J;F*H^9U,FLEP<=CYX88PH^$K88:#MVF_"W@+%2%]H<*/J@6H&[TS4;T/
MYBLTO=HTM?S]D<4Y[TZO2WJKMD?X1OLXY[6Q&FW,1I\TYFI*&/.T]GSE[X!Y
M%>+L\HJ.=GC%=;=]*<)9O4CT,G\F]S9]5N!C_+3*U^AI)][PR?7?!N)Y"E P
M!W6M>3JJNW\ZJF%L@6+IY\TSLK\>69SX]>1:P5?5'<PO6@>I7\Z?#/QB<\[W
MBZL6[HN7'OJ+OY'SEQ 3AR]T,[NO7$OK+R(KR\\R&[-/<EN3CWGVYS^6.QA]
M:'8P^'#!\7=!VDS4C:HIJ(ZVJ:C::]-11=\6*67 UID)<'!Q-"BOHH/*IF#0
MW.4'A@>\P.H8!EQ.NH#G&4?P4[4#LIHUA&E8 EO3' 3:IB#5,8%4W?.0K6<(
MQ?H&4&N@#ZV&O^MFH2*JHVXRJKI[,BK_UC14&BR9% _;9W)A[X(P.+(\$$ZO
M\0;U31C0W^X$YKOMP'&?-7@<L 3?0^9 /&(*E*/&0%<V@JCCAB \H0\))_4@
M[:0NY)S2AM+36E!]YG=UE2NBJIHGH7(O*:&2GDU7$,'RR6S8-(,".^?Z(<\%
M%DXL=P'55;:@L\X<C#>:@,UF(W#9:@#8;7J WZX+@3MT@+)3"R)V:0)GMP;P
M]ZB#9,\Y2-ZK"MG[SD+!;ZNJ443E=*%0LD$4B@^S%)FP?%(PK)WF"UMFH6'/
M/'LXLL@23B\Q!HWE^J"_0@?,5FJ"S2IU<%IS#C!K5,%KK0H0UIT!TKK3R 7X
M%- WG 3.AA/ WW@<)!N5(7'3[\IM1A[_$@K%NX="T6&.(@D6*WG"BBG.L'ZZ
M-6R?90+[Y^J#\GQ-4%FH!IJ+5$#_K]-@\M=)L%QR'.R6*H/STJ. 7G8$<,L.
M@^_R0Q"P_""0EQ\ ZM_[(?+O?1#UV\![E1)@D>L$9O]T\#T\&P)/+H!@]640
M:K@60NRV AFW#P*#CH)_Y&G "\Z!MTP+/#/TP"/?$#!EYP%=:P*NK6;@U&GQ
MU:'7ZJ/=5>NWMD,V8]8CML^LGMB-6KRR?VCQVFZ\_F?X_QNV3 &/O=/![]!L
M"#J^ "AJRR#,8"U0;;=!B,=^""(J Y&N GY\#?"5ZH)WNB'@\HS!H\0,,-66
MX-9L_<VET_:38Z_=>_NK#F.V0X[/K1\X/;9ZXGS?\I7S7<LQQ_$"GY5*@$,,
MGGNF _' +* H+X PU67 T%L+=*OM$(8^ !2_$T"FG8- K@[X2XS -\44O+(M
M?^"*;+^Y5SI\13<X?7;M<'GGU.LVYG 5\\QNV..1S4/L7:LGN$'KE^@;UJ_<
MQ@M\$8,G8O#9-1V"]LV"L&/S@7%V*;!TU@++8CLP7 Y"F.\IH(1H )EM ($B
M4_!+LO[NFV'_Q3/?^1.V#/T!4^?QSJT=-^;<Z_W,X:KO0[L[^&'KAX0;UH]]
M^FU?8/ML7WJ,%^!7*('7S^^"=DZ#D+VS@'YT/K!5E@)7>RUP3;<#V^D0,+S.
M0%B0-E 8YW^0^5;?B D.GPGI;A^\<SW>XDJ\7KO7X%^A6_V?N?02'SE>)PW;
MW2%?M1D)ZK-[Y-]I_]2[P_ZYYW@! 3%X(P9_Y#Q+1?8F\\@\X)Y>"GS-M2 P
MW@'1]H>!@ST+C #=KV%A9I\H7/L/I#BWM_[)GF.^6?@7GH7$9QY5Y,?H%LHC
MUS[:'<>!\,MVMR,NV-^EM#N,D!J='A,:G)[XCM<_#9NF0."V:<C'[4R(.CP/
M^*>6@$AC#<09[0"A[9$?,1C5+QR"P7L&Q>H-C>GR,EC@^31 ZC?JFT9^X)E+
MO>=>2A]VJV?==+D0=<7Q&K?+<8#5XG0[O,[E;DBEZT-BA>LC__$"O[^5P.?G
M=T%;ID(DLO6B#\T%T<F_(%Y]#208;(=XJR.?XUS/O>-[&[WB!-D]C8AP?Q@2
M1;A+% ;?\I5%7,.ELR^YYW/[T)71/>C6F"ZWR_Q&EVN\:K=!9AEZB%:$N4\N
M<'\0.%[@CQA\-TT&RN:IP-HQ P3(UI.<^ L2U59#BM[VK\D61]XG.*F]$N.,
M'T<'.-Z/I'C=#&4$72'QPOK\XIC=/DE1[9Y9,2W88D&C1YVPWJ-'6(&Y%%OL
M<3TJ#WN+GH6[2\G$W2>/UR\#?N-DH"*;-PK9>J(#<T!V?#&DJ*[Z(=?9]E%N
M=F0LU4']28*[Z;U87Y<!3A"^/R*,W$UAA[>2!*Q&?RFO!I\FJ/3.$Y5Y5<85
M>[6)\W!]XFROJ]%R[P%FBL\P+=GG+F6\(  Q$!!#V,][(+9/!PFR]9*5%X'\
M[,JOV=I;W^88'WF>9:L^DN)F=E/BY=8?0\1WLD*#F\,C(VHI/'8Y*2ZZ." I
M-I^0%9>#+Y%D^C;&I_OVQ*?@+PD2"3<X4K_;X?%^P]3Q B)RKO??,!GHZZ<
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MZ^Y2U'I7F:_F;WVQHMM6,IFWG)02;]+5(J]S=(/_\#?QO19NR;D:9\>\FNY
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M5X#A2^SC"C#ZMN*[$2S_BLT9P;(O_UKZ*S!4)8+ESY^)P1PWDL!)@P^<#07
MR58(R&ZB8.<C!C81DF"5*@66A4O!HGHY6+2L /,NK%<&S(97@ME^[*@LF)V3
M!=-;<O.FS^2^F7V0^V+V56[&#.0^FL'*:7.0^?"O%;\"4V4BV"H1_]O?E'7_
MWHNAZ0F FZ404%T6@3-;'!R#EP Y82G8YRS_]WY0@RS8M,N!]?95\]:#JW]8
MC:[Y;C4A_]5J4G[.ZMK:6<M':Z>MWBF\MYI3>&L%\J^M8<TK:UCUT@;D7MB
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M+GEF5C]WS:[YZI!;@S9YM6CQ/4P!>$)GX3KUSG-- $>I?^_M86#[ @;6#XC
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M\KQ9MO%=G0XQG8N<HCI'7,([QUW#.L^ZAG<^=HKL_&0?U8G6,5UH0<PG>U9
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MB*OPZ297X>,KKL+[KUSY=_@/RR;N@4T LRF_G/*SS@+$7@$(O '@=@O [CZ
M]6=>H,H()B@#AJ@*^M3YM=$8--$*U-"144%W1A']&7D,8V0P@26%N2P)K&*)
M8QM+#!>3,;8('B#7R#/RQS_T;01HHO-?,9%_CO*O 03\ N!RA[(? !B_ 3!
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M)^:$35O,'9NV^#=F;0EHV)Z(>NU)J$TT)\,0VH-8@+?4MVY3[_Q7"1LNEO'
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MIZXQ*4X=-RU*/6U:F/K I"C]HUYQ!FJ59*(Z49T,PP$>T3[\*P?@#'6N0^4
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M-$*B0K^6FYB'*8UV"LW$E]83R:!0*H."A:2:S"(=I)=!@45DB.:VFHP1FH7
M7O@J< (^"UR%]P(/X;7 &_A# .&%(,)S(81G0LA\#[6IZ^O( 6K+TCKH56UB
M)H:T-[9 [VJ 4B$,2M!^B.>0,D*S$&MAOHIU,5_$%C"?Q)8P'\6&F?=BH\P[
ML4W,&[&=\%KL"+P4NPC/Q.[#(_%7\$#\&W-/ IG?R-U_NS,)ZE/7-Y $U)<
MU*57/9J'+IT+34M:CPN@<@"=F6CFBWPZ\T&^D'DG5\6\EFMD7LJU,R_DNIGG
M<@/,4[EES!.Y5<QCN?7,0[GMS .Y@\P]N?/,;?G?F%\47C(_*7QC755$UF5R
MB5S\#AI3MHDHH?YM*D9H'B8T"R,ZF_KV\%''"]YHA3$O-!*9WS5RF$?JI<P#
M]5KF-_4FYH[Z7.:V>A]S4WTQ\XOZ,'-#?2WSD_H6UC7U?:PK&J=9%S5NL<YI
M_L$^I?F5?4(+V<?(47*$')X$S2C?0A#0D@_0AM9A0VNR5H"O%MKPQLP"GAF[
MP$.C +AK&,W\:IC&7#<H8*X95+ N&]2S+AJTL"X8=+'/&2Q@GS%8RCYML))S
MTF ]Y[C!..>HP5'N$8-KW .&OW/W&'[DV66$/.-&R-U!MG\'K80HE[JW/1MP
M"JUCBC!\=92$EW;*\,A:'VY;V<)U2R^X9!7*G+=,8$Y;9K%.6!:SCUE4<0Y;
M-' .6K1R#UC,X]EGT<^SQWP9[R[S$=Z=YIOY=ECLX]MF<8Y_B\5]_@V6;_G'
M+)%_G27RC5HB[X0UDZ M[U^/=YT!/DUEX.54'GCI(@P/IDC SPZJ<-'1',Y,
M<85C4P*90U.B6?L<4]B['7.YXP[3>;8[S.#=:M_(M]F^C7^3?;? !KN% F-V
MPX)K[=8)C=J-"X_8'1=>97=39-C^I?"0 PHM<T#!00<46.J _).A(^O/_/<>
M]/9!'?R6#P,WO'C@NJL@G'>3A^,>AG# PQ%V>_@P.]S#V%O<XCD;W3)XQJ;F
M\ZYU+>,?<:T16.4R6W"ERQSA8><^D2'GI:*#SJO%ECAO$5_L?%!\H?-5B7Z7
M9^+S7;Z(]KFB2*\K"O5.I3M[DC^_7N=.O9=^O-\,HMY)_?-\$!O.^/+!$5\I
MV.NG SO\;6"3OSMKS"^(O<8WBKO*)YEWV#N+?YE7D<!2KPJAQ9XS119Z-HOV
M>W2)S?<8D.AU'Y;L=E\O-<]]CW2G^WGI#H]'TG,\/TFT>Z$8$6GS0N'))AYM
MOZ+K_XVRKU+O.QL!<"P<X% P!W9/$X>MP1JP/L0"UH2XL%8$^[&730OC+@F*
MYUL8F":P("!7J,^_1+C'KUJTRZ]!?*YON\0<WUZI-I^ETBT^HS+-/CMD9_N<
ME&OTN2?7Z/=>NL$/)1K\48R($I&_3<S@J3]U3LJ_0&\OQ^BM;C_9%<7 EG 1
M6!>I JLC36 HTI%9$N'%'@@/YO:%1?-UAR8)=(9D"G4$%XBT32L3:YE6*]$4
MU"PY*ZA+NB%PD6Q=X"JYVL"M\C,"CRI4!]Y2J IZ(ULU#:6(1%4PBA'1OWVE
MM[:'-(,?J7>>HK?\@]1_=Y(M].MU,4*P*E8!EL49P*(X.V9^K#N[.R: .S<Z
M@J\]*EZ@)3)-:'9$KDAC>(E8?5BUQ,RP1JG_P]A;AU=QM=_?:^9(_,0%$B3!
MB0 1B+N[N[M["$F 0(! @$#0!+?@% @4*]HB-4J]O[I05^I"9=YU<I*G?)_K
M^>.]>GVNF9QP9NW[WGOVWFMWSZ0]<8W%@L0M5O,3]HUI3CAEW91PP[HAX1V;
MAL0?QS0D2>8-R9)I8[)D3(Q&^2F<]< <O)3%'.2KUU_H>\F) F P5P>[\BPQ
MD#<-F_+<A'6Y_K+5.9&*[NQ$K659&;I+,O/U%V64J3K2:XT6I+>8S$];;-:<
MNLJR,76355WJGK&U*2>LJU.NVE2EOCZN*O7[L55IDF55NF16G2Z9$.-1?F ]
M?) *W*7OO%','-!WG2RGWZ$/WE.HQ$"1&3863T9OD;/04^@C+B\(DR_-C]-:
ME)>JTYZ;H]>:4VS0DEUEU)3=9%*?U6%6F[7"LCJS;TQEYD[K\HQC-J693XPK
MR7R9?&==DO6/96F69%Z:+9F694LFHWS+>^'M#-8#X[Y"_;.5]+W5G&OSN*U,
MQ,8R8_26V6)5V2QA>:F7V%D2+.\HCE$N*$K6:2G,TFLL*#"H+Z@PK,FO-ZG*
M:S.KR%MF69J[;DQQ[G;KPMPC-@6Y%\?EY=XCWUCGY_UM59 GF1/3PCS)9)2O
M$G@_L.YO,0>7J'N:_O=P/?T&CYLY_>FM-,+*JO%85N6 Q57N8GMEH&Q^1:2R
MJ3Q1N[XL0[>F--^@JJ3,L+RXUKBTN-6LN&BI14'16JN\PH&Q.86';+(*SX_+
M++Q+OK+)*OK+*KM(LB!F.462Z2B?\5Y\,4^S%G:>NB<:V0Z:.=^G!UQ71\]3
M9X"N.FLLJI^!MCHWH:763]98$ZZHK8[7JJI.TZVHRM4OK2Q1%5=4&Q=4M)CF
ME7=:9)>OMLHLVSHVO6S0)K7L\7$I9<^1+ZQ3R_ZT2BN3+-+*);/T,LETE(]X
M/S[/-GB5,9^A_M'YP%YZX*VMP"J68VF3'A8V6V)!\U0T-SL+]4T^8DU3J+RR
M,5:KK"%%I[@^6Z^@ODB55U=IE%W;9))9N] \K6:594KUYC%)U0>L$ZK/VL17
M/V,35_TYSQ]:)51+YHG5DADQ'>5=UL/399JUL%/4/TC_N7.A9@VFBV5I;]-"
M2YL9&MLGH;9]EE#5YBF6MP7)BA=$*0I:$[7S6C-TL^?GZV>TE!NF-=<;)S>W
MFR8V=5O$-6VRBFG<-R:Z<6AL9.,=\NG8J,8_+*,;)7-B&M,HF8SR&N_'IYB#
M<\S_<>KOIP?O7PJL)>V+Z;LZ1=1V&J-JR7B4+W% R9)Y0N$2?UE>9[@\>W&\
M,F-QFG;:HER]Y(6E!@D+:PWC.A881W<L,XMLWV 1WK[',K3]E%5(^RVKX/9/
MK$+:?K<(;9/,0A=()F$+).-17BAA/; -#K6Q+7+ZO9,>>&,WT$U:214I76F
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M2*;3F2572 :L(7W6D$XF).U24H]_M-KPE]92-HH>_*[5AU^56_&3<A=^4![
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MZ=G-_)P!/4-S_PQS\<S/Y.]A5C#OK<QY.>/.9+PQU/4[1_V+FCTP8Z\"QC<
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M4"N?.A74::!&&S4Z>>5N:JREQD9J#/":>WC-0ZRJD_B<N?B4KO]C5N1'5/^
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MC#+DG?0(ZI<?_\;N[:OQ['+(Z_SY)5,1]]A&GM:SP V#*7A"Y8SS*C^<,8S
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MK*'W;M"\H641:6QD6ZRG[V)Y8EB>P$H9O"M4\*RT@$?E1+A73L?<JCEPJ_*
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MJ#F5.5/OP?!G3-'42J5.'C7*\ EJV2R:&4,'HUR*=UF.MUF.-["9U]R!EW$
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MHDXR=;)P"H54*.==4,O:;Z%.!W6646,-K[L9>YF+W<(1[!3/88?L#K8I[F-
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M@O?!0?=+K@=&R^&@D\8==->8 WX:?2!,-@=(A [ +P\R^!]D\#E HSY $!W
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MWIYVI_NC65^ER[M,.[DD=W0&HB]&9ZB3DRI 3R6VU^/M5FJ^B]8P%3TST3.
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MBG7.960_SI-6_+@?QSI',3(?\B(^>848>0T[7B<Q_;]\Z0_4R1]I(W\DR-_
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MDSU$SB3JHYOZ,&8YC1.(NJQXQ@?_&T=@,<2<9=@]XD]NQY"SC=1D/7Y98>-
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MZ#!7!0[#RG/<H5S'$\IVO$-93K]0IM,[RG3^&IB4!>Y$YSF&M2.D&WM2C>?
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M?L^#:YLNR:Q_ />1&/C*@R<7;=($'WWP,06/5N!A!T[.% G<WQ=R1) OK"(
MF@@!GPC4'P.)$F&Y:10$37:%Y03P;G8Y!4MZB5[\Q;N-F<E%F/(W:_*OP%J
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M4,@A<X6U9*:PCYHK7"-3Q7?47+&6S)#7@_\26XP#!_Y=K&/L$=LR>T!:\O>
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MUYY.:MHK255[-ZGH7$)^2ZHZM:2&O,*9?QYI"O!L.L*^D5YU[Z-!V-,#D"W
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MIMO \M4\WGOJ>#-[,')9,OQY)ZL<D*D*W0..* .VNP+<?QXX]S30Q F@F:-
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M[#V>_X)3+T1KGE=@:)#!O98F@5=Z-'\?RE"83DS=61S_?B"+A XB8#[02S/
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M#Z3)(GCNPZZ"1<#>,R-,<).]7OR339%G(TAP@TU0N^2WPY;2MO:)%K%[:-.
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M,YG>V&0=#/D(O0!+J?!B P.FL(/<=UEOU94%R=<[/V$0_MQDBCEFH=%B324
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MU?S!S^S2M8-AQT8G;(#8VDR_/(4'*=#SV=;5S7/O88NLC]J^!THP-A\]HC_
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M\S5L^N^ADPK_Z4TT4.G3*YZQ\B.X$W@*Y.1N=7Z$H[U%J"$72US+':$K-JT
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MH;NUM,,B6^Q4CV%Q^ 6/,2ET@-%*]Y,$&K,=LVU)0QA"'\+0Z2CIQ^D>]R<
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MZ8VXJ#D:$!M!_U'6<':8P K8M*;_Y6Y< >=L3$U]J%$KGUH=$KVKFU350L>
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M^'T<SUB6SES5BJB'[EI^TJ]G*P3KRJMY,F /$OWL#<6*]61:K+GV17_K4;M
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M55H"4KA_2UZ_9W(SA^O@%9];,*8YA2MM[=D1HQK?T>QAL1M4TE1"<(9#2VK
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ME-ZJB'>@K(/Q4.PUF(P3E.%AP_7.:\:^;OH&KK^F>.-7_?20^GM_UL_XJ_X
MI1:2CD'WT+6B)YKEVJGF!E1I#8>;NH)H 1.3JT&^ WL3P;QS^XG$C?5I5@:.
MSW%:BP4>5VQHMXC5SI5ESMM-ZIK(PB_-"=K-N DCUVY$YMG9%2TFM6CDI&[4
M('PCEA$.GXJ:B*W;0(L7TH#$?8OLQIIYOJ\_L_<=K9XBZ;!.&TU?8]80<YOL
M/*]A7#RG1]@['O3FVKCOF\0'4TJNDF*"SHA=/"0*Y[N?^*-(_$UWTZ?@+3Q:
MQ(QMF8!F^<405@7W5,CKX5@IP[[F%B_[)Z(A0 $O@@\FX+;0D';#4@Q4%,HP
M?W3YBQD!>MY,^&BK&N*J377&<]7T5$J^AE"U##ETG?JX\:*\=URK-KG?Z:BH
MGCZAMKYJ4F-:R%955=91:O6.6A%M^ &8SJ,8M-5+*S;5QJ"&5+[FA4\@UR/M
MH81F==]T2>*P.W"A&..I76? /'5ABCSI>\45>N7<8I'>Z*!?2>=1D@[)B7B6
M^&K?KG\MKL:JT^=@")(5<J'?;7(P[VD<&NE]MOO ZP#?$J';5K:6<&QSM=%(
M",F(ED9,"N^@/:X>_^XY:XM8CZ(@ L#F$X>^MOG((TUW"<)Z'HWK2/-D#);A
M[0R5D23\_*"II%U3F9F.Q1D!0_ EZ=D"&;@XJ]P(2L\2>,W5CM$[?G]P'45\
M@QJ@R8ZW=V\+U./OG!?1M.70/-B9+?$(H4T+FH7F$RW$Y@3(FKE';KLNV.(.
M]8L@;2FG(5S4@-U"#6VGWDMW%@874^QJ/*]K;I_9*R#E;T@4#2F(<U3N"=>K
M=0/TIKC%! 98PW;^.@]9F,/8S77=,,3ZL+T@7+&5H*Z&*5O!NL-[:,?FR92@
M[9KT;J;EB=".VPWS4G&>(A2[U&GNS5:4W3!6+<685>3>N8J-PDA+MN]SVM"L
M"S[&57CO0._FT;/:R=I2(I]2*""NR[RO*7)X.DN>L[Z*!$O>XGZNLSNK"!$C
M%MO,@A%*A]-<,"GWY1\R_3LA?PUS]9@&KNJQNO7L_(E!;PTA3>%W7I@9#ZX9
MO<K2]:$MO[CRHLV@?\9/A,0BV3<'PY*$O$BU*MJ4I7E[]'/5&\RO56](Q'@J
M+S33<B-*F#2DE@V] ]]?],;.TJYN-^@CUKRAUVK,P"]0)62=$N7(EL.*WU[C
M?9D;A*C$<#N<%=)9 C*V[\B*N^/V0Q.M(=5C?\VOI8A+5TH]KA@W\J*BQQ?3
MYRG^B OU  )FEL0C^*RO],QQRG$QN[?]DF):3K2Z=\*JO+)"T^7XKYTTI&0-
M%%MJ[Y@:"['RT*(QZ<[UJI165%L[]7$^R%1219>0R?-]Y%F4S^_BX5A,L('+
M:57X(,\9TN[;9Q[ID':"J?0LA9VHM3#XR8AH]W,]"W35(Q(T../>_T/(5X?%
MM21]DP1)\ 0/$MP'UT!"<'=W=V9PEP27 1+<W5UG<'<&"&Z#:_  P8+D(WOO
M[MZ5;]\_^NFG3G=75U57_:KZS'FFQ.*T ".&1<&2*DC_Z^ '=T+%Y&<!5H1+
M&"+[3AQ:3J:^Z]7S+ (1;39'.!8S^6=U\A\H\#SI;7<F),A]2F.L9L<C  B^
M@I/&6:W$[O8D!( ^>P#<;9'W1B0"^XE!PS8O_OI9S*P\U6L%9<9B#>Y\%9BX
MXDNV=,OC^]2O>KZ-P(P&82B@72D/48\Y>##@^-5=KWC>\\+P-!:/>A 7^:S,
M<U)CS2LON92"9VX<XSB0J':9\Y3F6?HCV"RE1"7@^T>]2F]KOWIG+LT/\1*7
M8DGK5]X1;B%?$**=X_-O!LLL!M.FF"O1 FQLAL&6[X)3.X[+(HT"26C,?DY.
MOS\^K*@GVVT#X[/(M5*^^*"F)U=@4F]QWS;W:GWF,#9]FZ=V*R&\_Q<"G>+R
M4L'UP9N*\@H8)G&6WP+/6-IG[U5W>D5+.24BYCU.HTP SL'W:][E65[=F_<@
M+C39<(Q>6$,"&MIY97-OU:*VK?Z7$<7S^(<W[EK=@W$*BXY-[LI5MC''^G-N
M^GB*MO&[<G!,5#SP!X\]E[-2R7Y5@4.ID2M3L)CCREFQ%+-6:X!,JT:KVK<Q
M3H/82=6Z*VE*"30B6M[E9WBUG$-K6HU(:-];YVI>31?R9Z!5X64!$1S!J-%7
M+-SD1"P6X6-J0]*37S)DAM?[<MH^(2!S<#?U-C!]XLF(AAPN6A>F,H1R,"*G
M>5X)AXZ6, CQ&;0,IM@H)<[.Z$6L&JFJJRG4A+PRZ$Y.SJ[/,SMD!-31#(Z<
M_D)@,H3+QG&!<D=FIEXCKWY^I]1)!_ )2"M-1MS- 5[73H3(S'-P)>=*WIU@
M*^5G@;B=*E^]J[-IT;=5M$2I-HGS1!K\A7"6.W<P##:L8@3XM19#?CZ2>Z!9
M73;EM@8<H)'TGD_ZS)OO*(N3J<,1L8H6^:^^&(?@O1Q32?\,58[G*AQXKRN"
M3*[^"R%M?JN$2D=4 OR2R1N4TY)_?$G"NR_'=-]W%(6\E^2<P\Z7*N).QR5Y
M!VN?E(LI>/8\ZI7UY$XI)5U9"'3I;93F39U+9!SQC:WSOIS\)?.?2Y.C_64*
MOD:I;,-[E9^V)2;K3.H]9UJW4/J%D/(+X>A%2:&Z/#55O"3@*P^%$9BL/#OD
M%\+HBV"*,3Y-5?ASA0%&<-_0H9;]=++F+1C.5O-6+3;86/_=$\8#0TO78:'.
MG!XS=-:F)<R\]V/8(IB,3^FE>ILV'OV//UV]+.I25QKCG=Z;V''7,QW,=EGA
MN2&KMS< %(5IZJU/0IV3-@FH34%7J<[N\]]72]BJK@B@QDV>RJ <V"Y]B<8M
MG'"(H[+=9Y=!>GH[->JCA>XO!+BH@Y#M XJXJ[+^F>?D39/?0,B]=/#'QK8Z
MK+T[*)1DBEU=YOV<.-X+'4=&G,%>5[%8!TG#SBEV UB @B(*>N&S/2W^6%\Z
M+(Y^,#%:8,WHR>XEL..^GO?990>H,!?3AS]REJXJK %IQLI<,9A?(:53OKG6
M+RL6_Q?"LZB96-SSOXMI@B6S/HKUTEM7K3R*I7?#  .[IBY$$>L%U2Y.B#U_
MIU8<9/2XX-+U[ZPIBZ3EOD>H:&F3OFQ4(U=]S8C'%\,(2E'/IS$[1H)%VKG0
MEG U\U5!T!B4Z$6>TO%B_(Q#_87@Z&U!_J.29/R4 %(MDB#SDC]:S=6&K1>;
M<9=_[*/EWZUQN>%SRPDD;L>?.E"7$[%"C?<]KE8:Q6BZ76&.CY"-#SZ+DQ<\
M_,,31L6 ?.F!!9OOME0+(\6;+Z3&Z);'&32K&WQ?Q04I%!%N;?RIEGY[? >7
MS/HT:M4"TF3\Z#=:K^O4."*04TET P!UW!!+XE7\\%G%H_/D-+Z!["*H#:7Z
MVU9A,!(Q)=C8F9=82=C<OV:++%>=W\LMW6=9U.-F)$)+D"D467Y+6MEJ(!)
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M4DWF^C5/.W)4E7^>[9K5XB.11)R/++OU%,\T$O4IWX<[#&+#9Q)SG1.0[UQ
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MGN+R^TZV"].((^Z'=<A-Y"K$JR[&;ZLUL>:7J+W!CTWJ?47A5_3 Y?@W!.S
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M'_S+'MD*O'"T7A3\B#-][4$<$[';7?0H.&+#&<\/T#_5D496D^Q\=1@VJB5
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MGWVY/?0SVW%P@8L.1,L1(_1[8G_5><>N0,'G*JST"I,S!H+73"7-GOF;@8]
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MZDS6U%K=RH8+9PB0>PS ZD+G%>$5$("=PJR>.1,:]F'?]S9W%(K*C]5V.;;
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MA@X=++=FZOQJTF<GMGNP6:T2D7\AA)";A"*L/34CR:JGTFHYZ:M<5O/@!QX
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M'\_A=8 Q:0FFUOU\H?$H=@N/)D=<>0Z1:F@@899A@F!P^YXM$[O+0(W?(F/
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MZW:>W ?TT"L=#9R;_.(3'/T1KK]/A30>A3U8KA:8W'%6[GFWSP^6*/+Z:W3
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M33P<OP5S%)[_5/@*B(S(9'+I4&#NAP[)S /UM:M\2"?MS2:=$]&76Q@D\G(
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M?Q(IY2-<D6QA%3'M5WIEB<PEZ?L-Z(F?]9<#_U,DF"B2T6.D&7XJ>]7H\\*
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M$=(SF'6VANF?T98@T-(1#^;HT",!T3D2 *0"=Q+)IFTDGXTX;,%O'ASH:J@
M:_.F@Y^"%\J[;Y(##.G)2*UP%\8_PT<F[+APF!,T[)]#:\88.1O(;@+BFF.D
M,N-Z/A$>"KK;(:$)VA)?GRD%T\;WGAOAG1@Z03WL""^/=/?:)$7V[[Q2.\!Z
M".D;-I-%$G6N8Y;E)@0),HPG; 6F*8XX UMC74&UL),S 3";0S:GY!+;/HI7
M-2T$Y(J"N_QSB,PSGF&$]ROJ)B)<F7JM#&*_ :@FD?S]PYHO"TQCW'6QW+BU
MK=4F)MSYR;&R3\>O!3*M^*!3OUK:"A*) U:6@]#=E\27#>#MJ)#()"(YK9\I
M)D]8:JH;T)4%\Y-G+"3PY_(2!DL'=VN!I@*%N=(.L,7SB*)2_##>H?,<D1>N
M4;0IRL5;X*X.V8-NW' =R]Q@ZN=V>[4$B5R+)[Q;76NW\$E)L30*7_+7UOQR
MJ,-JF1E!5 1(8P4 RNGY7?P)]ST$;9+%+2YFE[?ZI[#3FB5 J+1] WW12%<<
MKAVWV_O["85K2S8V.PB^ZD302NKWC#T>+DB1U4035M+46-D:V2/.Q6;$U6%]
M--0$;K+EZ][/&.5P$(@@Q-EH<L?!B(=&2+7D[&XX?=XJ[;&A6DH'J!H-#_Z=
MI<67+RY-"#^HVEM  YZW+&W$J1=0$4P"]83'FT@'\!O:L0_':M07EX@BL7/1
M511:)(I-#*2XJ^G.U==2DN/>0$0Q1KH ]DB"6CN/9]T:2TO]TV,T0:'X9M2C
M<A\#LYC<%U0<1VKJ%6*WZG"47ORL:RGVPNB1>2VF(@\R<KV HPW591?/VS0O
M:?9U+1SF>22B\JUB(;<A7R\WX'L"&-:5V#=_>O^03"8H._PV[%F'N/6160K;
MSJ1 W$Q%[B<W>Y3>N=L@'12C'>#QWB5=^2_$S/[.5U?3J:;EZBUL+\$D#\\D
M]]5+5<(XE\_MLPV'-@ VE [4X\UB*DNK/!AR;Q4NH2\)^+MEH2K@-4NWS#EV
MT#2G,T86]"09]"SE@HTTY6HNV<4L(,K440+ZR5E?&#^7T>U+ZV"G:DKL-<;D
MLKF.&YJ&QH1A?C'(FZPISA<8N0AB?55\V*EYV8KP06]_/.UX--3MH__&3=^!
MO7 EM1'Y+X*>S:S\Q9'<U5]EY:'K&,9,1=2"J0'(9H*38KE)3[132\6F>HI:
M$M&'J8>^5YJQK/DM"3'S>3BKD"!G QI'$4<$^79U4/WLI^MWGGSAG[4;UW6E
MCX'K\,4X^PO^NJ:Z!BG6G*07&;PF82_"[G61C[LD1(U@:=S/"QW<Z9R0PO*N
MHC&_ 9%<:B&)RXN=L8L$<$0-!NGHODJ4=JM<Y)G;6].4N0+JN[&BL"%A++7,
MR"60L>(X(D&R)8]CCQ+5.($(QH7^-A&M"%4&H061^Q)FG&,QA_@4$_+>8LCC
M/=^<;??BIIH:96P/#7MH39J6R-.L0J3MP3IITA@K&_03UGE_#)JTM*=*[#N6
M[R6,QC)>I82>:%.U%Q[0E<W<V8UNO+1WBN"8<%/SPR+<Q$0B@7";AI_;(RIZ
MW.E;XY4X$\A)FX\8N=&W%$YO #N07FW##&E<(M;61GLO;FJY%Y(LJ3K3USX%
M6ZP@FO@CJN(2G)AN50"X^EH8(IF%.(]POB,!;@G0#HKX<D-,]3NY&J^'#A>?
M^<$4KDH//^F75/TB.)I 3J0$(5@IHQV'F I7W">?)I7Z'&EV)6F(DBDZ./R&
MVAM"T+^6_A*_;#C(A+E&U4-WN828U]*8NA:%.APB9TAC<Y^5WK?&KV9J]D>3
M+RD%7) _6V0O1]+C#W&#-H%O-ZV'$%\_-VJC+V@EV$";@DG@_08$F[KY[*B?
M)VG9MR+U*7K35+V';)J/:V\K#8 +RX")=[DDGQ.#:J\HYM0"P6C8?V+#GBYO
M59%2FX&XX!HE'.7:F,.-?,*%:R44W.+S\#_F"'+!NRGUH<F,.,P$E.=P5%9@
MVZ;@+K-0_$B-1F3.,)TJ@T2S]_1AL1/&GI\6[U)6D\=@-6%1D5</ :27G^\W
M_$ ;N!>6\6&"HB)C*4]M(EYG954Q!C6'3,'W0_&(T@\3!(ZBPO(XY SA(>R+
M07RU0W;(0CBT(83$L;9GUI+ :('>9N82P^.(, M5#L4R!JWTH_RL\8S?F@J@
MEH/4](@V4^CJ['?UQ,OTA<W).P2C<Y!A8NNT8 \N\,E%T2.R!M,(VSL.;L;Q
M^'DNJE/D&9-40K!K_*>!:UP0%@0=8/,;L"FUF*2I.<K-6#6"^FZVC3)/0\P?
MNQS+XE6R)\=S[!W/M@Z"MR!P;O;?D5XE'G&@(:#8B[V_)9@UY'K(3S(#VG&3
M,RI[I*4U["MTRM.)OHF3J.6*I (]-'_8>7A'"<@;T5$00CLC&7 ?N'JJ_@;<
M6FF)M3#G7XFY_@: LLCE,1!=H0@GHDR]Y"VV96A<GXC@93;S;,*SXU*Z%\D=
MML,$/!TC%6WC+-J.E[_6>+!->N(3S/J\J1S=WK1H?N-5CM._NA9-LN)VR!+%
MM :8<_*<G42XLT,13655@R;R_NQW1M0JM2?"A_V\PG*.WT8TUN\Y.W+CLV[S
MK@-BO ?N,E"8H*>WXSF;N1ZYKHE:K-0FPI5SONNF4R][ +.UOKY0J?9?\CZ[
M"?D.4<W^J$QR,ZX;CX[89(NBXOK<EZ"XRPY&!%;#LDO2JV30 E81S^-9.K(Z
MG,MN(@'A&A2W7,[I4!BX^+[:8!BMYG;(VZ(6-XDMEYG]'/DI(^CU>&.$(M?:
M:\KR[L?H>=SK]<H@?RXIB:8;;P94O=8;%XJWPFTPS)D+$XK03V7;;[ARB*[_
M2/",QP>V1%U=Q4 N'IBP7$E$ZZ%<5P@0MEHK53L/#YNBG$REMB,O;H^<,5P^
M*=M6SVT,JTN4]>&D/%@*.0$WG5T<4/I(:H$"EH,\^;.V55,KZ$-GY_&88+(W
M",\V**V#HF)(CLHD%DRNC6IQCOYQ)<;14VH2G-C;9"3K:SRFTW,#R<3IB5$U
M:C_\_:NCG5BAQ'D]86YF"15ZF:LV,C2?C&ZM*U-IOU6[9TS[9&JZ0]T:F7?,
MG8)M3$2(-N")1=0]4')R=:EA0'WEZLPCWN:=RJ /X^Z<J?KB3%Q[?0R,<)?9
MYF_GI.V!#:SXW@U]>\UV]1-/N9C";4',D+PEWBH('7#")4B>[I?V)&S'FO=C
MT1K<X?#X-0;)+_51\P7*IKE_;+S\\U&47.U"51:OX!V^,#?"TUQGHFP;O8=V
MF(9^#.Y4106Q+RL[5KKQ,@^<HJSOYYA ^_XVYWG:<KH\_%AL11)=RT];(\:&
M??BV/\2+WTX2>,O\)NR]K1!/$V4%MAXQX^]!A@Q[6I3,T=C"M!T;-%Q+W?'A
M1C1L\1-_ Z";PHZA[IB$B:7PW"H"XZ\)ZBWW?^B6Z9@Z91TDK@N^X4!?=?9D
MH2',Z6R^A^;54'+/89Q:C@@OA,JY&9^T@G4F5>!GK20=4/7CM2>0Q$BL%U4:
MZFK\"'D0=>J@/+]['NYR&P2NU@TC(5,T(6K $?9=S-#*+ )?ZYKQ+;R)'/(<
MJ+CG?IX"^?Q+<>&+IOW[5,_5:/'$XCI$-5R"*=S2B\C (G-; "/FT"1>N >S
MAS@*>_B96 [-9C1N29W2]>QZKM?3>VZSSP)_!0/0E88Z5J@9LCB<SI%#P[8H
M;T=#GY)59"Q8(B1E#Z"'X$'#-@_+G<)LK\+#.(N%!?LDH^0H:?L;8SSA\NY9
MG&&X4UC*RT-YX[0.]];U=4BR[TO_$Q#I4<G]I5$',4N[X6%Q8^/ X9J8/&0!
MH@BBHX]EGO%5]&+'X64KW >E]7'U(PX@[+5Y9_^( P:N\#HC_D5PN X7Y92&
MUE[;U&R<"%-981PFLD_&XK8N5$8-\A-*'*K(0W"F=*\^HH0XQ,T5"Q'"O>D3
ME(7H-/4RB:3_YYQ'=:D@'[J%C[5\JS>:5#N%?E=;Q3V$"L()N>&85#AW#Y')
M2PZW.?%Z7TDMT9U 7>NB+A;3A(<T?2KTEA^MN8<"O71%AE13>=4N'*SBN<F8
M1!#<&!/I=:L>.Z$X)^W$2+PB%[<A_[N+7CK"NI7 IO*T:DZRA]SDR6'EJ2D!
M?#7N9)@*4(: $S.;QX%Z,%B8DO.'_ZU<'G80GOG[AB4%L[4K#XIU[3C./8FS
M=@$L"$MQ=D79_VH([$:I:KQTV2-Y4?*65(E=E&(392029BN_4:%YWVHB<\[I
M%2=VW([NW Q_\88D)<VR\)RP<6)G> %24 N!J:0->,/'B(W^O8<>['<2UZMF
M[\M^_I"U5YNOWFUOM'UK!/L0QE9"AT&J"8+@.&:"D % <&?:*YN0;78.XQD#
MEZF4<I-8&'AKB!4FK(B$!@D5,DLA9506^/]5V/\.*PT<Z!&]^!6-T+"]][B@
MO:<]"WUU\)IXFL(0R6>KEM)RT2!YT6CF9U['R575"]A8S]+ F'(ZLD9S#'VA
MDGURQ5^HXI#90,Y_"JWKQ1BUS>Z#][]JI88M)U7]*HQ6K\6T+X@PMWK33ZI^
MAJ%%&CE2!\: (.G;"Y9W9V"]W5,#Y<F_JP@DSG<3K>'H[Z"C:QFN:5*]3.KF
MBMQO[U'HD^[D>3]\N'Z]><G=&+F9.(_RH9_@;^%]_;M9]INH$7D JOA,3HMK
M_5T<B86\Q#8.%FI5,?GW""C _TW_;]V0F2_6\@?FQ0DX(_"@[QW?Q#&HX!42
M-_S0M5J/OHCI2^H>%%_'A=*3-WV%#T XGG5!$-5D-U?H:'F!TOV$KV[]JRO8
MRC["L!0G,"Q6-D?T %(WT\?)\^F;^]O4Q=[3P8-89S0SIX5%,45KNC2=:LNA
M^+GQ7ZU)!UEK!.__3HQ;5R%H?#?@97>0%!T(YG2(8[42:7=QK/-TBLC3KO-K
M71O8[MW6D#Q[X 47S5X?V345+=57V*"ME:MKT*8.0_PI_CS\7CS/&!T7A,CB
M_ZDQ9<:8A AIQAH8\:@99(T#XU)$[FEDA6!KOR<4;?%JHV.T!7Y*JSVCTB_S
M:*FN.M[H27?1W"%9K8"J*F/NW,LS9PLGD)C(46M"(V<'A'5>+7=55]K57=P@
M:U$!:^N*&_-3H&%S5P):E_<<UQ/[P*; <;R2&#A3QCYNZY(4!!6#JJJVF$6
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M3^&W)TPVYF&E^8T?"2DL956Y8E:S^5%R/'V10-KQ1!WUF/7A+3-]6 T-T"O
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M+';9+$Q>F9XPU^#9@MB_FB6D*')!LA4LW":6W)'K6JKBUU,8KN1 ]EIQ)Y1
M<:1B=*X85!''7)_1T3@Q[965V93.KT6" VUJ>$KNO%JTY*K2I:]DXL9)XCXM
M_B5?TR1-JEG4%4'H,W3NPOI?2?LQU6R&-0_US$K4JJA?OR1.5OGZ_"'MNDS2
MU6U^B\WB(;+E5Y+C-,1:C;FQ.R'_@J:@JNOEXY.77[0GR.ZSO[0+*)^<;?4S
MAR)\TGR&4%-.=$-?UK%\J/:[GIJW,^ZI/^]Q*XM]N[PT5194CI9'SADQY.SD
MF"[>COL4, [X75'%W#T?:S7<%R5>+8.]!-^X;F]^^^ATGMJ\)Q(2]V*=%&K
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M:/HLO_L<B%]XPAK!AK9*EZ_D+G?>A<9E8H SE-\%E#RA6&I8ROE\6T<>E"
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M5-NCH[U2&=WN 3@F\&=NJ?;'J6W#TT'ICO)CON_D%'WU"PM7S>#W?X,FZO[
MOFH+B=&P!\78=YNPM#G>N=V7K^E[WB5T:7CNP/J&/>NGV<&)K<2*JB:BP!I^
MP_VZ.^5E^H^4\(CWJU:7S08&LM-35DJRJ[P/>#XG>N\N7Z\S/&PG_G7X"J9V
M+A[VMNR\[&["\0*:5D =E#JW>\)7.'P,A49J*:41BABZCMQ\UHXMY)"(Q2/1
MBY@T*/-<_)'7,AW55SER.:YAEUXVLP)/L4^9UF9/!E)N!E9%]'>3-\8N?S.]
M[B-#1<-E:2WM\BP&7U(=;'NRQ,VAR!WM5+3Z3D*L9"*D5X18G_YR=1,M-YJX
M*/'!Q1PCRD9OA45!(EW+\(F)637R#Y0T<?YE.<5/<@*@DRFLNA]0MF[.R@I.
MU#03Q.1HF>(3=+^E1?5R#4]4#C\";D_OOKC:.<(-Q,+K.8#Z+1@TEKKZ=^ZF
MVNA262O;@T_CS37I0H90^QX!T90O2#[UY,2Y\N,8JIB>$^P,&2ZH$^L%5%VJ
MD/$-OG"F%<R_.-G%BTQN:JQJ;DRA1IU+\*R8')#,L1=P0WRUH^NH\@;#_J25
MQKJ$G=:_]A'@#,.5S;3F<\PF9Q612P:QV[T@A:%DN3=S.&,FQ:XH9E_.)N+.
MU8SI/]'RJB30RMPQ#:>D_E2Q>#";7EL?TR8,6?G\C:)AN,BK1']PQG,A!2WP
M)>3PM7E+9PRO[X$;;E0T%BF$&FX,EW*V< STX3.+1>O&U:(Z85SP%DP""'96
M(J<CN^;D\X+L<BXS/*F5QI<LQ_ FU.MN<.5H(QW)Z@6"_+Y"5@Y)ZA4#$&#1
MEWRV-NNO5,Z<K%\6R'0/'S93J,0:*O<L#UA:@JJYR1) ^Z!8=>48V/:4H?8)
M]3&67TW7$-;S$W;I27!:%_' !OQ;9$"325XCR=93/3DD7 G4\=]+(H>DKQ\!
MS)6"3([A3(TU2'O$40R=6?"[X[A*H>O^; 4K/:^-V8/$GXJR8SJOU;N:^OX.
M]1.,N<V!>DZI..+Q"$@&N>)/BU!7!-_/HQQF_RCY8A]P-?&@+2,D%+QMS"P!
MKD04*R6(E8]BZ03_F/M36I.>BTY)V7? TG<Q20A 7>Q\#<P/P=:#XDAVORC-
M?Y;6JQ.!/Z2%&6B*)8RY*Z=L"YF5VQ4[$TO-;!A)I\O*A9[0QDA3K? Z.&/?
MNJGS5Y^%X<!&PJ663(6$%JZ751C4F:S@T5;JYS&HV'XK7/TJ16H@AP^A\!R+
MF1P+LZEPVK(*OIYAZG%#_7ZQ%/Q&;54R+EL\\PAYRE +J\GT2$5VUO(-N<RH
M-UO.:FJE>K#BS+/H+A9 >WCB'?]$8>&[4.I8''.P235#>WW!](V45H\MVW0Q
MDT&@B#CA-)2<4!;!3UU=2@]H_*S4<]X(.T\;DQE5$"9_EH+4^V+RK887JN-)
M;%HPK)[\79@B&,V!3BC75&*1Q<CA&WI8Z:= ,F7=1,7*O(6F[C)0VK<8XD^F
MVKSE)7!W,_&&T&Q7NJH^D]V*EI<S&QO[D+/7-B]5T'4@6*/#507+.'77NI\E
M*T7'UA.Y#3AS$5W5N5"H9J01ID^*G_!0E!P[;LUU58ZSLC-;%UV\N&/-=[(W
MM,\TRZ1-T$B;+$\IGZ$Y@'WYINOXI?7@FQ5BC87==R&[1G9 ID7H^G%/52LO
M69=0(%BBP5:M0Q"F+Y1R3&ZCJS,G,GWZG+Z+38"[](^M_:-Y"#N'SXNE]Z@2
M[WXE;H=X%N.G+TU$7]>/]?U0%'U(LXOQ[&K^VGN>'EU5&DZD0P]M4HOK'AH9
MO\^+JX#C&S0S^\HA%A)$S5JROCS/.4>%/_7D6Q:T20W]<;$[U&9$_%/X$:#1
M>+ IRME\WY(F<VFQ&E<_[ FZ8L]5P240*2F_YPTI- A_N6%G(TZ0W0646:[E
M61L<RF\ R3G3U2W(87[XD$*JF5.90,@HGY+MZP[2,BW+R)8E8GH_A[6)4(MU
M'Q?.=S*R #6(0]&0/ZLD4[3+>=KMA-'/4;JH67?1QV,5LFFIT?^F3^Z'@N@]
M_+-&WLN7Q*>.ETU_IEN4BK8* ^IT @J^1O'BHJPU/$^#ISH2CZ/>-XD.#EWW
MBQH]W[;X;OZ\+/*B"OMCQOXOBZ>4HAC^"Z[==L+*2_2N'/+K_'Q6*QIRTCLM
MU$8%Q8Q*20ZM3P#,14IXIC%8BN0LZ8']CX"+N:L<7SH8>>J+6=Q:7DWQBURA
M?&N;"<6!>X5WA*/DP<N<,39'>6AC$+>6:!6*LV-*>S/(_ !=B)EA9E\E2DMO
M3KWQ>8\72)0>,Z]H#/-%KT4FX7ST OWT1'0VJQ#1?N#(-X[ [!P%.U;<;#1*
MH\8.MIJME PJ#';XX'X_6K0A"S*Y&!E72C'Z@058G$Q\DJNR"VPFLH06- "J
M))>C@8=!,DD$4] Z]!FI 7G-^=K:GEBI0EUF2-I[DSA&,20SO.Q:6@KQJKJ!
MJDK6&=8/ 89@4KQ%DJZA(1.GM2-D8Z0H)3%=<0%-S$$,F7T*/T,6F8MO=GEU
M>.LWT3H=T6^)]<?E"/PK1W#S T#V_3!?6]0#MI[J&A>:7_BFK<Y+:"*!ND0]
MRUAZRC$J%,2$4%J);&-@!9.&V3F3(DI A:/9(_V,F6)-C4A=GQXWO([7'905
M=3#0L)Y@917?V5%"T2AQT4*&)E[48\;4S=&BG?B"R:[7$:2%/G38ZYC#:<KH
MU)E;%<DQ&Y3"FK\)!(Z&4KD?H4B;-$P8!-.8?"$=(JGRXV/CI">!UX5B.QQ5
M0XIXGT9LJ>#Y%:K:3K."=?Q%^3V"5 B[E1KK\8,0?&=*E1*-%',*QY5U'95>
M:!C8RZ\(CFOG8I0'D>,>;KPK6/6:^ A-3&=[7^@S;<^=I?M %[@HE*S/HG!8
M;)TBHZ4=U8=9$#B8Q>3"%UKD;YWU^:WSV,;L(Z#%XJ:/XH'-YWNO$57'&^E)
M0^V'45?O47'7X.4QS%0!M\6R)?7A_N_L18<U>>%%71 4_C_+!ZEA7@D^Y28_
MWSGMF2O8FSWC8 OL"J@@]<4S&/FED9>#4"[_B299:FS";*\WO%,&:/8<M S_
M22.D5U4RPT%.TU192P9"LK0X6G'Q%D U;0)J>">62\3*Q8_-.9<HLD4<R_AK
M#RD=F7K<*![ZJ0&\O5NB)\E\=!.)+UX9!-YIQ>6X7A\MI,J$F)@^X^?R9"N<
M$42D'MYK>_YZ='E93F5"$N\1<.I^GT:^/XJ"O<+IR\[ B<Y\.?=)^=L8$9QU
MW)<=B%R#P<7(QJ%!LN>CB+BDUX-9[VD:&L/^TRU-3'A)AU7*;P^/ :\2TV+B
MW>1)]*!5:S>]3>Z[D3PPH;3RL'4-9-P:\E75&I'E97A319<Q[2Y.E*:]?F^7
M#2*6NG*/<42*N"L=>N_T/M%S"[(NS-?'AV34Z 6?C]T-F(L8GQ2- W@1%"O"
M)6IV.*#FY2'"T'TKDT? X%LN>96P%\TM@'VB*-'V;*S]$QW[M],!F4V)1@+-
M2JD1489X'^"BH!H.3/UO\,*1(4>NI-%HR?C/*E"\A-N?#7@X/&_+AD$J^M;D
M[CMSH?N6>M@I% &9U &J,OZHT^*K0QC[4B=4]Z [MNO;YGKT*FY'TNG<=O(P
M+OCP2OS;K^\KGZE?^VQ?'<S74=/J#8DC?3?%IXGX],W%?KS_(2^^+&7<XGKI
MM5CESU7Z.H>H2^:-#ST69N13?CUU"^D$%D"G;3Y.^-*0EX=3SW:*E0U==$2=
MAXM>Q+8<&$!65;&G(K/)9;0Z6!D@H<TS"YK4T'3J)9/#WBC,54+HNF<)1#<P
MJ1M?E#;RQI&I+!0ZDO@:L0_Z:QM(FB+BR(RH=MBX",=EZR-@!C24N?*V\_T7
MQ\]_%?&HATILAHX;VOS,OK=I/@*\@WWN,9XM7Q@XI)NYKHJ%DQH_$6"[_ICW
MPB!'M;H4HF/.BL #5G+I%DT5F)9AZ(G2G_M(8&8=0653<S^P YD1T2+:[M$:
MW]GX(MQX<9HH_0A0$9T^>=,P-NSP4,Z@UC+OL<UV:?%@]PA@-=X]798=.E+U
M]*!8""3FZYH=JW@RA'J6-_^,Q":,-=+*BUR:55%K8KHXFRF;A06@Y4= [2L^
M_B8L%&;ZL(G=:*2^J 3"LUY:@,=%MRMA[PU2 .\JB;_/4$$TW,AR/,;+2K.(
M3<FCLF>J^I@F>RW!6.7R34RPQ#KBD'J" B74:2T_A.@)/QUX9Y, \P$);MJD
M#][80[;5]'YD9.#WQ1\G27>11/>!O>XH.]]%BV63([S:+@\FW=C_:$X2'O;
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M;ZDYW*6U\>$J/)-UN5*$8-[JY^I%&=65Z!F5@#KB=Z+?D:F-$@0XTG#IE;*
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MZ*2,JMW(('-LI_+^1XL86@]Y'>Z_ &_?9Z]BU<=[^A&P2R)L(/ :,C3L+AM
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M&X\D/*R"I"\>S0F/H88Q3\O=W'(2D=[++FR[#Z.J/-[-PE2!<3FO;I>"V:#
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M1X9TS64ZH2@4Y$+-]M&^%8O7F/+?U<J$6TLXAKLQ& NEUN.NH:F* M!$ :,
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M"=<M;;?\%J+#_&3T<;HU^29@\G6 PJCQ[Q /.(Q9^[IP8.=DW[T>-1+/6%6
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M49^B^7QGI_EW9!>*2\6M-*NB&J198&WONT!F\PH\P2H3H@L#%C)2->M6P<
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M_K:9LYA8#&C%+ALHRK)2+DLFWEE2A&)DV8>1LY4G%0+$OF.J4/58B'$6U+'
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M3Z*+I:KOJ7E:A!M!=Z"(=YN2/U7NH1OCN=#XJ&U1VK<E#.;S#.Y].N =HCS
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MH!P+QF1<.%S';C,YI>0]1 69"^R*&E6Z_ZTKS%3D0\5O0!SE"WV=#[97S7-
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ME&#U%ASM;7JBHU!P^+JQ(T9E*^/U]T?ZWA5?T<7R(:(^E4293QCGFMII[Y8
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MVJM&L*JLKZ+JQ=2]]LGU!V';CU(K_X[9+-+^F=T*1)7!7NK+$#8#4@/)XWE
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M&]OH)Z?V!TI,/'%Y?T;"SJL2=+.TN9$KMI5BSJ7KJR1,:?Q.V<^%*]LBZUO
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MOZ7GCT1US(B?69OF*UXV.:>QN4_<]W_[S-##7W+;!('&.YB:W' 6SPY=S]U
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MWCNJJ;?;&HT(*J@($9 N71**4J5+AX2>A!:*2I,$ @0)2K,@O9<$I$E+2(&
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M_7+CHC,:H9BE=%%!]SHY>Q"_I:6JD8_&H3Z#\.^#,\9LRHQ,?5YFC+^#9ZF
MK'?+ZB0N$9,(DF.M4E-R _ZZ_(ZU5 6OZ#KXO>>PM^TRT"3Q6OV_ 'QT=?0$
M1C2\ITKLYK(' UJ;<<_3)]TBJ5#!%BL53[2\[B^U6G=<@OALXK<RU?,(%Z8)
M>]59TW$%%*@+^Z*](P6)FR$,Y7V8V^Z9DCI[#QO!3$P.U*X*US!N\AVV01GA
MN18=$'CKW?S5MW,ZG<[)\H!5MQB'YA45Q3B(VJ9*PQF.SQ\_L%5C8NP:=*YE
MM75;T!S1Z4?Q&NJY:FH3V3C'PF;T'3*RT*C0+LK:="N7=='#*\_>65?&2ZT
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M,[5'"/(&M^^WEHQU%^3'=))W*,QD,B%A/.3P9$LXRMGY'[/GUV>'/*QQNO&
MH_%5RO"8J-G(835XN$0]S)$3+7#:H<B>YM5RVCL![O; +MDJO-J\O6KP4L*
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M$4=963D>61G_Z#UR80FB..E\AJ40DKVS'_S8J4?A4LJ; A*N.Q_G7P)%@=I
M0 V441:!><0LH_8UE@4=2Y?!F/>V*6?\JK@A!H&MUU:S8 4X@:J%Y/G&03OI
MG0O/>]@%0RUJ)J**@EC$2:HW>5+46G;J552_] B7=&B/]1\\3'D3=XU^KW,=
MCVX$JEOG!%P4("\5QN&"J@M_W+O9$=]M ,']M1?RK=&*OW)X(!V@($)4 T@:
MD4?<%S.O/!,#VZ%'HBBTR!D2LWC^_'@XJ/RI_#;:H.W3W7?85:,T*S_^BT4@
MZE> "8$FU6;D7;][S/K:AQ?=9]0L\P$"<P@S$ ^\$E>#W:-^UD&.+>JF$1C/
MJ:)]Y@^__K+2:ZW@SDO)^"(S7*$<)_U,6"XJ$]=)<)&3P '/2,5IT+O<&UYE
M*E!<;59@=BS#SC66$B>W_!L8EKN#[7YH=P8^-O^O.J\[-$^XOK#C>+.5[PRC
M%90%[_\&!71N]??N4PU>?S_GD=W/S W%\;_&B9T'AYG@"]*OZ%7?$M?; 7U<
MB%C%"X=^= 1 $-A_6(^H%HPBYY5OH'+CBZW6#PU<'Q"Q/XZ'2A4$RNRLZ4\'
M -#[M9UDGQ1I7%.%P2H)BC$*'WZ8Z\#^727=Z<996/Z4(.1ZR]/L"*]TKYZ\
M"_>JKSU*7)XM:&]?V]Q]%!I>FMS^WRB8OLC U??\9G@BL< W;;97B$9)W5J2
M[ZX D#A341YN<<7BI!Z-)/7[:-:<>W"1/UG,C^1F\[9GZ) W(SSKT3</7*03
M!/F.PQ+O]FDRFLLD6Y0/)EH\D2\SCE>_$./Q!OOF*>]\,N!/N+(*Z6:4<-SP
MK;"_?,GW=;4!].#\E<T+S%*((PYK7(ZTQ2MHPB\65+#O7<P+"=D*9/<.E/4+
M40W23$%4Y1HX<WV!68JKMUSKN<<@Y++"K26\LN_XARTE"=J'OM ]?=QS/PV-
M/=2!,9"MU=OQO(EZY7"QINT*:H/,5BHB9Z2],LU.I:J.QD&3F^B1,P&TI%X$
M;[X.DY".4&N-8=JH?T_::-+--[W0I+:!"E#+**6*\P\:14LFG5L,&4.K;.3[
MX8UJM.2F P;[]Q+_L*=MHQ![Y2CIH@@:CV471@F9 XV%\\)&BVL];*K#5H'S
M989\OQGX2!->C6:/W^I?&L%TIIA6;9Z-2Y-10=,,&HHJ177G79/-_5C=6YAE
M4["7'2TE<1498,F=C;/$L6-"O==,$-E2HJTJ^6T52%R8$0L_]W(@?^O^R^67
M-2A"2 UH^@ U;HA&D-2^YJSC!))P)GF@579KU8TQFLCZ%DJ0*:5Y2)C4-O4A
M%=ZUJ:]7]M?YN/GV?<KWY-$KMHL]#V.M0\\[*,TDI"JWT+C@40VL+1DGTB@S
M;;B]PQ,)>4&S.IKX=,6,\B=9.ZB5P!5A0P4;BP2<0%&2/9YG4)VCEB;ZA2F:
MD1D]\9L!'1*[%!].!VWWK_TP'OX93>0>!S7;$B;U&]N*689=#"N&]13)0'.1
M),_SJ35//A5]IJ?[OR^YP9BJ6ZY="BNJN^XIK)+#PUG4Z1T$:$B+DFJ[X9_8
MC9/J\\O-NVI_Z--G :V:Q8LZ>A)KP3_WN.']A5.BD>4,HI$AL D"R,<2-E$"
M)\@8\<A -,%2\5(/8Z'D/D?R!-ZZ?'TEUMG9:[YT=%D1UB LD=-0U(\Z[_6L
M+T4S0.J>W;;WUKG]@[DZ.034E"C!!JN1WIY+*S5\$V-X2;&O6RBZCH,S7.6?
MS=O-R-VF-?%GVK1/-/6?GJAOY2"%=+:@\G8\3E\EVL-XJ?2QD-FD2-GL6\V9
MH!4YX48#JZ[>B:$:GG%6+79Q(WV,MZ5C=!D[[:#E"T/5SECP1JM\'VY;N.)-
MZ1O,D7K/7%TE6N/*E.Y$??9WV233J,=GS[F47TI5^?'7#<$K94U!U>INUA33
M9RQ+\2"'O2PK8VK8Q+#TI3J@R8HK=_EI4/Z0<8!48.^8ZH@S*E6D;$A\+X&.
MSR!X6L_KHWYX(<QW$Y!M@!XP'_,T\C:TWH]*51^M@/YME/:WY\!@=#&RDU.'
MB?.N1+B#JTI2W$.:3N7>'>Z6GSFFU>K//SA&7UK8OG$VWL8S>C)XQ &7AR;F
M=ZVK&+RZVG)B$NU*.,<#:!&R5 5PE19+,.W>"1E':T%%3-GGVH&?2JE6F>=#
M2H[J#D?VOGH2>Y.JA50_?YCY#^K*?_6"5'Z<7,R!!L:6-* ;O;N2<)Z)6]NO
MSERFO-%Z_@NG^\#8_*_?#$#LAP2P!JWR3!\K]Y#UZ/F$?+&#:.FP#N\70],F
M^,QT".H2C^'(]45ARYWEUH]LX'Z>K?*8C2$-&;[H4/13BV1LRB_T9N+"TK<C
M*7__T):3A7GG3\O^CLZ?CWI:!L+#G1]AU\W7LQ86OB8<==1'O.^;;XSX=?51
MX#T.)%?P&\MJ'].Z7><#.<D%V49">XJ6^PFJ#$_:K<Q3?(\UE#K=N<W[K"K,
MW[!50DK6W%'%D0AJ>:>]/^+^GBQBQ0XEIAK@74HS&:XO"R@)&\9[VI2Y,SZM
M&+KR/BM6Z*48=AQ "6ZT*7T/D1@3LM2\OB3OZ:AV 9(H1M42,?%R>*BQU:2H
MLGE-"0+'L8N!)47&_;YWS;S317'?*[:GQ]CY<\B4F=QM]+$E<"\J&F:4F@=T
MN1)BER4B$8)9^ZSY;Z5;J>VF4Y<9 D++>I^:)N$0--M37?I:YJ#K1#@XX/ O
M&PUZ:/5^15.K*2;LWCUUNKSE4WFS"9!:C<>*GOGW!YBFJ@"K+8F++T6&;G[*
M$ZPN01IP17P0,Y-0PDRZI[J LOLUAP$?9_,GI?B(S4_F1G^R$B #P$5LY:]M
M)&W5KA0V&YCCJQ<J,7KCBA>N5T;T3E-RH>HAFAR^$^/03G%X/7+>LC]R]_GK
M3TDCJ5=D0[*C1$6LN9]T)A_,Y,9[S4SB>#Q\] 5^*BCKR!<B ODM1$(!O6]/
MO;K6@Q R5X@9N8)<';B/C.I)2+30&YH/&7MP/PE[/#)3(<0Q;AWWYO%IO->S
M.K\\QM\,<4ES)H_DGJ$F_WJ3\"C>.M=1<GF!%'C4M+6WT\[3(=&5FMU;\?[3
M9@OI D"S6LN.9JT"O#0+*SSMQ1]*HWZ%6OG]O6R5W/04YQUP_F4D!^.YSA"*
M_^&D]T-I?'O)_&RU?V?2;EXN5"R NM;35,TKA @24T8]1XU&S3/'N'9^]RLJ
MU)V7B!.D6Z+6S^"O[):/;-[3>H4YZV.S"N#T4F0$J,\ 31^Z.]=2FGGD0&<\
MWA!B7%+7;.X=])C]9B <_N@?_M6TOK#_8B''?F%26.,7?N:KK,;Q,O'1R,E#
M#Z]'CL&[Q[?]!ZMV-U/^% ;0[>^X@I\!HQWK$;2,G,H)]T1=T"N5SF>^Q<=#
MK3:7%F*Z$%JAQMPL&<<O*,!(#@>\B@M>Q=JEU<VIBBJ(VA[U?B]9P;&PD34>
MXL#11@AZ!LADX0MB2MGU[#OLB3@AI;=5(IBB%6]9[="U:C^C[84/S^;CY1"O
M1XI[Q/%<5[VT]WOOE^V#YYO0.'5]C1Y3'Y,#OD7<V"=K.VMO\\)U_> AXQ/%
M-@(%K,N90:#H V0@AD 8]CX#,Y<9'4=2< Y8<;J'06!N4"0I">>O9:NL")DK
MA85;9@NO^'M'O &\WN]K<?-65%L5@O_4S3-"X2PBC%H:LQ&IL6''&)E^3X=#
M23P'>^XHTB"&Y\TFXG1J$'4Z+.=R34B>Z;.MB''S._OD!IS#.<PG':;'1*[W
M>W&O'$]O*Y6NAQ F*^KM2):;\$_6*%-#X'%O_3J-KR_GK*\7<SEZ(@M7]#7R
M1I6I3;2@I+!V@W#1^+RN/+AI:Q(6=4O,+=W<:E4?61NJ[_&A]^YVV+.?<W+^
M(TZD]HJ;(W(=G0HWE-XNG!T\,A)\-&RS$M"E'G^\0$K6@V%M#.3R0OH)(X*#
M#TMD+Q!CV854_4,;WJ(C$&7.UNH7M29V$G4):/74+YE7B3WME1<\@)O4D1,?
M8(1"RP "ID!D#TIE^U]AFJ]^LN)88MU[M!QFH'QT(U5#)V/'=_JC0V;8%!?[
MK?7E:\]:0A+-)A+9T\.UP7K^CB$)H[ZSWD;?^Q20UPZHW_T"%V=NZA?^9F"_
M:E!;DXUV3"F2";'N3_=WHM3(81I%<N3MK[@+V;0$C0B:J[_:OKR39\TUF3$?
M0G..BBTP<W]=("<>+5>6WD/DM?"$>IV.3&-G1E+[GYY/O%D@9\+_O(!/3<31
M""<"9><@ZXZ4%7[;&@7EEKV5HAZ$9EW-S74,NAHB![CI7+<!-&>P747!F3+N
M0JZHEO;>H'% UV(BJP<"W2'NL=T@G2;Q#Y8-&[(?7VL>NK45J:9ER"]3CTW-
M9&O)\.8ZTO@YV*7T;YG%-RM&EMI2/!J6X-'LKAR>I156;AAKM'VS^QA_ +AW
MG4:Q;M4I4:)6IO(_[.O568$)ZYQFEPKP:Z&JC'I;I:@N10JBJ1<&$!-5# P7
MP)IY*)5BZO%"R3"E&4([!>R=(V@;EUEPSWB-7)[RAF).QR(V8^,E"[LR*X(#
M"@D><]S0+$6U 6\LDN?LFMJ9\0L1IOL DZ;K2[B+M.;0F<#1FT\PEC*X8TWJ
MAXW]C2I]TP1"V26<B^PI;TU8$>S^4WK6?#&2AKLOX[W1V7+0#"V >:@%+G.1
M-Q_"7C]>Y!X@60C%(A6H>\3@=5/KEW5OKJ^IA<RP!#A"%LH<V?G+W'JS4,EE
M%[3-KUP"[A]S1UA0EP@]>(?:!R41AE?=@UOZ"RJ.K;28)'F:*BB]2&H2_/.T
M:1-.S!N61@7]79,&DH"0IC]XR/ZK\<2'>HL;.O_>W\_VQI+AO8.EK8!:6W%T
MO%]G<$JF=TR7&<$2+=54]P/VL/-!?%$CJP7C!^N:8\644UU@TAN"F0NKYG<3
M(];P[,)_ YKV8A6R#6P,:/KU[LTI6V8ALDGY: D(N5.D=U_T9U@C]3FV\I3%
MTPIY7M7]C&1U\EN6#P>#IWN:VZOP$N=!O47KSD43$M)"9"[D1'YS0%U%(!=5
MDOW7KU@9QY*I_)1'D/$^->K>T>/YIEH&-R][ID4U\^>JK@_T:.9?'[1LG++E
MB1>FTV*VB!$V)(]V"?ZQD+$/77ZP%;4<ZG)JIF94L=A%K.'V^HI\6TD',=$-
MYAVOJZA>[*>PX7?V(KXL:*0P'T8/&%QRX.,Z*USS'S2IAFLY)XO3A7^B=4/_
MH%*=>+LQJNM:*ACFQ\\AXWA7$_)\9?ZKDX/7&6'4<X14W*=;"'0L,_L&W/"P
M//Q/D'^4W'5T_LUPN:=9(SQ\:'+^U]X?; E;.HI]H37A,$/_^H,(>632\.LW
M0[YM^\^\G12S@];=+VXGF4WA0>:UFTDO!N(P^%Q$'H;H\.],3TD-631C$LJS
MD$>1VU92%7"[X8T0)WZJXD41*DG4U58$-3#E,MYK;(R$.PP/4%XU41(CN:1&
M9+D_0M,)1O8R%F+:H$9!.RM_A0W8LAG M E+ 1K/3ZH+FIZU#SRI<+Q*38\4
M]/SB4?FJ3"6]-RWGI20[PQUF3\W>U%8!1R-Z)B^478:XW.OR<O-:W<8YF$TT
M0UF%D Y?<I6P\2;"VK488J"PY5)%VH.V)$2D-'':F^]Z8U;X341_,^1@ZM^F
M'"!6B5T;H';'J&O90#2_G=^BPPN#^_JL'Q+)V>D604V (K>I1HJZX%EKU,=J
M&&5#WR7U2T*!9WCPIPO[.EI2CL8K].%:[WC&3,\9N .*M8X)M"8]=KA8#BT*
M;%K7P71Q@1'QDAEFVVO[_,ZF@0OK9ODSH9=Q^QH!/0'*?13N_7=NHX+9#7/F
MA'#R$FO,YDVT0#1<W\9]*/T:>&.T\-P=:.%>V9BOE_/=QSC-/3PP+V_T#W$-
M%03,:-5%. 6O^3J98&C5@)_^>AZ-Y?T#[TRGP;X-XZ;U+V6ZL&!C!G%=&"O/
ME=XQE%%ZGUB?$F),827AS%LHM  !I (C1U*>U[]4I8_@$9:]F]ZV;-O_/CO9
M,/F<+Y19&5@B<U\D0\Q^#)^6']ZMFYJZ8@K*TAD>KI!3MXYER+$I^\@KOYME
MQ'[T;T%8_IZCS TLWFL^#6E##5U;4RC8YO_-L&+^WN!>^.VQ?'EU\W")U+%F
MO5!:X+WXA7>_&7PPUS"7CJK_0C:8+Q6.^Z"4"Z[_^5. U+ J9O; SL?SH &B
MJ2XK9!GB8F:8,2^A 44$\&W[HC!%GP]O=EP(1:OU6*S0S_BIL%E_XN%,NAZF
M.$5485!-2BGEG=712.W$#L DP!Y3>VXOHEH&MC0C9P;;Z*]8(1D0>,9UT3_U
MNI:R@UE)CE&UEMQ4Z&S_7JM9[1G8['W-F@7N[.J&@7ZFQWO_J-<K_XN8G)^?
MJ3;ON>8?6AU^A/S-L'QXCZ;X=Y"I2?T)LF\OM/IF9N;]7AP=X5M49R8OMVE]
MV:F;G_\:#;F4 S;$J<4&@'S0#9L)7R0O=7R4594J%A@>;4JP88XLG]CP!Z@>
M=09]\O^WW>>5<W2IVQ7JV]%DV$27B&8LV/7)HW/?1@'ZK%+B**2O=@25/:];
MX<LIUJ'VL%Y=;6O$S',4.^>YP8;M^_NU):''\AGRNR[-F$_6GIX0IY\\ ^4C
MZ,GKZ,J6)QRL;:J?5H94LE-H[K\9?F9PJ5:F;&VV%%RN:=J/++K&1T;SEZFA
M;T:-[IZ+OP6AVX'@3EJ];B]#B'.7W#!CIM(EYFV2,IV>*2U;Z5N >GZCG,ZV
MD\S<E67NH^L:U *Y<NBF=QC8\,);/9_!@<;D=Z/*D+IX(P,G?:67*:<Z&Q8C
M-%DLYI"'P@'XZ0#VNG]DT)NHOP4[.F> ?RLQEC@NTJ1,-5=1LHD*ZOS$=S3D
M&&7J*\*8S3#Q87&1S<R;R B<+H3W.KR(GK&"%QNO.#BGC' RU("M'P!]&Z2L
M/AJ$JDUGLKM;@QH=[$0)WI9, <P-UE<%7VCX]DN'>%0&4E\+D^CW6!$R\=:1
MA#OPR+M^\ >OKE'AD;"J2H/WQ!OYUT2;0>J5^RV),D K#O=34YD?U(LR5I F
MH&;Y_'Y%*E7V5(I@R\)V];L?EM?"#=J;'1?B^1?&LL7LF@5M5@=@\EK<IO6D
MJ\5V]P8Q')=[<_UW6SEFT;?KW4_<7OP<ZYT?70CMO]V*6CM,^LVP)_6II+6]
M9O[ %K_D=6__%GT..J?_<S.6CL[\1J3E!6[E+HYH:>=P 0:%8%GC-?8?!/)"
MC?Q36'PYA_1%79N^73M3K6%\M2_I*TRB%]DX%1'+^3= GD[6'*!DX !@,3 ,
MS"1DN$VIP4H[>1AV.X04?"IWZ)H$03IG]P42^T^/Z%:T-'"H[<V:&PAIV/SG
MTH.%]O9&QV<ISO-?'8]V1G\S]&SMHKS^-AX(-#OX][X9C>1/@\Q8[XC]"6:<
MG2/\QAZQXUW/2_:C?(I6PW&7T7,W6TAX,OU(Z7S.Y*TN$]T:WC]L-+31\-;*
MH7E_8B)EW=R(0B-9AU&[W[W8X8EA?7D\&]I(67B4^-=LP9N],XG.1)#IF#0^
MN=XVDLK%&X^ECUYR S$%<E(EDT_2R]),-&[VIM3>Q$%*X^_\]<6).7"L@]+X
MH[#5:W+]'IN\>X5*LU(?$IN]QWAW<. 5@)AV'\0*,Q,MH+#I-<QM>N.3.TQJ
M7IX!.U3=L$C"YT=+ECX.4^_/CK@%6>+.[/0;^X2[3S$CV,A\15JK7DL:-"&.
M20 EIVJD"MA5:&)Z32%C;-=)&'+@NV8IJ^+>4#7'9P;!\0T_+<$,+JL63JE2
MI_J>L9'5HU5N6-N,YV69ZN"Y\U/R$.,.5 $)**3I"WXK/TK$0&R,\_K2O6L@
MO9JJ*^F>#CB?&%=%0J-D>1X;3"#R->Y7B-Z3"PKYJA0D U=(LS\TQ@AGZ]=_
M@%BJ[%W&T9,] S>XQJ(J\DG#'\Z9J0)43[WT+UOOVE109C/'K]F/I_G8/%BE
MV!=:8<%>LNRJ=S<E=1TXTA@V[WZ@(D*H4\KAZD6Z@F'+];;?C?Q4/P)7.HRR
MRHF=_MBS=/CXO6^?[R!_5=ECOF?H0N&//*8)CD:W"&_1-FVY186:ZI:Q(D+M
MU5V3&YI*)>ZAQJ.;X[X-IS)Y]?S&*)"RI,<!'M[XBSVV\18ABO<?1R7/_1L-
M]; S[C4;:D[E2JBR_;Q/G;T+""#:X;D-X]=5XZO@Z[3+7!IQ\DM/#]W"^%JK
M3YPGE!F^/Y93_PF,\SK7S%1Z 3[G0]DX[CX>S%X=S+\[*/]C>SWUX'#\8'ZA
MH%W^UPOZB]:9KXWEMR9G;"?#'X;L]QR?H(YW_8?GLW\SW$;?=MK^/C/ZU^9V
MY69[AT:8V\\(6L2]QH_^)H]J&FJJ#_^G]R+6HJ'S[YH_&HW;9:SH-58CE%%6
M%ZV\Q^T5G%--0\<)M;3B,R@&UR+YSI2A?ZYEA9M'?)1YN%V91U?\S=#[K"1A
MY[ C?-SY=GS!?V#,:<A7WW'U%[9Y?1Q@/_7$'\+^Z;Q,ZV:%K.:_&9:XZSO=
M.#GU;<:; ^UO:"J-@3:K$RV+;,2YN(AWK,7)DBFDU^Q&7#PY1(:N\RR(NZ+"
M-5K7FB+Q*A.5K0)7E]XCR5T"NOHMPG[J9JKBC@;4S\928I8ZZP#MD()_;RTH
MF.NU^]0SO#2Y(SS<K_F64'O[6O/NW!_L2)V>'WL;?C(PNU+P'VM/"S?/@:T7
MN1L #8[*#=+6>-UOAF/'!P[TRG(HJ S%FS\_8>S0A$'+?6I8>2\0JK_G;O7!
MQ;$HR>@BM>7!MUV] D;HY_+.M&BE'_8!3E?!*2>H)5PQ4@9FSJDC2'\D1^"Y
MNRE08U>S,7LH9&;]'=#=@%1I>VP.=+=$CDT;[VHL:S3\<\E\/KXRK-0$4R!6
M/ PL'0&(F<I:5G(Z]S?U06JO9/)W8@>#[T;<Z?;-_\O*&AW^;H/1FKNAF9[J
M8BE&8$VP-T1>3J:9):2=]Y#0@LB"NX#=$,8,8EU(LAS5U< Q(=@GJR!H=B>*
M:Q"*F,0F#'GTL0>*:L9$&6*KSWS,,^<J8C^L'T"ZF+RLM$ ?OC83.]\($HC@
M0LCO'&RI&Z])[LP=G[?/*2SV, [\4I^'&;19K7'($JAYF9+BKE?1%,^<G].3
MHWDC^![,=P.9;CF&*% T(@]1([%:F%M7JWM#5T6Y'+$#=:4R1ND7$:>%_UMC
M!7J8(A2?023Q^'OY7<F[;<J;3#[^*U%$]RS3%2=3RUFD8VR?L)DP)6LKPKG#
MVV)Y=0,ITW1E3-JX;_W1K[_(I&]&[&;RWU4#?0=N.#IP6(H3I=,.G!>LSU8O
M&<EX.I&W5"LL/P(CG\]/QQUG$HXB\C?V&IH/QR%YH:,.MN+/(IK!A#[TBP<4
MI;U8*2C>DSYJ:M(H>Z#<X*CR]6VK80LG5DJQ7V4\X.(:Z=P2[Z:OS(NE7M&"
M;?_BIM[0J2P0;",JOZE):EK-[YM+9C\O[15;DIIN@CGC/4S'C%/QMQ+G0^QX
MI/78Z[%F[H\\^\5T D4."M;:$ZOA.+7@]!RP&$=/=G-4.BN(J"NV#E//:153
MBS^^T\F?7";B7'^JAVW#X[M9$HD')-4\1>Z7-K);0OO@I$ML^KD*\;KFSVN:
MC)@:1L:*'W<^>/(_)O8&97&-ZNLG[&)K?WF@D&O.2!UTRVC<'[*&GX(\Z121
M\!;0(^-42C=6!?ZRUJ=  T"EENL6.9VM$[*GMMI"1JQEJNW/G=6[GW;L,)M,
MF4C6J&G;?WUZ:';0T$<I=[XPED?.JE.2JU&&G=2'%+J5V"R= 1$T1_T78\NC
MQH;-S"\#,_,^A3_IC[[]+-@V.>IH:Q\&S_][FR&5H[R3'=6+(B3U;XT+3*OL
MN6NY$\AW,U+?(5,60BNG.@*=J?T^R>N%K7!@V%,?<X\2,;UFX@O)A8;^B33.
M6+O"O?*Z$6V(:[^+3&>QBT;6BUR8VV"J=V>F2#MI4H.M0MYWZG-9V=C<7CZK
ME8+7(GQM&&#>A+LXKK+Q'MQ8<==MY!,6Z,ZJ+))S4=@1@@'B>3B1GUT;]REU
M_9ST2X,,@O]2DLR9CH?TY$'?)SJ'77*JD*A*%-\AR>-V^]2%GD0^%BU[BYWN
MRAKCBA0)8#55>:I+U"NS]'[G.BH#;WD0LO2*./I!0:(SEDM1%,#6$!5%D.%C
MT. QU7O7!=O*.X85%MA1;XL8>3EE3$!KP%'E.MS-PQD0;!3?VVN,5 6"ZG$9
M/2P9.4%A_0$KJ>#)3G3KYX?T,[4$EZUYPC&<@>"DY>1KZS;W2(?.!3/*4/(*
M2?JLS'ZWXL'5:"8-E0<$;+V 8NB3$)-8SA%FGBJTS''IY\T64LAS?MOH-_RL
M<-6+.5K!X8@%ASY(IXI-4-L7B#7@G1 "%J4PXU"W<>F9GY*T_+,<!2BY?^S^
M<\2UWHBN(, YL*76*]KWA\;GH9,%RT%.9BH?NDP%?GIL%+D?,9XN9F!GN,#,
M-G,:1G>8[WZ_R=;9O*R8 RE CH\@&[GO]"[2RA430Z/2M$,;QOO30N(MGHCE
MI'D9NKK+!,Q"GZ_J8]\]U(P1-A0S1G!SXTX_8;K8>DHYP5T@%XDQ5F[Q+N G
MB;.Y9G]T,B=U;NIL+'CHDQHO16:$LA\6.;Y;_>[4J)/WG<-;YOPFG\I!U<8'
ME@#KX;%I3R<=X8^?W\1Z-R%ST>"4KS9= DXVE;;D7NN;28/8[H!^@W/F,'@J
MJ$(]I5S1B$'=K*E,@3Z1BSO;;I9G1+$D@LO'D=9\._H%YA5Z]Y\#A9K>,I3]
M*8!A916NY^9<'=4X#/ \$RN&_S1;S!)"KHEX1XLA+?[4'TPBHMN0=R#/JH[
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MLZ.A@!)BQ@K>"'_3T(_N%P)@#BUR-G0VE[[NC+: 5;X )UEH50OFS#1(C$S
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M?H?>W%YZZT?\L73UKL]1N_7JMYRYGQR'C; CRUMA'P[SW'_)?!?L5SJQJ-$
M>42XQ3540V@BFM%N\5Q+NA@VS<QAO$51Z*N97M21*:V">U6I8D?[Q=5C_8:%
MI*7S?CUXX./<8'P&->/RY,T2'=%\E1L\$I#M OEJ:*C?A+A=$#F@:GK #N#_
MF@;LMGS\P4:8+Y/KI=#I4_HU099^PE9CLK*FGQ2I(A]*=2FW;0UX1PG0RHX*
ME;$U9 "99S(;&<@[>&\.*F-OK^=CP0?0?X#Z,7=30&GWV,@_^78>\8UAP6\&
MX^TOE5^#OWF/=JP+OU!^Z/>,3>#>3XG&[IJAT0^E9K\9RD)>B.E^+?T:CE?P
M>!9D$,^K\GS]ZYYD7[I!1+E$CT?+$]@$C1,+$,TP9G!K)M9_[$MEO2"X-)JC
MXMZ8E\HK:3S^:1><"3@R_MMO6A8QILW 97;Z?_+T;^/?6QXH(1?V4Q8$.FZ8
MQR1K_$JG[^(O'I9UX8)M5PPSWL2%QE]<J-3<O%:WZ4XP1ORCP<5\L7UM.6C.
MNL6T$?T.$]E#MMD\H$=!3 5236,=D.L8U@*SP!F/&(0V,&#2!EMV ?R_?"=Z
M-"-SP>6\E>G1JO Z(>D Y43S,@A>SO2LGORRH0OY"6PV '5.EXM%\O%9J;!6
MWXV'C>MR!8[^/@8?;#R?/D )$WULA G]#=Z6RW"'\HG5VB\N/?RAYX(E@-CH
MQV#PFV7;M?7/[XF/1C3^^Y^N(<I\)-FD%B/')M#3\F%\S<X6<W8[$8J_TB[\
MZ0N9XYW[S2S' !9972'1-);3[*,B<^5]_I;[3P(31ZDMZP5B%Y$?/IZO*[-7
M'B-\K-AM*B& SB&G*F'81E?*B)#).?#8N1:K\#XHJ,-]H_[SMM=@#P/8-37(
M^.Z(5W1S@IV>%5-T$FNI"OQ2/4Q"<RQNM^'O)BGGYC6%)=T9#-$! (0\.0-D
M9E1-G@2&#9$;"K"UKY\EZ^,US5HVO%D&V<3?$9@W I\L*LKS@,TD%#+8-:RO
MWE*&:)F;4$C&(4)#%DV7N#= ANK/D0M]N;[6[;P)T4G3'C+37)]E' P%270/
M,Y**$X1@B1/'Z!;?A(Y*F>6!1GZ0,@&]P+_9$-LHA$C EH E"]H6J@<FEHOI
M-C2NSWA@?< LS4Y)G0>H0&D>O&)@6 ES\+T>22L^97;U0O]I(>.9_\V'H+%.
MC[+YCS@9-$U/)-ZL.CC;,Z9AMEZE#$WTG73KJV@V+8%&++[QT^SG73>$D[R9
M(HM3/M8?.X7;H,%^,F=]C6O$#7BK8G[*6N=RCS6S([0[I6H\#%27(G%W0F*-
M)@<N'OM6/Y5S#GN8J9#_0572N(*.DPH[U#ZM6)D(VBL)NSC"(*BTDXORJ PV
M#GA!'9$8LV)=]N /\L3YCI_F.1M[[;*$Y%U5$69JNT.K'Y"GQC#UFP%BJ5*[
M9-1^T7JCGFRF,G*?\7XE$GYR>MKT3A-]4Q#-S=UL2)V.$%(8:$$ENRZ%LMHR
M2F)E-[I'UI5/XE4H_X>R]PQKJNO61E&Q ()(4VD/'1(,2HL407H)/04P%*5*
M@- #@H*"]-X"TFLJA":ABJCTIA@2D"9*D2XJ34'TZ/M^S[/W];W[.F>??^O'
MO-9<:]WW''.,N<:X1X8(Z49Z#BK#N'S@=G$29D"_9X@X?QR2 5A2?.R.SGG-
M,7T_M',<[[QQ4O7!Y)G05U*"<0*1P;3'KV./-2<;IR@E&\L-!)[E,M^K\%1S
M1).I<M$[; YL@^6[D_:6E79E(-G];JKDHE&H>!I\.NXA<]RM\#[AT&6^]==J
M5)7UFI;R9D'_GGDXCLM88M[" _W1WC\WSY^C<?W?J<ROIE-:DEGAOWT;0>TI
M(;[UK+]L03(D=+;64TE-Q@B7XEVF6<UM)SDCJ^=.*=JDVQPL+ (&20'6G@<(
M^R!PS,L.U+J#4 #OZAC7QXI0O=NTT*)"L:Q=<5>&]S1YIAWEQ0(@3B/:T,$L
M;!<KOC'D)ZRZ X*:AP\/#AJK^_/8XH.76U!PQU;Q? 4@1Q,!;O1"QAL N<XD
M'4MS>@NRYV^V\P: 6)4,*4.NFJDG6VW8PRN?PM+$,T2,M)=8NW+0YZ?6D>&N
MIAP*2S@7H)FJ8OF5"OJ$UQ"28,IJH3_^B-)WZ[K_5-F[,'00?=,D]B\M$T);
MYG!_CY./%OGY?;GK+4, 8_M0$*A!2U+EH1[PKT)>JMAH%7/34&Y'!1?"\6UV
MV0LH.?BK"?:,X3E3L>^WH?6B(&GF:/K._!'55Z4#Z1!D*6M),(GGC64ACA7<
MRC:X=3XI@%\G5ISSVJ[.=-NNW!N</;7J^';9&*C6;>%5RQ)]+6<C__[%U=(Q
M$QJ-;SM>&^,=2S.7A1I(1[#W>-IX[LV&Y:]$E-PL@[O1R'Y%@HJ]12P>_LRI
MIT_Z"YYC+[>B9LY&DN'!C[P+8HM;]A@K7>+E]NDN3;?- 4:7H,0O,S>[6T7U
M%AJ#G==^.UMU/[4\D.E3(!8S4$1&&2*'2INUTN#, ;)9JYQ52;8M,2O@*CL%
M.9&!?Y$^W)(I<#U57DP5RE=\8/S;RS!D"!A,Y[R$4ZT*2>45 2# Q<R1>F,N
M($>(O)ZS_'.7/A2\Z&1=Y;A4T)3^')$%H9DY%:=WX_@$_KIKOW&? J^4O7.F
MFBE1$,P[ NVHNJ"[J3+_'C:'.>\!]UL^><V@5)N]*_G,"R#,-*:6R1[Z6NC0
M8*8#<\]T4R *%+$=9L;Q\1F:+(145_ADN*B/6<.8FUA(RHEJ>U@9L!HS.X._
MO?0@O(S!KL\^NYH/^%SF%K;OFRR5>%_FIF/'] )+>0DKGTUM\#^#JI&])>^"
M*5^,XW!*4]YM1;A;.'M+,;I=^SI7[BF]-I-:<-PCG\8/: @K"Q(1R\K\:55Y
MY.Z,DHGU##["X5#<L86<3FST$+Z)Q^;?M[A,@EM/@_[TL@0MVPY3<2=X94Y\
MB7YC$<,F.]%^WTD)]D%G</?3W$4SGF^6#1WWFGNY]35Y+M<Z;OXSR M]:F[\
M2++&>NW "S.V"@\S*)M"\!=!@O)A*89QQ\\:>V&6[:U8=-&5Q&(FWY7=5HR7
M 78ZY*1<I*4S0;=F;H\B1;$(#1&<&*5/!7TW>TI+Y,-&4YBRTT//_ \O___V
MA6IFP/IO?!UY3E-,=!015<[U%C4TAPR^/,: 4UN,?!]2%NW 6WF%I_CTN?%'
M*!K%E5YU2M;G@IG"Y%.OQD'Q(:OA"KGHH7<&WZ03SETM2Q.4G\1+>!XIK"?W
MLZ +JBRJ55-Y4N]X\@S>-_817BM,QX7L06[A/&+TC8>2LB[;1;(YGN9^#%M/
MED[39!': ,,L&97@ \: 6,9M2.BB7Q</O@.:/_<@Z<[HE)Y)UBNY[P3MC#S9
M1RYD+.'L+NM[%]#0*67590'Q\LJG:]L<;,"%QOP4<^^V%!VOH0R%^]^OF!;(
MZ<8II@U@12%V25;S.)!><>#7$[X*__T0XU$>&QKU/.I,-Z>_P-61^NK]Q/>]
M++I*[9EV%[ @/'?70,6+=KO\6+NNV+/,3H.9YX0*G%<:@VA;J(MW,@'4]@CR
M/N-.1(FRO\'U2:=S?TGUZ_>4*KRU9%*52B(F#[)=7^(D6$T.JC_LMXF[?0=E
M@#-T%(1Q(6KE5?9S=O#GOJN'Y>1Y-C!R,WHIIV)]/KK2)[HZXY+<^,$)#D\8
MD8/ $#?A],S0*"S?99KZ#XXAOHCD227)PC"J?2Y[\!KD7MX;4Y^4@FZ#UU?'
M2W6?B'047%<7FZVDP=-#U?(;Z1!B<QS8^%%G0I<;8LNN9K%]C3R2 OE8 U]_
M4G>S1PM"5EM[?EWEI-/T+IL#N=X_S<!)[9Y'V[R\#AG+K&S=AE= K%IW^XJE
M8@F",,G%SUVIGXI7S(#6EZW>6I<YC("?0CT#1S>E&+&?+7!VYY^VZ8Q6^YO&
M(KJ.I7GY5.B2Z43JJ0=A)<9%P"+E&I&#0J*7SECWB1=VX$1PV]P6^#=!VF.)
M22\J)36Q+)Z?? ("4K4*KYZ(O>B=/=Q.\?QN]+R&XF)730K?9>6VC-O4>BL9
M5"29;J!"63=_BI6-%=3EC>;XQ72L(9.N 8I%]+>,IUA!#,^JB3F8O9F;YQCT
M 9?19(P=11V[;,>#[Q-6H9O6/#C"2^R)N<G>JH,ETA7#NSP=' 6!%LWO-;$!
M92M\!^4-C4>>!>(=3\:D![/ KC&Y$I"<PP;79Q^6[%X_A>.$#Q(T6A-V)AM6
MQRHNJ_)[7SJGEROT_"J'O)0J9+3FP$A=B7':OK;YDBO3T 5>[8)7ZD86S$W3
M%Y)@HYRJQX\'1#YGSY2RM\;<K61"(!H 9TEW.!#W3B_J_E5_PAEKM9/Q,J(H
M&/><1V7A^;6;1EL!WJ5#_$Y,&0_A)@:E5.G8BX0A\I7?K\L9;.>]YLHO8'X<
M>TVOP1N/B+QX.T&QU"A4:#Y.>VMC_5I$@Z>RI\ +[2FO9C='95$GQP)^I0O(
MI+ZL_6)SP0+GNUG=68,6G@H;7N\^/7$E.7E%C+?*\AU6V;[GF5^U4$)TQ0G>
M]9MDUQWW[#".9F*SD>0;;\V9A_5?4&@]^5V3*S?R^K(KWN0 8PU@XJ5?7FK"
M90S" 3!QCNO?CC7!:4K8BEWT%/9KQ=#PII/N1^]&G0[TM/<582Q'7Y,]$AH*
MC9EX7&@8EQTH&!Q:T(Y4YB!P: $R3-R7B%"/UR<#XCRR$8;Q-<M\P4 K(/3/
MB6.F<7>FQ6!&?/W-8+V\*]>$KP<+P&HU#X?8&X9 (G]RH"0!)WY'3&CUL8 Q
M#S+- VW>)N@+?%J^09%AU$CF9AW.VV5^?>NF]W-GVN4A$_M@BG,5@*C49GH)
MHY8]R=K?K<(I3H8/6,CFL3?%@ Q;P'20)?$"U&<ZTWOM?LBK.[<M'XN=;#>U
MZDYVT7)79$Z%)H?^M,M>?TEA[G!=/?YAEF'HX*N$RE5SL'KB\4&/TV8)1 ZC
M:9]L(>O4K7.G;D+&_Z4PZE!XF8A"A[I>\Y&L5_N2P_UJJCP:-OO3-BM.Y3OZ
M98/2NTBQ6F@X6J["$FGOF> SEO/1T.L"NZFD48K0,VGNQ!GQ*C<.M<HR>+AJ
M4[8T! TA.USC>FO"5>.5;V>DKT/>UJJJ\F86C:_^:&/=A2XE>;$BFSV#.]1N
MW4*C>!1==4R\AKMR+R"E'&''0PM-&_+O%;UAE^8(_#H1(X]<\F]RZTZ1*+T)
M[V&^,&F".V90UG?6K\_W-6[@R!C_P,@[RW+<;AYV>R>#(U([JD&3VL<0.<=O
M_F;)1FH-L<F0 :SP3A>7F./ZNU9YDI#,+,;&R\?=-7ZB\YN4/KTIG:1+90LJ
M'?!JQ!NE_[2/A2^GJPV<2V>"?>5KYGU5T4'D+],PS04E,N=Z?'$4ES18+-17
MF\9G?\WN4/W(^<%(4@;H>%%B4Y,"R]Z9PIJ[DE-TO&/N1-BOUI)-6RVJOU+Z
M>'#$[<P(.Q[?0\2-GU9"Y+'M>Z4C;$D^F N4@QS!;O[%;V3W\0JCH4C6-/8)
M]Y9'B7!)0YN3U[J6Z@U^,5%AOYB6SD_Y4'Y31J?"L@S 0[Z%S*F<N7"V#EEN
MZ>22()N^=\P38F$]ZK]T-H68E'/0Y@X,[PFV)O-./:UX+!H(5. 5[7WKG96!
M_\+>,*HBVHAC>9_Q=;+BP13I%]/7^$U>N_R/55IE=CLJ%G3R;F)ASKP6X45R
M\I91EBB-*SMR09KIF 1[09PV?# BZV:F1+T[K83-::V;>I#<_K+^XM<;HN(2
M[KF]ZD*")U(U;?[KOG/9!?.?DQ164#@@* X-2F1\ ,WD3:'7O&3/1,>D B)*
MU]D+.1  !RY4P"^FGQQC,@K=B1J/3'(6AOLQ.&YA0A!<QTYQ21I;9Z=[^1=3
M/DI6UO\!B,@Y,U:$A&4XZ2=3Q82*,DR<HAMQXLKV@BR"\@(1Z-V0GQPC?V0Z
M?*LZ/P?[[CSK;L:W-5*/@#;\K] 2^^/YY/@CTJ1[0GENN/9M88JR'3[) )(&
MQG2G72=T9STA-33&]C:S;I^::955GFY%'[_*>KQ09@ H6)K](0UH]*$Q'D%!
M5%N2N(ZGDY53Z5Y@:>@S#L-@!Q:063B5@U4OS^>XBK @^'>(:E?3]B>: 9CX
M]_%5#_GW5'']Z37=7?*+*1=%?),7K)? (9IST8G:MOU:K31V"H5_ <TNUX)H
M212?<+\S+8P.ZY1BSI;L?[(6C(9./P+ADOO#)(:PY_DQS $@*D_QI\$LV9$"
MJ!":A16 U\-;EX@DA\E[T$J"BC]KJXL)XU&X7TR$!GM_,Z6>K3LSX"=IH.L0
M6[, ]4O?SFH;J*2*QWE .+$@+ZAEM*BD"9+N!X%F=&?>90+_>+56\F)S>EVC
MO/XNTD:9^./C3##W-="I*IU@%U.BZ+)8,QQ5/F\)/YYXC"G]G-S!:G!1JV,;
M$-T;X)6]'IQF27GE(V N2G"KD51NMF>7] %C56#9O!+<"0(1=S 6[_<V=XOG
M\F9AWS3:P^\T?PR!_SSG,W=S\WL1X\:CZ>;Q>_\,HHF:I?Y039\+N]R2F1=P
M_7&#2POR3R;\,0]_MI.R.@]%HLXP^QCE>=A.Q#"XQ.>56JUGGR!K#)(DS>)@
MPKH[34(0/JA.%(_V\X78_]W,&E+F&6M!'F_R_;]S_557@[=UBK6TQRP7!8A
M++.C?MMOIE/2<?UG>Y.'&B2,,&?KA6+'UU\_78L20.44G(1 $XX!C/X_H!/
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MA7YQ9?>9+MUI";WTN@27"VRB/:Y9Y6ZK^,74^J;6F,6_?1-\JZXDDX,V+0-
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M+MEM*-/[IG-RU.6;<T\^PZ#/QRTM9.8XW>]RZQ:I\TSOYZN6BA3U?=ML"VC
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M#Z$0G4Z9HMJP(SJV-HX"%[_$5:H>918=YH"B, YKQ1;9/,5\S?S]6F_K2)V
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MG#Z-5)Y&T.BK>&FB1:LEC\L2*N23_+@ATLY;-Z;YBV4^<XZM+:QJ@0 Y9?X
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M./F M0EX0.#T^I"-FDQ>W^-NF'N)2;A&99;D^*ETVO<S=Z.B%]UP"#<Z1J$
M>:,^<RZF]IZ96;]I/?]H\UK <LUJ_UK5+3O<3JQTOMX7%=3OO85Z=]VY2"0&
M0(2Y%F3K;S%Q$R!8Y.N=[X1>.V&AW3D9?G]UJ_:)UY^:$]NTU1$?[@UW5L='
MT!5G-E,01%N^PG/&AC9NIS,D*&;VSI2HX_L(Q9_N/ N\<0>%K_QD"X!PR\L2
M6^?42:GZ4VHY.Y:\S;GUJXGO"2K?\*_E7X:>=.ONF!BZ<V?EO#*IH*\T[:,.
MY9I)Z2"?[,]?%5T8IDNL[1F"E:2D#O&:^1^$5*REFFP'8@ZD/:V:YY]7=[WB
M$A+*Q_2L?+H"9 G_B54+&8MU7?$V^^-C/69CJ=UM<'0W >Z^@(G[HZ/<N=C*
M:Z5"Q"=A4"WRX*>+50O:KE""T.F2X(1_5S)>4.D%-1C14!KBZ31KCGJ&<$U<
M#40R^.!Y\OL>5$0']X@F:^QY]/%^6BDJK+H?Z6@=65R8;T=[S%)DSK?F\_QW
M_RCPCJ$CZA:+%'NHRH7\T+N?EOU&?$5\_ ]1\AECJ IQ$T66T2REQC!TW/L\
M=K$)O2_2528\:)//1@8'16/U1:.04#("JF(YT5(Z6#-Q87/O0;IBWH!1-5?_
MJ"K59X_GE8FAJ%G+I^ @2S+-\X&31E\AJ^[#)&O3J.6%_+S*8*%\%[G"5?"?
M49$:X(B'(I&T@7Q&H_448<#CUZ FGUJ,R>IN$>^])[<>/WZC5O&%7/MU_T9$
M8[1+[S2AY$&=Y9"^#L\*KCB<7 'AKL6,;DMU#*"%W*E6;B/YMZ:&$F7[;:VS
M37MXA3W+-.QX-FB:U/BC'9&3@CBRR/+3L]V;[LY'BTU.7ZPL(<T2L9;%J>V;
M^=9\-[:JEW74!*H?A; 9:+WM6^T<6/W+S%+"HEVH][KA39ZJ\Q&RE(6W _<R
M@"S"5T3:X47')Z<+_.C8H)I8U1:Y8ZA2WY=;X0\H-A@B:0H6D DNNFM?VRV_
MT(VL?URUSFFGPDO>3>9M =Q,L%\522:(VN''*YA^G40Z]>.&]\\,7W%O?\P0
M1&C3ZIE^Z1\')=U'^BE8JR/%];?']K27;IW_SI49-?GQGZW^ORX619PK3;[F
M<YPM')P386,7NA^-)$B()$ZI(I#R?0E^&0G4&!@-[-"VDW@O6<<QDJS)#)7/
MI VE<Z]BEAS-')2X/55+$ ZJDZIZ>>M$4HPJZWL2![YR7$'U34&L4?#BF$Z^
M=67.H%6?F5'"TT+>B)$R6_?=^X^J#(N*]B)O&&<SYA=9@_4C55>5;5N3Y7A'
M392\0G/4TR$G999MAJD^J!KUI/DV[Q8T<J@"BM":5>$J__<"$OGO!;1/NI%+
M&X.(J@]*8,,;NX8^_WM!G6-L;<OW],%&WVD3EC1?P>)!ND=W=7V.1/<CYT3#
M+TKVHF*&"&52J]'.1@(#;;XZ;Z2+U83ZNX)\$-1PW8V7+YU,UU6[MR*B3!_-
M04V3BJ_-& A.)R"^[(<56LPX4^1HGT\Z1RS4OHNT_94U_BEK7<)Z+.@2F/\Q
MTF,J7LCY<*>)(26)"!ZM;-87FV?XY[U:[3O+BA9\<WL8BLDN,==C0&OC"Z<-
M8^@]KH@ VM1!C^P_+GVY]#4JO6NS/P?;#SKOK]46\00C>O$CI6\Q.34BO"$A
M+ 5#F=*Z(4RV_*\Q $UVB )FZE,Z[/&BFMAEWT:>7O-KG"#+[G?^/X4AD)#F
M2H/J_#Z>#1%.(7QV <*4R%TW\Y]H;J[2!Q-<7?'&I45U!W7?$QZT^K_K"+TO
M7KA<;O6H4^2T4,K*^0L/BOBM(<(=14GQ;WFC5^'3F3-$8!C*G'QB9VTB.OOZ
MCL? ,PW+"F6[C$[!D^<0R^G9;^KROVZ"T<V@7ZGCGYI4ONKM=TW6$ES&?DY5
M9FF_T>7=KU68;",C%[3>-6O5UC:QK>Z+F,_ !U?C7NLCU(D17M-^8 "=&JR!
M<HU_-!YOR&>QVOG58Y6>:5=-CV*"K-=?-<=(QRW^_OIJ2J8NE[(09W]'F(U?
M#^GCNT\"_!)<;2D4RG,^N71;C)<;%?D+OX::%\KE/44&Y&K&/:DTMF7_];OQ
M+83+7^*9CH**R$+R:M3/W">@I-S2S J!\CN)62H^,Y9VH@F+%(6V[ CUFYF<
MTR*\2OPFT+_SVO9GAM[W"!BC4X>C$GJLO^C$U_*1&@]U[54*Q4_#2]JR+$R?
M5 N.;,4K]*H>D4<HFN:K5=T+N+ S=GO;1_AME]:I=EP =9]28?]-<D]N#@.X
MM/::_I$LO'2F6OE!ME]"58LOR7DQVZNC@/\TT%;!SL)-TEI;(%Y-F"Q5EJ L
M8,)_D FXQ0'5Y0*UL"J)M/<-U+6;Q")3R5J*#-"%7P*,2B'40O1D178\."!Q
MS"M^!2W4I#,)/E%6]M7K?P.\HK*WBOG>!L]-M_73?7OL$98U&@I593R"B\;"
MVG8#7TB@>4+W7,V92?02@*8MEGOQKOFXTW"+57R+:2KA*?WBP!G_Y[=_< ]3
M];.0*[%SL W'$J+-;[P!JXG$$#%4"IT*F\]_/56FJ?,01"G7Y&_GB%/_G+HJ
M]V<6>I\?#_+IP\,P54R@S"IDT@TP4MZ_$<%(.U(N'-D59^G84^U\&'[C;[:U
MY'T*PY4,X\I!!J&7FA>?0^TJ>/ LN&9G$>:%+*;.'_%?M0NK*T3Y(UD[7^<:
M?S^XL97=E='R?:KJVA&6O&HFM*+$!O,Z31XIY*E>F^;!>8J'-/JJU9)K7U3-
M0NM,/UA)M>2,3FE]M>KZ;,A@:>[-$&M6IYRL5947U0_YG5,G_KVIW>R=#:%T
MC5M+_5Y<?).M==\HPZ=W6+)%W I_]K"PU:"'5, @#[WN3EF.4?F*RU/V<4K)
MCQO?(.3N:D*S/XF@\@D!ZH=IR\$[+ZTO'!?++2?MNPFCV#I^-3)Y?HG);"<%
MJLG\H9DVR)T.6] 2)H6!CC89QEW?YYS?=1/ZR]B6LU=X": ;$*-^EXN+I3.A
M +68B^)V,'4-]1G;!MM2CE<R6RE;_U"U>EQ8.7#F?C^51'Q6:T%KF%=35O??
MT.#]\H6%JLODK==&RD7Z>N Z7_5QQ4(?))-AGHA+8I%(-:.IFYDZ!:Y0ZX4W
M][UVY0F\?I6"8$458D6MC.:SG4F"F*;=9\>T-HJR&W^_Q8R'&D6- A2TN'YA
M^]\BC%X*^(=T,'6*)^$3:+#A47_7C_C%W]FE:\R[D+./!G95BB7.BZ)\>S&.
M9Q[[^RT+/,^51_4*LA!M"[*[^=XY?9[)X\I;,^5YHV*Y]_T)@ST).8_&@JD>
MD:N*+5?NXL5K!KEN:*BHW7]G$$(*XHQ#-J=JUQB$6_5#>$R^Y1SF(Z&B4A2S
M":+A 2ES175"^O+8=+ZTLVY.Z%M;M<JBKQZ0^XW?KP#<CV#Y-ZV*,@0.>M\(
M#\,2K=0*A]YHTZCP<.,[,<'<BVA>":7(0@\F]]&] ,WQB.^?=;F/@H446@,6
M/"G119ASW9(%6R'\(Z)&54E1A?X*I87*%,WFYD*KD(P?[-\9IRN,L*>!)IN1
MN6]>X%\\_;:^9L7SG-="S>YCG"E'+ 7_[NN8-J[/$K^9+[Z(MGZ6\K\"5%(_
M%%VWR',KZ^$]*K,1)_,8Y:NA$E/-_0X$52H<$#5C(>2D^E_&W?A,\2^J>>/G
M!WE%:CM&1'@*=?$B?><U!Z1[=%6F[BUQ^.K9B'!8_#>\QY1[W]I@_NN6)*<?
MJ!RC._WS>I8/JEZA-C[^)!8Q$.3(PZ\4%GJ_"G*FR1+4)97YK\3(*BWO&ORQ
M$615H"9K7OIYE;Z.PDG/54K)D2B'W >O1481X33A9FC4)"2TV&+@YJR'RB_A
MH5WVL,TW1/OJONRCOC=:,*J3^KZI^HL@]$.'2Z(.^R\+OCOXOY_E#(A4$>A_
M$W/VG1HI=_<>IEP!K%S_7U=MJ=V>%YK(5M+F/%]]XI+I_;.*/3EGQX04M:=Z
MGDY .=V^B/0M6O.H?\+!;Z.35&8V,7C[55ON:%7J5W17-"D?O\7VLLLO'D>#
ML*2A4?(O"@A5LW<()^H(O[FJQ=PN\I-X==_RNO^"IQ(^*^D?A;Z().A]YS[*
M8*OJ(?B&>E>VAM<X_Y=Z_"U(^-V$ ^4JQE>QO>[#SLHB.F+^"S;243X%MN*!
M:K4$CR=670HE4]DKSPR<#>NK\Z>IQ??S9!Y^2;"$\+O?_%A834KV#L0D\4"A
M2/ILDV]IRMW:92G-1=%.?"T2@D!B59#AS6E<99;6WDE\U7HFP8Y]_%]HMT1-
M/ZP'LY@_%&H>7D%Z#&\N\"F_$R"W1<C!>*V]-5#\O(%*7SF;WNIN1%2DOC<I
MOJ7"=P6X?YY>-$+%0^H#U95"+%3=ZX-!<6GZXO29#N]B][]%C(M?S+PWINI\
MZ+(A'H=:8(A7R2I$N$184'*KHG^;4=:?WB-*U/PM)&UR!;@:!9 0W22Z+0,X
M8<TYXVY*>A*FT2V!3J9Z_^K)ONN,$'1;^<WR1H][PD5DF%Z7#%^' @VK+N."
M65;9'!?1GBM[K<<P\0J.O<]A<X&(S8/+(@J?X7:?]!TED2QP<6,54[TT4JAZ
M9E&W:E<[-0PK]R:,!>'SW)A)W%CO-\H\?<F*&0M<_8S\K!=ZZS5PT>9&BC:9
M9#?7S;E#JQ;I<*9;E>6%7+'*FD@-O]S0/V\&LTMG)-=LR?3"GYF+0HKG77SS
M35_-3:E^//\I"@FN@G!\](A/K]"CW*WD=J\H+]G/5U'9GG;;*UX=U7,AXV#9
M#67?6:?ER]CU[7L: &;>34=XZ=NN4D(0332CM?Q<=1&4K(PSNZ-M9\HN4BTX
M,*4+%Y;E>+B(/%GCL>8*YWNJK<=^O*R@EJHQ(U561&8(1VU\&]S+/I@3FP>6
MCU-F.Y)C@M0HM#.!G^Q*QTZTQII*2UW4MFWB&YL$Y@U)%PTIJ7='^;Z/&FN(
M2B=SU0:#V(Y%M4O*I!N:8T,>BTI74SZ7F/LE(>N21#<6/H]4!X(<X+#-P*97
M94]X^5-NF(#O.URX2F//NX%<?VPU%$FMX32X7=&=I=95G:EYR8L)[#^]7FS3
MN+R7<E< D,(HS9^3M \-(+=[K/H:W*?]LTVI_*7EU:._H$@-XGU*9];$OZH9
MIW!"/9#Z(!^\LN7!!$WJ09;O.N%5KN\4)I5-9UZ)\M:)\^!9[$B;K;O$_'8/
M?BU?S6()44C@!3=[5=96*9&K0W)E5T2S]QJ76,M:+05V'9#O Z1X^MP9 KLH
MKP#JICU@FT5;?: A5]:L[TN,Q1D3^Z%.,CF+<)ISGA-UE[218L7+)-IPRW%8
MIDG306Z*3]<?RWDL+- ?W%J=X=ZX "QW#D>]409E)ST6<.&H%3O+#G5Z54A&
MAO!#HN+#D,K-5/ _[X0 -(; ?+V'Z'9#K:T]%HO)5DN(+%X%PJ/"2)7AP(;I
MG:?DK<V;3[\_>A$[M^55V;%(VZ]\*1 C)02XV <MG]H=L=CUA%)E)63*66DN
MD*DT4Y<A:4-X-9Y3XAT<#+U9-!*'@&&2)))G;VQ\&=['38(_Y">HL0)Y/">)
M1SE_<84J[H.6^L2N +D+E?-N8@SB/$TTP1BH_C9K9EF4N%!A!5V>$\MLZ'L,
MA_=[1_<G'X_%FWVZ6/FZ'UE)?_GIK0G2*?L3'2SY_8YGH,_S.-C+1"K/>J>:
M?_ZM6HXQL"&PF<I=CNDNDXJ@B9XL1@H93=,7/9J&GIY0N),K-.2PQ>E$@'\$
M:9=IC<W;PNC-_ V[Z0N.-?ZXJ%5C"\GOH1+NR '-YSF&JOX,Y/G-2OS6FL[<
M\Y*P=*DH_TI D\GMTU<":#38P.H-!XJ)OV?G&C+,)A"4M),-9E/#^,SD%J(A
MR:_J]6)U3?72]G\";P'@#G[P#-=E=M(SNJ#SK<&";O$QA=K9OBBO>Y7L_+ =
M<*=H]O)=H6C9C54T0]&,$0'>H:S7/99-'WNH:OC=E<F'DO4*4'-66*N5+&->
MD;LT5_5% >FY_)YW$<JQM!'PI^-HW)[Z"C#*,S; *3QSBBUXLY.Q<Y+.%Q=U
MX=1$/2@LUW#$\%UN:FG+1L&:^K-DIX>7Q&::3$63.9Z@JC6+RD)ESW"5^R4-
MS )/JK[I2-_1Z6-Y($H2%W_O#5$Z3:7*5FR+M&"H[TL<E!<1\L]&X,J; =*&
M$>X'(3UI3NT:0D@QE2T*[-B][-;Y:0>7QH-5<&"]Y*O#=0.G#'4>*^^'23,:
M@EM1H!$X0?HVC^4S&H<%OOR5T,XMKW+L6>M-#*GR?A?W+CMQK>_IQI"X@W*S
M: \7AY5D4ZUG;OJBE]^H/OEC>LQ7=G;WG6DY\$?'N<XRE9CRZF-9$!\'#ZIH
M^R+-Q_BZLN74^>2XY1'8[#8LSEQEN& V42O"P'Y5.SI'QKA(>]G)RP_+#D%H
MD2*0@CQ:, !@6'R9##OK <<*QU_: NL.X(<RVAPYXG$QLPPZR:1Z='E$(1(^
MQU/C6E5;'RY:F/[WT[*5&%R>Z"@J)0_A -%GT<">LE4Z\!*UMIU&>:O]N,>8
M?M=M_@Z0YCU [)#F%==Q>Z@<\/RG\J:WUM*FHYNOMKGO[:TQBI47C1P;W>WN
M"*U&Z"T$UT>B< DI=N.B@CQ*@L8#VEE&BO/84:,O2^T""/02LIMH3H+XH;S6
MA *TR]>N "#-4:4LN>1M%WM4G/H#R/&=Q?=0IXI0>!@M2H[H7^:VV'-]*/&A
MC17IK=(-((/(+-@8_8/L[0DXW,P$XY[;&309*IWGH$W![7,HEJ)_6C2]N+WK
MD]-\23%5R=3W(P ^ECXX7QK$_QQ_JMRQ8\J*FCG5FI(&"XS1_[A/(AEFE0EI
MD(C43@5[ 6VT4 JYJRQAHT@O'CFNGA$^U/"=UV):T#@]>GAUUOOLUKW;#8%A
MDO^Q/6TM<A[[&DS&U#)(/,Y>[R#-7'S@2XD2.#D^[PPPBHM:\E/X6)[E&5A
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M98;R=M\#68Z';\^6"IR:^U4<#]5K=([="6NJP9J5D)N1:,VC,YCTI<:U&ZX
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MQE^" YT*KG7.]U4Z)8YJ.&R+V2^FWS[ZB\IJT@SL1OPLL5GJXW+W/3:H](,
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MB>F_E;D>J/KGZX6H0F$6#S?T.3?,GE.6S_/5]UD88I1PC" *,@Q1$B20)(Q
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M[_^#8V!+G^=DQU)#HS\P>3D##WZ_K[8)C#&@LL9G:-\%8/H-C.FCR+A1,A=
M=10R<\E8/38Q=O)^E2+G=/Y>C_]LEB+5N[6;@D1B$J21@)%D$B)" XACR:&4
MH:2QC%B,D?5&A:W4*7-CHSG8JNZPG+5&W6*'80@L1V2Z(QA=6.T"9!TV X9
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M(:_U&.'2,\M?Z6I=Z.%E^4E]7"X>[F7Q]$ZRPTU+3)-,L43[<4%&(,)!"DF
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MUV3 1#DVAGF<:EZ!]IN$YT6S<9/V?()YE.3G=?">QSA[58L_J</RQK,P3EF
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MEJJ)U4%3@VT&V7>/IW67@^KW2.\"?<8]][L<N*/#00]#3J%7ZXN^?EE\GZ$
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MRBE$@8P@#;& 0LI8*,5I0)U(H4/6U(BA5O5J4XIO3]VF^XQCWDT7S);[!7[
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MND;=N@SN*X4=*PZ<@=G.$?((WL#$N(_;:UU!HZS'>@5VJ/BM87!&YKAU#>P
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M:AKYF!$8G5>1T^6CE"L@]"P<*@OC#,A.Z1=M8[U=WL49ZSH3+L[=V[N[UF&
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M,==.0)! BKB +*%*$!*:KG$N<[U3VM2F_4Y98+0U>TJ-OFY3OQMB.Q;P!MS
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M8F[$YF07Y>!&!OV@V_'"]4".0Q'&3O#&6/J;07#'V":0H0D; 77<"-A$C=R
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MU]0]@>>N[N"5(L]]L-MMDP4"<^B/^XZ5-T#_2Z\5.DAW3:ZUIIZ;=US_,Z2
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MT0A;K^%\<^-6:;CH]E%MALMW^![BTTJ:C(&#+V*!!"N(1#!"&85(Z642392
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M+%?T>FG?^F'CL;^K?WL? >>;_3;^;CDWG_]*?W/,4NU=.P8HRXHH01AF<5Q
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MKL]Y9_XX<C0H(VR?/NH8/W+J<-0>7^"=EWRZEL.#_+E^JTWZUTQPD264Q;#
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M8(O""UCU+P'/W3SB@N^"_?O+NTL7^\VPVGG:1VW9N]6RWO?_C_GZ>Y>"V+[
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MB",N4IIE-%)."NXVC4Z-OKH23ANCP8[5X,]Z.-:&NTJ+VG2 '9.%AG5@!@N
MJ+ODJ -$8:5';1H>5X+4 8HC*5*7>]WC@-J]N8_SBM/%?TI:?EB*]WI!.2,8
MD0P7"$HL3"F) D-28&7^23*5H@@ES#8:Z%PC4R.>UD[0& J,I4";"MY;%[OI
MA;2?6D(!-3"5>&'D%"]T"03OJ*&S#QXM=NB2:[L11!>O]8@C^B27^LHOY?RI
M+D\S*U D"Z(DC"4E>K;!"TB)U),/$7&59(I@9E]:X>#A4QO<C7G@V=CG4+[J
M)&[](_E:-(9>SC1 U*;U5YJZ#(1#B,<5@(Q?;\&$4BQJ@_]/M?/*[ 1:5,^2
MS]5<BJ!A%F= Z@V#.+QGO#"%,];NA1&<N\:#O>[?_EW2Q?H[IV47NQ\)CE4L
M$<QS6IA Q<+4AHEAELDD2S@O\LR>P(Z?/S4.NW\+MB8Z#-L3R%E0V'5X#,QB
M>U#XE(TY@8D#FUV'S>L6D"GE(RWK0]S#B#'-;?NXOEN5>MU1WQ:*XLXCU\MR
M)VX;C^C.V[S'=3V7A:A7NJN,F9 ,9:* !4USB)#^B141@H071*0XPZ1PS+D_
MW=#4"/"HA.85.I=GP;7; @H!V< <Z8G6E05&!]:A/-O8*Q80O:PL>?%ZS^/X
M<L6E%-5';> W$X5CI#^J6<K3.(N0I@>%];J.X1A2QCBD*"(R8P@7;I(<IYN9
M&CG4^=S/K:G ]%D;V.03AG0:6#MJN!ZN@8GARQY(M8FU^%#(8_5>#,(>II]N
M:MPC]%YWCP[.^Z^^LD3=@XG*GJ$DRP4A%$8R-R5:L@222"^2HI213"J<$))[
M%:6K'S^UL;\MIO9G;9]OU;D&.\M#(&]$AC[NL0;#OY#<GL_#E(YKFGB=8G%[
M[ITM#[=_E=^PK:N=-3D47;2]$#'!G'#(32UO1/6H95@#Q5!<1 7C.(^</M_'
M34QM^#8EW[K,!5J;ZC:"3\!H-XJO V?H78X:ETYI/GC6PGG?@X[H$\V,.JK/
MNWDXLGNN]-BP/$Q[NELVN4[?F@R^ZHR\WXSQ.)=%ED&51U)/WPF#C&$))2(T
MRR,49QPYJ*!>8XO56'A=Q5/AK'AZ5>=8;)P.B?4XO'.<?GRW;!..0><%N$YV
M]JI.<-BI':$S7N=\:ILM3,^,!E VR0$FDMHBH[@*M<5[)>2]^\"^SQYOL_A*
M[_=VE*]]EM^4]&[)2U/9[;UL_O=N67\7/VOGFX]B\X6<17G!2:J7F)G(E9ZG
M*CU%+=((BHQP5?!((1:[9=99MNSQ51IE NLS<;4%VVXV&Q+ <3XUG<7@36?S
M;X::&D"W=K>3X'!S7T>D@DZ(;=L>=9;L",CAU-GU]@'FTVT&6IYGB&>%GBY3
M86I&$H@CIJ"94<LX3QDM$KL,-/M&7<;3.#EHQ[)#1]_[@/,TFU2T8="<PD2X
M/R/-%\V <UQG5%]G1OMHS'13P1EMSGHB%]!SACIB@I^[9TZSSVN2_)K@L-7R
M\4&63^9T] ^Z?BEKO0C]5K2)A??J2SE?\OES$P'[4;]XMTOQH#\KDJJU+&>I
M9$E.\@C&F"*CG:L@3M,4QB1C),IS/4&-[0-8K[1F:INJ^M7,:_W7]<9$EU#/
M:_O&XFLP)N(#?RB,*T";] 3JJ(NM-V#K#KA78.-0$SIO7*I%X!Y>I8]<XG='
M[*N1/C^WFR_-0CL'Z]X3IO>T3^9DYP94NF$3**=>=!>5LDYR;D)IS+A:U6N4
M2O*NJ^=5]6*V6[[3-3#A<Z444C[5PG_L%S#2#&:1N 9J_E-?MBIU:Z;1^;*^
MY+DTLF[FP2:D^ 8\U2CKUO573VFGU]_UC776Q2_SZI@+:V1/_5&M%HLF);5;
M/^W\]6_@PT^^>!'&XJ5^P/RI>=AR^:*O>-:_6(D*_/5=+C=_[W[9>&5RD;0#
M=?1 ]_QJ<^BH\53:)?TNF*>M=M3HP!O=O0MC%7U^+E>4?_\M6.1TH->S/]3Z
MVD9&C,T.A,=^,'>HA[K-%:IR/?MJ5&SJ4O9$\9@SHB"3,H*(*0E)KDQAS#Q!
M/,$LM0MLV'OJU+[=YHAY7JWKZ>\?>CG]4K8'^OU%[WM@Z_\<>X,Q0BB#!P[6
MW''2[[Z]'GW#SCZ/_M?A'L_^$T<9\">=Z ;NZ3_Z;0SWU,?^+-<SR8N<9BR&
MDN6IGHV;@&2$,(Q(SH1B'.5%[J*XV-^<TY =2WW1;>_W IYV6[[A4!IX+#>&
MPMI2L#5U$]Z@K0VWO6N'2M!=W0M-CKJ9:^?^X1ZNY5V>A7!6*_'7?+&8(5P4
ME*;ZVRVH_@\G!:2QPA#I-X@4E#-<)$ZU;MH'3^T;WMGE6+2F@XG) J=9(2#F
MR& 5Y9!E&8.49"+10.%8Y+-F7JZ_DN5Z.+ .&QD>LAO Y.-\N31+!4;U);:[
MU4<H)CDIDBRFD,A4SQ$1E9!%,H&(8I:E,:.<\A;%#TO+4TI_#+LFQD!0+L7U
M\-E]@GP &?AC<W'PN1<W.G R;/VB[N'CEB@Z<.FH"M'AWP,<VK6YE@R))"KB
M",H"Z=$8J032(F&0Y92A7(F(Q59"1SUM3.U[<'26=,61D7T6[_78C'[$YI'-
M>P:?*\[0_C=D]1X=D UU&N:0J'OFUM<[[^I)V+UPJ6<>#O\NQ<M"WJN./A_D
MS_5;;=^_9GD1QU(5$DJ.D)[P%@QBQA7$(N.)S*,X4DY3WYZVIL9^G:EF>]AO
M9MP'K-T\)1!<0^]YG4"JS>0!QEY0&QPRJ><R+&$S?'K:&S?=Y[+C1[D_%K?X
M\<:M^*^7:MT*ZII2*TL^7TB][KY;\M63_+2J].]=2SFG,F&"$PD+$Z>)&-8+
M(<XYS)(L42PB@D=.=66',')J3+7CHXF<+CLOP5*NP9N%=M%$*!IWS9_-+WF;
M>;RI)+W:U(^F&W?_W8WM!GD=[&CRM3MY8'X]Z-^-@V8#$C0N@C>?ZF[6?YY"
ME? A.R0HLP]BZ*B?A"&A/OR6#-I6J-#_6\Y-E$3UI8F)N%V*.JYW8\).H9^9
MQ")*S5*^$+& R*2P499P2%(5Q2Q1@JG"Y6MSE363^ZRTIG?1)3LA)-ZENJ[K
M+KNOP6B=,##MGTDTV'3+EYUN:;(/MOS^R:*# F0@>  [<%Z"BT6OG*W@ =[E
M' :?AUZ[;?!>EO,?=;7WK6)0=;?<J [<JX]=>-67-KKJ(YV7_Z2+%[E=$9-<
M"8HB;,1<3=DSFD'"5 IEGJN,J3B/<^2WU1#$OJFQ\^ZB>^O@CGJ6B94#WW:#
MW#9>_M_FKJ:G<1B(WOD5%B>0L)3$KIU<D*#:VYY6>T>./]@*:%&3E;K_'CND
M(1#<V*GCS:5")=&\>=9,IO/B,3BZ>0.,HZ#Q=&IO(\SJ^_9#HJ]IQ!Y*D.6,
MU( )N@XS-6W"8/Q/C9Z@!-N;0V'-3)PLTSVDS+-LO:OJAYP0NC+]'YKPS.R-
MX[!$)84\18CGB*:%\FH'#4TL+:]_U'#/3?''-4;/R3)#&MVRZWGDS)P@>[6M
M07<#UJ>(\9\L8_4][&29H9FXDV6L;@XFR]BOG""JM\EC^WCWN)>R)WC2'!-%
M10YS_5L<8BD%+#DI("$KDBF:I:QP&AUUTLK28KS#"3J@'M*QE4L'<3T$0S,'
M^C?D3!'8K2QY2.PAV(HDLO?/1]*16[--\RY:O6LVJJJ.4]9Q>F7^<?D-VY?!
M]KB,\7=2E[?>'$^9'\/_29L?O7A:4;0V.+?U^TSS7YOJZ?[?O=SR/R]L_]3L
MDQ XPT)0"@LN,<0");!@J8")I$H5M!F_YU,BC1E<6C+]A!<8P*##Z[7]Q)EQ
MMVHJ)(\SI]QS*/2NM%QY"5IWC1J-6H6Y4O"U)G.^;Z*@_[?>O>S*S;.LVF<E
MXBN5$4YAPKBNS@21L)0E@;A,$1=XQ7*$O-3XKQ:6EDQZ #W5[P%WCM+U.8S,
MK3M_8!NOP/PU8IOG807>@96XZJS-R8&T:KUPZDD<2N[W1GLURNQO=OAQ>)7;
M2NI\(=7&-%8R+I)<\U5D.IYSLVTC*1!,A4Q21@4NB=-!1([VEA;G1[C=>S'L
MX!OQ8PR[Q7] WF;.!AUE[1LG&BMHP8*K%NYUR#,ZG(@)?%3':9N13^QP(F!X
M<(?;;;:TTE_!G_JOVXOC-_JC9)6\O7@#4$L#!!0    ( .U]I51UB>-E[WD
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MM!&@M8,R.H#5E8SRO<8X!9NR$^2"<IMJ>5&]_YP"R$"QLO2286C3A6 #XIY
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M=URFB2B,4WS H$BE0$66  O9SV"$95$Y2X%%$Q1M26@G\?^.N+A]<[29DCK
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M7D_G2!*>?WFQ6!$WVM%BL@XAUR;@RF>$P)F'5%N:9.0!4YNTY$-4C7OEHG-
M[J' #O;L^RJ#+8LII@Q!EYHJBQ8"Q6:@=0G>.Q3&-.HIO'L=;+.K"]T!< "E
M=0"]EV>O/97B9_SQZD?E)3_/\URFQQ-',7]@'DDDZ,G[]1'0&0N:>6DP,6%L
M&U/X"&'C7BKH#HQ#JK$#5-X^Y[\4W-KAN! :=U%&)CP(J1'(VR#&2C!@R.M
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MX,UQ/EI-E'?2HBP@A5.@7"(!<5,;E:5D8JP3X=J,\7F(JI%[((P<O>^FG(Z
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MD?HW/ ;:1A>=0NIZ'M/R@KZ$ IZK4-M\2(K(98+L>(RHN9#I<$T%GL QT%8
MV/H8:!MMC)TDN7Z2H1UJ8XR%J.O4G8R,>/""UE[FSDID_.;\Y3_",=!6^KK_
M&&@;X8VM]CO.+VQ.T>=@@4<607&M 7EF@(FY)$M44OQ1+WSO#( ]Q=CGWG(9
M(1O'<LY! 0NT[2JK'#AE:A\IXWW60=B;)X-_^&.@T1R7W;32$<*N2.QV*W"\
MW>7XKN#Z[*+IZ4_6 6+3[^L!%!.=O>4J\7KS().P!>WED?9WH[621?(HY<%"
MW<&YZV[_W!&+CX> XP+C#[98WLR_T\\OEC\G-KK$# :(,M8;.E(#Z8U!+E8(
M[D@2_F!'&ONST\<&T/5RV$WU8SNE0TJ W/)IQ%F=N;R>(/G7/$NO%\M/.,OO
MEQ\K8&:3J$I$J\A#)]<,E,P!O"2WSY.M<,Q1&*CC1A[O@0GO^*AOEP70O>[_
M8/O"A^7B6UX>__PPJR.GY^E"3A/C3="&XB"*=\AEC8FTETE[5LB0./T_\8.-
MOQN>O8Z/(GO9-X:!QA]LO=R<P[)N>?/Y*\[_LEBDWZ<S,B96&<6S@:BP'H0H
M<C<3:=.99+V)01YP]EP[-CN^VMG+^AD6*AVLHPNZ SV=&V0@7!T+HQS69'F"
M$AB%43E+=;,=Y%"=L;=!GWERZ-M)P'\D1_W]MW7)S/S+VXRK_''ZY>OQ^_*W
MU>FO3M#RY(+P8"S7H)Q!<"4AE.0X*Q38BU0.[J(_2/)&.+5/!J<=Z[L#\SAH
M"NNL@445R_LPFWY9/V["N#,BHX#:((T"%4%?H0V0I"PYJU2X;S/QLCUO&RT5
M]V262J>@V'Z9^--E,L]?:H>S,1?*^>YXIVS>D;W(@J%2*D(FXP"*%]HUM35@
MT,;"A>""':RB:PB&-EH2_O^6)3&H^I].9>U]@S\'+J=][#6-:FBWXFZD6?*F
M8D<'8-8BJ!(%!&\=>,]2]-I'AG^$F8.;GV5K57P(M=]'75T*F86 M4,PEZ@#
M]P)+V^+%/U;A[#;XVKUP=ANE=>!+O[Y_\O'SG[_A?RZ6+V9(>U.MWS.%V8))
M "9%84)"#LZ[""9HQ3TFR[#-@)LMB.P.D4/ Y/[YU8/JK&\X7C+V#H_.:\A8
MI+BU& 5"!T^1JY3@!?-@O1'HO D\M#D[V9+0<6'9##"; W-O[74 SA<GJ^/%
M45ZNFU!7I^KK]-MYSWT?F!9*.XB"^%&"%K5WS !)B^5DHJ3=IPD0'R"J6]#M
M#X9%&\UT ++/.7Z=+V:++S^?X^H.T9T-.#*R#HM0D#(6\F68!/3.@3 4$4IK
M$'6;_-1&Y(U;*W1(X VOK0X@^&Y1AXY^R\?YV9=E7L\=/>?$<9683)6).@[4
MB@P^B0(RFQBE+<;<+%<?"'?WTS1N7<XAP3:07CI &/G'WT[H<9\6Y?AWDO,-
MT9TQ5033UL5ZEZ.$VD:  1ES!S*Q()4KA:4V"8&-R!NWL.6@N^O@VNH @@]F
M7;./Y!L(!9H[K%E7,MB.W&&FE4[%!2]EIU.'.KB"L4]H.YA6.D+8L"4NJXFP
M*FBA)9A<.ZH+GP$U!6S":,=C\CDW[CXZ,$-]I&SV1]Q!*IRV4W\'J^#^C>IO
MJUQ.9F^G)4^*B21A;2 1:Z"2M>"4"J M$R5&%*R1O=V$NC[L[N#X'%PQ3VB&
MPMD<B3?S4O^JGPT]/^'^-[2:G; A3^.<[66"IE-!@5%)4I!2?&W&I*#(J)/E
MWL;&=UH/>[9WM4GIN6(^YN]Y?D+N$3-99^%!Z]K4/Z8,+BD/3L<LK/0EY8-U
MC;A)7!];<0-,;>!G[J6H#C;:AUAZEX_?U-Q!?EO'VEFLUEMSL)* H@*W@ P1
M!-J8I%=>^#;G>!N3V,>6.S(.=U=:GSOQV;HZ<X+7I8@[[+9W/&6 '?4QV@;:
M-6^_Y@)%5K+:SI>T*B.Y]9Z<.L=D JT2QR!%E+'-+/;[:=K7(IT]^34ML#I(
MKC[R[]/CK^>'-9])J,_IY_\Q4<B*JX,UI:^#7"T:\!(%%"S1DA=+RZG-:<:F
M%(Z[+PZ$FINVIXEZGHKI^7S:XV$0 _3Y2K^(H<W0770>P!@A]TY;"<%:!@I=
M(:_').#,*ANM+ZQ1D]MVQNCE=(5?OBSS:2WW^W+VIK5\+Z$NN @^9@4AU>:*
M.C# J"*@Q9)C3BGET(3QC<CKUPQM@9>;9FAXQ3P5&W06GU<F3W VC"VZ\<PF
M-NDANMO;IBAR22YDL)K1EF=$ A]Y M3"N.08$^&I.4H/+8&)BD9Q(Q"X281\
M+C1@40Z"4@$E*[G$-NG^AZCJUA)M@XYM+-%6:N@@&W"71U=;<:Q>?,7Y/,_6
MM7XI,J]MM:<RVCI#/("36@"96"6Y4 9UF_Y=FU W+L2&P\*MP_2!%?,$P'9>
M@^"\Y@HS\,)*K4$0%+;D!"Y$HRTJYDV;A@V;T3<NX(;'Q9; VT%)8]^(?SE=
MYGC\ 7_FLP9#%^50+@<I PG&\ A*2/(;E740.=)BY=;Z8![SK1Y\0]]8V465
MBZ'EVH%=^D0J69?)G:=9SRI63BO=DT_)B12 3'>=JL5J_UFA )/TB E+5&W2
MX ^2-6[JN]FV-YPJ>L#5*>UGRRQYYUS1$;2(M?"MNIQ&D?.9DK48HRFET>SS
MJV2,/&=Z./7>!,[.LAY[=WKS^=,9\>=-JC%HY%%#5K5_0,@,G'$"+*/@A+Z9
M,&VV*]U\\LBZWUU#BZ'$-;:N7_[VZE->?I_&O+K.A)2T)=J(H,AQ(YL9&:!'
M ;6!6V HZXVJS3R1>]XP\GS6870_B/A&Q,!J>3SYL%RDDWC\?GG&R=KRQ5KQ
M*H,'6W*==UX$!&0(3FBFC,(4S4;)*GK!E7V!_G5S3[B/@G%O1PSN3@PBZ#Z
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MDBD\96"ZU&[IO$ T(4')0NB,T6?51@'M.??WH$GN,09K)*^[0\N=:83.L*J
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M3W3+1;+Y89'?D/'_M'G\/FFEW1X\08IICQ5,E&ZZ\V:"Q;V7;TDS%!Z<0UE
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MVV_:JU_4+S&L\?_^G_\/4$L#!!0    ( .U]I50C(<?1E0<  +T>   9
M:6YF=2TR,#(R,#,S,7AE>'@S,3$Q+FAT;=U986_;.!+]?K^"Z^*Z+6#+EA,G
MC9,&V#HN:F"WW<MYK[>?#K1$V40H44M2=KR__MZ0DNW$29O<]9#F"M21Q.%P
M.//FS5 Z^^'BTVCZ^Z]CMG"Y8K_^]N[GR8BU.MWNYX-1MWLQO6 ?IK_\S ZC
M7LRFAA=6.JD+KKK=\<<6:RV<*X?=[FJUBE8'D3;S[O2R2ZH.NTIK*Z+4I:WS
M,WJ"7\'3\[^<_=#IL N=5+DH'$N,X$ZDK+*RF+//J;!7K-.II4:Z7!LY7SC6
M[_7[[+,V5W+)P[B33HGS1L]9-]R?=?TB9S.=KL_/4KED,GW;DB>]-P,1'_%L
M-D@.LY,C/GN3#9*L/S@^.3KA_?A?,8SL0CS,L6ZMQ-M6+HO.0M#ZP\-!Z4Y7
M,G6+8=SK_;7EY<[/,ETX+&8P.5P&'7N:G+AV':[DO!CZ_;3"U&8XT4J;X8N>
M_W=*(YV,YU*MAS].92XL^RA6[%+GO/BQ;1&#CA5&9D'0RC\%;()Y_G95VPL]
M2A:BL3^.^S!Z?+V0,^G801S%-RW>W34W<VS<Z7(8]Z%VQ_8$GA;FB8P?C2^G
MD_>3T4_3R:>/[-WO;/1A,G[/QO\<CWZ;3OXQ9I_>8W1\^="-/=$V)FUV*9,%
M-RF[D!-MI&ZS1!@GLS5S"^Y>OAB\.?W.]Q!';,(6?"F8$4LI5LA?MY"6_5%Q
M X"H-9Z7VCBF"_9>FYS%O<[?F,[8I,BJOZ^M$SG[H%6*E+=M/$PB[/KD>]]U
M/V+ON,5>L:M\S:X*O5(BG8MVV'R]Y51CQ4*#V:"0RX+Q8LVJPIE*P&!PG:<]
M^(*S''=&<L4RGN"183I'<CH=Y/8$"I$(:[E9DTC.KP36W=%I\2R%,5A2><[$
M&B202 ..A%B!Z; D%8:M%H @LQ7];.>OA!&U$MI +JT"F1(OKZ1;8(.V%(DW
MD/26,$VGV.82TU(V6^^ZX3G$\^ +\10LDP4\1L[?>JB-8$(<PV9G7!89,,ZI
M+N(Z454*G8C"CCO:B*"DO"CA1(H_X4*I;8!KW]I;2P-#J2^X;9*H% 0050W7
M^^6LMR?A=L$RI5>V";D1<VD=JK5CG!X&NV%E>R=RMC%FS]KG$+S#B$UO[/3E
MBS?]^/C4UN&I*97 J[-,XM;[8,*X$=[;\)Z<*4%>80(AGBEI%R1.8CD2EY*7
M[E-I$Z5MA7F4TD:KX/;2Z$2D>&S9*W@Y%0A;<.7X&OQ>S 7["=ER62E(Q >\
M$P]>B==^:CQ(PUVXE515BQ!NTL\HI790$*)"MCQXH>S&0AD6HGW>Q@8DB,4?
M57)"/R!!(X4;]H^?#  \@B<LNA*XPA/9U^/4)HY->&4?/H7(;B:V*P7ZU)6!
M J314EJ?G) 2A==#)7R;UKO48(3B/H@U?VX#T:YI@P8E4ARV6*UDZAMC6\VL
M3"4WDC8@ \M[LBI(4V6)>3WFK:=IG\KHO&$06F(_J415EDFE.#$0MN6-V#(X
M9H1ZL%O&<#43) B2P'R1/HH4OA>0S&Z#Y,&IMH>5AR?I@R$#F"UE2DC@%F<J
M8B-N@2*JU 0/](A-J  >R6=22;<FDK]K60*NCZH/6,#<#=&=2N])[[K>4%F9
M$H"QOB@EB3:I-\#7_+DH4&L4<(,141(@203]3, &@"M+\,ZS1$<2,;'DJO)Y
M1JX3688B+)?8M+VCF&Y*S -X(]S>75\]&# 1.6]#%9_IRMUOP4.8C6^D!;4H
MV==;-#9KFA^/[]H3L,?'DA9X;O%,H\95^RZG+KPNEG[DSK@^(L>)YG625(8<
MN\.I=VC-M75X3H=GZ+()%-4')?;JGBD9$(+LNR5=&XY^3_@#!)TMBFICU^M@
MU8+;30&BO/6($JDG-.^/FFS6."9<"56?)F[)M_]K%ST:14\$FL%_VDCZ\^\&
M;^UM.E%V[\9\FUD4M4=4H+U&86,:1[/@M+$;TO</H#+'"=()\07NFFEZ]8#Q
M5,(^K^05D &JL$1%^$LM2P-G\4<E8;Z';E4D_M#Q^KGVBW3BHJ(L$4;J?ZF3
M3J2 WVO"WO1M*\&OB(%#4?0<[,NY/Z0WIZ]'1;-NL<+IXXX,Y"DF6K%)P'LC
M7S<!F(+PH5:W0QFPJ &VRN%\^,1OIB:^.\^ISY;BT= 1DV<&@&_#I\+G**+B
M7UC4X6L'(I3%4JNE(#8L^+Q^[V+JM!9YJ?1:8'2UT"&7^0UP()C?I%1$C^ _
MYWO >GB&X K3@6<5+ZT8-A>GX)Q2\?50%MX_?M)IK6RFG=/YD-Y6+XFX4#[J
M=[<^@&%X^R([ZH67V<[@?]JL7 ]'?JCKTOVQ03_J'_7O'>Y%\;UC7U)[&!T?
M'G]SK0<GT=')_5-WU7:](TPCT$!O$*)#G92R)2_>M@Y:C4S)4^K2AST6>ZEF
MC?^!:&W=U^;TRVN:M?OB7HEL'Q"Z?*(DOD">^AK"?N%K-FC[KSN;-/FF_GN4
M+VY_L&GH;O!D=/?RQ2'(QO_>_FIPZXO3(_#Q;9%:TY1GL1(.HA<7K/',_TD8
MONCZ[\_<T4**C(VO15+149)]VNE;+^JN[S[X='TYN6-ONQ]"2QT^ P_#.ZVE
MV/LTND6'KT>][10^ T0JMS_E*U]3Z]_P8==_8C[_-U!+ P04    " #M?:54
MWP75[8D'  "G'@  &0   &EN9G4M,C R,C S,S%X97AX,S$R,2YH=&W=66UO
MVS@2_GZ_@NOBNBU@RZ_9M$X:H,T+:J";[F5S*/;3@9)&-A%*U)*4'>^OOV<H
M^25QTB9W/:2Y G4D<3@<SCSSS% Z_.GD\_'E'[^=BIG/M?CMGQ\^38Y%J]/M
M?AD>=[LGER?BX^6OG\0HZO7%I96%4UZ90NIN]_2\)5HS[\MQM[M8+*+%,#)V
MVKV\Z+*J45<;XRA*?=HZ.N0G^"69'OWM\*=.1YR8I,JI\"*Q)#VEHG*JF(HO
M*;DKT>DT4L>F7%HUG7DQZ T&XHNQ5VHNZW&OO*:CE9[#;GU_V V+',8F71X=
MIFHN5/JNI8;9/B7#)(YI-!R1[,G1_IML%/?VW]";7KH_^E<?1G8A7L]Q?JGI
M72M716=&O/YXM%?Z@X5*_6S<[_7^W@IR1X>9*3P6LYA<7]8Z=C1YNO8=J=6T
M&(?]M.JIJ^'$:&/'+WKAWP&/=#*9*[T<_WRI<G+BG!;BPN2R^+GM$(..(ZNR
M6M"IOP@VP;QPNVCLA1ZM"EK9W^\/8/3I]4S%RHMA/QK<M'A[U]).L7%ORG%_
M +5;MB?P--DG,O[X].)R<C8Y?G\Y^7PN/OPACC].3L_$V>3\_?GQY/TG\?D,
MHZ<7#]W8$VUCTA8?I+5+\;LGTM06"5FOLJ7P,^E?OMA[<_"#;Z ?B8F8R3D)
M2W-%"R2OGRDG_JRD!3KT$L]+8[TPA3@S-A?]7N<?PF1B4F35[TOG*1<?C4Z1
M[ZZ-ATF$7;_]T7<]B! VA[UB5_E27!5FH2F=(GYA\\V64X,5"P-:@T*I"B&+
MI:@*;RN"P2"ZP'GPA10Y[JR26F0RP2,K3([,]*:6VQ$H*"'G)' #D5Q>$=;=
MTNGP+(4Q6%('PL0:+) H"X*$6('IL"0E*Q8SE<R$J_AG,W]!EAHEO(%<.0TF
M95)>*#_#!EU)23"0]98PS:38YAS34A$OM]WP'.(Y_$H\262J@,?8^1L/M1%,
MB&/8;HVK(@/&)1=%7">Z2J$34=AR1QL15)P7)9S(\6=<:+T)<.-;=VMI8"@-
MU;;-$I6& *)JX/JPG OV)-+-1*;-PJU";FFJG$>I]D+RP]IN6-G>BIQ;&;-C
M[7,(WB@2ES=V^O+%FT%__\ UX6DHE<%KLDSA-OA@(J2EX&UX3\6:V"N"$.)8
M*S=C<1;+D;B<O'R?*I=HXRK,XY2V1M=N+ZU)*,5C)U[!RRDA;+4K3Z^3F2RF
M)-XC6RXJ#8G^4';Z>Z_H=9C:WTOKN_I6<4DMZG"S?L$IM86".BILRX,7RFXL
ME&$AWN=M;$""6?Q1):=N!A1HI/#CP?Z3 4!&\(1#2P)7!"+[=IS:S+&)K-S#
MIS#9Q;19J:9/4UDH0!K-E0O)"2DJ@AXNX9NTWJ8&2UJ&(#;\N0E$NZ$-'E1(
M<=CBC%9IZ(I=%3N5*FD5;T#5+!_(JF!-E6/F#9AW@:9#*J/MAD'HA\.D$E59
M)966S$#85C!BP^"84=>#[3*&JYA8$"2!^90^BA1^%)#$MT'RX%3;P<K#D_3!
MD ',YBIE)$B' Q6SD71 $5=JAH>TZ2I4 (^2L=+*+YGD[UJ6@1NB&@)68^Z&
MZ%:E#Z1WW6RHK&P)P+A0E)+$V#08$&K^E K4&@W<8(1*!B2+H)^IL0'@JA*\
M\RS1D42"YE)7(<_8=91E*,)JCDV[.XKINL0\@#?JV[OK:P #)B+G75W%8U/Y
M^RUX"+/)M31QBY)]NT43\:KY"?AN/ %[0BQY@><6SS1:N6K7Y=R%-\4RC-P9
MUT?D.-.\29+*LF.W./4.K;EQ'L_YY Q=+H&BYJ D7MTS)0-"D'VWI!O#T>]1
M.$#PV:*HUG:]KJV:2;<N0)RW 5&4!D(+_FC(9HECPA7IYC1Q2[[]7[OHT2AZ
M(M#L_:>-9#C_KO'6WJ039_=VS#>9Q5%[1 7::136IDDT"]Y8MR;]\  J<YP@
M/=%7N"LV*"L\GBK8%Y2\ C) %8ZI"'^Y95G!F?ZL%,P/T*V*)!PZ7C_7?I%/
M7%R4%<+(_2]WTHDB^+TA['7?MB!YQ0Q<%\7 P:&<AT/ZZO3UJ&@V+59]^K@C
M V6*B8[6"7AOY)LF %,0/M3J=ET&'&J JW(X'SX)FVF([\YSZK.E>#1TS.29
M!>#;\"F%'$54P@N+)GSMF@A5,3=Z3LR&A9PV[UULD]:4E]HL":.+F:ES6=X
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M]0NL.>U\!-V@(12?WF:*C &)RN].^<9WT^:W_H0;/B8?_1M02P,$%     @
M[7VE5)Y3'=F;!   31   !D   !I;F9U+3(P,C(P,S,Q>&5X>#,R,3$N:'1M
MW5=;;]LV%'[?KSAUL#0%;%UM)Y7= )WMH ;:I$O<=7L:*)&RB-*B2E)QW%^_
M0\I*G:3I#1VRS@^"I7/_SL=#<OQH>C99_/5Z!H59"7C]YK>7\PET>K[_-I[X
M_G0QA1>+5R^A[P4A+!0I-3=<ED3X_NRT YW"F"KQ_?5Z[:UC3ZJEOSCWK:N^
M+Z34S*.&=H[']@L^&:''OXP?]7HPE5F]8J6!3#%B&(5:\W();RG3[Z#7VVI-
M9+51?%D8B((H@K=2O>.7I)$;;@0[;OV,_>9][+L@XU32S?&8\DO@]%F'YX0%
MZ=.C* HSUL^'83H,C_KQ,!Y0FF:'C/P=8I(^JC<VVFP$>]99\;)7,!L_Z0\J
M,UIS:HHD#()?.T[O>)S+TF PA<;-W\;''4^&79D>$7Q9)JZ>3F/:BC,II$KV
M O<;64DO)RLN-LGC!5\Q#:=L#>=R1<K'78T]Z&FF>-XH:OZ!84Z8GGM=;_-%
M/X*7K,T_#"-,>G95\)0;B",OO)GQ;M5$+;%P(ZLDC-#M3NX9(LW4 R4_F9TO
MYB?SR?/%_.P4SDY@\F(^.X'9G[/)F\7\CQE^0NGL_*<K['6M=$TPKI%PP3*[
MON!I, 29@RD87!"5DI+IWMF58!MXGADKB8(@^NDJ/;BH4]U4J.& / %24CA(
MG]B"VLK#>!!T85*0"O.$86QE"[NV(3SJPIN2VVEQ87!H:)P/E#WY-A1X21&!
M)#JL'FH1[K9;?TN[X4#?#Y^^ 5]V S[S.?BZ+FJ-L"B-!$&IS'.>H3%:SLN\
MOMAHPU;P0@J*(UIW\6/F=8' E FR)HI!)E4E%7'Q#ZRW_3T<M<%H(E<5*3?N
M+1QA)"HQ:L$42S> $0S/-UT'0YT5;5BK'1Z.-+PKY5HPNF0V0V+V]P9'HY^M
MUPL$XWU-%/9";$ QA G;6<*)5"L(@][OD$OE&K#5 H8Y4WA%5%;L[X7#8!2'
MW6;WVT7VVK[%MF7/%G+(:X$!,WP3',M9<U,XN6+O:ZZ8W3+U3=I8/F$NX>"
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M"+5C*0D@=%IMC']!=9O=EVRBZLI:[6ZZ@N6W1M*G&"*K!YI24UQV;KSBW-G
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M !$              ( !     &EN9G4M,C R,C S,S$N:'1M4$L! A0#%
M  @ [7VE5!#*9\61$   1;   !$              ( !7Y@! &EN9G4M,C R
M,C S,S$N>'-D4$L! A0#%     @ [7VE5-7FURN])0  "7X! !4
M     ( !'ZD! &EN9G4M,C R,C S,S%?8V%L+GAM;%!+ 0(4 Q0    ( .U]
MI539!9OU.44  /WV @ 5              "  0_/ 0!I;F9U+3(P,C(P,S,Q
M7V1E9BYX;6Q02P$"% ,4    " #M?:54A!5+<]BS" "ZWPL %
M    @ %[% ( :6YF=2TR,#(R,#,S,5]G,2YJ<&=02P$"% ,4    " #M?:54
M.Z8VJH.]  !PM < %0              @ &%R H :6YF=2TR,#(R,#,S,5]L
M86(N>&UL4$L! A0#%     @ [7VE5'6)XV7O>0  IVP% !4
M ( !.X8+ &EN9G4M,C R,C S,S%?<')E+GAM;%!+ 0(4 Q0    ( .U]I50C
M(<?1E0<  +T>   9              "  5T # !I;F9U+3(P,C(P,S,Q>&5X
M>#,Q,3$N:'1M4$L! A0#%     @ [7VE5-\%U>V)!P  IQX  !D
M     ( !*0@, &EN9G4M,C R,C S,S%X97AX,S$R,2YH=&U02P$"% ,4
M" #M?:54GE,=V9L$  !-$   &0              @ 'I#PP :6YF=2TR,#(R
M,#,S,7AE>'@S,C$Q+FAT;5!+ 0(4 Q0    ( .U]I51&54F9D00  $ 0   9
M              "  ;L4# !I;F9U+3(P,C(P,S,Q>&5X>#,R,C$N:'1M4$L%
3!@     +  L Z (  (,9#     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
